,project_id,fiscal_year,report_title,principal_investigator,supervisor,research_org,lab_staff_within_org,extramural_collab,collab_other_NCI,collab_other_NIH,publications,url
0,BC004496-33,"October 01, 2009 -  September 30, 2010",Chromosomal Proteins and Chromosomal Functions,"Michael  Bustin; PhD



IRP Faculty Profile",NULL,"Protein Section, NCI","Tao  Deng



Takashi  Furusawa



Gabi  Gerlitz



Toshihiro  Kurahashi



Cedric  Malicet



Yuri  Postnikov; MD, PhD



Show all 8","Melinda K Duncan; PhD
(Biological Sciences, The University of Delaware)




Sergey  Grigoryev
(Biochemistry and Molecular Biology, Penn State University)




Vasily  Studitsky
(Department of Pharmacology, University of Medicine and Dentistry of New Jersey)","Gordon Lee Hager; PhD (Laboratory of Receptor Biology and Gene Expression)



Joost J Oppenheim; MD (Laboratory of Molecular Immunoregulation)



Yawen  Bai; PhD (Laboratory Of Biochemistry & Molecular Biology)","Keji  Zhao; PhD (NHLBI) 



Rafael Cristian Casellas; PhD (NIAMS)","Ordered by publication type and then author name.



1.
Gerlitz G, Hock R, Ueda T, Bustin M (2009). The dynamics of HMG protein-chromatin interactions in living cells. Biochem Cell Biol  87, 127-37.   https://doi.org/10.1139/O08-110




PubMed



        
     
Free Article


 


PubMed ID 19234529
         Pubmed Central ID 3459335 


 



2.
Kim YC, Gerlitz G, Furusawa T, Catez F, Nussenzweig A, Oh KS, Kraemer KH, Shiloh Y, Bustin M (2009). Activation of ATM depends on chromatin interactions occurring before induction of DNA damage. Nat Cell Biol  11, 92-6.   https://doi.org/10.1038/ncb1817




PubMed



        
     
Free Article


 


PubMed ID 19079244
         Pubmed Central ID 2717731 


 



3.
Kurahashi T, Furusawa T, Ueda T, Bustin M (2010). The nucleosome binding protein HMGN3 is expressed in pancreatic alpha-cells and affects plasma glucagon levels in mice. J Cell Biochem  109, 49-57.   https://doi.org/10.1002/jcb.22377




PubMed



        
     
Free Article


 


PubMed ID 19885867
         Pubmed Central ID 3402347 


 



4.
Postnikov Y, Bustin M (2010). Regulation of chromatin structure and function by HMGN proteins. Biochim Biophys Acta  1799, 62-8.   https://doi.org/10.1016/j.bbagrm.2009.11.016




PubMed



        
     
Free Article


 


PubMed ID 19948260
         Pubmed Central ID 2818575 


 



5.
Rochman M, Postnikov Y, Correll S, Malicet C, Wincovitch S, Karpova TS, McNally JG, Wu X, Bubunenko NA, Grigoryev S, Bustin M (2009). The interaction of NSBP1/HMGN5 with nucleosomes in euchromatin counteracts linker histone-mediated chromatin compaction and modulates transcription. Mol Cell  35, 642-56.   https://doi.org/10.1016/j.molcel.2009.07.002




PubMed



        
     
Free Article


 


PubMed ID 19748358
         Pubmed Central ID 2757144 


 



6.
Ueda T, Furusawa T, Kurahashi T, Tessarollo L, Bustin M (2009). The nucleosome binding protein HMGN3 modulates the transcription profile of pancreatic beta cells and affects insulin secretion. Mol Cell Biol  29, 5264-76.   https://doi.org/10.1128/MCB.00526-09




PubMed



        
     
Free Article


 


PubMed ID 19651901
         Pubmed Central ID 2747976",https://intramural.nih.gov/search/searchview.taf?ipid=62770
1,BC004504-38,"October 01, 2009 -  September 30, 2010",Interacting Signaling Pathways that Initiate Squamous Cell Carcinogenesis,"Stuart H Yuspa; MD



IRP Faculty Profile",NULL,"Laboratory of Cancer Biology and Genetics, NCI","Joanna  Anders



Christophe  Cataisson



Glenn  Merlino; PhD



Luowei  Li



Mariam Q Malik



Anjali  Shukla



Show all 11","Adam  Glick; PhD
(NCI)




David  Threadgill; PhD
(Department of Genetics, University of North Carolina School of Medicine)




Ronald  Wolf","Triantafyllos  Chavakis (Experimental Immunology Branch)



Dolph Lee Hatfield; PhD (Laboratory of Cancer Prevention)



Giorgio  Trinchieri (Cancer Inflammation Program)



Joost J Oppenheim; MD (Laboratory of Molecular Immunoregulation)",NULL,"Ordered by publication type and then author name.



1.
Cataisson C, Ohman R, Patel G, Pearson A, Tsien M, Jay S, Wright L, Hennings H, Yuspa SH (2009). Inducible cutaneous inflammation reveals a protumorigenic role for keratinocyte CXCR2 in skin carcinogenesis. Cancer Res  69, 319-28.   https://doi.org/10.1158/0008-5472.CAN-08-2490




PubMed



        
     
Free Article


 


PubMed ID 19118017
         Pubmed Central ID 2872171 


 



2.
Pérez-Lorenzo R, Markell LM, Hogan KA, Yuspa SH, Glick AB (2010). Transforming growth factor beta1 enhances tumor promotion in mouse skin carcinogenesis. Carcinogenesis  31, 1116-23.   https://doi.org/10.1093/carcin/bgq041




PubMed



        
     
Free Article


 


PubMed ID 20172950
         Pubmed Central ID 2878359 


 



3.
Virador VM, Flores-Obando RE, Berry A, Patel R, Zakhari J, Lo YC, Strain K, Anders J, Cataisson C, Hansen LA, Yuspa SH (2009). The human promyelocytic leukemia protein is a tumor suppressor for murine skin carcinogenesis. Mol Carcinog  48, 599-609.   https://doi.org/10.1002/mc.20498




PubMed



        
     
Free Article


 


PubMed ID 19058256
         Pubmed Central ID 2711034 


 



4.
Wolf R, Ruzicka T, Yuspa SH (2011). Novel S100A7 (psoriasin)/S100A15 (koebnerisin) subfamily: highly homologous but distinct in regulation and function. Amino Acids  41, 789-96.   https://doi.org/10.1007/s00726-010-0666-4




PubMed



        
     
Free Article


 


PubMed ID 20596736
         Pubmed Central ID 6410564",https://intramural.nih.gov/search/searchview.taf?ipid=62771
2,BC004517-34,"October 01, 2009 -  September 30, 2010",DNA Repair in Human Cancer-Prone Genetic Diseases,"Kenneth H Kraemer; MD



IRP Faculty Profile",NULL,"Dermatology Branch, NCI","John  Digiovanna



Sikandar  Khan



Taro  Masaki



Deborah E Schmidt



Xiao Hui  Tan; PhD



Christiane  Kuschal



Show all 7","Esther  Azzizi
(Tel Aviv Univ)




Douglas  Brash
(Neurology, Yale Univ)




Steffen  Emmert





Engin  Gozukara
(Malatya Univ)




Yuko  Hirai
(Genetics, Radiation Effects Research Foundation)




N G  Jaspers
(Genetics, Erasmus Univ)


Show all 15","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)



Michael  Bustin; PhD (Protein Section)



Mark  Raffeld; MD (Laboratory of Pathology)



Yves  Pommier; PhD (Developmental Therapeutics Branch)



Jere  Stern (Laboratory of Pathology)



Margaret Anne Tucker (Human Genetics Program)","Ira W Levin; PhD (NIDDK) 



Brian Patrick Brooks; MD, PhD (NEI) 



Carl C Baker; MD, PhD (NIAMS) 



Philip John Brooks; PhD (NIAAA) 



Nicholas  Patronas; MD (CC) 



Raphael  Schiffmann; MD (NINDS)","Ordered by publication type and then author name.



1.
Kraemer K, DiGiovanna J, Kraemer K (2010) Xeroderma pigmentosum, in Treatment of Skin Disease - comprehensive Therapeutic Strategies. Saunders, Elsevier (London) Volume third edition, pp. 78-9792.




 



2.
Christen-Zaech S, Imoto K, Khan SG, Oh KS, Tamura D, Digiovanna JJ, Boyle J, Patronas NJ, Schiffmann R, Kraemer KH, Paller AS (2009). Unexpected occurrence of xeroderma pigmentosum in an uncle and nephew. Arch Dermatol  145, 1285-91.   https://doi.org/10.1001/archdermatol.2009.279




PubMed



        
     
Free Article


 


PubMed ID 19917958
         Pubmed Central ID 3472955 


 



3.
Emmert S, Ueda T, Zumsteg U, Weber P, Khan SG, Oh KS, Boyle J, Laspe P, Zachmann K, Boeckmann L, Kuschal C, Bircher A, Kraemer KH (2009). Strict sun protection results in minimal skin changes in a patient with xeroderma pigmentosum and a novel c.2009delG mutation in XPD (ERCC2). Exp Dermatol  18, 64-8.   https://doi.org/10.1111/j.1600-0625.2008.00763.x




PubMed



        
     
Free Article


 


PubMed ID 18637129
         Pubmed Central ID 2605190 


 



4.
Khan SG, Oh KS, Emmert S, Imoto K, Tamura D, Digiovanna JJ, Shahlavi T, Armstrong N, Baker CC, Neuburg M, Zalewski C, Brewer C, Wiggs E, Schiffmann R, Kraemer KH (2009). XPC initiation codon mutation in xeroderma pigmentosum patients with and without neurological symptoms. DNA Repair (Amst)  8, 114-25.   https://doi.org/10.1016/j.dnarep.2008.09.007




PubMed



        
     
Free Article


 


PubMed ID 18955168
         Pubmed Central ID 2684809 


 



5.
Kim YC, Gerlitz G, Furusawa T, Catez F, Nussenzweig A, Oh KS, Kraemer KH, Shiloh Y, Bustin M (2009). Activation of ATM depends on chromatin interactions occurring before induction of DNA damage. Nat Cell Biol  11, 92-6.   https://doi.org/10.1038/ncb1817




PubMed



        
     
Free Article


 


PubMed ID 19079244
         Pubmed Central ID 2717731 


 



6.
Subramanian M, Gonzalez RW, Patil H, Ueda T, Lim JH, Kraemer KH, Bustin M, Bergel M (2009). The nucleosome-binding protein HMGN2 modulates global genome repair. FEBS J  276, 6646-57.   https://doi.org/10.1111/j.1742-4658.2009.07375.x




PubMed



        
     
Free Article


 


PubMed ID 19843163
         Pubmed Central ID 3460546 


 



7.
Ueda T, Compe E, Catez P, Kraemer KH, Egly JM (2009). Both XPD alleles contribute to the phenotype of compound heterozygote xeroderma pigmentosum patients. J Exp Med  206, 3031-46.   https://doi.org/10.1084/jem.20091892




PubMed



        
     
Free Article


 


PubMed ID 19934020
         Pubmed Central ID 2806454 


 



8.
Wang Y, Digiovanna JJ, Stern JB, Hornyak TJ, Raffeld M, Khan SG, Oh KS, Hollander MC, Dennis PA, Kraemer KH (2009). Evidence of ultraviolet type mutations in xeroderma pigmentosum melanomas. Proc Natl Acad Sci U S A  106, 6279-84.   https://doi.org/10.1073/pnas.0812401106




PubMed



        
     
Free Article


 


PubMed ID 19329485
         Pubmed Central ID 2669353",https://intramural.nih.gov/search/searchview.taf?ipid=62772
3,BC005093-32,"October 01, 2009 -  September 30, 2010",GrowthDifferentiation Factors in Organogenesis,Alan O Perantoni; PhD,NULL,"Cancer and Developmental Biology Laboratory, NCI","Michael David Hall



Nirmala D Sharma



Shunsuke  Tanigawa



Terence P Yamaguchi; PhD



Yili D Yang



Kangsun  Yun","Frank  Costantini; PhD
(Columbia University)




Edwin  Cuppen
(Hubrecht Institute)




Harold  Lovvorn
(Vanderbilt University)




Olga  Timofeeva
(Georgetown University)","Mark B Lewandoski (Genetics of Vertebrate Development Section)



Arthur A Hurwitz (Laboratory of Molecular Immunoregulation)



Nadya I Tarasova; PhD (Cancer Inflammation Program)",Lothar  Hennighausen; PhD (NIDDK),"Ordered by publication type and then author name.



1.
Diwan BA, Timofeeva O, Rice JM, Yang Y, Sharma N, Fortini ME, Wang H, Perantoni AO (2009). Inheritance of susceptibility to induction of nephroblastomas in the Noble rat. Differentiation  77, 424-32.   https://doi.org/10.1016/j.diff.2008.12.003




PubMed



        
     
Free Article


 


PubMed ID 19281789
         Pubmed Central ID 2696123 


 



2.
Ehrlich D, Bruder E, Thome MA, Gutt CN, von Knebel Doeberitz M, Niggli F, Perantoni AO, Koesters R (2010). Nuclear accumulation of beta-catenin protein indicates activation of wnt signaling in chemically induced rat nephroblastomas. Pediatr Dev Pathol  13, 1-8.   https://doi.org/10.2350/08-03-0443.1




PubMed



        
     
Free Article


 


PubMed ID 19348510
         Pubmed Central ID 2990985 


 



3.
Hernandez L, Roux KJ, Wong ES, Mounkes LC, Mutalif R, Navasankari R, Rai B, Cool S, Jeong JW, Wang H, Lee HS, Kozlov S, Grunert M, Keeble T, Jones CM, Meta MD, Young SG, Daar IO, Burke B, Perantoni AO, Stewart CL (2010). Functional coupling between the extracellular matrix and nuclear lamina by Wnt signaling in progeria. Dev Cell  19, 413-25.   https://doi.org/10.1016/j.devcel.2010.08.013




PubMed



        
     
Free Article


 


PubMed ID 20833363
         Pubmed Central ID 2953243",https://intramural.nih.gov/search/searchview.taf?ipid=62773
4,BC005148-31,"October 01, 2009 -  September 30, 2010",Mammary Tumorigenesis in Inbred and Feral Mice,Robert  Callahan; PhD,NULL,"Mammary Biology and Tumorigenesis Laboratory, NCI","Sharon A Bargo



Barry  Chestnut



Gilbert  Smith; PhD



Malgorzata B Klauzinska



Joseph Moon-Hee Lee



David M Mccurdy



Show all 8","Spyros  Artavanis-Tsakonas
(Developmental Biology and Cancer, Harvard Medical School)




Robert  Rhoads
(LSU Shreveport)




Charles  Theillet
(Inserm)","Jeffrey S Rubin; MD, PhD (Laboratory of Cellular and Molecular Biology)



Robert H Stephens (Business Operations Branch)",NULL,"Ordered by publication type and then author name.



1.
Callahan R, Raafat A, McCurdy D, Amirjazil I, Shu Y, Traicoff J, Plant J, Vonderhaar B, Callahan R (2010) Transforming acidic coiled-coiled protein-3 acts as a negative regulator of Notch signalingthrough to CDC10Ankyrin repeats. BBRC InPress.




 



2.
Li SJ, Yen TY, Endo Y, Klauzinska M, Baljinnyam B, Macher B, Callahan R, Rubin JS (2009). Loss-of-function point mutations and two-furin domain derivatives provide insights  about R-spondin2 structure and function. Cell Signal  21, 916-25.   https://doi.org/10.1016/j.cellsig.2009.02.001




PubMed



        
     
Free Article


 


PubMed ID 19385064
         Pubmed Central ID 2813491 


 



3.
Raafat A, Lawson S, Bargo S, Klauzinska M, Strizzi L, Goldhar AS, Buono K, Salomon D, Vonderhaar BK, Callahan R (2009). Rbpj conditional knockout reveals distinct functions of Notch4/Int3 in mammary gland development and tumorigenesis. Oncogene  28, 219-30.   https://doi.org/10.1038/onc.2008.379




PubMed



        
     
Free Article


 


PubMed ID 18836481
         Pubmed Central ID 2794555 


 



4.
Watanabe K, Nagaoka T, Lee JM, Bianco C, Gonzales M, Castro NP, Rangel MC, Sakamoto K, Sun Y, Callahan R, Salomon DS (2009). Enhancement of Notch receptor maturation and signaling sensitivity by Cripto-1. J Cell Biol  187, 343-53.   https://doi.org/10.1083/jcb.200905105




PubMed



        
     
Free Article


 


PubMed ID 19948478
         Pubmed Central ID 2779239",https://intramural.nih.gov/search/searchview.taf?ipid=62774
5,BC005177-30,"October 01, 2009 -  September 30, 2010",Interaction of Chemical Carcinogens and Chemotherapeutic Agents with DNA,Miriam Christine Poirier; PhD,NULL,"Laboratory of Cancer Biology and Genetics, NCI","Elena Estela Hernandez-Ramon



Karthik  John



Yongmin  Liu



Ofelia  Olivero; PhD","Maria Eugenia  Gonsebatt
(UNAM)




Francis  Martin
(Biological Sciences, Lancaster University)




Igor P Pogribny





Radim  Sram; MD
(Prague Institutes for Advanced Studies)","Qing  Lan (Occupational and Environmental Epidemiology Branch)



Nathaniel C Rothman; MD (Occupational and Environmental Epidemiology Branch)",NULL,"Ordered by publication type and then author name.



1.
John K, Ragavan N, Pratt MM, Singh PB, Al-Buheissi S, Matanhelia SS, Phillips DH, Poirier MC, Martin FL (2009). Quantification of phase I/II metabolizing enzyme gene expression and polycyclic aromatic hydrocarbon-DNA adduct levels in human prostate. Prostate  69, 505-19.   https://doi.org/10.1002/pros.20898




PubMed



        
     
Free Article


 


PubMed ID 19143007
         Pubmed Central ID 2647988 


 



2.
Keshava C, Divi RL, Einem TL, Richardson DL, Leonard SL, Keshava N, Poirier MC, Weston A (2009). Chlorophyllin significantly reduces benzo[a]pyrene-DNA adduct formation and alters cytochrome P450 1A1 and 1B1 expression and EROD activity in normal human mammary epithelial cells. Environ Mol Mutagen  50, 134-44.   https://doi.org/10.1002/em.20449




PubMed



        
     
Free Article


 


PubMed ID 19152381
         Pubmed Central ID 2637934 


 



3.
Schild-Hay LJ, Leil TA, Divi RL, Olivero OA, Weston A, Poirier MC (2009). Tamoxifen induces expression of immune response-related genes in cultured normal human mammary epithelial cells. Cancer Res  69, 1150-5.   https://doi.org/10.1158/0008-5472.CAN-08-2806




PubMed



        
     
Free Article


 


PubMed ID 19155303
         Pubmed Central ID 2633418",https://intramural.nih.gov/search/searchview.taf?ipid=62775
6,BC005258-31,"October 01, 2009 -  September 30, 2010",Molecular Studies of Eukaryotic Gene Regulation,"Bruce  Paterson; PhD



IRP Faculty Profile",NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI","Lili  Qin



Yikang  Rong



Ananda  Ravulapalli



Qin  Wei



Xiaomin  Yu",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Lipardi C, Paterson BM (2009). Identification of an RNA-dependent RNA polymerase in Drosophila involved in RNAi and transposon suppression. Proc Natl Acad Sci U S A  106, 15645-50.   https://doi.org/10.1073/pnas.0904984106




PubMed



        
     
Free Article


 


PubMed ID 19805217
         Pubmed Central ID 2736140",https://intramural.nih.gov/search/searchview.taf?ipid=62777
7,BC005263-29,"October 01, 2009 -  September 30, 2010",Eukaryotic Chromatin Structure and Gene Regulation,"Carl  Wu; PhD



IRP Faculty Profile",NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI","Yawen  Bai; PhD



Santhakumari  Harikrishnan



Yingzi  Huang



Joseph W Landry



Edward E Luk



Manabu  Mizuguchi



Show all 14",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=62778
8,BC005268-23,"October 01, 2009 -  September 30, 2010",Mechanism of Meiotic Recombination,"Michael Joseph Lichten; PhD



IRP Faculty Profile",NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI","Yaron  Dayani



Yikang  Rong



Arnaud Lucien de Muyt; PhD



Tamara  Goldfarb



Bryan Adam Leland; BA



Darpan Kaustuv Medhi



Show all 7","Alastair  Goldman
(University of Sheffield)




Eva  Hoffmann
(University of Sussex Sussex Centre for Genome Damage and Stability)




Franz  Klein
(Department of Botany, University of Vienna)",NULL,NULL,"Ordered by publication type and then author name.



1.
Buhler C, Shroff R, Lichten M (2009). Genome-wide mapping of meiotic DNA double-strand breaks in Saccharomyces cerevisiae. Methods Mol Biol  557, 143-64.   https://doi.org/10.1007/978-1-59745-527-5_10




PubMed


 


PubMed ID 19799181
    
     


 



2.
Jordan P, Copsey A, Newnham L, Kolar E, Lichten M, Hoffmann E (2009). Ipl1/Aurora B kinase coordinates synaptonemal complex disassembly with cell cycle progression and crossover formation in budding yeast meiosis. Genes Dev  23, 2237-51.   https://doi.org/10.1101/gad.536109




PubMed



        
     
Free Article


 


PubMed ID 19759266
         Pubmed Central ID 2751982 


 



3.
Lichten M, Lichten M (2010) Frequent and efficient use of the sister chromatid for DNA double-strand break repair during budding yeast meiosis. PLoS Biology, in press.




 



4.
Oh SD, Jessop L, Lao JP, Allers T, Lichten M, Hunter N (2009). Stabilization and electrophoretic analysis of meiotic recombination intermediates in Saccharomyces cerevisiae. Methods Mol Biol  557, 209-34.   https://doi.org/10.1007/978-1-59745-527-5_14




PubMed


 


PubMed ID 19799185",https://intramural.nih.gov/search/searchview.taf?ipid=62779
9,BC005270-29,"October 01, 2009 -  September 30, 2010",Molecular Mechanism of Action of Phorbol Ester,"Peter  Blumberg; PhD



IRP Faculty Profile",NULL,"Laboratory of Cancer Biology and Genetics, NCI","Tamas  Geczy



Noemi  Kedei



Nancy E Lewin



Emanuel S Lubart



Larry V Pearce



Juan  Tao



Show all 11","Simeon  Arseniyadis
(CNRS-Gif-sur-Yvette)




Tamas  Biro
(Debrecen Medical School)




Tamas  Biro
(Debrecen Medical School)




Derek C Braun





Chaya  Brodie
(Henry Ford Hospital)




Chaya  Brodie
(Henry Ford Hospital)


Show all 24","Victor  Marquez; PhD (Chemical Biology Laboratory)



Paul  Goldsmith; PhD (Basic Research Laboratory)



Susan H Garfield (Laboratory of Experimental Carcinogenesis)



Megan L Peach (Laboratory of Medicinal Chemistry)",NULL,"Ordered by publication type and then author name.



1.
Blumberg P, Gharat L, Khairathkar-Joshi N, Blumberg P, Szallasi A (2009) Screening TRPV1 antagonists for the treatment of pain - lessons learned over a dodecade. Exp Opin Drug Discovery 4:159-180.




 



2.
Choi HK, Choi S, Lee Y, Kang DW, Ryu H, Maeng HJ, Chung SJ, Pavlyukovets VA, Pearce LV, Toth A, Tran R, Wang Y, Morgan MA, Blumberg PM, Lee J (2009). Non-vanillyl resiniferatoxin analogues as potent and metabolically stable transient receptor potential vanilloid 1 agonists. Bioorg Med Chem  17, 690-8.   https://doi.org/10.1016/j.bmc.2008.11.085




PubMed



        
     
Free Article


 


PubMed ID 19135377
         Pubmed Central ID 2798733 


 



3.
Comin MJ, Czifra G, Kedei N, Telek A, Lewin NE, Kolusheva S, Velasquez JF, Kobylarz R, Jelinek R, Blumberg PM, Marquez VE (2009). Conformationally constrained analogues of diacylglycerol (DAG). 31. Modulation of the biological properties of diacylgycerol lactones (DAG-lactones) containing rigid-rod acyl groups separated from the core lactone by spacer units of different lengths. J Med Chem  52, 3274-83.   https://doi.org/10.1021/jm900186m




PubMed



        
     
Free Article


 


PubMed ID 19379015
         Pubmed Central ID 2708097 


 



4.
Keck GE, Li W, Kraft MB, Kedei N, Lewin NE, Blumberg PM (2009). The bryostatin 1 A-ring acetate is not the critical determinant for antagonism of phorbol ester-induced biological responses. Org Lett  11, 2277-80.   https://doi.org/10.1021/ol900585t




PubMed



        
     
Free Article


 


PubMed ID 19419164
         Pubmed Central ID 3075950 


 



5.
Keck GE, Poudel YB, Welch DS, Kraft MB, Truong AP, Stephens JC, Kedei N, Lewin NE, Blumberg PM (2009). Substitution on the A-ring confers to bryopyran analogues the unique biological activity characteristic of bryostatins and distinct from that of the phorbol esters. Org Lett  11, 593-6.   https://doi.org/10.1021/ol8027253




PubMed



        
     
Free Article


 


PubMed ID 19113896
         Pubmed Central ID 2647801 


 



6.
Kozikowski AP, Chen Y, Subhasish T, Lewin NE, Blumberg PM, Zhong Z, D'Annibale MA, Wang WL, Shen Y, Langley B (2009). Searching for disease modifiers-PKC activation and HDAC inhibition - a dual drug approach to Alzheimer's disease that decreases Abeta production while blocking oxidative stress. ChemMedChem  4, 1095-105.   https://doi.org/10.1002/cmdc.200900045




PubMed



        
     
Free Article


 


PubMed ID 19396896
         Pubmed Central ID 3057395 


 



7.
Ohashi N, Nomura W, Kato M, Narumi T, Lewin NE, Blumberg PM, Tamamura H (2009). Synthesis of protein kinase Cdelta C1b domain by native chemical ligation methodology and characterization of its folding and ligand binding. J Pept Sci  15, 642-6.   https://doi.org/10.1002/psc.1161




PubMed



        
     
Free Article


 


PubMed ID 19672879
         Pubmed Central ID 2811420 


 



8.
Pu Y, Garfield SH, Kedei N, Blumberg PM (2009). Characterization of the differential roles of the twin C1a and C1b domains of protein kinase C-delta. J Biol Chem  284, 1302-12.   https://doi.org/10.1074/jbc.M804796200




PubMed



        
     
Free Article


 


PubMed ID 19001377
         Pubmed Central ID 2613622 


 



9.
Sosa MS, Lewin NE, Choi SH, Blumberg PM, Kazanietz MG (2009). Biochemical characterization of hyperactive beta2-chimaerin mutants revealed an enhanced exposure of C1 and Rac-GAP domains. Biochemistry  48, 8171-8.   https://doi.org/10.1021/bi9010623




PubMed



        
     
Free Article


 


PubMed ID 19618918
         Pubmed Central ID 2756504 


 



10.
Stang SL, Lopez-Campistrous A, Song X, Dower NA, Blumberg PM, Wender PA, Stone JC (2009). A proapoptotic signaling pathway involving RasGRP, Erk, and Bim in B cells. Exp Hematol  37, 122-134.   https://doi.org/10.1016/j.exphem.2008.09.008




PubMed



        
     
Free Article


 


PubMed ID 19100522
         Pubmed Central ID 2708980 


 



11.
Tóth A, Blumberg PM, Boczán J (2009). Anandamide and the vanilloid receptor (TRPV1). Vitam Horm  81, 389-419.   https://doi.org/10.1016/S0083-6729(09)81015-7




PubMed


 


PubMed ID 19647120",https://intramural.nih.gov/search/searchview.taf?ipid=62780
10,BC005271-19,"October 01, 2009 -  September 30, 2010",Gene Regulation and Function: The B-ZIP Proteins,"Charles  Vinson; PhD



IRP Faculty Profile",NULL,"Nucleic Acids Section, NCI","Raghunath  Chatterjee



Ximiao  He



Vikas  Rishi



Jianfei  Zhao",NULL,"Gordon Lee Hager; PhD (Laboratory of Receptor Biology and Gene Expression)



Michael  Bustin; PhD (Protein Section)



Shioko  Kimura; PhD (Endocrinology Section)



Frank Jess Gonzalez; PhD (Laboratory of Metabolism)",NULL,"Ordered by publication type and then author name.



1.
Nunez NP, Hursting SD, Yakar S, Fowler D, Vinson C (2009). Obesity provides a permissive milieu in inflammation-associated carcinogenesis: analysis of insulin and IGF pathways. Methods Mol Biol  512, 29-37.   https://doi.org/10.1007/978-1-60327-530-9_3




PubMed



        
     
Free Article


 


PubMed ID 19347271
         Pubmed Central ID 5541853 


 



2.
Yuan Z, Gong S, Luo J, Zheng Z, Song B, Ma S, Guo J, Hu C, Thiel G, Vinson C, Hu CD, Wang Y, Li M (2009) Opposing roles for ATF2 and c-Fos in c-Jun-mediated neuronal apoptosis. Mol Cell Biol 29:2431-42.




PubMed



        
     
Free Article


 


PubMed ID 19255142
         Pubmed Central ID 2668374",https://intramural.nih.gov/search/searchview.taf?ipid=62781
11,BC005317-27,"October 01, 2009 -  September 30, 2010",Role of Selenium in Development and Health,"Dolph Lee Hatfield; PhD



IRP Faculty Profile",NULL,"Laboratory of Cancer Prevention, NCI","Bradley A Carlson



Min-Hyuk  Yoo



Petra Akiko Tsuji



Ryuta  Tobe



Salvador  Naranjo Suarez; PhD","Melinda  Beck
(University of North Carolina)




Marcus  Conrad
(Institute of Clinical Molecular Biology and Tumor Genetics)




Vadim  Gladyshev
(University of Nebraska)




Ulrich  Schweizer
(Neuroscience Research Center and, Charit-Universittsmedizin Berlin)","Cindy D Davis (Nutritional Science Research Group)



Jeffrey E Green; MD (Laboratory of Cancer Biology and Genetics)



Frank Jess Gonzalez; PhD (Laboratory of Metabolism)



Stuart H Yuspa; MD (Laboratory of Cancer Biology and Genetics)",NULL,"Ordered by publication type and then author name.



1.
Carlson BA, Schweizer U, Perella C, Shrimali RK, Feigenbaum L, Shen L, Speransky S, Floss T, Jeong SJ, Watts J, Hoffmann V, Combs GF, Gladyshev VN, Hatfield DL (2009). The selenocysteine tRNA STAF-binding region is essential for adequate selenocysteine tRNA status, selenoprotein expression and early age survival of mice. Biochem J  418, 61-71.   https://doi.org/10.1042/BJ20081304




PubMed



        
     
Free Article


 


PubMed ID 18973473
         Pubmed Central ID 2752860 


 



2.
Carlson BA, Yoo MH, Sano Y, Sengupta A, Kim JY, Irons R, Gladyshev VN, Hatfield DL, Park JM (2009). Selenoproteins regulate macrophage invasiveness and extracellular matrix-related gene expression. BMC Immunol  10, 57.   https://doi.org/10.1186/1471-2172-10-57




PubMed



        
     
Free Article


 


PubMed ID 19863805
         Pubmed Central ID 2774298 


 



3.
Carlson BA, Yoo MH, Tsuji PA, Gladyshev VN, Hatfield DL (2009). Mouse models targeting selenocysteine tRNA expression for elucidating the role of selenoproteins in health and development. Molecules  14, 3509-27.   https://doi.org/10.3390/molecules14093509




PubMed



        
     
Free Article


 


PubMed ID 19783940
         Pubmed Central ID 3459062 


 



4.
Downey CM, Horton CR, Carlson BA, Parsons TE, Hatfield DL, Hallgrímsson B, Jirik FR (2009). Osteo-chondroprogenitor-specific deletion of the selenocysteine tRNA gene, Trsp, leads to chondronecrosis and abnormal skeletal development: a putative model for Kashin-Beck disease. PLoS Genet  5, e1000616.   https://doi.org/10.1371/journal.pgen.1000616




PubMed



        
     
Free Article


 


PubMed ID 19696890
         Pubmed Central ID 2721633 


 



5.
Fomenko DE, Novoselov SV, Natarajan SK, Lee BC, Koc A, Carlson BA, Lee TH, Kim HY, Hatfield DL, Gladyshev VN (2009). MsrB1 (methionine-R-sulfoxide reductase 1) knock-out mice: roles of MsrB1 in redox regulation and identification of a novel selenoprotein form. J Biol Chem  284, 5986-93.   https://doi.org/10.1074/jbc.M805770200




PubMed



        
     
Free Article


 


PubMed ID 18990697
         Pubmed Central ID 2645841 


 



6.
Hatfield DL, Gladyshev VN (2009). The Outcome of Selenium and Vitamin E Cancer Prevention Trial (SELECT) reveals the need for better understanding of selenium biology. Mol Interv  9, 18-21.   https://doi.org/10.1124/mi.9.1.6




PubMed



        
     
Free Article


 


PubMed ID 19299660
         Pubmed Central ID 2718722 


 



7.
Kehr S, Malinouski M, Finney L, Vogt S, Labunskyy VM, Kasaikina MV, Carlson BA, Zhou Y, Hatfield DL, Gladyshev VN (2009). X-ray fluorescence microscopy reveals the role of selenium in spermatogenesis. J Mol Biol  389, 808-18.   https://doi.org/10.1016/j.jmb.2009.04.024




PubMed



        
     
Free Article


 


PubMed ID 19379757
         Pubmed Central ID 2778597 


 



8.
Labunskyy VM, Yoo MH, Hatfield DL, Gladyshev VN (2009). Sep15, a thioredoxin-like selenoprotein, is involved in the unfolded protein response and differentially regulated by adaptive and acute ER stresses. Biochemistry  48, 8458-65.   https://doi.org/10.1021/bi900717p




PubMed



        
     
Free Article


 


PubMed ID 19650649
         Pubmed Central ID 2778599 


 



9.
Lobanov AV, Hatfield DL, Gladyshev VN (2009). Eukaryotic selenoproteins and selenoproteomes. Biochim Biophys Acta  1790, 1424-8.   https://doi.org/10.1016/j.bbagen.2009.05.014




PubMed



        
     
Free Article


 


PubMed ID 19477234
         Pubmed Central ID 3471088 


 



10.
Sengupta A, Carlson BA, Labunskyy VM, Gladyshev VN, Hatfield DL (2009). Selenoprotein T deficiency alters cell adhesion and elevates selenoprotein W expression in murine fibroblast cells. Biochem Cell Biol  87, 953-61.   https://doi.org/10.1139/o09-064




PubMed



        
     
Free Article


 


PubMed ID 19935881
         Pubmed Central ID 3471091 


 



11.
Shim MS, Kim JY, Jung HK, Lee KH, Xu XM, Carlson BA, Kim KW, Kim IY, Hatfield DL, Lee BJ (2009). Elevation of glutamine level by selenophosphate synthetase 1 knockdown induces megamitochondrial formation in Drosophila cells. J Biol Chem  284, 32881-94.   https://doi.org/10.1074/jbc.M109.026492




PubMed



        
     
Free Article


 


PubMed ID 19755423
         Pubmed Central ID 2781704 


 



12.
Turanov AA, Hatfield DL, Gladyshev VN (2010). Characterization of protein targets of mammalian thioredoxin reductases. Methods Enzymol  474, 245-54.   https://doi.org/10.1016/S0076-6879(10)74014-3




PubMed



        
     
Free Article


 


PubMed ID 20609914
         Pubmed Central ID 3088097 


 



13.
Xu XM, Yoo MH, Carlson BA, Gladyshev VN, Hatfield DL (2009). Simultaneous knockdown of the expression of two genes using multiple shRNAs and subsequent knock-in of their expression. Nat Protoc  4, 1338-48.   https://doi.org/10.1038/nprot.2009.145




PubMed



        
     
Free Article


 


PubMed ID 19713955
         Pubmed Central ID 2753455 


 



14.
Yoo MH, Gu X, Xu XM, Kim JY, Carlson BA, Patterson AD, Cai H, Gladyshev VN, Hatfield DL (2010). Delineating the role of glutathione peroxidase 4 in protecting cells against lipid hydroperoxide damage and in Alzheimer's disease. Antioxid Redox Signal  12, 819-27.   https://doi.org/10.1089/ars.2009.2891




PubMed



        
     
Free Article


 


PubMed ID 19769463
         Pubmed Central ID 2861544",https://intramural.nih.gov/search/searchview.taf?ipid=62782
12,BC005352-28,"October 01, 2009 -  September 30, 2010",Mechanisms in Perinatal Carcinogenesis,Lucy M Anderson; PhD,NULL,"Cellular Pathogenesis Section, NCI","Janet R Fields



Yih-horng  Shiao","Gregory  Alvord
(Data Management Services)




Bhal  DIwan
(SAIC)","Kazimierz S Kasprzak; PhD, DSc (Laboratory of Comparative Carcinogenesis)



Miriam R Anver (Office Of The Director)","Gregory  Travlos; DVM, PhD (NIEHS)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=62783
13,BC005367-27,"October 01, 2009 -  September 30, 2010",The Genetic Structure of Natural Populations Past and Present,Stephen J O'Brien; PhD,NULL,"Laboratory of Genomic Diversity, NCI","Nicole J Crumpler



Warren  Johnson



Bailey D Kessing



Carl E Mcintosh



Polina  Perelman



Melody  Roekle-Parker



Show all 8","Agustinho  Antunes
(Universidad de Porto)




Belinda  Appleton
(University of Melbourne)




Jason  Chin
(Taipei Zoo)




William  Clark
(Iowa State University)




Mark  Cunningham
(Florida Fish and Wildlife Conservation Commission)




Eduardo  Eizirik
(Biosciences Department, Pontifcia Universidade Catlica do Rio Grande do Sul)


Show all 32",Robert  Stephens (Office Of The Director),Alejandro Alberto Schaffer; PhD (NLM),"Ordered by publication type and then author name.



1.
Driscoll CA, Clutton-Brock J, Kitchener AC, O'Brien SJ (2009). The Taming of the cat. Genetic and archaeological findings hint that wildcats became housecats earlier--and in a different place--than previously thought. Sci Am  300, 68-75.




PubMed



        
     
Free Article


 


PubMed ID 19485091
         Pubmed Central ID 5790555 


 



2.
Roelke ME, Brown MA, Troyer JL, Winterbach H, Winterbach C, Hemson G, Smith D, Johnson RC, Pecon-Slattery J, Roca AL, Alexander KA, Klein L, Martelli P, Krishnasamy K, O'Brien SJ (2009). Pathological manifestations of feline immunodeficiency virus (FIV) infection in wild African lions. Virology  390, 1-12.   https://doi.org/10.1016/j.virol.2009.04.011




PubMed



        
     
Free Article


 


PubMed ID 19464039
         Pubmed Central ID 2771374",https://intramural.nih.gov/search/searchview.taf?ipid=62784
14,BC005385-27,"October 01, 2009 -  September 30, 2010","The Development of the Domestic Cat, Felis catus, as an Animal Model for Genetic",Stephen J O'Brien; PhD,NULL,"Laboratory of Genomic Diversity, NCI","Nicole J Crumpler



Victor A David



Carlos Antonio Driscoll; PhD



Warren  Johnson



Bailey D Kessing



Marilyn  Raymond; PhD



Show all 7","Greg  Barsh
(Howard Hughes Medical Institute, Stanford University School of Medicine)




Jean  Bennett; MD, PhD
(Ophthalmology, University of Pennsylvania)




Eduardo  Eizirik
(Biosciences Department, Pontifcia Universidade Catlica do Rio Grande do Sul)




Steven  Hannah
(Nestle Purina PetCare Co.)




Rajendra  Kumar-Singh
(Dept. of Ophthalmology, Tufts University School of Medicine)




Kristina  Narfstrom; DVM
(Veterinary Medicine, University of Missouri)


Show all 8",Robert  Stephens (Office Of The Director),"Richa  Agarwala; BTech, MS, PhD (NLM) 



Alejandro Alberto Schaffer; PhD (NLM)","Ordered by publication type and then author name.



1.
Driscoll CA, Clutton-Brock J, Kitchener AC, O'Brien SJ (2009). The Taming of the cat. Genetic and archaeological findings hint that wildcats became housecats earlier--and in a different place--than previously thought. Sci Am  300, 68-75.




PubMed



        
     
Free Article


 


PubMed ID 19485091
         Pubmed Central ID 5790555 


 



2.
Menotti-Raymond M, David VA, Schäffer AA, Tomlin JF, Eizirik E, Phillip C, Wells D, Pontius JU, Hannah SS, O'Brien SJ (2009). An autosomal genetic linkage map of the domestic cat, Felis silvestris catus. Genomics  93, 305-13.   https://doi.org/10.1016/j.ygeno.2008.11.004




PubMed



        
     
Free Article


 


PubMed ID 19059333
         Pubmed Central ID 2656606",https://intramural.nih.gov/search/searchview.taf?ipid=62785
15,BC005389-27,"October 01, 2009 -  September 30, 2010",Reproductive Strategies in Animal Species Emphasizing Developmental Biology,Stephen J O'Brien; PhD,NULL,"Laboratory of Genomic Diversity, NCI","James  Kehler



Melody  Roekle-Parker","JoGayle  Howard
(Smithsonian National Zoological Park)




William  Murphy
(University of Nevada)




Kristina  Narfstrom; DVM
(Veterinary Medicine, University of Missouri)




Katherine  Pelican





Budhan  Pukazhenthi
(Smithsonian National Zoological Park)




David  Ryogo
(Center for Hearing Sciences, Johns Hopkins University)


Show all 7",NULL,NULL,"Ordered by publication type and then author name.



1.
Roelke ME, Brown MA, Troyer JL, Winterbach H, Winterbach C, Hemson G, Smith D, Johnson RC, Pecon-Slattery J, Roca AL, Alexander KA, Klein L, Martelli P, Krishnasamy K, O'Brien SJ (2009). Pathological manifestations of feline immunodeficiency virus (FIV) infection in wild African lions. Virology  390, 1-12.   https://doi.org/10.1016/j.virol.2009.04.011




PubMed



        
     
Free Article


 


PubMed ID 19464039
         Pubmed Central ID 2771374",https://intramural.nih.gov/search/searchview.taf?ipid=62786
16,BC005399-27,"October 01, 2009 -  September 30, 2010",Mechanistic Targeting of Lung Cancer,Lucy M Anderson; PhD,NULL,"Cellular Pathogenesis Section, NCI","Janet R Fields



Christopher  Hwang



John Jeon Lee



Ling-Chyi  Liao



Yih-horng  Shiao



Gunamani  Sithanandam","Gregory  Alvord
(Data Management Services)




Vadim  Gaponenko","Kazimierz S Kasprzak; PhD, DSc (Laboratory of Comparative Carcinogenesis)



Bruce Allen Shapiro; PhD (Image Processing Section)



Larry K Keefer; PhD (Laboratory of Comparative Carcinogenesis)",NULL,"Ordered by publication type and then author name.



1.
Abraham SJ, Nolet RP, Calvert RJ, Anderson LM, Gaponenko V (2009). The hypervariable region of K-Ras4B is responsible for its specific interactions with calmodulin. Biochemistry  48, 7575-83.   https://doi.org/10.1021/bi900769j




PubMed



        
     
Free Article


 


PubMed ID 19583261
         Pubmed Central ID 2729490 


 



2.
Shiao YH, Lupascu ST, Gu YD, Kasprzak W, Hwang CJ, Fields JR, Leighty RM, Quiñones O, Shapiro BA, Alvord WG, Anderson LM (2009). An intergenic non-coding rRNA correlated with expression of the rRNA and frequency of an rRNA single nucleotide polymorphism in lung cancer cells. PLoS One  4, e7505.   https://doi.org/10.1371/journal.pone.0007505




PubMed



        
     
Free Article


 


PubMed ID 19838300
         Pubmed Central ID 2759515",https://intramural.nih.gov/search/searchview.taf?ipid=62787
17,BC005445-26,"October 01, 2009 -  September 30, 2010",Pathways that Suppress or Accelerate Premalignant Progression of Squamous Cancer,"Stuart H Yuspa; MD



IRP Faculty Profile",NULL,"Laboratory of Cancer Biology and Genetics, NCI","Joanna  Anders



Lalage  Wakefield; PhD



Peter  Blumberg; PhD



Christophe  Cataisson



Luowei  Li



Mariam Q Malik



Show all 12",NULL,"Kyung  Lee; PhD (Chemistry Section)



Suresh V Ambudkar; PhD (Transport Biochemistry Section)



Lino  Tessarollo (Mouse Cancer Genetics Program)",NULL,"Ordered by publication type and then author name.



1.
Li L, Shukla S, Lee A, Garfield SH, Maloney DJ, Ambudkar SV, Yuspa SH (2010). The skin cancer chemotherapeutic agent ingenol-3-angelate (PEP005) is a substrate for the epidermal multidrug transporter (ABCB1) and targets tumor vasculature. Cancer Res  70, 4509-19.   https://doi.org/10.1158/0008-5472.CAN-09-4303




PubMed



        
     
Free Article


 


PubMed ID 20460505
         Pubmed Central ID 2880198 


 



2.
Malik M, Shukla A, Amin P, Niedelman W, Lee J, Jividen K, Phang JM, Ding J, Suh KS, Curmi PM, Yuspa SH (2010). S-nitrosylation regulates nuclear translocation of chloride intracellular channel protein CLIC4. J Biol Chem  285, 23818-28.   https://doi.org/10.1074/jbc.M109.091611




PubMed



        
     
Free Article


 


PubMed ID 20504765
         Pubmed Central ID 2911286 


 



3.
Shukla A, Yuspa SH (2010). CLIC4 and Schnurri-2: a dynamic duo in TGF-beta signaling with broader implications in cellular homeostasis and disease. Nucleus  1, 144-9.   https://doi.org/10.4161/nucl.1.2.10920




PubMed



        
     
Free Article


 


PubMed ID 20617112
         Pubmed Central ID 2898211 


 



4.
Stepp MA, Pal-Ghosh S, Tadvalkar G, Rajjoub L, Jurjus RA, Gerdes M, Ryscavage A, Cataisson C, Shukla A, Yuspa SH (2010). Loss of syndecan-1 is associated with malignant conversion in skin carcinogenesis. Mol Carcinog  49, 363-73.   https://doi.org/10.1002/mc.20609




PubMed



        
     
Free Article


 


PubMed ID 20082322
         Pubmed Central ID 3653623",https://intramural.nih.gov/search/searchview.taf?ipid=62788
18,BC005450-27,"October 01, 2009 -  September 30, 2010",Chromatin Structure and Gene Expression,"Gordon Lee Hager; PhD



IRP Faculty Profile",NULL,"Laboratory of Receptor Biology and Gene Expression, NCI","Songjoon  Baek



Simon Cameron Biddie



Thomas A Johnson



Kip  Nalley



Rodney Louis Schiltz; PhD



Ty Cole Voss



Show all 8","Michael J Garabedian; PhD
(Microbiology and Kaplan Cancer Center, New York University Medical Center)




Philippe  Georgel
(NCI)




Susanne  Mandrup
(University of Southern Denmark)




Ken  Pearce
(Gene Expression and Protein Biochemistry, GlaxoSmithKline Discovery Research)




Fahri  Saatcioglu
(Department of Biology, University of Oslo)




Michael  Stallcup
(Univ of Southern California)


Show all 10","John Carl Oberholtzer (Laboratory of Pathology)



Paul S Meltzer; MD, PhD (Cancer Genetics Branch)



Charles  Vinson; PhD (Nucleic Acids Section)



Sean Richard Davis; MD, PhD (Cancer Genetics Branch)



David  Levens; PhD (Laboratory of Pathology)","Michael J Pazin; PhD (NIA) 



Kenneth Steven Korach; PhD (NIEHS)","Ordered by publication type and then author name.



1.
Hager GL, McNally JG, Misteli T (2009). Transcription dynamics. Mol Cell  35, 741-53.   https://doi.org/10.1016/j.molcel.2009.09.005




PubMed



        
     
Free Article


 


PubMed ID 19782025
         Pubmed Central ID 6326382 


 



2.
Hakim O, Sung MH, Hager GL (2010). 3D shortcuts to gene regulation. Curr Opin Cell Biol  22, 305-13.   https://doi.org/10.1016/j.ceb.2010.04.005




PubMed



        
     
Free Article


 


PubMed ID 20466532
         Pubmed Central ID 2916936 


 



3.
John S, Johnson TA, Sung MH, Biddie SC, Trump S, Koch-Paiz CA, Davis SR, Walker R, Meltzer PS, Hager GL (2009). Kinetic complexity of the global response to glucocorticoid receptor action. Endocrinology  150, 1766-74.   https://doi.org/10.1210/en.2008-0863




PubMed



        
     
Free Article


 


PubMed ID 19131569
         Pubmed Central ID 2659280 


 



4.
Sung MH, Salvatore L, De Lorenzi R, Indrawan A, Pasparakis M, Hager GL, Bianchi ME, Agresti A (2009). Sustained oscillations of NF-kappaB produce distinct genome scanning and gene expression profiles. PLoS One  4, e7163.   https://doi.org/10.1371/journal.pone.0007163




PubMed



        
     
Free Article


 


PubMed ID 19787057
         Pubmed Central ID 2747007 


 



5.
Voss TC, Schiltz RL, Sung MH, Johnson TA, John S, Hager GL (2009). Combinatorial probabilistic chromatin interactions produce transcriptional heterogeneity. J Cell Sci  122, 345-56.   https://doi.org/10.1242/jcs.035865




PubMed



        
     
Free Article


 


PubMed ID 19126674
         Pubmed Central ID 2724732",https://intramural.nih.gov/search/searchview.taf?ipid=62789
19,BC005453-26,"October 01, 2009 -  September 30, 2010",Cellular and Molecular Biology of the Hepatic Stem Cell Compartment,"Snorri S. Thorgeirsson; MD, PhD",NULL,"Laboratory of Experimental Carcinogenesis, NCI","Agnes  Holczbauer



Seung Bum  Lee



Marian E Durkin



Phuongnga  Ton



Daekwan  Seo; PhD, MS, BA","Hanne  Bisgaard
(Medical Biochemistry and Genetics, University of Copenhagen)




Steve  Duncan
(Medical College of Wisconsin)




Peter  Nagy
(Pathology, Sammelweiss University)




Aranzazu  Sanchez-munoz
(Biochemsitry and Molecular Biology, Complutense University of Madrid)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=62790
20,BC005480-25,"October 01, 2009 -  September 30, 2010",Molecular Epidemiology of Human Lung Cancer,"Curtis  Harris; MD



IRP Faculty Profile",NULL,"Laboratory of Human Carcinogenesis, NCI","Elise Dawn Bowman



Jin  Jen



Mohammed A. Khan; PhD



Leah E Mechanic



Sharon R Pine



Brid Mairead Ryan



Show all 10",NULL,"Stephen J Chanock; MD, PhD (Laboratory Translational Genomics)



Neil Edward Caporaso; MS, MD (Genetic Epidemiology Branch)",NULL,"Ordered by publication type and then author name.



1.
Enewold L, Mechanic LE, Bowman ED, Zheng YL, Yu Z, Trivers G, Alberg AJ, Harris CC (2009). Serum concentrations of cytokines and lung cancer survival in African Americans and Caucasians. Cancer Epidemiol Biomarkers Prev  18, 215-22.   https://doi.org/10.1158/1055-9965.EPI-08-0705




PubMed



        
     
Free Article


 


PubMed ID 19124500
         Pubmed Central ID 2790156 


 



2.
Olivo-Marston SE, Yang P, Mechanic LE, Bowman ED, Pine SR, Loffredo CA, Alberg AJ, Caporaso N, Shields PG, Chanock S, Wu Y, Jiang R, Cunningham J, Jen J, Harris CC (2009). Childhood exposure to secondhand smoke and functional mannose binding lectin polymorphisms are associated with increased lung cancer risk. Cancer Epidemiol Biomarkers Prev  18, 3375-83.   https://doi.org/10.1158/1055-9965.EPI-09-0986




PubMed



        
     
Free Article


 


PubMed ID 19959685
         Pubmed Central ID 2951599 


 



3.
Rudin CM, Avila-Tang E, Harris CC, Herman JG, Hirsch FR, Pao W, Schwartz AG, Vahakangas KH, Samet JM (2009). Lung cancer in never smokers: molecular profiles and therapeutic implications. Clin Cancer Res  15, 5646-61.   https://doi.org/10.1158/1078-0432.CCR-09-0377




PubMed



        
     
Free Article


 


PubMed ID 19755392
         Pubmed Central ID 2950319 


 



4.
Sander M, Slaga TJ, Harris CC (2010). The 24th Aspen Cancer Conference: Mechanisms of toxicity, carcinogenesis, cancer prevention and cancer therapy 2009. Mol Carcinog  49, 410-28.   https://doi.org/10.1002/mc.20608




PubMed


 


PubMed ID 20082328
    
     


 



5.
Zheng YL, Kosti O, Loffredo CA, Bowman E, Mechanic L, Perlmutter D, Jones R, Shields PG, Harris CC (2010). Elevated lung cancer risk is associated with deficiencies in cell cycle checkpoints: genotype and phenotype analyses from a case-control study. Int J Cancer  126, 2199-210.   https://doi.org/10.1002/ijc.24771




PubMed



        
     
Free Article


 


PubMed ID 19626602
         Pubmed Central ID 2950001",https://intramural.nih.gov/search/searchview.taf?ipid=62791
21,BC005488-25,"October 01, 2009 -  September 30, 2010",Mechanisms of Inorganic Carcinogenesis,Michael  Waalkes; PhD,NULL,"Inorganic Carcinogenesis Section, NCI","Lida  Cheng



Rachel Joy Person; PhD



Yang  Sun



Erik James Tokar; PhD



Wei  Qu; PhD","Curt  Klaassen
(Toxicology, University of Kansas)




Jingbo  Pi
(CIIT)




Walt  Prozialeck
(Midwestern University)




Ellen  Silbergeld
(Environmental Health Sciences, Johns Hopkins)




Mirek  Styblo
(UNC Chapel Hill)




Mukta  Webber
(Michigan State)","Alan O Perantoni; PhD (Cancer and Developmental Biology Laboratory)



Larry K Keefer; PhD (Laboratory of Comparative Carcinogenesis)","Jonathan H Freedman; MS, PhD (NIEHS) 



Ronald  Mason; PhD (NIEHS) 



Dori Rabin Germolec; PhD (NIEHS)","Ordered by publication type and then author name.



1.
Waalkes M, Benbrahim-Tallaa L, Waalkes M (2010) Metal Ions in Human Cancer Development, in Metal Ions in Life Sciences. Royal Society of Chemistry (London), in press.




 



2.
Waalkes M, Liu J (2009) Metallothionein in Inorganic Carcinogenesis, in Metal Ions in Life Science. Royal Society of Chemistry (London) Volume 5, pp. 399-412.




 



3.
Ahlborn GJ, Nelson GM, Grindstaff RD, Waalkes MP, Diwan BA, Allen JW, Kitchin KT, Preston RJ, Hernandez-Zavala A, Adair B, Thomas DJ, Delker DA (2009). Impact of life stage and duration of exposure on arsenic-induced proliferative lesions and neoplasia in C3H mice. Toxicology  262, 106-13.   https://doi.org/10.1016/j.tox.2009.05.003




PubMed



        
     
Free Article


 


PubMed ID 19450653
         Pubmed Central ID 3496158 


 



4.
Benbrahim-Tallaa L, Tokar EJ, Diwan BA, Dill AL, Coppin JF, Waalkes MP (2009). Cadmium malignantly transforms normal human breast epithelial cells into a basal-like phenotype. Environ Health Perspect  117, 1847-52.   https://doi.org/10.1289/ehp.0900999




PubMed



        
     
Free Article


 


PubMed ID 20049202
         Pubmed Central ID 2799457 


 



5.
Hester S, Drobná Z, Andrews D, Liu J, Waalkes M, Thomas Dj, Styblo M (2009). Expression of AS3MT alters transcriptional profiles in human urothelial cells exposed to arsenite. Hum Exp Toxicol  28, 49-61.   https://doi.org/10.1177/0960327109102368




PubMed



        
     
Free Article


 


PubMed ID 19411561
         Pubmed Central ID 3513271 


 



6.
Kojima C, Ramirez DC, Tokar EJ, Himeno S, Drobná Z, Stýblo M, Mason RP, Waalkes MP (2009). Requirement of arsenic biomethylation for oxidative DNA damage. J Natl Cancer Inst  101, 1670-81.   https://doi.org/10.1093/jnci/djp414




PubMed



        
     
Free Article


 


PubMed ID 19933942
         Pubmed Central ID 2794302 


 



7.
Liu J, Malavya S, Wang X, Saavedra JE, Keefer LK, Tokar E, Qu W, Waalkes MP, Shami PJ (2009). Gene expression profiling for nitric oxide prodrug JS-K to kill HL-60 myeloid leukemia cells. Genomics  94, 32-8.   https://doi.org/10.1016/j.ygeno.2009.03.005




PubMed



        
     
Free Article


 


PubMed ID 19348908
         Pubmed Central ID 3496159 


 



8.
Liu J, Zhou ZX, Zhang W, Bell MW, Waalkes MP (2009). Changes in hepatic gene expression in response to hepatoprotective levels of zinc. Liver Int  29, 1222-9.   https://doi.org/10.1111/j.1478-3231.2009.02007.x




PubMed



        
     
Free Article


 


PubMed ID 19490425
         Pubmed Central ID 3500762 


 



9.
Qu W, Liu J, Dill AL, Saavedra JE, Keefer LK, Waalkes MP (2009). V-PROLI/NO, a nitric oxide donor prodrug, protects liver cells from arsenic-induced toxicity. Cancer Sci  100, 382-8.   https://doi.org/10.1111/j.1349-7006.2008.01050.x




PubMed



        
     
Free Article


 


PubMed ID 19154403
         Pubmed Central ID 2678544 


 



10.
Sun Y, Pi J, Wang X, Tokar EJ, Liu J, Waalkes MP (2009). Aberrant cytokeratin expression during arsenic-induced acquired malignant phenotype in human HaCaT keratinocytes consistent with epidermal carcinogenesis. Toxicology  262, 162-70.   https://doi.org/10.1016/j.tox.2009.06.003




PubMed



        
     
Free Article


 


PubMed ID 19524636
         Pubmed Central ID 2747077 


 



11.
Tokar EJ, Diwan BA, Waalkes MP (2010). Arsenic exposure transforms human epithelial stem/progenitor cells into a cancer stem-like phenotype. Environ Health Perspect  118, 108-15.   https://doi.org/10.1289/ehp.0901059




PubMed



        
     
Free Article


 


PubMed ID 20056578
         Pubmed Central ID 2831952 


 



12.
Tokar EJ, Diwan BA, Waalkes MP (2010). Early life inorganic lead exposure induces testicular teratoma and renal and urinary bladder preneoplasia in adult metallothionein-knockout mice but not in wild type mice. Toxicology  276, 5-10.   https://doi.org/10.1016/j.tox.2010.06.006




PubMed



               Available in future as a Free Article 


 


PubMed ID 20600549
         Pubmed Central ID 2951012 


 



13.
Tokar EJ, Qu W, Liu J, Liu W, Webber MM, Phang JM, Waalkes MP (2010). Arsenic-specific stem cell selection during malignant transformation. J Natl Cancer Inst  102, 638-49.   https://doi.org/10.1093/jnci/djq093




PubMed



        
     
Free Article


 


PubMed ID 20339138
         Pubmed Central ID 2864291 


 



14.
Waalkes M, Carmignani M, Di Benedetto M, Claudio L, Waalkes M, van Bokhoven A, Tokar E, Claudio P (2010) Cadmium induces p53-dependent apoptosis in human prostate epithelial cell lines. Cell Death Diff, in press.




 



15.
Waalkes M, Waalkes M (2009) Inorganic arsenic and human prostate cancer. Cien Saude Colet 14:307-18.




 



16.
Zuo P, Qu W, Cooper RN, Goyer RA, Diwan BA, Waalkes MP (2009). Potential role of alpha-synuclein and metallothionein in lead-induced inclusion body formation. Toxicol Sci  111, 100-8.   https://doi.org/10.1093/toxsci/kfp132




PubMed



        
     
Free Article


 


PubMed ID 19542206
         Pubmed Central ID 2726298",https://intramural.nih.gov/search/searchview.taf?ipid=62792
22,BC005522-23,"October 01, 2009 -  September 30, 2010",Thyroid StemProgenitor Cells,"Shioko  Kimura; PhD



IRP Faculty Profile",NULL,"Endocrinology Section, NCI","Masaaki  Miyakoshi



Minoru  Okamoto",NULL,"Snorri S. Thorgeirsson; MD, PhD (Laboratory of Experimental Carcinogenesis)",NULL,"Ordered by publication type and then author name.



1.
Hoshi S, Hoshi N, Okamoto M, Paiz J, Kusakabe T, Ward JM, Kimura S (2009). Role of NKX2-1 in N-bis(2-hydroxypropyl)-nitrosamine-induced thyroid adenoma in mice. Carcinogenesis  30, 1614-9.   https://doi.org/10.1093/carcin/bgp167




PubMed



        
     
Free Article


 


PubMed ID 19581346
         Pubmed Central ID 2736302",https://intramural.nih.gov/search/searchview.taf?ipid=62793
23,BC005561-23,"October 01, 2009 -  September 30, 2010",Liver-Enriched Transcription Factors,"Frank Jess Gonzalez; PhD



IRP Faculty Profile",NULL,"Laboratory of Metabolism, NCI","Jessica  Bonzo



Linda G Byrd



Jung Hwan  Kim","Guillermo  Elizondo
(CINVESTAV-IPN)




Tatsuhiko  Kodama
(Laboratory of Systems Biology and Medicine, Research Center for Advanced
              Science and Technology, Tokyo University)




AgnÃ¨s  Ribeiro
(UniversitÃ© Pierre et Marie Curie)




Iannis  Talianidis
(Biomedical Sciences Research Center Alexander Fleming)




Wen  Xie
(University of Pittsburgh)",NULL,NULL,"Ordered by publication type and then author name.



1.
Bonzo JA, Patterson AD, Krausz KW, Gonzalez FJ (2010). Metabolomics identifies novel Hnf1alpha-dependent physiological pathways in vivo. Mol Endocrinol  24, 2343-55.   https://doi.org/10.1210/me.2010-0130




PubMed



        
     
Free Article


 


PubMed ID 20943816
         Pubmed Central ID 2999475 


 



2.
Cattin AL, Le Beyec J, Barreau F, Saint-Just S, Houllier A, Gonzalez FJ, Robine S, Pinçon-Raymond M, Cardot P, Lacasa M, Ribeiro A (2009). Hepatocyte nuclear factor 4alpha, a key factor for homeostasis, cell architecture, and barrier function of the adult intestinal epithelium. Mol Cell Biol  29, 6294-308.   https://doi.org/10.1128/MCB.00939-09




PubMed



        
     
Free Article


 


PubMed ID 19805521
         Pubmed Central ID 2786690 


 



3.
Ichihara S, Yamada Y, Gonzalez FJ, Nakajima T, Murohara T, Ichihara G (2009). Inhibition of ischemia-induced angiogenesis by benzo[a]pyrene in a manner dependent on the aryl hydrocarbon receptor. Biochem Biophys Res Commun  381, 44-9.   https://doi.org/10.1016/j.bbrc.2009.01.187




PubMed



        
     
Free Article


 


PubMed ID 19351592
         Pubmed Central ID 2790146 


 



4.
Kurobe H, Urata M, Ueno M, Ueki M, Ono S, Izawa-Ishizawa Y, Fukuhara Y, Lei Y, Ripen AM, Kanbara T, Aihara K, Ishizawa K, Akaike M, Gonzalez FJ, Tamaki T, Takahama Y, Yoshizumi M, Kitagawa T, Tomita S (2010). Role of hypoxia-inducible factor 1alpha in T cells as a negative regulator in development of vascular remodeling. Arterioscler Thromb Vasc Biol  30, 210-7.   https://doi.org/10.1161/ATVBAHA.109.192666




PubMed



        
     
Free Article


 


PubMed ID 20007912
         Pubmed Central ID 6392182 


 



5.
Lee JH, Wada T, Febbraio M, He J, Matsubara T, Lee MJ, Gonzalez FJ, Xie W (2010). A novel role for the dioxin receptor in fatty acid metabolism and hepatic steatosis. Gastroenterology  139, 653-63.   https://doi.org/10.1053/j.gastro.2010.03.033




PubMed



        
     
Free Article


 


PubMed ID 20303349
         Pubmed Central ID 2910786 


 



6.
Li Y, Ramdhan DH, Naito H, Yamagishi N, Ito Y, Hayashi Y, Yanagiba Y, Okamura A, Tamada H, Gonzalez FJ, Nakajima T (2011). Ammonium perfluorooctanoate may cause testosterone reduction by adversely affecting testis in relation to PPARα. Toxicol Lett  205, 265-72.   https://doi.org/10.1016/j.toxlet.2011.06.015




PubMed



        
     
Free Article


 


PubMed ID 21712084
         Pubmed Central ID 6661110 


 



7.
Liu A, Yang J, Gonzalez FJ, Cheng GQ, Dai R (2011). Biphasic regulation of intracellular calcium by gemfibrozil contributes to inhibiting L6 myoblast differentiation: implications for clinical myotoxicity. Chem Res Toxicol  24, 229-37.   https://doi.org/10.1021/tx100312h




PubMed



        
     
Free Article


 


PubMed ID 21175127
         Pubmed Central ID 6631347 


 



8.
Martinez-Jimenez CP, Kyrmizi I, Cardot P, Gonzalez FJ, Talianidis I (2010). Hepatocyte nuclear factor 4alpha coordinates a transcription factor network regulating hepatic fatty acid metabolism. Mol Cell Biol  30, 565-77.   https://doi.org/10.1128/MCB.00927-09




PubMed



        
     
Free Article


 


PubMed ID 19933841
         Pubmed Central ID 2812226 


 



9.
Minata M, Harada KH, Kärrman A, Hitomi T, Hirosawa M, Murata M, Gonzalez FJ, Koizumi A (2010). Role of peroxisome proliferator-activated receptor-alpha in hepatobiliary injury induced by ammonium perfluorooctanoate in mouse liver. Ind Health  48, 96-107.   https://doi.org/10.2486/indhealth.48.96




PubMed


 


PubMed ID 20160413
    
     


 



10.
Reyes-Hernández OD, Mejía-García A, Sánchez-Ocampo EM, Cabañas-Cortés MA, Ramírez P, Chávez-González L, Gonzalez FJ, Elizondo G (2010). Ube2l3 gene expression is modulated by activation of the aryl hydrocarbon receptor: implications for p53 ubiquitination. Biochem Pharmacol  80, 932-40.   https://doi.org/10.1016/j.bcp.2010.05.007




PubMed



        
     
Free Article


 


PubMed ID 20478272
         Pubmed Central ID 6624428 


 



11.
Sekine H, Mimura J, Oshima M, Okawa H, Kanno J, Igarashi K, Gonzalez FJ, Ikuta T, Kawajiri K, Fujii-Kuriyama Y (2009). Hypersensitivity of aryl hydrocarbon receptor-deficient mice to lipopolysaccharide-induced septic shock. Mol Cell Biol  29, 6391-400.   https://doi.org/10.1128/MCB.00337-09




PubMed



        
     
Free Article


 


PubMed ID 19822660
         Pubmed Central ID 2786870 


 



12.
Shen HW, Jiang XL, Gonzalez FJ, Yu AM (2011). Humanized transgenic mouse models for drug metabolism and pharmacokinetic research. Curr Drug Metab  12, 997-1006.   https://doi.org/10.2174/138920011798062265




PubMed



        
     
Free Article


 


PubMed ID 22023319
         Pubmed Central ID 6310623 


 



13.
Shi S, Yoon DY, Hodge-Bell KC, Bebenek IG, Whitekus MJ, Zhang R, Cochran AJ, Huerta-Yepez S, Yim SH, Gonzalez FJ, Jaiswal AK, Hankinson O (2009) The aryl hydrocarbon receptor nuclear translocator (Arnt) is required for tumor initiation by benzoapyrene. Carcinogenesis 30:1957-61.




PubMed



        
     
Free Article


 


PubMed ID 19755658
         Pubmed Central ID 2791324 


 



14.
Stroeve JH, Brufau G, Stellaard F, Gonzalez FJ, Staels B, Kuipers F (2010). Intestinal FXR-mediated FGF15 production contributes to diurnal control of hepatic bile acid synthesis in mice. Lab Invest  90, 1457-67.   https://doi.org/10.1038/labinvest.2010.107




PubMed



        
     
Free Article


 


PubMed ID 20531290
         Pubmed Central ID 6643294 


 



15.
Takahashi K, Kamijo Y, Hora K, Hashimoto K, Higuchi M, Nakajima T, Ehara T, Shigematsu H, Gonzalez FJ, Aoyama T (2011). Pretreatment by low-dose fibrates protects against acute free fatty acid-induced renal tubule toxicity by counteracting PPARα deterioration. Toxicol Appl Pharmacol  252, 237-49.   https://doi.org/10.1016/j.taap.2011.02.012




PubMed



        
     
Free Article


 


PubMed ID 21338618
         Pubmed Central ID 6300991 


 



16.
Tanaka N, Zhang X, Sugiyama E, Kono H, Horiuchi A, Nakajima T, Kanbe H, Tanaka E, Gonzalez FJ, Aoyama T (2010). Eicosapentaenoic acid improves hepatic steatosis independent of PPARα activation through inhibition of SREBP-1 maturation in mice. Biochem Pharmacol  80, 1601-12.   https://doi.org/10.1016/j.bcp.2010.07.031




PubMed



        
     
Free Article


 


PubMed ID 20691165
         Pubmed Central ID 6338080",https://intramural.nih.gov/search/searchview.taf?ipid=62794
24,BC005562-23,"October 01, 2009 -  September 30, 2010",Xenobiotic-Metabolizing Enzymes,"Frank Jess Gonzalez; PhD



IRP Faculty Profile",NULL,"Laboratory of Metabolism, NCI","Linda G Byrd



Jie  Cheng



Kristopher W Krausz



Fei  Li



Soumen Kanti Manna



Tsutomu  Matsubara



Show all 8","Renke  Dai
(NCI)




Jeffrey  Idle
(Charles  University)",NULL,NULL,"Ordered by publication type and then author name.



1.
Liu A, Chen Y, Yang Z, Feng Y, Rui W, Luo W, Liu Y, Gonzalez FJ, Dai R (2009). New metabolites of fenofibrate in Sprague-Dawley rats by UPLC-ESI-QTOF-MS-based metabolomics coupled with LC-MS/MS. Xenobiotica  39, 345-54.   https://doi.org/10.1080/00498250802680827




PubMed



        
     
Free Article


 


PubMed ID 19350456
         Pubmed Central ID 2794380 


 



2.
Minata M, Harada KH, Kärrman A, Hitomi T, Hirosawa M, Murata M, Gonzalez FJ, Koizumi A (2010). Role of peroxisome proliferator-activated receptor-alpha in hepatobiliary injury induced by ammonium perfluorooctanoate in mouse liver. Ind Health  48, 96-107.   https://doi.org/10.2486/indhealth.48.96




PubMed


 


PubMed ID 20160413
    
     


 



3.
Patterson AD, Lanz C, Gonzalez FJ, Idle JR (2010). The role of mass spectrometry-based metabolomics in medical countermeasures against radiation. Mass Spectrom Rev  29, 503-21.   https://doi.org/10.1002/mas.20272




PubMed



        
     
Free Article


 


PubMed ID 19890938
         Pubmed Central ID 3690279 


 



4.
Reyes-Hernández OD, Mejía-García A, Sánchez-Ocampo EM, Cabañas-Cortés MA, Ramírez P, Chávez-González L, Gonzalez FJ, Elizondo G (2010). Ube2l3 gene expression is modulated by activation of the aryl hydrocarbon receptor: implications for p53 ubiquitination. Biochem Pharmacol  80, 932-40.   https://doi.org/10.1016/j.bcp.2010.05.007




PubMed



        
     
Free Article


 


PubMed ID 20478272
         Pubmed Central ID 6624428 


 



5.
Stroeve JH, Brufau G, Stellaard F, Gonzalez FJ, Staels B, Kuipers F (2010). Intestinal FXR-mediated FGF15 production contributes to diurnal control of hepatic bile acid synthesis in mice. Lab Invest  90, 1457-67.   https://doi.org/10.1038/labinvest.2010.107




PubMed



        
     
Free Article


 


PubMed ID 20531290
         Pubmed Central ID 6643294 


 



6.
Swanson HI, Njar VC, Yu Z, Castro DJ, Gonzalez FJ, Williams DE, Huang Y, Kong AN, Doloff JC, Ma J, Waxman DJ, Scott EE (2010). Targeting drug-metabolizing enzymes for effective chemoprevention and chemotherapy. Drug Metab Dispos  38, 539-44.   https://doi.org/10.1124/dmd.109.031351




PubMed



        
     
Free Article


 


PubMed ID 20233842
         Pubmed Central ID 2845935",https://intramural.nih.gov/search/searchview.taf?ipid=62795
25,BC005597-21,"October 01, 2009 -  September 30, 2010",Biochemistry of Energy-Dependent (Intracellular) Protein Degradation,"Michael  Maurizi; PhD



IRP Faculty Profile",NULL,"Biochemistry of Proteins Section, NCI","Gian Marco Dedonatis



Ramatoulaye Kane Deme



Erica Nicole Jones



Ebenezer  Joseph



Jeong Han  Kang



Yang  Zhang","Sun-Shin  Cha
(Korea Ocean Research and Development Institute)




Sung Gyun Kang; PhD





Joaquin  Ortega
(McMaster University Health Sciences Centre)




Carolyn  Suzuki
(Biochemistry and Molecular Biology, University of Medicine and Dentistry of New Jersey)","Alexander  Wlodawer; PhD (Macromolecular Crystallography Laboratory)



Susan  Gottesman; PhD (Biochemical Genetics Section)



Di S Xia; PhD, MS, BS (Crystallography Section)","Douglas S Auld (NHGRI) 



Grzegorz  Piszczek; PhD (NHLBI) 



Alasdair C Steven; PhD (NIAMS)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=62797
26,BC005598-21,"October 01, 2009 -  September 30, 2010",Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells,"Michael Marc Gottesman; MD



IRP Faculty Profile",NULL,"Chemical Immunology Section, NCI","Carol O Cardarelli



King Leung Fung



Jean-Pierre  Gillet



Andrew Simon Goldsborough



Matthew David Hall



Misty  Handley



Show all 9",NULL,"Suresh V Ambudkar; PhD (Transport Biochemistry Section)



Di S Xia; PhD, MS, BS (Crystallography Section)","Chava  Kimchi-Sarfaty (OD) 



Robert  Innis; MD (NIMH) 



Christopher P Austin; AB, MD (NHGRI)","Ordered by publication type and then author name.



1.
Brimacombe KR, Hall MD, Auld DS, Inglese J, Austin CP, Gottesman MM, Fung KL (2009). A dual-fluorescence high-throughput cell line system for probing multidrug resistance. Assay Drug Dev Technol  7, 233-49.   https://doi.org/10.1089/adt.2008.165




PubMed



        
     
Free Article


 


PubMed ID 19548831
         Pubmed Central ID 2814070 


 



2.
Fung KL, Gottesman MM (2009). A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function. Biochim Biophys Acta  1794, 860-71.   https://doi.org/10.1016/j.bbapap.2009.02.014




PubMed



        
     
Free Article


 


PubMed ID 19285158
         Pubmed Central ID 2810319 


 



3.
Gillet JP, Gottesman MM (2010). Mechanisms of multidrug resistance in cancer. Methods Mol Biol  596, 47-76.   https://doi.org/10.1007/978-1-60761-416-6_4




PubMed


 


PubMed ID 19949920
    
     


 



4.
Hall MD, Handley MD, Gottesman MM (2009). Is resistance useless? Multidrug resistance and collateral sensitivity. Trends Pharmacol Sci  30, 546-56.   https://doi.org/10.1016/j.tips.2009.07.003




PubMed



        
     
Free Article


 


PubMed ID 19762091
         Pubmed Central ID 2774243 


 



5.
Hall MD, Salam NK, Hellawell JL, Fales HM, Kensler CB, Ludwig JA, Szakács G, Hibbs DE, Gottesman MM (2009). Synthesis, activity, and pharmacophore development for isatin-beta-thiosemicarbazones with selective activity toward multidrug-resistant cells. J Med Chem  52, 3191-204.   https://doi.org/10.1021/jm800861c




PubMed



        
     
Free Article


 


PubMed ID 19397322
         Pubmed Central ID 2744114 


 



6.
Hunt R, Sauna ZE, Ambudkar SV, Gottesman MM, Kimchi-Sarfaty C (2009). Silent (synonymous) SNPs: should we care about them? Methods Mol Biol  578, 23-39.   https://doi.org/10.1007/978-1-60327-411-1_2




PubMed


 


PubMed ID 19768585
    
     


 



7.
Kannan P, John C, Zoghbi SS, Halldin C, Gottesman MM, Innis RB, Hall MD (2009). Imaging the function of P-glycoprotein with radiotracers: pharmacokinetics and in vivo applications. Clin Pharmacol Ther  86, 368-77.   https://doi.org/10.1038/clpt.2009.138




PubMed



        
     
Free Article


 


PubMed ID 19625998
         Pubmed Central ID 2746858 


 



8.
Türk D, Hall MD, Chu BF, Ludwig JA, Fales HM, Gottesman MM, Szakács G (2009). Identification of compounds selectively killing multidrug-resistant cancer cells. Cancer Res  69, 8293-301.   https://doi.org/10.1158/0008-5472.CAN-09-2422




PubMed



        
     
Free Article


 


PubMed ID 19843850
         Pubmed Central ID 2783730",https://intramural.nih.gov/search/searchview.taf?ipid=62798
27,BC005599-20,"October 01, 2009 -  September 30, 2010","Tumor Suppressor Protein, p53","Ettore  Appella; MD



IRP Faculty Profile",NULL,"Chemical Immunology Section, NCI","Ryo  Hayashi



Lisa Marie Jenkins



Sharlyn  Mazur; PhD



Michael Zeev Stern



Hidetsugu  Fujigaki","Or  Gozani
(Stanford Cancer Center, Stanford University)




Donald  Hunt
(Department of Chemistry, University of Minnesota)




Tatiana  Kutateladze
(University of Colorado Denver School of Medicine)




James G. Omichinski; PhD
(Department of Biochemistry, University of Montreal)




Yang  Xu
(University of California)","Curtis  Harris; MD (Laboratory of Human Carcinogenesis)



Howard A Fine; MD, PhD (Neuro-Oncology Branch)



Stewart  Durell (Laboratory of Cell Biology)



Yawen  Bai; PhD (Laboratory Of Biochemistry & Molecular Biology)",NULL,"Ordered by publication type and then author name.



1.
Appella E, Murata K, Shimada M, Ogawa K, Ohta K, Suzuki K, Fujigaki H, Khaw A, Banerjee B, Hande M, Miyamoto T, Miyoshi I, Shirai T, Motoyama N, Delhase M, Appella E, Nakanishi M (2010) Cooperative functions of Chk1 and Chk2 reduce tumor susceptibility in vivo. The EMBO Journal, in press.




 



2.
Appella E, Roy S, Lachmi-Weiner K, Hayashi R, Shi X, Appella E, Kutateladze T, Gozani O (2010) The MBT repeats of L3MBTL1 link SET8 mediated p53 methylation at lysine 382 to target gene repression. J Biol Chem, in press.




 



3.
Feng H, Jenkins LM, Durell SR, Hayashi R, Mazur SJ, Cherry S, Tropea JE, Miller M, Wlodawer A, Appella E, Bai Y (2009). Structural basis for p300 Taz2-p53 TAD1 binding and modulation by phosphorylation. Structure  17, 202-10.   https://doi.org/10.1016/j.str.2008.12.009




PubMed



        
     
Free Article


 


PubMed ID 19217391
         Pubmed Central ID 2705179 


 



4.
Jenkins LM, Yamaguchi H, Hayashi R, Cherry S, Tropea JE, Miller M, Wlodawer A, Appella E, Mazur SJ (2009). Two distinct motifs within the p53 transactivation domain bind to the Taz2 domain of p300 and are differentially affected by phosphorylation. Biochemistry  48, 1244-55.   https://doi.org/10.1021/bi801716h




PubMed



        
     
Free Article


 


PubMed ID 19166313
         Pubmed Central ID 2848171 


 



5.
Topisirovic I, Gutierrez GJ, Chen M, Appella E, Borden KL, Ronai ZA (2009). Control of p53 multimerization by Ubc13 is JNK-regulated. Proc Natl Acad Sci U S A  106, 12676-81.   https://doi.org/10.1073/pnas.0900596106




PubMed



        
     
Free Article


 


PubMed ID 19651615
         Pubmed Central ID 2722327",https://intramural.nih.gov/search/searchview.taf?ipid=62799
28,BC005643-20,"October 01, 2009 -  September 30, 2010",Mechanism and Regulation of mRNA Export,Ravi  Dhar; PhD,NULL,"Basic Research Laboratory, NCI","Xiaoyuan  He



Saikat  Saha



Saravana P Selvanathan",NULL,"Andrew  Patterson (Nucleic Acids Section)



Timothy D Veenstra (Office Of The Director)",NULL,"Ordered by publication type and then author name.



1.
Selvanathan SP, Thakurta AG, Dhakshnamoorthy J, Zhou M, Veenstra TD, Dhar R (2010). Schizosaccharomyces pombe Dss1p is a DNA damage checkpoint protein that recruits Rad24p, Cdc25p, and Rae1p to DNA double-strand breaks. J Biol Chem  285, 14122-33.   https://doi.org/10.1074/jbc.M109.083485




PubMed



        
     
Free Article


 


PubMed ID 20231270
         Pubmed Central ID 2863230",https://intramural.nih.gov/search/searchview.taf?ipid=62800
29,BC005645-21,"October 01, 2009 -  September 30, 2010",T-cell Transformation by Oncoviruses,"Genoveffa  Franchini; MD



IRP Faculty Profile",NULL,"Vaccine Branch, NCI","Robyn M Washington Parks



Claudio  Fenizia



Cody R Buchmann



Maria Fernanda  Amarante



Heather Lauren Gold



Luiz Carlos Alcantara; PhD","Vincenzo  Ciminale
(Department of Oncology and Surgical Sciences, University of Padova)




Christophe  Nicot
(-, University of Kansas Medical Center)","Kathryn  Jones; PhD (Laboratory of Experimental Immunology)



Francis W Ruscetti; PhD (Laboratory of Experimental Immunology)",Steven J Jacobson; PhD (NINDS),"Ordered by publication type and then author name.



1.
Moutaftsi M, Tscharke DC, Vaughan K, Koelle DM, Stern L, Calvo-Calle M, Ennis F, Terajima M, Sutter G, Crotty S, Drexler I, Franchini G, Yewdell JW, Head SR, Blum J, Peters B, Sette A (2010). Uncovering the interplay between CD8, CD4 and antibody responses to complex pathogens. Future Microbiol  5, 221-39.   https://doi.org/10.2217/fmb.09.110




PubMed



        
     
Free Article


 


PubMed ID 20143946
         Pubmed Central ID 3363998",https://intramural.nih.gov/search/searchview.taf?ipid=62801
30,BC005657-21,"October 01, 2009 -  September 30, 2010",Molecular Basis for the Pathogenesis of Murine Retroviruses,Sandra  Ruscetti; PhD,NULL,"Laboratory of Cancer Prevention, NCI","Joan L Cmarik



Charlotte A Hanson



Monika  Kaczmarek



Stephen  Lavanier



Jami A Wolfe



Xiang  Zhang","Judy  Mikovits
(Whittemore Peterson Institute)




Kazuo  Nishigaki","Francis W Ruscetti; PhD (Laboratory of Experimental Immunology)



Larry K Keefer; PhD (Laboratory of Comparative Carcinogenesis)",NULL,"Ordered by publication type and then author name.



1.
Li X, Hanson C, Cmarik JL, Ruscetti S (2009). Neurodegeneration induced by PVC-211 murine leukemia virus is associated with increased levels of vascular endothelial growth factor and macrophage inflammatory protein 1 alpha and is inhibited by blocking activation of microglia. J Virol  83, 4912-22.   https://doi.org/10.1128/JVI.02343-08




PubMed



        
     
Free Article


 


PubMed ID 19279110
         Pubmed Central ID 2682059 


 



2.
Lombardi VC, Ruscetti FW, Das Gupta J, Pfost MA, Hagen KS, Peterson DL, Ruscetti SK, Bagni RK, Petrow-Sadowski C, Gold B, Dean M, Silverman RH, Mikovits JA (2009). Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science  326, 585-9.   https://doi.org/10.1126/science.1179052




PubMed


 


PubMed ID 19815723",https://intramural.nih.gov/search/searchview.taf?ipid=62802
31,BC005673-20,"October 01, 2009 -  September 30, 2010",Using Diazeniumdiolate Chemistry to Design Nitric Oxide-Based Therapies,Larry K Keefer; PhD,NULL,"Laboratory of Comparative Carcinogenesis, NCI","Debanjan  Biswas



Zhao  Cao



Kenyatta Meticeo Cosby; MD



James Ming Phang; MD



Rahul Shripad Nandurdikar



Joseph  Saavedra



Show all 8","Christian  Bogdan
(Universitat Freiburg, Institut fur Medizinische Mikrobiologie und Hygiene)




Jeffrey  Deschamps
(Naval Research Laboratory)




Sonia  Donzelli





Melina  Kibbe
(Division of Vascular Surgery, Northwestern University)




Mark  Meyerhoff
(Department of Chemistry, University of Michigan)




Katrina  Miranda
(University of Arizona)","Regina Gale Ziegler; PhD, MPH (Epidemiology and Biostatistics Program)



David Anderson Wink (Radiation Biology Branch)



Michael  Waalkes; PhD (Inorganic Carcinogenesis Section)",NULL,"Ordered by publication type and then author name.



1.
Fuhrman BJ, Pfeiffer R, Xu X, Wu AH, Korde L, Gail MH, Keefer LK, Veenstra TD, Hoover RN, Ziegler RG (2009). Soy intake is associated with increased 2-hydroxylation and decreased 16alpha-hydroxylation of estrogens in Asian-American women. Cancer Epidemiol Biomarkers Prev  18, 2751-60.   https://doi.org/10.1158/1055-9965.EPI-09-0388




PubMed



        
     
Free Article


 


PubMed ID 19789363
         Pubmed Central ID 2759852 


 



2.
Keefer L, Keefer L, Saavedra J (2009) Primary amine diazeniumdiolate ions of structure RNN(O)NOR'- as ambident nucleophiles. Tetrahedron Lett 50:5917-19.




 



3.
Keefer L, Nandurdikar R, Keefer L, Saavedra J, Chakrapani H (2009) An improved synthesis of V-PROLINO, a cytochrome P450-activated nitric oxide prodrug. Tetrahedron Lett. 50:4545-8.




 



4.
Keefer L, Saavedra J, Keefer L, Chakrapani H (2009) Improved synthesis of V-PYRRONO, a liver-selective nitric oxide prodrug, and analogues. Tetrahedron Lett. 50:2069-71.




 



5.
Keefer L, Saavedra J, Showalter B, Valdez C, Shanklin A, Oh B, Keefer L, Meyerhoff M (2010) Tailored synthesis of nitric oxide-releasing polyurethanes using O2-protected diazeniumdiolated chain extenders. J. Mater. Chem 20:3107-14.




 



6.
Keefer LK, behalf of the JS-K Consortium (2010). Broad-Spectrum Anti-Cancer Activity of O-Arylated Diazeniumdiolates. For Immunopathol Dis Therap  1, 205-218.   https://doi.org/10.1615/ForumImmunDisTher.v1.i3.30




PubMed



        
     
Free Article


 


PubMed ID 21949595
         Pubmed Central ID 3179376 


 



7.
Qu W, Liu J, Dill AL, Saavedra JE, Keefer LK, Waalkes MP (2009). V-PROLI/NO, a nitric oxide donor prodrug, protects liver cells from arsenic-induced toxicity. Cancer Sci  100, 382-8.   https://doi.org/10.1111/j.1349-7006.2008.01050.x




PubMed



        
     
Free Article


 


PubMed ID 19154403
         Pubmed Central ID 2678544 


 



8.
Rai G, Sayed AA, Lea WA, Luecke HF, Chakrapani H, Prast-Nielsen S, Jadhav A, Leister W, Shen M, Inglese J, Austin CP, Keefer L, Arnér ES, Simeonov A, Maloney DJ, Williams DL, Thomas CJ (2009). Structure mechanism insights and the role of nitric oxide donation guide the development of oxadiazole-2-oxides as therapeutic agents against schistosomiasis. J Med Chem  52, 6474-83.   https://doi.org/10.1021/jm901021k




PubMed



        
     
Free Article


 


PubMed ID 19761212
         Pubmed Central ID 2772170 


 



9.
Saavedra JE, Davies KM, Barchi JJ, Keefer LK (2009). Unexpected Incorporation of Bromine at a Non-anomeric Position during the Synthesis of an O-Glycosylated Diazeniumdiolate. Org Prep Proced Int  41, 143-147.   https://doi.org/10.1080/00304940902801968




PubMed



        
     
Free Article


 


PubMed ID 20354584
         Pubmed Central ID 2846713",https://intramural.nih.gov/search/searchview.taf?ipid=62803
32,BC005688-20,"October 01, 2009 -  September 30, 2010",Understanding the Role of the Host Response in HIVSIV Infection,"Genoveffa  Franchini; MD



IRP Faculty Profile",NULL,"Vaccine Branch, NCI","Melvin Nelson Doster



Shari  Gordon; PhD



Poonam  Poonam



Monica  Vaccari



Galyna  Kutsyna; MD, PhD



Robyn M Washington Parks","Savita  Pahwa
(Miller School of Medicine, University of Miami)




Eckhard  Podack
(Department of Microbiology, University of Miami)




Rafick  Sekaly; PhD
(Vaccine & Gene Therapy Institute)",Gene  Shearer; PhD (Cell Mediated Immunity Section),Vanessa  Hirsch (NIAID),"Ordered by publication type and then author name.



1.
Cecchinato V, Franchini G (2010). Th17 cells in pathogenic simian immunodeficiency virus infection of macaques. Curr Opin HIV AIDS  5, 141-5.   https://doi.org/10.1097/COH.0b013e32833653ec




PubMed



        
     
Free Article


 


PubMed ID 20543591
         Pubmed Central ID 2898129 


 



2.
Poirier MC, Olivero OA, Hardy AW, Franchini G, Borojerdi JP, Walker VE, Walker DM, Shearer GM (2009). Antiretroviral activity of the aminothiol WR1065 against Human Immunodeficiency virus (HIV-1) in vitro and Simian Immunodeficiency virus (SIV) ex vivo. AIDS Res Ther  6, 24.   https://doi.org/10.1186/1742-6405-6-24




PubMed



        
     
Free Article


 


PubMed ID 19895691
         Pubmed Central ID 2777914",https://intramural.nih.gov/search/searchview.taf?ipid=62804
33,BC005708-19,"October 01, 2009 -  September 30, 2010",Xenobiotic Receptors,"Frank Jess Gonzalez; PhD



IRP Faculty Profile",NULL,"Laboratory of Metabolism, NCI","Jessica  Bonzo



Linda G Byrd



Jie  Cheng



Changtao  Jiang



Jung Hwan  Kim



Kristopher W Krausz



Show all 11","Toshifumi  Aoyama
(Department of Metabolic Regulation, Shinshu University, Institute on Aging and Adaptation)




Tatsuhiko  Kodama
(Laboratory of Systems Biology and Medicine, Research Center for Advanced
              Science and Technology, Tokyo University)




Tami  Nakajima
(Nagoya University)




Jeffrey  Peters
(NCI)




Francesc  Villarroya
(nstitut de Biomedicina de la Universitat de Barcelona (IBUB) and CIBER Fisiopatologia de la Obesidad y NutriciÃ³n (CIBEROBN))",NULL,NULL,"Ordered by publication type and then author name.



1.
Foreman JE, Sorg JM, McGinnis KS, Rigas B, Williams JL, Clapper ML, Gonzalez FJ, Peters JM (2009). Regulation of peroxisome proliferator-activated receptor-beta/delta by the APC/beta-CATENIN pathway and nonsteroidal antiinflammatory drugs. Mol Carcinog  48, 942-52.   https://doi.org/10.1002/mc.20546




PubMed



        
     
Free Article


 


PubMed ID 19415698
         Pubmed Central ID 2790141 


 



2.
Guettier JM, Gautam D, Scarselli M, Ruiz de Azua I, Li JH, Rosemond E, Ma X, Gonzalez FJ, Armbruster BN, Lu H, Roth BL, Wess J (2009). A chemical-genetic approach to study G protein regulation of beta cell function in vivo. Proc Natl Acad Sci U S A  106, 19197-202.   https://doi.org/10.1073/pnas.0906593106




PubMed



        
     
Free Article


 


PubMed ID 19858481
         Pubmed Central ID 2767362 


 



3.
Kanda T, Brown JD, Orasanu G, Vogel S, Gonzalez FJ, Sartoretto J, Michel T, Plutzky J (2009). PPARgamma in the endothelium regulates metabolic responses to high-fat diet in mice. J Clin Invest  119, 110-24.   https://doi.org/10.1172/JCI36233




PubMed



        
     
Free Article


 


PubMed ID 19065047
         Pubmed Central ID 2613459 


 



4.
Manna SK, Patterson AD, Yang Q, Krausz KW, Li H, Idle JR, Fornace AJ, Gonzalez FJ (2010). Identification of noninvasive biomarkers for alcohol-induced liver disease using urinary metabolomics and the Ppara-null mouse. J Proteome Res  9, 4176-88.   https://doi.org/10.1021/pr100452b




PubMed



        
     
Free Article


 


PubMed ID 20540569
         Pubmed Central ID 2917755 


 



5.
Maran RR, Thomas A, Roth M, Sheng Z, Esterly N, Pinson D, Gao X, Zhang Y, Ganapathy V, Gonzalez FJ, Guo GL (2009). Farnesoid X receptor deficiency in mice leads to increased intestinal epithelial cell proliferation and tumor development. J Pharmacol Exp Ther  328, 469-77.   https://doi.org/10.1124/jpet.108.145409




PubMed



        
     
Free Article


 


PubMed ID 18981289
         Pubmed Central ID 2682273 


 



6.
Nakajima T, Tanaka N, Kanbe H, Hara A, Kamijo Y, Zhang X, Gonzalez FJ, Aoyama T (2009). Bezafibrate at clinically relevant doses decreases serum/liver triglycerides via down-regulation of sterol regulatory element-binding protein-1c in mice: a novel peroxisome proliferator-activated receptor alpha-independent mechanism. Mol Pharmacol  75, 782-92.   https://doi.org/10.1124/mol.108.052928




PubMed



        
     
Free Article


 


PubMed ID 19124612
         Pubmed Central ID 2684924 


 



7.
Nakamura T, Ito Y, Yanagiba Y, Ramdhan DH, Kono Y, Naito H, Hayashi Y, Li Y, Aoyama T, Gonzalez FJ, Nakajima T (2009) Microgram-order ammonium perfluorooctanoate may activate mouse peroxisome proliferator-activated receptor alpha, but not human PPARalpha. Toxicology 265:27-33.




PubMed



        
     
Free Article


 


PubMed ID 19751795
         Pubmed Central ID 2848383 


 



8.
Okiyama W, Tanaka N, Nakajima T, Tanaka E, Kiyosawa K, Gonzalez FJ, Aoyama T (2009). Polyenephosphatidylcholine prevents alcoholic liver disease in PPARalpha-null mice through attenuation of increases in oxidative stress. J Hepatol  50, 1236-46.   https://doi.org/10.1016/j.jhep.2009.01.025




PubMed



        
     
Free Article


 


PubMed ID 19398233
         Pubmed Central ID 2809859 


 



9.
Pang X, Cheng J, Krausz KW, Guo DA, Gonzalez FJ (2011). Pregnane X receptor-mediated induction of Cyp3a by black cohosh. Xenobiotica  41, 112-23.   https://doi.org/10.3109/00498254.2010.527021




PubMed



        
     
Free Article


 


PubMed ID 20979450
         Pubmed Central ID 3019262 


 



10.
Wang XX, Jiang T, Shen Y, Adorini L, Pruzanski M, Gonzalez FJ, Scherzer P, Lewis L, Miyazaki-Anzai S, Levi M (2009). The farnesoid X receptor modulates renal lipid metabolism and diet-induced renal inflammation, fibrosis, and proteinuria. Am J Physiol Renal Physiol  297, F1587-96.   https://doi.org/10.1152/ajprenal.00404.2009




PubMed



        
     
Free Article


 


PubMed ID 19776172
         Pubmed Central ID 2801344",https://intramural.nih.gov/search/searchview.taf?ipid=62806
34,BC005740-18,"October 01, 2009 -  September 30, 2010",Transgenic Models for Prostate and Breast Cancer,Jeffrey E Green; MD,NULL,"Laboratory of Cancer Biology and Genetics, NCI","Christina  Bennett



Aleksandra M Michalowska



Isabel  Chu



Ziyao M Liu



Tinghu  Qiu



Christine  Tomlinson","Patricia  Berg
(George Washington University)




Alfonso  Calvo
(University of Pamplona)




Kartiki  Desai
(Genome Institute of Singapore)




Joe  Gray
(Lawrence Berkeley National Labs)




Tamaro  Hudson
(Howard University)




Kristin  Kee



Show all 8","Dolph Lee Hatfield; PhD (Laboratory of Cancer Prevention)



Melinda  Hollingshead (Biological Testing Branch)



Stanley  Lipkowitz; MD, PhD (Laboratory of Cellular and Molecular Biology)



Chand  Khanna; MD (Pediatric Oncology Branch)",Chuxia  Deng; PhD (NIDDK),"Ordered by publication type and then author name.



1.
Green J, Michalowski A, Green J (2011) Expression Profiling of Mouse Models of Human Cancer: model categorization and guidance for preclinical testing, in Genetically-engineered Mice for Cancer Research: design, analysis, pathways, validation and pre-clinical testing, in press.




 



2.
Barkan D, Green JE, Chambers AF (2010). Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth. Eur J Cancer  46, 1181-8.   https://doi.org/10.1016/j.ejca.2010.02.027




PubMed



        
     
Free Article


 


PubMed ID 20304630
         Pubmed Central ID 2856784 


 



3.
Bennett CN, Green JE (2010). Genomic analyses as a guide to target identification and preclinical testing of mouse models of breast cancer. Toxicol Pathol  38, 88-95.   https://doi.org/10.1177/0192623309357074




PubMed



        
     
Free Article


 


PubMed ID 20080934
         Pubmed Central ID 3483042 


 



4.
Gonzalez-Moreno O, Lecanda J, Green JE, Segura V, Catena R, Serrano D, Calvo A (2010). VEGF elicits epithelial-mesenchymal transition (EMT) in prostate intraepithelial neoplasia (PIN)-like cells via an autocrine loop. Exp Cell Res  316, 554-67.   https://doi.org/10.1016/j.yexcr.2009.11.020




PubMed


 


PubMed ID 20006606
    
     


 



5.
Hoenerhoff MJ, Chu I, Barkan D, Liu ZY, Datta S, Dimri GP, Green JE (2009). BMI1 cooperates with H-RAS to induce an aggressive breast cancer phenotype with brain metastases. Oncogene  28, 3022-32.   https://doi.org/10.1038/onc.2009.165




PubMed



        
     
Free Article


 


PubMed ID 19543317
         Pubmed Central ID 2733922",https://intramural.nih.gov/search/searchview.taf?ipid=62807
35,BC005785-16,"October 01, 2009 -  September 30, 2010",TGF-betas in breast cancer progression,"Lalage  Wakefield; PhD



IRP Faculty Profile",NULL,"Laboratory of Cancer Biology and Genetics, NCI","Catherine L Daniel



Yoshiko  Nagano



Kent W Hunter; PhD



Misako  Sato



Binwu  Tang



Kathleen C Flanders; PhD



Show all 7",NULL,"Maxwell P Lee; PhD (Laboratory of Population Genetics)



Mark E Sherman; MD (Hormonal and Reproductive Epidemiology Branch)



Miriam R Anver (Office Of The Director)



Chand  Khanna; MD (Pediatric Oncology Branch)



Christina  Stuelten (Laboratory Of Genitourinary Cancer Pathogenesis)",Ashok Balkrishna Kulkarni; PhD (NIDCR),"Ordered by publication type and then author name.



1.
Bian Y, Terse A, Du J, Hall B, Molinolo A, Zhang P, Chen W, Flanders KC, Gutkind JS, Wakefield LM, Kulkarni AB (2009). Progressive tumor formation in mice with conditional deletion of TGF-beta signaling in head and neck epithelia is associated with activation of the PI3K/Akt pathway. Cancer Res  69, 5918-26.   https://doi.org/10.1158/0008-5472.CAN-08-4623




PubMed



        
     
Free Article


 


PubMed ID 19584284
         Pubmed Central ID 2758611 


 



2.
Flanders KC, Wakefield LM (2009). Transforming growth factor-(beta)s and mammary gland involution; functional roles and implications for cancer progression. J Mammary Gland Biol Neoplasia  14, 131-44.   https://doi.org/10.1007/s10911-009-9122-z




PubMed



        
     
Free Article


 


PubMed ID 19396528
         Pubmed Central ID 2797127 


 



3.
Kadota M, Sato M, Duncan B, Ooshima A, Yang HH, Diaz-Meyer N, Gere S, Kageyama S, Fukuoka J, Nagata T, Tsukada K, Dunn BK, Wakefield LM, Lee MP (2009). Identification of novel gene amplifications in breast cancer and coexistence of gene amplification with an activating mutation of PIK3CA. Cancer Res  69, 7357-65.   https://doi.org/10.1158/0008-5472.CAN-09-0064




PubMed



        
     
Free Article


 


PubMed ID 19706770
         Pubmed Central ID 2745517",https://intramural.nih.gov/search/searchview.taf?ipid=62809
36,BC005793-16,"October 01, 2009 -  September 30, 2010",Mechanism of viral hepatitis-mediated hepatocarcinogenesis,"Xin Wei Wang; PhD



IRP Faculty Profile",NULL,"Laboratory of Human Carcinogenesis, NCI",Curtis  Harris; MD,NULL,"Robert  Wiltrout; PhD (Laboratory of Experimental Immunology)



Howard A Young; PhD (Laboratory of Experimental Immunology)",NULL,"Ordered by publication type and then author name.



1.
Ji J, Wang XW (2010). A Yin-Yang balancing act of the lin28/let-7 link in tumorigenesis. J Hepatol  53, 974-5.   https://doi.org/10.1016/j.jhep.2010.07.001




PubMed



               Available in future as a Free Article 


 


PubMed ID 20739081
         Pubmed Central ID 2949515 


 



2.
Ji J, Zhao L, Budhu A, Forgues M, Jia HL, Qin LX, Ye QH, Yu J, Shi X, Tang ZY, Wang XW (2010). Let-7g targets collagen type I alpha2 and inhibits cell migration in hepatocellular carcinoma. J Hepatol  52, 690-7.   https://doi.org/10.1016/j.jhep.2009.12.025




PubMed



        
     
Free Article


 


PubMed ID 20338660
         Pubmed Central ID 2862772",https://intramural.nih.gov/search/searchview.taf?ipid=62810
37,BC005795-16,"October 01, 2009 -  September 30, 2010",p53 Tumor Suppressor Pathway,"Curtis  Harris; MD



IRP Faculty Profile",NULL,"Laboratory of Human Carcinogenesis, NCI","Kaori  Fujita



Izumi  Horikawa



Abdul Matin Mondal



Giang Huong Nguyen



Sharon R Pine



Brid Mairead Ryan



Show all 11",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Binet R, Ythier D, Robles AI, Collado M, Larrieu D, Fonti C, Brambilla E, Brambilla C, Serrano M, Harris CC, Pedeux R (2009). WNT16B is a new marker of cellular senescence that regulates p53 activity and the phosphoinositide 3-kinase/AKT pathway. Cancer Res  69, 9183-91.   https://doi.org/10.1158/0008-5472.CAN-09-1016




PubMed


 


PubMed ID 19951988
    
     


 



2.
Fujita K, Mondal AM, Horikawa I, Nguyen GH, Kumamoto K, Sohn JJ, Bowman ED, Mathe EA, Schetter AJ, Pine SR, Ji H, Vojtesek B, Bourdon JC, Lane DP, Harris CC (2009). p53 isoforms Delta133p53 and p53beta are endogenous regulators of replicative cellular senescence. Nat Cell Biol  11, 1135-42.   https://doi.org/10.1038/ncb1928




PubMed



        
     
Free Article


 


PubMed ID 19701195
         Pubmed Central ID 2802853 


 



3.
Simone NL, Soule BP, Ly D, Saleh AD, Savage JE, Degraff W, Cook J, Harris CC, Gius D, Mitchell JB (2009). Ionizing radiation-induced oxidative stress alters miRNA expression. PLoS One  4, e6377.   https://doi.org/10.1371/journal.pone.0006377




PubMed



        
     
Free Article


 


PubMed ID 19633716
         Pubmed Central ID 2712071 


 



4.
Zeng S, Xiang T, Pandita TK, Gonzalez-Suarez I, Gonzalo S, Harris CC, Yang Q (2009). Telomere recombination requires the MUS81 endonuclease. Nat Cell Biol  11, 616-23.   https://doi.org/10.1038/ncb1867




PubMed



        
     
Free Article


 


PubMed ID 19363487
         Pubmed Central ID 2675667",https://intramural.nih.gov/search/searchview.taf?ipid=62811
38,BC006140-34,"October 01, 2009 -  September 30, 2010",Studies of Histone Functions in Chromatin; H2AX and DNA DSBs,"William M Bonner; PhD



IRP Faculty Profile",NULL,"Developmental Therapeutics Branch, NCI","Asako  Nakamura



Palak Rajendra Parekh



Christophe  Redon



Olga A Sedelnikova; PhD



Yves  Pommier; PhD



Mirit I Aladjem; PhD



Show all 8","Sergey  Andreev
(Russian Academy of Sciences)




Valeria  Audoshina
(Georgetown University)




William F Blakely; PhD
(Armed Forces Radiobiological Research Institute)




David  Brenner
(Columbia University)




Michael  Cheezum
(Walter Reed Army Medical Center)




Sean  Collins
(Georgetown University)


Show all 17","Jiuping  Ji (Office of the Director)



Lionel  Feigenbaum (Office Of The Director)



Susan  Bates; MD (Medical Oncology Branch)



Scott Michael Lawrence (Office Of The Director)



Martin W Brechbiel; PhD (Radiation Oncology Branch)","Alexander L Kovalchuk; MD, PhD (NIAID) 



Gary Leonard Griffiths; BSc, PhD (NHLBI) 



Irina  Panyutin; MD (CC) 



Karen P Usdin; PhD (NIDDK) 



Ronald D Neumann; MD (CC) 



Igor  Panyutin; PhD (CC)","Ordered by publication type and then author name.



1.
Bonner W, Nakamura A, Sordet O, Dickey J, Gouliaeva K, Tabb B, Lawrence S, Kinders R, Bonner W, Sedelnikova O (2011) g-H2AX Detection in Peripheral Blood Lymphocytes, Splenocytes, Bone Marrow, Xenografts, and Skin, in DNA Damage Detection In Situ, Ex Vivo, and In Vivo. Springer Science, in press.




 



2.
Bonner W, Nakamura A, Zhang Y, Ji J, Bonner W, Kinders R, Parchment R, Doroshow J, Pommier Y (2010) Histone gammaH2AX and Poly(ADP Ribose) as Clinical Pharmacodynamic Biomarkers. Clinical Cancer Research, in press.




 



3.
Dickey JS, Baird BJ, Redon CE, Sokolov MV, Sedelnikova OA, Bonner WM (2009). Intercellular communication of cellular stress monitored by gamma-H2AX induction. Carcinogenesis  30, 1686-95.   https://doi.org/10.1093/carcin/bgp192




PubMed



        
     
Free Article


 


PubMed ID 19651821
         Pubmed Central ID 2757548 


 



4.
Dickey JS, Redon CE, Nakamura AJ, Baird BJ, Sedelnikova OA, Bonner WM (2009). H2AX: functional roles and potential applications. Chromosoma  118, 683-92.   https://doi.org/10.1007/s00412-009-0234-4




PubMed



        
     
Free Article


 


PubMed ID 19707781
         Pubmed Central ID 3094848 


 



5.
Nakamura AJ, Redon CE, Bonner WM, Sedelnikova OA (2009). Telomere-dependent and telomere-independent origins of endogenous DNA damage in tumor cells. Aging (Albany NY)  1, 212-8.   https://doi.org/10.18632/aging.100019




PubMed



        
     
Free Article


 


PubMed ID 20157510
         Pubmed Central ID 2806003 


 



6.
Nowsheen S, Wukovich RL, Aziz K, Kalogerinis PT, Richardson CC, Panayiotidis MI, Bonner WM, Sedelnikova OA, Georgakilas AG (2009). Accumulation of oxidatively induced clustered DNA lesions in human tumor tissues. Mutat Res  674, 131-6.   https://doi.org/10.1016/j.mrgentox.2008.09.010




PubMed



        
     
Free Article


 


PubMed ID 18948225
         Pubmed Central ID 6944316 


 



7.
Redon CE, Dickey JS, Bonner WM, Sedelnikova OA (2009). γ-H2AX as a biomarker of DNA damage induced by ionizing radiation in human peripheral blood lymphocytes and artificial skin. Adv Space Res  43, 1171-1178.   https://doi.org/10.1016/j.asr.2008.10.011




PubMed



        
     
Free Article


 


PubMed ID 20046946
         Pubmed Central ID 2735274 


 



8.
Sedelnikova OA, Redon CE, Dickey JS, Nakamura AJ, Georgakilas AG, Bonner WM (2010). Role of oxidatively induced DNA lesions in human pathogenesis. Mutat Res  704, 152-9.   https://doi.org/10.1016/j.mrrev.2009.12.005




PubMed



        
     
Free Article


 


PubMed ID 20060490
         Pubmed Central ID 3074954 


 



9.
Sordet O, Redon CE, Guirouilh-Barbat J, Smith S, Solier S, Douarre C, Conti C, Nakamura AJ, Das BB, Nicolas E, Kohn KW, Bonner WM, Pommier Y (2009). Ataxia telangiectasia mutated activation by transcription- and topoisomerase I-induced DNA double-strand breaks. EMBO Rep  10, 887-93.   https://doi.org/10.1038/embor.2009.97




PubMed



        
     
Free Article


 


PubMed ID 19557000
         Pubmed Central ID 2726680",https://intramural.nih.gov/search/searchview.taf?ipid=62812
39,BC006150-29,"October 01, 2009 -  September 30, 2010","DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs","Yves  Pommier; PhD



IRP Faculty Profile",NULL,"Developmental Therapeutics Branch, NCI","Sheena Margie-Ann Aris



Benu Brata  Das



Celine  Douarre



Elisabetta  Leo



Junko  Murai



Marie Odette Regairaz



Show all 16","Mark  Cushman
(Medicinal Chemistry, Purdue University)




William  Gmeiner
(PHARMACOLOGY, WAKE FOREST UNIVERSITY)




William  Jorgensen
(CHEMISTRY, Yale University)




Gary  Olson
(Provid Pharma)




Christopher  Self
(Provide Pharma)




Yoshi  Shiloh
(Tel Aviv University)","Dominic  Scudiero (Screening Technologies Branch)



Paul S Meltzer; MD, PhD (Cancer Genetics Branch)



Robert J Fisher (Office Of The Director)



Melinda  Hollingshead (Biological Testing Branch)



Marc C Nicklaus (Chemical Biology Laboratory)



Robert  Shoemaker (Screening Technologies Branch)","Christopher P Austin; AB, MD (NHGRI) 



Weidong  Wang; PhD (NIA)","Ordered by publication type and then author name.



1.
Das BB, Antony S, Gupta S, Dexheimer TS, Redon CE, Garfield S, Shiloh Y, Pommier Y (2009). Optimal function of the DNA repair enzyme TDP1 requires its phosphorylation by ATM and/or DNA-PK. EMBO J  28, 3667-80.   https://doi.org/10.1038/emboj.2009.302




PubMed



        
     
Free Article


 


PubMed ID 19851285
         Pubmed Central ID 2790489 


 



2.
Dexheimer TS, Gediya LK, Stephen AG, Weidlich I, Antony S, Marchand C, Interthal H, Nicklaus M, Fisher RJ, Njar VC, Pommier Y (2009). 4-Pregnen-21-ol-3,20-dione-21-(4-bromobenzenesulfonate) (NSC 88915) and related novel steroid derivatives as tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors. J Med Chem  52, 7122-31.   https://doi.org/10.1021/jm901061s




PubMed



        
     
Free Article


 


PubMed ID 19883083
         Pubmed Central ID 2784989 


 



3.
Guirouilh-Barbat J, Zhang YW, Pommier Y (2009). Induction of glutathione-dependent DNA double-strand breaks by the novel anticancer drug brostallicin. Mol Cancer Ther  8, 1985-94.   https://doi.org/10.1158/1535-7163.MCT-09-0320




PubMed



        
     
Free Article


 


PubMed ID 19584235
         Pubmed Central ID 2760303 


 



4.
Jobson AG, Lountos GT, Lorenzi PL, Llamas J, Connelly J, Cerna D, Tropea JE, Onda A, Zoppoli G, Kondapaka S, Zhang G, Caplen NJ, Cardellina JH, Yoo SS, Monks A, Self C, Waugh DS, Shoemaker RH, Pommier Y (2009). Cellular inhibition of checkpoint kinase 2 (Chk2) and potentiation of camptothecins and radiation by the novel Chk2 inhibitor PV1019 [7-nitro-1H-indole-2-carboxylic acid {4-[1-(guanidinohydrazone)-ethyl]-phenyl}-amide]. J Pharmacol Exp Ther  331, 816-26.   https://doi.org/10.1124/jpet.109.154997




PubMed



        
     
Free Article


 


PubMed ID 19741151
         Pubmed Central ID 2784710 


 



5.
Kohn KW, Aladjem MI, Weinstein JN, Pommier Y (2009). Network architecture of signaling from uncoupled helicase-polymerase to cell cycle checkpoints and trans-lesion DNA synthesis. Cell Cycle  8, 2281-99.   https://doi.org/10.4161/cc.8.14.9102




PubMed



        
     
Free Article


 


PubMed ID 19556879
         Pubmed Central ID 4018747 


 



6.
Lorenzi PL, Reinhold WC, Varma S, Hutchinson AA, Pommier Y, Chanock SJ, Weinstein JN (2009). DNA fingerprinting of the NCI-60 cell line panel. Mol Cancer Ther  8, 713-24.   https://doi.org/10.1158/1535-7163.MCT-08-0921




PubMed



        
     
Free Article


 


PubMed ID 19372543
         Pubmed Central ID 4020356 


 



7.
Lountos GT, Tropea JE, Zhang D, Jobson AG, Pommier Y, Shoemaker RH, Waugh DS (2009). Crystal structure of checkpoint kinase 2 in complex with NSC 109555, a potent and selective inhibitor. Protein Sci  18, 92-100.   https://doi.org/10.1002/pro.16




PubMed



        
     
Free Article


 


PubMed ID 19177354
         Pubmed Central ID 2708046 


 



8.
Orina JN, Calcagno AM, Wu CP, Varma S, Shih J, Lin M, Eichler G, Weinstein JN, Pommier Y, Ambudkar SV, Gottesman MM, Gillet JP (2009). Evaluation of current methods used to analyze the expression profiles of ATP-binding cassette transporters yields an improved drug-discovery database. Mol Cancer Ther  8, 2057-66.   https://doi.org/10.1158/1535-7163.MCT-09-0256




PubMed



        
     
Free Article


 


PubMed ID 19584229
         Pubmed Central ID 2736804 


 



9.
Pfister TD, Reinhold WC, Agama K, Gupta S, Khin SA, Kinders RJ, Parchment RE, Tomaszewski JE, Doroshow JH, Pommier Y (2009). Topoisomerase I levels in the NCI-60 cancer cell line panel determined by validated ELISA and microarray analysis and correlation with indenoisoquinoline sensitivity. Mol Cancer Ther  8, 1878-84.   https://doi.org/10.1158/1535-7163.MCT-09-0016




PubMed



        
     
Free Article


 


PubMed ID 19584232
         Pubmed Central ID 2728499 


 



10.
Solier S, Sordet O, Kohn KW, Pommier Y (2009). Death receptor-induced activation of the Chk2- and histone H2AX-associated DNA damage response pathways. Mol Cell Biol  29, 68-82.   https://doi.org/10.1128/MCB.00581-08




PubMed



        
     
Free Article


 


PubMed ID 18955500
         Pubmed Central ID 2612481 


 



11.
Sordet O, Redon CE, Guirouilh-Barbat J, Smith S, Solier S, Douarre C, Conti C, Nakamura AJ, Das BB, Nicolas E, Kohn KW, Bonner WM, Pommier Y (2009). Ataxia telangiectasia mutated activation by transcription- and topoisomerase I-induced DNA double-strand breaks. EMBO Rep  10, 887-93.   https://doi.org/10.1038/embor.2009.97




PubMed



        
     
Free Article


 


PubMed ID 19557000
         Pubmed Central ID 2726680 


 



12.
Weidlich IE, Dexheimer T, Marchand C, Antony S, Pommier Y, Nicklaus MC (2010). Inhibitors of human tyrosyl-DNA phospodiesterase (hTdp1) developed by virtual screening using ligand-based pharmacophores. Bioorg Med Chem  18, 182-9.   https://doi.org/10.1016/j.bmc.2009.11.008




PubMed



        
     
Free Article


 


PubMed ID 19963390
         Pubmed Central ID 4123439 


 



13.
Xu D, Muniandy P, Leo E, Yin J, Thangavel S, Shen X, Ii M, Agama K, Guo R, Fox D, Meetei AR, Wilson L, Nguyen H, Weng NP, Brill SJ, Li L, Vindigni A, Pommier Y, Seidman M, Wang W (2010). Rif1 provides a new DNA-binding interface for the Bloom syndrome complex to maintain normal replication. EMBO J  29, 3140-55.   https://doi.org/10.1038/emboj.2010.186




PubMed



        
     
Free Article


 


PubMed ID 20711169
         Pubmed Central ID 2944062 


 



14.
Zhang YW, Jones TL, Martin SE, Caplen NJ, Pommier Y (2009). Implication of checkpoint kinase-dependent up-regulation of ribonucleotide reductase R2 in DNA damage response. J Biol Chem  284, 18085-95.   https://doi.org/10.1074/jbc.M109.003020




PubMed



        
     
Free Article


 


PubMed ID 19416980
         Pubmed Central ID 2709352",https://intramural.nih.gov/search/searchview.taf?ipid=62813
40,BC006161-27,"October 01, 2009 -  September 30, 2010",DNA Topoisomerases as Target of Action of Anticancer Drugs,"Yves  Pommier; PhD



IRP Faculty Profile",NULL,"Developmental Therapeutics Branch, NCI","Ilaria  Dalla Rosa



Benu Brata  Das



James Halpern Doroshow



Celine  Douarre



Kurt  Kohn; PhD



Elisabetta  Leo



Show all 13","Mark  Cushman
(Medicinal Chemistry, Purdue University)




Takehiro  Yasukawa
(University College of London)","Melinda  Hollingshead (Biological Testing Branch)



Susan  Bates; MD (Medical Oncology Branch)



Joseph E Tomaszewski (Office of the Director)",NULL,"Ordered by publication type and then author name.



1.
Cinelli MA, Cordero B, Dexheimer TS, Pommier Y, Cushman M (2009). Synthesis and biological evaluation of 14-(aminoalkyl-aminomethyl)aromathecins as topoisomerase I inhibitors: investigating the hypothesis of shared structure-activity relationships. Bioorg Med Chem  17, 7145-55.   https://doi.org/10.1016/j.bmc.2009.08.066




PubMed



        
     
Free Article


 


PubMed ID 19783447
         Pubmed Central ID 2769207 


 



2.
Dalla Rosa I, Goffart S, Wurm M, Wiek C, Essmann F, Sobek S, Schroeder P, Zhang H, Krutmann J, Hanenberg H, Schulze-Osthoff K, Mielke C, Pommier Y, Boege F, Christensen MO (2009). Adaptation of topoisomerase I paralogs to nuclear and mitochondrial DNA. Nucleic Acids Res  37, 6414-28.   https://doi.org/10.1093/nar/gkp708




PubMed



        
     
Free Article


 


PubMed ID 19720733
         Pubmed Central ID 2770673 


 



3.
Lebedeva NA, Rechkunova NI, Agama K, Pommier Y, Lavrik OI (2009). Interaction of DNA topoisomerase 1 with DNA intermediates and proteins of base excision repair. Biochemistry (Mosc)  74, 1278-84.   https://doi.org/10.1134/s0006297909110157




PubMed


 


PubMed ID 19916945
    
     


 



4.
Oussedik K, François JC, Halby L, Senamaud-Beaufort C, Toutirais G, Dallavalle S, Pommier Y, Pisano C, Arimondo PB (2010). Sequence-specific targeting of IGF-I and IGF-IR genes by camptothecins. FASEB J  24, 2235-44.   https://doi.org/10.1096/fj.09-132324




PubMed



        
     
Free Article


 


PubMed ID 20179147
         Pubmed Central ID 2887256 


 



5.
Pfister TD, Reinhold WC, Agama K, Gupta S, Khin SA, Kinders RJ, Parchment RE, Tomaszewski JE, Doroshow JH, Pommier Y (2009). Topoisomerase I levels in the NCI-60 cancer cell line panel determined by validated ELISA and microarray analysis and correlation with indenoisoquinoline sensitivity. Mol Cancer Ther  8, 1878-84.   https://doi.org/10.1158/1535-7163.MCT-09-0016




PubMed



        
     
Free Article


 


PubMed ID 19584232
         Pubmed Central ID 2728499 


 



6.
Pommier Y (2009). DNA topoisomerase I inhibitors: chemistry, biology, and interfacial inhibition. Chem Rev  109, 2894-902.   https://doi.org/10.1021/cr900097c




PubMed



        
     
Free Article


 


PubMed ID 19476377
         Pubmed Central ID 2707511 


 



7.
Pommier Y, Cushman M (2009). The indenoisoquinoline noncamptothecin topoisomerase I inhibitors: update and perspectives. Mol Cancer Ther  8, 1008-14.   https://doi.org/10.1158/1535-7163.MCT-08-0706




PubMed



        
     
Free Article


 


PubMed ID 19383846
         Pubmed Central ID 2888777 


 



8.
Sordet O, Redon CE, Guirouilh-Barbat J, Smith S, Solier S, Douarre C, Conti C, Nakamura AJ, Das BB, Nicolas E, Kohn KW, Bonner WM, Pommier Y (2009). Ataxia telangiectasia mutated activation by transcription- and topoisomerase I-induced DNA double-strand breaks. EMBO Rep  10, 887-93.   https://doi.org/10.1038/embor.2009.97




PubMed



        
     
Free Article


 


PubMed ID 19557000
         Pubmed Central ID 2726680 


 



9.
Tuduri S, Crabbé L, Conti C, Tourrière H, Holtgreve-Grez H, Jauch A, Pantesco V, De Vos J, Thomas A, Theillet C, Pommier Y, Tazi J, Coquelle A, Pasero P (2009). Topoisomerase I suppresses genomic instability by preventing interference between replication and transcription. Nat Cell Biol  11, 1315-24.   https://doi.org/10.1038/ncb1984




PubMed



        
     
Free Article


 


PubMed ID 19838172
         Pubmed Central ID 2912930",https://intramural.nih.gov/search/searchview.taf?ipid=62814
41,BC006192-22,"October 01, 2009 -  September 30, 2010",Investigating Regulatory Networks that Control Cell Proliferation and Apoptosis,"Kurt  Kohn; PhD



IRP Faculty Profile",NULL,"Developmental Therapeutics Branch, NCI","Sohyoung  Kim



Geoffrey B Mcfadden



Mirit I Aladjem; PhD



Augustin  Luna",NULL,Ruth  Nussinov; PhD (Center for Cancer Research Nanobiology Program),NULL,"Ordered by publication type and then author name.



1.
Kohn KW, Aladjem MI, Weinstein JN, Pommier Y (2009). Network architecture of signaling from uncoupled helicase-polymerase to cell cycle checkpoints and trans-lesion DNA synthesis. Cell Cycle  8, 2281-99.   https://doi.org/10.4161/cc.8.14.9102




PubMed



        
     
Free Article


 


PubMed ID 19556879
         Pubmed Central ID 4018747 


 



2.
Liu H, D'Andrade P, Fulmer-Smentek S, Lorenzi P, Kohn KW, Weinstein JN, Pommier Y, Reinhold WC (2010). mRNA and microRNA expression profiles of the NCI-60 integrated with drug activities. Mol Cancer Ther  9, 1080-91.   https://doi.org/10.1158/1535-7163.MCT-09-0965




PubMed



        
     
Free Article


 


PubMed ID 20442302
         Pubmed Central ID 2879615",https://intramural.nih.gov/search/searchview.taf?ipid=62818
42,BC006198-21,"October 01, 2009 -  September 30, 2010",Inhibitors of Tyrosine Kinase-Dependent Signalling as Anti-Cancer Agents,"Terrence R Burke; PhD



IRP Faculty Profile",NULL,"Chemical Biology Laboratory, NCI","Medhanit  Bahta



Sung-Eun  Kim



Wen-Jian  Qian; PhD



Joshua D Thomas","Stephan  Feller
(Oxford University)




Robert  Ulrich
(Molecular Immunology, USAMRIID)




Michael  Yaffe
(Massachusetts Institute of Technology)","Robert J Fisher (Office Of The Director)



Allan M Weissman; MD (Laboratory of Protein Dynamics and Signaling)



Kyung  Lee; PhD (Chemistry Section)



Robert  Blumenthal; PhD (Center for Cancer Research Nanobiology Program)



David S Waugh; PhD (Protein Engineering Section)



Christoph  Rader; PhD (Experimental Transplantation and Immunology Branch)",NULL,"Ordered by publication type and then author name.



1.
Choi WJ, Kim SE, Stephen AG, Weidlich I, Giubellino A, Liu F, Worthy KM, Bindu L, Fivash MJ, Nicklaus MC, Bottaro DP, Fisher RJ, Burke TR (2009). Identification of Shc Src homology 2 domain-binding peptoid-peptide hybrids. J Med Chem  52, 1612-8.   https://doi.org/10.1021/jm800789h




PubMed



        
     
Free Article


 


PubMed ID 19226165
         Pubmed Central ID 2669314 


 



2.
Peach ML, Tan N, Choyke SJ, Giubellino A, Athauda G, Burke TR, Nicklaus MC, Bottaro DP (2009). Directed discovery of agents targeting the Met tyrosine kinase domain by virtual screening. J Med Chem  52, 943-51.   https://doi.org/10.1021/jm800791f




PubMed



        
     
Free Article


 


PubMed ID 19199650
         Pubmed Central ID 2698034 


 



3.
Yun SM, Moulaei T, Lim D, Bang JK, Park JE, Shenoy SR, Liu F, Kang YH, Liao C, Soung NK, Lee S, Yoon DY, Lim Y, Lee DH, Otaka A, Appella E, McMahon JB, Nicklaus MC, Burke TR, Yaffe MB, Wlodawer A, Lee KS (2009). Structural and functional analyses of minimal phosphopeptides targeting the polo-box domain of polo-like kinase 1. Nat Struct Mol Biol  16, 876-82.   https://doi.org/10.1038/nsmb.1628




PubMed



        
     
Free Article


 


PubMed ID 19597481
         Pubmed Central ID 2721907",https://intramural.nih.gov/search/searchview.taf?ipid=62819
43,BC007333-19,"October 01, 2009 -  September 30, 2010",Pharmacology of HIV Viral DNA  and  Retroviral Integrases,"Yves  Pommier; PhD



IRP Faculty Profile",NULL,"Developmental Therapeutics Branch, NCI","Kasthuraiah  Maddali



Mathieu Albert Metifiot



Alena  Naumova



Ann  Orr","Roberto  Di Santo
(Univerty of Roma ""La Sapienza"")




A. Jun  Komano
(AIDS Research Center)




Yuk  Sham
(University of Minnesota)




ZhengQuiang  Wang
(University of Minnesota)","Stuart F J Le Grice; PhD (Retroviral Replication Laboratory)



Marc C Nicklaus (Chemical Biology Laboratory)



Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)



Terrence R Burke; PhD (Chemical Biology Laboratory)



Alexander  Wlodawer; PhD (Macromolecular Crystallography Laboratory)



Stephen H Hughes; PhD (HIV Drug Resistance Program)",NULL,"Ordered by publication type and then author name.



1.
Marchand C, Maddali K, Métifiot M, Pommier Y (2009). HIV-1 IN inhibitors: 2010 update and perspectives. Curr Top Med Chem  9, 1016-37.   https://doi.org/10.2174/156802609789630910




PubMed



        
     
Free Article


 


PubMed ID 19747122
         Pubmed Central ID 2860603 


 



2.
Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H (2010). Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies. Bioorg Med Chem  18, 6771-5.   https://doi.org/10.1016/j.bmc.2010.07.050




PubMed



        
     
Free Article


 


PubMed ID 20708407
         Pubmed Central ID 4486254 


 



3.
Zhao XZ, Maddali K, Marchand C, Pommier Y, Burke TR (2009). Diketoacid-genre HIV-1 integrase inhibitors containing enantiomeric arylamide functionality. Bioorg Med Chem  17, 5318-24.   https://doi.org/10.1016/j.bmc.2009.05.008




PubMed



               Available in future as a Free Article 


 


PubMed ID 19527935
         Pubmed Central ID 2747503 


 



4.
Zhao XZ, Maddali K, Vu BC, Marchand C, Hughes SH, Pommier Y, Burke TR (2009). Examination of halogen substituent effects on HIV-1 integrase inhibitors derived from 2,3-dihydro-6,7-dihydroxy-1H-isoindol-1-ones and 4,5-dihydroxy-1H-isoindole-1,3(2H)-diones. Bioorg Med Chem Lett  19, 2714-7.   https://doi.org/10.1016/j.bmcl.2009.03.122




PubMed



        
     
Free Article


 


PubMed ID 19364649
         Pubmed Central ID 2747502",https://intramural.nih.gov/search/searchview.taf?ipid=62820
44,BC007363-16,"October 01, 2009 -  September 30, 2010",Design and Synthesis of HIV Integrase as Potential Anti-AIDS Drugs,"Terrence R Burke; PhD



IRP Faculty Profile",NULL,"Chemical Biology Laboratory, NCI","Xue Zhi  Zhao



Marc C Nicklaus","Peter  Cherepanov
(Imperial College London)




Serge  Fermandjian
(CNRS)




Mamuka  Kvaratskhelia; PhD
(College of Pharmacy, Ohio State University)




Anne  Skalka
(Fox Chase Cancer Center)","Robert J Fisher (Office Of The Director)



Yves  Pommier; PhD (Developmental Therapeutics Branch)



Alexander  Wlodawer; PhD (Macromolecular Crystallography Laboratory)



Eric O Freed; PhD (Retroviral Replication Laboratory)



Stephen H Hughes; PhD (HIV Drug Resistance Program)



Vinay K Pathak; PhD (Retroviral Replication Laboratory)",James H Hurley; PhD (NIDDK),"Ordered by publication type and then author name.



1.
Andrake MD, Ramcharan J, Merkel G, Zhao XZ, Burke TR, Skalka AM (2009). Comparison of metal-dependent catalysis by HIV-1 and ASV integrase proteins using a new and rapid, moderate throughput assay for joining activity in solution. AIDS Res Ther  6, 14.   https://doi.org/10.1186/1742-6405-6-14




PubMed



        
     
Free Article


 


PubMed ID 19563676
         Pubmed Central ID 2717984 


 



2.
Burke T, Kuo L, Ren X, Burgos P, Zhao X, Liu F, Burke T, Freed E, Hurley J (2010) Crystallographic and Functional Analysis of the ESCRT-I HIV-1 Gag PTAP Interaction. Structure, in press.




 



3.
Kessl JJ, Eidahl JO, Shkriabai N, Zhao Z, McKee CJ, Hess S, Burke TR, Kvaratskhelia M (2009). An allosteric mechanism for inhibiting HIV-1 integrase with a small molecule. Mol Pharmacol  76, 824-32.   https://doi.org/10.1124/mol.109.058883




PubMed



        
     
Free Article


 


PubMed ID 19638533
         Pubmed Central ID 2769043 


 



4.
Zhao XZ, Maddali K, Marchand C, Pommier Y, Burke TR (2009). Diketoacid-genre HIV-1 integrase inhibitors containing enantiomeric arylamide functionality. Bioorg Med Chem  17, 5318-24.   https://doi.org/10.1016/j.bmc.2009.05.008




PubMed



               Available in future as a Free Article 


 


PubMed ID 19527935
         Pubmed Central ID 2747503 


 



5.
Zhao XZ, Maddali K, Vu BC, Marchand C, Hughes SH, Pommier Y, Burke TR (2009). Examination of halogen substituent effects on HIV-1 integrase inhibitors derived from 2,3-dihydro-6,7-dihydroxy-1H-isoindol-1-ones and 4,5-dihydroxy-1H-isoindole-1,3(2H)-diones. Bioorg Med Chem Lett  19, 2714-7.   https://doi.org/10.1016/j.bmcl.2009.03.122




PubMed



        
     
Free Article


 


PubMed ID 19364649
         Pubmed Central ID 2747502",https://intramural.nih.gov/search/searchview.taf?ipid=62821
45,BC007365-16,"October 01, 2009 -  September 30, 2010",Regulation of ADP-ribosylation factor,"Paul A Randazzo; MD, PhD



IRP Faculty Profile",NULL,"Laboratory of Cellular and Molecular Biology, NCI","Pei-Wen  Chen



Xiaoying  Jian; PhD



Ruibai  Luo



Yoko  Shiba



Marek  Sramko



Emily Frances Winterbottom



Show all 8","Sylvain  Bourgain
(University of Laval)




Richard  Kahn
(Emory University)




Wolfgang  Losert; PhD
(University of Maryland)




Elizabeth  Sztul
(University of Alabama)","Ira  Daar; PhD (Laboratory of Cell and Developmental Signaling)



Robert Andrew Byrd (Structural Biophysics Laboratory)



Lino  Tessarollo (Mouse Cancer Genetics Program)","J Silvio  Gutkind; PhD (NIDCR) 



James  Gruschus; PhD (NHLBI) 



Kenneth Manao Yamada; MD, PhD (NIDCR)","Ordered by publication type and then author name.



1.
Campa F, Yoon HY, Ha VL, Szentpetery Z, Balla T, Randazzo PA (2009). A PH domain in the Arf GTPase-activating protein (GAP) ARAP1 binds phosphatidylinositol 3,4,5-trisphosphate and regulates Arf GAP activity independently of recruitment to the plasma membranes. J Biol Chem  284, 28069-83.   https://doi.org/10.1074/jbc.M109.028266




PubMed



        
     
Free Article


 


PubMed ID 19666464
         Pubmed Central ID 2788858 


 



2.
Gruschus JM, Chen PW, Luo R, Randazzo PA (2009). Journey to the ends of the Arf. Structure  17, 2-4.   https://doi.org/10.1016/j.str.2008.12.002




PubMed


 


PubMed ID 19141275
    
     


 



3.
Jian X, Brown P, Schuck P, Gruschus JM, Balbo A, Hinshaw JE, Randazzo PA (2009). Autoinhibition of Arf GTPase-activating protein activity by the BAR domain in ASAP1. J Biol Chem  284, 1652-63.   https://doi.org/10.1074/jbc.M804218200




PubMed



        
     
Free Article


 


PubMed ID 19017632
         Pubmed Central ID 2615509 


 



4.
Liljegren SJ, Leslie ME, Darnielle L, Lewis MW, Taylor SM, Luo R, Geldner N, Chory J, Randazzo PA, Yanofsky MF, Ecker JR (2009). Regulation of membrane trafficking and organ separation by the NEVERSHED ARF-GAP protein. Development  136, 1909-18.   https://doi.org/10.1242/dev.033605




PubMed



        
     
Free Article


 


PubMed ID 19429787
         Pubmed Central ID 2680113 


 



5.
Luo R, Ha VL, Hayashi R, Randazzo PA (2009). Arf GAP2 is positively regulated by coatomer and cargo. Cell Signal  21, 1169-79.   https://doi.org/10.1016/j.cellsig.2009.03.006




PubMed



        
     
Free Article


 


PubMed ID 19296914
         Pubmed Central ID 2692659 


 



6.
Mazelova J, Astuto-Gribble L, Inoue H, Tam BM, Schonteich E, Prekeris R, Moritz OL, Randazzo PA, Deretic D (2009). Ciliary targeting motif VxPx directs assembly of a trafficking module through Arf4. EMBO J  28, 183-92.   https://doi.org/10.1038/emboj.2008.267




PubMed



        
     
Free Article


 


PubMed ID 19153612
         Pubmed Central ID 2637330",https://intramural.nih.gov/search/searchview.taf?ipid=62822
46,BC008226-34,"October 01, 2009 -  September 30, 2010",Prolactin Interactions in Mammary Gland Development and Tumorigenesis,Barbara V Vonderhaar; PhD,NULL,"Mammary Biology and Tumorigenesis Laboratory, NCI","Robert  Callahan; PhD



Jennifer L Rudolph



Erika P Ginsburg



Anita  Goldhar



David  Salomon; PhD","Charles  Brooks
(Ohio State University)




Kennichi  Satoh
(Gastroenterology, Tohoku University School of Medicine)




Luigi  Strizzi",Paul  Goldsmith; PhD (Basic Research Laboratory),NULL,"Ordered by publication type and then author name.



1.
di Bari MG, Ginsburg E, Plant J, Strizzi L, Salomon DS, Vonderhaar BK (2009). Msx2 induces epithelial-mesenchymal transition in mouse mammary epithelial cells through upregulation of Cripto-1. J Cell Physiol  219, 659-66.   https://doi.org/10.1002/jcp.21712




PubMed



        
     
Free Article


 


PubMed ID 19170109
         Pubmed Central ID 2753837 


 



2.
Meethal SV, Liu T, Chan HW, Ginsburg E, Wilson AC, Gray DN, Bowen RL, Vonderhaar BK, Atwood CS (2009). Identification of a regulatory loop for the synthesis of neurosteroids: a steroidogenic acute regulatory protein-dependent mechanism involving hypothalamic-pituitary-gonadal axis receptors. J Neurochem  110, 1014-27.   https://doi.org/10.1111/j.1471-4159.2009.06192.x




PubMed



        
     
Free Article


 


PubMed ID 19493163
         Pubmed Central ID 2789665 


 



3.
Raafat A, Lawson S, Bargo S, Klauzinska M, Strizzi L, Goldhar AS, Buono K, Salomon D, Vonderhaar BK, Callahan R (2009). Rbpj conditional knockout reveals distinct functions of Notch4/Int3 in mammary gland development and tumorigenesis. Oncogene  28, 219-30.   https://doi.org/10.1038/onc.2008.379




PubMed



        
     
Free Article


 


PubMed ID 18836481
         Pubmed Central ID 2794555 


 



4.
Vonderhaar B, Ginsburg E, Fleming J, Susser L, Doucet T, Vonderhaar B (2010) 16 kDa prolactin reduces angiogenesis, but not growth of human breast cancer tumors in vivo. Hormones and Cancer 1:10.




 



5.
Wolf R, Voscopoulos C, Winston J, Dharamsi A, Goldsmith P, Gunsior M, Vonderhaar BK, Olson M, Watson PH, Yuspa SH (2009). Highly homologous hS100A15 and hS100A7 proteins are distinctly expressed in normal breast tissue and breast cancer. Cancer Lett  277, 101-7.   https://doi.org/10.1016/j.canlet.2008.11.032




PubMed



               Available in future as a Free Article 


 


PubMed ID 19136201
         Pubmed Central ID 2680177 


 



6.
Xu R, Nelson CM, Muschler JL, Veiseh M, Vonderhaar BK, Bissell MJ (2009). Sustained activation of STAT5 is essential for chromatin remodeling and maintenance of mammary-specific function. J Cell Biol  184, 57-66.   https://doi.org/10.1083/jcb.200807021




PubMed



        
     
Free Article


 


PubMed ID 19139262
         Pubmed Central ID 2615090",https://intramural.nih.gov/search/searchview.taf?ipid=62823
47,BC008303-38,"October 01, 2009 -  September 30, 2010",Mechanisms of Viral Fusion and Inactivation,"Robert  Blumenthal; PhD



IRP Faculty Profile",NULL,"Center for Cancer Research Nanobiology Program, NCI","Julie M Belanger



Eliahu  Heldman



Anu  Puri; PhD



Yossef  Raviv



Amichai  Yavlovich","Javad  Aman
(Medicine, USAMRID)




Assaf  Friedler
(Hebrew University)




Jeeseong  Hwang
(NIST)




Thomas  Luke; MD
(Naval Medical Research Institute)




Radha  Maheshwari
(Dept of Pathology, Uniformed Services University of the Health Sciences)




Yechiel  Shai
(Biological Chemistry, Weizmann  Institute, Israel)


Show all 8","Timothy D Veenstra (Office Of The Director)



Dimiter Stanchev Dimitrov; PhD (Membrane Structure and Function Section)



Ji Ming  Wang; MD, PhD (Laboratory of Molecular Immunoregulation)



Eric O Freed; PhD (Retroviral Replication Laboratory)



Jeffrey D Lifson; MD (Office Of The Director)



Vineet Narain KewalRamani; PhD (Retroviral Replication Laboratory)","Alasdair C Steven; PhD (NIAMS) 



Bernard  Moss; MD, PhD (NIAID)","Ordered by publication type and then author name.



1.
Blumenthal R, Blumenthal R (2009) HIV type 1 Entry Correlates with Plasma Membrane Microdomain Lateral Assemblies of Receptors: Implications in HIVAIDS Treatment. J Viral Entry 3:103-13.




 



2.
Garg H, Joshi A, Blumenthal R (2009). Altered bystander apoptosis induction and pathogenesis of enfuvirtide-resistant HIV type 1 Env mutants. AIDS Res Hum Retroviruses  25, 811-7.   https://doi.org/10.1089/aid.2009.0010




PubMed



        
     
Free Article


 


PubMed ID 19619009
         Pubmed Central ID 2791676 


 



3.
Viard M, Garg H, Blumenthal R, Raviv Y (2009). Photo-activation of the hydrophobic probe iodonaphthylazide in cells alters membrane protein function leading to cell death. BMC Cell Biol  10, 21.   https://doi.org/10.1186/1471-2121-10-21




PubMed



        
     
Free Article


 


PubMed ID 19323821
         Pubmed Central ID 2666636",https://intramural.nih.gov/search/searchview.taf?ipid=62824
48,BC008382-27,"October 01, 2009 -  September 30, 2010",Computational Approaches for RNA StructureFunction Determination,"Bruce Allen Shapiro; PhD



IRP Faculty Profile",NULL,"Image Processing Section, NCI","Eckart  Bindewald



Gregory C Cater



Alex R Diehl



Kazimierz Wojcieck Kasprzak



Mey  Khalili; PhD



Tae Jin  Kim



Show all 10","Juan  Arroyo
(Developmental Biology, Mitre Corporation)




John  Casey
(Microbiology and Immunology, Georgetown University)




Hugo  Martinez
(Consultant, SAIC)




R  Padmanabhan
(Department of Microbiology and Immunology, Geogetown University School of Medicine)




Luiz  Penalva
(Cellular and Structural Biology, Research Institute, University of Texas Health Science Center at San Antonio)




Vinagolu  Rajasekhar
(Memorial Sloan Kettering Cancer Center)


Show all 9","Nancy H Colburn; PhD (Laboratory of Cancer Prevention)



Yun Xing M Wang (Structural Biophysics Laboratory)",NULL,"Ordered by publication type and then author name.



1.
de Sousa Abreu R, Sanchez-Diaz PC, Vogel C, Burns SC, Ko D, Burton TL, Vo DT, Chennasamudaram S, Le SY, Shapiro BA, Penalva LO (2009) Genomic analyses of musashi1 downstream targets show a strong association with cancer-related processes. J Biol Chem 284:12125-35.




PubMed



        
     
Free Article


 


PubMed ID 19258308
         Pubmed Central ID 2673281 


 



2.
Linnstaedt SD, Kasprzak WK, Shapiro BA, Casey JL (2009). The fraction of RNA that folds into the correct branched secondary structure determines hepatitis delta virus type 3 RNA editing levels. RNA  15, 1177-87.   https://doi.org/10.1261/rna.1504009




PubMed



        
     
Free Article


 


PubMed ID 19383766
         Pubmed Central ID 2685515 


 



3.
Santhanam AN, Bindewald E, Rajasekhar VK, Larsson O, Sonenberg N, Colburn NH, Shapiro BA (2009). Role of 3'UTRs in the translation of mRNAs regulated by oncogenic eIF4E--a computational inference. PLoS One  4, e4868.   https://doi.org/10.1371/journal.pone.0004868




PubMed



        
     
Free Article


 


PubMed ID 19290046
         Pubmed Central ID 2654073 


 



4.
Shapiro B, de Sousa Abreu R, Ko D, Le S, Shapiro B, Burns S, Sandhu D, Boutz D, Marcotte E, Penalva L (2010) Sequence signatures and mRNA concentration can explain two-thirds of protein abundance variation in a human cell line. Molecular Systems Biology, in press.




 



5.
Shiao YH, Lupascu ST, Gu YD, Kasprzak W, Hwang CJ, Fields JR, Leighty RM, Quiñones O, Shapiro BA, Alvord WG, Anderson LM (2009). An intergenic non-coding rRNA correlated with expression of the rRNA and frequency of an rRNA single nucleotide polymorphism in lung cancer cells. PLoS One  4, e7505.   https://doi.org/10.1371/journal.pone.0007505




PubMed



        
     
Free Article


 


PubMed ID 19838300
         Pubmed Central ID 2759515 


 



6.
Spirollari J, Wang JT, Zhang K, Bellofatto V, Park Y, Shapiro BA (2009). Predicting consensus structures for RNA alignments via pseudo-energy minimization. Bioinform Biol Insights  3, 51-69.   https://doi.org/10.4137/bbi.s2578




PubMed



        
     
Free Article


 


PubMed ID 20140072
         Pubmed Central ID 2808183 


 



7.
Wang J, Zuo X, Yu P, Xu H, Starich MR, Tiede DM, Shapiro BA, Schwieters CD, Wang YX (2009). A method for helical RNA global structure determination in solution using small-angle x-ray scattering and NMR measurements. J Mol Biol  393, 717-34.   https://doi.org/10.1016/j.jmb.2009.08.001




PubMed



        
     
Free Article


 


PubMed ID 19666030
         Pubmed Central ID 2760655",https://intramural.nih.gov/search/searchview.taf?ipid=62825
49,BC008396-22,"October 01, 2009 -  September 30, 2010",Molecular Information Theory,Thomas Dana Schneider; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI",NULL,"James  Adair
(www.keystonenano.com, Keystone Nano)




Paul  Anagnostopoulos
(-, Windfall Software)




Thorkell  Andresson





Raul Eduardo Cachau





King Cheung Chan





Zehua  Chen



Show all 19","Haleem  Issaq (Office Of The Director)



Robert J Fisher (Office Of The Director)



Bruce Allen Shapiro; PhD (Image Processing Section)



Kenneth H Kraemer; MD (Dermatology Branch)



Mikhail V Kashlev (Molecular Mechanisms of Transcription Section)



David S Waugh; PhD (Protein Engineering Section)","Martin  Gellert; PhD (NIDDK) 



Gisela  Storz; PhD (NICHD)","Ordered by publication type and then author name.



1.
Schneider TD (2010). 70% efficiency of bistate molecular machines explained by information theory, high dimensional geometry and evolutionary convergence. Nucleic Acids Res  38, 5995-6006.   https://doi.org/10.1093/nar/gkq389




PubMed



        
     
Free Article


 


PubMed ID 20562221
         Pubmed Central ID 2952855",https://intramural.nih.gov/search/searchview.taf?ipid=62826
50,BC008710-33,"October 01, 2009 -  September 30, 2010",Molecular Chaperones and DNA Replication,"Sue H Wickner; PhD



IRP Faculty Profile",NULL,"DNA Molecular Biology Section, NCI","Jodi  Camberg



Shannon M Doyle



Olivier Patrick Genest



Joel R Hoskins



Danielle M Johnston



Marie-Caroline  Miot",NULL,Susan  Gottesman; PhD (Biochemical Genetics Section),Daniel C Masison; PhD (NIDDK),"Ordered by publication type and then author name.



1.
Camberg JL, Hoskins JR, Wickner S (2009) ClpXP protease degrades the cytoskeletal protein, FtsZ, and modulates FtsZ polymer dynamics. Proc Natl Acad Sci U S A 106:10614-9.




PubMed



        
     
Free Article


 


PubMed ID 19541655
         Pubmed Central ID 2705540 


 



2.
Hoskins JR, Doyle SM, Wickner S (2009) Coupling ATP utilization to protein remodeling by ClpB, a hexameric AAA+ protein. Proc Natl Acad Sci U S A 106:22233-8.




PubMed



        
     
Free Article


 


PubMed ID 19940245
         Pubmed Central ID 2799729",https://intramural.nih.gov/search/searchview.taf?ipid=62764
51,BC008714-33,"October 01, 2009 -  September 30, 2010",Bacterial Functions Involved in Cell Growth Control,"Susan  Gottesman; PhD



IRP Faculty Profile",NULL,"Biochemical Genetics Section, NCI","Nicholas  de Lay



Nadim  Majdalani



Pierre Marquis Mandin



Kyung  Moon



Daniel Joseph Schu



Song  Tong","Maude  Guillier





Linda  Kenney
(Microbiology, U. of Illinois School of Medicine)




Sarah  Woodson
(Department of Biophysics, Johns Hopkins University)","Yan Ning H Zhou (Gene Regulation and Chromosome Biology Laboratory)



Peter C Fitzgerald (Office of the Director)



Xinhua  Ji; PhD (Biomolecular Structure Section)","Stephen H Leppla; PhD (NIAID) 



Gisela  Storz; PhD (NICHD)","Ordered by publication type and then author name.



1.
De Lay N, Gottesman S (2009). The Crp-activated small noncoding regulatory RNA CyaR (RyeE) links nutritional status to group behavior. J Bacteriol  191, 461-76.   https://doi.org/10.1128/JB.01157-08




PubMed



        
     
Free Article


 


PubMed ID 18978044
         Pubmed Central ID 2620814 


 



2.
Mandin P, Gottesman S (2009). A genetic approach for finding small RNAs regulators of genes of interest identifies RybC as regulating the DpiA/DpiB two-component system. Mol Microbiol  72, 551-65.   https://doi.org/10.1111/j.1365-2958.2009.06665.x




PubMed



        
     
Free Article


 


PubMed ID 19426207
         Pubmed Central ID 2714224 


 



3.
Mandin P, Gottesman S (2009). Regulating the regulator: an RNA decoy acts as an OFF switch for the regulation of an sRNA. Genes Dev  23, 1981-5.   https://doi.org/10.1101/gad.1846609




PubMed



        
     
Free Article


 


PubMed ID 19723760
         Pubmed Central ID 2751972 


 



4.
Moon K, Gottesman S (2009). A PhoQ/P-regulated small RNA regulates sensitivity of Escherichia coli to antimicrobial peptides. Mol Microbiol  74, 1314-30.   https://doi.org/10.1111/j.1365-2958.2009.06944.x




PubMed



        
     
Free Article


 


PubMed ID 19889087
         Pubmed Central ID 2841474",https://intramural.nih.gov/search/searchview.taf?ipid=62827
52,BC008751-30,"October 01, 2009 -  September 30, 2010",Regulation of Gene Transcription,"Sankar  Adhya; PhD



IRP Faculty Profile",NULL,"Developmental Genetics Section, NCI","Elfalem Yetagessu Alemu



Zsolt  Csiszovszki



Amlanjyoti  Dhar



Phuoc  Le



Sang Jun  Lee



Dale  Lewis; PhD



Show all 9","Laura  Finzi
(University of Milan)




Kim  Sneppen
(Center for Models of Life, Niels Bohr Institute)","Peter C Fitzgerald (Office of the Director)



Victor  Zhurkin; PhD (Laboratory of Cell Biology)",NULL,"Ordered by publication type and then author name.



1.
Krishna S, Orosz L, Sneppen K, Adhya S, Semsey S (2009). Relation of intracellular signal levels and promoter activities in the gal regulon of Escherichia coli. J Mol Biol  391, 671-8.   https://doi.org/10.1016/j.jmb.2009.06.043




PubMed



        
     
Free Article


 


PubMed ID 19559028
         Pubmed Central ID 2779859 


 



2.
Lee SJ, Trostel A, Le P, Harinarayanan R, Fitzgerald PC, Adhya S (2009). Cellular stress created by intermediary metabolite imbalances. Proc Natl Acad Sci U S A  106, 19515-20.   https://doi.org/10.1073/pnas.0910586106




PubMed



        
     
Free Article


 


PubMed ID 19887636
         Pubmed Central ID 2780772 


 



3.
Semsey S, Krishna S, Erdossy J, Horváth P, Orosz L, Sneppen K, Adhya S (2009). Dominant negative autoregulation limits steady-state repression levels in gene networks. J Bacteriol  191, 4487-91.   https://doi.org/10.1128/JB.00056-09




PubMed



        
     
Free Article


 


PubMed ID 19429616
         Pubmed Central ID 2704710 


 



4.
Zurla C, Manzo C, Dunlap D, Lewis DE, Adhya S, Finzi L (2009). Direct demonstration and quantification of long-range DNA looping by the lambda bacteriophage repressor. Nucleic Acids Res  37, 2789-95.   https://doi.org/10.1093/nar/gkp134




PubMed



        
     
Free Article


 


PubMed ID 19276206
         Pubmed Central ID 2685085",https://intramural.nih.gov/search/searchview.taf?ipid=62829
53,BC008752-30,"October 01, 2009 -  September 30, 2010",Thyroid Hormone Receptors in Health and Disease,"Sheueyann  Cheng; PhD



IRP Faculty Profile",NULL,"Laboratory of Molecular Biology, NCI","Laura  Fozzatti



Celine Julie Guigon



Dong Wook  Kim; PhD



Changxue  Lu



Jeong-Won  Park



Li  Zhao



Show all 7","Antonio  Bianco
(University of Miami Miller School of Medicine)




G.R.  Williams
(Imperial College London, Imperial College London)




Mark  Willingham
(Wake Forest University School of Medicine)",NULL,NULL,"Ordered by publication type and then author name.



1.
Araki O, Ying H, Zhu XG, Willingham MC, Cheng SY (2009). Distinct dysregulation of lipid metabolism by unliganded thyroid hormone receptor isoforms. Mol Endocrinol  23, 308-15.   https://doi.org/10.1210/me.2008-0311




PubMed



        
     
Free Article


 


PubMed ID 19131509
         Pubmed Central ID 2654517 


 



2.
Furuya F, Lu C, Guigon CJ, Cheng SY (2009). Nongenomic activation of phosphatidylinositol 3-kinase signaling by thyroid hormone receptors. Steroids  74, 628-34.   https://doi.org/10.1016/j.steroids.2008.10.009




PubMed



        
     
Free Article


 


PubMed ID 19014961
         Pubmed Central ID 3272696 


 



3.
Guigon CJ, Cheng SY (2009). Novel non-genomic signaling of thyroid hormone receptors in thyroid carcinogenesis. Mol Cell Endocrinol  308, 63-9.   https://doi.org/10.1016/j.mce.2009.01.007




PubMed



        
     
Free Article


 


PubMed ID 19549593
         Pubmed Central ID 2744088 


 



4.
Guigon CJ, Cheng SY (2009). Novel oncogenic actions of TRbeta mutants in tumorigenesis. IUBMB Life  61, 528-36.   https://doi.org/10.1002/iub.180




PubMed



        
     
Free Article


 


PubMed ID 19391168
         Pubmed Central ID 2716728 


 



5.
Guigon CJ, Fozzatti L, Lu C, Willingham MC, Cheng SY (2010). Inhibition of mTORC1 signaling reduces tumor growth but does not prevent cancer progression in a mouse model of thyroid cancer. Carcinogenesis  31, 1284-91.   https://doi.org/10.1093/carcin/bgq059




PubMed



        
     
Free Article


 


PubMed ID 20299527
         Pubmed Central ID 2893796 


 



6.
Guigon CJ, Zhao L, Willingham MC, Cheng SY (2009). PTEN deficiency accelerates tumour progression in a mouse model of thyroid cancer. Oncogene  28, 509-17.   https://doi.org/10.1038/onc.2008.407




PubMed



        
     
Free Article


 


PubMed ID 18997818
         Pubmed Central ID 3457778 


 



7.
Huang Y, Guigon CJ, Fan J, Cheng SY, Zhu GZ (2010). Pituitary homeobox 2 (PITX2) promotes thyroid  carcinogenesis by activation of cyclin D2. Cell Cycle  9, 1333-41.   https://doi.org/10.4161/cc.9.7.11126




PubMed


 


PubMed ID 20372070
    
     


 



8.
Lu C, Zhao L, Ying H, Willingham MC, Cheng SY (2010). Growth activation alone is not sufficient to cause metastatic thyroid cancer in a mouse model of follicular thyroid carcinoma. Endocrinology  151, 1929-39.   https://doi.org/10.1210/en.2009-1017




PubMed



        
     
Free Article


 


PubMed ID 20133453
         Pubmed Central ID 2851190 


 



9.
Zhu XG, Cheng SY (2009). Modeling thyroid cancer in the mouse. Horm Metab Res  41, 488-99.   https://doi.org/10.1055/s-0029-1215572




PubMed



        
     
Free Article


 


PubMed ID 19358084
         Pubmed Central ID 3464089 


 



10.
Zhu XG, Zhao L, Willingham MC, Cheng SY (2010). Thyroid hormone receptors are tumor suppressors in a mouse model of metastatic follicular thyroid carcinoma. Oncogene  29, 1909-19.   https://doi.org/10.1038/onc.2009.476




PubMed



        
     
Free Article


 


PubMed ID 20062085
         Pubmed Central ID 3443884",https://intramural.nih.gov/search/searchview.taf?ipid=62830
54,BC008753-28,"October 01, 2009 -  September 30, 2010",Immunotoxin Therapy of Solid and Hematopoietic Tumors:  Preclinical Studies,"Ira H Pastan; MD



IRP Faculty Profile",NULL,"Molecular Biology Section, NCI","Peter  Acs



Richard A Beers



Tapan K Bera



Xing  Du



Song Jin  Ha; PhD



Ronit  Jolles Mazor; MSc



Show all 12","Ralph  Alderson
(Cambridge Antibody Technology, Inc)




DARELL  BIGNER
(Duke University Medical Center, Dept. of Pathology)




Satoshi  Nagata
(Sanford Research/USD)




Mark  Souweidane
(Weill Medical College of Cornell University)","Oleg Y Chertov (Office Of The Director)



Dimiter Stanchev Dimitrov; PhD (Membrane Structure and Function Section)



Raffit  Hassan (Laboratory of Molecular Biology)



Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)



Alan S Wayne; MD (Pediatric Oncology Branch)



Mitchell  Ho (Laboratory of Molecular Biology)",NULL,"Ordered by publication type and then author name.



1.
Alderson RF, Kreitman RJ, Chen T, Yeung P, Herbst R, Fox JA, Pastan I (2009). CAT-8015: a second-generation pseudomonas exotoxin A-based immunotherapy targeting CD22-expressing hematologic malignancies. Clin Cancer Res  15, 832-9.   https://doi.org/10.1158/1078-0432.CCR-08-1456




PubMed



        
     
Free Article


 


PubMed ID 19188153
         Pubmed Central ID 2742326 


 



2.
Carpenito C, Milone MC, Hassan R, Simonet JC, Lakhal M, Suhoski MM, Varela-Rohena A, Haines KM, Heitjan DF, Albelda SM, Carroll RG, Riley JL, Pastan I, June CH (2009). Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains. Proc Natl Acad Sci U S A  106, 3360-5.   https://doi.org/10.1073/pnas.0813101106




PubMed



        
     
Free Article


 


PubMed ID 19211796
         Pubmed Central ID 2651342 


 



3.
Feng Y, Xiao X, Zhu Z, Streaker E, Ho M, Pastan I, Dimitrov DS (2009). A novel human monoclonal antibody that binds with high affinity to mesothelin-expressing cells and kills them by antibody-dependent cell-mediated cytotoxicity. Mol Cancer Ther  8, 1113-8.   https://doi.org/10.1158/1535-7163.MCT-08-0945




PubMed



        
     
Free Article


 


PubMed ID 19417159
         Pubmed Central ID 2891957 


 



4.
Ho M, Pastan I (2009). Display and selection of scFv antibodies on HEK-293T cells. Methods Mol Biol  562, 99-113.   https://doi.org/10.1007/978-1-60327-302-2_8




PubMed



        
     
Free Article


 


PubMed ID 19554290
         Pubmed Central ID 2790380 


 



5.
Ho M, Pastan I (2009). In vitro antibody affinity maturation targeting germline hotspots. Methods Mol Biol  525, 293-308, xiv.   https://doi.org/10.1007/978-1-59745-554-1_15




PubMed



        
     
Free Article


 


PubMed ID 19252855
         Pubmed Central ID 3473074 


 



6.
Ho M, Pastan I (2009). Mammalian cell display for antibody engineering. Methods Mol Biol  525, 337-52, xiv.   https://doi.org/10.1007/978-1-59745-554-1_18




PubMed



        
     
Free Article


 


PubMed ID 19252852
         Pubmed Central ID 3475965 


 



7.
Nagata S, Ise T, Pastan I (2009). Fc receptor-like 3 protein expressed on IL-2 nonresponsive subset of human regulatory T cells. J Immunol  182, 7518-26.   https://doi.org/10.4049/jimmunol.0802230




PubMed



        
     
Free Article


 


PubMed ID 19494275
         Pubmed Central ID 2745186 


 



8.
Nagata S, Pastan I (2009). Removal of B cell epitopes as a practical approach for reducing the immunogenicity of foreign protein-based therapeutics. Adv Drug Deliv Rev  61, 977-85.   https://doi.org/10.1016/j.addr.2009.07.014




PubMed



        
     
Free Article


 


PubMed ID 19679153
         Pubmed Central ID 2757538 


 



9.
Weldon JE, Xiang L, Chertov O, Margulies I, Kreitman RJ, FitzGerald DJ, Pastan I (2009). A protease-resistant immunotoxin against CD22 with greatly increased activity against CLL and diminished animal toxicity. Blood  113, 3792-800.   https://doi.org/10.1182/blood-2008-08-173195




PubMed



        
     
Free Article


 


PubMed ID 18988862
         Pubmed Central ID 2670794 


 



10.
Xiao X, Ho M, Zhu Z, Pastan I, Dimitrov DS (2009). Identification and characterization of fully human anti-CD22 monoclonal antibodies. MAbs  1, 297-303.   https://doi.org/10.4161/mabs.1.3.8113




PubMed



        
     
Free Article


 


PubMed ID 20065646
         Pubmed Central ID 2726586",https://intramural.nih.gov/search/searchview.taf?ipid=62831
55,BC008756-23,"October 01, 2009 -  September 30, 2010",Genetically Engineered Mouse Models to Study RTK Function in Melanoma,"Glenn  Merlino; PhD



IRP Faculty Profile",NULL,"Laboratory of Cancer Biology and Genetics, NCI","Chi-Ping  Day



Theresa Wen-Wen Guo



Andrew J Lu



Prasun J Mishra



Jennifer D Rieker



Yanlin  Yu



Show all 8","Boris  Bastian
(UCSF)




Dot  Bennett
(St. George's Hospital Medical School)




Lynda  Chin
(Harvard Medical School)




Chris  Counter
(Duke University)




Edward  De Fabo
(GWU)




Ron  DePinho
(Dana Farber, Harvard)


Show all 11","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)



Kathleen  Kelly; PhD (Laboratory Of Genitourinary Cancer Pathogenesis)



Melinda  Hollingshead (Biological Testing Branch)



Giorgio  Trinchieri (Cancer Inflammation Program)



Margaret Anne Tucker (Human Genetics Program)



Miriam R Anver (Office Of The Director)","Francis S Collins; MD, PhD (OD) 



Heinz  Arnheiter; MD (NINDS)","Ordered by publication type and then author name.



1.
Esteve-Puig R, Canals F, Colomé N, Merlino G, Recio JA (2009). Uncoupling of the LKB1-AMPKalpha energy sensor pathway by growth factors and oncogenic BRAF. PLoS One  4, e4771.   https://doi.org/10.1371/journal.pone.0004771




PubMed



        
     
Free Article


 


PubMed ID 19274086
         Pubmed Central ID 2651576 


 



2.
Merlino G (2009). Building the perfect beast: complex mouse models teach surprisingly simple melanoma lessons. Pigment Cell Melanoma Res  22, 246-7.   https://doi.org/10.1111/j.1755-148X.2009.00574.x




PubMed


 


PubMed ID 19397758
    
     


 



3.
Mishra PJ, Merlino G (2009). MicroRNA reexpression as differentiation therapy in cancer. J Clin Invest  119, 2119-23.   https://doi.org/10.1172/JCI40107




PubMed



        
     
Free Article


 


PubMed ID 19620782
         Pubmed Central ID 2719926 


 



4.
Mishra PJ, Song B, Mishra PJ, Wang Y, Humeniuk R, Banerjee D, Merlino G, Ju J, Bertino JR (2009). MiR-24 tumor suppressor activity is regulated independent of p53 and through a target site polymorphism. PLoS One  4, e8445.   https://doi.org/10.1371/journal.pone.0008445




PubMed



        
     
Free Article


 


PubMed ID 20041160
         Pubmed Central ID 2794546 


 



5.
Schultz JM, Khan SN, Ahmed ZM, Riazuddin S, Waryah AM, Chhatre D, Starost MF, Ploplis B, Buckley S, Velásquez D, Kabra M, Lee K, Hassan MJ, Ali G, Ansar M, Ghosh M, Wilcox ER, Ahmad W, Merlino G, Leal SM, Riazuddin S, Friedman TB, Morell RJ (2009). Noncoding mutations of HGF are associated with nonsyndromic hearing loss, DFNB39. Am J Hum Genet  85, 25-39.   https://doi.org/10.1016/j.ajhg.2009.06.003




PubMed



        
     
Free Article


 


PubMed ID 19576567
         Pubmed Central ID 2706959 


 



6.
Yu Y, Merlino G (2010). Roles for aberrant CXCR3 signaling in basal cell carcinoma: a case for dual activity. Am J Pathol  176, 2088-91.   https://doi.org/10.2353/ajpath.2010.091284




PubMed



        
     
Free Article


 


PubMed ID 20185576
         Pubmed Central ID 2861074",https://intramural.nih.gov/search/searchview.taf?ipid=62832
56,BC008757-23,"October 01, 2009 -  September 30, 2010",Bio-Therapies for the Treatment of Cancer and Infectious Disease,"David J Fitzgerald; PhD



IRP Faculty Profile",NULL,"Biotherapy Section, NCI","Antonella  Antignani; BS, PhD



Robert J Sarnovsky



Ashima K Sharma",NULL,"Peter C Fitzgerald (Office of the Director)



Ira H Pastan; MD (Molecular Biology Section)",NULL,"Ordered by publication type and then author name.



1.
Kreitman RJ, Stetler-Stevenson M, Margulies I, Noel P, Fitzgerald DJ, Wilson WH, Pastan I (2009). Phase II trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with hairy cell leukemia. J Clin Oncol  27, 2983-90.   https://doi.org/10.1200/JCO.2008.20.2630




PubMed



        
     
Free Article


 


PubMed ID 19414673
         Pubmed Central ID 2702232 


 



2.
Sarnovsky R, Rea J, Makowski M, Hertle R, Kelly C, Antignani A, Pastrana DV, Fitzgerald DJ (2009). Proteolytic cleavage of a C-terminal prosequence, leading to autoprocessing at the N Terminus, activates leucine aminopeptidase from Pseudomonas aeruginosa. J Biol Chem  284, 10243-53.   https://doi.org/10.1074/jbc.M808686200




PubMed



        
     
Free Article


 


PubMed ID 19213733
         Pubmed Central ID 2665078 


 



3.
Weldon JE, Xiang L, Chertov O, Margulies I, Kreitman RJ, FitzGerald DJ, Pastan I (2009). A protease-resistant immunotoxin against CD22 with greatly increased activity against CLL and diminished animal toxicity. Blood  113, 3792-800.   https://doi.org/10.1182/blood-2008-08-173195




PubMed



        
     
Free Article


 


PubMed ID 18988862
         Pubmed Central ID 2670794",https://intramural.nih.gov/search/searchview.taf?ipid=62833
57,BC008905-29,"October 01, 2009 -  September 30, 2010",Tumor gene expression in vitro and in vivo,"Douglas  Lowy; MD



IRP Faculty Profile",NULL,"Laboratory of Cellular Oncology, NCI","Richard B Braverman



Xiao-Li  Du



Alexander G Papageorge



Xiaolan  Qian; MD, PhD



William C Vass",NULL,"Nicolae C Popescu; PhD (Laboratory of Experimental Carcinogenesis)



Kent W Hunter; PhD (Laboratory of Cancer Biology and Genetics)",NULL,"Ordered by publication type and then author name.



1.
Asnaghi L, Vass WC, Quadri R, Day PM, Qian X, Braverman R, Papageorge AG, Lowy DR (2010). E-cadherin negatively regulates neoplastic growth in non-small cell lung cancer: role of Rho GTPases. Oncogene  29, 2760-71.   https://doi.org/10.1038/onc.2010.39




PubMed



        
     
Free Article


 


PubMed ID 20228844
         Pubmed Central ID 3365679 


 



2.
Qian X, Li G, Vass WC, Papageorge A, Walker RC, Asnaghi L, Steinbach PJ, Tosato G, Hunter K, Lowy DR (2009). The Tensin-3 protein, including its SH2 domain, is phosphorylated by Src and contributes to tumorigenesis and metastasis. Cancer Cell  16, 246-58.   https://doi.org/10.1016/j.ccr.2009.07.031




PubMed



        
     
Free Article


 


PubMed ID 19732724
         Pubmed Central ID 3293497 


 



3.
Yang XY, Guan M, Vigil D, Der CJ, Lowy DR, Popescu NC (2009). p120Ras-GAP binds the DLC1 Rho-GAP tumor suppressor protein and inhibits its RhoA GTPase and growth-suppressing activities. Oncogene  28, 1401-9.   https://doi.org/10.1038/onc.2008.498




PubMed



        
     
Free Article


 


PubMed ID 19151751
         Pubmed Central ID 2715999",https://intramural.nih.gov/search/searchview.taf?ipid=62834
58,BC009003-28,"October 01, 2009 -  September 30, 2010",The Role of Cripto in the Pathogenesis of Breast and Colon Cancer,David  Salomon; PhD,NULL,"Mammary Biology and Tumorigenesis Laboratory, NCI","Caterina  Bianco; MD



Nadia  Castro



Monica I Gonzales



Hideaki  Karasawa



Tadahiro  Nagaoka



Maria Cristina Rangel","Gabriella  Minchiotti
(CNR, Institute of Genetics)




Masaharu  Seno
(Biotechnology, Okayama University)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=62835
59,BC009052-21,"October 01, 2009 -  September 30, 2010",Papillomavirus Virion Proteins and Vaccines,"John  Schiller; PhD



IRP Faculty Profile",NULL,"Laboratory of Cellular Oncology, NCI","Christopher  Buck



Rebecca  Cerio



Nicolas  Cuburu; PhD



Patricia  Day; PhD



Rhonda C Kines



Yuk Ying S Pang



Show all 7","Bryce C Chackerian





Reinhard  Glueck
(Etna Biotech)




Ari  Helenius
(Institute of Biochemistry, ETH)




Denise  Nardelli-Haefliger
(Centre Hospitalier Universitaire Vaudois)




Richard  Roden
(Johns Hopkins University)","Peter L Choyke; MD (Molecular Imaging Program)



Genoveffa  Franchini; MD (Vaccine Branch)



Ligia  Pinto (Infection & Immunoepidemiology Branch)



Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch)","Barney S Graham; MD, PhD (NIAID)","Ordered by publication type and then author name.



1.
Cantarella G, Liniger M, Zuniga A, Schiller JT, Billeter M, Naim HY, Glueck R (2009). Recombinant measles virus-HPV vaccine candidates for prevention of cervical carcinoma. Vaccine  27, 3385-90.   https://doi.org/10.1016/j.vaccine.2009.01.061




PubMed



        
     
Free Article


 


PubMed ID 19200837
         Pubmed Central ID 3487399 


 



2.
Cuburu N, Kweon MN, Hervouet C, Cha HR, Pang YY, Holmgren J, Stadler K, Schiller JT, Anjuère F, Czerkinsky C (2009). Sublingual immunization with nonreplicating antigens induces antibody-forming cells and cytotoxic T cells in the female genital tract mucosa and protects against genital papillomavirus infection. J Immunol  183, 7851-9.   https://doi.org/10.4049/jimmunol.0803740




PubMed


 


PubMed ID 19933861
    
     


 



3.
Day PM, Schiller JT (2009). The role of furin in papillomavirus infection. Future Microbiol  4, 1255-62.   https://doi.org/10.2217/fmb.09.86




PubMed



        
     
Free Article


 


PubMed ID 19995186
         Pubmed Central ID 2829937 


 



4.
Einstein MH, Schiller JT, Viscidi RP, Strickler HD, Coursaget P, Tan T, Halsey N, Jenkins D (2009). Clinician's guide to human papillomavirus immunology: knowns and unknowns. Lancet Infect Dis  9, 347-56.   https://doi.org/10.1016/S1473-3099(09)70108-2




PubMed


 


PubMed ID 19467474
    
     


 



5.
Jagu S, Karanam B, Gambhira R, Chivukula SV, Chaganti RJ, Lowy DR, Schiller JT, Roden RB (2009). Concatenated multitype L2 fusion proteins as candidate prophylactic pan-human papillomavirus vaccines. J Natl Cancer Inst  101, 782-92.   https://doi.org/10.1093/jnci/djp106




PubMed



        
     
Free Article


 


PubMed ID 19470949
         Pubmed Central ID 2689872 


 



6.
Johnson KM, Kines RC, Roberts JN, Lowy DR, Schiller JT, Day PM (2009). Role of heparan sulfate in attachment to and infection of the murine female genital tract by human papillomavirus. J Virol  83, 2067-74.   https://doi.org/10.1128/JVI.02190-08




PubMed



        
     
Free Article


 


PubMed ID 19073722
         Pubmed Central ID 2643729 


 



7.
Kines RC, Thompson CD, Lowy DR, Schiller JT, Day PM (2009). The initial steps leading to papillomavirus infection occur on the basement membrane prior to cell surface binding. Proc Natl Acad Sci U S A  106, 20458-63.   https://doi.org/10.1073/pnas.0908502106




PubMed



        
     
Free Article


 


PubMed ID 19920181
         Pubmed Central ID 2787115 


 



8.
Lee TY, Kim YH, Yoon SW, Choi JC, Yang JM, Kim CJ, Schiller JT, Sung MH, Poo H (2009). Oral administration of poly-gamma-glutamate induces TLR4- and dendritic cell-dependent antitumor effect. Cancer Immunol Immunother  58, 1781-94.   https://doi.org/10.1007/s00262-009-0689-4




PubMed


 


PubMed ID 19294383
    
     


 



9.
Schiller JT, Lowy DR (2009). Immunogenicity testing in human papillomavirus virus-like-particle vaccine trials. J Infect Dis  200, 166-71.   https://doi.org/10.1086/599988




PubMed



        
     
Free Article


 


PubMed ID 19519255
         Pubmed Central ID 3467007",https://intramural.nih.gov/search/searchview.taf?ipid=62836
60,BC009101-18,"October 01, 2009 -  September 30, 2010",Design of Antiviral Drugs Effective Against the HIV-1 Virus,"Ettore  Appella; MD



IRP Faculty Profile",NULL,"Chemical Immunology Section, NCI","Ryo  Hayashi



Lisa Marie Jenkins



Michal  Vascak



Kan  Tanoue","Cecilia  Cheng-Mayer
(The Aaron Diamond AIDS Research Center, Rockefeller University)




Robin  Shattock; PhD
(St George's Hospital Medical School)




James  Smith
(CDC)




Thomas  Smith
(Auritec Pharmaceuticals)","David E Ott (Office Of The Director)



Stewart  Durell (Laboratory of Cell Biology)",NULL,"Ordered by publication type and then author name.



1.
Appella E, Appella E, Hayashi R, Coren L, Wang D, Xu Q, Schito M, Inman J, Appella D, Appella E (2010) Inactivation of HIV-1 by repetitive intracellular acetyl transfer from acetyl-CoA to the nucleocapsid protein through a small molecule catalyst. Nature Chemical Biology, in press.




 



2.
Wallace GS, Cheng-Mayer C, Schito ML, Fletcher P, Miller Jenkins LM, Hayashi R, Neurath AR, Appella E, Shattock RJ (2009). Human immunodeficiency virus type 1 nucleocapsid inhibitors impede trans infection in cellular and explant models and protect nonhuman primates from infection. J Virol  83, 9175-82.   https://doi.org/10.1128/JVI.00820-09




PubMed



        
     
Free Article


 


PubMed ID 19587055
         Pubmed Central ID 2738238",https://intramural.nih.gov/search/searchview.taf?ipid=62837
61,BC009254-36,"October 01, 2009 -  September 30, 2010",Structure and Function of Toll-like Receptors,David M Segal; PhD,NULL,"Immune Targeting Section, NCI","Kevin Neal Brown



Ivett  Jelinek



Christopher James Schwartz; BA



Yan  Wang",NULL,NULL,David R Davies; PhD (NIDDK),"Ordered by publication type and then author name.



1.
Botos I, Liu L, Wang Y, Segal DM, Davies DR (2009). The toll-like receptor 3:dsRNA signaling complex. Biochim Biophys Acta  1789, 667-74.   https://doi.org/10.1016/j.bbagrm.2009.06.005




PubMed



        
     
Free Article


 


PubMed ID 19595807
         Pubmed Central ID 2784288 


 



2.
Leonard JN, Bell JK, Segal DM (2009). Predicting Toll-like receptor structures and characterizing ligand binding. Methods Mol Biol  517, 55-67.   https://doi.org/10.1007/978-1-59745-541-1_4




PubMed


 


PubMed ID 19378017",https://intramural.nih.gov/search/searchview.taf?ipid=62838
62,BC009257-35,"October 01, 2009 -  September 30, 2010",Mechanisms of Cellular Immune Responses,"James Stephen Shaw; PhD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI","Khadija  Ben-aissa



Michael John Kruhlak; PhD



Yin  Liu



Genaro  Patino Lopez",NULL,Lino  Tessarollo (Mouse Cancer Genetics Program),NULL,"Ordered by publication type and then author name.



1.
Gao Y, Balut CM, Bailey MA, Patino-Lopez G, Shaw S, Devor DC (2010) Recycling of the Ca2+-activated K+ channel, KCa2.3, is dependent upon RME-1, Rab35/EPI64C, and an N-terminal domain. J Biol Chem 285:17938-53.




PubMed



        
     
Free Article


 


PubMed ID 20360009
         Pubmed Central ID 2878556 


 



2.
Sobocinski GP, Toy K, Bobrowski WF, Shaw S, Anderson AO, Kaldjian EP (2010) Ultrastructural localization of extracellular matrix proteins of the lymph node cortex: evidence supporting the reticular network as a pathway for lymphocyte migration. BMC Immunol 11:42.




PubMed



        
     
Free Article


 


PubMed ID 20716349
         Pubmed Central ID 2933709",https://intramural.nih.gov/search/searchview.taf?ipid=62839
63,BC009262-28,"October 01, 2009 -  September 30, 2010",Immunophysiological Mechanisms in the Biological Therapy of Cancer,Robert  Wiltrout; PhD,NULL,"Laboratory of Experimental Immunology, NCI","Timothy  Back



Thomas Joseph Sayers; PhD



Tim  Chan



Lindsey Rene' Grove



Qun  Jiang



John R Ortaldo; PhD



Show all 9","Bruce  Blazar
(University of Minnesota)




Stephen A Miller





Bill  Murphy
(Clinical Research, University of Nevada at Reno)




Jon Marc Wigginton; MD
(NCI)","Syed Perwez  Hussain (Laboratory of Human Carcinogenesis)



David Anderson Wink (Radiation Biology Branch)



Curtis  Harris; MD (Laboratory of Human Carcinogenesis)



William Marston Linehan; MD (Urologic Oncology Branch)



Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)



Larry K Keefer; PhD (Laboratory of Comparative Carcinogenesis)",NULL,"Ordered by publication type and then author name.



1.
Chen X, Subleski JJ, Hamano R, Howard OM, Wiltrout RH, Oppenheim JJ (2010). Co-expression of TNFR2 and CD25 identifies more of the functional CD4+FOXP3+ regulatory T cells in human peripheral blood. Eur J Immunol  40, 1099-106.   https://doi.org/10.1002/eji.200940022




PubMed



        
     
Free Article


 


PubMed ID 20127680
         Pubmed Central ID 3096013 


 



2.
Kummar S, Kinders R, Gutierrez ME, Rubinstein L, Parchment RE, Phillips LR, Ji J, Monks A, Low JA, Chen A, Murgo AJ, Collins J, Steinberg SM, Eliopoulos H, Giranda VL, Gordon G, Helman L, Wiltrout R, Tomaszewski JE, Doroshow JH (2009). Phase 0 clinical trial of the poly (ADP-ribose) polymerase inhibitor ABT-888 in patients with advanced malignancies. J Clin Oncol  27, 2705-11.   https://doi.org/10.1200/JCO.2008.19.7681




PubMed



        
     
Free Article


 


PubMed ID 19364967
         Pubmed Central ID 2739635 


 



3.
Shanker A, Brooks AD, Jacobsen KM, Wine JW, Wiltrout RH, Yagita H, Sayers TJ (2009). Antigen presented by tumors in vivo determines the nature of CD8+ T-cell cytotoxicity. Cancer Res  69, 6615-23.   https://doi.org/10.1158/0008-5472.CAN-09-0685




PubMed



        
     
Free Article


 


PubMed ID 19654302
         Pubmed Central ID 2727577 


 



4.
Weiss JM, Back TC, Scarzello AJ, Subleski JJ, Hall VL, Stauffer JK, Chen X, Micic D, Alderson K, Murphy WJ, Wiltrout RH (2009). Successful immunotherapy with IL-2/anti-CD40 induces the chemokine-mediated mitigation of an immunosuppressive tumor microenvironment. Proc Natl Acad Sci U S A  106, 19455-60.   https://doi.org/10.1073/pnas.0909474106




PubMed



        
     
Free Article


 


PubMed ID 19892741
         Pubmed Central ID 2773732",https://intramural.nih.gov/search/searchview.taf?ipid=62840
64,BC009264-27,"October 01, 2009 -  September 30, 2010",Cytokine Regulation of Normal and Neoplastic Hematopoietic Cell Growth,Francis W Ruscetti; PhD,NULL,"Laboratory of Experimental Immunology, NCI","Maria  Birchenall-Roberts



Tao  Fu","Steven  Bartelmez
(stem cell biology, Betastem Therapeutics)




Pat  Iversen
(AVI-Biopharma)




John  Letterio
(Case Western Medical Center)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=62841
65,BC009265-28,"October 01, 2009 -  September 30, 2010",Analysis of the T Cell Repertoire,"Richard J Hodes; MD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI","Sumeena  Bhatia



Karen  Hathcock



Sarah Rhiannon Jenkinson



Joy A Williams



Jingjing  Zhang",NULL,Lionel  Feigenbaum (Office Of The Director),Ranjan  Sen; PhD (NIA),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=62842
66,BC009273-23,"October 01, 2009 -  September 30, 2010",T Cell Differentiation and Repertoire Selection,"Alfred  Singer; MD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI","Amala Shenai Alag



Terry I Guinter



Dinah  Singer; PhD



Susanna  Jeurling



Tejas Bharat Kadakia



Thomas  McCaughtry



Show all 7","Wilfried  Ellmeier
(Immunology, University of Vienna)




Batu M Erman





Deitmar  Kappes
(Immunology, Fox Chase Cancer Center)




Sophia D Sarafova
(NCI)




Arlene  Sharpe
(Dept of Pathology, Harvard Medical School)




Naomi  Taylor","Lionel  Feigenbaum (Office Of The Director)



Remy J Bosselut; MD, PhD (Laboratory of Immune Cell Biology)","Lothar  Hennighausen; PhD (NIDDK) 



Paul E Love; MD, PhD (NICHD)","Ordered by publication type and then author name.



1.
Park JH, Adoro S, Guinter T, Erman B, Alag AS, Catalfamo M, Kimura MY, Cui Y, Lucas PJ, Gress RE, Kubo M, Hennighausen L, Feigenbaum L, Singer A (2010). Signaling by intrathymic cytokines, not T cell antigen receptors, specifies CD8 lineage choice and promotes the differentiation of cytotoxic-lineage T cells. Nat Immunol  11, 257-64.   https://doi.org/10.1038/ni.1840




PubMed



        
     
Free Article


 


PubMed ID 20118929
         Pubmed Central ID 3555225 


 



2.
Sarafova SD, Van Laethem F, Adoro S, Guinter T, Sharrow SO, Feigenbaum L, Singer A (2009). Upregulation of CD4 expression during MHC class II-specific positive selection is essential for error-free lineage choice. Immunity  31, 480-90.   https://doi.org/10.1016/j.immuni.2009.07.006




PubMed



        
     
Free Article


 


PubMed ID 19747858
         Pubmed Central ID 2758695 


 



3.
Singer A (2010). Molecular and cellular basis of T cell lineage commitment: An overview. Semin Immunol  22, 253.   https://doi.org/10.1016/j.smim.2010.06.001




PubMed



        
     
Free Article


 


PubMed ID 20655758
         Pubmed Central ID 6691491",https://intramural.nih.gov/search/searchview.taf?ipid=62844
67,BC009279-25,"October 01, 2009 -  September 30, 2010",Regulation of Expression of MHC Class I Genes,"Dinah  Singer; PhD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI","Zohar Sara Barbash



Aparna  Kotekar



Susan  Sharrow



Namhoon  Lee



Jie  Mu



Jocelyn D Weissman",NULL,Brian  Lewis (Lymphoid Malignancies Branch),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=62845
68,BC009281-24,"October 01, 2009 -  September 30, 2010",Receptor Mediated T and B Cell Activation,"Richard J Hodes; MD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI","Sumeena  Bhatia



Yungping  Chiang



Masashi  Watanabe",NULL,Lionel  Feigenbaum (Office Of The Director),NULL,"Ordered by publication type and then author name.



1.
Chiang YJ, Jordan MS, Horai R, Schwartzberg PL, Koretzky GA, Hodes RJ (2009). Cbl enforces an SLP76-dependent signaling pathway for T cell differentiation. J Biol Chem  284, 4429-38.   https://doi.org/10.1074/jbc.M808679200




PubMed



        
     
Free Article


 


PubMed ID 19074136
         Pubmed Central ID 2640981",https://intramural.nih.gov/search/searchview.taf?ipid=62846
69,BC009283-26,"October 01, 2009 -  September 30, 2010",Control of Cytokine Gene Expression in LymphoidMyeloid Cells,"Howard A Young; PhD



IRP Faculty Profile",NULL,"Laboratory of Experimental Immunology, NCI","Casey Michelle Barry



Deborah L Hodge



Daniel  McVicar; PhD



Fan Ching  Lin



Catriona T Miller



Robert  Wiltrout; PhD



Show all 11",NULL,"Barbara K Felber (Vaccine Branch)



George N Pavlakis; MD, PhD (Vaccine Branch)



Lino  Tessarollo (Mouse Cancer Genetics Program)",NULL,"Ordered by publication type and then author name.



1.
Donnelly RP, Young HA, Rosenberg AS (2009). An overview of cytokines and cytokine antagonists as therapeutic agents. Ann N Y Acad Sci  1182, 1-13.   https://doi.org/10.1111/j.1749-6632.2009.05382.x




PubMed



        
     
Free Article


 


PubMed ID 20074270
         Pubmed Central ID 6580416 


 



2.
Hodge DL, Yang J, Buschman MD, Schaughency PM, Dang H, Bere W, Yang Y, Savan R, Subleski JJ, Yin XM, Loughran TP, Young HA (2009). Interleukin-15 enhances proteasomal degradation of bid in normal lymphocytes: implications for large granular lymphocyte leukemias. Cancer Res  69, 3986-94.   https://doi.org/10.1158/0008-5472.CAN-08-3735




PubMed



        
     
Free Article


 


PubMed ID 19366803
         Pubmed Central ID 2786937 


 



3.
Savan R, Chan T, Young HA (2010). Lentiviral gene transduction in human and mouse NK cell lines. Methods Mol Biol  612, 209-21.   https://doi.org/10.1007/978-1-60761-362-6_14




PubMed



        
     
Free Article


 


PubMed ID 20033643
         Pubmed Central ID 6634311 


 



4.
Savan R, Ravichandran S, Collins JR, Sakai M, Young HA (2009). Structural conservation of interferon gamma among vertebrates. Cytokine Growth Factor Rev  20, 115-24.   https://doi.org/10.1016/j.cytogfr.2009.02.006




PubMed



        
     
Free Article


 


PubMed ID 19268624
         Pubmed Central ID 2755191",https://intramural.nih.gov/search/searchview.taf?ipid=62847
70,BC009285-24,"October 01, 2009 -  September 30, 2010",Responses of MHC Class I Genes to Exogeneous Stimuli,"Dinah  Singer; PhD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI","Devaiah Nanjappa Ballachanda



Aparna  Kotekar



Namhoon  Lee



Jie  Mu



Jocelyn D Weissman



Katherine Chelsea Soe","Leonard  Kohn
(Ohio State Universit)




Martin  Villalba
(Institut de Génétique Moléculaire de Montpellier (IGMM))",Xuguang C Tai (Lymphocyte Development Section),NULL,"Ordered by publication type and then author name.



1.
Charni S, Aguilo JI, Garaude J, de Bettignies G, Jacquet C, Hipskind RA, Singer D, Anel A, Villalba M (2009). ERK5 knockdown generates mouse leukemia cells with low MHC class I levels that activate NK cells and block tumorigenesis. J Immunol  182, 3398-405.   https://doi.org/10.4049/jimmunol.0803006




PubMed



        
     
Free Article


 


PubMed ID 19265117
         Pubmed Central ID 6311211 


 



2.
Giuliani C, Bucci I, Montani V, Singer DS, Monaco F, Kohn LD, Napolitano G (2010). Regulation of major histocompatibility complex gene expression in thyroid epithelial cells by methimazole and phenylmethimazole. J Endocrinol  204, 57-66.   https://doi.org/10.1677/JOE-09-0172




PubMed



        
     
Free Article


 


PubMed ID 19837722
         Pubmed Central ID 6310398",https://intramural.nih.gov/search/searchview.taf?ipid=62848
71,BC009287-26,"October 01, 2009 -  September 30, 2010",Cytokines and T Cell Development,"Scott K Durum; PhD



IRP Faculty Profile",NULL,"Laboratory of Molecular Immunoregulation, NCI","Julie  Hixon



Arthur A Hurwitz



Qiong  Jiang



Wenqing  Li","Joao  Barata
(U.Lisbon)




andrew  farr
(university of washington)




Richard  Hotchkiss
(Wash U)",Jonathan  Keller; PhD (Laboratory of Cancer Prevention),Warren J Leonard; MD (NHLBI),"Ordered by publication type and then author name.



1.
Durum SK, Mazzucchelli RI (2009). Live from the liver: hepatocyte IL-7. Immunity  30, 320-1.   https://doi.org/10.1016/j.immuni.2009.03.001




PubMed



        
     
Free Article


 


PubMed ID 19303385
         Pubmed Central ID 6326359 


 



2.
Mazzucchelli RI, Warming S, Lawrence SM, Ishii M, Abshari M, Washington AV, Feigenbaum L, Warner AC, Sims DJ, Li WQ, Hixon JA, Gray DH, Rich BE, Morrow M, Anver MR, Cherry J, Naf D, Sternberg LR, McVicar DW, Farr AG, Germain RN, Rogers K, Jenkins NA, Copeland NG, Durum SK (2009). Visualization and identification of IL-7 producing cells in reporter mice. PLoS One  4, e7637.   https://doi.org/10.1371/journal.pone.0007637




PubMed



        
     
Free Article


 


PubMed ID 19907640
         Pubmed Central ID 2770321",https://intramural.nih.gov/search/searchview.taf?ipid=62849
72,BC009297-19,"October 01, 2009 -  September 30, 2010",Ubiquitin And SUMO Post-Translational Modifications In Development And Disease,Michael Robert Kuehn; PhD,NULL,"Laboratory of Protein Dynamics and Signaling, NCI","Margaret M O'Toole-Lualdi



Allan M Weissman; MD



Prashant  Sharma",NULL,Stephen J Lockett; PhD (Office Of The Director),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=62850
73,BC009304-16,"October 01, 2009 -  September 30, 2010",Structure-Function Studies and Design of Novel Glycosyltransferases,Pradman  Qasba; PhD,NULL,"Structural Glycobiology Section, NCI","Elizabeth  Boeggeman



Marta  Pasek



Boopathy  Ramakrishna",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Pasek M, Boeggeman E, Ramakrishnan B, Qasba PK (2010). Galectin-1 as a fusion partner for the production of soluble and folded human beta-1,4-galactosyltransferase-T7 in E. coli. Biochem Biophys Res Commun  394, 679-84.   https://doi.org/10.1016/j.bbrc.2010.03.051




PubMed



        
     
Free Article


 


PubMed ID 20226765
         Pubmed Central ID 2859968",https://intramural.nih.gov/search/searchview.taf?ipid=62851
74,BC009322-22,"October 01, 2009 -  September 30, 2010",Mechanisms of Leukocyte Migration Following Cytokine Administration to Mice,Robert  Wiltrout; PhD,NULL,"Laboratory of Experimental Immunology, NCI","Timothy  Back



Tim  Chan



Lindsey Rene' Grove



Qun  Jiang



John R Ortaldo; PhD



Jeffrey J Subleski","Esther H Chang





Jon Marc Wigginton; MD
(NCI)","Timothy D Veenstra (Office Of The Director)



Curtis  Harris; MD (Laboratory of Human Carcinogenesis)



William Marston Linehan; MD (Urologic Oncology Branch)



Snorri S. Thorgeirsson; MD, PhD (Laboratory of Experimental Carcinogenesis)",NULL,"Ordered by publication type and then author name.



1.
Subleski JJ, Wiltrout RH, Weiss JM (2009). Application of tissue-specific NK and NKT cell activity for tumor immunotherapy. J Autoimmun  33, 275-81.   https://doi.org/10.1016/j.jaut.2009.07.010




PubMed



        
     
Free Article


 


PubMed ID 19682859
         Pubmed Central ID 2783592",https://intramural.nih.gov/search/searchview.taf?ipid=62852
75,BC009369-20,"October 01, 2009 -  September 30, 2010",Studies of Chemokine-Receptor Interactions with Chemokines and alarmins,"Joost J Oppenheim; MD



IRP Faculty Profile",NULL,"Laboratory of Molecular Immunoregulation, NCI","Gonzalo  De La Rosa



Yana  Li



Poonam  Tewary



Anna Lee  Trivett



Feng  Wei



De  Yang



Show all 7","Robert  Goldman
(Peprotech)




Johannes  Rohrl
(University of Regensburg)




Ronald  Wolf





Ning  Zhang
(Tianjin Cancer Hospital)","Carol  Clayberger (Laboratory of Cellular and Molecular Biology)



Alan M Krensky (Laboratory of Cellular and Molecular Biology)



Michael  Bustin; PhD (Protein Section)",NULL,"Ordered by publication type and then author name.



1.
Röhrl J, Yang D, Oppenheim JJ, Hehlgans T (2010). Human beta-defensin 2 and 3 and their mouse orthologs induce chemotaxis through interaction with CCR2. J Immunol  184, 6688-94.   https://doi.org/10.4049/jimmunol.0903984




PubMed



        
     
Free Article


 


PubMed ID 20483750
         Pubmed Central ID 6309988 


 



2.
Röhrl J, Yang D, Oppenheim JJ, Hehlgans T (2010). Specific binding and chemotactic activity of mBD4 and its functional orthologue hBD2 to CCR6-expressing cells. J Biol Chem  285, 7028-34.   https://doi.org/10.1074/jbc.M109.091090




PubMed



        
     
Free Article


 


PubMed ID 20068036
         Pubmed Central ID 2844152 


 



3.
Taylor K, Rolfe M, Reynolds N, Kilanowski F, Pathania U, Clarke D, Yang D, Oppenheim J, Samuel K, Howie S, Barran P, Macmillan D, Campopiano D, Dorin J (2009). Defensin-related peptide 1 (Defr1) is allelic to Defb8 and chemoattracts immature DC and CD4+ T cells independently of CCR6. Eur J Immunol  39, 1353-60.   https://doi.org/10.1002/eji.200838566




PubMed



        
     
Free Article


 


PubMed ID 19404978
         Pubmed Central ID 2883079 


 



4.
Yang D, de la Rosa G, Tewary P, Oppenheim JJ (2009). Alarmins link neutrophils and dendritic cells. Trends Immunol  30, 531-7.   https://doi.org/10.1016/j.it.2009.07.004




PubMed



        
     
Free Article


 


PubMed ID 19699678
         Pubmed Central ID 2767430 


 



5.
Yang D, Tewary P, de la Rosa G, Wei F, Oppenheim JJ (2010). The alarmin functions of high-mobility group proteins. Biochim Biophys Acta  1799, 157-63.   https://doi.org/10.1016/j.bbagrm.2009.11.002




PubMed



        
     
Free Article


 


PubMed ID 20123077
         Pubmed Central ID 6309997 


 



6.
Yang D, Zhao Y, Guo H, Li Y, Tewary P, Xing G, Hou W, Oppenheim JJ, Zhang N (2010). [Gd@C(82)(OH)(22)](n) nanoparticles induce dendritic cell maturation and activate Th1 immune responses. ACS Nano  4, 1178-86.   https://doi.org/10.1021/nn901478z




PubMed



        
     
Free Article


 


PubMed ID 20121217
         Pubmed Central ID 2835518",https://intramural.nih.gov/search/searchview.taf?ipid=62853
76,BC009392-18,"October 01, 2009 -  September 30, 2010",Determining the Fate of Transmembrane Proteins,"Allan M Weissman; MD



IRP Faculty Profile",NULL,"Laboratory of Protein Dynamics and Signaling, NCI","Adam R Day



Zlatka  Kostova Lenard



Rhyan P Maditz



Jennifer B Mariano



Yien-Che  Tsai



Mei  Yang; MD



Show all 8","Robert  Coffey
(Vanderbilt University)




Michael  Glickman
(Technion)




Kazuhiro  Iwai
(Department of Molecular Cell Biology, Osaka City Medical University)




J  McCaffery
(Johns Hopkins University)




Janet  Shaw
(University of Utah)","John A Beutler (Molecular Targets Development Program)



Lee Jay Helman; MD (Pediatric Oncology Branch)



Chand  Khanna; MD (Pediatric Oncology Branch)



Stefan  Ambs (Molecular Genetics and Carcinogenesis Section)



Robert Andrew Byrd (Structural Biophysics Laboratory)",Juan S Bonifacino; PhD (NICHD),"Ordered by publication type and then author name.



1.
Amiott EA, Cohen MM, Saint-Georges Y, Weissman AM, Shaw JM (2009). A mutation associated with CMT2A neuropathy causes defects in Fzo1 GTP hydrolysis, ubiquitylation, and protein turnover. Mol Biol Cell  20, 5026-35.   https://doi.org/10.1091/mbc.e09-07-0622




PubMed



        
     
Free Article


 


PubMed ID 19812251
         Pubmed Central ID 2785744 


 



2.
Kostova Z, Mariano J, Scholz S, Koenig C, Weissman AM (2009). A Ubc7p-binding domain in Cue1p activates ER-associated protein degradation. J Cell Sci  122, 1374-81.   https://doi.org/10.1242/jcs.044255




PubMed



        
     
Free Article


 


PubMed ID 19366730
         Pubmed Central ID 2671930 


 



3.
Martin DN, Boersma BJ, Yi M, Reimers M, Howe TM, Yfantis HG, Tsai YC, Williams EH, Lee DH, Stephens RM, Weissman AM, Ambs S (2009). Differences in the tumor microenvironment between African-American and European-American breast cancer patients. PLoS One  4, e4531.   https://doi.org/10.1371/journal.pone.0004531




PubMed



        
     
Free Article


 


PubMed ID 19225562
         Pubmed Central ID 2638012 


 



4.
Shmueli A, Tsai YC, Yang M, Braun MA, Weissman AM (2009). Targeting of gp78 for ubiquitin-mediated proteasomal degradation by Hrd1: cross-talk between E3s in the endoplasmic reticulum. Biochem Biophys Res Commun  390, 758-62.   https://doi.org/10.1016/j.bbrc.2009.10.045




PubMed



        
     
Free Article


 


PubMed ID 19835843
         Pubmed Central ID 3014991",https://intramural.nih.gov/search/searchview.taf?ipid=62753
77,BC009404-16,"October 01, 2009 -  September 30, 2010",Regulation of MHC Class II Trafficking in Antigen Presenting Cells,"Paul A Roche; PhD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI","Berta  Bosch Pages



Karis  Faust



Kazuyuki  Furuta



Erica Lynn Heipertz



Adam  Berger



Even  Walseng","Oddmund  Bakke
(Biology, Univ. of Oslo)




Lisa  Denzin
(Immunology Program, Sloan-Kettering Institute)




Satoshi  Ishido
(Riken Center for Allergy and Immunology)




Laura  Santambrogio
(Memorial Sloan Kettering)




Sidney  Whiteheart
(Univ. of Kentucky)",Lionel  Feigenbaum (Office Of The Director),Katherine Walton Roche; PhD (NINDS),"Ordered by publication type and then author name.



1.
Berger AC, Roche PA (2009). MHC class II transport at a glance. J Cell Sci  122, 1-4.   https://doi.org/10.1242/jcs.035089




PubMed



        
     
Free Article


 


PubMed ID 19092054
         Pubmed Central ID 2714400 


 



2.
Suh YH, Terashima A, Petralia RS, Wenthold RJ, Isaac JT, Roche KW, Roche PA (2010). A neuronal role for SNAP-23 in postsynaptic glutamate receptor trafficking. Nat Neurosci  13, 338-43.   https://doi.org/10.1038/nn.2488




PubMed



        
     
Free Article


 


PubMed ID 20118925
         Pubmed Central ID 2861127",https://intramural.nih.gov/search/searchview.taf?ipid=62854
78,BC009405-16,"October 01, 2009 -  September 30, 2010",Regulation of Lymphocyte Proliferation and Replicative Capacity,"Richard J Hodes; MD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI","Yungping  Chiang



Karen  Hathcock



Masashi  Watanabe",NULL,"Lionel  Feigenbaum (Office Of The Director)



Lino  Tessarollo (Mouse Cancer Genetics Program)",Neal S Young; MD (NHLBI),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=62855
79,BC010001-15,"October 01, 2009 -  September 30, 2010",MolecularCellular Regulation of Hematopoiesis,Jonathan  Keller; PhD,NULL,"Laboratory of Cancer Prevention, NCI","Satyanarayana  Ande



Bjorg  Gudmundsdottir



Kathrin  Muegge; MD



Kristbjorn O Gudmundsson; MSc, PhD



Ming  Ji



Kimberly D Klarmann



Show all 8",NULL,"Timothy D Veenstra (Office Of The Director)



Laura  Schmidt (Urologic Oncology Branch)



Serguei V Kozlov (Office of the Director)



Masaya  Baba (Urologic Oncology Branch)



Howard A Young; PhD (Laboratory of Experimental Immunology)",NULL,"Ordered by publication type and then author name.



1.
Suh HC, Ji M, Gooya J, Lee M, Klarmann KD, Keller JR (2009). Cell-nonautonomous function of Id1 in the hematopoietic progenitor cell niche. Blood  114, 1186-95.   https://doi.org/10.1182/blood-2008-09-179788




PubMed



        
     
Free Article


 


PubMed ID 19478045
         Pubmed Central ID 2723014",https://intramural.nih.gov/search/searchview.taf?ipid=62856
80,BC010006-15,"October 01, 2009 -  September 30, 2010",Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways,"Ira  Daar; PhD



IRP Faculty Profile",NULL,"Laboratory of Cell and Developmental Signaling, NCI","Gopala  Battu



Yon Ju  Ji



Arvinder J Singh",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=62858
81,BC010008-15,"October 01, 2009 -  September 30, 2010",The Genetics of Susceptibility to Mouse Plasma Cell Tumors,"Beverly  Mock; PhD



IRP Faculty Profile",NULL,"Laboratory of Cancer Biology and Genetics, NCI","Jyoti  Patel



Rushi Bakul Patel



Margaret R Pruitt



Richard C Robinson



Kaori  Sakakibara



John K Simmons



Show all 8",NULL,Carole A Parent; PhD (Laboratory of Cellular and Molecular Biology),"Pamela Lee Schwartzberg; MD, PhD (NHGRI)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=62859
82,BC010012-15,"October 01, 2009 -  September 30, 2010",Mechanisms of Immune-mediated Tumor Cell Destruction,Thomas Joseph Sayers; PhD,NULL,"Laboratory of Experimental Immunology, NCI","Alan  Brooks



Rachel Lee Dekluyver; PhD



Robert  Wiltrout; PhD



Richard John Pompei



Anil  Shanker","Hyam  Levitsky
(Department of Oncology, Johns Hopkins University)




William  Murphy
(University of Nevada)




Linda A Sherman





Hideo  Yagita
(Immunology, Juntendo University)",William  Farrar (Laboratory of Cancer Prevention),NULL,"Ordered by publication type and then author name.



1.
Salcedo R, Hixon JA, Stauffer JK, Jalah R, Brooks AD, Khan T, Dai RM, Scheetz L, Lincoln E, Back TC, Powell D, Hurwitz AA, Sayers TJ, Kastelein R, Pavlakis GN, Felber BK, Trinchieri G, Wigginton JM (2009). Immunologic and therapeutic synergy of IL-27 and IL-2: enhancement of T cell sensitization, tumor-specific CTL reactivity and complete regression of disseminated neuroblastoma metastases in the liver and bone marrow. J Immunol  182, 4328-38.   https://doi.org/10.4049/jimmunol.0800471




PubMed



        
     
Free Article


 


PubMed ID 19299733
         Pubmed Central ID 2730673 


 



2.
Shanker A, Brooks AD, Jacobsen KM, Wine JW, Wiltrout RH, Yagita H, Sayers TJ (2009). Antigen presented by tumors in vivo determines the nature of CD8+ T-cell cytotoxicity. Cancer Res  69, 6615-23.   https://doi.org/10.1158/0008-5472.CAN-09-0685




PubMed



        
     
Free Article


 


PubMed ID 19654302
         Pubmed Central ID 2727577 


 



3.
Zaritskaya L, Shurin MR, Sayers TJ, Malyguine AM (2010). New flow cytometric assays for monitoring cell-mediated cytotoxicity. Expert Rev Vaccines  9, 601-16.   https://doi.org/10.1586/erv.10.49




PubMed



        
     
Free Article


 


PubMed ID 20518716
         Pubmed Central ID 2911950",https://intramural.nih.gov/search/searchview.taf?ipid=62860
83,BC010013-15,"October 01, 2009 -  September 30, 2010",Molecular Studies of Cellular Cytotoxicity,Stephen K Anderson; PhD,NULL,"Laboratory of Experimental Immunology, NCI","Mary  Carrington; MS, PhD



Hong-Chuan  Li



Daniel  McVicar; PhD



Neeraj  Sharma



Michael  Dean; PhD



Paul  Wright","Colin  Brooks
(School of Biosciences, University of Newcastle)




Kerry  Campbell
(Immunobiology, Fox Chase Cancer Institute)




Dan  Kaufman
(Division of Hematology, Oncology and Transplantation, University of Minnesota Cancer Center)




Andrew  Makrigiannis
(ICRM)




Jeffrey  Miller
(University of Minnesota Cancer Center)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=62861
84,BC010014-15,"October 01, 2009 -  September 30, 2010",Epigenetic control during embryogenesis,Kathrin  Muegge; MD,NULL,"Laboratory of Cancer Prevention, NCI","Victorino Cristito Robles Briones



Theresa M Geiman



Yong-Guang  Tao","Rabindranath  de la Fuente





Ina  Dobrinski",NULL,NULL,"Ordered by publication type and then author name.



1.
Tao Y, Xi S, Briones V, Muegge K (2010). Lsh mediated RNA polymerase II stalling at HoxC6 and HoxC8 involves DNA methylation. PLoS One  5, e9163.   https://doi.org/10.1371/journal.pone.0009163




PubMed



        
     
Free Article


 


PubMed ID 20161795
         Pubmed Central ID 2820093",https://intramural.nih.gov/search/searchview.taf?ipid=62862
85,BC010015-15,"October 01, 2009 -  September 30, 2010",The Role of Cellular Receptors Involved in Inflammation and Tumor Progression,"Ji Ming  Wang; MD, PhD



IRP Faculty Profile",NULL,"Laboratory of Molecular Immunoregulation, NCI","Wang Hua  Gong



Ying  Liu



Shao-Bo  Su; MD, PhD","Xiuwu  Bian
(Southwest Hospital, Institute of Pathology)




Yingying  Le
(Immunology, Institute for Nutritional Sciences)




Thomas  Rogers
(Temple University)




Chunfu  Wu
(Medicinal Chemistry, Shenyang Pharmaceutical University)",Keqiang  Chen (Laboratory of Molecular Immunoregulation),Philip M Murphy; MD (NIAID),"Ordered by publication type and then author name.



1.
Huang J, Chen K, Huang J, Gong W, Dunlop NM, Howard OM, Bian X, Gao Y, Wang JM (2009). Regulation of the leucocyte chemoattractant receptor FPR in glioblastoma cells by cell differentiation. Carcinogenesis  30, 348-55.   https://doi.org/10.1093/carcin/bgn266




PubMed



        
     
Free Article


 


PubMed ID 19037090
         Pubmed Central ID 2639049",https://intramural.nih.gov/search/searchview.taf?ipid=62863
86,BC010017-15,"October 01, 2009 -  September 30, 2010","Use of Bacteriophages to Prevent, Diagnose, and Treat Diseases","Sankar  Adhya; PhD



IRP Faculty Profile",NULL,"Developmental Genetics Section, NCI","Brian P Peddie



Robert A. Weisberg; PhD",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=62864
87,BC010020-15,"October 01, 2009 -  September 30, 2010",Clinical Trials with Immunotoxins,"Ira H Pastan; MD



IRP Faculty Profile",NULL,"Molecular Biology Section, NCI","Barbara  Debrah



Sonya C Duke



Linda L Ellison Dejewski



Elizabeth J Maestri



Rita  Mincemoyer; RN



Yvonne D Mallory



Show all 7","DARELL  BIGNER
(Duke University Medical Center, Dept. of Pathology)




JOHN  SAMPSON
(Div of Neurosurgery, Duke University Medical Center, Div. of Neurosurgery)","Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)



Raffit  Hassan (Laboratory of Molecular Biology)



Thomas Alexander Waldmann; MD, PhD (Lymphoid Malignancies Branch)



Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)



Alan S Wayne; MD (Pediatric Oncology Branch)



David J Fitzgerald; PhD (Biotherapy Section)",NULL,"Ordered by publication type and then author name.



1.
Ding D, Kanaly CW, Bigner DD, Cummings TJ, Herndon JE, Pastan I, Raghavan R, Sampson JH (2010). Convection-enhanced delivery of free gadolinium with the recombinant immunotoxin MR1-1. J Neurooncol  98, 1-7.   https://doi.org/10.1007/s11060-009-0046-7




PubMed



        
     
Free Article


 


PubMed ID 19898744
         Pubmed Central ID 3082317 


 



2.
Hassan R, Schweizer C, Lu KF, Schuler B, Remaley AT, Weil SC, Pastan I (2010). Inhibition of mesothelin-CA-125 interaction in patients with mesothelioma by the anti-mesothelin monoclonal antibody MORAb-009: Implications for cancer therapy. Lung Cancer  68, 455-9.   https://doi.org/10.1016/j.lungcan.2009.07.016




PubMed



        
     
Free Article


 


PubMed ID 19744744
         Pubmed Central ID 2864325 


 



3.
Kreitman RJ, Fitzgerald DJ, Pastan I (2009). Approach to the patient after relapse of hairy cell leukemia. Leuk Lymphoma  50 Suppl 1, 32-7.   https://doi.org/10.3109/10428190903142216




PubMed


 


PubMed ID 19814696
    
     


 



4.
Kreitman RJ, Hassan R, Fitzgerald DJ, Pastan I (2009). Phase I trial of continuous infusion anti-mesothelin recombinant immunotoxin SS1P. Clin Cancer Res  15, 5274-9.   https://doi.org/10.1158/1078-0432.CCR-09-0062




PubMed



        
     
Free Article


 


PubMed ID 19671873
         Pubmed Central ID 2754261 


 



5.
Kreitman RJ, Stetler-Stevenson M, Margulies I, Noel P, Fitzgerald DJ, Wilson WH, Pastan I (2009). Phase II trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with hairy cell leukemia. J Clin Oncol  27, 2983-90.   https://doi.org/10.1200/JCO.2008.20.2630




PubMed



        
     
Free Article


 


PubMed ID 19414673
         Pubmed Central ID 2702232",https://intramural.nih.gov/search/searchview.taf?ipid=62865
88,BC010021-15,"October 01, 2009 -  September 30, 2010",Biology of Mammary Gland Development and Tumorigenesis,"Gilbert  Smith; PhD



IRP Faculty Profile",NULL,"Mammary Biology and Tumorigenesis Laboratory, NCI","Robert  Callahan; PhD



Lisa  Higginbotham



Corinne A Boulanger-Espeut



Barbara V Vonderhaar; PhD



Robert D Bruno



David  Salomon; PhD



Show all 7",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Boulanger CA, Smith GH (2009). Reprogramming cell fates in the mammary microenvironment. Cell Cycle  8, 1127-32.   https://doi.org/10.4161/cc.8.8.8189




PubMed



        
     
Free Article


 


PubMed ID 19282662
         Pubmed Central ID 3492885 


 



2.
Smith GH, Salomon DS, Vonderhar BK (2009). Re: ""Evidence that an early pregnancy causes a persistent decrease in the number of functional mammary epithelial stem cells-implications for pregnancy-induced protection against breast cancer"" by Siwko et al. Stem Cells  27, 1223; author reply 1224-5.   https://doi.org/10.1002/stem.19




PubMed


 


PubMed ID 19418459",https://intramural.nih.gov/search/searchview.taf?ipid=62866
89,BC010022-15,"October 01, 2009 -  September 30, 2010",Genetics of Renal Disease in African Americans,Cheryl Ann Winkler,NULL,"Basic Research Laboratory, NCI","Ping  An; PhD



Elizabeth  Binns-Roemer



Christopher J Cueto



Megan Elise Etheridge



Nicholas D Pezza



Megan E Rigby



Show all 8","Barry  Freedman
(Wake Forest University)




David  Gasser
(Department of Genetics, University of Pennsylvania)




Sudha  Iyengar
(Case Western Reserve University)




Linda  Kao
(Dept. of Epidemiology, Johns Hopkins University)




Gregory D Kirk





Rulan  Parekh
(Johns Hopkins University)


Show all 9","Michael W Smith (Office Of The Director)



George  Nelson (Laboratory of Genomic Diversity)",Jeffrey Burnett Kopp; MD (NIDDK),"Ordered by publication type and then author name.



1.
Freedman BI, Hicks PJ, Bostrom MA, Comeau ME, Divers J, Bleyer AJ, Kopp JB, Winkler CA, Nelson GW, Langefeld CD, Bowden DW (2009). Non-muscle myosin heavy chain 9 gene MYH9 associations in African Americans with clinically diagnosed type 2 diabetes mellitus-associated ESRD. Nephrol Dial Transplant  24, 3366-71.   https://doi.org/10.1093/ndt/gfp316




PubMed



        
     
Free Article


 


PubMed ID 19567477
         Pubmed Central ID 2910323 


 



2.
Freedman BI, Hicks PJ, Bostrom MA, Cunningham ME, Liu Y, Divers J, Kopp JB, Winkler CA, Nelson GW, Langefeld CD, Bowden DW (2009). Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans. Kidney Int  75, 736-45.   https://doi.org/10.1038/ki.2008.701




PubMed



        
     
Free Article


 


PubMed ID 19177153
         Pubmed Central ID 2698223 


 



3.
Freedman BI, Kopp JB, Winkler CA, Nelson GW, Rao DC, Eckfeldt JH, Leppert MF, Hicks PJ, Divers J, Langefeld CD, Hunt SC (2009). Polymorphisms in the nonmuscle myosin heavy chain 9 gene (MYH9) are associated with albuminuria in hypertensive African Americans: the HyperGEN study. Am J Nephrol  29, 626-32.   https://doi.org/10.1159/000194791




PubMed



        
     
Free Article


 


PubMed ID 19153477
         Pubmed Central ID 2749685",https://intramural.nih.gov/search/searchview.taf?ipid=62867
90,BC010025-15,"October 01, 2009 -  September 30, 2010",The Role of AP-1 and Other Transcription Factors in Cancer Cause and Prevention,"Nancy H Colburn; PhD



IRP Faculty Profile",NULL,"Laboratory of Cancer Prevention, NCI","Alyson R Baker



Daniel Augusto Barrera



Glenn  Hegamyer



Moon-Il  Kang



Qiou  Wei



Matthew R Young; PhD","Powel  Brown
(Baylor Breast Center, Baylor College of Medicine)




Myung  Cho
(Laboratory of Toxicology, Seoul National University)","Curtis  Henrich (Molecular Targets Development Program)



James  McMahon; PhD (Molecular Targets Laboratory)",NULL,"Ordered by publication type and then author name.



1.
Beutler JA, Kang MI, Robert F, Clement JA, Pelletier J, Colburn NH, McKee TC, Goncharova E, McMahon JB, Henrich CJ (2009). Quassinoid inhibition of AP-1 function does not correlate with cytotoxicity or protein synthesis inhibition. J Nat Prod  72, 503-6.   https://doi.org/10.1021/np800732n




PubMed



        
     
Free Article


 


PubMed ID 19199792
         Pubmed Central ID 2837105 


 



2.
Kang MI, Henrich CJ, Bokesch HR, Gustafson KR, McMahon JB, Baker AR, Young MR, Colburn NH (2009). A selective small-molecule nuclear factor-kappaB inhibitor from a high-throughput cell-based assay for ""activator protein-1 hits"". Mol Cancer Ther  8, 571-81.   https://doi.org/10.1158/1535-7163.MCT-08-0811




PubMed



        
     
Free Article


 


PubMed ID 19258426
         Pubmed Central ID 2813146 


 



3.
Kitagaki J, Yang Y, Saavedra JE, Colburn NH, Keefer LK, Perantoni AO (2009). Nitric oxide prodrug JS-K inhibits ubiquitin E1 and kills tumor cells retaining wild-type p53. Oncogene  28, 619-24.   https://doi.org/10.1038/onc.2008.401




PubMed



        
     
Free Article


 


PubMed ID 18978812
         Pubmed Central ID 2854646 


 



4.
Yin Y, Wang S, Sun Y, Matt Y, Colburn NH, Shu Y, Han X (2009). JNK/AP-1 pathway is involved in tumor necrosis factor-alpha induced expression of vascular endothelial growth factor in MCF7 cells. Biomed Pharmacother  63, 429-35.   https://doi.org/10.1016/j.biopha.2009.04.045




PubMed



        
     
Free Article


 


PubMed ID 19553068
         Pubmed Central ID 3449307",https://intramural.nih.gov/search/searchview.taf?ipid=62868
91,BC010026-15,"October 01, 2009 -  September 30, 2010","The Role of Pdcd4 in Translation, Tumorigenesis and Tumor Progression","Nancy H Colburn; PhD



IRP Faculty Profile",NULL,"Laboratory of Cancer Prevention, NCI","Alyson R Baker



Glenn  Hegamyer



Arti  Santhanam



Noriko  Yoshikawa; PhD



Matthew R Young; PhD","Heike  Allgayer
(University of Munich)




Myung  Cho
(Laboratory of Toxicology, Seoul National University)




Michele  Pagano
(New York Univ)




Nahum  Sonenberg
(McGill University)




Ana  Tari
(Department of Experimental Therapeutics, M.D. Anderson Cancer Center)","Curtis  Henrich (Molecular Targets Development Program)



Stuart F J Le Grice; PhD (Retroviral Replication Laboratory)



Bruce Allen Shapiro; PhD (Image Processing Section)



James  McMahon; PhD (Molecular Targets Laboratory)",NULL,"Ordered by publication type and then author name.



1.
Santhanam AN, Bindewald E, Rajasekhar VK, Larsson O, Sonenberg N, Colburn NH, Shapiro BA (2009). Role of 3'UTRs in the translation of mRNAs regulated by oncogenic eIF4E--a computational inference. PLoS One  4, e4868.   https://doi.org/10.1371/journal.pone.0004868




PubMed



        
     
Free Article


 


PubMed ID 19290046
         Pubmed Central ID 2654073",https://intramural.nih.gov/search/searchview.taf?ipid=62869
92,BC010027-16,"October 01, 2009 -  September 30, 2010",Function of Steroid Receptors in Subcellular Compartments,"Gordon Lee Hager; PhD



IRP Faculty Profile",NULL,"Laboratory of Receptor Biology and Gene Expression, NCI","Anuja  George



Ofir  Hakim



Thomas A Johnson



Ty Cole Voss","Ken  Pearce
(Gene Expression and Protein Biochemistry, GlaxoSmithKline Discovery Research)




Paolo  Sassone-Corsi; PhD
(IGBMC)","Angie  Dull (Molecular Targets Development Program)



Kevin A Camphausen; MD (Radiation Oncology Branch)",John J O'Shea; MD (NIAMS),"Ordered by publication type and then author name.



1.
Biddie SC, Hager GL (2009). Glucocorticoid receptor dynamics and gene regulation. Stress  12, 193-205.   https://doi.org/10.1080/10253890802506409




PubMed



        
     
Free Article


 


PubMed ID 19051126
         Pubmed Central ID 6319377 


 



2.
George AA, Schiltz RL, Hager GL (2009). Dynamic access of the glucocorticoid receptor to response elements in chromatin. Int J Biochem Cell Biol  41, 214-24.   https://doi.org/10.1016/j.biocel.2008.09.019




PubMed



        
     
Free Article


 


PubMed ID 18930837
         Pubmed Central ID 2632576 


 



3.
Hakim O, John S, Ling JQ, Biddie SC, Hoffman AR, Hager GL (2009). Glucocorticoid receptor activation of the Ciz1-Lcn2 locus by long range interactions. J Biol Chem  284, 6048-52.   https://doi.org/10.1074/jbc.C800212200




PubMed



        
     
Free Article


 


PubMed ID 19124469
         Pubmed Central ID 2649095",https://intramural.nih.gov/search/searchview.taf?ipid=62870
93,BC010030-15,"October 01, 2009 -  September 30, 2010",Biochemical Analysis of Multidrug Resistance-linked Transport Proteins,"Suresh V Ambudkar; PhD



IRP Faculty Profile",NULL,"Transport Biochemistry Section, NCI","Eduardo Emilio Chufan; PhD



Shinobu  Ohnuma; MD, PhD



Zuben  Sauna; PhD



Suneet  Shukla



Latoya Crystal-Gail Sommer Silverton



Candice  Schwartz



Show all 11","Catherine  Booth-Genthe
(Pharamcokinetics and drug metabolism, Amgen, Inc.)




Zhe-Sheng  Chen
(Pharmaceutical Sciences, St. John's University)




John E Golin





Rajendra  Prasad
(Jawaharlal Nehru University)","Michael Marc Gottesman; MD (Chemical Immunology Section)



Susan  Bates; MD (Medical Oncology Branch)



Peter C Fitzgerald (Office of the Director)



Lyuba  Varticovski (Hormone Action and Oncogenesis Section)



Di S Xia; PhD, MS, BS (Crystallography Section)



Stewart  Durell (Laboratory of Cell Biology)",NULL,"Ordered by publication type and then author name.



1.
Abraham I, Jain S, Wu CP, Khanfar MA, Kuang Y, Dai CL, Shi Z, Chen X, Fu L, Ambudkar SV, Sayed KE, Chen ZS (2010) Marine sponge-derived sipholane triterpenoids reverse P-glycoprotein (ABCB1)-mediated multidrug resistance in cancer cells. Biochem Pharmacol 80:1497-506




PubMed



        
     
Free Article


 


PubMed ID 20696137
         Pubmed Central ID 2948058 


 



2.
Ambudkar S, Liang Y, Huang H, Zhao H, Wu C, Wang F, Tao L, Zhang C, Dai C, Tiwari A, Ma X, To K, Ambudkar S, Chen Z, Fu L (2010) Apatinib (YN968D1) reverses multidrug resistance by inhibiting the efflux function of multiple ATP-binding cassette transporters. Cancer Res, in press.




 



3.
Ambudkar S, Ohnuma S, Ambudkar S (2010) Discovering natural product modulators to overcome multidrug resistance in cancer chemotherapy. Curr. Pharmaceut. Biotechnol, in press.




 



4.
Ambudkar S, Ohnuma S, Ambudkar S (2010) Improving cancer chemotherapy with modulators of ABC drug transporters. Curr. Drug Targets, in press.




 



5.
Ambudkar S, Salcido C, Gillet J, Wu C, Fostel J, Mumau M, Gottesman M, Varticovski L, Ambudkar S (2010) Prolonged drug selection of breast cancer cells and enrichment of cancer stem-cell characteristics. J. Natl. Cancer Inst, in press.




 



6.
Deeken JF, Robey RW, Shukla S, Steadman K, Chakraborty AR, Poonkuzhali B, Schuetz EG, Holbeck S, Ambudkar SV, Bates SE (2009). Identification of compounds that correlate with ABCG2 transporter function in the National Cancer Institute Anticancer Drug Screen. Mol Pharmacol  76, 946-56.   https://doi.org/10.1124/mol.109.056192




PubMed



        
     
Free Article


 


PubMed ID 19633067
         Pubmed Central ID 2774997 


 



7.
Kumar A, Shukla S, Mandal A, Shukla S, Ambudkar SV, Prasad R (2010). Divergent signature motifs of nucleotide binding domains of ABC multidrug transporter, CaCdr1p of pathogenic Candida albicans, are functionally asymmetric and noninterchangeable. Biochim Biophys Acta  1798, 1757-66.   https://doi.org/10.1016/j.bbamem.2010.05.017




PubMed



        
     
Free Article


 


PubMed ID 20546701
         Pubmed Central ID 2917344",https://intramural.nih.gov/search/searchview.taf?ipid=62871
94,BC010033-15,"October 01, 2009 -  September 30, 2010",Inflammation and  Cancer,"Curtis  Harris; MD



IRP Faculty Profile",NULL,"Laboratory of Human Carcinogenesis, NCI","Elise Dawn Bowman



Mohammed A. Khan; PhD



Aaron Joseph Schetter



Jane J Sohn



Elisa A Spillare



Judith A Welsh



Show all 7",NULL,"David Anderson Wink (Radiation Biology Branch)



Robert  Wiltrout; PhD (Laboratory of Experimental Immunology)",NULL,"Ordered by publication type and then author name.



1.
Jones LE, Ying L, Hofseth AB, Jelezcova E, Sobol RW, Ambs S, Harris CC, Espey MG, Hofseth LJ, Wyatt MD (2009). Differential effects of reactive nitrogen species on DNA base excision repair initiated by the alkyladenine DNA glycosylase. Carcinogenesis  30, 2123-9.   https://doi.org/10.1093/carcin/bgp256




PubMed



        
     
Free Article


 


PubMed ID 19864471
         Pubmed Central ID 2792317 


 



2.
Schetter AJ, Heegaard NH, Harris CC (2010). Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways. Carcinogenesis  31, 37-49.   https://doi.org/10.1093/carcin/bgp272




PubMed



        
     
Free Article


 


PubMed ID 19955394
         Pubmed Central ID 2802675",https://intramural.nih.gov/search/searchview.taf?ipid=62872
95,BC010038-15,"October 01, 2009 -  September 30, 2010",Molecular Cytogenetics of Solid Tumors,Nicolae C Popescu; PhD,NULL,"Laboratory of Experimental Carcinogenesis, NCI","Veenu  Tripathi; PhD



Xu-Yu  Yang



Xiaoling  Zhou



Drazen  Zimonjic; PhD","Ragbir  Athwal
(Temple University School of Medicine)




Qian  Tao
(Department of Clinical Oncology)




George R Uhl; PhD, MD
(NIDA)",NULL,NULL,"Ordered by publication type and then author name.



1.
Drgonova J, Zimonjic DB, Hall FS, Uhl GR (2010). Effect of KEPI (Ppp1r14c) deletion on morphine analgesia and tolerance in mice of different genetic backgrounds: when a knockout is near a relevant quantitative trait locus. Neuroscience  165, 882-95.   https://doi.org/10.1016/j.neuroscience.2009.10.007




PubMed



        
     
Free Article


 


PubMed ID 19819304
         Pubmed Central ID 3170095 


 



2.
Liu J, Kaur G, Zhawar VK, Zimonjic DB, Popescu NC, Kandpal RP, Athwal RS (2009). Role of SV40 integration site at chromosomal interval 1q21.1 in immortalized CRL2504 cells. Cancer Res  69, 7819-25.   https://doi.org/10.1158/0008-5472.CAN-09-1003




PubMed



        
     
Free Article


 


PubMed ID 19789346
         Pubmed Central ID 2913896 


 



3.
Popescu N, Tao Q, Ka Ma Ng K, Goh H, Woo W, Ambinder R, Srivastava G, Shamay M, Chan A, Popescu N, Hsieh W (2010) A novel isoform of the 8p22 tumor suppressor gene DLC1 suppresses tumor growth and is frequently silenced in multiple common tumors. Oncogene, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=62873
96,BC010041-15,"October 01, 2009 -  September 30, 2010","Oligosaccharide Substrate and Inhibitor Interactions with beta-1,4-Gal-T1",Pradman  Qasba; PhD,NULL,"Structural Glycobiology Section, NCI",Boopathy  Ramakrishna,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Brown JR, Yang F, Sinha A, Ramakrishnan B, Tor Y, Qasba PK, Esko JD (2009). Deoxygenated disaccharide analogs as specific inhibitors of beta1-4-galactosyltransferase 1 and selectin-mediated tumor metastasis. J Biol Chem  284, 4952-9.   https://doi.org/10.1074/jbc.M805782200




PubMed



        
     
Free Article


 


PubMed ID 19106107
         Pubmed Central ID 2643505",https://intramural.nih.gov/search/searchview.taf?ipid=62874
97,BC010251-15,"October 01, 2009 -  September 30, 2010","R-spondins, Secreted Frizzled-Related Proteins and the Regulation of Wnt Signali","Jeffrey S Rubin; MD, PhD",NULL,"Laboratory of Cellular and Molecular Biology, NCI","Bolormaa  Baljinnyam



Yoshimi Endo Greer



Maria  Melikova; PhD



Charles Peter Xavier",NULL,Robert  Callahan; PhD (Mammary Biology and Tumorigenesis Laboratory),NULL,"Ordered by publication type and then author name.



1.
Li SJ, Yen TY, Endo Y, Klauzinska M, Baljinnyam B, Macher B, Callahan R, Rubin JS (2009). Loss-of-function point mutations and two-furin domain derivatives provide insights  about R-spondin2 structure and function. Cell Signal  21, 916-25.   https://doi.org/10.1016/j.cellsig.2009.02.001




PubMed



        
     
Free Article


 


PubMed ID 19385064
         Pubmed Central ID 2813491 


 



2.
Linehan WM, Rubin JS, Bottaro DP (2009). VHL loss of function and its impact on oncogenic signaling networks in clear cell renal cell carcinoma. Int J Biochem Cell Biol  41, 753-6.   https://doi.org/10.1016/j.biocel.2008.09.024




PubMed



        
     
Free Article


 


PubMed ID 18950731
         Pubmed Central ID 2684867",https://intramural.nih.gov/search/searchview.taf?ipid=62875
98,BC010252-15,"October 01, 2009 -  September 30, 2010",Pathogenic Effects of Human Retroviruses on Hematopoietic and Adherent Cells.,Francis W Ruscetti; PhD,NULL,"Laboratory of Experimental Immunology, NCI","Daniel C Bertolette



Tao  Fu



Yi  Huang



Stig Moelgaard Rask Jensen; PhD



Kathryn  Jones; PhD



Jennifer M Reid



Show all 7","Pat  Green
(Ohio State University)




Judy  Mikovits
(whittemore peterson inst)




Claudine  Pique
(Inserm)","Sandra  Ruscetti; PhD (Laboratory of Cancer Prevention)



Genoveffa  Franchini; MD (Vaccine Branch)



Robert  Blumenthal; PhD (Center for Cancer Research Nanobiology Program)



Vineet Narain KewalRamani; PhD (Retroviral Replication Laboratory)



Rachel  Beyer (Office Of The Director)



Gene  Shearer; PhD (Cell Mediated Immunity Section)",Steven J Jacobson; PhD (NINDS),"Ordered by publication type and then author name.



1.
Jones KS, Huang YK, Chevalier SA, Afonso PV, Petrow-Sadowski C, Bertolette DC, Gessain A, Ruscetti FW, Mahieux R (2009). The receptor complex associated with human T-cell lymphotropic virus type 3 (HTLV-3) Env-mediated binding and entry is distinct from, but overlaps with, the receptor complexes of HTLV-1 and HTLV-2. J Virol  83, 5244-55.   https://doi.org/10.1128/JVI.02285-08




PubMed



        
     
Free Article


 


PubMed ID 19279090
         Pubmed Central ID 2682092 


 



2.
Lambert S, Bouttier M, Vassy R, Seigneuret M, Petrow-Sadowski C, Janvier S, Heveker N, Ruscetti FW, Perret G, Jones KS, Pique C (2009). HTLV-1 uses HSPG and neuropilin-1 for entry by molecular mimicry of VEGF165. Blood  113, 5176-85.   https://doi.org/10.1182/blood-2008-04-150342




PubMed



        
     
Free Article


 


PubMed ID 19270265
         Pubmed Central ID 2686187 


 



3.
Lombardi VC, Ruscetti FW, Das Gupta J, Pfost MA, Hagen KS, Peterson DL, Ruscetti SK, Bagni RK, Petrow-Sadowski C, Gold B, Dean M, Silverman RH, Mikovits JA (2009). Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science  326, 585-9.   https://doi.org/10.1126/science.1179052




PubMed


 


PubMed ID 19815723",https://intramural.nih.gov/search/searchview.taf?ipid=62876
99,BC010253-15,"October 01, 2009 -  September 30, 2010",Molecular Mechanisms of Growth Factor Modulated Proliferation,William  Farrar,NULL,"Laboratory of Cancer Prevention, NCI","Suneetha  Thomas



Suresh R Volate



Xiaohu  Zhang",NULL,Victor  Marquez; PhD (Chemical Biology Laboratory),NULL,"Ordered by publication type and then author name.



1.
Kawasaki BT, Hurt EM, Kalathur M, Duhagon MA, Milner JA, Kim YS, Farrar WL (2009). Effects of the sesquiterpene lactone parthenolide on prostate tumor-initiating cells: An integrated molecular profiling approach. Prostate  69, 827-37.   https://doi.org/10.1002/pros.20931




PubMed



        
     
Free Article


 


PubMed ID 19204913
         Pubmed Central ID 2700306 


 



2.
Volate SR, Kawasaki BT, Hurt EM, Milner JA, Kim YS, White J, Farrar WL (2010). Gossypol induces apoptosis by activating p53 in prostate cancer cells and prostate tumor-initiating cells. Mol Cancer Ther  9, 461-70.   https://doi.org/10.1158/1535-7163.MCT-09-0507




PubMed



        
     
Free Article


 


PubMed ID 20124455
         Pubmed Central ID 2820604",https://intramural.nih.gov/search/searchview.taf?ipid=62877
100,BC010256-15,"October 01, 2009 -  September 30, 2010",The Nodal Signaling Pathway In Embryonic Development,Michael Robert Kuehn; PhD,NULL,"Laboratory of Protein Dynamics and Signaling, NCI","Oyvind  Dahle



Margaret M O'Toole-Lualdi",NULL,NULL,Amit  Kumar; PhD (NIDDK),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=62878
101,BC010272-14,"October 01, 2009 -  September 30, 2010",Facilitating Access to Information on Human Proteins and Their Phosphorylation,"James Stephen Shaw; PhD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI",NULL,NULL,"Matthew S Scilipoti (Human Immunology Section)



Mark A Parsons (Center For Biomedical Informatics & Information Technology)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=62879
102,BC010276-13,"October 01, 2009 -  September 30, 2010",Protein Folding Mechanism,"Yawen  Bai; PhD



IRP Faculty Profile",NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI","Hanqiao  Feng



Zheng  Zhou",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=62880
103,BC010277-13,"October 01, 2009 -  September 30, 2010",Mechanisms of Chromosome Maintenance in Bacteria,"Dhruba K Chattoraj; PhD



IRP Faculty Profile",NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI","Jonghwan  Baek



Jyoti Krishna Jha



Ryosuke  Kadoya



Tatiana B Venkova-Canova","Petra  Levin; PhD
(Biology, Washington U)




Rajagopala  Venkatappa
(J Craig Ventor Institute)",NULL,"Aravind L Iyer; PhD (NLM) 



Emilios K Dimitriadis; PhD (NIBIB)","Ordered by publication type and then author name.



1.
Aladjem M, Chattoraj DK (2009). EMBO Conference on Replication and Segregation of Chromosomes, Geilo, Norway, June 16-20. Replication and segregation of chromosomes in the three domains of life: EMBO conference reports common grounds. Meeting report. Plasmid  61, 89-93.   https://doi.org/10.1016/j.plasmid.2008.10.003




PubMed


 


PubMed ID 19041668
    
     


 



2.
Demarre G, Chattoraj DK (2010). DNA adenine methylation is required to replicate both Vibrio cholerae chromosomes once per cell cycle. PLoS Genet  6, e1000939.   https://doi.org/10.1371/journal.pgen.1000939




PubMed



        
     
Free Article


 


PubMed ID 20463886
         Pubmed Central ID 2865523",https://intramural.nih.gov/search/searchview.taf?ipid=62881
104,BC010278-13,"October 01, 2009 -  September 30, 2010",Imaging cellular assemblies with three-dimensional electron microscopy,"Sriram  Subramaniam; PhD



IRP Faculty Profile",NULL,"Laboratory of Cell Biology, NCI","Alberto  Bartesaghi



Michael Jason de la Cruz



Gavin Erick Murphy



Kedar  Narayan



Martin  Kessel; BSc, PhD","Mark  Hildebrand
(Scripps Institute of Oceanography)




Guillermo  Sapiro
(Electrical Engineering, Uinversity of Minnesota)




John Henry  Scott
(NIST)




Chris  Szakal
(NIST)","Vincent J. Hearing; PhD (Pigment Cell Biology Section)



Steven Aaron Rosenberg; MD, PhD (Surgery Branch)","Terry S Yoo; PhD (NLM) 



Donald F Bliss (NLM)","Ordered by publication type and then author name.



1.
Bartesaghi A, Subramaniam S (2009). Membrane protein structure determination using cryo-electron tomography and 3D image averaging. Curr Opin Struct Biol  19, 402-7.   https://doi.org/10.1016/j.sbi.2009.06.005




PubMed



        
     
Free Article


 


PubMed ID 19646859
         Pubmed Central ID 2752674 


 



2.
Fenton AK, Hobley L, Butan C, Subramaniam S, Sockett RE (2010). A coiled-coil-repeat protein 'Ccrp' in Bdellovibrio bacteriovorus prevents cellular indentation, but is not essential for vibroid cell morphology. FEMS Microbiol Lett  313, 89-95.   https://doi.org/10.1111/j.1574-6968.2010.02125.x




PubMed



        
     
Free Article


 


PubMed ID 20977494
         Pubmed Central ID 4803027 


 



3.
Heymann JA, Shi D, Kim S, Bliss D, Milne JL, Subramaniam S (2009). 3D imaging of mammalian cells with ion-abrasion scanning electron microscopy. J Struct Biol  166, 1-7.   https://doi.org/10.1016/j.jsb.2008.11.005




PubMed



        
     
Free Article


 


PubMed ID 19116171
         Pubmed Central ID 4804765 


 



4.
Hildebrand M, Kim S, Shi D, Scott K, Subramaniam S (2009). 3D imaging of diatoms with ion-abrasion scanning electron microscopy. J Struct Biol  166, 316-28.   https://doi.org/10.1016/j.jsb.2009.02.014




PubMed



        
     
Free Article


 


PubMed ID 19269330
         Pubmed Central ID 2743382 


 



5.
Hirai T, Subramaniam S (2009). Protein conformational changes in the bacteriorhodopsin photocycle: comparison of findings from electron and X-ray crystallographic analyses. PLoS One  4, e5769.   https://doi.org/10.1371/journal.pone.0005769




PubMed



        
     
Free Article


 


PubMed ID 19488399
         Pubmed Central ID 2685002 


 



6.
Hirai T, Subramaniam S, Lanyi JK (2009). Structural snapshots of conformational changes in a seven-helix membrane protein: lessons from bacteriorhodopsin. Curr Opin Struct Biol  19, 433-9.   https://doi.org/10.1016/j.sbi.2009.07.009




PubMed



        
     
Free Article


 


PubMed ID 19643594
         Pubmed Central ID 2747668 


 



7.
Subramaniam S, Ouyang H, Gray A, McLaughllin S, Subramaniam S (2009) Automatic mining of 3D images of whole cells. Pattern Recognition 1067-1079.",https://intramural.nih.gov/search/searchview.taf?ipid=62882
105,BC010283-13,"October 01, 2009 -  September 30, 2010",DNA Repair,"Andre A Nussenzweig; PhD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI",NULL,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=62883
106,BC010292-13,"October 01, 2009 -  September 30, 2010",Enzymes and Substrates of the Ubiquitin Conjugating System,"Allan M Weissman; MD



IRP Faculty Profile",NULL,"Laboratory of Protein Dynamics and Signaling, NCI","Shengjian  Li



Jennifer B Mariano



Ayelet  Shmueli Lavi



Yien-Che  Tsai



Michael Robert Kuehn; PhD



Gaye L Wilson



Show all 7","Robert  Coffey
(Vanderbilt University)




Karen H Vousden","John A Beutler (Molecular Targets Development Program)



Barry R O'Keefe (Molecular Targets Development Program)



Stefan  Ambs (Molecular Genetics and Carcinogenesis Section)



Robert Andrew Byrd (Structural Biophysics Laboratory)



Xinhua  Ji; PhD (Biomolecular Structure Section)",Juan S Bonifacino; PhD (NICHD),"Ordered by publication type and then author name.



1.
Das R, Mariano J, Tsai YC, Kalathur RC, Kostova Z, Li J, Tarasov SG, McFeeters RL, Altieri AS, Ji X, Byrd RA, Weissman AM (2009). Allosteric activation of E2-RING finger-mediated ubiquitylation by a structurally defined specific E2-binding region of gp78. Mol Cell  34, 674-85.   https://doi.org/10.1016/j.molcel.2009.05.010




PubMed



        
     
Free Article


 


PubMed ID 19560420
         Pubmed Central ID 3050579 


 



2.
Weissman A, Weissman A (2010) The unfolded protein response, degradation from the endoplasmic reticulum and cancer. Genes and Cancer, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=62754
107,BC010297-13,"October 01, 2009 -  September 30, 2010",Identification of Gene Polymorphisms Associated with Infectious Diseases,Cheryl Ann Winkler,NULL,"Basic Research Laboratory, NCI","Ping  An; PhD



Elizabeth  Binns-Roemer



Christopher J Cueto



Megan Elise Etheridge



Nicholas D Pezza



Megan E Rigby



Show all 8","Sharyne  Donfield
(Hemophilia Growth and Development Study, Rho, Inc.)




Max  Essex
(Department of Immuology and Infectious Diseases, Harvard Medical School)




Gregory D Kirk





James  Mullins; PhD
(Microbiology, University of Washington)




John P Phair





Jean-Francois  Zagury
(Conservatoire National des Arts et MÃ©tiers)","Stephen J O'Brien; PhD (Laboratory of Genomic Diversity)



James Jerome Goedert; MD (Infection & Immunoepidemiology Branch)",NULL,"Ordered by publication type and then author name.



1.
An P, Johnson R, Phair J, Kirk GD, Yu XF, Donfield S, Buchbinder S, Goedert JJ, Winkler CA (2009). APOBEC3B deletion and risk of HIV-1 acquisition. J Infect Dis  200, 1054-8.   https://doi.org/10.1086/605644




PubMed



        
     
Free Article


 


PubMed ID 19698078
         Pubmed Central ID 3690486 


 



2.
Guo X, Johnson RC, Deng H, Liao J, Guan L, Nelson GW, Tang M, Zheng Y, de The G, O'Brien SJ, Winkler CA, Zeng Y (2009). Evaluation of nonviral risk factors for nasopharyngeal carcinoma in a high-risk population of Southern China. Int J Cancer  124, 2942-7.   https://doi.org/10.1002/ijc.24293




PubMed



        
     
Free Article


 


PubMed ID 19296536
         Pubmed Central ID 4406046 


 



3.
Nyquist PA, Winkler CA, McKenzie LM, Yanek LR, Becker LC, Becker DM (2009). Single nucleotide polymorphisms in monocyte chemoattractant protein-1 and its receptor act synergistically to increase the risk of carotid atherosclerosis. Cerebrovasc Dis  28, 124-30.   https://doi.org/10.1159/000223437




PubMed



        
     
Free Article


 


PubMed ID 19506371
         Pubmed Central ID 2914430",https://intramural.nih.gov/search/searchview.taf?ipid=62884
108,BC010298-13,"October 01, 2009 -  September 30, 2010",Growth Regulation Section,"Ira H Pastan; MD



IRP Faculty Profile",NULL,"Molecular Biology Section, NCI","Richard A Beers



Tapan K Bera



Zhaoliang  Fei



Charissa  Kahue



Xiu Fen Liu



Gregory  Raciti",NULL,"Oleg Y Chertov (Office Of The Director)



Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)



Byungkook  Lee; PhD (Molecular Modeling Section)",NULL,"Ordered by publication type and then author name.



1.
Anaganti S, Hansen JK, Ha D, Hahn Y, Chertov O, Pastan I, Bera TK (2009). Non-AUG translational initiation of a short CAPC transcript generating  protein isoform. Biochem Biophys Res Commun  380, 508-13.   https://doi.org/10.1016/j.bbrc.2009.01.089




PubMed



        
     
Free Article


 


PubMed ID 19250639
         Pubmed Central ID 2664252 


 



2.
Cereda V, Poole DJ, Palena C, Das S, Bera TK, Remondo C, Gulley JL, Arlen PM, Yokokawa J, Pastan I, Schlom J, Tsang KY (2010). New gene expressed in prostate: a potential target for T cell-mediated prostate cancer immunotherapy. Cancer Immunol Immunother  59, 63-71.   https://doi.org/10.1007/s00262-009-0723-6




PubMed



        
     
Free Article


 


PubMed ID 19495750
         Pubmed Central ID 2782544 


 



3.
Hahn Y, Kim DS, Pastan IH, Lee B (2009). Anoctamin and transmembrane channel-like proteins are evolutionarily related. Int J Mol Med  24, 51-5.   https://doi.org/10.3892/ijmm_00000205




PubMed



        
     
Free Article


 


PubMed ID 19513534
         Pubmed Central ID 2695565",https://intramural.nih.gov/search/searchview.taf?ipid=62885
109,BC010300-13,"October 01, 2009 -  September 30, 2010",Signal Transduction of Paired Inhibitory Receptors of NK Cells and Macrophages,"Daniel  McVicar; PhD



IRP Faculty Profile",NULL,"Laboratory of Experimental Immunology, NCI","Jill Wallace Ford



Geraldine Martina O'Connor



Selinda Jane Orr



Laura Ann R Quigley","James  Finke
(Cleveland Clinic)




Neil  Gow
(Unversity of Aberdeen)




Mary  Nakamura
(Laboratoire d'Hematologie, UCSF)




Philip  Taylor
(Cardiff University)




Valance  Washington
(Anatomy and Cell biology, Universidad Central del Caribe)




Thomas  Yankee
(Microbiology, Univ. Kansas Medical Center)


Show all 7","Oleg Y Chertov (Office Of The Director)



Shyam K Sharan (Mouse Cancer Genetics Program)



Giorgio  Trinchieri (Cancer Inflammation Program)



William Marston Linehan; MD (Urologic Oncology Branch)



Stefan  Ambs (Molecular Genetics and Carcinogenesis Section)","Ivo  Francischetti; MD, PhD (NIAID) 



Doug B Kuhns; PhD (NIAID) 



Igal  Gery; PhD (NEI) 



Pamela Lee Schwartzberg; MD, PhD (NHGRI) 



Alasdair M Gilfillan; PhD (NIAID) 



Suk See De Ravin; MD, PhD (NIAID)","Ordered by publication type and then author name.



1.
Ford JW, McVicar DW (2009). TREM and TREM-like receptors in inflammation and disease. Curr Opin Immunol  21, 38-46.   https://doi.org/10.1016/j.coi.2009.01.009




PubMed



        
     
Free Article


 


PubMed ID 19230638
         Pubmed Central ID 2723941 


 



2.
McVicar DW, Trinchieri G (2009). CSF-1R, DAP12 and beta-catenin: a ménage à trois. Nat Immunol  10, 681-3.   https://doi.org/10.1038/ni0709-681




PubMed


 


PubMed ID 19536190
    
     


 



3.
Orr SJ, Quigley L, McVicar DW (2009). In vivo expression of signaling proteins in reconstituted NK cells. J Immunol Methods  340, 158-63.   https://doi.org/10.1016/j.jim.2008.10.014




PubMed



        
     
Free Article


 


PubMed ID 19028500
         Pubmed Central ID 2630801 


 



4.
Washington AV, Gibot S, Acevedo I, Gattis J, Quigley L, Feltz R, De La Mota A, Schubert RL, Gomez-Rodriguez J, Cheng J, Dutra A, Pak E, Chertov O, Rivera L, Morales J, Lubkowski J, Hunter R, Schwartzberg PL, McVicar DW (2009). TREM-like transcript-1 protects against inflammation-associated hemorrhage by facilitating platelet aggregation in mice and humans. J Clin Invest  119, 1489-501.   https://doi.org/10.1172/JCI36175




PubMed



        
     
Free Article


 


PubMed ID 19436112
         Pubmed Central ID 2689104",https://intramural.nih.gov/search/searchview.taf?ipid=62886
110,BC010301-13,"October 01, 2009 -  September 30, 2010",Development of Recombinant Toxins to Treat Hematologic Malignancies,"Robert J Kreitman; MD, PhD



IRP Faculty Profile",NULL,"Clinical Immunotherapy Section, NCI","Evgeny  Arons



Barbara  Debrah



Sonya C Duke



Rita  Mincemoyer; RN



Rajat  Singh



Linda L Ellison Dejewski



Show all 9",NULL,"Constance M Yuan (Laboratory of Pathology)



Daniel C Edelman (Cancer Genetics Branch)



Paul S Meltzer; MD, PhD (Cancer Genetics Branch)



Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)



John Charles Morris; MD (Lymphoid Malignancies Branch)



Thomas Alexander Waldmann; MD, PhD (Lymphoid Malignancies Branch)",NULL,"Ordered by publication type and then author name.



1.
Alderson RF, Kreitman RJ, Chen T, Yeung P, Herbst R, Fox JA, Pastan I (2009). CAT-8015: a second-generation pseudomonas exotoxin A-based immunotherapy targeting CD22-expressing hematologic malignancies. Clin Cancer Res  15, 832-9.   https://doi.org/10.1158/1078-0432.CCR-08-1456




PubMed



        
     
Free Article


 


PubMed ID 19188153
         Pubmed Central ID 2742326 


 



2.
Arons E, Suntum T, Stetler-Stevenson M, Kreitman RJ (2009). VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy. Blood  114, 4687-95.   https://doi.org/10.1182/blood-2009-01-201731




PubMed



        
     
Free Article


 


PubMed ID 19745070
         Pubmed Central ID 2780305 


 



3.
Kreitman RJ (2009). Recombinant immunotoxins containing truncated bacterial toxins for the treatment of hematologic malignancies. BioDrugs  23, 1-13.   https://doi.org/10.2165/00063030-200923010-00001




PubMed



        
     
Free Article


 


PubMed ID 19344187
         Pubmed Central ID 2671643 


 



4.
Kreitman RJ (2009). Recombinant immunotoxins for the treatment of chemoresistant hematologic malignancies. Curr Pharm Des  15, 2652-64.   https://doi.org/10.2174/138161209788923949




PubMed



        
     
Free Article


 


PubMed ID 19689336
         Pubmed Central ID 6321767 


 



5.
Kreitman RJ, Fitzgerald DJ, Pastan I (2009). Approach to the patient after relapse of hairy cell leukemia. Leuk Lymphoma  50 Suppl 1, 32-7.   https://doi.org/10.3109/10428190903142216




PubMed


 


PubMed ID 19814696
    
     


 



6.
Kreitman RJ, Hassan R, Fitzgerald DJ, Pastan I (2009). Phase I trial of continuous infusion anti-mesothelin recombinant immunotoxin SS1P. Clin Cancer Res  15, 5274-9.   https://doi.org/10.1158/1078-0432.CCR-09-0062




PubMed



        
     
Free Article


 


PubMed ID 19671873
         Pubmed Central ID 2754261 


 



7.
Kreitman RJ, Stetler-Stevenson M, Margulies I, Noel P, Fitzgerald DJ, Wilson WH, Pastan I (2009). Phase II trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with hairy cell leukemia. J Clin Oncol  27, 2983-90.   https://doi.org/10.1200/JCO.2008.20.2630




PubMed



        
     
Free Article


 


PubMed ID 19414673
         Pubmed Central ID 2702232 


 



8.
Weldon JE, Xiang L, Chertov O, Margulies I, Kreitman RJ, FitzGerald DJ, Pastan I (2009). A protease-resistant immunotoxin against CD22 with greatly increased activity against CLL and diminished animal toxicity. Blood  113, 3792-800.   https://doi.org/10.1182/blood-2008-08-173195




PubMed



        
     
Free Article


 


PubMed ID 18988862
         Pubmed Central ID 2670794",https://intramural.nih.gov/search/searchview.taf?ipid=62887
111,BC010304-12,"October 01, 2009 -  September 30, 2010",Biochemical Basis of T Cell Activation,"Lawrence Elliot Samelson; MD



IRP Faculty Profile",NULL,"Laboratory of Cellular and Molecular Biology, NCI","Lakshmi  Balagopalan



Valarie  Barr; PhD



Nathan  Coussens



Wenmei  Li; PhD



Robert Kent Merrill



John M Pinski



Show all 10",NULL,"Ettore  Appella; MD (Chemical Immunology Section)



Robert Mark Simpson; DVM, PhD (Laboratory of Cancer Biology and Genetics)","Peter W Schuck; PhD (NIBIB) 



Paul E Love; MD, PhD (NICHD) 



Jennifer A Lippincott Schwartz; PhD (NICHD)","Ordered by publication type and then author name.



1.
Balagopalan L, Barr VA, Samelson LE (2009). Endocytic events in TCR signaling: focus on adapters in microclusters. Immunol Rev  232, 84-98.   https://doi.org/10.1111/j.1600-065X.2009.00840.x




PubMed



        
     
Free Article


 


PubMed ID 19909358
         Pubmed Central ID 3138075 


 



2.
Barr VA, Bernot KM, Shaffer MH, Burkhardt JK, Samelson LE (2009). Formation of STIM and Orai complexes: puncta and distal caps. Immunol Rev  231, 148-59.   https://doi.org/10.1111/j.1600-065X.2009.00812.x




PubMed



        
     
Free Article


 


PubMed ID 19754895
         Pubmed Central ID 3110759 


 



3.
Kortum RL, Samelson LE (2009). Priming the pump: adhesion enhances T cell antigen receptor-induced signaling. Immunity  30, 3-5.   https://doi.org/10.1016/j.immuni.2008.12.007




PubMed



        
     
Free Article


 


PubMed ID 19144310
         Pubmed Central ID 6684054 


 



4.
Miyaji M, Kortum RL, Surana R, Li W, Woolard KD, Simpson RM, Samelson LE, Sommers CL (2009). Genetic evidence for the role of Erk activation in a lymphoproliferative disease of mice. Proc Natl Acad Sci U S A  106, 14502-7.   https://doi.org/10.1073/pnas.0903894106




PubMed



        
     
Free Article


 


PubMed ID 19667175
         Pubmed Central ID 2732887",https://intramural.nih.gov/search/searchview.taf?ipid=62888
112,BC010307-11,"October 01, 2009 -  September 30, 2010",Molecular Mechanisms Regulating Mouse Mammary Gland and Human Breast Tumor Cells,"Gisela Esta Sterneck; PhD



IRP Faculty Profile",NULL,"Laboratory of Cell and Developmental Signaling, NCI","Balamurugan  Kuppusamy



Tapasree  Roysarkar



Shikha  Sharan



Jun  Wang","Keiko  Akagi
(NCI)




Carlos  Caldas
(Cancer Research UK Cambridge Research Institute)




Nigel  Jones
(University of Liverpool)




Zdenek  Kleibel
(Dept. of Biochemistry and Experimental Oncology, Charles University in Prague)




Snehalata Anil Pawar





Ju-Ming  Wang
(National Cheng Kung University)","Melinda  Hollingshead (Biological Testing Branch)



Jonathan  Keller; PhD (Laboratory of Cancer Prevention)",NULL,"Ordered by publication type and then author name.



1.
Sterneck E, Roy Sarkar T, Zhou M, Sharan S, Ritt D, Veenstra T, Morrison D, Huang A, Sterneck E (2010) CCAATenhancer binding protein delta (CEBPdelta, CEBPD)-mediated nuclear import of FANCD2 by IPO4 augments cellular response to DNA damage. Proc. Natl. Acad. Sci. U.S.A, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=62766
113,BC010308-12,"October 01, 2009 -  September 30, 2010",In vivo Imaging Analysis of SteroidNuclear Receptor Function,"Gordon Lee Hager; PhD



IRP Faculty Profile",NULL,"Laboratory of Receptor Biology and Gene Expression, NCI","Rodney Louis Schiltz; PhD



Diana  Stavreva



Ty Cole Voss



Malgorzata  Wiench",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Stavreva DA, Wiench M, John S, Conway-Campbell BL, McKenna MA, Pooley JR, Johnson TA, Voss TC, Lightman SL, Hager GL (2009). Ultradian hormone stimulation induces glucocorticoid receptor-mediated pulses of gene transcription. Nat Cell Biol  11, 1093-102.   https://doi.org/10.1038/ncb1922




PubMed



               Available in future as a Free Article 


 


PubMed ID 19684579
         Pubmed Central ID 6711162 


 



2.
Sung MH, McNally JG (2011). Live cell imaging and systems biology. Wiley Interdiscip Rev Syst Biol Med  3, 167-82.   https://doi.org/10.1002/wsbm.108




PubMed



        
     
Free Article


 


PubMed ID 20730797
         Pubmed Central ID 2992103",https://intramural.nih.gov/search/searchview.taf?ipid=62891
114,BC010309-12,"October 01, 2009 -  September 30, 2010",Nuclear Architecture and Disease,"Thomas A Misteli; PhD



IRP Faculty Profile",NULL,"Laboratory of Receptor Biology and Gene Expression, NCI","Rebecca Catherine Burgess; PhD



Michelle Fos Devine



Travis  Dittmer



Maria Reina Fernandez De Luco



Stephen A Mabon



Karen J Meaburn



Show all 12","Giselle  Bonne
(CNRS)




Olivia  Perreira-Smith
(University of Texas)","Stephen J Lockett; PhD (Office Of The Director)



Leonard Pieter Kubben (Hormone Action and Oncogenesis Section)","Douglas S Auld (NHGRI) 



Christopher P Austin; AB, MD (NHGRI)","Ordered by publication type and then author name.



1.
Dundr M, Misteli T (2010). Biogenesis of nuclear bodies. Cold Spring Harb Perspect Biol  2, a000711.   https://doi.org/10.1101/cshperspect.a000711




PubMed



        
     
Free Article


 


PubMed ID 21068152
         Pubmed Central ID 2982170 


 



2.
Méjat A, Decostre V, Li J, Renou L, Kesari A, Hantaï D, Stewart CL, Xiao X, Hoffman E, Bonne G, Misteli T (2009). Lamin A/C-mediated neuromuscular junction defects in Emery-Dreifuss muscular dystrophy. J Cell Biol  184, 31-44.   https://doi.org/10.1083/jcb.200811035




PubMed



        
     
Free Article


 


PubMed ID 19124654
         Pubmed Central ID 2615092 


 



3.
Mathas S, Kreher S, Meaburn KJ, Jöhrens K, Lamprecht B, Assaf C, Sterry W, Kadin ME, Daibata M, Joos S, Hummel M, Stein H, Janz M, Anagnostopoulos I, Schrock E, Misteli T, Dörken B (2009). Gene deregulation and spatial genome reorganization near breakpoints prior to formation of translocations in anaplastic large cell lymphoma. Proc Natl Acad Sci U S A  106, 5831-6.   https://doi.org/10.1073/pnas.0900912106




PubMed



        
     
Free Article


 


PubMed ID 19321746
         Pubmed Central ID 2667034 


 



4.
Mathas S, Misteli T (2009). The dangers of transcription. Cell  139, 1047-9.   https://doi.org/10.1016/j.cell.2009.11.037




PubMed



        
     
Free Article


 


PubMed ID 20005797
         Pubmed Central ID 6312720 


 



5.
Meaburn KJ, Gudla PR, Khan S, Lockett SJ, Misteli T (2009). Disease-specific gene repositioning in breast cancer. J Cell Biol  187, 801-12.   https://doi.org/10.1083/jcb.200909127




PubMed



        
     
Free Article


 


PubMed ID 19995938
         Pubmed Central ID 2806312 


 



6.
Misteli T (2009). Self-organization in the genome. Proc Natl Acad Sci U S A  106, 6885-6.   https://doi.org/10.1073/pnas.0902010106




PubMed



        
     
Free Article


 


PubMed ID 19416923
         Pubmed Central ID 2678480 


 



7.
Misteli T, Soutoglou E (2009). The emerging role of nuclear architecture in DNA repair and genome maintenance. Nat Rev Mol Cell Biol  10, 243-54.   https://doi.org/10.1038/nrm2651




PubMed



        
     
Free Article


 


PubMed ID 19277046
         Pubmed Central ID 3478884 


 



8.
Pegoraro G, Kubben N, Wickert U, Göhler H, Hoffmann K, Misteli T (2009). Ageing-related chromatin defects through loss of the NURD complex. Nat Cell Biol  11, 1261-7.   https://doi.org/10.1038/ncb1971




PubMed



        
     
Free Article


 


PubMed ID 19734887
         Pubmed Central ID 2779731",https://intramural.nih.gov/search/searchview.taf?ipid=62892
115,BC010313-12,"October 01, 2009 -  September 30, 2010",Molecular signatures for liver cancer diagnosis and treatment stratification,"Xin Wei Wang; PhD



IRP Faculty Profile",NULL,"Laboratory of Human Carcinogenesis, NCI","Anuradha Samantha Budhu



Marshonna J Forgues



Curtis  Harris; MD



Junfang  Ji



Naoki  Oishi



Stephanie  Roessler



Show all 7","Yidong  Chen; PhD





Carlo M Croce





Ping  He





Christoffer  Loffredo
(Georgetown University)




Masao  Omata
(University of Tokyo)




Lun-Xiu  Qin
(Liver Cancer Institute)


Show all 9","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)



Robert Mark Simpson; DVM, PhD (Laboratory of Cancer Biology and Genetics)



Robert  Wiltrout; PhD (Laboratory of Experimental Immunology)



Snorri S. Thorgeirsson; MD, PhD (Laboratory of Experimental Carcinogenesis)



Howard A Young; PhD (Laboratory of Experimental Immunology)



Richard  Simon (Biometrics Research Branch)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=62894
116,BC010317-12,"October 01, 2009 -  September 30, 2010",Rapid Analysis of Single Nucleotide Polymorphism Genotypes in AIDS Cohorts,Stephen J O'Brien; PhD,NULL,"Laboratory of Genomic Diversity, NCI","Li  Guan



P Michelle Hall



Russ  Hanson



Sher L Hendrickson



Randall C Johnson



Bailey D Kessing



Show all 13",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Guo X, Johnson RC, Deng H, Liao J, Guan L, Nelson GW, Tang M, Zheng Y, de The G, O'Brien SJ, Winkler CA, Zeng Y (2009). Evaluation of nonviral risk factors for nasopharyngeal carcinoma in a high-risk population of Southern China. Int J Cancer  124, 2942-7.   https://doi.org/10.1002/ijc.24293




PubMed



        
     
Free Article


 


PubMed ID 19296536
         Pubmed Central ID 4406046 


 



2.
Hendrickson SL, Kingsley LA, Ruiz-Pesini E, Poole JC, Jacobson LP, Palella FJ, Bream JH, Wallace DC, O'Brien SJ (2009). Mitochondrial DNA haplogroups influence lipoatrophy after highly active antiretroviral therapy. J Acquir Immune Defic Syndr  51, 111-6.   https://doi.org/10.1097/QAI.0b013e3181a324d6




PubMed



        
     
Free Article


 


PubMed ID 19339895
         Pubmed Central ID 2742970 


 



3.
Oleksyk TK, Shrestha S, Truelove AL, Goedert JJ, Donfield SM, Phair J, Mehta S, O'Brien SJ, Smith MW (2009). Extended IL10 haplotypes and their association with HIV progression to AIDS. Genes Immun  10, 309-22.   https://doi.org/10.1038/gene.2009.9




PubMed



        
     
Free Article


 


PubMed ID 19295541
         Pubmed Central ID 3664918 


 



4.
Pontius JU, O'Brien SJ (2009). Artifacts of the 1.9x feline genome assembly derived from the feline-specific satellite sequence. J Hered  100 Suppl 1, S14-8.   https://doi.org/10.1093/jhered/esp035




PubMed



        
     
Free Article


 


PubMed ID 19531733
         Pubmed Central ID 3139362 


 



5.
Sezgin E, Lind JM, Shrestha S, Hendrickson S, Goedert JJ, Donfield S, Kirk GD, Phair JP, Troyer JL, O'Brien SJ, Smith MW (2009). Association of Y chromosome haplogroup I with HIV progression, and HAART outcome. Hum Genet  125, 281-94.   https://doi.org/10.1007/s00439-008-0620-7




PubMed



        
     
Free Article


 


PubMed ID 19169712
         Pubmed Central ID 2885350",https://intramural.nih.gov/search/searchview.taf?ipid=62895
117,BC010319-12,"October 01, 2009 -  September 30, 2010",Structural Analysis of Biological Membrane Proteins,"Di S Xia; PhD, MS, BS



IRP Faculty Profile",NULL,"Crystallography Section, NCI","Rui  Bao



Lothar  Esser



Jichun  Ma



Robert M Rutledge



Wai-Kwan  Tang",NULL,"Michael Marc Gottesman; MD (Chemical Immunology Section)



Susan  Bates; MD (Medical Oncology Branch)



Suresh V Ambudkar; PhD (Transport Biochemistry Section)",NULL,"Ordered by publication type and then author name.



1.
Gottesman MM, Ambudkar SV, Xia D (2009). Structure of a multidrug transporter. Nat Biotechnol  27, 546-7.   https://doi.org/10.1038/nbt0609-546




PubMed



        
     
Free Article


 


PubMed ID 19513059
         Pubmed Central ID 3392087 


 



2.
Polgar O, Ediriwickrema LS, Robey RW, Sharma A, Hegde RS, Li Y, Xia D, Ward Y, Dean M, Ozvegy-Laczka C, Sarkadi B, Bates SE (2009). Arginine 383 is a crucial residue in ABCG2 biogenesis. Biochim Biophys Acta  1788, 1434-43.   https://doi.org/10.1016/j.bbamem.2009.04.016




PubMed



        
     
Free Article


 


PubMed ID 19406100
         Pubmed Central ID 4163909 


 



3.
Yu L, Yang S, Yin Y, Cen X, Zhou F, Xia D, Yu CA (2009). Chapter 25 Analysis of electron transfer and superoxide generation in the cytochrome bc1 complex. Methods Enzymol  456, 459-73.   https://doi.org/10.1016/S0076-6879(08)04425-X




PubMed


 


PubMed ID 19348904",https://intramural.nih.gov/search/searchview.taf?ipid=62897
118,BC010326-11,"October 01, 2009 -  September 30, 2010","Biomolecular Structure and Mechanism, Structure-Based Drug Design","Xinhua  Ji; PhD



IRP Faculty Profile",NULL,"Biomolecular Structure Section, NCI","Yuhe  Liang; PhD



Gary X Shaw



Genbin  Shi



Jason R Stagno



Chao  Tu",NULL,"Allan M Weissman; MD (Laboratory of Protein Dynamics and Signaling)



David S Waugh; PhD (Protein Engineering Section)



Donald L Court; PhD (Molecular Control and Genetics Section)



Larry K Keefer; PhD (Laboratory of Comparative Carcinogenesis)



Robert Andrew Byrd (Structural Biophysics Laboratory)



Ding Jun Jin (Gene Regulation and Chromosome Biology Laboratory)",NULL,"Ordered by publication type and then author name.



1.
Dabrazhynetskaya A, Brendler T, Ji X, Austin S (2009). Switching protein-DNA recognition specificity by single-amino-acid substitutions in the P1 par family of plasmid partition elements. J Bacteriol  191, 1126-31.   https://doi.org/10.1128/JB.01358-08




PubMed



        
     
Free Article


 


PubMed ID 19028896
         Pubmed Central ID 2632008 


 



2.
Das R, Mariano J, Tsai YC, Kalathur RC, Kostova Z, Li J, Tarasov SG, McFeeters RL, Altieri AS, Ji X, Byrd RA, Weissman AM (2009). Allosteric activation of E2-RING finger-mediated ubiquitylation by a structurally defined specific E2-binding region of gp78. Mol Cell  34, 674-85.   https://doi.org/10.1016/j.molcel.2009.05.010




PubMed



        
     
Free Article


 


PubMed ID 19560420
         Pubmed Central ID 3050579 


 



3.
Tu C, Tropea JE, Austin BP, Court DL, Waugh DS, Ji X (2009). Structural basis for binding of RNA and cofactor by a KsgA methyltransferase. Structure  17, 374-85.   https://doi.org/10.1016/j.str.2009.01.010




PubMed



        
     
Free Article


 


PubMed ID 19278652
         Pubmed Central ID 2672589 


 



4.
Tu C, Zhou X, Tropea JE, Austin BP, Waugh DS, Court DL, Ji X (2009). Structure of ERA in complex with the 3' end of 16S rRNA: implications for ribosome biogenesis. Proc Natl Acad Sci U S A  106, 14843-8.   https://doi.org/10.1073/pnas.0904032106




PubMed



        
     
Free Article


 


PubMed ID 19706445
         Pubmed Central ID 2736428",https://intramural.nih.gov/search/searchview.taf?ipid=62898
119,BC010328-11,"October 01, 2009 -  September 30, 2010",Role of CEBP transcription factors in regulating cell growth and tumorigenesis,"Peter F Johnson; PhD



IRP Faculty Profile",NULL,"Laboratory of Cancer Prevention, NCI","Sandip  Basu



Jing  Hao



Christopher Jack  Huggins



Jonathan  Keller; PhD



Sook  Lee



Nancy C Martin



Show all 7","Maria  Hatzoglou
(Dept of Nutrition, Case Western Reserve University School of Medicine)




Richard  Schwartz
(Michigan State University)




Robert  Smart
(North Carolina State University)","Timothy D Veenstra (Office Of The Director)



Alexander  Wlodawer; PhD (Macromolecular Crystallography Laboratory)



Maria  Miller (Protein Structure Section)",NULL,"Ordered by publication type and then author name.



1.
Sebastian T, Johnson PF (2009). RasV12-mediated down-regulation of CCAAT/enhancer binding protein beta in immortalized fibroblasts requires loss of p19Arf and facilitates bypass of oncogene-induced senescence. Cancer Res  69, 2588-98.   https://doi.org/10.1158/0008-5472.CAN-08-2312




PubMed



        
     
Free Article


 


PubMed ID 19276382
         Pubmed Central ID 2693277 


 



2.
Staiger J, Lueben MJ, Berrigan D, Malik R, Perkins SN, Hursting SD, Johnson PF (2009). C/EBPbeta regulates body composition, energy balance-related hormones and tumor growth. Carcinogenesis  30, 832-40.   https://doi.org/10.1093/carcin/bgn273




PubMed



        
     
Free Article


 


PubMed ID 19056928
         Pubmed Central ID 2675647",https://intramural.nih.gov/search/searchview.taf?ipid=62899
120,BC010329-11,"October 01, 2009 -  September 30, 2010",Regulation of Ras-Dependent Signal Transduction Pathways,"Deborah K Morrison



IRP Faculty Profile",NULL,"Laboratory of Cell and Developmental Signaling, NCI","Alyson Kara Freeman



Daniel A Ritt



Melissa M Mckay



Suzanne I Specht",NULL,"Timothy D Veenstra (Office Of The Director)



Martin  Gutierrez (Medical Oncology Branch)",NULL,"Ordered by publication type and then author name.



1.
McKay MM, Ritt DA, Morrison DK (2009). Signaling dynamics of the KSR1 scaffold complex. Proc Natl Acad Sci U S A  106, 11022-7.   https://doi.org/10.1073/pnas.0901590106




PubMed



        
     
Free Article


 


PubMed ID 19541618
         Pubmed Central ID 2708738 


 



2.
Morrison DK (2009). The 14-3-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer development. Trends Cell Biol  19, 16-23.   https://doi.org/10.1016/j.tcb.2008.10.003




PubMed



        
     
Free Article


 


PubMed ID 19027299
         Pubmed Central ID 3073487",https://intramural.nih.gov/search/searchview.taf?ipid=62900
121,BC010331-11,"October 01, 2009 -  September 30, 2010",Phospholipid and Sphingolipid Signaling in Drosophila,"Jairaj K Acharya; MBBS, PhD



IRP Faculty Profile",NULL,"Laboratory of Cell and Developmental Signaling, NCI","Teresa  Kosakowska Cholo



Jingjing  Ma



Abid Rasheed Mattoo; PhD","Usha  Acharya
(University of Mass. Medical School)




joost  holthuis
(University of Utrecht)




Pedro  Labarca
(Arturo Prat 514, Centro de Estudios Cientificos)","Shyam K Sharan (Mouse Cancer Genetics Program)



Lino  Tessarollo (Mouse Cancer Genetics Program)",NULL,"Ordered by publication type and then author name.



1.
Dasgupta U, Bamba T, Chiantia S, Karim P, Tayoun AN, Yonamine I, Rawat SS, Rao RP, Nagashima K, Fukusaki E, Puri V, Dolph PJ, Schwille P, Acharya JK, Acharya U (2009). Ceramide kinase regulates phospholipase C and phosphatidylinositol 4, 5, bisphosphate in phototransduction. Proc Natl Acad Sci U S A  106, 20063-8.   https://doi.org/10.1073/pnas.0911028106




PubMed



        
     
Free Article


 


PubMed ID 19892737
         Pubmed Central ID 2785292 


 



2.
Masood MA, Xu X, Acharya JK, Veenstra TD, Blonder J (2009). Enhanced detection of sphingoid bases via divalent ruthenium bipyridine complex derivatization and electrospray ionization tandem mass spectrometry. Anal Chem  81, 495-502.   https://doi.org/10.1021/ac8019043




PubMed



        
     
Free Article


 


PubMed ID 19055420
         Pubmed Central ID 3006443",https://intramural.nih.gov/search/searchview.taf?ipid=62901
122,BC010333-11,"October 01, 2009 -  September 30, 2010",The Segregation of Bacterial Chromosomes to Daughter Cells,"Stuart J Austin



IRP Faculty Profile",NULL,"Cell Cycle Regulation Section, NCI","Therese G Brendler; BS, PhD



Sujatha B Gowda



Manjistha  Sengupta



Brenda L Youngren","Alba  Guarne; PhD





Flemming  Hansen
(BioCentrum, Technical University of Denmank)",Donald L Court; PhD (Molecular Control and Genetics Section),NULL,"Ordered by publication type and then author name.



1.
Chung YS, Brendler T, Austin S, Guarné A (2009). Structural insights into the cooperative binding of SeqA to a tandem GATC repeat. Nucleic Acids Res  37, 3143-52.   https://doi.org/10.1093/nar/gkp151




PubMed



        
     
Free Article


 


PubMed ID 19304745
         Pubmed Central ID 2691817",https://intramural.nih.gov/search/searchview.taf?ipid=62902
123,BC010334-11,"October 01, 2009 -  September 30, 2010",Posttranscriptional control of gene expression,"Barbara K Felber



IRP Faculty Profile",NULL,"Vaccine Branch, NCI","Jenifer L Bear



Guy Robert Pilkington



George N Pavlakis; MD, PhD



Mollly Christine Saunders



Andrei S Zolotukhin



Konstantinos  Apostolakis



Show all 8",NULL,"Stuart F J Le Grice; PhD (Retroviral Replication Laboratory)



Giorgio  Trinchieri (Cancer Inflammation Program)



Scott K Durum; PhD (Laboratory of Molecular Immunoregulation)



Howard A Young; PhD (Laboratory of Experimental Immunology)



Zhi Ming  Zheng; MD, PhD (HIV and AIDS Malignancy Branch)",NULL,"Ordered by publication type and then author name.



1.
Salcedo R, Hixon JA, Stauffer JK, Jalah R, Brooks AD, Khan T, Dai RM, Scheetz L, Lincoln E, Back TC, Powell D, Hurwitz AA, Sayers TJ, Kastelein R, Pavlakis GN, Felber BK, Trinchieri G, Wigginton JM (2009). Immunologic and therapeutic synergy of IL-27 and IL-2: enhancement of T cell sensitization, tumor-specific CTL reactivity and complete regression of disseminated neuroblastoma metastases in the liver and bone marrow. J Immunol  182, 4328-38.   https://doi.org/10.4049/jimmunol.0800471




PubMed



        
     
Free Article


 


PubMed ID 19299733
         Pubmed Central ID 2730673 


 



2.
Uranishi H, Zolotukhin AS, Lindtner S, Warming S, Zhang GM, Bear J, Copeland NG, Jenkins NA, Pavlakis GN, Felber BK (2009). The RNA-binding motif protein 15B (RBM15B/OTT3) acts as cofactor of the nuclear export receptor NXF1. J Biol Chem  284, 26106-16.   https://doi.org/10.1074/jbc.M109.040113




PubMed



        
     
Free Article


 


PubMed ID 19586903
         Pubmed Central ID 2758010 


 



3.
Zolotukhin AS, Uranishi H, Lindtner S, Bear J, Pavlakis GN, Felber BK (2009). Nuclear export factor RBM15 facilitates the access of DBP5 to mRNA. Nucleic Acids Res  37, 7151-62.   https://doi.org/10.1093/nar/gkp782




PubMed



        
     
Free Article


 


PubMed ID 19786495
         Pubmed Central ID 2790900",https://intramural.nih.gov/search/searchview.taf?ipid=62903
124,BC010336-11,"October 01, 2009 -  September 30, 2010",Lambda Genetic Networks and Lambda Red-Mediated Recombination,"Donald L Court; PhD



IRP Faculty Profile",NULL,"Molecular Control and Genetics Section, NCI","Teresa L Baker



Nathan Michael Brown



Mikhail G Bubunenko



Nina C Costantino



Xintian  Li



James A Sawitzke



Show all 8","David  Friedman
(University of Michigan School of Medicine)




Max  Gottesman
(Institute of Cancer Research, Columbia University)




William  Margolin
(Microbiology and Molecular Genetics, University of Texas Medical School)




Kenon  Murphy
(Molecular Genetics and Microbiology, University of Massachusetts Med. School)




Markus  Wahl
(X-Ray Crystallography, Max-Planck-Institute for Biophysical Chemistry)","Sankar  Adhya; PhD (Developmental Genetics Section)



Mikhail V Kashlev (Molecular Mechanisms of Transcription Section)



David S Waugh; PhD (Protein Engineering Section)



Ding Jun Jin (Gene Regulation and Chromosome Biology Laboratory)



Xinhua  Ji; PhD (Biomolecular Structure Section)",NULL,"Ordered by publication type and then author name.



1.
Sharan SK, Thomason LC, Kuznetsov SG, Court DL (2009). Recombineering: a homologous recombination-based method of genetic engineering. Nat Protoc  4, 206-23.   https://doi.org/10.1038/nprot.2008.227




PubMed



        
     
Free Article


 


PubMed ID 19180090
         Pubmed Central ID 2790811 


 



2.
Thomason LC, Oppenheim AB, Court DL (2009). Modifying bacteriophage lambda with recombineering. Methods Mol Biol  501, 239-51.   https://doi.org/10.1007/978-1-60327-164-6_21




PubMed


 


PubMed ID 19066825
    
     


 



3.
Tu C, Tropea JE, Austin BP, Court DL, Waugh DS, Ji X (2009). Structural basis for binding of RNA and cofactor by a KsgA methyltransferase. Structure  17, 374-85.   https://doi.org/10.1016/j.str.2009.01.010




PubMed



        
     
Free Article


 


PubMed ID 19278652
         Pubmed Central ID 2672589 


 



4.
Tu C, Zhou X, Tropea JE, Austin BP, Waugh DS, Court DL, Ji X (2009). Structure of ERA in complex with the 3' end of 16S rRNA: implications for ribosome biogenesis. Proc Natl Acad Sci U S A  106, 14843-8.   https://doi.org/10.1073/pnas.0904032106




PubMed



        
     
Free Article


 


PubMed ID 19706445
         Pubmed Central ID 2736428",https://intramural.nih.gov/search/searchview.taf?ipid=62904
125,BC010337-11,"October 01, 2009 -  September 30, 2010",Identifying Protein Factors and Pathways Leading to the Active Chromatin State,"Mikhail V Kashlev



IRP Faculty Profile",NULL,"Molecular Mechanisms of Transcription Section, NCI","Maria L Kireeva



Lucyna E Lubkowska","Carlos  Bustamante
(University of California - Berkeley)




Michelle  Wang
(Cornell University)",NULL,NULL,"Ordered by publication type and then author name.



1.
Hodges C, Bintu L, Lubkowska L, Kashlev M, Bustamante C (2009). Nucleosomal fluctuations govern the transcription dynamics of RNA polymerase II. Science  325, 626-8.   https://doi.org/10.1126/science.1172926




PubMed



        
     
Free Article


 


PubMed ID 19644123
         Pubmed Central ID 2775800 


 



2.
Jin J, Bai L, Johnson DS, Fulbright RM, Kireeva ML, Kashlev M, Wang MD (2010). Synergistic action of RNA polymerases in overcoming the nucleosomal barrier. Nat Struct Mol Biol  17, 745-52.   https://doi.org/10.1038/nsmb.1798




PubMed



        
     
Free Article


 


PubMed ID 20453861
         Pubmed Central ID 2938954",https://intramural.nih.gov/search/searchview.taf?ipid=62905
126,BC010338-11,"October 01, 2009 -  September 30, 2010",The Role of Fgf Signaling in Vertebrate Development,"Mark B Lewandoski



IRP Faculty Profile",NULL,"Genetics of Vertebrate Development Section, NCI","Naiche L Adler



Matthew J Anderson



Christopher Matthew Bradfield



Alexander James Stuffer



Cynthia M Elder",NULL,"Terence P Yamaguchi; PhD (Cancer and Developmental Biology Laboratory)



Alan O Perantoni; PhD (Cancer and Developmental Biology Laboratory)",NULL,"Ordered by publication type and then author name.



1.
Yi L, Domyan ET, Lewandoski M, Sun X (2009). Fibroblast growth factor 9 signaling inhibits airway smooth muscle differentiation in mouse lung. Dev Dyn  238, 123-37.   https://doi.org/10.1002/dvdy.21831




PubMed



        
     
Free Article


 


PubMed ID 19097117
         Pubmed Central ID 2853052",https://intramural.nih.gov/search/searchview.taf?ipid=62906
127,BC010340-11,"October 01, 2009 -  September 30, 2010",Ty Element Retrotransposition in Saccharomyces cerevisiae,David J. Garfinkel; PhD,NULL,"Movable Genetic Elements Section, NCI",NULL,NULL,Robert  Stephens (Office Of The Director),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=62908
128,BC010341-11,"October 01, 2009 -  September 30, 2010",Protein Expression and Purification in the Fast Lane,"David S Waugh; PhD



IRP Faculty Profile",NULL,"Protein Engineering Section, NCI","Brian P Austin



Danielle  Needle",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Austin BP, Nallamsetty S, Waugh DS (2009). Hexahistidine-tagged maltose-binding protein as a fusion partner for the production of soluble recombinant proteins in Escherichia coli. Methods Mol Biol  498, 157-72.   https://doi.org/10.1007/978-1-59745-196-3_11




PubMed


 


PubMed ID 18988025
    
     


 



2.
Tropea JE, Cherry S, Waugh DS (2009). Expression and purification of soluble His(6)-tagged TEV protease. Methods Mol Biol  498, 297-307.   https://doi.org/10.1007/978-1-59745-196-3_19




PubMed


 


PubMed ID 18988033
    
     


 



3.
Zhang D, Tözsér J, Waugh DS (2009). Molecular cloning, overproduction, purification and biochemical characterization of the p39 nsp2 protease domains encoded by three alphaviruses. Protein Expr Purif  64, 89-97.   https://doi.org/10.1016/j.pep.2008.10.013




PubMed



        
     
Free Article


 


PubMed ID 19013248
         Pubmed Central ID 2706578",https://intramural.nih.gov/search/searchview.taf?ipid=62909
129,BC010342-11,"October 01, 2009 -  September 30, 2010",Structural Proteomics of the Yersinia Yop Virulon,"David S Waugh; PhD



IRP Faculty Profile",NULL,"Protein Engineering Section, NCI","Brian P Austin



George T Lountos



Danielle  Needle



Ping  Sun","Gregory  Plano; PhD
(Microbiology and Immunology, University of Miami School of Medicine)




Robert  Ulrich
(Molecular Immunology, USAMRIID)","Terrence R Burke; PhD (Chemical Biology Laboratory)



Alexander  Wlodawer; PhD (Macromolecular Crystallography Laboratory)



Xinhua  Ji; PhD (Biomolecular Structure Section)",NULL,"Ordered by publication type and then author name.



1.
Lountos GT, Austin BP, Nallamsetty S, Waugh DS (2009). Atomic resolution structure of the cytoplasmic domain of Yersinia pestis YscU, a regulatory switch involved in type III secretion. Protein Sci  18, 467-74.   https://doi.org/10.1002/pro.56




PubMed



        
     
Free Article


 


PubMed ID 19165725
         Pubmed Central ID 2708055",https://intramural.nih.gov/search/searchview.taf?ipid=62910
130,BC010345-11,"October 01, 2009 -  September 30, 2010",The Role of Wnt Genes in Vertebrate Development and Cancer,"Terence P Yamaguchi; PhD



IRP Faculty Profile",NULL,"Cancer and Developmental Biology Laboratory, NCI","Rieko  Ajima



Kristin K Biris



Ravindra Babu  Chalamalasetty",NULL,Mark B Lewandoski (Genetics of Vertebrate Development Section),Benjamin  Feldman; PhD (NHGRI),"Ordered by publication type and then author name.



1.
Goss AM, Tian Y, Tsukiyama T, Cohen ED, Zhou D, Lu MM, Yamaguchi TP, Morrisey EE (2009). Wnt2/2b and beta-catenin signaling are necessary and sufficient to specify lung progenitors in the foregut. Dev Cell  17, 290-8.   https://doi.org/10.1016/j.devcel.2009.06.005




PubMed



        
     
Free Article


 


PubMed ID 19686689
         Pubmed Central ID 2763331 


 



2.
Yamaguchi T, Yamaguchi T (2009) High-density oligonucleotide microarray analysis for limiting amounts of embryonic sample. Methods in Molecular Biology, in press.




 



3.
Yamaguchi T, Yamaguchi T (2009) Two color in situ hybridization of whole-mount mouse embryos. Methods In Molecular Biology, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=62911
131,BC010346-11,"October 01, 2009 -  September 30, 2010",Structural Biology of Proteins Involved in Signal Transduction and Regulation of,"Robert Andrew Byrd



IRP Faculty Profile",NULL,"Structural Biophysics Laboratory, NCI","Yinghua  Chen



Yun Xing M Wang



Aaren  Gonzales



Jess R Li



Sergey G Tarasov",NULL,NULL,Charles  Schwieters; PhD (CIT),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=62912
132,BC010348-11,"October 01, 2009 -  September 30, 2010",Protein Structure,"Alexander  Wlodawer; PhD



IRP Faculty Profile",NULL,"Macromolecular Crystallography Laboratory, NCI","Prasenjit  Bhaumik



Jamaine S Davis



Alla E Gustchina



Zachary Jason Miknis



Tinoush  Moulaei



Dongwen  Zhou



Show all 7","David  Baker
(University of Washington)




Ben  Dunn
(Biochem. & Mol. Biol., University of Florida)




Mariusz  Jaskolski
(Adam Mickiewicz University)




Yoshiaki  Kiso
(Kyoto Pharmaceutical University)




Kohei  Oda
(Dept. Applied Biology, Kyoto Inst. of Technology)




Jan  Pohl
(CDC)","Zbigniew  Dauter (Synchrotron Radiation Research Section)



Barry R O'Keefe (Molecular Targets Development Program)",NULL,"Ordered by publication type and then author name.



1.
Acchione M, Lipschultz CA, DeSantis ME, Shanmuganathan A, Li M, Wlodawer A, Tarasov S, Smith-Gill SJ (2009). Light chain somatic mutations change thermodynamics of binding and water coordination in the HyHEL-10 family of antibodies. Mol Immunol  47, 457-64.   https://doi.org/10.1016/j.molimm.2009.08.018




PubMed



        
     
Free Article


 


PubMed ID 19781789
         Pubmed Central ID 6291001 


 



2.
Bhaumik P, Xiao H, Parr CL, Kiso Y, Gustchina A, Yada RY, Wlodawer A (2009). Crystal structures of the histo-aspartic protease (HAP) from Plasmodium falciparum. J Mol Biol  388, 520-40.   https://doi.org/10.1016/j.jmb.2009.03.011




PubMed



        
     
Free Article


 


PubMed ID 19285084
         Pubmed Central ID 2702178 


 



3.
Dauter Z, Wlodawer A (2009). Proteins do not have strong spines after all. Structure  17, 1278-9.   https://doi.org/10.1016/j.str.2009.09.002




PubMed


 


PubMed ID 19836327
    
     


 



4.
Feng H, Jenkins LM, Durell SR, Hayashi R, Mazur SJ, Cherry S, Tropea JE, Miller M, Wlodawer A, Appella E, Bai Y (2009). Structural basis for p300 Taz2-p53 TAD1 binding and modulation by phosphorylation. Structure  17, 202-10.   https://doi.org/10.1016/j.str.2008.12.009




PubMed



        
     
Free Article


 


PubMed ID 19217391
         Pubmed Central ID 2705179 


 



5.
Jaskolski M, Alexandratos JN, Bujacz G, Wlodawer A (2009). Piecing together the structure of retroviral integrase, an important target in AIDS therapy. FEBS J  276, 2926-46.   https://doi.org/10.1111/j.1742-4658.2009.07009.x




PubMed



        
     
Free Article


 


PubMed ID 19490099
         Pubmed Central ID 2747025 


 



6.
Jenkins LM, Yamaguchi H, Hayashi R, Cherry S, Tropea JE, Miller M, Wlodawer A, Appella E, Mazur SJ (2009). Two distinct motifs within the p53 transactivation domain bind to the Taz2 domain of p300 and are differentially affected by phosphorylation. Biochemistry  48, 1244-55.   https://doi.org/10.1021/bi801716h




PubMed



        
     
Free Article


 


PubMed ID 19166313
         Pubmed Central ID 2848171 


 



7.
Lee S, Miller M, Shuman JD, Johnson PF (2010). CCAAT/Enhancer-binding protein beta DNA binding is auto-inhibited by multiple elements that also mediate association with p300/CREB-binding protein (CBP). J Biol Chem  285, 21399-410.   https://doi.org/10.1074/jbc.M110.128413




PubMed



        
     
Free Article


 


PubMed ID 20452968
         Pubmed Central ID 2898398 


 



8.
Lee S, Shuman JD, Guszczynski T, Sakchaisri K, Sebastian T, Copeland TD, Miller M, Cohen MS, Taunton J, Smart RC, Xiao Z, Yu LR, Veenstra TD, Johnson PF (2010). RSK-mediated phosphorylation in the C/EBP{beta} leucine zipper regulates DNA binding, dimerization, and growth arrest activity. Mol Cell Biol  30, 2621-35.   https://doi.org/10.1128/MCB.00782-09




PubMed



        
     
Free Article


 


PubMed ID 20351173
         Pubmed Central ID 2876527 


 



9.
Magracheva E, Kozlov S, Stewart CL, Wlodawer A, Zdanov A (2009). Structure of the lamin A/C R482W mutant responsible for dominant familial partial lipodystrophy (FPLD). Acta Crystallogr Sect F Struct Biol Cryst Commun  65, 665-70.   https://doi.org/10.1107/S1744309109020302




PubMed



        
     
Free Article


 


PubMed ID 19574635
         Pubmed Central ID 2705630 


 



10.
Miller M (2010). The early years of retroviral protease crystal structures. Biopolymers  94, 521-9.   https://doi.org/10.1002/bip.21387




PubMed



        
     
Free Article


 


PubMed ID 20593466
         Pubmed Central ID 2938048 


 



11.
Miller M, Dauter Z, Cherry S, Tropea JE, Wlodawer A (2009). Structure of the Taz2 domain of p300: insights into ligand binding. Acta Crystallogr D Biol Crystallogr  65, 1301-8.   https://doi.org/10.1107/S0907444909040153




PubMed



        
     
Free Article


 


PubMed ID 19966416
         Pubmed Central ID 2789004 


 



12.
Pletnev S, Gurskaya NG, Pletneva NV, Lukyanov KA, Chudakov DM, Martynov VI, Popov VO, Kovalchuk MV, Wlodawer A, Dauter Z, Pletnev V (2009). Structural basis for phototoxicity of the genetically encoded photosensitizer KillerRed. J Biol Chem  284, 32028-39.   https://doi.org/10.1074/jbc.M109.054973




PubMed



        
     
Free Article


 


PubMed ID 19737938
         Pubmed Central ID 2797274 


 



13.
Sezgin E, Jabs DA, Hendrickson SL, Van Natta M, Zdanov A, Lewis RA, Smith MW, Troyer JL, O'Brien SJ, SOCA Research Group (2010). Effect of host genetics on the development of cytomegalovirus retinitis in patients with AIDS. J Infect Dis  202, 606-13.   https://doi.org/10.1086/654814




PubMed



        
     
Free Article


 


PubMed ID 20617924
         Pubmed Central ID 2932829 


 



14.
Yun SM, Moulaei T, Lim D, Bang JK, Park JE, Shenoy SR, Liu F, Kang YH, Liao C, Soung NK, Lee S, Yoon DY, Lim Y, Lee DH, Otaka A, Appella E, McMahon JB, Nicklaus MC, Burke TR, Yaffe MB, Wlodawer A, Lee KS (2009). Structural and functional analyses of minimal phosphopeptides targeting the polo-box domain of polo-like kinase 1. Nat Struct Mol Biol  16, 876-82.   https://doi.org/10.1038/nsmb.1628




PubMed



        
     
Free Article


 


PubMed ID 19597481
         Pubmed Central ID 2721907",https://intramural.nih.gov/search/searchview.taf?ipid=62913
133,BC010350-11,"October 01, 2009 -  September 30, 2010",Prevention of AIDS,"Barbara K Felber



IRP Faculty Profile",NULL,"Vaccine Branch, NCI","Candido  Alicea; PhD



Genoveffa  Franchini; MD



Jenifer L Bear



George N Pavlakis; MD, PhD



Viraj M Kulkarni



Rachel Elizabeth Kelly Beach



Show all 9","J. Thomas  August
(Molecular Biology and Genetics Department, Johns Hopkins University School of Medicine)




Ronald  Desrosiers
(New England Primate Research Center)




Michael  Fons
(Inovio Biomedical Corporatiton)




Bart  Haynes
(Duke Human Vaccine Institute)




Zimra  Israel
(Wyeth Lederle Vaccines)




Amitinder  Kaur
(New England Primate Research Center)


Show all 18",Jeffrey D Lifson; MD (Office Of The Director),NULL,"Ordered by publication type and then author name.



1.
Petrovas C, Chaon B, Ambrozak DR, Price DA, Melenhorst JJ, Hill BJ, Geldmacher C, Casazza JP, Chattopadhyay PK, Roederer M, Douek DC, Mueller YM, Jacobson JM, Kulkarni V, Felber BK, Pavlakis GN, Katsikis PD, Koup RA (2009). Differential association of programmed death-1 and CD57 with ex vivo survival of CD8+ T cells in HIV infection. J Immunol  183, 1120-32.   https://doi.org/10.4049/jimmunol.0900182




PubMed



        
     
Free Article


 


PubMed ID 19564339
         Pubmed Central ID 2923541 


 



2.
Rosati M, Bergamaschi C, Valentin A, Kulkarni V, Jalah R, Alicea C, Patel V, von Gegerfelt AS, Montefiori DC, Venzon DJ, Khan AS, Draghia-Akli R, Van Rompay KK, Felber BK, Pavlakis GN (2009). DNA vaccination in rhesus macaques induces potent immune responses and decreases acute and chronic viremia after SIVmac251 challenge. Proc Natl Acad Sci U S A  106, 15831-6.   https://doi.org/10.1073/pnas.0902628106




PubMed



        
     
Free Article


 


PubMed ID 19717425
         Pubmed Central ID 2734879 


 



3.
Valentin A, Chikhlikar P, Patel V, Rosati M, Maciel M, Chang KH, Silvera P, Felber BK, Pavlakis GN, August JT, Marques ET (2009). Comparison of DNA vaccines producing HIV-1 Gag and LAMP/Gag chimera in rhesus macaques reveals antigen-specific T-cell responses with distinct phenotypes. Vaccine  27, 4840-9.   https://doi.org/10.1016/j.vaccine.2009.05.093




PubMed



        
     
Free Article


 


PubMed ID 19539586
         Pubmed Central ID 2743166",https://intramural.nih.gov/search/searchview.taf?ipid=62914
134,BC010378-11,"October 01, 2009 -  September 30, 2010",Macromolecular Crystallography Research with Synchrotron Radiation,"Zbigniew  Dauter



IRP Faculty Profile",NULL,"Synchrotron Radiation Research Section, NCI","Krzysztof  Brzezinski



Anna  Brzuszkiewicz



John  Cobuzzi



Eugenia  Magracheva



Sergei V Pletnev","Mariusz  Jaskolski
(University of  Poznan)




Andrzej  Joachimiak
(Biosciences, Argonne Natl. Lab.)




Jozef  Kur
(Microbiology, University of Technology)




Wladek  Minor





Zbyszek  Otwinowski
(Biomedical Sciences, Southwestern Medical School)




Gerold  Rosenbaum
(SER-CAT, Univeresity of Georgia)


Show all 7",Alexander  Wlodawer; PhD (Macromolecular Crystallography Laboratory),NULL,"Ordered by publication type and then author name.



1.
Brzuszkiewicz A, Nowak E, Dauter Z, Dauter M, Cieśliński H, Długołecka A, Kur J (2009). Structure of EstA esterase from psychrotrophic Pseudoalteromonas sp. 643A covalently inhibited by monoethylphosphonate. Acta Crystallogr Sect F Struct Biol Cryst Commun  65, 862-5.   https://doi.org/10.1107/S1744309109030826




PubMed



        
     
Free Article


 


PubMed ID 19724118
         Pubmed Central ID 2795586 


 



2.
Dauter Z, Wlodawer A (2009). Proteins do not have strong spines after all. Structure  17, 1278-9.   https://doi.org/10.1016/j.str.2009.09.002




PubMed


 


PubMed ID 19836327
    
     


 



3.
Miller M, Dauter Z, Cherry S, Tropea JE, Wlodawer A (2009). Structure of the Taz2 domain of p300: insights into ligand binding. Acta Crystallogr D Biol Crystallogr  65, 1301-8.   https://doi.org/10.1107/S0907444909040153




PubMed



        
     
Free Article


 


PubMed ID 19966416
         Pubmed Central ID 2789004 


 



4.
Nowak E, Brzuszkiewicz A, Dauter M, Dauter Z, Rosenbaum G (2009). To scavenge or not to scavenge: that is the question. Acta Crystallogr D Biol Crystallogr  65, 1004-6.   https://doi.org/10.1107/S0907444909026821




PubMed



        
     
Free Article


 


PubMed ID 19690379
         Pubmed Central ID 2733885 


 



5.
Pletnev S, Gurskaya NG, Pletneva NV, Lukyanov KA, Chudakov DM, Martynov VI, Popov VO, Kovalchuk MV, Wlodawer A, Dauter Z, Pletnev V (2009). Structural basis for phototoxicity of the genetically encoded photosensitizer KillerRed. J Biol Chem  284, 32028-39.   https://doi.org/10.1074/jbc.M109.054973




PubMed



        
     
Free Article


 


PubMed ID 19737938
         Pubmed Central ID 2797274 


 



6.
Pletnev S, Morozova KS, Verkhusha VV, Dauter Z (2009). Rotational order-disorder structure of fluorescent protein FP480. Acta Crystallogr D Biol Crystallogr  65, 906-12.   https://doi.org/10.1107/S0907444909020927




PubMed



        
     
Free Article


 


PubMed ID 19690368
         Pubmed Central ID 2733879",https://intramural.nih.gov/search/searchview.taf?ipid=62915
135,BC010379-11,"October 01, 2009 -  September 30, 2010",Search for the Structural Basis of Biomacromolecular Function and Activity,"Yun Xing M Wang



IRP Faculty Profile",NULL,"Structural Biophysics Laboratory, NCI",NULL,"Paul  Fox
(Cleveland Clinic)




Anne  Simon
(Cell Biology and Molecular Genetics, University of Maryland)




David  Tilde
(Argonne National Laboratory)","Stuart F J Le Grice; PhD (Retroviral Replication Laboratory)



Bruce Allen Shapiro; PhD (Image Processing Section)",NULL,"Ordered by publication type and then author name.



1.
Wang J, Zuo X, Yu P, Byeon IJ, Jung J, Wang X, Dyba M, Seifert S, Schwieters CD, Qin J, Gronenborn AM, Wang YX (2009). Determination of multicomponent protein structures in solution using global orientation and shape restraints. J Am Chem Soc  131, 10507-15.   https://doi.org/10.1021/ja902528f




PubMed



        
     
Free Article


 


PubMed ID 19722627
         Pubmed Central ID 2873192 


 



2.
Wang J, Zuo X, Yu P, Xu H, Starich MR, Tiede DM, Shapiro BA, Schwieters CD, Wang YX (2009). A method for helical RNA global structure determination in solution using small-angle x-ray scattering and NMR measurements. J Mol Biol  393, 717-34.   https://doi.org/10.1016/j.jmb.2009.08.001




PubMed



        
     
Free Article


 


PubMed ID 19666030
         Pubmed Central ID 2760655",https://intramural.nih.gov/search/searchview.taf?ipid=62916
136,BC010380-11,"October 01, 2009 -  September 30, 2010",Recombination and Regulation,Jeffrey N Strathern,NULL,"Office of the Director, NCI","Deanna R Gotte



Jordan D Irvin



Alison J Rattray



Brenda K Shafer



Hui  Yang","Tanya  Paull
(University of Texas, Austin)




Hisashi  Tanaka
(Lerner Research Institute)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=62917
137,BC010381-11,"October 01, 2009 -  September 30, 2010",Studies on Silencing,Amar J S Klar; PhD,NULL,"Developmental Genetics Section, NCI","Michael J Bonaduce



Chuanhe  Yu",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=62918
138,BC010385-11,"October 01, 2009 -  September 30, 2010",Studies on mat1 Imprinting,Amar J S Klar; PhD,NULL,"Developmental Genetics Section, NCI","Michael J Bonaduce



Sharon P Moore



Chuanhe  Yu",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=62919
139,BC010386-11,"October 01, 2009 -  September 30, 2010",Human Handedness Psychosis Etiology Studies,Amar J S Klar; PhD,NULL,"Developmental Genetics Section, NCI",Stephan  Sauer,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=62920
140,BC010387-11,"October 01, 2009 -  September 30, 2010",Functional Analysis of Breast Cancer Susceptibility Genes in Mice,"Shyam K Sharan



IRP Faculty Profile",NULL,"Mouse Cancer Genetics Program, NCI","Kajal  Biswas



Suhwan  Chang



Rajani Kant Chittela



Susan L North



Stacey S Stauffer",NULL,Andre A Nussenzweig; PhD (Experimental Immunology Branch),NULL,"Ordered by publication type and then author name.



1.
Chang S, Biswas K, Martin BK, Stauffer S, Sharan SK (2009). Expression of human BRCA1 variants in mouse ES cells allows functional analysis of BRCA1 mutations. J Clin Invest  119, 3160-71.   https://doi.org/10.1172/JCI39836




PubMed



        
     
Free Article


 


PubMed ID 19770520
         Pubmed Central ID 2752086",https://intramural.nih.gov/search/searchview.taf?ipid=62921
141,BC010390-11,"October 01, 2009 -  September 30, 2010",Role of Neurotrophins in the Development of the Mammalian Nervous System,"Lino  Tessarollo



IRP Faculty Profile",NULL,"Mouse Cancer Genetics Program, NCI","Jodi L Becker



Dawn Chin Ing Koh



Mary Ellen  Palko



Sandrine Solange Marie Puverel; PhD



Sudhirkumar U Yanpallewar","Juan Carlos  Arevalo
(University of Salamanca)




Moses V Chao





Susan G Dorsey





Barbara  Hempstead; PhD
(Department of Genetics and Development, Cornell Medical College)




Francis  Lee
(Bristol Myers Squibb Pharmaceutical Research Institute)




Italo  Mocchetti
(Pharmacology, Georgetown University)


Show all 7","Paul A Randazzo; MD, PhD (Laboratory of Cellular and Molecular Biology)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=62922
142,BC010391-11,"October 01, 2009 -  September 30, 2010",Role of Trk Receptors in the Development and Function of Non-neuronal Structures,"Lino  Tessarollo



IRP Faculty Profile",NULL,"Mouse Cancer Genetics Program, NCI","Jodi L Becker



Dawn Chin Ing Koh



Mary Ellen  Palko



Sandrine Solange Marie Puverel; PhD","Susan G Dorsey





Gianluca  Fulgenzi





Uri  Saragovi
(Pharmacology and Therapeutics, McGill University)","Ola Mae Zack Howard (Laboratory of Molecular Immunoregulation)



Paul A Randazzo; MD, PhD (Laboratory of Cellular and Molecular Biology)",NULL,"Ordered by publication type and then author name.



1.
Arévalo JC, Wu SH, Takahashi T, Zhang H, Yu T, Yano H, Milner TA, Tessarollo L, Ninan I, Arancio O, Chao MV (2010). The ARMS/Kidins220 scaffold protein modulates synaptic transmission. Mol Cell Neurosci  45, 92-100.   https://doi.org/10.1016/j.mcn.2010.06.002




PubMed



               Available in future as a Free Article 


 


PubMed ID 20547223
         Pubmed Central ID 2923264",https://intramural.nih.gov/search/searchview.taf?ipid=62923
143,BC010411-11,"October 01, 2009 -  September 30, 2010",Initiation of DNA Replication in Mammalian Cells,"Mirit I Aladjem; PhD



IRP Faculty Profile",NULL,"Developmental Therapeutics Branch, NCI","Haiqing  Fu



Liang  Huang



Melvenia  Martin



Sita Laximi  Thirunavukkarasu



Chiimei (Cindy) L Tseng",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=62924
144,BC010412-11,"October 01, 2009 -  September 30, 2010",Structural Analysis of Macromolecular Complexes by Electron Microscopy,"Michael Marc Gottesman; MD



IRP Faculty Profile
 




Jacqueline L Milne",NULL,"Laboratory of Cell Biology, NCI","Dan  Shi



Sriram  Subramaniam; PhD



Mario J Borgnia; PhD",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=62925
145,BC010413-10,"October 01, 2009 -  September 30, 2010",Study of hereditary prostate cancer and human artificial chromosomes,"Vladimir L Larionov; PhD, DSc



IRP Faculty Profile",NULL,"Developmental Therapeutics Branch, NCI","William M Bonner; PhD



Indri  Erliandri



Jung-Hyun  Kim



Artem Vadimovich  Kononenko



Natalay  Kouprina



Nicholas Cheng Ooi Lee; PhD



Show all 8","William  Earnshaw
(Laboratory of Cell Biology, Wellcome Trust Centre for Cell Biology)




Mitsuo  Oshimura
(Tottori University)




Johanna  Schleutker
(Institute of Medical Technology)",NULL,Arya  Biragyn; PhD (NIA),"Ordered by publication type and then author name.



1.
Cardinale S, Bergmann JH, Kelly D, Nakano M, Valdivia MM, Kimura H, Masumoto H, Larionov V, Earnshaw WC (2009). Hierarchical inactivation of a synthetic human kinetochore by a chromatin modifier. Mol Biol Cell  20, 4194-204.   https://doi.org/10.1091/mbc.e09-06-0489




PubMed



        
     
Free Article


 


PubMed ID 19656847
         Pubmed Central ID 2754933 


 



2.
Larionov V, Kim J, Kazuki Y, Hoshiya H, Takiguchi M, Hayashi M, Erliandri I, Lee H, Samoshkin A, Masumoto M, Earnshaw W, Kouprina N, Larionov V, Oshimura M (2010) Human artificial chromosome with a conditional centromere for gene delivery and gene expression. DNA Research 1-10.",https://intramural.nih.gov/search/searchview.taf?ipid=62767
146,BC010418-11,"October 01, 2009 -  September 30, 2010",Signaling Events Regulating Chemotaxis,Carole A Parent; PhD,NULL,"Laboratory of Cellular and Molecular Biology, NCI","Satarupa  Das



Paul W Kriebel



Wolfgang  Losert; PhD



Colin P Mccann",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Bagorda A, Das S, Rericha EC, Chen D, Davidson J, Parent CA (2009). Real-time measurements of cAMP production in live Dictyostelium cells. J Cell Sci  122, 3907-14.   https://doi.org/10.1242/jcs.051987




PubMed



        
     
Free Article


 


PubMed ID 19808889
         Pubmed Central ID 2773191 


 



2.
Garcia GL, Rericha EC, Heger CD, Goldsmith PK, Parent CA (2009). The group migration of Dictyostelium cells is regulated by extracellular chemoattractant degradation. Mol Biol Cell  20, 3295-304.   https://doi.org/10.1091/mbc.e09-03-0223




PubMed



        
     
Free Article


 


PubMed ID 19477920
         Pubmed Central ID 2710833 


 



3.
Kriebel PW, Parent CA (2009). Group migration and signal relay in Dictyostelium. Methods Mol Biol  571, 111-24.   https://doi.org/10.1007/978-1-60761-198-1_7




PubMed


 


PubMed ID 19763962",https://intramural.nih.gov/search/searchview.taf?ipid=62926
147,BC010419-11,"October 01, 2009 -  September 30, 2010",Molecular Mechanisms of TGF-beta Signaling Pathway,"Ying  Zhang



IRP Faculty Profile",NULL,"Laboratory of Cellular and Molecular Biology, NCI","Mary E Heller



Katherine M Sixt



Yi  Tang



Liuya  Tang","Di  Chen
(University of Rochester Medical Center)




Zhigang  He
(Program in Neurobiology, Children's Hospital Boston, Harvard Medical School)




YU  LI-RONG
(FDA, National Center for Toxicological Research)","Carl  Wu; PhD (Laboratory Of Biochemistry & Molecular Biology)



Miriam R Anver (Office Of The Director)



Zhenggang  Liu; PhD (Laboratory Of Genitourinary Cancer Pathogenesis)","Chuxia  Deng; PhD (NIDDK) 



Sushil Gopal Rane; MS, PhD (NIDDK)","Ordered by publication type and then author name.



1.
Millet C, Yamashita M, Heller M, Yu LR, Veenstra TD, Zhang YE (2009). A negative feedback control of transforming growth factor-beta signaling by glycogen synthase kinase 3-mediated Smad3 linker phosphorylation at Ser-204. J Biol Chem  284, 19808-16.   https://doi.org/10.1074/jbc.M109.016667




PubMed



        
     
Free Article


 


PubMed ID 19458083
         Pubmed Central ID 2740406 


 



2.
Zhang YE (2009). Non-Smad pathways in TGF-beta signaling. Cell Res  19, 128-39.   https://doi.org/10.1038/cr.2008.328




PubMed



        
     
Free Article


 


PubMed ID 19114990
         Pubmed Central ID 2635127",https://intramural.nih.gov/search/searchview.taf?ipid=62927
148,BC010425-11,"October 01, 2009 -  September 30, 2010",Analysis of Human Immune Reponses in Cancer Vaccine Clinical Trials,"Jeffrey  Schlom; PhD



IRP Faculty Profile",NULL,"Laboratory of Tumor Immunology and Biology, NCI","Bonnie L Casey



Claudia Mercedes Palena



Diana G Chambers



James L Gulley; MD, PhD



Diane J Poole



Robin E Riley



Show all 9","Alex  Franzusoff
(Research and Development, GlobeImmune)




Philip  Kantoff
(Dana-Farber Cancer Institute)","Philip M Arlen; MD (Medical Oncology Branch)



Ravi  Madan (Medical Oncology Branch)



William Laurence Dahut; MD (Office of the Director)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=62928
149,BC010440-09,"October 01, 2009 -  September 30, 2010","Protein Structure, Stability, and Amyloid Formation",Ruth  Nussinov; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI","Hyunbum  Jang



Jin  Liu



Buyong  Ma



Yifat  Miller



Yong-Ping  Pan



Chung  Tsai



Show all 7","Carlos  Aleman
(Engineering, Univ. Barcelona)




Carlos  Cativiela
(Chemistry, Univ. Zaragoza)




Peter  Csermely
(Semmelweis University)




Antonio  del Sol
(Research & Development, Fujirebio Inc)




Turkan  Haliloglu





Bruce  Kagan
(UCLA)


Show all 12","Michael Marc Gottesman; MD (Chemical Immunology Section)



Suresh V Ambudkar; PhD (Transport Biochemistry Section)",NULL,"Ordered by publication type and then author name.



1.
Alemán C, Jiménez AI, Cativiela C, Nussinov R, Casanovas J (2009). Conformational preferences of 1-amino-2-phenylcyclohexanecarboxylic acid, a phenylalanine cyclohexane analogue. J Org Chem  74, 7834-43.   https://doi.org/10.1021/jo901594e




PubMed



        
     
Free Article


 


PubMed ID 19772338
         Pubmed Central ID 2771318 


 



2.
Boehr DD, Nussinov R, Wright PE (2009). The role of dynamic conformational ensembles in biomolecular recognition. Nat Chem Biol  5, 789-96.   https://doi.org/10.1038/nchembio.232




PubMed



        
     
Free Article


 


PubMed ID 19841628
         Pubmed Central ID 2916928 


 



3.
Buch I, Brooks BR, Wolfson HJ, Nussinov R (2009). Computational validation of protein nanotubes. Nano Lett  9, 1096-102.   https://doi.org/10.1021/nl803521j




PubMed



        
     
Free Article


 


PubMed ID 19199488
         Pubmed Central ID 3536542 


 



4.
Csermely P, Palotai R, Nussinov R (2010). Induced fit, conformational selection and independent dynamic segments: an extended view of binding events. Trends Biochem Sci  35, 539-46.   https://doi.org/10.1016/j.tibs.2010.04.009




PubMed



               Available in future as a Free Article 


 


PubMed ID 20541943
         Pubmed Central ID 3018770 


 



5.
del Sol A, Tsai CJ, Ma B, Nussinov R (2009). The origin of allosteric functional modulation: multiple pre-existing pathways. Structure  17, 1042-50.   https://doi.org/10.1016/j.str.2009.06.008




PubMed



        
     
Free Article


 


PubMed ID 19679084
         Pubmed Central ID 2749652 


 



6.
Fishelovitch D, Shaik S, Wolfson HJ, Nussinov R (2009). Theoretical characterization of substrate access/exit channels in the human cytochrome P450 3A4 enzyme: involvement of phenylalanine residues in the gating mechanism. J Phys Chem B  113, 13018-25.   https://doi.org/10.1021/jp810386z




PubMed



        
     
Free Article


 


PubMed ID 19728720
         Pubmed Central ID 2750738 


 



7.
Jang H, Arce FT, Capone R, Ramachandran S, Lal R, Nussinov R (2009). Misfolded amyloid ion channels present mobile beta-sheet subunits in contrast to conventional ion channels. Biophys J  97, 3029-37.   https://doi.org/10.1016/j.bpj.2009.09.014




PubMed



        
     
Free Article


 


PubMed ID 19948133
         Pubmed Central ID 2784570 


 



8.
Liu J, Nussinov R (2009). The mechanism of ubiquitination in the cullin-RING E3 ligase machinery: conformational control of substrate orientation. PLoS Comput Biol  5, e1000527.   https://doi.org/10.1371/journal.pcbi.1000527




PubMed



        
     
Free Article


 


PubMed ID 19798438
         Pubmed Central ID 2741574 


 



9.
Ma B, Nussinov R (2009). Amplification of signaling via cellular allosteric relay and protein disorder. Proc Natl Acad Sci U S A  106, 6887-8.   https://doi.org/10.1073/pnas.0903024106




PubMed



        
     
Free Article


 


PubMed ID 19416924
         Pubmed Central ID 2678435 


 



10.
Mustata M, Capone R, Jang H, Arce FT, Ramachandran S, Lal R, Nussinov R (2009). K3 fragment of amyloidogenic beta(2)-microglobulin forms ion channels: implication for dialysis related amyloidosis. J Am Chem Soc  131, 14938-45.   https://doi.org/10.1021/ja9049299




PubMed



        
     
Free Article


 


PubMed ID 19824733
         Pubmed Central ID 2782653 


 



11.
Pan Y, Nussinov R (2009). Cooperativity dominates the genomic organization of p53-response elements: a mechanistic view. PLoS Comput Biol  5, e1000448.   https://doi.org/10.1371/journal.pcbi.1000448




PubMed



        
     
Free Article


 


PubMed ID 19629163
         Pubmed Central ID 2705680 


 



12.
Pan Y, Tsai CJ, Ma B, Nussinov R (2009). How do transcription factors select specific binding sites in the genome? Nat Struct Mol Biol  16, 1118-20.   https://doi.org/10.1038/nsmb1109-1118




PubMed



        
     
Free Article


 


PubMed ID 19888307
         Pubmed Central ID 6416780 


 



13.
Pappu RV, Nussinov R (2009). Protein folding: lessons learned and new frontiers. Preface. Phys Biol  6, 010301.   https://doi.org/10.1088/1478-3975/6/1/010301




PubMed


 


PubMed ID 19208944
    
     


 



14.
Revilla-López G, Torras J, Jiménez AI, Cativiela C, Nussinov R, Alemán C (2009). Side-chain to backbone interactions dictate the conformational preferences of a cyclopentane arginine analogue. J Org Chem  74, 2403-12.   https://doi.org/10.1021/jo802704h




PubMed



        
     
Free Article


 


PubMed ID 19236034
         Pubmed Central ID 2682113 


 



15.
Tsai CJ, Del Sol A, Nussinov R (2009). Protein allostery, signal transmission and dynamics: a classification scheme of allosteric mechanisms. Mol Biosyst  5, 207-16.   https://doi.org/10.1039/b819720b




PubMed



        
     
Free Article


 


PubMed ID 19225609
         Pubmed Central ID 2898650 


 



16.
Yu X, Wang Q, Yang JC, Buch I, Tsai CJ, Ma B, Cheng SZ, Nussinov R, Zheng J (2009). Mutational analysis and allosteric effects in the HIV-1 capsid protein carboxyl-terminal dimerization domain. Biomacromolecules  10, 390-9.   https://doi.org/10.1021/bm801151r




PubMed



               Available in future as a Free Article 


 


PubMed ID 19199580
         Pubmed Central ID 2651736",https://intramural.nih.gov/search/searchview.taf?ipid=62889
150,BC010441-09,"October 01, 2009 -  September 30, 2010",Biomolecular Recognition and Binding Mechanisms,Ruth  Nussinov; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI","Buyong  Ma



Yong-Ping  Pan



Chung  Tsai



David  Zanuy Gomara","Carlos  Aleman
(Engineering, Univ. Barcelona)




David  Boehr
(Penn State)




Carlos  Cativiela
(Chemistry, Univ. Zaragoza)




Peter  Csermely
(Semmelweis University)




Antonio  del Sol
(Research & Development, Fujirebio Inc)




Attila  Gursoy
(Computer Science Dept., Koc University)


Show all 11",NULL,NULL,"Ordered by publication type and then author name.



1.
Alemán C, Jiménez AI, Cativiela C, Nussinov R, Casanovas J (2009). Conformational preferences of 1-amino-2-phenylcyclohexanecarboxylic acid, a phenylalanine cyclohexane analogue. J Org Chem  74, 7834-43.   https://doi.org/10.1021/jo901594e




PubMed



        
     
Free Article


 


PubMed ID 19772338
         Pubmed Central ID 2771318 


 



2.
Boehr DD, Nussinov R, Wright PE (2009). The role of dynamic conformational ensembles in biomolecular recognition. Nat Chem Biol  5, 789-96.   https://doi.org/10.1038/nchembio.232




PubMed



        
     
Free Article


 


PubMed ID 19841628
         Pubmed Central ID 2916928 


 



3.
del Sol A, Tsai CJ, Ma B, Nussinov R (2009). The origin of allosteric functional modulation: multiple pre-existing pathways. Structure  17, 1042-50.   https://doi.org/10.1016/j.str.2009.06.008




PubMed



        
     
Free Article


 


PubMed ID 19679084
         Pubmed Central ID 2749652 


 



4.
Dror O, Schneidman-Duhovny D, Inbar Y, Nussinov R, Wolfson HJ (2009). Novel approach for efficient pharmacophore-based virtual screening: method and applications. J Chem Inf Model  49, 2333-43.   https://doi.org/10.1021/ci900263d




PubMed



        
     
Free Article


 


PubMed ID 19803502
         Pubmed Central ID 2767445 


 



5.
Ma B, Nussinov R (2009). Amplification of signaling via cellular allosteric relay and protein disorder. Proc Natl Acad Sci U S A  106, 6887-8.   https://doi.org/10.1073/pnas.0903024106




PubMed



        
     
Free Article


 


PubMed ID 19416924
         Pubmed Central ID 2678435 


 



6.
Ma B, Nussinov R (2009). Regulating highly dynamic unstructured proteins and their coding mRNAs. Genome Biol  10, 204.   https://doi.org/10.1186/gb-2009-10-1-204




PubMed



        
     
Free Article


 


PubMed ID 19226433
         Pubmed Central ID 2687783 


 



7.
Mashiach E, Nussinov R, Wolfson HJ (2010). FiberDock: Flexible induced-fit backbone refinement in molecular docking. Proteins  78, 1503-19.   https://doi.org/10.1002/prot.22668




PubMed



        
     
Free Article


 


PubMed ID 20077569
         Pubmed Central ID 4290165 


 



8.
Pan Y, Nussinov R (2009). Cooperativity dominates the genomic organization of p53-response elements: a mechanistic view. PLoS Comput Biol  5, e1000448.   https://doi.org/10.1371/journal.pcbi.1000448




PubMed



        
     
Free Article


 


PubMed ID 19629163
         Pubmed Central ID 2705680 


 



9.
Pan Y, Tsai CJ, Ma B, Nussinov R (2009). How do transcription factors select specific binding sites in the genome? Nat Struct Mol Biol  16, 1118-20.   https://doi.org/10.1038/nsmb1109-1118




PubMed



        
     
Free Article


 


PubMed ID 19888307
         Pubmed Central ID 6416780 


 



10.
Revilla-López G, Torras J, Curcó D, Casanovas J, Calaza MI, Zanuy D, Jiménez AI, Cativiela C, Nussinov R, Grodzinski P, Alemán C (2010). NCAD, a database integrating the intrinsic conformational preferences of non-coded amino acids. J Phys Chem B  114, 7413-22.   https://doi.org/10.1021/jp102092m




PubMed



        
     
Free Article


 


PubMed ID 20455555
         Pubmed Central ID 2896893 


 



11.
Revilla-López G, Torras J, Jiménez AI, Cativiela C, Nussinov R, Alemán C (2009). Side-chain to backbone interactions dictate the conformational preferences of a cyclopentane arginine analogue. J Org Chem  74, 2403-12.   https://doi.org/10.1021/jo802704h




PubMed



        
     
Free Article


 


PubMed ID 19236034
         Pubmed Central ID 2682113 


 



12.
Shulman-Peleg A, Nussinov R, Wolfson HJ (2009). RsiteDB: a database of protein binding pockets that interact with RNA nucleotide bases. Nucleic Acids Res  37, D369-73.   https://doi.org/10.1093/nar/gkn759




PubMed



        
     
Free Article


 


PubMed ID 18953028
         Pubmed Central ID 2686467 


 



13.
Tsai CJ, Del Sol A, Nussinov R (2009). Protein allostery, signal transmission and dynamics: a classification scheme of allosteric mechanisms. Mol Biosyst  5, 207-16.   https://doi.org/10.1039/b819720b




PubMed



        
     
Free Article


 


PubMed ID 19225609
         Pubmed Central ID 2898650 


 



14.
Tuncbag N, Kar G, Gursoy A, Keskin O, Nussinov R (2009). Towards inferring time dimensionality in protein-protein interaction networks by integrating structures: the p53 example. Mol Biosyst  5, 1770-8.   https://doi.org/10.1039/B905661K




PubMed



        
     
Free Article


 


PubMed ID 19585003
         Pubmed Central ID 2898629 


 



15.
Tuncbag N, Kar G, Keskin O, Gursoy A, Nussinov R (2009). A survey of available tools and web servers for analysis of protein-protein interactions and interfaces. Brief Bioinform  10, 217-32.   https://doi.org/10.1093/bib/bbp001




PubMed



        
     
Free Article


 


PubMed ID 19240123
         Pubmed Central ID 2671387 


 



16.
Zanuy D, Flores-Ortega A, Jiménez AI, Calaza MI, Cativiela C, Nussinov R, Ruoslahti E, Alemán C (2009). In silico molecular engineering for a targeted replacement in a tumor-homing peptide. J Phys Chem B  113, 7879-89.   https://doi.org/10.1021/jp9006119




PubMed



        
     
Free Article


 


PubMed ID 19432404
         Pubmed Central ID 2734192",https://intramural.nih.gov/search/searchview.taf?ipid=62890
151,BC010442-09,"October 01, 2009 -  September 30, 2010",Method Development: Efficient Computer Vision Based Algorithms,Ruth  Nussinov; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI","Buyong  Ma



Chung  Tsai","Attila  Gursoy
(Computer Science Dept., Koc University)




Turkan  Haliloglu





Ozlem  Keskin
(Koc University)




Roded  Sharan
(Computer Science Dept., Tel Aviv University)




Haim  Wolfson
(Tel Aviv Univ)",NULL,Bernard R Brooks; PhD (NHLBI),"Ordered by publication type and then author name.



1.
Ahmad S, Keskin O, Mizuguchi K, Sarai A, Nussinov R (2010). CCRXP: exploring clusters of conserved residues in protein structures. Nucleic Acids Res  38, W398-401.   https://doi.org/10.1093/nar/gkq360




PubMed



        
     
Free Article


 


PubMed ID 20457748
         Pubmed Central ID 2896124 


 



2.
Buch I, Brooks BR, Wolfson HJ, Nussinov R (2009). Computational validation of protein nanotubes. Nano Lett  9, 1096-102.   https://doi.org/10.1021/nl803521j




PubMed



        
     
Free Article


 


PubMed ID 19199488
         Pubmed Central ID 3536542 


 



3.
Dror O, Schneidman-Duhovny D, Inbar Y, Nussinov R, Wolfson HJ (2009). Novel approach for efficient pharmacophore-based virtual screening: method and applications. J Chem Inf Model  49, 2333-43.   https://doi.org/10.1021/ci900263d




PubMed



        
     
Free Article


 


PubMed ID 19803502
         Pubmed Central ID 2767445 


 



4.
Mashiach E, Nussinov R, Wolfson HJ (2010). FiberDock: Flexible induced-fit backbone refinement in molecular docking. Proteins  78, 1503-19.   https://doi.org/10.1002/prot.22668




PubMed



        
     
Free Article


 


PubMed ID 20077569
         Pubmed Central ID 4290165 


 



5.
Shulman-Peleg A, Nussinov R, Wolfson HJ (2009). RsiteDB: a database of protein binding pockets that interact with RNA nucleotide bases. Nucleic Acids Res  37, D369-73.   https://doi.org/10.1093/nar/gkn759




PubMed



        
     
Free Article


 


PubMed ID 18953028
         Pubmed Central ID 2686467 


 



6.
Tuncbag N, Kar G, Gursoy A, Keskin O, Nussinov R (2009). Towards inferring time dimensionality in protein-protein interaction networks by integrating structures: the p53 example. Mol Biosyst  5, 1770-8.   https://doi.org/10.1039/B905661K




PubMed



        
     
Free Article


 


PubMed ID 19585003
         Pubmed Central ID 2898629 


 



7.
Tuncbag N, Kar G, Keskin O, Gursoy A, Nussinov R (2009). A survey of available tools and web servers for analysis of protein-protein interactions and interfaces. Brief Bioinform  10, 217-32.   https://doi.org/10.1093/bib/bbp001




PubMed



        
     
Free Article


 


PubMed ID 19240123
         Pubmed Central ID 2671387",https://intramural.nih.gov/search/searchview.taf?ipid=62893
152,BC010446-09,"October 01, 2009 -  September 30, 2010",DNA Double Strand Break Repair in Drosophila Melanogaster,Yikang  Rong,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",NULL,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=62896
153,BC010448-09,"October 01, 2009 -  September 30, 2010",Genetic Alterations in Lung Cancer,Jonathan S Wiest; PhD,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Zhihong  Shan,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=62929
154,BC010449-09,"October 01, 2009 -  September 30, 2010",Role of Novel Cytokine-like Molecules Secretoglobin (SCGB) 3A1 and 3A2 in Lung,"Shioko  Kimura; PhD



IRP Faculty Profile",NULL,"Endocrinology Section, NCI","Yan  Cai



Taketomo  Kido","Kensuke  Kumamoto
(Fukushima Medical University)




Reiko  Kurotani





Takeshi  Tomita
(Tokyo Women's Medical University)",Ilona  Linnoila; MD (Laboratory Of Genitourinary Cancer Pathogenesis),NULL,"Ordered by publication type and then author name.



1.
Tomita T, Yamada A, Miyakoshi M, Kido T, Sheikh F, Srisodsai A, Miyajima A, Donnelly RP, Kimura S (2009). Oncostatin M regulates secretoglobin 3A1 and 3A2 expression in a bidirectional manner. Am J Respir Cell Mol Biol  40, 620-30.   https://doi.org/10.1165/rcmb.2008-0062OC




PubMed



        
     
Free Article


 


PubMed ID 18978304
         Pubmed Central ID 2677441 


 



2.
Yamada A, Suzuki D, Miyazono A, Oshima K, Kamiya A, Zhao B, Takami M, Donnelly RP, Itabe H, Yamamoto M, Kimura S, Kamijo R (2009). IFN-gamma down-regulates Secretoglobin 3A1 gene expression. Biochem Biophys Res Commun  379, 964-8.   https://doi.org/10.1016/j.bbrc.2008.12.187




PubMed



        
     
Free Article


 


PubMed ID 19135978
         Pubmed Central ID 2792195",https://intramural.nih.gov/search/searchview.taf?ipid=62930
155,BC010450-09,"October 01, 2009 -  September 30, 2010",Development of Akt Inhibitors,"Phillip A Dennis; MD, PhD",NULL,"Medical Oncology Branch, NCI","Yoon Soo Chang; MD



Chun-Te  Chiang



Giuseppe  Giaccone; MD



Matthew C Dallos



Irem  Dogan



Joell J Gills



Show all 17",NULL,"Timothy D Veenstra (Office Of The Director)



Melinda  Hollingshead (Biological Testing Branch)



Maria  Tsokos; MD (Laboratory of Pathology)



Ilona  Linnoila; MD (Laboratory Of Genitourinary Cancer Pathogenesis)



Mones S Abu Asab (Laboratory of Pathology)



Susan L Holbeck (Information Technology Branch)",NULL,"Ordered by publication type and then author name.



1.
Dennis PA (2009). Rapamycin for chemoprevention of upper aerodigestive tract cancers. Cancer Prev Res (Phila)  2, 7-9.   https://doi.org/10.1158/1940-6207.CAPR-08-0215




PubMed


 


PubMed ID 19139011
    
     


 



2.
Gills JJ, Dennis PA (2009). Perifosine: update on a novel Akt inhibitor. Curr Oncol Rep  11, 102-10.   https://doi.org/10.1007/s11912-009-0016-4




PubMed



        
     
Free Article


 


PubMed ID 19216841
         Pubmed Central ID 6957247 


 



3.
Han W, Gills JJ, Memmott RM, Lam S, Dennis PA (2009). The chemopreventive agent myoinositol inhibits Akt and extracellular signal-regulated kinase in bronchial lesions from heavy smokers. Cancer Prev Res (Phila)  2, 370-6.   https://doi.org/10.1158/1940-6207.CAPR-08-0209




PubMed



        
     
Free Article


 


PubMed ID 19336734
         Pubmed Central ID 3715041 


 



4.
Memmott RM, Dennis PA (2009). LKB1 and mammalian target of rapamycin as predictive factors for the anticancer efficacy of metformin. J Clin Oncol  27, e226; author reply e227.   https://doi.org/10.1200/JCO.2009.25.3963




PubMed


 


PubMed ID 19858366",https://intramural.nih.gov/search/searchview.taf?ipid=62931
156,BC010451-09,"October 01, 2009 -  September 30, 2010",Carbohydrate Antigen-bearing Nanoparticles for Anti-adhesives and Tumor Vaccines,"Joseph John Barchi



IRP Faculty Profile",NULL,"Chemical Biology Laboratory, NCI","Raymond P Brinas







Joel Patrick Schneider; PhD",NULL,"Anil K Patri (Office Of The Director)



Howard A Young; PhD (Laboratory of Experimental Immunology)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63041
157,BC010453-09,"October 01, 2009 -  September 30, 2010",Identify SNPs and Polymorphisms Involved in the Development of Prostate Cancer,"William D Figg; PharmD



IRP Faculty Profile",Giuseppe  Giaccone; MD,"Medical Oncology Branch, NCI","Bevin Cathleen English



Christian Tyler Kirkland



Douglas K Price



Emily  Richardson



Sarah M Troutman","Romano  Danesi





Alan  Kristal
(Fred Hutchinson Cancer Research Center)","William Laurence Dahut; MD (Office of the Director)



James L Gulley; MD, PhD (Laboratory of Tumor Immunology and Biology)",NULL,"Ordered by publication type and then author name.



1.
Jain L, Vargo CA, Danesi R, Sissung TM, Price DK, Venzon D, Venitz J, Figg WD (2009). The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors. Mol Cancer Ther  8, 2496-508.   https://doi.org/10.1158/1535-7163.MCT-09-0302




PubMed



        
     
Free Article


 


PubMed ID 19755511
         Pubmed Central ID 2751847 


 



2.
Jonsson JG, Sissung TM, Figg WD (2009). A genomic strategy for predicting androgen receptor activity in prostate tumors. Cancer Biol Ther  8, 2002-3.   https://doi.org/10.4161/cbt.8.21.10180




PubMed


 


PubMed ID 19838047
    
     


 



3.
Kirkland CT, Price DK, Figg WD (2010). Genetic variant associated with aggressive not indolent prostate cancer. Cancer Biol Ther  9, 957-8.   https://doi.org/10.4161/cbt.9.12.12137




PubMed


 


PubMed ID 20581469
    
     


 



4.
Mucci LA, Stark JR, Figg WD, Schumacher F, Li H, Abe M, Hennessy K, Stampfer MJ, Gaziano JM, Ma J, Kantoff PW (2009). Polymorphism in endostatin, an angiogenesis inhibitor, and prostate cancer risk and survival: A prospective study. Int J Cancer  125, 1143-6.   https://doi.org/10.1002/ijc.24423




PubMed



        
     
Free Article


 


PubMed ID 19431146
         Pubmed Central ID 2838373 


 



5.
Platz EA, Till C, Goodman PJ, Parnes HL, Figg WD, Albanes D, Neuhouser ML, Klein EA, Thompson IM, Kristal AR (2009). Men with low serum cholesterol have a lower risk of high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev  18, 2807-13.   https://doi.org/10.1158/1055-9965.EPI-09-0472




PubMed



        
     
Free Article


 


PubMed ID 19887582
         Pubmed Central ID 2877916",https://intramural.nih.gov/search/searchview.taf?ipid=62932
158,BC010476-08,"October 01, 2009 -  September 30, 2010",Time Domian Electron Paramagnetic Resonance Imaging,"Murali  Krishna; PhD



IRP Faculty Profile",NULL,"Radiation Biology Branch, NCI","Nallathamby  Devasahayam



Shingo  Matsumoto



James B Mitchell; PhD



Keita  Saito



Sankaran  Subramanian; MD",NULL,NULL,"Anthony R Fletcher; PhD (CIT) 



Thomas J Pohida; MS (CIT) 



Jeeva P Munasinghe (NINDS) 



Calvin A Johnson; PhD (CIT) 



Alan Paul Koretsky; PhD (NINDS)","Ordered by publication type and then author name.



1.
Dharmaraj CD, Thadikonda K, Fletcher AR, Doan PN, Devasahayam N, Matsumoto S, Johnson CA, Cook JA, Mitchell JB, Subramanian S, Krishna MC (2009). Reconstruction for time-domain in vivo EPR 3D multigradient oximetric imaging--a parallel processing perspective. Int J Biomed Imaging  2009, 528639.   https://doi.org/10.1155/2009/528639




PubMed



        
     
Free Article


 


PubMed ID 19672315
         Pubmed Central ID 2721150 


 



2.
Hyodo F, Matsumoto S, Devasahayam N, Dharmaraj C, Subramanian S, Mitchell JB, Krishna MC (2009). Pulsed EPR imaging of nitroxides in mice. J Magn Reson  197, 181-5.   https://doi.org/10.1016/j.jmr.2008.12.018




PubMed



        
     
Free Article


 


PubMed ID 19157932
         Pubmed Central ID 3496157 


 



3.
Matsumoto S, Yasui H, Mitchell JB, Krishna MC (2010) Imaging cycling tumor hypoxia. Cancer Res 70:10019-23.




PubMed



        
     
Free Article


 


PubMed ID 21159626
         Pubmed Central ID 3059188 


 



4.
Samuni Y, Flores-Santana W, Krishna MC, Mitchell JB, Wink DA (2009). The inhibitors of histone deacetylase suberoylanilide hydroxamate and trichostatin A release nitric oxide upon oxidation. Free Radic Biol Med  47, 419-23.   https://doi.org/10.1016/j.freeradbiomed.2009.05.011




PubMed



        
     
Free Article


 


PubMed ID 19447172
         Pubmed Central ID 2730666",https://intramural.nih.gov/search/searchview.taf?ipid=62948
159,BC010477-08,"October 01, 2009 -  September 30, 2010",Overhauser Enhanced Magnetic Resonance Imaging (OMRI),"Murali  Krishna; PhD



IRP Faculty Profile",NULL,"Radiation Biology Branch, NCI","Shingo  Matsumoto



James B Mitchell; PhD



Keita  Saito",NULL,NULL,"Jeeva P Munasinghe (NINDS) 



Alan Paul Koretsky; PhD (NINDS)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=62946
160,BC010478-08,"October 01, 2009 -  September 30, 2010",Continuous Wave Electron Paramagnetic Resonance Imaging,"Murali  Krishna; PhD



IRP Faculty Profile",NULL,"Radiation Biology Branch, NCI","Nallathamby  Devasahayam



James B Mitchell; PhD



Sankaran  Subramanian; MD",NULL,NULL,Thomas J Pohida; MS (CIT),"Ordered by publication type and then author name.



1.
Samuni Y, Ishii H, Hyodo F, Samuni U, Krishna MC, Goldstein S, Mitchell JB (2010). Reactive oxygen species mediate hepatotoxicity induced by the Hsp90 inhibitor geldanamycin and its analogs. Free Radic Biol Med  48, 1559-63.   https://doi.org/10.1016/j.freeradbiomed.2010.03.001




PubMed



        
     
Free Article


 


PubMed ID 20211249
         Pubmed Central ID 2862863",https://intramural.nih.gov/search/searchview.taf?ipid=62947
161,BC010479-08,"October 01, 2009 -  September 30, 2010",Regulation of Melanocyte Development and Differentiation,Thomas J Hornyak,NULL,"Dermatology Branch, NCI",Shunlin  Jiang,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=62938
162,BC010481-08,"October 01, 2009 -  September 30, 2010",HIV-1 Reverse Transcriptase and Reverse Transcription,"Stephen H Hughes; PhD



IRP Faculty Profile",NULL,"HIV Drug Resistance Program, NCI","Michael E Abram



Paul L Boyer



Patrick K Clark



Caroline A Davis



Linda L Dunn



Andrea L Ferris



Show all 10","Zandrea  Ambrose
(University of Pittsburgh)




Eddy  Arnold; PhD
(Chemistry and Chemical Biology, CABM and Rutgers University)




Mark  Federspiel
(Mayo Clinic)




Maxine  Linial
(University of Washington)




Michael  Parniak; PhD
(Department of Medicine, McGill University)","Victor  Marquez; PhD (Chemical Biology Laboratory)



Jeffrey N Strathern (Office of the Director)



Gary T Pauly (Laboratory of Medicinal Chemistry)



Dwight V Nissley (Genome Recombination and Regulation Section)","Cynthia E Dunbar; MD (NHLBI) 



Craig Joseph Thomas (NHGRI)","Ordered by publication type and then author name.



1.
Hughes S, Arnold E, Hughes S (2010) HIV-1 reverse transcriptase structures, in Encyclopedia of Biological Chemistry. Elsevier, in press.




 



2.
Boyer PL, Vu BC, Ambrose Z, Julias JG, Warnecke S, Liao C, Meier C, Marquez VE, Hughes SH (2009). The nucleoside analogue D-carba T blocks HIV-1 reverse transcription. J Med Chem  52, 5356-64.   https://doi.org/10.1021/jm801176e




PubMed



        
     
Free Article


 


PubMed ID 19678643
         Pubmed Central ID 2756836 


 



3.
Das K, Bandwar RP, White KL, Feng JY, Sarafianos SG, Tuske S, Tu X, Clark AD, Boyer PL, Hou X, Gaffney BL, Jones RA, Miller MD, Hughes SH, Arnold E (2009). Structural basis for the role of the K65R mutation in HIV-1 reverse transcriptase polymerization, excision antagonism, and tenofovir resistance. J Biol Chem  284, 35092-100.   https://doi.org/10.1074/jbc.M109.022525




PubMed



        
     
Free Article


 


PubMed ID 19812032
         Pubmed Central ID 2787370 


 



4.
Dunn LL, McWilliams MJ, Das K, Arnold E, Hughes SH (2009). Mutations in the thumb allow human immunodeficiency virus type 1 reverse transcriptase to be cleaved by protease in virions. J Virol  83, 12336-44.   https://doi.org/10.1128/JVI.00676-09




PubMed



        
     
Free Article


 


PubMed ID 19759158
         Pubmed Central ID 2786724 


 



5.
Himmel DM, Maegley KA, Pauly TA, Bauman JD, Das K, Dharia C, Clark AD, Ryan K, Hickey MJ, Love RA, Hughes SH, Bergqvist S, Arnold E (2009). Structure of HIV-1 reverse transcriptase with the inhibitor beta-Thujaplicinol bound at the RNase H active site. Structure  17, 1625-1635.   https://doi.org/10.1016/j.str.2009.09.016




PubMed



        
     
Free Article


 


PubMed ID 20004166
         Pubmed Central ID 3365588 


 



6.
Hughes S, Das K, Han Q, Bauman J, Clark A, Hou X, Frenkel Y, Gaffney B, Jones R, Boyer P, Hughes S, Sarafianos S, Arnold E (2010) Structural basis of HIV-1 resistance to AZT by ATP-mediated excision. Nat Struct Mol Biol, in press.




 



7.
Lee K, Ambrose Z, Martin TD, Oztop I, Mulky A, Julias JG, Vandegraaff N, Baumann JG, Wang R, Yuen W, Takemura T, Shelton K, Taniuchi I, Li Y, Sodroski J, Littman DR, Coffin JM, Hughes SH, Unutmaz D, Engelman A, KewalRamani VN (2010). Flexible use of nuclear import pathways by HIV-1. Cell Host Microbe  7, 221-33.   https://doi.org/10.1016/j.chom.2010.02.007




PubMed



        
     
Free Article


 


PubMed ID 20227665
         Pubmed Central ID 2841689",https://intramural.nih.gov/search/searchview.taf?ipid=62942
163,BC010482-08,"October 01, 2009 -  September 30, 2010",Retroviral Integration,"Stephen H Hughes; PhD



IRP Faculty Profile",NULL,"HIV Drug Resistance Program, NCI","Patrick K Clark



Caroline A Davis



Linda L Dunn



Andrea L Ferris



Barry  Johnson



Mary J McWilliams



Show all 9","C. David  Allis
(Chromatin Biology, Rockefeller University)




Alan  Engelman; PhD
(Dana-Farber, Harvard University)




Mark  Federspiel
(Mayo Clinic)




Maxine  Linial
(University of Washington)","Yves  Pommier; PhD (Developmental Therapeutics Branch)



Terrence R Burke; PhD (Chemical Biology Laboratory)



Vineet Narain KewalRamani; PhD (Retroviral Replication Laboratory)",Cynthia E Dunbar; MD (NHLBI),"Ordered by publication type and then author name.



1.
Ferris AL, Wu X, Hughes CM, Stewart C, Smith SJ, Milne TA, Wang GG, Shun MC, Allis CD, Engelman A, Hughes SH (2010). Lens epithelium-derived growth factor fusion proteins redirect HIV-1 DNA integration. Proc Natl Acad Sci U S A  107, 3135-40.   https://doi.org/10.1073/pnas.0914142107




PubMed



        
     
Free Article


 


PubMed ID 20133638
         Pubmed Central ID 2840313 


 



2.
Lee K, Ambrose Z, Martin TD, Oztop I, Mulky A, Julias JG, Vandegraaff N, Baumann JG, Wang R, Yuen W, Takemura T, Shelton K, Taniuchi I, Li Y, Sodroski J, Littman DR, Coffin JM, Hughes SH, Unutmaz D, Engelman A, KewalRamani VN (2010). Flexible use of nuclear import pathways by HIV-1. Cell Host Microbe  7, 221-33.   https://doi.org/10.1016/j.chom.2010.02.007




PubMed



        
     
Free Article


 


PubMed ID 20227665
         Pubmed Central ID 2841689",https://intramural.nih.gov/search/searchview.taf?ipid=62941
164,BC010483-08,"October 01, 2009 -  September 30, 2010",TEM5 Ligand Hunt,Bradley D St Croix,NULL,"Mouse Cancer Genetics Program, NCI","Steven  Seaman



Lihong  Xu; PhD",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=62959
165,BC010484-08,"October 01, 2009 -  September 30, 2010",Functional Analysis of TEM5 and TEM8,Bradley D St Croix,NULL,"Mouse Cancer Genetics Program, NCI","Amit Madhulal Chaudhary



Xiujie  Li



Steven  Seaman",NULL,"Enrique  Zudaire Ubani; PhD (Radiation Oncology Branch)



Frank  Cuttitta; PhD (Radiation Oncology Branch)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=62960
166,BC010485-08,"October 01, 2009 -  September 30, 2010",Mechanism of DC-SIGN-Mediated Transmission of HIV,"Vineet Narain KewalRamani; PhD



IRP Faculty Profile",NULL,"Retroviral Replication Laboratory, NCI","Stuart F J Le Grice; PhD



Hyun Jae  Yu",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Chung NP, Breun SK, Bashirova A, Baumann JG, Martin TD, Karamchandani JM, Rausch JW, Le Grice SF, Wu L, Carrington M, Kewalramani VN (2010). HIV-1 transmission by dendritic cell-specific ICAM-3-grabbing nonintegrin (DC-SIGN) is regulated by determinants in the carbohydrate recognition domain that are absent in liver/lymph node-SIGN (L-SIGN). J Biol Chem  285, 2100-12.   https://doi.org/10.1074/jbc.M109.030619




PubMed



        
     
Free Article


 


PubMed ID 19833723
         Pubmed Central ID 2804366",https://intramural.nih.gov/search/searchview.taf?ipid=62943
167,BC010486-08,"October 01, 2009 -  September 30, 2010",Search for New Tumor Endothelial Markers,Bradley D St Croix,NULL,"Mouse Cancer Genetics Program, NCI",Steven  Seaman,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=62961
168,BC010487-08,"October 01, 2009 -  September 30, 2010",Cytoplasmic-Nuclear Trafficking of HIV-1,"Vineet Narain KewalRamani; PhD



IRP Faculty Profile",NULL,"Retroviral Replication Laboratory, NCI","Stuart F J Le Grice; PhD



Kyeongeun  Lee



Alok  Mulky



Alan  Rein; PhD



Eric O Freed; PhD



Hyun Jae  Yu



Show all 7","Zandrea  Ambrose
(University of Pittsburgh)




Paul  Bieniasz
(Rockefeller University, Aaron Diamond AIDS Research Center)




Alan  Engelman; PhD
(Dana-Farber, Harvard University)




Theodora  Hatziioannou
(Aaron Diamond AIDS Research Center)




Dan  Littman
(New York University)




Derya  Unutmaz
(New York University)","Stephen H Hughes; PhD (HIV Drug Resistance Program)



Sriram  Subramaniam; PhD (Laboratory of Cell Biology)",NULL,"Ordered by publication type and then author name.



1.
Furtak V, Mulky A, Rawlings SA, Kozhaya L, Lee K, Kewalramani VN, Unutmaz D (2010). Perturbation of the P-body component Mov10 inhibits HIV-1 infectivity. PLoS One  5, e9081.   https://doi.org/10.1371/journal.pone.0009081




PubMed



        
     
Free Article


 


PubMed ID 20140200
         Pubmed Central ID 2816699 


 



2.
Krishnan L, Matreyek KA, Oztop I, Lee K, Tipper CH, Li X, Dar MJ, Kewalramani VN, Engelman A (2010). The requirement for cellular transportin 3 (TNPO3 or TRN-SR2) during infection maps to human immunodeficiency virus type 1 capsid and not integrase. J Virol  84, 397-406.   https://doi.org/10.1128/JVI.01899-09




PubMed



        
     
Free Article


 


PubMed ID 19846519
         Pubmed Central ID 2798409 


 



3.
Lee K, Ambrose Z, Martin TD, Oztop I, Mulky A, Julias JG, Vandegraaff N, Baumann JG, Wang R, Yuen W, Takemura T, Shelton K, Taniuchi I, Li Y, Sodroski J, Littman DR, Coffin JM, Hughes SH, Unutmaz D, Engelman A, KewalRamani VN (2010). Flexible use of nuclear import pathways by HIV-1. Cell Host Microbe  7, 221-33.   https://doi.org/10.1016/j.chom.2010.02.007




PubMed



        
     
Free Article


 


PubMed ID 20227665
         Pubmed Central ID 2841689",https://intramural.nih.gov/search/searchview.taf?ipid=62944
169,BC010488-08,"October 01, 2009 -  September 30, 2010",Animal Models for HIV-1 Replication and Pathogenesis,"Vineet Narain KewalRamani; PhD



IRP Faculty Profile",NULL,"Retroviral Replication Laboratory, NCI","Kyeongeun  Lee



Hyun Jae  Yu



Wendy  Yuen","Zandrea  Ambrose
(University of Pittsburgh)




Paul  Bieniasz
(Rockefeller University, Aaron Diamond AIDS Research Center)




Theodora  Hatziioannou
(Aaron Diamond AIDS Research Center)




John W Mellors","Jeffrey D Lifson; MD (Office Of The Director)



Mary  Kearney (Host Virus Interaction Branch)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=62945
170,BC010493-08,"October 01, 2009 -  September 30, 2010",High-Resolution Protein and Nucleic Acid Footprinting,"Stuart F J Le Grice; PhD



IRP Faculty Profile",NULL,"Retroviral Replication Laboratory, NCI","Brittany Kathleen Ashe



Michal  Legiewicz



Jennifer T Miller



Katarzyna Joanna Purzycka; PhD



Yi  Wang



Michelle Hall Mitchell; PhD","Samson  Chow
(University of California at Los Angeles)




Dan  Fabris
(Chemistry and Biochemistry, University of Maryland, Baltimore County)




Matthias  Goette
(McGill University)




Myron F Goodman; PhD
(University of Southern California)




Marie-Louise  Hammarskjold; PhD
(Microbiology, University of Virginia)




Sidney  Hecht
(Lady Davis Institute-Jewish General Hospital, University of Virginia)


Show all 11","Nancy H Colburn; PhD (Laboratory of Cancer Prevention)



Barbara K Felber (Vaccine Branch)



Yun Xing M Wang (Structural Biophysics Laboratory)



Bruce Allen Shapiro; PhD (Image Processing Section)



George N Pavlakis; MD, PhD (Vaccine Branch)",NULL,"Ordered by publication type and then author name.



1.
Legrice S, Abbondanzieri E, Liu S, Zhuang X, Le Grice S (2010) Retrovirus replication: New perspectives on enzyme and substrate dynamics, in Recent Advances in Retroviruses, in press.




 



2.
Chung S, Wendeler M, Rausch JW, Beilhartz G, Gotte M, O'Keefe BR, Bermingham A, Beutler JA, Liu S, Zhuang X, Le Grice SF (2010) Structure-activity analysis of vinylogous urea inhibitors of human immunodeficiency virus-encoded ribonuclease H. Antimicrob Agents Chemother 54:3913-21.




PubMed



        
     
Free Article


 


PubMed ID 20547794
         Pubmed Central ID 2935023 


 



3.
Götte M, Rausch JW, Marchand B, Sarafianos S, Le Grice SF (2010). Reverse transcriptase in motion: conformational dynamics of enzyme-substrate interactions. Biochim Biophys Acta  1804, 1202-12.   https://doi.org/10.1016/j.bbapap.2009.07.020




PubMed



        
     
Free Article


 


PubMed ID 19665597
         Pubmed Central ID 2930377",https://intramural.nih.gov/search/searchview.taf?ipid=62951
171,BC010494-08,"October 01, 2009 -  September 30, 2010",Viral and Host Proteins as Therapeutic Targets,"Stuart F J Le Grice; PhD



IRP Faculty Profile",NULL,"Retroviral Replication Laboratory, NCI","Suhman  Chung



Michal  Legiewicz



Jennifer T Miller



Jason William Rausch



Marion Karla Bona; PhD","Eddy  Arnold; PhD
(Chemistry and Chemical Biology, CABM and Rutgers University)




Matthias  Goette
(McGill University)




Marie-Louise  Hammarskjold; PhD
(Microbiology, University of Virginia)




John  Marino
(Center for Advanced Research in Biotechnology)




David  Rekosh
(Myles Thayler AIDS Institute, University of Virginia)




Xiaowei  Zhuang
(Chemistry and Biology, Harvard University)","Deb  Chatterjee (Office Of The Director)



Marc C Nicklaus (Chemical Biology Laboratory)



Yves  Pommier; PhD (Developmental Therapeutics Branch)



John A Beutler (Molecular Targets Development Program)



Stephen H Hughes; PhD (HIV Drug Resistance Program)



Barry R O'Keefe (Molecular Targets Development Program)","Wei  Yang; PhD (NIDDK) 



Robert Joseph Crouch; PhD (NICHD) 



Craig Joseph Thomas (NHGRI)","Ordered by publication type and then author name.



1.
Legrice S, Abbondanzieri E, Liu S, Zhuang X, Le Grice S (2010) Retrovirus replication: New perspectives on enzyme and substrate dynamics, in Recent Advances in Retroviruses, in press.




 



2.
Legrice S, Rausch J, Le Grice S (2009) Targeting HIV-1 reverse transcriptase: A coat with many pockets, in Innovations in Pharmaceutical Technology. Samedan, Ltd (London, UK) Volume 31, pp. 48-51.




 



3.
Chung S, Wendeler M, Rausch JW, Beilhartz G, Gotte M, O'Keefe BR, Bermingham A, Beutler JA, Liu S, Zhuang X, Le Grice SF (2010) Structure-activity analysis of vinylogous urea inhibitors of human immunodeficiency virus-encoded ribonuclease H. Antimicrob Agents Chemother 54:3913-21.




PubMed



        
     
Free Article


 


PubMed ID 20547794
         Pubmed Central ID 2935023 


 



4.
Götte M, Rausch JW, Marchand B, Sarafianos S, Le Grice SF (2010). Reverse transcriptase in motion: conformational dynamics of enzyme-substrate interactions. Biochim Biophys Acta  1804, 1202-12.   https://doi.org/10.1016/j.bbapap.2009.07.020




PubMed



        
     
Free Article


 


PubMed ID 19665597
         Pubmed Central ID 2930377",https://intramural.nih.gov/search/searchview.taf?ipid=62949
172,BC010495-08,"October 01, 2009 -  September 30, 2010",Nucleoside and Amino Acid Analogs as Probes of HIV Replication Complexes,"Stuart F J Le Grice; PhD



IRP Faculty Profile",NULL,"Retroviral Replication Laboratory, NCI","Suhman  Chung



Jason William Rausch



Bridget  Dixon



Sabrina  Lusvarghi","Dan  Fabris
(Chemistry and Biochemistry, University of Maryland, Baltimore County)




Matthias  Goette
(McGill University)




Myron F Goodman; PhD
(University of Southern California)




Sidney  Hecht
(Lady Davis Institute-Jewish General Hospital, University of Virginia)




John  Marino
(Center for Advanced Research in Biotechnology)",NULL,NULL,"Ordered by publication type and then author name.



1.
Legrice S, Rausch J, Le Grice S (2009) Targeting HIV-1 reverse transcriptase: A coat with many pockets, in Innovations in Pharmaceutical Technology. Samedan, Ltd (London, UK) Volume 31, pp. 48-51.




 



2.
Ahmadibeni Y, Dash C, Hanley MJ, Le Grice SF, Agarwal HK, Parang K (2010) Synthesis of nucleoside 5-O-alpha,beta-methylene-beta-triphosphates and evaluation of their potency towards inhibition of HIV-1 reverse transcriptase. Org Biomol Chem 8:1271-4.




PubMed



        
     
Free Article


 


PubMed ID 20204192
         Pubmed Central ID 2928660 


 



3.
Ahmadibeni Y, Dash C, Le Grice SF, Parang K (2010) Solid-Phase Synthesis of 5-O-beta,gamma-Methylenetriphosphate Derivatives of Nucleosides and Evaluation of Their Inhibitory Activity Against HIV-1 Reverse Transcriptase. Tetrahedron Lett 51:3010-3013.




PubMed



        
     
Free Article


 


PubMed ID 20454539
         Pubmed Central ID 2864936 


 



4.
Chung S, Wendeler M, Rausch JW, Beilhartz G, Gotte M, O'Keefe BR, Bermingham A, Beutler JA, Liu S, Zhuang X, Le Grice SF (2010) Structure-activity analysis of vinylogous urea inhibitors of human immunodeficiency virus-encoded ribonuclease H. Antimicrob Agents Chemother 54:3913-21.




PubMed



        
     
Free Article


 


PubMed ID 20547794
         Pubmed Central ID 2935023 


 



5.
Götte M, Rausch JW, Marchand B, Sarafianos S, Le Grice SF (2010). Reverse transcriptase in motion: conformational dynamics of enzyme-substrate interactions. Biochim Biophys Acta  1804, 1202-12.   https://doi.org/10.1016/j.bbapap.2009.07.020




PubMed



        
     
Free Article


 


PubMed ID 19665597
         Pubmed Central ID 2930377",https://intramural.nih.gov/search/searchview.taf?ipid=62950
173,BC010499-08,"October 01, 2009 -  September 30, 2010",Maryland Prostate Cancer Case-Control Study,"Stefan  Ambs



IRP Faculty Profile",NULL,"Molecular Genetics and Carcinogenesis Section, NCI","Tiffany Marie Howe



Steves  Tietcheu



Tiffany A Wallace","Carlo M Croce





Chris  Loffredo
(Cancer Genetics and Epidemiology Program, Georgetown University)","Arthur A Hurwitz (Laboratory of Molecular Immunoregulation)



Liudmila  Prokunina-Olsson; PhD (Laboratory Translational Genomics)",NULL,"Ordered by publication type and then author name.



1.
Tahara H, Sato M, Thurin M, Wang E, Butterfield LH, Disis ML, Fox BA, Lee PP, Khleif SN, Wigginton JM, Ambs S, Akutsu Y, Chaussabel D, Doki Y, Eremin O, Fridman WH, Hirohashi Y, Imai K, Jacobson J, Jinushi M, Kanamoto A, Kashani-Sabet M, Kato K, Kawakami Y, Kirkwood JM, et al. [31 more authors] (2009). Emerging concepts in biomarker discovery; the US-Japan Workshop on Immunological Molecular Markers in Oncology. J Transl Med  7, 45.   https://doi.org/10.1186/1479-5876-7-45




PubMed



        
     
Free Article


 


PubMed ID 19534815
         Pubmed Central ID 2724494 


 



2.
Volinia S, Galasso M, Costinean S, Tagliavini L, Gamberoni G, Drusco A, Marchesini J, Mascellani N, Sana ME, Abu Jarour R, Desponts C, Teitell M, Baffa R, Aqeilan R, Iorio MV, Taccioli C, Garzon R, Di Leva G, Fabbri M, Catozzi M, Previati M, Ambs S, Palumbo T, Garofalo M, Veronese A, et al. [26 more authors] (2010). Reprogramming of miRNA networks in cancer and leukemia. Genome Res  20, 589-99.   https://doi.org/10.1101/gr.098046.109




PubMed



        
     
Free Article


 


PubMed ID 20439436
         Pubmed Central ID 2860161",https://intramural.nih.gov/search/searchview.taf?ipid=62933
174,BC010504-08,"October 01, 2009 -  September 30, 2010","Mechanisms of Retroviral Reverse Transcription, Recombination, and Replication","Wei-Shau  Hu; PhD



IRP Faculty Profile",NULL,"Retroviral Replication Laboratory, NCI","Jianbo  Chen



John Miller Coffin; PhD



Andrea  Galli



Na  Ni



Olga A Nikolaitchik



Vinay K Pathak; PhD



Show all 7","Marie-Louise  Hammarskjold; PhD
(Microbiology, University of Virginia)




Michael  Jordan
(Tufts University)




David  Rekosh
(Myles Thayler AIDS Institute, University of Virginia)




Marcelo  Soares; PhD
(Instituto Nacional de Cancer do Brasil)","Matthew  Fivash (Office Of The Director)



Mary  Kearney (Host Virus Interaction Branch)



Frank  Maldarelli (Host Virus Interaction Branch)",NULL,"Ordered by publication type and then author name.



1.
Chen J, Nikolaitchik O, Singh J, Wright A, Bencsics CE, Coffin JM, Ni N, Lockett S, Pathak VK, Hu WS (2009). High efficiency of HIV-1 genomic RNA packaging and heterozygote formation revealed by single virion analysis. Proc Natl Acad Sci U S A  106, 13535-40.   https://doi.org/10.1073/pnas.0906822106




PubMed



        
     
Free Article


 


PubMed ID 19628694
         Pubmed Central ID 2714765 


 



2.
Galli A, Kearney M, Nikolaitchik OA, Yu S, Chin MP, Maldarelli F, Coffin JM, Pathak VK, Hu WS (2010). Patterns of Human Immunodeficiency Virus type 1 recombination ex vivo provide evidence for coadaptation of distant sites, resulting in purifying selection for intersubtype recombinants during replication. J Virol  84, 7651-61.   https://doi.org/10.1128/JVI.00276-10




PubMed



        
     
Free Article


 


PubMed ID 20504919
         Pubmed Central ID 2897624 


 



3.
Moore MD, Nikolaitchik OA, Chen J, Hammarskjöld ML, Rekosh D, Hu WS (2009). Probing the HIV-1 genomic RNA trafficking pathway and dimerization by genetic recombination and single virion analyses. PLoS Pathog  5, e1000627.   https://doi.org/10.1371/journal.ppat.1000627




PubMed



        
     
Free Article


 


PubMed ID 19834549
         Pubmed Central ID 2757677",https://intramural.nih.gov/search/searchview.taf?ipid=62940
175,BC010506-08,"October 01, 2009 -  September 30, 2010","Mechanisms of Virus Assembly, Complementation, and Virion Structures","Wei-Shau  Hu; PhD



IRP Faculty Profile",NULL,"Retroviral Replication Laboratory, NCI","Jianbo  Chen



Kari Ann Dilley



Steven Carter Hatch



Na  Ni



Alan  Rein; PhD



Eric O Freed; PhD



Show all 8","John  Briggs
(European Molecular Biology Laboratory)




Akira  Ono
(University of Michigan)




Volker  Vogt
(Cornell University)","Kunio  Nagashima (Office Of The Director)



David E Ott (Office Of The Director)



Robert  Gorelick (Office Of The Director)



Sriram  Subramaniam; PhD (Laboratory of Cell Biology)



Stephen J Lockett; PhD (Office Of The Director)",George  Patterson; PhD (NIBIB),"Ordered by publication type and then author name.



1.
Burdick R, Smith JL, Chaipan C, Friew Y, Chen J, Venkatachari NJ, Delviks-Frankenberry KA, Hu WS, Pathak VK (2010). P body-associated protein Mov10 inhibits HIV-1 replication at multiple stages. J Virol  84, 10241-53.   https://doi.org/10.1128/JVI.00585-10




PubMed



        
     
Free Article


 


PubMed ID 20668078
         Pubmed Central ID 2937795 


 



2.
Paprotka T, Venkatachari NJ, Chaipan C, Burdick R, Delviks-Frankenberry KA, Hu WS, Pathak VK (2010). Inhibition of xenotropic murine leukemia virus-related virus by APOBEC3 proteins and antiviral drugs. J Virol  84, 5719-29.   https://doi.org/10.1128/JVI.00134-10




PubMed



        
     
Free Article


 


PubMed ID 20335265
         Pubmed Central ID 2876585",https://intramural.nih.gov/search/searchview.taf?ipid=62939
176,BC010511-08,"October 01, 2009 -  September 30, 2010",Retrovirus Assembly and Maturation,"Alan  Rein; PhD



IRP Faculty Profile",NULL,"Retroviral Replication Laboratory, NCI","Amanda  Aloia



Siddhartha  Datta; PhD



Wei-Shau  Hu; PhD



Demetria P Harvin



Jane  Mirro","Bogdan  Dragnea
(University of Indiana)




Susan  Krueger
(National Institute of Standards and Technology)




Walther  Mothes
(Yale University)




Karin  Musier-Forsyth
(Ohio State University)




Mark  Yeager





Adam  Zlotnick; PhD
(Biochemistry and Molecular Biology, University of Oklahoma)","Kunio  Nagashima (Office Of The Director)



Robert J Fisher (Office Of The Director)



Yun Xing M Wang (Structural Biophysics Laboratory)



Raul Eduardo Cachau (Office Of The Director)",NULL,"Ordered by publication type and then author name.



1.
Rein A, Datta S, Heinrich F, Losche M, Rein A, Krueger S, Curtis J (2010) Electrostatic interactions and binding orientation of HIV-1 matrix, studied by neutron reflectivity. Biophys J, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=62957
177,BC010512-08,"October 01, 2009 -  September 30, 2010",Interactions of Retroviral Proteins with Nucleic Acids,"Alan  Rein; PhD



IRP Faculty Profile",NULL,"Retroviral Replication Laboratory, NCI","Siddhartha  Datta; PhD



Demetria P Harvin



Tania Bibiana Lombo Rodriguez



Jane  Mirro



Smita  Nair; PhD



Ina  O'Carroll","Karin  Musier-Forsyth
(Ohio State University)




Vinayaka  Prasad
(Albert Einstein University)




Kevin  Weeks
(University of North Carolina)




Mark  Williams
(Northeastern University)","Robert  Gorelick (Office Of The Director)



Robert J Fisher (Office Of The Director)



Yun Xing M Wang (Structural Biophysics Laboratory)",Judith Goldstein Levin; PhD (NICHD),"Ordered by publication type and then author name.



1.
Wu T, Datta SA, Mitra M, Gorelick RJ, Rein A, Levin JG (2010). Fundamental differences between the nucleic acid chaperone activities of HIV-1 nucleocapsid protein and Gag or Gag-derived proteins: biological implications. Virology  405, 556-67.   https://doi.org/10.1016/j.virol.2010.06.042




PubMed



        
     
Free Article


 


PubMed ID 20655566
         Pubmed Central ID 2963451",https://intramural.nih.gov/search/searchview.taf?ipid=62958
178,BC010516-08,"October 01, 2009 -  September 30, 2010",Gated Optical DetectorsDose Guided Radiotherapy,Robert W Miller,Kevin A Camphausen; MD,"Radiation Oncology Branch, NCI","Yeonju Sarah Han-Oh



Frank S Harrington



Holly  Ning



John  Ondos



Hu-Chen  Xie



Jason Yulin Cheng; PhD



Show all 7","Wei  Chen
(University of Texas)




Alan  Huston
(Naval Research Laboratory)




Brian  Justus
(Optical Sciences Division, Naval Research Lab (NRL))




Maria  Plazas
(Departmento de Fiscia, Universidad Nacional de Colombia)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=62964
179,BC010518-08,"October 01, 2009 -  September 30, 2010",Role of BMP and FGF signaling during limb development,"Mark B Lewandoski



IRP Faculty Profile",NULL,"Genetics of Vertebrate Development Section, NCI","Maria  Kaltcheva



Cynthia M Elder



Ying  Zhang",NULL,NULL,"Yingzi  Yang; PhD (NHGRI) 



Heiner  Westphal; MD (NICHD)","Ordered by publication type and then author name.



1.
Tzchori I, Day TF, Carolan PJ, Zhao Y, Wassif CA, Li L, Lewandoski M, Gorivodsky M, Love PE, Porter FD, Westphal H, Yang Y (2009). LIM homeobox transcription factors integrate signaling events that control three-dimensional limb patterning and growth. Development  136, 1375-85.   https://doi.org/10.1242/dev.026476




PubMed



        
     
Free Article


 


PubMed ID 19304889
         Pubmed Central ID 2687467",https://intramural.nih.gov/search/searchview.taf?ipid=62970
180,BC010520-08,"October 01, 2009 -  September 30, 2010","Characterization of PBIP1, a novel polo-box-binding protein at the kinetochores","Kyung  Lee; PhD



IRP Faculty Profile",NULL,"Chemistry Section, NCI","Jung Eun  Park



Chi Hoon  Park",NULL,"Timothy D Veenstra (Office Of The Director)



Stuart H Yuspa; MD (Laboratory of Cancer Biology and Genetics)",NULL,"Ordered by publication type and then author name.



1.
Park JE, Li L, Park J, Knecht R, Strebhardt K, Yuspa SH, Lee KS (2009). Direct quantification of polo-like kinase 1 activity in cells and tissues using a highly sensitive and specific ELISA assay. Proc Natl Acad Sci U S A  106, 1725-30.   https://doi.org/10.1073/pnas.0812135106




PubMed



        
     
Free Article


 


PubMed ID 19181852
         Pubmed Central ID 2633213 


 



2.
Park JE, Soung NK, Johmura Y, Kang YH, Liao C, Lee KH, Park CH, Nicklaus MC, Lee KS (2010). Polo-box domain: a versatile mediator of polo-like kinase function. Cell Mol Life Sci  67, 1957-70.   https://doi.org/10.1007/s00018-010-0279-9




PubMed



        
     
Free Article


 


PubMed ID 20148280
         Pubmed Central ID 2877763",https://intramural.nih.gov/search/searchview.taf?ipid=62952
181,BC010523-08,"October 01, 2009 -  September 30, 2010",RNAi and Epigenetic Control of Higher-Order Chromatin Assembly,"Shivinder Singh Grewal



IRP Faculty Profile",NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI","Ozan  Aygun



Vanivilasini  Balachandran



Jothy  Dhakshnamoorthy



Natalia  Komissarova; PhD



Sameet Satish Mehta; PhD



Francisca Eugenia Reyes Turcu



Show all 8",NULL,Peter C Fitzgerald (Office of the Director),NULL,"Ordered by publication type and then author name.



1.
Cam HP, Chen ES, Grewal SI (2009). Transcriptional scaffolds for heterochromatin assembly. Cell  136, 610-4.   https://doi.org/10.1016/j.cell.2009.02.004




PubMed



        
     
Free Article


 


PubMed ID 19239883
         Pubmed Central ID 6309854 


 



2.
Fischer T, Cui B, Dhakshnamoorthy J, Zhou M, Rubin C, Zofall M, Veenstra TD, Grewal SI (2009). Diverse roles of HP1 proteins in heterochromatin assembly and functions in fission yeast. Proc Natl Acad Sci U S A  106, 8998-9003.   https://doi.org/10.1073/pnas.0813063106




PubMed



        
     
Free Article


 


PubMed ID 19443688
         Pubmed Central ID 2690032 


 



3.
Zofall M, Fischer T, Zhang K, Zhou M, Cui B, Veenstra TD, Grewal SI (2009). Histone H2A.Z cooperates with RNAi and heterochromatin factors to suppress antisense RNAs. Nature  461, 419-22.   https://doi.org/10.1038/nature08321




PubMed



        
     
Free Article


 


PubMed ID 19693008
         Pubmed Central ID 2746258",https://intramural.nih.gov/search/searchview.taf?ipid=62756
182,BC010524-08,"October 01, 2009 -  September 30, 2010",HIV Integrase Modeling and Computer-Aided Inhibitor Development,"Marc C Nicklaus



IRP Faculty Profile",NULL,"Chemical Biology Laboratory, NCI","Chenzhong  Liao



Terrence R Burke; PhD







Joel Patrick Schneider; PhD",NULL,"Stuart F J Le Grice; PhD (Retroviral Replication Laboratory)



Yves  Pommier; PhD (Developmental Therapeutics Branch)



Stephen H Hughes; PhD (HIV Drug Resistance Program)",NULL,"Ordered by publication type and then author name.



1.
Nicklaus M, Liao C (2010) Computer tools in the discovery of HIV-1 integrase inhibitors. Future Medicinal Chemistry 2:1123-1140.




 



2.
Nicklaus M, Marchand C, Burke T, Pommier Y, Nicklaus M (2010) Authentic HIV-1 integrase inhibitors. Future Medicinal Chemistry 2:1107-1122.",https://intramural.nih.gov/search/searchview.taf?ipid=62965
183,BC010525-08,"October 01, 2009 -  September 30, 2010",Immune Reconstitution,"Ronald E Gress; MD



IRP Faculty Profile",NULL,"Experimental Transplantation and Immunology Branch, NCI","Kevin  Chua



Francis  Flomerfelt; PhD



Diana Katherine Lee



Sarfraz A Memon



Reid Verne Wilkening",NULL,"Richard J Hodes; MD (Experimental Immunology Branch)



James Stephen Shaw; PhD (Experimental Immunology Branch)



Alfred  Singer; MD (Experimental Immunology Branch)",NULL,"Ordered by publication type and then author name.



1.
Gress RE, Deeks SG (2009). Reduced thymus activity and infection prematurely age the immune system. J Clin Invest  119, 2884-7.   https://doi.org/10.1172/JCI40855




PubMed



        
     
Free Article


 


PubMed ID 19770512
         Pubmed Central ID 2752092 


 



2.
Gress RE, Emerson SG, Drobyski WR (2010). Immune reconstitution: how it should work, what's broken, and why it matters. Biol Blood Marrow Transplant  16, S133-7.   https://doi.org/10.1016/j.bbmt.2009.10.003




PubMed



        
     
Free Article


 


PubMed ID 19819340
         Pubmed Central ID 2832716 


 



3.
Mackall C, Fry T, Gress R, Peggs K, Storek J, Toubert A, Center for International Blood and Marrow Transplant Research (CIBMTR), National Marrow Donor Program (NMDP), European Blood and Marrow Transplant Group (EBMT), American Society of Blood and Marrow Transplantation (ASBMT), Canadian Blood and Marrow Transplant Group (CBMTG), Infectious Disease Society of America (IDSA), Society for Healthcare Epidemiology of America (SHEA), Association of Medical Microbiology and Infectious Diseases Canada (AMMI), Centers for Disease Control and Prevention (CDC) (2009). Background to hematopoietic cell transplantation, including post transplant immune recovery. Bone Marrow Transplant  44, 457-62.   https://doi.org/10.1038/bmt.2009.255




PubMed


 


PubMed ID 19861978
    
     


 



4.
Sportès C, Gress RE, Mackall CL (2009). Perspective on potential clinical applications of recombinant human interleukin-7. Ann N Y Acad Sci  1182, 28-38.   https://doi.org/10.1111/j.1749-6632.2009.05075.x




PubMed



        
     
Free Article


 


PubMed ID 20074272
         Pubmed Central ID 6545488 


 



5.
Williams KM, Mella H, Lucas PJ, Williams JA, Telford W, Gress RE (2009). Single cell analysis of complex thymus stromal cell populations: rapid thymic epithelia preparation characterizes radiation injury. Clin Transl Sci  2, 279-85.   https://doi.org/10.1111/j.1752-8062.2009.00128.x




PubMed



        
     
Free Article


 


PubMed ID 19750208
         Pubmed Central ID 2741333",https://intramural.nih.gov/search/searchview.taf?ipid=62936
184,BC010530-08,"October 01, 2009 -  September 30, 2010",Molecular Therapeutics for HIVAIDS,"Dean H. Hamer; PhD



IRP Faculty Profile",NULL,"Vaccine Branch, NCI","Beda  Brichacek; PhD



Laurel  Lagenaur; PhD","Laurel  Lagenaur; PhD





Dominik  Wodarz
(U C Irvine)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=62937
185,BC010532-08,"October 01, 2009 -  September 30, 2010",Role of Connection and RNase H Domains of HIV-1 RT in Antiviral Drug Resistance,"Vinay K Pathak; PhD



IRP Faculty Profile",NULL,"Retroviral Replication Laboratory, NCI","Ryan C Burdick



John Miller Coffin; PhD



Krista A Delviks-Frankenberry



Wei-Shau  Hu; PhD



Narasimhan Jayanth  Venkatachari; PhD","Jean L Mbisa
(NCI)




Julie  Overbaugh
(Fred Hutchinson Cancer Research Center)




Marcelo  Soares; PhD
(Instituto Nacional de Cancer do Brasil)




Dalton  Wamalwa
(University of Nairobi)","Robert  Gorelick (Office Of The Director)



Jeffrey N Strathern (Office of the Director)



Frank  Maldarelli (Host Virus Interaction Branch)



Dwight V Nissley (Genome Recombination and Regulation Section)",NULL,"Ordered by publication type and then author name.



1.
Delviks-Frankenberry KA, Nikolenko GN, Pathak VK (2010). The ""Connection"" Between HIV Drug Resistance and RNase H. Viruses  2, 1476-1503.   https://doi.org/10.3390/v2071476




PubMed



        
     
Free Article


 


PubMed ID 21088701
         Pubmed Central ID 2982141 


 



2.
Nikolenko GN, Delviks-Frankenberry KA, Pathak VK (2010). A novel molecular mechanism of dual resistance to nucleoside and nonnucleoside reverse transcriptase inhibitors. J Virol  84, 5238-49.   https://doi.org/10.1128/JVI.01545-09




PubMed



        
     
Free Article


 


PubMed ID 20219933
         Pubmed Central ID 2863829 


 



3.
Pathak V, Nikolenko G, Pathak V (2010) The connection between HIV drug resistance and RNase H. Viruses, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=62968
186,BC010533-08,"October 01, 2009 -  September 30, 2010",Mechanisms of HIV-1 Reverse Transcription,"Vinay K Pathak; PhD



IRP Faculty Profile",NULL,"Retroviral Replication Laboratory, NCI","Krista A Delviks-Frankenberry



Wei-Shau  Hu; PhD



Yeshitila  Friew



Tobias  Paprotka



Ryan C Burdick",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Galli A, Kearney M, Nikolaitchik OA, Yu S, Chin MP, Maldarelli F, Coffin JM, Pathak VK, Hu WS (2010). Patterns of Human Immunodeficiency Virus type 1 recombination ex vivo provide evidence for coadaptation of distant sites, resulting in purifying selection for intersubtype recombinants during replication. J Virol  84, 7651-61.   https://doi.org/10.1128/JVI.00276-10




PubMed



        
     
Free Article


 


PubMed ID 20504919
         Pubmed Central ID 2897624",https://intramural.nih.gov/search/searchview.taf?ipid=62969
187,BC010538-08,"October 01, 2009 -  September 30, 2010",Molecular Analysis of Breast Cancer Metastasis to the Brain,"Patricia  Steeg; PhD



IRP Faculty Profile",NULL,"Developmental Therapeutics Branch, NCI","Lynda M Evans



Daniel  Fitzgerald



Natasha M Flores



Brunilde M Gril



Emily  Hua



Diane  Palmieri","Kenneth Dean Aldape; MD
(Laboratory Of Pathology)




Edi  Brogi
(Memorial Sloan Kettering Cancer Center)




Raffael  Kurek
(Department of Obstetrics and Gynecology, University of Tuebingen)




Paul  Lockman
(Texas Tech University)




Steven  Rubin
(Oncology, GlaxoSmithKline)




George  Sledge, Jr.
(Indiana University)


Show all 10","Giuseppe  Giaccone; MD (Medical Oncology Branch)



Kevin A Camphausen; MD (Radiation Oncology Branch)



Seth M Steinberg; PhD (Office of the Director)



Jo Anne N Zujewski (Clinical Investigations Branch)



Deedee Kay Smart (Radiation Oncology Branch)",NULL,"Ordered by publication type and then author name.



1.
Baschnagel A, Russo A, Burgan WE, Carter D, Beam K, Palmieri D, Steeg PS, Tofilon P, Camphausen K (2009). Vorinostat enhances the radiosensitivity of a breast cancer brain metastatic cell line grown in vitro and as intracranial xenografts. Mol Cancer Ther  8, 1589-95.   https://doi.org/10.1158/1535-7163.MCT-09-0038




PubMed



        
     
Free Article


 


PubMed ID 19509253
         Pubmed Central ID 3393105 


 



2.
Li SH, Hawthorne VS, Neal CL, Sanghera S, Xu J, Yang J, Guo H, Steeg PS, Yu D (2009). Upregulation of neutrophil gelatinase-associated lipocalin by ErbB2 through nuclear factor-kappaB activation. Cancer Res  69, 9163-8.   https://doi.org/10.1158/0008-5472.CAN-09-2483




PubMed



        
     
Free Article


 


PubMed ID 19951994
         Pubmed Central ID 2794902 


 



3.
Palmieri D, Fitzgerald D, Shreeve SM, Hua E, Bronder JL, Weil RJ, Davis S, Stark AM, Merino MJ, Kurek R, Mehdorn HM, Davis G, Steinberg SM, Meltzer PS, Aldape K, Steeg PS (2009). Analyses of resected human brain metastases of breast cancer reveal the association between up-regulation of hexokinase 2 and poor prognosis. Mol Cancer Res  7, 1438-45.   https://doi.org/10.1158/1541-7786.MCR-09-0234




PubMed



        
     
Free Article


 


PubMed ID 19723875
         Pubmed Central ID 2746883 


 



4.
Thomas FC, Taskar K, Rudraraju V, Goda S, Thorsheim HR, Gaasch JA, Mittapalli RK, Palmieri D, Steeg PS, Lockman PR, Smith QR (2009). Uptake of ANG1005, a novel paclitaxel derivative, through the blood-brain barrier into brain and experimental brain metastases of breast cancer. Pharm Res  26, 2486-94.   https://doi.org/10.1007/s11095-009-9964-5




PubMed



        
     
Free Article


 


PubMed ID 19774344
         Pubmed Central ID 2896053",https://intramural.nih.gov/search/searchview.taf?ipid=62962
188,BC010539-08,"October 01, 2009 -  September 30, 2010",Identification of Modifier Gene of Tumors Associated with NF1 and Astrocytoma,"Karlyne M Reilly; BS, PhD",NULL,"Mouse Cancer Genetics Program, NCI","Georgette Nicole Jones; PhD



Robert  Tuskan



Jessica Corinne Van Schaick



Jessica Catherine Walrath","Karl  Broman
(University of Michigan)




Mark  Ellisman
(UCSD)




Joel  Garbow
(Washington University)




David  Gutmann
(Washington University)




Norman  Lee
(Pharmacology & Physiology, George Washington Univ)




Joshua  Rubin
(Washington University)",Terry Anne Van Dyke (Office of the Director),"Douglas Russell Stewart; BA, MD (NHGRI)","Ordered by publication type and then author name.



1.
Reilly K (2009) The Nf1-+;Trp53-+cis mouse model of anaplastic astrocytoma and secondary glioblastoma: Dissecting genetic susceptibility to brain cancer, in CNS cancer, Models, Prognostic Factors and Targets. Humana Press (New York), pp. 93-118.




 



2.
Hawes JJ, Reilly KM (2010). Bioluminescent approaches for measuring tumor growth in a mouse model of neurofibromatosis. Toxicol Pathol  38, 123-30.   https://doi.org/10.1177/0192623309357075




PubMed



        
     
Free Article


 


PubMed ID 20176786
         Pubmed Central ID 6348901 


 



3.
Reilly KM (2009). Brain tumor susceptibility: the role of genetic factors and uses of mouse models to unravel risk. Brain Pathol  19, 121-31.   https://doi.org/10.1111/j.1750-3639.2008.00236.x




PubMed



        
     
Free Article


 


PubMed ID 19076777
         Pubmed Central ID 2761018 


 



4.
Walrath JC, Fox K, Truffer E, Gregory Alvord W, Quiñones OA, Reilly KM (2009). Chr 19(A/J) modifies tumor resistance in a sex- and parent-of-origin-specific manner. Mamm Genome  20, 214-23.   https://doi.org/10.1007/s00335-009-9179-4




PubMed



        
     
Free Article


 


PubMed ID 19347398
         Pubmed Central ID 2713021",https://intramural.nih.gov/search/searchview.taf?ipid=62955
189,BC010540-08,"October 01, 2009 -  September 30, 2010",Molecular Mechanisms of Proliferation and Infiltration of Astrocytoma,"Karlyne M Reilly; BS, PhD",NULL,"Mouse Cancer Genetics Program, NCI","Jessica J Hawes



Georgette Nicole Jones; PhD



Jessica Corinne Van Schaick



Jessica Catherine Walrath



Yvette Simone Connell-Albert



Robert  Tuskan","Ancha  Baranov
(Molecular and Microbiology, George Mason University)




David  Wiemer
(organic synthesis/molecular target identification, University of Iowa)","Terry Anne Van Dyke (Office of the Director)



John A Beutler (Molecular Targets Development Program)



James  McMahon; PhD (Molecular Targets Laboratory)



Thomas J Turbyville (Office Of The Director)



Stephen J Lockett; PhD (Office Of The Director)",NULL,"Ordered by publication type and then author name.



1.
Reilly KM (2009). Neurofibromatosis and lessons for the war on cancer. EMBO Mol Med  1, 198-200.   https://doi.org/10.1002/emmm.200900029




PubMed



        
     
Free Article


 


PubMed ID 20049721
         Pubmed Central ID 2804936",https://intramural.nih.gov/search/searchview.taf?ipid=62956
190,BC010541-08,"October 01, 2009 -  September 30, 2010",Development of Mouse Astrocytoma Model for Preclinical Testing,"Karlyne M Reilly; BS, PhD",NULL,"Mouse Cancer Genetics Program, NCI",Yvette Simone Connell-Albert,"Yetrib  Hathout





Roger  Packer
(CNMC)




Brian  Rood
(Pediatric Hematology-Oncology, Children's National Medical Center)




David  Wiemer
(organic synthesis/molecular target identification, University of Iowa)","Terry Anne Van Dyke (Office of the Director)



Curtis  Henrich (Molecular Targets Development Program)



Brigitte  Widemann; MD (Pediatric Oncology Branch)



John A Beutler (Molecular Targets Development Program)



James  McMahon; PhD (Molecular Targets Laboratory)



Serguei V Kozlov (Office of the Director)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=62954
191,BC010542-08,"October 01, 2009 -  September 30, 2010",Keratinocyte Stem Cells and Cancer Stem Cells in Non-Melanoma Skin Cancer,Jonathan  Vogel; MD,NULL,"Dermatology Branch, NCI","Xin Xin  Quan; PhD, MD



Atsushi  Terunuma



Mark  Udey; MD



Ying  Xiao



Carole L Yee",NULL,"Josip  Blonder (Office Of The Director)



Timothy D Veenstra (Office Of The Director)



Christoph  Rader; PhD (Experimental Transplantation and Immunology Branch)



William G Telford (Experimental Transplantation and Immunology Branch)



Stuart H Yuspa; MD (Laboratory of Cancer Biology and Genetics)",NULL,"Ordered by publication type and then author name.



1.
Terunuma A, Limgala RP, Park CJ, Choudhary I, Vogel JC (2010). Efficient procurement of epithelial stem cells from human tissue specimens using a Rho-associated protein kinase inhibitor Y-27632. Tissue Eng Part A  16, 1363-8.   https://doi.org/10.1089/ten.TEA.2009.0339




PubMed



        
     
Free Article


 


PubMed ID 19912046
         Pubmed Central ID 2862604",https://intramural.nih.gov/search/searchview.taf?ipid=62953
192,BC010544-08,"October 01, 2009 -  September 30, 2010",Epigenetic Regulation of Gene Expression and Resistance in Tumor Cells,"David R Gius; MD, PhD",NULL,"Radiation Oncology Branch, NCI",Alexandra  Lin,NULL,"Elise C Kohn; MD (Medical Oncology Branch)



Leonard  Neckers; PhD (Urologic Oncology Branch)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=62755
193,BC010547-08,"October 01, 2009 -  September 30, 2010",Development of Drugs That Target Prostate Cancer,"William D Figg; PharmD



IRP Faculty Profile",Giuseppe  Giaccone; MD,"Medical Oncology Branch, NCI","Cindy Huong-Bich Chau



Philip M Arlen; MD



Rui  Gao



Stephen T Pisle



Emily  Richardson



Sarah M Troutman",NULL,"Howard  Parnes (Prostate and Urologic Cancer Research Group)



John J Wright (Investigational Drug Branch)



Seth M Steinberg; PhD (Office of the Director)



William Laurence Dahut; MD (Office of the Director)



James L Gulley; MD, PhD (Laboratory of Tumor Immunology and Biology)","Clara Chi Chen; MD (CC) 



Elizabeth C Jones (CC)","Ordered by publication type and then author name.



1.
Figg W, Chau C, Gulley J, Dahut W, Figg W (2010) Immunomodulating Drugs (IMiDs) for the Treatment of Prostate Cancer, in Immunomodulating Drugs for the Treatment of Cancer. Lippincott Williams and Wilkins (Philadelphia), in press.




 



2.
Aragon-Ching JB, Jain L, Gulley JL, Arlen PM, Wright JJ, Steinberg SM, Draper D, Venitz J, Jones E, Chen CC, Figg WD, Dahut WL (2009). Final analysis of a phase II trial using sorafenib for metastatic castration-resistant prostate cancer. BJU Int  103, 1636-40.   https://doi.org/10.1111/j.1464-410X.2008.08327.x




PubMed



        
     
Free Article


 


PubMed ID 19154507
         Pubmed Central ID 2818665 


 



3.
Baum CE, Price DK, Figg WD (2010). Sarcosine as a potential prostate cancer biomarker and therapeutic target. Cancer Biol Ther  9, 341-2.   https://doi.org/10.4161/cbt.9.5.11310




PubMed



        
     
Free Article


 


PubMed ID 20150759
         Pubmed Central ID 2874119 


 



4.
Dahut WL, Aragon-Ching JB, Woo S, Tohnya TM, Gulley JL, Arlen PM, Wright JJ, Ventiz J, Figg WD (2009). Phase I study of oral lenalidomide in patients with refractory metastatic cancer. J Clin Pharmacol  49, 650-60.   https://doi.org/10.1177/0091270009335001




PubMed



        
     
Free Article


 


PubMed ID 19451403
         Pubmed Central ID 2808857 


 



5.
Figg WD, Hussain MH, Gulley JL, Arlen PM, Aragon-Ching JB, Petrylak DP, Higano CS, Steinberg SM, Chatta GS, Parnes H, Wright JJ, Sartor O, Dahut WL (2009). A double-blind randomized crossover study of oral thalidomide versus placebo for androgen dependent prostate cancer treated with intermittent androgen ablation. J Urol  181, 1104-13; discussion 1113.   https://doi.org/10.1016/j.juro.2008.11.026




PubMed



        
     
Free Article


 


PubMed ID 19167733
         Pubmed Central ID 2838198 


 



6.
Ning YM, Figg WD, Dahut WL (2009). Reversal of docetaxel resistance with bevacizumab and thalidomide. Clin Genitourin Cancer  7, E37-8.   https://doi.org/10.3816/CGC.2009.n.020




PubMed



        
     
Free Article


 


PubMed ID 19692321
         Pubmed Central ID 3438454 


 



7.
Sissung TM, Thordardottir S, Gardner ER, Figg WD (2009). Current status of thalidomide and CC-5013 in the treatment of metastatic prostate cancer. Anticancer Agents Med Chem  9, 1058-69.   https://doi.org/10.2174/187152009789735017




PubMed



        
     
Free Article


 


PubMed ID 19719457
         Pubmed Central ID 6415974 


 



8.
Zhu W, Zhu DS, Madan RA, Gulley JL, Figg WD, Dahut WL (2010). Treatment of castration-resistant prostate cancer: updates on therapeutics targeting the androgen receptor signaling pathway. Am J Ther  17, 176-81.   https://doi.org/10.1097/MJT.0b013e3181c6c0b2




PubMed



        
     
Free Article


 


PubMed ID 20019584
         Pubmed Central ID 6357221",https://intramural.nih.gov/search/searchview.taf?ipid=62935
194,BC010549-08,"October 01, 2009 -  September 30, 2010",Zebrafish Models of Cancer,"Dennis D Hickstein



IRP Faculty Profile",NULL,"Experimental Transplantation and Immunology Branch, NCI","Lisa J Embree



Gagandeep Kaur Raju



Heather R Shive



Robert R West",NULL,NULL,"Paul P. Liu; MD, PhD (NHGRI)","Ordered by publication type and then author name.



1.
Embree LJ, Azuma M, Hickstein DD (2009). Ewing sarcoma fusion protein EWSR1/FLI1 interacts with EWSR1 leading to mitotic defects in zebrafish embryos and human cell lines. Cancer Res  69, 4363-71.   https://doi.org/10.1158/0008-5472.CAN-08-3229




PubMed



        
     
Free Article


 


PubMed ID 19417137
         Pubmed Central ID 2766243",https://intramural.nih.gov/search/searchview.taf?ipid=62757
195,BC010558-08,"October 01, 2009 -  September 30, 2010",The Maintenance of Plasmids in Pathogenic Organisms,"Stuart J Austin



IRP Faculty Profile",NULL,"Cell Cycle Regulation Section, NCI","Sujatha B Gowda



Manjistha  Sengupta



Brenda L Youngren",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Dabrazhynetskaya A, Brendler T, Ji X, Austin S (2009). Switching protein-DNA recognition specificity by single-amino-acid substitutions in the P1 par family of plasmid partition elements. J Bacteriol  191, 1126-31.   https://doi.org/10.1128/JB.01358-08




PubMed



        
     
Free Article


 


PubMed ID 19028896
         Pubmed Central ID 2632008",https://intramural.nih.gov/search/searchview.taf?ipid=63039
196,BC010561-07,"October 01, 2009 -  September 30, 2010",Transcription factor mobility,James G McNally; PhD,Gordon Lee Hager; PhD,"Laboratory of Receptor Biology and Gene Expression, NCI","Alice Marya Abernathy



Tatiana  Karpova



Min Jeong Kim



Davide  Mazza



Florian  Mueller



Waltraud  Mueller



Show all 8",NULL,Charles  Vinson; PhD (Nucleic Acids Section),"Keiko  Ozato; PhD (NICHD) 



Jay Robert Knutson; PhD (NHLBI)","Ordered by publication type and then author name.



1.
Hager GL, McNally JG, Misteli T (2009). Transcription dynamics. Mol Cell  35, 741-53.   https://doi.org/10.1016/j.molcel.2009.09.005




PubMed



        
     
Free Article


 


PubMed ID 19782025
         Pubmed Central ID 6326382 


 



2.
Michelman-Ribeiro A, Mazza D, Rosales T, Stasevich TJ, Boukari H, Rishi V, Vinson C, Knutson JR, McNally JG (2009). Direct measurement of association and dissociation rates of DNA binding in live cells by fluorescence correlation spectroscopy. Biophys J  97, 337-46.   https://doi.org/10.1016/j.bpj.2009.04.027




PubMed



        
     
Free Article


 


PubMed ID 19580772
         Pubmed Central ID 2711375 


 



3.
Mueller F, Mazza D, Stasevich TJ, McNally JG (2010). FRAP and kinetic modeling in the analysis of nuclear protein dynamics: what do we really know? Curr Opin Cell Biol  22, 403-11.   https://doi.org/10.1016/j.ceb.2010.03.002




PubMed



        
     
Free Article


 


PubMed ID 20413286
         Pubmed Central ID 2916960 


 



4.
Rochman M, Postnikov Y, Correll S, Malicet C, Wincovitch S, Karpova TS, McNally JG, Wu X, Bubunenko NA, Grigoryev S, Bustin M (2009). The interaction of NSBP1/HMGN5 with nucleosomes in euchromatin counteracts linker histone-mediated chromatin compaction and modulates transcription. Mol Cell  35, 642-56.   https://doi.org/10.1016/j.molcel.2009.07.002




PubMed



        
     
Free Article


 


PubMed ID 19748358
         Pubmed Central ID 2757144 


 



5.
Stasevich TJ, Mueller F, Brown DT, McNally JG (2010). Dissecting the binding mechanism of the linker histone in live cells: an integrated FRAP analysis. EMBO J  29, 1225-34.   https://doi.org/10.1038/emboj.2010.24




PubMed



        
     
Free Article


 


PubMed ID 20224551
         Pubmed Central ID 2857466 


 



6.
Stocker G, Fischer M, Rieder D, Bindea G, Kainz S, Oberstolz M, McNally JG, Trajanoski Z (2009). iLAP: a workflow-driven software for experimental protocol development, data acquisition and analysis. BMC Bioinformatics  10, 390.   https://doi.org/10.1186/1471-2105-10-390




PubMed



        
     
Free Article


 


PubMed ID 19941647
         Pubmed Central ID 2789074",https://intramural.nih.gov/search/searchview.taf?ipid=62999
197,BC010562-07,"October 01, 2009 -  September 30, 2010",Molecular Interaction Maps and Analysis of Bioregulatory Networks,"Mirit I Aladjem; PhD



IRP Faculty Profile",NULL,"Developmental Therapeutics Branch, NCI","Yves  Pommier; PhD



Kurt  Kohn; PhD",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Kohn KW, Aladjem MI, Weinstein JN, Pommier Y (2009). Network architecture of signaling from uncoupled helicase-polymerase to cell cycle checkpoints and trans-lesion DNA synthesis. Cell Cycle  8, 2281-99.   https://doi.org/10.4161/cc.8.14.9102




PubMed



        
     
Free Article


 


PubMed ID 19556879
         Pubmed Central ID 4018747 


 



2.
Le Novère N, Hucka M, Mi H, Moodie S, Schreiber F, Sorokin A, Demir E, Wegner K, Aladjem MI, Wimalaratne SM, Bergman FT, Gauges R, Ghazal P, Kawaji H, Li L, Matsuoka Y, Villéger A, Boyd SE, Calzone L, Courtot M, Dogrusoz U, Freeman TC, Funahashi A, Ghosh S, Jouraku A, et al. [14 more authors] (2009). The Systems Biology Graphical Notation. Nat Biotechnol  27, 735-41.   https://doi.org/10.1038/nbt.1558




PubMed


 


PubMed ID 19668183",https://intramural.nih.gov/search/searchview.taf?ipid=62979
198,BC010564-07,"October 01, 2009 -  September 30, 2010",Large Scale Chromatin Structure,James G McNally; PhD,Gordon Lee Hager; PhD,"Laboratory of Receptor Biology and Gene Expression, NCI",Waltraud  Mueller,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
McNally JG (2009). Transcription, chromatin condensation, and gene migration. J Cell Biol  185, 7-9.   https://doi.org/10.1083/jcb.200903056




PubMed



        
     
Free Article


 


PubMed ID 19349577
         Pubmed Central ID 2700513 


 



2.
McNally JG, Mazza D (2010). Fractal geometry in the nucleus. EMBO J  29, 2-3.   https://doi.org/10.1038/emboj.2009.375




PubMed



        
     
Free Article


 


PubMed ID 20051993
         Pubmed Central ID 2808382",https://intramural.nih.gov/search/searchview.taf?ipid=63000
199,BC010565-07,"October 01, 2009 -  September 30, 2010",Determinants of Melanocyte Transformation and Melanoma Progression,Thomas J Hornyak,NULL,"Dermatology Branch, NCI","Tao  Fan



Jennifer Marian Huang



Shunlin  Jiang",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=62986
200,BC010566-07,"October 01, 2009 -  September 30, 2010",Tumor and Metastasis Biology,Chand  Khanna; MD,Crystal L. Mackall; MD,"Pediatric Oncology Branch, NCI","Martin  Mendoza; BS



Anita C Epps



Sung-Hyeok  Hong



Arnulfo G Mendoza



Ling  Ren



Lee Jay Helman; MD","Mark  Berryman
(Ohio University College of Osteopathic Medicine)




Matthew  Breen; PhD
(Veterinary Medicine, North Carolina State University)




Anthony  Bretscher
(Cell Biology, Cornell University)




Richard  Gorlick
(Laboratory of Cellular Carcinogenesis and Tumor Promotion, Albert Einstein College of Medicine)




Eugenie  Kleinerman
(Pediatric Oncology, MD Anderson Cancer Center)




Udo  Kontney
(ZKJ, Klinik IV, UNIVERSITAETSKLINIKUM FREIBURG)


Show all 10","Timothy D Veenstra (Office Of The Director)



Paul S Meltzer; MD, PhD (Cancer Genetics Branch)



Allan M Weissman; MD (Laboratory of Protein Dynamics and Signaling)



Kent W Hunter; PhD (Laboratory of Cancer Biology and Genetics)



Jeffrey E Green; MD (Laboratory of Cancer Biology and Genetics)



John A Beutler (Molecular Targets Development Program)",Rocky S Tuan; PhD (NIAMS),"Ordered by publication type and then author name.



1.
Hong SH, Briggs J, Newman R, Hoffman K, Mendoza A, LeRoith D, Helman L, Yakar S, Khanna C (2009). Murine osteosarcoma primary tumour growth and metastatic progression is maintained after marked suppression of serum insulin-like growth factor I. Int J Cancer  124, 2042-9.   https://doi.org/10.1002/ijc.24169




PubMed



        
     
Free Article


 


PubMed ID 19132750
         Pubmed Central ID 6948843 


 



2.
Leaner VD, Chick JF, Donninger H, Linniola I, Mendoza A, Khanna C, Birrer MJ (2009). Inhibition of AP-1 transcriptional activity blocks the migration, invasion, and experimental metastasis of murine osteosarcoma. Am J Pathol  174, 265-75.   https://doi.org/10.2353/ajpath.2009.071006




PubMed



        
     
Free Article


 


PubMed ID 19074613
         Pubmed Central ID 2631339 


 



3.
Mushinski JF, Nguyen P, Stevens LM, Khanna C, Lee S, Chung EJ, Lee MJ, Kim YS, Linehan WM, Horisberger MA, Trepel JB (2009). Inhibition of tumor cell motility by the interferon-inducible GTPase MxA. J Biol Chem  284, 15206-14.   https://doi.org/10.1074/jbc.M806324200




PubMed



        
     
Free Article


 


PubMed ID 19297326
         Pubmed Central ID 2685701 


 



4.
Taylor JG, Cheuk AT, Tsang PS, Chung JY, Song YK, Desai K, Yu Y, Chen QR, Shah K, Youngblood V, Fang J, Kim SY, Yeung C, Helman LJ, Mendoza A, Ngo V, Staudt LM, Wei JS, Khanna C, Catchpoole D, Qualman SJ, Hewitt SM, Merlino G, Chanock SJ, Khan J (2009). Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models. J Clin Invest  119, 3395-407.   https://doi.org/10.1172/JCI39703




PubMed



        
     
Free Article


 


PubMed ID 19809159
         Pubmed Central ID 2769177 


 



5.
Wan X, Kim SY, Guenther LM, Mendoza A, Briggs J, Yeung C, Currier D, Zhang H, Mackall C, Li WJ, Tuan RS, Deyrup AT, Khanna C, Helman L (2009). Beta4 integrin promotes osteosarcoma metastasis and interacts with ezrin. Oncogene  28, 3401-11.   https://doi.org/10.1038/onc.2009.206




PubMed



        
     
Free Article


 


PubMed ID 19597468
         Pubmed Central ID 2753583",https://intramural.nih.gov/search/searchview.taf?ipid=62995
201,BC010578-07,"October 01, 2009 -  September 30, 2010",Targeting TEMs in Preclinical Tumor Models,Bradley D St Croix,NULL,"Mouse Cancer Genetics Program, NCI","Amit Madhulal Chaudhary



Steven  Seaman",NULL,NULL,Stephen H Leppla; PhD (NIAID),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=62761
202,BC010579-07,"October 01, 2009 -  September 30, 2010",Papillomavirus Virion Proteins and Vaccines,"Douglas  Lowy; MD



IRP Faculty Profile",NULL,"Laboratory of Cellular Oncology, NCI","Christopher  Buck



Alexander G Papageorge



John  Schiller; PhD



William C Vass","Joel  Palefsky
(Department of Medicine, University of California at San Francisco)




Richard  Roden
(Johns Hopkins School of Medicine)","Peter L Choyke; MD (Molecular Imaging Program)



Lauren V Wood; MD (Vaccine Branch)



Ligia  Pinto (Infection & Immunoepidemiology Branch)



Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch)",NULL,"Ordered by publication type and then author name.



1.
Buck CB, Lowy DR (2009). Getting stronger: the relationship between a newly identified virus and Merkel cell carcinoma. J Invest Dermatol  129, 9-11.   https://doi.org/10.1038/jid.2008.302




PubMed



        
     
Free Article


 


PubMed ID 19078983
         Pubmed Central ID 3401601 


 



2.
García-Piñeres AJ, Hildesheim A, Dodd L, Kemp TJ, Yang J, Fullmer B, Harro C, Lowy DR, Lempicki RA, Pinto LA (2009). Gene expression patterns induced by HPV-16 L1 virus-like particles in leukocytes from vaccine recipients. J Immunol  182, 1706-29.   https://doi.org/10.4049/jimmunol.182.3.1706




PubMed



        
     
Free Article


 


PubMed ID 19155521
         Pubmed Central ID 2701477 


 



3.
Jagu S, Karanam B, Gambhira R, Chivukula SV, Chaganti RJ, Lowy DR, Schiller JT, Roden RB (2009). Concatenated multitype L2 fusion proteins as candidate prophylactic pan-human papillomavirus vaccines. J Natl Cancer Inst  101, 782-92.   https://doi.org/10.1093/jnci/djp106




PubMed



        
     
Free Article


 


PubMed ID 19470949
         Pubmed Central ID 2689872 


 



4.
Johnson KM, Kines RC, Roberts JN, Lowy DR, Schiller JT, Day PM (2009). Role of heparan sulfate in attachment to and infection of the murine female genital tract by human papillomavirus. J Virol  83, 2067-74.   https://doi.org/10.1128/JVI.02190-08




PubMed



        
     
Free Article


 


PubMed ID 19073722
         Pubmed Central ID 2643729 


 



5.
Kines RC, Thompson CD, Lowy DR, Schiller JT, Day PM (2009). The initial steps leading to papillomavirus infection occur on the basement membrane prior to cell surface binding. Proc Natl Acad Sci U S A  106, 20458-63.   https://doi.org/10.1073/pnas.0908502106




PubMed



        
     
Free Article


 


PubMed ID 19920181
         Pubmed Central ID 2787115 


 



6.
Schiller JT, Lowy DR (2009). Immunogenicity testing in human papillomavirus virus-like-particle vaccine trials. J Infect Dis  200, 166-71.   https://doi.org/10.1086/599988




PubMed



        
     
Free Article


 


PubMed ID 19519255
         Pubmed Central ID 3467007",https://intramural.nih.gov/search/searchview.taf?ipid=62997
203,BC010580-07,"October 01, 2009 -  September 30, 2010",Phase II Trial of PEG-Intron in Children with Diffuse Pontine Gliomas,"Katherine Elizabeth Warren; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI","Robyn S Bent



Pamela  Wolters



Laurie  Steffen",NULL,Kevin A Camphausen; MD (Radiation Oncology Branch),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=62976
204,BC010585-07,"October 01, 2009 -  September 30, 2010",A Phase I Trial of CC-5013 (lenalidomide) in Pediatric Patients with Recurrent o,"Katherine Elizabeth Warren; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI",Robyn S Bent,"Susan  Blaney
(Baylor University/TCCC)




Stewart  Goldman
(Pediatric Oncology, Children's Memorial Hospital)




Larry  Kun
(Radiation Oncology, St. Jude Children's Research Hospital)",NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=63040
205,BC010589-07,"October 01, 2009 -  September 30, 2010",Imaging as a Biomarker for Diffuse Intrinsic Brainstem Gliomas,"Katherine Elizabeth Warren; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI","Sean Joseph Hipp



Laurie  Steffen",NULL,NULL,"Joelle  Sarlls; PhD (NICHD) 



David M Thomasson; PhD (CC) 



Johan W Van Der Veen; PhD (NIMH) 



Alan Seth Barnett; PhD (NIMH) 



Eva Halle Baker; MD, PhD (CC) 



Nicholas  Patronas; MD (CC)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=62974
206,BC010590-07,"October 01, 2009 -  September 30, 2010",Phase II Trial of O6-Benzylguanine and Temozolomide in Pediatric Patients with H,"Katherine Elizabeth Warren; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI",Robyn S Bent,"Susan  Blaney
(Baylor University/TCCC)




Stewart  Goldman
(Pediatric Oncology, Children's Memorial Hospital)




Larry  Kun
(Radiation Oncology, St. Jude Children's Research Hospital)




Roger  Packer
(CNMC)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=62975
207,BC010591-07,"October 01, 2009 -  September 30, 2010",Characterization of Xenograft Models of Childhood Cancers,"Javed  Khan; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI","Qingrong  Chen



Carol J Thiele



Jun S Wei



Chand  Khanna; MD



Xinyu  Wen",NULL,Malcolm A Smith (Clinical Investigations Branch),NULL,"Ordered by publication type and then author name.



1.
Nishijo K, Chen QR, Zhang L, McCleish AT, Rodriguez A, Cho MJ, Prajapati SI, Gelfond JA, Chisholm GB, Michalek JE, Aronow BJ, Barr FG, Randall RL, Ladanyi M, Qualman SJ, Rubin BP, LeGallo RD, Wang C, Khan J, Keller C (2009). Credentialing a preclinical mouse model of alveolar rhabdomyosarcoma. Cancer Res  69, 2902-11.   https://doi.org/10.1158/0008-5472.CAN-08-3723




PubMed



        
     
Free Article


 


PubMed ID 19339268
         Pubmed Central ID 2789740 


 



2.
Wei JS, Johansson P, Chen QR, Song YK, Durinck S, Wen X, Cheuk AT, Smith MA, Houghton P, Morton C, Khan J (2009). microRNA profiling identifies cancer-specific and prognostic signatures in pediatric malignancies. Clin Cancer Res  15, 5560-8.   https://doi.org/10.1158/1078-0432.CCR-08-3287




PubMed



        
     
Free Article


 


PubMed ID 19706822
         Pubmed Central ID 2737097",https://intramural.nih.gov/search/searchview.taf?ipid=62993
208,BC010592-07,"October 01, 2009 -  September 30, 2010",Comparative Genomic Hybridization of Neuroblastoma,"Javed  Khan; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI","James  Badgett



Qingrong  Chen



Jianbin Na He



Peter  Johansson



Young K Song



Jun S Wei



Show all 7","Daniel  Catchpoole,
(The Children's Hospital at Westmead)




John  Maris
(Pharmacology, Children's Hospital of Philadelphia)




Andrew  Pearson
(Paediatric Section, Institute of Cancer Research)




Manfred  Schwab
(German Cancer Research Center)




Robert  Seeger
(Division of Pediatric Hematology-Oncology, Children's Hospital of Los Angeles)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=62994
209,BC010595-07,"October 01, 2009 -  September 30, 2010",Structure and Function of APOBEC Proteins,"Vinay K Pathak; PhD



IRP Faculty Profile",NULL,"Retroviral Replication Laboratory, NCI","Wei  Bu



Yeshitila  Friew



Salim  Manoharadas



Jessica  Smith



Krista A Delviks-Frankenberry



Ryan C Burdick



Show all 11","Reuben  Harris
(Biochemistry, University of Minnesota)




Jean L Mbisa
(NCI)




Carsten  Munk
(Paul-Ehrlich-Institut)","Ralph F Hopkins (Office Of The Director)



Dominic  Esposito; PhD (Office Of The Director)



William  Gillette (Office Of The Director)



Robert  Gorelick (Office Of The Director)



Andrew G Stephen (Office Of The Director)



Robert J Fisher (Office Of The Director)","James  Inglese (NHGRI) 



Douglas S Auld (NHGRI)","Ordered by publication type and then author name.



1.
Mbisa JL, Bu W, Pathak VK (2010). APOBEC3F and APOBEC3G inhibit HIV-1 DNA integration by different mechanisms. J Virol  84, 5250-9.   https://doi.org/10.1128/JVI.02358-09




PubMed



        
     
Free Article


 


PubMed ID 20219927
         Pubmed Central ID 2863843 


 



2.
Paprotka T, Venkatachari NJ, Chaipan C, Burdick R, Delviks-Frankenberry KA, Hu WS, Pathak VK (2010). Inhibition of xenotropic murine leukemia virus-related virus by APOBEC3 proteins and antiviral drugs. J Virol  84, 5719-29.   https://doi.org/10.1128/JVI.00134-10




PubMed



        
     
Free Article


 


PubMed ID 20335265
         Pubmed Central ID 2876585 


 



3.
Smith JL, Bu W, Burdick RC, Pathak VK (2009). Multiple ways of targeting APOBEC3-virion infectivity factor interactions for anti-HIV-1 drug development. Trends Pharmacol Sci  30, 638-46.   https://doi.org/10.1016/j.tips.2009.09.006




PubMed



        
     
Free Article


 


PubMed ID 19837465
         Pubmed Central ID 2787722",https://intramural.nih.gov/search/searchview.taf?ipid=63002
210,BC010598-07,"October 01, 2009 -  September 30, 2010",Human T Cell Responses to Tumor Antigens for Cancer Vaccine Development,"Jeffrey  Schlom; PhD



IRP Faculty Profile",NULL,"Laboratory of Tumor Immunology and Biology, NCI","Diana G Chambers



James W Hodge; PhD



Jianping  Huang



Claudia Mercedes Palena



Robin E Riley



Kwong Yok Tsang



Show all 7",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Litzinger MT, Foon KA, Sabzevari H, Tsang KY, Schlom J, Palena C (2009). Chronic lymphocytic leukemia (CLL) cells genetically modified to express B7-1, ICAM-1, and LFA-3 confer APC capacity to T cells from CLL patients. Cancer Immunol Immunother  58, 955-65.   https://doi.org/10.1007/s00262-008-0611-5




PubMed



        
     
Free Article


 


PubMed ID 19009294
         Pubmed Central ID 2664396",https://intramural.nih.gov/search/searchview.taf?ipid=62758
211,BC010600-07,"October 01, 2009 -  September 30, 2010",Study of AAA proteins by X-ray protein crystallography,"Di S Xia; PhD, MS, BS



IRP Faculty Profile",NULL,"Crystallography Section, NCI",Wai-Kwan  Tang,NULL,Michael  Maurizi; PhD (Biochemistry of Proteins Section),NULL,"Ordered by publication type and then author name.



1.
Tang WK, Li D, Esser L, Xia D (2009). Purification, crystallization and preliminary X-ray diffraction analysis of disease-related mutants of p97. Acta Crystallogr Sect F Struct Biol Cryst Commun  65, 1166-70.   https://doi.org/10.1107/S174430910904055X




PubMed



        
     
Free Article


 


PubMed ID 19923742
         Pubmed Central ID 2777050",https://intramural.nih.gov/search/searchview.taf?ipid=62978
212,BC010603-07,"October 01, 2009 -  September 30, 2010",Receptor-directed Therapy,John  Janik; MD,"Thomas Alexander Waldmann; MD, PhD","Lymphoid Malignancies Branch, NCI","Arlethia J Spencer



Louis  Staudt; MD",NULL,"Kathryn  Jones; PhD (Laboratory of Experimental Immunology)



Francis W Ruscetti; PhD (Laboratory of Experimental Immunology)



Jane Beth Trepel (Medical Oncology Branch)",Warren J Leonard; MD (NHLBI),"Ordered by publication type and then author name.



1.
Arun I, Wulu JA, Janik JE, Jasper GA, Yuan CM, Venzon D, Stetler-Stevenson M (2010). Visual inspection versus quantitative flow cytometry to detect aberrant CD2 expression in malignant T cells. Cytometry B Clin Cytom  78, 169-75.   https://doi.org/10.1002/cyto.b.20507




PubMed



        
     
Free Article


 


PubMed ID 20020522
         Pubmed Central ID 2916169 


 



2.
Janik J, O'Mahony D, Waldmann T, Morris J (2009) Monoclonal antibody therapy of T cell lymphoma: single agent trials of anti-CD2 (Siplizumab) and anti-CD4 (HuMax-CD4). Hematology Meeting Reports 3:61-68.




 



3.
Jiang L, Yuan CM, Hubacheck J, Janik JE, Wilson W, Morris JC, Jasper GA, Stetler-Stevenson M (2009). Variable CD52 expression in mature T cell and NK cell malignancies: implications for alemtuzumab therapy. Br J Haematol  145, 173-9.   https://doi.org/10.1111/j.1365-2141.2009.07606.x




PubMed



        
     
Free Article


 


PubMed ID 19236377
         Pubmed Central ID 3487105 


 



4.
Pise-Masison CA, Radonovich M, Dohoney K, Morris JC, O'Mahony D, Lee MJ, Trepel J, Waldmann TA, Janik JE, Brady JN (2009). Gene expression profiling of ATL patients: compilation of disease-related genes and evidence for TCF4 involvement in BIRC5 gene expression and cell viability. Blood  113, 4016-26.   https://doi.org/10.1182/blood-2008-08-175901




PubMed



        
     
Free Article


 


PubMed ID 19131553
         Pubmed Central ID 2673128 


 



5.
Tsukasaki K, Hermine O, Bazarbachi A, Ratner L, Ramos JC, Harrington W, O'Mahony D, Janik JE, Bittencourt AL, Taylor GP, Yamaguchi K, Utsunomiya A, Tobinai K, Watanabe T (2009). Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting. J Clin Oncol  27, 453-9.   https://doi.org/10.1200/JCO.2008.18.2428




PubMed



        
     
Free Article


 


PubMed ID 19064971
         Pubmed Central ID 2737379",https://intramural.nih.gov/search/searchview.taf?ipid=62987
213,BC010607-07,"October 01, 2009 -  September 30, 2010",Ras-mediated signals in human epithelial cell transformation and metastasis,"Kathleen  Kelly; PhD



IRP Faculty Profile",NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI","William Bradley O'Dell



Victoria  Seng



Juanjuan  Yin",NULL,Glenn  Merlino; PhD (Laboratory of Cancer Biology and Genetics),Alan Paul Koretsky; PhD (NINDS),"Ordered by publication type and then author name.



1.
JuanYin J, Tracy K, Zhang L, Munasinghe J, Shapiro E, Koretsky A, Kelly K (2009). Noninvasive imaging of the functional effects of anti-VEGF therapy on tumor cell extravasation and regional blood volume in an experimental brain metastasis model. Clin Exp Metastasis  26, 403-14.   https://doi.org/10.1007/s10585-009-9238-y




PubMed



               Available in future as a Free Article 


 


PubMed ID 19277878
         Pubmed Central ID 3200557",https://intramural.nih.gov/search/searchview.taf?ipid=62990
214,BC010612-07,"October 01, 2009 -  September 30, 2010",The Role of miRNA-mediated RNAI in the Biology of Cancer,"Natasha  Caplen



IRP Faculty Profile","Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI","Konrad  Huppi; MD, PhD



Mark  Mackiewicz



Jason James Pitt","Eric A Collisson





Siegfried  Janz
(University of Iowa)




Catherine  Park
(UCSF)




Carol L Prives





Matthias  Wabl
(Dept Microbiology and Immunology, UCSF)","Robert  Stephens (Office Of The Director)



Michael R Emmert-Buck; MD, PhD (Laboratory of Pathology)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63012
215,BC010613-07,"October 01, 2009 -  September 30, 2010",The Induction of Gene-specific RNAi Against Cancer-associated Genes,"Natasha  Caplen



IRP Faculty Profile","Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI","Kristen G Stover



Sapna  Gopalasubramanian



Konrad  Huppi; MD, PhD



Tamara L Jones



Karl Thomas Ried; MD



Jason James Pitt","Amanda  Hummon





Eric  Lader
(Gene Silencing, Qiagen Inc.)




John  Weinstein
(MD Anderson)","Paul  Goldsmith; PhD (Basic Research Laboratory)



Yves  Pommier; PhD (Developmental Therapeutics Branch)



Lee Jay Helman; MD (Pediatric Oncology Branch)



Stanley  Lipkowitz; MD, PhD (Laboratory of Cellular and Molecular Biology)



Beverly  Mock; PhD (Laboratory of Cancer Biology and Genetics)



Liudmila  Prokunina-Olsson; PhD (Laboratory Translational Genomics)",Scott E Martin (NHGRI),"Ordered by publication type and then author name.



1.
Zhang YW, Jones TL, Martin SE, Caplen NJ, Pommier Y (2009). Implication of checkpoint kinase-dependent up-regulation of ribonucleotide reductase R2 in DNA damage response. J Biol Chem  284, 18085-95.   https://doi.org/10.1074/jbc.M109.003020




PubMed



        
     
Free Article


 


PubMed ID 19416980
         Pubmed Central ID 2709352",https://intramural.nih.gov/search/searchview.taf?ipid=63013
216,BC010615-07,"October 01, 2009 -  September 30, 2010",RNAi Screening for the Systematic Discovery of Cancer Gene Function,"Natasha  Caplen



IRP Faculty Profile","Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI","Kristen G Stover



Tamara L Jones



Karl Thomas Ried; MD



Lihui  Ou; PhD



Jason James Pitt","Eric  Lader
(Gene Silencing, Qiagen Inc.)




John  Weinstein
(MD Anderson)","Yves  Pommier; PhD (Developmental Therapeutics Branch)



Lee Jay Helman; MD (Pediatric Oncology Branch)



Stanley  Lipkowitz; MD, PhD (Laboratory of Cellular and Molecular Biology)



Beverly  Mock; PhD (Laboratory of Cancer Biology and Genetics)","Scott E Martin (NHGRI) 



Christopher P Austin; AB, MD (NHGRI)","Ordered by publication type and then author name.



1.
Zhang YW, Jones TL, Martin SE, Caplen NJ, Pommier Y (2009). Implication of checkpoint kinase-dependent up-regulation of ribonucleotide reductase R2 in DNA damage response. J Biol Chem  284, 18085-95.   https://doi.org/10.1074/jbc.M109.003020




PubMed



        
     
Free Article


 


PubMed ID 19416980
         Pubmed Central ID 2709352",https://intramural.nih.gov/search/searchview.taf?ipid=63014
217,BC010620-07,"October 01, 2009 -  September 30, 2010",Clinical Studies to Circumvent Drug Resistance,Susan  Bates; MD,NULL,"Medical Oncology Branch, NCI","Robert W Robey



Zhirong  Zhan



Wilfred D Stein



William D Figg; PharmD



Antonio  Fojo; MD, PhD","John F Deeken





Merrill  Egorin
(University of Pittsburgh)




Thomas  Litman
(University of Copenhagen)




Wilfred  Stein
(Hebrew University, Jerusalem)","Peter L Choyke; MD (Molecular Imaging Program)



Yves  Pommier; PhD (Developmental Therapeutics Branch)



Seth M Steinberg; PhD (Office of the Director)



James Halpern Doroshow (Developmental Therapeutics Branch)



Jo Anne N Zujewski (Clinical Investigations Branch)



Patricia  Steeg; PhD (Developmental Therapeutics Branch)","Robert  Innis; MD (NIMH) 



Clara Chi Chen; MD (CC)","Ordered by publication type and then author name.



1.
Stein WD, Huang H, Menefee M, Edgerly M, Kotz H, Dwyer A, Yang J, Bates SE (2009). Other paradigms: growth rate constants and tumor burden determined using computed tomography data correlate strongly with the overall survival of patients with renal cell carcinoma. Cancer J  15, 441-7.   https://doi.org/10.1097/PPO.0b013e3181be1b90




PubMed



        
     
Free Article


 


PubMed ID 19826366
         Pubmed Central ID 3667552",https://intramural.nih.gov/search/searchview.taf?ipid=62982
218,BC010621-07,"October 01, 2009 -  September 30, 2010",Translational Studies of the Histone Deacetylase Inhibitor Romidepsin,Susan  Bates; MD,NULL,"Medical Oncology Branch, NCI","Julian  Bahr



Arup Ratan Chakraborty



Victoria  Luchenko



Fahd  Rahman; MD



Robert W Robey



William D Figg; PharmD



Show all 9",NULL,"Maria L Turner; MD (Dermatology Branch)



Seth M Steinberg; PhD (Office of the Director)



Elaine S Jaffe; MD (Laboratory of Pathology)



Patricia A Fetsch (Laboratory of Pathology)



Maryalice  Stetler-Stevenson; MD, PhD (Laboratory of Pathology)","Danny L Sackett; PhD (NICHD) 



Douglas R Rosing; MD (NHLBI) 



Alexander  Ling (CC) 



April R Robbins; PhD (NIDDK)","Ordered by publication type and then author name.



1.
Bates SE (2009). Epigenetic therapies reach main street. Clin Cancer Res  15, 3917.   https://doi.org/10.1158/1078-0432.CCR-15-12-INT




PubMed


 


PubMed ID 19528089
    
     


 



2.
Piekarz RL, Bates SE (2009). Epigenetic modifiers: basic understanding and clinical development. Clin Cancer Res  15, 3918-26.   https://doi.org/10.1158/1078-0432.CCR-08-2788




PubMed



        
     
Free Article


 


PubMed ID 19509169
         Pubmed Central ID 6946182 


 



3.
Piekarz RL, Frye R, Turner M, Wright JJ, Allen SL, Kirschbaum MH, Zain J, Prince HM, Leonard JP, Geskin LJ, Reeder C, Joske D, Figg WD, Gardner ER, Steinberg SM, Jaffe ES, Stetler-Stevenson M, Lade S, Fojo AT, Bates SE (2009). Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma. J Clin Oncol  27, 5410-7.   https://doi.org/10.1200/JCO.2008.21.6150




PubMed



        
     
Free Article


 


PubMed ID 19826128
         Pubmed Central ID 2773225 


 



4.
Ritchie D, Piekarz RL, Blombery P, Karai LJ, Pittaluga S, Jaffe ES, Raffeld M, Janik JE, Prince HM, Bates SE (2009). Reactivation of DNA viruses in association with histone deacetylase inhibitor therapy: a case series report. Haematologica  94, 1618-22.   https://doi.org/10.3324/haematol.2009.008607




PubMed



        
     
Free Article


 


PubMed ID 19608677
         Pubmed Central ID 2770976 


 



5.
Woo S, Gardner ER, Chen X, Ockers SB, Baum CE, Sissung TM, Price DK, Frye R, Piekarz RL, Bates SE, Figg WD (2009). Population pharmacokinetics of romidepsin in patients with cutaneous T-cell lymphoma and relapsed peripheral T-cell lymphoma. Clin Cancer Res  15, 1496-503.   https://doi.org/10.1158/1078-0432.CCR-08-1215




PubMed



        
     
Free Article


 


PubMed ID 19228751
         Pubmed Central ID 2707030",https://intramural.nih.gov/search/searchview.taf?ipid=62980
219,BC010622-07,"October 01, 2009 -  September 30, 2010",Investigation of the ABC Half-Transporter ABCG2,Susan  Bates; MD,NULL,"Medical Oncology Branch, NCI","Agnes Marie Therese Basseville



Robert W Robey



Akina  Tamaki



William D Figg; PharmD



Zhirong  Zhan","John F Deeken





Thomas  Litman
(University of Copenhagen)




Balazs  Sarkadi
(Dept Cell Metabolism, National Insitute of Hematology and Immunology)




Alex  Sparreboom





Hendrik  van Veen
(Department of Pharmacology, University of Cambridge)","Curtis  Henrich (Molecular Targets Development Program)



Yves  Pommier; PhD (Developmental Therapeutics Branch)



Suresh V Ambudkar; PhD (Transport Biochemistry Section)



Di S Xia; PhD, MS, BS (Crystallography Section)



Michael  Dean; PhD (Laboratory of Experimental Immunology)



Patricia A Fetsch (Laboratory of Pathology)",NULL,"Ordered by publication type and then author name.



1.
Henrich CJ, Robey RW, Takada K, Bokesch HR, Bates SE, Shukla S, Ambudkar SV, McMahon JB, Gustafson KR (2009). Botryllamides: natural product inhibitors of ABCG2. ACS Chem Biol  4, 637-47.   https://doi.org/10.1021/cb900134c




PubMed



        
     
Free Article


 


PubMed ID 19555120
         Pubmed Central ID 2853803 


 



2.
Polgar O, Deeken JF, Ediriwickrema LS, Tamaki A, Steinberg SM, Robey RW, Bates SE (2009). The 315-316 deletion determines the BXP-21 antibody epitope but has no effect on the function of wild type ABCG2 or the Q141K variant. Mol Cell Biochem  322, 63-71.   https://doi.org/10.1007/s11010-008-9940-0




PubMed



        
     
Free Article


 


PubMed ID 19002564
         Pubmed Central ID 2631614 


 



3.
Polgar O, Ediriwickrema LS, Robey RW, Sharma A, Hegde RS, Li Y, Xia D, Ward Y, Dean M, Ozvegy-Laczka C, Sarkadi B, Bates SE (2009). Arginine 383 is a crucial residue in ABCG2 biogenesis. Biochim Biophys Acta  1788, 1434-43.   https://doi.org/10.1016/j.bbamem.2009.04.016




PubMed



        
     
Free Article


 


PubMed ID 19406100
         Pubmed Central ID 4163909 


 



4.
Robey RW, Obrzut T, Shukla S, Polgar O, Macalou S, Bahr JC, Di Pietro A, Ambudkar SV, Bates SE (2009). Becatecarin (rebeccamycin analog, NSC 655649) is a transport substrate and induces expression of the ATP-binding cassette transporter, ABCG2, in lung carcinoma cells. Cancer Chemother Pharmacol  64, 575-83.   https://doi.org/10.1007/s00280-008-0908-2




PubMed



        
     
Free Article


 


PubMed ID 19132374
         Pubmed Central ID 2693460 


 



5.
Robey RW, To KK, Polgar O, Dohse M, Fetsch P, Dean M, Bates SE (2009). ABCG2: a perspective. Adv Drug Deliv Rev  61, 3-13.   https://doi.org/10.1016/j.addr.2008.11.003




PubMed



        
     
Free Article


 


PubMed ID 19135109
         Pubmed Central ID 3105088 


 



6.
Shi Z, Parmar S, Peng XX, Shen T, Robey RW, Bates SE, Fu LW, Shao Y, Chen YM, Zang F, Chen ZS (2009). The epidermal growth factor tyrosine kinase inhibitor AG1478 and erlotinib reverse ABCG2-mediated drug resistance. Oncol Rep  21, 483-9.




PubMed



        
     
Free Article


 


PubMed ID 19148526
         Pubmed Central ID 2845641 


 



7.
Shi Z, Tiwari AK, Shukla S, Robey RW, Kim IW, Parmar S, Bates SE, Si QS, Goldblatt CS, Abraham I, Fu LW, Ambudkar SV, Chen ZS (2009). Inhibiting the function of ABCB1 and ABCG2 by the EGFR tyrosine kinase inhibitor AG1478. Biochem Pharmacol  77, 781-93.   https://doi.org/10.1016/j.bcp.2008.11.007




PubMed



        
     
Free Article


 


PubMed ID 19059384
         Pubmed Central ID 2843910 


 



8.
Shukla S, Robey RW, Bates SE, Ambudkar SV (2009). Sunitinib (Sutent, SU11248), a small-molecule receptor tyrosine kinase inhibitor, blocks function of the ATP-binding cassette (ABC) transporters P-glycoprotein (ABCB1) and ABCG2. Drug Metab Dispos  37, 359-65.   https://doi.org/10.1124/dmd.108.024612




PubMed



               Available in future as a Free Article 


 


PubMed ID 18971320
         Pubmed Central ID 2680522 


 



9.
To KK, Robey RW, Knutsen T, Zhan Z, Ried T, Bates SE (2009). Escape from hsa-miR-519c enables drug-resistant cells to maintain high expression of ABCG2. Mol Cancer Ther  8, 2959-68.   https://doi.org/10.1158/1535-7163.MCT-09-0292




PubMed



        
     
Free Article


 


PubMed ID 19825807
         Pubmed Central ID 3680354",https://intramural.nih.gov/search/searchview.taf?ipid=62981
220,BC010624-07,"October 01, 2009 -  September 30, 2010",The Molecular Profile of Prostate Tumors in African-American Men,"Stefan  Ambs



IRP Faculty Profile",NULL,"Molecular Genetics and Carcinogenesis Section, NCI","Tiffany Marie Howe



Robert Scott Hudson



Steves  Tietcheu



Tiffany A Wallace","William  Isaacs; PhD
(Department of Urology, Johns Hopkins School of Medicine)




Chris  Loffredo
(Cancer Genetics and Epidemiology Program, Georgetown University)




Jun  Luo
(Johns Hopkins University)




Feng  Wang-Johanning
(University of Texas MD Anderson Cancer Center)","Arthur A Hurwitz (Laboratory of Molecular Immunoregulation)



William Marston Linehan; MD (Urologic Oncology Branch)



Francis W Ruscetti; PhD (Laboratory of Experimental Immunology)



Robert H Stephens (Business Operations Branch)",NULL,"Ordered by publication type and then author name.



1.
Tahara H, Sato M, Thurin M, Wang E, Butterfield LH, Disis ML, Fox BA, Lee PP, Khleif SN, Wigginton JM, Ambs S, Akutsu Y, Chaussabel D, Doki Y, Eremin O, Fridman WH, Hirohashi Y, Imai K, Jacobson J, Jinushi M, Kanamoto A, Kashani-Sabet M, Kato K, Kawakami Y, Kirkwood JM, et al. [31 more authors] (2009). Emerging concepts in biomarker discovery; the US-Japan Workshop on Immunological Molecular Markers in Oncology. J Transl Med  7, 45.   https://doi.org/10.1186/1479-5876-7-45




PubMed



        
     
Free Article


 


PubMed ID 19534815
         Pubmed Central ID 2724494",https://intramural.nih.gov/search/searchview.taf?ipid=63006
221,BC010625-07,"October 01, 2009 -  September 30, 2010",Microtubule (MT) Interfering Agents (MTAs): Mechanisms of Action and Resistance,"Antonio  Fojo; MD, PhD",NULL,"Medical Oncology Branch, NCI","Edina M Komlodi-pasztor



Marianne  Poruchynsky



Susan  Bates; MD



Shana Y Trostel



William D Figg; PharmD



Julia  Wilkerson",NULL,Yvona  Ward; PhD (Laboratory Of Genitourinary Cancer Pathogenesis),Danny L Sackett; PhD (NICHD),"Ordered by publication type and then author name.



1.
Huff LM, Sackett DL, Poruchynsky MS, Fojo T (2010). Microtubule-disrupting chemotherapeutics result in enhanced proteasome-mediated degradation and disappearance of tubulin in neural cells. Cancer Res  70, 5870-9.   https://doi.org/10.1158/0008-5472.CAN-09-4281




PubMed



        
     
Free Article


 


PubMed ID 20587529
         Pubmed Central ID 2908375 


 



2.
Widemann BC, Goodspeed W, Goodwin A, Fojo T, Balis FM, Fox E (2009). Phase I trial and pharmacokinetic study of ixabepilone administered daily for 5 days in children and adolescents with refractory solid tumors. J Clin Oncol  27, 550-6.   https://doi.org/10.1200/JCO.2008.17.6644




PubMed



        
     
Free Article


 


PubMed ID 19075272
         Pubmed Central ID 2645861",https://intramural.nih.gov/search/searchview.taf?ipid=62984
222,BC010626-07,"October 01, 2009 -  September 30, 2010",Adrenocortical Cancer and Thyroid Carcinomas: Models with Unique Properties,"Antonio  Fojo; MD, PhD",NULL,"Medical Oncology Branch, NCI","Marianne  Poruchynsky



Samuel A Wells



Shana Y Trostel



Susan  Bates; MD



Julia  Wilkerson",NULL,"Bradford J Wood; MD (Office of the Director)



Richard Lawrence Piekarz (Investigational Drug Branch)","Aradhana M Venkatesan (CC) 



Karel  Pacak; MD, PhD (NICHD)","Ordered by publication type and then author name.



1.
Ghayee HK, Havekes B, Corssmit EP, Eisenhofer G, Hammes SR, Ahmad Z, Tessnow A, Lazúrová I, Adams KT, Fojo AT, Pacak K, Auchus RJ (2009). Mediastinal paragangliomas: association with mutations in the succinate dehydrogenase genes and aggressive behavior. Endocr Relat Cancer  16, 291-9.   https://doi.org/10.1677/ERC-08-0214




PubMed



        
     
Free Article


 


PubMed ID 19075037
         Pubmed Central ID 4718401 


 



2.
He J, Makey D, Fojo T, Adams KT, Havekes B, Eisenhofer G, Sullivan P, Lai EW, Pacak K (2009). Successful chemotherapy of hepatic metastases in a case of succinate dehydrogenase subunit B-related paraganglioma. Endocrine  36, 189-93.   https://doi.org/10.1007/s12020-009-9219-6




PubMed



        
     
Free Article


 


PubMed ID 19618298
         Pubmed Central ID 4713025 


 



3.
Venkatesan AM, Locklin J, Lai EW, Adams KT, Fojo AT, Pacak K, Wood BJ (2009). Radiofrequency ablation of metastatic pheochromocytoma. J Vasc Interv Radiol  20, 1483-90.   https://doi.org/10.1016/j.jvir.2009.07.031




PubMed



        
     
Free Article


 


PubMed ID 19875067
         Pubmed Central ID 3608423 


 



4.
Veytsman I, Nieman L, Fojo T (2009). Management of endocrine manifestations and the use of mitotane as a chemotherapeutic agent for adrenocortical carcinoma. J Clin Oncol  27, 4619-29.   https://doi.org/10.1200/JCO.2008.17.2775




PubMed



        
     
Free Article


 


PubMed ID 19667279
         Pubmed Central ID 2754909",https://intramural.nih.gov/search/searchview.taf?ipid=63144
223,BC010627-07,"October 01, 2009 -  September 30, 2010",Clinical Pharmacogenetics,"William D Figg; PharmD



IRP Faculty Profile",Giuseppe  Giaccone; MD,"Medical Oncology Branch, NCI","Erin  Lepper



Christian Tyler Kirkland



Susan  Bates; MD



Douglas K Price



Tristan  Sissung



Emily  Richardson



Show all 7","Anthony  D'Amico
(Radiation Oncology, Harvard Medical School)




Romano  Danesi





John F Deeken





Alex  Sparreboom","Heidi H Kong (Dermatology Branch)



Seth M Steinberg; PhD (Office of the Director)



William Laurence Dahut; MD (Office of the Director)



Frank Jess Gonzalez; PhD (Laboratory of Metabolism)",NULL,"Ordered by publication type and then author name.



1.
Figg W, Figg W (2010) UGT1A1 Polymorphisms and Mutation in Irinotecan-Induced Toxicity, in Handbook of Therapeutic Biomarkers in Cancer, in press.




 



2.
Clump DA, Yu JJ, Cho Y, Gao R, Jett J, Zot H, Cunnick JM, Snyder B, Clump AC, Dodrill M, Gannett P, Coad JE, Shurina R, Figg WD, Reed E, Flynn DC (2010). A Polymorphic Variant of AFAP-110 Enhances cSrc Activity. Transl Oncol  3, 276-85.   https://doi.org/10.1593/tlo.10106




PubMed



        
     
Free Article


 


PubMed ID 20689769
         Pubmed Central ID 2915419 


 



3.
Deeken JF, Cormier T, Price DK, Sissung TM, Steinberg SM, Tran K, Liewehr DJ, Dahut WL, Miao X, Figg WD (2010). A pharmacogenetic study of docetaxel and thalidomide in patients with castration-resistant prostate cancer using the DMET genotyping platform. Pharmacogenomics J  10, 191-9.   https://doi.org/10.1038/tpj.2009.57




PubMed



        
     
Free Article


 


PubMed ID 20038957
         Pubmed Central ID 6631360 


 



4.
Jain L, Gardner ER, Figg WD, Chernick MS, Kong HH (2010). Lack of association between excretion of sorafenib in sweat and hand-foot skin reaction. Pharmacotherapy  30, 52-6.   https://doi.org/10.1592/phco.30.1.52




PubMed



        
     
Free Article


 


PubMed ID 20030473
         Pubmed Central ID 3542635 


 



5.
Jain L, Vargo CA, Danesi R, Sissung TM, Price DK, Venzon D, Venitz J, Figg WD (2009). The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors. Mol Cancer Ther  8, 2496-508.   https://doi.org/10.1158/1535-7163.MCT-09-0302




PubMed



        
     
Free Article


 


PubMed ID 19755511
         Pubmed Central ID 2751847",https://intramural.nih.gov/search/searchview.taf?ipid=62983
224,BC010629-07,"October 01, 2009 -  September 30, 2010",Characterization of Signaling Pathways involved in Cell Death and Survival,Srinivasa M Srinivasula,NULL,"Laboratory of Immune Cell Biology, NCI","Ken-Ichi  Fujita



Akiko  Kimura; MD, PhD



Kenji  Maeda



Qi  Xiao","Alison  O'Brien
(USUHS)




Stefan  Schütze
(Universitatsklinikum Schleswig Holstein, Institut für Immunologie)","Timothy D Veenstra (Office Of The Director)



Susan H Garfield (Laboratory of Experimental Carcinogenesis)",Alan  Sher; PhD (NIAID),"Ordered by publication type and then author name.



1.
Fujita K, Srinivasula SM (2009). Ubiquitination and TNFR1 signaling. Results Probl Cell Differ  49, 87-114.   https://doi.org/10.1007/400_2009_18




PubMed


 


PubMed ID 19582409",https://intramural.nih.gov/search/searchview.taf?ipid=62760
225,BC010632-07,"October 01, 2009 -  September 30, 2010",Transcription Regulation in E. coli and H. pylori,Ding Jun Jin,NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI","Cedric Nicolas Lionel Cagliero



Carolyn B McGill



Madushini  Dharmasena



Shanshan  Qin; PhD



Bo  Xiao; BS",NULL,"Jeffrey N Strathern (Office of the Director)



Mikhail V Kashlev (Molecular Mechanisms of Transcription Section)



Donald L Court; PhD (Molecular Control and Genetics Section)



Xinhua  Ji; PhD (Biomolecular Structure Section)",NULL,"Ordered by publication type and then author name.



1.
Cabrera JE, Cagliero C, Quan S, Squires CL, Jin DJ (2009). Active transcription of rRNA operons condenses the nucleoid in Escherichia coli: examining the effect of transcription on nucleoid structure in the absence of transertion. J Bacteriol  191, 4180-5.   https://doi.org/10.1128/JB.01707-08




PubMed



        
     
Free Article


 


PubMed ID 19395497
         Pubmed Central ID 2698504",https://intramural.nih.gov/search/searchview.taf?ipid=62989
226,BC010638-07,"October 01, 2009 -  September 30, 2010",The role of c-met in liver biology,"Snorri S. Thorgeirsson; MD, PhD",NULL,"Laboratory of Experimental Carcinogenesis, NCI","Mitsuteru  Kitade



Daekwan  Seo; PhD, MS, BA",NULL,"Glenn  Merlino; PhD (Laboratory of Cancer Biology and Genetics)



Robert  Wiltrout; PhD (Laboratory of Experimental Immunology)",NULL,"Ordered by publication type and then author name.



1.
Ishibe S, Karihaloo A, Ma H, Zhang J, Marlier A, Mitobe M, Togawa A, Schmitt R, Czyczk J, Kashgarian M, Geller DS, Thorgeirsson SS, Cantley LG (2009). Met and the epidermal growth factor receptor act cooperatively to regulate final nephron number and maintain collecting duct morphology. Development  136, 337-45.   https://doi.org/10.1242/dev.024463




PubMed



        
     
Free Article


 


PubMed ID 19103805
         Pubmed Central ID 2862758",https://intramural.nih.gov/search/searchview.taf?ipid=62973
227,BC010646-07,"October 01, 2009 -  September 30, 2010",Chromatin Remodeling Proteins,"Gordon Lee Hager; PhD



IRP Faculty Profile",NULL,"Laboratory of Receptor Biology and Gene Expression, NCI","Songjoon  Baek



Sam  John



Stephanie  Morris



Rodney Louis Schiltz; PhD",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=62985
228,BC010647-06,"October 01, 2009 -  September 30, 2010",Antibody Engineering for Therapy and Diagnosis of Hematologic Malignancies,Christoph  Rader; PhD,Ronald E Gress; MD,"Experimental Transplantation and Immunology Branch, NCI","Sivasubramanian  Baskar



Huiting  Cui



Hema  Dave



Patrick  North



Jiahui  Yang","Roman  Giger
(CENTER FOR AGING AND DEVELOPMENTAL BIOLOGY, University of Rochester School of Medicine and Dentistry)




GERALD  QUINNAN, JR.
(Preventive Medicine, Uniformed Services University of the Health Sciences)




LOUIS  WEINER
(Lombardi Comprehensive Cancer Center, Georgetown University Medical Center)","Dimiter Stanchev Dimitrov; PhD (Membrane Structure and Function Section)



Crystal L. Mackall; MD (Pediatric Oncology Branch)



Terrence R Burke; PhD (Chemical Biology Laboratory)","Paul T Wingfield; PhD (NIAMS) 



Rose G Mage; PhD (NIAID)","Ordered by publication type and then author name.



1.
Hofer T, Skeffington LR, Chapman CM, Rader C (2009). Molecularly defined antibody conjugation through a selenocysteine interface. Biochemistry  48, 12047-57.   https://doi.org/10.1021/bi901744t




PubMed



        
     
Free Article


 


PubMed ID 19894757
         Pubmed Central ID 2825887 


 



2.
Kwong KY, Rader C (2009). E. coli expression and purification of Fab antibody fragments. Curr Protoc Protein Sci  Chapter 6, Unit 6.10.   https://doi.org/10.1002/0471140864.ps0610s55




PubMed


 


PubMed ID 19235139
    
     


 



3.
Rader C (2009). Generation and selection of rabbit antibody libraries by phage display. Methods Mol Biol  525, 101-28, xiv.   https://doi.org/10.1007/978-1-59745-554-1_5




PubMed


 


PubMed ID 19252834
    
     


 



4.
Rader C (2009). Overview on concepts and applications of Fab antibody fragments. Curr Protoc Protein Sci  Chapter 6, Unit 6.9.   https://doi.org/10.1002/0471140864.ps0609s55




PubMed


 


PubMed ID 19235140
    
     


 



5.
Robak LA, Venkatesh K, Lee H, Raiker SJ, Duan Y, Lee-Osbourne J, Hofer T, Mage RG, Rader C, Giger RJ (2009). Molecular basis of the interactions of the Nogo-66 receptor and its homolog NgR2 with myelin-associated glycoprotein: development of NgROMNI-Fc, a novel antagonist of CNS myelin inhibition. J Neurosci  29, 5768-83.   https://doi.org/10.1523/JNEUROSCI.4935-08.2009




PubMed



        
     
Free Article


 


PubMed ID 19420245
         Pubmed Central ID 2779053",https://intramural.nih.gov/search/searchview.taf?ipid=63033
229,BC010648-06,"October 01, 2009 -  September 30, 2010","Discovery of Drugs, Targets, and Target Strategies for Immunotherapy of CLL",Christoph  Rader; PhD,Ronald E Gress; MD,"Experimental Transplantation and Immunology Branch, NCI","Sivasubramanian  Baskar



Hema  Dave



Steven  Pavletic; MD, MS



Brian Carl Shaffer; MD



Jiahui  Yang



Michael R Bishop; MD","JOHN  BYRD
(The Ohio State University)




NICHOLAS  CHIORAZZI
(The Feinstein Institute for Medical Research)




DANIEL  LEAHY
(Department of Biophysics and Biophysical Chemistry, Johns Hopkins University School of Medicine)




Jeffrey A. Medin; PhD
(University of Toronto)




ELIZABETH  RAVECHE
(New Jersey Medical School)




Stanley R Riddell
(Fred Hutchinson Cancer Research Center)","Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)



Alan S Wayne; MD (Pediatric Oncology Branch)



Ira H Pastan; MD (Molecular Biology Section)","Adrian U Wiestner; MD, PhD (NHLBI) 



Gerald Ernest Marti (OD)","Ordered by publication type and then author name.



1.
Baskar S, Suschak JM, Samija I, Srinivasan R, Childs RW, Pavletic SZ, Bishop MR, Rader C (2009). A human monoclonal antibody drug and target discovery platform for B-cell chronic lymphocytic leukemia based on allogeneic hematopoietic stem cell transplantation and phage display. Blood  114, 4494-502.   https://doi.org/10.1182/blood-2009-05-222786




PubMed



        
     
Free Article


 


PubMed ID 19667400
         Pubmed Central ID 2777128",https://intramural.nih.gov/search/searchview.taf?ipid=63034
230,BC010649-06,"October 01, 2009 -  September 30, 2010",Immunotherapy Strategies for Gastrointestinal and Hepatocellular Cancer,Udai S Kammula,NULL,"Surgery Branch, NCI","Tamara A Aghamolla



Melissa Marie Alvarez Downing; MD



Yu Matthew Chiu



Tejaswi Venkata Mudigonda



Anran  Wang",NULL,"Xin Wei Wang; PhD (Laboratory of Human Carcinogenesis)



Snorri S. Thorgeirsson; MD, PhD (Laboratory of Experimental Carcinogenesis)",Francesco M. Marincola; MD (CC),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63025
231,BC010652-06,"October 01, 2009 -  September 30, 2010",Lipid-based Nanocapsules and Triggered Chemotherapy,"Robert  Blumenthal; PhD



IRP Faculty Profile",NULL,"Center for Cancer Research Nanobiology Program, NCI","Julie M Belanger



Christopher J Conner



Kshitij  Gupta



Alex Owen Haber



Eliahu  Heldman



Jae Ho  Lee



Show all 13","Sara  Grinberg
(Ben Gurion University)




Angela  Hight Walker





Jeeseong  Hwang
(NIST)




Radha  Maheshwari
(Dept of Pathology, Uniformed Services University of the Health Sciences)




Michael  Nantz
(University of Louisville)




Paul  Wang","Jacek  Capala; PhD (Radiation Oncology Branch)



Timothy D Veenstra (Office Of The Director)



Dimiter Stanchev Dimitrov; PhD (Membrane Structure and Function Section)



Giorgio  Trinchieri (Cancer Inflammation Program)



Pradman  Qasba; PhD (Structural Glycobiology Section)



Terrence R Burke; PhD (Chemical Biology Laboratory)","Xiaoyuan  Chen; PhD (NIBIB) 



Gary Leonard Griffiths; BSc, PhD (NHLBI) 



Victor  Frenkel (CC) 



Rachel R Caspi; PhD (NEI)","Ordered by publication type and then author name.



1.
Blumenthal R, Blumenthal R (2009) Understanding the Design Principles of Living Systems at the Nanoscale. Curr Nanosci 5:45-50.




 



2.
Kang JH, Garg H, Sigano DM, Francella N, Blumenthal R, Marquez VE (2009). Ceramides: branched alkyl chains in the sphingolipid siblings of diacylglycerol improve biological potency. Bioorg Med Chem  17, 1498-505.   https://doi.org/10.1016/j.bmc.2009.01.005




PubMed



        
     
Free Article


 


PubMed ID 19171486
         Pubmed Central ID 6980351 


 



3.
Puri A, Loomis K, Smith B, Lee JH, Yavlovich A, Heldman E, Blumenthal R (2009). Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic. Crit Rev Ther Drug Carrier Syst  26, 523-80.   https://doi.org/10.1615/critrevtherdrugcarriersyst.v26.i6.10




PubMed



        
     
Free Article


 


PubMed ID 20402623
         Pubmed Central ID 2885142 


 



4.
Wang PC, Blumenthal RP, Zhao Y, Schneider JA, Miller N, Grodzinski P, Gottesman MM, Tinkle S, Wang K, Wang C, Liang XJ (2009). Building scientific progress without borders: nanobiology and nanomedicine in China and the U.S. Cancer Res  69, 5294-5.   https://doi.org/10.1158/0008-5472.CAN-09-0563




PubMed



        
     
Free Article


 


PubMed ID 19549890
         Pubmed Central ID 2756036 


 



5.
Yavlovich A, Singh A, Tarasov S, Capala J, Blumenthal R, Puri A (2009). DESIGN OF LIPOSOMES CONTAINING PHOTOPOLYMERIZABLE PHOSPHOLIPIDS FOR TRIGGERED RELEASE OF CONTENTS. J Therm Anal Calorim  98, 97-104.   https://doi.org/10.1007/s10973-009-0228-8




PubMed



        
     
Free Article


 


PubMed ID 20160877
         Pubmed Central ID 2772073 


 



6.
Zielinski R, Lyakhov I, Jacobs A, Chertov O, Kramer-Marek G, Francella N, Stephen A, Fisher R, Blumenthal R, Capala J (2009). Affitoxin--a novel recombinant, HER2-specific, anticancer agent for targeted therapy of HER2-positive tumors. J Immunother  32, 817-25.   https://doi.org/10.1097/CJI.0b013e3181ad4d5d




PubMed



        
     
Free Article


 


PubMed ID 19752752
         Pubmed Central ID 3402039",https://intramural.nih.gov/search/searchview.taf?ipid=63011
232,BC010654-06,"October 01, 2009 -  September 30, 2010",Lymphatic Imaging,"Peter L Choyke; MD



IRP Faculty Profile",NULL,"Molecular Imaging Program, NCI","Marcelino  Bernardo



Dagane  Daar



Ismail Baris Turkbey



Mark  Williams



Karen J Wong","Donald  McDonald
(Pathology, UCSF)




Laureen  Sena
(Dept of Radiology, Boston Childrens Hospital)",Martin W Brechbiel; PhD (Radiation Oncology Branch),David M Thomasson; PhD (CC),"Ordered by publication type and then author name.



1.
Barrett T, Ravizzini G, Choyke PL, Kobayashi H (2009). Dendrimers in medical nanotechnology. IEEE Eng Med Biol Mag  28, 12-22.   https://doi.org/10.1109/MEMB.2008.931012




PubMed



        
     
Free Article


 


PubMed ID 19150767
         Pubmed Central ID 2995329 


 



2.
Kosaka N, Ogawa M, Sato N, Choyke PL, Kobayashi H (2009). In vivo real-time, multicolor, quantum dot lymphatic imaging. J Invest Dermatol  129, 2818-22.   https://doi.org/10.1038/jid.2009.161




PubMed



        
     
Free Article


 


PubMed ID 19536144
         Pubmed Central ID 3417231 


 



3.
Lucarelli RT, Ogawa M, Kosaka N, Turkbey B, Kobayashi H, Choyke PL (2009). New approaches to lymphatic imaging. Lymphat Res Biol  7, 205-14.   https://doi.org/10.1089/lrb.2009.0021




PubMed



        
     
Free Article


 


PubMed ID 20143919
         Pubmed Central ID 2883526 


 



4.
Ravizzini G, Turkbey B, Barrett T, Kobayashi H, Choyke PL (2009). Nanoparticles in sentinel lymph node mapping. Wiley Interdiscip Rev Nanomed Nanobiotechnol  1, 610-23.   https://doi.org/10.1002/wnan.48




PubMed



        
     
Free Article


 


PubMed ID 20049820
         Pubmed Central ID 6309687",https://intramural.nih.gov/search/searchview.taf?ipid=63018
233,BC010655-06,"October 01, 2009 -  September 30, 2010",Prostate Cancer Imaging,"Peter L Choyke; MD



IRP Faculty Profile",NULL,"Molecular Imaging Program, NCI","Stephen Scott Adler



Marcelino  Bernardo



Veerendra  Bhadrasetty



Dagane  Daar



Philip Charles Eclarinal



Karen A Kurdziel; MD



Show all 13",NULL,"Gennady  Bratslavsky (Urologic Oncology Branch)



Peter A Pinto; MD (Urologic Oncology Branch)



Kevin A Camphausen; MD (Radiation Oncology Branch)



Bradford J Wood; MD (Office of the Director)



William Laurence Dahut; MD (Office of the Director)



William Marston Linehan; MD (Urologic Oncology Branch)","David M Thomasson; PhD (CC) 



Thomas J Pohida; MS (CIT)","Ordered by publication type and then author name.



1.
Mukherjee S, Richardson AM, Rodriguez-Canales J, Ylaya K, Erickson HS, Player A, Kawasaki ES, Pinto PA, Choyke PL, Merino MJ, Albert PS, Chuaqui RF, Emmert-Buck MR (2009). Identification of EpCAM as a molecular target of prostate cancer stroma. Am J Pathol  175, 2277-87.   https://doi.org/10.2353/ajpath.2009.090013




PubMed



        
     
Free Article


 


PubMed ID 19850885
         Pubmed Central ID 2789605 


 



2.
Ravizzini G, Turkbey B, Kurdziel K, Choyke PL (2009). New horizons in prostate cancer imaging. Eur J Radiol  70, 212-26.   https://doi.org/10.1016/j.ejrad.2008.09.019




PubMed



        
     
Free Article


 


PubMed ID 18993004
         Pubmed Central ID 2702141 


 



3.
Türkbey B, Thomasson D, Pang Y, Bernardo M, Choyke PL (2010). The role of dynamic contrast-enhanced MRI in cancer diagnosis and treatment. Diagn Interv Radiol  16, 186-92.   https://doi.org/10.4261/1305-3825.DIR.2537-08.1




PubMed



        
     
Free Article


 


PubMed ID 19885783
         Pubmed Central ID 3518910 


 



4.
Turkbey B, Albert PS, Kurdziel K, Choyke PL (2009). Imaging localized prostate cancer: current approaches and new developments. AJR Am J Roentgenol  192, 1471-80.   https://doi.org/10.2214/AJR.09.2527




PubMed



        
     
Free Article


 


PubMed ID 19457807
         Pubmed Central ID 3523175 


 



5.
Turkbey B, Kobayashi H, Ogawa M, Bernardo M, Choyke PL (2009). Imaging of tumor angiogenesis: functional or targeted? AJR Am J Roentgenol  193, 304-13.   https://doi.org/10.2214/AJR.09.2869




PubMed



        
     
Free Article


 


PubMed ID 19620425
         Pubmed Central ID 3523171 


 



6.
Turkbey B, Pinto PA, Choyke PL (2009). Imaging techniques for prostate cancer: implications for focal therapy. Nat Rev Urol  6, 191-203.   https://doi.org/10.1038/nrurol.2009.27




PubMed



        
     
Free Article


 


PubMed ID 19352394
         Pubmed Central ID 3520096",https://intramural.nih.gov/search/searchview.taf?ipid=63019
234,BC010656-06,"October 01, 2009 -  September 30, 2010",Growth Factor Imaging,"Peter L Choyke; MD



IRP Faculty Profile",NULL,"Molecular Imaging Program, NCI","Stephen Scott Adler



Veerendra  Bhadrasetty



Philip Charles Eclarinal



Elaine Marie Jagoda; MS



Karen A Kurdziel; MD



Gideon K Kwarteng



Show all 12",NULL,"Giuseppe  Giaccone; MD (Medical Oncology Branch)



Ola Anders Landgren (Medical Oncology Branch)



Gennady  Bratslavsky (Urologic Oncology Branch)



Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)



Peter A Pinto; MD (Urologic Oncology Branch)



Kevin A Camphausen; MD (Radiation Oncology Branch)",NULL,"Ordered by publication type and then author name.



1.
Bumb A, Regino CA, Perkins MR, Bernardo M, Ogawa M, Fugger L, Choyke PL, Dobson PJ, Brechbiel MW (2010). Preparation and characterization of a magnetic and optical dual-modality molecular probe. Nanotechnology  21, 175704.   https://doi.org/10.1088/0957-4484/21/17/175704




PubMed



        
     
Free Article


 


PubMed ID 20368682
         Pubmed Central ID 2859998 


 



2.
Kobayashi H, Ogawa M, Alford R, Choyke PL, Urano Y (2010). New strategies for fluorescent probe design in medical diagnostic imaging. Chem Rev  110, 2620-40.   https://doi.org/10.1021/cr900263j




PubMed



        
     
Free Article


 


PubMed ID 20000749
         Pubmed Central ID 3241938 


 



3.
Kosaka N, Ogawa M, Choyke PL, Karassina N, Corona C, McDougall M, Lynch DT, Hoyt CC, Levenson RM, Los GV, Kobayashi H (2009). In vivo stable tumor-specific painting in various colors using dehalogenase-based protein-tag fluorescent ligands. Bioconjug Chem  20, 1367-74.   https://doi.org/10.1021/bc9001344




PubMed



        
     
Free Article


 


PubMed ID 19514716
         Pubmed Central ID 2841743 


 



4.
Ogawa M, Kosaka N, Choyke PL, Kobayashi H (2009). Tumor-specific detection of an optically targeted antibody combined with a quencher-conjugated neutravidin ""quencher-chaser"": a dual ""quench and chase"" strategy to improve target to nontarget ratios for molecular imaging of cancer. Bioconjug Chem  20, 147-54.   https://doi.org/10.1021/bc8003765




PubMed



        
     
Free Article


 


PubMed ID 19072537
         Pubmed Central ID 2789002 


 



5.
Regino CA, Ogawa M, Alford R, Wong KJ, Kosaka N, Williams M, Feild BJ, Takahashi M, Choyke PL, Kobayashi H (2010). Two-step synthesis of galactosylated human serum albumin as a targeted optical imaging agent for peritoneal carcinomatosis. J Med Chem  53, 1579-86.   https://doi.org/10.1021/jm901228u




PubMed



        
     
Free Article


 


PubMed ID 20102220
         Pubmed Central ID 3230036 


 



6.
Regino CA, Wong KJ, Milenic DE, Holmes EH, Garmestani K, Choyke PL, Brechbiel MW (2009). Preclinical evaluation of a monoclonal antibody (3C6) specific for prostate-specific membrane antigen. Curr Radiopharm  2, 9-17.   https://doi.org/10.2174/1874471010902010009




PubMed



        
     
Free Article


 


PubMed ID 20047017
         Pubmed Central ID 2678849",https://intramural.nih.gov/search/searchview.taf?ipid=63020
235,BC010657-06,"October 01, 2009 -  September 30, 2010",Intracellular In vivo Imaging,"Peter L Choyke; MD



IRP Faculty Profile",NULL,"Molecular Imaging Program, NCI","Marcelino  Bernardo



Hisataka  Kobayashi



Makoto  Mitsunaga",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Alford R, Ogawa M, Choyke PL, Kobayashi H (2009). Molecular probes for the in vivo imaging of cancer. Mol Biosyst  5, 1279-91.   https://doi.org/10.1039/b911307j




PubMed



        
     
Free Article


 


PubMed ID 19823742
         Pubmed Central ID 3407672 


 



2.
Alford R, Ogawa M, Hassan M, Gandjbakhche AH, Choyke PL, Kobayashi H (2010). Fluorescence lifetime imaging of activatable target specific molecular probes. Contrast Media Mol Imaging  5, 1-8.   https://doi.org/10.1002/cmmi.360




PubMed



        
     
Free Article


 


PubMed ID 20101762
         Pubmed Central ID 3404610 


 



3.
Barrett T, Ravizzini G, Choyke PL, Kobayashi H (2009). Dendrimers in medical nanotechnology. IEEE Eng Med Biol Mag  28, 12-22.   https://doi.org/10.1109/MEMB.2008.931012




PubMed



        
     
Free Article


 


PubMed ID 19150767
         Pubmed Central ID 2995329 


 



4.
Kobayashi H, Longmire MR, Ogawa M, Choyke PL, Kawamoto S (2010). Multiplexed imaging in cancer diagnosis: applications and future advances. Lancet Oncol  11, 589-95.   https://doi.org/10.1016/S1470-2045(10)70009-7




PubMed



        
     
Free Article


 


PubMed ID 20338808
         Pubmed Central ID 3412687 


 



5.
Kobayashi H, Ogawa M, Alford R, Choyke PL, Urano Y (2010). New strategies for fluorescent probe design in medical diagnostic imaging. Chem Rev  110, 2620-40.   https://doi.org/10.1021/cr900263j




PubMed



        
     
Free Article


 


PubMed ID 20000749
         Pubmed Central ID 3241938 


 



6.
Kobayashi H, Ogawa M, Kosaka N, Choyke PL, Urano Y (2009). Multicolor imaging of lymphatic function with two nanomaterials: quantum dot-labeled cancer cells and dendrimer-based optical agents. Nanomedicine (Lond)  4, 411-9.   https://doi.org/10.2217/nnm.09.15




PubMed



        
     
Free Article


 


PubMed ID 19505244
         Pubmed Central ID 2714945 


 



7.
Kosaka N, McCann TE, Mitsunaga M, Choyke PL, Kobayashi H (2010). Real-time optical imaging using quantum dot and related nanocrystals. Nanomedicine (Lond)  5, 765-76.   https://doi.org/10.2217/nnm.10.49




PubMed



        
     
Free Article


 


PubMed ID 20662647
         Pubmed Central ID 3420008 


 



8.
Kosaka N, Ogawa M, Choyke PL, Karassina N, Corona C, McDougall M, Lynch DT, Hoyt CC, Levenson RM, Los GV, Kobayashi H (2009). In vivo stable tumor-specific painting in various colors using dehalogenase-based protein-tag fluorescent ligands. Bioconjug Chem  20, 1367-74.   https://doi.org/10.1021/bc9001344




PubMed



        
     
Free Article


 


PubMed ID 19514716
         Pubmed Central ID 2841743 


 



9.
Kosaka N, Ogawa M, Choyke PL, Kobayashi H (2009). Clinical implications of near-infrared fluorescence imaging in cancer. Future Oncol  5, 1501-11.   https://doi.org/10.2217/fon.09.109




PubMed



        
     
Free Article


 


PubMed ID 19903075
         Pubmed Central ID 3413951 


 



10.
Kosaka N, Ogawa M, Longmire MR, Choyke PL, Kobayashi H (2009). Multi-targeted multi-color in vivo optical imaging in a model of disseminated peritoneal ovarian cancer. J Biomed Opt  14, 014023.   https://doi.org/10.1117/1.3083449




PubMed



        
     
Free Article


 


PubMed ID 19256711
         Pubmed Central ID 2788995 


 



11.
Kosaka N, Ogawa M, Paik DS, Paik CH, Choyke PL, Kobayashi H (2010). Semiquantitative assessment of the microdistribution of fluorescence-labeled monoclonal antibody in small peritoneal disseminations of ovarian cancer. Cancer Sci  101, 820-5.   https://doi.org/10.1111/j.1349-7006.2009.01423.x




PubMed



        
     
Free Article


 


PubMed ID 19961490
         Pubmed Central ID 2848296 


 



12.
Kosaka N, Ogawa M, Sato N, Choyke PL, Kobayashi H (2009). In vivo real-time, multicolor, quantum dot lymphatic imaging. J Invest Dermatol  129, 2818-22.   https://doi.org/10.1038/jid.2009.161




PubMed



        
     
Free Article


 


PubMed ID 19536144
         Pubmed Central ID 3417231 


 



13.
Longmire M, Kosaka N, Ogawa M, Choyke PL, Kobayashi H (2009). Multicolor in vivo targeted imaging to guide real-time surgery of HER2-positive micrometastases in a two-tumor coincident model of ovarian cancer. Cancer Sci  100, 1099-104.   https://doi.org/10.1111/j.1349-7006.2009.01133.x




PubMed



        
     
Free Article


 


PubMed ID 19302283
         Pubmed Central ID 2736472 


 



14.
Lucarelli RT, Ogawa M, Kosaka N, Turkbey B, Kobayashi H, Choyke PL (2009). New approaches to lymphatic imaging. Lymphat Res Biol  7, 205-14.   https://doi.org/10.1089/lrb.2009.0021




PubMed



        
     
Free Article


 


PubMed ID 20143919
         Pubmed Central ID 2883526 


 



15.
Ogawa M, Kosaka N, Choyke PL, Kobayashi H (2009). H-type dimer formation of fluorophores: a mechanism for activatable, in vivo optical molecular imaging. ACS Chem Biol  4, 535-46.   https://doi.org/10.1021/cb900089j




PubMed



        
     
Free Article


 


PubMed ID 19480464
         Pubmed Central ID 2743556 


 



16.
Ogawa M, Kosaka N, Longmire MR, Urano Y, Choyke PL, Kobayashi H (2009). Fluorophore-quencher based activatable targeted optical probes for detecting in vivo cancer metastases. Mol Pharm  6, 386-95.   https://doi.org/10.1021/mp800115t




PubMed



        
     
Free Article


 


PubMed ID 19718793
         Pubmed Central ID 2891627 


 



17.
Ogawa M, Kosaka N, Regino CA, Mitsunaga M, Choyke PL, Kobayashi H (2010). High sensitivity detection of cancer in vivo using a dual-controlled activation fluorescent imaging probe based on H-dimer formation and pH activation. Mol Biosyst  6, 888-93.   https://doi.org/10.1039/b917876g




PubMed



        
     
Free Article


 


PubMed ID 20567775
         Pubmed Central ID 3464101 


 



18.
Ogawa M, Regino CA, Choyke PL, Kobayashi H (2009). In vivo target-specific activatable near-infrared optical labeling of humanized monoclonal antibodies. Mol Cancer Ther  8, 232-9.   https://doi.org/10.1158/1535-7163.MCT-08-0862




PubMed



        
     
Free Article


 


PubMed ID 19139133
         Pubmed Central ID 2790275 


 



19.
Ogawa M, Regino CA, Marcelino B, Williams M, Kosaka N, Bryant LH, Choyke PL, Kobayashi H (2010). New nanosized biocompatible MR contrast agents based on lysine-dendri-graft macromolecules. Bioconjug Chem  21, 955-60.   https://doi.org/10.1021/bc9005442




PubMed



        
     
Free Article


 


PubMed ID 20235572
         Pubmed Central ID 2884170 


 



20.
Ogawa M, Regino CA, Seidel J, Green MV, Xi W, Williams M, Kosaka N, Choyke PL, Kobayashi H (2009). Dual-modality molecular imaging using antibodies labeled with activatable fluorescence and a radionuclide for specific and quantitative targeted cancer detection. Bioconjug Chem  20, 2177-84.   https://doi.org/10.1021/bc900362k




PubMed



        
     
Free Article


 


PubMed ID 19919110
         Pubmed Central ID 2782620 


 



21.
Regino CA, Wong KJ, Milenic DE, Holmes EH, Garmestani K, Choyke PL, Brechbiel MW (2009). Preclinical evaluation of a monoclonal antibody (3C6) specific for prostate-specific membrane antigen. Curr Radiopharm  2, 9-17.   https://doi.org/10.2174/1874471010902010009




PubMed



        
     
Free Article


 


PubMed ID 20047017
         Pubmed Central ID 2678849 


 



22.
Urano Y, Asanuma D, Hama Y, Koyama Y, Barrett T, Kamiya M, Nagano T, Watanabe T, Hasegawa A, Choyke PL, Kobayashi H (2009). Selective molecular imaging of viable cancer cells with pH-activatable fluorescence probes. Nat Med  15, 104-9.   https://doi.org/10.1038/nm.1854




PubMed



        
     
Free Article


 


PubMed ID 19029979
         Pubmed Central ID 2790281",https://intramural.nih.gov/search/searchview.taf?ipid=63021
236,BC010660-06,"October 01, 2009 -  September 30, 2010",The Molecular Profile of Prostate Tumors in Smokers,"Stefan  Ambs



IRP Faculty Profile",NULL,"Molecular Genetics and Carcinogenesis Section, NCI","Tiffany Marie Howe



Tiffany A Wallace","William  Isaacs; PhD
(Department of Urology, Johns Hopkins School of Medicine)




Chris  Loffredo
(Cancer Genetics and Epidemiology Program, Georgetown University)




Jun  Luo
(Johns Hopkins University)","Arthur A Hurwitz (Laboratory of Molecular Immunoregulation)



Robert H Stephens (Business Operations Branch)",NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=63007
237,BC010661-06,"October 01, 2009 -  September 30, 2010",Vaccine and Drug Combination Therapy for Human Cancers,James W Hodge; PhD,Jeffrey  Schlom; PhD,"Laboratory of Tumor Immunology and Biology, NCI","Andressa  Ardiani



Amanda L Boehm; PhD



Benedetto Paolo Farsaci; PhD



Sofia Ribeiro Gameiro



Marion G Taylor",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Hodge J, Arlen P, Hodge J, Schlom J (2010) Vaccines and immunostimulants, in Holland-Frei Cancer Medicine, 8th edition. People's Medical Publishing House US (Shelton, CT), pp. 725-736.




 



2.
Boehm AL, Higgins J, Franzusoff A, Schlom J, Hodge JW (2010). Concurrent vaccination with two distinct vaccine platforms targeting the same antigen generates phenotypically and functionally distinct T-cell populations. Cancer Immunol Immunother  59, 397-408.   https://doi.org/10.1007/s00262-009-0759-7




PubMed



        
     
Free Article


 


PubMed ID 19756595
         Pubmed Central ID 2809788 


 



3.
Gulley JL, Arlen PM, Madan RA, Tsang KY, Pazdur MP, Skarupa L, Jones JL, Poole DJ, Higgins JP, Hodge JW, Cereda V, Vergati M, Steinberg SM, Halabi S, Jones E, Chen C, Parnes H, Wright JJ, Dahut WL, Schlom J (2010). Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer. Cancer Immunol Immunother  59, 663-74.   https://doi.org/10.1007/s00262-009-0782-8




PubMed



        
     
Free Article


 


PubMed ID 19890632
         Pubmed Central ID 2832083 


 



4.
Madan RA, Arlen PM, Mohebtash M, Hodge JW, Gulley JL (2009). Prostvac-VF: a vector-based vaccine targeting PSA in prostate cancer. Expert Opin Investig Drugs  18, 1001-11.   https://doi.org/10.1517/13543780902997928




PubMed



        
     
Free Article


 


PubMed ID 19548854
         Pubmed Central ID 3449276 


 



5.
Rotow J, Gameiro SR, Madan RA, Gulley JL, Schlom J, Hodge JW (2010). Vaccines as monotherapy and in combination therapy for prostate cancer. Clin Transl Sci  3, 116-22.   https://doi.org/10.1111/j.1752-8062.2010.00186.x




PubMed



        
     
Free Article


 


PubMed ID 20590682
         Pubmed Central ID 2914613",https://intramural.nih.gov/search/searchview.taf?ipid=63036
238,BC010663-06,"October 01, 2009 -  September 30, 2010",The Role of JAM-C  in Adhesive Interactions of Immune Cells,Triantafyllos  Chavakis,NULL,"Experimental Immunology Branch, NCI","Eun-Young  Choi



Sunil  Kaul



Harald Franz Langer



Valeria  Orlova",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Choi EY, Santoso S, Chavakis T (2009). Mechanisms of neutrophil transendothelial migration. Front Biosci (Landmark Ed)  14, 1596-605.   https://doi.org/10.2741/3327




PubMed



        
     
Free Article


 


PubMed ID 19273149
         Pubmed Central ID 2672407 


 



2.
Immenschuh S, Naidu S, Chavakis T, Beschmann H, Ludwig RJ, Santoso S (2009). Transcriptional induction of junctional adhesion molecule-C gene expression in activated T cells. J Leukoc Biol  85, 796-803.   https://doi.org/10.1189/jlb.0708422




PubMed



        
     
Free Article


 


PubMed ID 19204148
         Pubmed Central ID 2669407 


 



3.
Langer HF, Chavakis T (2009). Leukocyte-endothelial interactions in inflammation. J Cell Mol Med  13, 1211-20.   https://doi.org/10.1111/j.1582-4934.2009.00811.x




PubMed



        
     
Free Article


 


PubMed ID 19538472
         Pubmed Central ID 2861890",https://intramural.nih.gov/search/searchview.taf?ipid=63015
239,BC010664-06,"October 01, 2009 -  September 30, 2010",Crosstalk Between Inflammation and Angiogenesis,Triantafyllos  Chavakis,NULL,"Experimental Immunology Branch, NCI","Eun-Young  Choi



Harald Franz Langer



Andre A Nussenzweig; PhD



Valeria  Orlova",NULL,NULL,"Xuri  Li (NEI) 



Manfred  Boehm; MD (NHLBI)","Ordered by publication type and then author name.



1.
Chavakis T, Orlova VV, Langer HF (2009). A possible crosstalk between DNA repair pathways and angiogenesis. Cell Cycle  8, 3438-9.   https://doi.org/10.4161/cc.8.21.9750




PubMed



        
     
Free Article


 


PubMed ID 19838053
         Pubmed Central ID 2783752 


 



2.
Economopoulou M, Langer HF, Celeste A, Orlova VV, Choi EY, Ma M, Vassilopoulos A, Callen E, Deng C, Bassing CH, Boehm M, Nussenzweig A, Chavakis T (2009). Histone H2AX is integral to hypoxia-driven neovascularization. Nat Med  15, 553-8.   https://doi.org/10.1038/nm.1947




PubMed



        
     
Free Article


 


PubMed ID 19377486
         Pubmed Central ID 2713773 


 



3.
Kumar A, Hou X, Lee C, Li Y, Maminishkis A, Tang Z, Zhang F, Langer HF, Arjunan P, Dong L, Wu Z, Zhu LY, Wang L, Min W, Colosi P, Chavakis T, Li X (2010). Platelet-derived growth factor-DD targeting arrests pathological angiogenesis by modulating glycogen synthase kinase-3beta phosphorylation. J Biol Chem  285, 15500-10.   https://doi.org/10.1074/jbc.M110.113787




PubMed



        
     
Free Article


 


PubMed ID 20231273
         Pubmed Central ID 2865282 


 



4.
Langer HF, Chung KJ, Orlova VV, Choi EY, Kaul S, Kruhlak MJ, Alatsatianos M, DeAngelis RA, Roche PA, Magotti P, Li X, Economopoulou M, Rafail S, Lambris JD, Chavakis T (2010). Complement-mediated inhibition of neovascularization reveals a point of convergence between innate immunity and angiogenesis. Blood  116, 4395-403.   https://doi.org/10.1182/blood-2010-01-261503




PubMed



        
     
Free Article


 


PubMed ID 20625009
         Pubmed Central ID 2996109 


 



5.
Vassilopoulos A, Deng CX, Chavakis T (2010). Crosstalk between the DNA damage response, histone modifications and neovascularisation. Int J Biochem Cell Biol  42, 193-7.   https://doi.org/10.1016/j.biocel.2009.11.020




PubMed



        
     
Free Article


 


PubMed ID 19945543
         Pubmed Central ID 2818768",https://intramural.nih.gov/search/searchview.taf?ipid=63016
240,BC010666-06,"October 01, 2009 -  September 30, 2010",Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines,"James L Gulley; MD, PhD



IRP Faculty Profile",NULL,"Laboratory of Tumor Immunology and Biology, NCI","Sandra  Doren



Theresa A Ferrara



Sheri A Mcmahon



Mary P Pazdur



Myrna B Rauckhorst



Carol  Smith



Show all 7","William  Carson
(Molecular Virology, Immunology and Medical Genetics, Ohio State University)




Robert  DiPaola
(Medicine, Cancer Institute of New Jersey)




John  Marshall","Philip M Arlen; MD (Medical Oncology Branch)



Peter A Pinto; MD (Urologic Oncology Branch)



Kevin A Camphausen; MD (Radiation Oncology Branch)



William Laurence Dahut; MD (Office of the Director)



William D Figg; PharmD (Medical Oncology Branch)



William Marston Linehan; MD (Urologic Oncology Branch)",NULL,"Ordered by publication type and then author name.



1.
Arlen PM, Gulley JL (2009). Current perspectives in prostate cancer vaccines. Anticancer Agents Med Chem  9, 1052-7.   https://doi.org/10.2174/187152009789735062




PubMed



        
     
Free Article


 


PubMed ID 19719454
         Pubmed Central ID 3471219 


 



2.
Cereda V, Poole DJ, Palena C, Das S, Bera TK, Remondo C, Gulley JL, Arlen PM, Yokokawa J, Pastan I, Schlom J, Tsang KY (2010). New gene expressed in prostate: a potential target for T cell-mediated prostate cancer immunotherapy. Cancer Immunol Immunother  59, 63-71.   https://doi.org/10.1007/s00262-009-0723-6




PubMed



        
     
Free Article


 


PubMed ID 19495750
         Pubmed Central ID 2782544 


 



3.
Kelly RJ, Gulley JL, Giaccone G (2010). Targeting the immune system in non-small-cell lung cancer: bridging the gap between promising concept and therapeutic reality. Clin Lung Cancer  11, 228-37.   https://doi.org/10.3816/CLC.2010.n.029




PubMed



        
     
Free Article


 


PubMed ID 20630824
         Pubmed Central ID 3474196 


 



4.
Madan RA, Arlen PM, Mohebtash M, Hodge JW, Gulley JL (2009). Prostvac-VF: a vector-based vaccine targeting PSA in prostate cancer. Expert Opin Investig Drugs  18, 1001-11.   https://doi.org/10.1517/13543780902997928




PubMed



        
     
Free Article


 


PubMed ID 19548854
         Pubmed Central ID 3449276 


 



5.
Mohebtash M, Gulley JL, Madan RA, Ferrara T, Arlen PM (2009). Cancer vaccines: current directions and perspectives in prostate cancer. Curr Opin Mol Ther  11, 31-6.




PubMed



        
     
Free Article


 


PubMed ID 19169957
         Pubmed Central ID 3488286 


 



6.
Rotow J, Gameiro SR, Madan RA, Gulley JL, Schlom J, Hodge JW (2010). Vaccines as monotherapy and in combination therapy for prostate cancer. Clin Transl Sci  3, 116-22.   https://doi.org/10.1111/j.1752-8062.2010.00186.x




PubMed



        
     
Free Article


 


PubMed ID 20590682
         Pubmed Central ID 2914613",https://intramural.nih.gov/search/searchview.taf?ipid=63035
241,BC010668-06,"October 01, 2009 -  September 30, 2010",Instrumentation for microSPECT and microPET imaging,"Peter L Choyke; MD



IRP Faculty Profile",NULL,"Molecular Imaging Program, NCI","Michael  Green



Jurgen  Seidel; PhD",NULL,NULL,Thomas J Pohida; MS (CIT),"Ordered by publication type and then author name.



1.
Martiniova L, Kotys MS, Thomasson D, Schimel D, Lai EW, Bernardo M, Merino MJ, Powers JF, Ruzicka J, Kvetnansky R, Choyke PL, Pacak K (2009). Noninvasive monitoring of a murine model of metastatic pheochromocytoma: a comparison of contrast-enhanced microCT and nonenhanced MRI. J Magn Reson Imaging  29, 685-91.   https://doi.org/10.1002/jmri.21654




PubMed



        
     
Free Article


 


PubMed ID 19243052
         Pubmed Central ID 2750094",https://intramural.nih.gov/search/searchview.taf?ipid=63017
242,BC010670-06,"October 01, 2009 -  September 30, 2010",Molecular-Targeted Radiation Therapy,"Norman Norman Coleman; MD



IRP Faculty Profile",NULL,"Radiation Oncology Branch, NCI","Molykutty J Aryankalayil



Adeola Yetunde Makinde



Sanjeewani T Palayoor","Lance  Liotta
(George Mason University)




Emanuel  Petricoin
(George Mason University)","James B Mitchell; PhD (Radiation Biology Branch)



Sunghan  Yoo (Molecular Radiation Therapeutics Branch)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63005
243,BC010671-06,"October 01, 2009 -  September 30, 2010",Genetic Analysis of T-cell Differentiation,"Remy J Bosselut; MD, PhD



IRP Faculty Profile",NULL,"Laboratory of Immune Cell Biology, NCI","Andrea Christine Bohrer



Jong Kyong  Kim



Santosh  Kumar



Melanie S Vacchio; PhD



Yumei  Xiong; PhD



Monica B Zamisch","Albert  Bendelac
(University of Chicago)




I-Cheng  Ho
(Rheumatology, Immunology and Allergy, Harvard (Brigham and Women's))","Lionel  Feigenbaum (Office Of The Director)



Alfred  Singer; MD (Experimental Immunology Branch)



Lino  Tessarollo (Mouse Cancer Genetics Program)","William E Paul; MD (NIAID) 



Paul E Love; MD, PhD (NICHD) 



Yasmine  Belkaid; PhD (NIAID)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63003
244,BC010675-06,"October 01, 2009 -  September 30, 2010",Development of a Carbohydrate Microarray,"Jeffrey  Gildersleeve



IRP Faculty Profile",NULL,"Chemical Biology Laboratory, NCI","David W Farnsworth



Olaf R Ludek



Yalong  Zhang",NULL,"Luis G Rodriguez (Office Of The Director)



John T. Simpson; PhD (Office Of The Director)",NULL,"Ordered by publication type and then author name.



1.
Campbell CT, Zhang Y, Gildersleeve JC (2010) Construction and use of glycan microarrays. Curr Protoc Chem Biol 2:37-53




PubMed



        
     
Free Article


 


PubMed ID 23836542
         Pubmed Central ID 4533865 


 



2.
Oyelaran O, Gildersleeve JC (2009). Glycan arrays: recent advances and future challenges. Curr Opin Chem Biol  13, 406-13.   https://doi.org/10.1016/j.cbpa.2009.06.021




PubMed



               Available in future as a Free Article 


 


PubMed ID 19625207
         Pubmed Central ID 2749919 


 



3.
Oyelaran O, Li Q, Farnsworth D, Gildersleeve JC (2009). Microarrays with varying carbohydrate density reveal distinct subpopulations of serum antibodies. J Proteome Res  8, 3529-38.   https://doi.org/10.1021/pr9002245




PubMed



        
     
Free Article


 


PubMed ID 19366269
         Pubmed Central ID 2730745",https://intramural.nih.gov/search/searchview.taf?ipid=63023
245,BC010677-06,"October 01, 2009 -  September 30, 2010",NADPH Oxidase 1: A Novel Target for Colon Cancer Therapy,"James Halpern Doroshow



IRP Faculty Profile",NULL,"Developmental Therapeutics Branch, NCI","Agnes  Juhasz



Jiamo  Lu; MD, MPH, MHS",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63022
246,BC010678-06,"October 01, 2009 -  September 30, 2010",Keratinocyte Growth Factor (KGF): Clinical Applications,"Jeffrey S Rubin; MD, PhD",NULL,"Laboratory of Cellular and Molecular Biology, NCI",NULL,NULL,NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=63037
247,BC010680-06,"October 01, 2009 -  September 30, 2010",Characterization of the hCenexin-Plk1 interaction at the centrosomes,"Kyung  Lee; PhD



IRP Faculty Profile",NULL,"Chemistry Section, NCI","Yoshikazu  Johmura



Tae Sung  Kim",NULL,Timothy D Veenstra (Office Of The Director),NULL,"Ordered by publication type and then author name.



1.
Soung NK, Park JE, Yu LR, Lee KH, Lee JM, Bang JK, Veenstra TD, Rhee K, Lee KS (2009). Plk1-dependent and -independent roles of an ODF2 splice variant, hCenexin1, at the centrosome of somatic cells. Dev Cell  16, 539-50.   https://doi.org/10.1016/j.devcel.2009.02.004




PubMed



        
     
Free Article


 


PubMed ID 19386263
         Pubmed Central ID 2741019",https://intramural.nih.gov/search/searchview.taf?ipid=63029
248,BC010681-06,"October 01, 2009 -  September 30, 2010",Development of anti-polo-box therapeutic agents,"Kyung  Lee; PhD



IRP Faculty Profile",NULL,"Chemistry Section, NCI",Jung Eun  Park,"Bo  Kim
(Korea Research Institute of Bioscience and Biotechnology)




Michael  Yaffe
(Massachusetts Institute of Technology)","Marc C Nicklaus (Chemical Biology Laboratory)



Alexander  Wlodawer; PhD (Macromolecular Crystallography Laboratory)



James  McMahon; PhD (Molecular Targets Laboratory)



Stuart H Yuspa; MD (Laboratory of Cancer Biology and Genetics)",NULL,"Ordered by publication type and then author name.



1.
Lee K, Park J, Lee K, Burke Jr. T (2009) Preparation of orthogonally protected (2S,3R)-2-amino-3-methyl-4-phosphonobutyric acid (Pmab) as a phosphatase-stable phosphothreonine mimetic and its use in the synthesis of polo-box domain-binding peptides. Tetrahedron 65 (47):9673-9679.




 



2.
Yun SM, Moulaei T, Lim D, Bang JK, Park JE, Shenoy SR, Liu F, Kang YH, Liao C, Soung NK, Lee S, Yoon DY, Lim Y, Lee DH, Otaka A, Appella E, McMahon JB, Nicklaus MC, Burke TR, Yaffe MB, Wlodawer A, Lee KS (2009). Structural and functional analyses of minimal phosphopeptides targeting the polo-box domain of polo-like kinase 1. Nat Struct Mol Biol  16, 876-82.   https://doi.org/10.1038/nsmb.1628




PubMed



        
     
Free Article


 


PubMed ID 19597481
         Pubmed Central ID 2721907",https://intramural.nih.gov/search/searchview.taf?ipid=63030
249,BC010683-06,"October 01, 2009 -  September 30, 2010",Role of FH loss in development of HLRCC heriditary kidney cancer,"Leonard  Neckers; PhD



IRP Faculty Profile",NULL,"Urologic Oncology Branch, NCI","Kristin  Eckfeld



William Marston Linehan; MD



Mehdi  Mollapour



Bradley T Scroggins



Suiquan  Wang; PhD",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Linehan WM, Pinto PA, Bratslavsky G, Pfaffenroth E, Merino M, Vocke CD, Toro JR, Bottaro D, Neckers L, Schmidt LS, Srinivasan R (2009). Hereditary kidney cancer: unique opportunity for disease-based therapy. Cancer  115, 2252-61.   https://doi.org/10.1002/cncr.24230




PubMed



        
     
Free Article


 


PubMed ID 19402075
         Pubmed Central ID 2720093 


 



2.
Sudarshan S, Sourbier C, Kong HS, Block K, Valera Romero VA, Yang Y, Galindo C, Mollapour M, Scroggins B, Goode N, Lee MJ, Gourlay CW, Trepel J, Linehan WM, Neckers L (2009). Fumarate hydratase deficiency in renal cancer induces glycolytic addiction and hypoxia-inducible transcription factor 1alpha stabilization by glucose-dependent generation of reactive oxygen species. Mol Cell Biol  29, 4080-90.   https://doi.org/10.1128/MCB.00483-09




PubMed



               Available in future as a Free Article 


 


PubMed ID 19470762
         Pubmed Central ID 2715796",https://intramural.nih.gov/search/searchview.taf?ipid=63032
250,BC010692-06,"October 01, 2009 -  September 30, 2010",Significance of Marrow Karyotypes in Inherited Bone Marrow Failure Syndromes,Diane Carol Arthur; MD,John Carl Oberholtzer,"Laboratory of Pathology, NCI","Shannon I Skarshaug



Valerie M Zgonc",NULL,"Sharon Ann Savage (Clinical Genetics Branch)



Neelam K Giri; MD (Clinical Genetics Branch)



Blanche P Alter (Clinical Genetics Branch)",Irina  Maric; MD (CC),There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=63008
251,BC010695-06,"October 01, 2009 -  September 30, 2010",Prostate stem cells and cancer stem cells,Jonathan  Vogel; MD,NULL,"Dermatology Branch, NCI","Alok  Mishra



Atsushi  Terunuma



Ying  Xiao



Carole L Yee



Renuka  Pudi","Johng  Rhim
(Uniformed Service University of Health sciences)




Arnold  Schwartz
(George Washington Univ. Medical Center)","Peter A Pinto; MD (Urologic Oncology Branch)



Kathleen  Kelly; PhD (Laboratory Of Genitourinary Cancer Pathogenesis)



Lionel  Feigenbaum (Office Of The Director)



Michael R Emmert-Buck; MD, PhD (Laboratory of Pathology)



William G Telford (Experimental Transplantation and Immunology Branch)",NULL,"Ordered by publication type and then author name.



1.
Terunuma A, Limgala RP, Park CJ, Choudhary I, Vogel JC (2010). Efficient procurement of epithelial stem cells from human tissue specimens using a Rho-associated protein kinase inhibitor Y-27632. Tissue Eng Part A  16, 1363-8.   https://doi.org/10.1089/ten.TEA.2009.0339




PubMed



        
     
Free Article


 


PubMed ID 19912046
         Pubmed Central ID 2862604",https://intramural.nih.gov/search/searchview.taf?ipid=63038
252,BC010696-06,"October 01, 2009 -  September 30, 2010",Study of Hereditary Renal and Other Familial Syndromes,"Maria  Merino; PhD



IRP Faculty Profile",NULL,"Laboratory of Pathology, NCI","Maria  Tsokos; MD



Linda S Wrathall



Beatriz  Walter-rodriguez; MD



David D Roberts; PhD",NULL,William Marston Linehan; MD (Urologic Oncology Branch),NULL,"Ordered by publication type and then author name.



1.
Hasumi Y, Baba M, Ajima R, Hasumi H, Valera VA, Klein ME, Haines DC, Merino MJ, Hong SB, Yamaguchi TP, Schmidt LS, Linehan WM (2009). Homozygous loss of BHD causes early embryonic lethality and kidney tumor development with activation of mTORC1 and mTORC2. Proc Natl Acad Sci U S A  106, 18722-7.   https://doi.org/10.1073/pnas.0908853106




PubMed



        
     
Free Article


 


PubMed ID 19850877
         Pubmed Central ID 2765925 


 



2.
Linehan WM, Pinto PA, Bratslavsky G, Pfaffenroth E, Merino M, Vocke CD, Toro JR, Bottaro D, Neckers L, Schmidt LS, Srinivasan R (2009). Hereditary kidney cancer: unique opportunity for disease-based therapy. Cancer  115, 2252-61.   https://doi.org/10.1002/cncr.24230




PubMed



        
     
Free Article


 


PubMed ID 19402075
         Pubmed Central ID 2720093 


 



3.
Solis DC, Burnichon N, Timmers HJ, Raygada MJ, Kozupa A, Merino MJ, Makey D, Adams KT, Venisse A, Gimenez-Roqueplo AP, Pacak K (2009). Penetrance and clinical consequences of  a gross SDHB deletion in a large family. Clin Genet  75, 354-63.   https://doi.org/10.1111/j.1399-0004.2009.01157.x




PubMed



        
     
Free Article


 


PubMed ID 19389109
         Pubmed Central ID 4718153",https://intramural.nih.gov/search/searchview.taf?ipid=63031
253,BC010698-06,"October 01, 2009 -  September 30, 2010",Developing Immunoablative Regimens for the Engraftment of Allogeneic HSCT,Michael R Bishop; MD,NULL,"Experimental Transplantation and Immunology Branch, NCI","Sivasubramanian  Baskar



Daniel H Fowler



Steven  Pavletic; MD, MS



Ronald E Gress; MD



Frances  Hakim; PhD



Christoph  Rader; PhD","Thea  Friedman
(Hackensack University Medical Center)




Robert  Korngold
(Cancer Center, Hackensack University)",Crystal L. Mackall; MD (Pediatric Oncology Branch),NULL,"Ordered by publication type and then author name.



1.
Bishop MR, Dean RM, Steinberg SM, Odom J, Pollack SM, Pavletic SZ, Sportes C, Gress RE, Fowler DH (2010). Correlation of pretransplant and early post-transplant response assessment with outcomes after reduced-intensity allogeneic hematopoietic stem cell transplantation for non-Hodgkin's lymphoma. Cancer  116, 852-62.   https://doi.org/10.1002/cncr.24845




PubMed



        
     
Free Article


 


PubMed ID 20041482
         Pubmed Central ID 6582966 


 



2.
Giralt S, Bishop MR (2009). Principles and overview of allogeneic hematopoietic stem cell transplantation. Cancer Treat Res  144, 1-21.   https://doi.org/10.1007/978-0-387-78580-6_1




PubMed



        
     
Free Article


 


PubMed ID 19779888
         Pubmed Central ID 6953421 


 



3.
Pollack SM, Steinberg SM, Odom J, Dean RM, Fowler DH, Bishop MR (2009). Assessment of the hematopoietic cell transplantation comorbidity index in non-Hodgkin lymphoma patients receiving reduced-intensity allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant  15, 223-30.   https://doi.org/10.1016/j.bbmt.2008.11.023




PubMed



        
     
Free Article


 


PubMed ID 19167682
         Pubmed Central ID 2842937",https://intramural.nih.gov/search/searchview.taf?ipid=63010
254,BC010701-05,"October 01, 2009 -  September 30, 2010",Human Monoclonal Antibodies Against Cancer,Dimiter Stanchev Dimitrov; PhD,NULL,"Membrane Structure and Function Section, NCI","Weizao  Chen



Yang  Feng



John  Owens",NULL,"Robert  Blumenthal; PhD (Center for Cancer Research Nanobiology Program)



Ira H Pastan; MD (Molecular Biology Section)



Xinhua  Ji; PhD (Biomolecular Structure Section)",NULL,"Ordered by publication type and then author name.



1.
Chen W, Xiao X, Wang Y, Zhu Z, Dimitrov DS (2010). Bifunctional fusion proteins of the human engineered antibody domain m36 with human soluble CD4 are potent inhibitors of diverse HIV-1 isolates. Antiviral Res  88, 107-15.   https://doi.org/10.1016/j.antiviral.2010.08.004




PubMed



               Available in future as a Free Article 


 


PubMed ID 20709110
         Pubmed Central ID 2954370 


 



2.
Chen W, Zhu Z, Xiao X, Dimitrov DS (2009). Construction of a human antibody domain (VH) library. Methods Mol Biol  525, 81-99, xiii.   https://doi.org/10.1007/978-1-59745-554-1_4




PubMed



        
     
Free Article


 


PubMed ID 19252835
         Pubmed Central ID 2801874 


 



3.
Dimitrov DS (2009). Engineered CH2 domains (nanoantibodies). MAbs  1, 26-8.   https://doi.org/10.4161/mabs.1.1.7480




PubMed



        
     
Free Article


 


PubMed ID 20046570
         Pubmed Central ID 2715188 


 



4.
Dimitrov DS, Marks JD (2009). Therapeutic antibodies: current state and future trends--is a paradigm change coming soon? Methods Mol Biol  525, 1-27, xiii.   https://doi.org/10.1007/978-1-59745-554-1_1




PubMed



        
     
Free Article


 


PubMed ID 19252861
         Pubmed Central ID 3402212 


 



5.
Feng Y, Dimitrov DS (2009). Scaling-up and production of therapeutic antibodies for preclinical studies. Methods Mol Biol  525, 499-508, xiii.   https://doi.org/10.1007/978-1-59745-554-1_26




PubMed



        
     
Free Article


 


PubMed ID 19252843
         Pubmed Central ID 3402213 


 



6.
Feng Y, Xiao X, Zhu Z, Streaker E, Ho M, Pastan I, Dimitrov DS (2009). A novel human monoclonal antibody that binds with high affinity to mesothelin-expressing cells and kills them by antibody-dependent cell-mediated cytotoxicity. Mol Cancer Ther  8, 1113-8.   https://doi.org/10.1158/1535-7163.MCT-08-0945




PubMed



        
     
Free Article


 


PubMed ID 19417159
         Pubmed Central ID 2891957 


 



7.
Gong R, Vu BK, Feng Y, Prieto DA, Dyba MA, Walsh JD, Prabakaran P, Veenstra TD, Tarasov SG, Ishima R, Dimitrov DS (2009). Engineered human antibody constant domains with increased stability. J Biol Chem  284, 14203-10.   https://doi.org/10.1074/jbc.M900769200




PubMed



        
     
Free Article


 


PubMed ID 19307178
         Pubmed Central ID 2682868 


 



8.
Kimura T, Kuwata T, Ashimine S, Yamazaki M, Yamauchi C, Nagai K, Ikehara A, Feng Y, Dimitrov DS, Saito S, Ochiai A (2010). Targeting of bone-derived insulin-like growth factor-II by a human neutralizing antibody suppresses the growth of prostate cancer cells in a human bone environment. Clin Cancer Res  16, 121-9.   https://doi.org/10.1158/1078-0432.CCR-09-0982




PubMed



        
     
Free Article


 


PubMed ID 20028742
         Pubmed Central ID 2802676 


 



9.
Ramakrishnan B, Boeggeman E, Manzoni M, Zhu Z, Loomis K, Puri A, Dimitrov DS, Qasba PK (2009). Multiple site-specific in vitro labeling of single-chain antibody. Bioconjug Chem  20, 1383-9.   https://doi.org/10.1021/bc900149r




PubMed



        
     
Free Article


 


PubMed ID 19507852
         Pubmed Central ID 3402211 


 



10.
Vu BK, Walsh JD, Dimitrov DS, Ishima R (2009). Dynamics of antibody domains studied by solution NMR. Methods Mol Biol  525, 533-43, xv.   https://doi.org/10.1007/978-1-59745-554-1_29




PubMed



        
     
Free Article


 


PubMed ID 19252840
         Pubmed Central ID 3423202 


 



11.
Xiao X, Ho M, Zhu Z, Pastan I, Dimitrov DS (2009). Identification and characterization of fully human anti-CD22 monoclonal antibodies. MAbs  1, 297-303.   https://doi.org/10.4161/mabs.1.3.8113




PubMed



        
     
Free Article


 


PubMed ID 20065646
         Pubmed Central ID 2726586 


 



12.
Zhang MY, Feng Y, Wang Y, Dimitrov DS (2009). Characterization of a chimeric monoclonal antibody against the insulin-like growth factor-I receptor. MAbs  1, 475-80.   https://doi.org/10.4161/mabs.1.5.9580




PubMed



        
     
Free Article


 


PubMed ID 20065647
         Pubmed Central ID 2759497 


 



13.
Zhu Z, Dimitrov DS (2009). Construction of a large naïve human phage-displayed Fab library through one-step cloning. Methods Mol Biol  525, 129-42, xv.   https://doi.org/10.1007/978-1-59745-554-1_6




PubMed



        
     
Free Article


 


PubMed ID 19252833
         Pubmed Central ID 3423197",https://intramural.nih.gov/search/searchview.taf?ipid=63043
255,BC010707-05,"October 01, 2009 -  September 30, 2010",Role of T regulatory suppression in autoimmunity and cancer,"Joost J Oppenheim; MD



IRP Faculty Profile",NULL,"Laboratory of Molecular Immunoregulation, NCI","Xin  Chen



Huiting  Fan



Anna Lee  Trivett



Ola Mae Zack Howard","Robert  Goldman
(Peprotech)




Daniela  Maennel
(Immunology, University of Regensburg)","Giorgio  Trinchieri (Cancer Inflammation Program)



Jeffrey J Subleski (Laboratory of Experimental Immunology)



Robert  Wiltrout; PhD (Laboratory of Experimental Immunology)",NULL,"Ordered by publication type and then author name.



1.
Oppenheim J, Oppenheim J (2010) Crrent Directions in Autoimmunity. Karger Publisher (Basel).




 



2.
Chen X, Hamano R, Subleski JJ, Hurwitz AA, Howard OM, Oppenheim JJ (2010). Expression of costimulatory TNFR2 induces resistance of CD4+FoxP3- conventional T cells to suppression by CD4+FoxP3+ regulatory T cells. J Immunol  185, 174-82.   https://doi.org/10.4049/jimmunol.0903548




PubMed



        
     
Free Article


 


PubMed ID 20525892
         Pubmed Central ID 6314668 


 



3.
Chen X, Oppenheim JJ (2010). TNF-alpha: an activator of CD4+FoxP3+TNFR2+ regulatory T cells. Curr Dir Autoimmun  11, 119-34.   https://doi.org/10.1159/000289201




PubMed



        
     
Free Article


 


PubMed ID 20173391
         Pubmed Central ID 6314650 


 



4.
Chen X, Subleski JJ, Hamano R, Howard OM, Wiltrout RH, Oppenheim JJ (2010). Co-expression of TNFR2 and CD25 identifies more of the functional CD4+FOXP3+ regulatory T cells in human peripheral blood. Eur J Immunol  40, 1099-106.   https://doi.org/10.1002/eji.200940022




PubMed



        
     
Free Article


 


PubMed ID 20127680
         Pubmed Central ID 3096013 


 



5.
Oppenheim J, Oppenheim J (2009) Regulatory T cells, Th17 cells and TLRs: implication for autoimmunity and cancer (review). Pathways 10:2-5.",https://intramural.nih.gov/search/searchview.taf?ipid=63048
256,BC010708-05,"October 01, 2009 -  September 30, 2010",Consequences of receptor cross talk on inflammation and algesia,"Joost J Oppenheim; MD



IRP Faculty Profile",NULL,"Laboratory of Molecular Immunoregulation, NCI","Ola Mae Zack Howard



Jia  Qi; PhD



Anna Lee  Trivett



Feng  Wei",NULL,NULL,Jeffrey  Cohen; MD (NIAID),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63049
257,BC010709-05,"October 01, 2009 -  September 30, 2010",An Exploratory Study of Biologic and Pathophysiologic Efects of Radiation Therap,"Katherine Elizabeth Warren; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI","Robyn S Bent



Pamela  Wolters



Laurie  Steffen",NULL,"Kevin A Camphausen; MD (Radiation Oncology Branch)



Deborah E Citrin (Radiation Oncology Branch)","Carlo  Pierpaoli; MD, PhD (NICHD)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63077
258,BC010714-05,"October 01, 2009 -  September 30, 2010",Angiogenesis imaging,"Peter L Choyke; MD



IRP Faculty Profile",NULL,"Molecular Imaging Program, NCI","Stephen Scott Adler



Marcelino  Bernardo



Dagane  Daar



Philip Charles Eclarinal



Elaine Marie Jagoda; MS



Hisataka  Kobayashi



Show all 12","Donald  McDonald
(Pathology, UCSF)




Jeff  Winick
(GE Healthcare)




James  Zhang
(Siemens Medical Systems)","Giuseppe  Giaccone; MD (Medical Oncology Branch)



Ola Anders Landgren (Medical Oncology Branch)



Gennady  Bratslavsky (Urologic Oncology Branch)



Peter A Pinto; MD (Urologic Oncology Branch)



James L Tatum (Cancer Imaging Program)



William Laurence Dahut; MD (Office of the Director)","David M Thomasson; PhD (CC) 



Thomas J Pohida; MS (CIT)","Ordered by publication type and then author name.



1.
Barrett T, Ravizzini G, Choyke PL, Kobayashi H (2009). Dendrimers in medical nanotechnology. IEEE Eng Med Biol Mag  28, 12-22.   https://doi.org/10.1109/MEMB.2008.931012




PubMed



        
     
Free Article


 


PubMed ID 19150767
         Pubmed Central ID 2995329 


 



2.
Kobayashi H, Ogawa M, Kosaka N, Choyke PL, Urano Y (2009). Multicolor imaging of lymphatic function with two nanomaterials: quantum dot-labeled cancer cells and dendrimer-based optical agents. Nanomedicine (Lond)  4, 411-9.   https://doi.org/10.2217/nnm.09.15




PubMed



        
     
Free Article


 


PubMed ID 19505244
         Pubmed Central ID 2714945 


 



3.
Kosaka N, Ogawa M, Paik DS, Paik CH, Choyke PL, Kobayashi H (2010). Semiquantitative assessment of the microdistribution of fluorescence-labeled monoclonal antibody in small peritoneal disseminations of ovarian cancer. Cancer Sci  101, 820-5.   https://doi.org/10.1111/j.1349-7006.2009.01423.x




PubMed



        
     
Free Article


 


PubMed ID 19961490
         Pubmed Central ID 2848296 


 



4.
Kosaka N, Ogawa M, Sato N, Choyke PL, Kobayashi H (2009). In vivo real-time, multicolor, quantum dot lymphatic imaging. J Invest Dermatol  129, 2818-22.   https://doi.org/10.1038/jid.2009.161




PubMed



        
     
Free Article


 


PubMed ID 19536144
         Pubmed Central ID 3417231 


 



5.
Lucarelli RT, Ogawa M, Kosaka N, Turkbey B, Kobayashi H, Choyke PL (2009). New approaches to lymphatic imaging. Lymphat Res Biol  7, 205-14.   https://doi.org/10.1089/lrb.2009.0021




PubMed



        
     
Free Article


 


PubMed ID 20143919
         Pubmed Central ID 2883526 


 



6.
Türkbey B, Thomasson D, Pang Y, Bernardo M, Choyke PL (2010). The role of dynamic contrast-enhanced MRI in cancer diagnosis and treatment. Diagn Interv Radiol  16, 186-92.   https://doi.org/10.4261/1305-3825.DIR.2537-08.1




PubMed



        
     
Free Article


 


PubMed ID 19885783
         Pubmed Central ID 3518910 


 



7.
Turkbey B, Kobayashi H, Ogawa M, Bernardo M, Choyke PL (2009). Imaging of tumor angiogenesis: functional or targeted? AJR Am J Roentgenol  193, 304-13.   https://doi.org/10.2214/AJR.09.2869




PubMed



        
     
Free Article


 


PubMed ID 19620425
         Pubmed Central ID 3523171",https://intramural.nih.gov/search/searchview.taf?ipid=63059
259,BC010715-05,"October 01, 2009 -  September 30, 2010",Phase II study of flavopiridol in mantle cell lymphoma and DLBCL,"Wyndham H Wilson; MD, PhD



IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI","Kieron Michael Dunleavy



Douglas C Matthews



John  Janik; MD",NULL,"Stefania  Pittaluga (Laboratory of Pathology)



Elaine S Jaffe; MD (Laboratory of Pathology)","Adrian U Wiestner; MD, PhD (NHLBI)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63078
260,BC010716-05,"October 01, 2009 -  September 30, 2010",Phase I and II study of BCL-family inhibitors in lymphoma,"Wyndham H Wilson; MD, PhD



IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI","Louis  Staudt; MD



John  Janik; MD",NULL,"Stefania  Pittaluga (Laboratory of Pathology)



Elaine S Jaffe; MD (Laboratory of Pathology)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63079
261,BC010717-05,"October 01, 2009 -  September 30, 2010",Phase I study of bortezomib and DA-EPOCH-R with microarray in DLBCL,"Wyndham H Wilson; MD, PhD



IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",NULL,NULL,"Stefania  Pittaluga (Laboratory of Pathology)



Louis  Staudt; MD (Lymphoid Malignancies Branch)



Elaine S Jaffe; MD (Laboratory of Pathology)",NULL,"Ordered by publication type and then author name.



1.
Dunleavy K, Pittaluga S, Czuczman MS, Dave SS, Wright G, Grant N, Shovlin M, Jaffe ES, Janik JE, Staudt LM, Wilson WH (2009). Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma. Blood  113, 6069-76.   https://doi.org/10.1182/blood-2009-01-199679




PubMed



        
     
Free Article


 


PubMed ID 19380866
         Pubmed Central ID 2699229",https://intramural.nih.gov/search/searchview.taf?ipid=63080
262,BC010719-05,"October 01, 2009 -  September 30, 2010",Randomized Phase II study of borteozmibEPOCH-R in Mantle cell lymphoma,"Wyndham H Wilson; MD, PhD



IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",John  Janik; MD,NULL,"Stefania  Pittaluga (Laboratory of Pathology)



Elaine S Jaffe; MD (Laboratory of Pathology)","Adrian U Wiestner; MD, PhD (NHLBI)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63081
263,BC010720-05,"October 01, 2009 -  September 30, 2010","Isolation, Characterization, and Behavior of Melanocyte Stem Cells",Thomas J Hornyak,NULL,"Dermatology Branch, NCI","Maira A Castaneda



Jennifer Marian Huang



Shunlin  Jiang",NULL,Glenn  Merlino; PhD (Laboratory of Cancer Biology and Genetics),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63063
264,BC010721-05,"October 01, 2009 -  September 30, 2010",Modeling of the structure and functional mechanisms of voltage-gated channels,Homer Robert Guy; PhD,NULL,"Laboratory of Cell Biology, NCI",Adina L Milac,"Andriy  Anishkin
(Biology, Univ Maryland, College Park)




Steffen  Hering
(Institut für Pharmakologie und Toxikologie, Universität Wien)




Sergei  Sukharev
(Univ Maryland, College Park)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63061
265,BC010722-05,"October 01, 2009 -  September 30, 2010",Modeling of amyloid peptides and proteins,Homer Robert Guy; PhD,NULL,"Laboratory of Cell Biology, NCI","Stewart  Durell



Sijung  Yun","Andriy  Anishkin
(Biology, Univ Maryland, College Park)




Nelson  Arispe
(Anat/Physiol/Genet, Uniformed Serv Univ Hlth Sci)




Harvey  Pollard
(Uniformed Serv Univ Hlth Sci)",NULL,NULL,"Ordered by publication type and then author name.



1.
Shafrir Y, Durell S, Arispe N, Guy HR (2010). Models of membrane-bound Alzheimer's Abeta peptide assemblies. Proteins  78, 3473-87.   https://doi.org/10.1002/prot.22853




PubMed



        
     
Free Article


 


PubMed ID 20939098
         Pubmed Central ID 2976831 


 



2.
Shafrir Y, Durell SR, Anishkin A, Guy HR (2010). Beta-barrel models of soluble amyloid beta oligomers and annular protofibrils. Proteins  78, 3458-72.   https://doi.org/10.1002/prot.22832




PubMed



        
     
Free Article


 


PubMed ID 20830782
         Pubmed Central ID 2976788",https://intramural.nih.gov/search/searchview.taf?ipid=63062
266,BC010725-05,"October 01, 2009 -  September 30, 2010",Role of Formylpeptide Receptors in Host Defense,"Ji Ming  Wang; MD, PhD



IRP Faculty Profile",NULL,"Laboratory of Molecular Immunoregulation, NCI","Keqiang  Chen



Wang Hua  Gong



Ying  Liu","Xiuwu  Bian
(Southwest Hospital, Institute of Pathology)




Yingying  Le
(Immunology, Institute for Nutritional Sciences)




Thomas  Rogers
(Temple University)




Gert  Schmid-Schonbein
(Whitaker Institute, UC San Diego)




Chunfu  Wu
(Medicinal Chemistry, Shenyang Pharmaceutical University)",NULL,Philip M Murphy; MD (NIAID),"Ordered by publication type and then author name.



1.
Chen K, Huang J, Liu Y, Gong W, Cui Y, Wang JM (2009). Synergy of TRIF-dependent TLR3 and MyD88-dependent TLR7 in up-regulating expression of mouse FPR2, a promiscuous G-protein-coupled receptor, in microglial cells. J Neuroimmunol  213, 69-77.   https://doi.org/10.1016/j.jneuroim.2009.05.018




PubMed



        
     
Free Article


 


PubMed ID 19559490
         Pubmed Central ID 2761824 


 



2.
Ye RD, Boulay F, Wang JM, Dahlgren C, Gerard C, Parmentier M, Serhan CN, Murphy PM (2009). International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family. Pharmacol Rev  61, 119-61.   https://doi.org/10.1124/pr.109.001578




PubMed



        
     
Free Article


 


PubMed ID 19498085
         Pubmed Central ID 2745437",https://intramural.nih.gov/search/searchview.taf?ipid=63055
267,BC010727-05,"October 01, 2009 -  September 30, 2010",Molecular Imaging and Targeted Therapy of HER2-Positive Breast Cancers,Jacek  Capala; PhD,NULL,"Radiation Oncology Branch, NCI","Alesia J Holly



Gabriela  Kramer-Marek



Monika Agnieszka Kuban



Ilya  Lyakhov



Rafal Jerzy Zielinski",NULL,"Barbara V Vonderhaar; PhD (Mammary Biology and Tumorigenesis Laboratory)



Peter L Choyke; MD (Molecular Imaging Program)



Robert  Blumenthal; PhD (Center for Cancer Research Nanobiology Program)","Gary Leonard Griffiths; BSc, PhD (NHLBI) 



Amir Hossein Gandjbakhche; PhD (NICHD) 



Peter  Herscovitch; MD (CC) 



Dale Oscar Kiesewetter; BS, PhD (NIBIB)","Ordered by publication type and then author name.



1.
Bouchelouche K, Capala J, Oehr P (2009). Positron emission tomography/computed tomography and radioimmunotherapy of prostate cancer. Curr Opin Oncol  21, 469-74.   https://doi.org/10.1097/CCO.0b013e32832d56e4




PubMed



        
     
Free Article


 


PubMed ID 19535981
         Pubmed Central ID 2788311 


 



2.
Kramer-Marek G, Kiesewetter DO, Capala J (2009). Changes in HER2 expression in breast cancer xenografts after therapy can be quantified using PET and (18)F-labeled affibody molecules. J Nucl Med  50, 1131-9.   https://doi.org/10.2967/jnumed.108.057695




PubMed



        
     
Free Article


 


PubMed ID 19525458
         Pubmed Central ID 2787241 


 



3.
Yavlovich A, Singh A, Tarasov S, Capala J, Blumenthal R, Puri A (2009). DESIGN OF LIPOSOMES CONTAINING PHOTOPOLYMERIZABLE PHOSPHOLIPIDS FOR TRIGGERED RELEASE OF CONTENTS. J Therm Anal Calorim  98, 97-104.   https://doi.org/10.1007/s10973-009-0228-8




PubMed



        
     
Free Article


 


PubMed ID 20160877
         Pubmed Central ID 2772073 


 



4.
Zielinski R, Lyakhov I, Jacobs A, Chertov O, Kramer-Marek G, Francella N, Stephen A, Fisher R, Blumenthal R, Capala J (2009). Affitoxin--a novel recombinant, HER2-specific, anticancer agent for targeted therapy of HER2-positive tumors. J Immunother  32, 817-25.   https://doi.org/10.1097/CJI.0b013e3181ad4d5d




PubMed



        
     
Free Article


 


PubMed ID 19752752
         Pubmed Central ID 3402039 


 



5.
Zielinski R, Przytycki PF, Zheng J, Zhang D, Przytycka TM, Capala J (2009). The crosstalk between EGF, IGF, and Insulin cell signaling pathways--computational and experimental analysis. BMC Syst Biol  3, 88.   https://doi.org/10.1186/1752-0509-3-88




PubMed



        
     
Free Article


 


PubMed ID 19732446
         Pubmed Central ID 2751744",https://intramural.nih.gov/search/searchview.taf?ipid=63058
268,BC010728-05,"October 01, 2009 -  September 30, 2010",Phase III Study of R-CHOP v DA-EPOCH-R with microarray,"Wyndham H Wilson; MD, PhD



IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",John  Janik; MD,"Bruce Allan Chabner





Bruce  Cheson
(NCI)




Myron  Czuczman
(Oncology, Roswell Park Cancer Institute)




Andrew  Zelenetz
(Medicine, MSKCC)","Stefania  Pittaluga (Laboratory of Pathology)



Louis  Staudt; MD (Lymphoid Malignancies Branch)



Elaine S Jaffe; MD (Laboratory of Pathology)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63082
269,BC010729-05,"October 01, 2009 -  September 30, 2010",Technology Development,"Michael R Emmert-Buck; MD, PhD",NULL,"Laboratory of Pathology, NCI","Michael D Armani



Michael  Tangrea



Liang  Zhu; PhD","Benjamin  Shapiro
(Engineering, University of Maryland)




Elisabeth  Smela
(Engineering, University of Maryland)",NULL,Robert F Bonner; PhD (NICHD),"Ordered by publication type and then author name.



1.
Armani M, Rodriguez-Canales J, Gillespie J, Tangrea M, Erickson H, Emmert-Buck MR, Shapiro B, Smela E (2009). 2D-PCR: a method of mapping DNA in tissue sections. Lab Chip  9, 3526-34.   https://doi.org/10.1039/b910807f




PubMed



        
     
Free Article


 


PubMed ID 20024032
         Pubmed Central ID 2910845 


 



2.
Arnott D, Emmert-Buck MR (2010). Proteomic profiling of cancer--opportunities, challenges, and context. J Pathol  222, 16-20.   https://doi.org/10.1002/path.2750




PubMed


 


PubMed ID 20623483
    
     


 



3.
Eberle FC, Hanson JC, Killian JK, Wei L, Ylaya K, Hewitt SM, Jaffe ES, Emmert-Buck MR, Rodriguez-Canales J (2010). Immunoguided laser assisted microdissection techniques for DNA methylation analysis of archival tissue specimens. J Mol Diagn  12, 394-401.   https://doi.org/10.2353/jmoldx.2010.090200




PubMed



        
     
Free Article


 


PubMed ID 20413681
         Pubmed Central ID 2893622 


 



4.
Johann DJ, Rodriguez-Canales J, Mukherjee S, Prieto DA, Hanson JC, Emmert-Buck M, Blonder J (2009). Approaching solid tumor heterogeneity on a cellular basis by tissue proteomics using laser capture microdissection and biological mass spectrometry. J Proteome Res  8, 2310-8.   https://doi.org/10.1021/pr8009403




PubMed



        
     
Free Article


 


PubMed ID 19284784
         Pubmed Central ID 2858576 


 



5.
Zoon CK, Starker EQ, Wilson AM, Emmert-Buck MR, Libutti SK, Tangrea MA (2009). Current molecular diagnostics of breast cancer and the potential incorporation of microRNA. Expert Rev Mol Diagn  9, 455-67.   https://doi.org/10.1586/erm.09.25




PubMed



        
     
Free Article


 


PubMed ID 19580430
         Pubmed Central ID 2758104",https://intramural.nih.gov/search/searchview.taf?ipid=63044
270,BC010731-05,"October 01, 2009 -  September 30, 2010",In Vivo MRI imaging of single metastatic cells,"Kathleen  Kelly; PhD



IRP Faculty Profile",NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",William Bradley O'Dell,NULL,NULL,Alan Paul Koretsky; PhD (NINDS),"Ordered by publication type and then author name.



1.
JuanYin J, Tracy K, Zhang L, Munasinghe J, Shapiro E, Koretsky A, Kelly K (2009). Noninvasive imaging of the functional effects of anti-VEGF therapy on tumor cell extravasation and regional blood volume in an experimental brain metastasis model. Clin Exp Metastasis  26, 403-14.   https://doi.org/10.1007/s10585-009-9238-y




PubMed



               Available in future as a Free Article 


 


PubMed ID 19277878
         Pubmed Central ID 3200557 


 



2.
Yin JJ, Zhang L, Munasinghe J, Linnoila RI, Kelly K (2010). Cediranib/AZD2171 inhibits bone and brain metastasis in a preclinical model of advanced prostate cancer. Cancer Res  70, 8662-73.   https://doi.org/10.1158/0008-5472.CAN-10-1435




PubMed



               Available in future as a Free Article 


 


PubMed ID 20959486
         Pubmed Central ID 2989818",https://intramural.nih.gov/search/searchview.taf?ipid=63046
271,BC010733-05,"October 01, 2009 -  September 30, 2010",Dermatoscopy in the Evaluation of Pigmented Lesions,Thomas J Hornyak,NULL,"Dermatology Branch, NCI",Kenneth H Kraemer; MD,NULL,John  Digiovanna (DNA Repair Section),NULL,"Ordered by publication type and then author name.



1.
Wang Y, Digiovanna JJ, Stern JB, Hornyak TJ, Raffeld M, Khan SG, Oh KS, Hollander MC, Dennis PA, Kraemer KH (2009). Evidence of ultraviolet type mutations in xeroderma pigmentosum melanomas. Proc Natl Acad Sci U S A  106, 6279-84.   https://doi.org/10.1073/pnas.0812401106




PubMed



        
     
Free Article


 


PubMed ID 19329485
         Pubmed Central ID 2669353",https://intramural.nih.gov/search/searchview.taf?ipid=63064
272,BC010734-05,"October 01, 2009 -  September 30, 2010",Cutaneous Lesions in Neurofibromatosis Type I and Other Pre-cancerous Syndromes,Thomas J Hornyak,NULL,"Dermatology Branch, NCI",NULL,NULL,"Chyi-Chia Richard Lee (Laboratory of Pathology)



Brigitte  Widemann; MD (Pediatric Oncology Branch)



Phillip A Dennis; MD, PhD (Medical Oncology Branch)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63065
273,BC010735-05,"October 01, 2009 -  September 30, 2010",Structural studies of fimbriae of enterotoxigenic E. coli (ETEC),"Di S Xia; PhD, MS, BS



IRP Faculty Profile",NULL,"Crystallography Section, NCI",Rui  Bao,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Li YF, Poole S, Nishio K, Jang K, Rasulova F, McVeigh A, Savarino SJ, Xia D, Bullitt E (2009). Structure of CFA/I fimbriae from enterotoxigenic Escherichia coli. Proc Natl Acad Sci U S A  106, 10793-8.   https://doi.org/10.1073/pnas.0812843106




PubMed



        
     
Free Article


 


PubMed ID 19515814
         Pubmed Central ID 2705562 


 



2.
Li YF, Poole S, Rasulova F, McVeigh AL, Savarino SJ, Xia D (2009). Crystallization and preliminary X-ray diffraction analyses of several forms of the CfaB major subunit of enterotoxigenic Escherichia coli CFA/I fimbriae. Acta Crystallogr Sect F Struct Biol Cryst Commun  65, 242-7.   https://doi.org/10.1107/S1744309109001584




PubMed



        
     
Free Article


 


PubMed ID 19255474
         Pubmed Central ID 2650451",https://intramural.nih.gov/search/searchview.taf?ipid=63057
274,BC010736-05,"October 01, 2009 -  September 30, 2010",Using mouse knockouts to unravel endothelial gene function,Bradley D St Croix,NULL,"Mouse Cancer Genetics Program, NCI","Steven  Seaman



Mi Young  Yang",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63076
275,BC010738-05,"October 01, 2009 -  September 30, 2010","Molecular Genetic Study of Stem Cells, Cancer Stem Cells, and Stem Cell Aging","Steven X Hou



IRP Faculty Profile",NULL,"Mouse Cancer Genetics Program, NCI","Ozanna  Burnicka-Turek; PhD



Chhavi  Chauhan; PhD



Lino  Tessarollo



Ying  Liu



Hyunhee  Shin



Shree Ram  Singh



Show all 7","Neal  Copeland
(Institute of Molecular and Cell Biology)




Nancy  Jenkins
(Institute of Molecular and Cell Biology)",Jonathan  Keller; PhD (Laboratory of Cancer Prevention),NULL,"Ordered by publication type and then author name.



1.
Liu W, Singh SR, Hou SX (2010). JAK-STAT is restrained by Notch to control cell proliferation of the Drosophila intestinal stem cells. J Cell Biochem  109, 992-9.   https://doi.org/10.1002/jcb.22482




PubMed



        
     
Free Article


 


PubMed ID 20082318
         Pubmed Central ID 2893559 


 



2.
Satyanarayana A, Gudmundsson KO, Chen X, Coppola V, Tessarollo L, Keller JR, Hou SX (2010). RapGEF2 is essential for embryonic hematopoiesis but dispensable for adult hematopoiesis. Blood  116, 2921-31.   https://doi.org/10.1182/blood-2010-01-262964




PubMed



        
     
Free Article


 


PubMed ID 20595512
         Pubmed Central ID 2974602 


 



3.
Singh SR, Hou SX (2009). Multipotent stem cells in the Malpighian tubules of adult Drosophila melanogaster. J Exp Biol  212, 413-23.   https://doi.org/10.1242/jeb.024216




PubMed



        
     
Free Article


 


PubMed ID 19151216
         Pubmed Central ID 2699409 


 



4.
Singh SR, Zheng Z, Wang H, Oh SW, Chen X, Hou SX (2010). Competitiveness for the niche and mutual dependence of the germline and somatic stem cells in the Drosophila testis are regulated by the JAK/STAT signaling. J Cell Physiol  223, 500-10.   https://doi.org/10.1002/jcp.22073




PubMed



        
     
Free Article


 


PubMed ID 20143337
         Pubmed Central ID 2894562 


 



5.
Zeng X, Singh SR, Hou D, Hou SX (2010). Tumor suppressors Sav/Scrib and oncogene Ras regulate stem-cell transformation in adult Drosophila malpighian tubules. J Cell Physiol  224, 766-74.   https://doi.org/10.1002/jcp.22179




PubMed



        
     
Free Article


 


PubMed ID 20432470
         Pubmed Central ID 3391499",https://intramural.nih.gov/search/searchview.taf?ipid=63066
276,BC010740-05,"October 01, 2009 -  September 30, 2010",Carbohydrate Microarray Profiling of Glycan-Binding Antibodies and Lectins,"Jeffrey  Gildersleeve



IRP Faculty Profile",NULL,"Chemical Biology Laboratory, NCI","Christopher Thomas Campbell; MD, PhD



Yalong  Zhang","Amit  Basu
(Center for Microbial Pathogenesis, Brown University)




Uwe  Karsten
(Toxicology and Chemotherapy, Glycotope, GmbH)




Lara  Mahal
(Chemistry, University of Texas at Austin)




Cristina  Voss
(Department of Chemistry, German Cancer Research Center)




Mai  Xu; PhD





Matthew  Zimmt
(Brown University)",Miriam R Anver (Office Of The Director),NULL,"Ordered by publication type and then author name.



1.
Li Q, Anver MR, Butcher DO, Gildersleeve JC (2009). Resolving conflicting data on expression of the Tn antigen and implications for clinical trials with cancer vaccines. Mol Cancer Ther  8, 971-9.   https://doi.org/10.1158/1535-7163.MCT-08-0934




PubMed



        
     
Free Article


 


PubMed ID 19372570
         Pubmed Central ID 2752371 


 



2.
Li Q, Anver MR, Li Z, Butcher DO, Gildersleeve JC (2010). GalNAcalpha1-3Gal, a new prognostic marker for cervical cancer. Int J Cancer  126, 459-68.   https://doi.org/10.1002/ijc.24716




PubMed



        
     
Free Article


 


PubMed ID 19585575
         Pubmed Central ID 2794947 


 



3.
Oyelaran O, Gildersleeve JC (2009). Glycan arrays: recent advances and future challenges. Curr Opin Chem Biol  13, 406-13.   https://doi.org/10.1016/j.cbpa.2009.06.021




PubMed



               Available in future as a Free Article 


 


PubMed ID 19625207
         Pubmed Central ID 2749919 


 



4.
Oyelaran O, Li Q, Farnsworth D, Gildersleeve JC (2009). Microarrays with varying carbohydrate density reveal distinct subpopulations of serum antibodies. J Proteome Res  8, 3529-38.   https://doi.org/10.1021/pr9002245




PubMed



        
     
Free Article


 


PubMed ID 19366269
         Pubmed Central ID 2730745 


 



5.
Zhang Y, Campbell C, Li Q, Gildersleeve JC (2010). Multidimensional glycan arrays for enhanced antibody profiling. Mol Biosyst  6, 1583-91.   https://doi.org/10.1039/c002259d




PubMed



        
     
Free Article


 


PubMed ID 20711537
         Pubmed Central ID 3462433 


 



6.
Zhang Y, Li Q, Rodriguez LG, Gildersleeve JC (2010). An array-based method to identify multivalent inhibitors. J Am Chem Soc  132, 9653-62.   https://doi.org/10.1021/ja100608w




PubMed



        
     
Free Article


 


PubMed ID 20583754
         Pubmed Central ID 2923827",https://intramural.nih.gov/search/searchview.taf?ipid=63060
277,BC010742-05,"October 01, 2009 -  September 30, 2010",Utilizing Glycosyltransferases for Bioconjugation,Pradman  Qasba; PhD,NULL,"Structural Glycobiology Section, NCI","Elizabeth  Boeggeman



Marta  Pasek



Boopathy  Ramakrishna",NULL,Timothy D Veenstra (Office Of The Director),NULL,"Ordered by publication type and then author name.



1.
Boeggeman E, Ramakrishnan B, Pasek M, Manzoni M, Puri A, Loomis KH, Waybright TJ, Qasba PK (2009). Site specific conjugation of fluoroprobes to the remodeled Fc N-glycans of monoclonal antibodies using mutant glycosyltransferases: application for cell surface antigen detection. Bioconjug Chem  20, 1228-36.   https://doi.org/10.1021/bc900103p




PubMed



        
     
Free Article


 


PubMed ID 19425533
         Pubmed Central ID 3464487 


 



2.
Pasek M, Ramakrishnan B, Boeggeman E, Manzoni M, Waybright TJ, Qasba PK (2009). Bioconjugation and detection of lactosamine moiety using alpha1,3-galactosyltransferase mutants that transfer C2-modified galactose with a chemical handle. Bioconjug Chem  20, 608-18.   https://doi.org/10.1021/bc800534r




PubMed



        
     
Free Article


 


PubMed ID 19245254
         Pubmed Central ID 3464485 


 



3.
Ramakrishnan B, Boeggeman E, Manzoni M, Zhu Z, Loomis K, Puri A, Dimitrov DS, Qasba PK (2009). Multiple site-specific in vitro labeling of single-chain antibody. Bioconjug Chem  20, 1383-9.   https://doi.org/10.1021/bc900149r




PubMed



        
     
Free Article


 


PubMed ID 19507852
         Pubmed Central ID 3402211",https://intramural.nih.gov/search/searchview.taf?ipid=63074
278,BC010743-05,"October 01, 2009 -  September 30, 2010",Metabolic Mechanisms for Programmed Cell Death,"James Ming Phang; MD



IRP Faculty Profile",NULL,"Laboratory of Comparative Carcinogenesis, NCI","Gregory L Borchert



Chad Nathaniel Hancock; PhD



Shadi  Khalil



Wei  Liu",NULL,"Lucy M Anderson; PhD (Cellular Pathogenesis Section)



Yih-horng  Shiao (Cellular Pathogenesis Section)



Alan O Perantoni; PhD (Cancer and Developmental Biology Laboratory)",Donna Day Baird; PhD (NIEHS),"Ordered by publication type and then author name.



1.
Liu W, Zabirnyk O, Wang H, Shiao YH, Nickerson ML, Khalil S, Anderson LM, Perantoni AO, Phang JM (2010). miR-23b targets proline oxidase, a novel tumor suppressor protein in renal cancer. Oncogene  29, 4914-24.   https://doi.org/10.1038/onc.2010.237




PubMed



        
     
Free Article


 


PubMed ID 20562915
         Pubmed Central ID 4398970 


 



2.
Liu Y, Borchert GL, Donald SP, Diwan BA, Anver M, Phang JM (2009). Proline oxidase functions as a mitochondrial tumor suppressor in human cancers. Cancer Res  69, 6414-22.   https://doi.org/10.1158/0008-5472.CAN-09-1223




PubMed



        
     
Free Article


 


PubMed ID 19654292
         Pubmed Central ID 4287397",https://intramural.nih.gov/search/searchview.taf?ipid=63052
279,BC010744-05,"October 01, 2009 -  September 30, 2010",Regulation of Proline Oxidase for Bioenergetics during Nutrient Stress,"James Ming Phang; MD



IRP Faculty Profile",NULL,"Laboratory of Comparative Carcinogenesis, NCI","James C Gould



Chad Nathaniel Hancock; PhD



Shadi  Khalil



Wei  Liu","Chien-An  Hu
(Biochemistry & Molecular Biology, U. New Mexico School of Medicine)




Vassiliki  Karantza-Wadsworth
(UMDNJ)




David  Valle
(Johns Hopkins University School of Medicine)",NULL,Donna Day Baird; PhD (NIEHS),"Ordered by publication type and then author name.



1.
Pandhare J, Donald SP, Cooper SK, Phang JM (2009). Regulation and function of proline oxidase under nutrient stress. J Cell Biochem  107, 759-68.   https://doi.org/10.1002/jcb.22174




PubMed



        
     
Free Article


 


PubMed ID 19415679
         Pubmed Central ID 2801574 


 



2.
Seleverstov O, Phang JM, Zabirnyk O (2009). Semiconductor nanocrystals in autophagy research: methodology improvement at nanosized scale. Methods Enzymol  452, 277-96.   https://doi.org/10.1016/S0076-6879(08)03618-5




PubMed


 


PubMed ID 19200889
    
     


 



3.
Tokar EJ, Qu W, Liu J, Liu W, Webber MM, Phang JM, Waalkes MP (2010). Arsenic-specific stem cell selection during malignant transformation. J Natl Cancer Inst  102, 638-49.   https://doi.org/10.1093/jnci/djq093




PubMed



        
     
Free Article


 


PubMed ID 20339138
         Pubmed Central ID 2864291",https://intramural.nih.gov/search/searchview.taf?ipid=63053
280,BC010746-05,"October 01, 2009 -  September 30, 2010",Extracellular Matrix and Stress Substrates: the Role of Prolidase,"James Ming Phang; MD



IRP Faculty Profile",NULL,"Laboratory of Comparative Carcinogenesis, NCI","Gregory L Borchert



Kyle  Christian","Antonella  Forlino
(University of Pavia)




Teresa  Gunn
(McLaughlin Research Institute)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63054
281,BC010747-05,"October 01, 2009 -  September 30, 2010",Charaterization of the Expression and Ligands of KIR3DS1,"Daniel  McVicar; PhD



IRP Faculty Profile",NULL,"Laboratory of Experimental Immunology, NCI","Mary  Carrington; MS, PhD



Geraldine Martina O'Connor



Stephen K Anderson; PhD","Marcus  Altfeld
(Infectious Disease Unit, Partners AIDS Research Center)




Bernardo  Galvao-Castro
(Goncalo Moniz Research Center)",James Jerome Goedert; MD (Infection & Immunoepidemiology Branch),"Suk See De Ravin; MD, PhD (NIAID)","Ordered by publication type and then author name.



1.
Thomas R, Apps R, Qi Y, Gao X, Male V, O'hUigin C, O'Connor G, Ge D, Fellay J, Martin JN, Margolick J, Goedert JJ, Buchbinder S, Kirk GD, Martin MP, Telenti A, Deeks SG, Walker BD, Goldstein D, McVicar DW, Moffett A, Carrington M (2009). HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C. Nat Genet  41, 1290-4.   https://doi.org/10.1038/ng.486




PubMed



        
     
Free Article


 


PubMed ID 19935663
         Pubmed Central ID 2887091",https://intramural.nih.gov/search/searchview.taf?ipid=63047
282,BC010748-05,"October 01, 2009 -  September 30, 2010",Clinical Investigation of Signal Transduction Inhibitors,"Phillip A Dennis; MD, PhD",NULL,"Medical Oncology Branch, NCI","Giuseppe  Giaccone; MD



Betsy J Morrow



William D Figg; PharmD",NULL,"Joanna H Shih (Biometrics Research Branch)



Ilona  Linnoila; MD (Laboratory Of Genitourinary Cancer Pathogenesis)



Seth M Steinberg; PhD (Office of the Director)



Stephen M Hewitt; MD, PhD (Laboratory of Pathology)",NULL,"Ordered by publication type and then author name.



1.
Dennis PA (2009). Rapamycin for chemoprevention of upper aerodigestive tract cancers. Cancer Prev Res (Phila)  2, 7-9.   https://doi.org/10.1158/1940-6207.CAPR-08-0215




PubMed


 


PubMed ID 19139011
    
     


 



2.
Han W, Gills JJ, Memmott RM, Lam S, Dennis PA (2009). The chemopreventive agent myoinositol inhibits Akt and extracellular signal-regulated kinase in bronchial lesions from heavy smokers. Cancer Prev Res (Phila)  2, 370-6.   https://doi.org/10.1158/1940-6207.CAPR-08-0209




PubMed



        
     
Free Article


 


PubMed ID 19336734
         Pubmed Central ID 3715041 


 



3.
Wang Y, Digiovanna JJ, Stern JB, Hornyak TJ, Raffeld M, Khan SG, Oh KS, Hollander MC, Dennis PA, Kraemer KH (2009). Evidence of ultraviolet type mutations in xeroderma pigmentosum melanomas. Proc Natl Acad Sci U S A  106, 6279-84.   https://doi.org/10.1073/pnas.0812401106




PubMed



        
     
Free Article


 


PubMed ID 19329485
         Pubmed Central ID 2669353",https://intramural.nih.gov/search/searchview.taf?ipid=63042
283,BC010749-05,"October 01, 2009 -  September 30, 2010",DNA Vaccines,"George N Pavlakis; MD, PhD



IRP Faculty Profile",NULL,"Vaccine Branch, NCI","Rachel Elizabeth Kelly Beach



Bhabadeb S Chowdhury; PhD



Samir N. Khleif; MD



Adriana Paola  Martin Morales; MD



Barbara K Felber



Vainav Vikram Patel



Show all 12","J. Thomas  August
(Molecular Biology and Genetics Department, Johns Hopkins University School of Medicine)




Christian  Brander
(AIDS Research Center, Massachusetts General Hospital)




Ronald  Desrosiers
(New England Primate Research Center)




Angelos  Hatzakis
(University of Athens Medical School)




David  Heckerman
(Microsoft Research)




Richard  Heller
(Old Dominion University)


Show all 26","Claes  Ohlen (Office Of The Director)



Giorgio  Trinchieri (Cancer Inflammation Program)



Jeffrey D Lifson; MD (Office Of The Director)","Konstantinos  Petrovas (NIAID) 



Richard A Koup; MD (NIAID)","Ordered by publication type and then author name.



1.
Petrovas C, Chaon B, Ambrozak DR, Price DA, Melenhorst JJ, Hill BJ, Geldmacher C, Casazza JP, Chattopadhyay PK, Roederer M, Douek DC, Mueller YM, Jacobson JM, Kulkarni V, Felber BK, Pavlakis GN, Katsikis PD, Koup RA (2009). Differential association of programmed death-1 and CD57 with ex vivo survival of CD8+ T cells in HIV infection. J Immunol  183, 1120-32.   https://doi.org/10.4049/jimmunol.0900182




PubMed



        
     
Free Article


 


PubMed ID 19564339
         Pubmed Central ID 2923541 


 



2.
Rosati M, Bergamaschi C, Valentin A, Kulkarni V, Jalah R, Alicea C, Patel V, von Gegerfelt AS, Montefiori DC, Venzon DJ, Khan AS, Draghia-Akli R, Van Rompay KK, Felber BK, Pavlakis GN (2009). DNA vaccination in rhesus macaques induces potent immune responses and decreases acute and chronic viremia after SIVmac251 challenge. Proc Natl Acad Sci U S A  106, 15831-6.   https://doi.org/10.1073/pnas.0902628106




PubMed



        
     
Free Article


 


PubMed ID 19717425
         Pubmed Central ID 2734879 


 



3.
Valentin A, Chikhlikar P, Patel V, Rosati M, Maciel M, Chang KH, Silvera P, Felber BK, Pavlakis GN, August JT, Marques ET (2009). Comparison of DNA vaccines producing HIV-1 Gag and LAMP/Gag chimera in rhesus macaques reveals antigen-specific T-cell responses with distinct phenotypes. Vaccine  27, 4840-9.   https://doi.org/10.1016/j.vaccine.2009.05.093




PubMed



        
     
Free Article


 


PubMed ID 19539586
         Pubmed Central ID 2743166",https://intramural.nih.gov/search/searchview.taf?ipid=63050
284,BC010750-05,"October 01, 2009 -  September 30, 2010",Cytokines in AIDS and Cancer,"George N Pavlakis; MD, PhD



IRP Faculty Profile",NULL,"Vaccine Branch, NCI","Eirini  Christodoulaki



Barbara K Felber



Rachel Elizabeth Kelly Beach



Bhabadeb S Chowdhury; PhD



Brunda  Ganneru; PhD



Ashish  Singh; PhD



Show all 8","Angelos  Hatzakis
(University of Athens Medical School)




Richard  Heller
(Old Dominion University)




Amir  Khan
(VGX Pharmaceuticals)




Maninder  Sidhu
(Wyeth Vaccines Research)




David  Weiner
(University of Pennsylvania)","Claes  Ohlen (Office Of The Director)



Giorgio  Trinchieri (Cancer Inflammation Program)



Jeffrey D Lifson; MD (Office Of The Director)



Howard A Young; PhD (Laboratory of Experimental Immunology)",NULL,"Ordered by publication type and then author name.



1.
Petrovas C, Chaon B, Ambrozak DR, Price DA, Melenhorst JJ, Hill BJ, Geldmacher C, Casazza JP, Chattopadhyay PK, Roederer M, Douek DC, Mueller YM, Jacobson JM, Kulkarni V, Felber BK, Pavlakis GN, Katsikis PD, Koup RA (2009). Differential association of programmed death-1 and CD57 with ex vivo survival of CD8+ T cells in HIV infection. J Immunol  183, 1120-32.   https://doi.org/10.4049/jimmunol.0900182




PubMed



        
     
Free Article


 


PubMed ID 19564339
         Pubmed Central ID 2923541 


 



2.
Salcedo R, Hixon JA, Stauffer JK, Jalah R, Brooks AD, Khan T, Dai RM, Scheetz L, Lincoln E, Back TC, Powell D, Hurwitz AA, Sayers TJ, Kastelein R, Pavlakis GN, Felber BK, Trinchieri G, Wigginton JM (2009). Immunologic and therapeutic synergy of IL-27 and IL-2: enhancement of T cell sensitization, tumor-specific CTL reactivity and complete regression of disseminated neuroblastoma metastases in the liver and bone marrow. J Immunol  182, 4328-38.   https://doi.org/10.4049/jimmunol.0800471




PubMed



        
     
Free Article


 


PubMed ID 19299733
         Pubmed Central ID 2730673 


 



3.
Uranishi H, Zolotukhin AS, Lindtner S, Warming S, Zhang GM, Bear J, Copeland NG, Jenkins NA, Pavlakis GN, Felber BK (2009). The RNA-binding motif protein 15B (RBM15B/OTT3) acts as cofactor of the nuclear export receptor NXF1. J Biol Chem  284, 26106-16.   https://doi.org/10.1074/jbc.M109.040113




PubMed



        
     
Free Article


 


PubMed ID 19586903
         Pubmed Central ID 2758010 


 



4.
Zolotukhin AS, Uranishi H, Lindtner S, Bear J, Pavlakis GN, Felber BK (2009). Nuclear export factor RBM15 facilitates the access of DBP5 to mRNA. Nucleic Acids Res  37, 7151-62.   https://doi.org/10.1093/nar/gkp782




PubMed



        
     
Free Article


 


PubMed ID 19786495
         Pubmed Central ID 2790900",https://intramural.nih.gov/search/searchview.taf?ipid=63051
285,BC010752-05,"October 01, 2009 -  September 30, 2010",Anti-angiogenesis targeted vaccine therapy,Samir N. Khleif; MD,NULL,"Vaccine Branch, NCI",Estella Callie Raulfs,NULL,"Steven  Libutti; MD (Surgery Branch)



Michael  Birrer (Laboratory Of Genitourinary Cancer Pathogenesis)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63067
286,BC010755-05,"October 01, 2009 -  September 30, 2010",Enhancing immune response strategies:,Samir N. Khleif; MD,NULL,"Vaccine Branch, NCI","Maher Yacoub Abdalla; PhD



Lotta Kristina Gustafsson



Mikayel  Mkrtichyan; PhD



Yana George Najjar; MD



Masaki  Terabe



Laurent L Ozbun



Show all 9","Vincent  Herrin; MD





Emanuel  Petricoin; PhD
(George Mason University)","John  Schiller; PhD (Laboratory of Cellular Oncology)



Yuk Ying S Pang (Laboratory of Cellular Oncology)



Barry  Gause; PhD (Medical Oncology Branch)



Franklin R Grollman (Medical Oncology Branch)



David J Venzon; PhD (Biostatistics and Data Management Section)",Francesco M. Marincola; MD (CC),"Ordered by publication type and then author name.



1.
Rahma OE, Ashtar E, Ibrahim R, Toubaji A, Gause B, Herrin VE, Linehan WM, Steinberg SM, Grollman F, Grimes G, Bernstein SA, Berzofsky JA, Khleif SN (2010). A pilot clinical trial testing mutant von Hippel-Lindau peptide as a novel immune therapy in metastatic renal cell carcinoma. J Transl Med  8, 8.   https://doi.org/10.1186/1479-5876-8-8




PubMed



        
     
Free Article


 


PubMed ID 20109232
         Pubmed Central ID 2843651",https://intramural.nih.gov/search/searchview.taf?ipid=63068
287,BC010756-05,"October 01, 2009 -  September 30, 2010",Development a combined prophylactic and therapeutic cervical cancer vaccine u,Samir N. Khleif; MD,NULL,"Vaccine Branch, NCI","Jay Arthur Berzofsky; MD, PhD","Joe  Lucci
(Gynecologic Oncology, University of Florida)




Joan  Walker
(University of Oklahoma Health Sciences Center)",John  Schiller; PhD (Laboratory of Cellular Oncology),NULL,"Ordered by publication type and then author name.



1.
Samara RN, Khleif SN (2009). HPV as a model for the development of prophylactic and therapeutic cancer vaccines. Curr Mol Med  9, 766-73.   https://doi.org/10.2174/156652409788970625




PubMed



        
     
Free Article


 


PubMed ID 19689303
         Pubmed Central ID 6948838",https://intramural.nih.gov/search/searchview.taf?ipid=63069
288,BC010757-05,"October 01, 2009 -  September 30, 2010",Clinical trial development in cancer vaccines,Samir N. Khleif; MD,NULL,"Vaccine Branch, NCI","Jay Arthur Berzofsky; MD, PhD



Osama Entoun Rahma; MD","Vincent  Herrin; MD





Joe  Lucci
(Gynecologic Oncology, University of Florida)




Therresa  Whiteside
(Immuunoligy, University of Pittsburg)","Barry  Gause; PhD (Medical Oncology Branch)



Franklin R Grollman (Medical Oncology Branch)



David J Venzon; PhD (Biostatistics and Data Management Section)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63070
289,BC010759-05,"October 01, 2009 -  September 30, 2010",Functional Genomics of Sarcoma,"Paul S Meltzer; MD, PhD



IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","Ogan D Abaan



Princy  Francis



Arthur A Glatfelter; MS



Yuan  Jiang; MD



Jeffrey Anderson Knight



John E Lueders



Show all 11","Laurakay  Bruhn
(Genomics Institute, Agilent Technologies)




Charles  Keller
(University of Texas)",NULL,NULL,"Ordered by publication type and then author name.



1.
Kauer M, Ban J, Kofler R, Walker B, Davis S, Meltzer P, Kovar H (2009). A molecular function map of Ewing's sarcoma. PLoS One  4, e5415.   https://doi.org/10.1371/journal.pone.0005415




PubMed



        
     
Free Article


 


PubMed ID 19404404
         Pubmed Central ID 2671847 


 



2.
Paoloni M, Davis S, Lana S, Withrow S, Sangiorgi L, Picci P, Hewitt S, Triche T, Meltzer P, Khanna C (2009). Canine tumor cross-species genomics uncovers targets linked to osteosarcoma progression. BMC Genomics  10, 625.   https://doi.org/10.1186/1471-2164-10-625




PubMed



        
     
Free Article


 


PubMed ID 20028558
         Pubmed Central ID 2803201",https://intramural.nih.gov/search/searchview.taf?ipid=63072
290,BC010761-05,"October 01, 2009 -  September 30, 2010",Studies of Proteins with Important Roles in Immunology andor Cancer Biology,Jacek Tadeusz Lubkowski,NULL,"Macromolecular Crystallography Laboratory, NCI","Reetesh Raj Akhouri



Di  Zhang","Roy  Duhe
(University of Mississippi, Medical Center)




Mei  Hong
(Iowa State University,)




Jan  Konvalinka
(Institute of Organic Chemistry and Biochemistry, Academy of Sciences of Czech Republic)




Wuyuan  Lu
(Institute of Virology, University of Maryland)




Martin G Pomper





Scott  Sieg
(Department of Biological Sciences, Case Western Reserve University)


Show all 8","Daniel  McVicar; PhD (Laboratory of Experimental Immunology)



Shioko  Kimura; PhD (Endocrinology Section)



Joost J Oppenheim; MD (Laboratory of Molecular Immunoregulation)",John J O'Shea; MD (NIAMS),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63071
291,BC010762-05,"October 01, 2009 -  September 30, 2010",Molecular Alterations of Primary Breast Cancer and Metastasis,"Maria  Merino; PhD



IRP Faculty Profile",NULL,"Laboratory of Pathology, NCI",Beatriz  Walter-rodriguez; MD,NULL,Patricia  Steeg; PhD (Developmental Therapeutics Branch),NULL,"Ordered by publication type and then author name.



1.
Palmieri D, Fitzgerald D, Shreeve SM, Hua E, Bronder JL, Weil RJ, Davis S, Stark AM, Merino MJ, Kurek R, Mehdorn HM, Davis G, Steinberg SM, Meltzer PS, Aldape K, Steeg PS (2009). Analyses of resected human brain metastases of breast cancer reveal the association between up-regulation of hexokinase 2 and poor prognosis. Mol Cancer Res  7, 1438-45.   https://doi.org/10.1158/1541-7786.MCR-09-0234




PubMed



        
     
Free Article


 


PubMed ID 19723875
         Pubmed Central ID 2746883",https://intramural.nih.gov/search/searchview.taf?ipid=63073
292,BC010763-05,"October 01, 2009 -  September 30, 2010",Building on the success of the adoptive immunotherapy of cancer,"Nicholas Phillip Restifo; MD



IRP Faculty Profile",NULL,"Surgery Branch, NCI","Megan Elizabeth Bachinski



Dorina  Frasheri



Luca  Gattinoni



Yun  Ji



James Chung-Yin Yang; MD, PhD



Sidharth  Kerkar



Show all 16","Paul  Antony
(Univeristy of Maryland)




Vincenzo  Bronte





Carl  June
(Univesity of Pennsylvania)




Michelle  Krogsgaard
(New York University)




Ton  Schumacher
(Netherlands Cancer Institute)




Christopher  Touloukian
(Indianna University)",Giorgio  Trinchieri (Cancer Inflammation Program),"Robert L Danner; MD (CC) 



Mario  Roederer; PhD (NIAID)","Ordered by publication type and then author name.



1.
Brandmaier AG, Leitner WW, Ha SP, Sidney J, Restifo NP, Touloukian CE (2009). High-avidity autoreactive CD4+ T cells induce host CTL, overcome T(regs) and mediate tumor destruction. J Immunother  32, 677-88.   https://doi.org/10.1097/CJI.0b013e3181ab1824




PubMed



        
     
Free Article


 


PubMed ID 19561540
         Pubmed Central ID 2747815 


 



2.
Gattinoni L, Klebanoff CA, Restifo NP (2009). Pharmacologic induction of CD8+ T cell memory: better living through chemistry. Sci Transl Med  1, 11ps12.   https://doi.org/10.1126/scitranslmed.3000302




PubMed



        
     
Free Article


 


PubMed ID 20371454
         Pubmed Central ID 3241001 


 



3.
Gattinoni L, Zhong XS, Palmer DC, Ji Y, Hinrichs CS, Yu Z, Wrzesinski C, Boni A, Cassard L, Garvin LM, Paulos CM, Muranski P, Restifo NP (2009). Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells. Nat Med  15, 808-13.   https://doi.org/10.1038/nm.1982




PubMed



        
     
Free Article


 


PubMed ID 19525962
         Pubmed Central ID 2707501 


 



4.
Hinrichs CS, Borman ZA, Cassard L, Gattinoni L, Spolski R, Yu Z, Sanchez-Perez L, Muranski P, Kern SJ, Logun C, Palmer DC, Ji Y, Reger RN, Leonard WJ, Danner RL, Rosenberg SA, Restifo NP (2009). Adoptively transferred effector cells derived from naive rather than central memory CD8+ T cells mediate superior antitumor immunity. Proc Natl Acad Sci U S A  106, 17469-74.   https://doi.org/10.1073/pnas.0907448106




PubMed



        
     
Free Article


 


PubMed ID 19805141
         Pubmed Central ID 2762661 


 



5.
Hinrichs CS, Kaiser A, Paulos CM, Cassard L, Sanchez-Perez L, Heemskerk B, Wrzesinski C, Borman ZA, Muranski P, Restifo NP (2009). Type 17 CD8+ T cells display enhanced antitumor immunity. Blood  114, 596-9.   https://doi.org/10.1182/blood-2009-02-203935




PubMed



        
     
Free Article


 


PubMed ID 19471017
         Pubmed Central ID 2713473 


 



6.
Johnson LA, Morgan RA, Dudley ME, Cassard L, Yang JC, Hughes MS, Kammula US, Royal RE, Sherry RM, Wunderlich JR, Lee CC, Restifo NP, Schwarz SL, Cogdill AP, Bishop RJ, Kim H, Brewer CC, Rudy SF, VanWaes C, Davis JL, Mathur A, Ripley RT, Nathan DA, Laurencot CM, Rosenberg SA (2009). Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen. Blood  114, 535-46.   https://doi.org/10.1182/blood-2009-03-211714




PubMed



        
     
Free Article


 


PubMed ID 19451549
         Pubmed Central ID 2929689 


 



7.
Klebanoff CA, Yu Z, Hwang LN, Palmer DC, Gattinoni L, Restifo NP (2009). Programming tumor-reactive effector memory CD8+ T cells in vitro obviates the requirement for in vivo vaccination. Blood  114, 1776-83.   https://doi.org/10.1182/blood-2008-12-192419




PubMed



        
     
Free Article


 


PubMed ID 19561320
         Pubmed Central ID 2738567 


 



8.
Palmer DC, Restifo NP (2009). Suppressors of cytokine signaling (SOCS) in T cell differentiation, maturation, and function. Trends Immunol  30, 592-602.   https://doi.org/10.1016/j.it.2009.09.009




PubMed



        
     
Free Article


 


PubMed ID 19879803
         Pubmed Central ID 2787651 


 



9.
Schumacher TN, Restifo NP (2009). Adoptive T cell therapy of cancer. Curr Opin Immunol  21, 187-9.   https://doi.org/10.1016/j.coi.2009.03.006




PubMed



        
     
Free Article


 


PubMed ID 19328668
         Pubmed Central ID 2693351 


 



10.
Tewalt EF, Grant JM, Granger EL, Palmer DC, Heuss ND, Gregerson DS, Restifo NP, Norbury CC (2009). Viral sequestration of antigen subverts cross presentation to CD8(+) T cells. PLoS Pathog  5, e1000457.   https://doi.org/10.1371/journal.ppat.1000457




PubMed



        
     
Free Article


 


PubMed ID 19478869
         Pubmed Central ID 2680035 


 



11.
Yeh S, Karne NK, Kerkar SP, Heller CK, Palmer DC, Johnson LA, Li Z, Bishop RJ, Wong WT, Sherry RM, Yang JC, Dudley ME, Restifo NP, Rosenberg SA, Nussenblatt RB (2009). Ocular and systemic autoimmunity after successful tumor-infiltrating lymphocyte immunotherapy for recurrent, metastatic melanoma. Ophthalmology  116, 981-989.e1.   https://doi.org/10.1016/j.ophtha.2008.12.004




PubMed



        
     
Free Article


 


PubMed ID 19410956
         Pubmed Central ID 2715843",https://intramural.nih.gov/search/searchview.taf?ipid=63075
293,BC010766-04,"October 01, 2009 -  September 30, 2010",High Throughput Isolation of Antigen Specific T-cells for Cancer Therapy,Udai S Kammula,NULL,"Surgery Branch, NCI","Tamara A Aghamolla



Melissa Marie Alvarez Downing; MD



Yu Matthew Chiu



Tejaswi Venkata Mudigonda



Anran  Wang",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63156
294,BC010767-04,"October 01, 2009 -  September 30, 2010",Biosynthesis of Selenocysteine and Its Incorporation into Protein,"Dolph Lee Hatfield; PhD



IRP Faculty Profile",NULL,"Laboratory of Cancer Prevention, NCI","Ryuta  Tobe



Xueming  Xu



Bradley A Carlson



Ellen Guan Zhang



Min-Hyuk  Yoo","Marla  Berry
(Molecular Biology, U of Hawaii)




Vadim  Gladyshev
(University of Nebraska)




Byeong Jae  Lee
(Seoul National University)




Ulrich  Schweizer
(Neuroscience Research Center and, Charit-Universittsmedizin Berlin)




Markus  Wahl
(X-Ray Crystallography, Max-Planck-Institute for Biophysical Chemistry)",NULL,NULL,"Ordered by publication type and then author name.



1.
Hatfield D, Hatfield D (2009) Selenocysteine biosynthesis, selenoproteins and selenoproteomes, in Recoding: Expansion of decoding rules enriches gene expression. Springer+Science Media, LLC (New York) Volume 1, pp. 3-27.




 



2.
Kim JY, Lee KH, Shim MS, Shin H, Xu XM, Carlson BA, Hatfield DL, Lee BJ (2010). Human selenophosphate synthetase 1 has five splice variants with unique interactions, subcellular localizations and expression patterns. Biochem Biophys Res Commun  397, 53-8.   https://doi.org/10.1016/j.bbrc.2010.05.055




PubMed



        
     
Free Article


 


PubMed ID 20471958
         Pubmed Central ID 2924440 


 



3.
Shim MS, Kim JY, Jung HK, Lee KH, Xu XM, Carlson BA, Kim KW, Kim IY, Hatfield DL, Lee BJ (2009). Elevation of glutamine level by selenophosphate synthetase 1 knockdown induces megamitochondrial formation in Drosophila cells. J Biol Chem  284, 32881-94.   https://doi.org/10.1074/jbc.M109.026492




PubMed



        
     
Free Article


 


PubMed ID 19755423
         Pubmed Central ID 2781704 


 



4.
Turanov AA, Lobanov AV, Fomenko DE, Morrison HG, Sogin ML, Klobutcher LA, Hatfield DL, Gladyshev VN (2009). Genetic code supports targeted insertion of two amino acids by one codon. Science  323, 259-61.   https://doi.org/10.1126/science.1164748




PubMed



        
     
Free Article


 


PubMed ID 19131629
         Pubmed Central ID 3088105",https://intramural.nih.gov/search/searchview.taf?ipid=63158
295,BC010768-04,"October 01, 2009 -  September 30, 2010","Isolation, Propagation and Characterization of Breast Stem Cells",Barbara V Vonderhaar; PhD,NULL,"Mammary Biology and Tumorigenesis Laboratory, NCI","Jodie  Fleming



David  Salomon; PhD



Erika P Ginsburg



Gilbert  Smith; PhD



Michal Antoni Kidacki



Jennie Gear McCollum","Pepper  Schedin
(University of Colorado)




Luigi  Strizzi",David  Danforth (Surgery Branch),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63159
296,BC010770-04,"October 01, 2009 -  September 30, 2010",Genotoxicity and mitochondrial toxicity of antiretroviral NRTI and PI drugs,Miriam Christine Poirier; PhD,NULL,"Laboratory of Cancer Biology and Genetics, NCI","Yongmin  Liu



Phuonggiang T Nguyen



Ofelia  Olivero; PhD","Steve  Lipshultz
(University of Miami Medical School)




Kris  Oursler
(Veterans Administration Hospital)




Maria  Rugeles
(Immunovirology, Unversidad de Antioquia)




Dale  Walker
(BioMosaics, Inc.)




Vernon  Walker
(University of Vermont)","Genoveffa  Franchini; MD (Vaccine Branch)



Ettore  Appella; MD (Chemical Immunology Section)



Marjorie  Robert-Guroff; PhD (Vaccine Branch)



Gene  Shearer; PhD (Cell Mediated Immunity Section)",NULL,"Ordered by publication type and then author name.



1.
Borojerdi JP, Ming J, Cooch C, Ward Y, Semino-Mora C, Yu M, Braun HM, Taylor BJ, Poirier MC, Olivero OA (2009). Centrosomal amplification and aneuploidy induced by the antiretroviral drug AZT in hamster and human cells. Mutat Res  665, 67-74.   https://doi.org/10.1016/j.mrfmmm.2009.03.004




PubMed



        
     
Free Article


 


PubMed ID 19427513
         Pubmed Central ID 2680773 


 



2.
Poirier MC, Olivero OA, Hardy AW, Franchini G, Borojerdi JP, Walker VE, Walker DM, Shearer GM (2009). Antiretroviral activity of the aminothiol WR1065 against Human Immunodeficiency virus (HIV-1) in vitro and Simian Immunodeficiency virus (SIV) ex vivo. AIDS Res Ther  6, 24.   https://doi.org/10.1186/1742-6405-6-24




PubMed



        
     
Free Article


 


PubMed ID 19895691
         Pubmed Central ID 2777914 


 



3.
Walker DM, Kajon AE, Torres SM, Carter MM, McCash CL, Swenberg JA, Upton PB, Hardy AW, Olivero OA, Shearer GM, Poirier MC, Walker VE (2009). WR1065 mitigates AZT-ddI-induced mutagenesis and inhibits viral replication. Environ Mol Mutagen  50, 460-72.   https://doi.org/10.1002/em.20482




PubMed



        
     
Free Article


 


PubMed ID 19334055
         Pubmed Central ID 3197270 


 



4.
Yu M, Ward Y, Poirier MC, Olivero OA (2009). Centrosome amplification induced by the antiretroviral nucleoside reverse transcriptase inhibitors lamivudine, stavudine, and didanosine. Environ Mol Mutagen  50, 718-24.   https://doi.org/10.1002/em.20509




PubMed



        
     
Free Article


 


PubMed ID 19562754
         Pubmed Central ID 2760687",https://intramural.nih.gov/search/searchview.taf?ipid=63163
297,BC010771-04,"October 01, 2009 -  September 30, 2010",Medusa(TM) Sequencer,Thomas Dana Schneider; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI",NULL,"James  Adair
(www.keystonenano.com, Keystone Nano)




Raul Eduardo Cachau





Joseph  Lakowicz
(Department of Biochemistry, Center for Fluorescence Spectroscopy, University of Maryland School of Medicine)




Stephen  Lockett
(SAIC Frederick, Inc.)




Chandran  Sabanayagam
(Department of Physics and Pre-engineering, Delaware State University)",NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=63160
298,BC010772-04,"October 01, 2009 -  September 30, 2010",Rod-Tether Nanoprobe,Thomas Dana Schneider; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI",NULL,"James  Adair
(www.keystonenano.com, Keystone Nano)




Raul Eduardo Cachau





Neil  Zimmerman
(College of Medicine, NIST)",Robert J Fisher (Office Of The Director),NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=63161
299,BC010773-04,"October 01, 2009 -  September 30, 2010",Interactions of APOBEC3 Proteins with Murine Leukemia Viruses,"Alan  Rein; PhD



IRP Faculty Profile",NULL,"Retroviral Replication Laboratory, NCI","Amanda  Aloia



Demetria P Harvin



Jane  Mirro



Smita  Nair; PhD



Silvia  Sanchez Martinez","John  Coffin
(Tufts University)




Patric  Jern
(Tufts University)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63162
300,BC010774-04,"October 01, 2009 -  September 30, 2010",T Cell Alternative p38 Activation Pathway,"Jonathan D Ashwell; MD



IRP Faculty Profile",NULL,"Laboratory of Immune Cell Biology, NCI","Muhammad Shamsul Alam



Maria Letizia  Giardino Torchia",NULL,Ettore  Appella; MD (Chemical Immunology Section),Dragana  Jankovic; PhD (NIAID),"Ordered by publication type and then author name.



1.
Jirmanova L, Ashwell JD (2010). T cell priming: let there be light. Cell Res  20, 608-10.   https://doi.org/10.1038/cr.2010.72




PubMed


 


PubMed ID 20502440
    
     


 



2.
Jirmanova L, Sarma DN, Jankovic D, Mittelstadt PR, Ashwell JD (2009). Genetic disruption of p38alpha Tyr323 phosphorylation prevents T-cell receptor-mediated p38alpha activation and impairs interferon-gamma production. Blood  113, 2229-37.   https://doi.org/10.1182/blood-2008-04-153304




PubMed



        
     
Free Article


 


PubMed ID 19011223
         Pubmed Central ID 2652368 


 



3.
Mittelstadt PR, Yamaguchi H, Appella E, Ashwell JD (2009). T cell receptor-mediated activation of p38{alpha} by mono-phosphorylation of the activation loop results in altered substrate specificity. J Biol Chem  284, 15469-74.   https://doi.org/10.1074/jbc.M901004200




PubMed



        
     
Free Article


 


PubMed ID 19324872
         Pubmed Central ID 2708844",https://intramural.nih.gov/search/searchview.taf?ipid=63083
301,BC010775-04,"October 01, 2009 -  September 30, 2010","Retroviral Gag Trafficking, Env Incorporation, and Virus Assembly","Eric O Freed; PhD



IRP Faculty Profile",NULL,"Retroviral Replication Laboratory, NCI","Sherimay  Ablan



Wei-Shau  Hu; PhD



Muthukumar  Balasubramaniam



Mary Ann  Checkley



Sagar Bhalchandra Kudchodkar



Vineet Narain KewalRamani; PhD



Show all 11","Angela Maria Gronenborn; PhD
(Department of Structural Biology, University of Pittsburgh)




Scott  Morham
(Myriad Pharmaceuticals)




Tsutomu  Murakami
(National Institute of Infectious Diseases)




Akira  Ono
(University of Michigan)




Tatyana  Polenova; PhD
(University of Delaware)




Jamil  Saad
(University of Alabama)


Show all 8","Robert J Fisher (Office Of The Director)



Sriram  Subramaniam; PhD (Laboratory of Cell Biology)","Juan S Bonifacino; PhD (NICHD) 



Judith Goldstein Levin; PhD (NICHD) 



Jennifer A Lippincott Schwartz; PhD (NICHD)","Ordered by publication type and then author name.



1.
Adamson CS, Freed EO (2010). Novel approaches to inhibiting HIV-1 replication. Antiviral Res  85, 119-41.   https://doi.org/10.1016/j.antiviral.2009.09.009




PubMed



        
     
Free Article


 


PubMed ID 19782103
         Pubmed Central ID 2815006 


 



2.
Bennett AE, Narayan K, Shi D, Hartnell LM, Gousset K, He H, Lowekamp BC, Yoo TS, Bliss D, Freed EO, Subramaniam S (2009). Ion-abrasion scanning electron microscopy reveals surface-connected tubular conduits in HIV-infected macrophages. PLoS Pathog  5, e1000591.   https://doi.org/10.1371/journal.ppat.1000591




PubMed



        
     
Free Article


 


PubMed ID 19779568
         Pubmed Central ID 2743285 


 



3.
Freed E, Freed E (2010) HIV-1 Gag as a target for antiviral therapy. Curr Top Med Chem, in press.




 



4.
Freed E, Freed E (2010) Macrophages and cell-cell spread of HIV-1. Viruses, in press.




 



5.
Joshi A, Nagashima K, Freed EO (2009). Defects in cellular sorting and retroviral assembly induced by GGA overexpression. BMC Cell Biol  10, 72.   https://doi.org/10.1186/1471-2121-10-72




PubMed



        
     
Free Article


 


PubMed ID 19788741
         Pubmed Central ID 2760529 


 



6.
Luttge BG, Freed EO (2010). FIV Gag: virus assembly and host-cell interactions. Vet Immunol Immunopathol  134, 3-13.   https://doi.org/10.1016/j.vetimm.2009.10.003




PubMed



        
     
Free Article


 


PubMed ID 19910057
         Pubmed Central ID 2822131",https://intramural.nih.gov/search/searchview.taf?ipid=63098
302,BC010776-04,"October 01, 2009 -  September 30, 2010",Retrovirus Budding and Endosomal Sorting,"Eric O Freed; PhD



IRP Faculty Profile",NULL,"Retroviral Replication Laboratory, NCI","Sherimay  Ablan



Muthukumar  Balasubramaniam



Mary Ann  Checkley



Lillian Susanna Kuo; PhD



Benjamin G Luttge



Philip Richard Tedbury



Show all 9","Scott  Morham
(Myriad Pharmaceuticals)




Jamil  Saad
(University of Alabama)




Michael  Summers
(University of Maryland, Baltimore County)","Timothy D Veenstra (Office Of The Director)



Robert J Fisher (Office Of The Director)



Terrence R Burke; PhD (Chemical Biology Laboratory)



Sriram  Subramaniam; PhD (Laboratory of Cell Biology)","Juan S Bonifacino; PhD (NICHD) 



Douglas S Auld (NHGRI) 



James H Hurley; PhD (NIDDK)","Ordered by publication type and then author name.



1.
Adamson CS, Freed EO (2010). Novel approaches to inhibiting HIV-1 replication. Antiviral Res  85, 119-41.   https://doi.org/10.1016/j.antiviral.2009.09.009




PubMed



        
     
Free Article


 


PubMed ID 19782103
         Pubmed Central ID 2815006 


 



2.
Freed E, Freed E (2010) HIV-1 Gag as a target for antiviral therapy. Curr Top Med Chem, in press.




 



3.
Freed E, Freed E (2010) Macrophages and cell-cell spread of HIV-1. Viruses, in press.




 



4.
Freed E, Kuo L, Ren X, Burgos P, Zhao X, Burke T, Bonifacino J, Freed E, Hurley J (2010) Crystallographic and functional analysis of the ESCRT-1HIV-1 Gag PTAP interaction. Structure, in press.




 



5.
Joshi A, Nagashima K, Freed EO (2009). Defects in cellular sorting and retroviral assembly induced by GGA overexpression. BMC Cell Biol  10, 72.   https://doi.org/10.1186/1471-2121-10-72




PubMed



        
     
Free Article


 


PubMed ID 19788741
         Pubmed Central ID 2760529 


 



6.
Liu F, Stephen AG, Waheed AA, Freed EO, Fisher RJ, Burke TR (2010). Application of ring-closing metathesis macrocyclization to the development of Tsg101-binding antagonists. Bioorg Med Chem Lett  20, 318-21.   https://doi.org/10.1016/j.bmcl.2009.10.105




PubMed



        
     
Free Article


 


PubMed ID 19914066
         Pubmed Central ID 2818493 


 



7.
Luttge BG, Freed EO (2010). FIV Gag: virus assembly and host-cell interactions. Vet Immunol Immunopathol  134, 3-13.   https://doi.org/10.1016/j.vetimm.2009.10.003




PubMed



        
     
Free Article


 


PubMed ID 19910057
         Pubmed Central ID 2822131",https://intramural.nih.gov/search/searchview.taf?ipid=63099
303,BC010777-04,"October 01, 2009 -  September 30, 2010",Lipid Microdomains and HIV-1 Replication,"Eric O Freed; PhD



IRP Faculty Profile",NULL,"Retroviral Replication Laboratory, NCI","Sherimay  Ablan



Abdul Latheef Abdul Waheed



Kayoko  Waki","Akira  Ono
(University of Michigan)




Carl  Schaffner
(-, Rutgers University)","Timothy D Veenstra (Office Of The Director)



Elena  Chertova (Office Of The Director)



Sriram  Subramaniam; PhD (Laboratory of Cell Biology)",NULL,"Ordered by publication type and then author name.



1.
Adamson CS, Freed EO (2010). Novel approaches to inhibiting HIV-1 replication. Antiviral Res  85, 119-41.   https://doi.org/10.1016/j.antiviral.2009.09.009




PubMed



        
     
Free Article


 


PubMed ID 19782103
         Pubmed Central ID 2815006 


 



2.
Freed E, Freed E (2010) HIV-1 Gag as a target for antiviral therapy. Curr Top Med Chem, in press.




 



3.
Freed E, Freed E (2010) The role of lipids in retrovirus replication. Viruses 2:1146-1180.




 



4.
Waheed AA, Ablan SD, Sowder RC, Roser JD, Schaffner CP, Chertova E, Freed EO (2010). Effect of mutations in the human immunodeficiency virus type 1 protease on cleavage of the gp41 cytoplasmic tail. J Virol  84, 3121-6.   https://doi.org/10.1128/JVI.02002-09




PubMed



        
     
Free Article


 


PubMed ID 20042499
         Pubmed Central ID 2826043",https://intramural.nih.gov/search/searchview.taf?ipid=63096
304,BC010778-04,"October 01, 2009 -  September 30, 2010",Inhibition of HIV-1 Maturation,"Eric O Freed; PhD



IRP Faculty Profile",NULL,"Retroviral Replication Laboratory, NCI","Sherimay  Ablan



Sagar Bhalchandra Kudchodkar



Alan  Rein; PhD



Philip Richard Tedbury



Abdul Latheef Abdul Waheed



Kayoko  Waki","Christopher  Aiken
(Vanderbilt University)




Asim  Debnath
(Lindsley F. Kimball Research Institute of the New York Blood Center)




Angela Maria Gronenborn; PhD
(Department of Structural Biology, University of Pittsburgh)




Tsutomu  Murakami
(National Institute of Infectious Diseases)




Tatyana  Polenova; PhD
(University of Delaware)




Michael  Summers
(University of Maryland, Baltimore County)",Elena  Chertova (Office Of The Director),Alasdair C Steven; PhD (NIAMS),"Ordered by publication type and then author name.



1.
Adamson CS, Freed EO (2010). Novel approaches to inhibiting HIV-1 replication. Antiviral Res  85, 119-41.   https://doi.org/10.1016/j.antiviral.2009.09.009




PubMed



        
     
Free Article


 


PubMed ID 19782103
         Pubmed Central ID 2815006 


 



2.
Adamson CS, Sakalian M, Salzwedel K, Freed EO (2010). Polymorphisms in Gag spacer peptide 1 confer varying levels of resistance to the HIV- 1 maturation inhibitor bevirimat. Retrovirology  7, 36.   https://doi.org/10.1186/1742-4690-7-36




PubMed



        
     
Free Article


 


PubMed ID 20406463
         Pubmed Central ID 2873507 


 



3.
Checkley MA, Luttge BG, Soheilian F, Nagashima K, Freed EO (2010). The capsid-spacer peptide 1 Gag processing intermediate is a dominant-negative inhibitor of HIV-1 maturation. Virology  400, 137-44.   https://doi.org/10.1016/j.virol.2010.01.028




PubMed



               Available in future as a Free Article 


 


PubMed ID 20172577
         Pubmed Central ID 2838455 


 



4.
Freed E, Freed E (2010) HIV-1 Gag as a target for antiviral therapy. Curr Top Med Chem, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=63097
305,BC010779-04,"October 01, 2009 -  September 30, 2010",Regulation and Consequences of Ubiquitination,"Jonathan D Ashwell; MD



IRP Faculty Profile",NULL,"Laboratory of Immune Cell Biology, NCI","Dietrich B Conze



Netra Pal Meena



Ivana  Munitic



Maria Letizia  Giardino Torchia",NULL,NULL,Dragana  Jankovic; PhD (NIAID),"Ordered by publication type and then author name.



1.
Lo YC, Lin SC, Rospigliosi CC, Conze DB, Wu CJ, Ashwell JD, Eliezer D, Wu H (2009). Structural basis for recognition of diubiquitins by NEMO. Mol Cell  33, 602-15.   https://doi.org/10.1016/j.molcel.2009.01.012




PubMed



        
     
Free Article


 


PubMed ID 19185524
         Pubmed Central ID 2749619",https://intramural.nih.gov/search/searchview.taf?ipid=63084
306,BC010780-04,"October 01, 2009 -  September 30, 2010",Structural studies of molecular cancer targets and drug development,"David S Waugh; PhD



IRP Faculty Profile",NULL,"Protein Engineering Section, NCI","Brian P Austin



George T Lountos



Danielle  Needle",NULL,"Charles  Vinson; PhD (Nucleic Acids Section)



Yves  Pommier; PhD (Developmental Therapeutics Branch)



Robert  Shoemaker (Screening Technologies Branch)



Terrence R Burke; PhD (Chemical Biology Laboratory)",NULL,"Ordered by publication type and then author name.



1.
Jobson AG, Lountos GT, Lorenzi PL, Llamas J, Connelly J, Cerna D, Tropea JE, Onda A, Zoppoli G, Kondapaka S, Zhang G, Caplen NJ, Cardellina JH, Yoo SS, Monks A, Self C, Waugh DS, Shoemaker RH, Pommier Y (2009). Cellular inhibition of checkpoint kinase 2 (Chk2) and potentiation of camptothecins and radiation by the novel Chk2 inhibitor PV1019 [7-nitro-1H-indole-2-carboxylic acid {4-[1-(guanidinohydrazone)-ethyl]-phenyl}-amide]. J Pharmacol Exp Ther  331, 816-26.   https://doi.org/10.1124/jpet.109.154997




PubMed



        
     
Free Article


 


PubMed ID 19741151
         Pubmed Central ID 2784710 


 



2.
Lountos GT, Tropea JE, Cherry S, Waugh DS (2009). Overproduction, purification and structure determination of human dual-specificity phosphatase 14. Acta Crystallogr D Biol Crystallogr  65, 1013-20.   https://doi.org/10.1107/S0907444909023762




PubMed



        
     
Free Article


 


PubMed ID 19770498
         Pubmed Central ID 2748964 


 



3.
Lountos GT, Tropea JE, Zhang D, Jobson AG, Pommier Y, Shoemaker RH, Waugh DS (2009). Crystal structure of checkpoint kinase 2 in complex with NSC 109555, a potent and selective inhibitor. Protein Sci  18, 92-100.   https://doi.org/10.1002/pro.16




PubMed



        
     
Free Article


 


PubMed ID 19177354
         Pubmed Central ID 2708046 


 



4.
Muus U, Hose C, Yao W, Kosakowska-Cholody T, Farnsworth D, Dyba M, Lountos GT, Waugh DS, Monks A, Burke TR, Michejda CJ (2010). Development of antiproliferative phenylmaleimides that activate the unfolded protein response. Bioorg Med Chem  18, 4535-41.   https://doi.org/10.1016/j.bmc.2010.04.057




PubMed



        
     
Free Article


 


PubMed ID 20472436
         Pubmed Central ID 2892248 


 



5.
Waugh D, Jobson A, Tropea J, Zhang D, Self C, Shoemaker R, Pommier Y, Waugh D (2009) Structure-assisted discovery of novel inhibitors ofhuman checkpoint kinase 2 (Chk2). Acta Biochim. Pol. 56S:69-70.",https://intramural.nih.gov/search/searchview.taf?ipid=63104
307,BC010782-04,"October 01, 2009 -  September 30, 2010",Study of the Roles of SDF1 and CXCR4 in Hematopoiesis,"Giovanna  Tosato; PhD



IRP Faculty Profile",NULL,"Laboratory of Cellular Oncology, NCI","Inn-Inn  Chen



Paola  Gasperini



Douglas  Lowy; MD



Kan  Jiang



Peter J Mccormick



Maria de la Luz  Sierra","Anna C Berardi





Catherine  Porcher
(Oxford Univ)","Stefania  Pittaluga (Laboratory of Pathology)



Elaine S Jaffe; MD (Laboratory of Pathology)



David  Levens; PhD (Laboratory of Pathology)","Dragan  Maric; PhD (NINDS) 



William E Paul; MD (NIAID) 



Jinfang  Zhu; PhD (NIAID)","Ordered by publication type and then author name.



1.
McCormick PJ, Segarra M, Gasperini P, Gulino AV, Tosato G (2009). Impaired recruitment of Grk6 and beta-Arrestin 2 causes delayed internalization and desensitization of a WHIM syndrome-associated CXCR4 mutant receptor. PLoS One  4, e8102.   https://doi.org/10.1371/journal.pone.0008102




PubMed



        
     
Free Article


 


PubMed ID 19956569
         Pubmed Central ID 2779657 


 



2.
Qian X, Li G, Vass WC, Papageorge A, Walker RC, Asnaghi L, Steinbach PJ, Tosato G, Hunter K, Lowy DR (2009). The Tensin-3 protein, including its SH2 domain, is phosphorylated by Src and contributes to tumorigenesis and metastasis. Cancer Cell  16, 246-58.   https://doi.org/10.1016/j.ccr.2009.07.031




PubMed



        
     
Free Article


 


PubMed ID 19732724
         Pubmed Central ID 3293497",https://intramural.nih.gov/search/searchview.taf?ipid=63105
308,BC010783-04,"October 01, 2009 -  September 30, 2010",The Molecular Mechanism of TNF-induced Necrotic Cell Death,"Zhenggang  Liu; PhD



IRP Faculty Profile",NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI","Swati Suresh Choksi



Ilona  Linnoila; MD



Siriporn  Jitkaew



Michael J Morgan



Yan  Zhang",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Morgan MJ, Kim YS, Liu ZG (2009). Membrane-bound Fas ligand requires RIP1 for efficient activation of caspase-8 within the death-inducing signaling complex. J Immunol  183, 3278-84.   https://doi.org/10.4049/jimmunol.0803428




PubMed



        
     
Free Article


 


PubMed ID 19641134
         Pubmed Central ID 2730434",https://intramural.nih.gov/search/searchview.taf?ipid=63106
309,BC010784-04,"October 01, 2009 -  September 30, 2010",Biochemistry of Melanins and Photoprotection of the Skin,Vincent J. Hearing; PhD,NULL,"Pigment Cell Biology Section, NCI","Won Seon  Choi



Sergio  Coelho



Melanie Jean Schafer



Lanlan  Yin","Janusz  Beer
(Center for Devices & Radiological Health, Food & Drug Administration)




Shosuke  Ito
(Department of Chemistry, Fujita Health University)




Ludger  Kolbe
(Beiersdorf AG)




Yuji  Yamaguchi",NULL,NULL,"Ordered by publication type and then author name.



1.
Brenner M, Coelho SG, Beer JZ, Miller SA, Wolber R, Smuda C, Hearing VJ (2009). Long-lasting molecular changes in human skin after repetitive in situ UV irradiation. J Invest Dermatol  129, 1002-11.   https://doi.org/10.1038/jid.2008.325




PubMed



        
     
Free Article


 


PubMed ID 18946495
         Pubmed Central ID 2709208 


 



2.
Coelho SG, Choi W, Brenner M, Miyamura Y, Yamaguchi Y, Wolber R, Smuda C, Batzer J, Kolbe L, Ito S, Wakamatsu K, Zmudzka BZ, Beer JZ, Miller SA, Hearing VJ (2009). Short- and long-term effects of UV radiation on the pigmentation of human skin. J Investig Dermatol Symp Proc  14, 32-5.   https://doi.org/10.1038/jidsymp.2009.10




PubMed



        
     
Free Article


 


PubMed ID 19675550
         Pubmed Central ID 2799903 


 



3.
Coelho SG, Koo E, Hearing VJ (2009). Standardization of in vitro macrophotography for assessment of cutaneous responses. Photochem Photobiol  85, 1032-7.   https://doi.org/10.1111/j.1751-1097.2009.00549.x




PubMed



        
     
Free Article


 


PubMed ID 19320841
         Pubmed Central ID 2705686 


 



4.
Coelho SG, Zhou Y, Bushar HF, Miller SA, Zmudzka BZ, Hearing VJ, Beer JZ (2009). Long-lasting pigmentation of human skin, a new look at an overlooked response to UV. Pigment Cell Melanoma Res  22, 238-41.   https://doi.org/10.1111/j.1755-148X.2009.00550.x




PubMed



        
     
Free Article


 


PubMed ID 19226313
         Pubmed Central ID 2709973 


 



5.
Hearing V, Coelho S, Schlenz K, Batzer J, Smuda C, Choi W, Brenner M, Passeron T, Wolber R, Hearing V (2010) The deceptive nature of UVA-tanning versus the modest protective effects of UVB-tanning on human skin. Pigment Cell and Melanoma Res, in press.




 



6.
Kornhauser A, Wei RR, Yamaguchi Y, Coelho SG, Kaidbey K, Barton C, Takahashi K, Beer JZ, Miller SA, Hearing VJ (2009). The effects of topically applied glycolic acid and salicylic acid on ultraviolet radiation-induced erythema, DNA damage and sunburn cell formation in human skin. J Dermatol Sci  55, 10-7.   https://doi.org/10.1016/j.jdermsci.2009.03.011




PubMed



        
     
Free Article


 


PubMed ID 19411163
         Pubmed Central ID 2791365 


 



7.
Yamaguchi Y, Hearing VJ (2009). Physiological factors that regulate skin pigmentation. Biofactors  35, 193-9.   https://doi.org/10.1002/biof.29




PubMed



        
     
Free Article


 


PubMed ID 19449448
         Pubmed Central ID 2793097",https://intramural.nih.gov/search/searchview.taf?ipid=63107
310,BC010785-04,"October 01, 2009 -  September 30, 2010",Characterization of Pigmentary Disorders and Melanoma Targeting,Vincent J. Hearing; PhD,NULL,"Pigment Cell Biology Section, NCI","Mirei  Kanzaki



Masakazu  Kawaguchi



Taisuke  Kondo



Maria Elena Romero



Julio C Valencia; MD



Lanlan  Yin","Takeshi  Namiki





Thierry  Passeron





Michael  Pickart
(Department of Biology, University of Wisconsin)




Yuji  Yamaguchi","Michael Marc Gottesman; MD (Chemical Immunology Section)



Ettore  Appella; MD (Chemical Immunology Section)



Sriram  Subramaniam; PhD (Laboratory of Cell Biology)",Kevin G Chen; MD (NINDS),"Ordered by publication type and then author name.



1.
Hearing V, Merlino G (2009) Melanocyte biology and metastasis, in Cutaneous Melanoma. Quality Medical Publ (St. Louis) Volume 5th Edition, pp. 821-45.




 



2.
Chen KG, Leapman RD, Zhang G, Lai B, Valencia JC, Cardarelli CO, Vieira WD, Hearing VJ, Gottesman MM (2009). Influence of melanosome dynamics on melanoma drug sensitivity. J Natl Cancer Inst  101, 1259-71.   https://doi.org/10.1093/jnci/djp259




PubMed



        
     
Free Article


 


PubMed ID 19704071
         Pubmed Central ID 2744727 


 



3.
Chen KG, Valencia JC, Gillet JP, Hearing VJ, Gottesman MM (2009). Involvement of ABC transporters in melanogenesis and the development of multidrug resistance of melanoma. Pigment Cell Melanoma Res  22, 740-9.   https://doi.org/10.1111/j.1755-148X.2009.00630.x




PubMed



        
     
Free Article


 


PubMed ID 19725928
         Pubmed Central ID 2766009 


 



4.
Passeron T, Valencia JC, Namiki T, Vieira WD, Passeron H, Miyamura Y, Hearing VJ (2009). Upregulation of SOX9 inhibits the growth of human and mouse melanomas and restores their sensitivity to retinoic acid. J Clin Invest  119, 954-63.   https://doi.org/10.1172/JCI34015




PubMed



        
     
Free Article


 


PubMed ID 19273910
         Pubmed Central ID 2662541",https://intramural.nih.gov/search/searchview.taf?ipid=63108
311,BC010786-04,"October 01, 2009 -  September 30, 2010",The Regulation of Mammalian Pigmentation,Vincent J. Hearing; PhD,NULL,"Pigment Cell Biology Section, NCI","Won Seon  Choi



Mirei  Kanzaki



Masakazu  Kawaguchi



Taisuke  Kondo



Julio C Valencia; MD



Lanlan  Yin","Ludger  Kolbe
(Beiersdorf AG)




Takeshi  Namiki





Thierry  Passeron





Michael  Pickart
(Department of Biology, University of Wisconsin)




Yuji  Yamaguchi",Sriram  Subramaniam; PhD (Laboratory of Cell Biology),NULL,"Ordered by publication type and then author name.



1.
Ando H, Ichihashi M, Hearing VJ (2009). Role of the ubiquitin proteasome system in regulating skin pigmentation. Int J Mol Sci  10, 4428-34.   https://doi.org/10.3390/ijms10104428




PubMed



        
     
Free Article


 


PubMed ID 20057953
         Pubmed Central ID 2790116 


 



2.
Choi W, Wolber R, Gerwat W, Mann T, Batzer J, Smuda C, Liu H, Kolbe L, Hearing VJ (2010). The fibroblast-derived paracrine factor neuregulin-1 has a novel role in regulating the constitutive color and melanocyte function in human skin. J Cell Sci  123, 3102-11.   https://doi.org/10.1242/jcs.064774




PubMed



        
     
Free Article


 


PubMed ID 20736300
         Pubmed Central ID 2931604 


 



3.
Hearing VJ (2009). The expanding role and presence of neuromelanins in the human brain - why gray matter is gray. Pigment Cell Melanoma Res  22, 10-1.   https://doi.org/10.1111/j.1755-148X.2008.00537.x




PubMed



        
     
Free Article


 


PubMed ID 19140885
         Pubmed Central ID 2791353 


 



4.
Le Pape E, Passeron T, Giubellino A, Valencia JC, Wolber R, Hearing VJ (2009). Microarray analysis sheds light on the dedifferentiating role of agouti signal protein in murine melanocytes via the Mc1r. Proc Natl Acad Sci U S A  106, 1802-7.   https://doi.org/10.1073/pnas.0806753106




PubMed



        
     
Free Article


 


PubMed ID 19174519
         Pubmed Central ID 2644118 


 



5.
Plonka PM, Passeron T, Brenner M, Tobin DJ, Shibahara S, Thomas A, Slominski A, Kadekaro AL, Hershkovitz D, Peters E, Nordlund JJ, Abdel-Malek Z, Takeda K, Paus R, Ortonne JP, Hearing VJ, Schallreuter KU (2009). What are melanocytes really doing all day long..? Exp Dermatol  18, 799-819.   https://doi.org/10.1111/j.1600-0625.2009.00912.x




PubMed



        
     
Free Article


 


PubMed ID 19659579
         Pubmed Central ID 2792575 


 



6.
Randhawa M, Huff T, Valencia JC, Younossi Z, Chandhoke V, Hearing VJ, Baranova A (2009). Evidence for the ectopic synthesis of melanin in human adipose tissue. FASEB J  23, 835-43.   https://doi.org/10.1096/fj.08-116327




PubMed



        
     
Free Article


 


PubMed ID 18971261
         Pubmed Central ID 2653983 


 



7.
Sánchez-Laorden BL, Herraiz C, Valencia JC, Hearing VJ, Jiménez-Cervantes C, García-Borrón JC (2009). Aberrant trafficking of human melanocortin 1 receptor variants associated with red hair and skin cancer: Steady-state retention of mutant forms in the proximal golgi. J Cell Physiol  220, 640-54.   https://doi.org/10.1002/jcp.21804




PubMed



        
     
Free Article


 


PubMed ID 19452503
         Pubmed Central ID 2705480 


 



8.
Yamaguchi Y, Hearing VJ (2009). Physiological factors that regulate skin pigmentation. Biofactors  35, 193-9.   https://doi.org/10.1002/biof.29




PubMed



        
     
Free Article


 


PubMed ID 19449448
         Pubmed Central ID 2793097 


 



9.
Yamaguchi Y, Morita A, Maeda A, Hearing VJ (2009). Regulation of skin pigmentation and thickness by Dickkopf 1 (DKK1). J Investig Dermatol Symp Proc  14, 73-5.   https://doi.org/10.1038/jidsymp.2009.4




PubMed



        
     
Free Article


 


PubMed ID 19675559
         Pubmed Central ID 2793095",https://intramural.nih.gov/search/searchview.taf?ipid=63109
312,BC010787-04,"October 01, 2009 -  September 30, 2010",Redox Imaging using Nitroxides and MRI,"James B Mitchell; PhD



IRP Faculty Profile",NULL,"Radiation Biology Branch, NCI","John Andrew Cook; PhD



Murali  Krishna; PhD



Ryan Miller Davis



Anastasia L Sowers",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Hyodo F, Matsumoto S, Devasahayam N, Dharmaraj C, Subramanian S, Mitchell JB, Krishna MC (2009). Pulsed EPR imaging of nitroxides in mice. J Magn Reson  197, 181-5.   https://doi.org/10.1016/j.jmr.2008.12.018




PubMed



        
     
Free Article


 


PubMed ID 19157932
         Pubmed Central ID 3496157",https://intramural.nih.gov/search/searchview.taf?ipid=63110
313,BC010788-04,"October 01, 2009 -  September 30, 2010",Regulation of Differentiation of Pediatric Embryonal Tumors- Neuroblastoma,"Carol J Thiele



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI","Zhihui  Liu



Lauren  Marks



Alan S Wayne; MD



Doo-Yi  Oh



Chand  Khanna; MD



Ryan  Virden



Show all 9","David  Kaplan
(Hospital for Sick Kids)




Jinhua  Zhang
(Hematology, 2nd China Medical School)","Ira H Pastan; MD (Molecular Biology Section)



Lino  Tessarollo (Mouse Cancer Genetics Program)",Kai  Ge; PhD (NIDDK),"Ordered by publication type and then author name.



1.
Panicker J, Li Z, McMahon C, Sizer C, Steadman K, Piekarz R, Bates SE, Thiele CJ (2010). Romidepsin (FK228/depsipeptide) controls growth and induces apoptosis in neuroblastoma tumor cells. Cell Cycle  9, 1830-8.   https://doi.org/10.4161/cc.9.9.11543




PubMed



        
     
Free Article


 


PubMed ID 20404560
         Pubmed Central ID 6659113",https://intramural.nih.gov/search/searchview.taf?ipid=63111
314,BC010789-04,"October 01, 2009 -  September 30, 2010",Pathophysiologic Consequences of Neurotrophin Activation of Trk in Neuroblastoma,"Carol J Thiele



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI","Zhi-Jie  Li



Lauren  Marks



Doo-Yi  Oh



Chunxi  Wang



Chand  Khanna; MD



Shuang  Yan



Show all 7","David  Kaplan
(Hospital for Sick Kids)




Jinhua  Zhang
(Hematology, 2nd China Medical School)","Susan  Bates; MD (Medical Oncology Branch)



Giovanni  Melillo (Screening Technologies Branch)



Seth M Steinberg; PhD (Office of the Director)



David J Liewehr (Biostatistics and Data Management Section)",NULL,"Ordered by publication type and then author name.



1.
Li Z, Tan F, Liewehr DJ, Steinberg SM, Thiele CJ (2010). In vitro and in vivo inhibition of neuroblastoma tumor cell growth by AKT inhibitor perifosine. J Natl Cancer Inst  102, 758-70.   https://doi.org/10.1093/jnci/djq125




PubMed



        
     
Free Article


 


PubMed ID 20463309
         Pubmed Central ID 2879416 


 



2.
Reid GS, Shan X, Coughlin CM, Lassoued W, Pawel BR, Wexler LH, Thiele CJ, Tsokos M, Pinkus JL, Pinkus GS, Grupp SA, Vonderheide RH (2009). Interferon-gamma-dependent infiltration of human T cells into neuroblastoma tumors in vivo. Clin Cancer Res  15, 6602-8.   https://doi.org/10.1158/1078-0432.CCR-09-0829




PubMed



        
     
Free Article


 


PubMed ID 19825945
         Pubmed Central ID 2783677 


 



3.
Thiele CJ, Li Z, McKee AE (2009) On Trk--the TrkB signal transduction pathway is an increasingly important target in cancer biology. Clin Cancer Res 15:5962-7




PubMed



        
     
Free Article


 


PubMed ID 19755385
         Pubmed Central ID 2756331",https://intramural.nih.gov/search/searchview.taf?ipid=63112
315,BC010790-04,"October 01, 2009 -  September 30, 2010",Regulation of Leukocyte Integrins in Inflammatory Cell Recruitment,Triantafyllos  Chavakis,NULL,"Experimental Immunology Branch, NCI","Eun-Young  Choi



Sunil  Kaul



Harald Franz Langer","Stefanie  Dimmeler
(Cardiology, University Frankfurt)




Carl  Gahmberg
(Biochemistry, University of Helsinki)




Paul  Kubes
(University of Calgary)




Tom  Quertermous
(Cardiovascular Medicine, Stanford University)




Christian  Weber
(RWTH University Aachen)",NULL,"Xuri  Li (NEI) 



Kevin Graham Becker; BS, MAS, PhD (NIA)","Ordered by publication type and then author name.



1.
Chavakis E, Choi EY, Chavakis T (2009). Novel aspects in the regulation of the leukocyte adhesion cascade. Thromb Haemost  102, 191-7.   https://doi.org/10.1160/TH08-12-0844




PubMed



        
     
Free Article


 


PubMed ID 19652868
         Pubmed Central ID 2722029 


 



2.
Gahmberg CG, Fagerholm SC, Nurmi SM, Chavakis T, Marchesan S, Grönholm M (2009). Regulation of integrin activity and signalling. Biochim Biophys Acta  1790, 431-44.   https://doi.org/10.1016/j.bbagen.2009.03.007




PubMed



        
     
Free Article


 


PubMed ID 19289150
         Pubmed Central ID 2734279 


 



3.
Langer HF, Chavakis T (2009). Leukocyte-endothelial interactions in inflammation. J Cell Mol Med  13, 1211-20.   https://doi.org/10.1111/j.1582-4934.2009.00811.x




PubMed



        
     
Free Article


 


PubMed ID 19538472
         Pubmed Central ID 2861890 


 



4.
Sá-Nunes A, Bafica A, Antonelli LR, Choi EY, Francischetti IM, Andersen JF, Shi GP, Chavakis T, Ribeiro JM, Kotsyfakis M (2009). The immunomodulatory action of sialostatin L on dendritic cells reveals its potential to interfere with autoimmunity. J Immunol  182, 7422-9.   https://doi.org/10.4049/jimmunol.0900075




PubMed



        
     
Free Article


 


PubMed ID 19494265
         Pubmed Central ID 2694955",https://intramural.nih.gov/search/searchview.taf?ipid=63090
316,BC010791-04,"October 01, 2009 -  September 30, 2010","Effects of genetic polymorphism in MHC, KIR, and related loci on human disease","Mary  Carrington; MS, PhD",NULL,"Laboratory of Experimental Immunology, NCI","Richard  Apps; PhD



Arman A Bashirova



Fuh-Mei  Duh



Luz Maria Fuentes



Xiaojiang  Gao



Smita V Kulkarni; PhD



Show all 11","Marcus  Altfeld
(Infectious Disease Unit, Partners AIDS Research Center)




William  Carr
(University of KwaZulu Natal)




Steven  Deeks
(San Francisco General Hospital, University of California, San Francisco)




James  Elder
(University of Michigan)




Carey  Farquhar
(Epidemiology and Medicine, University of Washington)




David  Goldstein
(Duke University)


Show all 17","Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch)



James Jerome Goedert; MD (Infection & Immunoepidemiology Branch)",Barbara  Rehermann; MD (NIDDK),"Ordered by publication type and then author name.



1.
Abdou AM, Gao X, Cozen W, Cerhan JR, Rothman N, Martin MP, Davis S, Schenk M, Chanock SJ, Hartge P, Carrington M, Wang SS (2010). Human leukocyte antigen (HLA) A1-B8-DR3 (8.1) haplotype, tumor necrosis factor (TNF) G-308A, and risk of non-Hodgkin lymphoma. Leukemia  24, 1055-8.   https://doi.org/10.1038/leu.2010.17




PubMed



        
     
Free Article


 


PubMed ID 20147981
         Pubmed Central ID 4847717 


 



2.
Alter G, Rihn S, Walter K, Nolting A, Martin M, Rosenberg ES, Miller JS, Carrington M, Altfeld M (2009). HLA class I subtype-dependent expansion of KIR3DS1+ and KIR3DL1+ NK cells during acute human immunodeficiency virus type 1 infection. J Virol  83, 6798-805.   https://doi.org/10.1128/JVI.00256-09




PubMed



        
     
Free Article


 


PubMed ID 19386717
         Pubmed Central ID 2698561 


 



3.
Brumme Z, Wang B, Nair K, Brumme C, de Pierres C, Reddy S, Julg B, Moodley E, Thobakgale C, Lu Z, van der Stok M, Bishop K, Mncube Z, Chonco F, Yuki Y, Frahm N, Brander C, Carrington M, Freedberg K, Kiepiela P, Goulder P, Walker B, Ndung'u T, Losina E (2009). Impact of select immunologic and virologic biomarkers on CD4 cell count decrease in patients with chronic HIV-1 subtype C infection: results from Sinikithemba Cohort, Durban, South Africa. Clin Infect Dis  49, 956-64.   https://doi.org/10.1086/605503




PubMed



        
     
Free Article


 


PubMed ID 19663693
         Pubmed Central ID 2777678 


 



4.
Chung NP, Breun SK, Bashirova A, Baumann JG, Martin TD, Karamchandani JM, Rausch JW, Le Grice SF, Wu L, Carrington M, Kewalramani VN (2010). HIV-1 transmission by dendritic cell-specific ICAM-3-grabbing nonintegrin (DC-SIGN) is regulated by determinants in the carbohydrate recognition domain that are absent in liver/lymph node-SIGN (L-SIGN). J Biol Chem  285, 2100-12.   https://doi.org/10.1074/jbc.M109.030619




PubMed



        
     
Free Article


 


PubMed ID 19833723
         Pubmed Central ID 2804366 


 



5.
Duda A, Lee-Turner L, Fox J, Robinson N, Dustan S, Kaye S, Fryer H, Carrington M, McClure M, McLean AR, Fidler S, Weber J, Phillips RE, Frater AJ, SPARTAC Trial Investigators (2009). HLA-associated clinical progression correlates with epitope reversion rates in early human immunodeficiency virus infection. J Virol  83, 1228-39.   https://doi.org/10.1128/JVI.01545-08




PubMed



        
     
Free Article


 


PubMed ID 19019964
         Pubmed Central ID 2620910 


 



6.
Fellay J, Ge D, Shianna KV, Colombo S, Ledergerber B, Cirulli ET, Urban TJ, Zhang K, Gumbs CE, Smith JP, Castagna A, Cozzi-Lepri A, De Luca A, Easterbrook P, Günthard HF, Mallal S, Mussini C, Dalmau J, Martinez-Picado J, Miro JM, Obel N, Wolinsky SM, Martinson JJ, Detels R, Margolick JB, NIAID Center for HIV/AIDS Vaccine Immunology (CHAVI), et al. [12 more authors] (2009). Common genetic variation and the control of HIV-1 in humans. PLoS Genet  5, e1000791.   https://doi.org/10.1371/journal.pgen.1000791




PubMed



        
     
Free Article


 


PubMed ID 20041166
         Pubmed Central ID 2791220 


 



7.
Gao X, O'Brien TR, Welzel TM, Marti D, Qi Y, Goedert JJ, Phair J, Pfeiffer R, Carrington M (2010). HLA-B alleles associate consistently with HIV heterosexual transmission, viral load, and progression to AIDS, but not susceptibility to infection. AIDS  24, 1835-40.   https://doi.org/10.1097/QAD.0b013e32833c3219




PubMed



        
     
Free Article


 


PubMed ID 20588164
         Pubmed Central ID 2902625 


 



8.
Huang J, Goedert JJ, Sundberg EJ, Cung TD, Burke PS, Martin MP, Preiss L, Lifson J, Lichterfeld M, Carrington M, Yu XG (2009). HLA-B*35-Px-mediated acceleration of HIV-1 infection by increased inhibitory immunoregulatory impulses. J Exp Med  206, 2959-66.   https://doi.org/10.1084/jem.20091386




PubMed



        
     
Free Article


 


PubMed ID 20008523
         Pubmed Central ID 2806456 


 



9.
Julg B, Reddy S, van der Stok M, Kulkarni S, Qi Y, Bass S, Gold B, Nalls MA, Nelson GW, Walker BD, Carrington M, Ndung'u T (2009). Lack of Duffy antigen receptor for chemokines: no influence on HIV disease progression in an African treatment-naive population. Cell Host Microbe  5, 413-5; author reply 418-9.   https://doi.org/10.1016/j.chom.2009.04.009




PubMed



        
     
Free Article


 


PubMed ID 19454341
         Pubmed Central ID 2749504 


 



10.
Julg B, Williams KL, Reddy S, Bishop K, Qi Y, Carrington M, Goulder PJ, Ndung'u T, Walker BD (2010). Enhanced anti-HIV functional activity associated with Gag-specific CD8 T-cell responses. J Virol  84, 5540-9.   https://doi.org/10.1128/JVI.02031-09




PubMed



        
     
Free Article


 


PubMed ID 20335261
         Pubmed Central ID 2876607 


 



11.
Kosmrlj A, Read EL, Qi Y, Allen TM, Altfeld M, Deeks SG, Pereyra F, Carrington M, Walker BD, Chakraborty AK (2010). Effects of thymic selection of the T-cell repertoire on HLA class I-associated control of HIV infection. Nature  465, 350-4.   https://doi.org/10.1038/nature08997




PubMed



        
     
Free Article


 


PubMed ID 20445539
         Pubmed Central ID 3098720 


 



12.
Kuniholm MH, Kovacs A, Gao X, Xue X, Marti D, Thio CL, Peters MG, Terrault NA, Greenblatt RM, Goedert JJ, Cohen MH, Minkoff H, Gange SJ, Anastos K, Fazzari M, Harris TG, Young MA, Strickler HD, Carrington M (2010). Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia. Hepatology  51, 1514-22.   https://doi.org/10.1002/hep.23515




PubMed



        
     
Free Article


 


PubMed ID 20169624
         Pubmed Central ID 2946382 


 



13.
Meier A, Chang JJ, Chan ES, Pollard RB, Sidhu HK, Kulkarni S, Wen TF, Lindsay RJ, Orellana L, Mildvan D, Bazner S, Streeck H, Alter G, Lifson JD, Carrington M, Bosch RJ, Robbins GK, Altfeld M (2009). Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1. Nat Med  15, 955-9.   https://doi.org/10.1038/nm.2004




PubMed



        
     
Free Article


 


PubMed ID 19597505
         Pubmed Central ID 2821111 


 



14.
O'Connor SL, Lhost JJ, Becker EA, Detmer AM, Johnson RC, Macnair CE, Wiseman RW, Karl JA, Greene JM, Burwitz BJ, Bimber BN, Lank SM, Tuscher JJ, Mee ET, Rose NJ, Desrosiers RC, Hughes AL, Friedrich TC, Carrington M, O'Connor DH (2010). MHC heterozygote advantage in simian immunodeficiency virus-infected Mauritian cynomolgus macaques. Sci Transl Med  2, 22ra18.   https://doi.org/10.1126/scitranslmed.3000524




PubMed



        
     
Free Article


 


PubMed ID 20375000
         Pubmed Central ID 2865159 


 



15.
Pelak K, Goldstein DB, Walley NM, Fellay J, Ge D, Shianna KV, Gumbs C, Gao X, Maia JM, Cronin KD, Hussain SK, Carrington M, Michael NL, Weintrob AC, Infectious Disease Clinical Research Program HIV Working Group, National Institute of Allergy and Infectious Diseases Center for HIV/AIDS Vaccine Immunology (CHAVI) (2010). Host determinants of HIV-1 control in African Americans. J Infect Dis  201, 1141-9.   https://doi.org/10.1086/651382




PubMed



        
     
Free Article


 


PubMed ID 20205591
         Pubmed Central ID 2838940 


 



16.
Specht A, Telenti A, Martinez R, Fellay J, Bailes E, Evans DT, Carrington M, Hahn BH, Goldstein DB, Kirchhoff F (2010). Counteraction of HLA-C-mediated immune control of HIV-1 by Nef. J Virol  84, 7300-11.   https://doi.org/10.1128/JVI.00619-10




PubMed



        
     
Free Article


 


PubMed ID 20463068
         Pubmed Central ID 2898263 


 



17.
Streeck H, Jolin JS, Qi Y, Yassine-Diab B, Johnson RC, Kwon DS, Addo MM, Brumme C, Routy JP, Little S, Jessen HK, Kelleher AD, Hecht FM, Sekaly RP, Rosenberg ES, Walker BD, Carrington M, Altfeld M (2009). Human immunodeficiency virus type 1-specific CD8+ T-cell responses during primary infection are major determinants of the viral set point and loss of CD4+ T cells. J Virol  83, 7641-8.   https://doi.org/10.1128/JVI.00182-09




PubMed



        
     
Free Article


 


PubMed ID 19458000
         Pubmed Central ID 2708622 


 



18.
Tang M, Zeng Y, Poisson A, Marti D, Guan L, Zheng Y, Deng H, Liao J, Guo X, Sun S, Nelson G, de Thé G, Winkler CA, O'Brien SJ, Carrington M, Gao X (2010). Haplotype-dependent HLA susceptibility to nasopharyngeal carcinoma in a Southern Chinese population. Genes Immun  11, 334-42.   https://doi.org/10.1038/gene.2009.109




PubMed



        
     
Free Article


 


PubMed ID 20072141
         Pubmed Central ID 3737777 


 



19.
Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, O'Huigin C, Kidd J, Kidd K, Khakoo SI, Alexander G, Goedert JJ, Kirk GD, Donfield SM, Rosen HR, Tobler LH, Busch MP, McHutchison JG, Goldstein DB, Carrington M (2009). Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature  461, 798-801.   https://doi.org/10.1038/nature08463




PubMed



        
     
Free Article


 


PubMed ID 19759533
         Pubmed Central ID 3172006 


 



20.
Thomas R, Apps R, Qi Y, Gao X, Male V, O'hUigin C, O'Connor G, Ge D, Fellay J, Martin JN, Margolick J, Goedert JJ, Buchbinder S, Kirk GD, Martin MP, Telenti A, Deeks SG, Walker BD, Goldstein D, McVicar DW, Moffett A, Carrington M (2009). HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C. Nat Genet  41, 1290-4.   https://doi.org/10.1038/ng.486




PubMed



        
     
Free Article


 


PubMed ID 19935663
         Pubmed Central ID 2887091 


 



21.
Tomescu C, Duh FM, Lanier MA, Kapalko A, Mounzer KC, Martin MP, Carrington M, Metzger DS, Montaner LJ (2010). Increased plasmacytoid dendritic cell maturation and natural killer cell activation in HIV-1 exposed, uninfected intravenous drug users. AIDS  24, 2151-60.   https://doi.org/10.1097/QAD.0b013e32833dfc20




PubMed



        
     
Free Article


 


PubMed ID 20647906
         Pubmed Central ID 3253656 


 



22.
Torimiro JN, Javanbakht H, Diaz-Griffero F, Kim J, Carr JK, Carrington M, Sawitzke J, Burke DS, Wolfe ND, Dean M, Sodroski J (2009). A rare null allele potentially encoding a dominant-negative TRIM5alpha protein in Baka pygmies. Virology  391, 140-7.   https://doi.org/10.1016/j.virol.2009.05.038




PubMed



        
     
Free Article


 


PubMed ID 19577266
         Pubmed Central ID 2760473 


 



23.
Urban TJ, Weintrob AC, Fellay J, Colombo S, Shianna KV, Gumbs C, Rotger M, Pelak K, Dang KK, Detels R, Martinson JJ, O'Brien SJ, Letvin NL, McMichael AJ, Haynes BF, Carrington M, Telenti A, Michael NL, Goldstein DB (2009). CCL3L1 and HIV/AIDS susceptibility. Nat Med  15, 1110-2.   https://doi.org/10.1038/nm1009-1110




PubMed



        
     
Free Article


 


PubMed ID 19812560
         Pubmed Central ID 2821825 


 



24.
Walley NM, Julg B, Dickson SP, Fellay J, Ge D, Walker BD, Carrington M, Cohen MS, de Bakker PI, Goldstein DB, Shianna KV, Haynes BF, Letvin NL, McMichael AJ, Michael NL, Weintrob AC (2009). The Duffy antigen receptor for chemokines null promoter variant does not influence HIV-1 acquisition or disease progression. Cell Host Microbe  5, 408-10; author reply 418-9.   https://doi.org/10.1016/j.chom.2009.04.011




PubMed



        
     
Free Article


 


PubMed ID 19454339
         Pubmed Central ID 2720554 


 



25.
Wang SS, Abdou AM, Morton LM, Thomas R, Cerhan JR, Gao X, Cozen W, Rothman N, Davis S, Severson RK, Bernstein L, Hartge P, Carrington M (2010). Human leukocyte antigen class I and II alleles in non-Hodgkin lymphoma etiology. Blood  115, 4820-3.   https://doi.org/10.1182/blood-2010-01-266775




PubMed



        
     
Free Article


 


PubMed ID 20385791
         Pubmed Central ID 2890176 


 



26.
Wang YE, Li B, Carlson JM, Streeck H, Gladden AD, Goodman R, Schneidewind A, Power KA, Toth I, Frahm N, Alter G, Brander C, Carrington M, Walker BD, Altfeld M, Heckerman D, Allen TM (2009). Protective HLA class I alleles that restrict acute-phase CD8+ T-cell responses are associated with viral escape mutations located in highly conserved regions of human immunodeficiency virus type 1. J Virol  83, 1845-55.   https://doi.org/10.1128/JVI.01061-08




PubMed



        
     
Free Article


 


PubMed ID 19036810
         Pubmed Central ID 2643763 


 



27.
Welzel TM, Morgan TR, Bonkovsky HL, Naishadham D, Pfeiffer RM, Wright EC, Hutchinson AA, Crenshaw AT, Bashirova A, Carrington M, Dotrang M, Sterling RK, Lindsay KL, Fontana RJ, Lee WM, Di Bisceglie AM, Ghany MG, Gretch DR, Chanock SJ, Chung RT, O'Brien TR, HALT-C Trial Group (2009). Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial. Hepatology  49, 1847-58.   https://doi.org/10.1002/hep.22877




PubMed



        
     
Free Article


 


PubMed ID 19434718
         Pubmed Central ID 2692559 


 



28.
Wong AH, Williams K, Reddy S, Wilson D, Giddy J, Alter G, Ghebremichael M, Carrington MN, Ndung'u T, Walker BD, Altfeld M, Carr WH (2010). Alterations in natural killer cell receptor profiles during HIV type 1 disease progression among chronically infected South African adults. AIDS Res Hum Retroviruses  26, 459-69.   https://doi.org/10.1089/aid.2009.0176




PubMed



        
     
Free Article


 


PubMed ID 20380481
         Pubmed Central ID 3111148 


 



29.
Yindom LM, Leligdowicz A, Martin MP, Gao X, Qi Y, Zaman SM, van der Loeff MS, van Tienen C, Jaye A, Aveika A, Worwui A, Diatta M, Vincent T, Whittle HC, Rowland-Jones SL, Walton R, Carrington M (2010). Influence of HLA class I and HLA-KIR compound genotypes on HIV-2 infection and markers of disease progression in a Manjako community in West Africa. J Virol  84, 8202-8.   https://doi.org/10.1128/JVI.00116-10




PubMed



        
     
Free Article


 


PubMed ID 20519398
         Pubmed Central ID 2916551 


 



30.
Yu KJ, Gao X, Chen CJ, Yang XR, Diehl SR, Goldstein A, Hsu WL, Liang XS, Marti D, Liu MY, Chen JY, Carrington M, Hildesheim A (2009). Association of human leukocyte antigens with nasopharyngeal carcinoma in high-risk multiplex families in Taiwan. Hum Immunol  70, 910-4.   https://doi.org/10.1016/j.humimm.2009.08.005




PubMed



        
     
Free Article


 


PubMed ID 19683024
         Pubmed Central ID 2764811",https://intramural.nih.gov/search/searchview.taf?ipid=63089
317,BC010792-04,"October 01, 2009 -  September 30, 2010",Molecular genetics and population studies of the KIR and HLA gene complexes,"Mary  Carrington; MS, PhD",NULL,"Laboratory of Experimental Immunology, NCI","Richard  Apps; PhD



Daniel  McVicar; PhD



Stephen K Anderson; PhD



Arman A Bashirova



Fuh-Mei  Duh



Xiaojiang  Gao



Show all 10","Marcus  Altfeld
(Infectious Disease Unit, Partners AIDS Research Center)




Judith  Kidd
(Yale University)




Kenneth  Kidd
(Yale University)




Diogo  Meyer
(Genetics and evolutionary biology, University of Sao Paulo)




Richard  Single
(University of Vermont)




Judith  Torimiro
(Johns Hopkins School of Public Health)


Show all 8",NULL,NULL,"Ordered by publication type and then author name.



1.
Averdam A, Petersen B, Rosner C, Neff J, Roos C, Eberle M, Aujard F, Münch C, Schempp W, Carrington M, Shiina T, Inoko H, Knaust F, Coggill P, Sehra H, Beck S, Abi-Rached L, Reinhardt R, Walter L (2009). A novel system of polymorphic and diverse NK cell receptors in primates. PLoS Genet  5, e1000688.   https://doi.org/10.1371/journal.pgen.1000688




PubMed



        
     
Free Article


 


PubMed ID 19834558
         Pubmed Central ID 2757895 


 



2.
Hiby SE, Ashrafian-Bonab M, Farrell L, Single RM, Balloux F, Carrington M, Moffett A, Ebrahimi Z (2010). Distribution of killer cell immunoglobulin-like receptors  (KIR) and their HLA-C ligands in two Iranian populations. Immunogenetics  62, 65-73.   https://doi.org/10.1007/s00251-009-0408-5




PubMed



        
     
Free Article


 


PubMed ID 19936734
         Pubmed Central ID 2814031 


 



3.
Kulkarni S, Martin MP, Carrington M (2010). KIR genotyping by multiplex PCR-SSP. Methods Mol Biol  612, 365-75.   https://doi.org/10.1007/978-1-60761-362-6_25




PubMed



        
     
Free Article


 


PubMed ID 20033654
         Pubmed Central ID 3464904 


 



4.
Traherne JA, Martin M, Ward R, Ohashi M, Pellett F, Gladman D, Middleton D, Carrington M, Trowsdale J (2010). Mechanisms of copy number variation and hybrid gene formation in the KIR immune gene complex. Hum Mol Genet  19, 737-51.   https://doi.org/10.1093/hmg/ddp538




PubMed



        
     
Free Article


 


PubMed ID 19959527
         Pubmed Central ID 2816608",https://intramural.nih.gov/search/searchview.taf?ipid=63088
318,BC010793-04,"October 01, 2009 -  September 30, 2010","Role of inflammation, innate resistance, and immunity in carcinogenesis.","Giorgio  Trinchieri



IRP Faculty Profile",NULL,"Cancer Inflammation Program, NCI","Maariya  Bassa



Ren Ming  Dai



Christopher  Ecker



Silvana Romina Goldszmid



Zsofia  Gyulai



Yava  Jones



Show all 14","Mario  Colombo
(Experimental Oncology, National Institute of Surgery and Cure of Tumors)




Franca  Gerosa
(Pathology/Immunology, University of Verona)




Uzma  Hasan
(Infections and Cancer Biology, International Agency for Research on Cancer (IARC-WHO))




Dominique  Kaiserlian
(U404, INSERM)




Xiaojing  Ma
(Microbiology and Immunology, Weill Medical College)




Sergei A. Nedospasov; PhD, DSc","Nancy H Colburn; PhD (Laboratory of Cancer Prevention)



Glenn  Merlino; PhD (Laboratory of Cancer Biology and Genetics)



Barbara K Felber (Vaccine Branch)



George N Pavlakis; MD, PhD (Vaccine Branch)



Francis W Ruscetti; PhD (Laboratory of Experimental Immunology)



Stuart H Yuspa; MD (Laboratory of Cancer Biology and Genetics)","Francesco M. Marincola; MD (CC) 



Alan  Sher; PhD (NIAID)","Ordered by publication type and then author name.



1.
Trinchieri G, Trinchieri G (2010) Turning on and off the immunological switch: Immune response polarization and its control by IL-10 and STAT3, in Immunologic Signature of Rejection. Springer (New York), in press.




 



2.
Goldszmid RS, Hasan UA, Trinchieri G (2009). Double stranded RNA tricks melanoma cells into committing suicide. Pigment Cell Melanoma Res  22, 705-6.   https://doi.org/10.1111/j.1755-148X.2009.00631.x




PubMed


 


PubMed ID 19725927
    
     


 



3.
Gordon S, Trinchieri G (2009). Innate resistance and inflammation. Curr Opin Immunol  21, 1-2.   https://doi.org/10.1016/j.coi.2009.02.001




PubMed


 


PubMed ID 19223161
    
     


 



4.
McVicar DW, Trinchieri G (2009). CSF-1R, DAP12 and beta-catenin: a ménage à trois. Nat Immunol  10, 681-3.   https://doi.org/10.1038/ni0709-681




PubMed


 


PubMed ID 19536190
    
     


 



5.
Nussenblatt RB, Bielekova B, Childs R, Krensky A, Strober W, Trinchieri G, Center for Human Immunology, Autoimmunity and Inflammation, National Institutes of Health (2010). National Institutes of Health Center for Human Immunology Conference, September 2009. Ann N Y Acad Sci  1200 Suppl 1, E1-23.   https://doi.org/10.1111/j.1749-6632.2010.05682.x




PubMed


 


PubMed ID 20633145
    
     


 



6.
Salcedo R, Hixon JA, Stauffer JK, Jalah R, Brooks AD, Khan T, Dai RM, Scheetz L, Lincoln E, Back TC, Powell D, Hurwitz AA, Sayers TJ, Kastelein R, Pavlakis GN, Felber BK, Trinchieri G, Wigginton JM (2009). Immunologic and therapeutic synergy of IL-27 and IL-2: enhancement of T cell sensitization, tumor-specific CTL reactivity and complete regression of disseminated neuroblastoma metastases in the liver and bone marrow. J Immunol  182, 4328-38.   https://doi.org/10.4049/jimmunol.0800471




PubMed



        
     
Free Article


 


PubMed ID 19299733
         Pubmed Central ID 2730673 


 



7.
Stewart CA, Trinchieri G (2009). Reinforcing suppression using regulators: a new link between STAT3, IL-23, and Tregs in tumor immunosuppression. Cancer Cell  15, 81-3.   https://doi.org/10.1016/j.ccr.2009.01.008




PubMed


 


PubMed ID 19185840",https://intramural.nih.gov/search/searchview.taf?ipid=63113
319,BC010794-04,"October 01, 2009 -  September 30, 2010",Characterization of Cancer Stem Cells,William  Farrar,NULL,"Laboratory of Cancer Prevention, NCI","Stephanie Marie Cabarcas



Lesley A Mathews



Suneetha  Thomas



Ji  Zheng; PhD",NULL,"Timothy D Veenstra (Office Of The Director)



Nadya I Tarasova; PhD (Cancer Inflammation Program)",NULL,"Ordered by publication type and then author name.



1.
Crea F, Mathews LA, Farrar WL, Hurt EM (2009). Targeting prostate cancer stem cells. Anticancer Agents Med Chem  9, 1105-13.   https://doi.org/10.2174/187152009789735053




PubMed


 


PubMed ID 19925394
    
     


 



2.
Kawasaki BT, Hurt EM, Kalathur M, Duhagon MA, Milner JA, Kim YS, Farrar WL (2009). Effects of the sesquiterpene lactone parthenolide on prostate tumor-initiating cells: An integrated molecular profiling approach. Prostate  69, 827-37.   https://doi.org/10.1002/pros.20931




PubMed



        
     
Free Article


 


PubMed ID 19204913
         Pubmed Central ID 2700306 


 



3.
Klarmann GJ, Hurt EM, Mathews LA, Zhang X, Duhagon MA, Mistree T, Thomas SB, Farrar WL (2009). Invasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signature. Clin Exp Metastasis  26, 433-46.   https://doi.org/10.1007/s10585-009-9242-2




PubMed



        
     
Free Article


 


PubMed ID 19221883
         Pubmed Central ID 2782741 


 



4.
Mathews LA, Crea F, Farrar WL (2009). Epigenetic gene regulation in stem cells and correlation to cancer. Differentiation  78, 1-17.   https://doi.org/10.1016/j.diff.2009.04.002




PubMed



        
     
Free Article


 


PubMed ID 19443100
         Pubmed Central ID 2706282",https://intramural.nih.gov/search/searchview.taf?ipid=63092
320,BC010795-04,"October 01, 2009 -  September 30, 2010",Mechanisms of transcription fidelity in prokaryotes and eukaryotes,"Mikhail V Kashlev



IRP Faculty Profile",NULL,"Molecular Mechanisms of Transcription Section, NCI","Ashley Renee Burg



Maria L Kireeva



Lucyna E Lubkowska



Celine Marguerite Paulette Walmacq","Zachary  Burton
(Department of Biochemistry and Molecular Biology, Michigan State University)




Benoit  Coulombe
(Institut de recherches cliniques de Montreal)




Jianhua  Fu
(Cornell University)




Max  Gottesman
(Institute of Cancer Research, Columbia University)




Leonard C Lutter; PhD
(Molecular Biology Research Program, Henry Ford Hospital)




Charles  Turnbough
(Unversity of Alabama)","Jeffrey N Strathern (Office of the Director)



Donald L Court; PhD (Molecular Control and Genetics Section)



Ding Jun Jin (Gene Regulation and Chromosome Biology Laboratory)",NULL,"Ordered by publication type and then author name.



1.
Domecq C, Kireeva M, Archambault J, Kashlev M, Coulombe B, Burton ZF (2010). Site-directed mutagenesis, purification and assay of Saccharomyces cerevisiae RNA polymerase II. Protein Expr Purif  69, 83-90.   https://doi.org/10.1016/j.pep.2009.06.016




PubMed



        
     
Free Article


 


PubMed ID 19567268
         Pubmed Central ID 2783771 


 



2.
Kireeva M, Nedialkov YA, Gong XQ, Zhang C, Xiong Y, Moon W, Burton ZF, Kashlev M (2009). Millisecond phase kinetic analysis of elongation catalyzed by human, yeast, and Escherichia coli RNA polymerase. Methods  48, 333-45.   https://doi.org/10.1016/j.ymeth.2009.04.008




PubMed



        
     
Free Article


 


PubMed ID 19398005
         Pubmed Central ID 2721912 


 



3.
Kireeva ML, Kashlev M (2009). Mechanism of sequence-specific pausing of bacterial RNA polymerase. Proc Natl Acad Sci U S A  106, 8900-5.   https://doi.org/10.1073/pnas.0900407106




PubMed



        
     
Free Article


 


PubMed ID 19416863
         Pubmed Central ID 2690050 


 



4.
Walmacq C, Kireeva ML, Irvin J, Nedialkov Y, Lubkowska L, Malagon F, Strathern JN, Kashlev M (2009). Rpb9 subunit controls transcription fidelity by delaying NTP sequestration in RNA polymerase II. J Biol Chem  284, 19601-12.   https://doi.org/10.1074/jbc.M109.006908




PubMed



        
     
Free Article


 


PubMed ID 19439405
         Pubmed Central ID 2740586",https://intramural.nih.gov/search/searchview.taf?ipid=63114
321,BC010796-04,"October 01, 2009 -  September 30, 2010",Differentiation of tissue- and devlopment of tumor stem cells,John Edward Niederhuber,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI","Christina  Stuelten



Tae-Aug  Kim



Saejeong  Kim



John  Whang



Eun Sung  Yang",NULL,"Lalage  Wakefield; PhD (Laboratory of Cancer Biology and Genetics)



Maxwell P Lee; PhD (Laboratory of Population Genetics)



Robert  Shoemaker (Screening Technologies Branch)



Susan  Mertins (Screening Technologies Branch)



Jeffrey E Green; MD (Laboratory of Cancer Biology and Genetics)



Thomas A Misteli; PhD (Laboratory of Receptor Biology and Gene Expression)",Ronald  McKay; PhD (NINDS),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63103
322,BC010797-04,"October 01, 2009 -  September 30, 2010",Mechanisms of Stromal Cell Activation by the Developing Tumor,John Edward Niederhuber,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI","Amelia  Macintyre



Christina  Stuelten



Olga  Aprelikova; PhD



Xiang  Yu



John  Palla



Karen Jeng-Pei Shou","Amir  Jazaeri
(Obstetrics & Gynecology, University of Virginia)




John I Risinger; PhD
(NCI)","Bih-Rong  Wei (Laboratory of Cancer Biology and Genetics)



Jeffrey S Rubin; MD, PhD (Laboratory of Cellular and Molecular Biology)



Robert Mark Simpson; DVM, PhD (Laboratory of Cancer Biology and Genetics)",NULL,"Ordered by publication type and then author name.



1.
Stuelten CH, Busch JI, Tang B, Flanders KC, Oshima A, Sutton E, Karpova TS, Roberts AB, Wakefield LM, Niederhuber JE (2010). Transient tumor-fibroblast interactions increase tumor cell malignancy by a TGF-Beta mediated mechanism in a mouse xenograft model of breast cancer. PLoS One  5, e9832.   https://doi.org/10.1371/journal.pone.0009832




PubMed



        
     
Free Article


 


PubMed ID 20352126
         Pubmed Central ID 2843748",https://intramural.nih.gov/search/searchview.taf?ipid=63115
323,BC010800-04,"October 01, 2009 -  September 30, 2010",Convection enhanced delivery of  agents into the brainstem of patients with diff,"Katherine Elizabeth Warren; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI",Robyn S Bent,NULL,NULL,"Ashok R Asthagiri; MD (NINDS) 



Joelle  Sarlls; PhD (NICHD) 



Russell R Lonser; MD (NINDS) 



Carlo  Pierpaoli; MD, PhD (NICHD)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63116
324,BC010801-04,"October 01, 2009 -  September 30, 2010",Development of Therapies for Neurofibromatosis Type 1 Related Tumors and other G,"Brigitte  Widemann; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI","Andrea Maria Baldwin



Eva  Dombi



Katherine Elizabeth Warren; MD



Andrea F Gillespie



Pamela  Wolters



Nalini M Jayaprakash



Show all 10","Dusica  Babovic-Vuksanovich
(Genetics, Mayo-Clinic)




Larry  Baker
(SARC)




Jean  Belasco
(Neurooncology, Children's Hospital of Philadelphia)




Susan  Blaney
(Texas Children's Cancer Center)




Karen  Cichowski
(Brigham and Women's Hospital)




Jan  Friedman
(University of British Columbia)


Show all 18","Seth M Steinberg; PhD (Office of the Director)



Thomas J Hornyak (Dermatology Branch)



Karlyne M Reilly; BS, PhD (Mouse Cancer Genetics Program)","James C Reynolds; MD (CC) 



Douglas Russell Stewart; BA, MD (NHGRI) 



Constantine Argyrios Stratakis; MD, DSc (NICHD) 



Daniel L Handel (CC) 



Jeffrey M Solomon; BS, MS, PhD (CC) 



Clara Chi Chen; MD (CC)","Ordered by publication type and then author name.



1.
Evans DG, Kalamarides M, Hunter-Schaedle K, Blakeley J, Allen J, Babovic-Vuskanovic D, Belzberg A, Bollag G, Chen R, DiTomaso E, Golfinos J, Harris G, Jacob A, Kalpana G, Karajannis M, Korf B, Kurzrock R, Law M, McClatchey A, Packer R, Roehm P, Rubenstein A, Slattery W, Tonsgard JH, Welling DB, et al. [3 more authors] (2009). Consensus recommendations to accelerate clinical trials for neurofibromatosis type 2. Clin Cancer Res  15, 5032-5039.   https://doi.org/10.1158/1078-0432.CCR-08-3011




PubMed



        
     
Free Article


 


PubMed ID 19671848
         Pubmed Central ID 4513640 


 



2.
Kim A, Gillespie A, Dombi E, Goodwin A, Goodspeed W, Fox E, Balis FM, Widemann BC (2009). Characteristics of children enrolled in treatment trials for NF1-related plexiform neurofibromas. Neurology  73, 1273-9.   https://doi.org/10.1212/WNL.0b013e3181bd1326




PubMed



        
     
Free Article


 


PubMed ID 19841379
         Pubmed Central ID 2764415 


 



3.
Widemann BC (2009). Current status of sporadic and neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors. Curr Oncol Rep  11, 322-8.   https://doi.org/10.1007/s11912-009-0045-z




PubMed



        
     
Free Article


 


PubMed ID 19508838
         Pubmed Central ID 6689400",https://intramural.nih.gov/search/searchview.taf?ipid=63117
325,BC010802-04,"October 01, 2009 -  September 30, 2010",Tumor stem cells and metastatic outcomes in mouse models of prostate cancer,"Kathleen  Kelly; PhD



IRP Faculty Profile",NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI","Wassim Gergy  Abou-Kheir



Paul Gerard Hynes



Yen Nien  Liu



Victoria  Seng



Juanjuan  Yin",NULL,Jonathan  Vogel; MD (Dermatology Branch),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63118
326,BC010803-04,"October 01, 2009 -  September 30, 2010",Characterizing a novel tumor recognition mechanism,"James Chung-Yin Yang; MD, PhD



IRP Faculty Profile",NULL,"Surgery Branch, NCI",Qiong J Wang,NULL,NULL,"David Harvey Margulies; MD, PhD (NIAID)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63119
327,BC010804-04,"October 01, 2009 -  September 30, 2010",Using Glycosyltransferases for the Development of Targeted Drug Delivery System,Pradman  Qasba; PhD,NULL,"Structural Glycobiology Section, NCI","Juan Antonio Alvarez-Gonzalez



Elizabeth  Boeggeman



Natalia  Mercer



Boopathy  Ramakrishna",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63120
328,BC010805-04,"October 01, 2009 -  September 30, 2010",Using Glycosyltransferases for Conjugation of Single-Chain Antibodies and Lipids,Pradman  Qasba; PhD,NULL,"Structural Glycobiology Section, NCI","Elizabeth  Boeggeman



Boopathy  Ramakrishna",NULL,"Dimiter Stanchev Dimitrov; PhD (Membrane Structure and Function Section)



Robert  Blumenthal; PhD (Center for Cancer Research Nanobiology Program)",NULL,"Ordered by publication type and then author name.



1.
Boeggeman E, Ramakrishnan B, Pasek M, Manzoni M, Puri A, Loomis KH, Waybright TJ, Qasba PK (2009). Site specific conjugation of fluoroprobes to the remodeled Fc N-glycans of monoclonal antibodies using mutant glycosyltransferases: application for cell surface antigen detection. Bioconjug Chem  20, 1228-36.   https://doi.org/10.1021/bc900103p




PubMed



        
     
Free Article


 


PubMed ID 19425533
         Pubmed Central ID 3464487 


 



2.
Pasek M, Ramakrishnan B, Boeggeman E, Manzoni M, Waybright TJ, Qasba PK (2009). Bioconjugation and detection of lactosamine moiety using alpha1,3-galactosyltransferase mutants that transfer C2-modified galactose with a chemical handle. Bioconjug Chem  20, 608-18.   https://doi.org/10.1021/bc800534r




PubMed



        
     
Free Article


 


PubMed ID 19245254
         Pubmed Central ID 3464485 


 



3.
Ramakrishnan B, Boeggeman E, Manzoni M, Zhu Z, Loomis K, Puri A, Dimitrov DS, Qasba PK (2009). Multiple site-specific in vitro labeling of single-chain antibody. Bioconjug Chem  20, 1383-9.   https://doi.org/10.1021/bc900149r




PubMed



        
     
Free Article


 


PubMed ID 19507852
         Pubmed Central ID 3402211",https://intramural.nih.gov/search/searchview.taf?ipid=63121
329,BC010806-04,"October 01, 2009 -  September 30, 2010",Targeting High-risk Neuroblastoma using high through put siRNA screening,"Javed  Khan; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI","James  Badgett



Qingrong  Chen



Lee Jay Helman; MD



Carol J Thiele



Patricia S Tsang; PhD



Jun S Wei","David  Azorsa
(NHGRI)




John  Maris
(Pharmacology, Children's Hospital of Philadelphia)",Malcolm A Smith (Clinical Investigations Branch),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63122
330,BC010808-04,"October 01, 2009 -  September 30, 2010",Nucleosome Dynamics,"Yawen  Bai; PhD



IRP Faculty Profile",NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI","Hanqiao  Feng



Carl  Wu; PhD



Jingjun  Hong



Hidenori  Kato



Junqian  Zhang



Bing-Rui  Zhou



Show all 7",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63085
331,BC010814-04,"October 01, 2009 -  September 30, 2010",Mechanisms of Retroviral RNA Trafficking and Packaging,"Wei-Shau  Hu; PhD



IRP Faculty Profile",NULL,"Retroviral Replication Laboratory, NCI","Jianbo  Chen



John Miller Coffin; PhD



Kari Ann Dilley



Alan  Rein; PhD



Steven Carter Hatch



Vinay K Pathak; PhD



Show all 10","William W Fu





Marie-Louise  Hammarskjold; PhD
(Microbiology, University of Virginia)




Roger  Ptak
(Southern Research Institute)




David  Rekosh
(Myles Thayler AIDS Institute, University of Virginia)




Andrew  Wright
(Tufts University)","Sriram  Subramaniam; PhD (Laboratory of Cell Biology)



Stephen J Lockett; PhD (Office Of The Director)",George  Patterson; PhD (NIBIB),"Ordered by publication type and then author name.



1.
Chen J, Nikolaitchik O, Singh J, Wright A, Bencsics CE, Coffin JM, Ni N, Lockett S, Pathak VK, Hu WS (2009). High efficiency of HIV-1 genomic RNA packaging and heterozygote formation revealed by single virion analysis. Proc Natl Acad Sci U S A  106, 13535-40.   https://doi.org/10.1073/pnas.0906822106




PubMed



        
     
Free Article


 


PubMed ID 19628694
         Pubmed Central ID 2714765 


 



2.
Hussein IT, Ni N, Galli A, Chen J, Moore MD, Hu WS (2010). Delineation of the preferences and requirements of the human immunodeficiency virus type 1 dimerization initiation signal by using an in vivo cell-based selection approach. J Virol  84, 6866-75.   https://doi.org/10.1128/JVI.01930-09




PubMed



        
     
Free Article


 


PubMed ID 20410279
         Pubmed Central ID 2903283 


 



3.
Moore MD, Nikolaitchik OA, Chen J, Hammarskjöld ML, Rekosh D, Hu WS (2009). Probing the HIV-1 genomic RNA trafficking pathway and dimerization by genetic recombination and single virion analyses. PLoS Pathog  5, e1000627.   https://doi.org/10.1371/journal.ppat.1000627




PubMed



        
     
Free Article


 


PubMed ID 19834549
         Pubmed Central ID 2757677",https://intramural.nih.gov/search/searchview.taf?ipid=63124
332,BC010815-04,"October 01, 2009 -  September 30, 2010",Regulation of Hypoxia-Inducible Factors in Pluripotent Cancer Cells.,John Edward Niederhuber,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Olga  Aprelikova; PhD,NULL,"Yoshimi Endo Greer (Laboratory of Cellular and Molecular Biology)



Jeffrey S Rubin; MD, PhD (Laboratory of Cellular and Molecular Biology)",NULL,"Ordered by publication type and then author name.



1.
Aprelikova O, Pandolfi S, Tackett S, Ferreira M, Salnikow K, Ward Y, Risinger JI, Barrett JC, Niederhuber J (2009). Melanoma antigen-11 inhibits the hypoxia-inducible factor prolyl hydroxylase 2 and activates hypoxic response. Cancer Res  69, 616-24.   https://doi.org/10.1158/0008-5472.CAN-08-0811




PubMed



        
     
Free Article


 


PubMed ID 19147576
         Pubmed Central ID 2629394",https://intramural.nih.gov/search/searchview.taf?ipid=63125
333,BC010816-04,"October 01, 2009 -  September 30, 2010",Immunotherapy for Malignant Mesothelioma,"Raffit  Hassan



IRP Faculty Profile",NULL,"Laboratory of Molecular Biology, NCI","Sonya C Duke



Neetu  Kalra



Elad  Sharon



Jingli  Zhang",NULL,"Peter L Choyke; MD (Molecular Imaging Program)



Ira H Pastan; MD (Molecular Biology Section)","Alan T Remaley; MD, PhD (CC)","Ordered by publication type and then author name.



1.
Carpenito C, Milone MC, Hassan R, Simonet JC, Lakhal M, Suhoski MM, Varela-Rohena A, Haines KM, Heitjan DF, Albelda SM, Carroll RG, Riley JL, Pastan I, June CH (2009). Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains. Proc Natl Acad Sci U S A  106, 3360-5.   https://doi.org/10.1073/pnas.0813101106




PubMed



        
     
Free Article


 


PubMed ID 19211796
         Pubmed Central ID 2651342 


 



2.
Kreitman RJ, Hassan R, Fitzgerald DJ, Pastan I (2009). Phase I trial of continuous infusion anti-mesothelin recombinant immunotoxin SS1P. Clin Cancer Res  15, 5274-9.   https://doi.org/10.1158/1078-0432.CCR-09-0062




PubMed



        
     
Free Article


 


PubMed ID 19671873
         Pubmed Central ID 2754261",https://intramural.nih.gov/search/searchview.taf?ipid=63126
334,BC010817-04,"October 01, 2009 -  September 30, 2010",Role of normal cervical stem cells in the HPV induced initiation of cervical can,John Edward Niederhuber,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Xiang  Yu,NULL,John  Schiller; PhD (Laboratory of Cellular Oncology),NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=63127
335,BC010818-04,"October 01, 2009 -  September 30, 2010",Replication Dynamics in Patients on Suppressive Antiretroviral Therapy,Frank  Maldarelli,Stephen H Hughes; PhD,"Host Virus Interaction Branch, NCI","Karoll  Cortez



Francesca  Cossarini","Zandrea  Ambrose
(University of Pittsburgh)




Jintanat  Ananworanich; MD, PhD
(HIV Netherlands Australia Thailand Research Collaboration (HIV/NAT))




Thomas  Benfield
(University of Copenhagen)




Scott  Brun
(-, Abbott Laboratories)




Nancy  Crum-Clanfione
(Naval Medical Center)




Lisa  Demeter
(University of Washington)


Show all 27",Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch),"Joseph A Kovacs; MD (CC) 



Joseph P Casazza (NIAID) 



Irini  Sereti; MD (NIAID) 



Michael  Proschan; PhD (NIAID) 



Henry  Masur; MD (CC) 



Michael  Polis; MD (NIAID)","Ordered by publication type and then author name.



1.
Gandhi RT, Zheng L, Bosch RJ, Chan ES, Margolis DM, Read S, Kallungal B, Palmer S, Medvik K, Lederman MM, Alatrakchi N, Jacobson JM, Wiegand A, Kearney M, Coffin JM, Mellors JW, Eron JJ, AIDS Clinical Trials Group A5244 team (2010) The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trial. PLoS Med 7.




PubMed



        
     
Free Article


 


PubMed ID 20711481
         Pubmed Central ID 2919424 


 



2.
McMahon D, Jones J, Wiegand A, Gange SJ, Kearney M, Palmer S, McNulty S, Metcalf JA, Acosta E, Rehm C, Coffin JM, Mellors JW, Maldarelli F (2010). Short-course raltegravir intensification does not reduce persistent low-level viremia in patients with HIV-1 suppression during receipt of combination antiretroviral therapy. Clin Infect Dis  50, 912-9.   https://doi.org/10.1086/650749




PubMed



        
     
Free Article


 


PubMed ID 20156060
         Pubmed Central ID 2897152",https://intramural.nih.gov/search/searchview.taf?ipid=63128
336,BC010819-04,"October 01, 2009 -  September 30, 2010",HIV-1 Genetic Variation in Infected Individuals,Frank  Maldarelli,Stephen H Hughes; PhD,"Host Virus Interaction Branch, NCI",Francesca  Cossarini,"Guilliaume  Achaz
(University of Paris)




Zandrea  Ambrose
(University of Pittsburgh)




Sunil  Arora
(PGIMER)




Thomas  Benfield
(University of Copenhagen)




James Coston Brooks





Eric  Daar
(Infectious Diseases, Harbor-UCL Medical Center)


Show all 20","Wei-Shau  Hu; PhD (Retroviral Replication Laboratory)



Mary  Carrington; MS, PhD (Laboratory of Experimental Immunology)



Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)



Eric O Freed; PhD (Retroviral Replication Laboratory)



Vineet Narain KewalRamani; PhD (Retroviral Replication Laboratory)



Vinay K Pathak; PhD (Retroviral Replication Laboratory)","Joseph A Kovacs; MD (CC) 



Henry  Masur; MD (CC) 



Caryn G Morse; MD (NIAID) 



Michael  Polis; MD (NIAID) 



Shyamasundaran  Kottilil; MD, PhD (NIAID) 



H. Clifford  Lane; MD (NIAID)","Ordered by publication type and then author name.



1.
Galli A, Kearney M, Nikolaitchik OA, Yu S, Chin MP, Maldarelli F, Coffin JM, Pathak VK, Hu WS (2010). Patterns of Human Immunodeficiency Virus type 1 recombination ex vivo provide evidence for coadaptation of distant sites, resulting in purifying selection for intersubtype recombinants during replication. J Virol  84, 7651-61.   https://doi.org/10.1128/JVI.00276-10




PubMed



        
     
Free Article


 


PubMed ID 20504919
         Pubmed Central ID 2897624 


 



2.
Jordan MR, Kearney M, Palmer S, Shao W, Maldarelli F, Coakley EP, Chappey C, Wanke C, Coffin JM (2010). Comparison of standard PCR/cloning to single genome sequencing for analysis of HIV-1 populations. J Virol Methods  168, 114-20.   https://doi.org/10.1016/j.jviromet.2010.04.030




PubMed



        
     
Free Article


 


PubMed ID 20451557
         Pubmed Central ID 3949620 


 



3.
Kutty G, Achaz G, Maldarelli F, Varma A, Shroff R, Becker S, Fantoni G, Kovacs JA (2010). Characterization of the meiosis-specific recombinase Dmc1 of pneumocystis. J Infect Dis  202, 1920-9.   https://doi.org/10.1086/657414




PubMed



        
     
Free Article


 


PubMed ID 21050123
         Pubmed Central ID 3058675 


 



4.
Shao W, Kearney M, Maldarelli F, Mellors JW, Stephens RM, Lifson JD, KewalRamani VN, Ambrose Z, Coffin JM, Palmer SE (2009). RT-SHIV subpopulation dynamics in infected macaques during anti-HIV therapy. Retrovirology  6, 101.   https://doi.org/10.1186/1742-4690-6-101




PubMed



        
     
Free Article


 


PubMed ID 19889213
         Pubmed Central ID 2776578",https://intramural.nih.gov/search/searchview.taf?ipid=63129
337,BC010820-04,"October 01, 2009 -  September 30, 2010",Appearance and Disappearance of Drug Resistance Mutations,Frank  Maldarelli,Stephen H Hughes; PhD,"Host Virus Interaction Branch, NCI",NULL,"Zandrea  Ambrose
(University of Pittsburgh)




John W Mellors





Lynn  Morris
(National Institute for Communicable Diseases)




Douglas  Richman





Pat  Robertson
(-, Boehringer Ingelheim)","Eric O Freed; PhD (Retroviral Replication Laboratory)



Vineet Narain KewalRamani; PhD (Retroviral Replication Laboratory)","Henry  Masur; MD (CC) 



H. Clifford  Lane; MD (NIAID) 



Richard T Davey; MD (NIAID)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63130
338,BC010821-04,"October 01, 2009 -  September 30, 2010",Role of Specific Drugs and Mutations in Partial Suppression of Viremia,Frank  Maldarelli,Stephen H Hughes; PhD,"Host Virus Interaction Branch, NCI",NULL,"Nancy  Crum-Clanfione
(Naval Medical Center)




Anuradha  Ganesan
(Henry M. Jackson Foundation)","Mary  Carrington; MS, PhD (Laboratory of Experimental Immunology)



Paul L Boyer (Retroviral Replication Laboratory)



Eric O Freed; PhD (Retroviral Replication Laboratory)



Vinay K Pathak; PhD (Retroviral Replication Laboratory)","Irini  Sereti; MD (NIAID) 



Rohan  Hazra (NICHD) 



Alice K Pau; PharmD (NIAID) 



Henry  Masur; MD (CC) 



H. Clifford  Lane; MD (NIAID) 



Joann  Mican; MD (NIAID)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63131
339,BC010822-04,"October 01, 2009 -  September 30, 2010",Molecular Determinants of Chromosome Transmission and Cell Cycle Regulation,"Munira A Basrai; PhD



IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","Wei-Chun  Au



Paul S Meltzer; MD, PhD



John S Choy



Karl Thomas Ried; MD



Sultan Y Ciftci



Anna V Roschke



Show all 9","Richard  Baker
(Univ. of Massachusetts, Amherst)




Kenneth  Belanger
(Biology, Colgate University)




Maitreya  Dunham
(Genome Sciences, Univ of Washington,)




Grant  Hartzog
(MCD Biology, Univ. of California, Santa Cruz)




Oliver J. Rando
(Stanford University)",NULL,NULL,"Ordered by publication type and then author name.



1.
Deng Y, Guo Y, Watson H, Au WC, Shakoury-Elizeh M, Basrai MA, Bonifacino JS, Philpott CC (2009). Gga2 mediates sequential ubiquitin-independent and ubiquitin-dependent steps in the trafficking of ARN1 from the trans-Golgi network to the vacuole. J Biol Chem  284, 23830-41.   https://doi.org/10.1074/jbc.M109.030015




PubMed



        
     
Free Article


 


PubMed ID 19574226
         Pubmed Central ID 2749155",https://intramural.nih.gov/search/searchview.taf?ipid=63086
340,BC010824-04,"October 01, 2009 -  September 30, 2010",Molecular structure of the bacterial chemotaxis apparatus,"Sriram  Subramaniam; PhD



IRP Faculty Profile",NULL,"Laboratory of Cell Biology, NCI","Martin  Kessel; BSc, PhD



Lisa M. Hartnell



Joel Reuben Meyerson



Rachna C Nandwani","Jerry  Hazelbauer
(Biochemistry, University of Missouri)




Victor  Sourjik
(University of Heidelberg)




Yuhai  Tu
(IBM)",NULL,Bernard R Brooks; PhD (NHLBI),"Ordered by publication type and then author name.



1.
Bartesaghi A, Subramaniam S (2009). Membrane protein structure determination using cryo-electron tomography and 3D image averaging. Curr Opin Struct Biol  19, 402-7.   https://doi.org/10.1016/j.sbi.2009.06.005




PubMed



        
     
Free Article


 


PubMed ID 19646859
         Pubmed Central ID 2752674 


 



2.
Hirai T, Subramaniam S (2009). Protein conformational changes in the bacteriorhodopsin photocycle: comparison of findings from electron and X-ray crystallographic analyses. PLoS One  4, e5769.   https://doi.org/10.1371/journal.pone.0005769




PubMed



        
     
Free Article


 


PubMed ID 19488399
         Pubmed Central ID 2685002 


 



3.
Subramaniam S, Ouyang H, Gray A, McLaughllin S, Subramaniam S (2009) Automatic mining of 3D images of whole cells. Pattern Recognition 1067-1079.",https://intramural.nih.gov/search/searchview.taf?ipid=63132
341,BC010825-04,"October 01, 2009 -  September 30, 2010",HIV neutralization and mechanisms of cellular entry,"Sriram  Subramaniam; PhD



IRP Faculty Profile",NULL,"Laboratory of Cell Biology, NCI","Gabriel Abraham Frank



Audray  Harris; PhD



Erin E Tran



Joel Reuben Meyerson","Sina  Bavari
(-, USAMRIID)




Thomas  Hope
(University of Illinois-Chicago)




John  Moore
(Cornell University)




William  Olson
(Progenics Inc.)","Dimiter Stanchev Dimitrov; PhD (Membrane Structure and Function Section)



Eric O Freed; PhD (Retroviral Replication Laboratory)



Robert  Blumenthal; PhD (Center for Cancer Research Nanobiology Program)



Jeffrey D Lifson; MD (Office Of The Director)",NULL,"Ordered by publication type and then author name.



1.
Bartesaghi A, Subramaniam S (2009). Membrane protein structure determination using cryo-electron tomography and 3D image averaging. Curr Opin Struct Biol  19, 402-7.   https://doi.org/10.1016/j.sbi.2009.06.005




PubMed



        
     
Free Article


 


PubMed ID 19646859
         Pubmed Central ID 2752674 


 



2.
Bennett AE, Narayan K, Shi D, Hartnell LM, Gousset K, He H, Lowekamp BC, Yoo TS, Bliss D, Freed EO, Subramaniam S (2009). Ion-abrasion scanning electron microscopy reveals surface-connected tubular conduits in HIV-infected macrophages. PLoS Pathog  5, e1000591.   https://doi.org/10.1371/journal.ppat.1000591




PubMed



        
     
Free Article


 


PubMed ID 19779568
         Pubmed Central ID 2743285 


 



3.
Hirai T, Subramaniam S (2009). Protein conformational changes in the bacteriorhodopsin photocycle: comparison of findings from electron and X-ray crystallographic analyses. PLoS One  4, e5769.   https://doi.org/10.1371/journal.pone.0005769




PubMed



        
     
Free Article


 


PubMed ID 19488399
         Pubmed Central ID 2685002 


 



4.
Hirai T, Subramaniam S, Lanyi JK (2009). Structural snapshots of conformational changes in a seven-helix membrane protein: lessons from bacteriorhodopsin. Curr Opin Struct Biol  19, 433-9.   https://doi.org/10.1016/j.sbi.2009.07.009




PubMed



        
     
Free Article


 


PubMed ID 19643594
         Pubmed Central ID 2747668 


 



5.
Narayan K, Perkins EM, Murphy GE, Dalai SK, Edidin M, Subramaniam S, Sadegh-Nasseri S (2009). Staphylococcal enterotoxin A induces small clusters of HLA-DR1 on B cells. PLoS One  4, e6188.   https://doi.org/10.1371/journal.pone.0006188




PubMed



        
     
Free Article


 


PubMed ID 19587800
         Pubmed Central ID 2705189 


 



6.
Subramaniam S, Ouyang H, Gray A, McLaughllin S, Subramaniam S (2009) Automatic mining of 3D images of whole cells. Pattern Recognition 1067-1079.",https://intramural.nih.gov/search/searchview.taf?ipid=63133
342,BC010826-04,"October 01, 2009 -  September 30, 2010",Technology Development for 3D Electron Microscopy,"Sriram  Subramaniam; PhD



IRP Faculty Profile",NULL,"Laboratory of Cell Biology, NCI","Michael Jason de la Cruz



Lisa M. Hartnell



Rachna C Nandwani



Alberto  Bartesaghi



Kedar  Narayan","Guillermo  Sapiro
(Electrical Engineering, Uinversity of Minnesota)




John Henry  Scott
(NIST)




Chris  Szakal
(NIST)",NULL,"Terry S Yoo; PhD (NLM) 



Bernard R Brooks; PhD (NHLBI)","Ordered by publication type and then author name.



1.
Bartesaghi A, Subramaniam S (2009). Membrane protein structure determination using cryo-electron tomography and 3D image averaging. Curr Opin Struct Biol  19, 402-7.   https://doi.org/10.1016/j.sbi.2009.06.005




PubMed



        
     
Free Article


 


PubMed ID 19646859
         Pubmed Central ID 2752674 


 



2.
Heymann JA, Shi D, Kim S, Bliss D, Milne JL, Subramaniam S (2009). 3D imaging of mammalian cells with ion-abrasion scanning electron microscopy. J Struct Biol  166, 1-7.   https://doi.org/10.1016/j.jsb.2008.11.005




PubMed



        
     
Free Article


 


PubMed ID 19116171
         Pubmed Central ID 4804765 


 



3.
Hildebrand M, Kim S, Shi D, Scott K, Subramaniam S (2009). 3D imaging of diatoms with ion-abrasion scanning electron microscopy. J Struct Biol  166, 316-28.   https://doi.org/10.1016/j.jsb.2009.02.014




PubMed



        
     
Free Article


 


PubMed ID 19269330
         Pubmed Central ID 2743382 


 



4.
Hirai T, Subramaniam S (2009). Protein conformational changes in the bacteriorhodopsin photocycle: comparison of findings from electron and X-ray crystallographic analyses. PLoS One  4, e5769.   https://doi.org/10.1371/journal.pone.0005769




PubMed



        
     
Free Article


 


PubMed ID 19488399
         Pubmed Central ID 2685002 


 



5.
Hirai T, Subramaniam S, Lanyi JK (2009). Structural snapshots of conformational changes in a seven-helix membrane protein: lessons from bacteriorhodopsin. Curr Opin Struct Biol  19, 433-9.   https://doi.org/10.1016/j.sbi.2009.07.009




PubMed



        
     
Free Article


 


PubMed ID 19643594
         Pubmed Central ID 2747668 


 



6.
Subramaniam S, Ouyang H, Gray A, McLaughllin S, Subramaniam S (2009) Automatic mining of 3D images of whole cells. Pattern Recognition 1067-1079.",https://intramural.nih.gov/search/searchview.taf?ipid=63134
343,BC010827-04,"October 01, 2009 -  September 30, 2010",Structural Studies of Bacterial Architecture Using Electron Tomography,Jacqueline L Milne,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI","Dan  Shi



Sriram  Subramaniam; PhD



Mario J Borgnia; PhD",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Milne J (2010) Structure and regulation of pyruvate dehydrogenase complexes, in Encyclopedia of Biological Chemistry. M. Daniel Lane and William Lennarz, eds. Elsevier Inc, in press.




 



2.
Heymann JA, Shi D, Kim S, Bliss D, Milne JL, Subramaniam S (2009). 3D imaging of mammalian cells with ion-abrasion scanning electron microscopy. J Struct Biol  166, 1-7.   https://doi.org/10.1016/j.jsb.2008.11.005




PubMed



        
     
Free Article


 


PubMed ID 19116171
         Pubmed Central ID 4804765 


 



3.
Hildebrand M, Kim S, Shi D, Scott K, Subramaniam S (2009). 3D imaging of diatoms with ion-abrasion scanning electron microscopy. J Struct Biol  166, 316-28.   https://doi.org/10.1016/j.jsb.2009.02.014




PubMed



        
     
Free Article


 


PubMed ID 19269330
         Pubmed Central ID 2743382",https://intramural.nih.gov/search/searchview.taf?ipid=63135
344,BC010830-04,"October 01, 2009 -  September 30, 2010",Mechanisms of non-classical multidrug resistance in cancer,"Michael Marc Gottesman; MD



IRP Faculty Profile",NULL,"Chemical Immunology Section, NCI","Carol O Cardarelli



Jean-Pierre  Gillet



Matthew David Hall



Rajalakshm L Padmanabhan



Ding wu  Shen; PhD



Wilfred D Vieira



Show all 7","Ben  Davidson
(Norwegian Radium Hospital)




Ram  Ganapathy
(Cleveland Clinic)




Jacob  Hochman
(Hebrew University)




Bo  Rueda
(Massachusetts General Hospital)




Michael  Seiden
(Hematology Oncology, Dana-Farber/Partners Cancer Care Program)","Anna Maria Calcagno (Office Of The Director)



Vincent J. Hearing; PhD (Pigment Cell Biology Section)



Suresh V Ambudkar; PhD (Transport Biochemistry Section)","Kevin G Chen; MD (NINDS) 



Joshua  Zimmerberg; PhD, MD (NICHD) 



Ronald  McKay; PhD (NINDS)","Ordered by publication type and then author name.



1.
Gottesman M, Okabe M, Gottesman M (2009) The Hepatocyte and the Cancer Cell: Dr. Jekyll and Mr. Hyde, in The liver: Biology and Pathobiology, 5th Edition. Wiley-Blackwell (Oxford, England), pp. 1075-1090.




 



2.
Chen KG, Leapman RD, Zhang G, Lai B, Valencia JC, Cardarelli CO, Vieira WD, Hearing VJ, Gottesman MM (2009). Influence of melanosome dynamics on melanoma drug sensitivity. J Natl Cancer Inst  101, 1259-71.   https://doi.org/10.1093/jnci/djp259




PubMed



        
     
Free Article


 


PubMed ID 19704071
         Pubmed Central ID 2744727 


 



3.
Gottesman M, Salcido C, Gillet J, Wu C, Fostel J, Mumau M, Gottesman M, Varticovski L, Ambudkar S (2010) Prolonged Drug Selection of Breast Cancer Cells and Enrichment of Cancer Stem-Cell Characteristics. J. Natl. Cancer Inst, in press.




 



4.
Orina JN, Calcagno AM, Wu CP, Varma S, Shih J, Lin M, Eichler G, Weinstein JN, Pommier Y, Ambudkar SV, Gottesman MM, Gillet JP (2009). Evaluation of current methods used to analyze the expression profiles of ATP-binding cassette transporters yields an improved drug-discovery database. Mol Cancer Ther  8, 2057-66.   https://doi.org/10.1158/1535-7163.MCT-09-0256




PubMed



        
     
Free Article


 


PubMed ID 19584229
         Pubmed Central ID 2736804",https://intramural.nih.gov/search/searchview.taf?ipid=63136
345,BC010831-04,"October 01, 2009 -  September 30, 2010",Characterization of Small Open Reading Frames (sORFs) that Encode for Proteins,"Munira A Basrai; PhD



IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI",Wei-Chun  Au,"Jef  Boeke
(Johns Hopkins University)




Ron  Davis
(Biochemistry and Genome Technology Center, Stanford University)




Michael  Snyder
(Yale University)",NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=63087
346,BC010832-04,"October 01, 2009 -  September 30, 2010",Fundamentals of Ligand-Protein Interactions,"Marc C Nicklaus



IRP Faculty Profile",NULL,"Chemical Biology Laboratory, NCI","Igor V Filippov



Chenzhong  Liao



Markus  Sitzmann



Iwona Elzbieta Weidlich







Joel Patrick Schneider; PhD","Heather  Carlson
(Univ. of Michigan)




Wolf-Dietrich  Ihlenfeldt
(Xemistry GmbH)




Kenneth  Merz
(University of Florida)




Alexander  Tropsha
(Univ. of North Carolina)




John  Westbrook
(RSCB/Rutgers)",Raul Eduardo Cachau (Office Of The Director),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63137
347,BC010833-04,"October 01, 2009 -  September 30, 2010",Identification and functional characterization of colorectal cancer genes,"Karl Thomas Ried; MD



IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","Markus Alexander Brown



Natasha  Caplen



Bernard N Chen



Chi Chung  Cheng



Yue  Hu



Jana  Kinder



Show all 11",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Camps J, Nguyen QT, Padilla-Nash HM, Knutsen T, McNeil NE, Wangsa D, Hummon AB, Grade M, Ried T, Difilippantonio MJ (2009). Integrative genomics reveals mechanisms of copy number alterations responsible for transcriptional deregulation in colorectal cancer. Genes Chromosomes Cancer  48, 1002-17.   https://doi.org/10.1002/gcc.20699




PubMed



        
     
Free Article


 


PubMed ID 19691111
         Pubmed Central ID 4721599 


 



2.
Difilippantonio MJ, Ghadimi BM, Howard T, Camps J, Nguyen QT, Ferris DK, Sackett DL, Ried T (2009). Nucleation capacity and presence of centrioles define a distinct category of centrosome abnormalities that induces multipolar mitoses in cancer cells. Environ Mol Mutagen  50, 672-96.   https://doi.org/10.1002/em.20532




PubMed



        
     
Free Article


 


PubMed ID 19768832
         Pubmed Central ID 4322947 


 



3.
Gertz EM, Sengupta K, Difilippantonio MJ, Ried T, Schäffer AA (2009). Evaluating annotations of an Agilent expression chip suggests that many features cannot be interpreted. BMC Genomics  10, 566.   https://doi.org/10.1186/1471-2164-10-566




PubMed



        
     
Free Article


 


PubMed ID 19948035
         Pubmed Central ID 2791105 


 



4.
Grade M, Gaedcke J, Wangsa D, Varma S, Beckmann J, Liersch T, Hess C, Becker H, Difilippantonio MJ, Ried T, Ghadimi BM (2009). Chromosomal copy number changes of locally advanced rectal cancers treated with preoperative chemoradiotherapy. Cancer Genet Cytogenet  193, 19-28.   https://doi.org/10.1016/j.cancergencyto.2009.03.016




PubMed



        
     
Free Article


 


PubMed ID 19602460
         Pubmed Central ID 2714587 


 



5.
Liersch T, Grade M, Gaedcke J, Varma S, Difilippantonio MJ, Langer C, Hess CF, Becker H, Ried T, Ghadimi BM (2009). Preoperative chemoradiotherapy in locally advanced rectal cancer: correlation of a gene expression-based response signature with recurrence. Cancer Genet Cytogenet  190, 57-65.   https://doi.org/10.1016/j.cancergencyto.2008.11.011




PubMed



        
     
Free Article


 


PubMed ID 19380020
         Pubmed Central ID 2766806",https://intramural.nih.gov/search/searchview.taf?ipid=63138
348,BC010834-04,"October 01, 2009 -  September 30, 2010","Identifying Diagnostic Markers for Cervical Cancer, Breast Cancer, and Prostate","Karl Thomas Ried; MD



IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","Amanda Iris Bradley



Bernard N Chen



Chi Chung  Cheng



Timo  Gaiser



Yue  Hu



Jana  Kinder



Show all 10","Gert  Auer





Elisabeth  Unger",NULL,NULL,"Ordered by publication type and then author name.



1.
Andersson S, Sowjanya P, Wangsa D, Hjerpe A, Johansson B, Auer G, Gravitt PE, Larsson C, Wallin KL, Ried T, Heselmeyer-Haddad K (2009). Detection of genomic amplification of the human telomerase gene TERC, a potential marker for triage of women with HPV-positive, abnormal Pap smears. Am J Pathol  175, 1831-47.   https://doi.org/10.2353/ajpath.2009.090122




PubMed



        
     
Free Article


 


PubMed ID 19880826
         Pubmed Central ID 2770709 


 



2.
Habermann JK, Doering J, Hautaniemi S, Roblick UJ, Bündgen NK, Nicorici D, Kronenwett U, Rathnagiriswaran S, Mettu RK, Ma Y, Krüger S, Bruch HP, Auer G, Guo NL, Ried T (2009). The gene expression signature of genomic instability in breast cancer is an independent predictor of clinical outcome. Int J Cancer  124, 1552-64.   https://doi.org/10.1002/ijc.24017




PubMed



        
     
Free Article


 


PubMed ID 19101988
         Pubmed Central ID 2707256 


 



3.
Swanton C, Nicke B, Schuett M, Eklund AC, Ng C, Li Q, Hardcastle T, Lee A, Roy R, East P, Kschischo M, Endesfelder D, Wylie P, Kim SN, Chen JG, Howell M, Ried T, Habermann JK, Auer G, Brenton JD, Szallasi Z, Downward J (2009). Chromosomal instability determines taxane response. Proc Natl Acad Sci U S A  106, 8671-6.   https://doi.org/10.1073/pnas.0811835106




PubMed



        
     
Free Article


 


PubMed ID 19458043
         Pubmed Central ID 2688979 


 



4.
Wangsa D, Heselmeyer-Haddad K, Ried P, Eriksson E, Schäffer AA, Morrison LE, Luo J, Auer G, Munck-Wikland E, Ried T, Lundqvist EA (2009). Fluorescence in situ hybridization markers for prediction of cervical lymph node metastases. Am J Pathol  175, 2637-45.   https://doi.org/10.2353/ajpath.2009.090289




PubMed



        
     
Free Article


 


PubMed ID 19893027
         Pubmed Central ID 2789632",https://intramural.nih.gov/search/searchview.taf?ipid=63139
349,BC010835-04,"October 01, 2009 -  September 30, 2010",Consequences of Genomic Instability and Aneuploidy on the Colorectal Cancer Tran,"Karl Thomas Ried; MD



IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","Jordi  Camps Polo



Eric  Cardin



Chanelle Monet Case Borden



Bernard N Chen



Chi Chung  Cheng



Timo  Gaiser



Show all 11",NULL,"Andre A Nussenzweig; PhD (Experimental Immunology Branch)



Thomas A Misteli; PhD (Laboratory of Receptor Biology and Gene Expression)",NULL,"Ordered by publication type and then author name.



1.
Callén E, Bunting S, Huang CY, Difilippantonio MJ, Wong N, Khor B, Mahowald G, Kruhlak MJ, Ried T, Sleckman BP, Nussenzweig A (2009). Chimeric IgH-TCRalpha/delta translocations in T lymphocytes mediated by RAG. Cell Cycle  8, 2408-12.   https://doi.org/10.4161/cc.8.15.9085




PubMed



        
     
Free Article


 


PubMed ID 19556863
         Pubmed Central ID 3587430 


 



2.
Camps J, Nguyen QT, Padilla-Nash HM, Knutsen T, McNeil NE, Wangsa D, Hummon AB, Grade M, Ried T, Difilippantonio MJ (2009). Integrative genomics reveals mechanisms of copy number alterations responsible for transcriptional deregulation in colorectal cancer. Genes Chromosomes Cancer  48, 1002-17.   https://doi.org/10.1002/gcc.20699




PubMed



        
     
Free Article


 


PubMed ID 19691111
         Pubmed Central ID 4721599 


 



3.
Difilippantonio MJ, Ghadimi BM, Howard T, Camps J, Nguyen QT, Ferris DK, Sackett DL, Ried T (2009). Nucleation capacity and presence of centrioles define a distinct category of centrosome abnormalities that induces multipolar mitoses in cancer cells. Environ Mol Mutagen  50, 672-96.   https://doi.org/10.1002/em.20532




PubMed



        
     
Free Article


 


PubMed ID 19768832
         Pubmed Central ID 4322947 


 



4.
Gaedcke J, Grade M, Jung K, Camps J, Jo P, Emons G, Gehoff A, Sax U, Schirmer M, Becker H, Beissbarth T, Ried T, Ghadimi BM (2010). Mutated KRAS results in overexpression of DUSP4, a MAP-kinase phosphatase, and SMYD3, a histone methyltransferase, in rectal carcinomas. Genes Chromosomes Cancer  49, 1024-34.   https://doi.org/10.1002/gcc.20811




PubMed



        
     
Free Article


 


PubMed ID 20725992
         Pubmed Central ID 3535184 


 



5.
Gertz EM, Sengupta K, Difilippantonio MJ, Ried T, Schäffer AA (2009). Evaluating annotations of an Agilent expression chip suggests that many features cannot be interpreted. BMC Genomics  10, 566.   https://doi.org/10.1186/1471-2164-10-566




PubMed



        
     
Free Article


 


PubMed ID 19948035
         Pubmed Central ID 2791105 


 



6.
Grade M, Gaedcke J, Wangsa D, Varma S, Beckmann J, Liersch T, Hess C, Becker H, Difilippantonio MJ, Ried T, Ghadimi BM (2009). Chromosomal copy number changes of locally advanced rectal cancers treated with preoperative chemoradiotherapy. Cancer Genet Cytogenet  193, 19-28.   https://doi.org/10.1016/j.cancergencyto.2009.03.016




PubMed



        
     
Free Article


 


PubMed ID 19602460
         Pubmed Central ID 2714587 


 



7.
Grade M, Hummon AB, Camps J, Emons G, Spitzner M, Gaedcke J, Hoermann P, Ebner R, Becker H, Difilippantonio MJ, Ghadimi BM, Beissbarth T, Caplen NJ, Ried T (2011). A genomic strategy for the functional validation of colorectal cancer genes identifies potential therapeutic targets. Int J Cancer  128, 1069-79.   https://doi.org/10.1002/ijc.25453




PubMed



        
     
Free Article


 


PubMed ID 20473941
         Pubmed Central ID 3008507",https://intramural.nih.gov/search/searchview.taf?ipid=63140
350,BC010836-04,"October 01, 2009 -  September 30, 2010",Cancer Genomics,"Karl Thomas Ried; MD



IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","Markus Alexander Brown



Jordi  Camps Polo



Eric  Cardin



Chanelle Monet Case Borden



Bernard N Chen



Chi Chung  Cheng



Show all 12","Gert  Auer





Michael  Ghadimi
(Surgery, U. of Goettingen)",NULL,NULL,"Ordered by publication type and then author name.



1.
Andersson S, Sowjanya P, Wangsa D, Hjerpe A, Johansson B, Auer G, Gravitt PE, Larsson C, Wallin KL, Ried T, Heselmeyer-Haddad K (2009). Detection of genomic amplification of the human telomerase gene TERC, a potential marker for triage of women with HPV-positive, abnormal Pap smears. Am J Pathol  175, 1831-47.   https://doi.org/10.2353/ajpath.2009.090122




PubMed



        
     
Free Article


 


PubMed ID 19880826
         Pubmed Central ID 2770709 


 



2.
Callén E, Bunting S, Huang CY, Difilippantonio MJ, Wong N, Khor B, Mahowald G, Kruhlak MJ, Ried T, Sleckman BP, Nussenzweig A (2009). Chimeric IgH-TCRalpha/delta translocations in T lymphocytes mediated by RAG. Cell Cycle  8, 2408-12.   https://doi.org/10.4161/cc.8.15.9085




PubMed



        
     
Free Article


 


PubMed ID 19556863
         Pubmed Central ID 3587430 


 



3.
Camps J, Nguyen QT, Padilla-Nash HM, Knutsen T, McNeil NE, Wangsa D, Hummon AB, Grade M, Ried T, Difilippantonio MJ (2009). Integrative genomics reveals mechanisms of copy number alterations responsible for transcriptional deregulation in colorectal cancer. Genes Chromosomes Cancer  48, 1002-17.   https://doi.org/10.1002/gcc.20699




PubMed



        
     
Free Article


 


PubMed ID 19691111
         Pubmed Central ID 4721599 


 



4.
Gertz EM, Sengupta K, Difilippantonio MJ, Ried T, Schäffer AA (2009). Evaluating annotations of an Agilent expression chip suggests that many features cannot be interpreted. BMC Genomics  10, 566.   https://doi.org/10.1186/1471-2164-10-566




PubMed



        
     
Free Article


 


PubMed ID 19948035
         Pubmed Central ID 2791105 


 



5.
Knutsen T, Padilla-Nash HM, Wangsa D, Barenboim-Stapleton L, Camps J, McNeil N, Difilippantonio MJ, Ried T (2010). Definitive molecular cytogenetic characterization of 15 colorectal cancer cell lines. Genes Chromosomes Cancer  49, 204-23.   https://doi.org/10.1002/gcc.20730




PubMed



        
     
Free Article


 


PubMed ID 19927377
         Pubmed Central ID 2818350 


 



6.
Robbiani DF, Bunting S, Feldhahn N, Bothmer A, Camps J, Deroubaix S, McBride KM, Klein IA, Stone G, Eisenreich TR, Ried T, Nussenzweig A, Nussenzweig MC (2009). AID produces DNA double-strand breaks in non-Ig genes and mature B cell lymphomas with reciprocal chromosome translocations. Mol Cell  36, 631-41.   https://doi.org/10.1016/j.molcel.2009.11.007




PubMed



        
     
Free Article


 


PubMed ID 19941823
         Pubmed Central ID 2805907 


 



7.
Wangsa D, Heselmeyer-Haddad K, Ried P, Eriksson E, Schäffer AA, Morrison LE, Luo J, Auer G, Munck-Wikland E, Ried T, Lundqvist EA (2009). Fluorescence in situ hybridization markers for prediction of cervical lymph node metastases. Am J Pathol  175, 2637-45.   https://doi.org/10.2353/ajpath.2009.090289




PubMed



        
     
Free Article


 


PubMed ID 19893027
         Pubmed Central ID 2789632",https://intramural.nih.gov/search/searchview.taf?ipid=63141
351,BC010837-04,"October 01, 2009 -  September 30, 2010",Prediction of Therapy Response in Colorectal Cancer,"Karl Thomas Ried; MD



IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","Jordi  Camps Polo



Eric  Cardin



Chanelle Monet Case Borden



Bernard N Chen



Chi Chung  Cheng



Timo  Gaiser



Show all 11",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Camps J, Nguyen QT, Padilla-Nash HM, Knutsen T, McNeil NE, Wangsa D, Hummon AB, Grade M, Ried T, Difilippantonio MJ (2009). Integrative genomics reveals mechanisms of copy number alterations responsible for transcriptional deregulation in colorectal cancer. Genes Chromosomes Cancer  48, 1002-17.   https://doi.org/10.1002/gcc.20699




PubMed



        
     
Free Article


 


PubMed ID 19691111
         Pubmed Central ID 4721599 


 



2.
Grade M, Gaedcke J, Wangsa D, Varma S, Beckmann J, Liersch T, Hess C, Becker H, Difilippantonio MJ, Ried T, Ghadimi BM (2009). Chromosomal copy number changes of locally advanced rectal cancers treated with preoperative chemoradiotherapy. Cancer Genet Cytogenet  193, 19-28.   https://doi.org/10.1016/j.cancergencyto.2009.03.016




PubMed



        
     
Free Article


 


PubMed ID 19602460
         Pubmed Central ID 2714587 


 



3.
Knutsen T, Padilla-Nash HM, Wangsa D, Barenboim-Stapleton L, Camps J, McNeil N, Difilippantonio MJ, Ried T (2010). Definitive molecular cytogenetic characterization of 15 colorectal cancer cell lines. Genes Chromosomes Cancer  49, 204-23.   https://doi.org/10.1002/gcc.20730




PubMed



        
     
Free Article


 


PubMed ID 19927377
         Pubmed Central ID 2818350 


 



4.
Liersch T, Grade M, Gaedcke J, Varma S, Difilippantonio MJ, Langer C, Hess CF, Becker H, Ried T, Ghadimi BM (2009). Preoperative chemoradiotherapy in locally advanced rectal cancer: correlation of a gene expression-based response signature with recurrence. Cancer Genet Cytogenet  190, 57-65.   https://doi.org/10.1016/j.cancergencyto.2008.11.011




PubMed



        
     
Free Article


 


PubMed ID 19380020
         Pubmed Central ID 2766806 


 



5.
Swanton C, Nicke B, Schuett M, Eklund AC, Ng C, Li Q, Hardcastle T, Lee A, Roy R, East P, Kschischo M, Endesfelder D, Wylie P, Kim SN, Chen JG, Howell M, Ried T, Habermann JK, Auer G, Brenton JD, Szallasi Z, Downward J (2009). Chromosomal instability determines taxane response. Proc Natl Acad Sci U S A  106, 8671-6.   https://doi.org/10.1073/pnas.0811835106




PubMed



        
     
Free Article


 


PubMed ID 19458043
         Pubmed Central ID 2688979",https://intramural.nih.gov/search/searchview.taf?ipid=63143
352,BC010839-04,"October 01, 2009 -  September 30, 2010",Exploring the Therapeutic Potential of Stem Cell Biology in Gliomas,"Howard A Fine; MD, PhD",NULL,"Neuro-Oncology Branch, NCI","Susie  Ahn



Peter  Bauer; PhD



Carolyn A Bryant



Margaret  Cam; PhD



Emely  Castro-Rivera



Chibawanye Isidore Ene



Show all 23",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Kotliarov Y, Kotliarova S, Charong N, Li A, Walling J, Aquilanti E, Ahn S, Steed ME, Su Q, Center A, Zenklusen JC, Fine HA (2009). Correlation analysis between single-nucleotide polymorphism and expression arrays in gliomas identifies potentially relevant target genes. Cancer Res  69, 1596-603.   https://doi.org/10.1158/0008-5472.CAN-08-2496




PubMed



        
     
Free Article


 


PubMed ID 19190341
         Pubmed Central ID 2644341 


 



2.
Li A, Walling J, Ahn S, Kotliarov Y, Su Q, Quezado M, Oberholtzer JC, Park J, Zenklusen JC, Fine HA (2009). Unsupervised analysis of transcriptomic profiles reveals six glioma subtypes. Cancer Res  69, 2091-9.   https://doi.org/10.1158/0008-5472.CAN-08-2100




PubMed



        
     
Free Article


 


PubMed ID 19244127
         Pubmed Central ID 2845963",https://intramural.nih.gov/search/searchview.taf?ipid=63093
353,BC010840-04,"October 01, 2009 -  September 30, 2010",Elucidation and Exploitation of GSK3 as a Novel Glioma Therapeutic Target,"Howard A Fine; MD, PhD",NULL,"Neuro-Oncology Branch, NCI","Susie  Ahn



Peter  Bauer; PhD



Carolyn A Bryant



Margaret  Cam; PhD



Emely  Castro-Rivera



Chibawanye Isidore Ene



Show all 23",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Kotliarov Y, Kotliarova S, Charong N, Li A, Walling J, Aquilanti E, Ahn S, Steed ME, Su Q, Center A, Zenklusen JC, Fine HA (2009). Correlation analysis between single-nucleotide polymorphism and expression arrays in gliomas identifies potentially relevant target genes. Cancer Res  69, 1596-603.   https://doi.org/10.1158/0008-5472.CAN-08-2496




PubMed



        
     
Free Article


 


PubMed ID 19190341
         Pubmed Central ID 2644341 


 



2.
Li A, Walling J, Ahn S, Kotliarov Y, Su Q, Quezado M, Oberholtzer JC, Park J, Zenklusen JC, Fine HA (2009). Unsupervised analysis of transcriptomic profiles reveals six glioma subtypes. Cancer Res  69, 2091-9.   https://doi.org/10.1158/0008-5472.CAN-08-2100




PubMed



        
     
Free Article


 


PubMed ID 19244127
         Pubmed Central ID 2845963",https://intramural.nih.gov/search/searchview.taf?ipid=63094
354,BC010841-04,"October 01, 2009 -  September 30, 2010",ROLE OF NONCANONICAL WNT PATHWAYS IN TISSUE MORPHOGENESIS.,"Terence P Yamaguchi; PhD



IRP Faculty Profile",NULL,"Cancer and Developmental Biology Laboratory, NCI","Rieko  Ajima



Alan O Perantoni; PhD



Kristin K Biris","Ernest  Arenas
(CEDB, Karolinska Institute)




Raymond  Habas





Xi  He
(NCI)




Matthias  Hebrok
(UCSF)




Ed  Morrissey
(U. Pennsylvania)




Anthony  Wynshaw-Boris
(NHGRI)",NULL,NULL,"Ordered by publication type and then author name.



1.
Bryja V, Andersson ER, Schambony A, Esner M, Bryjová L, Biris KK, Hall AC, Kraft B, Cajanek L, Yamaguchi TP, Buckingham M, Arenas E (2009). The extracellular domain of Lrp5/6 inhibits noncanonical Wnt signaling in vivo. Mol Biol Cell  20, 924-36.   https://doi.org/10.1091/mbc.e08-07-0711




PubMed



        
     
Free Article


 


PubMed ID 19056682
         Pubmed Central ID 2633404 


 



2.
Cervantes S, Yamaguchi TP, Hebrok M (2009). Wnt5a is essential for intestinal elongation in mice. Dev Biol  326, 285-94.   https://doi.org/10.1016/j.ydbio.2008.11.020




PubMed



        
     
Free Article


 


PubMed ID 19100728
         Pubmed Central ID 2654720 


 



3.
Huang L, Pu Y, Hu WY, Birch L, Luccio-Camelo D, Yamaguchi T, Prins GS (2009). The role of Wnt5a in prostate gland development. Dev Biol  328, 188-99.   https://doi.org/10.1016/j.ydbio.2009.01.003




PubMed



        
     
Free Article


 


PubMed ID 19389372
         Pubmed Central ID 2828764 


 



4.
Lindqvist M, Horn Z, Bryja V, Schulte G, Papachristou P, Ajima R, Dyberg C, Arenas E, Yamaguchi TP, Lagercrantz H, Ringstedt T (2010). Vang-like protein 2 and Rac1 interact to regulate adherens junctions. J Cell Sci  123, 472-83.   https://doi.org/10.1242/jcs.048074




PubMed



        
     
Free Article


 


PubMed ID 20067994
         Pubmed Central ID 2816190",https://intramural.nih.gov/search/searchview.taf?ipid=63145
355,BC010844-04,"October 01, 2009 -  September 30, 2010",DNA Folding in Chromatin and Interaction with Transcription Factors,"Victor  Zhurkin; PhD



IRP Faculty Profile",NULL,"Laboratory of Cell Biology, NCI","Feng  Cui



Tatiana Vladimirovna Nikitina



Difei  Wang","Sergei  Grigoryev
(Pennsylvania State University College of Medicine)




Tom  Jovin
(Dept Mol Biol, Max Planck Inst. Biophys. Chem)




Wilma  Olson
(Wright-Rieman Laboratories, Rutgers University)",Sankar  Adhya; PhD (Developmental Genetics Section),Ronald D Neumann; MD (CC),"Ordered by publication type and then author name.



1.
Cui F, Zhurkin VB (2009). Distinctive sequence patterns in metazoan and yeast nucleosomes: implications for linker histone binding to AT-rich and methylated DNA. Nucleic Acids Res  37, 2818-29.   https://doi.org/10.1093/nar/gkp113




PubMed



        
     
Free Article


 


PubMed ID 19282449
         Pubmed Central ID 2685081 


 



2.
Cui F, Zhurkin VB (2010). Structure-based analysis of DNA sequence patterns guiding nucleosome positioning in vitro. J Biomol Struct Dyn  27, 821-41.   https://doi.org/10.1080/073911010010524947




PubMed



        
     
Free Article


 


PubMed ID 20232936
         Pubmed Central ID 2993692 


 



3.
Wang D, Ulyanov NB, Zhurkin VB (2010). Sequence-dependent Kink-and-Slide deformations of nucleosomal DNA facilitated by histone arginines bound in the minor groove. J Biomol Struct Dyn  27, 843-59.   https://doi.org/10.1080/07391102.2010.10508586




PubMed



        
     
Free Article


 


PubMed ID 20232937
         Pubmed Central ID 2987563",https://intramural.nih.gov/search/searchview.taf?ipid=63146
356,BC010845-04,"October 01, 2009 -  September 30, 2010",p53-induced Regulation of Transcription in the Chromatin Context,"Victor  Zhurkin; PhD



IRP Faculty Profile",NULL,"Laboratory of Cell Biology, NCI","Feng  Cui



Difei  Wang",NULL,"Ettore  Appella; MD (Chemical Immunology Section)



Curtis  Harris; MD (Laboratory of Human Carcinogenesis)",Ronald D Neumann; MD (CC),"Ordered by publication type and then author name.



1.
Sahu G, Wang D, Chen CB, Zhurkin VB, Harrington RE, Appella E, Hager GL, Nagaich AK (2010). p53 binding to nucleosomal DNA depends on the rotational positioning of DNA response element. J Biol Chem  285, 1321-32.   https://doi.org/10.1074/jbc.M109.081182




PubMed



        
     
Free Article


 


PubMed ID 19887449
         Pubmed Central ID 2801259",https://intramural.nih.gov/search/searchview.taf?ipid=63102
357,BC010846-04,"October 01, 2009 -  September 30, 2010",Mechanisms of Transcriptional Control by p300,"Kevin  Gardner; MD, PhD",NULL,"Hormone Action and Oncogenesis Section, NCI","Jung Shin  Byun



Temesgen D Fufa



Cynthia  Haggerty



Jesse F Quintero



Tara  Taylor



Clay Torao Wakano; PhD



Show all 7",NULL,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)



Gordon Lee Hager; PhD (Laboratory of Receptor Biology and Gene Expression)



William D Figg; PharmD (Medical Oncology Branch)",Dan L Longo; MD (NIA),"Ordered by publication type and then author name.



1.
Byun JS, Wong MM, Cui W, Idelman G, Li Q, De Siervi A, Bilke S, Haggerty CM, Player A, Wang YH, Thirman MJ, Kaberlein JJ, Petrovas C, Koup RA, Longo D, Ozato K, Gardner K (2009). Dynamic bookmarking of primary response genes by p300 and RNA polymerase II complexes. Proc Natl Acad Sci U S A  106, 19286-91.   https://doi.org/10.1073/pnas.0905469106




PubMed



        
     
Free Article


 


PubMed ID 19880750
         Pubmed Central ID 2780808 


 



2.
De Siervi A, De Luca P, Byun JS, Di LJ, Fufa T, Haggerty CM, Vazquez E, Moiola C, Longo DL, Gardner K (2010). Transcriptional autoregulation by BRCA1. Cancer Res  70, 532-42.   https://doi.org/10.1158/0008-5472.CAN-09-1477




PubMed



        
     
Free Article


 


PubMed ID 20068145
         Pubmed Central ID 2952428 


 



3.
De Siervi A, De Luca P, Moiola C, Gueron G, Tongbai R, Chandramouli GV, Haggerty C, Dzekunova I, Petersen D, Kawasaki E, Kil WJ, Camphausen K, Longo D, Gardner K (2009). Identification of new Rel/NFkappaB regulatory networks by focused genome location analysis. Cell Cycle  8, 2093-100.   https://doi.org/10.4161/cc.8.13.8926




PubMed



        
     
Free Article


 


PubMed ID 19502793
         Pubmed Central ID 2809250 


 



4.
Moiola C, De Luca P, Gardner K, Vazquez E, De Siervi A (2010). Cyclin T1 overexpression induces malignant  transformation and tumor growth. Cell Cycle  9, 3119-26.   https://doi.org/10.4161/cc.9.15.12526




PubMed



        
     
Free Article


 


PubMed ID 20714219
         Pubmed Central ID 3040930",https://intramural.nih.gov/search/searchview.taf?ipid=63100
358,BC010847-04,"October 01, 2009 -  September 30, 2010",Gene-specific Mechanisms of BRCA1 transcriptional Control,"Kevin  Gardner; MD, PhD",NULL,"Hormone Action and Oncogenesis Section, NCI","Lijun  Di



Cynthia  Haggerty



Jesse F Quintero",NULL,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)



Kent W Hunter; PhD (Laboratory of Cancer Biology and Genetics)



Kevin A Camphausen; MD (Radiation Oncology Branch)",Dan L Longo; MD (NIA),"Ordered by publication type and then author name.



1.
De Siervi A, De Luca P, Moiola C, Gueron G, Tongbai R, Chandramouli GV, Haggerty C, Dzekunova I, Petersen D, Kawasaki E, Kil WJ, Camphausen K, Longo D, Gardner K (2009). Identification of new Rel/NFkappaB regulatory networks by focused genome location analysis. Cell Cycle  8, 2093-100.   https://doi.org/10.4161/cc.8.13.8926




PubMed



        
     
Free Article


 


PubMed ID 19502793
         Pubmed Central ID 2809250 


 



2.
Gardner K, Fernandez A, De Siervi A, Longo D, Gardner K (2010) Transcriptional regulation of BRCA1 expression by a metabolic switch. Nat Struct Mol Biol inPress.




 



3.
Luo X, Li Z, Yan Q, Li X, Tao D, Wang J, Leng Y, Gardner K, Judge SI, Li QQ, Hu J, Gong J (2009). The human WW45 protein enhances MST1-mediated apoptosis in vivo. Int J Mol Med  23, 357-62.




PubMed



        
     
Free Article


 


PubMed ID 19212654
         Pubmed Central ID 2851627",https://intramural.nih.gov/search/searchview.taf?ipid=63101
359,BC010849-04,"October 01, 2009 -  September 30, 2010",Evaluation of Novel Radiation Modifiers,"Deborah E Citrin



IRP Faculty Profile",NULL,"Radiation Oncology Branch, NCI","Eunjoo Serena Chung



Ayla Oksuz White",NULL,James B Mitchell; PhD (Radiation Biology Branch),NULL,"Ordered by publication type and then author name.



1.
Chung EJ, Brown AP, Asano H, Mandler M, Burgan WE, Carter D, Camphausen K, Citrin D (2009). In vitro and in vivo radiosensitization with AZD6244 (ARRY-142886), an inhibitor of mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 kinase. Clin Cancer Res  15, 3050-7.   https://doi.org/10.1158/1078-0432.CCR-08-2954




PubMed



        
     
Free Article


 


PubMed ID 19366835
         Pubmed Central ID 2798161",https://intramural.nih.gov/search/searchview.taf?ipid=63147
360,BC010850-04,"October 01, 2009 -  September 30, 2010",Mechanisms of Normal Tissue Toxicity,"Deborah E Citrin



IRP Faculty Profile",NULL,"Radiation Oncology Branch, NCI","Eunjoo Serena Chung



Ayla Oksuz White



William P Shield



Kiran Karim Toor



Mary Ellen  Urick; PhD","David  Gaffney
(University of Utah)




Radaition  Oncology
(Unniversity of Pennsylvania)",James B Mitchell; PhD (Radiation Biology Branch),NULL,"Ordered by publication type and then author name.



1.
Fox E, Citrin D, Balis FM (2009). The legacy of cancer therapy in children. J Natl Cancer Inst  101, 1105-7.   https://doi.org/10.1093/jnci/djp238




PubMed


 


PubMed ID 19648512
    
     


 



2.
Van Waes C, Allen CT, Citrin D, Gius D, Colevas AD, Harold NA, Rudy S, Nottingham L, Muir C, Chen Z, Singh AK, Dancey J, Morris JC (2010). Molecular and clinical responses in a pilot study of gefitinib with paclitaxel and radiation in locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys  77, 447-54.   https://doi.org/10.1016/j.ijrobp.2009.05.037




PubMed



        
     
Free Article


 


PubMed ID 19879702
         Pubmed Central ID 2868084",https://intramural.nih.gov/search/searchview.taf?ipid=63148
361,BC010852-04,"October 01, 2009 -  September 30, 2010",Mechanism of action and therapeutic utility of immunostimulatory CpG oligonucleo,"Dennis M Klinman; MD, PhD



IRP Faculty Profile",NULL,"Laboratory of Experimental Immunology, NCI","Hiroyasu  Ito



Takeshi  Kinjo



Nobuaki  Kobayashi; MD, PhD



Corinna  Meyer



Howard A Young; PhD



Hidekazu  Shirota



Show all 13","Ihsan  Gursel





Jay  Hooper
(USAMRIID)




Yoshiaki  Ishigatsubo; MD, PhD
(Yokohama City Univ Medical School)




Sven  Klaschik","Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)



Giorgio  Trinchieri (Cancer Inflammation Program)



Joost J Oppenheim; MD (Laboratory of Molecular Immunoregulation)",Igal  Gery; PhD (NEI),"Ordered by publication type and then author name.



1.
Abe S, Okuda K, Ura T, Kondo A, Yoshida A, Yoshizaki S, Mizuguchi H, Klinman D, Shimada M (2009). Adenovirus type 5 with modified hexons induces robust transgene-specific immune responses in mice with pre-existing immunity against adenovirus type 5. J Gene Med  11, 570-9.   https://doi.org/10.1002/jgm.1332




PubMed


 


PubMed ID 19391169
    
     


 



2.
Klaschik S, Tross D, Klinman DM (2009). Inductive and suppressive networks regulate TLR9-dependent gene expression in vivo. J Leukoc Biol  85, 788-95.   https://doi.org/10.1189/jlb.1008671




PubMed



        
     
Free Article


 


PubMed ID 19179452
         Pubmed Central ID 2669411 


 



3.
Klinman DM, Klaschik S, Sato T, Tross D (2009). CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases. Adv Drug Deliv Rev  61, 248-55.   https://doi.org/10.1016/j.addr.2008.12.012




PubMed


 


PubMed ID 19272313
    
     


 



4.
Klinman DM, Klaschik S, Tross D, Shirota H, Steinhagen F (2010). FDA guidance on prophylactic DNA vaccines: analysis and recommendations. Vaccine  28, 2801-5.   https://doi.org/10.1016/j.vaccine.2009.11.025




PubMed



        
     
Free Article


 


PubMed ID 19941989
         Pubmed Central ID 2847045 


 



5.
Klinman DM, Tross D (2009). A single-dose combination therapy that both prevents and treats anthrax infection. Vaccine  27, 1811-5.   https://doi.org/10.1016/j.vaccine.2009.01.094




PubMed



        
     
Free Article


 


PubMed ID 19402202
         Pubmed Central ID 6335648 


 



6.
Klinman DM, Yamamoto M, Tross D, Tomaru K (2009). Anthrax prevention and treatment: utility of therapy combining antibiotic plus vaccine. Expert Opin Biol Ther  9, 1477-86.   https://doi.org/10.1517/14712590903307347




PubMed


 


PubMed ID 19769541
    
     


 



7.
Shimada M, Wang HB, Kondo A, Xu XP, Yoshida A, Shinoda K, Ura T, Mizuguchi H, Klinman D, Luo JL, Bai H, Okuda K (2009). Effect of therapeutic immunization using Ad5/35 and MVA vectors on SIV infection of rhesus monkeys undergoing antiretroviral therapy. Gene Ther  16, 218-28.   https://doi.org/10.1038/gt.2008.152




PubMed


 


PubMed ID 18923453
    
     


 



8.
Shirota H, Petrenko L, Hattori T, Klinman DM (2009). Contribution of IRF-3 mediated IFNbeta production to DNA vaccine dependent cellular immune responses. Vaccine  27, 2144-9.   https://doi.org/10.1016/j.vaccine.2009.01.134




PubMed



        
     
Free Article


 


PubMed ID 19356618
         Pubmed Central ID 2667800 


 



9.
Sloane E, Langer S, Jekich B, Mahoney J, Hughes T, Frank M, Seibert W, Huberty G, Coats B, Harrison J, Klinman D, Poole S, Maier S, Johnson K, Chavez R, Watkins LR, Leinwand L, Milligan E (2009). Immunological priming potentiates non-viral anti-inflammatory gene therapy treatment of neuropathic pain. Gene Ther  16, 1210-22.   https://doi.org/10.1038/gt.2009.79




PubMed



        
     
Free Article


 


PubMed ID 19571887
         Pubmed Central ID 2762489 


 



10.
Tross D, Petrenko L, Klaschik S, Zhu Q, Klinman DM (2009). Global changes in gene expression and synergistic interactions induced by TLR9 and TLR3. Mol Immunol  46, 2557-64.   https://doi.org/10.1016/j.molimm.2009.05.011




PubMed



        
     
Free Article


 


PubMed ID 19535142
         Pubmed Central ID 2713800",https://intramural.nih.gov/search/searchview.taf?ipid=63154
362,BC010853-04,"October 01, 2009 -  September 30, 2010",Mechanism of action and therapeutic utility of immunosuppressive oligonucleotide,"Dennis M Klinman; MD, PhD



IRP Faculty Profile",NULL,"Laboratory of Experimental Immunology, NCI","Christian Hans Bode; MD



Hidekazu  Ikeuchi



Hiroyasu  Ito



Takeshi  Kinjo



Nobuaki  Kobayashi; MD, PhD



Hidekazu  Shirota



Show all 9",NULL,"Giorgio  Trinchieri (Cancer Inflammation Program)



Joost J Oppenheim; MD (Laboratory of Molecular Immunoregulation)",Igal  Gery; PhD (NEI),"Ordered by publication type and then author name.



1.
Fujimoto C, Klinman DM, Shi G, Yin H, Vistica BP, Lovaas JD, Wawrousek EF, Igarashi T, Chan CC, Gery I (2009). A suppressive oligodeoxynucleotide inhibits ocular inflammation. Clin Exp Immunol  156, 528-34.   https://doi.org/10.1111/j.1365-2249.2009.03918.x




PubMed



        
     
Free Article


 


PubMed ID 19438607
         Pubmed Central ID 2691983 


 



2.
Klaschik S, Tross D, Klinman DM (2009). Inductive and suppressive networks regulate TLR9-dependent gene expression in vivo. J Leukoc Biol  85, 788-95.   https://doi.org/10.1189/jlb.1008671




PubMed



        
     
Free Article


 


PubMed ID 19179452
         Pubmed Central ID 2669411 


 



3.
Klinman DM, Tross D, Klaschik S, Shirota H, Sato T (2009). Therapeutic applications and mechanisms underlying the activity of immunosuppressive oligonucleotides. Ann N Y Acad Sci  1175, 80-8.   https://doi.org/10.1111/j.1749-6632.2009.04970.x




PubMed


 


PubMed ID 19796080",https://intramural.nih.gov/search/searchview.taf?ipid=63155
363,BC010867-03,"October 01, 2009 -  September 30, 2010",Genetically Modifying Lactobacillus to Alter Gut Inflammation and Pathogens,"Howard A Young; PhD



IRP Faculty Profile",NULL,"Laboratory of Experimental Immunology, NCI","Augustina  Addison



Fan Ching  Lin



Adelle P McFarland



Michael E Sanford



Ram  Savan



Yuanmin  Zhu","TODD  KLAENHAMMER
(NORTH CAROLINA ST UNIV)




STEFANIE  VOGEL
(UNIV. OF MARYLAND SCHOOL OF MEDICINE)",Nancy H Colburn; PhD (Laboratory of Cancer Prevention),Brian  Kelsall; MD (NIAID),There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=63317
364,BC010870-03,"October 01, 2009 -  September 30, 2010",Hematopoietic Stem Cell Transplant for Immunodeficiency with MDS,"Dennis D Hickstein



IRP Faculty Profile",NULL,"Experimental Transplantation and Immunology Branch, NCI",NULL,NULL,NULL,Steven M Holland; MD (NIAID),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63237
365,BC010871-03,"October 01, 2009 -  September 30, 2010",Use of Mouse Models of Human Rhabdomyosarcoma to Study Progression to Metastasis,"Glenn  Merlino; PhD



IRP Faculty Profile",NULL,"Laboratory of Cancer Biology and Genetics, NCI",Yanlin  Yu,"Lynda  Chin
(Harvard Medical School)




Ron  DePinho
(Dana Farber, Harvard)","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)



Melinda  Hollingshead (Biological Testing Branch)



Miriam R Anver (Office Of The Director)



Javed  Khan; MD (Pediatric Oncology Branch)",NULL,"Ordered by publication type and then author name.



1.
Taylor JG, Cheuk AT, Tsang PS, Chung JY, Song YK, Desai K, Yu Y, Chen QR, Shah K, Youngblood V, Fang J, Kim SY, Yeung C, Helman LJ, Mendoza A, Ngo V, Staudt LM, Wei JS, Khanna C, Catchpoole D, Qualman SJ, Hewitt SM, Merlino G, Chanock SJ, Khan J (2009). Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models. J Clin Invest  119, 3395-407.   https://doi.org/10.1172/JCI39703




PubMed



        
     
Free Article


 


PubMed ID 19809159
         Pubmed Central ID 2769177",https://intramural.nih.gov/search/searchview.taf?ipid=63369
366,BC010872-03,"October 01, 2009 -  September 30, 2010",High troughput screen for small molecule inhibitors of Ran regulated functions,Petr  Kalab; PhD,NULL,"Laboratory of Cellular and Molecular Biology, NCI",NULL,NULL,NULL,Douglas S Auld (NHGRI),There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=63326
367,BC010873-03,"October 01, 2009 -  September 30, 2010",Underlying Cause of Radiation-induced Fibrosis,Nicole L Simone; MD,Kevin A Camphausen; MD,"Radiation Oncology Branch, NCI",Jason E Savage,NULL,James B Mitchell; PhD (Radiation Biology Branch),Benjamin  Soule (NIAID),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63261
368,BC010874-03,"October 01, 2009 -  September 30, 2010",Biomarkers of Human Lung Cancer,"Curtis  Harris; MD



IRP Faculty Profile",NULL,"Laboratory of Human Carcinogenesis, NCI","Akagi  Ichiro; MD, PhD



Elise Dawn Bowman



Jin  Jen



Leah E Mechanic



Abdul Matin Mondal



Sharon R Pine



Show all 15","Aage  Haugen
(National Institute of Occupational Health)




Jun  Yokota
(National Cancer Center Research Institute)","Stephen J Chanock; MD, PhD (Laboratory Translational Genomics)",NULL,"Ordered by publication type and then author name.



1.
Pine SR, Ryan BM, Varticovski L, Robles AI, Harris CC (2010). Microenvironmental modulation of asymmetric cell division in human lung cancer cells. Proc Natl Acad Sci U S A  107, 2195-200.   https://doi.org/10.1073/pnas.0909390107




PubMed



        
     
Free Article


 


PubMed ID 20080668
         Pubmed Central ID 2836660 


 



2.
Seike M, Goto A, Okano T, Bowman ED, Schetter AJ, Horikawa I, Mathe EA, Jen J, Yang P, Sugimura H, Gemma A, Kudoh S, Croce CM, Harris CC (2009). MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers. Proc Natl Acad Sci U S A  106, 12085-90.   https://doi.org/10.1073/pnas.0905234106




PubMed



        
     
Free Article


 


PubMed ID 19597153
         Pubmed Central ID 2715493 


 



3.
Volinia S, Galasso M, Costinean S, Tagliavini L, Gamberoni G, Drusco A, Marchesini J, Mascellani N, Sana ME, Abu Jarour R, Desponts C, Teitell M, Baffa R, Aqeilan R, Iorio MV, Taccioli C, Garzon R, Di Leva G, Fabbri M, Catozzi M, Previati M, Ambs S, Palumbo T, Garofalo M, Veronese A, et al. [26 more authors] (2010). Reprogramming of miRNA networks in cancer and leukemia. Genome Res  20, 589-99.   https://doi.org/10.1101/gr.098046.109




PubMed



        
     
Free Article


 


PubMed ID 20439436
         Pubmed Central ID 2860161",https://intramural.nih.gov/search/searchview.taf?ipid=63232
369,BC010875-03,"October 01, 2009 -  September 30, 2010",Inhibitor of Normal Growth (ING),"Curtis  Harris; MD



IRP Faculty Profile",NULL,"Laboratory of Human Carcinogenesis, NCI","Elise Dawn Bowman



Motonobu  Saito



Elisa A Spillare



Judith A Welsh",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Kumamoto K, Fujita K, Kurotani R, Saito M, Unoki M, Hagiwara N, Shiga H, Bowman ED, Yanaihara N, Okamura S, Nagashima M, Miyamoto K, Takenoshita S, Yokota J, Harris CC (2009). ING2 is upregulated in colon cancer and increases invasion by enhanced MMP13 expression. Int J Cancer  125, 1306-15.   https://doi.org/10.1002/ijc.24437




PubMed



        
     
Free Article


 


PubMed ID 19437536
         Pubmed Central ID 2790157 


 



2.
Unoki M, Kumamoto K, Harris CC (2009). ING proteins as potential anticancer drug targets. Curr Drug Targets  10, 442-54.   https://doi.org/10.2174/138945009788185059




PubMed



        
     
Free Article


 


PubMed ID 19442116
         Pubmed Central ID 2802283 


 



3.
Unoki M, Kumamoto K, Takenoshita S, Harris CC (2009). Reviewing the current classification of inhibitor of growth family proteins. Cancer Sci  100, 1173-9.   https://doi.org/10.1111/j.1349-7006.2009.01183.x




PubMed



        
     
Free Article


 


PubMed ID 19432890
         Pubmed Central ID 2790152",https://intramural.nih.gov/search/searchview.taf?ipid=63233
370,BC010876-03,"October 01, 2009 -  September 30, 2010",The role of cancer stem cells in liver cancer heterogeneity and subtypes,"Xin Wei Wang; PhD



IRP Faculty Profile",NULL,"Laboratory of Human Carcinogenesis, NCI",NULL,"Yidong  Chen; PhD





Carlo M Croce





Lun-Xiu  Qin
(Liver Cancer Institute)




Zhao-You  Tang
(Liver Cancer Institute)




Qinghai  Ye
(Liver Cancer Insitute)","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)



Robert  Wiltrout; PhD (Laboratory of Experimental Immunology)



Snorri S. Thorgeirsson; MD, PhD (Laboratory of Experimental Carcinogenesis)



Howard A Young; PhD (Laboratory of Experimental Immunology)","Paul P. Liu; MD, PhD (NHGRI)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63300
371,BC010877-03,"October 01, 2009 -  September 30, 2010",The identification of human hepatocellular carcinoma metastasis genes,"Xin Wei Wang; PhD



IRP Faculty Profile",NULL,"Laboratory of Human Carcinogenesis, NCI","Anuradha Samantha Budhu



Marshonna J Forgues



Junfang  Ji



Stephanie  Roessler","Yidong  Chen; PhD





Carlo M Croce





Ping  He





Lun-Xiu  Qin
(Liver Cancer Institute)




Zhao-You  Tang
(Liver Cancer Institute)




Qinghai  Ye
(Liver Cancer Insitute)","Paul  Goldsmith; PhD (Basic Research Laboratory)



Richard  Simon (Biometrics Research Branch)



Udai S Kammula (Surgery Branch)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63299
372,BC010878-03,"October 01, 2009 -  September 30, 2010",Human Colon Cancer,"Curtis  Harris; MD



IRP Faculty Profile",NULL,"Laboratory of Human Carcinogenesis, NCI","Elise Dawn Bowman



Mohammed A. Khan; PhD



Derek  Kong



Abdul Matin Mondal



Aaron Joseph Schetter



Yizhe  Tang



Show all 10","Carlo  Croce
(Ohio State University)




Suet  Leung
(Hong Kong University)",NULL,NULL,"Ordered by publication type and then author name.



1.
Olivo-Marston SE, Hursting SD, Lavigne J, Perkins SN, Maarouf RS, Yakar S, Harris CC (2009). Genetic reduction of circulating insulin-like growth factor-1 inhibits azoxymethane-induced colon tumorigenesis in mice. Mol Carcinog  48, 1071-6.   https://doi.org/10.1002/mc.20577




PubMed



        
     
Free Article


 


PubMed ID 19760669
         Pubmed Central ID 2951004 


 



2.
Schetter AJ, Harris CC (2009). Plasma microRNAs: a potential biomarker for colorectal cancer? Gut  58, 1318-9.   https://doi.org/10.1136/gut.2009.176875




PubMed


 


PubMed ID 19749133
    
     


 



3.
Schetter AJ, Nguyen GH, Bowman ED, Mathé EA, Yuen ST, Hawkes JE, Croce CM, Leung SY, Harris CC (2009). Association of inflammation-related and microRNA gene expression with cancer-specific mortality of colon adenocarcinoma. Clin Cancer Res  15, 5878-87.   https://doi.org/10.1158/1078-0432.CCR-09-0627




PubMed



        
     
Free Article


 


PubMed ID 19737943
         Pubmed Central ID 2745503 


 



4.
Volinia S, Galasso M, Costinean S, Tagliavini L, Gamberoni G, Drusco A, Marchesini J, Mascellani N, Sana ME, Abu Jarour R, Desponts C, Teitell M, Baffa R, Aqeilan R, Iorio MV, Taccioli C, Garzon R, Di Leva G, Fabbri M, Catozzi M, Previati M, Ambs S, Palumbo T, Garofalo M, Veronese A, et al. [26 more authors] (2010). Reprogramming of miRNA networks in cancer and leukemia. Genome Res  20, 589-99.   https://doi.org/10.1101/gr.098046.109




PubMed



        
     
Free Article


 


PubMed ID 20439436
         Pubmed Central ID 2860161",https://intramural.nih.gov/search/searchview.taf?ipid=63234
373,BC010879-03,"October 01, 2009 -  September 30, 2010",Role of Toll-like receptors in the generation of acquired immunity,David M Segal; PhD,NULL,"Immune Targeting Section, NCI","Ivett  Jelinek



Yan  Wang



Kevin Neal Brown",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63255
374,BC010880-03,"October 01, 2009 -  September 30, 2010",Mechanisms of Prostate Tumorigenesis Using Genetically Engineered Mouse Models,Terry Anne Van Dyke,NULL,"Office of the Director, NCI","Yurong  Song; PhD



Debra J Gilbert



Xiuyun  Lu



Linda S Cleveland



Theresa N O'Sullivan



Chunhui  Wang","Cory  Abate-shen





Paul  Dayton
(University of North Carolina at Chapel Hill)




Sherri  Kuzlak
(University of North Carolina)",NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=63294
375,BC010881-03,"October 01, 2009 -  September 30, 2010",Development of TGF-beta antagonists for cancer therapy,"Lalage  Wakefield; PhD



IRP Faculty Profile",NULL,"Laboratory of Cancer Biology and Genetics, NCI","Kathleen C Flanders; PhD



Amy L Hapip



Dror  Luger; PhD



Michael A Welsh



Yu-an  Yang","Scott  Lonning
(Gene Therapy, Genzyme Corp.)




John  McPherson
(Genzyme Corp.)","Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)



John Charles Morris; MD (Lymphoid Malignancies Branch)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63297
376,BC010885-03,"October 01, 2009 -  September 30, 2010",Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies,"Robert  Yarchoan; MD



IRP Faculty Profile",NULL,"HIV and AIDS Malignancy Branch, NCI","Karen O Aleman



David A Davis; MD



Mark Niccolo Polizzotto; MD



Joseph M Ziegelbauer



Thomas S Uldrick



Victoria Y Wang



Show all 12",NULL,"Giovanna  Tosato; PhD (Laboratory of Cellular Oncology)



Stefania  Pittaluga (Laboratory of Pathology)



Denise  Whitby (Office Of The Director)","Joseph A Kovacs; MD (CC) 



Peter  Burbelo; PhD (NIDCR)","Ordered by publication type and then author name.



1.
Mbisa GL, Miley W, Gamache CJ, Gillette WK, Esposito D, Hopkins R, Busch MP, Schreiber GB, Little RF, Yarchoan R, Ortiz-Conde BA, Labò N, Whitby D (2010). Detection of antibodies to Kaposi's sarcoma-associated herpesvirus: a new approach using K8.1 ELISA and a newly developed recombinant LANA ELISA. J Immunol Methods  356, 39-46.   https://doi.org/10.1016/j.jim.2010.02.015




PubMed



        
     
Free Article


 


PubMed ID 20211626
         Pubmed Central ID 2981141 


 



2.
Uldrick TS, Wang V, O'Mahony D, Aleman K, Wyvill KM, Marshall V, Steinberg SM, Pittaluga S, Maric I, Whitby D, Tosato G, Little RF, Yarchoan R (2010). An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease. Clin Infect Dis  51, 350-8.   https://doi.org/10.1086/654798




PubMed



        
     
Free Article


 


PubMed ID 20583924
         Pubmed Central ID 2946207",https://intramural.nih.gov/search/searchview.taf?ipid=63316
377,BC010886-03,"October 01, 2009 -  September 30, 2010",Non-coding RNAs as Prognostic and Diagnostic Markers in Prostate Cancer,"Stefan  Ambs



IRP Faculty Profile",NULL,"Molecular Genetics and Carcinogenesis Section, NCI","Tiffany Marie Howe



Robert Scott Hudson",NULL,Arthur A Hurwitz (Laboratory of Molecular Immunoregulation),NULL,"Ordered by publication type and then author name.



1.
Ji J, Shi J, Budhu A, Yu Z, Forgues M, Roessler S, Ambs S, Chen Y, Meltzer PS, Croce CM, Qin LX, Man K, Lo CM, Lee J, Ng IO, Fan J, Tang ZY, Sun HC, Wang XW (2009). MicroRNA expression, survival, and response to interferon in liver cancer. N Engl J Med  361, 1437-47.   https://doi.org/10.1056/NEJMoa0901282




PubMed



        
     
Free Article


 


PubMed ID 19812400
         Pubmed Central ID 2786938",https://intramural.nih.gov/search/searchview.taf?ipid=63165
378,BC010887-03,"October 01, 2009 -  September 30, 2010",Novel Markers for Disease Outcome in Breast Cancer,"Stefan  Ambs



IRP Faculty Profile",NULL,"Molecular Genetics and Carcinogenesis Section, NCI","Tiffany Marie Howe



Steves  Tietcheu



Tiffany A Wallace",NULL,David Anderson Wink (Radiation Biology Branch),NULL,"Ordered by publication type and then author name.



1.
Glynn SA, Boersma BJ, Howe TM, Edvardsen H, Geisler SB, Goodman JE, Ridnour LA, Lønning PE, Børresen-Dale AL, Naume B, Kristensen VN, Chanock SJ, Wink DA, Ambs S (2009). A mitochondrial target sequence polymorphism in manganese superoxide dismutase predicts inferior survival in breast cancer patients treated with cyclophosphamide. Clin Cancer Res  15, 4165-73.   https://doi.org/10.1158/1078-0432.CCR-09-0119




PubMed



        
     
Free Article


 


PubMed ID 19509150
         Pubmed Central ID 2697269 


 



2.
Martin DN, Boersma BJ, Yi M, Reimers M, Howe TM, Yfantis HG, Tsai YC, Williams EH, Lee DH, Stephens RM, Weissman AM, Ambs S (2009). Differences in the tumor microenvironment between African-American and European-American breast cancer patients. PLoS One  4, e4531.   https://doi.org/10.1371/journal.pone.0004531




PubMed



        
     
Free Article


 


PubMed ID 19225562
         Pubmed Central ID 2638012",https://intramural.nih.gov/search/searchview.taf?ipid=63166
379,BC010888-03,"October 01, 2009 -  September 30, 2010",Clinical Trials of Patients with AIDS-Related Malignancies,"Robert  Yarchoan; MD



IRP Faculty Profile",NULL,"HIV and AIDS Malignancy Branch, NCI","Karen O Aleman



Mark Niccolo Polizzotto; MD



Thomas S Uldrick



Victoria Y Wang



Kathleen M Wyvill



Joseph M Ziegelbauer



Show all 8",NULL,"Kieron Michael Dunleavy (Lymphoid Malignancies Branch)



Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)



Giovanna  Tosato; PhD (Laboratory of Cellular Oncology)



Seth M Steinberg; PhD (Office of the Director)



George N Pavlakis; MD, PhD (Vaccine Branch)



Stefania  Pittaluga (Laboratory of Pathology)","Joseph A Kovacs; MD (CC) 



Peter  Burbelo; PhD (NIDCR) 



Moinuddin  Hassan; PhD (NICHD) 



Amir Hossein Gandjbakhche; PhD (NICHD) 



Irina  Maric; MD (CC) 



H. Clifford  Lane; MD (NIAID)","Ordered by publication type and then author name.



1.
Yarchoan R, Little R, Yarchoan R (2010) AIDS and cancer, in Cancer - The Outlaw Cell. American Chemical Society and Oxford University Press USA (New York), in press.




 



2.
Yarchoan R, Pauza C (2009) Cancers and HIV Infection: An evolving story, in From Cause to Care. Commemorating 25 Years of HIVAIDS Research. American Association for the Advancement of Science (Washington, DC), pp. 38-40.




 



3.
Housri N, Yarchoan R, Kaushal A (2010). Radiotherapy for patients with the human immunodeficiency virus: are special precautions necessary? Cancer  116, 273-83.   https://doi.org/10.1002/cncr.24878




PubMed



        
     
Free Article


 


PubMed ID 20014399
         Pubmed Central ID 3409663 


 



4.
Yarchoan R, Woo S, Dahut W, Kohn E, Kummar S, Yarchoan R, Giaccone G, Venitz J, Figg W (2010) Population pharmacokinetics of sorafenib in patients with solid tumors using clinical and pharmacogenetic covariates. Clin. Pharm Therapeutics, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=63315
380,BC010889-03,"October 01, 2009 -  September 30, 2010",Role of Selenium-containing Proteins in Cancer,"Dolph Lee Hatfield; PhD



IRP Faculty Profile",NULL,"Laboratory of Cancer Prevention, NCI","Bradley A Carlson



Salvador  Naranjo Suarez; PhD



Xueming  Xu



Min-Hyuk  Yoo



Ryuta  Tobe



Petra Akiko Tsuji",NULL,Cindy D Davis (Nutritional Science Research Group),NULL,"Ordered by publication type and then author name.



1.
Hatfield DL, Gladyshev VN (2009). The Outcome of Selenium and Vitamin E Cancer Prevention Trial (SELECT) reveals the need for better understanding of selenium biology. Mol Interv  9, 18-21.   https://doi.org/10.1124/mi.9.1.6




PubMed



        
     
Free Article


 


PubMed ID 19299660
         Pubmed Central ID 2718722 


 



2.
Hatfield DL, Yoo MH, Carlson BA, Gladyshev VN (2009). Selenoproteins that function in cancer prevention and promotion. Biochim Biophys Acta  1790, 1541-5.   https://doi.org/10.1016/j.bbagen.2009.03.001




PubMed



        
     
Free Article


 


PubMed ID 19272412
         Pubmed Central ID 2763959 


 



3.
Labunskyy VM, Yoo MH, Hatfield DL, Gladyshev VN (2009). Sep15, a thioredoxin-like selenoprotein, is involved in the unfolded protein response and differentially regulated by adaptive and acute ER stresses. Biochemistry  48, 8458-65.   https://doi.org/10.1021/bi900717p




PubMed



        
     
Free Article


 


PubMed ID 19650649
         Pubmed Central ID 2778599 


 



4.
Lobanov AV, Hatfield DL, Gladyshev VN (2009). Eukaryotic selenoproteins and selenoproteomes. Biochim Biophys Acta  1790, 1424-8.   https://doi.org/10.1016/j.bbagen.2009.05.014




PubMed



        
     
Free Article


 


PubMed ID 19477234
         Pubmed Central ID 3471088 


 



5.
Xu XM, Yoo MH, Carlson BA, Gladyshev VN, Hatfield DL (2009). Simultaneous knockdown of the expression of two genes using multiple shRNAs and subsequent knock-in of their expression. Nat Protoc  4, 1338-48.   https://doi.org/10.1038/nprot.2009.145




PubMed



        
     
Free Article


 


PubMed ID 19713955
         Pubmed Central ID 2753455",https://intramural.nih.gov/search/searchview.taf?ipid=63235
381,BC010891-03,"October 01, 2009 -  September 30, 2010",Antibody Therapy of Cancer,"Mitchell  Ho



IRP Faculty Profile",NULL,"Laboratory of Molecular Biology, NCI","Mingqian  Feng



Raffit  Hassan



Heungnam  Kim



Yen T Phung



Ruoqi  Wang



Xinran  Xiang



Show all 7","V. Courtney  Broaddus
(UCSF)




Gregory  Gore
(Mayo Clinic)




Min  Qian
(East China Normal University)




Shuichi  Takayama
(University of Michigan)","Dimiter Stanchev Dimitrov; PhD (Membrane Structure and Function Section)



Xin Wei Wang; PhD (Laboratory of Human Carcinogenesis)



David Erwin Kleiner; MD, PhD (Laboratory of Pathology)



Christoph  Rader; PhD (Experimental Transplantation and Immunology Branch)



Ira H Pastan; MD (Molecular Biology Section)



David J Fitzgerald; PhD (Biotherapy Section)",NULL,"Ordered by publication type and then author name.



1.
Ho M, Ho M (2010) Recombinant Immunotoxins for Treating Cancer, in Antibody Engineering. Springer (Heidelberg Dordrecht London New York) Volume II, pp. 127-146.




 



2.
Zhang Y, Hansen JK, Xiang L, Kawa S, Onda M, Ho M, Hassan R, Pastan I (2010). A flow cytometry method to quantitate internalized immunotoxins shows that taxol synergistically increases cellular immunotoxins uptake. Cancer Res  70, 1082-9.   https://doi.org/10.1158/0008-5472.CAN-09-2405




PubMed



        
     
Free Article


 


PubMed ID 20103626
         Pubmed Central ID 2818704",https://intramural.nih.gov/search/searchview.taf?ipid=63238
382,BC010892-03,"October 01, 2009 -  September 30, 2010",Characterization of the interaction between inflammation and cancer progression,Robert  Wiltrout; PhD,NULL,"Laboratory of Experimental Immunology, NCI","Timothy  Back



Thomas Joseph Sayers; PhD



Lindsey Rene' Grove



Qun  Jiang



John R Ortaldo; PhD



Howard A Young; PhD



Show all 11","Bruce  Blazar
(University of Minnesota)




Esther H Chang





Bill  Murphy
(Clinical Research, University of Nevada at Reno)




Jon Marc Wigginton; MD
(NCI)","David Anderson Wink (Radiation Biology Branch)



Larry K Keefer; PhD (Laboratory of Comparative Carcinogenesis)",NULL,"Ordered by publication type and then author name.



1.
Kummar S, Kinders R, Gutierrez ME, Rubinstein L, Parchment RE, Phillips LR, Ji J, Monks A, Low JA, Chen A, Murgo AJ, Collins J, Steinberg SM, Eliopoulos H, Giranda VL, Gordon G, Helman L, Wiltrout R, Tomaszewski JE, Doroshow JH (2009). Phase 0 clinical trial of the poly (ADP-ribose) polymerase inhibitor ABT-888 in patients with advanced malignancies. J Clin Oncol  27, 2705-11.   https://doi.org/10.1200/JCO.2008.19.7681




PubMed



        
     
Free Article


 


PubMed ID 19364967
         Pubmed Central ID 2739635 


 



2.
Subleski JJ, Wiltrout RH, Weiss JM (2009). Application of tissue-specific NK and NKT cell activity for tumor immunotherapy. J Autoimmun  33, 275-81.   https://doi.org/10.1016/j.jaut.2009.07.010




PubMed



        
     
Free Article


 


PubMed ID 19682859
         Pubmed Central ID 2783592 


 



3.
Weiss JM, Back TC, Scarzello AJ, Subleski JJ, Hall VL, Stauffer JK, Chen X, Micic D, Alderson K, Murphy WJ, Wiltrout RH (2009). Successful immunotherapy with IL-2/anti-CD40 induces the chemokine-mediated mitigation of an immunosuppressive tumor microenvironment. Proc Natl Acad Sci U S A  106, 19455-60.   https://doi.org/10.1073/pnas.0909474106




PubMed



        
     
Free Article


 


PubMed ID 19892741
         Pubmed Central ID 2773732",https://intramural.nih.gov/search/searchview.taf?ipid=63305
383,BC010893-03,"October 01, 2009 -  September 30, 2010",Tumor models for the study of inflammation and oncogenesis,Robert  Wiltrout; PhD,NULL,"Laboratory of Experimental Immunology, NCI","Timothy  Back



Tim  Chan



Lindsey Rene' Grove



Heather N Kopf



John R Ortaldo; PhD



Anthony J Scarzello



Show all 9",NULL,"Xin Wei Wang; PhD (Laboratory of Human Carcinogenesis)



Curtis  Harris; MD (Laboratory of Human Carcinogenesis)



William Marston Linehan; MD (Urologic Oncology Branch)



Snorri S. Thorgeirsson; MD, PhD (Laboratory of Experimental Carcinogenesis)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63306
384,BC010898-03,"October 01, 2009 -  September 30, 2010",Redox Mechanism Process of Angiogenesis and Wound Healing,"David Anderson Wink



IRP Faculty Profile",NULL,"Radiation Biology Branch, NCI","Yuk Sing Robert Cheng



Lisa Ann Ridnour



Murali  Krishna; PhD



Christopher H Switzer



Wilmarie  Flores-santana",NULL,"Curtis  Harris; MD (Laboratory of Human Carcinogenesis)



Stefan  Ambs (Molecular Genetics and Carcinogenesis Section)



David D Roberts; PhD (Laboratory of Pathology)",NULL,"Ordered by publication type and then author name.



1.
Glynn SA, Boersma BJ, Howe TM, Edvardsen H, Geisler SB, Goodman JE, Ridnour LA, Lønning PE, Børresen-Dale AL, Naume B, Kristensen VN, Chanock SJ, Wink DA, Ambs S (2009). A mitochondrial target sequence polymorphism in manganese superoxide dismutase predicts inferior survival in breast cancer patients treated with cyclophosphamide. Clin Cancer Res  15, 4165-73.   https://doi.org/10.1158/1078-0432.CCR-09-0119




PubMed



        
     
Free Article


 


PubMed ID 19509150
         Pubmed Central ID 2697269",https://intramural.nih.gov/search/searchview.taf?ipid=63307
385,BC010899-03,"October 01, 2009 -  September 30, 2010",Properties of redox modified NSAIDs in cancer prevention and treatment,"David Anderson Wink



IRP Faculty Profile",NULL,"Radiation Biology Branch, NCI","Wilmarie  Flores-santana



James B Mitchell; PhD



Christopher H Switzer



Murali  Krishna; PhD","Piero  del Soldato
(Pharma, CTG Pharma)




Bruce  King
(Department of Chemistry, Wake Forest University)","Grace  Yeh; PhD (Laboratory of Metabolism)



Larry K Keefer; PhD (Laboratory of Comparative Carcinogenesis)



David D Roberts; PhD (Laboratory of Pathology)",NULL,"Ordered by publication type and then author name.



1.
Bass SE, Sienkiewicz P, Macdonald CJ, Cheng RY, Sparatore A, Del Soldato P, Roberts DD, Moody TW, Wink DA, Yeh GC (2009). Novel dithiolethione-modified nonsteroidal anti-inflammatory drugs in human hepatoma HepG2 and colon LS180 cells. Clin Cancer Res  15, 1964-72.   https://doi.org/10.1158/1078-0432.CCR-08-1870




PubMed



        
     
Free Article


 


PubMed ID 19276279
         Pubmed Central ID 2755634 


 



2.
MacDonald CJ, Cheng RY, Roberts DD, Wink DA, Yeh GC (2009). Modulation of carcinogen metabolism by nitric oxide-aspirin 2 is associated with suppression of DNA damage and DNA adduct formation. J Biol Chem  284, 22099-107.   https://doi.org/10.1074/jbc.M109.021063




PubMed



        
     
Free Article


 


PubMed ID 19542225
         Pubmed Central ID 2755934 


 



3.
Mancardi D, Penna C, Merlino A, Del Soldato P, Wink DA, Pagliaro P (2009). Physiological and pharmacological features of the novel gasotransmitter: hydrogen sulfide. Biochim Biophys Acta  1787, 864-72.   https://doi.org/10.1016/j.bbabio.2009.03.005




PubMed



        
     
Free Article


 


PubMed ID 19285949
         Pubmed Central ID 3538351 


 



4.
Switzer CH, Flores-Santana W, Mancardi D, Donzelli S, Basudhar D, Ridnour LA, Miranda KM, Fukuto JM, Paolocci N, Wink DA (2009). The emergence of nitroxyl (HNO) as a pharmacological agent. Biochim Biophys Acta  1787, 835-40.   https://doi.org/10.1016/j.bbabio.2009.04.015




PubMed



        
     
Free Article


 


PubMed ID 19426703
         Pubmed Central ID 2761033",https://intramural.nih.gov/search/searchview.taf?ipid=63308
386,BC010907-03,"October 01, 2009 -  September 30, 2010",Papillomavirus Infectious Entry,"Christopher  Buck



IRP Faculty Profile",NULL,"Laboratory of Cellular Oncology, NCI","Katherine Ann Pumphrey



Rachel  Schowalter; PhD",NULL,NULL,"David Eric Anderson; PhD (NIDDK) 



Alasdair C Steven; PhD (NIAMS) 



Benes L Trus; PhD (CIT)","Ordered by publication type and then author name.



1.
Pérez-Andino J, Buck CB, Ribbeck K (2009). Adsorption of human papillomavirus 16 to live human sperm. PLoS One  4, e5847.   https://doi.org/10.1371/journal.pone.0005847




PubMed



        
     
Free Article


 


PubMed ID 19513123
         Pubmed Central ID 2689348",https://intramural.nih.gov/search/searchview.taf?ipid=63180
387,BC010910-03,"October 01, 2009 -  September 30, 2010",Genomic Rearrangements in Multiple Myeloma,"Walter M Kuehl; MD, PhD",NULL,"Cancer Genetics Branch, NCI","Leslie Ann Brents



Wei-Dong  Chen



Oleg K Glebov



Anna V Roschke","Bart  Barlogie
(Univ. of Arkansas for Medical Sciences)




P.  Bergsagel
(Divison of Hematology, Mayo Clinic)




Rafael  Fonseca
(Division of Hematology, Mayo Clinic)




Jeffrey  Sawyer
(University of Arkansas for Medical Sciences)




John  Shaughnessy
(Universiy of Arkansas for Medical Sciences)",Louis  Staudt; MD (Lymphoid Malignancies Branch),NULL,"Ordered by publication type and then author name.



1.
Dib A, Glebov OK, Shou Y, Singer RH, Kuehl WM (2009). A der(8)t(8;11) chromosome in the Karpas-620 myeloma cell line expresses only cyclin D1: yet both cyclin D1 and MYC are repositioned in close proximity to the 3'IGH enhancer. DNA Repair (Amst)  8, 330-5.   https://doi.org/10.1016/j.dnarep.2008.11.010




PubMed



        
     
Free Article


 


PubMed ID 19064000
         Pubmed Central ID 2678939 


 



2.
Fonseca R, Bergsagel PL, Drach J, Shaughnessy J, Gutierrez N, Stewart AK, Morgan G, Van Ness B, Chesi M, Minvielle S, Neri A, Barlogie B, Kuehl WM, Liebisch P, Davies F, Chen-Kiang S, Durie BG, Carrasco R, Sezer O, Reiman T, Pilarski L, Avet-Loiseau H, International Myeloma Working Group (2009). International Myeloma Working Group molecular classification of multiple myeloma: spotlight review. Leukemia  23, 2210-21.   https://doi.org/10.1038/leu.2009.174




PubMed



        
     
Free Article


 


PubMed ID 19798094
         Pubmed Central ID 2964268 


 



3.
Våtsveen TK, Tian E, Kresse SH, Meza-Zepeda LA, Gabrea A, Glebov O, Dai HY, Sundan A, Kuehl WM, Børset M (2009). OH-2, a hyperdiploid myeloma cell line without an IGH translocation, has a complex translocation juxtaposing MYC near MAFB and the IGK locus. Leuk Res  33, 1670-7.   https://doi.org/10.1016/j.leukres.2009.03.001




PubMed



        
     
Free Article


 


PubMed ID 19395026
         Pubmed Central ID 6944273 


 



4.
Zingone A, Cultraro CM, Shin DM, Bean CM, Morse HC, Janz S, Kuehl WM (2010). Ectopic expression of wild-type FGFR3 cooperates with MYC to accelerate development of B-cell lineage neoplasms. Leukemia  24, 1171-8.   https://doi.org/10.1038/leu.2010.50




PubMed



        
     
Free Article


 


PubMed ID 20393505
         Pubmed Central ID 3118571",https://intramural.nih.gov/search/searchview.taf?ipid=63341
388,BC010914-03,"October 01, 2009 -  September 30, 2010",Gene Expression Profiling and Clinical Characterization of Phototoxicity,"Heidi H Kong



IRP Faculty Profile",Mark  Udey; MD,"Dermatology Branch, NCI","Effie Y Nomicos; BS, BSN",NULL,NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=63335
389,BC010925-03,"October 01, 2009 -  September 30, 2010",Phase I Study of Topical Romidepsin in Early Stage Cutaneous T-cell Lymphoma,"Heidi H Kong



IRP Faculty Profile",Mark  Udey; MD,"Dermatology Branch, NCI","Melony A Avella



Effie Y Nomicos; BS, BSN",NULL,Susan  Bates; MD (Medical Oncology Branch),NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=63336
390,BC010929-03,"October 01, 2009 -  September 30, 2010",Tumor Stroma Interactions:  Wound Promoted Tumor Growth,John Edward Niederhuber,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI","Amelia  Macintyre



Christina  Stuelten",NULL,"Lalage  Wakefield; PhD (Laboratory of Cancer Biology and Genetics)



Kent W Hunter; PhD (Laboratory of Cancer Biology and Genetics)",NULL,"Ordered by publication type and then author name.



1.
Pastar I, Stojadinovic O, Krzyzanowska A, Barrientos S, Stuelten C, Zimmerman K, Blumenberg M, Brem H, Tomic-Canic M (2010) Attenuation of the transforming growth factor beta-signaling pathway in chronic venous ulcers. Mol Med 16:92-101.




PubMed



        
     
Free Article


 


PubMed ID 20069132
         Pubmed Central ID 2804290",https://intramural.nih.gov/search/searchview.taf?ipid=63380
391,BC010932-03,"October 01, 2009 -  September 30, 2010",T Cell Memory,"Jonathan D Ashwell; MD



IRP Faculty Profile",NULL,"Laboratory of Immune Cell Biology, NCI","Ivana  Munitic



Mirela  Kuka",NULL,NULL,Dragana  Jankovic; PhD (NIAID),"Ordered by publication type and then author name.



1.
Allam A, Conze DB, Giardino Torchia ML, Munitic I, Yagita H, Sowell RT, Marzo AL, Ashwell JD (2009). The CD8+ memory T-cell state of readiness is actively maintained and reversible. Blood  114, 2121-30.   https://doi.org/10.1182/blood-2009-05-220087




PubMed



        
     
Free Article


 


PubMed ID 19617575
         Pubmed Central ID 2744573",https://intramural.nih.gov/search/searchview.taf?ipid=63170
392,BC010935-03,"October 01, 2009 -  September 30, 2010",Regulation of Metastasis and Angiogenesis by Autotaxin and its Products,Mary  Stracke,John Carl Oberholtzer,"Laboratory of Pathology, NCI","Russell William Bandle



Elliott  Schiffmann



Malgorzata  Ptaszynska



Timothy  Clair; MS



Michael L Pendrak","Demetrios T Braddock; MD, PhD





Neerja  Kaushik-Basu
(UMDNJ-New Jersey Med School)",NULL,NULL,"Ordered by publication type and then author name.



1.
Koh E, Bandle RW, Roberts DD, Stracke ML, Clair T (2009). Novel point mutations attenuate autotaxin activity. Lipids Health Dis  8, 4.   https://doi.org/10.1186/1476-511X-8-4




PubMed



        
     
Free Article


 


PubMed ID 19222837
         Pubmed Central ID 2649126",https://intramural.nih.gov/search/searchview.taf?ipid=63283
393,BC010938-03,"October 01, 2009 -  September 30, 2010",Studies of Skin Microflora in Healthy Individuals and Atopic Dermatitis Patients,"Heidi H Kong



IRP Faculty Profile",Mark  Udey; MD,"Dermatology Branch, NCI","Melony A Avella



Effie Y Nomicos; BS, BSN



Christiana Lynn Booher",NULL,NULL,"Alexandra  Freeman (NIAID) 



Patrick R. Murray; PhD (CC) 



Julia A Segre; PhD (NHGRI) 



Hirsh David Komarow; MD (NIAID) 



Robert A Sokolic (NHGRI)","Ordered by publication type and then author name.



1.
Grice EA, Kong HH, Conlan S, Deming CB, Davis J, Young AC, NISC Comparative Sequencing Program, Bouffard GG, Blakesley RW, Murray PR, Green ED, Turner ML, Segre JA (2009). Topographical and temporal diversity of the human skin microbiome. Science  324, 1190-2.   https://doi.org/10.1126/science.1171700




PubMed



        
     
Free Article


 


PubMed ID 19478181
         Pubmed Central ID 2805064",https://intramural.nih.gov/search/searchview.taf?ipid=63337
394,BC010939-03,"October 01, 2009 -  September 30, 2010",RNAi Analysis and Screening for Study of Genes and Anti-Cancer Treatments,"Natasha  Caplen



IRP Faculty Profile","Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI","Kristen G Stover



Konrad  Huppi; MD, PhD



Tamara L Jones



Mark  Mackiewicz



Lihui  Ou; PhD



Jason James Pitt","Philip L Lorenzi





Shigeki  Miyamoto
(University of Wisconsin)




John  Weinstein
(MD Anderson)","Yves  Pommier; PhD (Developmental Therapeutics Branch)



Lee Jay Helman; MD (Pediatric Oncology Branch)



Stanley  Lipkowitz; MD, PhD (Laboratory of Cellular and Molecular Biology)



Beverly  Mock; PhD (Laboratory of Cancer Biology and Genetics)",Scott E Martin (NHGRI),"Ordered by publication type and then author name.



1.
Jobson AG, Lountos GT, Lorenzi PL, Llamas J, Connelly J, Cerna D, Tropea JE, Onda A, Zoppoli G, Kondapaka S, Zhang G, Caplen NJ, Cardellina JH, Yoo SS, Monks A, Self C, Waugh DS, Shoemaker RH, Pommier Y (2009). Cellular inhibition of checkpoint kinase 2 (Chk2) and potentiation of camptothecins and radiation by the novel Chk2 inhibitor PV1019 [7-nitro-1H-indole-2-carboxylic acid {4-[1-(guanidinohydrazone)-ethyl]-phenyl}-amide]. J Pharmacol Exp Ther  331, 816-26.   https://doi.org/10.1124/jpet.109.154997




PubMed



        
     
Free Article


 


PubMed ID 19741151
         Pubmed Central ID 2784710 


 



2.
Murrow LM, Garimella SV, Jones TL, Caplen NJ, Lipkowitz S (2010). Identification of WEE1 as a potential molecular target in cancer cells by RNAi screening of the human tyrosine kinome. Breast Cancer Res Treat  122, 347-57.   https://doi.org/10.1007/s10549-009-0571-2




PubMed



        
     
Free Article


 


PubMed ID 19821025
         Pubmed Central ID 3462346 


 



3.
Zhang YW, Jones TL, Martin SE, Caplen NJ, Pommier Y (2009). Implication of checkpoint kinase-dependent up-regulation of ribonucleotide reductase R2 in DNA damage response. J Biol Chem  284, 18085-95.   https://doi.org/10.1074/jbc.M109.003020




PubMed



        
     
Free Article


 


PubMed ID 19416980
         Pubmed Central ID 2709352",https://intramural.nih.gov/search/searchview.taf?ipid=63193
395,BC010940-03,"October 01, 2009 -  September 30, 2010",Cutaneous Adverse Drug Reactions,"Heidi H Kong



IRP Faculty Profile",Mark  Udey; MD,"Dermatology Branch, NCI",NULL,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Azad NS, Aragon-Ching JB, Dahut WL, Gutierrez M, Figg WD, Jain L, Steinberg SM, Turner ML, Kohn EC, Kong HH (2009). Hand-foot skin reaction increases with cumulative sorafenib dose and with combination anti-vascular endothelial growth factor therapy. Clin Cancer Res  15, 1411-6.   https://doi.org/10.1158/1078-0432.CCR-08-1141




PubMed



        
     
Free Article


 


PubMed ID 19228742
         Pubmed Central ID 2718558 


 



2.
Azad NS, Aragon-Ching JB, Kong HH (2009).  Clin Cancer Res  15, 7749.   https://doi.org/10.1158/1078-0432.CCR-09-1836




PubMed


 


PubMed ID 20008856
    
     


 



3.
Kong HH, Fine HA, Stern JB, Turner ML (2009). Cutaneous pigmentation after photosensitivity induced by vandetanib therapy. Arch Dermatol  145, 923-5.   https://doi.org/10.1001/archdermatol.2009.177




PubMed



        
     
Free Article


 


PubMed ID 19687425
         Pubmed Central ID 3521518 


 



4.
Kong HH, Turner ML (2009). Array of cutaneous adverse effects associated with sorafenib. J Am Acad Dermatol  61, 360-1.   https://doi.org/10.1016/j.jaad.2009.02.004




PubMed



        
     
Free Article


 


PubMed ID 19615549
         Pubmed Central ID 2744380",https://intramural.nih.gov/search/searchview.taf?ipid=63334
396,BC010944-03,"October 01, 2009 -  September 30, 2010",Control of the immune response for cancer vaccine development,"Jeffrey  Schlom; PhD



IRP Faculty Profile",NULL,"Laboratory of Tumor Immunology and Biology, NCI","Diana G Chambers



Claudia Mercedes Palena



John  Greiner; PhD



James W Hodge; PhD



Kwong Yok Tsang



Curtis  Randolph



Show all 8",NULL,Lalage  Wakefield; PhD (Laboratory of Cancer Biology and Genetics),NULL,"Ordered by publication type and then author name.



1.
di Bari MG, Lutsiak ME, Takai S, Mostböck S, Farsaci B, Semnani RT, Wakefield LM, Schlom J, Sabzevari H (2009). TGF-beta modulates the functionality of tumor-infiltrating CD8+ T cells through effects on TCR signaling and Spred1 expression. Cancer Immunol Immunother  58, 1809-18.   https://doi.org/10.1007/s00262-009-0692-9




PubMed



        
     
Free Article


 


PubMed ID 19319531
         Pubmed Central ID 3499107 


 



2.
Hance KW, Rogers CJ, Zaharoff DA, Canter D, Schlom J, Greiner JW (2009). The antitumor and immunoadjuvant effects of IFN-alpha in combination with recombinant poxvirus vaccines. Clin Cancer Res  15, 2387-96.   https://doi.org/10.1158/1078-0432.CCR-08-1752




PubMed



        
     
Free Article


 


PubMed ID 19276249
         Pubmed Central ID 2844936 


 



3.
Hodge JW, Higgins J, Schlom J (2009). Harnessing the unique local immunostimulatory properties of modified vaccinia Ankara (MVA) virus to generate superior tumor-specific immune responses and antitumor activity in a diversified prime and boost vaccine regimen. Vaccine  27, 4475-82.   https://doi.org/10.1016/j.vaccine.2009.05.017




PubMed



        
     
Free Article


 


PubMed ID 19450631
         Pubmed Central ID 3518379 


 



4.
Remondo C, Cereda V, Mostböck S, Sabzevari H, Franzusoff A, Schlom J, Tsang KY (2009). Human dendritic cell maturation and activation by a heat-killed recombinant yeast (Saccharomyces cerevisiae) vector encoding carcinoembryonic antigen. Vaccine  27, 987-94.   https://doi.org/10.1016/j.vaccine.2008.12.002




PubMed



        
     
Free Article


 


PubMed ID 19110021
         Pubmed Central ID 3518400 


 



5.
Zaharoff DA, Hance KW, Rogers CJ, Schlom J, Greiner JW (2010). Intratumoral immunotherapy of established solid tumors with chitosan/IL-12. J Immunother  33, 697-705.   https://doi.org/10.1097/CJI.0b013e3181eb826d




PubMed



        
     
Free Article


 


PubMed ID 20664357
         Pubmed Central ID 3468951 


 



6.
Zaharoff DA, Hoffman BS, Hooper HB, Benjamin CJ, Khurana KK, Hance KW, Rogers CJ, Pinto PA, Schlom J, Greiner JW (2009). Intravesical immunotherapy of superficial bladder cancer with chitosan/interleukin-12. Cancer Res  69, 6192-9.   https://doi.org/10.1158/0008-5472.CAN-09-1114




PubMed



        
     
Free Article


 


PubMed ID 19638573
         Pubmed Central ID 2788203",https://intramural.nih.gov/search/searchview.taf?ipid=63252
397,BC010945-03,"October 01, 2009 -  September 30, 2010",Clinical trials employing cancer vaccine combination therapies,"James L Gulley; MD, PhD



IRP Faculty Profile",NULL,"Laboratory of Tumor Immunology and Biology, NCI","Sandra  Doren



Theresa A Ferrara



Sheri A Mcmahon



Mary P Pazdur



Myrna B Rauckhorst



Carol  Smith



Show all 7","William  Carson
(Molecular Virology, Immunology and Medical Genetics, Ohio State University)




Robert  DiPaola
(Medicine, Cancer Institute of New Jersey)




John  Marshall","Philip M Arlen; MD (Medical Oncology Branch)



Peter A Pinto; MD (Urologic Oncology Branch)



Kevin A Camphausen; MD (Radiation Oncology Branch)



William Laurence Dahut; MD (Office of the Director)



William D Figg; PharmD (Medical Oncology Branch)



William Marston Linehan; MD (Urologic Oncology Branch)",NULL,"Ordered by publication type and then author name.



1.
Arlen PM, Mohebtash M, Madan RA, Gulley JL (2009). Promising novel immunotherapies and combinations for prostate cancer. Future Oncol  5, 187-96.   https://doi.org/10.2217/14796694.5.2.187




PubMed



        
     
Free Article


 


PubMed ID 19284377
         Pubmed Central ID 2705770 


 



2.
Ferrara TA, Hodge JW, Gulley JL (2009). Combining radiation and immunotherapy for synergistic antitumor therapy. Curr Opin Mol Ther  11, 37-42.




PubMed



        
     
Free Article


 


PubMed ID 19169958
         Pubmed Central ID 3474202",https://intramural.nih.gov/search/searchview.taf?ipid=63228
398,BC010946-03,"October 01, 2009 -  September 30, 2010",Protection against Radiation-Induced Carcinogenesis,"James B Mitchell; PhD



IRP Faculty Profile",NULL,"Radiation Biology Branch, NCI","Kristin  Askin



Maria E Figueroa



Anastasia L Sowers



John Andrew Cook; PhD",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63370
399,BC010954-03,"October 01, 2009 -  September 30, 2010",Tumor Growth and Microenvironment Influence T Cell Tolerance to Tumor Antigens,Arthur A Hurwitz,NULL,"Laboratory of Molecular Immunoregulation, NCI","Martha Milton Sklavos



Katherine  Stagliano



Scott K Durum; PhD



Terri L Stull



Joost J Oppenheim; MD



Ziqiang  Zhu



Show all 7",NULL,"Giorgio  Trinchieri (Cancer Inflammation Program)



William Marston Linehan; MD (Urologic Oncology Branch)



Stefan  Ambs (Molecular Genetics and Carcinogenesis Section)",NULL,"Ordered by publication type and then author name.



1.
Salcedo R, Hixon JA, Stauffer JK, Jalah R, Brooks AD, Khan T, Dai RM, Scheetz L, Lincoln E, Back TC, Powell D, Hurwitz AA, Sayers TJ, Kastelein R, Pavlakis GN, Felber BK, Trinchieri G, Wigginton JM (2009). Immunologic and therapeutic synergy of IL-27 and IL-2: enhancement of T cell sensitization, tumor-specific CTL reactivity and complete regression of disseminated neuroblastoma metastases in the liver and bone marrow. J Immunol  182, 4328-38.   https://doi.org/10.4049/jimmunol.0800471




PubMed



        
     
Free Article


 


PubMed ID 19299733
         Pubmed Central ID 2730673 


 



2.
Shafer-Weaver KA, Anderson MJ, Stagliano K, Malyguine A, Greenberg NM, Hurwitz AA (2009). Cutting Edge: Tumor-specific CD8+ T cells infiltrating prostatic tumors are induced to become suppressor cells. J Immunol  183, 4848-52.   https://doi.org/10.4049/jimmunol.0900848




PubMed



        
     
Free Article


 


PubMed ID 19801511
         Pubmed Central ID 6948842 


 



3.
Shafer-Weaver KA, Watkins SK, Anderson MJ, Draper LJ, Malyguine A, Alvord WG, Greenberg NM, Hurwitz AA (2009). Immunity to murine prostatic tumors: continuous provision of T-cell help prevents CD8 T-cell tolerance and activates tumor-infiltrating dendritic cells. Cancer Res  69, 6256-64.   https://doi.org/10.1158/0008-5472.CAN-08-4516




PubMed



        
     
Free Article


 


PubMed ID 19622771
         Pubmed Central ID 2732120",https://intramural.nih.gov/search/searchview.taf?ipid=63322
400,BC010955-03,"October 01, 2009 -  September 30, 2010",The Role of T Cell Avidity in Determining Tumor Immunity and Autoimmunity,Arthur A Hurwitz,NULL,"Laboratory of Molecular Immunoregulation, NCI","Martha Milton Sklavos



Katherine  Stagliano



Terri L Stull



Ziqiang  Zhu",NULL,"Nicholas Phillip Restifo; MD (Surgery Branch)



Lionel  Feigenbaum (Office Of The Director)



Lino  Tessarollo (Mouse Cancer Genetics Program)",NULL,"Ordered by publication type and then author name.



1.
Singh V, Ji Q, Feigenbaum L, Leighty RM, Hurwitz AA (2009). Melanoma progression despite infiltration by in vivo-primed TRP-2-specific T cells. J Immunother  32, 129-39.   https://doi.org/10.1097/CJI.0b013e31819144d7




PubMed



        
     
Free Article


 


PubMed ID 19238011
         Pubmed Central ID 2648128",https://intramural.nih.gov/search/searchview.taf?ipid=63321
401,BC010956-03,"October 01, 2009 -  September 30, 2010",EpCAM (CD326) Function in Epithelial Cell Biology and Immunophysiology,Mark  Udey; MD,NULL,"Dermatology Branch, NCI","Maria Rita Becker



Joshua Zachary Drago



Xu  Feng; PhD



Hyouk Soo  Kwon



Michael C Lu



Chuanjin  Wu","Daniel M Kaplan





Asma  Nusrat
(Emory University School of Medicine)","Robert Mark Simpson; DVM, PhD (Laboratory of Cancer Biology and Genetics)



Susan  Mackem; MD (Cancer and Developmental Biology Laboratory)



Lino  Tessarollo (Mouse Cancer Genetics Program)","Maria Irene Morasso; PhD (NIAMS) 



Jeffrey Burnett Kopp; MD (NIDDK)","Ordered by publication type and then author name.



1.
Nagao K, Zhu J, Heneghan MB, Hanson JC, Morasso MI, Tessarollo L, Mackem S, Udey MC (2009). Abnormal placental development and early embryonic lethality in EpCAM-null mice. PLoS One  4, e8543.   https://doi.org/10.1371/journal.pone.0008543




PubMed



        
     
Free Article


 


PubMed ID 20046825
         Pubmed Central ID 2796178",https://intramural.nih.gov/search/searchview.taf?ipid=63292
402,BC010957-03,"October 01, 2009 -  September 30, 2010",Transplant Models,"Ronald E Gress; MD



IRP Faculty Profile",NULL,"Experimental Transplantation and Immunology Branch, NCI","Anthony David Foster; PhD



Philip J Lucas; PhD



Amogh  Sivarapatna; BS



Ruifeng  Teng



Shirin  Treadwell



Jiun  Wang",NULL,"Richard J Hodes; MD (Experimental Immunology Branch)



James Stephen Shaw; PhD (Experimental Immunology Branch)



Alfred  Singer; MD (Experimental Immunology Branch)",Arya  Biragyn; PhD (NIA),"Ordered by publication type and then author name.



1.
ElKassar N, Gress RE (2010). An overview of IL-7 biology and its use in immunotherapy. J Immunotoxicol  7, 1-7.   https://doi.org/10.3109/15476910903453296




PubMed



        
     
Free Article


 


PubMed ID 20017587
         Pubmed Central ID 2826542 


 



2.
Imanguli MM, Swaim WD, League SC, Gress RE, Pavletic SZ, Hakim FT (2009). Increased T-bet+ cytotoxic effectors and type I interferon-mediated processes in chronic graft-versus-host disease of the oral mucosa. Blood  113, 3620-30.   https://doi.org/10.1182/blood-2008-07-168351




PubMed



        
     
Free Article


 


PubMed ID 19168793
         Pubmed Central ID 2668847 


 



3.
Kapoor V, Hakim FT, Rehman N, Gress RE, Telford WG (2009). Quantum dots thermal stability improves simultaneous phenotype-specific telomere length measurement by FISH-flow cytometry. J Immunol Methods  344, 6-14.   https://doi.org/10.1016/j.jim.2009.02.004




PubMed



        
     
Free Article


 


PubMed ID 19268672
         Pubmed Central ID 2752384 


 



4.
Olkhanud PB, Baatar D, Bodogai M, Hakim F, Gress R, Anderson RL, Deng J, Xu M, Briest S, Biragyn A (2009). Breast cancer lung metastasis requires expression of chemokine receptor CCR4 and regulatory T cells. Cancer Res  69, 5996-6004.   https://doi.org/10.1158/0008-5472.CAN-08-4619




PubMed



        
     
Free Article


 


PubMed ID 19567680
         Pubmed Central ID 2743688 


 



5.
Sportès C, Babb RR, Krumlauf MC, Hakim FT, Steinberg SM, Chow CK, Brown MR, Fleisher TA, Noel P, Maric I, Stetler-Stevenson M, Engel J, Buffet R, Morre M, Amato RJ, Pecora A, Mackall CL, Gress RE (2010). Phase I study of recombinant human interleukin-7 administration in subjects with refractory malignancy. Clin Cancer Res  16, 727-35.   https://doi.org/10.1158/1078-0432.CCR-09-1303




PubMed



        
     
Free Article


 


PubMed ID 20068111
         Pubmed Central ID 2808195 


 



6.
Sportès C, Gress RE, Mackall CL (2009). Perspective on potential clinical applications of recombinant human interleukin-7. Ann N Y Acad Sci  1182, 28-38.   https://doi.org/10.1111/j.1749-6632.2009.05075.x




PubMed



        
     
Free Article


 


PubMed ID 20074272
         Pubmed Central ID 6545488 


 



7.
Williams KM, Mella H, Lucas PJ, Williams JA, Telford W, Gress RE (2009). Single cell analysis of complex thymus stromal cell populations: rapid thymic epithelia preparation characterizes radiation injury. Clin Transl Sci  2, 279-85.   https://doi.org/10.1111/j.1752-8062.2009.00128.x




PubMed



        
     
Free Article


 


PubMed ID 19750208
         Pubmed Central ID 2741333",https://intramural.nih.gov/search/searchview.taf?ipid=63226
403,BC010958-03,"October 01, 2009 -  September 30, 2010","Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion","Ira  Daar; PhD



IRP Faculty Profile",NULL,"Laboratory of Cell and Developmental Signaling, NCI","Kathleen T Soria



Emily Frances Winterbottom



Yoo-Seok  Hwang","Ken  Cho
(University of California, Irvine)




Christof  Niehrs; PhD
(DKFZ Heidelberg)




Herbert  Steinbeisser
(University of Heidelberg)","Paul A Randazzo; MD, PhD (Laboratory of Cellular and Molecular Biology)",NULL,"Ordered by publication type and then author name.



1.
Lee HS, Daar IO (2009). EphrinB reverse signaling in cell-cell adhesion: is it just par for the course? Cell Adh Migr  3, 250-5.   https://doi.org/10.4161/cam.3.3.8211




PubMed



        
     
Free Article


 


PubMed ID 19276658
         Pubmed Central ID 2712803 


 



2.
Lee HS, Mood K, Battu G, Ji YJ, Singh A, Daar IO (2009). Fibroblast growth factor receptor-induced phosphorylation of ephrinB1 modulates its interaction with Dishevelled. Mol Biol Cell  20, 124-33.   https://doi.org/10.1091/mbc.e08-06-0662




PubMed



        
     
Free Article


 


PubMed ID 19005214
         Pubmed Central ID 2613129",https://intramural.nih.gov/search/searchview.taf?ipid=63196
404,BC010959-03,"October 01, 2009 -  September 30, 2010",Relationship between DNA damage detection and signaling,"Andre A Nussenzweig; PhD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI",NULL,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63381
405,BC010960-03,"October 01, 2009 -  September 30, 2010",Clinical Trials,"Ronald E Gress; MD



IRP Faculty Profile",NULL,"Experimental Transplantation and Immunology Branch, NCI","Juan Carlos Gea-Banacloche; MD



Steven  Pavletic; MD, MS","Robert  Korngold
(Cancer Center, Hackensack University)




Andrew  Pecora
(Cancer Center, Hackensack University)","Crystal L. Mackall; MD (Pediatric Oncology Branch)



Steven Aaron Rosenberg; MD, PhD (Surgery Branch)",NULL,"Ordered by publication type and then author name.



1.
Sportès C, Gress RE, Mackall CL (2009). Perspective on potential clinical applications of recombinant human interleukin-7. Ann N Y Acad Sci  1182, 28-38.   https://doi.org/10.1111/j.1749-6632.2009.05075.x




PubMed



        
     
Free Article


 


PubMed ID 20074272
         Pubmed Central ID 6545488 


 



2.
Sportès C, Steinberg SM, Liewehr DJ, Gea-Banacloche J, Danforth DN, Avila DN, Bryant KE, Krumlauf MC, Fowler DH, Pavletic S, Hardy NM, Bishop MR, Gress RE (2009). Strategies to improve long-term outcome in stage IIIB inflammatory breast cancer: multimodality treatment including dose-intensive induction and high-dose chemotherapy. Biol Blood Marrow Transplant  15, 963-70.   https://doi.org/10.1016/j.bbmt.2009.04.018




PubMed



        
     
Free Article


 


PubMed ID 19589486
         Pubmed Central ID 2709825",https://intramural.nih.gov/search/searchview.taf?ipid=63227
406,BC010969-03,"October 01, 2009 -  September 30, 2010",The use of chitosan for cancer vaccine delivery,John  Greiner; PhD,Jeffrey  Schlom; PhD,"Laboratory of Tumor Immunology and Biology, NCI","Lajuan  Chase



Garland M Davis



Bertina L Gibbs



Michael  Heffernan



Shinji  Takai



Jonathan Kroemer Fallon; PhD","Connie  Rogers
(Penn State University)




David A Zaharoff","Peter A Pinto; MD (Urologic Oncology Branch)



William Marston Linehan; MD (Urologic Oncology Branch)",NULL,"Ordered by publication type and then author name.



1.
Zaharoff DA, Hoffman BS, Hooper HB, Benjamin CJ, Khurana KK, Hance KW, Rogers CJ, Pinto PA, Schlom J, Greiner JW (2009). Intravesical immunotherapy of superficial bladder cancer with chitosan/interleukin-12. Cancer Res  69, 6192-9.   https://doi.org/10.1158/0008-5472.CAN-09-1114




PubMed



        
     
Free Article


 


PubMed ID 19638573
         Pubmed Central ID 2788203",https://intramural.nih.gov/search/searchview.taf?ipid=63223
407,BC010970-03,"October 01, 2009 -  September 30, 2010",The connection of innate and adaptive anti-cancer immunity,John  Greiner; PhD,Jeffrey  Schlom; PhD,"Laboratory of Tumor Immunology and Biology, NCI","Lajuan  Chase



Garland M Davis



Jonathan Kroemer Fallon; PhD



Bertina L Gibbs



Michael  Heffernan



Shinji  Takai",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Hance KW, Rogers CJ, Zaharoff DA, Canter D, Schlom J, Greiner JW (2009). The antitumor and immunoadjuvant effects of IFN-alpha in combination with recombinant poxvirus vaccines. Clin Cancer Res  15, 2387-96.   https://doi.org/10.1158/1078-0432.CCR-08-1752




PubMed



        
     
Free Article


 


PubMed ID 19276249
         Pubmed Central ID 2844936",https://intramural.nih.gov/search/searchview.taf?ipid=63224
408,BC010972-03,"October 01, 2009 -  September 30, 2010",Identification of human tumor-associated antigens,Kwong Yok Tsang,Jeffrey  Schlom; PhD,"Laboratory of Tumor Immunology and Biology, NCI","Ngar Yee  Huen



Claudia Mercedes Palena



Chiara  Intrivici



Caroline Mikaela Maria Jochems; PhD



Diane J Poole



Matteo  Vergati



Show all 7",NULL,"Philip M Arlen; MD (Medical Oncology Branch)



Tapan K Bera (Molecular Biology Section)



Ira H Pastan; MD (Molecular Biology Section)",NULL,"Ordered by publication type and then author name.



1.
Gulley JL, Arlen PM, Madan RA, Tsang KY, Pazdur MP, Skarupa L, Jones JL, Poole DJ, Higgins JP, Hodge JW, Cereda V, Vergati M, Steinberg SM, Halabi S, Jones E, Chen C, Parnes H, Wright JJ, Dahut WL, Schlom J (2010). Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer. Cancer Immunol Immunother  59, 663-74.   https://doi.org/10.1007/s00262-009-0782-8




PubMed



        
     
Free Article


 


PubMed ID 19890632
         Pubmed Central ID 2832083 


 



2.
Litzinger MT, Foon KA, Sabzevari H, Tsang KY, Schlom J, Palena C (2009). Chronic lymphocytic leukemia (CLL) cells genetically modified to express B7-1, ICAM-1, and LFA-3 confer APC capacity to T cells from CLL patients. Cancer Immunol Immunother  58, 955-65.   https://doi.org/10.1007/s00262-008-0611-5




PubMed



        
     
Free Article


 


PubMed ID 19009294
         Pubmed Central ID 2664396",https://intramural.nih.gov/search/searchview.taf?ipid=63290
409,BC010973-03,"October 01, 2009 -  September 30, 2010",Analyses of human T regulatory cells,Kwong Yok Tsang,Jeffrey  Schlom; PhD,"Laboratory of Tumor Immunology and Biology, NCI","Ngar Yee  Huen



Chiara  Intrivici



James L Gulley; MD, PhD



Caroline Mikaela Maria Jochems; PhD



Matteo  Vergati","Pierpaolo  Correale
(NCI)




Alex  Franzusoff
(Research and Development, GlobeImmune)",Philip M Arlen; MD (Medical Oncology Branch),NULL,"Ordered by publication type and then author name.



1.
Remondo C, Cereda V, Mostböck S, Sabzevari H, Franzusoff A, Schlom J, Tsang KY (2009). Human dendritic cell maturation and activation by a heat-killed recombinant yeast (Saccharomyces cerevisiae) vector encoding carcinoembryonic antigen. Vaccine  27, 987-94.   https://doi.org/10.1016/j.vaccine.2008.12.002




PubMed



        
     
Free Article


 


PubMed ID 19110021
         Pubmed Central ID 3518400",https://intramural.nih.gov/search/searchview.taf?ipid=63291
410,BC010974-03,"October 01, 2009 -  September 30, 2010",The development of Saccharomyces (yeast) vaccines for cancer therapy,James W Hodge; PhD,Jeffrey  Schlom; PhD,"Laboratory of Tumor Immunology and Biology, NCI","Andressa  Ardiani



Kenneth W Hance



Amanda L Boehm; PhD



Benedetto Paolo Farsaci; PhD



John  Greiner; PhD



Sofia Ribeiro Gameiro



Show all 7",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63318
411,BC010975-03,"October 01, 2009 -  September 30, 2010",Vaccine and radiation for the therapy of human cancers,James W Hodge; PhD,Jeffrey  Schlom; PhD,"Laboratory of Tumor Immunology and Biology, NCI","Andressa  Ardiani



Amanda L Boehm; PhD



Benedetto Paolo Farsaci; PhD



Sofia Ribeiro Gameiro



Marion G Taylor","Alex  Franzusoff
(Research and Development, GlobeImmune)




Eric  Reits
(Netherlands Cancer Institute)",Kevin A Camphausen; MD (Radiation Oncology Branch),NULL,"Ordered by publication type and then author name.



1.
Ferrara TA, Hodge JW, Gulley JL (2009). Combining radiation and immunotherapy for synergistic antitumor therapy. Curr Opin Mol Ther  11, 37-42.




PubMed



        
     
Free Article


 


PubMed ID 19169958
         Pubmed Central ID 3474202 


 



2.
Kamrava M, Bernstein MB, Camphausen K, Hodge JW (2009). Combining radiation, immunotherapy, and antiangiogenesis agents in the management of cancer: the Three Musketeers or just another quixotic combination? Mol Biosyst  5, 1262-70.   https://doi.org/10.1039/b911313b




PubMed



        
     
Free Article


 


PubMed ID 19823740
         Pubmed Central ID 6309404",https://intramural.nih.gov/search/searchview.taf?ipid=63319
412,BC010976-03,"October 01, 2009 -  September 30, 2010",Role of MFG-E8 in Tumor Biology and Immunophysiology,Mark  Udey; MD,NULL,"Dermatology Branch, NCI","Joshua Zachary Drago



Michael C Lu



Sei-Ichiro  Motegi",NULL,"Triantafyllos  Chavakis (Experimental Immunology Branch)



James B Mitchell; PhD (Radiation Biology Branch)",Jeffrey Burnett Kopp; MD (NIDDK),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63293
413,BC010977-03,"October 01, 2009 -  September 30, 2010",Cbl Proteins as Regulators of Tyrosine Kinase Signaling,"Stanley  Lipkowitz; MD, PhD



IRP Faculty Profile",NULL,"Laboratory of Cellular and Molecular Biology, NCI","Stephen Charles Kales



Marion M Nau



Philip  Ryan",NULL,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)



Allan M Weissman; MD (Laboratory of Protein Dynamics and Signaling)



Jeffrey E Green; MD (Laboratory of Cancer Biology and Genetics)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63353
414,BC010982-03,"October 01, 2009 -  September 30, 2010",Collaborative Pathways that Lead to Leukemia,"Peter D Aplan; MD



IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","Sarah H Beachy; PhD



Paul S Meltzer; MD, PhD



Rachel  Novak



Masahiro  Onozawa",NULL,"Linda  Wolff; PhD (Laboratory of Cellular Oncology)



Lino  Tessarollo (Mouse Cancer Genetics Program)",NULL,"Ordered by publication type and then author name.



1.
Beachy SH, Aplan PD (2010). Mouse models of myelodysplastic syndromes. Hematol Oncol Clin North Am  24, 361-75.   https://doi.org/10.1016/j.hoc.2010.02.002




PubMed



        
     
Free Article


 


PubMed ID 20359631
         Pubmed Central ID 2848962",https://intramural.nih.gov/search/searchview.taf?ipid=63168
415,BC010983-03,"October 01, 2009 -  September 30, 2010",Pre-clinical Studies of Therapy for Myelodysplastic Syndrome,"Peter D Aplan; MD



IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","Sarah H Beachy; PhD



Yang-Jo  Chung



Sheryl Maxine Gough","JP  Issa
(MD Anderson)




Steven  Nimer
(MSKCC)",Terry J Fry (Pediatric Oncology Branch),"Perry Justin Blackshear; MD, DPhil (NIEHS)","Ordered by publication type and then author name.



1.
Beachy SH, Aplan PD (2010). Mouse models of myelodysplastic syndromes. Hematol Oncol Clin North Am  24, 361-75.   https://doi.org/10.1016/j.hoc.2010.02.002




PubMed



        
     
Free Article


 


PubMed ID 20359631
         Pubmed Central ID 2848962 


 



2.
Estécio MR, Gallegos J, Vallot C, Castoro RJ, Chung W, Maegawa S, Oki Y, Kondo Y, Jelinek J, Shen L, Hartung H, Aplan PD, Czerniak BA, Liang S, Issa JP (2010). Genome architecture marked by retrotransposons modulates predisposition to DNA methylation in cancer. Genome Res  20, 1369-82.   https://doi.org/10.1101/gr.107318.110




PubMed



        
     
Free Article


 


PubMed ID 20716667
         Pubmed Central ID 2945186 


 



3.
Lin YW, Beharry ZM, Hill EG, Song JH, Wang W, Xia Z, Zhang Z, Aplan PD, Aster JC, Smith CD, Kraft AS (2010). A small molecule inhibitor of Pim protein kinases blocks the growth of precursor T-cell lymphoblastic leukemia/lymphoma. Blood  115, 824-33.   https://doi.org/10.1182/blood-2009-07-233445




PubMed



        
     
Free Article


 


PubMed ID 19965690
         Pubmed Central ID 2941996",https://intramural.nih.gov/search/searchview.taf?ipid=63169
416,BC010984-03,"October 01, 2009 -  September 30, 2010",Adoptive Cell Transfer Immunotherapy of Cancer,"Steven Aaron Rosenberg; MD, PhD



IRP Faculty Profile",NULL,"Surgery Branch, NCI","Ellen E Douglas



Mark E Dudley



Marybeth S Hughes



Joyce G Landry



Nicholas Phillip Restifo; MD



Carolyn  Laurencot



Show all 21",NULL,NULL,Yardena Rachel Samuels; PhD (NHGRI),"Ordered by publication type and then author name.



1.
Cárdenas-Navia LI, Cruz P, Lin JC, NISC Comparative Sequencing Program, Rosenberg SA, Samuels Y (2010). Novel somatic mutations in heterotrimeric G proteins in melanoma. Cancer Biol Ther  10, 33-7.   https://doi.org/10.4161/cbt.10.1.11949




PubMed



        
     
Free Article


 


PubMed ID 20424519
         Pubmed Central ID 3040832 


 



2.
Frankel TL, Burns WR, Peng PD, Yu Z, Chinnasamy D, Wargo JA, Zheng Z, Restifo NP, Rosenberg SA, Morgan RA (2010). Both CD4 and CD8 T cells mediate equally effective in vivo tumor treatment when engineered with a highly avid TCR targeting tyrosinase. J Immunol  184, 5988-98.   https://doi.org/10.4049/jimmunol.1000189




PubMed



        
     
Free Article


 


PubMed ID 20427771
         Pubmed Central ID 6290481 


 



3.
Goff SL, Robbins PF, El-Gamil M, Rosenberg SA (2009). No correlation between clinical response to CTLA-4 blockade and presence of NY-ESO-1 antibody in patients with metastatic melanoma. J Immunother  32, 884-5.   https://doi.org/10.1097/CJI.0b013e3181affbf0




PubMed



        
     
Free Article


 


PubMed ID 19752745
         Pubmed Central ID 6327840 


 



4.
Hinrichs CS, Borman ZA, Cassard L, Gattinoni L, Spolski R, Yu Z, Sanchez-Perez L, Muranski P, Kern SJ, Logun C, Palmer DC, Ji Y, Reger RN, Leonard WJ, Danner RL, Rosenberg SA, Restifo NP (2009). Adoptively transferred effector cells derived from naive rather than central memory CD8+ T cells mediate superior antitumor immunity. Proc Natl Acad Sci U S A  106, 17469-74.   https://doi.org/10.1073/pnas.0907448106




PubMed



        
     
Free Article


 


PubMed ID 19805141
         Pubmed Central ID 2762661 


 



5.
Kalbasi A, Shrimali RK, Chinnasamy D, Rosenberg SA (2010). Prevention of interleukin-2 withdrawal-induced apoptosis in lymphocytes retrovirally cotransduced with genes encoding an antitumor T-cell receptor and an antiapoptotic protein. J Immunother  33, 672-83.   https://doi.org/10.1097/CJI.0b013e3181e475cd




PubMed



        
     
Free Article


 


PubMed ID 20664359
         Pubmed Central ID 6390957 


 



6.
Kerkar SP, Kemp CD, Duffy A, Kammula US, Schrump DS, Kwong KF, Quezado M, Goldspiel BR, Venkatesan A, Berger A, Walker M, Toomey MA, Steinberg SM, Giaccone G, Rosenberg SA, Avital I (2009). The GYMSSA trial: a prospective randomized trial comparing gastrectomy, metastasectomy plus systemic therapy versus systemic therapy alone. Trials  10, 121.   https://doi.org/10.1186/1745-6215-10-121




PubMed



        
     
Free Article


 


PubMed ID 20030854
         Pubmed Central ID 2803175 


 



7.
Lopez GY, Reitman ZJ, Solomon D, Waldman T, Bigner DD, McLendon RE, Rosenberg SA, Samuels Y, Yan H (2010). IDH1(R132) mutation identified in one human melanoma metastasis, but not correlated with metastases to the brain. Biochem Biophys Res Commun  398, 585-7.   https://doi.org/10.1016/j.bbrc.2010.06.125




PubMed



        
     
Free Article


 


PubMed ID 20603105
         Pubmed Central ID 2987603 


 



8.
Morgan RA, Dudley ME, Rosenberg SA (2010). Adoptive cell therapy: genetic modification to redirect effector cell specificity. Cancer J  16, 336-41.   https://doi.org/10.1097/PPO.0b013e3181eb3879




PubMed



        
     
Free Article


 


PubMed ID 20693844
         Pubmed Central ID 6348476 


 



9.
Prickett TD, Agrawal NS, Wei X, Yates KE, Lin JC, Wunderlich JR, Cronin JC, Cruz P, Rosenberg SA, Samuels Y (2009). Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4. Nat Genet  41, 1127-32.   https://doi.org/10.1038/ng.438




PubMed



        
     
Free Article


 


PubMed ID 19718025
         Pubmed Central ID 2897709 


 



10.
Smith FO, Klapper JA, Wunderlich JR, Rosenberg SA, Dudley ME (2009). Impact of a recombinant fowlpox vaccine on the efficacy of adoptive cell therapy with tumor infiltrating lymphocytes in a patient with metastatic melanoma. J Immunother  32, 870-4.   https://doi.org/10.1097/CJI.0b013e3181b36b69




PubMed



        
     
Free Article


 


PubMed ID 19752747
         Pubmed Central ID 6290459 


 



11.
Zhao Y, Wang QJ, Yang S, Kochenderfer JN, Zheng Z, Zhong X, Sadelain M, Eshhar Z, Rosenberg SA, Morgan RA (2009). A herceptin-based chimeric antigen receptor with modified signaling domains leads to enhanced survival of transduced T lymphocytes and antitumor activity. J Immunol  183, 5563-74.   https://doi.org/10.4049/jimmunol.0900447




PubMed



        
     
Free Article


 


PubMed ID 19843940
         Pubmed Central ID 6292203",https://intramural.nih.gov/search/searchview.taf?ipid=63248
417,BC010985-03,"October 01, 2009 -  September 30, 2010",Gene therapy of cancer,"Steven Aaron Rosenberg; MD, PhD



IRP Faculty Profile",NULL,"Surgery Branch, NCI","Dhana  Chinnasamy; PhD



Marybeth S Hughes



Ellen E Douglas



Nicholas Phillip Restifo; MD



Mark E Dudley



James Chung-Yin Yang; MD, PhD



Show all 25",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Wrzesinski C, Paulos CM, Kaiser A, Muranski P, Palmer DC, Gattinoni L, Yu Z, Rosenberg SA, Restifo NP (2010). Increased intensity lymphodepletion enhances tumor treatment efficacy of adoptively transferred tumor-specific T cells. J Immunother  33, 1-7.   https://doi.org/10.1097/CJI.0b013e3181b88ffc




PubMed



        
     
Free Article


 


PubMed ID 19952961
         Pubmed Central ID 3247626",https://intramural.nih.gov/search/searchview.taf?ipid=63247
418,BC010986-03,"October 01, 2009 -  September 30, 2010",Allele-specific gene expression and epigenetic information,Maxwell P Lee; PhD,NULL,"Laboratory of Population Genetics, NCI","Beverly W Duncan



Sheryl A Gere



Mitsutaka  Kadota



Howard H Yang



Kenneth  Buetow; PhD",NULL,"Jiuping  Ji (Office of the Director)



Lalage  Wakefield; PhD (Laboratory of Cancer Biology and Genetics)



Philip  Taylor; MD, ScD (Genetic Epidemiology Branch)



Alisa  Goldstein; PhD (Genetic Epidemiology Branch)",NULL,"Ordered by publication type and then author name.



1.
Kadota M, Sato M, Duncan B, Ooshima A, Yang HH, Diaz-Meyer N, Gere S, Kageyama S, Fukuoka J, Nagata T, Tsukada K, Dunn BK, Wakefield LM, Lee MP (2009). Identification of novel gene amplifications in breast cancer and coexistence of gene amplification with an activating mutation of PIK3CA. Cancer Res  69, 7357-65.   https://doi.org/10.1158/0008-5472.CAN-09-0064




PubMed



        
     
Free Article


 


PubMed ID 19706770
         Pubmed Central ID 2745517",https://intramural.nih.gov/search/searchview.taf?ipid=63345
419,BC010992-03,"October 01, 2009 -  September 30, 2010",Fidelity of Transcription,Jeffrey N Strathern,NULL,"Office of the Director, NCI","Mary K Ernst



Deanna R Gotte



Jordan D Irvin



Dwight V Nissley



Alison J Rattray



Kathleen Marie Scibelli



Show all 7",NULL,"Mikhail V Kashlev (Molecular Mechanisms of Transcription Section)



Stephen H Hughes; PhD (HIV Drug Resistance Program)



Ding Jun Jin (Gene Regulation and Chromosome Biology Laboratory)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63284
420,BC010993-03,"October 01, 2009 -  September 30, 2010",Molecular architecture of lymphocyte cortex,"James Stephen Shaw; PhD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI","Natalya  Belkina



Yin  Liu



Michael John Kruhlak; PhD



Genaro  Patino Lopez","Matthew  Krummel; PhD

(UCSF)




E. Michael  Ostap
(Pennsylvania Muscle Institute, University of Pennsylvania)




Matthew  Tyska
(Vanderbilt University School of Medicine)




Edward  Weinman
(Department of Physiology, University of Maryland School of Medicine)","Dominic  Esposito; PhD (Office Of The Director)



James L Hartley (Office Of The Director)",NULL,"Ordered by publication type and then author name.



1.
Patino-Lopez G, Aravind L, Dong X, Kruhlak MJ, Ostap EM, Shaw S (2010). Myosin 1G is an abundant class I myosin in lymphocytes whose localization at the plasma membrane depends on its ancient divergent pleckstrin homology (PH) domain (Myo1PH). J Biol Chem  285, 8675-86.   https://doi.org/10.1074/jbc.M109.086959




PubMed



        
     
Free Article


 


PubMed ID 20071333
         Pubmed Central ID 2838290",https://intramural.nih.gov/search/searchview.taf?ipid=63260
421,BC010994-03,"October 01, 2009 -  September 30, 2010",Lymphocyte membrane-proximal basophilic kinases,"James Stephen Shaw; PhD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI",Natalya  Belkina,"Luc  Sabourin; PhD
(Ottawa Hospital Research Institute, Canada)




Siu-Pok  Yee
(University of Connecticut Health Center)","Dominic  Esposito; PhD (Office Of The Director)



James L Hartley (Office Of The Director)",NULL,"Ordered by publication type and then author name.



1.
Belkina NV, Liu Y, Hao JJ, Karasuyama H, Shaw S (2009) LOK is a major ERM kinase in resting lymphocytes and regulates cytoskeletal rearrangement through ERM phosphorylation. Proc Natl Acad Sci U S A 106:4707-12.




PubMed



        
     
Free Article


 


PubMed ID 19255442
         Pubmed Central ID 2660762 


 



2.
Cannons JL, Wu JZ, Gomez-Rodriguez J, Zhang J, Dong B, Liu Y, Shaw S, Siminovitch KA, Schwartzberg PL (2010). Biochemical and genetic evidence for a SAP-PKC-theta interaction contributing to IL-4 regulation. J Immunol  185, 2819-27.   https://doi.org/10.4049/jimmunol.0902182




PubMed



        
     
Free Article


 


PubMed ID 20668219
         Pubmed Central ID 3422635",https://intramural.nih.gov/search/searchview.taf?ipid=63257
422,BC010995-03,"October 01, 2009 -  September 30, 2010",ERM phosphorylation in lymphocytes,"James Stephen Shaw; PhD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI","Natalya  Belkina



Yin  Liu",NULL,NULL,"Rajat  Varma; PhD (NIAID) 



Chung  Park (NIAID) 



Dragana  Jankovic; PhD (NIAID) 



Alan  Sher; PhD (NIAID) 



John H Kehrl; MD (NIAID)","Ordered by publication type and then author name.



1.
Belkina NV, Liu Y, Hao JJ, Karasuyama H, Shaw S (2009) LOK is a major ERM kinase in resting lymphocytes and regulates cytoskeletal rearrangement through ERM phosphorylation. Proc Natl Acad Sci U S A 106:4707-12.




PubMed



        
     
Free Article


 


PubMed ID 19255442
         Pubmed Central ID 2660762 


 



2.
Hao JJ, Liu Y, Kruhlak M, Debell KE, Rellahan BL, Shaw S (2009). Phospholipase C-mediated hydrolysis of PIP2 releases ERM proteins from lymphocyte membrane. J Cell Biol  184, 451-62.   https://doi.org/10.1083/jcb.200807047




PubMed



        
     
Free Article


 


PubMed ID 19204146
         Pubmed Central ID 2646552",https://intramural.nih.gov/search/searchview.taf?ipid=63258
423,BC010996-03,"October 01, 2009 -  September 30, 2010",Molecular mechanisms of ERM regulation,"James Stephen Shaw; PhD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI","Natalya  Belkina



Khadija  Ben-aissa



Michael John Kruhlak; PhD



Genaro  Patino Lopez",NULL,NULL,"Tilman J Rosales (NHLBI) 



Jay Robert Knutson; PhD (NHLBI)","Ordered by publication type and then author name.



1.
Hao JJ, Liu Y, Kruhlak M, Debell KE, Rellahan BL, Shaw S (2009). Phospholipase C-mediated hydrolysis of PIP2 releases ERM proteins from lymphocyte membrane. J Cell Biol  184, 451-62.   https://doi.org/10.1083/jcb.200807047




PubMed



        
     
Free Article


 


PubMed ID 19204146
         Pubmed Central ID 2646552",https://intramural.nih.gov/search/searchview.taf?ipid=63259
424,BC010997-03,"October 01, 2009 -  September 30, 2010",Purification of a Novel Antibody Against Solid Organ Cancer Stem Cells,Itzhak  Avital,NULL,"Surgery Branch, NCI",NULL,NULL,"Paul  Goldsmith; PhD (Basic Research Laboratory)



Snorri S. Thorgeirsson; MD, PhD (Laboratory of Experimental Carcinogenesis)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63172
425,BC010998-03,"October 01, 2009 -  September 30, 2010",Identification of Novel Mutations In Pediatric Cancers,"Javed  Khan; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI","James  Badgett



Qingrong  Chen



Tai Chi  Cheuk



Jianbin Na He



Lee Jay Helman; MD



Peter  Johansson



Show all 11","Daniel  Catchpoole,
(The Children's Hospital at Westmead)




Douglas  Hawkins
(Pediatric Oncology, Children's Hosp. of Seattle)




John  Maris
(Pharmacology, Children's Hospital of Philadelphia)




Stephen  Skapek
(The University of Chicago)","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)



Malcolm A Smith (Clinical Investigations Branch)","Steven M Holland; MD (NIAID) 



James G Taylor; MD (NHLBI)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63330
426,BC010999-03,"October 01, 2009 -  September 30, 2010",Characterization of FGFR4 mutations in Rhabdomyosarcoma,"Javed  Khan; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI","Young K Song



Patricia S Tsang; PhD



Tai Chi  Cheuk



Chand  Khanna; MD",NULL,"Stephen J Chanock; MD, PhD (Laboratory Translational Genomics)



Glenn  Merlino; PhD (Laboratory of Cancer Biology and Genetics)",James G Taylor; MD (NHLBI),"Ordered by publication type and then author name.



1.
Taylor JG, Cheuk AT, Tsang PS, Chung JY, Song YK, Desai K, Yu Y, Chen QR, Shah K, Youngblood V, Fang J, Kim SY, Yeung C, Helman LJ, Mendoza A, Ngo V, Staudt LM, Wei JS, Khanna C, Catchpoole D, Qualman SJ, Hewitt SM, Merlino G, Chanock SJ, Khan J (2009). Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models. J Clin Invest  119, 3395-407.   https://doi.org/10.1172/JCI39703




PubMed



        
     
Free Article


 


PubMed ID 19809159
         Pubmed Central ID 2769177",https://intramural.nih.gov/search/searchview.taf?ipid=63331
427,BC011001-03,"October 01, 2009 -  September 30, 2010",Micro RNA  Profiling in Pediatric Cancers,"Javed  Khan; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI","Qingrong  Chen



Jun S Wei",NULL,Malcolm A Smith (Clinical Investigations Branch),NULL,"Ordered by publication type and then author name.



1.
Wei JS, Johansson P, Chen QR, Song YK, Durinck S, Wen X, Cheuk AT, Smith MA, Houghton P, Morton C, Khan J (2009). microRNA profiling identifies cancer-specific and prognostic signatures in pediatric malignancies. Clin Cancer Res  15, 5560-8.   https://doi.org/10.1158/1078-0432.CCR-08-3287




PubMed



        
     
Free Article


 


PubMed ID 19706822
         Pubmed Central ID 2737097",https://intramural.nih.gov/search/searchview.taf?ipid=63332
428,BC011002-03,"October 01, 2009 -  September 30, 2010",BIOINFORMATICS: SYSTEMS BIOLOGY OF NEUROBLASTOMA,"Javed  Khan; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI","Qingrong  Chen



Jianbin Na He



Peter  Johansson",NULL,Timothy D Veenstra (Office Of The Director),NULL,"Ordered by publication type and then author name.



1.
Ambros PF, Ambros IM, Brodeur GM, Haber M, Khan J, Nakagawara A, Schleiermacher G, Speleman F, Spitz R, London WB, Cohn SL, Pearson AD, Maris JM (2009). International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee. Br J Cancer  100, 1471-82.   https://doi.org/10.1038/sj.bjc.6605014




PubMed



        
     
Free Article


 


PubMed ID 19401703
         Pubmed Central ID 2694415 


 



2.
Chen QR, Song YK, Yu LR, Wei JS, Chung JY, Hewitt SM, Veenstra TD, Khan J (2010). Global genomic and proteomic analysis identifies biological pathways related to high-risk neuroblastoma. J Proteome Res  9, 373-82.   https://doi.org/10.1021/pr900701v




PubMed



        
     
Free Article


 


PubMed ID 19921788
         Pubmed Central ID 2801773 


 



3.
Gheeya JS, Chen QR, Benjamin CD, Cheuk AT, Tsang P, Chung JY, Metaferia BB, Badgett TC, Johansson P, Wei JS, Hewitt SM, Khan J (2009). Screening a panel of drugs with diverse mechanisms of action yields potential therapeutic agents against neuroblastoma. Cancer Biol Ther  8, 2386-95.   https://doi.org/10.4161/cbt.8.24.10184




PubMed



        
     
Free Article


 


PubMed ID 19946221
         Pubmed Central ID 2829338 


 



4.
Vasudevan SA, Shang X, Shang X, Chang S, Ge N, Diaz-Miron JL, Russell HV, Hicks MJ, Ludwig AD, Wesson CL, Burlingame SM, Kim ES, Khan J, Yang J, Nuchtern JG (2009). Neuroblastoma-derived secretory protein is a novel secreted factor overexpressed in neuroblastoma. Mol Cancer Ther  8, 2478-89.   https://doi.org/10.1158/1535-7163.MCT-08-1132




PubMed



        
     
Free Article


 


PubMed ID 19671756
         Pubmed Central ID 3618953 


 



5.
Wei JS, Johansson P, Chen QR, Song YK, Durinck S, Wen X, Cheuk AT, Smith MA, Houghton P, Morton C, Khan J (2009). microRNA profiling identifies cancer-specific and prognostic signatures in pediatric malignancies. Clin Cancer Res  15, 5560-8.   https://doi.org/10.1158/1078-0432.CCR-08-3287




PubMed



        
     
Free Article


 


PubMed ID 19706822
         Pubmed Central ID 2737097",https://intramural.nih.gov/search/searchview.taf?ipid=63328
429,BC011003-03,"October 01, 2009 -  September 30, 2010",Asymmetric Division and Self Renewal of Cancer Stem Cells,Itzhak  Avital,NULL,"Surgery Branch, NCI","John Ellis Mullinax



Satyajit  Ray; PhD



Hongwu  Xin",NULL,"Paul  Goldsmith; PhD (Basic Research Laboratory)



Snorri S. Thorgeirsson; MD, PhD (Laboratory of Experimental Carcinogenesis)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63173
430,BC011004-03,"October 01, 2009 -  September 30, 2010",Bone Marrow Stem Cells Participation in Solid Organ Cancers Carcinogenesis,Itzhak  Avital,NULL,"Surgery Branch, NCI","John Ellis Mullinax



Satyajit  Ray; PhD



Udo  Rudloff



Hongwu  Xin



Udai S Kammula",NULL,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)



Snorri S. Thorgeirsson; MD, PhD (Laboratory of Experimental Carcinogenesis)



Deborah E Citrin (Radiation Oncology Branch)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63174
431,BC011005-03,"October 01, 2009 -  September 30, 2010",Isolation and Purification of Cancer Stem Cells Based on Functional Appraoch,Itzhak  Avital,NULL,"Surgery Branch, NCI",NULL,NULL,"Snorri S. Thorgeirsson; MD, PhD (Laboratory of Experimental Carcinogenesis)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63171
432,BC011006-03,"October 01, 2009 -  September 30, 2010",Molecular diagnosis and outcome prediction in lymphoma,"Louis  Staudt; MD



IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI","Georg  Lenz



Wyndham H Wilson; MD, PhD



Weihong  Xu","Elias  Campo
(University of Barcelona)




John  Chan
(Univ. of Nebraska Medical Center)




Joseph  Connors
(British Columbia Cancer Agency)




Richard  Fisher
(University of Rochester School of Medicine)




Randy  Gascoyne
(British Columbia Cancer Center)




T. Andrew  Lister
(St. Bartholomew Hospital)


Show all 9","Elaine S Jaffe; MD (Laboratory of Pathology)



George W Wright (Biometrics Research Branch)","Wenming  Xiao; PhD (CIT) 



John I Powell (CIT)","Ordered by publication type and then author name.



1.
Hartmann EM, Campo E, Wright G, Lenz G, Salaverria I, Jares P, Xiao W, Braziel RM, Rimsza LM, Chan WC, Weisenburger DD, Delabie J, Jaffe ES, Gascoyne RD, Dave SS, Mueller-Hermelink HK, Staudt LM, Ott G, Beà S, Rosenwald A (2010). Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling. Blood  116, 953-61.   https://doi.org/10.1182/blood-2010-01-263806




PubMed



        
     
Free Article


 


PubMed ID 20421449
         Pubmed Central ID 2924229 


 



2.
Leich E, Salaverria I, Bea S, Zettl A, Wright G, Moreno V, Gascoyne RD, Chan WC, Braziel RM, Rimsza LM, Weisenburger DD, Delabie J, Jaffe ES, Lister A, Fitzgibbon J, Staudt LM, Hartmann EM, Mueller-Hermelink HK, Campo E, Ott G, Rosenwald A (2009). Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations. Blood  114, 826-34.   https://doi.org/10.1182/blood-2009-01-198580




PubMed



        
     
Free Article


 


PubMed ID 19471018
         Pubmed Central ID 2716022 


 



3.
Mozos A, Royo C, Hartmann E, De Jong D, Baró C, Valera A, Fu K, Weisenburger DD, Delabie J, Chuang SS, Jaffe ES, Ruiz-Marcellan C, Dave S, Rimsza L, Braziel R, Gascoyne RD, Solé F, López-Guillermo A, Colomer D, Staudt LM, Rosenwald A, Ott G, Jares P, Campo E (2009). SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype. Haematologica  94, 1555-62.   https://doi.org/10.3324/haematol.2009.010264




PubMed



        
     
Free Article


 


PubMed ID 19880778
         Pubmed Central ID 2770966 


 



4.
O'Riain C, O'Shea DM, Yang Y, Le Dieu R, Gribben JG, Summers K, Yeboah-Afari J, Bhaw-Rosun L, Fleischmann C, Mein CA, Crook T, Smith P, Kelly G, Rosenwald A, Ott G, Campo E, Rimsza LM, Smeland EB, Chan WC, Johnson N, Gascoyne RD, Reimer S, Braziel RM, Wright GW, Staudt LM, et al. [2 more authors] (2009). Array-based DNA methylation profiling in follicular lymphoma. Leukemia  23, 1858-66.   https://doi.org/10.1038/leu.2009.114




PubMed



        
     
Free Article


 


PubMed ID 19587707
         Pubmed Central ID 2762475 


 



5.
O'Shea D, O'Riain C, Gupta M, Waters R, Yang Y, Wrench D, Gribben J, Rosenwald A, Ott G, Rimsza LM, Holte H, Cazier JB, Johnson NA, Campo E, Chan WC, Gascoyne RD, Young BD, Staudt LM, Lister TA, Fitzgibbon J (2009). Regions of acquired uniparental disomy at diagnosis of follicular lymphoma are associated with both overall survival and risk of transformation. Blood  113, 2298-301.   https://doi.org/10.1182/blood-2008-08-174953




PubMed



        
     
Free Article


 


PubMed ID 19141865
         Pubmed Central ID 2652373",https://intramural.nih.gov/search/searchview.taf?ipid=63276
433,BC011007-03,"October 01, 2009 -  September 30, 2010",RNA interference-based screens for molecular targets in cancer,"Louis  Staudt; MD



IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI","Holger Friedrich Kohlhammer



Vu  Ngo



Yandan  Yang; PhD



Hong  Zhao",NULL,George W Wright (Biometrics Research Branch),"Wenming  Xiao; PhD (CIT) 



John I Powell (CIT)","Ordered by publication type and then author name.



1.
Bidère N, Ngo VN, Lee J, Collins C, Zheng L, Wan F, Davis RE, Lenz G, Anderson DE, Arnoult D, Vazquez A, Sakai K, Zhang J, Meng Z, Veenstra TD, Staudt LM, Lenardo MJ (2009). Casein kinase 1alpha governs antigen-receptor-induced NF-kappaB activation and human lymphoma cell survival. Nature  458, 92-6.   https://doi.org/10.1038/nature07613




PubMed



        
     
Free Article


 


PubMed ID 19118383
         Pubmed Central ID 2688735 


 



2.
Coffey GP, Rajapaksa R, Liu R, Sharpe O, Kuo CC, Krauss SW, Sagi Y, Davis RE, Staudt LM, Sharman JP, Robinson WH, Levy S (2009). Engagement of CD81 induces ezrin tyrosine phosphorylation and its cellular redistribution with filamentous actin. J Cell Sci  122, 3137-44.   https://doi.org/10.1242/jcs.045658




PubMed



        
     
Free Article


 


PubMed ID 19654214
         Pubmed Central ID 2729262 


 



3.
Taylor JG, Cheuk AT, Tsang PS, Chung JY, Song YK, Desai K, Yu Y, Chen QR, Shah K, Youngblood V, Fang J, Kim SY, Yeung C, Helman LJ, Mendoza A, Ngo V, Staudt LM, Wei JS, Khanna C, Catchpoole D, Qualman SJ, Hewitt SM, Merlino G, Chanock SJ, Khan J (2009). Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models. J Clin Invest  119, 3395-407.   https://doi.org/10.1172/JCI39703




PubMed



        
     
Free Article


 


PubMed ID 19809159
         Pubmed Central ID 2769177",https://intramural.nih.gov/search/searchview.taf?ipid=63277
434,BC011008-03,"October 01, 2009 -  September 30, 2010",Oncogenic mechanisms and molecular targets in lymphoma,"Louis  Staudt; MD



IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI","Richard E Davis



Wyndham H Wilson; MD, PhD



N C Tolga Emre



Lloyd T Lam



Georg  Lenz



Vu  Ngo



Show all 11","Elias  Campo
(University of Barcelona)




John  Chan
(Univ. of Nebraska Medical Center)




Joseph  Connors
(British Columbia Cancer Agency)




Richard  Fisher
(University of Rochester School of Medicine)




Randy  Gascoyne
(British Columbia Cancer Center)




T. Andrew  Lister
(St. Bartholomew Hospital)


Show all 9",Elaine S Jaffe; MD (Laboratory of Pathology),"Wenming  Xiao; PhD (CIT) 



John I Powell (CIT)","Ordered by publication type and then author name.



1.
Bidère N, Ngo VN, Lee J, Collins C, Zheng L, Wan F, Davis RE, Lenz G, Anderson DE, Arnoult D, Vazquez A, Sakai K, Zhang J, Meng Z, Veenstra TD, Staudt LM, Lenardo MJ (2009). Casein kinase 1alpha governs antigen-receptor-induced NF-kappaB activation and human lymphoma cell survival. Nature  458, 92-6.   https://doi.org/10.1038/nature07613




PubMed



        
     
Free Article


 


PubMed ID 19118383
         Pubmed Central ID 2688735 


 



2.
Dunleavy K, Pittaluga S, Czuczman MS, Dave SS, Wright G, Grant N, Shovlin M, Jaffe ES, Janik JE, Staudt LM, Wilson WH (2009). Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma. Blood  113, 6069-76.   https://doi.org/10.1182/blood-2009-01-199679




PubMed



        
     
Free Article


 


PubMed ID 19380866
         Pubmed Central ID 2699229 


 



3.
Hailfinger S, Lenz G, Ngo V, Posvitz-Fejfar A, Rebeaud F, Guzzardi M, Penas EM, Dierlamm J, Chan WC, Staudt LM, Thome M (2009). Essential role of MALT1 protease activity in activated B cell-like diffuse large B-cell lymphoma. Proc Natl Acad Sci U S A  106, 19946-51.   https://doi.org/10.1073/pnas.0907511106




PubMed



        
     
Free Article


 


PubMed ID 19897720
         Pubmed Central ID 2785272 


 



4.
Rui L, Emre NC, Kruhlak MJ, Chung HJ, Steidl C, Slack G, Wright GW, Lenz G, Ngo VN, Shaffer AL, Xu W, Zhao H, Yang Y, Lamy L, Davis RE, Xiao W, Powell J, Maloney D, Thomas CJ, Möller P, Rosenwald A, Ott G, Muller-Hermelink HK, Savage K, Connors JM, et al. [10 more authors] (2010). Cooperative epigenetic modulation by cancer amplicon genes. Cancer Cell  18, 590-605.   https://doi.org/10.1016/j.ccr.2010.11.013




PubMed



        
     
Free Article


 


PubMed ID 21156283
         Pubmed Central ID 3049192",https://intramural.nih.gov/search/searchview.taf?ipid=63274
435,BC011010-03,"October 01, 2009 -  September 30, 2010",Oncogenic mechanisms and molecular targets in myeloma,"Louis  Staudt; MD



IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI","Laurence  Lamy



Arthur L Shaffer","Bart  Barlogie
(Univ. of Arkansas for Medical Sciences)




John  Shaughnessy
(Univ. of Arkansas for Medical Sciences)","Ola Anders Landgren (Medical Oncology Branch)



Walter M Kuehl; MD, PhD (Cancer Genetics Branch)



Christina M Annunziata (Medical Oncology Branch)",NULL,"Ordered by publication type and then author name.



1.
Shaffer AL, Emre NC, Romesser PB, Staudt LM (2009). IRF4: Immunity. Malignancy! Therapy? Clin Cancer Res  15, 2954-61.   https://doi.org/10.1158/1078-0432.CCR-08-1845




PubMed



        
     
Free Article


 


PubMed ID 19383829
         Pubmed Central ID 2790720",https://intramural.nih.gov/search/searchview.taf?ipid=63275
436,BC011011-03,"October 01, 2009 -  September 30, 2010",The genome-wide function of supercoiling and alternative DNA conformations,"David  Levens; PhD



IRP Faculty Profile",NULL,"Laboratory of Pathology, NCI","Laura  Baranello



Ashutosh  Gupta



Fedor Edmundovich Kouzine



Suzanne Laurie Sanford",NULL,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)



Yves  Pommier; PhD (Developmental Therapeutics Branch)","Keji  Zhao; PhD (NHLBI) 



Teresa M Przytycka (NLM) 



Rafael Cristian Casellas; PhD (NIAMS)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63347
437,BC011012-03,"October 01, 2009 -  September 30, 2010",Study of Hepatic Arterial Infusion of Melphalan for Malignancy in the liver,Marybeth S Hughes,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI",Caroline C Webb,"Sanjiv  Agarwla
(St. Luke's Hospital and Health System)




H. Denis Alexander; PhD
(Department of Hematology, Belfast City Hospital)




Mark  Faries
(John Wayne Cancer Institute)




Charles  Nutting
(Sweedish Medical Center)




Orhan  Ozkan
(University of Texas at Galveston)




James F Pingpank
(NCI)


Show all 9",William D Figg; PharmD (Medical Oncology Branch),NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=63320
438,BC011017-03,"October 01, 2009 -  September 30, 2010",The study of underlying mechanism of EGFR-Ras signaling in glioblastoma,Terry Anne Van Dyke,NULL,"Office of the Director, NCI","Linda S Cleveland



Debra J Gilbert



Yurong  Song; PhD



Teresa L Sullivan



Theresa N O'Sullivan



Xiuyun  Lu



Show all 7",NULL,Nadya I Tarasova; PhD (Cancer Inflammation Program),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63295
439,BC011018-03,"October 01, 2009 -  September 30, 2010",Differential Gene Expression and Targeting of Gliomas Using Radiation,"Katherine Elizabeth Warren; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI",NULL,NULL,Kevin A Camphausen; MD (Radiation Oncology Branch),"Russell R Lonser; MD (NINDS) 



Marsha J Merrill; PhD (NINDS)",There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=63303
440,BC011019-03,"October 01, 2009 -  September 30, 2010",Diffuse Intrinsic Pontine Glioma Genomic Study,"Katherine Elizabeth Warren; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI",NULL,NULL,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)



Jonathan Keith Killian (Cancer Genetics Branch)



Martha Maria Nicacio Quezado; MD (Laboratory of Pathology)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63302
441,BC011024-03,"October 01, 2009 -  September 30, 2010",Tumor and Metastasis Therapy,Chand  Khanna; MD,Crystal L. Mackall; MD,"Pediatric Oncology Branch, NCI","Arnulfo G Mendoza



Anita C Epps



Sung-Hyeok  Hong



Lee Jay Helman; MD



Ling  Ren","Laurence  Baker
(SARC)




Timothy  Fan
(Veterinary Clinical Medicine, University of Illinois)




Richard  Gorlick
(Laboratory of Cellular Carcinogenesis and Tumor Promotion, Albert Einstein College of Medicine)




Timothy  Green
(AstraZeneca)




Stephen  Lesnick
(Huntsman Cancer Center)




Aykut  Uren
(Georgetown University Medical Center)","Timothy D Veenstra (Office Of The Director)



Paul S Meltzer; MD, PhD (Cancer Genetics Branch)



Allan M Weissman; MD (Laboratory of Protein Dynamics and Signaling)



Stephen M Hewitt; MD, PhD (Laboratory of Pathology)",NULL,"Ordered by publication type and then author name.



1.
Paoloni M, Davis S, Lana S, Withrow S, Sangiorgi L, Picci P, Hewitt S, Triche T, Meltzer P, Khanna C (2009). Canine tumor cross-species genomics uncovers targets linked to osteosarcoma progression. BMC Genomics  10, 625.   https://doi.org/10.1186/1471-2164-10-625




PubMed



        
     
Free Article


 


PubMed ID 20028558
         Pubmed Central ID 2803201 


 



2.
Wan X, Kim SY, Guenther LM, Mendoza A, Briggs J, Yeung C, Currier D, Zhang H, Mackall C, Li WJ, Tuan RS, Deyrup AT, Khanna C, Helman L (2009). Beta4 integrin promotes osteosarcoma metastasis and interacts with ezrin. Oncogene  28, 3401-11.   https://doi.org/10.1038/onc.2009.206




PubMed



        
     
Free Article


 


PubMed ID 19597468
         Pubmed Central ID 2753583 


 



3.
Wu Y, Brodt P, Sun H, Mejia W, Novosyadlyy R, Nunez N, Chen X, Mendoza A, Hong SH, Khanna C, Yakar S (2010). Insulin-like growth factor-I regulates the liver microenvironment in obese mice and promotes liver metastasis. Cancer Res  70, 57-67.   https://doi.org/10.1158/0008-5472.CAN-09-2472




PubMed



        
     
Free Article


 


PubMed ID 20048072
         Pubmed Central ID 5488282",https://intramural.nih.gov/search/searchview.taf?ipid=63333
442,BC011025-03,"October 01, 2009 -  September 30, 2010",Regulation of RANTES expression in T lymphocytes,Alan M Krensky,NULL,"Laboratory of Cellular and Molecular Biology, NCI","Carol  Clayberger



Dong Seok  Kim; PhD



Dazhi  Lai



Seok Joo  Kwon; PhD



Wei  Zhang; PhD",NULL,NULL,Keji  Zhao; PhD (NHLBI),"Ordered by publication type and then author name.



1.
Krensky A, Clayberger C (2010) Chemokines and cytotoxic effector molecules in rejection, in Signatures of Immune Rejection. Springer (New York), in press.




 



2.
Schall TJ, Jongstra J, Dyer BJ, Jorgensen J, Clayberger C, Davis MM, Krensky AM (2009). A human T cell-specific molecule is a member of a new gene family. 1988. J Immunol  182, 3947-54.




PubMed


 


PubMed ID 19299689",https://intramural.nih.gov/search/searchview.taf?ipid=63338
443,BC011026-03,"October 01, 2009 -  September 30, 2010",Function of granulysin,Alan M Krensky,NULL,"Laboratory of Cellular and Molecular Biology, NCI","Carol  Clayberger



Michael Wehren Finn; PhD



Andre D Rosario



Paul A Randazzo; MD, PhD



Reena Vohra  Saini



Tianhong  Wang



Show all 8",NULL,"Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)



Jeffrey D Lifson; MD (Office Of The Director)



Joost J Oppenheim; MD (Laboratory of Molecular Immunoregulation)","David F Stroncek; MD (CC) 



Francesco M. Marincola; MD (CC)","Ordered by publication type and then author name.



1.
Krensky A, Clayberger C (2010) Chemokines and cytotoxic effector molecules in rejection, in Signatures of Immune Rejection. Springer (New York), in press.




 



2.
Krensky A, Bielekova B, Childs R, Krensky A, Strober W, Trinchieri G (2010) Meeting the human immunology challenge. Annals NY Acad Sci, in press.




 



3.
Krensky AM, Clayberger C (2009). Biology and clinical relevance of granulysin. Tissue Antigens  73, 193-8.   https://doi.org/10.1111/j.1399-0039.2008.01218.x




PubMed



        
     
Free Article


 


PubMed ID 19254247
         Pubmed Central ID 2679253",https://intramural.nih.gov/search/searchview.taf?ipid=63339
444,BC011027-03,"October 01, 2009 -  September 30, 2010",Animal models to study the role of INK4b loss in human acute myeloid leukemia,"Linda  Wolff; PhD



IRP Faculty Profile",NULL,"Laboratory of Cellular Oncology, NCI","Juraj  Bies



Joanna  Fares



Rita  Humeniuk",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63312
445,BC011028-03,"October 01, 2009 -  September 30, 2010",Clinical Studies of the Molecular Genetic Basis of Kidney Cancer,"William Marston Linehan; MD



IRP Faculty Profile",NULL,"Urologic Oncology Branch, NCI","Donald P Bottaro; PhD



Celene  Chua



Donna  Drake



Sarah M Fowler; RN



Julia C Friend; PA



Rabindra  Gautam



Show all 28","William  Kaelin, M.D.
(HHMI, Dana Farber Cancer Institute)




Sunil  Sudarshan





Masahiro  Yao, M.D.
(Urologic Surgery, Yokohama City University Medical School)","Maria L Turner; MD (Dermatology Branch)



Peter L Choyke; MD (Molecular Imaging Program)



Maria  Merino; PhD (Laboratory of Pathology)



Bradford J Wood; MD (Office of the Director)



Steven  Libutti; MD (Surgery Branch)



Jorge R Toro (Genetic Epidemiology Branch)","Richard  Childs; MD (NHLBI) 



Russell R Lonser; MD (NINDS) 



Pamela  Stratton; MD (NICHD) 



Karel  Pacak; MD, PhD (NICHD) 



Emily Y Chew; MD (NEI)","Ordered by publication type and then author name.



1.
Atkins MB, Bukowski RM, Escudier BJ, Figlin RA, Hudes GH, Kaelin WG, Linehan WM, McDermott DF, Mier JW, Pedrosa I, Rini BI, Signoretti S, Sosman JA, Teh BT, Wood CG, Zurita AJ, King L (2009). Innovations and challenges in renal cancer: summary statement from the Third Cambridge Conference. Cancer  115, 2247-51.   https://doi.org/10.1002/cncr.24229




PubMed



        
     
Free Article


 


PubMed ID 19402064
         Pubmed Central ID 2892290 


 



2.
Beroukhim R, Brunet JP, Di Napoli A, Mertz KD, Seeley A, Pires MM, Linhart D, Worrell RA, Moch H, Rubin MA, Sellers WR, Meyerson M, Linehan WM, Kaelin WG, Signoretti S (2009). Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney. Cancer Res  69, 4674-81.   https://doi.org/10.1158/0008-5472.CAN-09-0146




PubMed



        
     
Free Article


 


PubMed ID 19470766
         Pubmed Central ID 2745239 


 



3.
Boris R, Proano M, Linehan WM, Pinto PA, Bratslavsky G (2009). Initial experience with robot assisted partial nephrectomy for multiple renal masses. J Urol  182, 1280-6.   https://doi.org/10.1016/j.juro.2009.06.036




PubMed



        
     
Free Article


 


PubMed ID 19683275
         Pubmed Central ID 2746326 


 



4.
Giubellino A, Linehan WM, Bottaro DP (2009). Targeting the Met signaling pathway in renal cancer. Expert Rev Anticancer Ther  9, 785-93.   https://doi.org/10.1586/era.09.43




PubMed



        
     
Free Article


 


PubMed ID 19496715
         Pubmed Central ID 2737331 


 



5.
Grubb RL, Deng J, Pinto PA, Mohler JL, Chinnaiyan A, Rubin M, Linehan WM, Liotta LA, Petricoin EF, Wulfkuhle JD (2009). Pathway biomarker profiling of localized and metastatic human prostate cancer reveal metastatic and prognostic signatures. J Proteome Res  8, 3044-54.   https://doi.org/10.1021/pr8009337




PubMed



        
     
Free Article


 


PubMed ID 19275204
         Pubmed Central ID 2790378 


 



6.
Hasumi Y, Baba M, Ajima R, Hasumi H, Valera VA, Klein ME, Haines DC, Merino MJ, Hong SB, Yamaguchi TP, Schmidt LS, Linehan WM (2009). Homozygous loss of BHD causes early embryonic lethality and kidney tumor development with activation of mTORC1 and mTORC2. Proc Natl Acad Sci U S A  106, 18722-7.   https://doi.org/10.1073/pnas.0908853106




PubMed



        
     
Free Article


 


PubMed ID 19850877
         Pubmed Central ID 2765925 


 



7.
Hong SB, Oh H, Valera VA, Baba M, Schmidt LS, Linehan WM (2010). Inactivation of the FLCN tumor suppressor gene induces TFE3 transcriptional activity by increasing its nuclear localization. PLoS One  5, e15793.   https://doi.org/10.1371/journal.pone.0015793




PubMed



        
     
Free Article


 


PubMed ID 21209915
         Pubmed Central ID 3012117 


 



8.
Hong SB, Oh H, Valera VA, Stull J, Ngo DT, Baba M, Merino MJ, Linehan WM, Schmidt LS (2010). Tumor suppressor FLCN inhibits tumorigenesis of a FLCN-null renal cancer cell line and regulates expression of key molecules in TGF-beta signaling. Mol Cancer  9, 160.   https://doi.org/10.1186/1476-4598-9-160




PubMed



        
     
Free Article


 


PubMed ID 20573232
         Pubmed Central ID 2907329 


 



9.
Kowalczyk KJ, Hooper HB, Linehan WM, Pinto PA, Wood BJ, Bratslavsky G (2009). Partial nephrectomy after previous radio frequency ablation: the National Cancer Institute experience. J Urol  182, 2158-63.   https://doi.org/10.1016/j.juro.2009.07.064




PubMed



        
     
Free Article


 


PubMed ID 19758659
         Pubmed Central ID 3404484 


 



10.
Linehan WM (2009). Genetic basis of bilateral renal cancer: implications for evaluation and management. J Clin Oncol  27, 3731-3.   https://doi.org/10.1200/JCO.2009.23.0045




PubMed



        
     
Free Article


 


PubMed ID 19597019
         Pubmed Central ID 5036849 


 



11.
Linehan WM, Pinto PA, Bratslavsky G, Pfaffenroth E, Merino M, Vocke CD, Toro JR, Bottaro D, Neckers L, Schmidt LS, Srinivasan R (2009). Hereditary kidney cancer: unique opportunity for disease-based therapy. Cancer  115, 2252-61.   https://doi.org/10.1002/cncr.24230




PubMed



        
     
Free Article


 


PubMed ID 19402075
         Pubmed Central ID 2720093 


 



12.
Linehan WM, Rubin JS, Bottaro DP (2009). VHL loss of function and its impact on oncogenic signaling networks in clear cell renal cell carcinoma. Int J Biochem Cell Biol  41, 753-6.   https://doi.org/10.1016/j.biocel.2008.09.024




PubMed



        
     
Free Article


 


PubMed ID 18950731
         Pubmed Central ID 2684867 


 



13.
Linguraru MG, Gautam R, Peterson J, Yao J, Linehan WM, Summers RM (2009). RENAL TUMOR QUANTIFICATION AND CLASSIFICATION IN TRIPLE-PHASE CONTRAST-ENHANCED ABDOMINAL CT. Proc IEEE Int Symp Biomed Imaging  2009, 1310-1313.   https://doi.org/10.1109/ISBI.2009.5193305




PubMed



        
     
Free Article


 


PubMed ID 20383290
         Pubmed Central ID 2851160 


 



14.
Linguraru MG, Wang S, Shah F, Gautam R, Peterson J, Linehan W, Summers RM (2009). Computer-aided renal cancer quantification and classification from contrast-enhanced CT via histograms of curvature-related features. Conf Proc IEEE Eng Med Biol Soc  2009, 6679-82.   https://doi.org/10.1109/IEMBS.2009.5334012




PubMed



        
     
Free Article


 


PubMed ID 19964705
         Pubmed Central ID 2790723 


 



15.
Linguraru MG, Yao J, Gautam R, Peterson J, Li Z, Linehan WM, Summers RM (2009). Renal Tumor Quantification and Classification in Contrast-Enhanced Abdominal CT. Pattern Recognit  42, 1149-1161.   https://doi.org/10.1016/j.patcog.2008.09.018




PubMed



        
     
Free Article


 


PubMed ID 19492069
         Pubmed Central ID 2658597 


 



16.
Rosner I, Bratslavsky G, Pinto PA, Linehan WM (2009). The clinical implications of the genetics of renal cell carcinoma. Urol Oncol  27, 131-6.   https://doi.org/10.1016/j.urolonc.2008.11.001




PubMed



        
     
Free Article


 


PubMed ID 19285230
         Pubmed Central ID 2686112 


 



17.
Shen HC, Adem A, Ylaya K, Wilson A, He M, Lorang D, Hewitt SM, Pechhold K, Harlan DM, Lubensky IA, Schmidt LS, Linehan WM, Libutti SK (2009). Deciphering von Hippel-Lindau (VHL/Vhl)-associated pancreatic manifestations by inactivating Vhl in specific pancreatic cell populations. PLoS One  4, e4897.   https://doi.org/10.1371/journal.pone.0004897




PubMed



        
     
Free Article


 


PubMed ID 19340311
         Pubmed Central ID 2660574 


 



18.
Sorbellini M, Bratslavsky G (2010) Renal cell carcinoma and prognostic factors predictive of survival. Ann Surg Oncol 17:362-3.




PubMed



        
     
Free Article


 


PubMed ID 19908098
         Pubmed Central ID 2816801 


 



19.
Sudarshan S, Sourbier C, Kong HS, Block K, Valera Romero VA, Yang Y, Galindo C, Mollapour M, Scroggins B, Goode N, Lee MJ, Gourlay CW, Trepel J, Linehan WM, Neckers L (2009). Fumarate hydratase deficiency in renal cancer induces glycolytic addiction and hypoxia-inducible transcription factor 1alpha stabilization by glucose-dependent generation of reactive oxygen species. Mol Cell Biol  29, 4080-90.   https://doi.org/10.1128/MCB.00483-09




PubMed



               Available in future as a Free Article 


 


PubMed ID 19470762
         Pubmed Central ID 2715796 


 



20.
Xie H, Valera VA, Merino MJ, Amato AM, Signoretti S, Linehan WM, Sukhatme VP, Seth P (2009). LDH-A inhibition, a therapeutic strategy for treatment of hereditary leiomyomatosis and renal cell cancer. Mol Cancer Ther  8, 626-35.   https://doi.org/10.1158/1535-7163.MCT-08-1049




PubMed



        
     
Free Article


 


PubMed ID 19276158
         Pubmed Central ID 2671637",https://intramural.nih.gov/search/searchview.taf?ipid=63351
446,BC011031-03,"October 01, 2009 -  September 30, 2010",Cancer stem cells and human liver cancer,"Snorri S. Thorgeirsson; MD, PhD",NULL,"Laboratory of Experimental Carcinogenesis, NCI","Jesper B Andersen; PhD



Jens Uwe Marquardt



Chiara  Raggi; PhD



Daekwan  Seo; PhD, MS, BA



Hirofumi  Akita","Ju-Seog  Lee; PhD
(NCI)




Tania  Roskams
(Dpt. Pathology, K.U.Leuven University)","Xin Wei Wang; PhD (Laboratory of Human Carcinogenesis)



Steven Aaron Rosenberg; MD, PhD (Surgery Branch)



Itzhak  Avital (Surgery Branch)",NULL,"Ordered by publication type and then author name.



1.
Marquardt JU, Thorgeirsson SS (2010). Stem cells in hepatocarcinogenesis: evidence from genomic data. Semin Liver Dis  30, 26-34.   https://doi.org/10.1055/s-0030-1247130




PubMed



        
     
Free Article


 


PubMed ID 20175031
         Pubmed Central ID 3492884",https://intramural.nih.gov/search/searchview.taf?ipid=63288
447,BC011032-03,"October 01, 2009 -  September 30, 2010",Post-translational modifications of Hsp90 that impact drug efficacy,"Leonard  Neckers; PhD



IRP Faculty Profile",NULL,"Urologic Oncology Branch, NCI","Kristin  Eckfeld



Mehdi  Mollapour



Zachary David Palchick



Bradley T Scroggins



Shinji  Tsutsumi



Suiquan  Wang; PhD



Show all 8","Brian  Blagg
(Chemistry, University of Kansas)




Robert  Cotter
(Johns Hopkins University)




Larry  Karnitz
(Mayo Clinic)




Neal  Rosen
(Medicine, Memorial Sloan Kettering Cancer Center)




Nicolas  Winssinger
(University of Strassbourg)",James G McNally; PhD (Laboratory of Receptor Biology and Gene Expression),NULL,"Ordered by publication type and then author name.



1.
Kang BH, Plescia J, Song HY, Meli M, Colombo G, Beebe K, Scroggins B, Neckers L, Altieri DC (2009). Combinatorial drug design targeting multiple cancer signaling networks controlled by mitochondrial Hsp90. J Clin Invest  119, 454-64.   https://doi.org/10.1172/JCI37613




PubMed



        
     
Free Article


 


PubMed ID 19229106
         Pubmed Central ID 2648691 


 



2.
Kawabe M, Mandic M, Taylor JL, Vasquez CA, Wesa AK, Neckers LM, Storkus WJ (2009). Heat shock protein 90 inhibitor 17-dimethylaminoethylamino-17-demethoxygeldanamycin enhances EphA2+ tumor cell recognition by specific CD8+ T cells. Cancer Res  69, 6995-7003.   https://doi.org/10.1158/0008-5472.CAN-08-4511




PubMed



        
     
Free Article


 


PubMed ID 19690146
         Pubmed Central ID 2745213 


 



3.
Koga F, Kihara K, Neckers L (2009). Inhibition of cancer invasion and metastasis by targeting the molecular chaperone heat-shock protein 90. Anticancer Res  29, 797-807.




PubMed


 


PubMed ID 19414312
    
     


 



4.
Kummar S, Gutierrez ME, Gardner ER, Chen X, Figg WD, Zajac-Kaye M, Chen M, Steinberg SM, Muir CA, Yancey MA, Horneffer YR, Juwara L, Melillo G, Ivy SP, Merino M, Neckers L, Steeg PS, Conley BA, Giaccone G, Doroshow JH, Murgo AJ (2010). Phase I trial of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG), a heat shock protein inhibitor, administered twice weekly in patients with advanced malignancies. Eur J Cancer  46, 340-7.   https://doi.org/10.1016/j.ejca.2009.10.026




PubMed



        
     
Free Article


 


PubMed ID 19945858
         Pubmed Central ID 2818572",https://intramural.nih.gov/search/searchview.taf?ipid=63379
448,BC011033-03,"October 01, 2009 -  September 30, 2010",Mechanisms of MHC Class II Association with Plasma Membrane Microdomains,"Paul A Roche; PhD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI","Berta  Bosch Pages



Karis  Faust



Sanjay  Khandelwal



Adam  Berger","Satoshi  Ishido
(Riken Center for Allergy and Immunology)




Laura  Santambrogio
(Memorial Sloan Kettering)",Lionel  Feigenbaum (Office Of The Director),NULL,"Ordered by publication type and then author name.



1.
Berger AC, Roche PA (2009). MHC class II transport at a glance. J Cell Sci  122, 1-4.   https://doi.org/10.1242/jcs.035089




PubMed



        
     
Free Article


 


PubMed ID 19092054
         Pubmed Central ID 2714400",https://intramural.nih.gov/search/searchview.taf?ipid=63245
449,BC011034-03,"October 01, 2009 -  September 30, 2010",. Methylation and silencing of human p15INK4b in acute myeloid leukemia,"Linda  Wolff; PhD



IRP Faculty Profile",NULL,"Laboratory of Cellular Oncology, NCI",Thomas  Paul,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Paul TA, Bies J, Small D, Wolff L (2010). Signatures of polycomb repression and reduced H3K4 trimethylation are associated with p15INK4b DNA methylation in AML. Blood  115, 3098-108.   https://doi.org/10.1182/blood-2009-07-233858




PubMed



        
     
Free Article


 


PubMed ID 20190193
         Pubmed Central ID 2858468",https://intramural.nih.gov/search/searchview.taf?ipid=63313
450,BC011035-03,"October 01, 2009 -  September 30, 2010",Regulation of Exocytosis from Immune Cells,"Paul A Roche; PhD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI","Karis  Faust



Kazuyuki  Furuta","Satoshi  Ishido
(Riken Center for Allergy and Immunology)




Laura  Santambrogio
(Memorial Sloan Kettering)




Sidney  Whiteheart
(Univ. of Kentucky)",Lionel  Feigenbaum (Office Of The Director),Katherine Walton Roche; PhD (NINDS),"Ordered by publication type and then author name.



1.
Danielian S, Basile N, Rocco C, Prieto E, Rossi J, Barsotti D, Roche PA, Bernasconi A, Oleastro M, Zelazko M, Braier J (2010). Novel syntaxin 11 gene (STX11) mutation in three Argentinean patients with hemophagocytic lymphohistiocytosis. J Clin Immunol  30, 330-7.   https://doi.org/10.1007/s10875-009-9350-4




PubMed


 


PubMed ID 19967551
    
     


 



2.
Tang TT, Badger JD, Roche PA, Roche KW (2010). Novel approach to probe subunit-specific contributions to N-methyl-D-aspartate (NMDA) receptor trafficking reveals a dominant role for NR2B in receptor recycling. J Biol Chem  285, 20975-81.   https://doi.org/10.1074/jbc.M110.102210




PubMed



        
     
Free Article


 


PubMed ID 20427279
         Pubmed Central ID 2898322",https://intramural.nih.gov/search/searchview.taf?ipid=63244
451,BC011036-03,"October 01, 2009 -  September 30, 2010",NanoBioSensor Initiative,"Javed  Khan; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI",NULL,"Stephanie  Getty
(NASA Goddard Space Flight Center)




Romel  Gomez",NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=63329
452,BC011037-03,"October 01, 2009 -  September 30, 2010",Developing new immunotherapies based of CD4 T cells,"Nicholas Phillip Restifo; MD



IRP Faculty Profile",NULL,"Surgery Branch, NCI","Zachary Andrew Borman



Pawel J Muranski",NULL,NULL,Robert L Danner; MD (CC),"Ordered by publication type and then author name.



1.
Hinrichs CS, Borman ZA, Cassard L, Gattinoni L, Spolski R, Yu Z, Sanchez-Perez L, Muranski P, Kern SJ, Logun C, Palmer DC, Ji Y, Reger RN, Leonard WJ, Danner RL, Rosenberg SA, Restifo NP (2009). Adoptively transferred effector cells derived from naive rather than central memory CD8+ T cells mediate superior antitumor immunity. Proc Natl Acad Sci U S A  106, 17469-74.   https://doi.org/10.1073/pnas.0907448106




PubMed



        
     
Free Article


 


PubMed ID 19805141
         Pubmed Central ID 2762661 


 



2.
Muranski P, Restifo NP (2009). Adoptive immunotherapy of cancer using CD4(+) T cells. Curr Opin Immunol  21, 200-8.   https://doi.org/10.1016/j.coi.2009.02.004




PubMed



        
     
Free Article


 


PubMed ID 19285848
         Pubmed Central ID 2715842 


 



3.
Quezada SA, Simpson TR, Peggs KS, Merghoub T, Vider J, Fan X, Blasberg R, Yagita H, Muranski P, Antony PA, Restifo NP, Allison JP (2010). Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts. J Exp Med  207, 637-50.   https://doi.org/10.1084/jem.20091918




PubMed



        
     
Free Article


 


PubMed ID 20156971
         Pubmed Central ID 2839156",https://intramural.nih.gov/search/searchview.taf?ipid=63239
453,BC011038-03,"October 01, 2009 -  September 30, 2010",Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene,"William Marston Linehan; MD



IRP Faculty Profile",NULL,"Urologic Oncology Branch, NCI","Donald P Bottaro; PhD



Gopal N Gupta



Carole  Sourbier



Ramaprasad  Srinivasan; MD, PhD



Cathy  Vocke; PhD



Ming-Hui  Wei



Show all 7","William  Kaelin, M.D.
(HHMI, Dana Farber Cancer Institute)




Sunil  Sudarshan","Maria L Turner; MD (Dermatology Branch)



Peter L Choyke; MD (Molecular Imaging Program)



Maria  Merino; PhD (Laboratory of Pathology)



Bradford J Wood; MD (Office of the Director)



James  McMahon; PhD (Molecular Targets Laboratory)



Steven  Libutti; MD (Surgery Branch)","Pamela  Stratton; MD (NICHD) 



Karel  Pacak; MD, PhD (NICHD) 



Emily Y Chew; MD (NEI)","Ordered by publication type and then author name.



1.
Grubb RL, Deng J, Pinto PA, Mohler JL, Chinnaiyan A, Rubin M, Linehan WM, Liotta LA, Petricoin EF, Wulfkuhle JD (2009). Pathway biomarker profiling of localized and metastatic human prostate cancer reveal metastatic and prognostic signatures. J Proteome Res  8, 3044-54.   https://doi.org/10.1021/pr8009337




PubMed



        
     
Free Article


 


PubMed ID 19275204
         Pubmed Central ID 2790378 


 



2.
Linehan WM (2009). Genetic basis of bilateral renal cancer: implications for evaluation and management. J Clin Oncol  27, 3731-3.   https://doi.org/10.1200/JCO.2009.23.0045




PubMed



        
     
Free Article


 


PubMed ID 19597019
         Pubmed Central ID 5036849 


 



3.
Linehan WM, Pinto PA, Bratslavsky G, Pfaffenroth E, Merino M, Vocke CD, Toro JR, Bottaro D, Neckers L, Schmidt LS, Srinivasan R (2009). Hereditary kidney cancer: unique opportunity for disease-based therapy. Cancer  115, 2252-61.   https://doi.org/10.1002/cncr.24230




PubMed



        
     
Free Article


 


PubMed ID 19402075
         Pubmed Central ID 2720093 


 



4.
Linehan WM, Rubin JS, Bottaro DP (2009). VHL loss of function and its impact on oncogenic signaling networks in clear cell renal cell carcinoma. Int J Biochem Cell Biol  41, 753-6.   https://doi.org/10.1016/j.biocel.2008.09.024




PubMed



        
     
Free Article


 


PubMed ID 18950731
         Pubmed Central ID 2684867 


 



5.
Shen HC, Adem A, Ylaya K, Wilson A, He M, Lorang D, Hewitt SM, Pechhold K, Harlan DM, Lubensky IA, Schmidt LS, Linehan WM, Libutti SK (2009). Deciphering von Hippel-Lindau (VHL/Vhl)-associated pancreatic manifestations by inactivating Vhl in specific pancreatic cell populations. PLoS One  4, e4897.   https://doi.org/10.1371/journal.pone.0004897




PubMed



        
     
Free Article


 


PubMed ID 19340311
         Pubmed Central ID 2660574 


 



6.
Sudarshan S, Sourbier C, Kong HS, Block K, Valera Romero VA, Yang Y, Galindo C, Mollapour M, Scroggins B, Goode N, Lee MJ, Gourlay CW, Trepel J, Linehan WM, Neckers L (2009). Fumarate hydratase deficiency in renal cancer induces glycolytic addiction and hypoxia-inducible transcription factor 1alpha stabilization by glucose-dependent generation of reactive oxygen species. Mol Cell Biol  29, 4080-90.   https://doi.org/10.1128/MCB.00483-09




PubMed



               Available in future as a Free Article 


 


PubMed ID 19470762
         Pubmed Central ID 2715796 


 



7.
Xie H, Valera VA, Merino MJ, Amato AM, Signoretti S, Linehan WM, Sukhatme VP, Seth P (2009). LDH-A inhibition, a therapeutic strategy for treatment of hereditary leiomyomatosis and renal cell cancer. Mol Cancer Ther  8, 626-35.   https://doi.org/10.1158/1535-7163.MCT-08-1049




PubMed



        
     
Free Article


 


PubMed ID 19276158
         Pubmed Central ID 2671637",https://intramural.nih.gov/search/searchview.taf?ipid=63352
454,BC011039-03,"October 01, 2009 -  September 30, 2010",Long distant regulation of c-myb in normal cells and acute myeloid leukemia,"Linda  Wolff; PhD



IRP Faculty Profile",NULL,"Laboratory of Cellular Oncology, NCI",Junfang  Zhang,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63311
455,BC011043-03,"October 01, 2009 -  September 30, 2010",Molecular Therapeutics of Kidney Cancer:  MET Gene and BHD Gene,"William Marston Linehan; MD



IRP Faculty Profile",NULL,"Urologic Oncology Branch, NCI","Masaya  Baba



Donald P Bottaro; PhD



Yukiko  Hasumi



Hisashi  Hasumi



Seung-Boem  Hong



Robert  Hughes



Show all 11","Mutsuo  Furihata





Yoshihiko  Kakinuma
(Kochi Medical School)




Eric  Miska
(Gurdon Institute)




Alessio  Nencioni
(University of Genoa)




Arnim  Pause
(McGill University)




Junichi  Sadoshima
(UMDNJ)


Show all 7","Maria L Turner; MD (Dermatology Branch)



Peter L Choyke; MD (Molecular Imaging Program)



Deborah K Morrison (Laboratory of Cell and Developmental Signaling)



Maria  Merino; PhD (Laboratory of Pathology)



Terence P Yamaguchi; PhD (Cancer and Developmental Biology Laboratory)



Serguei V Kozlov (Office of the Director)",David R Davies; PhD (NIDDK),"Ordered by publication type and then author name.



1.
Atkins MB, Bukowski RM, Escudier BJ, Figlin RA, Hudes GH, Kaelin WG, Linehan WM, McDermott DF, Mier JW, Pedrosa I, Rini BI, Signoretti S, Sosman JA, Teh BT, Wood CG, Zurita AJ, King L (2009). Innovations and challenges in renal cancer: summary statement from the Third Cambridge Conference. Cancer  115, 2247-51.   https://doi.org/10.1002/cncr.24229




PubMed



        
     
Free Article


 


PubMed ID 19402064
         Pubmed Central ID 2892290 


 



2.
Bratslavsky G, Linehan WM (2010). Long-term management of bilateral, multifocal, recurrent renal carcinoma. Nat Rev Urol  7, 267-75.   https://doi.org/10.1038/nrurol.2010.44




PubMed



        
     
Free Article


 


PubMed ID 20448660
         Pubmed Central ID 3164766 


 



3.
Giubellino A, Linehan WM, Bottaro DP (2009). Targeting the Met signaling pathway in renal cancer. Expert Rev Anticancer Ther  9, 785-93.   https://doi.org/10.1586/era.09.43




PubMed



        
     
Free Article


 


PubMed ID 19496715
         Pubmed Central ID 2737331 


 



4.
Hasumi Y, Baba M, Ajima R, Hasumi H, Valera VA, Klein ME, Haines DC, Merino MJ, Hong SB, Yamaguchi TP, Schmidt LS, Linehan WM (2009). Homozygous loss of BHD causes early embryonic lethality and kidney tumor development with activation of mTORC1 and mTORC2. Proc Natl Acad Sci U S A  106, 18722-7.   https://doi.org/10.1073/pnas.0908853106




PubMed



        
     
Free Article


 


PubMed ID 19850877
         Pubmed Central ID 2765925 


 



5.
Hong SB, Oh H, Valera VA, Baba M, Schmidt LS, Linehan WM (2010). Inactivation of the FLCN tumor suppressor gene induces TFE3 transcriptional activity by increasing its nuclear localization. PLoS One  5, e15793.   https://doi.org/10.1371/journal.pone.0015793




PubMed



        
     
Free Article


 


PubMed ID 21209915
         Pubmed Central ID 3012117 


 



6.
Hong SB, Oh H, Valera VA, Stull J, Ngo DT, Baba M, Merino MJ, Linehan WM, Schmidt LS (2010). Tumor suppressor FLCN inhibits tumorigenesis of a FLCN-null renal cancer cell line and regulates expression of key molecules in TGF-beta signaling. Mol Cancer  9, 160.   https://doi.org/10.1186/1476-4598-9-160




PubMed



        
     
Free Article


 


PubMed ID 20573232
         Pubmed Central ID 2907329 


 



7.
Johann DJ, Wei BR, Prieto DA, Chan KC, Ye X, Valera VA, Simpson RM, Rudnick PA, Xiao Z, Issaq HJ, Linehan WM, Stein SE, Veenstra TD, Blonder J (2010). Combined blood/tissue analysis for cancer biomarker discovery: application to renal cell carcinoma. Anal Chem  82, 1584-8.   https://doi.org/10.1021/ac902204k




PubMed



        
     
Free Article


 


PubMed ID 20121140
         Pubmed Central ID 3251958 


 



8.
Kowalczyk KJ, Hooper HB, Linehan WM, Pinto PA, Wood BJ, Bratslavsky G (2009). Partial nephrectomy after previous radio frequency ablation: the National Cancer Institute experience. J Urol  182, 2158-63.   https://doi.org/10.1016/j.juro.2009.07.064




PubMed



        
     
Free Article


 


PubMed ID 19758659
         Pubmed Central ID 3404484 


 



9.
Linehan WM (2009). Genetic basis of bilateral renal cancer: implications for evaluation and management. J Clin Oncol  27, 3731-3.   https://doi.org/10.1200/JCO.2009.23.0045




PubMed



        
     
Free Article


 


PubMed ID 19597019
         Pubmed Central ID 5036849 


 



10.
Linehan WM, Pinto PA, Bratslavsky G, Pfaffenroth E, Merino M, Vocke CD, Toro JR, Bottaro D, Neckers L, Schmidt LS, Srinivasan R (2009). Hereditary kidney cancer: unique opportunity for disease-based therapy. Cancer  115, 2252-61.   https://doi.org/10.1002/cncr.24230




PubMed



        
     
Free Article


 


PubMed ID 19402075
         Pubmed Central ID 2720093 


 



11.
Rosner I, Bratslavsky G, Pinto PA, Linehan WM (2009). The clinical implications of the genetics of renal cell carcinoma. Urol Oncol  27, 131-6.   https://doi.org/10.1016/j.urolonc.2008.11.001




PubMed



        
     
Free Article


 


PubMed ID 19285230
         Pubmed Central ID 2686112 


 



12.
Singer EA, Bratslavsky G, Linehan WM, Srinivasan R (2010). Targeted therapies for non-clear renal cell carcinoma. Target Oncol  5, 119-29.   https://doi.org/10.1007/s11523-010-0148-3




PubMed



        
     
Free Article


 


PubMed ID 20680492
         Pubmed Central ID 3003336",https://intramural.nih.gov/search/searchview.taf?ipid=63348
456,BC011046-03,"October 01, 2009 -  September 30, 2010",Mechanisms of apoptosis regulation which impede cancer cell death in lung cancer,King F Kwong,NULL,"Surgery Branch, NCI","Keytam Salem Awad; PhD



Yili  Xie",NULL,"Jordi  Camps Polo (Cancer Genetics Branch)



Karl Thomas Ried; MD (Cancer Genetics Branch)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63342
457,BC011049-03,"October 01, 2009 -  September 30, 2010",Development and evaluation of apoptosis targeted therapies in lung cancer,King F Kwong,NULL,"Surgery Branch, NCI","Keytam Salem Awad; PhD



Yili  Xie","Matthias  Epple
(University of Duisburg-Essen)




Viktoriya  Sokolova
(University of Duisburg-Essen)","Deb  Chatterjee (Office Of The Director)



Stanislaw J Kaczmarczyk (Office Of The Director)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63343
458,BC011053-03,"October 01, 2009 -  September 30, 2010",TMPRSS2-ERG chromosomal translocations and prostate cancer,"Kathleen  Kelly; PhD



IRP Faculty Profile",NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI","Wassim Gergy  Abou-Kheir



Orla Majella Casey



Paul Gerard Hynes",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63327
459,BC011054-03,"October 01, 2009 -  September 30, 2010",Nuclear Factor-kappaB in Ovarian Cancer,"Christina M Annunziata



IRP Faculty Profile",Giuseppe  Giaccone; MD,"Medical Oncology Branch, NCI","Lidia F Hernandez



Elise C Kohn; MD



Sarah C Hsu",NULL,Louis  Staudt; MD (Lymphoid Malignancies Branch),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63167
460,BC011055-03,"October 01, 2009 -  September 30, 2010",Serum Antibody Profiling with a Carbohydrate Microarray,"Jeffrey  Gildersleeve



IRP Faculty Profile",NULL,"Chemical Biology Laboratory, NCI","Christopher Thomas Campbell; MD, PhD



Sean Rogers Llewellyn



Yalong  Zhang",NULL,"Mark E Sherman; MD (Hormonal and Reproductive Epidemiology Branch)



Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)



James L Gulley; MD, PhD (Laboratory of Tumor Immunology and Biology)



Lisa  Mcshane (Biometrics Research Branch)



Marjorie  Robert-Guroff; PhD (Vaccine Branch)",Lori E Dodd (NIAID),"Ordered by publication type and then author name.



1.
Li Q, Rodriguez LG, Farnsworth DF, Gildersleeve JC (2010). Effects of hapten density on the induced antibody repertoire. Chembiochem  11, 1686-91.   https://doi.org/10.1002/cbic.201000235




PubMed



        
     
Free Article


 


PubMed ID 20602400
         Pubmed Central ID 3462448 


 



2.
Oyelaran O, Li Q, Farnsworth D, Gildersleeve JC (2009). Microarrays with varying carbohydrate density reveal distinct subpopulations of serum antibodies. J Proteome Res  8, 3529-38.   https://doi.org/10.1021/pr9002245




PubMed



        
     
Free Article


 


PubMed ID 19366269
         Pubmed Central ID 2730745 


 



3.
Oyelaran O, McShane LM, Dodd L, Gildersleeve JC (2009). Profiling human serum antibodies with a carbohydrate antigen microarray. J Proteome Res  8, 4301-10.   https://doi.org/10.1021/pr900515y




PubMed



        
     
Free Article


 


PubMed ID 19624168
         Pubmed Central ID 2738755 


 



4.
Zhang Y, Campbell C, Li Q, Gildersleeve JC (2010). Multidimensional glycan arrays for enhanced antibody profiling. Mol Biosyst  6, 1583-91.   https://doi.org/10.1039/c002259d




PubMed



        
     
Free Article


 


PubMed ID 20711537
         Pubmed Central ID 3462433",https://intramural.nih.gov/search/searchview.taf?ipid=63221
461,BC011056-03,"October 01, 2009 -  September 30, 2010",Promoting tumor cell apoptosis by death ligands,Thomas Joseph Sayers; PhD,NULL,"Laboratory of Experimental Immunology, NCI","Alan  Brooks



Rachel Lee Dekluyver; PhD



Richard John Pompei



Anil  Shanker","Avi  Ashkenazi
(Genentech, Inc.)




William  Murphy
(University of Nevada)




Noako  Seki
(Kurume University)




Hideo  Yagita
(Immunology, Juntendo University)","Kirk R Gustafson; PhD (Molecular Targets Laboratory)



William  Farrar (Laboratory of Cancer Prevention)



Curtis  Henrich (Molecular Targets Development Program)



James  McMahon; PhD (Molecular Targets Laboratory)



Stanley  Lipkowitz; MD, PhD (Laboratory of Cellular and Molecular Biology)



Natasha  Caplen (Cancer Genetics Branch)",NULL,"Ordered by publication type and then author name.



1.
de Kluyver RL, Sayers TJ (2010). Breast cancer bone metastases: combination therapy targeting cancer cells and the tumor microenvironment. Cancer Biol Ther  9, 551-3.   https://doi.org/10.4161/cbt.9.7.11580




PubMed


 


PubMed ID 20234180
    
     


 



2.
Liu X, Ryland L, Yang J, Liao A, Aliaga C, Watts R, Tan SF, Kaiser J, Shanmugavelandy SS, Rogers A, Loughran K, Petersen B, Yuen J, Meng F, Baab KT, Jarbadan NR, Broeg K, Zhang R, Liao J, Sayers TJ, Kester M, Loughran TP (2010). Targeting of survivin by nanoliposomal ceramide induces complete remission in a rat model of NK-LGL leukemia. Blood  116, 4192-201.   https://doi.org/10.1182/blood-2010-02-271080




PubMed



        
     
Free Article


 


PubMed ID 20671121
         Pubmed Central ID 2993625",https://intramural.nih.gov/search/searchview.taf?ipid=63251
462,BC011058-03,"October 01, 2009 -  September 30, 2010",Development of a Vaccine for HIVAIDS: Humoral Immunity,"Marjorie  Robert-Guroff; PhD



IRP Faculty Profile",NULL,"Vaccine Branch, NCI","Egidio  Brocca-Cofano



Barbara K Felber



Mara E Daltabuit-test



Genoveffa  Franchini; MD



Thorsten  Demberg



George N Pavlakis; MD, PhD



Show all 13","Susan  Barnett
(Chiron Corporation)




Satya  Dandekar
(University of California, Davis)




Barbara  Ensoli
(Istituto Superiore di Sanita)




Timothy  Fouts
(Profectus BioSciences, Inc.)




Robert  Gallo; MD
(Institute of Human Virology, Maryland University)




Jonathan  Heeney
(University of Cambridge)


Show all 16",David J Venzon; PhD (Biostatistics and Data Management Section),NULL,"Ordered by publication type and then author name.



1.
Florese RH, Demberg T, Xiao P, Kuller L, Larsen K, Summers LE, Venzon D, Cafaro A, Ensoli B, Robert-Guroff M (2009). Contribution of nonneutralizing vaccine-elicited antibody activities to improved protective efficacy in rhesus macaques immunized with Tat/Env compared with multigenic vaccines. J Immunol  182, 3718-27.   https://doi.org/10.4049/jimmunol.0803115




PubMed



        
     
Free Article


 


PubMed ID 19265150
         Pubmed Central ID 2744397 


 



2.
Hidajat R, Xiao P, Zhou Q, Venzon D, Summers LE, Kalyanaraman VS, Montefiori DC, Robert-Guroff M (2009). Correlation of vaccine-elicited systemic and mucosal nonneutralizing antibody activities with reduced acute viremia following intrarectal simian immunodeficiency virus SIVmac251 challenge of rhesus macaques. J Virol  83, 791-801.   https://doi.org/10.1128/JVI.01672-08




PubMed



        
     
Free Article


 


PubMed ID 18971271
         Pubmed Central ID 2612365",https://intramural.nih.gov/search/searchview.taf?ipid=63242
463,BC011059-03,"October 01, 2009 -  September 30, 2010",Biologic Pathway Analysis,Kenneth  Buetow; PhD,NULL,"Laboratory of Population Genetics, NCI","Sharon I Greenblum



Sol  Efroni",NULL,Carl F Schaefer (Cancer Informatics Branch),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63182
464,BC011061-03,"October 01, 2009 -  September 30, 2010",Computational RNA Nanodesign,"Bruce Allen Shapiro; PhD



IRP Faculty Profile",NULL,"Image Processing Section, NCI","Eckart  Bindewald



Gregory C Cater



Alex R Diehl



Kazimierz Wojcieck Kasprzak



Mey  Khalili; PhD



Tae Jin  Kim



Show all 10","Juan  Arroyo
(Developmental Biology, Mitre Corporation)




Luc  Jaeger
(University of California Santa Barbara)




Robert L Jernigan; PhD
(NCI)




Hugo  Martinez
(Consultant, SAIC)




Roderick  Melnik
(M2Net Laboratory, Wilfrid Laurier University)","Victor  Marquez; PhD (Chemical Biology Laboratory)



Robert J Fisher (Office Of The Director)



Yun Xing M Wang (Structural Biophysics Laboratory)



Joseph John Barchi (Chemical Biology Laboratory)



Howard A Young; PhD (Laboratory of Experimental Immunology)



Javed  Khan; MD (Pediatric Oncology Branch)",NULL,"Ordered by publication type and then author name.



1.
Shapiro B, Geary C, Jaeger L, Bindewald E, Kasprzak W, Shapiro B (2009) Computational and Experimental RNA Nanoparticle Design, in Automation in Genomics and Proteomics: An Engineering Case-Based Approach. Wiley Publishing (Hoboken), pp. 193-220.




 



2.
Paliy M, Melnik R, Shapiro BA (2009). Molecular dynamics study of the RNA ring nanostructure: a phenomenon of self-stabilization. Phys Biol  6, 046003.   https://doi.org/10.1088/1478-3975/6/4/046003




PubMed



        
     
Free Article


 


PubMed ID 19741282
         Pubmed Central ID 2790865 


 



3.
Shapiro B, Bindewald E, Yaghoubian A, Voss N, Jacovetty E, Shapiro B, Jaeger L (2010) In vitro assembly of cubic RNA-based scaffolds designed in silico. Nature Nanotechnology, in press.




 



4.
Wang J, Zuo X, Yu P, Xu H, Starich MR, Tiede DM, Shapiro BA, Schwieters CD, Wang YX (2009). A method for helical RNA global structure determination in solution using small-angle x-ray scattering and NMR measurements. J Mol Biol  393, 717-34.   https://doi.org/10.1016/j.jmb.2009.08.001




PubMed



        
     
Free Article


 


PubMed ID 19666030
         Pubmed Central ID 2760655",https://intramural.nih.gov/search/searchview.taf?ipid=63256
465,BC011062-03,"October 01, 2009 -  September 30, 2010",Development of a Vaccine for HIVAIDS: Cellular Immunity,"Marjorie  Robert-Guroff; PhD



IRP Faculty Profile",NULL,"Vaccine Branch, NCI","Mara E Daltabuit-test



Barbara K Felber



Thorsten  Demberg



Rachmat  Hidajat



George N Pavlakis; MD, PhD



Seraphin  Kuate; PhD



Show all 9","Susan  Barnett
(Chiron Corporation)




Satya  Dandekar
(University of California, Davis)




Barbara  Ensoli
(Istituto Superiore di Sanita)




Ashley  Haase
(University of Minnesota)




Welkin  Johnson; PhD
(Dept of Microbiology and Mol Genetics, Harvard Medical School)




Michael G. Katze; PhD
(University of Washington)


Show all 10",David J Venzon; PhD (Biostatistics and Data Management Section),"Vanessa  Hirsch (NIAID) 



Terence Martyn Phillips; PhD, DSc (NIBIB) 



Robert Alan Seder; MD (NIAID)","Ordered by publication type and then author name.



1.
Hidajat R, Kuate S, Venzon D, Kalyanaraman V, Kalisz I, Treece J, Lian Y, Barnett SW, Robert-Guroff M (2010). Construction and immunogenicity of replication-competent adenovirus 5 host range mutant recombinants expressing HIV-1 gp160 of SF162 and TV1 strains. Vaccine  28, 3963-71.   https://doi.org/10.1016/j.vaccine.2010.03.046




PubMed



        
     
Free Article


 


PubMed ID 20382241
         Pubmed Central ID 2875308",https://intramural.nih.gov/search/searchview.taf?ipid=63243
466,BC011063-03,"October 01, 2009 -  September 30, 2010",Development of a Vaccine for HIVAIDS: Translation to the Clinic,"Marjorie  Robert-Guroff; PhD



IRP Faculty Profile",NULL,"Vaccine Branch, NCI","Jay Arthur Berzofsky; MD, PhD



Janet M Dipasquale



Barbara K Felber



Rachmat  Hidajat



Seraphin  Kuate; PhD



Lois Jean Patterson



Show all 8","Susan  Barnett
(Chiron Corporation)




Timothy  Fouts
(Profectus BioSciences, Inc.)




Robert  Gallo; MD
(Institute of Human Virology, Maryland University)




Ashley  Haase
(University of Minnesota)




Jonathan  Heeney
(University of Cambridge)




Christopher  Miller
(University of California, Davis)",NULL,Margaret I Johnston (NIAID),"Ordered by publication type and then author name.



1.
Demberg T, Robert-Guroff M (2009). Mucosal immunity and protection against HIV/SIV infection: strategies and challenges for vaccine design. Int Rev Immunol  28, 20-48.   https://doi.org/10.1080/08830180802684331




PubMed



        
     
Free Article


 


PubMed ID 19241252
         Pubmed Central ID 3466469",https://intramural.nih.gov/search/searchview.taf?ipid=63241
467,BC011064-03,"October 01, 2009 -  September 30, 2010",A Modifier of Plasmacytoma Susceptibility Maps to Mouse Chr 1,"Beverly  Mock; PhD



IRP Faculty Profile",NULL,"Laboratory of Cancer Biology and Genetics, NCI","Jyoti  Patel



John K Simmons



Ke  Zhang",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63373
468,BC011065-03,"October 01, 2009 -  September 30, 2010",Preclinical Testing of HDAC and mTOR Inhibitors,"Beverly  Mock; PhD



IRP Faculty Profile",NULL,"Laboratory of Cancer Biology and Genetics, NCI","Jyoti  Patel



Rushi Bakul Patel



Robert Mark Simpson; DVM, PhD



John K Simmons



Ke  Zhang",NULL,Ola Anders Landgren (Medical Oncology Branch),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63374
469,BC011066-03,"October 01, 2009 -  September 30, 2010",Genetic Pathways Altered by MMTV in Mouse Mammary Tumors,Robert  Callahan; PhD,NULL,"Mammary Biology and Tumorigenesis Laboratory, NCI","David M Mccurdy



Ahmed M Raafat



Gilbert  Smith; PhD",NULL,"David  Munroe (Office Of The Director)



Robert H Stephens (Business Operations Branch)",NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=63188
470,BC011069-03,"October 01, 2009 -  September 30, 2010",Biology of T Cell Depletion,Crystal L. Mackall; MD,NULL,"Pediatric Oncology Branch, NCI","Natasha Marie Fewkes



Wangko Pieter Henning Lundstrom",NULL,"Claude  Sportes (Experimental Transplantation and Immunology Branch)



Ronald E Gress; MD (Experimental Transplantation and Immunology Branch)",Warren J Leonard; MD (NHLBI),"Ordered by publication type and then author name.



1.
Capitini CM, Chisti AA, Mackall CL (2009). Modulating T-cell homeostasis with IL-7: preclinical and clinical studies. J Intern Med  266, 141-53.   https://doi.org/10.1111/j.1365-2796.2009.02085.x




PubMed



        
     
Free Article


 


PubMed ID 19623690
         Pubmed Central ID 2797310 


 



2.
Guimond M, Veenstra RG, Grindler DJ, Zhang H, Cui Y, Murphy RD, Kim SY, Na R, Hennighausen L, Kurtulus S, Erman B, Matzinger P, Merchant MS, Mackall CL (2009). Interleukin 7 signaling in dendritic cells regulates the homeostatic proliferation and niche size of CD4+ T cells. Nat Immunol  10, 149-57.   https://doi.org/10.1038/ni.1695




PubMed



        
     
Free Article


 


PubMed ID 19136960
         Pubmed Central ID 2713006 


 



3.
Mackall C, Fry T, Gress R, Peggs K, Storek J, Toubert A, Center for International Blood and Marrow Transplant Research (CIBMTR), National Marrow Donor Program (NMDP), European Blood and Marrow Transplant Group (EBMT), American Society of Blood and Marrow Transplantation (ASBMT), Canadian Blood and Marrow Transplant Group (CBMTG), Infectious Disease Society of America (IDSA), Society for Healthcare Epidemiology of America (SHEA), Association of Medical Microbiology and Infectious Diseases Canada (AMMI), Centers for Disease Control and Prevention (CDC) (2009). Background to hematopoietic cell transplantation, including post transplant immune recovery. Bone Marrow Transplant  44, 457-62.   https://doi.org/10.1038/bmt.2009.255




PubMed


 


PubMed ID 19861978
    
     


 



4.
Peggs KS, Krauss AC, Mackall CL (2009). Clinical implications of immune reconstitution following hematopoietic stem cell transplantation. Cancer Treat Res  144, 131-54.   https://doi.org/10.1007/978-0-387-78580-6_6




PubMed


 


PubMed ID 19779871",https://intramural.nih.gov/search/searchview.taf?ipid=63358
471,BC011070-03,"October 01, 2009 -  September 30, 2010",Hematopathology Diagnosis,"Elaine S Jaffe; MD



IRP Faculty Profile",NULL,"Laboratory of Pathology, NCI","Theresa M Davies Hill



Franziska Carola Eberle



Qingyan  Liu



Stefania  Pittaluga



Mark  Raffeld; MD



Haipeng  Shao; MD



Show all 8","Elias  Campo
(University of Barcelona)




Wing  Chan
(Pathology, University of Nebraska)




Andreas  Chott
(Pathology, University of Vienna)




Fabio  Facchetti
(University of Brescia)




Falko  Fend





Nancy  Harris



Show all 9","Kieron Michael Dunleavy (Lymphoid Malignancies Branch)



Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)



Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)



Susan  Bates; MD (Medical Oncology Branch)



Richard  Little; MD, PhD (Clinical Investigations Branch)



Louis  Staudt; MD (Lymphoid Malignancies Branch)","Katherine Rainsford Calvo (CC) 



Adrian U Wiestner; MD, PhD (NHLBI) 



Vemulkonda Koneti Rao; MD, FRCPA (NIAID) 



Jeffrey  Cohen; MD (NIAID)","Ordered by publication type and then author name.



1.
Chang CC, Zhou X, Taylor JJ, Huang WT, Ren X, Monzon F, Feng Y, Rao PH, Lu XY, Fabio F, Hilsenbeck S, Creighton CJ, Jaffe ES, Lau CC (2009). Genomic profiling of plasmablastic lymphoma using array comparative genomic hybridization (aCGH): revealing significant overlapping genomic lesions with diffuse large B-cell lymphoma. J Hematol Oncol  2, 47.   https://doi.org/10.1186/1756-8722-2-47




PubMed



        
     
Free Article


 


PubMed ID 19909553
         Pubmed Central ID 2789747 


 



2.
Cohen JI, Kimura H, Nakamura S, Ko YH, Jaffe ES (2009). Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008. Ann Oncol  20, 1472-82.   https://doi.org/10.1093/annonc/mdp064




PubMed



        
     
Free Article


 


PubMed ID 19515747
         Pubmed Central ID 2731018 


 



3.
Davis RE, Ngo VN, Lenz G, Tolar P, Young RM, Romesser PB, Kohlhammer H, Lamy L, Zhao H, Yang Y, Xu W, Shaffer AL, Wright G, Xiao W, Powell J, Jiang JK, Thomas CJ, Rosenwald A, Ott G, Muller-Hermelink HK, Gascoyne RD, Connors JM, Johnson NA, Rimsza LM, Campo E, et al. [12 more authors] (2010). Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma. Nature  463, 88-92.   https://doi.org/10.1038/nature08638




PubMed



        
     
Free Article


 


PubMed ID 20054396
         Pubmed Central ID 2845535 


 



4.
Dowdell KC, Niemela JE, Price S, Davis J, Hornung RL, Oliveira JB, Puck JM, Jaffe ES, Pittaluga S, Cohen JI, Fleisher TA, Rao VK (2010). Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome. Blood  115, 5164-9.   https://doi.org/10.1182/blood-2010-01-263145




PubMed



        
     
Free Article


 


PubMed ID 20360470
         Pubmed Central ID 2892951 


 



5.
Dunleavy K, Little RF, Pittaluga S, Grant N, Wayne AS, Carrasquillo JA, Steinberg SM, Yarchoan R, Jaffe ES, Wilson WH (2010). The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphoma. Blood  115, 3017-24.   https://doi.org/10.1182/blood-2009-11-253039




PubMed



        
     
Free Article


 


PubMed ID 20130244
         Pubmed Central ID 2858473 


 



6.
Dunleavy K, Pittaluga S, Czuczman MS, Dave SS, Wright G, Grant N, Shovlin M, Jaffe ES, Janik JE, Staudt LM, Wilson WH (2009). Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma. Blood  113, 6069-76.   https://doi.org/10.1182/blood-2009-01-199679




PubMed



        
     
Free Article


 


PubMed ID 19380866
         Pubmed Central ID 2699229 


 



7.
Eberle FC, Mani H, Jaffe ES (2009). Histopathology of Hodgkin's lymphoma. Cancer J  15, 129-37.   https://doi.org/10.1097/PPO.0b013e31819e31cf




PubMed


 


PubMed ID 19390308
    
     


 



8.
Gradowski JF, Jaffe ES, Warnke RA, Pittaluga S, Surti U, Gole LA, Swerdlow SH (2010). Follicular lymphomas with plasmacytic differentiation include two subtypes. Mod Pathol  23, 71-9.   https://doi.org/10.1038/modpathol.2009.146




PubMed



        
     
Free Article


 


PubMed ID 19838161
         Pubmed Central ID 6349384 


 



9.
Hartmann EM, Campo E, Wright G, Lenz G, Salaverria I, Jares P, Xiao W, Braziel RM, Rimsza LM, Chan WC, Weisenburger DD, Delabie J, Jaffe ES, Gascoyne RD, Dave SS, Mueller-Hermelink HK, Staudt LM, Ott G, Beà S, Rosenwald A (2010). Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling. Blood  116, 953-61.   https://doi.org/10.1182/blood-2010-01-263806




PubMed



        
     
Free Article


 


PubMed ID 20421449
         Pubmed Central ID 2924229 


 



10.
Jaffe ES (2009). The 2008 WHO classification of lymphomas: implications for clinical practice and translational research. Hematology Am Soc Hematol Educ Program   523-31  https://doi.org/10.1182/asheducation-2009.1.523




PubMed



        
     
Free Article


 


PubMed ID 20008237
         Pubmed Central ID 6324557 


 



11.
Jegalian AG, Facchetti F, Jaffe ES (2009). Plasmacytoid dendritic cells: physiologic roles and pathologic states. Adv Anat Pathol  16, 392-404.   https://doi.org/10.1097/PAP.0b013e3181bb6bc2




PubMed



        
     
Free Article


 


PubMed ID 19851130
         Pubmed Central ID 6329307 


 



12.
Koch R, Jaffe ES, Mensing C, Zeis M, Schmitz N, Sander CA (2009). Cutaneous gamma/delta T-cell lymphoma. J Dtsch Dermatol Ges  7, 1065-7.   https://doi.org/10.1111/j.1610-0387.2009.07209.x




PubMed



        
     
Free Article


 


PubMed ID 19694889
         Pubmed Central ID 3471805 


 



13.
Lamant L, Pileri S, Sabattini E, Brugières L, Jaffe ES, Delsol G (2010). Cutaneous presentation of ALK-positive anaplastic large cell lymphoma following insect bites: evidence for an association in five cases. Haematologica  95, 449-55.   https://doi.org/10.3324/haematol.2009.015024




PubMed



        
     
Free Article


 


PubMed ID 19951975
         Pubmed Central ID 2833075 


 



14.
Leich E, Salaverria I, Bea S, Zettl A, Wright G, Moreno V, Gascoyne RD, Chan WC, Braziel RM, Rimsza LM, Weisenburger DD, Delabie J, Jaffe ES, Lister A, Fitzgibbon J, Staudt LM, Hartmann EM, Mueller-Hermelink HK, Campo E, Ott G, Rosenwald A (2009). Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations. Blood  114, 826-34.   https://doi.org/10.1182/blood-2009-01-198580




PubMed



        
     
Free Article


 


PubMed ID 19471018
         Pubmed Central ID 2716022 


 



15.
Mani H, Jaffe ES (2009). Hodgkin lymphoma: an update on its biology with new insights into classification. Clin Lymphoma Myeloma  9, 206-16.   https://doi.org/10.3816/CLM.2009.n.042




PubMed



        
     
Free Article


 


PubMed ID 19525189
         Pubmed Central ID 2806063 


 



16.
Morovic A, Jaffe ES, Raffeld M, Schrager JA (2009). Metachronous EBV-associated B-cell and T-cell posttransplant lymphoproliferative disorders in a heart transplant recipient. Am J Surg Pathol  33, 149-54.   https://doi.org/10.1097/PAS.0b013e318181a826




PubMed



        
     
Free Article


 


PubMed ID 18941401
         Pubmed Central ID 6324846 


 



17.
Mozos A, Royo C, Hartmann E, De Jong D, Baró C, Valera A, Fu K, Weisenburger DD, Delabie J, Chuang SS, Jaffe ES, Ruiz-Marcellan C, Dave S, Rimsza L, Braziel R, Gascoyne RD, Solé F, López-Guillermo A, Colomer D, Staudt LM, Rosenwald A, Ott G, Jares P, Campo E (2009). SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype. Haematologica  94, 1555-62.   https://doi.org/10.3324/haematol.2009.010264




PubMed



        
     
Free Article


 


PubMed ID 19880778
         Pubmed Central ID 2770966 


 



18.
Ouansafi I, Bell S, Jaffe ES (2010). Adrenal Hodgkin lymphoma. Br J Haematol  148, 341.   https://doi.org/10.1111/j.1365-2141.2009.07776.x




PubMed


 


PubMed ID 19563514
    
     


 



19.
Piekarz RL, Frye R, Turner M, Wright JJ, Allen SL, Kirschbaum MH, Zain J, Prince HM, Leonard JP, Geskin LJ, Reeder C, Joske D, Figg WD, Gardner ER, Steinberg SM, Jaffe ES, Stetler-Stevenson M, Lade S, Fojo AT, Bates SE (2009). Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma. J Clin Oncol  27, 5410-7.   https://doi.org/10.1200/JCO.2008.21.6150




PubMed



        
     
Free Article


 


PubMed ID 19826128
         Pubmed Central ID 2773225 


 



20.
Raffeld M, Jaffe ES (2010). Avidin-biotin labeling of cellular antigens in cryostat-sectioned tissue. Methods Mol Biol  588, 271-9.   https://doi.org/10.1007/978-1-59745-324-0_27




PubMed


 


PubMed ID 20012838
    
     


 



21.
Rimsza LM, Chan WC, Gascoyne RD, Campo E, Jaffe ES, Staudt LM, Delabie J, Rosenwald A, Murphy SP (2009). CIITA or RFX coding region loss of function mutations occur rarely in diffuse large B-cell lymphoma cases and cell lines with low levels of major histocompatibility complex class II expression. Haematologica  94, 596-8.   https://doi.org/10.3324/haematol.2008.000752




PubMed



        
     
Free Article


 


PubMed ID 19229048
         Pubmed Central ID 2663627 


 



22.
Ritchie D, Piekarz RL, Blombery P, Karai LJ, Pittaluga S, Jaffe ES, Raffeld M, Janik JE, Prince HM, Bates SE (2009). Reactivation of DNA viruses in association with histone deacetylase inhibitor therapy: a case series report. Haematologica  94, 1618-22.   https://doi.org/10.3324/haematol.2009.008607




PubMed



        
     
Free Article


 


PubMed ID 19608677
         Pubmed Central ID 2770976 


 



23.
Vanan I, Redner A, Atlas M, Marin L, Kadkade P, Bandovic J, Jaffe ES (2009). Solitary extramedullary plasmacytoma of the vocal cord in an adolescent. J Clin Oncol  27, e244-7.   https://doi.org/10.1200/JCO.2009.23.7461




PubMed



        
     
Free Article


 


PubMed ID 19858382
         Pubmed Central ID 6340145 


 



24.
Wang Y, Tan XH, DiGiovanna JJ, Lee CC, Stern JB, Raffeld M, Jaffe ES, Kraemer KH (2010). Genetic diversity in melanoma metastases from a patient with xeroderma pigmentosum. J Invest Dermatol  130, 1188-91.   https://doi.org/10.1038/jid.2009.377




PubMed



        
     
Free Article


 


PubMed ID 19956187
         Pubmed Central ID 3471362 


 



25.
Wilkinson ST, Fernandez DR, Murphy SP, Braziel RM, Campo E, Chan WC, Delabie J, Gascoyne RD, Staudt LM, Jaffe ES, Rosenwald A, Rimsza LM (2009). Decreased major histocompatibility complex class II expression in diffuse large B-cell lymphoma does not correlate with CpG methylation of class II transactivator promoters III and IV. Leuk Lymphoma  50, 1875-8.   https://doi.org/10.3109/10428190903297531




PubMed



        
     
Free Article


 


PubMed ID 19814686
         Pubmed Central ID 2988580",https://intramural.nih.gov/search/searchview.taf?ipid=63324
472,BC011072-03,"October 01, 2009 -  September 30, 2010",Developing Immune Based  Therapies,Crystal L. Mackall; MD,NULL,"Pediatric Oncology Branch, NCI","Yongzhi  Cui; MD



Daniel W Lee



Rimas Jonas Orentas



Alan S Wayne; MD



Hua  Zhang","Carl  June
(University of Pennsylvania)




Bruce  Levine
(Abramson Family Cancer Research Center, University of Pennsylvania)","Claude  Sportes (Experimental Transplantation and Immunology Branch)



Ronald E Gress; MD (Experimental Transplantation and Immunology Branch)



Steven Aaron Rosenberg; MD, PhD (Surgery Branch)



Christoph  Rader; PhD (Experimental Transplantation and Immunology Branch)",NULL,"Ordered by publication type and then author name.



1.
Ahmed N, Heslop HE, Mackall CL (2010). T-cell-based therapies for malignancy and infection in childhood. Pediatr Clin North Am  57, 83-96.   https://doi.org/10.1016/j.pcl.2009.11.002




PubMed



        
     
Free Article


 


PubMed ID 20307713
         Pubmed Central ID 2844874 


 



2.
Cairo MS, Jordan CT, Maley CC, Chao C, Melnick A, Armstrong SA, Shlomchik W, Molldrem J, Ferrone S, Mackall C, Zitvogel L, Bishop MR, Giralt SA, June CH (2010). NCI first International Workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on the biological considerations of hematological relapse following allogeneic stem cell transplantation unrelated to graft-versus-tumor effects: state of the science. Biol Blood Marrow Transplant  16, 709-28.   https://doi.org/10.1016/j.bbmt.2010.03.002




PubMed



        
     
Free Article


 


PubMed ID 20227509
         Pubmed Central ID 3711411 


 



3.
Capitini CM, Chisti AA, Mackall CL (2009). Modulating T-cell homeostasis with IL-7: preclinical and clinical studies. J Intern Med  266, 141-53.   https://doi.org/10.1111/j.1365-2796.2009.02085.x




PubMed



        
     
Free Article


 


PubMed ID 19623690
         Pubmed Central ID 2797310 


 



4.
Capitini CM, Cooper LJ, Egeler RM, Handgretinger R, Locatelli F, Sondel PM, Mackall CL (2009). Highlights of the First International ""Immunotherapy in Pediatric Oncology: Progress and Challenges"" Meeting. J Pediatr Hematol Oncol  31, 227-44.   https://doi.org/10.1097/MPH.0b013e31819a5d8d




PubMed



        
     
Free Article


 


PubMed ID 19346873
         Pubmed Central ID 2714285 


 



5.
Capitini CM, Fry TJ, Mackall CL (2009). Cytokines as Adjuvants for Vaccine and Cellular Therapies for Cancer. Am J Immunol  5, 65-83.   https://doi.org/10.3844/ajisp.2009.65.83




PubMed



        
     
Free Article


 


PubMed ID 20182648
         Pubmed Central ID 2826803 


 



6.
Capitini CM, Mackall CL, Wayne AS (2010). Immune-based therapeutics for pediatric cancer. Expert Opin Biol Ther  10, 163-78.   https://doi.org/10.1517/14712590903431022




PubMed



        
     
Free Article


 


PubMed ID 19947897
         Pubmed Central ID 2809805 


 



7.
Cui Y, Zhang H, Meadors J, Poon R, Guimond M, Mackall CL (2009). Harnessing the physiology of lymphopenia to support adoptive immunotherapy in lymphoreplete hosts. Blood  114, 3831-40.   https://doi.org/10.1182/blood-2009-03-212134




PubMed



        
     
Free Article


 


PubMed ID 19704119
         Pubmed Central ID 2773493 


 



8.
Fry TJ, Shand JL, Milliron M, Tasian SK, Mackall CL (2009). Antigen loading of DCs with irradiated apoptotic tumor cells induces improved anti-tumor immunity compared to other approaches. Cancer Immunol Immunother  58, 1257-64.   https://doi.org/10.1007/s00262-008-0638-7




PubMed



        
     
Free Article


 


PubMed ID 19139888
         Pubmed Central ID 2791794 


 



9.
Guimond M, Freud AG, Mao HC, Yu J, Blaser BW, Leong JW, Vandeusen JB, Dorrance A, Zhang J, Mackall CL, Caligiuri MA (2010). In vivo role of Flt3 ligand and dendritic cells in NK cell homeostasis. J Immunol  184, 2769-75.   https://doi.org/10.4049/jimmunol.0900685




PubMed



        
     
Free Article


 


PubMed ID 20142363
         Pubmed Central ID 2924750 


 



10.
Sportès C, Babb RR, Krumlauf MC, Hakim FT, Steinberg SM, Chow CK, Brown MR, Fleisher TA, Noel P, Maric I, Stetler-Stevenson M, Engel J, Buffet R, Morre M, Amato RJ, Pecora A, Mackall CL, Gress RE (2010). Phase I study of recombinant human interleukin-7 administration in subjects with refractory malignancy. Clin Cancer Res  16, 727-35.   https://doi.org/10.1158/1078-0432.CCR-09-1303




PubMed



        
     
Free Article


 


PubMed ID 20068111
         Pubmed Central ID 2808195 


 



11.
Sportès C, Gress RE, Mackall CL (2009). Perspective on potential clinical applications of recombinant human interleukin-7. Ann N Y Acad Sci  1182, 28-38.   https://doi.org/10.1111/j.1749-6632.2009.05075.x




PubMed



        
     
Free Article


 


PubMed ID 20074272
         Pubmed Central ID 6545488 


 



12.
Wayne AS, Capitini CM, Mackall CL (2010). Immunotherapy of childhood cancer: from biologic understanding to clinical application. Curr Opin Pediatr  22, 2-11.   https://doi.org/10.1097/MOP.0b013e3283350d3e




PubMed



        
     
Free Article


 


PubMed ID 19952749
         Pubmed Central ID 2845444",https://intramural.nih.gov/search/searchview.taf?ipid=63355
473,BC011073-03,"October 01, 2009 -  September 30, 2010",Immunobiology of Pediatric Tumors,Crystal L. Mackall; MD,NULL,"Pediatric Oncology Branch, NCI","Yongzhi  Cui; MD



Joanna L Meadors



Carol J Thiele



Chand  Khanna; MD



Javed  Khan; MD",NULL,Maria  Tsokos; MD (Laboratory of Pathology),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63356
474,BC011074-03,"October 01, 2009 -  September 30, 2010",Clinical Program in Pediatric Sarcomas,Crystal L. Mackall; MD,NULL,"Pediatric Oncology Branch, NCI","Donna B Bernstein



Lee Jay Helman; MD",NULL,Maria  Tsokos; MD (Laboratory of Pathology),NULL,"Ordered by publication type and then author name.



1.
Capitini CM, Derdak J, Hughes MS, Love CP, Baird K, Mackall CL, Fry TJ (2009). Unusual sites of extraskeletal metastases of Ewing sarcoma after allogeneic hematopoietic stem cell transplantation. J Pediatr Hematol Oncol  31, 142-4.   https://doi.org/10.1097/MPH.0b013e31819146e5




PubMed



        
     
Free Article


 


PubMed ID 19194203
         Pubmed Central ID 2644462 


 



2.
Capitini CM, Fry TJ, Mackall CL (2009). Cytokines as Adjuvants for Vaccine and Cellular Therapies for Cancer. Am J Immunol  5, 65-83.   https://doi.org/10.3844/ajisp.2009.65.83




PubMed



        
     
Free Article


 


PubMed ID 20182648
         Pubmed Central ID 2826803 


 



3.
Fitzhugh CD, Wise B, Baird K, Tsokos M, Helman L, Mackall C, Savage SA, Warren KE (2009). Secondary supratentorial primitive neuroectodermal tumor following treatment of childhood osteosarcoma. Pediatr Blood Cancer  53, 496-8.   https://doi.org/10.1002/pbc.22074




PubMed



        
     
Free Article


 


PubMed ID 19434734
         Pubmed Central ID 2760453 


 



4.
Fox E, Widemann BC, Hawkins DS, Jayaprakash N, Dagher R, Aikin AA, Bernstein D, Long L, Mackall C, Helman L, Steinberg SM, Balis FM (2009). Randomized trial and pharmacokinetic study of pegfilgrastim versus filgrastim after dose-intensive chemotherapy in young adults and children with sarcomas. Clin Cancer Res  15, 7361-7.   https://doi.org/10.1158/1078-0432.CCR-09-0761




PubMed



        
     
Free Article


 


PubMed ID 19920107
         Pubmed Central ID 2787766 


 



5.
Guimond M, Freud AG, Mao HC, Yu J, Blaser BW, Leong JW, Vandeusen JB, Dorrance A, Zhang J, Mackall CL, Caligiuri MA (2010). In vivo role of Flt3 ligand and dendritic cells in NK cell homeostasis. J Immunol  184, 2769-75.   https://doi.org/10.4049/jimmunol.0900685




PubMed



        
     
Free Article


 


PubMed ID 20142363
         Pubmed Central ID 2924750 


 



6.
Sportès C, Gress RE, Mackall CL (2009). Perspective on potential clinical applications of recombinant human interleukin-7. Ann N Y Acad Sci  1182, 28-38.   https://doi.org/10.1111/j.1749-6632.2009.05075.x




PubMed



        
     
Free Article


 


PubMed ID 20074272
         Pubmed Central ID 6545488 


 



7.
Wan X, Kim SY, Guenther LM, Mendoza A, Briggs J, Yeung C, Currier D, Zhang H, Mackall C, Li WJ, Tuan RS, Deyrup AT, Khanna C, Helman L (2009). Beta4 integrin promotes osteosarcoma metastasis and interacts with ezrin. Oncogene  28, 3401-11.   https://doi.org/10.1038/onc.2009.206




PubMed



        
     
Free Article


 


PubMed ID 19597468
         Pubmed Central ID 2753583",https://intramural.nih.gov/search/searchview.taf?ipid=63357
475,BC011076-03,"October 01, 2009 -  September 30, 2010",Roles of NADPH Oxidase 5 and Dual Oxidase 2 in Cancer,"James Halpern Doroshow



IRP Faculty Profile",NULL,"Developmental Therapeutics Branch, NCI","Smitha  Antony



Yongzhong  Wu",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63197
476,BC011078-03,"October 01, 2009 -  September 30, 2010",Phase 01 Clinical Trials,"James Halpern Doroshow



IRP Faculty Profile",NULL,"Developmental Therapeutics Branch, NCI","Agnes  Juhasz



Yves  Pommier; PhD",NULL,Joseph E Tomaszewski (Office of the Director),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63198
477,BC011081-03,"October 01, 2009 -  September 30, 2010",Prostate Section,Peter A Pinto; MD,William Marston Linehan; MD,"Urologic Oncology Branch, NCI","Graham Dalton Fowler



Katherine Anne Klos



Todd Henry Sterling



Donald P Bottaro; PhD



Leonard  Neckers; PhD",NULL,"Aradhana  Kaushal (Radiation Oncology Branch)



Stuart F J Le Grice; PhD (Retroviral Replication Laboratory)



Peter L Choyke; MD (Molecular Imaging Program)



Jonathan  Vogel; MD (Dermatology Branch)



Alan  Rein; PhD (Retroviral Replication Laboratory)



Maria  Merino; PhD (Laboratory of Pathology)",NULL,"Ordered by publication type and then author name.



1.
Erickson HS, Albert PS, Gillespie JW, Rodriguez-Canales J, Marston Linehan W, Pinto PA, Chuaqui RF, Emmert-Buck MR (2009). Quantitative RT-PCR gene expression analysis of laser microdissected tissue samples. Nat Protoc  4, 902-22.   https://doi.org/10.1038/nprot.2009.61




PubMed



        
     
Free Article


 


PubMed ID 19478806
         Pubmed Central ID 2760821 


 



2.
Grubb RL, Deng J, Pinto PA, Mohler JL, Chinnaiyan A, Rubin M, Linehan WM, Liotta LA, Petricoin EF, Wulfkuhle JD (2009). Pathway biomarker profiling of localized and metastatic human prostate cancer reveal metastatic and prognostic signatures. J Proteome Res  8, 3044-54.   https://doi.org/10.1021/pr8009337




PubMed



        
     
Free Article


 


PubMed ID 19275204
         Pubmed Central ID 2790378 


 



3.
Mukherjee S, Richardson AM, Rodriguez-Canales J, Ylaya K, Erickson HS, Player A, Kawasaki ES, Pinto PA, Choyke PL, Merino MJ, Albert PS, Chuaqui RF, Emmert-Buck MR (2009). Identification of EpCAM as a molecular target of prostate cancer stroma. Am J Pathol  175, 2277-87.   https://doi.org/10.2353/ajpath.2009.090013




PubMed



        
     
Free Article


 


PubMed ID 19850885
         Pubmed Central ID 2789605 


 



4.
Shah V, Pohida T, Turkbey B, Mani H, Merino M, Pinto PA, Choyke P, Bernardo M (2009). A method for correlating in vivo prostate magnetic resonance imaging and histopathology using individualized magnetic resonance-based molds. Rev Sci Instrum  80, 104301.   https://doi.org/10.1063/1.3242697




PubMed



        
     
Free Article


 


PubMed ID 19895076
         Pubmed Central ID 2774342 


 



5.
Turkbey B, Pinto PA, Choyke PL (2009). Imaging techniques for prostate cancer: implications for focal therapy. Nat Rev Urol  6, 191-203.   https://doi.org/10.1038/nrurol.2009.27




PubMed



        
     
Free Article


 


PubMed ID 19352394
         Pubmed Central ID 3520096",https://intramural.nih.gov/search/searchview.taf?ipid=63385
478,BC011084-03,"October 01, 2009 -  September 30, 2010",Cellular functions of Ran GTPase,Petr  Kalab; PhD,NULL,"Laboratory of Cellular and Molecular Biology, NCI","Keisuke  Hasegawa



Sung Jin  Ryu","Cecile  Fradin
(McMaster University)




Rebecca  Heald
(University of California at Berkeley)




Inke  Nathke
(University of Dundee)




Arnd  Pralle
(SUNY Buffalo)




John  Yates
(The Scripps Research Institute)",NULL,NULL,"Ordered by publication type and then author name.



1.
Abu-Arish A, Kalab P, Ng-Kamstra J, Weis K, Fradin C (2009). Spatial distribution and mobility of the Ran GTPase in live interphase cells. Biophys J  97, 2164-78.   https://doi.org/10.1016/j.bpj.2009.07.055




PubMed



        
     
Free Article


 


PubMed ID 19843449
         Pubmed Central ID 2764085 


 



2.
Kaláb P, Soderholm J (2010). The design of Frster (fluorescence) resonance energy transfer (FRET)-based molecular sensors for Ran GTPase. Methods  51, 220-32.   https://doi.org/10.1016/j.ymeth.2010.01.022




PubMed



        
     
Free Article


 


PubMed ID 20096786
         Pubmed Central ID 2884063 


 



3.
Kalab P, Siegel J, Kalab P, Siu M, Weis K, Lipphardt J (2010) Selectivity mechanism of the nuclear pore complex characterized by single cargo tracking. Nature Advance online publi:1-5.




 



4.
O'Connell CB, Loncarek J, Kaláb P, Khodjakov A (2009). Relative contributions of chromatin and kinetochores to mitotic spindle assembly. J Cell Biol  187, 43-51.   https://doi.org/10.1083/jcb.200903076




PubMed



        
     
Free Article


 


PubMed ID 19805628
         Pubmed Central ID 2762104",https://intramural.nih.gov/search/searchview.taf?ipid=63325
479,BC011088-03,"October 01, 2009 -  September 30, 2010",Functional genomics of breast cancer,"Paul S Meltzer; MD, PhD



IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","John R Cornelison



Sean Richard Davis; MD, PhD



Arthur A Glatfelter; MS



John E Lueders



Robert L Walker; BS



Fan  Yang



Show all 7","Rosemary  Balleine
(Translational Oncology, Westmead Hospital)




Laurakay  Bruhn
(Genomics Institute, Agilent Technologies)","Mark E Sherman; MD (Hormonal and Reproductive Epidemiology Branch)



Jonine Danya Figueroa (Hormonal and Reproductive Epidemiology Branch)",NULL,"Ordered by publication type and then author name.



1.
Palmieri D, Fitzgerald D, Shreeve SM, Hua E, Bronder JL, Weil RJ, Davis S, Stark AM, Merino MJ, Kurek R, Mehdorn HM, Davis G, Steinberg SM, Meltzer PS, Aldape K, Steeg PS (2009). Analyses of resected human brain metastases of breast cancer reveal the association between up-regulation of hexokinase 2 and poor prognosis. Mol Cancer Res  7, 1438-45.   https://doi.org/10.1158/1541-7786.MCR-09-0234




PubMed



        
     
Free Article


 


PubMed ID 19723875
         Pubmed Central ID 2746883",https://intramural.nih.gov/search/searchview.taf?ipid=63367
480,BC011090-03,"October 01, 2009 -  September 30, 2010",Merkel Cell Carcinoma Polyomavirus,"Christopher  Buck



IRP Faculty Profile",NULL,"Laboratory of Cellular Oncology, NCI","Diana  Pastrana



Katherine Ann Pumphrey



Rachel  Schowalter; PhD","Yuan  Chang
(Cancer Institute, University of Pittsburgh)




Patrick  Moore
(Cancer Institute, University of Pittsburgh)




Herbert  Pfister
(University of Cologne)","Ola Anders Landgren (Medical Oncology Branch)



Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)","Adrian U Wiestner; MD, PhD (NHLBI)","Ordered by publication type and then author name.



1.
Buck CB, Lowy DR (2009). Getting stronger: the relationship between a newly identified virus and Merkel cell carcinoma. J Invest Dermatol  129, 9-11.   https://doi.org/10.1038/jid.2008.302




PubMed



        
     
Free Article


 


PubMed ID 19078983
         Pubmed Central ID 3401601 


 



2.
Giraud G, Ramqvist T, Pastrana DV, Pavot V, Lindau C, Kogner P, Orrego A, Buck CB, Allander T, Holm S, Gustavsson B, Dalianis T (2009). DNA from KI, WU and Merkel cell polyomaviruses is not detected in childhood central nervous system tumours or neuroblastomas. PLoS One  4, e8239.   https://doi.org/10.1371/journal.pone.0008239




PubMed



        
     
Free Article


 


PubMed ID 20011509
         Pubmed Central ID 2785879 


 



3.
Pastrana DV, Tolstov YL, Becker JC, Moore PS, Chang Y, Buck CB (2009). Quantitation of human seroresponsiveness to Merkel cell polyomavirus. PLoS Pathog  5, e1000578.   https://doi.org/10.1371/journal.ppat.1000578




PubMed



        
     
Free Article


 


PubMed ID 19750217
         Pubmed Central ID 2734180 


 



4.
Tolstov YL, Pastrana DV, Feng H, Becker JC, Jenkins FJ, Moschos S, Chang Y, Buck CB, Moore PS (2009). Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays. Int J Cancer  125, 1250-6.   https://doi.org/10.1002/ijc.24509




PubMed



        
     
Free Article


 


PubMed ID 19499548
         Pubmed Central ID 2747737",https://intramural.nih.gov/search/searchview.taf?ipid=63181
481,BC011091-03,"October 01, 2009 -  September 30, 2010",Cancer Genomics Technology Development,"Paul S Meltzer; MD, PhD



IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","Sean Richard Davis; MD, PhD



Yevgeniy  Gindin



Arthur A Glatfelter; MS



Yuan  Jiang; MD



Munira A Basrai; PhD



John E Lueders



Show all 9","Laurakay  Bruhn
(Genomics Institute, Agilent Technologies)




Ed  DeFabo
(Environmental and Occupational Health, George Washington University)




Jian-Bing  Fang
(Medicine, Illumina)","Sharon Ann Savage (Clinical Genetics Branch)



Glenn  Merlino; PhD (Laboratory of Cancer Biology and Genetics)



Gordon Lee Hager; PhD (Laboratory of Receptor Biology and Gene Expression)



Kenneth H Kraemer; MD (Dermatology Branch)



Xin Wei Wang; PhD (Laboratory of Human Carcinogenesis)



Alan S Wayne; MD (Pediatric Oncology Branch)",Jeffery L Miller; MD (NIDDK),"Ordered by publication type and then author name.



1.
Ji J, Shi J, Budhu A, Yu Z, Forgues M, Roessler S, Ambs S, Chen Y, Meltzer PS, Croce CM, Qin LX, Man K, Lo CM, Lee J, Ng IO, Fan J, Tang ZY, Sun HC, Wang XW (2009). MicroRNA expression, survival, and response to interferon in liver cancer. N Engl J Med  361, 1437-47.   https://doi.org/10.1056/NEJMoa0901282




PubMed



        
     
Free Article


 


PubMed ID 19812400
         Pubmed Central ID 2786938 


 



2.
John S, Johnson TA, Sung MH, Biddie SC, Trump S, Koch-Paiz CA, Davis SR, Walker R, Meltzer PS, Hager GL (2009). Kinetic complexity of the global response to glucocorticoid receptor action. Endocrinology  150, 1766-74.   https://doi.org/10.1210/en.2008-0863




PubMed



        
     
Free Article


 


PubMed ID 19131569
         Pubmed Central ID 2659280 


 



3.
Wang D, Xia X, Liu Y, Oetting A, Walker RL, Zhu Y, Meltzer P, Cole PA, Shi YB, Yen PM (2009). Negative regulation of TSHalpha target gene by thyroid hormone involves histone acetylation and corepressor complex dissociation. Mol Endocrinol  23, 600-9.   https://doi.org/10.1210/me.2008-0389




PubMed



        
     
Free Article


 


PubMed ID 19196836
         Pubmed Central ID 2675953",https://intramural.nih.gov/search/searchview.taf?ipid=63368
482,BC011095-03,"October 01, 2009 -  September 30, 2010",Identification of HIF-Regulated Oncogenic Mediators in Renal Cell Carcinoma,Donald P Bottaro; PhD,William Marston Linehan; MD,"Urologic Oncology Branch, NCI","Daniel Christopher Rabe



Ramaprasad  Srinivasan; MD, PhD



Peter A Pinto; MD



Leonard  Neckers; PhD",NULL,"Tawnya Carlene McKee; BA, PhD (Molecular Targets Development Program)",NULL,"Ordered by publication type and then author name.



1.
Linehan WM, Bratslavsky G, Pinto PA, Schmidt LS, Neckers L, Bottaro DP, Srinivasan R (2010). Molecular diagnosis and therapy of kidney cancer. Annu Rev Med  61, 329-43.   https://doi.org/10.1146/annurev.med.042808.171650




PubMed



        
     
Free Article


 


PubMed ID 20059341
         Pubmed Central ID 2921612 


 



2.
Linehan WM, Rubin JS, Bottaro DP (2009). VHL loss of function and its impact on oncogenic signaling networks in clear cell renal cell carcinoma. Int J Biochem Cell Biol  41, 753-6.   https://doi.org/10.1016/j.biocel.2008.09.024




PubMed



        
     
Free Article


 


PubMed ID 18950731
         Pubmed Central ID 2684867",https://intramural.nih.gov/search/searchview.taf?ipid=63177
483,BC011099-03,"October 01, 2009 -  September 30, 2010",Canine Glioma and Embryonic Neural Stem Cell Project,"Howard A Fine; MD, PhD",NULL,"Neuro-Oncology Branch, NCI",Kevin D Woolard,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Woolard K, Fine HA (2009). Glioma stem cells: better flat than round. Cell Stem Cell  4, 466-7.   https://doi.org/10.1016/j.stem.2009.05.013




PubMed


 


PubMed ID 19497271",https://intramural.nih.gov/search/searchview.taf?ipid=63214
484,BC011100-03,"October 01, 2009 -  September 30, 2010",SCF as a Novel CNS and Glioma-Derived Angiogenic Factor and SC Chemotaxic Factor,"Howard A Fine; MD, PhD",NULL,"Neuro-Oncology Branch, NCI","Susie  Ahn



Peter  Bauer; PhD



Carolyn A Bryant



Margaret  Cam; PhD



Emely  Castro-Rivera



Chibawanye Isidore Ene



Show all 23",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Kotliarov Y, Kotliarova S, Charong N, Li A, Walling J, Aquilanti E, Ahn S, Steed ME, Su Q, Center A, Zenklusen JC, Fine HA (2009). Correlation analysis between single-nucleotide polymorphism and expression arrays in gliomas identifies potentially relevant target genes. Cancer Res  69, 1596-603.   https://doi.org/10.1158/0008-5472.CAN-08-2496




PubMed



        
     
Free Article


 


PubMed ID 19190341
         Pubmed Central ID 2644341 


 



2.
Li A, Walling J, Ahn S, Kotliarov Y, Su Q, Quezado M, Oberholtzer JC, Park J, Zenklusen JC, Fine HA (2009). Unsupervised analysis of transcriptomic profiles reveals six glioma subtypes. Cancer Res  69, 2091-9.   https://doi.org/10.1158/0008-5472.CAN-08-2100




PubMed



        
     
Free Article


 


PubMed ID 19244127
         Pubmed Central ID 2845963",https://intramural.nih.gov/search/searchview.taf?ipid=63209
485,BC011101-03,"October 01, 2009 -  September 30, 2010",Identifying New Glioma-Associated Tumor Suppressors and Oncogenes,"Howard A Fine; MD, PhD",NULL,"Neuro-Oncology Branch, NCI","Susie  Ahn



Peter  Bauer; PhD



Carolyn A Bryant



Margaret  Cam; PhD



Emely  Castro-Rivera



Chibawanye Isidore Ene



Show all 23",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Kotliarov Y, Kotliarova S, Charong N, Li A, Walling J, Aquilanti E, Ahn S, Steed ME, Su Q, Center A, Zenklusen JC, Fine HA (2009). Correlation analysis between single-nucleotide polymorphism and expression arrays in gliomas identifies potentially relevant target genes. Cancer Res  69, 1596-603.   https://doi.org/10.1158/0008-5472.CAN-08-2496




PubMed



        
     
Free Article


 


PubMed ID 19190341
         Pubmed Central ID 2644341 


 



2.
Li A, Walling J, Ahn S, Kotliarov Y, Su Q, Quezado M, Oberholtzer JC, Park J, Zenklusen JC, Fine HA (2009). Unsupervised analysis of transcriptomic profiles reveals six glioma subtypes. Cancer Res  69, 2091-9.   https://doi.org/10.1158/0008-5472.CAN-08-2100




PubMed



        
     
Free Article


 


PubMed ID 19244127
         Pubmed Central ID 2845963",https://intramural.nih.gov/search/searchview.taf?ipid=63210
486,BC011102-03,"October 01, 2009 -  September 30, 2010",The Role of miRNAs in Glioma Stem Cell and Glioma Biology,"Howard A Fine; MD, PhD",NULL,"Neuro-Oncology Branch, NCI","Susie  Ahn



Peter  Bauer; PhD



Carolyn A Bryant



Margaret  Cam; PhD



Emely  Castro-Rivera



Chibawanye Isidore Ene



Show all 23",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Kotliarov Y, Kotliarova S, Charong N, Li A, Walling J, Aquilanti E, Ahn S, Steed ME, Su Q, Center A, Zenklusen JC, Fine HA (2009). Correlation analysis between single-nucleotide polymorphism and expression arrays in gliomas identifies potentially relevant target genes. Cancer Res  69, 1596-603.   https://doi.org/10.1158/0008-5472.CAN-08-2496




PubMed



        
     
Free Article


 


PubMed ID 19190341
         Pubmed Central ID 2644341 


 



2.
Li A, Walling J, Ahn S, Kotliarov Y, Su Q, Quezado M, Oberholtzer JC, Park J, Zenklusen JC, Fine HA (2009). Unsupervised analysis of transcriptomic profiles reveals six glioma subtypes. Cancer Res  69, 2091-9.   https://doi.org/10.1158/0008-5472.CAN-08-2100




PubMed



        
     
Free Article


 


PubMed ID 19244127
         Pubmed Central ID 2845963",https://intramural.nih.gov/search/searchview.taf?ipid=63211
487,BC011105-03,"October 01, 2009 -  September 30, 2010",Study of HIV Protease Dimerization (PD) and Identification of PD Inhibitors,Hiroaki  Mitsuya,NULL,"HIV and AIDS Malignancy Branch, NCI","Debananda  Das; PhD



Robert  Yarchoan; MD



David A Davis; MD



Ravikiran S Yedidi","Masayuki  Amano
(Kumamoto University School of Medicine)




Arun  Ghosh





Yasuhiro  Koh
(Kumamoto University School of Medicine)




Hiromi  Ogata-Aoki
(Kumamoto University School of Medicine)




Irene  Weber
(Department of Biology, Georgia State University)",NULL,NULL,"Ordered by publication type and then author name.



1.
Mitsuya H, Amano M, Towata T, Danish M, Leshchenko-Yashchuk S, Das D, Nakayama, M, Tojo Y, Ghosh A, Mitsuya H (2010) In vitro selection of highly darunavir-resistant and replication-competent HIV-1 variants using a mixture of clinical HIV-1 isolates resistant to multiple conventional protease inhibitors. J Virol, in press.




 



2.
Mitsuya H, Xu C, Rao K, Baldridge A, Tie Y, Wang Y, Weber I, Aoki M, Gomez S, Amano M, Mitsuya H (2010) Probing multidrug-resistance and protein-ligand interactions with new oxatricyclic designed ligands in HIV-1 protease inhibitors. Chem Med Chem, in press.




 



3.
Tojo Y, Koh Y, Amano M, Aoki M, Das D, Kulkarni S, Anderson DD, Ghosh AK, Mitsuya H (2010). Novel protease inhibitors (PIs) containing macrocyclic components and 3(R),3a(S),6a(R)-bis-tetrahydrofuranylurethane that are potent against multi-PI-resistant HIV-1 variants in vitro. Antimicrob Agents Chemother  54, 3460-70.   https://doi.org/10.1128/AAC.01766-09




PubMed



        
     
Free Article


 


PubMed ID 20439612
         Pubmed Central ID 2916336",https://intramural.nih.gov/search/searchview.taf?ipid=63371
488,BC011106-03,"October 01, 2009 -  September 30, 2010",Specification of T cell function during development,"Alfred  Singer; MD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI","Amala Shenai Alag



Terry I Guinter



Gil  Katz



Leonid  Popezinsky","Wilfried  Ellmeier
(Immunology, University of Vienna)




Batu M Erman





Sophia D Sarafova
(NCI)","Lionel  Feigenbaum (Office Of The Director)



Remy J Bosselut; MD, PhD (Laboratory of Immune Cell Biology)","Paul E Love; MD, PhD (NICHD)","Ordered by publication type and then author name.



1.
Sarafova SD, Van Laethem F, Adoro S, Guinter T, Sharrow SO, Feigenbaum L, Singer A (2009). Upregulation of CD4 expression during MHC class II-specific positive selection is essential for error-free lineage choice. Immunity  31, 480-90.   https://doi.org/10.1016/j.immuni.2009.07.006




PubMed



        
     
Free Article


 


PubMed ID 19747858
         Pubmed Central ID 2758695",https://intramural.nih.gov/search/searchview.taf?ipid=63271
489,BC011107-03,"October 01, 2009 -  September 30, 2010",Analysis of the Function and Regulation of Protein Scaffolds and Signal Modulato,"Deborah K Morrison



IRP Faculty Profile",NULL,"Laboratory of Cell and Developmental Signaling, NCI","Prashanth Thirupopuliyur Bhaskar



Ira  Daar; PhD



Junghwa  Lim



Natasha Rose Schuh



Melissa M Mckay","Robert  Lewis
(Univeristy of Nebraska Medical Center)




John  Scott
(Oregon Health and Science University)




Kate  Storey
(University of Dundee)




Matthias  TschÃ¶p
(University of Cincinnati)",Timothy D Veenstra (Office Of The Director),NULL,"Ordered by publication type and then author name.



1.
Costanzo-Garvey DL, Pfluger PT, Dougherty MK, Stock JL, Boehm M, Chaika O, Fernandez MR, Fisher K, Kortum RL, Hong EG, Jun JY, Ko HJ, Schreiner A, Volle DJ, Treece T, Swift AL, Winer M, Chen D, Wu M, Leon LR, Shaw AS, McNeish J, Kim JK, Morrison DK, Tschöp MH, et al. [1 more author] (2009). KSR2 is an essential regulator of AMP kinase, energy expenditure, and insulin sensitivity. Cell Metab  10, 366-78.   https://doi.org/10.1016/j.cmet.2009.09.010




PubMed



        
     
Free Article


 


PubMed ID 19883615
         Pubmed Central ID 2773684 


 



2.
Dougherty MK, Ritt DA, Zhou M, Specht SI, Monson DM, Veenstra TD, Morrison DK (2009). KSR2 is a calcineurin substrate that promotes ERK cascade activation in response to calcium signals. Mol Cell  34, 652-62.   https://doi.org/10.1016/j.molcel.2009.06.001




PubMed



        
     
Free Article


 


PubMed ID 19560418
         Pubmed Central ID 2737517 


 



3.
McKay MM, Ritt DA, Morrison DK (2009). Signaling dynamics of the KSR1 scaffold complex. Proc Natl Acad Sci U S A  106, 11022-7.   https://doi.org/10.1073/pnas.0901590106




PubMed



        
     
Free Article


 


PubMed ID 19541618
         Pubmed Central ID 2708738",https://intramural.nih.gov/search/searchview.taf?ipid=63375
490,BC011108-03,"October 01, 2009 -  September 30, 2010",MAP Kinase signal transduction disruption in cancer,Jonathan S Wiest; PhD,NULL,"Laboratory of Cancer Biology and Genetics, NCI","Kathleen L Decicco



Sarah Anderson Jung



Zhihong  Shan",NULL,"Giorgio  Trinchieri (Cancer Inflammation Program)



Phillip A Dennis; MD, PhD (Medical Oncology Branch)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63304
491,BC011109-03,"October 01, 2009 -  September 30, 2010",Study of Structures of CCR5 and Its Interactions with CCR5 Inhibitors,Hiroaki  Mitsuya,NULL,"HIV and AIDS Malignancy Branch, NCI","Debananda  Das; PhD



Kenji  Maeda



Yasuhiro  Hayashi



Hirotomo  Nakata



Zachary Haines Smith; BA



Matthew  Trachtenberg



Show all 7","Arun  Ghosh





Hiromi  Ogata-Aoki
(Kumamoto University School of Medicine)




Yoshikazu  Takaoka
(Ono Pharmaceutical Co. Ltd.)",Seth M Steinberg; PhD (Office of the Director),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63372
492,BC011111-03,"October 01, 2009 -  September 30, 2010",Cytokine signaling in developing thymocytes and T cells,"Alfred  Singer; MD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI",Terry I Guinter,NULL,Lionel  Feigenbaum (Office Of The Director),Lothar  Hennighausen; PhD (NIDDK),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63272
493,BC011112-03,"October 01, 2009 -  September 30, 2010",Development and function of regulatory T cells,"Alfred  Singer; MD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI","Gil  Katz



Xuguang C Tai",NULL,Lionel  Feigenbaum (Office Of The Director),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63268
494,BC011113-03,"October 01, 2009 -  September 30, 2010",T cell survival,"Alfred  Singer; MD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI",Motoko  Kimura,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63269
495,BC011114-03,"October 01, 2009 -  September 30, 2010",Role of microRNAs in T cell development,"Alfred  Singer; MD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI","Terry I Guinter



Leonid  Popezinsky",NULL,Lionel  Feigenbaum (Office Of The Director),"Paul E Love; MD, PhD (NICHD)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63270
496,BC011115-03,"October 01, 2009 -  September 30, 2010",Epigenetic Mechanisms of Gene Expression in Lung Cancer Cells,"David  Schrump; MD



IRP Faculty Profile",NULL,"Surgery Branch, NCI",Mahadev  Rao,NULL,Victor  Marquez; PhD (Chemical Biology Laboratory),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63253
497,BC011116-03,"October 01, 2009 -  September 30, 2010",MHC-independent T cells,"Alfred  Singer; MD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI","Anastassia  Tikhonova



Francois  Van Laethem",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63266
498,BC011117-03,"October 01, 2009 -  September 30, 2010",T cell receptor regulation of cytokine signaling,"Alfred  Singer; MD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI",Gil  Katz,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63267
499,BC011118-03,"October 01, 2009 -  September 30, 2010",Role of Shh in developmental patterning and proliferation of digit skeleton,"Susan  Mackem; MD



IRP Faculty Profile",NULL,"Cancer and Developmental Biology Laboratory, NCI","Xiaozhong  Bao



Bau Lin Huang



Jianjian  Zhu



Junming  Yang","Gerard  Evan
(UCSF)




Licia  Selleri
(Cornell Univ Weill Medical College)




Rolf  Zeller
(Univ. Basel)",Stephen J Lockett; PhD (Office Of The Director),"Yosuke  Mukoyama; PhD (NHLBI) 



Sohyun  Ahn; PhD (NICHD)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63361
500,BC011119-03,"October 01, 2009 -  September 30, 2010",Hoxd gene functions in digit morphogenesis and role of Gli3-Hoxd interaction,"Susan  Mackem; MD



IRP Faculty Profile",NULL,"Cancer and Developmental Biology Laboratory, NCI","Xiaozhong  Bao



Aki  Furusawa



Bau Lin Huang



Junming  Yang","Denis  Duboule
(Zoology and Animal Biology, Univ. of Geneva)




Masahiro  Iwamoto; DDS, PhD
(Thomas Jefferson University)




John  Rasweiler
(SUNY Downstate)




Makoto  Taketo
(Orthopedics, Kyoto University)




Rolf  Zeller
(Univ. Basel)",NULL,Yingzi  Yang; PhD (NHGRI),"Ordered by publication type and then author name.



1.
Nguyen MT, Zhu J, Nakamura E, Bao X, Mackem S (2009). Tamoxifen-dependent, inducible Hoxb6CreERT recombinase function in lateral plate and limb mesoderm, CNS isthmic organizer, posterior trunk neural crest, hindgut, and tailbud. Dev Dyn  238, 467-74.   https://doi.org/10.1002/dvdy.21846




PubMed



        
     
Free Article


 


PubMed ID 19161221
         Pubmed Central ID 3483870 


 



2.
Yuasa T, Kondo N, Yasuhara R, Shimono K, Mackem S, Pacifici M, Iwamoto M, Enomoto-Iwamoto M (2009). Transient activation of Wnt/{beta}-catenin signaling induces abnormal growth plate closure and articular cartilage thickening in postnatal mice. Am J Pathol  175, 1993-2003.   https://doi.org/10.2353/ajpath.2009.081173




PubMed



        
     
Free Article


 


PubMed ID 19815716
         Pubmed Central ID 2774063",https://intramural.nih.gov/search/searchview.taf?ipid=63362
501,BC011120-03,"October 01, 2009 -  September 30, 2010",Genome-wide identification of target promoters of developmental regulators,"Susan  Mackem; MD



IRP Faculty Profile",NULL,"Cancer and Developmental Biology Laboratory, NCI","Xiaozhong  Bao



Bau Lin Huang



Jixia  Liu



Junming  Yang","Benoit  Bruneau
(UCSF)




Steve  Vokes
(U. Texas, Austin)",NULL,Ivan  Ovcharenko; PhD (NLM),There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=63359
502,BC011121-03,"October 01, 2009 -  September 30, 2010",RNA interference approach to dissect roles of notochord regulators,"Susan  Mackem; MD



IRP Faculty Profile",NULL,"Cancer and Developmental Biology Laboratory, NCI","Junming  Yang



Terence P Yamaguchi; PhD



Jianjian  Zhu",NULL,Mark B Lewandoski (Genetics of Vertebrate Development Section),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63360
503,BC011122-03,"October 01, 2009 -  September 30, 2010",Epigenetic Alterations Induced by Tobacco Smoke,"David  Schrump; MD



IRP Faculty Profile",NULL,"Surgery Branch, NCI","Julie A Hong



Fang  Liu



Sichuan  Xi



Mary R Zhang",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63254
504,BC011123-03,"October 01, 2009 -  September 30, 2010",Development of Grb2 SH2 Domain Antagonists as Anti-Cancer Therapeutics,Donald P Bottaro; PhD,William Marston Linehan; MD,"Urologic Oncology Branch, NCI","Alessio  Giubellino



Peter A Pinto; MD",NULL,"Sima  Hayavi (Toxicology and Pharmacology Branch)



Robert J Fisher (Office Of The Director)



Lawrence R Phillips (Biological Testing Branch)



Melinda  Hollingshead (Biological Testing Branch)



Terrence R Burke; PhD (Chemical Biology Laboratory)



Ettore  Appella; MD (Chemical Immunology Section)",NULL,"Ordered by publication type and then author name.



1.
Choi WJ, Kim SE, Stephen AG, Weidlich I, Giubellino A, Liu F, Worthy KM, Bindu L, Fivash MJ, Nicklaus MC, Bottaro DP, Fisher RJ, Burke TR (2009). Identification of Shc Src homology 2 domain-binding peptoid-peptide hybrids. J Med Chem  52, 1612-8.   https://doi.org/10.1021/jm800789h




PubMed



        
     
Free Article


 


PubMed ID 19226165
         Pubmed Central ID 2669314 


 



2.
Giubellino A, Linehan WM, Bottaro DP (2009). Targeting the Met signaling pathway in renal cancer. Expert Rev Anticancer Ther  9, 785-93.   https://doi.org/10.1586/era.09.43




PubMed



        
     
Free Article


 


PubMed ID 19496715
         Pubmed Central ID 2737331",https://intramural.nih.gov/search/searchview.taf?ipid=63178
505,BC011124-03,"October 01, 2009 -  September 30, 2010",Oncogenic Met Signaling in Urologic Malignancies,Donald P Bottaro; PhD,William Marston Linehan; MD,"Urologic Oncology Branch, NCI","Fabiola  Cecchi



Ramaprasad  Srinivasan; MD, PhD



Daniel Christopher Rabe



Laura  Schmidt



Cathy  Vocke; PhD","Stuart  Aaronson
(Research, Mount Sinai Medical Center)




Teresa  Burgess
(Preclinical Development, Amgen)




Ascoli  Carl
(Clinical Development Oncology, Rockland Immunologicals, Inc)




James  Christensen
(Oncology Research, Pfizer)




Angela  Coxon
(Amgen)




Regina  Day
(NCI)


Show all 25","Sandra  Ruscetti; PhD (Laboratory of Cancer Prevention)



Peter L Choyke; MD (Molecular Imaging Program)



Marc C Nicklaus (Chemical Biology Laboratory)



Jeffrey S Rubin; MD, PhD (Laboratory of Cellular and Molecular Biology)



Terrence R Burke; PhD (Chemical Biology Laboratory)



Maria  Merino; PhD (Laboratory of Pathology)",NULL,"Ordered by publication type and then author name.



1.
Giubellino A, Linehan WM, Bottaro DP (2009). Targeting the Met signaling pathway in renal cancer. Expert Rev Anticancer Ther  9, 785-93.   https://doi.org/10.1586/era.09.43




PubMed



        
     
Free Article


 


PubMed ID 19496715
         Pubmed Central ID 2737331 


 



2.
Linehan WM, Pinto PA, Bratslavsky G, Pfaffenroth E, Merino M, Vocke CD, Toro JR, Bottaro D, Neckers L, Schmidt LS, Srinivasan R (2009). Hereditary kidney cancer: unique opportunity for disease-based therapy. Cancer  115, 2252-61.   https://doi.org/10.1002/cncr.24230




PubMed



        
     
Free Article


 


PubMed ID 19402075
         Pubmed Central ID 2720093 


 



3.
Peach ML, Tan N, Choyke SJ, Giubellino A, Athauda G, Burke TR, Nicklaus MC, Bottaro DP (2009). Directed discovery of agents targeting the Met tyrosine kinase domain by virtual screening. J Med Chem  52, 943-51.   https://doi.org/10.1021/jm800791f




PubMed



        
     
Free Article


 


PubMed ID 19199650
         Pubmed Central ID 2698034",https://intramural.nih.gov/search/searchview.taf?ipid=63179
506,BC011126-03,"October 01, 2009 -  September 30, 2010",Preventive Vaccines for HIV,"Genoveffa  Franchini; MD



IRP Faculty Profile",NULL,"Vaccine Branch, NCI","Melvin Nelson Doster



Shari  Gordon; PhD



Poonam  Poonam



Monica  Vaccari



Marjorie  Robert-Guroff; PhD","Guido  Ferrari
(Duke University)




Donald  Forthal
(School of Medicine, Univ of CA)




Chris  Miller; MS





David C Montefiori; PhD
(Department of Surgery, NIAID)




Eckhard  Podack
(Department of Microbiology, University of Miami)




Rafick  Sekaly; PhD
(Vaccine & Gene Therapy Institute)","Christopher  Buck (Laboratory of Cellular Oncology)



John  Schiller; PhD (Laboratory of Cellular Oncology)



Jeffrey  Roberts (Laboratory of Cellular Oncology)



Rhonda C Kines (Laboratory of Cellular Oncology)","Nancy R Miller (NIAID) 



Vanessa  Hirsch (NIAID)","Ordered by publication type and then author name.



1.
Franchini G (2009). Choosing the right memory T cell for HIV. Nat Med  15, 244-6.   https://doi.org/10.1038/nm0309-244




PubMed



        
     
Free Article


 


PubMed ID 19265821
         Pubmed Central ID 2669705 


 



2.
Franchini G (2010). HTLV-1 and HIV-1 ""accessory"" proteins: a misleading misnomer. Mol Aspects Med  31, 331-2.   https://doi.org/10.1016/j.mam.2010.08.001




PubMed


 


PubMed ID 20708638",https://intramural.nih.gov/search/searchview.taf?ipid=63217
507,BC011127-03,"October 01, 2009 -  September 30, 2010",Structural Biology of the Antitermination Process Regulating Transcription,"Robert Andrew Byrd



IRP Faculty Profile",NULL,"Structural Biophysics Laboratory, NCI","Amanda S Altieri; PhD



Jess R Li



Sergey G Tarasov",NULL,"Donald L Court; PhD (Molecular Control and Genetics Section)



Xinhua  Ji; PhD (Biomolecular Structure Section)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63187
508,BC011130-03,"October 01, 2009 -  September 30, 2010",Investigation of the Hepatocyte Growth FactorMet Pathway,"Robert Andrew Byrd



IRP Faculty Profile",NULL,"Structural Biophysics Laboratory, NCI",NULL,NULL,Donald P Bottaro; PhD (Urologic Oncology Branch),NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=63185
509,BC011131-03,"October 01, 2009 -  September 30, 2010",Investigation of Protein-Protein Interactions in the ERAD Ubiquitylation Pathway,"Robert Andrew Byrd



IRP Faculty Profile",NULL,"Structural Biophysics Laboratory, NCI","Yinghua  Chen



Ranabir  Das



Aaren  Gonzales



Jess R Li



Shan  Liu



Sergey G Tarasov",NULL,"Allan M Weissman; MD (Laboratory of Protein Dynamics and Signaling)



Terrence R Burke; PhD (Chemical Biology Laboratory)



Xinhua  Ji; PhD (Biomolecular Structure Section)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63186
510,BC011132-03,"October 01, 2009 -  September 30, 2010",Methods Development,"Robert Andrew Byrd



IRP Faculty Profile",NULL,"Structural Biophysics Laboratory, NCI","Yinghua  Chen



Yun Xing M Wang



Ranabir  Das



Aaren  Gonzales



Jess R Li",NULL,NULL,Charles  Schwieters; PhD (CIT),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63183
511,BC011135-03,"October 01, 2009 -  September 30, 2010",Molecular Mechanisms of Lymphomagenesis,Mark  Raffeld; MD,John Carl Oberholtzer,"Laboratory of Pathology, NCI",Stefania  Pittaluga,"Leticia  Quintanilla-Martinez
(Pathology, Technical University of Munich)




Martina  Rudelius",NULL,NULL,"Ordered by publication type and then author name.



1.
Anastasov N, Bonzheim I, Rudelius M, Klier M, Dau T, Angermeier D, Duyster J, Pittaluga S, Fend F, Raffeld M, Quintanilla-Martinez L (2010) C/EBPbeta expression in ALK-positive anaplastic large cell lymphomas is required for cell proliferation and is induced by the STAT3 signaling pathway. Haematologica 95:760-7.




PubMed



        
     
Free Article


 


PubMed ID 20015877
         Pubmed Central ID 2864382",https://intramural.nih.gov/search/searchview.taf?ipid=63387
512,BC011149-02,"October 01, 2009 -  September 30, 2010",Role of microRNAs in Regulating Gene Expression,"Howard A Young; PhD



IRP Faculty Profile",NULL,"Laboratory of Experimental Immunology, NCI","Adelle P McFarland



Mary  Carrington; MS, PhD



Karthika  Ramakrishnan



Daniel  McVicar; PhD



Ram  Savan",NULL,"Stuart F J Le Grice; PhD (Retroviral Replication Laboratory)



Bruce Allen Shapiro; PhD (Image Processing Section)",NULL,"Ordered by publication type and then author name.



1.
Savan R, Chan T, Young HA (2010). Lentiviral gene transduction in human and mouse NK cell lines. Methods Mol Biol  612, 209-21.   https://doi.org/10.1007/978-1-60761-362-6_14




PubMed



        
     
Free Article


 


PubMed ID 20033643
         Pubmed Central ID 6634311 


 



2.
Savan R, Ravichandran S, Collins JR, Sakai M, Young HA (2009). Structural conservation of interferon gamma among vertebrates. Cytokine Growth Factor Rev  20, 115-24.   https://doi.org/10.1016/j.cytogfr.2009.02.006




PubMed



        
     
Free Article


 


PubMed ID 19268624
         Pubmed Central ID 2755191",https://intramural.nih.gov/search/searchview.taf?ipid=63473
513,BC011150-02,"October 01, 2009 -  September 30, 2010",Chronic Inflammation and Carcinogenesis,"Scott K Durum; PhD



IRP Faculty Profile",NULL,"Laboratory of Molecular Immunoregulation, NCI","Miranda L Hanson



Julie  Hixon



Wenqing  Li



Wei  Shen",NULL,"Giorgio  Trinchieri (Cancer Inflammation Program)



Howard A Young; PhD (Laboratory of Experimental Immunology)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63408
514,BC011152-02,"October 01, 2009 -  September 30, 2010",Regulation of human dendritic cell activation,"Giorgio  Trinchieri



IRP Faculty Profile",NULL,"Cancer Inflammation Program, NCI","Earl W Bere



Marco  Cardone



Lyudmila A Lyakh



Robin T Winkler Pickett","Franca  Gerosa
(Pathology/Immunology, University of Verona)




Uzma  Hasan
(Infections and Cancer Biology, International Agency for Research on Cancer (IARC-WHO))




Xiaojing  Ma
(Microbiology and Immunology, Weill Medical College)","Barbara K Felber (Vaccine Branch)



George N Pavlakis; MD, PhD (Vaccine Branch)



Francis W Ruscetti; PhD (Laboratory of Experimental Immunology)",NULL,"Ordered by publication type and then author name.



1.
Trinchieri G, Trinchieri G (2010) Turning on and off the immunological switch: Immune response polarization and its control by IL-10 and STAT3, in Immunologic Signature of Rejection. Springer (New York), in press.




 



2.
McVicar DW, Trinchieri G (2009). CSF-1R, DAP12 and beta-catenin: a ménage à trois. Nat Immunol  10, 681-3.   https://doi.org/10.1038/ni0709-681




PubMed


 


PubMed ID 19536190
    
     


 



3.
Stewart CA, Trinchieri G (2009). Reinforcing suppression using regulators: a new link between STAT3, IL-23, and Tregs in tumor immunosuppression. Cancer Cell  15, 81-3.   https://doi.org/10.1016/j.ccr.2009.01.008




PubMed


 


PubMed ID 19185840",https://intramural.nih.gov/search/searchview.taf?ipid=63464
515,BC011153-02,"October 01, 2009 -  September 30, 2010",Role of mouse microbiome in acancer and inflammation,"Giorgio  Trinchieri



IRP Faculty Profile",NULL,"Cancer Inflammation Program, NCI","Amiran  Dzutsev; PhD



Silvana Romina Goldszmid",NULL,NULL,Francesco M. Marincola; MD (CC),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63463
516,BC011154-02,"October 01, 2009 -  September 30, 2010",Biological functions of chromosomal proteins,"Michael  Bustin; PhD



IRP Faculty Profile",NULL,"Protein Section, NCI","Liron  Abuhatzira; PhD



Tao  Deng



Takashi  Furusawa



Gabi  Gerlitz



Toshihiro  Kurahashi



Cedric  Malicet



Show all 8","Melinda K Duncan; PhD
(Biological Sciences, The University of Delaware)




Stavros  Lomvardas
(University of California, San Francisco)




Eran  Meshorer
(Hebrew University)




Leon  Mullenders
(Radiation Genetics, University of Leiden)




Joseph  Orly
(Hebrew University)","Kenneth H Kraemer; MD (Dermatology Branch)



Joost J Oppenheim; MD (Laboratory of Molecular Immunoregulation)",NULL,"Ordered by publication type and then author name.



1.
Furusawa T, Bustin M (2009). Visualization of the expression of HMGN nucleosomal binding proteins in the developing mouse embryo and in adult mouse tissues. Methods Mol Biol  523, 67-82.   https://doi.org/10.1007/978-1-59745-190-1_5




PubMed



        
     
Free Article


 


PubMed ID 19381921
         Pubmed Central ID 3402339 


 



2.
Furusawa T, Ko JH, Birger Y, Bustin M (2009). Expression of nucleosomal protein HMGN1 in the cycling mouse hair follicle. Gene Expr Patterns  9, 289-95.   https://doi.org/10.1016/j.gep.2009.03.002




PubMed



        
     
Free Article


 


PubMed ID 19303948
         Pubmed Central ID 2738608 


 



3.
Gerlitz G, Bustin M (2009). Nucleosome binding proteins potentiate ATM activation and DNA damage response by modifying chromatin. Cell Cycle  8, 1641.   https://doi.org/10.4161/cc.8.11.8569




PubMed



        
     
Free Article


 


PubMed ID 19411861
         Pubmed Central ID 3402338 


 



4.
Gerlitz G, Bustin M (2010). Efficient cell migration requires global chromatin condensation. J Cell Sci  123, 2207-17.   https://doi.org/10.1242/jcs.058271




PubMed



        
     
Free Article


 


PubMed ID 20530575
         Pubmed Central ID 2886743 


 



5.
Kim YC, Gerlitz G, Furusawa T, Catez F, Nussenzweig A, Oh KS, Kraemer KH, Shiloh Y, Bustin M (2009). Activation of ATM depends on chromatin interactions occurring before induction of DNA damage. Nat Cell Biol  11, 92-6.   https://doi.org/10.1038/ncb1817




PubMed



        
     
Free Article


 


PubMed ID 19079244
         Pubmed Central ID 2717731 


 



6.
Rochman M, Malicet C, Bustin M (2010). HMGN5/NSBP1: a new member of the HMGN protein family that affects chromatin structure and function. Biochim Biophys Acta  1799, 86-92.   https://doi.org/10.1016/j.bbagrm.2009.09.012




PubMed



        
     
Free Article


 


PubMed ID 20123071
         Pubmed Central ID 2818475 


 



7.
Shirakawa H, Rochman M, Furusawa T, Kuehn MR, Horigome S, Haketa K, Sugita Y, Inada T, Komai M, Bustin M (2009). The nucleosomal binding protein NSBP1 is highly expressed in the placenta and modulates the expression of differentiation markers in placental Rcho-1 cells. J Cell Biochem  106, 651-8.   https://doi.org/10.1002/jcb.22046




PubMed



        
     
Free Article


 


PubMed ID 19160411
         Pubmed Central ID 2846783 


 



8.
Subramanian M, Gonzalez RW, Patil H, Ueda T, Lim JH, Kraemer KH, Bustin M, Bergel M (2009). The nucleosome-binding protein HMGN2 modulates global genome repair. FEBS J  276, 6646-57.   https://doi.org/10.1111/j.1742-4658.2009.07375.x




PubMed



        
     
Free Article


 


PubMed ID 19843163
         Pubmed Central ID 3460546 


 



9.
Ueda T, Furusawa T, Kurahashi T, Tessarollo L, Bustin M (2009). The nucleosome binding protein HMGN3 modulates the transcription profile of pancreatic beta cells and affects insulin secretion. Mol Cell Biol  29, 5264-76.   https://doi.org/10.1128/MCB.00526-09




PubMed



        
     
Free Article


 


PubMed ID 19651901
         Pubmed Central ID 2747976",https://intramural.nih.gov/search/searchview.taf?ipid=63398
517,BC011155-02,"October 01, 2009 -  September 30, 2010",Antibody-based therapeutics and vaccines against AIDS,Dimiter Stanchev Dimitrov; PhD,NULL,"Membrane Structure and Function Section, NCI","Weizao  Chen



Yang  Feng



Rui  Gong; PhD



John  Owens



Haiyan  Qin



Emily D Streaker



Show all 9","Christopher  Broder
(Uniformed Services University of the Health Sciences)




Barton  Haynes
(Duke University)




Shibo  Jiang
(Virology, New York Blood Center)




David C Montefiori; PhD
(Department of Surgery, NIAID)




Gerald  Quinnan
(Uniformed Services University of the Health Sciences)




Ruth  Ruprecht
(Harvard Medical School)


Show all 7",NULL,Peter D Kwong; PhD (NIAID),"Ordered by publication type and then author name.



1.
Chen W, Dimitrov DS (2009). Human monoclonal antibodies and engineered antibody domains as HIV-1 entry inhibitors. Curr Opin HIV AIDS  4, 112-7.   https://doi.org/10.1097/COH.0b013e328322f95e




PubMed



        
     
Free Article


 


PubMed ID 19339949
         Pubmed Central ID 2762325 


 



2.
Chen W, Zhu Z, Xiao X, Dimitrov DS (2009). Construction of a human antibody domain (VH) library. Methods Mol Biol  525, 81-99, xiii.   https://doi.org/10.1007/978-1-59745-554-1_4




PubMed



        
     
Free Article


 


PubMed ID 19252835
         Pubmed Central ID 2801874 


 



3.
Dimitrov DS (2009). Engineered CH2 domains (nanoantibodies). MAbs  1, 26-8.   https://doi.org/10.4161/mabs.1.1.7480




PubMed



        
     
Free Article


 


PubMed ID 20046570
         Pubmed Central ID 2715188 


 



4.
Dimitrov DS, Marks JD (2009). Therapeutic antibodies: current state and future trends--is a paradigm change coming soon? Methods Mol Biol  525, 1-27, xiii.   https://doi.org/10.1007/978-1-59745-554-1_1




PubMed



        
     
Free Article


 


PubMed ID 19252861
         Pubmed Central ID 3402212 


 



5.
Feng Y, Dimitrov DS (2009). Scaling-up and production of therapeutic antibodies for preclinical studies. Methods Mol Biol  525, 499-508, xiii.   https://doi.org/10.1007/978-1-59745-554-1_26




PubMed



        
     
Free Article


 


PubMed ID 19252843
         Pubmed Central ID 3402213 


 



6.
Gong R, Vu BK, Feng Y, Prieto DA, Dyba MA, Walsh JD, Prabakaran P, Veenstra TD, Tarasov SG, Ishima R, Dimitrov DS (2009). Engineered human antibody constant domains with increased stability. J Biol Chem  284, 14203-10.   https://doi.org/10.1074/jbc.M900769200




PubMed



        
     
Free Article


 


PubMed ID 19307178
         Pubmed Central ID 2682868 


 



7.
Vu BK, Walsh JD, Dimitrov DS, Ishima R (2009). Dynamics of antibody domains studied by solution NMR. Methods Mol Biol  525, 533-43, xv.   https://doi.org/10.1007/978-1-59745-554-1_29




PubMed



        
     
Free Article


 


PubMed ID 19252840
         Pubmed Central ID 3423202 


 



8.
Xiao X, Chen W, Feng Y, Zhu Z, Prabakaran P, Wang Y, Zhang MY, Longo NS, Dimitrov DS (2009). Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: implications for evasion of immune responses and design of vaccine immunogens. Biochem Biophys Res Commun  390, 404-9.   https://doi.org/10.1016/j.bbrc.2009.09.029




PubMed



        
     
Free Article


 


PubMed ID 19748484
         Pubmed Central ID 2787893 


 



9.
Xiao X, Feng Y, Vu BK, Ishima R, Dimitrov DS (2009). A large library based on a novel (CH2) scaffold: identification of HIV-1 inhibitors. Biochem Biophys Res Commun  387, 387-92.   https://doi.org/10.1016/j.bbrc.2009.07.044




PubMed



        
     
Free Article


 


PubMed ID 19615335
         Pubmed Central ID 2753272 


 



10.
Zhang MY, Dimitrov DS (2009). Competitive antigen panning for selection of HIV-1 neutralizing human monoclonal antibodies specific for gp41. Methods Mol Biol  525, 175-86, xv.   https://doi.org/10.1007/978-1-59745-554-1_9




PubMed



        
     
Free Article


 


PubMed ID 19252830
         Pubmed Central ID 3399416 


 



11.
Zhang MY, Dimitrov DS (2009). Sequential antigen panning for selection of broadly cross-reactive HIV-1-neutralizing human monoclonal antibodies. Methods Mol Biol  562, 143-54.   https://doi.org/10.1007/978-1-60327-302-2_11




PubMed



        
     
Free Article


 


PubMed ID 19554293
         Pubmed Central ID 3402911 


 



12.
Zhang MY, Wang Y, Mankowski MK, Ptak RG, Dimitrov DS (2009). Cross-reactive HIV-1-neutralizing activity of serum IgG from a rabbit immunized with gp41 fused to IgG1 Fc: possible role of the prolonged half-life of the immunogen. Vaccine  27, 857-63.   https://doi.org/10.1016/j.vaccine.2008.11.083




PubMed



        
     
Free Article


 


PubMed ID 19084043
         Pubmed Central ID 3399430 


 



13.
Zhu Z, Dimitrov DS (2009). Construction of a large naïve human phage-displayed Fab library through one-step cloning. Methods Mol Biol  525, 129-42, xv.   https://doi.org/10.1007/978-1-59745-554-1_6




PubMed



        
     
Free Article


 


PubMed ID 19252833
         Pubmed Central ID 3423197",https://intramural.nih.gov/search/searchview.taf?ipid=63407
518,BC011156-02,"October 01, 2009 -  September 30, 2010",Antibody therapeutics against biodefense-related diseases,Dimiter Stanchev Dimitrov; PhD,NULL,"Membrane Structure and Function Section, NCI",Zhongyu  Zhu,"Kei  Amemiya; PhD
(NINDS)




Christopher  Broder
(Uniformed Services University of the Health Sciences)",NULL,NULL,"Ordered by publication type and then author name.



1.
Bossart KN, Zhu Z, Middleton D, Klippel J, Crameri G, Bingham J, McEachern JA, Green D, Hancock TJ, Chan YP, Hickey AC, Dimitrov DS, Wang LF, Broder CC (2009). A neutralizing human monoclonal antibody protects against lethal disease in a new ferret model of acute nipah virus infection. PLoS Pathog  5, e1000642.   https://doi.org/10.1371/journal.ppat.1000642




PubMed



        
     
Free Article


 


PubMed ID 19888339
         Pubmed Central ID 2765826 


 



2.
Prabakaran P, Zhu Z, Xiao X, Biragyn A, Dimitrov AS, Broder CC, Dimitrov DS (2009). Potent human monoclonal antibodies against SARS CoV, Nipah and Hendra viruses. Expert Opin Biol Ther  9, 355-68.   https://doi.org/10.1517/14712590902763755




PubMed



        
     
Free Article


 


PubMed ID 19216624
         Pubmed Central ID 2705284",https://intramural.nih.gov/search/searchview.taf?ipid=63406
519,BC011158-02,"October 01, 2009 -  September 30, 2010",Study the role(s) of p53 in embryonic stem cells,"Jing  Huang



IRP Faculty Profile",NULL,"Laboratory of Cancer Biology and Genetics, NCI",Zhang  Xinyue,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Huang J, Dorsey J, Chuikov S, Pérez-Burgos L, Zhang X, Jenuwein T, Reinberg D, Berger SL (2010). G9a and Glp methylate lysine 373 in the tumor suppressor p53. J Biol Chem  285, 9636-41.   https://doi.org/10.1074/jbc.M109.062588




PubMed



        
     
Free Article


 


PubMed ID 20118233
         Pubmed Central ID 2843213",https://intramural.nih.gov/search/searchview.taf?ipid=63421
520,BC011159-02,"October 01, 2009 -  September 30, 2010",Identification of Biomarkers for Response to Chemoprevention of Colon Cancer,"Nancy H Colburn; PhD



IRP Faculty Profile",NULL,"Laboratory of Cancer Prevention, NCI","Christopher  Dextras



Matthew R Young; PhD","Robert  Chapkin
(Texas A&M)




Terry  Hartman
(Penn State Univ)",NULL,NULL,"Ordered by publication type and then author name.



1.
Kim YS, Young MR, Bobe G, Colburn NH, Milner JA (2009). Bioactive food components, inflammatory targets, and cancer prevention. Cancer Prev Res (Phila)  2, 200-8.   https://doi.org/10.1158/1940-6207.CAPR-08-0141




PubMed



        
     
Free Article


 


PubMed ID 19258539
         Pubmed Central ID 3449301 


 



2.
Mentor-Marcel RA, Bobe G, Barrett KG, Young MR, Albert PS, Bennink MR, Lanza E, Colburn NH (2009). Inflammation-associated serum and colon markers as indicators of dietary attenuation of colon carcinogenesis in ob/ob mice. Cancer Prev Res (Phila)  2, 60-9.   https://doi.org/10.1158/1940-6207.CAPR-08-0086




PubMed



        
     
Free Article


 


PubMed ID 19139019
         Pubmed Central ID 2794693 


 



3.
Young MR, Ileva LV, Bernardo M, Riffle LA, Jones YL, Kim YS, Colburn NH, Choyke PL (2009). Monitoring of tumor promotion and progression in a mouse model of inflammation-induced colon cancer with magnetic resonance colonography. Neoplasia  11, 237-46, 1p following 246.   https://doi.org/10.1593/neo.81326




PubMed



        
     
Free Article


 


PubMed ID 19242605
         Pubmed Central ID 2647726 


 



4.
Zhao C, Ivanov I, Dougherty ER, Hartman TJ, Lanza E, Bobe G, Colburn NH, Lupton JR, Davidson LA, Chapkin RS (2009). Noninvasive detection of candidate molecular biomarkers in subjects with a history of insulin resistance and colorectal adenomas. Cancer Prev Res (Phila)  2, 590-7.   https://doi.org/10.1158/1940-6207.CAPR-08-0233




PubMed



        
     
Free Article


 


PubMed ID 19470793
         Pubmed Central ID 2745241",https://intramural.nih.gov/search/searchview.taf?ipid=63402
521,BC011160-02,"October 01, 2009 -  September 30, 2010",Mechanisms in development  and  regulation of metastasis in lung cancer,King F Kwong,NULL,"Surgery Branch, NCI",Keytam Salem Awad; PhD,NULL,NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=63439
522,BC011162-02,"October 01, 2009 -  September 30, 2010",Molecular Profiling of Pancreatic Cancer,"Syed Perwez  Hussain



IRP Faculty Profile",NULL,"Laboratory of Human Carcinogenesis, NCI","Peijun  He



Geng  Zhang",NULL,Karl Thomas Ried; MD (Cancer Genetics Branch),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63423
523,BC011163-02,"October 01, 2009 -  September 30, 2010",Host immature myeloid cells in tumor suppressor or promoter roles of TGFbeta,"Li  Yang; PhD



IRP Faculty Profile",NULL,"Laboratory of Cancer Biology and Genetics, NCI","Bhagelu Ram  Achyut



Zhaoyang  Li; PhD



Yanli  Pang



Hangyi  Yan",NULL,John Charles Morris; MD (Lymphoid Malignancies Branch),NULL,"Ordered by publication type and then author name.



1.
Hembruff SL, Jokar I, Yang L, Cheng N (2010). Loss of transforming growth factor-beta signaling in mammary fibroblasts enhances CCL2 secretion to promote mammary tumor progression through macrophage-dependent and -independent mechanisms. Neoplasia  12, 425-33.   https://doi.org/10.1593/neo.10200




PubMed



        
     
Free Article


 


PubMed ID 20454514
         Pubmed Central ID 2864480 


 



2.
Yang L (2010). TGFbeta and cancer metastasis: an inflammation link. Cancer Metastasis Rev  29, 263-71.   https://doi.org/10.1007/s10555-010-9226-3




PubMed



        
     
Free Article


 


PubMed ID 20437081
         Pubmed Central ID 6640647 


 



3.
Yang L (2010). TGFbeta, a potent regulator of tumor microenvironment and host immune response, implication for therapy. Curr Mol Med  10, 374-80.   https://doi.org/10.2174/156652410791317039




PubMed


 


PubMed ID 20455854
    
     


 



4.
Yang L, Edwards CM, Mundy GR (2010). Gr-1+CD11b+ myeloid-derived suppressor cells: formidable partners in tumor metastasis. J Bone Miner Res  25, 1701-6.   https://doi.org/10.1002/jbmr.154




PubMed



        
     
Free Article


 


PubMed ID 20572008
         Pubmed Central ID 3153347 


 



5.
Yang L, Pang Y, Moses HL (2010). TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression. Trends Immunol  31, 220-7.   https://doi.org/10.1016/j.it.2010.04.002




PubMed



        
     
Free Article


 


PubMed ID 20538542
         Pubmed Central ID 2891151",https://intramural.nih.gov/search/searchview.taf?ipid=63469
524,BC011165-02,"October 01, 2009 -  September 30, 2010",Role of immature myeloid cells in premetastatic lung,"Li  Yang; PhD



IRP Faculty Profile",NULL,"Laboratory of Cancer Biology and Genetics, NCI","Bhagelu Ram  Achyut



Zhaoyang  Li; PhD



Hangyi  Yan",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Yan HH, Pickup M, Pang Y, Gorska AE, Li Z, Chytil A, Geng Y, Gray JW, Moses HL, Yang L (2010). Gr-1+CD11b+ myeloid cells tip the balance of immune protection to tumor promotion in the premetastatic lung. Cancer Res  70, 6139-49.   https://doi.org/10.1158/0008-5472.CAN-10-0706




PubMed



        
     
Free Article


 


PubMed ID 20631080
         Pubmed Central ID 4675145",https://intramural.nih.gov/search/searchview.taf?ipid=63470
525,BC011167-02,"October 01, 2009 -  September 30, 2010",A novel preclinical model of spontaneous metastasis,"Glenn  Merlino; PhD



IRP Faculty Profile",NULL,"Laboratory of Cancer Biology and Genetics, NCI",Chi-Ping  Day,NULL,"Dominic  Esposito; PhD (Office Of The Director)



Melinda  Hollingshead (Biological Testing Branch)",NULL,"Ordered by publication type and then author name.



1.
Day CP, Carter J, Bonomi C, Esposito D, Crise B, Ortiz-Conde B, Hollingshead M, Merlino G (2009). Lentivirus-mediated bifunctional cell labeling for in vivo melanoma study. Pigment Cell Melanoma Res  22, 283-95.   https://doi.org/10.1111/j.1755-148X.2009.00545.x




PubMed



        
     
Free Article


 


PubMed ID 19175523
         Pubmed Central ID 2726997",https://intramural.nih.gov/search/searchview.taf?ipid=63444
526,BC011168-02,"October 01, 2009 -  September 30, 2010",Physiological and pathological functions of E3 ubiquitin ligases Smurfs,"Ying  Zhang



IRP Faculty Profile",NULL,"Laboratory of Cellular and Molecular Biology, NCI","Michael  Blank



Mary E Heller



Yi  Tang



Xiangchun  Wang",NULL,Miriam R Anver (Office Of The Director),Chuxia  Deng; PhD (NIDDK),"Ordered by publication type and then author name.



1.
Jin C, Yang YA, Anver MR, Morris N, Wang X, Zhang YE (2009). Smad ubiquitination regulatory factor 2 promotes metastasis of breast cancer cells by enhancing migration and invasiveness. Cancer Res  69, 735-40.   https://doi.org/10.1158/0008-5472.CAN-08-1463




PubMed



        
     
Free Article


 


PubMed ID 19155312
         Pubmed Central ID 2639752",https://intramural.nih.gov/search/searchview.taf?ipid=63474
527,BC011169-02,"October 01, 2009 -  September 30, 2010",Inflammation and Prostate Carcinogenesis,Arthur A Hurwitz,NULL,"Laboratory of Molecular Immunoregulation, NCI","Katherine  Stagliano



Terri L Stull



Stephanie K Watkins",NULL,"William  Farrar (Laboratory of Cancer Prevention)



Lionel  Feigenbaum (Office Of The Director)



Francis W Ruscetti; PhD (Laboratory of Experimental Immunology)



Stefan  Ambs (Molecular Genetics and Carcinogenesis Section)",NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=63422
528,BC011170-02,"October 01, 2009 -  September 30, 2010",Comparative Functional Genomics,"Snorri S. Thorgeirsson; MD, PhD",NULL,"Laboratory of Experimental Carcinogenesis, NCI","Nicolae C Popescu; PhD



Daekwan  Seo; PhD, MS, BA



Phuongnga  Ton



Jesper B Andersen; PhD","Hanne  Bisgaard
(Medical Biochemistry and Genetics, University of Copenhagen)




Diego F Calvisi
(NCI)","Glenn  Merlino; PhD (Laboratory of Cancer Biology and Genetics)



Douglas  Lowy; MD (Laboratory of Cellular Oncology)



Robert  Wiltrout; PhD (Laboratory of Experimental Immunology)",NULL,"Ordered by publication type and then author name.



1.
Andersen JB, Loi R, Perra A, Factor VM, Ledda-Columbano GM, Columbano A, Thorgeirsson SS (2010). Progenitor-derived hepatocellular carcinoma model in the rat. Hepatology  51, 1401-9.   https://doi.org/10.1002/hep.23488




PubMed



        
     
Free Article


 


PubMed ID 20054870
         Pubmed Central ID 2914300",https://intramural.nih.gov/search/searchview.taf?ipid=63462
529,BC011173-02,"October 01, 2009 -  September 30, 2010",Genomic Classification of Human Liver Cancer,"Snorri S. Thorgeirsson; MD, PhD",NULL,"Laboratory of Experimental Carcinogenesis, NCI","Jesper B Andersen; PhD



Marian E Durkin



Daekwan  Seo; PhD, MS, BA



Phuongnga  Ton","Peter  Galle





Ju-Seog  Lee; PhD
(NCI)




Tania  Roskams
(Dpt. Pathology, K.U.Leuven University)","Laufey Thora Amundadottir (Laboratory Translational Genomics)



Xin Wei Wang; PhD (Laboratory of Human Carcinogenesis)



Curtis  Harris; MD (Laboratory of Human Carcinogenesis)",NULL,"Ordered by publication type and then author name.



1.
Coulouarn C, Factor VM, Andersen JB, Durkin ME, Thorgeirsson SS (2009). Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties. Oncogene  28, 3526-36.   https://doi.org/10.1038/onc.2009.211




PubMed



        
     
Free Article


 


PubMed ID 19617899
         Pubmed Central ID 3492882 


 



2.
Kaposi-Novak P, Libbrecht L, Woo HG, Lee YH, Sears NC, Coulouarn C, Conner EA, Factor VM, Roskams T, Thorgeirsson SS (2009). Central role of c-Myc during malignant conversion in human hepatocarcinogenesis. Cancer Res  69, 2775-82.   https://doi.org/10.1158/0008-5472.CAN-08-3357




PubMed



        
     
Free Article


 


PubMed ID 19276364
         Pubmed Central ID 2680077 


 



3.
Woo HG, Park ES, Lee JS, Lee YH, Ishikawa T, Kim YJ, Thorgeirsson SS (2009). Identification of potential driver genes in human liver carcinoma by genomewide screening. Cancer Res  69, 4059-66.   https://doi.org/10.1158/0008-5472.CAN-09-0164




PubMed



        
     
Free Article


 


PubMed ID 19366792
         Pubmed Central ID 2750086 


 



4.
Zimonjic DB, Ullmannova-Benson V, Factor VM, Thorgeirsson SS, Popescu NC (2009). Recurrent and nonrandom DNA copy number and chromosome alterations in Myc transgenic mouse model for hepatocellular carcinogenesis: implications for human disease. Cancer Genet Cytogenet  191, 17-26.   https://doi.org/10.1016/j.cancergencyto.2008.12.014




PubMed



        
     
Free Article


 


PubMed ID 19389504
         Pubmed Central ID 2693875 


 



5.
Zimonjic DB, Zhou X, Lee JS, Ullmannova-Benson V, Tripathi V, Thorgeirsson SS, Popescu NC (2009). Acquired genetic and functional alterations associated with transforming growth factor beta type I resistance in Hep3B human hepatocellular carcinoma cell line. J Cell Mol Med  13, 3985-92.   https://doi.org/10.1111/j.1582-4934.2009.00769.x




PubMed



        
     
Free Article


 


PubMed ID 19426152
         Pubmed Central ID 4516545",https://intramural.nih.gov/search/searchview.taf?ipid=63460
530,BC011175-02,"October 01, 2009 -  September 30, 2010",Validation of Therapeutic Target Genes in Human Liver Cancer,"Snorri S. Thorgeirsson; MD, PhD",NULL,"Laboratory of Experimental Carcinogenesis, NCI","Jesper B Andersen; PhD



Yun Han Lee



Jens Uwe Marquardt",NULL,"Steven Aaron Rosenberg; MD, PhD (Surgery Branch)



Itzhak  Avital (Surgery Branch)



Udai S Kammula (Surgery Branch)",NULL,"Ordered by publication type and then author name.



1.
Wang XW, Thorgeirsson SS (2009). Transcriptome analysis of liver cancer: ready for the clinic? J Hepatol  50, 1062-4.   https://doi.org/10.1016/j.jhep.2009.02.007




PubMed



        
     
Free Article


 


PubMed ID 19328580
         Pubmed Central ID 2696489",https://intramural.nih.gov/search/searchview.taf?ipid=63461
531,BC011176-02,"October 01, 2009 -  September 30, 2010",Functions of KSHV microRNAs,"Joseph M Ziegelbauer



IRP Faculty Profile",NULL,"HIV and AIDS Malignancy Branch, NCI","Johanna  Abend; PhD



Thomas S Uldrick



Vera Lynn Flowers



Philippe Cedric Kieffer-Kwon",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63475
532,BC011177-02,"October 01, 2009 -  September 30, 2010",Botulinum Toxin for Painful Cutaneous Leiomyomas,"Heidi H Kong



IRP Faculty Profile",Mark  Udey; MD,"Dermatology Branch, NCI","Edward W Cowen



Effie Y Nomicos; BS, BSN",NULL,NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=63438
533,BC011179-02,"October 01, 2009 -  September 30, 2010",Biomarkers of Human Esophageal Cancer,"Curtis  Harris; MD



IRP Faculty Profile",NULL,"Laboratory of Human Carcinogenesis, NCI","Akagi  Ichiro; MD, PhD



Mohammed A. Khan; PhD



Giang Huong Nguyen



Aaron Joseph Schetter



Yiqiang  Zhao



Elise Dawn Bowman



Show all 8",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Mathé EA, Nguyen GH, Bowman ED, Zhao Y, Budhu A, Schetter AJ, Braun R, Reimers M, Kumamoto K, Hughes D, Altorki NK, Casson AG, Liu CG, Wang XW, Yanaihara N, Hagiwara N, Dannenberg AJ, Miyashita M, Croce CM, Harris CC (2009). MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival. Clin Cancer Res  15, 6192-200.   https://doi.org/10.1158/1078-0432.CCR-09-1467




PubMed



        
     
Free Article


 


PubMed ID 19789312
         Pubmed Central ID 2933109",https://intramural.nih.gov/search/searchview.taf?ipid=63418
534,BC011180-02,"October 01, 2009 -  September 30, 2010",SIRT3 is a genomically expressed mitochondrial TSG,"David R Gius; MD, PhD",NULL,"Radiation Oncology Branch, NCI",Alexandra  Lin,NULL,NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=63412
535,BC011181-02,"October 01, 2009 -  September 30, 2010",Functional Analysis of Variants Identified in Human Breast Cancer Susceptibility,"Shyam K Sharan



IRP Faculty Profile",NULL,"Mouse Cancer Genetics Program, NCI","Kajal  Biswas



Suhwan  Chang



Rajani Kant Chittela



Susan L North



Stacey S Stauffer","William  Foulkes
(McGill University)




Debananda  Pati
(Texas Children's Cancer Center, Baylor College of Medicine)",Andre A Nussenzweig; PhD (Experimental Immunology Branch),NULL,"Ordered by publication type and then author name.



1.
Chang S, Biswas K, Martin BK, Stauffer S, Sharan SK (2009). Expression of human BRCA1 variants in mouse ES cells allows functional analysis of BRCA1 mutations. J Clin Invest  119, 3160-71.   https://doi.org/10.1172/JCI39836




PubMed



        
     
Free Article


 


PubMed ID 19770520
         Pubmed Central ID 2752086 


 



2.
Li L, Biswas K, Habib LA, Kuznetsov SG, Hamel N, Kirchhoff T, Wong N, Armel S, Chong G, Narod SA, Claes K, Offit K, Robson ME, Stauffer S, Sharan SK, Foulkes WD (2009). Functional redundancy of exon 12 of BRCA2 revealed by a comprehensive analysis of the c.6853A>G (p.I2285V) variant. Hum Mutat  30, 1543-50.   https://doi.org/10.1002/humu.21101




PubMed



        
     
Free Article


 


PubMed ID 19795481
         Pubmed Central ID 3501199 


 



3.
Sharan SK, Thomason LC, Kuznetsov SG, Court DL (2009). Recombineering: a homologous recombination-based method of genetic engineering. Nat Protoc  4, 206-23.   https://doi.org/10.1038/nprot.2008.227




PubMed



        
     
Free Article


 


PubMed ID 19180090
         Pubmed Central ID 2790811",https://intramural.nih.gov/search/searchview.taf?ipid=63453
536,BC011184-02,"October 01, 2009 -  September 30, 2010",Mechanism of Radiation Affects on microRNA,Nicole L Simone; MD,Kevin A Camphausen; MD,"Radiation Oncology Branch, NCI",Anthony D Saleh,NULL,James B Mitchell; PhD (Radiation Biology Branch),Benjamin  Soule (NIAID),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63456
537,BC011185-02,"October 01, 2009 -  September 30, 2010",Role of Inflammation in the Development and Progression of Pancreatic Cancer,"Syed Perwez  Hussain



IRP Faculty Profile",NULL,"Laboratory of Human Carcinogenesis, NCI","Naotake  Funamizu; MD, PhD



Peijun  He","Carlo  Croce
(Ohio State University Cancer Center)




Jochen  Gaedcke","Karl Thomas Ried; MD (Cancer Genetics Branch)



David Anderson Wink (Radiation Biology Branch)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63424
538,BC011186-02,"October 01, 2009 -  September 30, 2010",Animal model of Pancreatic Cancer,"Syed Perwez  Hussain



IRP Faculty Profile",NULL,"Laboratory of Human Carcinogenesis, NCI","Naotake  Funamizu; MD, PhD



Peijun  He



Geng  Zhang",NULL,Robert  Wiltrout; PhD (Laboratory of Experimental Immunology),NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=63425
539,BC011187-02,"October 01, 2009 -  September 30, 2010",Sphingolipid Signaling in Mammals,"Jairaj K Acharya; MBBS, PhD



IRP Faculty Profile",NULL,"Laboratory of Cell and Developmental Signaling, NCI","Diwash  Acharya



Teresa  Kosakowska Cholo



Pralhada Rao  Raghavendra","Usha  Acharya
(University of Mass. Medical School)




joost  holthuis
(University of Utrecht)","Shyam K Sharan (Mouse Cancer Genetics Program)



Lino  Tessarollo (Mouse Cancer Genetics Program)",NULL,"Ordered by publication type and then author name.



1.
Dasgupta U, Bamba T, Chiantia S, Karim P, Tayoun AN, Yonamine I, Rawat SS, Rao RP, Nagashima K, Fukusaki E, Puri V, Dolph PJ, Schwille P, Acharya JK, Acharya U (2009). Ceramide kinase regulates phospholipase C and phosphatidylinositol 4, 5, bisphosphate in phototransduction. Proc Natl Acad Sci U S A  106, 20063-8.   https://doi.org/10.1073/pnas.0911028106




PubMed



        
     
Free Article


 


PubMed ID 19892737
         Pubmed Central ID 2785292 


 



2.
Masood MA, Xu X, Acharya JK, Veenstra TD, Blonder J (2009). Enhanced detection of sphingoid bases via divalent ruthenium bipyridine complex derivatization and electrospray ionization tandem mass spectrometry. Anal Chem  81, 495-502.   https://doi.org/10.1021/ac8019043




PubMed



        
     
Free Article


 


PubMed ID 19055420
         Pubmed Central ID 3006443 


 



3.
Wang X, Rao RP, Kosakowska-Cholody T, Masood MA, Southon E, Zhang H, Berthet C, Nagashim K, Veenstra TK, Tessarollo L, Acharya U, Acharya JK (2009). Mitochondrial degeneration and not apoptosis is the primary cause of embryonic lethality in ceramide transfer protein mutant mice. J Cell Biol  184, 143-58.   https://doi.org/10.1083/jcb.200807176




PubMed



        
     
Free Article


 


PubMed ID 19139267
         Pubmed Central ID 2615084",https://intramural.nih.gov/search/searchview.taf?ipid=63391
540,BC011188-02,"October 01, 2009 -  September 30, 2010",Diazeniumdiolates as Broad-Spectrum Anticancer Agents,Larry K Keefer; PhD,NULL,"Laboratory of Comparative Carcinogenesis, NCI","Kenyatta Meticeo Cosby; MD



Ryan John Holland; PhD



Joseph  Saavedra","Khosrow  Kashfi
(CUNY Med School)




Robert  Prud'homme
(Princeton University)




Paul  Shami
(Medical Oncology, U of Utah)","Lucy M Anderson; PhD (Cellular Pathogenesis Section)



Xinhua  Ji; PhD (Biomolecular Structure Section)



Michael  Waalkes; PhD (Inorganic Carcinogenesis Section)",NULL,"Ordered by publication type and then author name.



1.
Keefer L (2010) Broad-spectrum anti-cancer activity of O2-arylated diazeniumdiolates. Immunopathol. Dis. Ther, in press.




 



2.
Keefer L, Anderson K, Kutok J, Jia L, Boucher K, Saavedra J, Keefer L, Shami P (2010) JS-K has potent anti-angiogenic activity in vitro and inhibits tumour angiogenesis in a multiple myeloma model in vivo. J. Pharm. Pharmacol 62:145-51.




 



3.
Kitagaki J, Yang Y, Saavedra JE, Colburn NH, Keefer LK, Perantoni AO (2009). Nitric oxide prodrug JS-K inhibits ubiquitin E1 and kills tumor cells retaining wild-type p53. Oncogene  28, 619-24.   https://doi.org/10.1038/onc.2008.401




PubMed



        
     
Free Article


 


PubMed ID 18978812
         Pubmed Central ID 2854646 


 



4.
Liu J, Malavya S, Wang X, Saavedra JE, Keefer LK, Tokar E, Qu W, Waalkes MP, Shami PJ (2009). Gene expression profiling for nitric oxide prodrug JS-K to kill HL-60 myeloid leukemia cells. Genomics  94, 32-8.   https://doi.org/10.1016/j.ygeno.2009.03.005




PubMed



        
     
Free Article


 


PubMed ID 19348908
         Pubmed Central ID 3496159 


 



5.
Nandurdikar RS, Maciag AE, Citro ML, Shami PJ, Keefer LK, Saavedra JE, Chakrapani H (2009). Synthesis and evaluation of piperazine and homopiperazine analogues of JS-K, an anti-cancer lead compound. Bioorg Med Chem Lett  19, 2760-2.   https://doi.org/10.1016/j.bmcl.2009.03.115




PubMed



        
     
Free Article


 


PubMed ID 19364650
         Pubmed Central ID 2755573 


 



6.
Shami PJ, Maciag AE, Eddington JK, Udupi V, Kosak KM, Saavedra JE, Keefer LK (2009). JS-K, an arylating nitric oxide (NO) donor, has synergistic anti-leukemic activity with cytarabine (ARA-C). Leuk Res  33, 1525-9.   https://doi.org/10.1016/j.leukres.2009.01.002




PubMed



        
     
Free Article


 


PubMed ID 19193435
         Pubmed Central ID 2756046",https://intramural.nih.gov/search/searchview.taf?ipid=63433
541,BC011189-02,"October 01, 2009 -  September 30, 2010",Molecular Pathogenic Mechanism of Rhabdomyosarcoma,Liang  Cao,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI","Zhigang  Kang



Yunkai  Yu",NULL,Lee Jay Helman; MD (Pediatric Oncology Branch),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63399
542,BC011190-02,"October 01, 2009 -  September 30, 2010",CHemical Biology of Nitroxyl (HNO),"David Anderson Wink



IRP Faculty Profile",NULL,"Radiation Biology Branch, NCI","Yuk Sing Robert Cheng



James B Mitchell; PhD



Wilmarie  Flores-santana



Murali  Krishna; PhD



Christopher H Switzer","Jon  Fukuto
(UCLA)




Bruce  King
(Department of Chemistry, Wake Forest University)




Nazerano  Paolocci
(Department of Cardiology, Johns Hopkins University Medical School)",Larry K Keefer; PhD (Laboratory of Comparative Carcinogenesis),NULL,"Ordered by publication type and then author name.



1.
Paolocci N, Wink DA (2009). The shy Angeli and his elusive creature: the HNO route to vasodilation. Am J Physiol Heart Circ Physiol  296, H1217-20.   https://doi.org/10.1152/ajpheart.00243.2009




PubMed



        
     
Free Article


 


PubMed ID 19286958
         Pubmed Central ID 2685361 


 



2.
Samuni Y, Flores-Santana W, Krishna MC, Mitchell JB, Wink DA (2009). The inhibitors of histone deacetylase suberoylanilide hydroxamate and trichostatin A release nitric oxide upon oxidation. Free Radic Biol Med  47, 419-23.   https://doi.org/10.1016/j.freeradbiomed.2009.05.011




PubMed



        
     
Free Article


 


PubMed ID 19447172
         Pubmed Central ID 2730666 


 



3.
Switzer CH, Flores-Santana W, Mancardi D, Donzelli S, Basudhar D, Ridnour LA, Miranda KM, Fukuto JM, Paolocci N, Wink DA (2009). The emergence of nitroxyl (HNO) as a pharmacological agent. Biochim Biophys Acta  1787, 835-40.   https://doi.org/10.1016/j.bbabio.2009.04.015




PubMed



        
     
Free Article


 


PubMed ID 19426703
         Pubmed Central ID 2761033",https://intramural.nih.gov/search/searchview.taf?ipid=63468
543,BC011191-02,"October 01, 2009 -  September 30, 2010",Preclinical Mouse Model of Thyroid Carcinogenesis,"Sheueyann  Cheng; PhD



IRP Faculty Profile",NULL,"Laboratory of Molecular Biology, NCI","Laura  Fozzatti



Celine Julie Guigon



Dong Wook  Kim; PhD



Changxue  Lu



Jeong-Won  Park



Li  Zhao



Show all 7","Mark  Willingham
(Wake Forest University School of Medicine)




GZ  Zhu
(Marshall University)","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,"Ordered by publication type and then author name.



1.
Araki O, Ying H, Zhu XG, Willingham MC, Cheng SY (2009). Distinct dysregulation of lipid metabolism by unliganded thyroid hormone receptor isoforms. Mol Endocrinol  23, 308-15.   https://doi.org/10.1210/me.2008-0311




PubMed



        
     
Free Article


 


PubMed ID 19131509
         Pubmed Central ID 2654517 


 



2.
Cheng SY, Leonard JL, Davis PJ (2010). Molecular aspects of thyroid hormone actions. Endocr Rev  31, 139-70.   https://doi.org/10.1210/er.2009-0007




PubMed



        
     
Free Article


 


PubMed ID 20051527
         Pubmed Central ID 2852208 


 



3.
Furuya F, Lu C, Guigon CJ, Cheng SY (2009). Nongenomic activation of phosphatidylinositol 3-kinase signaling by thyroid hormone receptors. Steroids  74, 628-34.   https://doi.org/10.1016/j.steroids.2008.10.009




PubMed



        
     
Free Article


 


PubMed ID 19014961
         Pubmed Central ID 3272696 


 



4.
Guigon CJ, Cheng SY (2009). Novel non-genomic signaling of thyroid hormone receptors in thyroid carcinogenesis. Mol Cell Endocrinol  308, 63-9.   https://doi.org/10.1016/j.mce.2009.01.007




PubMed



        
     
Free Article


 


PubMed ID 19549593
         Pubmed Central ID 2744088 


 



5.
Guigon CJ, Cheng SY (2009). Novel oncogenic actions of TRbeta mutants in tumorigenesis. IUBMB Life  61, 528-36.   https://doi.org/10.1002/iub.180




PubMed



        
     
Free Article


 


PubMed ID 19391168
         Pubmed Central ID 2716728 


 



6.
Guigon CJ, Zhao L, Willingham MC, Cheng SY (2009). PTEN deficiency accelerates tumour progression in a mouse model of thyroid cancer. Oncogene  28, 509-17.   https://doi.org/10.1038/onc.2008.407




PubMed



        
     
Free Article


 


PubMed ID 18997818
         Pubmed Central ID 3457778 


 



7.
Lu C, Cheng SY (2010). Thyroid hormone receptors regulate adipogenesis and carcinogenesis via crosstalk signaling with peroxisome proliferator-activated receptors. J Mol Endocrinol  44, 143-54.   https://doi.org/10.1677/JME-09-0107




PubMed



        
     
Free Article


 


PubMed ID 19741045
         Pubmed Central ID 3464095 


 



8.
Ribeiro MO, Bianco SD, Kaneshige M, Schultz JJ, Cheng SY, Bianco AC, Brent GA (2010). Expression of uncoupling protein 1 in mouse brown adipose tissue is thyroid hormone receptor-beta isoform specific and required for adaptive thermogenesis. Endocrinology  151, 432-40.   https://doi.org/10.1210/en.2009-0667




PubMed



        
     
Free Article


 


PubMed ID 19906816
         Pubmed Central ID 2817565 


 



9.
Zhu X, Cheng SY (2010). New insights into regulation of lipid metabolism by thyroid hormone. Curr Opin Endocrinol Diabetes Obes  17, 408-13.   https://doi.org/10.1097/MED.0b013e32833d6d46




PubMed



        
     
Free Article


 


PubMed ID 20644471
         Pubmed Central ID 3457777 


 



10.
Zhu XG, Cheng SY (2009). Modeling thyroid cancer in the mouse. Horm Metab Res  41, 488-99.   https://doi.org/10.1055/s-0029-1215572




PubMed



        
     
Free Article


 


PubMed ID 19358084
         Pubmed Central ID 3464089",https://intramural.nih.gov/search/searchview.taf?ipid=63401
544,BC011192-02,"October 01, 2009 -  September 30, 2010",The Mechanism of Thymic Lymphomagenesis in Genetically Engineered Mouse Model,Terry Anne Van Dyke,NULL,"Office of the Director, NCI","Linda S Cleveland



Debra J Gilbert



Yurong  Song; PhD



Teresa L Sullivan



Xiuyun  Lu



Theresa N O'Sullivan



Show all 7",NULL,Jonathan  Keller; PhD (Laboratory of Cancer Prevention),NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=63467
545,BC011194-02,"October 01, 2009 -  September 30, 2010",Modeling the MET Oncogene in Osteosarcoma,Su-Young  Kim,Crystal L. Mackall; MD,"Pediatric Oncology Branch, NCI",NULL,NULL,Donald P Bottaro; PhD (Urologic Oncology Branch),NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=63435
546,BC011195-02,"October 01, 2009 -  September 30, 2010",Sequencing the Osteosarcoma Kinome,Su-Young  Kim,Crystal L. Mackall; MD,"Pediatric Oncology Branch, NCI",NULL,NULL,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,"Ordered by publication type and then author name.



1.
Kim SY, Helman LJ (2009). Strategies to explore new approaches in the investigation and treatment of osteosarcoma. Cancer Treat Res  152, 517-28.   https://doi.org/10.1007/978-1-4419-0284-9_31




PubMed


 


PubMed ID 20213413",https://intramural.nih.gov/search/searchview.taf?ipid=63436
547,BC011196-02,"October 01, 2009 -  September 30, 2010",The NIH Pediatric and wildtype GIST Clinic,Su-Young  Kim,Crystal L. Mackall; MD,"Pediatric Oncology Branch, NCI",NULL,NULL,NULL,"Constantine Argyrios Stratakis; MD, DSc (NICHD)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63437
548,BC011197-02,"October 01, 2009 -  September 30, 2010",Regulation and Function of WIP1 Phosphatase and its Role in Tumor Cells,"Ettore  Appella; MD



IRP Faculty Profile",NULL,"Chemical Immunology Section, NCI","Ryo  Hayashi



Lisa Marie Jenkins



Sharlyn  Mazur; PhD



Michael Zeev Stern



Hidetsugu  Fujigaki



Michal  Vascak



Show all 7",NULL,Stewart  Durell (Laboratory of Cell Biology),Daniel  Appella; PhD (NIDDK),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63392
549,BC011199-02,"October 01, 2009 -  September 30, 2010",Embryonic Transcription Factor Function in Human Colorectal Cancer Stem Cells,John M Jessup,NULL,"Laboratory of Experimental Carcinogenesis, NCI","Snorri S. Thorgeirsson; MD, PhD



Jingyu  Zhang",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63427
550,BC011200-02,"October 01, 2009 -  September 30, 2010",Shape change and Nitric Oxide (NO) Modulation of Core Pluripotent TF Expression,John M Jessup,NULL,"Laboratory of Experimental Carcinogenesis, NCI","Snorri S. Thorgeirsson; MD, PhD



Jingyu  Zhang",NULL,NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=63428
551,BC011201-02,"October 01, 2009 -  September 30, 2010",National Program to Standardize the BCR-ABL qRT-PCR Assay for CML,John M Jessup,NULL,"Laboratory of Experimental Carcinogenesis, NCI",NULL,"Maher  Albitar
(Quest Diagnostics)




Janina  Longtine
(Brigham & Women's Hospital)




Raja  Luthra
(University of Texas MD Anderson Cancer Center)




Glenn  Miller; PhD
(National Naval Dental School)




Elizabeth  Peters
(Gene Express Co.)




Jerry  Radich
(Fred Hutchinson Cancer Research Center)


Show all 7",Lisa  Mcshane (Biometrics Research Branch),NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=63429
552,BC011202-02,"October 01, 2009 -  September 30, 2010",Mechanism of the initial steps in transcription-coupled DNA repair (TCR),"Mikhail V Kashlev



IRP Faculty Profile",NULL,"Molecular Mechanisms of Transcription Section, NCI","Lucyna E Lubkowska



Celine Marguerite Paulette Walmacq",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Walmacq C, Kireeva ML, Irvin J, Nedialkov Y, Lubkowska L, Malagon F, Strathern JN, Kashlev M (2009). Rpb9 subunit controls transcription fidelity by delaying NTP sequestration in RNA polymerase II. J Biol Chem  284, 19601-12.   https://doi.org/10.1074/jbc.M109.006908




PubMed



        
     
Free Article


 


PubMed ID 19439405
         Pubmed Central ID 2740586",https://intramural.nih.gov/search/searchview.taf?ipid=63432
553,BC011203-02,"October 01, 2009 -  September 30, 2010",Proteolysis and Regulation of Bacterial Cell Growth Control,"Susan  Gottesman; PhD



IRP Faculty Profile",NULL,"Biochemical Genetics Section, NCI","Aurelia  Battesti



Nadim  Majdalani



Paola Andrea Milanesio



Song  Tong",NULL,"Yan Ning H Zhou (Gene Regulation and Chromosome Biology Laboratory)



Sue H Wickner; PhD (DNA Molecular Biology Section)



Michael  Maurizi; PhD (Biochemistry of Proteins Section)



Xinhua  Ji; PhD (Biomolecular Structure Section)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63413
554,BC011204-02,"October 01, 2009 -  September 30, 2010",Preclinical development of AlaTIMP-2 as an cancer therapeutic,"William G Stetler-Stevenson; MD, PhD



IRP Faculty Profile",NULL,"Radiation Oncology Branch, NCI","Dimitra  Bourmpoulia; PhD



Frank  Cuttitta; PhD



Liliana  Guedez; PhD



Hui  Han



Sandra  Jensen-Taubman



Clifford John Kwityn



Show all 9",NULL,"Peter L Choyke; MD (Molecular Imaging Program)



Maryalice  Stetler-Stevenson; MD, PhD (Laboratory of Pathology)



William  Saxinger; PhD (Office of the Director)",NULL,"Ordered by publication type and then author name.



1.
Sun J, Stetler-Stevenson WG (2009). Overexpression of tissue inhibitors of metalloproteinase 2 up-regulates NF-kappaB activity in melanoma cells. J Mol Signal  4, 4.   https://doi.org/10.1186/1750-2187-4-4




PubMed



        
     
Free Article


 


PubMed ID 19627587
         Pubmed Central ID 2720935",https://intramural.nih.gov/search/searchview.taf?ipid=63458
555,BC011205-02,"October 01, 2009 -  September 30, 2010",Population based studies,Ola Anders Landgren,NULL,"Medical Oncology Branch, NCI","Sham  Mailankody



Brendan  Weiss","Magnus  Bjorkholm
(Karolinska)




Sigurdur  Kristinsson
(Karolinska)




Robert  Kyle
(Mayo Clinic)




Vincent  Rajkumar
(Mayo Clinic)","Eric Andrew Engels; PhD (Infection & Immunoepidemiology Branch)



Neil Edward Caporaso; MS, MD (Genetic Epidemiology Branch)



Martha S Linet; PhD (Radiation Epidemiology Branch)",NULL,"Ordered by publication type and then author name.



1.
Anderson LA, Pfeiffer RM, Landgren O, Gadalla S, Berndt SI, Engels EA (2009). Risks of myeloid malignancies in patients with autoimmune conditions. Br J Cancer  100, 822-8.   https://doi.org/10.1038/sj.bjc.6604935




PubMed



        
     
Free Article


 


PubMed ID 19259097
         Pubmed Central ID 2653768 


 



2.
Chiao EY, Engels EA, Kramer JR, Pietz K, Henderson L, Giordano TP, Landgren O (2009). Risk of immune thrombocytopenic purpura and autoimmune hemolytic anemia among 120 908 US veterans with hepatitis C virus infection. Arch Intern Med  169, 357-63.   https://doi.org/10.1001/archinternmed.2008.576




PubMed



        
     
Free Article


 


PubMed ID 19237719
         Pubmed Central ID 2782638 


 



3.
Dores GM, Landgren O, McGlynn KA, Curtis RE, Linet MS, Devesa SS (2009). Plasmacytoma of bone, extramedullary plasmacytoma, and multiple myeloma: incidence and survival in the United States, 1992-2004. Br J Haematol  144, 86-94.   https://doi.org/10.1111/j.1365-2141.2008.07421.x




PubMed



        
     
Free Article


 


PubMed ID 19016727
         Pubmed Central ID 2610331 


 



4.
Goldin LR, Björkholm M, Kristinsson SY, Samuelsson J, Landgren O (2009). Germline and somatic JAK2 mutations and susceptibility to chronic myeloproliferative neoplasms. Genome Med  1, 55.   https://doi.org/10.1186/gm55




PubMed



        
     
Free Article


 


PubMed ID 19490586
         Pubmed Central ID 2689447 


 



5.
Goldin LR, Björkholm M, Kristinsson SY, Turesson I, Landgren O (2009). Elevated risk of chronic lymphocytic leukemia and other indolent non-Hodgkin's lymphomas among relatives of patients with chronic lymphocytic leukemia. Haematologica  94, 647-53.   https://doi.org/10.3324/haematol.2008.003632




PubMed



        
     
Free Article


 


PubMed ID 19286886
         Pubmed Central ID 2675676 


 



6.
Goldin LR, Björkholm M, Kristinsson SY, Turesson I, Landgren O (2009). Highly increased familial risks for specific lymphoma subtypes. Br J Haematol  146, 91-4.   https://doi.org/10.1111/j.1365-2141.2009.07721.x




PubMed



        
     
Free Article


 


PubMed ID 19438470
         Pubmed Central ID 2702464 


 



7.
Kristinsson SY, Björkholm M, Andersson TM, Eloranta S, Dickman PW, Goldin LR, Blimark C, Mellqvist UH, Wahlin A, Turesson I, Landgren O (2009). Patterns of survival and causes of death following a diagnosis of monoclonal gammopathy of undetermined significance: a population-based study. Haematologica  94, 1714-20.   https://doi.org/10.3324/haematol.2009.010066




PubMed



        
     
Free Article


 


PubMed ID 19608666
         Pubmed Central ID 2791946 


 



8.
Kristinsson SY, Björkholm M, Goldin LR, Blimark C, Mellqvist UH, Wahlin A, Turesson I, Landgren O (2009). Patterns of hematologic malignancies and solid tumors among 37,838 first-degree relatives of 13,896 patients with multiple myeloma in Sweden. Int J Cancer  125, 2147-50.   https://doi.org/10.1002/ijc.24514




PubMed



        
     
Free Article


 


PubMed ID 19582882
         Pubmed Central ID 2737604 


 



9.
Landgren O, Gilbert ES, Rizzo JD, Socié G, Banks PM, Sobocinski KA, Horowitz MM, Jaffe ES, Kingma DW, Travis LB, Flowers ME, Martin PJ, Deeg HJ, Curtis RE (2009). Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation. Blood  113, 4992-5001.   https://doi.org/10.1182/blood-2008-09-178046




PubMed



        
     
Free Article


 


PubMed ID 19264919
         Pubmed Central ID 2686146 


 



10.
Landgren O, Kristinsson SY, Goldin LR, Caporaso NE, Blimark C, Mellqvist UH, Wahlin A, Bjorkholm M, Turesson I (2009). Risk of plasma cell and lymphoproliferative disorders among 14621 first-degree relatives of 4458 patients with monoclonal gammopathy of undetermined significance in Sweden. Blood  114, 791-5.   https://doi.org/10.1182/blood-2008-12-191676




PubMed



        
     
Free Article


 


PubMed ID 19182202
         Pubmed Central ID 2716021 


 



11.
Landgren O, Kyle RA, Pfeiffer RM, Katzmann JA, Caporaso NE, Hayes RB, Dispenzieri A, Kumar S, Clark RJ, Baris D, Hoover R, Rajkumar SV (2009). Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study. Blood  113, 5412-7.   https://doi.org/10.1182/blood-2008-12-194241




PubMed



        
     
Free Article


 


PubMed ID 19179464
         Pubmed Central ID 2689042 


 



12.
Liang XS, Caporaso N, McMaster ML, Ng D, Landgren O, Yeager M, Chanock S, Goldin LR (2009). Common genetic variants in candidate genes and risk of familial lymphoid malignancies. Br J Haematol  146, 418-23.   https://doi.org/10.1111/j.1365-2141.2009.07790.x




PubMed



        
     
Free Article


 


PubMed ID 19573080
         Pubmed Central ID 2890251 


 



13.
Turesson I, Velez R, Kristinsson SY, Landgren O (2010). Patterns of improved survival in patients with multiple myeloma in the twenty-first century: a population-based study. J Clin Oncol  28, 830-4.   https://doi.org/10.1200/JCO.2009.25.4177




PubMed



        
     
Free Article


 


PubMed ID 20038719
         Pubmed Central ID 2834396",https://intramural.nih.gov/search/searchview.taf?ipid=63440
556,BC011206-02,"October 01, 2009 -  September 30, 2010",Genome wide profiling of histone variants in colorectal cancer cells,"Yamini Praful Dalal



IRP Faculty Profile",NULL,"Hormone Action and Oncogenesis Section, NCI","Minh  Bui



Rajbir K Gill



Song  Fu",NULL,Karl Thomas Ried; MD (Cancer Genetics Branch),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63403
557,BC011207-02,"October 01, 2009 -  September 30, 2010",Analysis of centromere identity and structure in human cells,"Yamini Praful Dalal



IRP Faculty Profile",NULL,"Hormone Action and Oncogenesis Section, NCI","Rajbir K Gill



Paul Gregory Donlin-Asp



Delphine Chantal Anne Marie Quenet; PhD



Minh  Bui



Michael James Shlossman","Amander  Clark
(University of California, LA)




Stephan  Diekmann
(Leibniz Institute for Aging/Fritz Lippman Institute)",NULL,Emilios K Dimitriadis; PhD (NIBIB),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63404
558,BC011208-02,"October 01, 2009 -  September 30, 2010",Roles of Chromatin-modifying Factors in Epigenetic Control of the Genome,"Shivinder Singh Grewal



IRP Faculty Profile",NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI","Vanivilasini  Balachandran



Bowen  Cui



Jothy  Dhakshnamoorthy



Emiko  Matsuda



Sameet Satish Mehta; PhD



Takeshi  Mizuguchi



Show all 8",NULL,Peter C Fitzgerald (Office of the Director),NULL,"Ordered by publication type and then author name.



1.
Cam HP, Chen ES, Grewal SI (2009). Transcriptional scaffolds for heterochromatin assembly. Cell  136, 610-4.   https://doi.org/10.1016/j.cell.2009.02.004




PubMed



        
     
Free Article


 


PubMed ID 19239883
         Pubmed Central ID 6309854 


 



2.
Fischer T, Cui B, Dhakshnamoorthy J, Zhou M, Rubin C, Zofall M, Veenstra TD, Grewal SI (2009). Diverse roles of HP1 proteins in heterochromatin assembly and functions in fission yeast. Proc Natl Acad Sci U S A  106, 8998-9003.   https://doi.org/10.1073/pnas.0813063106




PubMed



        
     
Free Article


 


PubMed ID 19443688
         Pubmed Central ID 2690032 


 



3.
Grewal SI (2010). RNAi-dependent formation of heterochromatin and its diverse functions. Curr Opin Genet Dev  20, 134-41.   https://doi.org/10.1016/j.gde.2010.02.003




PubMed



        
     
Free Article


 


PubMed ID 20207534
         Pubmed Central ID 3005588",https://intramural.nih.gov/search/searchview.taf?ipid=63416
559,BC011209-02,"October 01, 2009 -  September 30, 2010",Kinetochore Interaction with Centromere Chromatin in human cells,"Yamini Praful Dalal



IRP Faculty Profile",NULL,"Hormone Action and Oncogenesis Section, NCI","Minh  Bui



Michael James Shlossman",NULL,NULL,Aleksandra Urszula Nita-Lazar; PhD (NIAID),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63405
560,BC011210-02,"October 01, 2009 -  September 30, 2010",Magnetic Drug Delivery for Cancer,"Michael R Emmert-Buck; MD, PhD",NULL,"Laboratory of Pathology, NCI",Michael  Tangrea,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63409
561,BC011211-02,"October 01, 2009 -  September 30, 2010",Subcellular protein localization in B. subtilis,"Kumaran S Ramamurthi



IRP Faculty Profile",NULL,"Laboratory of Molecular Biology, NCI","Jean-Philippe  Castaing



Sarah Elaine Ebmeier



Prahathees  Eswara Moorthy",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Ramamurthi KS, Lecuyer S, Stone HA, Losick R (2009). Geometric cue for protein localization in a bacterium. Science  323, 1354-7.   https://doi.org/10.1126/science.1169218




PubMed



        
     
Free Article


 


PubMed ID 19265022
         Pubmed Central ID 2652684 


 



2.
Ramamurthi KS, Losick R (2009). Negative membrane curvature as a cue for subcellular localization of a bacterial protein. Proc Natl Acad Sci U S A  106, 13541-5.   https://doi.org/10.1073/pnas.0906851106




PubMed



        
     
Free Article


 


PubMed ID 19666580
         Pubmed Central ID 2726380",https://intramural.nih.gov/search/searchview.taf?ipid=63450
562,BC011212-02,"October 01, 2009 -  September 30, 2010",Functions of IKKalpha in Skin Homeostasis and Skin Tumorigenesis,"Yinling  Hu



IRP Faculty Profile",NULL,"Laboratory of Experimental Immunology, NCI",Howard A Young; PhD,NULL,"Ji Ming  Wang; MD, PhD (Laboratory of Molecular Immunoregulation)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63420
563,BC011213-02,"October 01, 2009 -  September 30, 2010",Application of Gold Nanoparticles to Increase the Efficacy of Radiation Therapy,Jacek  Capala; PhD,NULL,"Radiation Oncology Branch, NCI","Simeon Kolawole Adesina



Kevin A Camphausen; MD



Alesia J Holly



Gabriela  Kramer-Marek



Ilya  Lyakhov",NULL,Robert  Blumenthal; PhD (Center for Cancer Research Nanobiology Program),"Gary Leonard Griffiths; BSc, PhD (NHLBI)","Ordered by publication type and then author name.



1.
Morgan NY, Kramer-Marek G, Smith PD, Camphausen K, Capala J (2009). Nanoscintillator conjugates as photodynamic therapy-based radiosensitizers: calculation of required physical parameters. Radiat Res  171, 236-44.   https://doi.org/10.1667/RR1470.1




PubMed



               Available in future as a Free Article 


 


PubMed ID 19267550
         Pubmed Central ID 3184550",https://intramural.nih.gov/search/searchview.taf?ipid=63400
564,BC011214-02,"October 01, 2009 -  September 30, 2010",Post-Transcriptional Regulation of Interleukin-7 Receptor Expression,"Jung-Hyun  Park



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI","Changwan  Hong



Megan A Luckey



Saho  Maruyama; PhD","Thomas  Hunig
(University of Wuerzburg)




Scott  Walsh
(University of Maryland)",NULL,"Bibiana  Bielekova; MD (NINDS) 



Marta Liliana Catalfamo; PhD (NIAID)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63448
565,BC011215-02,"October 01, 2009 -  September 30, 2010",Immune Regulatory Roles of Suppressor Of Cytokine Signaling (SOCS) Molecules,"Jung-Hyun  Park



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI","Changwan  Hong



James Stephen Shaw; PhD



Megan A Luckey



Alfred  Singer; MD",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63449
566,BC011216-02,"October 01, 2009 -  September 30, 2010",CHEMOTACTIC SIGNALS REGULATING HUMAN NEUTROPHIL AND BREAST METASTATIC MIGRATION,Carole A Parent; PhD,NULL,"Laboratory of Cellular and Molecular Biology, NCI","Philippe  Afonso



Satarupa  Das



Mirkka Maarit Janka-junttila



Lunhua  Liu



Vidya  Vedham",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Liu L, Das S, Losert W, Parent CA (2010). mTORC2 regulates neutrophil chemotaxis in a cAMP- and RhoA-dependent fashion. Dev Cell  19, 845-57.   https://doi.org/10.1016/j.devcel.2010.11.004




PubMed



        
     
Free Article


 


PubMed ID 21145500
         Pubmed Central ID 3071587",https://intramural.nih.gov/search/searchview.taf?ipid=63447
567,BC011217-02,"October 01, 2009 -  September 30, 2010",Preclinical Characterization of Drugs in Mouse Model of Lung Cancer,Terry Anne Van Dyke,NULL,"Office of the Director, NCI","Simone  Difilippantonio



Deborah B Householder



Zoe W Ohler","David  Gandara
(University of Califormia at Davis)




Neal  Goodwin
(Jackson Laboratory, West)




Kwok-Kin  Wong
(Harvard University)",Giuseppe  Giaccone; MD (Medical Oncology Branch),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63465
568,BC011219-02,"October 01, 2009 -  September 30, 2010",Combination Gene Therapy and Th1Th2 Therapy,Daniel H Fowler,NULL,"Experimental Transplantation and Immunology Branch, NCI","Shoba M Amarnath



Tania Cristina Felizardo



J  Foley



Anu  Gangopadhyay



Miriam E Mossoba","Carl  June
(University of Penn)




Bruce  Levine
(Abramson Family Cancer Research Center, University of Pennsylvania)




Jeffrey A. Medin; PhD
(University of Toronto)",NULL,David F Stroncek; MD (CC),"Ordered by publication type and then author name.



1.
Loisel-Meyer S, Felizardo T, Mariotti J, Mossoba ME, Foley JE, Kammerer R, Mizue N, Keefe R, McCart JA, Zimmermann W, Dropulic B, Fowler DH, Medin JA (2009). Potent induction of B- and T-cell immunity against human carcinoembryonic antigen-expressing tumors in human carcinoembryonic antigen transgenic mice mediated by direct lentivector injection. Mol Cancer Ther  8, 692-702.   https://doi.org/10.1158/1535-7163.MCT-08-0769




PubMed



        
     
Free Article


 


PubMed ID 19276164
         Pubmed Central ID 2846382 


 



2.
Scaife MD, Neschadim A, Fowler DH, Medin JA (2009). Novel application of lentiviral vectors towards treatment of graft-versus-host disease. Expert Opin Biol Ther  9, 749-61.   https://doi.org/10.1517/14712590903002021




PubMed


 


PubMed ID 19456209
    
     


 



3.
Symes JC, Siatskas C, Fowler DH, Medin JA (2009). Retrovirally transduced murine T lymphocytes expressing FasL mediate effective killing of prostate cancer cells. Cancer Gene Ther  16, 439-52.   https://doi.org/10.1038/cgt.2008.96




PubMed



        
     
Free Article


 


PubMed ID 19096446
         Pubmed Central ID 2857530",https://intramural.nih.gov/search/searchview.taf?ipid=63410
569,BC011220-02,"October 01, 2009 -  September 30, 2010",Understanding T Cell Rapamycin Resistance,Daniel H Fowler,NULL,"Experimental Transplantation and Immunology Branch, NCI","Shoba M Amarnath



Tania Cristina Felizardo



J  Foley



Anu  Gangopadhyay



Miriam E Mossoba","Carl  June
(University of Penn)




Bruce  Levine
(Abramson Family Cancer Research Center, University of Pennsylvania)",NULL,David F Stroncek; MD (CC),"Ordered by publication type and then author name.



1.
Amarnath S, Flomerfelt FA, Costanzo CM, Foley JE, Mariotti J, Konecki DM, Gangopadhyay A, Eckhaus M, Wong S, Levine BL, June CH, Fowler DH (2010). Rapamycin generates anti-apoptotic human Th1/Tc1 cells via autophagy for induction of xenogeneic GVHD. Autophagy  6, 523-41.   https://doi.org/10.4161/auto.6.4.11811




PubMed



        
     
Free Article


 


PubMed ID 20404486
         Pubmed Central ID 3707503 


 



2.
Fowler D, Hoffmann P, Edinger M (2009). Functionally defined T cell subsets in transplantation biology and therapy: regulatory T cells and Th2 cells. Cancer Treat Res  144, 155-86.   https://doi.org/10.1007/978-0-387-78580-6_7




PubMed


 


PubMed ID 19779870
    
     


 



3.
Granville CA, Memmott RM, Balogh A, Mariotti J, Kawabata S, Han W, Lopiccolo J, Foley J, Liewehr DJ, Steinberg SM, Fowler DH, Hollander MC, Dennis PA (2009). A central role for Foxp3+ regulatory T cells in K-Ras-driven lung tumorigenesis. PLoS One  4, e5061.   https://doi.org/10.1371/journal.pone.0005061




PubMed



        
     
Free Article


 


PubMed ID 19330036
         Pubmed Central ID 2659439",https://intramural.nih.gov/search/searchview.taf?ipid=63411
570,BC011222-02,"October 01, 2009 -  September 30, 2010",CNS sirtuins in radiation-induced vascular permeability and neurodegeneration,Deedee Kay Smart,Kevin A Camphausen; MD,"Radiation Oncology Branch, NCI",NULL,NULL,Jane Beth Trepel (Medical Oncology Branch),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63457
571,BC011223-02,"October 01, 2009 -  September 30, 2010",Function of O-GlcNAc-modified Human RNA Polymerase II in Transcription,Brian  Lewis,NULL,"Lymphoid Malignancies Branch, NCI","Jason Alexander Piotrowski; BA, MS",NULL,NULL,John Allan Hanover; PhD (NIDDK),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63443
572,BC011224-02,"October 01, 2009 -  September 30, 2010",Wnt-Dependent Neurite Outgrowth in Ewing Tumor Cells,"Jeffrey S Rubin; MD, PhD",NULL,"Laboratory of Cellular and Molecular Biology, NCI","Maria  Melikova; PhD



Yoshimi Endo Greer",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63452
573,BC011225-02,"October 01, 2009 -  September 30, 2010",Identification of Molecular Factors Associated with Response to Interleukin-2,"James Chung-Yin Yang; MD, PhD



IRP Faculty Profile",NULL,"Surgery Branch, NCI","William D Jones



Qiong J Wang",NULL,NULL,"Ena  Wang (CC) 



Marianna  Sabatino (CC) 



Francesco M. Marincola; MD (CC)",There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=63472
574,BC011226-02,"October 01, 2009 -  September 30, 2010",Optimization of tissue depletion for LCM-MS coupling,Donald J Johann,Giuseppe  Giaccone; MD,"Medical Oncology Branch, NCI",Sumana  Mukherjee,NULL,"Michael R Emmert-Buck; MD, PhD (Laboratory of Pathology)",NULL,"Ordered by publication type and then author name.



1.
Johann DJ, Rodriguez-Canales J, Mukherjee S, Prieto DA, Hanson JC, Emmert-Buck M, Blonder J (2009). Approaching solid tumor heterogeneity on a cellular basis by tissue proteomics using laser capture microdissection and biological mass spectrometry. J Proteome Res  8, 2310-8.   https://doi.org/10.1021/pr8009403




PubMed



        
     
Free Article


 


PubMed ID 19284784
         Pubmed Central ID 2858576 


 



2.
Mbeunkui F, Johann DJ (2009). Cancer and the tumor microenvironment: a review of an essential relationship. Cancer Chemother Pharmacol  63, 571-82.   https://doi.org/10.1007/s00280-008-0881-9




PubMed



        
     
Free Article


 


PubMed ID 19083000
         Pubmed Central ID 2858592",https://intramural.nih.gov/search/searchview.taf?ipid=63430
575,BC011227-02,"October 01, 2009 -  September 30, 2010",Estrogen metabolite profiling of thin tissue sections,Donald J Johann,Giuseppe  Giaccone; MD,"Medical Oncology Branch, NCI",NULL,NULL,"Michael R Emmert-Buck; MD, PhD (Laboratory of Pathology)",NULL,"Ordered by publication type and then author name.



1.
Johann DJ, Rodriguez-Canales J, Mukherjee S, Prieto DA, Hanson JC, Emmert-Buck M, Blonder J (2009). Approaching solid tumor heterogeneity on a cellular basis by tissue proteomics using laser capture microdissection and biological mass spectrometry. J Proteome Res  8, 2310-8.   https://doi.org/10.1021/pr8009403




PubMed



        
     
Free Article


 


PubMed ID 19284784
         Pubmed Central ID 2858576",https://intramural.nih.gov/search/searchview.taf?ipid=63431
576,BC011228-02,"October 01, 2009 -  September 30, 2010",Tumor-Reactive Immune Cells Generated from Drosphila Antigen Presenting Cells,"James Chung-Yin Yang; MD, PhD



IRP Faculty Profile",NULL,"Surgery Branch, NCI",Qiong J Wang,"Mann-Cheong  Fung
(Johnson and Johnson)




Didier  Leturcq
(Johnson and Johnson)",NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=63471
577,BC011229-02,"October 01, 2009 -  September 30, 2010",Mechanisms of Tumor Cell Dormancy and Tumor Recurrence,Jeffrey E Green; MD,NULL,"Laboratory of Cancer Biology and Genetics, NCI","Isabel  Chu



Aleksandra M Michalowska



Seung-Myung  Dong



Lara Helmi el Touny



Ziyao M Liu","Thorkel  Andresson
(NCI-FCRDC)




Mina  Bissell
(Lawrence Berkeley National Laboratory)




Ann  Chambers
(London Regional Cancer Center)




Goberdhan  Dimri
(Wayne State)




Jack  Gauldie
(McMaster)




Tim  Veenstra
(NCI-FCRDC)","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)



James B Mitchell; PhD (Radiation Biology Branch)



Chand  Khanna; MD (Pediatric Oncology Branch)","Mark  Hoenerhoff; DVM, PhD (NIEHS)","Ordered by publication type and then author name.



1.
Hoenerhoff MJ, Chu I, Barkan D, Liu ZY, Datta S, Dimri GP, Green JE (2009). BMI1 cooperates with H-RAS to induce an aggressive breast cancer phenotype with brain metastases. Oncogene  28, 3022-32.   https://doi.org/10.1038/onc.2009.165




PubMed



        
     
Free Article


 


PubMed ID 19543317
         Pubmed Central ID 2733922",https://intramural.nih.gov/search/searchview.taf?ipid=63414
578,BC011230-02,"October 01, 2009 -  September 30, 2010",Gastric Cancer Therapy and Genetically Engineered Mouse Models,Jeffrey E Green; MD,NULL,"Laboratory of Cancer Biology and Genetics, NCI","Seung-Myung  Dong



Aleksandra M Michalowska



Ziyao M Liu



Tinghu  Qiu","Hark  Kim
(National Cancer Center)




Tim  Veenstra
(NCI-FCRDC)




Ming  Yi",Robert J Fisher (Office Of The Director),NULL,"Ordered by publication type and then author name.



1.
Kim HK, Reyzer ML, Choi IJ, Kim CG, Kim HS, Oshima A, Chertov O, Colantonio S, Fisher RJ, Allen JL, Caprioli RM, Green JE (2010). Gastric cancer-specific protein profile identified using endoscopic biopsy samples via MALDI mass spectrometry. J Proteome Res  9, 4123-30.   https://doi.org/10.1021/pr100302b




PubMed



        
     
Free Article


 


PubMed ID 20557134
         Pubmed Central ID 3441055",https://intramural.nih.gov/search/searchview.taf?ipid=63415
579,BC011231-02,"October 01, 2009 -  September 30, 2010",Clinical Trial of AZD0530 in Recurrent Osteosarcoma,Su-Young  Kim,Crystal L. Mackall; MD,"Pediatric Oncology Branch, NCI",NULL,NULL,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=63434
580,BC011232-02,"October 01, 2009 -  September 30, 2010",A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead,"Joseph John Barchi



IRP Faculty Profile",NULL,"Chemical Biology Laboratory, NCI","Kristie M Adams



M A Siddiqui







Joel Patrick Schneider; PhD","Frank  Delaglio; PhD





Susan  Keay





Alex  Mackerell Jr
(University of Maryland)",NULL,Daron  Freedberg (OD),"Ordered by publication type and then author name.



1.
Barchi J, Tocci G, Keay S, Adams K, Zhang C, Koch K, Grkovic D, Guo L, Michejda C, Barchi J (2010) Structure-Activity Studies on Antiproliferative Factor (APF) Glycooctapeptide Derivatives. ACS Medicinal Chemistry Letters Article ASAP:5.




 



2.
Barchi JJ, Kaczmarek P (2009). Short and sweet: evolution of a small glycopeptide from a bladder disorder to an anticancer lead. Mol Interv  9, 14-7.   https://doi.org/10.1124/mi.9.1.5




PubMed



        
     
Free Article


 


PubMed ID 19299659
         Pubmed Central ID 3139374",https://intramural.nih.gov/search/searchview.taf?ipid=63394
581,BC011233-02,"October 01, 2009 -  September 30, 2010",Structural Bioinformatics,"Byungkook  Lee; PhD



IRP Faculty Profile",NULL,"Molecular Modeling Section, NCI","Dukka Bahadur Kc



Bangalore K Sathyanarayana



Chin-Hsien  Tai



Todd J Taylor","Jean  Garnier; PhD





Jean-Francois  Gibrat
(INRA)",NULL,"Peter Jonathan Munson; BA, MA, PhD (CIT)","Ordered by publication type and then author name.



1.
Kim C, Tai CH, Lee B (2009). Iterative refinement of structure-based sequence alignments by Seed Extension. BMC Bioinformatics  10, 210.   https://doi.org/10.1186/1471-2105-10-210




PubMed



        
     
Free Article


 


PubMed ID 19589133
         Pubmed Central ID 2753854 


 



2.
Tai CH, Vincent JJ, Kim C, Lee B (2009). SE: an algorithm for deriving sequence alignment from a pair of superimposed structures. BMC Bioinformatics  10 Suppl 1, S4.   https://doi.org/10.1186/1471-2105-10-S1-S4




PubMed



        
     
Free Article


 


PubMed ID 19208141
         Pubmed Central ID 2648757",https://intramural.nih.gov/search/searchview.taf?ipid=63442
582,BC011238-02,"October 01, 2009 -  September 30, 2010",Computational Biology,"Byungkook  Lee; PhD



IRP Faculty Profile",NULL,"Molecular Modeling Section, NCI",NULL,"John  Moult
(University of Maryland Biotechnology Institute)




Youngshang  Pak





Ron  Unger; PhD",NULL,NULL,"Ordered by publication type and then author name.



1.
Yomtovian I, Teerakulkittipong N, Lee B, Moult J, Unger R (2010). Composition bias and the origin of ORFan genes. Bioinformatics  26, 996-9.   https://doi.org/10.1093/bioinformatics/btq093




PubMed



        
     
Free Article


 


PubMed ID 20231229
         Pubmed Central ID 2853687",https://intramural.nih.gov/search/searchview.taf?ipid=63441
583,BC011239-02,"October 01, 2009 -  September 30, 2010",Relapse after Allogeneci Hematopoietic Stem Cell Transplantation,Michael R Bishop; MD,NULL,"Experimental Transplantation and Immunology Branch, NCI","Ronald E Gress; MD



Frances  Hakim; PhD



Nancy M Hardy","Sergio  Giralt
(M.D. ANDERSON CANCER CENTER)




Carl  June
(University of Pennsylvania)","Terry J Fry (Pediatric Oncology Branch)



Crystal L. Mackall; MD (Pediatric Oncology Branch)



Alan S Wayne; MD (Pediatric Oncology Branch)",NULL,"Ordered by publication type and then author name.



1.
Bishop MR, Dean RM, Steinberg SM, Odom J, Pollack SM, Pavletic SZ, Sportes C, Gress RE, Fowler DH (2010). Correlation of pretransplant and early post-transplant response assessment with outcomes after reduced-intensity allogeneic hematopoietic stem cell transplantation for non-Hodgkin's lymphoma. Cancer  116, 852-62.   https://doi.org/10.1002/cncr.24845




PubMed



        
     
Free Article


 


PubMed ID 20041482
         Pubmed Central ID 6582966",https://intramural.nih.gov/search/searchview.taf?ipid=63396
584,BC011240-02,"October 01, 2009 -  September 30, 2010",Pathway Analysis in Mouse Model for Astrocytoma via Systems Biology Approach,Terry Anne Van Dyke,NULL,"Office of the Director, NCI","Simone  Difilippantonio



Deborah B Householder",NULL,"Howard A Fine; MD, PhD (Neuro-Oncology Branch)



Karlyne M Reilly; BS, PhD (Mouse Cancer Genetics Program)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63466
585,BC011250-01,"October 01, 2009 -  September 30, 2010",Informatics Solutions to Biomedical Research,Maxwell P Lee; PhD,NULL,"Laboratory of Population Genetics, NCI","Howard H Yang



Kenneth  Buetow; PhD",NULL,"Lalage  Wakefield; PhD (Laboratory of Cancer Biology and Genetics)



Kent W Hunter; PhD (Laboratory of Cancer Biology and Genetics)



Philip  Taylor; MD, ScD (Genetic Epidemiology Branch)



Dinah  Singer; PhD (Experimental Immunology Branch)



Alisa  Goldstein; PhD (Genetic Epidemiology Branch)",NULL,"Ordered by publication type and then author name.



1.
Hu N, Wang C, Ng D, Clifford R, Yang HH, Tang ZZ, Wang QH, Han XY, Giffen C, Goldstein AM, Taylor PR, Lee MP (2009). Genomic characterization of esophageal squamous cell carcinoma from a high-risk population in China. Cancer Res  69, 5908-17.   https://doi.org/10.1158/0008-5472.CAN-08-4622




PubMed



        
     
Free Article


 


PubMed ID 19584285
         Pubmed Central ID 2734334 


 



2.
Kadota M, Sato M, Duncan B, Ooshima A, Yang HH, Diaz-Meyer N, Gere S, Kageyama S, Fukuoka J, Nagata T, Tsukada K, Dunn BK, Wakefield LM, Lee MP (2009). Identification of novel gene amplifications in breast cancer and coexistence of gene amplification with an activating mutation of PIK3CA. Cancer Res  69, 7357-65.   https://doi.org/10.1158/0008-5472.CAN-09-0064




PubMed



        
     
Free Article


 


PubMed ID 19706770
         Pubmed Central ID 2745517 


 



3.
Kadota M, Yang HH, Gomez B, Sato M, Clifford RJ, Meerzaman D, Dunn BK, Wakefield LM, Lee MP (2010). Delineating genetic alterations for tumor progression in the MCF10A series of breast cancer cell lines. PLoS One  5, e9201.   https://doi.org/10.1371/journal.pone.0009201




PubMed



        
     
Free Article


 


PubMed ID 20169162
         Pubmed Central ID 2821407",https://intramural.nih.gov/search/searchview.taf?ipid=67515
586,BC011251-01,"October 01, 2009 -  September 30, 2010",Molecular Genetic Epidemiology of Primary Hepatocellular Carcinoma,Kenneth  Buetow; PhD,NULL,"Laboratory of Population Genetics, NCI","Constance M Cultraro



Michael N Edmonson



Sol  Efroni



Sharon I Greenblum



Ying  Hu; PhD



Daoud M Meerzaman



Show all 10",NULL,"Katherine Ann McGlynn; PhD (Hormonal and Reproductive Epidemiology Branch)



Dinah  Singer; PhD (Experimental Immunology Branch)",NULL,"Ordered by publication type and then author name.



1.
Braun R, Rowe W, Schaefer C, Zhang J, Buetow K (2009). Needles in the haystack: identifying individuals present in pooled genomic data. PLoS Genet  5, e1000668.   https://doi.org/10.1371/journal.pgen.1000668




PubMed



        
     
Free Article


 


PubMed ID 19798441
         Pubmed Central ID 2747273",https://intramural.nih.gov/search/searchview.taf?ipid=67517
587,BC011252-01,"October 01, 2009 -  September 30, 2010",The Cancer Genome Anatomy Projects Genetic Annotation Initiative,Kenneth  Buetow; PhD,NULL,"Laboratory of Population Genetics, NCI","Robert  Clifford



Jenny M Kelley



Maxwell P Lee; PhD



Cu  Nguyen",NULL,"Lalage  Wakefield; PhD (Laboratory of Cancer Biology and Genetics)



Philip  Taylor; MD, ScD (Genetic Epidemiology Branch)



Dinah  Singer; PhD (Experimental Immunology Branch)",NULL,"Ordered by publication type and then author name.



1.
Kadota M, Yang HH, Gomez B, Sato M, Clifford RJ, Meerzaman D, Dunn BK, Wakefield LM, Lee MP (2010). Delineating genetic alterations for tumor progression in the MCF10A series of breast cancer cell lines. PLoS One  5, e9201.   https://doi.org/10.1371/journal.pone.0009201




PubMed



        
     
Free Article


 


PubMed ID 20169162
         Pubmed Central ID 2821407",https://intramural.nih.gov/search/searchview.taf?ipid=67541
588,BC011253-01,"October 01, 2009 -  September 30, 2010",Genetics and Epigenetics of Cancer,Maxwell P Lee; PhD,NULL,"Laboratory of Population Genetics, NCI","Beverly W Duncan



Sheryl A Gere



Mitsutaka  Kadota



Howard H Yang



Kenneth  Buetow; PhD","Charles  Adisa
(Abia State University Teaching Hospital)




Junya  Fukuoka
(Toyama University)","Jiuping  Ji (Office of the Director)



Lalage  Wakefield; PhD (Laboratory of Cancer Biology and Genetics)



Kent W Hunter; PhD (Laboratory of Cancer Biology and Genetics)



Philip  Taylor; MD, ScD (Genetic Epidemiology Branch)



Dinah  Singer; PhD (Experimental Immunology Branch)



Alisa  Goldstein; PhD (Genetic Epidemiology Branch)",NULL,"Ordered by publication type and then author name.



1.
Hu N, Wang C, Ng D, Clifford R, Yang HH, Tang ZZ, Wang QH, Han XY, Giffen C, Goldstein AM, Taylor PR, Lee MP (2009). Genomic characterization of esophageal squamous cell carcinoma from a high-risk population in China. Cancer Res  69, 5908-17.   https://doi.org/10.1158/0008-5472.CAN-08-4622




PubMed



        
     
Free Article


 


PubMed ID 19584285
         Pubmed Central ID 2734334 


 



2.
Kadota M, Sato M, Duncan B, Ooshima A, Yang HH, Diaz-Meyer N, Gere S, Kageyama S, Fukuoka J, Nagata T, Tsukada K, Dunn BK, Wakefield LM, Lee MP (2009). Identification of novel gene amplifications in breast cancer and coexistence of gene amplification with an activating mutation of PIK3CA. Cancer Res  69, 7357-65.   https://doi.org/10.1158/0008-5472.CAN-09-0064




PubMed



        
     
Free Article


 


PubMed ID 19706770
         Pubmed Central ID 2745517",https://intramural.nih.gov/search/searchview.taf?ipid=67543
589,BC011254-01,"October 01, 2009 -  September 30, 2010",Molecular Genetic Epidemiology of Leading  U.S. Cancers,Kenneth  Buetow; PhD,NULL,"Laboratory of Population Genetics, NCI",NULL,NULL,Barbara  Dunn (Basic Prevention Science Research Group),NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=67545
590,BC011255-01,"October 01, 2009 -  September 30, 2010",Genetic Modifiers of Intitiation and Progression of Mammary Cancer,"Kent W Hunter; PhD



IRP Faculty Profile",NULL,"Laboratory of Cancer Biology and Genetics, NCI","Jude  Alsarraj



Lalage  Wakefield; PhD



Thomas Rudolf Geiger



Natalie E Goldberger; PhD



Luanne M Lukes



Renard Cerrell Walker



Show all 8","Hoda  Anton-Culver
(Department of Epidemiology, UCI)




John  Foekens
(Erasmus University)




Daniel  Pomp
(UNC)




David  Threadgill; PhD
(Department of Genetics, University of North Carolina School of Medicine)",Douglas  Lowy; MD (Laboratory of Cellular Oncology),Keiko  Ozato; PhD (NICHD),"Ordered by publication type and then author name.



1.
Crawford NP, Yang H, Mattaini KR, Hunter KW (2009). The metastasis efficiency modifier ribosomal RNA processing 1 homolog B (RRP1B) is a chromatin-associated factor. J Biol Chem  284, 28660-73.   https://doi.org/10.1074/jbc.M109.023457




PubMed



        
     
Free Article


 


PubMed ID 19710015
         Pubmed Central ID 2781410 


 



2.
Hancock H, Dreher MR, Crawford N, Pollock CB, Shih J, Wood BJ, Hunter K, Frenkel V (2009). Evaluation of pulsed high intensity focused ultrasound exposures on metastasis in a murine model. Clin Exp Metastasis  26, 729-38.   https://doi.org/10.1007/s10585-009-9272-9




PubMed



        
     
Free Article


 


PubMed ID 19517258
         Pubmed Central ID 4136696 


 



3.
Hsieh SM, Look MP, Sieuwerts AM, Foekens JA, Hunter KW (2009). Distinct inherited metastasis susceptibility exists for different breast cancer subtypes: a prognosis study. Breast Cancer Res  11, R75.   https://doi.org/10.1186/bcr2412




PubMed



        
     
Free Article


 


PubMed ID 19825179
         Pubmed Central ID 2790856 


 



4.
Hsieh SM, Smith RA, Lintell NA, Hunter KW, Griffiths LR (2009). Polymorphisms of the SIPA1 gene and sporadic breast cancer susceptibility. BMC Cancer  9, 331.   https://doi.org/10.1186/1471-2407-9-331




PubMed



        
     
Free Article


 


PubMed ID 19765277
         Pubmed Central ID 2751777 


 



5.
Hunter K, Hunter K (2009) Metastasis. Wiley Interdisciplinary Reviews: Systems Biology and Medicine 89-96.




 



6.
Hunter K, La Merrill M, Hunter K, Threadgill D, Pomp D (2010) Genetic architecture of tumor gene expression in dietary fat responsive mouse metastatic mammary cancer. Clinical and Experimental Metastasis, in press.




 



7.
Hunter K, Osborne T, Khan A, Campbell K, Briggs J, Buquo L, Ren L, Hewitt S, Dakir E, Garfield S, Walker R, Merlino G, Green J, Hunter K, Wakefield L, Hong S, Khanna C (2010) An ex vivo lung culture assay provides a novel perspective on cancer metastasis. Journal of Clinical Investigation, in press.




 



8.
Hunter KW, Alsarraj J (2009). Gene expression profiles and breast cancer metastasis: a genetic perspective. Clin Exp Metastasis  26, 497-503.   https://doi.org/10.1007/s10585-009-9249-8




PubMed



        
     
Free Article


 


PubMed ID 19347591
         Pubmed Central ID 6563922 


 



9.
Lukes L, Crawford NP, Walker R, Hunter KW (2009). The origins of breast cancer prognostic gene expression profiles. Cancer Res  69, 310-8.   https://doi.org/10.1158/0008-5472.CAN-08-3520




PubMed



        
     
Free Article


 


PubMed ID 19118016
         Pubmed Central ID 2613551 


 



10.
Qian X, Li G, Vass WC, Papageorge A, Walker RC, Asnaghi L, Steinbach PJ, Tosato G, Hunter K, Lowy DR (2009). The Tensin-3 protein, including its SH2 domain, is phosphorylated by Src and contributes to tumorigenesis and metastasis. Cancer Cell  16, 246-58.   https://doi.org/10.1016/j.ccr.2009.07.031




PubMed



        
     
Free Article


 


PubMed ID 19732724
         Pubmed Central ID 3293497",https://intramural.nih.gov/search/searchview.taf?ipid=67547
591,BC011256-01,"October 01, 2009 -  September 30, 2010",Molecular Targets - Colon Cancer,Kenneth  Buetow; PhD,NULL,"Laboratory of Population Genetics, NCI",NULL,NULL,NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=67550
592,BC011258-01,"October 01, 2009 -  September 30, 2010",Analysis of tumor cell death on antigen-specific immune responses,"Tim Friedrich Greten



IRP Faculty Profile",NULL,"Medical Oncology Branch, NCI","Jaba  Gamrekelashvili



Tamar  Kapanadze","Lothar  JÃ¤ntsch
(Helmholtz Centre for Infection Research)




Michael Peter Manns; MD
(epartment of Gastroenterology and Hepatology, edizinische Hochschule Hannover)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=67577
593,BC011259-01,"October 01, 2009 -  September 30, 2010",Effect of the Ras oncogene on genomic stability,"Ji  Luo



IRP Faculty Profile",NULL,"Medical Oncology Branch, NCI",NULL,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=67579
594,BC011260-01,"October 01, 2009 -  September 30, 2010",Study the chromatin binding proteins in embryonic stem cells,"Jing  Huang



IRP Faculty Profile",NULL,"Laboratory of Cancer Biology and Genetics, NCI",Mangmang  Li,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=67581
595,BC011261-01,"October 01, 2009 -  September 30, 2010",Molecule-Guided Investigations into p53 Biology,"Federico  Bernal



IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",Elisabeth Avery Russell,"Douglas  Green; PhD
(St. Jude Children's Hospital)




Charles  Stiles
(Dana-Farber Cancer Institute)




Geoffrey  Wahl
(The Salk Institute for Biological Studies)




Loren  Walensky
(Dana-Farber Cancer Institute)




Richard  Williams
(St. Jude Children's Research Hospital)",NULL,NULL,"Ordered by publication type and then author name.



1.
Bernal F, Wade M, Godes M, Davis TN, Whitehead DG, Kung AL, Wahl GM, Walensky LD (2010). A stapled p53 helix overcomes HDMX-mediated suppression of p53. Cancer Cell  18, 411-22.   https://doi.org/10.1016/j.ccr.2010.10.024




PubMed



        
     
Free Article


 


PubMed ID 21075307
         Pubmed Central ID 3050021",https://intramural.nih.gov/search/searchview.taf?ipid=67583
596,BC011262-01,"October 01, 2009 -  September 30, 2010",Optimization of the Chemistry of Hydrocarbon-Stabilized Peptides,"Federico  Bernal



IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",Elisabeth Avery Russell,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Bernal F, Wade M, Godes M, Davis TN, Whitehead DG, Kung AL, Wahl GM, Walensky LD (2010). A stapled p53 helix overcomes HDMX-mediated suppression of p53. Cancer Cell  18, 411-22.   https://doi.org/10.1016/j.ccr.2010.10.024




PubMed



        
     
Free Article


 


PubMed ID 21075307
         Pubmed Central ID 3050021",https://intramural.nih.gov/search/searchview.taf?ipid=67585
597,BC011263-01,"October 01, 2009 -  September 30, 2010",Mechanisms of HTLV-1 Release and Transmission,Gisela H Fanning-Heidecker,Stephen H Hughes; PhD,"Retroviral Replication Laboratory, NCI","Batsukh  Dorjbal



Shawn A Hill



Anna N Ilinskaya



Patricia A Lloyd



Vladimir  Pak



Gerald L Princler","Alexander  Filatov
(Institute of Immunology)




Thomas M Folks; PhD
(HIV and Retrovirology Branch, CDC)




Walid  Heneine
(-, Centers for Disease Control and Prevention)




Dmitriy  Mazurov
(Institute of Immunology)




Walther  Mothes
(Yale University)




Akira  Ono
(University of Michigan)


Show all 8","Genoveffa  Franchini; MD (Vaccine Branch)



Cynthia  Masison (Laboratory of Cellular Oncology)","Judith Goldstein Levin; PhD (NICHD) 



Fadila  Bouamr; BS, MS, PhD (NIAID)","Ordered by publication type and then author name.



1.
Ilinskaya A, Heidecker G, Derse D (2010) Opposing effects of a tyrosine-based sorting motif and a PDZ-binding motif regulate human T-lymphotropic virus type 1 envelope trafficking. J Virol 84:6995-7004.




PubMed



        
     
Free Article


 


PubMed ID 20463077
         Pubmed Central ID 2898256 


 



2.
Jin J, Sherer NM, Heidecker G, Derse D, Mothes W (2009). Assembly of the murine leukemia virus is directed towards sites of cell-cell contact. PLoS Biol  7, e1000163.   https://doi.org/10.1371/journal.pbio.1000163




PubMed



        
     
Free Article


 


PubMed ID 19636361
         Pubmed Central ID 2709449 


 



3.
Mazurov D, Ilinskaya A, Heidecker G, Lloyd P, Derse D (2010) Quantitative comparison of HTLV-1 and HIV-1 cell-to-cell infection with new replication dependent vectors. PLoS Pathog 6:e1000788.




PubMed



        
     
Free Article


 


PubMed ID 20195464
         Pubmed Central ID 2829072",https://intramural.nih.gov/search/searchview.taf?ipid=67587
598,BC011264-01,"October 01, 2009 -  September 30, 2010",Glucocorticoids and T cell development and function,"Jonathan D Ashwell; MD



IRP Faculty Profile",NULL,"Laboratory of Immune Cell Biology, NCI",Paul  Mittelstadt; PhD,NULL,NULL,"Daniel C Douek; MD (NIAID) 



Dragana  Jankovic; PhD (NIAID)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=67589
599,BC011266-01,"October 01, 2009 -  September 30, 2010",Retrovirus-APOBEC3 Interactions,Gisela H Fanning-Heidecker,Stephen H Hughes; PhD,"Retroviral Replication Laboratory, NCI","Shawn A Hill



Patricia A Lloyd



Vladimir  Pak



Gerald L Princler",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
LaRue RS, Andrésdóttir V, Blanchard Y, Conticello SG, Derse D, Emerman M, Greene WC, Jónsson SR, Landau NR, Löchelt M, Malik HS, Malim MH, Münk C, O'Brien SJ, Pathak VK, Strebel K, Wain-Hobson S, Yu XF, Yuhki N, Harris RS (2009). Guidelines for naming nonprimate APOBEC3 genes and proteins. J Virol  83, 494-7.   https://doi.org/10.1128/JVI.01976-08




PubMed



        
     
Free Article


 


PubMed ID 18987154
         Pubmed Central ID 2612408",https://intramural.nih.gov/search/searchview.taf?ipid=67593
600,BC011267-01,"October 01, 2009 -  September 30, 2010",Preclinical drug development in pancreas cancer,"Udo  Rudloff



IRP Faculty Profile",NULL,"Surgery Branch, NCI","Anne Michele Miermont-Eltejaye



Yaroslav  Teper",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=67595
601,BC011268-01,"October 01, 2009 -  September 30, 2010",Lung Cancer Stem Cell program,Giuseppe  Giaccone; MD,NULL,"Medical Oncology Branch, NCI","Alan  Lee



Kathleen Mary Tompkins",NULL,"Curtis  Harris; MD (Laboratory of Human Carcinogenesis)



David  Schrump; MD (Surgery Branch)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=67597
602,BC011269-01,"October 01, 2009 -  September 30, 2010",Thorarcic Cancer Research Laboratory,Giuseppe  Giaccone; MD,NULL,"Medical Oncology Branch, NCI","Arlene Wendy Berman



Guinevere Joy Ng Chun



Roopa  Dechowdhury



Taishi  Harada



Corrine Marie Keen



Ronan J Kelly



Show all 18",NULL,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)



Terry  Moody; PhD (Office of the Director)



Curtis  Harris; MD (Laboratory of Human Carcinogenesis)",NULL,"Ordered by publication type and then author name.



1.
Ceresa C, Giovannetti E, Voortman J, Laan AC, Honeywell R, Giaccone G, Peters GJ (2009). Bortezomib induces schedule-dependent modulation of gemcitabine pharmacokinetics and pharmacodynamics in non-small cell lung cancer and blood mononuclear cells. Mol Cancer Ther  8, 1026-36.   https://doi.org/10.1158/1535-7163.MCT-08-0700




PubMed


 


PubMed ID 19383850
    
     


 



2.
Hwang JH, Voortman J, Giovannetti E, Steinberg SM, Leon LG, Kim YT, Funel N, Park JK, Kim MA, Kang GH, Kim SW, Del Chiaro M, Peters GJ, Giaccone G (2010). Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer. PLoS One  5, e10630.   https://doi.org/10.1371/journal.pone.0010630




PubMed



        
     
Free Article


 


PubMed ID 20498843
         Pubmed Central ID 2871055 


 



3.
Moody TW, Berna MJ, Mantey S, Sancho V, Ridnour L, Wink DA, Chan D, Giaccone G, Jensen RT (2010). Neuromedin B receptors regulate EGF receptor tyrosine phosphorylation in lung cancer cells. Eur J Pharmacol  637, 38-45.   https://doi.org/10.1016/j.ejphar.2010.03.057




PubMed



        
     
Free Article


 


PubMed ID 20388507
         Pubmed Central ID 3921891 


 



4.
Moody TW, Switzer C, Santana-Flores W, Ridnour LA, Berna M, Thill M, Jensen RT, Sparatore A, Del Soldato P, Yeh GC, Roberts DD, Giaccone G, Wink DA (2010). Dithiolethione modified valproate and diclofenac increase E-cadherin expression and decrease proliferation of non-small cell lung cancer cells. Lung Cancer  68, 154-60.   https://doi.org/10.1016/j.lungcan.2009.06.012




PubMed



        
     
Free Article


 


PubMed ID 19628293
         Pubmed Central ID 3835159",https://intramural.nih.gov/search/searchview.taf?ipid=67599
603,BC011272-01,"October 01, 2009 -  September 30, 2010",Regulation of HTLV-1 Transcription,Cynthia  Masison,Douglas  Lowy; MD,"Laboratory of Cellular Oncology, NCI","Won-Kyung  Cho



Sebastine  Chevalier",NULL,NULL,Moon Kyoo  Jang; PhD (NIAID),"Ordered by publication type and then author name.



1.
Zhou M, Huang K, Jung KJ, Cho WK, Klase Z, Kashanchi F, Pise-Masison CA, Brady JN (2009) Bromodomain protein Brd4 regulates human immunodeficiency virus transcription through phosphorylation of CDK9 at threonine 29. J Virol 83:1036-44.




PubMed



        
     
Free Article


 


PubMed ID 18971272
         Pubmed Central ID 2612389",https://intramural.nih.gov/search/searchview.taf?ipid=67606
604,BC011275-01,"October 01, 2009 -  September 30, 2010",Gene expression and regulation in endocrine cancers,"Electron  Kebebew; MD



IRP Faculty Profile",NULL,"Surgery Branch, NCI","Mei  He



Mio  Kitano



Nesrin S Rechache



Yin  Xiong; PhD



Krisana  Gesuwan



Meenu  Jain



Show all 9","Frank  Rauscher
(The Wistar Institute)




Martha  Zeiger
(Surgery, Johns Hopkins)","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)



Antonio  Fojo; MD, PhD (Medical Oncology Branch)","Constantine Argyrios Stratakis; MD, DSc (NICHD) 



Karel  Pacak; MD, PhD (NICHD)","Ordered by publication type and then author name.



1.
Arcinas A, Yen TY, Kebebew E, Macher BA (2009). Cell surface and secreted protein profiles of human thyroid cancer cell lines reveal distinct glycoprotein patterns. J Proteome Res  8, 3958-68.   https://doi.org/10.1021/pr900278c




PubMed



        
     
Free Article


 


PubMed ID 19530676
         Pubmed Central ID 2735218 


 



2.
Bauer J, Weng J, Kebebew E, Soares P, Trovisco V, Bastian BC (2009). Germline variation of the melanocortin-1 receptor does not explain shared risk for melanoma and thyroid cancer. Exp Dermatol  18, 548-52.   https://doi.org/10.1111/j.1600-0625.2008.00827.x




PubMed



        
     
Free Article


 


PubMed ID 19493000
         Pubmed Central ID 2862686 


 



3.
Fernandez-Ranvier GG, Khanafshar E, Tacha D, Wong M, Kebebew E, Duh QY, Clark OH (2009). Defining a molecular phenotype for benign and malignant parathyroid tumors. Cancer  115, 334-44.   https://doi.org/10.1002/cncr.24037




PubMed


 


PubMed ID 19107770
    
     


 



4.
Meyer-Rochow GY, Jackson NE, Conaglen JV, Whittle DE, Kunnimalaiyaan M, Chen H, Westin G, Sandgren J, Stålberg P, Khanafshar E, Shibru D, Duh QY, Clark OH, Kebebew E, Gill AJ, Clifton-Bligh R, Robinson BG, Benn DE, Sidhu SB (2010). MicroRNA profiling of benign and malignant pheochromocytomas identifies novel diagnostic and therapeutic targets. Endocr Relat Cancer  17, 835-46.   https://doi.org/10.1677/ERC-10-0142




PubMed


 


PubMed ID 20621999
    
     


 



5.
Moses W, Weng J, Sansano I, Peng M, Khanafshar E, Ljung BM, Duh QY, Clark OH, Kebebew E (2010). Molecular testing for somatic mutations improves the accuracy of thyroid fine-needle aspiration biopsy. World J Surg  34, 2589-94.   https://doi.org/10.1007/s00268-010-0720-0




PubMed



        
     
Free Article


 


PubMed ID 20703476
         Pubmed Central ID 2949559 


 



6.
Suh I, Guerrero MA, Kebebew E (2009). Gene-expression profiling of adrenocortical carcinoma. Expert Rev Mol Diagn  9, 343-51.   https://doi.org/10.1586/erm.09.13




PubMed


 


PubMed ID 19441174
    
     


 



7.
Suh I, Shibru D, Eisenhofer G, Pacak K, Duh QY, Clark OH, Kebebew E (2009). Candidate genes associated with malignant pheochromocytomas by genome-wide expression profiling. Ann Surg  250, 983-90.   https://doi.org/10.1097/SLA.0b013e3181b248bb




PubMed


 


PubMed ID 19661783",https://intramural.nih.gov/search/searchview.taf?ipid=67609
605,BC011276-01,"October 01, 2009 -  September 30, 2010",Inhibition of p53 Tumor Suppressor Function,Cynthia  Masison,Douglas  Lowy; MD,"Laboratory of Cellular Oncology, NCI",Dustin  Edwards,NULL,"Thomas Alexander Waldmann; MD, PhD (Lymphoid Malignancies Branch)



Genoveffa  Franchini; MD (Vaccine Branch)",NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=67611
606,BC011277-01,"October 01, 2009 -  September 30, 2010",Procaspase 3 activator compounds combined with X-ray irradiation,Karl Erick Haglund,Kevin A Camphausen; MD,"Radiation Oncology Branch, NCI",Kheem Singh Bisht,NULL,NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=67613
607,BC011278-01,"October 01, 2009 -  September 30, 2010",Mechanisms of Early Stage Mammary Tumorigenesis,Terry Anne Van Dyke,NULL,"Office of the Director, NCI","Sanaz Arkani Jansen



Xiuyun  Lu



Linda S Cleveland",NULL,"Joseph D Kalen (Office Of The Director)



Peter L Choyke; MD (Molecular Imaging Program)","Roberto  Weigert; MSc Chemistry, PhD (NIDCR)",There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=67615
608,BC011280-01,"October 01, 2009 -  September 30, 2010",Cancer Therapy Trials using novel vaccine platforms,"Ravi  Madan



IRP Faculty Profile",Giuseppe  Giaccone; MD,"Medical Oncology Branch, NCI","Philip M Arlen; MD



William D Figg; PharmD",NULL,"William Laurence Dahut; MD (Office of the Director)



Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)



James L Gulley; MD, PhD (Laboratory of Tumor Immunology and Biology)",NULL,"Ordered by publication type and then author name.



1.
Madan RA, Arlen PM, Mohebtash M, Hodge JW, Gulley JL (2009). Prostvac-VF: a vector-based vaccine targeting PSA in prostate cancer. Expert Opin Investig Drugs  18, 1001-11.   https://doi.org/10.1517/13543780902997928




PubMed



        
     
Free Article


 


PubMed ID 19548854
         Pubmed Central ID 3449276 


 



2.
Madan RA, Mohebtash M, Schlom J, Gulley JL (2010). Therapeutic vaccines in metastatic castration-resistant prostate cancer: principles in clinical trial design. Expert Opin Biol Ther  10, 19-28.   https://doi.org/10.1517/14712590903321421




PubMed



        
     
Free Article


 


PubMed ID 19857185
         Pubmed Central ID 6628898",https://intramural.nih.gov/search/searchview.taf?ipid=67617
609,BC011281-01,"October 01, 2009 -  September 30, 2010",Combination therapies involving novel cancer vaccines,"Ravi  Madan



IRP Faculty Profile",Giuseppe  Giaccone; MD,"Medical Oncology Branch, NCI","Philip M Arlen; MD



William D Figg; PharmD","Robert  DiPaola
(Cancer Center of New Jersey)




Edwin M Posadas","William Laurence Dahut; MD (Office of the Director)



Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)



James L Gulley; MD, PhD (Laboratory of Tumor Immunology and Biology)",NULL,"Ordered by publication type and then author name.



1.
Arlen PM, Mohebtash M, Madan RA, Gulley JL (2009). Promising novel immunotherapies and combinations for prostate cancer. Future Oncol  5, 187-96.   https://doi.org/10.2217/14796694.5.2.187




PubMed



        
     
Free Article


 


PubMed ID 19284377
         Pubmed Central ID 2705770 


 



2.
Kamrava M, Tsang KY, Madan RA, Kaushal A, Coleman CN, Gulley J (2009). Long-term survival and PSA control with radiation and immunotherapy for node positive prostate cancer. Clin Dev Immunol  2009, 363914.   https://doi.org/10.1155/2009/363914




PubMed



        
     
Free Article


 


PubMed ID 20224813
         Pubmed Central ID 2834955 


 



3.
Mohebtash M, Gulley JL, Madan RA, Ferrara T, Arlen PM (2009). Cancer vaccines: current directions and perspectives in prostate cancer. Curr Opin Mol Ther  11, 31-6.




PubMed



        
     
Free Article


 


PubMed ID 19169957
         Pubmed Central ID 3488286 


 



4.
Rotow J, Gameiro SR, Madan RA, Gulley JL, Schlom J, Hodge JW (2010). Vaccines as monotherapy and in combination therapy for prostate cancer. Clin Transl Sci  3, 116-22.   https://doi.org/10.1111/j.1752-8062.2010.00186.x




PubMed



        
     
Free Article


 


PubMed ID 20590682
         Pubmed Central ID 2914613",https://intramural.nih.gov/search/searchview.taf?ipid=67619
610,BC011282-01,"October 01, 2009 -  September 30, 2010",RNAi screen for chromatin modifiers in DNA repair and aging,"Philipp  Oberdoerffer



IRP Faculty Profile",NULL,"Mouse Cancer Genetics Program, NCI","Sandra  Burkett



Katherine M Nyswaner



Lei  Shi",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Sinclair DA, Oberdoerffer P (2009). The ageing epigenome: damaged beyond repair? Ageing Res Rev  8, 189-98.   https://doi.org/10.1016/j.arr.2009.04.004




PubMed



        
     
Free Article


 


PubMed ID 19439199
         Pubmed Central ID 2696802",https://intramural.nih.gov/search/searchview.taf?ipid=67621
611,BC011283-01,"October 01, 2009 -  September 30, 2010",Investigating the role of DNA breaks in mammalian aging,"Philipp  Oberdoerffer



IRP Faculty Profile",NULL,"Mouse Cancer Genetics Program, NCI",Katherine M Nyswaner,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Sinclair DA, Oberdoerffer P (2009). The ageing epigenome: damaged beyond repair? Ageing Res Rev  8, 189-98.   https://doi.org/10.1016/j.arr.2009.04.004




PubMed



        
     
Free Article


 


PubMed ID 19439199
         Pubmed Central ID 2696802",https://intramural.nih.gov/search/searchview.taf?ipid=67623
612,BC011284-01,"October 01, 2009 -  September 30, 2010",Investigating the impact of SIRT1 on age-related mutagenesis in vivo,"Philipp  Oberdoerffer



IRP Faculty Profile",NULL,"Mouse Cancer Genetics Program, NCI",Katherine M Nyswaner,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Sinclair DA, Oberdoerffer P (2009). The ageing epigenome: damaged beyond repair? Ageing Res Rev  8, 189-98.   https://doi.org/10.1016/j.arr.2009.04.004




PubMed



        
     
Free Article


 


PubMed ID 19439199
         Pubmed Central ID 2696802",https://intramural.nih.gov/search/searchview.taf?ipid=67625
613,BC011286-01,"October 01, 2009 -  September 30, 2010",Therapeutic targets and novel anticancer agents for endocrine cancers,"Electron  Kebebew; MD



IRP Faculty Profile",NULL,"Surgery Branch, NCI","Krisana  Gesuwan



Mei  He



Meenu  Jain



Erin Elizabeth Patterson



Nesrin S Rechache



Yin  Xiong; PhD



Show all 7",NULL,NULL,Douglas S Auld (NHGRI),"Ordered by publication type and then author name.



1.
Suh I, Weng J, Fernandez-Ranvier G, Shen WT, Duh QY, Clark OH, Kebebew E (2010). Antineoplastic effects of decitabine, an inhibitor of DNA promoter methylation, in adrenocortical carcinoma cells. Arch Surg  145, 226-32.   https://doi.org/10.1001/archsurg.2009.292




PubMed



        
     
Free Article


 


PubMed ID 20231622
         Pubmed Central ID 3478887",https://intramural.nih.gov/search/searchview.taf?ipid=67629
614,BC011287-01,"October 01, 2009 -  September 30, 2010",Clinical and genetic studies in familial nonmedullary thyroid cancer (FNMTC),"Electron  Kebebew; MD



IRP Faculty Profile",NULL,"Surgery Branch, NCI",Krisana  Gesuwan,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Suh I, Filetti S, Vriens MR, Guerrero MA, Tumino S, Wong M, Shen WT, Kebebew E, Duh QY, Clark OH (2009). Distinct loci on chromosome 1q21 and 6q22 predispose to familial nonmedullary thyroid cancer: a SNP array-based linkage analysis of 38 families. Surgery  146, 1073-80.   https://doi.org/10.1016/j.surg.2009.09.012




PubMed


 


PubMed ID 19958934",https://intramural.nih.gov/search/searchview.taf?ipid=67631
615,BC011293-01,"October 01, 2009 -  September 30, 2010",Impact of chromatin structure on alternative splicing of CD45 pre-mRNA,"Shalini  Oberdoerffer



IRP Faculty Profile",NULL,"Mouse Cancer Genetics Program, NCI","Melissa K Gregory



Philipp  Oberdoerffer



Sanjeev  Shukla",NULL,Robert H Stephens (Business Operations Branch),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=67637
616,BC011294-01,"October 01, 2009 -  September 30, 2010",Conditional manipulation of hnRNPLL expression in murine models,"Shalini  Oberdoerffer



IRP Faculty Profile",NULL,"Mouse Cancer Genetics Program, NCI",Bojan  Shutinoski; PhD,NULL,NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=67639
617,BC011295-01,"October 01, 2009 -  September 30, 2010",Optimizing the graft versus leukemia effect for pediatric ALL,"Terry J Fry



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI","Crystal L. Mackall; MD



Haiying  Qin



Jessica Carolyn Shand",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Fry TJ, Shand JL, Milliron M, Tasian SK, Mackall CL (2009). Antigen loading of DCs with irradiated apoptotic tumor cells induces improved anti-tumor immunity compared to other approaches. Cancer Immunol Immunother  58, 1257-64.   https://doi.org/10.1007/s00262-008-0638-7




PubMed



        
     
Free Article


 


PubMed ID 19139888
         Pubmed Central ID 2791794",https://intramural.nih.gov/search/searchview.taf?ipid=67641
618,BC011296-01,"October 01, 2009 -  September 30, 2010",Development of dipeptidyl peptidase inhibitors as novel immune adjuvants,"Terry J Fry



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI","Brynn  Duncan



Najat  Bouchkouj; MD",NULL,Bradford J Wood; MD (Office of the Director),NULL,"Ordered by publication type and then author name.



1.
Dromi SA, Walsh MP, Herby S, Traughber B, Xie J, Sharma KV, Sekhar KP, Luk A, Liewehr DJ, Dreher MR, Fry TJ, Wood BJ (2009). Radiofrequency ablation induces antigen-presenting cell infiltration and amplification of weak tumor-induced immunity. Radiology  251, 58-66.   https://doi.org/10.1148/radiol.2511072175




PubMed



        
     
Free Article


 


PubMed ID 19251937
         Pubmed Central ID 2663580",https://intramural.nih.gov/search/searchview.taf?ipid=67643
619,BC011298-01,"October 01, 2009 -  September 30, 2010",Ph I Radiation and Lenalidomide in pediatric malignant glioma,"Katherine Elizabeth Warren; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI","Robyn S Bent



Sean Joseph Hipp



Laurie  Steffen",NULL,"Kevin A Camphausen; MD (Radiation Oncology Branch)



Deborah E Citrin (Radiation Oncology Branch)",Joelle  Sarlls; PhD (NICHD),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=67645
620,BC011299-01,"October 01, 2009 -  September 30, 2010",Noninvasive Evaluation of Pediatric CNS Tumors,"Katherine Elizabeth Warren; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI",NULL,NULL,"Karen A Kurdziel; MD (Molecular Imaging Program)



Peter L Choyke; MD (Molecular Imaging Program)",Dima Ali Hammoud; MD (CC),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=67647
621,BC011300-01,"October 01, 2009 -  September 30, 2010",CANCER AND INFLAMMATION GENETICS,"Michael  Dean; PhD



IRP Faculty Profile",NULL,"Laboratory of Experimental Immunology, NCI","Zhang-Qun  Chen



Stephen K Anderson; PhD



Albert M Gold



Silvia  Jimenez-Morales



Brittany  Kostiha



Kate M McGee



Show all 10","Federico  Antillon
(UNOP)




Ken  Offitt
(Medicine, Sloan Kettering Cancer Center)




Lorena  Orozco
(INMEGEN)




Ana  Ortiz
(University of Puerto Rico Comprehensive Cancer Center)","Meredith  Yeager (Office of the Director)



Nadya I Tarasova; PhD (Cancer Inflammation Program)",NULL,"Ordered by publication type and then author name.



1.
Kirchhoff T, Chen ZQ, Gold B, Pal P, Gaudet MM, Kosarin K, Levine DA, Gregersen P, Spencer S, Harlan M, Robson M, Klein RJ, Hudis CA, Norton L, Dean M, Offit K (2009). The 6q22.33 locus and breast cancer susceptibility. Cancer Epidemiol Biomarkers Prev  18, 2468-75.   https://doi.org/10.1158/1055-9965.EPI-09-0151




PubMed



        
     
Free Article


 


PubMed ID 19690183
         Pubmed Central ID 4286363 


 



2.
Lou H, Yeager M, Li H, Bosquet JG, Hayes RB, Orr N, Yu K, Hutchinson A, Jacobs KB, Kraft P, Wacholder S, Chatterjee N, Feigelson HS, Thun MJ, Diver WR, Albanes D, Virtamo J, Weinstein S, Ma J, Gaziano JM, Stampfer M, Schumacher FR, Giovannucci E, Cancel-Tassin G, Cussenot O, et al. [11 more authors] (2009). Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibility. Proc Natl Acad Sci U S A  106, 7933-8.   https://doi.org/10.1073/pnas.0902104106




PubMed



        
     
Free Article


 


PubMed ID 19383797
         Pubmed Central ID 2671324 


 



3.
Yeager M, Deng Z, Boland J, Matthews C, Bacior J, Lonsberry V, Hutchinson A, Burdett LA, Qi L, Jacobs KB, Gonzalez-Bosquet J, Berndt SI, Hayes RB, Hoover RN, Thomas G, Hunter DJ, Dean M, Chanock SJ (2009). Comprehensive resequence analysis of a 97 kb region of chromosome 10q11.2 containing the MSMB gene associated with prostate cancer. Hum Genet  126, 743-50.   https://doi.org/10.1007/s00439-009-0723-9




PubMed



        
     
Free Article


 


PubMed ID 19644707
         Pubmed Central ID 2778717",https://intramural.nih.gov/search/searchview.taf?ipid=67649
622,BC011301-01,"October 01, 2009 -  September 30, 2010",CANCER AND INFLAMMATION: FUNCTION AND THERAPY,"Michael  Dean; PhD



IRP Faculty Profile",NULL,"Laboratory of Experimental Immunology, NCI","Albert M Gold



Daniel  McVicar; PhD



Karobi  Moitra



Julie  Sawitzke



Wei  Tan



Stephen K Anderson; PhD","Rando  Allikmets
(Columbia University)




Ken  Offitt
(Medicine, Sloan Kettering Cancer Center)","Susan  Bates; MD (Medical Oncology Branch)



Meredith  Yeager (Office of the Director)



Antonio  Fojo; MD, PhD (Medical Oncology Branch)



Nadya I Tarasova; PhD (Cancer Inflammation Program)",Daniel R. Weinberger; MD (NIMH),"Ordered by publication type and then author name.



1.
Allikmets R, Bergen AA, Dean M, Guymer RH, Hageman GS, Klaver CC, Stefansson K, Weber BH, International Age-related Macular Degeneration Genetics Consortium (2009). Geographic atrophy in age-related macular degeneration and TLR3. N Engl J Med  360, 2252-4; author reply 2255-6.




PubMed



        
     
Free Article


 


PubMed ID 19469038
         Pubmed Central ID 4853941 


 



2.
Allikmets R, Dean M, Hageman GS, Baird PN, Klaver CC, Bergen AA, Weber BH, International AMD Genetics Consortium (2009). The SERPING1 gene and age-related macular degeneration. Lancet  374, 875-6; author reply 876-7.   https://doi.org/10.1016/S0140-6736(09)61618-4




PubMed



        
     
Free Article


 


PubMed ID 19748388
         Pubmed Central ID 4853912 


 



3.
Bergeron-Sawitzke J, Gold B, Olsh A, Schlotterbeck S, Lemon K, Visvanathan K, Allikmets R, Dean M (2009). Multilocus analysis of age-related macular degeneration. Eur J Hum Genet  17, 1190-9.   https://doi.org/10.1038/ejhg.2009.23




PubMed



        
     
Free Article


 


PubMed ID 19259132
         Pubmed Central ID 2729805 


 



4.
Dean M (2009). ABC transporters, drug resistance, and cancer stem cells. J Mammary Gland Biol Neoplasia  14, 3-9.   https://doi.org/10.1007/s10911-009-9109-9




PubMed


 


PubMed ID 19224345
    
     


 



5.
Li Q, Sadowski S, Frank M, Chai C, Váradi A, Ho SY, Lou H, Dean M, Thisse C, Thisse B, Uitto J (2010). The abcc6a gene expression is required for normal zebrafish development. J Invest Dermatol  130, 2561-8.   https://doi.org/10.1038/jid.2010.174




PubMed



        
     
Free Article


 


PubMed ID 20596085
         Pubmed Central ID 3357064 


 



6.
Lombardi VC, Ruscetti FW, Das Gupta J, Pfost MA, Hagen KS, Peterson DL, Ruscetti SK, Bagni RK, Petrow-Sadowski C, Gold B, Dean M, Silverman RH, Mikovits JA (2009). Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science  326, 585-9.   https://doi.org/10.1126/science.1179052




PubMed


 


PubMed ID 19815723
    
     


 



7.
Polgar O, Ediriwickrema LS, Robey RW, Sharma A, Hegde RS, Li Y, Xia D, Ward Y, Dean M, Ozvegy-Laczka C, Sarkadi B, Bates SE (2009). Arginine 383 is a crucial residue in ABCG2 biogenesis. Biochim Biophys Acta  1788, 1434-43.   https://doi.org/10.1016/j.bbamem.2009.04.016




PubMed



        
     
Free Article


 


PubMed ID 19406100
         Pubmed Central ID 4163909 


 



8.
Robey RW, To KK, Polgar O, Dohse M, Fetsch P, Dean M, Bates SE (2009). ABCG2: a perspective. Adv Drug Deliv Rev  61, 3-13.   https://doi.org/10.1016/j.addr.2008.11.003




PubMed



        
     
Free Article


 


PubMed ID 19135109
         Pubmed Central ID 3105088 


 



9.
Sturm A, Cunningham P, Dean M (2009). The ABC transporter gene family of Daphnia pulex. BMC Genomics  10, 170.   https://doi.org/10.1186/1471-2164-10-170




PubMed



        
     
Free Article


 


PubMed ID 19383151
         Pubmed Central ID 2680897 


 



10.
Torimiro JN, Javanbakht H, Diaz-Griffero F, Kim J, Carr JK, Carrington M, Sawitzke J, Burke DS, Wolfe ND, Dean M, Sodroski J (2009). A rare null allele potentially encoding a dominant-negative TRIM5alpha protein in Baka pygmies. Virology  391, 140-7.   https://doi.org/10.1016/j.virol.2009.05.038




PubMed



        
     
Free Article


 


PubMed ID 19577266
         Pubmed Central ID 2760473 


 



11.
Yeager M, Deng Z, Boland J, Matthews C, Bacior J, Lonsberry V, Hutchinson A, Burdett LA, Qi L, Jacobs KB, Gonzalez-Bosquet J, Berndt SI, Hayes RB, Hoover RN, Thomas G, Hunter DJ, Dean M, Chanock SJ (2009). Comprehensive resequence analysis of a 97 kb region of chromosome 10q11.2 containing the MSMB gene associated with prostate cancer. Hum Genet  126, 743-50.   https://doi.org/10.1007/s00439-009-0723-9




PubMed



        
     
Free Article


 


PubMed ID 19644707
         Pubmed Central ID 2778717",https://intramural.nih.gov/search/searchview.taf?ipid=67651
623,BC011302-01,"October 01, 2009 -  September 30, 2010",Screen for Ras inhibitors,"Ji  Luo



IRP Faculty Profile",NULL,"Medical Oncology Branch, NCI",Meng-Tzu  Weng,NULL,NULL,Anton  Simeonov (NHGRI),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=67653
624,BC011303-01,"October 01, 2009 -  September 30, 2010",Ras oncogene induced protein SUMOylation changes,"Ji  Luo



IRP Faculty Profile",NULL,"Medical Oncology Branch, NCI","Christina M Annunziata



Meng-Tzu  Weng",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=67655
625,BC011304-01,"October 01, 2009 -  September 30, 2010",New shRNA vectors for mammalian genetic analysis,"Ji  Luo



IRP Faculty Profile",NULL,"Medical Oncology Branch, NCI",NULL,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Luo J, Emanuele MJ, Li D, Creighton CJ, Schlabach MR, Westbrook TF, Wong KK, Elledge SJ (2009). A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene. Cell  137, 835-48.   https://doi.org/10.1016/j.cell.2009.05.006




PubMed



        
     
Free Article


 


PubMed ID 19490893
         Pubmed Central ID 2768667",https://intramural.nih.gov/search/searchview.taf?ipid=67657
626,BC011305-01,"October 01, 2009 -  September 30, 2010",Sensitivty of MM cells to PLK1 inhibition,"Ji  Luo



IRP Faculty Profile",NULL,"Medical Oncology Branch, NCI","Ola Anders Landgren



Christina M Annunziata",NULL,"Walter M Kuehl; MD, PhD (Cancer Genetics Branch)",NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=67659
627,BC011306-01,"October 01, 2009 -  September 30, 2010",Inhibitors of protein-protein interactions,Nadya I Tarasova; PhD,Giorgio  Trinchieri,"Cancer Inflammation Program, NCI","Mateusz J Gabryszuk



Liv H Johannessen



Jessica Marie Vaughan



Joanna Ray-Jia Yeh","Vadim  Gaponenko





Alla  Ivanova





Joseph R Kates","Arthur A Hurwitz (Laboratory of Molecular Immunoregulation)



Susan  Bates; MD (Medical Oncology Branch)



Joseph John Barchi (Chemical Biology Laboratory)



Francis W Ruscetti; PhD (Laboratory of Experimental Immunology)



Michael  Dean; PhD (Laboratory of Experimental Immunology)



Joost J Oppenheim; MD (Laboratory of Molecular Immunoregulation)",NULL,"Ordered by publication type and then author name.



1.
Polgar O, Ierano C, Tamaki A, Stanley B, Ward Y, Xia D, Tarasova N, Robey RW, Bates SE (2010). Mutational analysis of threonine 402 adjacent to the GXXXG dimerization motif in transmembrane segment 1 of ABCG2. Biochemistry  49, 2235-45.   https://doi.org/10.1021/bi902085q




PubMed



        
     
Free Article


 


PubMed ID 20088606
         Pubmed Central ID 2836409",https://intramural.nih.gov/search/searchview.taf?ipid=67661
628,BC011307-01,"October 01, 2009 -  September 30, 2010",Self-assembling protoviral nanoparticles,Nadya I Tarasova; PhD,Giorgio  Trinchieri,"Cancer Inflammation Program, NCI",Yuhong  Chen; PhD,"Vadim  Gaponenko





Joseph R Kates","Joost J Oppenheim; MD (Laboratory of Molecular Immunoregulation)



Sriram  Subramaniam; PhD (Laboratory of Cell Biology)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=67663
629,BC011308-01,"October 01, 2009 -  September 30, 2010",Expression Profiles in ATL Patients,Cynthia  Masison,Douglas  Lowy; MD,"Laboratory of Cellular Oncology, NCI","Sebastine  Chevalier



Giovanna  Tosato; PhD","Michael  Birrer
(NCI)




Renaud  Mahieux
(Department of Viral Oncology, Pasteur Institute)","Thomas Alexander Waldmann; MD, PhD (Lymphoid Malignancies Branch)



John  Janik; MD (Lymphoid Malignancies Branch)",NULL,"Ordered by publication type and then author name.



1.
Mok SC, Bonome T, Vathipadiekal V, Bell A, Johnson ME, Wong KK, Park DC, Hao K, Yip DK, Donninger H, Ozbun L, Samimi G, Brady J, Randonovich M, Pise-Masison CA, Barrett JC, Wong WH, Welch WR, Berkowitz RS, Birrer MJ (2009) A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2. Cancer Cell 16:521-32.




PubMed



        
     
Free Article


 


PubMed ID 19962670
         Pubmed Central ID 3008560 


 



2.
Pise-Masison CA, Radonovich M, Dohoney K, Morris JC, O'Mahony D, Lee MJ, Trepel J, Waldmann TA, Janik JE, Brady JN (2009). Gene expression profiling of ATL patients: compilation of disease-related genes and evidence for TCF4 involvement in BIRC5 gene expression and cell viability. Blood  113, 4016-26.   https://doi.org/10.1182/blood-2008-08-175901




PubMed



        
     
Free Article


 


PubMed ID 19131553
         Pubmed Central ID 2673128 


 



3.
Sakakibara S, Pise-Masison CA, Brady JN, Tosato G (2009). Gene regulation and functional alterations induced by Kaposi's sarcoma-associated herpesvirus-encoded ORFK13/vFLIP in endothelial cells. J Virol  83, 2140-53.   https://doi.org/10.1128/JVI.01871-08




PubMed



        
     
Free Article


 


PubMed ID 19091861
         Pubmed Central ID 2643737",https://intramural.nih.gov/search/searchview.taf?ipid=67665
630,BC011311-01,"October 01, 2009 -  September 30, 2010",Identification of genetic interactors of Brca2,"Shyam K Sharan



IRP Faculty Profile",NULL,"Mouse Cancer Genetics Program, NCI",Suhwan  Chang,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=67671
631,BC011312-01,"October 01, 2009 -  September 30, 2010",Protein regulation in multiple myeloma,"Christina M Annunziata



IRP Faculty Profile",Giuseppe  Giaccone; MD,"Medical Oncology Branch, NCI","James J Driscoll; MD



Ola Anders Landgren



Jonathan S Gootenberg



Ji  Luo",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=67673
632,BC011313-01,"October 01, 2009 -  September 30, 2010",Deign and Utility of Novel Protienaceous Biomaterials,"Joel Patrick Schneider; PhD



IRP Faculty Profile",NULL,"Chemical Biology Laboratory, NCI","Monica Cristina Branco



Iris Maria Geisler



Michael Christopher Giano



Kevin Matthew Harlen



Katelyn Jean Nagy



Chomdao  Sinthuvanich



Show all 7","Eric  Furst
(University of Delaware)




Darrin  Pochan
(University of Delaware)




Mehmet  Sarikaya
(University of Washington)




Norm  Wagner
(University of Delaware)","Robert  Blumenthal; PhD (Center for Cancer Research Nanobiology Program)



Ruth  Nussinov; PhD (Center for Cancer Research Nanobiology Program)",NULL,"Ordered by publication type and then author name.



1.
Branco MC, Nettesheim F, Pochan DJ, Schneider JP, Wagner NJ (2009). Fast dynamics of semiflexible chain networks of self-assembled peptides. Biomacromolecules  10, 1374-80.   https://doi.org/10.1021/bm801396e




PubMed



        
     
Free Article


 


PubMed ID 19391585
         Pubmed Central ID 2738993 


 



2.
Branco MC, Pochan DJ, Wagner NJ, Schneider JP (2009). Macromolecular diffusion and release from self-assembled beta-hairpin peptide hydrogels. Biomaterials  30, 1339-47.   https://doi.org/10.1016/j.biomaterials.2008.11.019




PubMed



        
     
Free Article


 


PubMed ID 19100615
         Pubmed Central ID 2642624 


 



3.
Branco MC, Schneider JP (2009). Self-assembling materials for therapeutic delivery. Acta Biomater  5, 817-31.   https://doi.org/10.1016/j.actbio.2008.09.018




PubMed



        
     
Free Article


 


PubMed ID 19010748
         Pubmed Central ID 2729065 


 



4.
Larsen TH, Branco MC, Rajagopal K, Schneider JP, Furst EM (2009). Sequence-dependent gelation kinetics of β-hairpin peptide hydrogels. Macromolecules  42, 8443-8450.   https://doi.org/10.1021/ma901423n




PubMed



        
     
Free Article


 


PubMed ID 20161466
         Pubmed Central ID 2791542 


 



5.
Rajagopal K, Lamm MS, Haines-Butterick LA, Pochan DJ, Schneider JP (2009). Tuning the pH responsiveness of beta-hairpin peptide folding, self-assembly, and hydrogel material formation. Biomacromolecules  10, 2619-25.   https://doi.org/10.1021/bm900544e




PubMed


 


PubMed ID 19663418
    
     


 



6.
Rughani RV, Salick DA, Lamm MS, Yucel T, Pochan DJ, Schneider JP (2009). Folding, self-assembly, and bulk material properties of a de novo designed three-stranded beta-sheet hydrogel. Biomacromolecules  10, 1295-304.   https://doi.org/10.1021/bm900113z




PubMed


 


PubMed ID 19344123
    
     


 



7.
Schneider J, Nagarkar R, Boualem H, Schneider J, Pochan D (2009) Dependence of Self-Assembled Peptide Hydrogel Network Structure on Local Fibril Nanstructure. Macromolecules 42:7137-7145.




 



8.
Schneider J, Pochan D, Wagner N, Schneider J (2010) The Effect of Protein Structure on Their Controlled Release from an Injectable Peptide Hydrogel. Biomaterials inpress.",https://intramural.nih.gov/search/searchview.taf?ipid=67675
633,BC011314-01,"October 01, 2009 -  September 30, 2010",Development of antibacterial agents and materials,"Joel Patrick Schneider; PhD



IRP Faculty Profile",NULL,"Chemical Biology Laboratory, NCI","Daniel James Smith



Ana Salome Rocha Do Nascimento Veiga",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Schneider J, Pochan D, Schneider J (2009) Design of an injectable beta-hairpin hydrogel that kills methicillin-resistant Staphylococcus aureus. Advanced Materials 21:4120-4123.",https://intramural.nih.gov/search/searchview.taf?ipid=67677
634,BC011315-01,"October 01, 2009 -  September 30, 2010",Molecular characterization of endometrial cancer,"Christina M Annunziata



IRP Faculty Profile",Giuseppe  Giaccone; MD,"Medical Oncology Branch, NCI","Anne Mary Noonan; MD



Elise C Kohn; MD",NULL,Larry  Maxwell (Mammary Biology and Tumorigenesis Laboratory),NULL,"Ordered by publication type and then author name.



1.
Annunziata CM, Kotz HL (2009). Uterine papillary serous carcinoma: a new paradigm for treatment? Cancer  115, 3594-6.   https://doi.org/10.1002/cncr.24425




PubMed


 


PubMed ID 19452535",https://intramural.nih.gov/search/searchview.taf?ipid=67679
635,BC011316-01,"October 01, 2009 -  September 30, 2010",Role of the human transcription factor T in chordoma growth,Karl Erick Haglund,Kevin A Camphausen; MD,"Radiation Oncology Branch, NCI","Kheem Singh Bisht



Shane Michael Lince",NULL,NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=67681
636,BC011318-01,"October 01, 2009 -  September 30, 2010",Detection and Analysis of Mouse Retroviruses in Humans,Frank  Maldarelli,Stephen H Hughes; PhD,"Host Virus Interaction Branch, NCI",NULL,NULL,"Peter A Pinto; MD (Urologic Oncology Branch)



Kathryn  Jones; PhD (Laboratory of Experimental Immunology)



William Marston Linehan; MD (Urologic Oncology Branch)



Francis W Ruscetti; PhD (Laboratory of Experimental Immunology)



Vinay K Pathak; PhD (Retroviral Replication Laboratory)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=67685
637,BC011319-01,"October 01, 2009 -  September 30, 2010",Role of FIR in limb morphogenesis,"Susan  Mackem; MD



IRP Faculty Profile",NULL,"Cancer and Developmental Biology Laboratory, NCI","Bau Lin Huang



Junming  Yang",NULL,David  Levens; PhD (Laboratory of Pathology),NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=67687
638,BC011320-01,"October 01, 2009 -  September 30, 2010",Targeting dendritic cells for selective modulation of GVHD,"Terry J Fry



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI","Christian  Capitini



Crystal L. Mackall; MD



Nicole M Nasholm",NULL,NULL,Lothar  Hennighausen; PhD (NIDDK),"Ordered by publication type and then author name.



1.
Capitini CM, Herby S, Milliron M, Anver MR, Mackall CL, Fry TJ (2009). Bone marrow deficient in IFN-{gamma} signaling selectively reverses GVHD-associated immunosuppression and enhances a tumor-specific GVT effect. Blood  113, 5002-9.   https://doi.org/10.1182/blood-2008-11-187385




PubMed



        
     
Free Article


 


PubMed ID 19258593
         Pubmed Central ID 2686147",https://intramural.nih.gov/search/searchview.taf?ipid=67689
639,BC011321-01,"October 01, 2009 -  September 30, 2010",Identification and characterization of FGF target genes,"Mark B Lewandoski



IRP Faculty Profile",NULL,"Genetics of Vertebrate Development Section, NCI","Ying  Zhang



Cynthia M Elder",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=67691
640,BC011322-01,"October 01, 2009 -  September 30, 2010",Molecular profiling of  tumor tissue using targeted clinical proteomics,Donald J Johann,Giuseppe  Giaccone; MD,"Medical Oncology Branch, NCI",Sumana  Mukherjee,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Johann DJ, Rodriguez-Canales J, Mukherjee S, Prieto DA, Hanson JC, Emmert-Buck M, Blonder J (2009). Approaching solid tumor heterogeneity on a cellular basis by tissue proteomics using laser capture microdissection and biological mass spectrometry. J Proteome Res  8, 2310-8.   https://doi.org/10.1021/pr8009403




PubMed



        
     
Free Article


 


PubMed ID 19284784
         Pubmed Central ID 2858576",https://intramural.nih.gov/search/searchview.taf?ipid=67693
641,BC011323-01,"October 01, 2009 -  September 30, 2010",The role of nuclear transport system in cell senescence,Petr  Kalab; PhD,NULL,"Laboratory of Cellular and Molecular Biology, NCI","Keisuke  Hasegawa



Sung Jin  Ryu",NULL,NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=67695
642,BC011324-01,"October 01, 2009 -  September 30, 2010",Centrosomal proteins in the regulation of spindle bipolarity and ciliogenesis,"Kyung  Lee; PhD



IRP Faculty Profile",NULL,"Chemistry Section, NCI","Yoshikazu  Johmura



Kyung Ho  Lee



Jung Eun  Park",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=67697
643,BC011325-01,"October 01, 2009 -  September 30, 2010",Search for XMRV,"Alan  Rein; PhD



IRP Faculty Profile",NULL,"Retroviral Replication Laboratory, NCI","Amanda  Aloia



Demetria P Harvin



Jane  Mirro","Angelo  DeMarzo
(Johns Hopkins U)




Jennifer L Hicks





William  Isaacs; PhD
(Department of Urology, Johns Hopkins School of Medicine)




Kenneth  Pienta
(University of Michigan)




Karen  Sfanos
(Johns Hopkins School of Medicine)




Qizhi  Zheng
(Johns Hopkins School of Medicine)","Peter A Pinto; MD (Urologic Oncology Branch)



William Marston Linehan; MD (Urologic Oncology Branch)



Frank  Maldarelli (Host Virus Interaction Branch)



Cathy  Vocke; PhD (Urologic Oncology Branch)",NULL,"Ordered by publication type and then author name.



1.
Gherghe C, Lombo T, Leonard CW, Datta SA, Bess JW, Gorelick RJ, Rein A, Weeks KM (2010). Definition of a high-affinity Gag recognition structure mediating packaging of a retroviral RNA genome. Proc Natl Acad Sci U S A  107, 19248-53.   https://doi.org/10.1073/pnas.1006897107




PubMed



        
     
Free Article


 


PubMed ID 20974908
         Pubmed Central ID 2984214",https://intramural.nih.gov/search/searchview.taf?ipid=67699
644,BC011326-01,"October 01, 2009 -  September 30, 2010",Sensitization of chordoma cell lines to ionizing radiation,Karl Erick Haglund,Kevin A Camphausen; MD,"Radiation Oncology Branch, NCI","Shane Michael Lince



Kheem Singh Bisht",NULL,NULL,"Menghang  Xia (NHGRI) 



Ruili  Huang (NHGRI) 



Christopher P Austin; AB, MD (NHGRI)",There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=67701
645,BC011327-01,"October 01, 2009 -  September 30, 2010",Construction of a S. cerevisiae Ty1-less strain.,David J. Garfinkel; PhD,NULL,"Movable Genetic Elements Section, NCI",Karen Marie Stefanisko,NULL,NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=67703
646,BC011328-01,"October 01, 2009 -  September 30, 2010",Characterization of the Osteosarcoma Genome,"Paul S Meltzer; MD, PhD



IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","Sean Richard Davis; MD, PhD



Princy  Francis



Yuan  Jiang; MD



John E Lueders



So Young  Moon



Robert L Walker; BS



Show all 7",NULL,Chand  Khanna; MD (Pediatric Oncology Branch),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=67705
647,BC011330-01,"October 01, 2009 -  September 30, 2010",Tumor heterogeneity in breast cancer brain metastasis after brain radiation,Deedee Kay Smart,Kevin A Camphausen; MD,"Radiation Oncology Branch, NCI",NULL,NULL,Patricia  Steeg; PhD (Developmental Therapeutics Branch),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=67707
648,BC011332-01,"October 01, 2009 -  September 30, 2010",Tumor Microenvironment in Cancer Progression,"Rosandra N Kaplan



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI","Miki B Kasai



Melinda S Merchant



Crystal L. Mackall; MD



Lee Jay Helman; MD



Carol J Thiele



Chand  Khanna; MD



Show all 7","Jackie  Bromberg
(Memorial Sloan Kettering Cancer Center)




David  Lyden
(Weill Cornell Medical Center)




Shakeel  Modak
(Memorial Sloan Kettering Cancer Center)




Shahin  Rafii
(Weill Cornell Medical Center)




Tanya  Trippett
(Pediatrics, Memorial Sloan Kettering)




Leonard  Wexler
(Memorial Sloan Kettering Cancer Center)",NULL,NULL,"Ordered by publication type and then author name.



1.
Chan AS, Jensen KK, Skokos D, Doty S, Lederman HK, Kaplan RN, Rafii S, Rivella S, Lyden D (2009). Id1 represses osteoclast-dependent transcription and affects bone formation and hematopoiesis. PLoS One  4, e7955.   https://doi.org/10.1371/journal.pone.0007955




PubMed



        
     
Free Article


 


PubMed ID 19956687
         Pubmed Central ID 2776978",https://intramural.nih.gov/search/searchview.taf?ipid=67711
649,BC011333-01,"October 01, 2009 -  September 30, 2010",Neuropsychological outcome measures in patients receiving whole brain radiation,Deedee Kay Smart,Kevin A Camphausen; MD,"Radiation Oncology Branch, NCI",NULL,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=67713
650,BC011334-01,"October 01, 2009 -  September 30, 2010",Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis,"Rosandra N Kaplan



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI","Miki B Kasai



Melinda S Merchant



Katherine Elizabeth Warren; MD



Crystal L. Mackall; MD



Lee Jay Helman; MD



Chand  Khanna; MD



Show all 7","Jackie  Bromberg
(Memorial Sloan Kettering Cancer Center)




Ira  Dunkel
(Memorial Sloan Kettering Cancer Center)




Paul  Meyers
(Memorial Sloan Kettering Cancer Center)




Shakeel  Modak
(Memorial Sloan Kettering Cancer Center)




Peter  Steinherz
(Memorial Sloan Kettering Cancer Center)




Tanya  Trippett
(Pediatrics, Memorial Sloan Kettering)


Show all 7",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=67715
651,BC011335-01,"October 01, 2009 -  September 30, 2010",Targeting of Integration,David J. Garfinkel; PhD,NULL,"Movable Genetic Elements Section, NCI",NULL,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Moore SP, Garfinkel DJ (2009). Functional analysis of N-terminal residues of ty1 integrase. J Virol  83, 9502-11.   https://doi.org/10.1128/JVI.00159-09




PubMed



        
     
Free Article


 


PubMed ID 19570857
         Pubmed Central ID 2738233",https://intramural.nih.gov/search/searchview.taf?ipid=67717
652,BC011336-01,"October 01, 2009 -  September 30, 2010",Tools for Prediction of Drug Metabolism and Metabolites,"Marc C Nicklaus



IRP Faculty Profile",NULL,"Chemical Biology Laboratory, NCI","Angelo  Pugliese; PhD







Joel Patrick Schneider; PhD",NULL,NULL,"Christopher P Austin; AB, MD (NHGRI)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=67719
653,BC011337-01,"October 01, 2009 -  September 30, 2010",Generation of T-cell receptors recognizing antigens on non-melanoma tumors,"James Chung-Yin Yang; MD, PhD



IRP Faculty Profile",NULL,"Surgery Branch, NCI","Nicholas Phillip Restifo; MD



Qiong J Wang",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=67721
654,BC011338-01,"October 01, 2009 -  September 30, 2010",Functional Analysis of the REL Transcription Factors in B-Cells,Brian  Lewis,NULL,"Lymphoid Malignancies Branch, NCI","Alfonso  Fernandez; PhD



Louis  Staudt; MD



Jason Alexander Piotrowski; BA, MS",NULL,NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=67723
655,BC011339-01,"October 01, 2009 -  September 30, 2010",Replication and Pathogenic Potential of XMRV in Humans,"Vinay K Pathak; PhD



IRP Faculty Profile",NULL,"Retroviral Replication Laboratory, NCI","Ryan C Burdick



Chawaree  Chaipan



Krista A Delviks-Frankenberry



Tobias  Paprotka



Narasimhan Jayanth  Venkatachari; PhD","Ralph  deVere White
(University of California, Davis)




Hsing-Jien  Kung
(Department of Biological Chemistry, University of California, Davis)




Cliffort  Pepper
(University of California, Davis)",NULL,NULL,"Ordered by publication type and then author name.



1.
Paprotka T, Venkatachari NJ, Chaipan C, Burdick R, Delviks-Frankenberry KA, Hu WS, Pathak VK (2010). Inhibition of xenotropic murine leukemia virus-related virus by APOBEC3 proteins and antiviral drugs. J Virol  84, 5719-29.   https://doi.org/10.1128/JVI.00134-10




PubMed



        
     
Free Article


 


PubMed ID 20335265
         Pubmed Central ID 2876585",https://intramural.nih.gov/search/searchview.taf?ipid=67725
656,BC011340-01,"October 01, 2009 -  September 30, 2010",Preclinical development of new therapeutics for children with CNS Tumors,"Katherine Elizabeth Warren; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI","Cynthia M Lester mccully



Nalini M Jayaprakash



Devang  Pastakia



Brigitte  Widemann; MD","Vinay  Jain
(Arog Pharmaceuticals LLC)




Sil  Lutkewitte
(Targepeutics)",Kevin A Camphausen; MD (Radiation Oncology Branch),"Russell R Lonser; MD (NINDS) 



Marsha J Merrill; PhD (NINDS)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=67727
657,BC011341-01,"October 01, 2009 -  September 30, 2010","Familial Gastric Cancer: Diagnosis, DNA Sequencing, Early detection",Itzhak  Avital,NULL,"Surgery Branch, NCI",Satyajit  Ray; PhD,NULL,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",Theo  Heller; MD (NIDDK),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=67729
658,BC011342-01,"October 01, 2009 -  September 30, 2010",Pancreatic perfusion for locally unresectable pancreatic cancer,Itzhak  Avital,NULL,"Surgery Branch, NCI","John Ellis Mullinax



Satyajit  Ray; PhD



Udo  Rudloff



Udai S Kammula",NULL,Bradford J Wood; MD (Office of the Director),Elliot Brian Levy (CC),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=67731
659,BC011343-01,"October 01, 2009 -  September 30, 2010",Clinical protocols for the treatment of GI cancer,"Tim Friedrich Greten



IRP Faculty Profile",NULL,"Medical Oncology Branch, NCI","Austin Gerard Duffy



Douglas K Price



William D Figg; PharmD



Jane Beth Trepel",NULL,"Peter L Choyke; MD (Molecular Imaging Program)



Bradford J Wood; MD (Office of the Director)



Liang  Cao (Cancer Genetics Branch)



Xin  Wang (National Cancer Institute)",Aradhana M Venkatesan (CC),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=67733
660,BC011344-01,"October 01, 2009 -  September 30, 2010",Analysis of immune suppressor mechanisms in patients with HCC,"Tim Friedrich Greten



IRP Faculty Profile",NULL,"Medical Oncology Branch, NCI",Fei  Zhao,NULL,Nicholas Phillip Restifo; MD (Surgery Branch),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=67735
661,BC011345-01,"October 01, 2009 -  September 30, 2010",Analysis of myeloid derived suppressor cells in mice,"Tim Friedrich Greten



IRP Faculty Profile",NULL,"Medical Oncology Branch, NCI",Lydia Asrat Haile,"Jan  Buer
(University of Essen)




Michael Peter Manns; MD
(epartment of Gastroenterology and Hepatology, edizinische Hochschule Hannover)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=67737
662,BC011346-01,"October 01, 2009 -  September 30, 2010",Immune suppressor mechanism in a murine model of hepatitis and liver cancer,"Tim Friedrich Greten



IRP Faculty Profile",NULL,"Medical Oncology Branch, NCI",Tamar  Kapanadze,NULL,NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=67739
663,BC011347-01,"October 01, 2009 -  September 30, 2010",Genetic Correlation with Efficacy and Toxicity of Brain Tumor Therapies,Fabio  Iwamoto,"Howard A Fine; MD, PhD","Neuro-Oncology Branch, NCI",NULL,NULL,"Preetha  Rajaraman (Radiation Epidemiology Branch)



Stephen J Chanock; MD, PhD (Laboratory Translational Genomics)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=67741
664,BC011348-01,"October 01, 2009 -  September 30, 2010",Aging and Primary Central Nervous System Tumors,Fabio  Iwamoto,"Howard A Fine; MD, PhD","Neuro-Oncology Branch, NCI",NULL,"Lisa  DeAngelis
(MSKCC)




Adilia  Hormigo
(MSKCC)




Jacob  Scott
(Moffitt Cancer Center)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=67743
665,BC011350-01,"October 01, 2009 -  September 30, 2010",Molecular Discovery Program,"Robert Andrew Byrd



IRP Faculty Profile",NULL,"Structural Biophysics Laboratory, NCI",NULL,NULL,NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=67747
666,BC011351-01,"October 01, 2009 -  September 30, 2010",Bladder Cancer Program,"Andrea Borghese Apolo



IRP Faculty Profile",Giuseppe  Giaccone; MD,"Medical Oncology Branch, NCI","Ravi  Madan



William D Figg; PharmD



Jane Beth Trepel",NULL,"William Laurence Dahut; MD (Office of the Director)



James L Gulley; MD, PhD (Laboratory of Tumor Immunology and Biology)",NULL,"Ordered by publication type and then author name.



1.
Apolo AB, Milowsky M, Bajorin DF (2009). Clinical states model for biomarkers in bladder cancer. Future Oncol  5, 977-92.   https://doi.org/10.2217/fon.09.57




PubMed



        
     
Free Article


 


PubMed ID 19792967
         Pubmed Central ID 3705955 


 



2.
Apolo AB, Riches J, Schöder H, Akin O, Trout A, Milowsky MI, Bajorin DF (2010). Clinical value of fluorine-18 2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in bladder cancer. J Clin Oncol  28, 3973-8.   https://doi.org/10.1200/JCO.2010.28.7052




PubMed



        
     
Free Article


 


PubMed ID 20679618
         Pubmed Central ID 2940395",https://intramural.nih.gov/search/searchview.taf?ipid=67749
667,BC011352-01,"October 01, 2009 -  September 30, 2010",Molecular and clinical profiling,Ola Anders Landgren,NULL,"Medical Oncology Branch, NCI","Jonathan W Farag



Sham  Mailankody



Brendan  Weiss



Adriana  Zingone; MD","Magnus  Bjorkholm
(Karolinska)




Sigurdur  Kristinsson
(Karolinska)




Robert  Kyle
(Mayo Clinic)




Vincent  Rajkumar
(Mayo Clinic)",NULL,NULL,"Ordered by publication type and then author name.



1.
Dores GM, Landgren O, McGlynn KA, Curtis RE, Linet MS, Devesa SS (2009). Plasmacytoma of bone, extramedullary plasmacytoma, and multiple myeloma: incidence and survival in the United States, 1992-2004. Br J Haematol  144, 86-94.   https://doi.org/10.1111/j.1365-2141.2008.07421.x




PubMed



        
     
Free Article


 


PubMed ID 19016727
         Pubmed Central ID 2610331 


 



2.
Kristinsson SY, Björkholm M, Andersson TM, Eloranta S, Dickman PW, Goldin LR, Blimark C, Mellqvist UH, Wahlin A, Turesson I, Landgren O (2009). Patterns of survival and causes of death following a diagnosis of monoclonal gammopathy of undetermined significance: a population-based study. Haematologica  94, 1714-20.   https://doi.org/10.3324/haematol.2009.010066




PubMed



        
     
Free Article


 


PubMed ID 19608666
         Pubmed Central ID 2791946 


 



3.
Kristinsson SY, Björkholm M, Goldin LR, Blimark C, Mellqvist UH, Wahlin A, Turesson I, Landgren O (2009). Patterns of hematologic malignancies and solid tumors among 37,838 first-degree relatives of 13,896 patients with multiple myeloma in Sweden. Int J Cancer  125, 2147-50.   https://doi.org/10.1002/ijc.24514




PubMed



        
     
Free Article


 


PubMed ID 19582882
         Pubmed Central ID 2737604 


 



4.
Kristinsson SY, Goldin LR, Björkholm M, Koshiol J, Turesson I, Landgren O (2009). Genetic and immune-related factors in the pathogenesis of lymphoproliferative and plasma cell malignancies. Haematologica  94, 1581-9.   https://doi.org/10.3324/haematol.2009.008979




PubMed



        
     
Free Article


 


PubMed ID 19586941
         Pubmed Central ID 2770969 


 



5.
Kristinsson SY, Landgren O, Rajkumar VS (2009) Novel therapies in multiple myeloma for newly diagnosed nontransplant candidates. Cancer J 15:473-8.




PubMed



        
     
Free Article


 


PubMed ID 20010166
         Pubmed Central ID 2818857 


 



6.
Landgren O, Gilbert ES, Rizzo JD, Socié G, Banks PM, Sobocinski KA, Horowitz MM, Jaffe ES, Kingma DW, Travis LB, Flowers ME, Martin PJ, Deeg HJ, Curtis RE (2009). Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation. Blood  113, 4992-5001.   https://doi.org/10.1182/blood-2008-09-178046




PubMed



        
     
Free Article


 


PubMed ID 19264919
         Pubmed Central ID 2686146 


 



7.
Landgren O, Kristinsson SY, Goldin LR, Caporaso NE, Blimark C, Mellqvist UH, Wahlin A, Bjorkholm M, Turesson I (2009). Risk of plasma cell and lymphoproliferative disorders among 14621 first-degree relatives of 4458 patients with monoclonal gammopathy of undetermined significance in Sweden. Blood  114, 791-5.   https://doi.org/10.1182/blood-2008-12-191676




PubMed



        
     
Free Article


 


PubMed ID 19182202
         Pubmed Central ID 2716021 


 



8.
Landgren O, Kyle RA, Pfeiffer RM, Katzmann JA, Caporaso NE, Hayes RB, Dispenzieri A, Kumar S, Clark RJ, Baris D, Hoover R, Rajkumar SV (2009). Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study. Blood  113, 5412-7.   https://doi.org/10.1182/blood-2008-12-194241




PubMed



        
     
Free Article


 


PubMed ID 19179464
         Pubmed Central ID 2689042 


 



9.
McMaster ML, Kristinsson SY, Turesson I, Björkholm M, Landgren O (2009). Novel aspects pertaining to the relationship of Waldenström's macroglobulinemia, IgM monoclonal gammopathy of undetermined significance, polyclonal gammopathy, and hypoglobulinemia. Clin Lymphoma Myeloma  9, 19-22.   https://doi.org/10.3816/CLM.2009.n.003




PubMed



        
     
Free Article


 


PubMed ID 19362963
         Pubmed Central ID 2722444 


 



10.
Turesson I, Velez R, Kristinsson SY, Landgren O (2010). Patterns of improved survival in patients with multiple myeloma in the twenty-first century: a population-based study. J Clin Oncol  28, 830-4.   https://doi.org/10.1200/JCO.2009.25.4177




PubMed



        
     
Free Article


 


PubMed ID 20038719
         Pubmed Central ID 2834396",https://intramural.nih.gov/search/searchview.taf?ipid=67751
668,BC011353-01,"October 01, 2009 -  September 30, 2010",Development and validation of preclinical mouse model for serous ovarian cancer,Terry Anne Van Dyke,NULL,"Office of the Director, NCI","Simone  Difilippantonio



Deborah B Householder



Zoe W Ohler",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=67753
669,BC011354-01,"October 01, 2009 -  September 30, 2010",BCR Signaling in ABC DLBCL,"Wyndham H Wilson; MD, PhD



IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI","Kieron Michael Dunleavy



Douglas C Matthews",NULL,"Stefania  Pittaluga (Laboratory of Pathology)



Louis  Staudt; MD (Lymphoid Malignancies Branch)



Elaine S Jaffe; MD (Laboratory of Pathology)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=67755
670,BC011356-01,"October 01, 2009 -  September 30, 2010",FLSC - Vaccine Branch HIV Vaccine Primate Study,Mary C Custer,Robert  Wiltrout; PhD,"Office of the Director, NCI",NULL,NULL,"Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)



Barbara K Felber (Vaccine Branch)



George N Pavlakis; MD, PhD (Vaccine Branch)



Marjorie  Robert-Guroff; PhD (Vaccine Branch)",NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=67796
671,CO020003-02,"October 01, 2009 -  September 30, 2010",Office of Cancer Genomics,"Douglas  Lowy; MD



IRP Faculty Profile",NULL,"National Cancer Institute, NCI",Daniela S Gerhard,NULL,NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=63479
672,CP000101-06,"October 01, 2009 -  September 30, 2010",Human Studies of Diet and Nutrition,"Philip  Taylor; MD, ScD",NULL,"Genetic Epidemiology Branch, NCI",NULL,"David  Baer
(BHNRC, USDA)




Jerry  Combs
(USDA)




Joanne  Dorgan; PhD
(NCI)




Terryl  Hartman
(Penn State University)




Meryl  Wastney
(Metabolic Modeling Services)","Ruth  Pfeiffer; PhD (Biostatistics Branch)



Somdat  Mahabir (Analytic Epidemiology Research Branch)



Blossom  Patterson (Biometry Research Group)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63533
673,CP000112-06,"October 01, 2009 -  September 30, 2010",Nutrition Intervention Trials in Linxian China,"Christian Cormac Abnet; PhD, MPH



IRP Faculty Profile
 


 

Sanford Martin Dawsey; MD



IRP Faculty Profile
 




Philip  Taylor; MD, ScD",NULL,"Nutritional Epidemiology Branch, NCI

Genetic Epidemiology Branch, NCI","Farin  Kamangar



Mark J Roth



Nan  Hu","You-Lin  Qiao
(Cancer Institute of the Chinese Academy of Science)




Guo-Qing  Wang
(CICAMS)




Wen-Qiang  Wei
(Cancer Institute, Chinese Academy of Medical Sciences)",NULL,NULL,"Ordered by publication type and then author name.



1.
Lin SW, Fan JH, Dawsey SM, Taylor PR, Qiao YL, Abnet CC (2011). Serum thyroglobulin, a biomarker for iodine deficiency, is not associated with increased risk of upper gastrointestinal cancers in a large Chinese cohort. Int J Cancer  129, 2284-9.   https://doi.org/10.1002/ijc.25789




PubMed



        
     
Free Article


 


PubMed ID 21105043
         Pubmed Central ID 3075342",https://intramural.nih.gov/search/searchview.taf?ipid=63531
674,CP000150-06,"October 01, 2009 -  September 30, 2010",Biologic Specimen Bank for Early Lung Cancer Markers in Chinese Tin Miners,"Philip  Taylor; MD, ScD",NULL,"Genetic Epidemiology Branch, NCI","Nan  Hu



Chaoyu C Wang



Alisa  Goldstein; PhD



Asieh  Golozar



Ying  Gao","Brooks  Cash
(NNMC)




You-Lin  Qiao
(Cancer Institute of the Chinese Academy of Science)




Xia-Ou  Shu
(Vanderbilt University Medical Center)




Jian-Min  Yuan; MD, PhD
(Epidemiology and Community Health, University of Minnesota, School of Public Health)




Wei  Zheng
(Venderbilt University)




Yun-Ling  Zheng","Maxwell P Lee; PhD (Laboratory of Population Genetics)



Michael R Emmert-Buck; MD, PhD (Laboratory of Pathology)



Christian Cormac Abnet; PhD, MPH (Nutritional Epidemiology Branch)



Stephen M Hewitt; MD, PhD (Laboratory of Pathology)



Ruth  Pfeiffer; PhD (Biostatistics Branch)



Mark J Roth (Nutritional Epidemiology Branch)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63532
675,CP000176-06,"October 01, 2009 -  September 30, 2010",Biologic Specimen Bank for Early Lung Cancer Markers in Chinese Tin Miners,"Philip  Taylor; MD, ScD",NULL,"Genetic Epidemiology Branch, NCI",NULL,"You-Lin  Qiao
(Cancer Institute of the Chinese Academy of Science)




Wendy  Wang
(NCI/DCP)",Ping  Hu; MS (Biometry Research Group),NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=63534
676,CP000185-06,"October 01, 2009 -  September 30, 2010",Upper Gastrointestinal Cancer Studies,"Christian Cormac Abnet; PhD, MPH



IRP Faculty Profile
 




Philip  Taylor; MD, ScD

 


 

Sanford Martin Dawsey; MD



IRP Faculty Profile",NULL,"Nutritional Epidemiology Branch, NCI

Genetic Epidemiology Branch, NCI","Mark J Roth



Gwen  Murphy



Arash  Etemadi



Nan  Hu







Neal David Freedman","Paolo  Boffetta
(International Agency for Research on Cancer)




Paul  Brennan
(International Agency for Research on Cancer, Lyon, France)




Renato  Fagundes





David  Fleischer
(Mayo Clinic (Scottsdale))




Reza  Malekzadeh
(Digestive Disease Research Center, Tehran University of Medical Sciences)




You-Lin  Qiao
(Cancer Institute of the Chinese Academy of Science)


Show all 10",Edward L Korn (Clinical Trials Section),NULL,"Ordered by publication type and then author name.



1.
Abnet CC, Freedman ND, Kamangar F, Leitzmann MF, Hollenbeck AR, Schatzkin A (2009). Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysis. Br J Cancer  100, 551-7.   https://doi.org/10.1038/sj.bjc.6604880




PubMed



        
     
Free Article


 


PubMed ID 19156150
         Pubmed Central ID 2658549 


 



2.
Cardwell CR, Abnet CC, Cantwell MM, Murray LJ (2010). Exposure to oral bisphosphonates and risk of esophageal cancer. JAMA  304, 657-63.   https://doi.org/10.1001/jama.2010.1098




PubMed



        
     
Free Article


 


PubMed ID 20699457
         Pubmed Central ID 3513370 


 



3.
Hu N, Clifford RJ, Yang HH, Wang C, Goldstein AM, Ding T, Taylor PR, Lee MP (2010). Genome wide analysis of DNA copy number neutral loss of heterozygosity (CNNLOH) and its relation to gene expression in esophageal squamous cell carcinoma. BMC Genomics  11, 576.   https://doi.org/10.1186/1471-2164-11-576




PubMed



        
     
Free Article


 


PubMed ID 20955586
         Pubmed Central ID 3091724 


 



4.
O'Doherty MG, Abnet CC, Murray LJ, Woodside JV, Anderson LA, Brockman JD, Cantwell MM (2010). Iron intake and markers of iron status and risk of Barrett's esophagus and esophageal adenocarcinoma. Cancer Causes Control  21, 2269-79.   https://doi.org/10.1007/s10552-010-9652-0




PubMed



        
     
Free Article


 


PubMed ID 20936528
         Pubmed Central ID 3438890 


 



5.
Parker RK, Dawsey SM, Abnet CC, White RE (2010). Frequent occurrence of esophageal cancer in young people in western Kenya. Dis Esophagus  23, 128-35.   https://doi.org/10.1111/j.1442-2050.2009.00977.x




PubMed



        
     
Free Article


 


PubMed ID 19473205
         Pubmed Central ID 3505035 


 



6.
Roth MJ, Katki HA, Wei WQ, Qiao YL, Bagni R, Wang GQ, Whitby D, Dong ZW, Gail MH, Limburg PJ, Giffen CA, Taylor PR, Dawsey SM (2010). Serum cytokine analysis in a positive chemoprevention trial: selenium, interleukin-2, and an association with squamous preneoplastic disease. Cancer Prev Res (Phila)  3, 810-7.   https://doi.org/10.1158/1940-6207.CAPR-09-0269




PubMed



        
     
Free Article


 


PubMed ID 20587703
         Pubmed Central ID 2900463 


 



7.
Roth MJ, Wei WQ, Baer J, Abnet CC, Wang GQ, Sternberg LR, Warner AC, Johnson LL, Lu N, Giffen CA, Dawsey SM, Qiao YL, Cherry J (2009). Aryl hydrocarbon receptor expression is associated with a family history of upper gastrointestinal tract cancer in a high-risk population exposed to aromatic hydrocarbons. Cancer Epidemiol Biomarkers Prev  18, 2391-6.   https://doi.org/10.1158/1055-9965.EPI-08-1098




PubMed



        
     
Free Article


 


PubMed ID 19690180
         Pubmed Central ID 2796959 


 



8.
Zhang YM, Bergman JJ, Weusten B, Dawsey SM, Fleischer DE, Lu N, He S, Wang GQ (2010). Radiofrequency ablation for early esophageal squamous cell neoplasia. Endoscopy  42, 327-33.   https://doi.org/10.1055/s-0029-1244017




PubMed



        
     
Free Article


 


PubMed ID 20235007
         Pubmed Central ID 2848283",https://intramural.nih.gov/search/searchview.taf?ipid=63535
677,CP004410-34,"October 01, 2009 -  September 30, 2010",Family Studies,"Neil Edward Caporaso; MS, MD



IRP Faculty Profile
 




Lynn Rachel Goldin; PhD

 


 

Alisa  Goldstein; PhD



IRP Faculty Profile
 


 

Maria Teresa Pia Landi; MD, PhD



IRP Faculty Profile
 


 

Xiaohong Rose Yang; PhD



IRP Faculty Profile
 


 

Margaret Anne Tucker



IRP Faculty Profile",NULL,"Genetic Epidemiology Branch, NCI

Human Genetics Program, NCI","Gladys M. Glenn; MD, PhD



Mary C Fraser



Mary Louise McMaster; MD



Dilys  Parry; PhD



David  Ng; AB, MD","Janis  Beach
(Information Management Systems)




Giovanna  Bianchi-Scarra
(University of Genova)




Tim  Bishop
(Institute for Cancer Research)




Donato  Calista
(Bufalini Hospital)




Florence  Demenais
(Institut National de la Sante et de la Recherche Medicale)




David  Elder
(University of Pennsylvania School of Medicine, Philadelphia, PA)


Show all 11","June  Peters (Clinical Genetics Branch)



Kenneth H Kraemer; MD (DNA Repair Section)","Jeffery P Struewing; MS, MD (NHGRI)","Ordered by publication type and then author name.



1.
Anderson WF, Pfeiffer RM, Tucker MA, Rosenberg PS (2009). Divergent cancer pathways for early-onset and late-onset cutaneous malignant melanoma. Cancer  115, 4176-85.   https://doi.org/10.1002/cncr.24481




PubMed



        
     
Free Article


 


PubMed ID 19536874
         Pubmed Central ID 2741537 


 



2.
Gerstenblith MR, Goldstein AM, Tucker MA (2010). Hereditary genodermatoses with cancer predisposition. Hematol Oncol Clin North Am  24, 885-906.   https://doi.org/10.1016/j.hoc.2010.06.003




PubMed



        
     
Free Article


 


PubMed ID 20816579
         Pubmed Central ID 3276063 


 



3.
Goldin LR, Lanasa MC, Slager SL, Cerhan JR, Vachon CM, Strom SS, Camp NJ, Spector LG, Leis JF, Morrison VA, Glenn M, Rabe KG, Achenbach SJ, Algood SD, Abbasi F, Fontaine L, Yau M, Rassenti LZ, Kay NE, Call TG, Hanson CA, Weinberg JB, Marti GE, Caporaso NE (2010). Common occurrence of monoclonal B-cell lymphocytosis among members of high-risk CLL families. Br J Haematol  151, 152-8.   https://doi.org/10.1111/j.1365-2141.2010.08339.x




PubMed



               Available in future as a Free Article 


 


PubMed ID 20738309
         Pubmed Central ID 2966536 


 



4.
Goldin LR, Landgren O, Marti GE, Caporaso NE (2010). Familial Aspects of Chronic Lymphocytic Leukemia, Monoclonal B-Cell Lymphocytosis (MBL), and Related Lymphomas. European J Clin Med Oncol  2, 119-126.




PubMed



        
     
Free Article


 


PubMed ID 21191471
         Pubmed Central ID 3010372 


 



5.
Goldin LR, Slager SL, Caporaso NE (2010). Familial chronic lymphocytic leukemia. Curr Opin Hematol  17, 350-5.   https://doi.org/10.1097/MOH.0b013e328338cd99




PubMed



        
     
Free Article


 


PubMed ID 20389242
         Pubmed Central ID 2891437 


 



6.
Liang XS, Caporaso N, McMaster ML, Ng D, Landgren O, Yeager M, Chanock S, Goldin LR (2009). Common genetic variants in candidate genes and risk of familial lymphoid malignancies. Br J Haematol  146, 418-23.   https://doi.org/10.1111/j.1365-2141.2009.07790.x




PubMed



        
     
Free Article


 


PubMed ID 19573080
         Pubmed Central ID 2890251 


 



7.
McMaster ML, Kristinsson SY, Turesson I, Björkholm M, Landgren O (2009). Novel aspects pertaining to the relationship of Waldenström's macroglobulinemia, IgM monoclonal gammopathy of undetermined significance, polyclonal gammopathy, and hypoglobulinemia. Clin Lymphoma Myeloma  9, 19-22.   https://doi.org/10.3816/CLM.2009.n.003




PubMed



        
     
Free Article


 


PubMed ID 19362963
         Pubmed Central ID 2722444 


 



8.
Royer RH, Koshiol J, Giambarresi TR, Vasquez LG, Pfeiffer RM, McMaster ML (2010). Differential characteristics of Waldenström macroglobulinemia according to patterns of familial aggregation. Blood  115, 4464-71.   https://doi.org/10.1182/blood-2009-10-247973




PubMed



        
     
Free Article


 


PubMed ID 20308603
         Pubmed Central ID 2881498 


 



9.
Slager SL, Goldin LR, Strom SS, Lanasa MC, Spector LG, Rassenti L, Leis JF, Camp NJ, Kay NE, Vachon CM, Glenn M, Weinberg JB, Rabe KG, Cunningham JM, Achenbach SJ, Hanson CA, Marti GE, Call TG, Caporaso NE, Cerhan JR (2010). Genetic susceptibility variants for chronic lymphocytic leukemia. Cancer Epidemiol Biomarkers Prev  19, 1098-102.   https://doi.org/10.1158/1055-9965.EPI-09-1217




PubMed



        
     
Free Article


 


PubMed ID 20332261
         Pubmed Central ID 2852480 


 



10.
Solomon DA, Kim JS, Yang XR, Tucker MA, Goldstein AM, Samuels Y, Waldman T (2009). Lack of inherited mutations of PTPRD in familial melanoma and melanoma-astrocytoma syndrome. Pigment Cell Melanoma Res  22, 489-91.   https://doi.org/10.1111/j.1755-148X.2009.00587.x




PubMed



        
     
Free Article


 


PubMed ID 19500277
         Pubmed Central ID 2758084 


 



11.
Tsai HT, Cross AJ, Graubard BI, Oken M, Schatzkin A, Caporaso NE (2010). Dietary factors and risk of chronic lymphocytic leukemia and small lymphocytic lymphoma: a pooled analysis of two prospective studies. Cancer Epidemiol Biomarkers Prev  19, 2680-4.   https://doi.org/10.1158/1055-9965.EPI-10-0585




PubMed



        
     
Free Article


 


PubMed ID 20929883
         Pubmed Central ID 3501724 


 



12.
Tucker MA (2009). Melanoma epidemiology. Hematol Oncol Clin North Am  23, 383-95, vii.   https://doi.org/10.1016/j.hoc.2009.03.010




PubMed



        
     
Free Article


 


PubMed ID 19464592
         Pubmed Central ID 3234163 


 



13.
Yang XR, Ng D, Alcorta DA, Liebsch NJ, Sheridan E, Li S, Goldstein AM, Parry DM, Kelley MJ (2009). T (brachyury) gene duplication confers major susceptibility to familial chordoma. Nat Genet  41, 1176-8.   https://doi.org/10.1038/ng.454




PubMed



        
     
Free Article


 


PubMed ID 19801981
         Pubmed Central ID 2901855 


 



14.
Yang XR, Pfeiffer RM, Wheeler W, Yeager M, Chanock S, Tucker MA, Goldstein AM (2009). Identification of modifier genes for cutaneous malignant melanoma in melanoma-prone families with and without CDKN2A mutations. Int J Cancer  125, 2912-7.   https://doi.org/10.1002/ijc.24622




PubMed



               Available in future as a Free Article 


 


PubMed ID 19626699
         Pubmed Central ID 2767393",https://intramural.nih.gov/search/searchview.taf?ipid=63498
678,CP005782-16,"October 01, 2009 -  September 30, 2010",Epidemiology of Oncogenic Viruses,"Thomas R O'Brien; BA, MPH, MD



IRP Faculty Profile",NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,"Mary  Carrington; MS, PhD (Laboratory of Experimental Immunology)



Stephen J Chanock; MD, PhD (Laboratory Translational Genomics)



Ruth  Pfeiffer; PhD (Biostatistics Branch)



Kai  Yu (Biostatistics Branch)",NULL,"Ordered by publication type and then author name.



1.
Bekker V, Chanock SJ, Yeager M, Hutchinson AA, von Hahn T, Chen S, Xiao N, Dotrang M, Brown M, Busch MP, Edlin BR, Rice CM, O'Brien TR (2010). Genetic variation in CLDN1 and susceptibility to hepatitis C virus infection. J Viral Hepat  17, 192-200.   https://doi.org/10.1111/j.1365-2893.2009.01166.x




PubMed



        
     
Free Article


 


PubMed ID 19674288
         Pubmed Central ID 2921226 


 



2.
Bekker V, O'Brien TR, Chanock S (2009). Population genetics and comparative genetics of CLDN1, a gene involved in hepatitis C virus entry. Hum Hered  67, 206-16.   https://doi.org/10.1159/000181159




PubMed



        
     
Free Article


 


PubMed ID 19077439
         Pubmed Central ID 2868922 


 



3.
O'Brien T, ProkuninaOlsson L, Pfeiffer R, Maeder D, Kohaar I, Yeager M, Schadt E (2010) Human Genetic Variants Linked to Chronic Hepatitis B Are Associated with Expression of HLA-DPA1 and HLA-DPB1. JOURNAL OF HEPATOLOGY 52:1




 



4.
O'Brien T, ProkuninaOlsson L, Pfeiffer R, Maeder D, Kohaar I, Yeager M, Schadt E (2010) Human Genetic Variants Linked to Chronic Hepatitis B Are Associated with Expression of HLA-DPA1 and HLA-DPB1. JOURNAL OF HEPATOLOGY 52:1",https://intramural.nih.gov/search/searchview.taf?ipid=63497
679,CP005803-16,"October 01, 2009 -  September 30, 2010",Genetic Epidemiology,"Lynn Rachel Goldin; PhD

 


 

Maria Teresa Pia Landi; MD, PhD



IRP Faculty Profile
 


 

Margaret Anne Tucker



IRP Faculty Profile
 


 

Xiaohong Rose Yang; PhD



IRP Faculty Profile
 


 

Alisa  Goldstein; PhD



IRP Faculty Profile",NULL,"Genetic Epidemiology Branch, NCI

Human Genetics Program, NCI","Neil Edward Caporaso; MS, MD



Mary C Fraser



Gladys M. Glenn; MD, PhD



Mary Louise McMaster; MD



Dilys  Parry; PhD



Thomas  Fears; PhD



Show all 8","Timothy  Bishop
(Institute for Cancer Research)




Donato  Calista
(Bufalini Hospital)




Florence  Demenais
(Institut National de la Sante et de la Recherche Medicale)




Kari  Hemminki; PhD
(Department of Biosciences, Karolinska Institute)




Lene  Mellemkjaer
(Danish Cancer Society)




Jorgen  Olsen
(Danish Cancer Society)","Martha S Linet; PhD (Radiation Epidemiology Branch)



Roni T Falk (Hormonal and Reproductive Epidemiology Branch)



Mitchell Henry Gail; PhD, MD (Biostatistics Branch)



Ruth  Pfeiffer; PhD (Biostatistics Branch)



Sholom  Wacholder; PhD (Biostatistics Branch)



Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)",NULL,"Ordered by publication type and then author name.



1.
Azzato EM, Pharoah PD, Harrington P, Easton DF, Greenberg D, Caporaso NE, Chanock SJ, Hoover RN, Thomas G, Hunter DJ, Kraft P (2010). A genome-wide association study of prognosis in breast cancer. Cancer Epidemiol Biomarkers Prev  19, 1140-3.   https://doi.org/10.1158/1055-9965.EPI-10-0085




PubMed



        
     
Free Article


 


PubMed ID 20332263
         Pubmed Central ID 2852476 


 



2.
Bradford PT, Anderson WF, Purdue MP, Goldstein AM, Tucker MA (2010). Rising melanoma incidence rates of the trunk among younger women in the United States. Cancer Epidemiol Biomarkers Prev  19, 2401-6.   https://doi.org/10.1158/1055-9965.EPI-10-0503




PubMed



        
     
Free Article


 


PubMed ID 20826837
         Pubmed Central ID 2939095 


 



3.
Goldin LR, Björkholm M, Kristinsson SY, Samuelsson J, Landgren O (2009). Germline and somatic JAK2 mutations and susceptibility to chronic myeloproliferative neoplasms. Genome Med  1, 55.   https://doi.org/10.1186/gm55




PubMed



        
     
Free Article


 


PubMed ID 19490586
         Pubmed Central ID 2689447 


 



4.
Goldin LR, Björkholm M, Kristinsson SY, Turesson I, Landgren O (2009). Elevated risk of chronic lymphocytic leukemia and other indolent non-Hodgkin's lymphomas among relatives of patients with chronic lymphocytic leukemia. Haematologica  94, 647-53.   https://doi.org/10.3324/haematol.2008.003632




PubMed



        
     
Free Article


 


PubMed ID 19286886
         Pubmed Central ID 2675676 


 



5.
Goldin LR, Björkholm M, Kristinsson SY, Turesson I, Landgren O (2009). Highly increased familial risks for specific lymphoma subtypes. Br J Haematol  146, 91-4.   https://doi.org/10.1111/j.1365-2141.2009.07721.x




PubMed



        
     
Free Article


 


PubMed ID 19438470
         Pubmed Central ID 2702464 


 



6.
Goldin LR, Landgren O (2009). Autoimmunity and lymphomagenesis. Int J Cancer  124, 1497-502.   https://doi.org/10.1002/ijc.24141




PubMed



        
     
Free Article


 


PubMed ID 19089924
         Pubmed Central ID 2666348 


 



7.
Klug HL, Tooze JA, Graff-Cherry C, Anver MR, Noonan FP, Fears TR, Tucker MA, De Fabo EC, Merlino G (2010). Sunscreen prevention of melanoma in man and mouse. Pigment Cell Melanoma Res  23, 835-7.   https://doi.org/10.1111/j.1755-148X.2010.00756.x




PubMed



        
     
Free Article


 


PubMed ID 20726949
         Pubmed Central ID 2995311 


 



8.
Kristinsson SY, Björkholm M, Andersson TM, Eloranta S, Dickman PW, Goldin LR, Blimark C, Mellqvist UH, Wahlin A, Turesson I, Landgren O (2009). Patterns of survival and causes of death following a diagnosis of monoclonal gammopathy of undetermined significance: a population-based study. Haematologica  94, 1714-20.   https://doi.org/10.3324/haematol.2009.010066




PubMed



        
     
Free Article


 


PubMed ID 19608666
         Pubmed Central ID 2791946 


 



9.
Kristinsson SY, Koshiol J, Björkholm M, Goldin LR, McMaster ML, Turesson I, Landgren O (2010). Immune-related and inflammatory conditions and risk of lymphoplasmacytic lymphoma or Waldenstrom macroglobulinemia. J Natl Cancer Inst  102, 557-67.   https://doi.org/10.1093/jnci/djq043




PubMed



        
     
Free Article


 


PubMed ID 20181958
         Pubmed Central ID 2857799 


 



10.
Kristinsson SY, Koshiol J, Goldin LR, Björkholm M, Turesson I, Gridley G, McMaster ML, Landgren O (2009). Genetics- and immune-related factors in the pathogenesis of lymphoplasmacytic lymphoma/ Waldenström's macroglobulinemia. Clin Lymphoma Myeloma  9, 23-6.   https://doi.org/10.3816/CLM.2009.n.004




PubMed



        
     
Free Article


 


PubMed ID 19362964
         Pubmed Central ID 2796606 


 



11.
Kristinsson SY, Landgren O, Samuelsson J, Björkholm M, Goldin LR (2010). Autoimmunity and the risk of myeloproliferative neoplasms. Haematologica  95, 1216-20.   https://doi.org/10.3324/haematol.2009.020412




PubMed



        
     
Free Article


 


PubMed ID 20053870
         Pubmed Central ID 2895049 


 



12.
Kristinsson SY, Landgren O, Sjöberg J, Turesson I, Björkholm M, Goldin LR (2009). Autoimmunity and risk for Hodgkin's lymphoma by subtype. Haematologica  94, 1468-9.   https://doi.org/10.3324/haematol.2009.010512




PubMed



        
     
Free Article


 


PubMed ID 19794095
         Pubmed Central ID 2754970 


 



13.
Landgren O, Gilbert ES, Rizzo JD, Socié G, Banks PM, Sobocinski KA, Horowitz MM, Jaffe ES, Kingma DW, Travis LB, Flowers ME, Martin PJ, Deeg HJ, Curtis RE (2009). Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation. Blood  113, 4992-5001.   https://doi.org/10.1182/blood-2008-09-178046




PubMed



        
     
Free Article


 


PubMed ID 19264919
         Pubmed Central ID 2686146 


 



14.
Landgren O, Kristinsson SY, Goldin LR, Caporaso NE, Blimark C, Mellqvist UH, Wahlin A, Bjorkholm M, Turesson I (2009). Risk of plasma cell and lymphoproliferative disorders among 14621 first-degree relatives of 4458 patients with monoclonal gammopathy of undetermined significance in Sweden. Blood  114, 791-5.   https://doi.org/10.1182/blood-2008-12-191676




PubMed



        
     
Free Article


 


PubMed ID 19182202
         Pubmed Central ID 2716021 


 



15.
Mai P, Chatterjee N, Tucker M, Brody PhD L, Struewing J, Wacholder S (2010) Potential excess mortality in BRCA12 mutation carriers beyond breast, ovarian, prostate and pancreatic cancers, and melanoma. PLoS One 4:e4812




 



16.
Mai P, Chatterjee N, Tucker M, Brody PhD L, Struewing J, Wacholder S (2010) Potential excess mortality in BRCA12 mutation carriers beyond breast, ovarian, prostate and pancreatic cancers, and melanoma. PLoS One 4:e4812",https://intramural.nih.gov/search/searchview.taf?ipid=63496
680,CP005804-16,"October 01, 2009 -  September 30, 2010",Pharmacogenetic Studies,"Maria Teresa Pia Landi; MD, PhD



IRP Faculty Profile
 


 

Neil Edward Caporaso; MS, MD



IRP Faculty Profile",NULL,"Genetic Epidemiology Branch, NCI","Alisa  Goldstein; PhD



Lynn Rachel Goldin; PhD","Janis  Beach
(Information Management Systems)




Maria  Landi
(DCEG)",Margaret Anne Tucker (Human Genetics Program),NULL,"Ordered by publication type and then author name.



1.
Consonni D, De Matteis S, Lubin JH, Wacholder S, Tucker M, Pesatori AC, Caporaso NE, Bertazzi PA, Landi MT (2010). Lung cancer and occupation in a population-based case-control study. Am J Epidemiol  171, 323-33.   https://doi.org/10.1093/aje/kwp391




PubMed



        
     
Free Article


 


PubMed ID 20047975
         Pubmed Central ID 2808498 


 



2.
Dores GM, Landgren O, McGlynn KA, Curtis RE, Linet MS, Devesa SS (2009). Plasmacytoma of bone, extramedullary plasmacytoma, and multiple myeloma: incidence and survival in the United States, 1992-2004. Br J Haematol  144, 86-94.   https://doi.org/10.1111/j.1365-2141.2008.07421.x




PubMed



        
     
Free Article


 


PubMed ID 19016727
         Pubmed Central ID 2610331 


 



3.
Gao Y, Goldstein AM, Consonni D, Pesatori AC, Wacholder S, Tucker MA, Caporaso NE, Goldin L, Landi MT (2009). Family history of cancer and nonmalignant lung diseases as risk factors for lung cancer. Int J Cancer  125, 146-52.   https://doi.org/10.1002/ijc.24283




PubMed



        
     
Free Article


 


PubMed ID 19350630
         Pubmed Central ID 2865851 


 



4.
Landgren O, Kyle RA, Hoppin JA, Beane Freeman LE, Cerhan JR, Katzmann JA, Rajkumar SV, Alavanja MC (2009). Pesticide exposure and risk of monoclonal gammopathy of undetermined significance in the Agricultural Health Study. Blood  113, 6386-91.   https://doi.org/10.1182/blood-2009-02-203471




PubMed



        
     
Free Article


 


PubMed ID 19387005
         Pubmed Central ID 2710931 


 



5.
Landi MT, Chatterjee N, Yu K, Goldin LR, Goldstein AM, Rotunno M, Mirabello L, Jacobs K, Wheeler W, Yeager M, Bergen AW, Li Q, Consonni D, Pesatori AC, Wacholder S, Thun M, Diver R, Oken M, Virtamo J, Albanes D, Wang Z, Burdette L, Doheny KF, Pugh EW, Laurie C, et al. [43 more authors] (2009). A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum Genet  85, 679-91.   https://doi.org/10.1016/j.ajhg.2009.09.012




PubMed



        
     
Free Article


 


PubMed ID 19836008
         Pubmed Central ID 2775843 


 



6.
Landi MT, Zhao Y, Rotunno M, Koshiol J, Liu H, Bergen AW, Rubagotti M, Goldstein AM, Linnoila I, Marincola FM, Tucker MA, Bertazzi PA, Pesatori AC, Caporaso NE, McShane LM, Wang E (2010). MicroRNA expression differentiates histology and predicts survival of lung cancer. Clin Cancer Res  16, 430-41.   https://doi.org/10.1158/1078-0432.CCR-09-1736




PubMed



        
     
Free Article


 


PubMed ID 20068076
         Pubmed Central ID 3163170",https://intramural.nih.gov/search/searchview.taf?ipid=63495
681,CP010119-15,"October 01, 2009 -  September 30, 2010",Studies of Occupational Cancer (Pesticides),"Laura Elizabeth Beane Freeman



IRP Faculty Profile
 




Jay  Lubin; PhD

 


 

Mary Helen Ward; MS, PhD



IRP Faculty Profile
 




Shelia K Zahm; ScM, ScD

 




Michael  Alavanja; PhD",NULL,"Occupational and Environmental Epidemiology Branch, NCI

Biostatistics Branch, NCI

Office of the Director, NCI","Stella  Koutros



Jonathan Nicholas Hofmann



Debra  Silverman; ScD, ScM



Nathaniel C Rothman; MD



Dalsu  Baris



Joanne S Colt



Show all 7","Jane  Hoppin; ScD





Lisbeth  Lopez-Carrillo
(Mexican National Institute of Public Health)




Andrew  Olshan
(University of North Carolina)




Sandra  Petralia
(Roche Laboratories)




Dale  Sandler; PhD
(NIEHS)




Dennis  Weisenburger
(University of Nebraska Medical Center)","Ola Anders Landgren (Medical Oncology Branch)



Neil Edward Caporaso; MS, MD (Genetic Epidemiology Branch)



Sharon Ann Savage (Clinical Genetics Branch)



Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)",NULL,"Ordered by publication type and then author name.



1.
Andreotti G, Freeman LE, Hou L, Coble J, Rusiecki J, Hoppin JA, Silverman DT, Alavanja MC (2009). Agricultural pesticide use and pancreatic cancer risk in the Agricultural Health Study Cohort. Int J Cancer  124, 2495-500.   https://doi.org/10.1002/ijc.24185




PubMed



        
     
Free Article


 


PubMed ID 19142867
         Pubmed Central ID 2674312 


 



2.
Andreotti G, Hou L, Beane Freeman LE, Mahajan R, Koutros S, Coble J, Lubin J, Blair A, Hoppin JA, Alavanja M (2010). Body mass index, agricultural pesticide use, and cancer incidence in the Agricultural Health Study cohort. Cancer Causes Control  21, 1759-75.   https://doi.org/10.1007/s10552-010-9603-9




PubMed



        
     
Free Article


 


PubMed ID 20730623
         Pubmed Central ID 2962760 


 



3.
Bhatti P, Blair A, Bell EM, Rothman N, Lan Q, Barr DB, Needham LL, Portengen L, Figgs LW, Vermeulen R (2010). Predictors of 2,4-dichlorophenoxyacetic acid exposure among herbicide applicators. J Expo Sci Environ Epidemiol  20, 160-8.   https://doi.org/10.1038/jes.2009.14




PubMed



        
     
Free Article


 


PubMed ID 19319162
         Pubmed Central ID 2823960 


 



4.
Blair A, Freeman LB (2009). Epidemiologic studies in agricultural populations: observations and future directions. J Agromedicine  14, 125-31.   https://doi.org/10.1080/10599240902779436




PubMed



        
     
Free Article


 


PubMed ID 19437268
         Pubmed Central ID 2682692 


 



5.
Bonner MR, Williams BA, Rusiecki JA, Blair A, Beane Freeman LE, Hoppin JA, Dosemeci M, Lubin J, Sandler DP, Alavanja MC (2010). Occupational exposure to terbufos and the incidence of cancer in the Agricultural Health Study. Cancer Causes Control  21, 871-7.   https://doi.org/10.1007/s10552-010-9514-9




PubMed



        
     
Free Article


 


PubMed ID 20155313
         Pubmed Central ID 2935663 


 



6.
Chang CM, Schroeder JC, Olshan AF, Dunphy CH, Huang WY, Baric RS, Conway K, Cerhan JR, Lynch CF, Rothman N, Cantor KP, Blair A (2010). A case-control study of tobacco use and other non-occupational risk factors for lymphoma subtypes defined by t(14; 18) translocations and bcl-2 expression. Cancer Causes Control  21, 1147-54.   https://doi.org/10.1007/s10552-010-9531-8




PubMed



        
     
Free Article


 


PubMed ID 20232134
         Pubmed Central ID 3052629 


 



7.
Christensen CH, Platz EA, Andreotti G, Blair A, Hoppin JA, Koutros S, Lynch CF, Sandler DP, Alavanja MC (2010). Coumaphos exposure and incident cancer among male participants in the Agricultural Health Study (AHS). Environ Health Perspect  118, 92-6.   https://doi.org/10.1289/ehp.0800446




PubMed



        
     
Free Article


 


PubMed ID 20056581
         Pubmed Central ID 2831974 


 



8.
Coble J (2009) Assessing a Pesticide Exposure Intensity Algoithm in the Agricultural Health Study. Journal of Exposure Science and Environmental Epidemiology Epub:1-3.




 



9.
Dayton SB, Sandler DP, Blair A, Alavanja M, Beane Freeman LE, Hoppin JA (2010). Pesticide use and myocardial infarction incidence among farm women in the agricultural health study. J Occup Environ Med  52, 693-7.   https://doi.org/10.1097/JOM.0b013e3181e66d25




PubMed



        
     
Free Article


 


PubMed ID 20595914
         Pubmed Central ID 2927225 


 



10.
Delancey JO, Alavanja MC, Coble J, Blair A, Hoppin JA, Austin HD, Beane Freeman LE (2009). Occupational exposure to metribuzin and the incidence of cancer in the Agricultural Health Study. Ann Epidemiol  19, 388-95.   https://doi.org/10.1016/j.annepidem.2008.12.018




PubMed



        
     
Free Article


 


PubMed ID 19369095
         Pubmed Central ID 2693328 


 



11.
Dennis LK, Lynch CF, Sandler DP, Alavanja MC (2010). Pesticide use and cutaneous melanoma in pesticide applicators in the agricultural heath study. Environ Health Perspect  118, 812-7.   https://doi.org/10.1289/ehp.0901518




PubMed



        
     
Free Article


 


PubMed ID 20164001
         Pubmed Central ID 2898858 


 



12.
Hoppin JA, Umbach DM, London SJ, Henneberger PK, Kullman GJ, Coble J, Alavanja MC, Beane Freeman LE, Sandler DP (2009). Pesticide use and adult-onset asthma among male farmers in the Agricultural Health Study. Eur Respir J  34, 1296-303.   https://doi.org/10.1183/09031936.00005509




PubMed



        
     
Free Article


 


PubMed ID 19541724
         Pubmed Central ID 2822385 


 



13.
Koutros S, Alavanja MC, Lubin JH, Sandler DP, Hoppin JA, Lynch CF, Knott C, Blair A, Freeman LE (2010). An update of cancer incidence in the Agricultural Health Study. J Occup Environ Med  52, 1098-105.   https://doi.org/10.1097/JOM.0b013e3181f72b7c




PubMed



               Available in future as a Free Article 


 


PubMed ID 21063187
         Pubmed Central ID 3052640 


 



14.
Koutros S, Beane Freeman LE, Berndt SI, Andreotti G, Lubin JH, Sandler DP, Hoppin JA, Yu K, Li Q, Burdette LA, Yuenger J, Yeager M, Alavanja MC (2010). Pesticide use modifies the association between genetic variants on chromosome 8q24 and prostate cancer. Cancer Res  70, 9224-33.   https://doi.org/10.1158/0008-5472.CAN-10-1078




PubMed



        
     
Free Article


 


PubMed ID 20978189
         Pubmed Central ID 2982856 


 



15.
Koutros S, Lynch CF, Ma X, Lee WJ, Hoppin JA, Christensen CH, Andreotti G, Freeman LB, Rusiecki JA, Hou L, Sandler DP, Alavanja MC (2009). Heterocyclic aromatic amine pesticide use and human cancer risk: results from the U.S. Agricultural Health Study. Int J Cancer  124, 1206-12.   https://doi.org/10.1002/ijc.24020




PubMed



        
     
Free Article


 


PubMed ID 19058219
         Pubmed Central ID 2904521 


 



16.
Landgren O, Kyle RA, Hoppin JA, Beane Freeman LE, Cerhan JR, Katzmann JA, Rajkumar SV, Alavanja MC (2009). Pesticide exposure and risk of monoclonal gammopathy of undetermined significance in the Agricultural Health Study. Blood  113, 6386-91.   https://doi.org/10.1182/blood-2009-02-203471




PubMed



        
     
Free Article


 


PubMed ID 19387005
         Pubmed Central ID 2710931 


 



17.
Lynch SM, Mahajan R, Beane Freeman LE, Hoppin JA, Alavanja MC (2009). Cancer incidence among pesticide applicators exposed to butylate in the Agricultural Health Study (AHS). Environ Res  109, 860-8.   https://doi.org/10.1016/j.envres.2009.06.006




PubMed



        
     
Free Article


 


PubMed ID 19615679
         Pubmed Central ID 3799990 


 



18.
Mills KT, Blair A, Freeman LE, Sandler DP, Hoppin JA (2009). Pesticides and myocardial infarction incidence and mortality among male pesticide applicators in the Agricultural Health Study. Am J Epidemiol  170, 892-900.   https://doi.org/10.1093/aje/kwp214




PubMed



        
     
Free Article


 


PubMed ID 19700503
         Pubmed Central ID 2765359 


 



19.
Montgomery MP, Kamel F, Hoppin JA, Beane Freeman LE, Alavanja MC, Sandler DP (2010). Effects of self-reported health conditions and pesticide exposures on probability of follow-up in a prospective cohort study. Am J Ind Med  53, 486-96.   https://doi.org/10.1002/ajim.20789




PubMed



               Available in future as a Free Article 


 


PubMed ID 20017198
         Pubmed Central ID 3184944 


 



20.
Romitti PA, Watanabe-Galloway S, Budelier WT, Lynch CF, Puzhankara S, Wong-Gibbons D, Hoppin JA, Alavanja MC (2010). Identification of Iowa live births in the Agricultural Health Study. Arch Environ Occup Health  65, 154-62.   https://doi.org/10.1080/19338241003730903




PubMed



        
     
Free Article


 


PubMed ID 20705576
         Pubmed Central ID 2936500 


 



21.
Rusiecki JA, Patel R, Koutros S, Beane-Freeman L, Landgren O, Bonner MR, Coble J, Lubin J, Blair A, Hoppin JA, Alavanja MC (2009). Cancer incidence among pesticide applicators exposed to permethrin in the Agricultural Health Study. Environ Health Perspect  117, 581-6.   https://doi.org/10.1289/ehp.11318




PubMed



        
     
Free Article


 


PubMed ID 19440497
         Pubmed Central ID 2679602 


 



22.
Thomas KW, Dosemeci M, Hoppin JA, Sheldon LS, Croghan CW, Gordon SM, Jones ML, Reynolds SJ, Raymer JH, Akland GG, Lynch CF, Knott CE, Sandler DP, Blair AE, Alavanja MC (2010). Urinary biomarker, dermal, and air measurement results for 2,4-D and chlorpyrifos farm applicators in the Agricultural Health Study. J Expo Sci Environ Epidemiol  20, 119-34.   https://doi.org/10.1038/jes.2009.6




PubMed



        
     
Free Article


 


PubMed ID 19240759
         Pubmed Central ID 3633453",https://intramural.nih.gov/search/searchview.taf?ipid=63490
682,CP010120-15,"October 01, 2009 -  September 30, 2010",Studies of Occupational Cancer,"Michael  Alavanja; PhD

 




Wong H Chow

 


 

Nathaniel C Rothman; MD



IRP Faculty Profile
 


 

Debra  Silverman; ScD, ScM



IRP Faculty Profile
 


 

Qing  Lan



IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Dalsu  Baris



Joanne S Colt



Bu Tian  Ji



Mary Helen Ward; MS, PhD



Aaron E Blair; PhD, MPH



Patricia S Stewart; PhD



Show all 13","Paolo  Boffetta
(International Agency for Research on Cancer)




Paul  Brennan
(International Agency for Research on Cancer, Lyon, France)




Leon  Burmeister
(University of Iowa)




Brian  Chiu
(Northwestern University)




Pierluigi  Cocco
(University of Cagliari)




Larwence  Figgs
(St. Louis University)


Show all 21","Jay  Lubin; PhD (Biostatistics Branch)



Louise  Brinton; PhD (Hormonal and Reproductive Epidemiology Branch)



Montserrat  Garcia-Closas; MD, PhD (Hormonal and Reproductive Epidemiology Branch)","Dale  Sandler; PhD (NIEHS) 



Jane  Hoppin; ScD (NIEHS) 



Freya  Kamel; PhD, MPH (NIEHS)","Ordered by publication type and then author name.



1.
Beane Freeman LE, Blair A, Lubin JH, Stewart PA, Hayes RB, Hoover RN, Hauptmann M (2009). Mortality from lymphohematopoietic malignancies among workers in formaldehyde industries: the National Cancer Institute Cohort. J Natl Cancer Inst  101, 751-61.   https://doi.org/10.1093/jnci/djp096




PubMed



        
     
Free Article


 


PubMed ID 19436030
         Pubmed Central ID 2684555 


 



2.
Blair A (2009). Occupation and cancer in the Nordic countries. Acta Oncol  48, 644-5.   https://doi.org/10.1080/02841860902988696




PubMed



        
     
Free Article


 


PubMed ID 19925374
         Pubmed Central ID 2793089 


 



3.
Blair A, Saracci R, Vineis P, Cocco P, Forastiere F, Grandjean P, Kogevinas M, Kriebel D, McMichael A, Pearce N, Porta M, Samet J, Sandler DP, Costantini AS, Vainio H (2009). Epidemiology, public health, and the rhetoric of false positives. Environ Health Perspect  117, 1809-13.   https://doi.org/10.1289/ehp.0901194




PubMed



        
     
Free Article


 


PubMed ID 20049197
         Pubmed Central ID 2799452 


 



4.
Chang CM, Schroeder JC, Olshan AF, Dunphy CH, Huang WY, Baric RS, Conway K, Cerhan JR, Lynch CF, Rothman N, Cantor KP, Blair A (2010). A case-control study of tobacco use and other non-occupational risk factors for lymphoma subtypes defined by t(14; 18) translocations and bcl-2 expression. Cancer Causes Control  21, 1147-54.   https://doi.org/10.1007/s10552-010-9531-8




PubMed



        
     
Free Article


 


PubMed ID 20232134
         Pubmed Central ID 3052629 


 



5.
Dong LM, Brennan P, Karami S, Hung RJ, Menashe I, Berndt SI, Yeager M, Chanock S, Zaridze D, Matveev V, Janout V, Kollarova H, Bencko V, Schwartz K, Davis F, Navratilova M, Szeszenia-Dabrowska N, Mates D, Colt JS, Holcatova I, Boffetta P, Rothman N, Chow WH, Rosenberg PS, Moore LE (2009). An analysis of growth, differentiation and apoptosis genes with risk of renal cancer. PLoS One  4, e4895.   https://doi.org/10.1371/journal.pone.0004895




PubMed



        
     
Free Article


 


PubMed ID 19603096
         Pubmed Central ID 2656573 


 



6.
Hauptmann M, Stewart PA, Lubin JH, Beane Freeman LE, Hornung RW, Herrick RF, Hoover RN, Fraumeni JF, Blair A, Hayes RB (2009). Mortality from lymphohematopoietic malignancies and brain cancer among embalmers exposed to formaldehyde. J Natl Cancer Inst  101, 1696-708.   https://doi.org/10.1093/jnci/djp416




PubMed



        
     
Free Article


 


PubMed ID 19933446
         Pubmed Central ID 2794303 


 



7.
Hein MJ, Waters MA, Ruder AM, Stenzel MR, Blair A, Stewart PA (2010). Statistical modeling of occupational chlorinated solvent exposures for case-control studies using a literature-based database. Ann Occup Hyg  54, 459-72.   https://doi.org/10.1093/annhyg/meq027




PubMed



        
     
Free Article


 


PubMed ID 20418277
         Pubmed Central ID 2913720 


 



8.
Karami S, Brennan P, Navratilova M, Mates D, Zaridze D, Janout V, Kollarova H, Bencko V, Matveev V, Szesznia-Dabrowska N, Holcatova I, Yeager M, Chanock S, Rothman N, Boffetta P, Chow WH, Moore LE (2010). Vitamin d pathway genes, diet, and risk of renal cell carcinoma. Int J Endocrinol  2010, 879362.   https://doi.org/10.1155/2010/879362




PubMed



        
     
Free Article


 


PubMed ID 20049159
         Pubmed Central ID 2798114 


 



9.
Karami S, Brennan P, Rosenberg PS, Navratilova M, Mates D, Zaridze D, Janout V, Kollarova H, Bencko V, Matveev V, Szeszenia-Dabrowska N, Holcatova I, Yeager M, Chanock S, Menashe I, Rothman N, Chow WH, Boffetta P, Moore LE (2009). Analysis of SNPs and haplotypes in vitamin D pathway genes and renal cancer risk. PLoS One  4, e7013.   https://doi.org/10.1371/journal.pone.0007013




PubMed



        
     
Free Article


 


PubMed ID 19753122
         Pubmed Central ID 2737618 


 



10.
Kilfoy BA, Ward MH, Zheng T, Holford TR, Boyle P, Zhao P, Dai M, Leaderer B, Zhang Y (2010). Risk of non-Hodgkin lymphoma and nitrate and nitrite from the diet in Connecticut women. Cancer Causes Control  21, 889-96.   https://doi.org/10.1007/s10552-010-9517-6




PubMed



        
     
Free Article


 


PubMed ID 20204494
         Pubmed Central ID 3086573 


 



11.
Lan Q (2009) Effect of chimneys on indoor air concentrations of PM10 and benzoapyrene in Xuan Wei, China. Atmos Environ 43:3352-55.




 



12.
Lee KM, Chapman RS, Shen M, Lubin JH, Silverman DT, He X, Hosgood HD, Chen BE, Rajaraman P, Caporaso NE, Fraumeni JF, Blair A, Lan Q (2010). Differential effects of smoking on lung cancer mortality before and after household stove improvement in Xuanwei, China. Br J Cancer  103, 727-9.   https://doi.org/10.1038/sj.bjc.6605791




PubMed



        
     
Free Article


 


PubMed ID 20648014
         Pubmed Central ID 2938247 


 



13.
Purdue MP, Engel LS, Langseth H, Needham LL, Andersen A, Barr DB, Blair A, Rothman N, McGlynn KA (2009). Prediagnostic serum concentrations of organochlorine compounds and risk of testicular germ cell tumors. Environ Health Perspect  117, 1514-9.   https://doi.org/10.1289/ehp.0800359




PubMed



        
     
Free Article


 


PubMed ID 20019899
         Pubmed Central ID 2790503 


 



14.
Timpson NJ, Brennan P, Gaborieau V, Moore L, Zaridze D, Matveev V, Szeszenia-Dabrowska N, Lissowska J, Mates D, Bencko V, Foretova L, Janout V, Chow WH, Rothman N, Boffetta P, Harbord RM, Smith GD (2010). Can lactase persistence genotype be used to reassess the relationship between renal cell carcinoma and milk drinking? Potentials and problems in the application of Mendelian randomization. Cancer Epidemiol Biomarkers Prev  19, 1341-8.   https://doi.org/10.1158/1055-9965.EPI-09-1019




PubMed



        
     
Free Article


 


PubMed ID 20447925
         Pubmed Central ID 4141143",https://intramural.nih.gov/search/searchview.taf?ipid=63492
683,CP010121-15,"October 01, 2009 -  September 30, 2010",Molecular Epidemiology Studies of Occupational and Environmental Exposures,"Nathaniel C Rothman; MD



IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Dalsu  Baris



Mary Helen Ward; MS, PhD



Michael  Alavanja; PhD



Laura Elizabeth Beane Freeman



Kenneth  Cantor; PhD



Aaron E Blair; PhD, MPH



Show all 11","Robert  Branch
(University of Pittsburgh)




Paul  Brennan
(International Agency for Research on Cancer, Lyon, France)




David  DeMarini
(United States Environmental Protection Agency)




Manolis  Kogevinas





Nria  Malats
(Institut Municipal dInvestigaci Mdica)




Stephen  Rappaport
(School of Public Health, University of California)


Show all 12","Shelia K Zahm; ScM, ScD (Office of the Director)



Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)",NULL,"Ordered by publication type and then author name.



1.
Castillejo A, Rothman N, Murta-Nascimento C, Malats N, García-Closas M, Gómez-Martínez A, Lloreta J, Tardón A, Serra C, García-Closas R, Chanock S, Silverman DT, Dosemeci M, Kogevinas M, Carrato A, Soto JL, Real FX (2009). TGFB1 and TGFBR1 polymorphic variants in relationship to bladder cancer risk and prognosis. Int J Cancer  124, 608-13.   https://doi.org/10.1002/ijc.24013




PubMed



        
     
Free Article


 


PubMed ID 19004027
         Pubmed Central ID 6896897 


 



2.
García-Closas M, Hein DW, Silverman D, Malats N, Yeager M, Jacobs K, Doll MA, Figueroa JD, Baris D, Schwenn M, Kogevinas M, Johnson A, Chatterjee N, Moore LE, Moeller T, Real FX, Chanock S, Rothman N (2011). A single nucleotide polymorphism tags variation in the arylamine N-acetyltransferase 2 phenotype in populations of European background. Pharmacogenet Genomics  21, 231-6.   https://doi.org/10.1097/FPC.0b013e32833e1b54




PubMed



        
     
Free Article


 


PubMed ID 20739907
         Pubmed Central ID 3003749 


 



3.
Han X, Zheng T, Lan Q, Zhang Y, Kilfoy BA, Qin Q, Rothman N, Zahm SH, Holford TR, Leaderer B, Zhang Y (2009). Genetic polymorphisms in nitric oxide synthase genes modify the relationship between vegetable and fruit intake and risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev  18, 1429-38.   https://doi.org/10.1158/1055-9965.EPI-09-0001




PubMed



        
     
Free Article


 


PubMed ID 19423521
         Pubmed Central ID 2965355 


 



4.
Hosgood HD, Boffetta P, Greenland S, Lee YC, McLaughlin J, Seow A, Duell EJ, Andrew AS, Zaridze D, Szeszenia-Dabrowska N, Rudnai P, Lissowska J, Fabiánová E, Mates D, Bencko V, Foretova L, Janout V, Morgenstern H, Rothman N, Hung RJ, Brennan P, Lan Q (2010). In-home coal and wood use and lung cancer risk: a pooled analysis of the International Lung Cancer Consortium. Environ Health Perspect  118, 1743-7.   https://doi.org/10.1289/ehp.1002217




PubMed



        
     
Free Article


 


PubMed ID 20846923
         Pubmed Central ID 3002194 


 



5.
Hosgood HD, Cawthon R, He X, Chanock S, Lan Q (2009). Genetic variation in telomere maintenance genes, telomere length, and lung cancer susceptibility. Lung Cancer  66, 157-61.   https://doi.org/10.1016/j.lungcan.2009.02.005




PubMed



        
     
Free Article


 


PubMed ID 19285750
         Pubmed Central ID 2783462 


 



6.
Hosgood HD, Menashe I, He X, Chanock S, Lan Q (2009). PTEN identified as important risk factor of chronic obstructive pulmonary disease. Respir Med  103, 1866-70.   https://doi.org/10.1016/j.rmed.2009.06.016




PubMed



        
     
Free Article


 


PubMed ID 19625176
         Pubmed Central ID 2783799 


 



7.
Hosgood HD, Zhang L, Shen M, Berndt SI, Vermeulen R, Li G, Yin S, Yeager M, Yuenger J, Rothman N, Chanock S, Smith M, Lan Q (2009). Association between genetic variants in VEGF, ERCC3 and occupational benzene haematotoxicity. Occup Environ Med  66, 848-53.   https://doi.org/10.1136/oem.2008.044024




PubMed



        
     
Free Article


 


PubMed ID 19773279
         Pubmed Central ID 2928224 


 



8.
Hsiung CA, Lan Q, Hong YC, Chen CJ, Hosgood HD, Chang IS, Chatterjee N, Brennan P, Wu C, Zheng W, Chang GC, Wu T, Park JY, Hsiao CF, Kim YH, Shen H, Seow A, Yeager M, Tsai YH, Kim YT, Chow WH, Guo H, Wang WC, Sung SW, Hu Z, et al. [55 more authors] (2010). The 5p15.33 locus is associated with risk of lung adenocarcinoma in never-smoking females in Asia. PLoS Genet  6.   https://doi.org/10.1371/journal.pgen.1001051




PubMed



        
     
Free Article


 


PubMed ID 20700438
         Pubmed Central ID 2916850 


 



9.
Kilfoy BA, Zheng T, Lan Q, Han X, Holford T, Hein DW, Qin Q, Leaderer B, Morton LM, Yeager M, Boyle P, Zhao P, Chanock S, Rothman N, Zhang Y (2010). Genetic variation in N-acetyltransferases 1 and 2, cigarette smoking, and risk of non-Hodgkin lymphoma. Cancer Causes Control  21, 127-33.   https://doi.org/10.1007/s10552-009-9442-8




PubMed



        
     
Free Article


 


PubMed ID 19809881
         Pubmed Central ID 2972187 


 



10.
Kilfoy BA, Zheng T, Lan Q, Han X, Qin Q, Rothman N, Holford T, Zhang Y (2009). Genetic polymorphisms in glutathione S-transferases and cytochrome P450s, tobacco smoking, and risk of non-Hodgkin lymphoma. Am J Hematol  84, 279-82.   https://doi.org/10.1002/ajh.21386




PubMed



        
     
Free Article


 


PubMed ID 19338043
         Pubmed Central ID 2790381 


 



11.
Lan Q, Cawthon R, Shen M, Weinstein SJ, Virtamo J, Lim U, Hosgood HD, Albanes D, Rothman N (2009). A prospective study of telomere length measured by monochrome multiplex quantitative PCR and risk of non-Hodgkin lymphoma. Clin Cancer Res  15, 7429-33.   https://doi.org/10.1158/1078-0432.CCR-09-0845




PubMed



        
     
Free Article


 


PubMed ID 19934287
         Pubmed Central ID 2787641 


 



12.
Lan Q, Morton LM, Armstrong B, Hartge P, Menashe I, Zheng T, Purdue MP, Cerhan JR, Zhang Y, Grulich A, Cozen W, Yeager M, Holford TR, Vajdic CM, Davis S, Leaderer B, Kricker A, Schenk M, Zahm SH, Chatterjee N, Chanock SJ, Rothman N, Wang SS (2009). Genetic variation in caspase genes and risk of non-Hodgkin lymphoma: a pooled analysis of 3 population-based case-control studies. Blood  114, 264-7.   https://doi.org/10.1182/blood-2009-01-198697




PubMed



        
     
Free Article


 


PubMed ID 19414860
         Pubmed Central ID 2714202 


 



13.
Lan Q, Zhang L, Shen M, Jo WJ, Vermeulen R, Li G, Vulpe C, Lim S, Ren X, Rappaport SM, Berndt SI, Yeager M, Yuenger J, Hayes RB, Linet M, Yin S, Chanock S, Smith MT, Rothman N (2009). Large-scale evaluation of candidate genes identifies associations between DNA repair and genomic maintenance and development of benzene hematotoxicity. Carcinogenesis  30, 50-8.   https://doi.org/10.1093/carcin/bgn249




PubMed



        
     
Free Article


 


PubMed ID 18978339
         Pubmed Central ID 2639030 


 



14.
Lan Q, Zhang L, Tang X, Shen M, Smith MT, Qiu C, Ge Y, Ji Z, Xiong J, He J, Reiss B, Hao Z, Liu S, Xie Y, Guo W, Purdue MP, Galvan N, Xin KX, Hu W, Beane Freeman LE, Blair AE, Li L, Rothman N, Vermeulen R, Huang H (2010). Occupational exposure to trichloroethylene is associated with a decline in lymphocyte subsets and soluble CD27 and CD30 markers. Carcinogenesis  31, 1592-6.   https://doi.org/10.1093/carcin/bgq121




PubMed



        
     
Free Article


 


PubMed ID 20530238
         Pubmed Central ID 2930801 


 



15.
Purdue MP, Lan Q, Wang SS, Kricker A, Menashe I, Zheng TZ, Hartge P, Grulich AE, Zhang Y, Morton LM, Vajdic CM, Holford TR, Severson RK, Leaderer BP, Cerhan JR, Yeager M, Cozen W, Jacobs K, Davis S, Rothman N, Chanock SJ, Chatterjee N, Armstrong BK (2009). A pooled investigation of Toll-like receptor gene variants and risk of non-Hodgkin lymphoma. Carcinogenesis  30, 275-81.   https://doi.org/10.1093/carcin/bgn262




PubMed



        
     
Free Article


 


PubMed ID 19029192
         Pubmed Central ID 2639046 


 



16.
Purdue MP, Severson RK, Colt JS, Stewart P, De Roos AJ, Cerhan JR, Cozen W, Davis S, Hartge P, Schenk M, Blair A (2009). Degreasing and risk of non-Hodgkin lymphoma. Occup Environ Med  66, 557-60.   https://doi.org/10.1136/oem.2008.040386




PubMed



        
     
Free Article


 


PubMed ID 19017696
         Pubmed Central ID 2995288 


 



17.
Shen M (2009) Coal use, stove improvement and risk of pneumonia in Xuanwei, China: a retrospective cohort study. Environ Health Perspect 117:261-6.




 



18.
Shen M, Menashe I, Morton LM, Zhang Y, Armstrong B, Wang SS, Lan Q, Hartge P, Purdue MP, Cerhan JR, Grulich A, Cozen W, Yeager M, Holford TR, Vajdic CM, Davis S, Leaderer B, Kricker A, Severson RK, Zahm SH, Chatterjee N, Rothman N, Chanock SJ, Zheng T (2010). Polymorphisms in DNA repair genes and risk of non-Hodgkin lymphoma in a pooled analysis of three studies. Br J Haematol  151, 239-44.   https://doi.org/10.1111/j.1365-2141.2010.08364.x




PubMed



        
     
Free Article


 


PubMed ID 20813000
         Pubmed Central ID 2967772 


 



19.
Shen M, Vermeulen R, Rajaraman P, Menashe I, He X, Chapman RS, Yeager M, Thomas G, Burdett L, Hutchinson A, Yuenger J, Chanock S, Lan Q (2009). Polymorphisms in innate immunity genes and lung cancer risk in Xuanwei, China. Environ Mol Mutagen  50, 285-90.   https://doi.org/10.1002/em.20452




PubMed



        
     
Free Article


 


PubMed ID 19170196
         Pubmed Central ID 2666781 


 



20.
Stern MC, Lin J, Figueroa JD, Kelsey KT, Kiltie AE, Yuan JM, Matullo G, Fletcher T, Benhamou S, Taylor JA, Placidi D, Zhang ZF, Steineck G, Rothman N, Kogevinas M, Silverman D, Malats N, Chanock S, Wu X, Karagas MR, Andrew AS, Nelson HH, Bishop DT, Sak SC, Choudhury A, International Consortium of Bladder Cancer, et al. [23 more authors] (2009). Polymorphisms in DNA repair genes, smoking, and bladder cancer risk: findings from the international consortium of bladder cancer. Cancer Res  69, 6857-64.   https://doi.org/10.1158/0008-5472.CAN-09-1091




PubMed



        
     
Free Article


 


PubMed ID 19706757
         Pubmed Central ID 2782435 


 



21.
Villanueva CM, Silverman DT, Malats N, Tardon A, Garcia-Closas R, Serra C, Carrato A, Fortuny J, Rothman N, Dosemeci M, Kogevinas M (2009). Determinants of quality of interview and impact on risk estimates in a case-control study of bladder cancer. Am J Epidemiol  170, 237-43.   https://doi.org/10.1093/aje/kwp136




PubMed



        
     
Free Article


 


PubMed ID 19478234
         Pubmed Central ID 3159381 


 



22.
Villanueva CM, Silverman DT, Murta-Nascimento C, Malats N, Garcia-Closas M, Castro F, Tardon A, Garcia-Closas R, Serra C, Carrato A, Rothman N, Real FX, Dosemeci M, Kogevinas M (2009). Coffee consumption, genetic susceptibility and bladder cancer risk. Cancer Causes Control  20, 121-7.   https://doi.org/10.1007/s10552-008-9226-6




PubMed



        
     
Free Article


 


PubMed ID 18798002
         Pubmed Central ID 2912840 


 



23.
Wang R, Zhang Y, Lan Q, Holford TR, Leaderer B, Zahm SH, Boyle P, Dosemeci M, Rothman N, Zhu Y, Qin Q, Zheng T (2009). Occupational exposure to solvents and risk of non-Hodgkin lymphoma in Connecticut women. Am J Epidemiol  169, 176-85.   https://doi.org/10.1093/aje/kwn300




PubMed



        
     
Free Article


 


PubMed ID 19056833
         Pubmed Central ID 2727253 


 



24.
Wang SS, Maurer MJ, Morton LM, Habermann TM, Davis S, Cozen W, Lynch CF, Severson RK, Rothman N, Chanock SJ, Hartge P, Cerhan JR (2009). Polymorphisms in DNA repair and one-carbon metabolism genes and overall survival in diffuse large B-cell lymphoma and follicular lymphoma. Leukemia  23, 596-602.   https://doi.org/10.1038/leu.2008.240




PubMed



        
     
Free Article


 


PubMed ID 18830263
         Pubmed Central ID 3066015",https://intramural.nih.gov/search/searchview.taf?ipid=63493
684,CP010122-15,"October 01, 2009 -  September 30, 2010",Occupational Exposure Assessment,"Melissa Charmaine Friesen



IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Michael  Alavanja; PhD



Dalsu  Baris



Aaron E Blair; PhD, MPH



Kenneth  Cantor; PhD



Wong H Chow



Joanne S Colt



Show all 20","Olufemi  Adegoke
(Meharry Medical College, Nashville, TN)




Wolfgang  Ahrens
(University of Bremen)




Ruth  Allen
(Environmental Protection Agency, Washington, DC)




Tye  Arbuckle
(Health Canada)




Michael  Attfield
(National Institute for Occupational Safety and Health, Morgantown, WV)




Berit  Bakke
(National Institute of Occupational Health)


Show all 57","Nilanjan  Chatterjee (Biostatistics Branch)



Montserrat  Garcia-Closas; MD, PhD (Hormonal and Reproductive Epidemiology Branch)



Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch)



Peter D Inskip; ScD (Radiation Epidemiology Branch)



Martha S Linet; PhD (Radiation Epidemiology Branch)



Jay  Lubin; PhD (Biostatistics Branch)",NULL,"Ordered by publication type and then author name.



1.
Pronk A, Ji BT, Shu XO, Xue S, Yang G, Li HL, Rothman N, Gao YT, Zheng W, Chow WH (2010). Night-shift work and breast cancer risk in a cohort of Chinese women. Am J Epidemiol  171, 953-9.   https://doi.org/10.1093/aje/kwq029




PubMed



        
     
Free Article


 


PubMed ID 20375193
         Pubmed Central ID 2877476 


 



2.
Yang G, Gao YT, Shu XO, Cai Q, Li GL, Li HL, Ji BT, Rothman N, Dyba M, Xiang YB, Chung FL, Chow WH, Zheng W (2010). Isothiocyanate exposure, glutathione S-transferase polymorphisms, and colorectal cancer risk. Am J Clin Nutr  91, 704-11.   https://doi.org/10.3945/ajcn.2009.28683




PubMed



        
     
Free Article


 


PubMed ID 20042523
         Pubmed Central ID 2824157",https://intramural.nih.gov/search/searchview.taf?ipid=63491
685,CP010123-15,"October 01, 2009 -  September 30, 2010",Occupational and Environmental Determinants of Cancer among Women and Minorities,"Michael  Alavanja; PhD

 


 

Laura Elizabeth Beane Freeman



IRP Faculty Profile
 


 

Melissa Charmaine Friesen



IRP Faculty Profile
 


 

Qing  Lan



IRP Faculty Profile
 




Jay  Lubin; PhD

 




Lee Elizabeth Moore; PhD, MD

 


 

Mark  Purdue



IRP Faculty Profile
 


 

Nathaniel C Rothman; MD



IRP Faculty Profile
 


 

Debra  Silverman; ScD, ScM



IRP Faculty Profile
 


 

Mary Helen Ward; MS, PhD



IRP Faculty Profile
 




Wong H Chow",NULL,"Occupational and Environmental Epidemiology Branch, NCI

Biostatistics Branch, NCI","Dalsu  Baris



Aaron E Blair; PhD, MPH



Bu Tian  Ji



Patricia S Stewart; PhD



Joanne S Colt",NULL,"Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)



Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)



Shelia K Zahm; ScM, ScD (Office of the Director)



Martha S Linet; PhD (Radiation Epidemiology Branch)",NULL,"Ordered by publication type and then author name.



1.
Bhatti P, Stewart PA, Hutchinson A, Rothman N, Linet MS, Inskip PD, Rajaraman P (2009). Lead exposure, polymorphisms in genes related to oxidative stress, and risk of adult brain tumors. Cancer Epidemiol Biomarkers Prev  18, 1841-8.   https://doi.org/10.1158/1055-9965.EPI-09-0197




PubMed



        
     
Free Article


 


PubMed ID 19505917
         Pubmed Central ID 2750838 


 



2.
Dai Q, Shu XO, Li H, Yang G, Shrubsole MJ, Cai H, Ji B, Wen W, Franke A, Gao YT, Zheng W (2010). Is green tea drinking associated with a later onset of breast cancer? Ann Epidemiol  20, 74-81.   https://doi.org/10.1016/j.annepidem.2009.09.005




PubMed



        
     
Free Article


 


PubMed ID 20006278
         Pubmed Central ID 2848451 


 



3.
Gold LS, De Roos AJ, Brown EE, Lan Q, Milliken K, Davis S, Chanock SJ, Zhang Y, Severson R, Zahm SH, Zheng T, Rothman N, Baris D (2009). Associations of common variants in genes involved in metabolism and response to exogenous chemicals with risk of multiple myeloma. Cancer Epidemiol  33, 276-80.   https://doi.org/10.1016/j.canep.2009.08.005




PubMed



        
     
Free Article


 


PubMed ID 19736056
         Pubmed Central ID 2808169 


 



4.
Han S, Lan Q, Park AK, Lee KM, Park SK, Ahn HS, Shin HY, Kang HJ, Koo HH, Seo JJ, Choi JE, Ahn YO, Chanock SJ, Kim H, Rothman N, Kang D (2010). Polymorphisms in innate immunity genes and risk of childhood leukemia. Hum Immunol  71, 727-30.   https://doi.org/10.1016/j.humimm.2010.04.004




PubMed



        
     
Free Article


 


PubMed ID 20438785
         Pubmed Central ID 2967770 


 



5.
Han X, Zheng T, Foss FM, Lan Q, Holford TR, Rothman N, Ma S, Zhang Y (2010). Genetic polymorphisms in the metabolic pathway and non-Hodgkin lymphoma survival. Am J Hematol  85, 51-6.   https://doi.org/10.1002/ajh.21580




PubMed



        
     
Free Article


 


PubMed ID 20029944
         Pubmed Central ID 2964927 


 



6.
Hosgood HD, Baris D, Zhang Y, Berndt SI, Menashe I, Morton LM, Lee KM, Yeager M, Zahm SH, Chanock S, Zheng T, Lan Q (2009). Genetic variation in cell cycle and apoptosis related genes and multiple myeloma risk. Leuk Res  33, 1609-14.   https://doi.org/10.1016/j.leukres.2009.03.013




PubMed



        
     
Free Article


 


PubMed ID 19362737
         Pubmed Central ID 2749910 


 



7.
Kilfoy BA, Zheng T, Lan Q, Han X, Holford T, Hein DW, Qin Q, Leaderer B, Morton LM, Yeager M, Boyle P, Zhao P, Chanock S, Rothman N, Zhang Y (2010). Genetic variation in N-acetyltransferases 1 and 2, cigarette smoking, and risk of non-Hodgkin lymphoma. Cancer Causes Control  21, 127-33.   https://doi.org/10.1007/s10552-009-9442-8




PubMed



        
     
Free Article


 


PubMed ID 19809881
         Pubmed Central ID 2972187 


 



8.
Lan Q, Au WY, Chanock S, Tse J, Wong KF, Shen M, Siu LP, Yuenger J, Yeager M, Hosgood HD, Purdue MP, Liang R, Rothman N (2010). Genetic susceptibility for chronic lymphocytic leukemia among Chinese in Hong Kong. Eur J Haematol  85, 492-5.   https://doi.org/10.1111/j.1600-0609.2010.01518.x




PubMed



        
     
Free Article


 


PubMed ID 20731705
         Pubmed Central ID 2980583 


 



9.
Lee KH, Shu XO, Gao YT, Ji BT, Yang G, Blair A, Rothman N, Zheng W, Chow WH, Kang D (2010). Breast cancer and urinary biomarkers of polycyclic aromatic hydrocarbon and oxidative stress in the Shanghai Women's Health Study. Cancer Epidemiol Biomarkers Prev  19, 877-83.   https://doi.org/10.1158/1055-9965.EPI-09-1098




PubMed



        
     
Free Article


 


PubMed ID 20160264
         Pubmed Central ID 2836395 


 



10.
Lee KM, Baris D, Zhang Y, Hosgood HD, Menashe I, Yeager M, Zahm SH, Wang SS, Purdue MP, Chanock S, Zheng T, Rothman N, Lan Q (2010). Common single nucleotide polymorphisms in immunoregulatory genes and multiple myeloma risk among women in Connecticut. Am J Hematol  85, 560-3.   https://doi.org/10.1002/ajh.21760




PubMed



        
     
Free Article


 


PubMed ID 20568250
         Pubmed Central ID 2910184 


 



11.
Li Y, Zheng T, Kilfoy BA, Lan Q, Holford T, Han X, Zhao P, Dai M, Leaderer B, Rothman N, Zhang Y (2010). Genetic polymorphisms in cytochrome P450s, GSTs, NATs, alcohol consumption and risk of non-Hodgkin lymphoma. Am J Hematol  85, 213-5.   https://doi.org/10.1002/ajh.21608




PubMed



        
     
Free Article


 


PubMed ID 20131310
         Pubmed Central ID 2965357 


 



12.
Luo J, Gao YT, Chow WH, Shu XO, Li H, Yang G, Cai Q, Rothman N, Cai H, Shrubsole MJ, Franke AA, Zheng W, Dai Q (2010). Urinary polyphenols and breast cancer risk: results from the Shanghai Women's Health Study. Breast Cancer Res Treat  120, 693-702.   https://doi.org/10.1007/s10549-009-0487-x




PubMed



        
     
Free Article


 


PubMed ID 19653095
         Pubmed Central ID 2842475 


 



13.
Mendelsohn JB, Li QZ, Ji BT, Shu XO, Yang G, Li HL, Lee KM, Yu K, Rothman N, Gao YT, Zheng W, Chow WH (2009). Personal use of hair dye and cancer risk in a prospective cohort of Chinese women. Cancer Sci  100, 1088-91.   https://doi.org/10.1111/j.1349-7006.2009.01149.x




PubMed



        
     
Free Article


 


PubMed ID 19385970
         Pubmed Central ID 2768318 


 



14.
Pronk A, Coble J, Stewart PA (2009). Occupational exposure to diesel engine exhaust: a literature review. J Expo Sci Environ Epidemiol  19, 443-57.   https://doi.org/10.1038/jes.2009.21




PubMed



        
     
Free Article


 


PubMed ID 19277070
         Pubmed Central ID 3073453 


 



15.
Shen M, Menashe I, Morton LM, Zhang Y, Armstrong B, Wang SS, Lan Q, Hartge P, Purdue MP, Cerhan JR, Grulich A, Cozen W, Yeager M, Holford TR, Vajdic CM, Davis S, Leaderer B, Kricker A, Severson RK, Zahm SH, Chatterjee N, Rothman N, Chanock SJ, Zheng T (2010). Polymorphisms in DNA repair genes and risk of non-Hodgkin lymphoma in a pooled analysis of three studies. Br J Haematol  151, 239-44.   https://doi.org/10.1111/j.1365-2141.2010.08364.x




PubMed



        
     
Free Article


 


PubMed ID 20813000
         Pubmed Central ID 2967772",https://intramural.nih.gov/search/searchview.taf?ipid=63494
686,CP010124-15,"October 01, 2009 -  September 30, 2010",Cervical cancer and human papillomavirus (HPV) infection,"Philip E Castle; PhD, MPH",NULL,"Hormonal and Reproductive Epidemiology Branch, NCI","Mark E Sherman; MD



Lauren  Wilson; PhD







Nicolas Albert Hermann Wentzensen","Marc  Arbyn
(Scientific Institute of Public Health)




Robert  Burk
(Albert Einstein College of Medicine)




G  Clifford
(IARC)




J  Cox; PhD
(Henry Jackson Foundation)




Jack  Cuzick
(Wolfson Institute of Preventive Medicine and Queen Mary University of Londo)




Maire A Duggan



Show all 27","Sholom  Wacholder; PhD (Biostatistics Branch)



Julia  Gage (Clinical Genetics Branch)



Hormuzdiar Aspandiar Katki; MS (Biostatistics Branch)



Douglas  Lowy; MD (Laboratory of Cellular Oncology)



Mark  Schiffman; MD (Clinical Genetics Branch)



John  Schiller; PhD (Laboratory of Cellular Oncology)",NULL,"Ordered by publication type and then author name.



1.
Arbyn M, Ronco G, Cuzick J, Wentzensen N, Castle PE (2009). How to evaluate emerging technologies in cervical cancer screening? Int J Cancer  125, 2489-96.   https://doi.org/10.1002/ijc.24774




PubMed



        
     
Free Article


 


PubMed ID 19626591
         Pubmed Central ID 2790915 


 



2.
Castle P (2009) Commentary on Statement on HPV DNA Test Utilization. Am J Clin Pathol 131:770-3.




 



3.
Castle PE (2011). Do selective estrogen receptor modulators treat cervical precancer and cancer? Time to pool data from relevant trials. Int J Cancer  128, 997-8.   https://doi.org/10.1002/ijc.25393




PubMed



        
     
Free Article


 


PubMed ID 20473883
         Pubmed Central ID 2944904 


 



4.
Castle PE, Fetterman B, Akhtar I, Husain M, Gold MA, Guido R, Glass AG, Kinney W (2009). Age-appropriate use of human papillomavirus vaccines in the U.S. Gynecol Oncol  114, 365-9.   https://doi.org/10.1016/j.ygyno.2009.04.035




PubMed



        
     
Free Article


 


PubMed ID 19464729
         Pubmed Central ID 2729751 


 



5.
Castle PE, Fetterman B, Poitras N, Lorey T, Shaber R, Kinney W (2009). Five-year experience of human papillomavirus DNA and Papanicolaou test cotesting. Obstet Gynecol  113, 595-600.   https://doi.org/10.1097/AOG.0b013e3181996ffa




PubMed



        
     
Free Article


 


PubMed ID 19300322
         Pubmed Central ID 2747731 


 



6.
Castle PE, Kreimer AR, Wacholder S, Wheeler CM, Koutsky LA, Rydzak G, Buckman DW, Graubard B, Schiffman M (2009). Influence of loop electrosurgical excision procedure on subsequent acquisition of new human papillomavirus infections. J Infect Dis  199, 1612-20.   https://doi.org/10.1086/598981




PubMed



        
     
Free Article


 


PubMed ID 19405865
         Pubmed Central ID 2790913 


 



7.
Castle PE, Rodríguez AC, Burk RD, Herrero R, Wacholder S, Alfaro M, Morales J, Guillen D, Sherman ME, Solomon D, Schiffman M, Proyecto Epidemiológico Guanacaste (PEG) Group (2009). Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study. BMJ  339, b2569.   https://doi.org/10.1136/bmj.b2569




PubMed



        
     
Free Article


 


PubMed ID 19638649
         Pubmed Central ID 2718087 


 



8.
Castle PE, Sadorra M, Lau T, Aldrich C, Garcia FA, Kornegay J (2009). Evaluation of a prototype real-time PCR assay for carcinogenic human papillomavirus (HPV) detection and simultaneous HPV genotype 16 (HPV16) and HPV18 genotyping. J Clin Microbiol  47, 3344-7.   https://doi.org/10.1128/JCM.00725-09




PubMed



        
     
Free Article


 


PubMed ID 19675214
         Pubmed Central ID 2756930 


 



9.
Castle PE, Schiffman M, Wheeler CM, Solomon D (2009). Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2. Obstet Gynecol  113, 18-25.   https://doi.org/10.1097/AOG.0b013e31818f5008




PubMed



        
     
Free Article


 


PubMed ID 19104355
         Pubmed Central ID 2694845 


 



10.
Galgano MT, Castle PE, Atkins KA, Brix WK, Nassau SR, Stoler MH (2010). Using biomarkers as objective standards in the diagnosis of cervical biopsies. Am J Surg Pathol  34, 1077-87.   https://doi.org/10.1097/PAS.0b013e3181e8b2c4




PubMed



        
     
Free Article


 


PubMed ID 20661011
         Pubmed Central ID 2921638 


 



11.
Grabe N, Lahrmann B, Pommerencke T, von Knebel Doeberitz M, Reuschenbach M, Wentzensen N (2010). A virtual microscopy system to scan, evaluate and archive biomarker enhanced cervical cytology slides. Cell Oncol  32, 109-19.   https://doi.org/10.3233/CLO-2009-0508




PubMed



        
     
Free Article


 


PubMed ID 20208139
         Pubmed Central ID 4237613 


 



12.
Massad LS, Einstein M, Myers E, Wheeler CM, Wentzensen N, Solomon D (2009). The impact of human papillomavirus vaccination on cervical cancer prevention efforts. Gynecol Oncol  114, 360-4.   https://doi.org/10.1016/j.ygyno.2009.04.005




PubMed



        
     
Free Article


 


PubMed ID 19410282
         Pubmed Central ID 2703690 


 



13.
Massad LS, Jeronimo J, Katki HA, Schiffman M, National Institutes of Health/American Society for Colposcopy and Cervical Pathology Research Group (2009). The accuracy of colposcopic grading for detection of high-grade cervical intraepithelial neoplasia. J Low Genit Tract Dis  13, 137-44.   https://doi.org/10.1097/LGT.0b013e31819308d4




PubMed



        
     
Free Article


 


PubMed ID 19550210
         Pubmed Central ID 2921444 


 



14.
Moore G, Fetterman B, Cox JT, Poitras N, Lorey T, Kinney W, Castle PE (2010). Lessons from practice: risk of CIN 3 or cancer associated with an LSIL or HPV-positive ASC-US screening result in women aged 21 to 24. J Low Genit Tract Dis  14, 97-102.   https://doi.org/10.1097/LGT.0b013e3181b8b024




PubMed



        
     
Free Article


 


PubMed ID 20354416
         Pubmed Central ID 2907060 


 



15.
Safaeian M, Schiffman M, Gage J, Solomon D, Wheeler CM, Castle PE (2009). Detection of precancerous cervical lesions is differential by human papillomavirus type. Cancer Res  69, 3262-6.   https://doi.org/10.1158/0008-5472.CAN-08-4192




PubMed



        
     
Free Article


 


PubMed ID 19351830
         Pubmed Central ID 3155840 


 



16.
Schiffman M, Rodriguez AC, Chen Z, Wacholder S, Herrero R, Hildesheim A, Desalle R, Befano B, Yu K, Safaeian M, Sherman ME, Morales J, Guillen D, Alfaro M, Hutchinson M, Solomon D, Castle PE, Burk RD (2010). A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia. Cancer Res  70, 3159-69.   https://doi.org/10.1158/0008-5472.CAN-09-4179




PubMed



        
     
Free Article


 


PubMed ID 20354192
         Pubmed Central ID 2855741 


 



17.
Schweizer J, Lu PS, Mahoney CW, Berard-Bergery M, Ho M, Ramasamy V, Silver JE, Bisht A, Labiad Y, Peck RB, Lim J, Jeronimo J, Howard R, Gravitt PE, Castle PE (2010). Feasibility study of a human papillomavirus E6 oncoprotein test for diagnosis of cervical precancer and cancer. J Clin Microbiol  48, 4646-8.   https://doi.org/10.1128/JCM.01315-10




PubMed



        
     
Free Article


 


PubMed ID 20926711
         Pubmed Central ID 3008434 


 



18.
Wentzensen N, Gravitt PE, Solomon D, Wheeler CM, Castle PE (2009). A study of Amplicor human papillomavirus DNA detection in the atypical squamous cells of undetermined significance-low-grade squamous intraepithelial lesion triage study. Cancer Epidemiol Biomarkers Prev  18, 1341-9.   https://doi.org/10.1158/1055-9965.EPI-08-1180




PubMed



        
     
Free Article


 


PubMed ID 19423515
         Pubmed Central ID 2804087 


 



19.
Wentzensen N, Schiffman M, Dunn ST, Zuna RE, Walker J, Allen RA, Zhang R, Sherman ME, Wacholder S, Jeronimo J, Gold MA, Wang SS (2009). Grading the severity of cervical neoplasia based on combined histopathology, cytopathology, and HPV genotype distribution among 1,700 women referred to colposcopy in Oklahoma. Int J Cancer  124, 964-9.   https://doi.org/10.1002/ijc.23969




PubMed



        
     
Free Article


 


PubMed ID 19030188
         Pubmed Central ID 2796188 


 



20.
Wentzensen N, Schiffman M, Dunn T, Zuna RE, Gold MA, Allen RA, Zhang R, Sherman ME, Wacholder S, Walker J, Wang SS (2009). Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants. Int J Cancer  125, 2151-8.   https://doi.org/10.1002/ijc.24528




PubMed



        
     
Free Article


 


PubMed ID 19585494
         Pubmed Central ID 2755508 


 



21.
Wentzensen N, Sherman ME, Schiffman M, Wang SS (2009). Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science. Gynecol Oncol  112, 293-9.   https://doi.org/10.1016/j.ygyno.2008.10.012




PubMed



        
     
Free Article


 


PubMed ID 19054549
         Pubmed Central ID 2673716 


 



22.
Wentzensen N, Zuna RE, Sherman ME, Gold MA, Schiffman M, Dunn ST, Jeronimo J, Zhang R, Walker J, Wang SS (2009). Accuracy of cervical specimens obtained for biomarker studies in women with CIN3. Gynecol Oncol  115, 493-6.   https://doi.org/10.1016/j.ygyno.2009.09.001




PubMed



        
     
Free Article


 


PubMed ID 19773045
         Pubmed Central ID 2783867 


 



23.
Xi LF, Koutsky LA, Castle PE, Edelstein ZR, Meyers C, Ho J, Schiffman M (2009). Relationship between cigarette smoking and human papilloma virus types 16 and 18 DNA load. Cancer Epidemiol Biomarkers Prev  18, 3490-6.   https://doi.org/10.1158/1055-9965.EPI-09-0763




PubMed



        
     
Free Article


 


PubMed ID 19959700
         Pubmed Central ID 2920639 


 



24.
Zhao FH, Lin MJ, Chen F, Hu SY, Zhang R, Belinson JL, Sellors JW, Franceschi S, Qiao YL, Castle PE, Cervical Cancer Screening Group in China (2010). Performance of high-risk human papillomavirus DNA testing as a primary screen for cervical cancer: a pooled analysis of individual patient data from 17 population-based studies from China. Lancet Oncol  11, 1160-71.   https://doi.org/10.1016/S1470-2045(10)70256-4




PubMed



        
     
Free Article


 


PubMed ID 21075054
         Pubmed Central ID 5716831 


 



25.
Zuna RE, Moore WE, Shanesmith RP, Dunn ST, Wang SS, Schiffman M, Blakey GL, Teel T (2009). Association of HPV16 E6 variants with diagnostic severity in cervical cytology samples of 354 women in a US population. Int J Cancer  125, 2609-13.   https://doi.org/10.1002/ijc.24706




PubMed



        
     
Free Article


 


PubMed ID 19569178
         Pubmed Central ID 2757470",https://intramural.nih.gov/search/searchview.taf?ipid=63485
687,CP010125-15,"October 01, 2009 -  September 30, 2010",Cancer Risk and Environmental Exposures,"Mary Helen Ward; MS, PhD



IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Dalsu  Baris



Joanne S Colt



Debra  Silverman; ScD, ScM



Michael  Alavanja; PhD



Nathaniel C Rothman; MD



Aaron E Blair; PhD, MPH



Show all 12","Lorraine  Backer
(Centers for Disease Control)




Benjamin  Blount
(CDC)




Robert  Branch
(University of Pittsburgh)




John W Brock
(CDC)




Patricia  Buffler
(Univerity of California at Berkeley)




James  Cerhan
(Mayo Clinic)


Show all 27","Shelia K Zahm; ScM, ScD (Office of the Director)



Jay  Lubin; PhD (Biostatistics Branch)",NULL,"Ordered by publication type and then author name.



1.
Baris D, Karagas MR, Verrill C, Johnson A, Andrew AS, Marsit CJ, Schwenn M, Colt JS, Cherala S, Samanic C, Waddell R, Cantor KP, Schned A, Rothman N, Lubin J, Fraumeni JF, Hoover RN, Kelsey KT, Silverman DT (2009). A case-control study of smoking and bladder cancer risk: emergent patterns over time. J Natl Cancer Inst  101, 1553-61.   https://doi.org/10.1093/jnci/djp361




PubMed



        
     
Free Article


 


PubMed ID 19917915
         Pubmed Central ID 2778671 


 



2.
Brock KE, Gridley G, Chiu BC, Ershow AG, Lynch CF, Cantor KP (2009). Dietary fat and risk of renal cell carcinoma in the USA: a case-control study. Br J Nutr  101, 1228-38.   https://doi.org/10.1017/S0007114508056043




PubMed



        
     
Free Article


 


PubMed ID 18786276
         Pubmed Central ID 3075010 


 



3.
Danforth KN, Gierach GL, Brinton LA, Hollenbeck AR, Katki HA, Leitzmann MF, Schatzkin A, Lacey JV (2009). Nonsteroidal anti-inflammatory drug use and endometrial cancer risk in the NIH-AARP Diet and Health Study. Cancer Prev Res (Phila)  2, 466-72.   https://doi.org/10.1158/1940-6207.CAPR-08-0239




PubMed



        
     
Free Article


 


PubMed ID 19401534
         Pubmed Central ID 2997357 


 



4.
Dubrow R, Darefsky AS, Park Y, Mayne ST, Moore SC, Kilfoy B, Cross AJ, Sinha R, Hollenbeck AR, Schatzkin A, Ward MH (2010). Dietary components related to N-nitroso compound formation: a prospective study of adult glioma. Cancer Epidemiol Biomarkers Prev  19, 1709-22.   https://doi.org/10.1158/1055-9965.EPI-10-0225




PubMed



        
     
Free Article


 


PubMed ID 20570910
         Pubmed Central ID 2901412 


 



5.
Johnson PT, Townsend AR, Cleveland CC, Glibert PM, Howarth RW, McKenzie VJ, Rejmankova E, Ward MH (2010). Linking environmental nutrient enrichment and disease emergence in humans and wildlife. Ecol Appl  20, 16-29.   https://doi.org/10.1890/08-0633.1




PubMed



        
     
Free Article


 


PubMed ID 20349828
         Pubmed Central ID 2848386 


 



6.
Ward M (2009) Residential Exposure to PCBs and Organochlorine Pesticides and Risk of Childhood Leukemia. Lancet 117:1007-13.




 



7.
Ward MH, Kilfoy BA, Weyer PJ, Anderson KE, Folsom AR, Cerhan JR (2010). Nitrate intake and the risk of thyroid cancer and thyroid disease. Epidemiology  21, 389-95.   https://doi.org/10.1097/EDE.0b013e3181d6201d




PubMed



        
     
Free Article


 


PubMed ID 20335813
         Pubmed Central ID 2879161 


 



8.
Whitehead T, Metayer C, Ward MH, Nishioka MG, Gunier R, Colt JS, Reynolds P, Selvin S, Buffler P, Rappaport SM (2009). Is house-dust nicotine a good surrogate for household smoking? Am J Epidemiol  169, 1113-23.   https://doi.org/10.1093/aje/kwp021




PubMed



        
     
Free Article


 


PubMed ID 19299402
         Pubmed Central ID 2727236",https://intramural.nih.gov/search/searchview.taf?ipid=63499
688,CP010126-15,"October 01, 2009 -  September 30, 2010",Hormone-Related Cancers,"Jonine Danya Figueroa

 


 

Katherine Ann McGlynn; PhD



IRP Faculty Profile
 




Louise  Brinton; PhD",NULL,"Hormonal and Reproductive Epidemiology Branch, NCI","Patricia  Madigan



Mark E Sherman; MD



Roni T Falk



Michael Blaise Cook







Gretchen L Gierach




Nicolas Albert Hermann Wentzensen","David  Alberts
(University of Arizona Cancer Center)




Douglas  Bauer
(University of California at San Francisco)




Ralph  Coates
(Centers for Disease Control and Prevention)




Joanne  Dorgan; PhD
(NCI)




Kathleen  Egan
(Harvard University)




R  Erickson
(Department of Defense)


Show all 11","Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch)



Barry Ira Graubard; PhD (Biostatistics Branch)



William Frederick Anderson (Biostatistics Branch)



Regina Gale Ziegler; PhD, MPH (Epidemiology and Biostatistics Program)



Nilanjan  Chatterjee (Biostatistics Branch)



Stephen J Chanock; MD, PhD (Laboratory Translational Genomics)","Jeffery P Struewing; MS, MD (NHGRI) 



Matthew P. Longnecker; MD, ScD (NIEHS)","Ordered by publication type and then author name.



1.
Alam SS, Cantwell MM, Cardwell CR, Cook MB, Murray LJ (2010). Maternal body mass index and risk of testicular cancer in male offspring: a systematic review and meta-analysis. Cancer Epidemiol  34, 509-15.   https://doi.org/10.1016/j.canep.2010.07.006




PubMed



               Available in future as a Free Article 


 


PubMed ID 20800565
         Pubmed Central ID 3069655 


 



2.
Blows FM, Driver KE, Schmidt MK, Broeks A, van Leeuwen FE, Wesseling J, Cheang MC, Gelmon K, Nielsen TO, Blomqvist C, Heikkilä P, Heikkinen T, Nevanlinna H, Akslen LA, Bégin LR, Foulkes WD, Couch FJ, Wang X, Cafourek V, Olson JE, Baglietto L, Giles GG, Severi G, McLean CA, Southey MC, et al. [18 more authors] (2010). Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies. PLoS Med  7, e1000279.   https://doi.org/10.1371/journal.pmed.1000279




PubMed



        
     
Free Article


 


PubMed ID 20520800
         Pubmed Central ID 2876119 


 



3.
Bolton KL, Garcia-Closas M, Pfeiffer RM, Duggan MA, Howat WJ, Hewitt SM, Yang XR, Cornelison R, Anzick SL, Meltzer P, Davis S, Lenz P, Figueroa JD, Pharoah PD, Sherman ME (2010). Assessment of automated image analysis of breast cancer tissue microarrays for epidemiologic studies. Cancer Epidemiol Biomarkers Prev  19, 992-9.   https://doi.org/10.1158/1055-9965.EPI-09-1023




PubMed



        
     
Free Article


 


PubMed ID 20332278
         Pubmed Central ID 2852578 


 



4.
Brinton LA, Moghissi KS, Westhoff CL, Lamb EJ, Scoccia B (2010). Cancer risk among infertile women with androgen excess or menstrual disorders (including polycystic ovary syndrome). Fertil Steril  94, 1787-92.   https://doi.org/10.1016/j.fertnstert.2009.10.012




PubMed



               Available in future as a Free Article 


 


PubMed ID 19939368
         Pubmed Central ID 2888728 


 



5.
Chia VM, Li Y, Goldin LR, Graubard BI, Greene MH, Korde L, Rubertone MV, Erickson RL, McGlynn KA (2009). Risk of cancer in first- and second-degree relatives of testicular germ cell tumor cases and controls. Int J Cancer  124, 952-7.   https://doi.org/10.1002/ijc.23971




PubMed



        
     
Free Article


 


PubMed ID 19035442
         Pubmed Central ID 2605179 


 



6.
Chia VM, Li Y, Quraishi SM, Graubard BI, Figueroa JD, Weber JP, Chanock SJ, Rubertone MV, Erickson RL, McGlynn KA (2010). Effect modification of endocrine disruptors and testicular germ cell tumour risk by hormone-metabolizing genes. Int J Androl  33, 588-96.   https://doi.org/10.1111/j.1365-2605.2009.00975.x




PubMed



        
     
Free Article


 


PubMed ID 19627379
         Pubmed Central ID 2891172 


 



7.
Cook MB, Akre O, Forman D, Madigan MP, Richiardi L, McGlynn KA (2009). A systematic review and meta-analysis of perinatal variables in relation to the risk of testicular cancer--experiences of the mother. Int J Epidemiol  38, 1532-42.   https://doi.org/10.1093/ije/dyp287




PubMed



        
     
Free Article


 


PubMed ID 19776243
         Pubmed Central ID 2786253 


 



8.
Cook MB, Dawsey SM, Freedman ND, Inskip PD, Wichner SM, Quraishi SM, Devesa SS, McGlynn KA (2009). Sex disparities in cancer incidence by period and age. Cancer Epidemiol Biomarkers Prev  18, 1174-82.   https://doi.org/10.1158/1055-9965.EPI-08-1118




PubMed



        
     
Free Article


 


PubMed ID 19293308
         Pubmed Central ID 2793271 


 



9.
Doherty JA, Rossing MA, Cushing-Haugen KL, Chen C, Van Den Berg DJ, Wu AH, Pike MC, Ness RB, Moysich K, Chenevix-Trench G, Beesley J, Webb PM, Chang-Claude J, Wang-Gohrke S, Goodman MT, Lurie G, Thompson PJ, Carney ME, Hogdall E, Kjaer SK, Hogdall C, Goode EL, Cunningham JM, Fridley BL, Vierkant RA, Australian Ovarian Cancer Study Management Group, Australian Cancer Study (Ovarian Cancer), Ovarian Cancer Association Consortium (OCAC), et al. [25 more authors] (2010). ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium study. Cancer Epidemiol Biomarkers Prev  19, 245-50.   https://doi.org/10.1158/1055-9965.EPI-09-0729




PubMed



        
     
Free Article


 


PubMed ID 20056644
         Pubmed Central ID 2863004 


 



10.
Dorgan JF, Spittle CS, Egleston BL, Shaw CM, Kahle LL, Brinton LA (2010). Assay reproducibility and within-person variation of Müllerian inhibiting substance. Fertil Steril  94, 301-4.   https://doi.org/10.1016/j.fertnstert.2009.03.032




PubMed



        
     
Free Article


 


PubMed ID 19409547
         Pubmed Central ID 2876207 


 



11.
Dorgan JF, Stanczyk FZ, Egleston BL, Kahle LL, Shaw CM, Spittle CS, Godwin AK, Brinton LA (2009). Prospective case-control study of serum mullerian inhibiting substance and breast cancer risk. J Natl Cancer Inst  101, 1501-9.   https://doi.org/10.1093/jnci/djp331




PubMed



        
     
Free Article


 


PubMed ID 19820206
         Pubmed Central ID 2773186 


 



12.
Faupel-Badger JM, Sherman ME, Garcia-Closas M, Gaudet MM, Falk RT, Andaya A, Pfeiffer RM, Yang XR, Lissowska J, Brinton LA, Peplonska B, Vonderhaar BK, Figueroa JD (2010). Prolactin serum levels and breast cancer: relationships with risk factors and tumour characteristics among pre- and postmenopausal women in a population-based case-control study from Poland. Br J Cancer  103, 1097-102.   https://doi.org/10.1038/sj.bjc.6605844




PubMed



        
     
Free Article


 


PubMed ID 20736944
         Pubmed Central ID 2965860 


 



13.
Fletcher O, Johnson N, dos Santos Silva I, Orr N, Ashworth A, Nevanlinna H, Heikkinen T, Aittomäki K, Blomqvist C, Burwinkel B, Bartram CR, Meindl A, Schmutzler RK, Cox A, Brock I, Elliott G, Reed MW, Southey MC, Smith L, Spurdle AB, Hopper JL, Couch FJ, Olson JE, Wang X, Fredericksen Z, kConFab Investigators, AOCS Group, GENICA Consortium, Breast Cancer Association Consortium, et al. [64 more authors] (2010). Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls. Cancer Epidemiol Biomarkers Prev  19, 2143-51.   https://doi.org/10.1158/1055-9965.EPI-10-0374




PubMed



        
     
Free Article


 


PubMed ID 20826828
         Pubmed Central ID 2938473 


 



14.
Gaudet MM, Campan M, Figueroa JD, Yang XR, Lissowska J, Peplonska B, Brinton LA, Rimm DL, Laird PW, Garcia-Closas M, Sherman ME (2009). DNA hypermethylation of ESR1 and PGR in breast cancer: pathologic and epidemiologic associations. Cancer Epidemiol Biomarkers Prev  18, 3036-43.   https://doi.org/10.1158/1055-9965.EPI-09-0678




PubMed



        
     
Free Article


 


PubMed ID 19861523
         Pubmed Central ID 2783691 


 



15.
Gaudet MM, Hunter K, Pharoah P, Dunning AM, Driver K, Lissowska J, Sherman M, Peplonska B, Brinton LA, Chanock S, Garcia-Closas M (2009). Genetic variation in SIPA1 in relation to breast cancer risk and survival after breast cancer diagnosis. Int J Cancer  124, 1716-20.   https://doi.org/10.1002/ijc.23919




PubMed



        
     
Free Article


 


PubMed ID 19089925
         Pubmed Central ID 2914460 


 



16.
Gierach GL, Burke A, Anderson WF (2010). Epidemiology of triple negative breast cancers. Breast Dis  32, 5-24.   https://doi.org/10.3233/BD-2010-0319




PubMed



        
     
Free Article


 


PubMed ID 21965309
         Pubmed Central ID 4684941 


 



17.
Kim C, McGlynn KA, McCorkle R, Zheng T, Erickson RL, Niebuhr DW, Ma S, Zhang Y, Bai Y, Dai L, Graubard BI, Kilfoy B, Barry KH, Zhang Y (2010). Fertility among testicular cancer survivors: a case-control study in the U.S. J Cancer Surviv  4, 266-73.   https://doi.org/10.1007/s11764-010-0134-x




PubMed



        
     
Free Article


 


PubMed ID 20571931
         Pubmed Central ID 3057887 


 



18.
Lacey JV, Sherman ME, Rush BB, Ronnett BM, Ioffe OB, Duggan MA, Glass AG, Richesson DA, Chatterjee N, Langholz B (2010). Absolute risk of endometrial carcinoma during 20-year follow-up among women with endometrial hyperplasia. J Clin Oncol  28, 788-92.   https://doi.org/10.1200/JCO.2009.24.1315




PubMed



        
     
Free Article


 


PubMed ID 20065186
         Pubmed Central ID 2834395 


 



19.
McGlynn KA, Cook MB (2009). Etiologic factors in testicular germ-cell tumors. Future Oncol  5, 1389-402.   https://doi.org/10.2217/fon.09.116




PubMed



        
     
Free Article


 


PubMed ID 19903067
         Pubmed Central ID 3000220 


 



20.
McGlynn KA, Quraishi SM, Graubard BI, Weber JP, Rubertone MV, Erickson RL (2009). Polychlorinated biphenyls and risk of testicular germ cell tumors. Cancer Res  69, 1901-9.   https://doi.org/10.1158/0008-5472.CAN-08-3935




PubMed



        
     
Free Article


 


PubMed ID 19223531
         Pubmed Central ID 2794125 


 



21.
Murphy MA, Wentzensen N (2011). Frequency of mismatch repair deficiency in ovarian cancer: a systematic review This article is a US Government work and, as such, is in the public domain of the United States of America. Int J Cancer  129, 1914-22.   https://doi.org/10.1002/ijc.25835




PubMed



        
     
Free Article


 


PubMed ID 21140452
         Pubmed Central ID 3107885 


 



22.
Peplonska B, Stewart P, Szeszenia-Dabrowska N, Lissowska J, Brinton LA, Gromiec JP, Brzeznicki S, Yang XR, Sherman M, García-Closas M, Blair A (2010). Occupational exposure to organic solvents and breast cancer in women. Occup Environ Med  67, 722-9.   https://doi.org/10.1136/oem.2009.046557




PubMed



               Available in future as a Free Article 


 


PubMed ID 19819862
         Pubmed Central ID 2891315 


 



23.
Song H, Ramus SJ, Tyrer J, Bolton KL, Gentry-Maharaj A, Wozniak E, Anton-Culver H, Chang-Claude J, Cramer DW, DiCioccio R, Dörk T, Goode EL, Goodman MT, Schildkraut JM, Sellers T, Baglietto L, Beckmann MW, Beesley J, Blaakaer J, Carney ME, Chanock S, Chen Z, Cunningham JM, Dicks E, Doherty JA, Australian Cancer (Ovarian) Study, Australian Ovarian Cancer Study Group, Ovarian Cancer Association Consortium, et al. [60 more authors] (2009). A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. Nat Genet  41, 996-1000.   https://doi.org/10.1038/ng.424




PubMed



        
     
Free Article


 


PubMed ID 19648919
         Pubmed Central ID 2844110 


 



24.
Sutcliffe S, Viscidi RP, Till C, Goodman PJ, Hoque AM, Hsing AW, Thompson IM, Zenilman JM, De Marzo AM, Platz EA (2010). Human papillomavirus types 16, 18, and 31 serostatus and prostate cancer risk in the Prostate Cancer Prevention Trial. Cancer Epidemiol Biomarkers Prev  19, 614-8.   https://doi.org/10.1158/1055-9965.EPI-09-1080




PubMed



        
     
Free Article


 


PubMed ID 20142255
         Pubmed Central ID 2820385 


 



25.
Zhu K, Devesa SS, Wu H, Zahm SH, Jatoi I, Anderson WF, Peoples GE, Maxwell LG, Granger E, Potter JF, McGlynn KA (2009). Cancer incidence in the U.S. military population: comparison with rates from the SEER program. Cancer Epidemiol Biomarkers Prev  18, 1740-5.   https://doi.org/10.1158/1055-9965.EPI-09-0041




PubMed



        
     
Free Article


 


PubMed ID 19505907
         Pubmed Central ID 2780333",https://intramural.nih.gov/search/searchview.taf?ipid=63500
689,CP010127-15,"October 01, 2009 -  September 30, 2010",Etiologic Studies of Diet and Cancer,"Rashmi P Sinha; PhD



IRP Faculty Profile
 




Arthur  Schatzkin; PhD",NULL,"Nutritional Epidemiology Branch, NCI","Carrie  Daniel



Yikyung  Park","Henry  Appelman
(University of Michigan)




Colin  Begg
(Memorial Sloan-Kettering Cancer Center)




Sheila  Bingham
(University of Cambridge)




M  Cooper
(Wake Forest University School of Medicine)




Stanley  Hamilton
(M.D. Anderson Cancer Center)




Frank  Iber
(Edward Hines Jr. Veterans Administration Hospital)


Show all 15","Barry Ira Graubard; PhD (Biostatistics Branch)



Amy F Subar (Risk Factor Monitoring and Methods Branch)



Victor  Kipnis (Biometry Research Group)



Frances E Thompson (Risk Factor Monitoring and Methods Branch)



Douglas N Midthune (Biometry Research Group)



Richard P Troiano (Risk Factor Monitoring and Methods Branch)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63525
690,CP010128-15,"October 01, 2009 -  September 30, 2010",Therapeutic and Diagnostic Factors as Related to Cancer Risk,Louise  Brinton; PhD,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI","Mark E Sherman; MD







Gretchen L Gierach","Douglas  Bauer
(University of California at San Francisco)




Lenore  Buckley
(Virginia Commonwealth University)




Theodore  Colton
(Boston University School of Public Health)




Olga  Dvorkina
(SUNY Health Sciences Center)




Susanne  Kruger-Kjaer
(Danish Cancer Registry)




Emmet  Lamb
(Stanford University)


Show all 8","Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch)



Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)



Catherine G Schairer (Biostatistics Branch)



Arthur  Schatzkin; PhD (Nutritional Epidemiology Branch)



Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)



Jay  Lubin; PhD (Biostatistics Branch)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63501
691,CP010131-15,"October 01, 2009 -  September 30, 2010",Studies of Medical Radiation and Other Therapeutic Agents,"Peter D Inskip; ScD

 


 

Amy  de Gonzalez



IRP Faculty Profile",NULL,"Radiation Epidemiology Branch, NCI","Rochelle E Curtis



Ruth Anne Kleinerman; MPH



Michele M Doody; MS



Alice  Sigurdson; PhD



Steven L Simon



Kiyohiko  Mabuchi; MD, DPhil



Show all 14","David  Abramson
(New York Presbyterian Hospital)




Michael  Andersson
(Danish Cancer Society)




Florent  de Vathaire





Sophie  Fossa





Mary  Gospodarowicz
(Princess Margaret Hospital)




Per  Hall
(Karolinska Instituet)


Show all 24","Margaret Anne Tucker (Human Genetics Program)



Jay  Lubin; PhD (Biostatistics Branch)",NULL,"Ordered by publication type and then author name.



1.
Bhatti P, Veiga LH, Ronckers CM, Sigurdson AJ, Stovall M, Smith SA, Weathers R, Leisenring W, Mertens AC, Hammond S, Friedman DL, Neglia JP, Meadows AT, Donaldson SS, Sklar CA, Robison LL, Inskip PD (2010). Risk of second primary thyroid cancer after radiotherapy for a childhood cancer in a large cohort study: an update from the childhood cancer survivor study. Radiat Res  174, 741-52.   https://doi.org/10.1667/RR2240.1




PubMed



        
     
Free Article


 


PubMed ID 21128798
         Pubmed Central ID 3080023 


 



2.
Cebulla CM, Kleinerman RA, Alegret A, Kulak A, Dubovy SR, Hess DJ, Murray TG (2009). Rapid appearance of rhabdomyosarcoma after radiation and chemotherapy for retinoblastoma: a clinicopathologic correlation. Retin Cases Brief Rep  3, 343-6.   https://doi.org/10.1097/ICB.0b013e31817377a5




PubMed



        
     
Free Article


 


PubMed ID 20634992
         Pubmed Central ID 2902172 


 



3.
Chodick G, Kleinerman RA, Stovall M, Abramson DH, Seddon JM, Smith SA, Tucker MA (2009). Risk of cataract extraction among adult retinoblastoma survivors. Arch Ophthalmol  127, 1500-4.   https://doi.org/10.1001/archophthalmol.2009.271




PubMed



        
     
Free Article


 


PubMed ID 19901216
         Pubmed Central ID 2818500 


 



4.
Curtis R (2009) Letter to the Editor Response: Solid cancers after allogeneic hematopoietic cell transplantation. Blood 114:225-6.




 



5.
Dores GM, Anderson WF, Beane Freeman LE, Fraumeni JF, Curtis RE (2010). Risk of breast cancer according to clinicopathologic features among long-term survivors of Hodgkin's lymphoma treated with radiotherapy. Br J Cancer  103, 1081-4.   https://doi.org/10.1038/sj.bjc.6605877




PubMed



        
     
Free Article


 


PubMed ID 20842115
         Pubmed Central ID 2965878 


 



6.
Ghabach B, Anderson WF, Curtis RE, Huycke MM, Lavigne JA, Dores GM (2010). Adenoid cystic carcinoma of the breast in the United States (1977 to 2006): a population-based cohort study. Breast Cancer Res  12, R54.   https://doi.org/10.1186/bcr2613




PubMed



        
     
Free Article


 


PubMed ID 20653964
         Pubmed Central ID 2949643 


 



7.
Inskip PD, Robison LL, Stovall M, Smith SA, Hammond S, Mertens AC, Whitton JA, Diller L, Kenney L, Donaldson SS, Meadows AT, Neglia JP (2009). Radiation dose and breast cancer risk in the childhood cancer survivor study. J Clin Oncol  27, 3901-7.   https://doi.org/10.1200/JCO.2008.20.7738




PubMed



        
     
Free Article


 


PubMed ID 19620485
         Pubmed Central ID 2734395 


 



8.
Kim KP, Einstein AJ, Berrington de González A (2009). Coronary artery calcification screening: estimated radiation dose and cancer risk. Arch Intern Med  169, 1188-94.   https://doi.org/10.1001/archinternmed.2009.162




PubMed



               Available in future as a Free Article 


 


PubMed ID 19597067
         Pubmed Central ID 2765044 


 



9.
Kleinerman R, Weinstock R, Mabuchi K (2010) High-dose Abdominal Radiotherapy and Risk of Diabetes Mellitus. Archives of Internal Medicine 170:1506-7




 



10.
Kleinerman RA (2009). Radiation-sensitive genetically susceptible pediatric sub-populations. Pediatr Radiol  39 Suppl 1, S27-31.   https://doi.org/10.1007/s00247-008-1015-6




PubMed



        
     
Free Article


 


PubMed ID 19083227
         Pubmed Central ID 2656401 


 



11.
Kleinerman RA, Weinstock RM, Mabuchi K (2010) High-dose abdominal radiotherapy and risk of diabetes mellitus. Arch Intern Med 170:1506-7.




PubMed


 


PubMed ID 20837842
    
     


 



12.
Lee C, Lodwick D, Hurtado J, Pafundi D, Williams JL, Bolch WE (2010). The UF family of reference hybrid phantoms for computational radiation dosimetry. Phys Med Biol  55, 339-63.   https://doi.org/10.1088/0031-9155/55/2/002




PubMed



        
     
Free Article


 


PubMed ID 20019401
         Pubmed Central ID 2800036 


 



13.
Leitzmann MF, Brenner A, Moore SC, Koebnick C, Park Y, Hollenbeck A, Schatzkin A, Ron E (2010). Prospective study of body mass index, physical activity and thyroid cancer. Int J Cancer  126, 2947-56.   https://doi.org/10.1002/ijc.24913




PubMed



        
     
Free Article


 


PubMed ID 19795465
         Pubmed Central ID 2919690 


 



14.
Linet MS, Kim KP, Miller DL, Kleinerman RA, Simon SL, Berrington de Gonzalez A (2010). Historical review of occupational exposures and cancer risks in medical radiation workers. Radiat Res  174, 793-808.   https://doi.org/10.1667/RR2014.1




PubMed



        
     
Free Article


 


PubMed ID 21128805
         Pubmed Central ID 4098897 


 



15.
Linet MS, Kim KP, Rajaraman P (2009). Children's exposure to diagnostic medical radiation and cancer risk: epidemiologic and dosimetric considerations. Pediatr Radiol  39 Suppl 1, S4-26.   https://doi.org/10.1007/s00247-008-1026-3




PubMed



        
     
Free Article


 


PubMed ID 19083224
         Pubmed Central ID 2814780 


 



16.
Miller DL, Simon SL, Thierry-Chef I, Land CE (2010). Stochastic and deterministic risk in children undergoing neurointerventional procedures. AJR Am J Roentgenol  195, W87-8; author reply W89.   https://doi.org/10.2214/AJR.09.4180




PubMed


 


PubMed ID 20566788
    
     


 



17.
Morton LM, Curtis RE, Linet MS, Bluhm EC, Tucker MA, Caporaso N, Ries LA, Fraumeni JF (2010). Second malignancy risks after non-Hodgkin's lymphoma and chronic lymphocytic leukemia: differences by lymphoma subtype. J Clin Oncol  28, 4935-44.   https://doi.org/10.1200/JCO.2010.29.1112




PubMed



        
     
Free Article


 


PubMed ID 20940199
         Pubmed Central ID 3020697 


 



18.
Rizzo JD, Curtis RE, Socié G, Sobocinski KA, Gilbert E, Landgren O, Travis LB, Travis WD, Flowers ME, Friedman DL, Horowitz MM, Wingard JR, Deeg HJ (2009). Solid cancers after allogeneic hematopoietic cell transplantation. Blood  113, 1175-83.   https://doi.org/10.1182/blood-2008-05-158782




PubMed



        
     
Free Article


 


PubMed ID 18971419
         Pubmed Central ID 2635083 


 



19.
Yu CL, Tucker MA, Abramson DH, Furukawa K, Seddon JM, Stovall M, Fraumeni JF, Kleinerman RA (2009). Cause-specific mortality in long-term survivors of retinoblastoma. J Natl Cancer Inst  101, 581-91.   https://doi.org/10.1093/jnci/djp046




PubMed



        
     
Free Article


 


PubMed ID 19351917
         Pubmed Central ID 2669101",https://intramural.nih.gov/search/searchview.taf?ipid=63502
692,CP010132-15,"October 01, 2009 -  September 30, 2010",Studies of Populations Exposed to Environmental Sources of Radiation,"Martha S Linet; PhD



IRP Faculty Profile",NULL,"Radiation Epidemiology Branch, NCI","Andre  Bouville



Nickolas  Luckyanov



Steven L Simon



Alina V Brenner



Maureen Cusack Hatch; MD



Kiyohiko  Mabuchi; MD, DPhil



Show all 11","Bruce  Alexander
(University of Minnesota)




Boris  Gusev
(Kazakh Institute for Radiation Medicine and Ecology)




M  Hartshorne
(Pennsylvania State University)




Margaret  Karagas
(Dartmouth University, Lebanon, NH)




Heather  Nelson
(Harvard School of Public Health)




Alex  Romanukha
(National Institute for Standards and Technology)


Show all 9",NULL,NULL,"Ordered by publication type and then author name.



1.
Bozhok Y, Greenebaum E, Bogdanova TI, McConnell RJ, Zelinskaya A, Brenner AV, Zurnadzhy LY, Zablotska L, Tronko MD, Hatch M (2009). NA cohort study of thyroid cancer and other thyroid diseases after the Chernobyl accident: cytohistopathologic correlation and accuracy of fine-needle aspiration biopsy in nodules detected during the first screening in Ukraine (1998-2000). Cancer  117, 73-81.   https://doi.org/10.1002/cncy.20002




PubMed



        
     
Free Article


 


PubMed ID 19365829
         Pubmed Central ID 2909031 


 



2.
Freedman D, Fuhrman B, Graubard BI, Chang SC (2009). Vitamin D and cancer mortality. Cancer Epidemiol Biomarkers Prev  18, 359; author reply 359-60.   https://doi.org/10.1158/1055-9965.EPI-08-1023




PubMed



        
     
Free Article


 


PubMed ID 19124522
         Pubmed Central ID 2648349 


 



3.
Freedman D, Looker A, Abnet C, Linet M, Graubard B (2010) Serum 25-hydroxyvitamin D and Cancer Mortality in the NHANES III Study (1988-2006). Cancer Research 70:8587-97




 



4.
Freedman DM, Looker AC, Abnet CC, Linet MS, Graubard BI (2010). Serum 25-hydroxyvitamin D and cancer mortality in the NHANES III study (1988-2006). Cancer Res  70, 8587-97.   https://doi.org/10.1158/0008-5472.CAN-10-1420




PubMed



               Available in future as a Free Article 


 


PubMed ID 20847342
         Pubmed Central ID 2974315 


 



5.
Hatch M, Furukawa K, Brenner A, Olinjyk v, Ron E, Zablotska L, Terekhova G, McConnell R, Markov V, Shpak V, Bouville A, Tronko M (2010) Prevalence of hyperthyroidism after exposure during childhood or adolescence to radioiodines from the Chornobyl nuclear accident: dose-response results from the Ukrainian-American Cohort Study. Radiat Res 174:763-72




 



6.
Hatch M, Furukawa K, Brenner A, Olinjyk V, Ron E, Zablotska L, Terekhova G, McConnell R, Markov V, Shpak V, Ostroumova E, Bouville A, Tronko M (2010). Prevalence of hyperthyroidism after exposure during childhood or adolescence to radioiodines from the chornobyl nuclear accident: dose-response results from the Ukrainian-American Cohort Study. Radiat Res  174, 763-72.   https://doi.org/10.1667/RR2003.1




PubMed



        
     
Free Article


 


PubMed ID 21128800
         Pubmed Central ID 3927725 


 



7.
Khrutchinsky A, Kutsen S, Minenko V, Zhukova O, Luckyanov N, Bouville A, Drozdovitch V (2009). Monte Carlo modeling of beta-radiometer device used to measure milk contaminated as a result of the Chernobyl accident. Appl Radiat Isot  67, 1089-93.   https://doi.org/10.1016/j.apradiso.2009.01.072




PubMed



        
     
Free Article


 


PubMed ID 19233662
         Pubmed Central ID 2673802 


 



8.
Kukush A, Shklyar S, Masiuk S, Likhtarov I, Kovgan L, Carroll RJ, Bouville A (2011). Methods for estimation of radiation risk in epidemiological studies accounting for classical and Berkson errors in doses. Int J Biostat  7, 15.   https://doi.org/10.2202/1557-4679.1281




PubMed



        
     
Free Article


 


PubMed ID 21423564
         Pubmed Central ID 3058406 


 



9.
Michael S, Schonfeld S, Drozdovitch V, Akimzhanov K, Aldyngurov D, Bouville A, Land C, Luckyanov N, Mabuchi K, Semenova Y, Simon S, Tokaeva A, Zhumadilov Z, Potischman N (2010) The Utility of Focus Group Interviews to Capture Dietary Consumption Data in the Distant Past: Dairy Consumption in Kazakhstan Villages 50 Years Ago. Journal of Developmental Origins of Health Disease 1:192-202




 



10.
O'Kane P, Shelkovoy E, McConnell RJ, Shpak V, Parker L, Brenner A, Zablotska L, Tronko M, Hatch M (2010). Frequency of undetected thyroid nodules in a large I-131-exposed population repeatedly screened by ultrasonography: results from the Ukrainian-American cohort study of thyroid cancer and other thyroid diseases following the Chornobyl accident. Thyroid  20, 959-64.   https://doi.org/10.1089/thy.2010.0032




PubMed



               Available in future as a Free Article 


 


PubMed ID 20615138
         Pubmed Central ID 2964362 


 



11.
Ron E, Brenner A (2010) Non-malignant thyroid diseases following a wide range of radiation exposures. Radiation Research 174:877-88




 



12.
Ron E, Brenner A (2010). Non-malignant thyroid diseases after a wide range of radiation exposures. Radiat Res  174, 877-88.   https://doi.org/10.1667/RR1953.1




PubMed



        
     
Free Article


 


PubMed ID 21128812
         Pubmed Central ID 3927789 


 



13.
Schwerin M, Schonfeld S, Drozdovitch V, Akimzhanov K, Aldyngurov D, Bouville A, Land C, Luckyanov N, Mabuchi K, Semenova Y, Simon S, Tokaeva A, Zhumadilov Z, Potischman N (2010) The Utility of Focus Group Interviews to Capture Dietary Consumption Data in the Distant Past: Dairy Consumption in Kazakhstan Villages 50 Years Ago. Journal of Developmental Origins of Health Disease 1:192-202




 



14.
Sigurdson AJ, Land CE, Bhatti P, Pineda M, Brenner A, Carr Z, Gusev BI, Zhumadilov Z, Simon SL, Bouville A, Rutter JL, Ron E, Struewing JP (2009). Thyroid nodules, polymorphic variants in DNA repair and RET-related genes, and interaction with ionizing radiation exposure from nuclear tests in Kazakhstan. Radiat Res  171, 77-88.   https://doi.org/10.1667/RR1327.1




PubMed



        
     
Free Article


 


PubMed ID 19138047
         Pubmed Central ID 2875679 


 



15.
Skryabin AM, Drozdovitch V, Belsky Y, Leshcheva SV, Mirkhaidarov AK, Voillequé P, Luckyanov N, Bouville A (2010). Thyroid mass in children and adolescents living in the most exposed areas to Chernobyl fallout in Belarus. Radiat Prot Dosimetry  142, 292-9.   https://doi.org/10.1093/rpd/ncq209




PubMed



        
     
Free Article


 


PubMed ID 20823035
         Pubmed Central ID 3148090",https://intramural.nih.gov/search/searchview.taf?ipid=63486
693,CP010133-15,"October 01, 2009 -  September 30, 2010",Studies of Populations Exposed to Occupational Sources of Radiation,"Elaine  Ron; PhD

 


 

Martha S Linet; PhD



IRP Faculty Profile",NULL,"Radiation Epidemiology Branch, NCI","Andre  Bouville



Michele M Doody; MS



Daryl  Freedman



Maureen Cusack Hatch; MD



Peter D Inskip; ScD



Alice  Sigurdson; PhD



Show all 9","Bruce  Alexander
(University of Minnesota)




Anssi P Auvinen





Timo  Hakulinen
(Finnish Cancer Registry)




M  Hartshorne
(Pennsylvania State University)




Juozas  Kurtinaitis
(Lithuanian Cancer Registry)




Lynne  Pinkerton
(National Institute of Occupational Safety and Health, Cincinnati, OH)


Show all 17",NULL,NULL,"Ordered by publication type and then author name.



1.
Bhatti P, Doody MM, Rajaraman P, Alexander BH, Yeager M, Hutchinson A, Burdette L, Thomas G, Hunter DJ, Simon SL, Weinstock RM, Rosenstein M, Stovall M, Preston DL, Linet MS, Hoover RN, Chanock SJ, Sigurdson AJ (2010). Novel breast cancer risk alleles and interaction with ionizing radiation among U.S. radiologic technologists. Radiat Res  173, 214-24.   https://doi.org/10.1667/RR1985.1




PubMed



        
     
Free Article


 


PubMed ID 20095854
         Pubmed Central ID 2922870 


 



2.
Bhatti P, Kampa D, Alexander BH, McClure C, Ringer D, Doody MM, Sigurdson AJ (2009). Blood spots as an alternative to whole blood collection and the effect of a small monetary incentive to increase participation in genetic association studies. BMC Med Res Methodol  9, 76.   https://doi.org/10.1186/1471-2288-9-76




PubMed



        
     
Free Article


 


PubMed ID 19912630
         Pubmed Central ID 2781815 


 



3.
Bhatti P, Yong LC, Doody MM, Preston DL, Kampa DM, Ramsey MJ, Ward EM, Edwards AA, Ron E, Tucker JD, Sigurdson AJ (2010). Diagnostic X-ray examinations and increased chromosome translocations: evidence from three studies. Radiat Environ Biophys  49, 685-92.   https://doi.org/10.1007/s00411-010-0307-z




PubMed



        
     
Free Article


 


PubMed ID 20602108
         Pubmed Central ID 3075914 


 



4.
Freedman DM, Kimlin MG, Hoffbeck RW, Alexander BH, Linet MS (2010) Multiple indicators of ambient and personal sun exposure and risk of non-Hodgkin lymphoma (United States). J Photochem Photobiol B 101:321-5




 



5.
Kryuchkov V, Chumak V, Maceika E, Anspaugh LR, Cardis E, Bakhanova E, Golovanov I, Drozdovitch V, Luckyanov N, Kesminiene A, Voillequé P, Bouville A (2009). Radrue method for reconstruction of external photon doses for Chernobyl liquidators in epidemiological studies. Health Phys  97, 275-98.   https://doi.org/10.1097/HP.0b013e3181ac9306




PubMed



        
     
Free Article


 


PubMed ID 19741357
         Pubmed Central ID 2930607 


 



6.
Sigurdson AJ, Bhatti P, Chang SC, Rajaraman P, Doody MM, Bowen L, Simon SL, Weinstock RM, Linet MS, Rosenstein M, Stovall M, Alexander BH, Preston DL, Struewing JP (2009). Polymorphisms in estrogen biosynthesis and metabolism-related genes, ionizing radiation exposure, and risk of breast cancer among US radiologic technologists. Breast Cancer Res Treat  118, 177-84.   https://doi.org/10.1007/s10549-009-0307-3




PubMed



        
     
Free Article


 


PubMed ID 19214745
         Pubmed Central ID 2860373 


 



7.
Yong LC, Petersen MR, Sigurdson AJ, Sampson LA, Ward EM (2009). High dietary antioxidant intakes are associated with decreased chromosome translocation frequency in airline pilots. Am J Clin Nutr  90, 1402-10.   https://doi.org/10.3945/ajcn.2009.28207




PubMed



        
     
Free Article


 


PubMed ID 19793852
         Pubmed Central ID 2762162 


 



8.
Yong LC, Sigurdson AJ, Ward EM, Waters MA, Whelan EA, Petersen MR, Bhatti P, Ramsey MJ, Ron E, Tucker JD (2009). Increased frequency of chromosome translocations in airline pilots with long-term flying experience. Occup Environ Med  66, 56-62.   https://doi.org/10.1136/oem.2008.038901




PubMed



               Available in future as a Free Article 


 


PubMed ID 19074211
         Pubmed Central ID 2608721",https://intramural.nih.gov/search/searchview.taf?ipid=63503
694,CP010134-15,"October 01, 2009 -  September 30, 2010",Studies of Atomic Bomb Survivors,"Amy  de Gonzalez



IRP Faculty Profile",NULL,"Radiation Epidemiology Branch, NCI","Martha S Linet; PhD



Elaine  Ron; PhD



Alina V Brenner



Mark Peter Little







Kiyohiko  Mabuchi; MD, DPhil","Kyoji  Furukawa; PhD





Yuko  Hirai
(Genetics, Radiation Effects Research Foundation)




Kazunori  Kodama
(Radiation Effects Research Foundation, Japan)




Jun  Nagano
(Radiation Effects Research Foundation)




Nori  Nakamwa
(Radiation Effects Research Foundation)




Kazuo  Neriishi
(Radiation Effects Research Foundation)


Show all 12",NULL,NULL,"Ordered by publication type and then author name.



1.
Darby SC, Cutter DJ, Boerma M, Constine LS, Fajardo LF, Kodama K, Mabuchi K, Marks LB, Mettler FA, Pierce LJ, Trott KR, Yeh ET, Shore RE (2010). Radiation-related heart disease: current knowledge and future prospects. Int J Radiat Oncol Biol Phys  76, 656-65.   https://doi.org/10.1016/j.ijrobp.2009.09.064




PubMed



        
     
Free Article


 


PubMed ID 20159360
         Pubmed Central ID 3910096 


 



2.
Furukawa K, Preston DL, Lönn S, Funamoto S, Yonehara S, Matsuo T, Egawa H, Tokuoka S, Ozasa K, Kasagi F, Kodama K, Mabuchi K (2010). Radiation and smoking effects on lung cancer incidence among atomic bomb survivors. Radiat Res  174, 72-82.   https://doi.org/10.1667/RR2083.1




PubMed



        
     
Free Article


 


PubMed ID 20681801
         Pubmed Central ID 3857029 


 



3.
Li CI, Nishi N, McDougall JA, Semmens EO, Sugiyama H, Soda M, Sakata R, Hayashi M, Kasagi F, Suyama A, Mabuchi K, Davis S, Kodama K, Kopecky KJ (2010). Relationship between radiation exposure and risk of second primary cancers among atomic bomb survivors. Cancer Res  70, 7187-98.   https://doi.org/10.1158/0008-5472.CAN-10-0276




PubMed



        
     
Free Article


 


PubMed ID 20843820
         Pubmed Central ID 2941904",https://intramural.nih.gov/search/searchview.taf?ipid=63537
695,CP010135-15,"October 01, 2009 -  September 30, 2010",Studies of Non-Ionizing Radiation-Related Cancer,"Martha S Linet; PhD



IRP Faculty Profile
 




Peter D Inskip; ScD",NULL,"Radiation Epidemiology Branch, NCI","Alina V Brenner



Preetha  Rajaraman



Daryl  Freedman



Alice  Sigurdson; PhD



Gila I Neta","Bruce  Alexander
(University of Minnesota)




Bryan  Bassig





Peter  Black
(Brigham and Women's Hospital & Dana Farber Cancer Center)




WA  Bleyer
(Children's Cancer Group)




Mary Brantley Butler





H  Fine
(Neuro-Oncology Branch, National Cancer Institute)


Show all 12",Nathaniel C Rothman; MD (Occupational and Environmental Epidemiology Branch),NULL,"Ordered by publication type and then author name.



1.
Chatterjee N, Wacholder S (2009). Invited commentary: efficient testing of gene-environment interaction. Am J Epidemiol  169, 231-3; discussion 234-5.   https://doi.org/10.1093/aje/kwn352




PubMed



        
     
Free Article


 


PubMed ID 19022825
         Pubmed Central ID 2727258 


 



2.
Coble JB, Dosemeci M, Stewart PA, Blair A, Bowman J, Fine HA, Shapiro WR, Selker RG, Loeffler JS, Black PM, Linet MS, Inskip PD (2009). Occupational exposure to magnetic fields and the risk of brain tumors. Neuro Oncol  11, 242-9.   https://doi.org/10.1215/15228517-2009-002




PubMed



        
     
Free Article


 


PubMed ID 19234232
         Pubmed Central ID 2718968 


 



3.
Linet MS, Inskip PD (2010). Cellular (mobile) telephone use and cancer risk. Rev Environ Health  25, 51-5.   https://doi.org/10.1515/reveh.2010.25.1.51




PubMed



        
     
Free Article


 


PubMed ID 20429159
         Pubmed Central ID 3855294 


 



4.
McKean-Cowdin R, Barnholtz-Sloan J, Inskip PD, Ruder AM, Butler M, Rajaraman P, Razavi P, Patoka J, Wiencke JK, Bondy ML, Wrensch M (2009). Associations between polymorphisms in DNA repair genes and glioblastoma. Cancer Epidemiol Biomarkers Prev  18, 1118-26.   https://doi.org/10.1158/1055-9965.EPI-08-1078




PubMed



        
     
Free Article


 


PubMed ID 19318434
         Pubmed Central ID 2667563 


 



5.
Rajaraman P, Brenner AV, Butler MA, Wang SS, Pfeiffer RM, Ruder AM, Linet MS, Yeager M, Wang Z, Orr N, Fine HA, Kwon D, Thomas G, Rothman N, Inskip PD, Chanock SJ (2009). Common variation in genes related to innate immunity and risk of adult glioma. Cancer Epidemiol Biomarkers Prev  18, 1651-8.   https://doi.org/10.1158/1055-9965.EPI-08-1041




PubMed



        
     
Free Article


 


PubMed ID 19423540
         Pubmed Central ID 2771723 


 



6.
Rajaraman P, Hutchinson A, Wichner S, Black P, Fine H, Loeffler J, Selker R, Shapiro W, Rothman N, Linet M, Inskip P (2010) DNA repair gene polymorphisms and risk of adult meningioma, glioma, and acoustic neuroma. neuro-oncology 12:37-48




 



7.
Rajaraman P, Hutchinson A, Wichner S, Black P, Fine H, Loeffler J, Selker R, Shapiro W, Rothman N, Linet M, Inskip P (2010) DNA repair gene polymorphisms and risk of adult meningioma, glioma, and acoustic neuroma. Neuro-oncology 12:37-48",https://intramural.nih.gov/search/searchview.taf?ipid=63504
696,CP010136-15,"October 01, 2009 -  September 30, 2010",Cancer Risk in Human Populations,"Debra  Silverman; ScD, ScM



IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Bu Tian  Ji



Dalsu  Baris



Joanne S Colt



Mary Helen Ward; MS, PhD



Claudine M Samanic



Michael  Alavanja; PhD



Show all 10",NULL,Mark  Schiffman; MD (Clinical Genetics Branch),NULL,"Ordered by publication type and then author name.



1.
Cook MB, Kamangar F, Whiteman DC, Freedman ND, Gammon MD, Bernstein L, Brown LM, Risch HA, Ye W, Sharp L, Pandeya N, Webb PM, Wu AH, Ward MH, Giffen C, Casson AG, Abnet CC, Murray LJ, Corley DA, Nyrén O, Vaughan TL, Chow WH (2010). Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium. J Natl Cancer Inst  102, 1344-53.   https://doi.org/10.1093/jnci/djq289




PubMed



        
     
Free Article


 


PubMed ID 20716718
         Pubmed Central ID 2935475 


 



2.
Figueroa JD, Terry MB, Gammon MD, Vaughan TL, Risch HA, Zhang FF, Kleiner DE, Bennett WP, Howe CL, Dubrow R, Mayne ST, Fraumeni JF, Chow WH (2009). Cigarette smoking, body mass index, gastro-esophageal reflux disease, and non-steroidal anti-inflammatory drug use and risk of subtypes of esophageal and gastric cancers by P53 overexpression. Cancer Causes Control  20, 361-8.   https://doi.org/10.1007/s10552-008-9250-6




PubMed



        
     
Free Article


 


PubMed ID 18989634
         Pubmed Central ID 2726999 


 



3.
Hou L, Wang H, Sartori S, Gawron A, Lissowska J, Bollati V, Tarantini L, Zhang FF, Zatonski W, Chow WH, Baccarelli A (2010). Blood leukocyte DNA hypomethylation and gastric cancer risk in a high-risk Polish population. Int J Cancer  127, 1866-74.   https://doi.org/10.1002/ijc.25190




PubMed



        
     
Free Article


 


PubMed ID 20099281
         Pubmed Central ID 3009461 


 



4.
Hoyo C, Schildkraut JM, Murphy SK, Chow WH, Vaughan TL, Risch H, Marks JR, Jirtle RL, Calingaert B, Calingeart B, Mayne S, Fraumeni J, Gammon MD (2009). IGF2R polymorphisms and risk of esophageal and gastric adenocarcinomas. Int J Cancer  125, 2673-8.   https://doi.org/10.1002/ijc.24623




PubMed



        
     
Free Article


 


PubMed ID 19626700
         Pubmed Central ID 3008656 


 



5.
Lee YC, Cook MB, Bhatia S, Chow WH, El-Omar EM, Goto H, Lin JT, Li YQ, Rhee PL, Sharma P, Sung JJ, Wong JY, Wu JC, Ho KY, Asian Barrett''s Consortium (2010). Interobserver reliability in the endoscopic diagnosis and grading of Barrett's esophagus: an Asian multinational study. Endoscopy  42, 699-704.   https://doi.org/10.1055/s-0030-1255629




PubMed



        
     
Free Article


 


PubMed ID 20806154
         Pubmed Central ID 3000217 


 



6.
Purdue MP, Hashibe M, Berthiller J, La Vecchia C, Dal Maso L, Herrero R, Franceschi S, Castellsague X, Wei Q, Sturgis EM, Morgenstern H, Zhang ZF, Levi F, Talamini R, Smith E, Muscat J, Lazarus P, Schwartz SM, Chen C, Neto JE, Wünsch-Filho V, Zaridze D, Koifman S, Curado MP, Benhamou S, et al. [15 more authors] (2009). Type of alcoholic beverage and risk of head and neck cancer--a pooled analysis within the INHANCE Consortium. Am J Epidemiol  169, 132-42.   https://doi.org/10.1093/aje/kwn306




PubMed



        
     
Free Article


 


PubMed ID 19064644
         Pubmed Central ID 2727255 


 



7.
Zheng Z, Jia Y, Hou L, Persson C, Yeager M, Lissowska J, Chanock SJ, Blaser M, Chow WH, Ye W (2009). Genetic variation in a4GnT in relation to Helicobacter pylori serology and gastric cancer risk. Helicobacter  14, 120-5.   https://doi.org/10.1111/j.1523-5378.2009.00708.x




PubMed



        
     
Free Article


 


PubMed ID 19751437
         Pubmed Central ID 3008782",https://intramural.nih.gov/search/searchview.taf?ipid=63505
697,CP010142-12,"October 01, 2009 -  September 30, 2010",Genetic and Pharmacogenetic Modifiers of Cancer Risk and Intervention Outcomes,"Sonja  Berndt



IRP Faculty Profile
 


 

Barry Ira Graubard; PhD



IRP Faculty Profile
 


 

Hormuzdiar Aspandiar Katki; MS



IRP Faculty Profile
 


 

Sharon Ann Savage



IRP Faculty Profile
 


 

Mark H Greene; MD



IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI

Biostatistics Branch, NCI

Clinical Genetics Branch, NCI","Philip Samuel Rosenberg; PhD







Barbara  Dunn","John  Bryant
(National Surgical Adjuvant Breast and Bowel Project)




Joseph  Constantino
(National Surgical Adjuvant Breast & Bowel Project Statistical Center)




Chester  Douglass
(Harvard School of Dentistry)




Howard  McLeod
(Washington University)




Gareth  Morgan
(University of Leeds)




Michael  Pollak
(McGill University)


Show all 8","Kenneth  Buetow; PhD (Laboratory of Population Genetics)



Stephen J Chanock; MD, PhD (Laboratory Translational Genomics)",NULL,"Ordered by publication type and then author name.



1.
Anderson WF, Camargo MC, Fraumeni JF, Correa P, Rosenberg PS, Rabkin CS (2010). Age-specific trends in incidence of noncardia gastric cancer in US adults. JAMA  303, 1723-8.   https://doi.org/10.1001/jama.2010.496




PubMed



        
     
Free Article


 


PubMed ID 20442388
         Pubmed Central ID 3142962 


 



2.
Dunn B, Greene M, Kelley J (2010) Novel pathway analysis of genomic polymorphism-cancer risk interaction in the breast cancer prevention trial. Int J Mol Epidemiol Genet 1:332-349.




 



3.
Dunn BK, Greene MH, Kelley JM, Costantino JP, Clifford RJ, Hu Y, Tang G, Kazerouni N, Rosenberg PS, Meerzaman DM, Buetow KH (2010) Novel pathway analysis of genomic polymorphism-cancer risk interaction in the breast cancer prevention trial. Int J Mol Epidemiol Genet 1:332-349




 



4.
Dunn BK, Greene MH, Kelley JM, Costantino JP, Clifford RJ, Hu Y, Tang G, Kazerouni N, Rosenberg PS, Meerzaman DM, Buetow KH (2010) Novel pathway analysis of genomic polymorphism-cancer risk interaction in the breast cancer prevention trial. Int J Mol Epidemiol Genet 1:332-349




 



5.
Dunn BK, Greene MH, Kelley JM, Costantino JP, Clifford RJ, Hu Y, Tang G, Kazerouni N, Rosenberg PS, Meerzaman DM, Buetow KH (2010). Novel pathway analysis of genomic polymorphism-cancer risk interaction in the Breast Cancer Prevention Trial. Int J Mol Epidemiol Genet  1, 332-49.




PubMed



        
     
Free Article


 


PubMed ID 21152245
         Pubmed Central ID 2998292 


 



6.
Mirabello L, Berndt SI, Seratti GF, Burdett L, Yeager M, Chowdhury S, Teshome K, Uzoka A, Douglass C, Hayes RB, Hoover RN, Savage SA, National Osteosarcoma Etiology Study Group (2010). Genetic variation at chromosome 8q24 in osteosarcoma cases and controls. Carcinogenesis  31, 1400-4.   https://doi.org/10.1093/carcin/bgq117




PubMed



        
     
Free Article


 


PubMed ID 20530236
         Pubmed Central ID 2915635 


 



7.
Mirabello L, Troisi RJ, Savage SA (2009). International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons. Int J Cancer  125, 229-34.   https://doi.org/10.1002/ijc.24320




PubMed



        
     
Free Article


 


PubMed ID 19330840
         Pubmed Central ID 3048853 


 



8.
Mirabello L, Troisi RJ, Savage SA (2009). Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program. Cancer  115, 1531-43.   https://doi.org/10.1002/cncr.24121




PubMed



        
     
Free Article


 


PubMed ID 19197972
         Pubmed Central ID 2813207",https://intramural.nih.gov/search/searchview.taf?ipid=63508
698,CP010144-12,"October 01, 2009 -  September 30, 2010",Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes,"Sharon Ann Savage



IRP Faculty Profile
 


 

Mark H Greene; MD



IRP Faculty Profile",NULL,"Clinical Genetics Branch, NCI","Blanche P Alter



Neelam K Giri; MD



Sadie  Hutson



Jennifer T Loud



June  Peters







Christian Peter Kratz","David  Alberts
(University of Arizona Cancer Center)




Timothy  Bishop
(Institute for Cancer Research)




Robert  Brodsky
(Johns Hopkins University School of Medicine)




Joseph  Califano
(Johns Hopkins University School of Medicine)




George  Dover
(Johns Hopkins University School of Medicine)




Peter  Durie
(Toronto Hospital for Sick Children)


Show all 58","Thomas  Fears; PhD (Genetic Epidemiology Branch)



Mitchell Henry Gail; PhD, MD (Biostatistics Branch)



Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)



Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)



Katherine Ann McGlynn; PhD (Hormonal and Reproductive Epidemiology Branch)



Philip Samuel Rosenberg; PhD (Biostatistics Branch)","Jeffery P Struewing; MS, MD (NHGRI) 



Pamela  Stratton; MD (NICHD)","Ordered by publication type and then author name.



1.
Alter B (2009) Inherited Aplastic Anemia Syndromes, in Wintrobes Clinical Hematology, Twelfth Edition. Volume 12, pp. 1173-1184.




 



2.
Loud J, Hutson S (2010) Chapter 7: Genetic Risk and Hereditary Cancer Syndromes, in Cancer Nursing: Principles and Practice., pp. 1-25.




 



3.
Allanson JE, Bohring A, Dörr HG, Dufke A, Gillessen-Kaesbach G, Horn D, König R, Kratz CP, Kutsche K, Pauli S, Raskin S, Rauch A, Turner A, Wieczorek D, Zenker M (2010). The face of Noonan syndrome: Does phenotype predict genotype. Am J Med Genet A  152A, 1960-6.   https://doi.org/10.1002/ajmg.a.33518




PubMed



        
     
Free Article


 


PubMed ID 20602484
         Pubmed Central ID 3115585 


 



4.
Alter BP, Giri N, Savage SA, Peters JA, Loud JT, Leathwood L, Carr AG, Greene MH, Rosenberg PS (2010). Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study. Br J Haematol  150, 179-88.   https://doi.org/10.1111/j.1365-2141.2010.08212.x




PubMed



        
     
Free Article


 


PubMed ID 20507306
         Pubmed Central ID 3125983 


 



5.
Alter BP, Giri N, Savage SA, Rosenberg PS (2009). Cancer in dyskeratosis congenita. Blood  113, 6549-57.   https://doi.org/10.1182/blood-2008-12-192880




PubMed



        
     
Free Article


 


PubMed ID 19282459
         Pubmed Central ID 2710915 


 



6.
Antoniou A, Wang X, Fredericksen Z, McGuffog L, Tarrell R, Sinilnikova O, Healey S, Morrison J, Kartsonaki C, Ghoussaini M, Peock S, StoppaLyonnet D, Hogervorst F, Devilee P, Lubinski J, Jakubowska A, Spurdle A, John E, Hopper J, Buys S, Daly M, Southey M, Terry M, Schmutzler R, Domchek S, et al. [75 more authors] (2010) A genome-wide association study identifies a 19p13 locus that modifies the risk of breast cancer in BRCA1 mutation carriers and which is associated with estrogen receptor-negative and triple-negative breast cancer in the general population. Nature Genetics 42:1




 



7.
Antoniou AC, Beesley J, McGuffog L, Sinilnikova OM, Healey S, Neuhausen SL, Ding YC, Rebbeck TR, Weitzel JN, Lynch HT, Isaacs C, Ganz PA, Tomlinson G, Olopade OI, Couch FJ, Wang X, Lindor NM, Pankratz VS, Radice P, Manoukian S, Peissel B, Zaffaroni D, Barile M, Viel A, Allavena A, Ontario Cancer Genetics Network, SWE-BRCA, HEBON, EMBRACE, GEMO, GEMO, Breast Cancer Family Registry, kConFab, CIMBA, et al. [153 more authors] (2010). Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. Cancer Res  70, 9742-54.   https://doi.org/10.1158/0008-5472.CAN-10-1907




PubMed



        
     
Free Article


 


PubMed ID 21118973
         Pubmed Central ID 2999830 


 



8.
Antoniou AC, Sinilnikova OM, McGuffog L, Healey S, Nevanlinna H, Heikkinen T, Simard J, Spurdle AB, Beesley J, Chen X, Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer, Neuhausen SL, Ding YC, Couch FJ, Wang X, Fredericksen Z, Peterlongo P, Peissel B, Bonanni B, Viel A, Bernard L, Radice P, Szabo CI, Foretova L, Zikan M, Claes K, OCGN, HEBON, EMBRACE, GEMO, Breast Cancer Family Registry, CIMBA, et al. [112 more authors] (2009). Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers. Hum Mol Genet  18, 4442-56.   https://doi.org/10.1093/hmg/ddp372




PubMed



        
     
Free Article


 


PubMed ID 19656774
         Pubmed Central ID 2782243 


 



9.
Antonis A, Wang X, Fredericksen Z, McGuffog L, Tarrell R, Sinilnikova O, Healey S, Morrison J, Kartsonaki C, Ghoussaini M, Peock S, StoppaLyonnet D, Hogervorst F, Devilee P, Lubinski J, Jakubowska A, Spurdle 
, John E, Hopper J, Buys S, Daly M, Southey M, Terry M, Schmutzler R, Domchek S, et al. [75 more authors] (2010) A genome-wide association study identifies a 19p13 locus that modifies the risk of breast cancer in BRCA1 mutation carriers and which is associated with estrogen receptor-negative and triple-negative breast cancer in the general population. Nature Genetics 42:1




 



10.
Christophe E, Versmold B, Wappenschmidt B, Simard J, Easton D, Peock S, Cook M, Oliver C, Frost D, Mayes R, Evans D, Eeles R, Paterson J, Brewer C, McGuffog L, Antoniou A, StoppaLyonnet D, Sinilnikova O, Barjhoux L, Frenay M, Michel C, Leroux D, Dreyfus H, Toulas C, Gladieff L, et al. [44 more authors] (2010) Association of the Variants CASP8 D302H and CASP10 V410I with Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers. Cancer Epidemiology Biomarkers Prevention 19:2859-2868




 



11.
Cirstea IC, Kutsche K, Dvorsky R, Gremer L, Carta C, Horn D, Roberts AE, Lepri F, Merbitz-Zahradnik T, König R, Kratz CP, Pantaleoni F, Dentici ML, Joshi VA, Kucherlapati RS, Mazzanti L, Mundlos S, Patton MA, Silengo MC, Rossi C, Zampino G, Digilio C, Stuppia L, Seemanova E, Pennacchio LA, et al. [6 more authors] (2010). A restricted spectrum of NRAS mutations causes Noonan syndrome. Nat Genet  42, 27-9.   https://doi.org/10.1038/ng.497




PubMed



        
     
Free Article


 


PubMed ID 19966803
         Pubmed Central ID 3118669 


 



12.
Engel C, Versmold B, Wappenschmidt B, Simard J, Easton D, Peock S, Cook M, Oliver C, Frost D, Mayes R, Evans D, Eeles R, Paterson J, Brewer C, McGuffog L, Antoniou A, StoppaLyonnet D, Sinilnikova O, Barjhoux L, Frenay M, Michel C, Leroux D, Dreyfus H, Toulas C, Gladieff L, et al. [44 more authors] (2010) Association of the Variants CASP8 D302H and CASP10 V410I with Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers. Cancer Epidemiology Biomarkers Prevention 19:2859-2868




 



13.
Gaudet M, Mai P, Greene M, Offit K (2010) COMMON GENETIC VARIANTS AND MODIFICATION OF PENETRANCE OF BRCA2-ASSOCIATED BREAST CANCER. PLoS Genetics 6:e1001183




 



14.
Giri N (2009) Proliferative Retinopathy as a Complication of Dyskeratosis Congenita. Retinal cases and brief reports 3:259-262.




 



15.
Greene M, Kratz C, Mai P, Mueller C, Peters J, Bratslavsky G, Ling A, Choyke P, Premkumar A, Bracci J, Watkins R, Mcmaster M, Korde L (2010) Familial Testicular Germ Cell Tumors in Adults: 2010 Summary of Genetic Risk Factors and Clinical Phenotype. Endocrine-Related Cancer 17:R109-R121




 



16.
Jakubowska A, Rozkrut D, Antoniou A, Hamann U, Lubinski J (2010) The Leu33Pro polymorphism in the ITGB3 gene does not modify BRCA1/2-associated breast or ovarian cancer risks: results from a multicenter study among 15,542 BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat 121:639-49




PubMed



        
     
Free Article


 


PubMed ID 19876733
         Pubmed Central ID 3077711 


 



17.
Korde LA, Gadalla SM (2009). Cancer risk assessment for the primary care physician. Prim Care  36, 471-88.   https://doi.org/10.1016/j.pop.2009.04.006




PubMed



        
     
Free Article


 


PubMed ID 19616151
         Pubmed Central ID 2713871 


 



18.
Korde LA, Zujewski JA, Kamin L, Giordano S, Domchek S, Anderson WF, Bartlett JM, Gelmon K, Nahleh Z, Bergh J, Cutuli B, Pruneri G, McCaskill-Stevens W, Gralow J, Hortobagyi G, Cardoso F (2010). Multidisciplinary meeting on male breast cancer: summary and research recommendations. J Clin Oncol  28, 2114-22.   https://doi.org/10.1200/JCO.2009.25.5729




PubMed



        
     
Free Article


 


PubMed ID 20308661
         Pubmed Central ID 2860409 


 



19.
Kratz C, Mai P, Greene M (2010) Familial Testicular Germ Cell Tumors. Best Practice Research Clinical Endocrinology Metabolism 24:503-513




 



20.
Loud JT (2010). Direct-to-Consumer Genetic and Genomic Testing: Preparing Nurse Practitioners for Genomic Healthcare. J Nurse Pract  6, 585-594.   https://doi.org/10.1016/j.nurpra.2010.06.007




PubMed



        
     
Free Article


 


PubMed ID 21132113
         Pubmed Central ID 2995214 


 



21.
Mai PL, Chen BE, Tucker K, Friedlander M, Phillips KA, Hogg D, Jewett MA, Bodrogi I, Geczi L, Olah E, Heimdal K, Fosså SD, Nathanson KL, Korde L, Easton DF, Dudakia D, Huddart R, Stratton MR, Bishop DT, Rapley EA, Greene MH (2009). Younger age-at-diagnosis for familial malignant testicular germ cell tumor. Fam Cancer  8, 451-6.   https://doi.org/10.1007/s10689-009-9264-6




PubMed



        
     
Free Article


 


PubMed ID 19609727
         Pubmed Central ID 2903045 


 



22.
Mai PL, Friedlander M, Tucker K, Phillips KA, Hogg D, Jewett MA, Lohynska R, Daugaard G, Richard S, Bonaïti-Pellié C, Heidenreich A, Albers P, Bodrogi I, Geczi L, Olah E, Daly PA, Guilford P, Fosså SD, Heimdal K, Liubchenko L, Tjulandin SA, Stoll H, Weber W, Easton DF, Dudakia D, et al. [8 more authors] (2010). The International Testicular Cancer Linkage Consortium: a clinicopathologic descriptive analysis of 461 familial malignant testicular germ cell tumor kindred. Urol Oncol  28, 492-9.   https://doi.org/10.1016/j.urolonc.2008.10.004




PubMed



        
     
Free Article


 


PubMed ID 19162511
         Pubmed Central ID 2891341 


 



23.
Mia G, Mai P, Greene M, Offit K (2010) COMMON GENETIC VARIANTS AND MODIFICATION OF PENETRANCE OF BRCA2-ASSOCIATED BREAST CANCER. PLoS Genetics 6:e1001183




 



24.
Mirabello L, Savage SA, Korde L, Gadalla SM, Greene MH (2010). LINE-1 methylation is inherited in familial testicular cancer kindreds. BMC Med Genet  11, 77.   https://doi.org/10.1186/1471-2350-11-77




PubMed



        
     
Free Article


 


PubMed ID 20478068
         Pubmed Central ID 2880977 


 



25.
Osorio A, Milne RL, Pita G, Peterlongo P, Heikkinen T, Simard J, Chenevix-Trench G, Spurdle AB, Beesley J, Chen X, Healey S, KConFab, Neuhausen SL, Ding YC, Couch FJ, Wang X, Lindor N, Manoukian S, Barile M, Viel A, Tizzoni L, Szabo CI, Foretova L, Zikan M, Claes K, Greene MH, OCGN, SWE-BRCA, HEBON, EMBRACE, GEMO, Breast Cancer Family Registry, CMBA, et al. [108 more authors] (2009). Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA). Br J Cancer  101, 2048-54.   https://doi.org/10.1038/sj.bjc.6605416




PubMed



        
     
Free Article


 


PubMed ID 19920816
         Pubmed Central ID 2795432 


 



26.
Savage SA, Alter BP (2009). Dyskeratosis congenita. Hematol Oncol Clin North Am  23, 215-31.   https://doi.org/10.1016/j.hoc.2009.01.003




PubMed



        
     
Free Article


 


PubMed ID 19327580
         Pubmed Central ID 2702847 


 



27.
Savage SA, Dokal I, Armanios M, Aubert G, Cowen EW, Domingo DL, Giri N, Greene MH, Orchard PJ, Tolar J, Tsilou E, Van Waes C, Wong JM, Young NS, Alter BP (2009). Dyskeratosis congenita: the first NIH clinical research workshop. Pediatr Blood Cancer  53, 520-3.   https://doi.org/10.1002/pbc.22061




PubMed



        
     
Free Article


 


PubMed ID 19415736
         Pubmed Central ID 2739803 


 



28.
Shimamura A, Alter BP (2010). Pathophysiology and management of inherited bone marrow failure syndromes. Blood Rev  24, 101-22.   https://doi.org/10.1016/j.blre.2010.03.002




PubMed



        
     
Free Article


 


PubMed ID 20417588
         Pubmed Central ID 3733544 


 



29.
Sinilnikova OM, Antoniou AC, Simard J, Healey S, Léoné M, Sinnett D, Spurdle AB, Beesley J, Chen X, kConFab, Greene MH, Loud JT, Lejbkowicz F, Rennert G, Dishon S, Andrulis IL, OCGN, Domchek SM, Nathanson KL, Manoukian S, Radice P, Konstantopoulou I, Blanco I, Laborde AL, Durán M, Osorio A, Benitez J, HEBON, EMBRACE, GEMO, GC-HBOC, Consortium of Investigators of Modifiers of BRCA1/2, et al. [43 more authors] (2009). The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Br J Cancer  101, 1456-60.   https://doi.org/10.1038/sj.bjc.6605279




PubMed



        
     
Free Article


 


PubMed ID 19707196
         Pubmed Central ID 2768437 


 



30.
Tamary H, Nishri D, Yacobovich J, Zilber R, Dgany O, Krasnov T, Aviner S, Stepensky P, Ravel-Vilk S, Bitan M, Kaplinsky C, Ben Barak A, Elhasid R, Kapelusnik J, Koren A, Levin C, Attias D, Laor R, Yaniv I, Rosenberg PS, Alter BP (2010). Frequency and natural history of inherited bone marrow failure syndromes: the Israeli Inherited Bone Marrow Failure Registry. Haematologica  95, 1300-7.   https://doi.org/10.3324/haematol.2009.018119




PubMed



        
     
Free Article


 


PubMed ID 20435624
         Pubmed Central ID 2913078 


 



31.
Tsilou ET, Giri N, Weinstein S, Mueller C, Savage SA, Alter BP (2010). Ocular and orbital manifestations of the inherited bone marrow failure syndromes: Fanconi anemia and dyskeratosis congenita. Ophthalmology  117, 615-22.   https://doi.org/10.1016/j.ophtha.2009.08.023




PubMed



        
     
Free Article


 


PubMed ID 20022637
         Pubmed Central ID 2830377 


 



32.
Vadaparampil ST, Moser RP, Loud J, Peters JA, Greene MH, Korde L (2009). Factors associated with testicular self-examination among unaffected men from multiple-case testicular cancer families. Hered Cancer Clin Pract  7, 11.   https://doi.org/10.1186/1897-4287-7-11




PubMed



        
     
Free Article


 


PubMed ID 19480691
         Pubmed Central ID 2696412 


 



33.
Wimmer K, Kratz CP (2010). Constitutional mismatch repair-deficiency syndrome. Haematologica  95, 699-701.   https://doi.org/10.3324/haematol.2009.021626




PubMed



        
     
Free Article


 


PubMed ID 20442441
         Pubmed Central ID 2864372",https://intramural.nih.gov/search/searchview.taf?ipid=63509
699,CP010145-11,"October 01, 2009 -  September 30, 2010",Intervention Trials in Persons at Increased Genetic Risk of Cancer,"Mark H Greene; MD



IRP Faculty Profile",NULL,"Clinical Genetics Branch, NCI","Phuong L Mai



Jennifer T Loud



Christine M Mueller



June  Peters","David  Alberts
(University of Arizona Cancer Center)




Deborah A. Bell; MD
(Department of Laboratory Medicine and Pathology, Mayo Clinic)




Molly  Brewer
(Arizona Cancer Center)




Robert  Brodsky
(Johns Hopkins University School of Medicine)




Joseph  Califano
(Johns Hopkins University School of Medicine)




Catherine K Chow; MD
(CC)


Show all 18","Mark E Sherman; MD (Hormonal and Reproductive Epidemiology Branch)



Gretchen L Gierach (Hormonal and Reproductive Epidemiology Branch)



Mitchell Henry Gail; PhD, MD (Biostatistics Branch)



Margaret Anne Tucker (Human Genetics Program)



Paul Kj Han (Outcomes Research Branch)



Richard P Moser (Behavioral Research Program)",Jennifer  Eng Wong (NIDDK),"Ordered by publication type and then author name.



1.
Antoniou AC, Sinilnikova OM, McGuffog L, Healey S, Nevanlinna H, Heikkinen T, Simard J, Spurdle AB, Beesley J, Chen X, Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer, Neuhausen SL, Ding YC, Couch FJ, Wang X, Fredericksen Z, Peterlongo P, Peissel B, Bonanni B, Viel A, Bernard L, Radice P, Szabo CI, Foretova L, Zikan M, Claes K, OCGN, HEBON, EMBRACE, GEMO, Breast Cancer Family Registry, CIMBA, et al. [112 more authors] (2009). Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers. Hum Mol Genet  18, 4442-56.   https://doi.org/10.1093/hmg/ddp372




PubMed



        
     
Free Article


 


PubMed ID 19656774
         Pubmed Central ID 2782243 


 



2.
Gierach GL, Loud JT, Chow CK, Prindiville SA, Eng-Wong J, Soballe PW, Giambartolomei C, Mai PL, Galbo CE, Nichols K, Calzone KA, Vachon C, Gail MH, Greene MH (2010). Mammographic density does not differ between unaffected BRCA1/2 mutation carriers and women at low-to-average risk of breast cancer. Breast Cancer Res Treat  123, 245-55.   https://doi.org/10.1007/s10549-010-0749-7




PubMed



        
     
Free Article


 


PubMed ID 20130984
         Pubmed Central ID 3125980 


 



3.
Greene M, Mai P, Schwartz P (2010) Does Risk-Reducing Bilateral Salpingectomy with Ovarian Retention (BSOR) Warrant Consideration as a Temporary Bridge to Risk-Reducing Bilateral Oophorectomy (RRBO) in BRCA12 Mutation Carriers who are not Currently Ready for RRSO?. American Journal of Obstetrics and Gynecology 203:1




 



4.
Greene M, Mai P, Schwartz P (2010) Does Risk-Reducing Bilateral Salpingectomy with Ovarian Retention (BSOR) Warrant Consideration as a Temporary Bridge to Risk-Reducing Bilateral Oophorectomy (RRBO) in BRCA12 Mutation Carriers who are not Currently Ready for RRSO?. American Journal of Obstetrics and Gynecology 203:1




 



5.
Greene MH, Mai PL (2009). What have we learned from risk-reducing salpingo-oophorectomy? J Natl Cancer Inst  101, 70-1.   https://doi.org/10.1093/jnci/djn476




PubMed



        
     
Free Article


 


PubMed ID 19141782
         Pubmed Central ID 2639316 


 



6.
Koehly LM, Peters JA, Kenen R, Hoskins LM, Ersig AL, Kuhn NR, Loud JT, Greene MH (2009). Characteristics of health information gatherers, disseminators, and blockers within families at risk of hereditary cancer: implications for family health communication interventions. Am J Public Health  99, 2203-9.   https://doi.org/10.2105/AJPH.2008.154096




PubMed



        
     
Free Article


 


PubMed ID 19833996
         Pubmed Central ID 2775786 


 



7.
Loud J (2009) Invited Commentary: Multiple Cancer Screening Tests - What's a Practicing Clinician to Do? Ann Fam Med 7:e1-e2.




 



8.
Loud JT, Beckjord EB, Nichols K, Peters J, Giusti R, Greene MH (2009). Tolerability of breast ductal lavage in women from families at high genetic risk of breast cancer. BMC Womens Health  9, 20.   https://doi.org/10.1186/1472-6874-9-20




PubMed



        
     
Free Article


 


PubMed ID 19602282
         Pubmed Central ID 2731043 


 



9.
Loud JT, Thiébaut AC, Abati AD, Filie AC, Nichols K, Danforth D, Giusti R, Prindiville SA, Greene MH (2009). Ductal lavage in women from BRCA1/2 families: is there a future for ductal lavage in women at increased genetic risk of breast cancer? Cancer Epidemiol Biomarkers Prev  18, 1243-51.   https://doi.org/10.1158/1055-9965.EPI-08-0795




PubMed



        
     
Free Article


 


PubMed ID 19336560
         Pubmed Central ID 2729059 


 



10.
Rebbeck TR, Antoniou AC, Llopis TC, Nevanlinna H, Aittomäki K, Simard J, Spurdle AB, KConFab, Couch FJ, Pereira LH, Greene MH, Andrulis IL, Ontario Cancer Genetics Network, Pasche B, Kaklamani V, Breast Cancer Family Registry, Hamann U, Szabo C, Peock S, Cook M, Harrington PA, Donaldson A, Male AM, Gardiner CA, Gregory H, Side LE, Robinson AC, Emmerson L, EMBRACE, GEMO, et al. [19 more authors] (2009). No association of TGFB1 L10P genotypes and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a multi-center cohort study. Breast Cancer Res Treat  115, 185-92.   https://doi.org/10.1007/s10549-008-0064-8




PubMed



        
     
Free Article


 


PubMed ID 18523885
         Pubmed Central ID 2700286",https://intramural.nih.gov/search/searchview.taf?ipid=63510
700,CP010150-11,"October 01, 2009 -  September 30, 2010","Infections, immunity, and inflammation in cancer","Eric Andrew Engels; PhD



IRP Faculty Profile",NULL,"Infection & Immunoepidemiology Branch, NCI",Meredith Sarah Shiels,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Anderson LA, Engels EA (2010). Autoimmune conditions and hairy cell leukemia: an exploratory case-control study. J Hematol Oncol  3, 35.   https://doi.org/10.1186/1756-8722-3-35




PubMed



        
     
Free Article


 


PubMed ID 20920342
         Pubmed Central ID 2958876 


 



2.
Anderson LA, Pfeiffer RM, Landgren O, Gadalla S, Berndt SI, Engels EA (2009). Risks of myeloid malignancies in patients with autoimmune conditions. Br J Cancer  100, 822-8.   https://doi.org/10.1038/sj.bjc.6604935




PubMed



        
     
Free Article


 


PubMed ID 19259097
         Pubmed Central ID 2653768 


 



3.
Chiao EY, Engels EA, Kramer JR, Pietz K, Henderson L, Giordano TP, Landgren O (2009). Risk of immune thrombocytopenic purpura and autoimmune hemolytic anemia among 120 908 US veterans with hepatitis C virus infection. Arch Intern Med  169, 357-63.   https://doi.org/10.1001/archinternmed.2008.576




PubMed



        
     
Free Article


 


PubMed ID 19237719
         Pubmed Central ID 2782638 


 



4.
Drummond MB, Kirk GD, Ricketts EP, McCormack MC, Hague JC, McDyer JF, Mehta SH, Engels EA, Wise RA, Merlo CA (2010). Cross sectional analysis of respiratory symptoms in an injection drug user cohort: the impact of obstructive lung disease and HIV. BMC Pulm Med  10, 27.   https://doi.org/10.1186/1471-2466-10-27




PubMed



        
     
Free Article


 


PubMed ID 20459792
         Pubmed Central ID 2876103 


 



5.
Engels EA (2009). Non-AIDS-defining malignancies in HIV-infected persons: etiologic puzzles, epidemiologic perils, prevention opportunities. AIDS  23, 875-85.   https://doi.org/10.1097/QAD.0b013e328329216a




PubMed



        
     
Free Article


 


PubMed ID 19349851
         Pubmed Central ID 2677638 


 



6.
Engels EA (2010). Epidemiology of thymoma and associated malignancies. J Thorac Oncol  5, S260-5.   https://doi.org/10.1097/JTO.0b013e3181f1f62d




PubMed



               Available in future as a Free Article 


 


PubMed ID 20859116
         Pubmed Central ID 2951303 


 



7.
Engels EA, Cho ER, Jee SH (2010). Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: a cohort study. Lancet Oncol  11, 827-34.   https://doi.org/10.1016/S1470-2045(10)70167-4




PubMed



        
     
Free Article


 


PubMed ID 20688564
         Pubmed Central ID 2933963 


 



8.
Guech-Ongey M, Simard EP, Anderson WF, Engels EA, Bhatia K, Devesa SS, Mbulaiteye SM (2010). AIDS-related Burkitt lymphoma in the United States: what do age and CD4 lymphocyte patterns tell us about etiology and/or biology? Blood  116, 5600-4.   https://doi.org/10.1182/blood-2010-03-275917




PubMed



        
     
Free Article


 


PubMed ID 20813897
         Pubmed Central ID 3031406 


 



9.
Landgren O, Goedert JJ, Rabkin CS, Wilson WH, Dunleavy K, Kyle RA, Katzmann JA, Rajkumar SV, Engels EA (2010). Circulating serum free light chains as predictive markers of AIDS-related lymphoma. J Clin Oncol  28, 773-9.   https://doi.org/10.1200/JCO.2009.25.1322




PubMed



        
     
Free Article


 


PubMed ID 20048176
         Pubmed Central ID 2834393 


 



10.
Lanoy E, Engels EA (2010). Skin cancers associated with autoimmune conditions among elderly adults. Br J Cancer  103, 112-4.   https://doi.org/10.1038/sj.bjc.6605733




PubMed



        
     
Free Article


 


PubMed ID 20551958
         Pubmed Central ID 2894998 


 



11.
Marshall MM, Kirk GD, Caporaso NE, McCormack MC, Merlo CA, Hague JC, Mehta SH, Engels EA (2011). Tobacco use and nicotine dependence among HIV-infected and uninfected injection drug users. Addict Behav  36, 61-7.   https://doi.org/10.1016/j.addbeh.2010.08.022




PubMed



        
     
Free Article


 


PubMed ID 20875704
         Pubmed Central ID 2981673 


 



12.
Quinlan SC, Landgren O, Morton LM, Engels EA (2010). Hodgkin lymphoma among US solid organ transplant recipients. Transplantation  90, 1011-5.   https://doi.org/10.1097/TP.0b013e3181f5c3a6




PubMed



        
     
Free Article


 


PubMed ID 20733533
         Pubmed Central ID 2967618 


 



13.
Shebl FM, Engels EA, Goedert JJ, Chaturvedi AK (2010). Pulmonary infections and risk of lung cancer among persons with AIDS. J Acquir Immune Defic Syndr  55, 375-9.   https://doi.org/10.1097/QAI.0b013e3181eef4f7




PubMed



               Available in future as a Free Article 


 


PubMed ID 20736841
         Pubmed Central ID 2955766 


 



14.
Shiels MS, Goedert JJ, Engels EA (2010) Recent trends and future directions in HIV-associated cancer. Cancer 0:5507-16




 



15.
Shiels MS, Goedert JJ, Engels EA (2010) Recent trends and future directions in HIV-associated cancer. Cancer 0:5507-16




 



16.
Shiels MS, Goedert JJ, Moore RD, Platz EA, Engels EA (2010). Reduced risk of prostate cancer in U.S. Men with AIDS. Cancer Epidemiol Biomarkers Prev  19, 2910-5.   https://doi.org/10.1158/1055-9965.EPI-10-0741




PubMed



               Available in future as a Free Article 


 


PubMed ID 20837717
         Pubmed Central ID 2976800 


 



17.
Shiels MS, Pfeiffer RM, Engels EA (2010). Age at cancer diagnosis among persons with AIDS in the United States. Ann Intern Med  153, 452-60.   https://doi.org/10.7326/0003-4819-153-7-201010050-00008




PubMed



        
     
Free Article


 


PubMed ID 20921544
         Pubmed Central ID 3071616 


 



18.
Simard EP, Engels EA (2010). Cancer as a cause of death among people with AIDS in the United States. Clin Infect Dis  51, 957-62.   https://doi.org/10.1086/656416




PubMed



               Available in future as a Free Article 


 


PubMed ID 20825305
         Pubmed Central ID 2943990 


 



19.
Simard EP, Pfeiffer RM, Engels EA (2010). Spectrum of cancer risk late after AIDS onset in the United States. Arch Intern Med  170, 1337-45.   https://doi.org/10.1001/archinternmed.2010.253




PubMed



        
     
Free Article


 


PubMed ID 20696958
         Pubmed Central ID 2921231",https://intramural.nih.gov/search/searchview.taf?ipid=63511
701,CP010152-11,"October 01, 2009 -  September 30, 2010",PLCO Trial Etiologic and Early Marker Study,"Robert  Hoover; MD, ScD



IRP Faculty Profile
 


 

Mark  Purdue



IRP Faculty Profile
 




Ann  Hsing; PhD",NULL,"Occupational and Environmental Epidemiology Branch, NCI

Hormonal and Reproductive Epidemiology Branch, NCI

Epidemiology and Biostatistics Program, NCI","Wen-Yi  Huang



Amanda  Black","Gerry  Andriole
(Washington University)




Thomas  Beck
(NCI)




Saundra  Buys
(Hunstman Cancer Institute, University of Utah)




Timothy R. Church; PhD
(Environ & Occup Health, University of Minnesota School of Public Health)




David T Crawford





Mona  Fouad
(University of Alabama, Birmingham)


Show all 11","Christine Dorothy Berg (Early Detection Research Group)



Prisca N Fall (Biostatistics Branch)",NULL,"Ordered by publication type and then author name.



1.
Ahn J, Schumacher FR, Berndt SI, Pfeiffer R, Albanes D, Andriole GL, Ardanaz E, Boeing H, Bueno-de-Mesquita B, Chanock SJ, Clavel-Chapelon F, Diver WR, Feigelson HS, Gaziano JM, Giovannucci E, Haiman CA, Henderson BE, Hoover RN, Kolonel LN, Kraft P, Ma J, Le Marchand L, Overvad K, Palli D, Stattin P, et al. [12 more authors] (2009). Quantitative trait loci predicting circulating sex steroid hormones in men from the NCI-Breast and Prostate Cancer Cohort Consortium (BPC3). Hum Mol Genet  18, 3749-57.   https://doi.org/10.1093/hmg/ddp302




PubMed



        
     
Free Article


 


PubMed ID 19574343
         Pubmed Central ID 2742399 


 



2.
Berndt SI, Huang WY, Yeager M, Weissfeld JL, Chanock SJ, Hayes RB (2009). Genetic variants in frizzled-related protein (FRZB) and the risk of colorectal neoplasia. Cancer Causes Control  20, 487-90.   https://doi.org/10.1007/s10552-008-9274-y




PubMed



        
     
Free Article


 


PubMed ID 19067193
         Pubmed Central ID 2667207 


 



3.
Chu LW, Meyer TE, Li Q, Menashe I, Yu K, Rosenberg PS, Huang WY, Quraishi SM, Kaaks R, Weiss JM, Hayes RB, Chanock SJ, Hsing AW (2010). Association between genetic variants in the 8q24 cancer risk regions and circulating levels of androgens and sex hormone-binding globulin. Cancer Epidemiol Biomarkers Prev  19, 1848-54.   https://doi.org/10.1158/1055-9965.EPI-10-0101




PubMed



        
     
Free Article


 


PubMed ID 20551303
         Pubmed Central ID 2901401 


 



4.
Dossus L, Kaaks R, Canzian F, Albanes D, Berndt SI, Boeing H, Buring J, Chanock SJ, Clavel-Chapelon F, Feigelson HS, Gaziano JM, Giovannucci E, Gonzalez C, Haiman CA, Hallmans G, Hankinson SE, Hayes RB, Henderson BE, Hoover RN, Hunter DJ, Khaw KT, Kolonel LN, Kraft P, Ma J, Le Marchand L, et al. [15 more authors] (2010). PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3). Carcinogenesis  31, 455-61.   https://doi.org/10.1093/carcin/bgp307




PubMed



        
     
Free Article


 


PubMed ID 19965896
         Pubmed Central ID 2832545 


 



5.
Freedman AN, Slattery ML, Ballard-Barbash R, Willis G, Cann BJ, Pee D, Gail MH, Pfeiffer RM (2009). Colorectal cancer risk prediction tool for white men and women without known susceptibility. J Clin Oncol  27, 686-93.   https://doi.org/10.1200/JCO.2008.17.4797




PubMed



        
     
Free Article


 


PubMed ID 19114701
         Pubmed Central ID 2645090 


 



6.
García-Piñeres AJ, Hildesheim A, Dodd L, Kemp TJ, Yang J, Fullmer B, Harro C, Lowy DR, Lempicki RA, Pinto LA (2009). Gene expression patterns induced by HPV-16 L1 virus-like particles in leukocytes from vaccine recipients. J Immunol  182, 1706-29.   https://doi.org/10.4049/jimmunol.182.3.1706




PubMed



        
     
Free Article


 


PubMed ID 19155521
         Pubmed Central ID 2701477 


 



7.
Hofmann JN, Yu K, Horst RL, Hayes RB, Purdue MP (2010). Long-term variation in serum 25-hydroxyvitamin D concentration among participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Epidemiol Biomarkers Prev  19, 927-31.   https://doi.org/10.1158/1055-9965.EPI-09-1121




PubMed



        
     
Free Article


 


PubMed ID 20332255
         Pubmed Central ID 2857993 


 



8.
Huang WY, Sheehy TM, Moore LE, Hsing AW, Purdue MP (2010). Simultaneous recovery of DNA and RNA from formalin-fixed paraffin-embedded tissue and application in epidemiologic studies. Cancer Epidemiol Biomarkers Prev  19, 973-7.   https://doi.org/10.1158/1055-9965.EPI-10-0091




PubMed



        
     
Free Article


 


PubMed ID 20332269
         Pubmed Central ID 2864144 


 



9.
Johnson CC, Hayes RB, Schoen RE, Gunter MJ, Huang WY, PLCO Trial Team (2010). Non-steroidal anti-inflammatory drug use and colorectal polyps in the Prostate, Lung, Colorectal, And Ovarian Cancer Screening Trial. Am J Gastroenterol  105, 2646-55.   https://doi.org/10.1038/ajg.2010.349




PubMed



        
     
Free Article


 


PubMed ID 20808298
         Pubmed Central ID 5557093 


 



10.
Koutros S, Berndt SI, Sinha R, Ma X, Chatterjee N, Alavanja MC, Zheng T, Huang WY, Hayes RB, Cross AJ (2009). Xenobiotic metabolizing gene variants, dietary heterocyclic amine intake, and risk of prostate cancer. Cancer Res  69, 1877-84.   https://doi.org/10.1158/0008-5472.CAN-08-2447




PubMed



        
     
Free Article


 


PubMed ID 19223546
         Pubmed Central ID 2662592 


 



11.
Koutros S, Schumacher FR, Hayes RB, Ma J, Huang WY, Albanes D, Canzian F, Chanock SJ, Crawford ED, Diver WR, Feigelson HS, Giovanucci E, Haiman CA, Henderson BE, Hunter DJ, Kaaks R, Kolonel LN, Kraft P, Le Marchand L, Riboli E, Siddiq A, Stampfer MJ, Stram DO, Thomas G, Travis RC, et al. [3 more authors] (2010). Pooled analysis of phosphatidylinositol 3-kinase pathway variants and risk of prostate cancer. Cancer Res  70, 2389-96.   https://doi.org/10.1158/0008-5472.CAN-09-3575




PubMed



        
     
Free Article


 


PubMed ID 20197460
         Pubmed Central ID 2840184 


 



12.
Lacey JV, Kreimer AR, Buys SS, Marcus PM, Chang SC, Leitzmann MF, Hoover RN, Prorok PC, Berg CD, Hartge P, Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Project Team (2009). Breast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Cohort. BMC Cancer  9, 84.   https://doi.org/10.1186/1471-2407-9-84




PubMed



        
     
Free Article


 


PubMed ID 19292893
         Pubmed Central ID 2670317 


 



13.
Lee KM, Kang D, Park SK, Berndt SI, Reding D, Chatterjee N, Chanock S, Huang WY, Hayes RB (2009). Nitric oxide synthase gene polymorphisms and prostate cancer risk. Carcinogenesis  30, 621-5.   https://doi.org/10.1093/carcin/bgp028




PubMed



        
     
Free Article


 


PubMed ID 19168583
         Pubmed Central ID 2664454 


 



14.
Stolzenberg-Solomon RZ, Hayes RB, Horst RL, Anderson KE, Hollis BW, Silverman DT (2009). Serum vitamin D and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian screening trial. Cancer Res  69, 1439-47.   https://doi.org/10.1158/0008-5472.CAN-08-2694




PubMed



        
     
Free Article


 


PubMed ID 19208842
         Pubmed Central ID 3052200",https://intramural.nih.gov/search/searchview.taf?ipid=63512
702,CP010158-10,"October 01, 2009 -  September 30, 2010",Studies of Rare Cancers,"Philip E Castle; PhD, MPH

 


 

Allan  Hildesheim; PhD



IRP Faculty Profile
 




Ann  Hsing; PhD

 


 

Katherine Ann McGlynn; PhD



IRP Faculty Profile
 




Louise  Brinton; PhD",NULL,"Infection & Immunoepidemiology Branch, NCI

Hormonal and Reproductive Epidemiology Branch, NCI","Kelly Jen-Yi Yu



Michael Blaise Cook","Streamson  Chua
(Columbia University)




Scott  Davis
(Fred Hutchinson Cancer Research Center)




James  Dick
(Johns Hopkins Univeristy)




James  Fox
(MIT)




Yu-Tang  Gao
(Shanghai Cancer Institute)




Evelyene  Lennette
(Virolab, Inc.)


Show all 12",Gabriella  Andreotti (Occupational and Environmental Epidemiology Branch),NULL,"Ordered by publication type and then author name.



1.
Andreotti G, Menashe I, Chen J, Chang SC, Rashid A, Gao YT, Han TQ, Sakoda LC, Chanock S, Rosenberg PS, Hsing AW (2009). Genetic determinants of serum lipid levels in Chinese subjects: a population-based study in Shanghai, China. Eur J Epidemiol  24, 763-74.   https://doi.org/10.1007/s10654-009-9402-3




PubMed



        
     
Free Article


 


PubMed ID 19888660
         Pubmed Central ID 2885778 


 



2.
Brinton LA, Carreon JD, Gierach GL, McGlynn KA, Gridley G (2010). Etiologic factors for male breast cancer in the U.S. Veterans Affairs medical care system database. Breast Cancer Res Treat  119, 185-92.   https://doi.org/10.1007/s10549-009-0379-0




PubMed



        
     
Free Article


 


PubMed ID 19330525
         Pubmed Central ID 2807736 


 



3.
Davila JA, Morgan RO, Richardson PA, Du XL, McGlynn KA, El-Serag HB (2010). Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States. Hepatology  52, 132-41.   https://doi.org/10.1002/hep.23615




PubMed



        
     
Free Article


 


PubMed ID 20578139
         Pubmed Central ID 3835698 


 



4.
Enewold L, Brinton LA, McGlynn KA, Zahm SH, Potter JF, Zhu K (2010). Oral contraceptive use among women in the military and the general U.S. population. J Womens Health (Larchmt)  19, 839-45.   https://doi.org/10.1089/jwh.2009.1706




PubMed



        
     
Free Article


 


PubMed ID 20350205
         Pubmed Central ID 2940458 


 



5.
Meyer TE, O'Brien TG, Andreotti G, Yu K, Li Q, Gao YT, Rashid A, Shen MC, Wang BS, Han TQ, Zhang BH, Niwa S, Fraumeni JF, Hsing AW (2010). Androgen receptor CAG repeat length and risk of biliary tract cancer and stones. Cancer Epidemiol Biomarkers Prev  19, 787-93.   https://doi.org/10.1158/1055-9965.EPI-09-0973




PubMed



        
     
Free Article


 


PubMed ID 20200439
         Pubmed Central ID 2837546 


 



6.
Park SK, Andreotti G, Rashid A, Chen J, Rosenberg PS, Yu K, Olsen J, Gao YT, Deng J, Sakoda LC, Zhang M, Shen MC, Wang BS, Han TQ, Zhang BH, Yeager M, Chanock SJ, Hsing AW (2010). Polymorphisms of estrogen receptors and risk of biliary tract cancers and gallstones: a population-based study in Shanghai, China. Carcinogenesis  31, 842-6.   https://doi.org/10.1093/carcin/bgq038




PubMed



        
     
Free Article


 


PubMed ID 20172949
         Pubmed Central ID 2864412 


 



7.
Shebl FM, Andreotti G, Rashid A, Gao YT, Yu K, Shen MC, Wang BS, Li Q, Han TQ, Zhang BH, Fraumeni JF, Hsing AW (2010). Diabetes in relation to biliary tract cancer and stones: a population-based study in Shanghai, China. Br J Cancer  103, 115-9.   https://doi.org/10.1038/sj.bjc.6605706




PubMed



        
     
Free Article


 


PubMed ID 20517308
         Pubmed Central ID 2905288",https://intramural.nih.gov/search/searchview.taf?ipid=63515
703,CP010167-10,"October 01, 2009 -  September 30, 2010",General Studies of Epidemiology,"Robert  Hoover; MD, ScD



IRP Faculty Profile",NULL,"Epidemiology and Biostatistics Program, NCI","Rebecca  Troisi



Patricia  Hartge; ScD",NULL,Sharon Ann Savage (Clinical Genetics Branch),NULL,"Ordered by publication type and then author name.



1.
Ferrucci LM, Cross AJ, Graubard BI, Brinton LA, McCarty CA, Ziegler RG, Ma X, Mayne ST, Sinha R (2009). Intake of meat, meat mutagens, and iron and the risk of breast cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Br J Cancer  101, 178-84.   https://doi.org/10.1038/sj.bjc.6605118




PubMed



        
     
Free Article


 


PubMed ID 19513076
         Pubmed Central ID 2713710 


 



2.
Tasevska N, Sinha R, Kipnis V, Subar AF, Leitzmann MF, Hollenbeck AR, Caporaso NE, Schatzkin A, Cross AJ (2009). A prospective study of meat, cooking methods, meat mutagens, heme iron, and lung cancer risks. Am J Clin Nutr  89, 1884-94.   https://doi.org/10.3945/ajcn.2008.27272




PubMed



        
     
Free Article


 


PubMed ID 19369370
         Pubmed Central ID 2683000",https://intramural.nih.gov/search/searchview.taf?ipid=63516
704,CP010168-10,"October 01, 2009 -  September 30, 2010",Early Life Exposures and Subsequent Cancer Risk,"Robert  Hoover; MD, ScD



IRP Faculty Profile",NULL,"Epidemiology and Biostatistics Program, NCI",NULL,"Ervin  Adam
(Baylor College of Medicine)




Elizabeth  Hatch
(Boston University)




Arthur  Herbst
(University of Chicago)




Chung  Hsieh
(University of Massachuetts)




Michele  Lauria
(Dartmouth Hitchcock Medical Center)




Julie  Palmer
(Boston University)


Show all 12",NULL,NULL,"Ordered by publication type and then author name.



1.
Faupel-Badger JM, Hoover RN, Potischman N, Roberts JM, Troisi R (2009). Pregnancy weight gain is not associated with maternal or mixed umbilical cord estrogen and androgen concentrations. Cancer Causes Control  20, 263-7.   https://doi.org/10.1007/s10552-008-9235-5




PubMed



        
     
Free Article


 


PubMed ID 18830676
         Pubmed Central ID 2631613 


 



2.
McGlynn KA, Guo X, Graubard BI, Brock JW, Klebanoff MA, Longnecker MP (2009). Maternal pregnancy levels of polychlorinated biphenyls and risk of hypospadias and cryptorchidism in male offspring. Environ Health Perspect  117, 1472-6.   https://doi.org/10.1289/ehp.0800389




PubMed



        
     
Free Article


 


PubMed ID 19750116
         Pubmed Central ID 2737028 


 



3.
Troisi R (2009) Prenatal Risk Factors for Breast Cancer and Clues to the Underlying Biological Mechanisms from Animal and Human Studies. Newnham JP, Ross MG (eds): Early Life Orgins of Human Health and Disease. Basel, Karger 15:183-191.




 



4.
Ward M (2009) Residential Exposure to Polychlorinated Biphenyls and Organochlorine Pesticides and Risk of Childhood Leukemia. na 117:1007-13.",https://intramural.nih.gov/search/searchview.taf?ipid=63517
705,CP010169-09,"October 01, 2009 -  September 30, 2010","Nutrition, Metabolism, and Cancer","Stephen J Chanock; MD, PhD



IRP Faculty Profile
 


 

Barry Ira Graubard; PhD



IRP Faculty Profile
 


 

Robert  Hoover; MD, ScD



IRP Faculty Profile
 


 

Regina Gale Ziegler; PhD, MPH



IRP Faculty Profile",NULL,"Biostatistics Branch, NCI

Epidemiology and Biostatistics Program, NCI

Laboratory Translational Genomics, NCI","Mitchell Henry Gail; PhD, MD



Patricia  Hartge; ScD



Hormuzdiar Aspandiar Katki; MS



Catherine G Schairer","Ray  Greenberg
(University of South Carolina)




Rudolf  Kaaks
(International Agency for Research on Cancer)




Lawrence  Kolonel
(University of Hawaii)




Abraham  Nomura
(School of Public Health, University of Hawaii)




Emmanuel  Petricoin





Malcolm  Pike
(University of Southern California)


Show all 11","Demetrius  Albanes; MD (Nutritional Epidemiology Branch)



Louise  Brinton; PhD (Hormonal and Reproductive Epidemiology Branch)



Roni T Falk (Hormonal and Reproductive Epidemiology Branch)



Peter D Inskip; ScD (Radiation Epidemiology Branch)



Larry K Keefer; PhD (Laboratory of Comparative Carcinogenesis)



Martha S Linet; PhD (Radiation Epidemiology Branch)",Christine J Swanson (OD),"Ordered by publication type and then author name.



1.
Brown LM, Gridley G, Wu AH, Falk RT, Hauptmann M, Kolonel LN, West DW, Nomura AM, Pike MC, Hoover RN, Ziegler RG (2010). Low level alcohol intake, cigarette smoking and risk of breast cancer in Asian-American women. Breast Cancer Res Treat  120, 203-10.   https://doi.org/10.1007/s10549-009-0464-4




PubMed



        
     
Free Article


 


PubMed ID 19597702
         Pubmed Central ID 2808456 


 



2.
Eliassen AH, Ziegler RG, Rosner B, Veenstra TD, Roman JM, Xu X, Hankinson SE (2009). Reproducibility of fifteen urinary estrogens and estrogen metabolites over a 2- to 3-year period in premenopausal women. Cancer Epidemiol Biomarkers Prev  18, 2860-8.   https://doi.org/10.1158/1055-9965.EPI-09-0591




PubMed



        
     
Free Article


 


PubMed ID 19843676
         Pubmed Central ID 2783292 


 



3.
Faupel-Badger JM, Fuhrman BJ, Xu X, Falk RT, Keefer LK, Veenstra TD, Hoover RN, Ziegler RG (2010). Comparison of liquid chromatography-tandem mass spectrometry, RIA, and ELISA methods for measurement of urinary estrogens. Cancer Epidemiol Biomarkers Prev  19, 292-300.   https://doi.org/10.1158/1055-9965.EPI-09-0643




PubMed



        
     
Free Article


 


PubMed ID 20056650
         Pubmed Central ID 2836837 


 



4.
Fuhrman BJ, Pfeiffer R, Xu X, Wu AH, Korde L, Gail MH, Keefer LK, Veenstra TD, Hoover RN, Ziegler RG (2009). Soy intake is associated with increased 2-hydroxylation and decreased 16alpha-hydroxylation of estrogens in Asian-American women. Cancer Epidemiol Biomarkers Prev  18, 2751-60.   https://doi.org/10.1158/1055-9965.EPI-09-0388




PubMed



        
     
Free Article


 


PubMed ID 19789363
         Pubmed Central ID 2759852 


 



5.
Fuhrman BJ, Xu X, Falk RT, Hankinson SE, Veenstra TD, Keefer LK, Ziegler RG (2010) Stability of Fifteen Estrogens and Estrogen Metabolites in Urine Samples under Processing and Storage Conditions Typically Used in Epidemiologic Studies. Int J Biol Markers 25:185-194




 



6.
Sue LY, Schairer C, Ma X, Williams C, Chang SC, Miller AB, McCarty CA, Willcox BJ, Ziegler RG (2009). Energy intake and risk of postmenopausal breast cancer: an expanded analysis in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) cohort. Cancer Epidemiol Biomarkers Prev  18, 2842-50.   https://doi.org/10.1158/1055-9965.EPI-09-0087




PubMed



        
     
Free Article


 


PubMed ID 19843674
         Pubmed Central ID 2783562 


 



7.
Ziegler RG, Faupel-Badger JM, Sue LY, Fuhrman BJ, Falk RT, Boyd-Morin J, Henderson MK, Hoover RN, Veenstra TD, Keefer LK, Xu X (2010). A new approach to measuring estrogen exposure and metabolism in epidemiologic studies. J Steroid Biochem Mol Biol  121, 538-45.   https://doi.org/10.1016/j.jsbmb.2010.03.068




PubMed



        
     
Free Article


 


PubMed ID 20382222
         Pubmed Central ID 6276800",https://intramural.nih.gov/search/searchview.taf?ipid=63522
706,CP010170-10,"October 01, 2009 -  September 30, 2010",Multidisciplinary Studies of Lymphoma,"Lindsay Mcomber Morton



IRP Faculty Profile
 




Patricia  Hartge; ScD",NULL,"Radiation Epidemiology Branch, NCI

Epidemiology and Biostatistics Program, NCI",Martha S Linet; PhD,"James  Cerhan
(Mayo Clinic)




Wendy  Cozen
(Norris Comprehensive Cancer Center)




Scott  Davis
(Fred Hutchinson Cancer Research Center)




Anneclaire  Roos
(Fred Hutchinson Cancer Center)




Maryjean  Schenk
(Barbara Karmanos Cancer Institute)




Richard  Severson
(Barbara Karmanos Cancer Institute)","Joanne S Colt (Occupational and Environmental Epidemiology Branch)



Shelia K Zahm; ScM, ScD (Office of the Director)



Aaron E Blair; PhD, MPH (Occupational and Environmental Epidemiology Branch)



Mary Helen Ward; MS, PhD (Occupational and Environmental Epidemiology Branch)



Nathaniel C Rothman; MD (Occupational and Environmental Epidemiology Branch)



Sophia S Wang; PhD (Infection & Immunoepidemiology Branch)",NULL,"Ordered by publication type and then author name.



1.
Abdou AM, Gao X, Cozen W, Cerhan JR, Rothman N, Martin MP, Davis S, Schenk M, Chanock SJ, Hartge P, Carrington M, Wang SS (2010). Human leukocyte antigen (HLA) A1-B8-DR3 (8.1) haplotype, tumor necrosis factor (TNF) G-308A, and risk of non-Hodgkin lymphoma. Leukemia  24, 1055-8.   https://doi.org/10.1038/leu.2010.17




PubMed



        
     
Free Article


 


PubMed ID 20147981
         Pubmed Central ID 4847717 


 



2.
Chang CM, Wang SS, Dave BJ, Jain S, Vasef MA, Weisenburger DD, Cozen W, Davis S, Severson RK, Lynch CF, Rothman N, Cerhan JR, Hartge P, Morton LM (2011). Risk factors for non-Hodgkin lymphoma subtypes defined by histology and t(14;18) in a population-based case-control study. Int J Cancer  129, 938-47.   https://doi.org/10.1002/ijc.25717




PubMed



        
     
Free Article


 


PubMed ID 20949561
         Pubmed Central ID 3125462 


 



3.
Colt JS, Rothman N, Severson RK, Hartge P, Cerhan JR, Chatterjee N, Cozen W, Morton LM, De Roos AJ, Davis S, Chanock S, Wang SS (2009). Organochlorine exposure, immune gene variation, and risk of non-Hodgkin lymphoma. Blood  113, 1899-905.   https://doi.org/10.1182/blood-2008-04-153858




PubMed



        
     
Free Article


 


PubMed ID 19066394
         Pubmed Central ID 2651009 


 



4.
De Roos AJ, Davis S, Colt JS, Blair A, Airola M, Severson RK, Cozen W, Cerhan JR, Hartge P, Nuckols JR, Ward MH (2010). Residential proximity to industrial facilities and risk of non-Hodgkin lymphoma. Environ Res  110, 70-8.   https://doi.org/10.1016/j.envres.2009.09.011




PubMed



        
     
Free Article


 


PubMed ID 19840879
         Pubmed Central ID 2795078 


 



5.
Morton LM, Purdue MP, Zheng T, Wang SS, Armstrong B, Zhang Y, Menashe I, Chatterjee N, Davis S, Lan Q, Vajdic CM, Severson RK, Holford TR, Kricker A, Cerhan JR, Leaderer B, Grulich A, Yeager M, Cozen W, Hoar Zahm S, Chanock SJ, Rothman N, Hartge P (2009). Risk of non-Hodgkin lymphoma associated with germline variation in genes that regulate the cell cycle, apoptosis, and lymphocyte development. Cancer Epidemiol Biomarkers Prev  18, 1259-70.   https://doi.org/10.1158/1055-9965.EPI-08-1037




PubMed



        
     
Free Article


 


PubMed ID 19336552
         Pubmed Central ID 2716008 


 



6.
Schenk M, Purdue MP, Colt JS, Hartge P, Blair A, Stewart P, Cerhan JR, De Roos AJ, Cozen W, Severson RK (2009). Occupation/industry and risk of non-Hodgkin's lymphoma in the United States. Occup Environ Med  66, 23-31.   https://doi.org/10.1136/oem.2007.036723




PubMed



        
     
Free Article


 


PubMed ID 18805886
         Pubmed Central ID 3051169 


 



7.
Turner JJ, Morton LM, Linet MS, Clarke CA, Kadin ME, Vajdic CM, Monnereau A, Maynadié M, Chiu BC, Marcos-Gragera R, Costantini AS, Cerhan JR, Weisenburger DD (2010). InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions. Blood  116, e90-8.   https://doi.org/10.1182/blood-2010-06-289561




PubMed



        
     
Free Article


 


PubMed ID 20699439
         Pubmed Central ID 2993636",https://intramural.nih.gov/search/searchview.taf?ipid=63518
707,CP010176-10,"October 01, 2009 -  September 30, 2010",Epidemiology and Natural History of Cancer-Associated Viruses,"Eric Andrew Engels; PhD



IRP Faculty Profile
 




James Jerome Goedert; MD

 


 

Barry Ira Graubard; PhD



IRP Faculty Profile
 


 

Thomas R O'Brien; BA, MPH, MD



IRP Faculty Profile
 


 

Ruth  Pfeiffer; PhD



IRP Faculty Profile
 


 

Philip Samuel Rosenberg; PhD



IRP Faculty Profile
 


 

Sam  Mbulaiteye



IRP Faculty Profile",NULL,"Infection & Immunoepidemiology Branch, NCI

Biostatistics Branch, NCI","Charles  Rabkin



Anil Kumar Chaturvedi","M  Eyster
(Pennsylvania State University)




Angelos  Hatzakis
(University of Athens Medical School)




Michael  Lederman; MD
(Case Western Reserve University)




Nino  Romano
(University of Palermo)




Cloe  Thio
(Dept of Medicine, Johns Hopkins University School of Medicine)




David  Thomas
(Johns Hopkins University)


Show all 7","Stephen J Chanock; MD, PhD (Laboratory Translational Genomics)",NULL,"Ordered by publication type and then author name.



1.
Bhatia K, Goedert JJ, Modali R, Preiss L, Ayers LW (2010). Merkel cell carcinoma subgroups by Merkel cell polyomavirus DNA relative abundance and oncogene expression. Int J Cancer  126, 2240-6.   https://doi.org/10.1002/ijc.24676




PubMed



        
     
Free Article


 


PubMed ID 19551862
         Pubmed Central ID 2908249 


 



2.
Bhatia K, Modali R, Goedert JJ (2010). Merkel cell polyomavirus is not detected in mesotheliomas. J Clin Virol  47, 196-8.   https://doi.org/10.1016/j.jcv.2009.11.019




PubMed



        
     
Free Article


 


PubMed ID 20006539
         Pubmed Central ID 2818524 


 



3.
Guech-Ongey M, Verboom M, Pfeiffer RM, Schulz TF, Ndugwa CM, Owor AM, Bakaki PM, Bhatia K, Figueiredo C, Eiz-Vesper B, Blasczyk R, Mbulaiteye SM (2010). HLA polymorphisms and detection of kaposi sarcoma-associated herpesvirus DNA in saliva and peripheral blood among children and their mothers in the uganda sickle cell anemia KSHV Study. Infect Agent Cancer  5, 21.   https://doi.org/10.1186/1750-9378-5-21




PubMed



        
     
Free Article


 


PubMed ID 21087485
         Pubmed Central ID 2995779 


 



4.
Mbulaiteye SM, Hisada M, El-Omar EM (2009). Helicobacter Pylori associated global gastric cancer burden. Front Biosci (Landmark Ed)  14, 1490-504.   https://doi.org/10.2741/3320




PubMed



        
     
Free Article


 


PubMed ID 19273142
         Pubmed Central ID 2654592",https://intramural.nih.gov/search/searchview.taf?ipid=63520
708,CP010180-09,"October 01, 2009 -  September 30, 2010",Prostate Cancer Studies,Ann  Hsing; PhD,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",Sabah  Quraishi,"Richard  Biritwum
(Univ of Ghana Medical School)




Peter  Carroll
(UCSF)




Chawnshang  Chang
(University of Rochester)




Chu  Chen
(University of Washington)




Streamson  Chua
(Columbia University)




Angelo  DeMarzo
(Johns Hopkins U)


Show all 15",NULL,NULL,"Ordered by publication type and then author name.



1.
Chu LW, Meyer TE, Li Q, Menashe I, Yu K, Rosenberg PS, Huang WY, Quraishi SM, Kaaks R, Weiss JM, Hayes RB, Chanock SJ, Hsing AW (2010). Association between genetic variants in the 8q24 cancer risk regions and circulating levels of androgens and sex hormone-binding globulin. Cancer Epidemiol Biomarkers Prev  19, 1848-54.   https://doi.org/10.1158/1055-9965.EPI-10-0101




PubMed



        
     
Free Article


 


PubMed ID 20551303
         Pubmed Central ID 2901401 


 



2.
Hoque A, Ambrosone CB, Till C, Goodman PJ, Tangen C, Kristal A, Lucia S, Wang Q, Kappil M, Thompson I, Hsing AW, Parnes H, Santella RM (2010). Serum oxidized protein and prostate cancer risk within the Prostate Cancer Prevention Trial. Cancer Prev Res (Phila)  3, 478-83.   https://doi.org/10.1158/1940-6207.CAPR-09-0201




PubMed



        
     
Free Article


 


PubMed ID 20332306
         Pubmed Central ID 2853720 


 



3.
Neuhouser ML, Till C, Kristal A, Goodman P, Hoque A, Platz EA, Hsing AW, Albanes D, Parnes HL, Pollak M (2010). Finasteride modifies the relation between serum C-peptide and prostate cancer risk: results from the Prostate Cancer Prevention Trial. Cancer Prev Res (Phila)  3, 279-89.   https://doi.org/10.1158/1940-6207.CAPR-09-0188




PubMed



        
     
Free Article


 


PubMed ID 20179296
         Pubmed Central ID 3846551 


 



4.
Platz EA, Till C, Goodman PJ, Parnes HL, Figg WD, Albanes D, Neuhouser ML, Klein EA, Thompson IM, Kristal AR (2009). Men with low serum cholesterol have a lower risk of high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev  18, 2807-13.   https://doi.org/10.1158/1055-9965.EPI-09-0472




PubMed



        
     
Free Article


 


PubMed ID 19887582
         Pubmed Central ID 2877916 


 



5.
Sutcliffe S, Viscidi RP, Till C, Goodman PJ, Hoque AM, Hsing AW, Thompson IM, Zenilman JM, De Marzo AM, Platz EA (2010). Human papillomavirus types 16, 18, and 31 serostatus and prostate cancer risk in the Prostate Cancer Prevention Trial. Cancer Epidemiol Biomarkers Prev  19, 614-8.   https://doi.org/10.1158/1055-9965.EPI-09-1080




PubMed



        
     
Free Article


 


PubMed ID 20142255
         Pubmed Central ID 2820385 


 



6.
Zheng SL, Hsing AW, Sun J, Chu LW, Yu K, Li G, Gao Z, Kim ST, Isaacs WB, Shen MC, Gao YT, Hoover RN, Xu J (2010). Association of 17 prostate cancer susceptibility loci with prostate cancer risk in Chinese men. Prostate  70, 425-32.   https://doi.org/10.1002/pros.21076




PubMed



        
     
Free Article


 


PubMed ID 19866473
         Pubmed Central ID 3078699",https://intramural.nih.gov/search/searchview.taf?ipid=63538
709,CP010181-08,"October 01, 2009 -  September 30, 2010",Methods for Epidemiology Studies,"Mitchell Henry Gail; PhD, MD



IRP Faculty Profile
 


 

Barry Ira Graubard; PhD



IRP Faculty Profile
 


 

Hormuzdiar Aspandiar Katki; MS



IRP Faculty Profile
 




Jay  Lubin; PhD

 


 

Ruth  Pfeiffer; PhD



IRP Faculty Profile
 


 

Philip Samuel Rosenberg; PhD



IRP Faculty Profile
 


 

Sholom  Wacholder; PhD



IRP Faculty Profile
 


 

Kai  Yu



IRP Faculty Profile
 




Nilanjan  Chatterjee",NULL,"Biostatistics Branch, NCI","Junmo  Nam







Joshua Neil Sampson




Jianxin  Shi","Efstathia  Bura
(The George Washington University, Washington, DC)




Raymond  Carroll
(Texas A&M University)




Sarah  Daugherty
(Occupational and Environmental Epidemiology Branch, DCEG, NCI)




Laure  El Ghormli
(GW Biostat)




Katherine  Flegal
(Centers for Disease Control and Prevention)




Kari  Hemminki; PhD
(Department of Biosciences, Karolinska Institute)


Show all 15","Thomas  Fears; PhD (Genetic Epidemiology Branch)



Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)



Edward L Korn (Clinical Trials Section)



Stephen J Chanock; MD, PhD (Laboratory Translational Genomics)



Montserrat  Garcia-Closas; MD, PhD (Hormonal and Reproductive Epidemiology Branch)



Eric Andrew Engels; PhD (Infection & Immunoepidemiology Branch)",NULL,"Ordered by publication type and then author name.



1.
Alexander S, Umlauf N, Pfeiffer R, Lang S (2010) Comparing Penalized Splines and Fractional Polynomials as Smoothing Techniques for Flexible Modeling the Effect of Continuous Predictor Values. COMPUT STAT DATA AN 55:1540-51




 



2.
Chatterjee N (2009) Analysis of Case-Control Association Studies: SNPs, Imputation and Haplotypes. Statistical Science 24:489-502.




 



3.
Chatterjee N, Li Y (2010) Inference in Semiparametric Regression Models under Partial Questionnaire Design and Nonmonotone Missing Data. J AM STAT ASSOC 105:787-797




 



4.
Chatterjee N, Sinha S, Feigelson H (2010) Analysis of cohort studies with multivariate and partially observed disease classification data. BIOMETRIKA 3:683-698




 



5.
Chatterjee N, Sinha S, Feigelson H (2010) Analysis of cohort studies with multivariate and partially observed disease classification data. BIOMETRIKA 3:683-698




 



6.
Gail MH (2009). Value of adding single-nucleotide polymorphism genotypes to a breast cancer risk model. J Natl Cancer Inst  101, 959-63.   https://doi.org/10.1093/jnci/djp130




PubMed



        
     
Free Article


 


PubMed ID 19535781
         Pubmed Central ID 2704229 


 



7.
Gilbert ES (2009). Ionising radiation and cancer risks: what have we learned from epidemiology? Int J Radiat Biol  85, 467-82.   https://doi.org/10.1080/09553000902883836




PubMed



        
     
Free Article


 


PubMed ID 19401906
         Pubmed Central ID 2859619 


 



8.
Graubard B (2009) Response to Biased Corrections or Biased About Corrections. OBESITY (Silver Spring) 17:940.




 



9.
Katki HA, Sanders CL, Graubard BI, Bergen AW (2010). Using DNA fingerprints to infer familial relationships within NHANES III households. J Am Stat Assoc  105, 552-563.   https://doi.org/10.1198/jasa.2010.ap09258




PubMed



        
     
Free Article


 


PubMed ID 20664713
         Pubmed Central ID 2909633 


 



10.
Katki HA, Wacholder S, Solomon D, Castle PE, Schiffman M (2009). Risk estimation for the next generation of prevention programmes for cervical cancer. Lancet Oncol  10, 1022-3.   https://doi.org/10.1016/S1470-2045(09)70253-0




PubMed



        
     
Free Article


 


PubMed ID 19767237
         Pubmed Central ID 2789459 


 



11.
Khoury MJ, Wacholder S (2009). Invited commentary: from genome-wide association studies to gene-environment-wide interaction studies--challenges and opportunities. Am J Epidemiol  169, 227-30; discussion 234-5.   https://doi.org/10.1093/aje/kwn351




PubMed



        
     
Free Article


 


PubMed ID 19022826
         Pubmed Central ID 2727257 


 



12.
Li H, Gail MH, Berndt S, Chatterjee N (2010). Using cases to strengthen inference on the association between single nucleotide polymorphisms and a secondary phenotype in genome-wide association studies. Genet Epidemiol  34, 427-33.   https://doi.org/10.1002/gepi.20495




PubMed



        
     
Free Article


 


PubMed ID 20583284
         Pubmed Central ID 2918520 


 



13.
Li H, Graubard BI, Gail MH (2010). Covariate adjustment and ranking methods to identify regions with high and low mortality rates. Biometrics  66, 613-20.   https://doi.org/10.1111/j.1541-0420.2009.01284.x




PubMed



        
     
Free Article


 


PubMed ID 19508235
         Pubmed Central ID 2889169 


 



14.
Li Q, Wacholder S, Hunter DJ, Hoover RN, Chanock S, Thomas G, Yu K (2009). Genetic background comparison using distance-based regression, with applications in population stratification evaluation and adjustment. Genet Epidemiol  33, 432-41.   https://doi.org/10.1002/gepi.20396




PubMed



        
     
Free Article


 


PubMed ID 19140130
         Pubmed Central ID 2706300 


 



15.
Li Q, Zhang H, Yu K (2010). Approaches for evaluating rare polymorphisms in genetic association studies. Hum Hered  69, 219-28.   https://doi.org/10.1159/000291927




PubMed



        
     
Free Article


 


PubMed ID 20332646
         Pubmed Central ID 2889258 


 



16.
Li Q, Zheng G, Liang X, Yu K (2009). Robust tests for single-marker analysis in case-control genetic association studies. Ann Hum Genet  73, 245-52.   https://doi.org/10.1111/j.1469-1809.2009.00506.x




PubMed



        
     
Free Article


 


PubMed ID 19208106
         Pubmed Central ID 5742554 


 



17.
Li Q, Zheng G, Liu A, Xiong S, Li Z, Yu K (2010) The limiting bound of Efron's W-formula for hypothesis testing when a nuisance parameter is present only under the alternative. Journal of Statistical Planning and Inference 140:1610-17




 



18.
Li Q, Zheng G, Liu A, Xiong S, Li Z, Yu K (2010) The limiting bound of Efron's W-formula for hypothesis testing when a nuisance parameter is present only under the alternative. Journal of Statistical Planning and Inference 140:1610-17




 



19.
Little MP, Wakeford R, Lubin JH, Kendall GM (2010). The statistical power of epidemiological studies analyzing the relationship between exposure to ionizing radiation and cancer, with special reference to childhood leukemia and natural background radiation. Radiat Res  174, 387-402.   https://doi.org/10.1667/RR2110.1




PubMed



        
     
Free Article


 


PubMed ID 20726729
         Pubmed Central ID 3967863 


 



20.
Luo S, Mukherjee B, Chen J, Chatterjee N (2009). Shrinkage estimation for robust and efficient screening of single-SNP association from case-control genome-wide association studies. Genet Epidemiol  33, 740-50.   https://doi.org/10.1002/gepi.20428




PubMed



        
     
Free Article


 


PubMed ID 19434716
         Pubmed Central ID 3103068 


 



21.
Milano MT, Li H, Gail MH, Constine LS, Travis LB (2010). Long-term survival among patients with Hodgkin's lymphoma who developed breast cancer: a population-based study. J Clin Oncol  28, 5088-96.   https://doi.org/10.1200/JCO.2010.29.5683




PubMed



        
     
Free Article


 


PubMed ID 20975072
         Pubmed Central ID 3018358 


 



22.
Mukherjee B, Ahn J, Gruber SB, Ghosh M, Chatterjee N (2010). Case-control studies of gene-environment interaction: Bayesian design and analysis. Biometrics  66, 934-48.   https://doi.org/10.1111/j.1541-0420.2009.01357.x




PubMed



        
     
Free Article


 


PubMed ID 19930190
         Pubmed Central ID 3103064 


 



23.
Pfeiffer R, Gail M, Pee D (2010) On combining data from genome-wide association studies to discover disease-associated SNPs. Statistical Science 24:547-560




 



24.
Pfeiffer R, Gail M, Pee D (2010) On combining data from genome-wide association studies to discover disease-associated SNPs. Statistical Science 24:547-560




 



25.
Rosenberg PS, Menashe I, Jatoi I, Anderson WF (2010). Re: Racial disparities in cancer survival among randomized clinical trials of the Southwest Oncology Group. J Natl Cancer Inst  102, 277; author reply 280-2.   https://doi.org/10.1093/jnci/djp510




PubMed



        
     
Free Article


 


PubMed ID 20075363
         Pubmed Central ID 2826181 


 



26.
Strasak A, Umlauf N, Pfeiffer R, Lang S (2010) Comparing Penalized Splines and Fractional Polynomials as Smoothing Techniques for Flexible Modeling the Effect of Continuous Predictor Values. COMPUT STAT DATA AN 55:1540-51




 



27.
Wacholder S, Hartge P, Prentice R, Garcia-Closas M, Feigelson HS, Diver WR, Thun MJ, Cox DG, Hankinson SE, Kraft P, Rosner B, Berg CD, Brinton LA, Lissowska J, Sherman ME, Chlebowski R, Kooperberg C, Jackson RD, Buckman DW, Hui P, Pfeiffer R, Jacobs KB, Thomas GD, Hoover RN, Gail MH, et al. [2 more authors] (2010). Performance of common genetic variants in breast-cancer risk models. N Engl J Med  362, 986-93.   https://doi.org/10.1056/NEJMoa0907727




PubMed



        
     
Free Article


 


PubMed ID 20237344
         Pubmed Central ID 2921181 


 



28.
Yu K (2009) Inference of non-centrality parameter of a truncated non-central chi-squared distribution. J Stat Plan Inference 139:2431-2444.




 



29.
Yu K, Li Q, Bergen AW, Pfeiffer RM, Rosenberg PS, Caporaso N, Kraft P, Chatterjee N (2009). Pathway analysis by adaptive combination of P-values. Genet Epidemiol  33, 700-9.   https://doi.org/10.1002/gepi.20422




PubMed



        
     
Free Article


 


PubMed ID 19333968
         Pubmed Central ID 2790032 


 



30.
Zhang H, Olschwang S, Yu K (2010). Statistical inference on the penetrances of rare genetic mutations based on a case-family design. Biostatistics  11, 519-32.   https://doi.org/10.1093/biostatistics/kxq009




PubMed



        
     
Free Article


 


PubMed ID 20179148
         Pubmed Central ID 2883298",https://intramural.nih.gov/search/searchview.taf?ipid=63488
710,CP010182-08,"October 01, 2009 -  September 30, 2010",Epidemiologic Field Studies,"Nilanjan  Chatterjee

 


 

Barry Ira Graubard; PhD



IRP Faculty Profile
 




Jay  Lubin; PhD

 


 

Ruth  Pfeiffer; PhD



IRP Faculty Profile
 


 

Mitchell Henry Gail; PhD, MD



IRP Faculty Profile",NULL,"Biostatistics Branch, NCI",Catherine G Schairer,"Farhat  Ayed
(Institute Salah Azaiz, Tunis)




Robert  Chamberlain
(M.D. Anderson Cancer Center)




Paul  Levine
(George Washington U)




Donghui  Li
(M.D. Anderson Cancer Center)




Sherif  Omar
(National Cancer Institute, Cairo, Egypt)




Amr  Soliman
(M.D. Anderson Cancer Center)


Show all 9","Joseph  Fraumeni; MD (Office of the Director)



Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)",NULL,"Ordered by publication type and then author name.



1.
Danforth KN, Schairer C, Schatzkin A, Lacey JV (2009). Bone fractures and incident epithelial ovarian cancer in a prospective cohort study. J Womens Health (Larchmt)  18, 1777-82.   https://doi.org/10.1089/jwh.2008.1341




PubMed



        
     
Free Article


 


PubMed ID 19951211
         Pubmed Central ID 2828254 


 



2.
Johnson JR, Lacey JV, Lazovich D, Geller MA, Schairer C, Schatzkin A, Flood A (2009). Menopausal hormone therapy and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev  18, 196-203.   https://doi.org/10.1158/1055-9965.EPI-08-0596




PubMed



        
     
Free Article


 


PubMed ID 19124498
         Pubmed Central ID 2644901",https://intramural.nih.gov/search/searchview.taf?ipid=63526
711,CP010183-08,"October 01, 2009 -  September 30, 2010",Descriptive Studies and Record Linkage,William Frederick Anderson,NULL,"Biostatistics Branch, NCI","Nilanjan  Chatterjee



Mitchell Henry Gail; PhD, MD



Jay  Lubin; PhD



Ruth  Pfeiffer; PhD



Philip Samuel Rosenberg; PhD



Catherine G Schairer



Show all 7","Hans-Olov  Adami
(Karolinska Institute)




Johanna  Adami
(Karolinska Institute)




Johan  Askling
(Karolinska Institute)




Paolo  Boffetta
(International Agency for Research on Cancer)




Paige  Bracci
(UCSF)




Leslie  Carroll
(Information Management Services, Inc)


Show all 28","Dalsu  Baris (Occupational and Environmental Epidemiology Branch)



Louise  Brinton; PhD (Hormonal and Reproductive Epidemiology Branch)



Neil Edward Caporaso; MS, MD (Genetic Epidemiology Branch)



Wong H Chow (Occupational and Environmental Epidemiology Branch)



Rochelle E Curtis (Radiation Epidemiology Branch)



Eric Andrew Engels; PhD (Infection & Immunoepidemiology Branch)",NULL,"Ordered by publication type and then author name.



1.
Silverman D (2010) Identification of research needs to resolve the carcinogenicity of high-priority IARC carcinogens, in IARC Technical Publication., pp. 00.




 



2.
Anderson WF, Jatoi I, Sherman ME (2009). Qualitative age interactions in breast cancer studies: mind the gap. J Clin Oncol  27, 5308-11.   https://doi.org/10.1200/JCO.2009.22.9450




PubMed



        
     
Free Article


 


PubMed ID 19826117
         Pubmed Central ID 2773215 


 



3.
Atchison EA, Gridley G, Carreon JD, Leitzmann MF, McGlynn KA (2011). Risk of cancer in a large cohort of U.S. veterans with diabetes. Int J Cancer  128, 635-43.   https://doi.org/10.1002/ijc.25362




PubMed



        
     
Free Article


 


PubMed ID 20473855
         Pubmed Central ID 2962873 


 



4.
Brinton LA, Carreon JD, Gierach GL, McGlynn KA, Gridley G (2010). Etiologic factors for male breast cancer in the U.S. Veterans Affairs medical care system database. Breast Cancer Res Treat  119, 185-92.   https://doi.org/10.1007/s10549-009-0379-0




PubMed



        
     
Free Article


 


PubMed ID 19330525
         Pubmed Central ID 2807736 


 



5.
Flegal K, Graubard B, Williamson D, Cooper R (2010) Reverse Causation and Illness-related Weight Loss in Observational Studies of Body Weight and Mortality. AM J EPIDEMIOL 173:1-9




 



6.
Graubard BI, Freedman AN, Gail MH (2010). Five-year and lifetime risk of breast cancer among U.S. subpopulations: implications for magnetic resonance imaging screening. Cancer Epidemiol Biomarkers Prev  19, 2430-6.   https://doi.org/10.1158/1055-9965.EPI-10-0324




PubMed



               Available in future as a Free Article 


 


PubMed ID 20841391
         Pubmed Central ID 2952062 


 



7.
Gravitt P, Paul P, Katki H, Vendantham H, Ramakrishna G, Sudula M, Kalpana B, Ronnett B, Vijayaraghavan K, Shah K (2010) Effectiveness of VIA, Pap, and HPV DNA testing in a cervical cancer screening program in a peri-urban community in Andhra Pradesh, India. PLOS ONE 5:e13711




 



8.
Katherine F, Graubard B, Williamson D, Cooper R (2010) Reverse Causation and Illness-related Weight Loss in Observational Studies of Body Weight and Mortality. AM J EPIDEMIOL 173:1-9




 



9.
Kilfoy BA, Devesa SS, Ward MH, Zhang Y, Rosenberg PS, Holford TR, Anderson WF (2009). Gender is an age-specific effect modifier for papillary cancers of the thyroid gland. Cancer Epidemiol Biomarkers Prev  18, 1092-100.   https://doi.org/10.1158/1055-9965.EPI-08-0976




PubMed



        
     
Free Article


 


PubMed ID 19293311
         Pubmed Central ID 2667567 


 



10.
Kristinsson SY, Pfeiffer RM, Björkholm M, Goldin LR, Schulman S, Blimark C, Mellqvist UH, Wahlin A, Turesson I, Landgren O (2010). Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study. Blood  115, 4991-8.   https://doi.org/10.1182/blood-2009-11-252072




PubMed



        
     
Free Article


 


PubMed ID 20299513
         Pubmed Central ID 2890150 


 



11.
Kristinsson SY, Tang M, Pfeiffer RM, Björkholm M, Blimark C, Mellqvist UH, Wahlin A, Turesson I, Landgren O (2010). Monoclonal gammopathy of undetermined significance and risk of skeletal fractures: a population-based study. Blood  116, 2651-5.   https://doi.org/10.1182/blood-2010-04-282848




PubMed



        
     
Free Article


 


PubMed ID 20610813
         Pubmed Central ID 3324256 


 



12.
Landgren O, Kyle RA, Pfeiffer RM, Katzmann JA, Caporaso NE, Hayes RB, Dispenzieri A, Kumar S, Clark RJ, Baris D, Hoover R, Rajkumar SV (2009). Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study. Blood  113, 5412-7.   https://doi.org/10.1182/blood-2008-12-194241




PubMed



        
     
Free Article


 


PubMed ID 19179464
         Pubmed Central ID 2689042 


 



13.
Lubin JH, Purdue M, Kelsey K, Zhang ZF, Winn D, Wei Q, Talamini R, Szeszenia-Dabrowska N, Sturgis EM, Smith E, Shangina O, Schwartz SM, Rudnai P, Neto JE, Muscat J, Morgenstern H, Menezes A, Matos E, Mates IN, Lissowska J, Levi F, Lazarus P, La Vecchia C, Koifman S, Herrero R, et al. [13 more authors] (2009). Total exposure and exposure rate effects for alcohol and smoking and risk of head and neck cancer: a pooled analysis of case-control studies. Am J Epidemiol  170, 937-47.   https://doi.org/10.1093/aje/kwp222




PubMed



        
     
Free Article


 


PubMed ID 19745021
         Pubmed Central ID 2800266 


 



14.
Menashe I, Anderson WF, Jatoi I, Rosenberg PS (2009). Underlying causes of the black-white racial disparity in breast cancer mortality: a population-based analysis. J Natl Cancer Inst  101, 993-1000.   https://doi.org/10.1093/jnci/djp176




PubMed



        
     
Free Article


 


PubMed ID 19584327
         Pubmed Central ID 2710374 


 



15.
Pfeiffer RM, Mitani A, Landgren O, Ekbom A, Kristinsson SY, Björkholm M, Biggar RJ, Brinton LA (2009). Timing of births and endometrial cancer risk in Swedish women. Cancer Causes Control  20, 1441-9.   https://doi.org/10.1007/s10552-009-9370-7




PubMed



        
     
Free Article


 


PubMed ID 19565342
         Pubmed Central ID 2843814 


 



16.
Rosenberg PS, Zeidler C, Bolyard AA, Alter BP, Bonilla MA, Boxer LA, Dror Y, Kinsey S, Link DC, Newburger PE, Shimamura A, Welte K, Dale DC (2010). Stable long-term risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapy. Br J Haematol  150, 196-9.   https://doi.org/10.1111/j.1365-2141.2010.08216.x




PubMed



        
     
Free Article


 


PubMed ID 20456363
         Pubmed Central ID 2906693 


 



17.
Strasak AM, Goebel G, Concin H, Pfeiffer RM, Brant LJ, Nagel G, Oberaigner W, Concin N, Diem G, Ruttmann E, Gruber-Moesenbacher U, Offner F, Pompella A, Pfeiffer KP, Ulmer H, VHM&PP Study Group (2010). Prospective study of the association of serum gamma-glutamyltransferase with cervical intraepithelial neoplasia III and invasive cervical cancer. Cancer Res  70, 3586-93.   https://doi.org/10.1158/0008-5472.CAN-09-3197




PubMed



        
     
Free Article


 


PubMed ID 20388786
         Pubmed Central ID 5911687 


 



18.
Wu H, Rusiecki JA, Zhu K, Potter J, Devesa SS (2009). Stomach carcinoma incidence patterns in the United States by histologic type and anatomic site. Cancer Epidemiol Biomarkers Prev  18, 1945-52.   https://doi.org/10.1158/1055-9965.EPI-09-0250




PubMed



        
     
Free Article


 


PubMed ID 19531677
         Pubmed Central ID 2786772 


 



19.
Yu K, Li Q, Bergen AW, Pfeiffer RM, Rosenberg PS, Caporaso N, Kraft P, Chatterjee N (2009). Pathway analysis by adaptive combination of P-values. Genet Epidemiol  33, 700-9.   https://doi.org/10.1002/gepi.20422




PubMed



        
     
Free Article


 


PubMed ID 19333968
         Pubmed Central ID 2790032",https://intramural.nih.gov/search/searchview.taf?ipid=63487
712,CP010184-08,"October 01, 2009 -  September 30, 2010",Consultation and Collaboration,"Jay  Lubin; PhD

 


 

Sholom  Wacholder; PhD



IRP Faculty Profile
 


 

Barry Ira Graubard; PhD



IRP Faculty Profile",NULL,"Biostatistics Branch, NCI","Nilanjan  Chatterjee



Mitchell Henry Gail; PhD, MD



Junmo  Nam



Ruth  Pfeiffer; PhD","Paul  Bakaki
(Makerere University Medical School and Mulago Hospital, Kampala, Uganda)




A.  Barrett
(National Heart, Lung, and Blood Institute)




Eleuterio  Bravo-Otero
(University of Puerto Rico)




David  Brenner
(Columbia University)




Robert  Burk
(Albert Einstein College of Medicine)




Julianne  Byrne
(Washington Children's hospital)


Show all 84","Michael  Alavanja; PhD (Occupational and Environmental Epidemiology Branch)



Aaron E Blair; PhD, MPH (Occupational and Environmental Epidemiology Branch)



Philip E Castle; PhD, MPH (Hormonal and Reproductive Epidemiology Branch)



Wong H Chow (Occupational and Environmental Epidemiology Branch)



Joanne S Colt (Occupational and Environmental Epidemiology Branch)



Michele M Doody; MS (Radiation Epidemiology Branch)","Harvey J Alter; MD (CC) 



Jane  Hoppin; ScD (NIEHS) 



Joni L Rutter (NIDA) 



Dale  Sandler; PhD (NIEHS) 



Jeffery P Struewing; MS, MD (NHGRI) 



Clarice  Weinberg; PhD (NIEHS)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63528
713,CP010185-08,"October 01, 2009 -  September 30, 2010",Biodefense Project,"Martha S Linet; PhD



IRP Faculty Profile",NULL,"Radiation Epidemiology Branch, NCI","Nickolas  Luckyanov



Elaine  Ron; PhD



Andre  Bouville



Alice  Sigurdson; PhD



Vladimir  Drozdovitch



Steven L Simon","Harold  Beck
(DOE Environmental Measurements Laboratory (retired))




Victor  Kryuchkov
(Institute of Biophysics)




Sergey  Shinkarev
(Moscow Institute of Biophysics)




Sergey  Sholom
(URPI)




Nikolai  Talerko
(Scientific Center of Radiation Medicine, Ukraine)




Eduardo  Yukihara
(Oklahoma State University)",NULL,NULL,"Ordered by publication type and then author name.



1.
Dewitt R, Klein DM, Yukihara EG, Simon SL, McKeever SW (2010). Optically stimulated luminescence (OSL) of tooth enamel and its potential use in post-radiation exposure triage. Health Phys  98, 432-9.   https://doi.org/10.1097/01.HP.0000347997.57654.17




PubMed



        
     
Free Article


 


PubMed ID 20065717
         Pubmed Central ID 2808129 


 



2.
Ibrahim SA, Simon SL, Bouville A, Melo D, Beck HL (2010). Alimentary tract absorption (f1 values) for radionuclides in local and regional fallout from nuclear tests. Health Phys  99, 233-51.   https://doi.org/10.1097/HP.0b013e3181b186ff




PubMed



        
     
Free Article


 


PubMed ID 20622554
         Pubmed Central ID 2913585 


 



3.
Land C, Bouville A, Apostoaie I, Simon S (2010) Projected lifetime cancer risks from exposure to local radioactive fallout in the Marshall Islands. Health Physics 99:201-15




 



4.
Land CE, Bouville A, Apostoaei I, Simon SL (2010). Projected lifetime cancer risks from exposure to regional radioactive fallout in the Marshall Islands. Health Phys  99, 201-15.   https://doi.org/10.1097/HP.0b013e3181dc4e84




PubMed



        
     
Free Article


 


PubMed ID 20622551
         Pubmed Central ID 3892964 


 



5.
Moroz BE, Beck HL, Bouville A, Simon SL (2010). Predictions of dispersion and deposition of fallout from nuclear testing using the NOAA-HYSPLIT meteorological model. Health Phys  99, 252-69.   https://doi.org/10.1097/HP.0b013e3181b43697




PubMed



        
     
Free Article


 


PubMed ID 20622555
         Pubmed Central ID 3864125 


 



6.
Simon S, Bouville A, Land C, Beck H (2010) Radiation doses and cancer risks in the Marshall Islands associated with exposure to fallout from Bikini and Enewetak nuclear weapons tests: summary. Health Physics 99:105-23




 



7.
Simon SL, Bouville A, Land CE, Beck HL (2010). Radiation doses and cancer risks in the Marshall Islands associated with exposure to radioactive fallout from Bikini and Enewetak nuclear weapons tests: summary. Health Phys  99, 105-23.   https://doi.org/10.1097/HP.0b013e3181dc523c




PubMed



        
     
Free Article


 


PubMed ID 20622547
         Pubmed Central ID 4042840",https://intramural.nih.gov/search/searchview.taf?ipid=63527
714,CP010187-06,"October 01, 2009 -  September 30, 2010",Cancer Genetic Markers of Susceptibility,"Stephen J Chanock; MD, PhD



IRP Faculty Profile
 


 

Mark  Purdue



IRP Faculty Profile
 


 

Nathaniel C Rothman; MD



IRP Faculty Profile
 


 

Margaret Anne Tucker



IRP Faculty Profile
 


 

Robert  Hoover; MD, ScD



IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI

Epidemiology and Biostatistics Program, NCI

Laboratory Translational Genomics, NCI

Human Genetics Program, NCI",NULL,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Chanock S (2009). High marks for GWAS. Nat Genet  41, 765-6.   https://doi.org/10.1038/ng0709-765




PubMed



        
     
Free Article


 


PubMed ID 19557077
         Pubmed Central ID 6310064 


 



2.
Wacholder S (2009). Bias in full cohort and nested case-control studies? Epidemiology  20, 339-40.   https://doi.org/10.1097/EDE.0b013e31819ec966




PubMed



        
     
Free Article


 


PubMed ID 19289961
         Pubmed Central ID 2774111",https://intramural.nih.gov/search/searchview.taf?ipid=63536
715,CP010188-06,"October 01, 2009 -  September 30, 2010",Risk prediction methods,"Barry Ira Graubard; PhD



IRP Faculty Profile
 


 

Mark H Greene; MD



IRP Faculty Profile
 




Patricia  Hartge; ScD

 


 

Robert  Hoover; MD, ScD



IRP Faculty Profile
 


 

Hormuzdiar Aspandiar Katki; MS



IRP Faculty Profile
 


 

Ruth  Pfeiffer; PhD



IRP Faculty Profile
 


 

Sholom  Wacholder; PhD



IRP Faculty Profile
 


 

Mitchell Henry Gail; PhD, MD



IRP Faculty Profile",NULL,"Biostatistics Branch, NCI

Epidemiology and Biostatistics Program, NCI

Clinical Genetics Branch, NCI","Catherine G Schairer



Ju-Hyun  Park","Garnet  Anderson
(WHI Clinical Coordinating Center)




Heather  Feigelson
(American Cancer Society)




David  Hunter
(Harvard School of Public Health)




Ross  Prentice
(Fred Hutchinson Cancer Research Center)","Andrew  Freedman (Risk Factor Monitoring and Methods Branch)



Demetrius  Albanes; MD (Nutritional Epidemiology Branch)



Kathleen A Cronin (Statistical Research and Applications Branch)



Yikyung  Park (Nutritional Epidemiology Branch)



Sara  Schonfeld (Radiation Epidemiology Branch)",NULL,"Ordered by publication type and then author name.



1.
Pfeiffer RM, Gail MH (2011). Two criteria for evaluating risk prediction models. Biometrics  67, 1057-65.   https://doi.org/10.1111/j.1541-0420.2010.01523.x




PubMed



        
     
Free Article


 


PubMed ID 21155746
         Pubmed Central ID 3135785",https://intramural.nih.gov/search/searchview.taf?ipid=63530
716,CP010190-05,"October 01, 2009 -  September 30, 2010",Genetic Epidemiology of Telomere Maintenance and Cancer Etiology,"Mark H Greene; MD



IRP Faculty Profile
 


 

Sharon Ann Savage



IRP Faculty Profile",NULL,"Clinical Genetics Branch, NCI",Lisa  Mirabello,"Steven  Artandi
(Stanford University)




Alison  Bertuch; MD, PhD
(Pediatrics, Baylor College of Medicine)




Richard  Cawthon
(University of Utah)




Immaculata  DeVivo
(Harvard Medical School)




David  Hunter
(Harvard School of Public Health)




Davide  Ruggero
(University of California San Francisco)


Show all 7",Shahinaz M Gadalla (Office Of The Director),NULL,"Ordered by publication type and then author name.



1.
Hou L, Savage SA, Blaser MJ, Perez-Perez G, Hoxha M, Dioni L, Pegoraro V, Dong LM, Zatonski W, Lissowska J, Chow WH, Baccarelli A (2009). Telomere length in peripheral leukocyte DNA and gastric cancer risk. Cancer Epidemiol Biomarkers Prev  18, 3103-9.   https://doi.org/10.1158/1055-9965.EPI-09-0347




PubMed



        
     
Free Article


 


PubMed ID 19861514
         Pubmed Central ID 2938741 


 



2.
Mirabello L, Huang WY, Wong JY, Chatterjee N, Reding D, Crawford ED, De Vivo I, Hayes RB, Savage SA (2009). The association between leukocyte telomere length and cigarette smoking, dietary and physical variables, and risk of prostate cancer. Aging Cell  8, 405-13.   https://doi.org/10.1111/j.1474-9726.2009.00485.x




PubMed



        
     
Free Article


 


PubMed ID 19493248
         Pubmed Central ID 2742954 


 



3.
Savage S (2009) Dyskeratosis Congenita. GeneReviews na:na.




 



4.
Savage S (2009) Dyskeratosis Congenita. Hematol Oncol Clin North Am 23:215-31.




 



5.
Savage SA, Alter BP (2009). Dyskeratosis congenita. Hematol Oncol Clin North Am  23, 215-31.   https://doi.org/10.1016/j.hoc.2009.01.003




PubMed



        
     
Free Article


 


PubMed ID 19327580
         Pubmed Central ID 2702847",https://intramural.nih.gov/search/searchview.taf?ipid=63539
717,CP010192-03,"October 01, 2009 -  September 30, 2010","Biorepository Processing, Storage, and Research","Shelia K Zahm; ScM, ScD",NULL,"Office of the Director, NCI",Marianne  Henderson,NULL,NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=63546
718,CP010193-04,"October 01, 2009 -  September 30, 2010",Whole Genome Scan for Pancreatic Cancer Risk in the Pancreatic Cancer Cohort Con,"Stephen J Chanock; MD, PhD



IRP Faculty Profile
 




Patricia  Hartge; ScD

 


 

Robert  Hoover; MD, ScD



IRP Faculty Profile
 


 

Rachael Zoe Solomon



IRP Faculty Profile",NULL,"Nutritional Epidemiology Branch, NCI

Epidemiology and Biostatistics Program, NCI

Laboratory Translational Genomics, NCI",Julie  Mendelsohn,"Alan  Arslan
(NYU)




Paige  Bracci
(UCSF)




H  Bueno-de-Mesquita
(Dept of Chronic Dis Epidemiology, Natl Inst for Pub Health and the Environ)




E  Duell
(Dartmouth Medical School, Norris Cotton Cancer Center)




Charles  Fuchs
(Harvard)




Steve  Gallinger
(MSHRI)


Show all 17","Geoffrey Scott Tobias (Human Genetics Program)



Kai  Yu (Biostatistics Branch)",NULL,"Ordered by publication type and then author name.



1.
Arslan AA, Helzlsouer KJ, Kooperberg C, Shu XO, Steplowski E, Bueno-de-Mesquita HB, Fuchs CS, Gross MD, Jacobs EJ, Lacroix AZ, Petersen GM, Stolzenberg-Solomon RZ, Zheng W, Albanes D, Amundadottir L, Bamlet WR, Barricarte A, Bingham SA, Boeing H, Boutron-Ruault MC, Buring JE, Chanock SJ, Clipp S, Gaziano JM, Giovannucci EL, Pancreatic Cancer Cohort Consortium (PanScan), et al. [26 more authors] (2010). Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). Arch Intern Med  170, 791-802.   https://doi.org/10.1001/archinternmed.2010.63




PubMed



        
     
Free Article


 


PubMed ID 20458087
         Pubmed Central ID 2920035 


 



2.
Jacobs EJ, Chanock SJ, Fuchs CS, Lacroix A, McWilliams RR, Steplowski E, Stolzenberg-Solomon RZ, Arslan AA, Bueno-de-Mesquita HB, Gross M, Helzlsouer K, Petersen G, Zheng W, Agalliu I, Allen NE, Amundadottir L, Boutron-Ruault MC, Buring JE, Canzian F, Clipp S, Dorronsoro M, Gaziano JM, Giovannucci EL, Hankinson SE, Hartge P, et al. [24 more authors] (2010). Family history of cancer and risk of pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). Int J Cancer  127, 1421-8.   https://doi.org/10.1002/ijc.25148




PubMed



        
     
Free Article


 


PubMed ID 20049842
         Pubmed Central ID 2926939 


 



3.
Lynch SM, Vrieling A, Lubin JH, Kraft P, Mendelsohn JB, Hartge P, Canzian F, Steplowski E, Arslan AA, Gross M, Helzlsouer K, Jacobs EJ, LaCroix A, Petersen G, Zheng W, Albanes D, Amundadottir L, Bingham SA, Boffetta P, Boutron-Ruault MC, Chanock SJ, Clipp S, Hoover RN, Jacobs K, Johnson KC, et al. [19 more authors] (2009). Cigarette smoking and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Am J Epidemiol  170, 403-13.   https://doi.org/10.1093/aje/kwp134




PubMed



        
     
Free Article


 


PubMed ID 19561064
         Pubmed Central ID 2733861 


 



4.
Michaud DS, Vrieling A, Jiao L, Mendelsohn JB, Steplowski E, Lynch SM, Wactawski-Wende J, Arslan AA, Bas Bueno-de-Mesquita H, Fuchs CS, Gross M, Helzlsouer K, Jacobs EJ, Lacroix A, Petersen G, Zheng W, Allen N, Ammundadottir L, Bergmann MM, Boffetta P, Buring JE, Canzian F, Chanock SJ, Clavel-Chapelon F, Clipp S, et al. [29 more authors] (2010). Alcohol intake and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium (PanScan). Cancer Causes Control  21, 1213-25.   https://doi.org/10.1007/s10552-010-9548-z




PubMed



        
     
Free Article


 


PubMed ID 20373013
         Pubmed Central ID 3098295 


 



5.
Petersen GM, Amundadottir L, Fuchs CS, Kraft P, Stolzenberg-Solomon RZ, Jacobs KB, Arslan AA, Bueno-de-Mesquita HB, Gallinger S, Gross M, Helzlsouer K, Holly EA, Jacobs EJ, Klein AP, LaCroix A, Li D, Mandelson MT, Olson SH, Risch HA, Zheng W, Albanes D, Bamlet WR, Berg CD, Boutron-Ruault MC, Buring JE, et al. [48 more authors] (2010). A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet  42, 224-8.   https://doi.org/10.1038/ng.522




PubMed



        
     
Free Article


 


PubMed ID 20101243
         Pubmed Central ID 2853179 


 



6.
Wolpin BM, Kraft P, Gross M, Helzlsouer K, Bueno-de-Mesquita HB, Steplowski E, Stolzenberg-Solomon RZ, Arslan AA, Jacobs EJ, Lacroix A, Petersen G, Zheng W, Albanes D, Allen NE, Amundadottir L, Anderson G, Boutron-Ruault MC, Buring JE, Canzian F, Chanock SJ, Clipp S, Gaziano JM, Giovannucci EL, Hallmans G, Hankinson SE, et al. [24 more authors] (2010). Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium. Cancer Res  70, 1015-23.   https://doi.org/10.1158/0008-5472.CAN-09-2993




PubMed



        
     
Free Article


 


PubMed ID 20103627
         Pubmed Central ID 2943735 


 



7.
Wolpin BM, Kraft P, Xu M, Steplowski E, Olsson ML, Arslan AA, Bueno-de-Mesquita HB, Gross M, Helzlsouer K, Jacobs EJ, LaCroix A, Petersen G, Stolzenberg-Solomon RZ, Zheng W, Albanes D, Allen NE, Amundadottir L, Austin MA, Boutron-Ruault MC, Buring JE, Canzian F, Chanock SJ, Gaziano JM, Giovannucci EL, Hallmans G, et al. [25 more authors] (2010). Variant ABO blood group alleles, secretor status, and risk of pancreatic cancer: results from the pancreatic cancer cohort consortium. Cancer Epidemiol Biomarkers Prev  19, 3140-9.   https://doi.org/10.1158/1055-9965.EPI-10-0751




PubMed



        
     
Free Article


 


PubMed ID 20971884
         Pubmed Central ID 3005538",https://intramural.nih.gov/search/searchview.taf?ipid=63540
719,CP010194-04,"October 01, 2009 -  September 30, 2010",Diet and Cancer in India,"Rashmi P Sinha; PhD



IRP Faculty Profile",NULL,"Nutritional Epidemiology Branch, NCI",NULL,NULL,Barry Ira Graubard; PhD (Biostatistics Branch),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63541
720,CP010195-04,"October 01, 2009 -  September 30, 2010","Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study","Demetrius  Albanes; MD



IRP Faculty Profile",NULL,"Nutritional Epidemiology Branch, NCI","Stephanie Joan Weinstein



Rachael Zoe Solomon



Arthur  Schatzkin; PhD



Rashmi P Sinha; PhD



Amanda  Cross



Christian Cormac Abnet; PhD, MPH



Show all 10","Paul  Brennan
(International Agency for Research on Cancer, Lyon, France)




Kaye  Brock





Federico  Canzian
(German Cancer Research Center)




Charles  Fuchs
(Harvard)




Susan  Hankinson
(Epidemiology Department, Harvard School of Public Health)




Richard  Hayes
(NYU Langone Medical Center, NYU Cancer Institute)


Show all 26","Stephen J Chanock; MD, PhD (Laboratory Translational Genomics)



Nathaniel C Rothman; MD (Occupational and Environmental Epidemiology Branch)



Qing  Lan (Occupational and Environmental Epidemiology Branch)



Neil Edward Caporaso; MS, MD (Genetic Epidemiology Branch)



Maria Teresa Pia Landi; MD, PhD (Genetic Epidemiology Branch)



Philip  Taylor; MD, ScD (Genetic Epidemiology Branch)",NULL,"Ordered by publication type and then author name.



1.
Abnet CC, Chen Y, Chow WH, Gao YT, Helzlsouer KJ, Le Marchand L, McCullough ML, Shikany JM, Virtamo J, Weinstein SJ, Xiang YB, Yu K, Zheng W, Albanes D, Arslan AA, Campbell DS, Campbell PT, Hayes RB, Horst RL, Kolonel LN, Nomura AM, Purdue MP, Snyder K, Shu XO (2010). Circulating 25-hydroxyvitamin D and risk of esophageal and gastric cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol  172, 94-106.   https://doi.org/10.1093/aje/kwq121




PubMed



        
     
Free Article


 


PubMed ID 20562192
         Pubmed Central ID 2892544 


 



2.
Ahn J, Lim U, Weinstein SJ, Schatzkin A, Hayes RB, Virtamo J, Albanes D (2009). Prediagnostic total and high-density lipoprotein cholesterol and risk of cancer. Cancer Epidemiol Biomarkers Prev  18, 2814-21.   https://doi.org/10.1158/1055-9965.EPI-08-1248




PubMed



        
     
Free Article


 


PubMed ID 19887581
         Pubmed Central ID 3534759 


 



3.
Ahn J, Yu K, Stolzenberg-Solomon R, Simon KC, McCullough ML, Gallicchio L, Jacobs EJ, Ascherio A, Helzlsouer K, Jacobs KB, Li Q, Weinstein SJ, Purdue M, Virtamo J, Horst R, Wheeler W, Chanock S, Hunter DJ, Hayes RB, Kraft P, Albanes D (2010). Genome-wide association study of circulating vitamin D levels. Hum Mol Genet  19, 2739-45.   https://doi.org/10.1093/hmg/ddq155




PubMed



        
     
Free Article


 


PubMed ID 20418485
         Pubmed Central ID 2883344 


 



4.
Arslan AA, Helzlsouer KJ, Kooperberg C, Shu XO, Steplowski E, Bueno-de-Mesquita HB, Fuchs CS, Gross MD, Jacobs EJ, Lacroix AZ, Petersen GM, Stolzenberg-Solomon RZ, Zheng W, Albanes D, Amundadottir L, Bamlet WR, Barricarte A, Bingham SA, Boeing H, Boutron-Ruault MC, Buring JE, Chanock SJ, Clipp S, Gaziano JM, Giovannucci EL, Pancreatic Cancer Cohort Consortium (PanScan), et al. [26 more authors] (2010). Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). Arch Intern Med  170, 791-802.   https://doi.org/10.1001/archinternmed.2010.63




PubMed



        
     
Free Article


 


PubMed ID 20458087
         Pubmed Central ID 2920035 


 



5.
Brock KE, Graubard BI, Fraser DR, Weinstein SJ, Stolzenberg-Solomon RZ, Lim U, Tangrea JA, Virtamo J, Ke L, Snyder K, Albanes D (2010). Predictors of vitamin D biochemical status in a large sample of middle-aged male smokers in Finland. Eur J Clin Nutr  64, 280-8.   https://doi.org/10.1038/ejcn.2009.137




PubMed



        
     
Free Article


 


PubMed ID 20051977
         Pubmed Central ID 3509794 


 



6.
Cook MB, Dawsey SM, Diaw L, Blaser MJ, Perez-Perez GI, Abnet CC, Taylor PR, Albanes D, Virtamo J, Kamangar F (2010). Serum pepsinogens and Helicobacter pylori in relation to the risk of esophageal squamous cell carcinoma in the alpha-tocopherol, beta-carotene cancer prevention study. Cancer Epidemiol Biomarkers Prev  19, 1966-75.   https://doi.org/10.1158/1055-9965.EPI-10-0270




PubMed



        
     
Free Article


 


PubMed ID 20647397
         Pubmed Central ID 2919643 


 



7.
Gallicchio L, Helzlsouer KJ, Chow WH, Freedman DM, Hankinson SE, Hartge P, Hartmuller V, Harvey C, Hayes RB, Horst RL, Koenig KL, Kolonel LN, Laden F, McCullough ML, Parisi D, Purdue MP, Shu XO, Snyder K, Stolzenberg-Solomon RZ, Tworoger SS, Varanasi A, Virtamo J, Wilkens LR, Xiang YB, Yu K, et al. [6 more authors] (2010). Circulating 25-hydroxyvitamin D and the risk of rarer cancers: Design and methods of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol  172, 10-20.   https://doi.org/10.1093/aje/kwq116




PubMed



        
     
Free Article


 


PubMed ID 20562188
         Pubmed Central ID 2892539 


 



8.
Gallicchio L, Moore LE, Stevens VL, Ahn J, Albanes D, Hartmuller V, Setiawan VW, Helzlsouer KJ, Yang G, Xiang YB, Shu XO, Snyder K, Weinstein SJ, Yu K, Zeleniuch-Jacquotte A, Zheng W, Cai Q, Campbell DS, Chen Y, Chow WH, Horst RL, Kolonel LN, McCullough ML, Purdue MP, Koenig KL (2010). Circulating 25-hydroxyvitamin D and risk of kidney cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol  172, 47-57.   https://doi.org/10.1093/aje/kwq115




PubMed



        
     
Free Article


 


PubMed ID 20562187
         Pubmed Central ID 2892538 


 



9.
Hosgood HD, Liu CS, Rothman N, Weinstein SJ, Bonner MR, Shen M, Lim U, Virtamo J, Cheng WL, Albanes D, Lan Q (2010). Mitochondrial DNA copy number and lung cancer risk in a prospective cohort study. Carcinogenesis  31, 847-9.   https://doi.org/10.1093/carcin/bgq045




PubMed



        
     
Free Article


 


PubMed ID 20176654
         Pubmed Central ID 2864414 


 



10.
Laiyemo AO, Kamangar F, Marcus PM, Taylor PR, Virtamo J, Albanes D, Stolzenberg-Solomon RZ (2009). Serum pepsinogen level, atrophic gastritis and the risk of incident pancreatic cancer--a prospective cohort study. Cancer Epidemiol  33, 368-73.   https://doi.org/10.1016/j.canep.2009.09.001




PubMed



        
     
Free Article


 


PubMed ID 19800305
         Pubmed Central ID 2787955 


 



11.
Laiyemo AO, Kamangar F, Marcus PM, Taylor PR, Virtamo J, Albanes D, Stolzenberg-Solomon RZ (2010). Atrophic gastritis and the risk of incident colorectal cancer. Cancer Causes Control  21, 163-70.   https://doi.org/10.1007/s10552-009-9446-4




PubMed



        
     
Free Article


 


PubMed ID 19838812
         Pubmed Central ID 3510266 


 



12.
Lee JE, Männistö S, Spiegelman D, Hunter DJ, Bernstein L, van den Brandt PA, Buring JE, Cho E, English DR, Flood A, Freudenheim JL, Giles GG, Giovannucci E, Håkansson N, Horn-Ross PL, Jacobs EJ, Leitzmann MF, Marshall JR, McCullough ML, Miller AB, Rohan TE, Ross JA, Schatzkin A, Schouten LJ, Virtamo J, et al. [3 more authors] (2009). Intakes of fruit, vegetables, and carotenoids and renal cell cancer risk: a pooled analysis of 13 prospective studies. Cancer Epidemiol Biomarkers Prev  18, 1730-9.   https://doi.org/10.1158/1055-9965.EPI-09-0045




PubMed



        
     
Free Article


 


PubMed ID 19505906
         Pubmed Central ID 2883186 


 



13.
Major JM, Pollak MN, Snyder K, Virtamo J, Albanes D (2010). Insulin-like growth factors and risk of kidney cancer in men. Br J Cancer  103, 132-5.   https://doi.org/10.1038/sj.bjc.6605722




PubMed



        
     
Free Article


 


PubMed ID 20517306
         Pubmed Central ID 2905287 


 



14.
Major JM, Stolzenberg-Solomon RZ, Pollak MN, Snyder K, Virtamo J, Albanes D (2010). Insulin-like growth factors and liver cancer risk in male smokers. Br J Cancer  103, 1089-92.   https://doi.org/10.1038/sj.bjc.6605842




PubMed



        
     
Free Article


 


PubMed ID 20717109
         Pubmed Central ID 2965858 


 



15.
Meinhold CL, Berrington de Gonzalez A, Albanes D, Weinstein SJ, Taylor PR, Virtamo J, Stolzenberg-Solomon RZ (2009). Predictors of fasting serum insulin and glucose and the risk of pancreatic cancer in smokers. Cancer Causes Control  20, 681-90.   https://doi.org/10.1007/s10552-008-9281-z




PubMed



        
     
Free Article


 


PubMed ID 19083105
         Pubmed Central ID 2718707 


 



16.
Mondul AM, Weinstein SJ, Männistö S, Snyder K, Horst RL, Virtamo J, Albanes D (2010). Serum vitamin D and risk of bladder cancer. Cancer Res  70, 9218-23.   https://doi.org/10.1158/0008-5472.CAN-10-0985




PubMed



        
     
Free Article


 


PubMed ID 20978193
         Pubmed Central ID 2982924 


 



17.
Moore SC, Leitzmann MF, Albanes D, Weinstein SJ, Snyder K, Virtamo J, Ahn J, Mayne ST, Yu H, Peters U, Gunter MJ (2009). Adipokine genes and prostate cancer risk. Int J Cancer  124, 869-76.   https://doi.org/10.1002/ijc.24043




PubMed



        
     
Free Article


 


PubMed ID 19035456
         Pubmed Central ID 2879625 


 



18.
Park Y, Spiegelman D, Hunter DJ, Albanes D, Bergkvist L, Buring JE, Freudenheim JL, Giovannucci E, Goldbohm RA, Harnack L, Kato I, Krogh V, Leitzmann MF, Limburg PJ, Marshall JR, McCullough ML, Miller AB, Rohan TE, Schatzkin A, Shore R, Sieri S, Stampfer MJ, Virtamo J, Weijenberg M, Willett WC, et al. [3 more authors] (2010). Intakes of vitamins A, C, and E and use of multiple vitamin supplements and risk of colon cancer: a pooled analysis of prospective cohort studies. Cancer Causes Control  21, 1745-57.   https://doi.org/10.1007/s10552-010-9549-y




PubMed



        
     
Free Article


 


PubMed ID 20820901
         Pubmed Central ID 3091388 


 



19.
Purdue MP, Freedman DM, Gapstur SM, Helzlsouer KJ, Laden F, Lim U, Maskarinec G, Rothman N, Shu XO, Stevens VL, Zeleniuch-Jacquotte A, Albanes D, Bertrand K, Weinstein SJ, Yu K, Irish L, Horst RL, Hoffman-Bolton J, Giovannucci EL, Kolonel LN, Snyder K, Willett W, Arslan AA, Hayes RB, Zheng W, et al. [2 more authors] (2010). Circulating 25-hydroxyvitamin D and risk of non-hodgkin lymphoma: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol  172, 58-69.   https://doi.org/10.1093/aje/kwq117




PubMed



        
     
Free Article


 


PubMed ID 20562184
         Pubmed Central ID 2892540 


 



20.
Stolzenberg-Solomon RZ (2009). Vitamin D and pancreatic cancer. Ann Epidemiol  19, 89-95.   https://doi.org/10.1016/j.annepidem.2008.03.010




PubMed



        
     
Free Article


 


PubMed ID 18504144
         Pubmed Central ID 2907505 


 



21.
Stolzenberg-Solomon RZ, Sheffler-Collins S, Weinstein S, Garabrant DH, Mannisto S, Taylor P, Virtamo J, Albanes D (2009). Vitamin E intake, alpha-tocopherol status, and pancreatic cancer in a cohort of male smokers. Am J Clin Nutr  89, 584-91.   https://doi.org/10.3945/ajcn.2008.26423




PubMed



        
     
Free Article


 


PubMed ID 19116326
         Pubmed Central ID 2647759 


 



22.
Watters JL, Gail MH, Weinstein SJ, Virtamo J, Albanes D (2009). Associations between alpha-tocopherol, beta-carotene, and retinol and prostate cancer survival. Cancer Res  69, 3833-41.   https://doi.org/10.1158/0008-5472.CAN-08-4640




PubMed



        
     
Free Article


 


PubMed ID 19383902
         Pubmed Central ID 2787239 


 



23.
Weinstein SJ, Mackrain K, Stolzenberg-Solomon RZ, Selhub J, Virtamo J, Albanes D (2009). Serum creatinine and prostate cancer risk in a prospective study. Cancer Epidemiol Biomarkers Prev  18, 2643-9.   https://doi.org/10.1158/1055-9965.EPI-09-0322




PubMed



        
     
Free Article


 


PubMed ID 19755655
         Pubmed Central ID 2759851 


 



24.
Wright ME, Groshong SD, Husgafvel-Pursiainen K, Genova E, Lucia MS, Wolff H, Virtamo J, Albanes D (2010). Effects of beta-carotene supplementation on molecular markers of lung carcinogenesis in male smokers. Cancer Prev Res (Phila)  3, 745-52.   https://doi.org/10.1158/1940-6207.CAPR-09-0107




PubMed



        
     
Free Article


 


PubMed ID 20484175
         Pubmed Central ID 3496925 


 



25.
Wright ME, Peters U, Gunter MJ, Moore SC, Lawson KA, Yeager M, Weinstein SJ, Snyder K, Virtamo J, Albanes D (2009). Association of variants in two vitamin e transport genes with circulating vitamin e concentrations and prostate cancer risk. Cancer Res  69, 1429-38.   https://doi.org/10.1158/0008-5472.CAN-08-2343




PubMed



        
     
Free Article


 


PubMed ID 19190344
         Pubmed Central ID 2644342 


 



26.
Zheng W, Danforth KN, Tworoger SS, Goodman MT, Arslan AA, Patel AV, McCullough ML, Weinstein SJ, Kolonel LN, Purdue MP, Shu XO, Snyder K, Steplowski E, Visvanathan K, Yu K, Zeleniuch-Jacquotte A, Gao YT, Hankinson SE, Harvey C, Hayes RB, Henderson BE, Horst RL, Helzlsouer KJ (2010). Circulating 25-hydroxyvitamin D and risk of epithelial ovarian cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol  172, 70-80.   https://doi.org/10.1093/aje/kwq118




PubMed



        
     
Free Article


 


PubMed ID 20562186
         Pubmed Central ID 2892541",https://intramural.nih.gov/search/searchview.taf?ipid=63542
721,CP010196-04,"October 01, 2009 -  September 30, 2010",Prospective Studies of Diet and Cancer in the AARP Cohort,Arthur  Schatzkin; PhD,NULL,"Nutritional Epidemiology Branch, NCI","Yikyung  Park



Rashmi P Sinha; PhD



Amanda  Cross



Rachael Zoe Solomon",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Anderson LA, Gadalla S, Morton LM, Landgren O, Pfeiffer R, Warren JL, Berndt SI, Ricker W, Parsons R, Engels EA (2009). Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies. Int J Cancer  125, 398-405.   https://doi.org/10.1002/ijc.24287




PubMed



        
     
Free Article


 


PubMed ID 19365835
         Pubmed Central ID 2692814 


 



2.
Carman S, Kamangar F, Freedman ND, Wright ME, Dawsey SM, Dixon LB, Subar A, Schatzkin A, Abnet CC (2009). Vitamin E intake and risk of esophageal and gastric cancers in the NIH-AARP Diet and Health Study. Int J Cancer  125, 165-70.   https://doi.org/10.1002/ijc.24342




PubMed



        
     
Free Article


 


PubMed ID 19326432
         Pubmed Central ID 2686122 


 



3.
Chaturvedi AK, Kleinerman RA, Hildesheim A, Gilbert ES, Storm H, Lynch CF, Hall P, Langmark F, Pukkala E, Kaijser M, Andersson M, Fossa SD, Joensuu H, Travis LB, Engels EA (2009). Second cancers after squamous cell carcinoma and adenocarcinoma of the cervix. J Clin Oncol  27, 967-73.   https://doi.org/10.1200/JCO.2008.18.4549




PubMed



        
     
Free Article


 


PubMed ID 19114696
         Pubmed Central ID 2738433 


 



4.
Cross AJ, Freedman ND, Ren J, Ward MH, Hollenbeck AR, Schatzkin A, Sinha R, Abnet CC (2011). Meat consumption and risk of esophageal and gastric cancer in a large prospective study. Am J Gastroenterol  106, 432-42.   https://doi.org/10.1038/ajg.2010.415




PubMed



        
     
Free Article


 


PubMed ID 20978481
         Pubmed Central ID 3039705 


 



5.
Danforth KN, Gierach GL, Brinton LA, Hollenbeck AR, Katki HA, Leitzmann MF, Schatzkin A, Lacey JV (2009). Nonsteroidal anti-inflammatory drug use and endometrial cancer risk in the NIH-AARP Diet and Health Study. Cancer Prev Res (Phila)  2, 466-72.   https://doi.org/10.1158/1940-6207.CAPR-08-0239




PubMed



        
     
Free Article


 


PubMed ID 19401534
         Pubmed Central ID 2997357 


 



6.
Fang F, Xu Q, Park Y, Huang X, Hollenbeck A, Blair A, Schatzkin A, Kamel F, Chen H (2010). Depression and the subsequent risk of Parkinson's disease in the NIH-AARP Diet and Health Study. Mov Disord  25, 1157-62.   https://doi.org/10.1002/mds.23092




PubMed



        
     
Free Article


 


PubMed ID 20310050
         Pubmed Central ID 2914462 


 



7.
Ferrucci LM, Sinha R, Ward MH, Graubard BI, Hollenbeck AR, Kilfoy BA, Schatzkin A, Michaud DS, Cross AJ (2010). Meat and components of meat and the risk of bladder cancer in the NIH-AARP Diet and Health Study. Cancer  116, 4345-53.   https://doi.org/10.1002/cncr.25463




PubMed



        
     
Free Article


 


PubMed ID 20681011
         Pubmed Central ID 2936663 


 



8.
Freedman ND, Derakhshan MH, Abnet CC, Schatzkin A, Hollenbeck AR, McColl KE (2010). Male predominance of upper gastrointestinal adenocarcinoma cannot be explained by differences in tobacco smoking in men versus women. Eur J Cancer  46, 2473-8.   https://doi.org/10.1016/j.ejca.2010.05.005




PubMed



        
     
Free Article


 


PubMed ID 20605442
         Pubmed Central ID 3514413 


 



9.
George SM, Irwin ML, Matthews CE, Mayne ST, Gail MH, Moore SC, Albanes D, Ballard-Barbash R, Hollenbeck AR, Schatzkin A, Leitzmann MF (2010). Beyond recreational physical activity: examining occupational and household activity, transportation activity, and sedentary behavior in relation to postmenopausal breast cancer risk. Am J Public Health  100, 2288-95.   https://doi.org/10.2105/AJPH.2009.180828




PubMed



        
     
Free Article


 


PubMed ID 20864719
         Pubmed Central ID 2951936 


 



10.
George SM, Mayne ST, Leitzmann MF, Park Y, Schatzkin A, Flood A, Hollenbeck A, Subar AF (2009). Dietary glycemic index, glycemic load, and risk of cancer: a prospective cohort study. Am J Epidemiol  169, 462-72.   https://doi.org/10.1093/aje/kwn347




PubMed



        
     
Free Article


 


PubMed ID 19095757
         Pubmed Central ID 2726642 


 



11.
George SM, Park Y, Leitzmann MF, Freedman ND, Dowling EC, Reedy J, Schatzkin A, Hollenbeck A, Subar AF (2009). Fruit and vegetable intake and risk of cancer: a prospective cohort study. Am J Clin Nutr  89, 347-53.   https://doi.org/10.3945/ajcn.2008.26722




PubMed



        
     
Free Article


 


PubMed ID 19056579
         Pubmed Central ID 2647712 


 



12.
Gierach GL, Chang SC, Brinton LA, Lacey JV, Hollenbeck AR, Schatzkin A, Leitzmann MF (2009). Physical activity, sedentary behavior, and endometrial cancer risk in the NIH-AARP Diet and Health Study. Int J Cancer  124, 2139-47.   https://doi.org/10.1002/ijc.24059




PubMed



        
     
Free Article


 


PubMed ID 19123463
         Pubmed Central ID 2845165 


 



13.
Hermansen SW, Leitzmann MF, Schatzkin A (2009). The impact on National Death Index ascertainment of limiting submissions to Social Security Administration Death Master File matches in epidemiologic studies of mortality. Am J Epidemiol  169, 901-8.   https://doi.org/10.1093/aje/kwn404




PubMed



        
     
Free Article


 


PubMed ID 19251755
         Pubmed Central ID 2732974 


 



14.
Kabat GC, Park Y, Hollenbeck AR, Schatzkin A, Rohan TE (2010). Intake of fruits and vegetables, and risk of endometrial cancer in the NIH-AARP Diet and Health Study. Cancer Epidemiol  34, 568-73.   https://doi.org/10.1016/j.canep.2010.06.005




PubMed



        
     
Free Article


 


PubMed ID 20619761
         Pubmed Central ID 3495318 


 



15.
Kant AK, Leitzmann MF, Park Y, Hollenbeck A, Schatzkin A (2009). Patterns of recommended dietary behaviors predict subsequent risk of mortality in a large cohort of men and women in the United States. J Nutr  139, 1374-80.   https://doi.org/10.3945/jn.109.104505




PubMed



        
     
Free Article


 


PubMed ID 19474153
         Pubmed Central ID 2696990 


 



16.
Koster A, Harris TB, Moore SC, Schatzkin A, Hollenbeck AR, van Eijk JT, Leitzmann MF (2009). Joint associations of adiposity and physical activity with mortality: the National Institutes of Health-AARP Diet and Health Study. Am J Epidemiol  169, 1344-51.   https://doi.org/10.1093/aje/kwp053




PubMed



        
     
Free Article


 


PubMed ID 19372216
         Pubmed Central ID 2800254 


 



17.
Leitzmann MF, Koebnick C, Freedman ND, Park Y, Ballard-Barbash R, Hollenbeck A, Schatzkin A, Abnet CC (2009). Physical activity and esophageal and gastric carcinoma in a large prospective study. Am J Prev Med  36, 112-9.   https://doi.org/10.1016/j.amepre.2008.09.033




PubMed



        
     
Free Article


 


PubMed ID 19062237
         Pubmed Central ID 2655147 


 



18.
Ma X, Lim U, Park Y, Mayne ST, Wang R, Hartge P, Hollenbeck AR, Schatzkin A (2009). Obesity, lifestyle factors, and risk of myelodysplastic syndromes in a large US cohort. Am J Epidemiol  169, 1492-9.   https://doi.org/10.1093/aje/kwp074




PubMed



        
     
Free Article


 


PubMed ID 19395696
         Pubmed Central ID 2727203 


 



19.
Major JM, Doubeni CA, Freedman ND, Park Y, Lian M, Hollenbeck AR, Schatzkin A, Graubard BI, Sinha R (2010). Neighborhood socioeconomic deprivation and mortality: NIH-AARP diet and health study. PLoS One  5, e15538.   https://doi.org/10.1371/journal.pone.0015538




PubMed



        
     
Free Article


 


PubMed ID 21124858
         Pubmed Central ID 2990774 


 



20.
Meinhold CL, Park Y, Stolzenberg-Solomon RZ, Hollenbeck AR, Schatzkin A, Berrington de Gonzalez A (2009). Alcohol intake and risk of thyroid cancer in the NIH-AARP Diet and Health Study. Br J Cancer  101, 1630-4.   https://doi.org/10.1038/sj.bjc.6605337




PubMed



        
     
Free Article


 


PubMed ID 19862001
         Pubmed Central ID 2778506 


 



21.
Midthune D, Schatzkin A, Subar AF, Thompson FE, Freedman LS, Carroll RJ, Shumakovich MA, Kipnis V (2011). Validating an FFQ for intake of episodically consumed foods: application to the National Institutes of Health-AARP Diet and Health Study. Public Health Nutr  14, 1212-21.   https://doi.org/10.1017/S1368980011000632




PubMed



        
     
Free Article


 


PubMed ID 21486523
         Pubmed Central ID 3190597 


 



22.
Moore SC, Peters TM, Ahn J, Park Y, Schatzkin A, Albanes D, Hollenbeck A, Leitzmann MF (2009). Age-specific physical activity and prostate cancer risk among white men and black men. Cancer  115, 5060-70.   https://doi.org/10.1002/cncr.24538




PubMed



        
     
Free Article


 


PubMed ID 19645029
         Pubmed Central ID 2767425 


 



23.
Morton LM, Wang SS, Richesson DA, Schatzkin A, Hollenbeck AR, Lacey JV (2009). Reproductive factors, exogenous hormone use and risk of lymphoid neoplasms among women in the National Institutes of Health-AARP Diet and Health Study Cohort. Int J Cancer  124, 2737-43.   https://doi.org/10.1002/ijc.24248




PubMed



        
     
Free Article


 


PubMed ID 19253366
         Pubmed Central ID 2701156 


 



24.
Park Y, Brinton LA, Subar AF, Hollenbeck A, Schatzkin A (2009). Dietary fiber intake and risk of breast cancer in postmenopausal women: the National Institutes of Health-AARP Diet and Health Study. Am J Clin Nutr  90, 664-71.   https://doi.org/10.3945/ajcn.2009.27758




PubMed



        
     
Free Article


 


PubMed ID 19625685
         Pubmed Central ID 2728649 


 



25.
Park Y, Freedman AN, Gail MH, Pee D, Hollenbeck A, Schatzkin A, Pfeiffer RM (2009). Validation of a colorectal cancer risk prediction model among white patients age 50 years and older. J Clin Oncol  27, 694-8.   https://doi.org/10.1200/JCO.2008.17.4813




PubMed



        
     
Free Article


 


PubMed ID 19114700
         Pubmed Central ID 2645089 


 



26.
Park Y, Leitzmann MF, Subar AF, Hollenbeck A, Schatzkin A (2009). Dairy food, calcium, and risk of cancer in the NIH-AARP Diet and Health Study. Arch Intern Med  169, 391-401.   https://doi.org/10.1001/archinternmed.2008.578




PubMed



        
     
Free Article


 


PubMed ID 19237724
         Pubmed Central ID 2796799 


 



27.
Peters TM, Schatzkin A, Gierach GL, Moore SC, Lacey JV, Wareham NJ, Ekelund U, Hollenbeck AR, Leitzmann MF (2009). Physical activity and postmenopausal breast cancer risk in the NIH-AARP diet and health study. Cancer Epidemiol Biomarkers Prev  18, 289-96.   https://doi.org/10.1158/1055-9965.EPI-08-0768




PubMed



               Available in future as a Free Article 


 


PubMed ID 19124511
         Pubmed Central ID 2679977 


 



28.
Ren JS, Freedman ND, Kamangar F, Dawsey SM, Hollenbeck AR, Schatzkin A, Abnet CC (2010). Tea, coffee, carbonated soft drinks and upper gastrointestinal tract cancer risk in a large United States prospective cohort study. Eur J Cancer  46, 1873-81.   https://doi.org/10.1016/j.ejca.2010.03.025




PubMed



        
     
Free Article


 


PubMed ID 20395127
         Pubmed Central ID 2891563 


 



29.
Schatzkin A, Abnet CC, Cross AJ, Gunter M, Pfeiffer R, Gail M, Lim U, Davey-Smith G (2009). Mendelian randomization: how it can--and cannot--help confirm causal relations between nutrition and cancer. Cancer Prev Res (Phila)  2, 104-13.   https://doi.org/10.1158/1940-6207.CAPR-08-0070




PubMed



        
     
Free Article


 


PubMed ID 19174578
         Pubmed Central ID 3052774 


 



30.
Schatzkin A, Subar AF, Moore S, Park Y, Potischman N, Thompson FE, Leitzmann M, Hollenbeck A, Morrissey KG, Kipnis V (2009). Observational epidemiologic studies of nutrition and cancer: the next generation (with better observation). Cancer Epidemiol Biomarkers Prev  18, 1026-32.   https://doi.org/10.1158/1055-9965.EPI-08-1129




PubMed



        
     
Free Article


 


PubMed ID 19336550
         Pubmed Central ID 2688809 


 



31.
Sinha R, Cross AJ, Graubard BI, Leitzmann MF, Schatzkin A (2009). Meat intake and mortality: a prospective study of over half a million people. Arch Intern Med  169, 562-71.   https://doi.org/10.1001/archinternmed.2009.6




PubMed



        
     
Free Article


 


PubMed ID 19307518
         Pubmed Central ID 2803089 


 



32.
Sinha R, Park Y, Graubard BI, Leitzmann MF, Hollenbeck A, Schatzkin A, Cross AJ (2009). Meat and meat-related compounds and risk of prostate cancer in a large prospective cohort study in the United States. Am J Epidemiol  170, 1165-77.   https://doi.org/10.1093/aje/kwp280




PubMed



        
     
Free Article


 


PubMed ID 19808637
         Pubmed Central ID 2781742 


 



33.
Wang H, O'Reilly ÉJ, Weisskopf MG, Logroscino G, McCullough ML, Schatzkin A, Kolonel LN, Ascherio A (2011). Vitamin E intake and risk of amyotrophic lateral sclerosis: a pooled analysis of data from 5 prospective cohort studies. Am J Epidemiol  173, 595-602.   https://doi.org/10.1093/aje/kwq416




PubMed



        
     
Free Article


 


PubMed ID 21335424
         Pubmed Central ID 3105261 


 



34.
Watters JL, Park Y, Hollenbeck A, Schatzkin A, Albanes D (2010). Alcoholic beverages and prostate cancer in a prospective US cohort study. Am J Epidemiol  172, 773-80.   https://doi.org/10.1093/aje/kwq200




PubMed



        
     
Free Article


 


PubMed ID 20813803
         Pubmed Central ID 2984257 


 



35.
Yang HP, Gierach GL, Danforth KN, Sherman ME, Park Y, Wentzensen N, Hollenbeck A, Schatzkin A, Brinton LA (2011). Alcohol and endometrial cancer risk in the NIH-AARP diet and health study. Int J Cancer  128, 2953-61.   https://doi.org/10.1002/ijc.25623




PubMed



        
     
Free Article


 


PubMed ID 20725997
         Pubmed Central ID 3020256",https://intramural.nih.gov/search/searchview.taf?ipid=63548
722,CP010197-04,"October 01, 2009 -  September 30, 2010","Physical Activity, Energy Balance, and Cancer","Demetrius  Albanes; MD



IRP Faculty Profile
 




Amanda  Cross

 


 

Rashmi P Sinha; PhD



IRP Faculty Profile
 


 

Rachael Zoe Solomon



IRP Faculty Profile",NULL,"Nutritional Epidemiology Branch, NCI","Steven  Moore



Charles E Matthews",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Ballard-Barbash R, Hunsberger S, Alciati MH, Blair SN, Goodwin PJ, McTiernan A, Wing R, Schatzkin A (2009). Physical activity, weight control, and breast cancer risk and survival: clinical trial rationale and design considerations. J Natl Cancer Inst  101, 630-43.   https://doi.org/10.1093/jnci/djp068




PubMed



        
     
Free Article


 


PubMed ID 19401543
         Pubmed Central ID 2677576 


 



2.
Leitzmann MF, Brenner A, Moore SC, Koebnick C, Park Y, Hollenbeck A, Schatzkin A, Ron E (2010). Prospective study of body mass index, physical activity and thyroid cancer. Int J Cancer  126, 2947-56.   https://doi.org/10.1002/ijc.24913




PubMed



        
     
Free Article


 


PubMed ID 19795465
         Pubmed Central ID 2919690 


 



3.
Moore SC, Gierach GL, Schatzkin A, Matthews CE (2010). Physical activity, sedentary behaviours, and the prevention of endometrial cancer. Br J Cancer  103, 933-8.   https://doi.org/10.1038/sj.bjc.6605902




PubMed



        
     
Free Article


 


PubMed ID 20877336
         Pubmed Central ID 2965881 


 



4.
Peters TM, Moore SC, Xiang YB, Yang G, Shu XO, Ekelund U, Ji BT, Tan YT, Liu DK, Schatzkin A, Zheng W, Chow WH, Matthews CE, Leitzmann MF (2010). Accelerometer-measured physical activity in Chinese adults. Am J Prev Med  38, 583-91.   https://doi.org/10.1016/j.amepre.2010.02.012




PubMed



        
     
Free Article


 


PubMed ID 20494234
         Pubmed Central ID 2897243 


 



5.
Peters TM, Shu XO, Moore SC, Xiang YB, Yang G, Ekelund U, Liu DK, Tan YT, Ji BT, Schatzkin AS, Zheng W, Chow WH, Matthews CE, Leitzmann MF (2010). Validity of a physical activity questionnaire in Shanghai. Med Sci Sports Exerc  42, 2222-30.   https://doi.org/10.1249/MSS.0b013e3181e1fcd5




PubMed



        
     
Free Article


 


PubMed ID 20404770
         Pubmed Central ID 2975050",https://intramural.nih.gov/search/searchview.taf?ipid=63543
723,CP010198-04,"October 01, 2009 -  September 30, 2010",Lower Gastrointestinal Cancer Studies,"Amanda  Cross

 




Arthur  Schatzkin; PhD",NULL,"Nutritional Epidemiology Branch, NCI",Rashmi P Sinha; PhD,"Andrew P Flood





Philip  Schoenfeld
(University of Michigan School of Medicine)",Elaine L Lanza (Laboratory of Cancer Prevention),NULL,"Ordered by publication type and then author name.



1.
Bobe G, Albert PS, Sansbury LB, Lanza E, Schatzkin A, Colburn NH, Cross AJ (2010). Interleukin-6 as a potential indicator for prevention of high-risk adenoma recurrence by dietary flavonols in the polyp prevention trial. Cancer Prev Res (Phila)  3, 764-75.   https://doi.org/10.1158/1940-6207.CAPR-09-0161




PubMed



        
     
Free Article


 


PubMed ID 20484173
         Pubmed Central ID 2881177 


 



2.
Bobe G, Murphy G, Albert PS, Sansbury LB, Lanza E, Schatzkin A, Colburn NH, Cross AJ (2010). Serum cytokine concentrations, flavonol intake and colorectal adenoma recurrence in the Polyp Prevention Trial. Br J Cancer  103, 1453-61.   https://doi.org/10.1038/sj.bjc.6605915




PubMed



        
     
Free Article


 


PubMed ID 20924374
         Pubmed Central ID 2990604 


 



3.
Bobe G, Murphy G, Rogers CJ, Hance KW, Albert PS, Laiyemo AO, Sansbury LB, Lanza E, Schatzkin A, Cross AJ (2010). Serum adiponectin, leptin, C-peptide, homocysteine, and colorectal adenoma recurrence in the Polyp Prevention Trial. Cancer Epidemiol Biomarkers Prev  19, 1441-52.   https://doi.org/10.1158/1055-9965.EPI-09-1082




PubMed



        
     
Free Article


 


PubMed ID 20501764
         Pubmed Central ID 2882997 


 



4.
Ferrucci LM, Sinha R, Graubard BI, Mayne ST, Ma X, Schatzkin A, Schoenfeld PS, Cash BD, Flood A, Cross AJ (2009). Dietary meat intake in relation to colorectal adenoma in asymptomatic women. Am J Gastroenterol  104, 1231-40.   https://doi.org/10.1038/ajg.2009.102




PubMed



        
     
Free Article


 


PubMed ID 19367270
         Pubmed Central ID 2891034 


 



5.
Laiyemo AO, Murphy G, Sansbury LB, Wang Z, Albert PS, Marcus PM, Schoen RE, Cross AJ, Schatzkin A, Lanza E (2009). Hyperplastic polyps and the risk of adenoma recurrence in the polyp prevention trial. Clin Gastroenterol Hepatol  7, 192-7.   https://doi.org/10.1016/j.cgh.2008.08.031




PubMed



        
     
Free Article


 


PubMed ID 18849014
         Pubmed Central ID 3498978 


 



6.
Laiyemo AO, Pinsky PF, Marcus PM, Lanza E, Cross AJ, Schatzkin A, Schoen RE (2009). Utilization and yield of surveillance colonoscopy in the continued follow-up study of the polyp prevention trial. Clin Gastroenterol Hepatol  7, 562-7; quiz 497.   https://doi.org/10.1016/j.cgh.2008.12.009




PubMed



        
     
Free Article


 


PubMed ID 19138760
         Pubmed Central ID 2701893 


 



7.
Wong HL, Peters U, Hayes RB, Huang WY, Schatzkin A, Bresalier RS, Velie EM, Brody LC (2010). Polymorphisms in the adenomatous polyposis coli (APC) gene and advanced colorectal adenoma risk. Eur J Cancer  46, 2457-66.   https://doi.org/10.1016/j.ejca.2010.04.020




PubMed



        
     
Free Article


 


PubMed ID 20510605
         Pubmed Central ID 2924917",https://intramural.nih.gov/search/searchview.taf?ipid=63544
724,CP010199-04,"October 01, 2009 -  September 30, 2010",Methods for Etiologic Studies of Diet and Cancer,"Rashmi P Sinha; PhD



IRP Faculty Profile
 




Arthur  Schatzkin; PhD",NULL,"Nutritional Epidemiology Branch, NCI","Amanda  Cross



Yikyung  Park







Charles E Matthews",NULL,"Amy F Subar (Risk Factor Monitoring and Methods Branch)



Victor  Kipnis (Biometry Research Group)



Frances E Thompson (Risk Factor Monitoring and Methods Branch)



Douglas N Midthune (Biometry Research Group)



Richard P Troiano (Risk Factor Monitoring and Methods Branch)",NULL,"Ordered by publication type and then author name.



1.
Daniel CR, Cross AJ, Koebnick C, Sinha R (2011). Trends in meat consumption in the USA. Public Health Nutr  14, 575-83.   https://doi.org/10.1017/S1368980010002077




PubMed



        
     
Free Article


 


PubMed ID 21070685
         Pubmed Central ID 3045642 


 



2.
Millen AE, Tooze JA, Subar AF, Kahle LL, Schatzkin A, Krebs-Smith SM (2009). Differences between food group reports of low-energy reporters and non-low-energy reporters on a food frequency questionnaire. J Am Diet Assoc  109, 1194-203.   https://doi.org/10.1016/j.jada.2009.04.004




PubMed



        
     
Free Article


 


PubMed ID 19559136
         Pubmed Central ID 3721508 


 



3.
Wu K, Sinha R, Holmes MD, Giovannucci E, Willett W, Cho E (2010). Meat mutagens and breast cancer in postmenopausal women--a cohort analysis. Cancer Epidemiol Biomarkers Prev  19, 1301-10.   https://doi.org/10.1158/1055-9965.EPI-10-0002




PubMed



        
     
Free Article


 


PubMed ID 20447922
         Pubmed Central ID 3065926",https://intramural.nih.gov/search/searchview.taf?ipid=63545
725,CP010200-03,"October 01, 2009 -  September 30, 2010",GEI - Genome-Wide Association Studies,"Neil Edward Caporaso; MS, MD



IRP Faculty Profile
 


 

Stephen J Chanock; MD, PhD



IRP Faculty Profile
 




Nilanjan  Chatterjee

 


 

Maria Teresa Pia Landi; MD, PhD



IRP Faculty Profile
 


 

Margaret Anne Tucker



IRP Faculty Profile
 


 

Joseph  Fraumeni; MD



IRP Faculty Profile",NULL,"Biostatistics Branch, NCI

Laboratory Translational Genomics, NCI

Genetic Epidemiology Branch, NCI

Human Genetics Program, NCI

Office of the Director, NCI",NULL,NULL,Mark  Purdue (Occupational and Environmental Epidemiology Branch),NULL,"Ordered by publication type and then author name.



1.
Bennett SN, Caporaso N, Fitzpatrick AL, Agrawal A, Barnes K, Boyd HA, Cornelis MC, Hansel NN, Heiss G, Heit JA, Kang JH, Kittner SJ, Kraft P, Lowe W, Marazita ML, Monroe KR, Pasquale LR, Ramos EM, van Dam RM, Udren J, Williams K, GENEVA Consortium (2011). Phenotype harmonization and cross-study collaboration in GWAS consortia: the GENEVA experience. Genet Epidemiol  35, 159-73.   https://doi.org/10.1002/gepi.20564




PubMed



        
     
Free Article


 


PubMed ID 21284036
         Pubmed Central ID 3055921 


 



2.
Cornelis MC, Agrawal A, Cole JW, Hansel NN, Barnes KC, Beaty TH, Bennett SN, Bierut LJ, Boerwinkle E, Doheny KF, Feenstra B, Feingold E, Fornage M, Haiman CA, Harris EL, Hayes MG, Heit JA, Hu FB, Kang JH, Laurie CC, Ling H, Manolio TA, Marazita ML, Mathias RA, Mirel DB, for the GENEVA Consortium (2010) The Gene, Environment Association Studies consortium (GENEVA): maximizing the knowledge obtained from GWAS by collaboration across studies of multiple conditions. Genet Epidemiol 34:364-72




PubMed



        
     
Free Article


 


PubMed ID 20091798
         Pubmed Central ID 2860056 


 



3.
Elks CE, Perry JR, Sulem P, Chasman DI, Franceschini N, He C, Lunetta KL, Visser JA, Byrne EM, Cousminer DL, Gudbjartsson DF, Esko T, Feenstra B, Hottenga JJ, Koller DL, Kutalik Z, Lin P, Mangino M, Marongiu M, McArdle PF, Smith AV, Stolk L, van Wingerden SH, Zhao JH, Albrecht E, GIANT Consortium, et al. [149 more authors] (2010). Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies. Nat Genet  42, 1077-85.   https://doi.org/10.1038/ng.714




PubMed



        
     
Free Article


 


PubMed ID 21102462
         Pubmed Central ID 3140055 


 



4.
Peters U, Hutter CM, Hsu L, Schumacher FR, Conti DV, Carlson CS, Edlund CK, Haile RW, Gallinger S, Zanke BW, Lemire M, Rangrej J, Vijayaraghavan R, Chan AT, Hazra A, Hunter DJ, Ma J, Fuchs CS, Giovannucci EL, Kraft P, Liu Y, Chen L, Jiao S, Makar KW, Taverna D, et al. [33 more authors] (2012). Meta-analysis of new genome-wide association studies of colorectal cancer risk. Hum Genet  131, 217-34.   https://doi.org/10.1007/s00439-011-1055-0




PubMed



        
     
Free Article


 


PubMed ID 21761138
         Pubmed Central ID 3257356",https://intramural.nih.gov/search/searchview.taf?ipid=63547
726,CP010201-01,"October 01, 2009 -  September 30, 2010",Laboratory of Translational Genomics,"Stephen J Chanock; MD, PhD



IRP Faculty Profile",NULL,"Laboratory Translational Genomics, NCI","Laufey Thora Amundadottir



Liudmila  Prokunina-Olsson; PhD",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Fu YP, Edvardsen H, Kaushiva A, Arhancet JP, Howe TM, Kohaar I, Porter-Gill P, Shah A, Landmark-Høyvik H, Fosså SD, Ambs S, Naume B, Børresen-Dale AL, Kristensen VN, Prokunina-Olsson L (2010). NOTCH2 in breast cancer: association of SNP rs11249433 with gene expression in ER-positive breast tumors without TP53 mutations. Mol Cancer  9, 113.   https://doi.org/10.1186/1476-4598-9-113




PubMed



        
     
Free Article


 


PubMed ID 20482849
         Pubmed Central ID 2887795 


 



2.
Rothman N, Garcia-Closas M, Chatterjee N, Malats N, Wu X, Figueroa JD, Real FX, Van Den Berg D, Matullo G, Baris D, Thun M, Kiemeney LA, Vineis P, De Vivo I, Albanes D, Purdue MP, Rafnar T, Hildebrandt MA, Kiltie AE, Cussenot O, Golka K, Kumar R, Taylor JA, Mayordomo JI, Jacobs KB, et al. [85 more authors] (2010). A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat Genet  42, 978-84.   https://doi.org/10.1038/ng.687




PubMed



        
     
Free Article


 


PubMed ID 20972438
         Pubmed Central ID 3049891 


 



3.
Wang Z, Hildesheim A, Wang SS, Herrero R, Gonzalez P, Burdette L, Hutchinson A, Thomas G, Chanock SJ, Yu K (2010). Genetic admixture and population substructure in Guanacaste Costa Rica. PLoS One  5, e13336.   https://doi.org/10.1371/journal.pone.0013336




PubMed



        
     
Free Article


 


PubMed ID 20967209
         Pubmed Central ID 2954167",https://intramural.nih.gov/search/searchview.taf?ipid=67757
727,CP010202-02,"October 01, 2009 -  September 30, 2010","Biochemical, molecular, and dietary studies for pancreatic cancer within PLCO","Rachael Zoe Solomon



IRP Faculty Profile",NULL,"Nutritional Epidemiology Branch, NCI",NULL,"K  Dodd
(DCCPS/NCI)




Brietta M Oaks","Cari Meinhold Kitahara (Radiation Epidemiology Branch)



Debra  Silverman; ScD, ScM (Occupational and Environmental Epidemiology Branch)",NULL,"Ordered by publication type and then author name.



1.
Oaks BM, Dodd KW, Meinhold CL, Jiao L, Church TR, Stolzenberg-Solomon RZ (2010). Folate intake, post-folic acid grain fortification, and pancreatic cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Am J Clin Nutr  91, 449-55.   https://doi.org/10.3945/ajcn.2009.28433




PubMed



        
     
Free Article


 


PubMed ID 20007302
         Pubmed Central ID 2806895",https://intramural.nih.gov/search/searchview.taf?ipid=63484
728,CP010206-01,"October 01, 2009 -  September 30, 2010","Human Papillomavirus (HPV) Natural History, Genomics and Risk Assessment","Mark  Schiffman; MD



IRP Faculty Profile",NULL,"Clinical Genetics Branch, NCI","Mark H Greene; MD



Julia  Gage



Lisa  Mirabello","Sameer K Antani; PhD





Robert  Burk
(Albert Einstein College of Medicine)




S  Goldie
(Harvard)




Rodney D Long





Attila  Lorincz
(Digene)","Philip E Castle; PhD, MPH (Hormonal and Reproductive Epidemiology Branch)



Douglas  Lowy; MD (Laboratory of Cellular Oncology)



Daniel R Soppet (Office Of The Director)



Nicolas Albert Hermann Wentzensen (Hormonal and Reproductive Epidemiology Branch)



Sholom  Wacholder; PhD (Biostatistics Branch)



Hormuzdiar Aspandiar Katki; MS (Biostatistics Branch)",NULL,"Ordered by publication type and then author name.



1.
Castle PE (2009). The evolving definition of carcinogenic human papillomavirus. Infect Agent Cancer  4, 7.   https://doi.org/10.1186/1750-9378-4-7




PubMed



        
     
Free Article


 


PubMed ID 19432962
         Pubmed Central ID 2686676 


 



2.
Castle PE, Rodríguez AC, Burk RD, Herrero R, Hildesheim A, Solomon D, Sherman ME, Jeronimo J, Alfaro M, Morales J, Guillén D, Hutchinson ML, Wacholder S, Schiffman M (2009). Neither one-time negative screening tests nor negative colposcopy provides absolute reassurance against cervical cancer. Int J Cancer  125, 1649-56.   https://doi.org/10.1002/ijc.24525




PubMed



        
     
Free Article


 


PubMed ID 19569231
         Pubmed Central ID 2766540 


 



3.
Gage JC, Rodriguez AC, Schiffman M, Adadevoh S, Larraondo MJ, Chumworathayi B, Lejarza SV, Araya LV, Garcia F, Budihas SR, Long R, Katki HA, Herrero R, Burk RD, Jeronimo J (2009). An evaluation by midwives and gynecologists of treatability of cervical lesions by cryotherapy among human papillomavirus-positive women. Int J Gynecol Cancer  19, 728-33.   https://doi.org/10.1111/IGC.0b013e3181a48b99




PubMed



        
     
Free Article


 


PubMed ID 19509579
         Pubmed Central ID 2882862 


 



4.
Gage JC, Rodriguez AC, Schiffman M, Garcia FM, Long RL, Budihas SR, Herrero R, Burk RD, Jeronimo J (2009). Treatability by cryotherapy in a screen-and-treat strategy. J Low Genit Tract Dis  13, 174-81.   https://doi.org/10.1097/LGT.0b013e3181909f30




PubMed



        
     
Free Article


 


PubMed ID 19550216
         Pubmed Central ID 2735767 


 



5.
Safaeian M, Falk RT, Rodriguez AC, Hildesheim A, Kemp T, Williams M, Morera L, Barrantes M, Herrero R, Porras C, Pinto L (2009). Factors associated with fluctuations in IgA and IgG levels at the cervix during the menstrual cycle. J Infect Dis  199, 455-63.   https://doi.org/10.1086/596060




PubMed



        
     
Free Article


 


PubMed ID 19133811
         Pubmed Central ID 4158917 


 



6.
Schiffman M, Clifford G, Buonaguro FM (2009). Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline. Infect Agent Cancer  4, 8.   https://doi.org/10.1186/1750-9378-4-8




PubMed



        
     
Free Article


 


PubMed ID 19486508
         Pubmed Central ID 2694995 


 



7.
Wang SS, Bratti MC, Rodríguez AC, Herrero R, Burk RD, Porras C, González P, Sherman ME, Wacholder S, Lan ZE, Schiffman M, Chanock SJ, Hildesheim A (2009). Common variants in immune and DNA repair genes and risk for human papillomavirus persistence and progression to cervical cancer. J Infect Dis  199, 20-30.   https://doi.org/10.1086/595563




PubMed



        
     
Free Article


 


PubMed ID 19012493
         Pubmed Central ID 3690375 


 



8.
Wang SS, Purdue MP, Cerhan JR, Zheng T, Menashe I, Armstrong BK, Lan Q, Hartge P, Kricker A, Zhang Y, Morton LM, Vajdic CM, Holford TR, Severson RK, Grulich A, Leaderer BP, Davis S, Cozen W, Yeager M, Chanock SJ, Chatterjee N, Rothman N (2009). Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma risk. PLoS One  4, e5360.   https://doi.org/10.1371/journal.pone.0005360




PubMed



        
     
Free Article


 


PubMed ID 19390683
         Pubmed Central ID 2669130 


 



9.
Wang SS, Zuna RE, Wentzensen N, Dunn ST, Sherman ME, Gold MA, Schiffman M, Wacholder S, Allen RA, Block I, Downing K, Jeronimo J, Carreon JD, Safaeian M, Brown D, Walker JL (2009). Human papillomavirus cofactors by disease progression and human papillomavirus types in the study to understand cervical cancer early endpoints and determinants. Cancer Epidemiol Biomarkers Prev  18, 113-20.   https://doi.org/10.1158/1055-9965.EPI-08-0591




PubMed



        
     
Free Article


 


PubMed ID 19124488
         Pubmed Central ID 2952430",https://intramural.nih.gov/search/searchview.taf?ipid=67759
729,CP010207-01,"October 01, 2009 -  September 30, 2010",PLCO EEMS and Extended Follow Up,"Robert  Hoover; MD, ScD



IRP Faculty Profile",NULL,"Epidemiology and Biostatistics Program, NCI",Amanda  Black,NULL,"Christine Dorothy Berg (Early Detection Research Group)



Philip  Prorok (Biometry Research Group)



Mark  Purdue (Occupational and Environmental Epidemiology Branch)



Ann  Hsing; PhD (Hormonal and Reproductive Epidemiology Branch)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=67761
730,CP010209-01,"October 01, 2009 -  September 30, 2010",HPV and cancer at multiple anatomic sites,"Aimee Rebecca Kreimer



IRP Faculty Profile",NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=67765
731,CP010210-01,"October 01, 2009 -  September 30, 2010","HPV, cervical neoplasia, and vaccination","Aimee Rebecca Kreimer



IRP Faculty Profile
 




Mahboobeh  Safaeian

 


 

Mark  Schiffman; MD



IRP Faculty Profile
 


 

Sholom  Wacholder; PhD



IRP Faculty Profile
 


 

Allan  Hildesheim; PhD



IRP Faculty Profile",NULL,"Infection & Immunoepidemiology Branch, NCI

Biostatistics Branch, NCI

Clinical Genetics Branch, NCI",Diane  Solomon; PhD,"Rolando  Herrero
(Proyecto Epidemiologico Guanacaste)




L  Pinto
(SAIC-NCI)




Ana  Rodriguez","Douglas  Lowy; MD (Laboratory of Cellular Oncology)



John  Schiller; PhD (Laboratory of Cellular Oncology)



Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)",NULL,"Ordered by publication type and then author name.



1.
Hildesheim A, Schiffman M, Solomon D, Wacholder S, Rodriguez AC, Herrero R (2009). Response to ""Analysis of adverse events of potential autoimmune aetiology in a large integrated safety database of AS04 adjuvanted vaccines"" by Verstraeten et al. Vaccine  27, 2529.   https://doi.org/10.1016/j.vaccine.2009.01.028




PubMed



        
     
Free Article


 


PubMed ID 19186195
         Pubmed Central ID 2745916 


 



2.
Porras C, Rodríguez AC, Hildesheim A, Herrero R, González P, Wacholder S, Burk RD, Schiffman M (2009). Human papillomavirus types by age in cervical cancer precursors: predominance of human papillomavirus 16 in young women. Cancer Epidemiol Biomarkers Prev  18, 863-5.   https://doi.org/10.1158/1055-9965.EPI-08-0951




PubMed



        
     
Free Article


 


PubMed ID 19273486
         Pubmed Central ID 2772192",https://intramural.nih.gov/search/searchview.taf?ipid=67767
732,CP010211-01,"October 01, 2009 -  September 30, 2010",Viral and Host Factors Associated with NPC,"Alisa  Goldstein; PhD



IRP Faculty Profile
 


 

Allan  Hildesheim; PhD



IRP Faculty Profile",NULL,"Infection & Immunoepidemiology Branch, NCI

Genetic Epidemiology Branch, NCI",NULL,"Chen-Jen  Chen
(Academia Sinica in Taiwan)




Meredith  Yeager","Mary  Carrington; MS, PhD (Laboratory of Experimental Immunology)",NULL,"Ordered by publication type and then author name.



1.
Yu KJ, Gao X, Chen CJ, Yang XR, Diehl SR, Goldstein A, Hsu WL, Liang XS, Marti D, Liu MY, Chen JY, Carrington M, Hildesheim A (2009). Association of human leukocyte antigens with nasopharyngeal carcinoma in high-risk multiplex families in Taiwan. Hum Immunol  70, 910-4.   https://doi.org/10.1016/j.humimm.2009.08.005




PubMed



        
     
Free Article


 


PubMed ID 19683024
         Pubmed Central ID 2764811 


 



2.
Yu KJ, Hsu WL, Chiang CJ, Cheng YJ, Pfeiffer RM, Diehl SR, Goldstein AM, Gravitt PE, Chen CJ, Hildesheim A (2009). Cancer patterns in nasopharyngeal carcinoma multiplex families in Taiwan. Int J Cancer  124, 1622-5.   https://doi.org/10.1002/ijc.24051




PubMed



        
     
Free Article


 


PubMed ID 19065653
         Pubmed Central ID 2796215",https://intramural.nih.gov/search/searchview.taf?ipid=67769
733,CP010212-01,"October 01, 2009 -  September 30, 2010",Molecular mechanisms of infection-related cancer,"Charles  Rabkin



IRP Faculty Profile",NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Anderson WF, Camargo MC, Fraumeni JF, Correa P, Rosenberg PS, Rabkin CS (2010). Age-specific trends in incidence of noncardia gastric cancer in US adults. JAMA  303, 1723-8.   https://doi.org/10.1001/jama.2010.496




PubMed



        
     
Free Article


 


PubMed ID 20442388
         Pubmed Central ID 3142962 


 



2.
Hold GL, Rabkin CS, Gammon MD, Berry SH, Smith MG, Lissowska J, Risch HA, Chow WH, Mowat NA, Vaughan TL, El-Omar EM (2009). CD14-159C/T and TLR9-1237T/C polymorphisms are not associated with gastric cancer risk in Caucasian populations. Eur J Cancer Prev  18, 117-9.   https://doi.org/10.1097/CEJ.0b013e3283101292




PubMed



        
     
Free Article


 


PubMed ID 19337058
         Pubmed Central ID 2679029",https://intramural.nih.gov/search/searchview.taf?ipid=67771
734,CP010213-01,"October 01, 2009 -  September 30, 2010",Studies of Head and Neck Cancers,"Anil Kumar Chaturvedi



IRP Faculty Profile",NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=67773
735,CP010214-01,"October 01, 2009 -  September 30, 2010",Microbes and Human Malignancies,James Jerome Goedert; MD,NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Abraham AG, Lau B, Deeks S, Moore RD, Zhang J, Eron J, Harrigan R, Gill MJ, Kitahata M, Klein M, Napravnik S, Rachlis A, Rodriguez B, Rourke S, Benson C, Bosch R, Collier A, Gebo K, Goedert J, Hogg R, Horberg M, Jacobson L, Justice A, Kirk G, Martin J, North American AIDS Cohort Collaboration on Research and Design of the International Epidemiologic Databases to Evaluate AIDS, et al. [6 more authors] (2011). Missing data on the estimation of the prevalence of accumulated human immunodeficiency virus drug resistance in patients treated with antiretroviral drugs in north america. Am J Epidemiol  174, 727-35.   https://doi.org/10.1093/aje/kwr141




PubMed



        
     
Free Article


 


PubMed ID 21813792
         Pubmed Central ID 3202147 


 



2.
Althoff K, Gebo K, Gange S, Klein M, Brooks J, Hogg R, Bosch R, Horberg M, Saag M, Kitahata M, Eron J, Napravnik S, Rourke S, Gill J, Rodriguez B, Sterling T, Deeks S, Martin J, Jacobson L, Kirk G, Collier A, Benson C, Silverberg M, Goedert J, McKaig R, et al. [5 more authors] (2010) CD4 count at presentation for HIV care in the United States and Canada: Are those over 50 years more likely to have a delayed presentation?. AIDS Research and Therapy 15:45




 



3.
Althoff KN, Gange SJ, Klein MB, Brooks JT, Hogg RS, Bosch RJ, Horberg MA, Saag MS, Kitahata MM, Justice AC, Gebo KA, Eron JJ, Rourke SB, Gill MJ, Rodriguez B, Sterling TR, Calzavara LM, Deeks SG, Martin JN, Rachlis AR, Napravnik S, Jacobson LP, Kirk GD, Collier AC, Benson CA, et al. [7 more authors] (2010). Late presentation for human immunodeficiency virus care in the United States and Canada. Clin Infect Dis  50, 1512-20.   https://doi.org/10.1086/652650




PubMed



        
     
Free Article


 


PubMed ID 20415573
         Pubmed Central ID 2862849 


 



4.
Bhatia K, Goedert JJ, Modali R, Preiss L, Ayers LW (2010). Merkel cell carcinoma subgroups by Merkel cell polyomavirus DNA relative abundance and oncogene expression. Int J Cancer  126, 2240-6.   https://doi.org/10.1002/ijc.24676




PubMed



        
     
Free Article


 


PubMed ID 19551862
         Pubmed Central ID 2908249 


 



5.
Bhatia K, Modali R, Goedert JJ (2010). Merkel cell polyomavirus is not detected in mesotheliomas. J Clin Virol  47, 196-8.   https://doi.org/10.1016/j.jcv.2009.11.019




PubMed



        
     
Free Article


 


PubMed ID 20006539
         Pubmed Central ID 2818524 


 



6.
Cirulli ET, Singh A, Shianna KV, Ge D, Smith JP, Maia JM, Heinzen EL, Goedert JJ, Goldstein DB, Center for HIV/AIDS Vaccine Immunology (CHAVI) (2010). Screening the human exome: a comparison of whole genome and whole transcriptome sequencing. Genome Biol  11, R57.   https://doi.org/10.1186/gb-2010-11-5-r57




PubMed



        
     
Free Article


 


PubMed ID 20598109
         Pubmed Central ID 2898068 


 



7.
Gao X, O'Brien TR, Welzel TM, Marti D, Qi Y, Goedert JJ, Phair J, Pfeiffer R, Carrington M (2010). HLA-B alleles associate consistently with HIV heterosexual transmission, viral load, and progression to AIDS, but not susceptibility to infection. AIDS  24, 1835-40.   https://doi.org/10.1097/QAD.0b013e32833c3219




PubMed



        
     
Free Article


 


PubMed ID 20588164
         Pubmed Central ID 2902625 


 



8.
Goedert J, Calamusa G, Dazzi C, Perna A, Pelser C, Anderson L, Madsen C, Preiss L, Airola M, Graubard B, Messina A, Lauria C, Romano N (2010) Risk of classic Kaposi sarcoma with exposures to plants and soils in Sicily. Cancer Epidemiol Biomarkers Prevention 5:23




 



9.
Goedert J, Calamusa G, Dazzi C, Perna A, Pelser C, Anderson L, Madsen C, Preiss L, Airola M, Graubard B, Messina A, Lauria C, Romano N (2010) Risk of classic Kaposi sarcoma with exposures to plants and soils in Sicily. Cancer Epidemiol Biomarkers Prevention 5:23




 



10.
Hendrickson SL, Lautenberger JA, Chinn LW, Malasky M, Sezgin E, Kingsley LA, Goedert JJ, Kirk GD, Gomperts ED, Buchbinder SP, Troyer JL, O'Brien SJ (2010) Genetic Variants in Nuclear-encoded mitochondrial genes influence AIDS progression. PLoS ONE 5:12862




 



11.
Hendrickson SL, Lautenberger JA, Chinn LW, Malasky M, Sezgin E, Kingsley LA, Goedert JJ, Kirk GD, Gomperts ED, Buchbinder SP, Troyer JL, O'Brien SJ (2010) Genetic Variants in Nuclear-encoded mitochondrial genes influence AIDS progression. PLoS ONE 5:12862




 



12.
Herbeck JT, Gottlieb GS, Winkler CA, Nelson GW, An P, Maust BS, Wong KG, Troyer JL, Goedert JJ, Kessing BD, Detels R, Wolinsky SM, Martinson J, Buchbinder S, Kirk GD, Jacobson LP, Margolick JB, Kaslow RA, O'Brien SJ, Mullins JI (2010). Multistage genomewide association study identifies a locus at 1q41 associated with rate of HIV-1 disease progression to clinical AIDS. J Infect Dis  201, 618-26.   https://doi.org/10.1086/649842




PubMed



        
     
Free Article


 


PubMed ID 20064070
         Pubmed Central ID 2928718 


 



13.
Huang J, Goedert JJ, Sundberg EJ, Cung TD, Burke PS, Martin MP, Preiss L, Lifson J, Lichterfeld M, Carrington M, Yu XG (2009). HLA-B*35-Px-mediated acceleration of HIV-1 infection by increased inhibitory immunoregulatory impulses. J Exp Med  206, 2959-66.   https://doi.org/10.1084/jem.20091386




PubMed



        
     
Free Article


 


PubMed ID 20008523
         Pubmed Central ID 2806456 


 



14.
Keri A, Gebo K, Gange 
, Klein M, Brooks J, Hogg R, Bosch R, Horberg M, Saag M, Kitahata M, Eron J, Napravnik S, Rourke S, Gill J, Rodriguez B, Sterling T, Deeks S, Martin J, Jacobson L, Kirk G, Collier A, Benson C, Silverberg M, Goedert J, McKaig R, et al. [5 more authors] (2010) CD4 count at presentation for HIV care in the United States and Canada: Are those over 50 years more likely to have a delayed presentation?. AIDS Research and Therapy 15:45




 



15.
Kuniholm MH, Kovacs A, Gao X, Xue X, Marti D, Thio CL, Peters MG, Terrault NA, Greenblatt RM, Goedert JJ, Cohen MH, Minkoff H, Gange SJ, Anastos K, Fazzari M, Harris TG, Young MA, Strickler HD, Carrington M (2010). Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia. Hepatology  51, 1514-22.   https://doi.org/10.1002/hep.23515




PubMed



        
     
Free Article


 


PubMed ID 20169624
         Pubmed Central ID 2946382 


 



16.
Martin MP, Qi Y, Goedert JJ, Hussain SK, Kirk GD, Hoots WK, Buchbinder S, Carrington M, Thio CL (2010). IL28B polymorphism does not determine outcomes of hepatitis B virus or HIV infection. J Infect Dis  202, 1749-53.   https://doi.org/10.1086/657146




PubMed



        
     
Free Article


 


PubMed ID 20977343
         Pubmed Central ID 2974014 


 



17.
Mendy ME, Welzel T, Lesi OA, Hainaut P, Hall AJ, Kuniholm MH, McConkey S, Goedert JJ, Kaye S, Rowland-Jones S, Whittle H, Kirk GD (2010). Hepatitis B viral load and risk for liver cirrhosis and hepatocellular carcinoma in The Gambia, West Africa. J Viral Hepat  17, 115-22.   https://doi.org/10.1111/j.1365-2893.2009.01168.x




PubMed



        
     
Free Article


 


PubMed ID 19874478
         Pubmed Central ID 2817443 


 



18.
Mosbruger TL, Duggal P, Goedert JJ, Kirk GD, Hoots WK, Tobler LH, Busch M, Peters MG, Rosen HR, Thomas DL, Thio CL (2010). Large-scale candidate gene analysis of spontaneous clearance of hepatitis C virus. J Infect Dis  201, 1371-80.   https://doi.org/10.1086/651606




PubMed



        
     
Free Article


 


PubMed ID 20331378
         Pubmed Central ID 2853721 


 



19.
Pelak K, Shianna KV, Ge D, Maia JM, Zhu M, Smith JP, Cirulli ET, Fellay J, Dickson SP, Gumbs CE, Heinzen EL, Need AC, Ruzzo EK, Singh A, Campbell CR, Hong LK, Lornsen KA, McKenzie AM, Sobreira NL, Hoover-Fong JE, Milner JD, Ottman R, Haynes BF, Goedert JJ, Goldstein DB (2010). The characterization of twenty sequenced human genomes. PLoS Genet  6, e1001111.   https://doi.org/10.1371/journal.pgen.1001111




PubMed



        
     
Free Article


 


PubMed ID 20838461
         Pubmed Central ID 2936541 


 



20.
Pelser C, Dazzi C, Graubard BI, Lauria C, Vitale F, Goedert JJ (2009). Risk of classic Kaposi sarcoma with residential exposure to volcanic and related soils in Sicily. Ann Epidemiol  19, 597-601.   https://doi.org/10.1016/j.annepidem.2009.04.002




PubMed



        
     
Free Article


 


PubMed ID 19576540
         Pubmed Central ID 2706785 


 



21.
Pelser C, Vitale F, Whitby D, Graubard BI, Messina A, Gafà L, Brown EE, Anderson LA, Romano N, Lauria C, Goedert JJ (2009). Socio-economic and other correlates of Kaposi sarcoma-associated herpesvirus seroprevalence among older adults in Sicily. J Med Virol  81, 1938-44.   https://doi.org/10.1002/jmv.21589




PubMed



        
     
Free Article


 


PubMed ID 19777527
         Pubmed Central ID 2784645 


 



22.
Rockville Merkel Cell Carcinoma Group (2009) Merkel cell carcinoma: recent progress and current priorities on etiology, pathogenesis, and clinical management. J Clin Oncol 27:4021-6.




PubMed



        
     
Free Article


 


PubMed ID 19597021
         Pubmed Central ID 2734399 


 



23.
Sterling T, Lau B, Zhang J, Freeman A, Bosch R, Brooks J, Deeks S, French A, Gange S, Gebo K, Gill M, Horberg M, Jacobson L, Kirk G, Kitahata M, Klein M, Martin J, Rodriguez B, Silverberg M, Willig J, Eron J, Goedert J, Hogg R, Justice A, McKaig R, et al. [3 more authors] (2010) Risk Factors for Tuberculosis After Highly Active Antiretroviral Therapy Initiation in theUnited States and Canada: Implications for Tuberculosis Screening Strategies. AIDS 204:893-901




 



24.
Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, O'Huigin C, Kidd J, Kidd K, Khakoo SI, Alexander G, Goedert JJ, Kirk GD, Donfield SM, Rosen HR, Tobler LH, Busch MP, McHutchison JG, Goldstein DB, Carrington M (2009). Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature  461, 798-801.   https://doi.org/10.1038/nature08463




PubMed



        
     
Free Article


 


PubMed ID 19759533
         Pubmed Central ID 3172006 


 



25.
Timothy S, Lau B, Zhang J, Freeman A, Bosch R, Brooks J, Deeks S, French A, Gange S, Gebo K, Gill M, Horberg M, Jacobson L, Kirk G, Kitahata M, Klein M, Martin J, Rodriguez B, Silverberg M, Willig J, Eron J, Goedert J, Hogg R, Justice A, McKaig R, et al. [3 more authors] (2010) Risk Factors for Tuberculosis After Highly Active Antiretroviral Therapy Initiation in theUnited States and Canada: Implications for Tuberculosis Screening Strategies. AIDS 204:893-901




 



26.
Wacholder S, Rotunno M (2009). Control selection options for genome-wide association studies in cohorts. Cancer Epidemiol Biomarkers Prev  18, 695-7.   https://doi.org/10.1158/1055-9965.EPI-08-1114




PubMed



        
     
Free Article


 


PubMed ID 19258469
         Pubmed Central ID 2668974",https://intramural.nih.gov/search/searchview.taf?ipid=67775
736,CP010215-01,"October 01, 2009 -  September 30, 2010",Human microbiome and cancer,Mahboobeh  Safaeian,NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=67777
737,CP010216-01,"October 01, 2009 -  September 30, 2010",Immune responses to HPV and HPV vaccination,Mahboobeh  Safaeian,NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=67779
738,SC000167-19,"October 01, 2009 -  September 30, 2010",Molecular Pathology of Pulmonary Carcinogenesis,Ilona  Linnoila; MD,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI","Abeba  Demelash



Yan  Li



Claire  McWhite



Xu  Naizhen



Florent Raphael  Suau



Xiaoyang  Wang",NULL,"Phillip A Dennis; MD, PhD (Medical Oncology Branch)",NULL,"Ordered by publication type and then author name.



1.
Jensen-Taubman S, Wang XY, Linnoila RI (2010) Achaete-scute homologue-1 tapers neuroendocrine cell differentiation in lungs after exposure to naphthalene. Toxicol Sci 117:238-48.




PubMed



        
     
Free Article


 


PubMed ID 20554700
         Pubmed Central ID 2923285 


 



2.
Wang XY, Demelash A, Kim H, Jensen-Taubman S, Dakir el H, Ozbun L, Birrer MJ, Linnoila RI (2009) Matrilysin-1 mediates bronchiolization of alveoli, a potential premalignant change in lung cancer. Am J Pathol 175:592-604.




PubMed



        
     
Free Article


 


PubMed ID 19608871
         Pubmed Central ID 2716959",https://intramural.nih.gov/search/searchview.taf?ipid=63563
739,SC000550-30,"October 01, 2009 -  September 30, 2010",Lymphoma Disease Discovery and Defintion,"Elaine S Jaffe; MD



IRP Faculty Profile",NULL,"Laboratory of Pathology, NCI","Theresa M Davies Hill



Franziska Carola Eberle



Qingyan  Liu



Stefania  Pittaluga



Mark  Raffeld; MD



Haipeng  Shao; MD



Show all 10","Elias  Campo
(University of Barcelona)




Wing  Chan
(Pathology, University of Nebraska)




Andreas  Chott
(Pathology, University of Vienna)




Stefan D Dojcinov





Fabio  Facchetti
(University of Brescia)




Nancy  Harris



Show all 9","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)



Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)



Jonathan Keith Killian (Cancer Genetics Branch)



Louis  Staudt; MD (Lymphoid Malignancies Branch)",Jeffrey  Cohen; MD (NIAID),"Ordered by publication type and then author name.



1.
Chang CC, Zhou X, Taylor JJ, Huang WT, Ren X, Monzon F, Feng Y, Rao PH, Lu XY, Fabio F, Hilsenbeck S, Creighton CJ, Jaffe ES, Lau CC (2009). Genomic profiling of plasmablastic lymphoma using array comparative genomic hybridization (aCGH): revealing significant overlapping genomic lesions with diffuse large B-cell lymphoma. J Hematol Oncol  2, 47.   https://doi.org/10.1186/1756-8722-2-47




PubMed



        
     
Free Article


 


PubMed ID 19909553
         Pubmed Central ID 2789747 


 



2.
Cohen JI, Kimura H, Nakamura S, Ko YH, Jaffe ES (2009). Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008. Ann Oncol  20, 1472-82.   https://doi.org/10.1093/annonc/mdp064




PubMed



        
     
Free Article


 


PubMed ID 19515747
         Pubmed Central ID 2731018 


 



3.
Davis RE, Ngo VN, Lenz G, Tolar P, Young RM, Romesser PB, Kohlhammer H, Lamy L, Zhao H, Yang Y, Xu W, Shaffer AL, Wright G, Xiao W, Powell J, Jiang JK, Thomas CJ, Rosenwald A, Ott G, Muller-Hermelink HK, Gascoyne RD, Connors JM, Johnson NA, Rimsza LM, Campo E, et al. [12 more authors] (2010). Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma. Nature  463, 88-92.   https://doi.org/10.1038/nature08638




PubMed



        
     
Free Article


 


PubMed ID 20054396
         Pubmed Central ID 2845535 


 



4.
Dunleavy K, Little RF, Pittaluga S, Grant N, Wayne AS, Carrasquillo JA, Steinberg SM, Yarchoan R, Jaffe ES, Wilson WH (2010). The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphoma. Blood  115, 3017-24.   https://doi.org/10.1182/blood-2009-11-253039




PubMed



        
     
Free Article


 


PubMed ID 20130244
         Pubmed Central ID 2858473 


 



5.
Dunleavy K, Pittaluga S, Czuczman MS, Dave SS, Wright G, Grant N, Shovlin M, Jaffe ES, Janik JE, Staudt LM, Wilson WH (2009). Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma. Blood  113, 6069-76.   https://doi.org/10.1182/blood-2009-01-199679




PubMed



        
     
Free Article


 


PubMed ID 19380866
         Pubmed Central ID 2699229 


 



6.
Eberle FC, Mani H, Jaffe ES (2009). Histopathology of Hodgkin's lymphoma. Cancer J  15, 129-37.   https://doi.org/10.1097/PPO.0b013e31819e31cf




PubMed


 


PubMed ID 19390308
    
     


 



7.
Gradowski JF, Jaffe ES, Warnke RA, Pittaluga S, Surti U, Gole LA, Swerdlow SH (2010). Follicular lymphomas with plasmacytic differentiation include two subtypes. Mod Pathol  23, 71-9.   https://doi.org/10.1038/modpathol.2009.146




PubMed



        
     
Free Article


 


PubMed ID 19838161
         Pubmed Central ID 6349384 


 



8.
Jaffe ES (2009). The 2008 WHO classification of lymphomas: implications for clinical practice and translational research. Hematology Am Soc Hematol Educ Program   523-31  https://doi.org/10.1182/asheducation-2009.1.523




PubMed



        
     
Free Article


 


PubMed ID 20008237
         Pubmed Central ID 6324557 


 



9.
Jegalian AG, Buxbaum NP, Facchetti F, Raffeld M, Pittaluga S, Wayne AS, Jaffe ES (2010). Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications. Haematologica  95, 1873-9.   https://doi.org/10.3324/haematol.2010.026179




PubMed



        
     
Free Article


 


PubMed ID 20663945
         Pubmed Central ID 2966909 


 



10.
Jegalian AG, Facchetti F, Jaffe ES (2009). Plasmacytoid dendritic cells: physiologic roles and pathologic states. Adv Anat Pathol  16, 392-404.   https://doi.org/10.1097/PAP.0b013e3181bb6bc2




PubMed



        
     
Free Article


 


PubMed ID 19851130
         Pubmed Central ID 6329307 


 



11.
Koch R, Jaffe ES, Mensing C, Zeis M, Schmitz N, Sander CA (2009). Cutaneous gamma/delta T-cell lymphoma. J Dtsch Dermatol Ges  7, 1065-7.   https://doi.org/10.1111/j.1610-0387.2009.07209.x




PubMed



        
     
Free Article


 


PubMed ID 19694889
         Pubmed Central ID 3471805 


 



12.
Lamant L, Pileri S, Sabattini E, Brugières L, Jaffe ES, Delsol G (2010). Cutaneous presentation of ALK-positive anaplastic large cell lymphoma following insect bites: evidence for an association in five cases. Haematologica  95, 449-55.   https://doi.org/10.3324/haematol.2009.015024




PubMed



        
     
Free Article


 


PubMed ID 19951975
         Pubmed Central ID 2833075 


 



13.
Landgren O, Gilbert ES, Rizzo JD, Socié G, Banks PM, Sobocinski KA, Horowitz MM, Jaffe ES, Kingma DW, Travis LB, Flowers ME, Martin PJ, Deeg HJ, Curtis RE (2009). Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation. Blood  113, 4992-5001.   https://doi.org/10.1182/blood-2008-09-178046




PubMed



        
     
Free Article


 


PubMed ID 19264919
         Pubmed Central ID 2686146 


 



14.
Leich E, Salaverria I, Bea S, Zettl A, Wright G, Moreno V, Gascoyne RD, Chan WC, Braziel RM, Rimsza LM, Weisenburger DD, Delabie J, Jaffe ES, Lister A, Fitzgibbon J, Staudt LM, Hartmann EM, Mueller-Hermelink HK, Campo E, Ott G, Rosenwald A (2009). Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations. Blood  114, 826-34.   https://doi.org/10.1182/blood-2009-01-198580




PubMed



        
     
Free Article


 


PubMed ID 19471018
         Pubmed Central ID 2716022 


 



15.
Mani H, Climent F, Colomo L, Pittaluga S, Raffeld M, Jaffe ES (2010). Gall bladder and extrahepatic bile duct lymphomas: clinicopathological observations and biological implications. Am J Surg Pathol  34, 1277-86.   https://doi.org/10.1097/PAS.0b013e3181e9bb8b




PubMed



        
     
Free Article


 


PubMed ID 20679881
         Pubmed Central ID 2929270 


 



16.
Mani H, Jaffe ES (2009). Hodgkin lymphoma: an update on its biology with new insights into classification. Clin Lymphoma Myeloma  9, 206-16.   https://doi.org/10.3816/CLM.2009.n.042




PubMed



        
     
Free Article


 


PubMed ID 19525189
         Pubmed Central ID 2806063 


 



17.
Morovic A, Jaffe ES, Raffeld M, Schrager JA (2009). Metachronous EBV-associated B-cell and T-cell posttransplant lymphoproliferative disorders in a heart transplant recipient. Am J Surg Pathol  33, 149-54.   https://doi.org/10.1097/PAS.0b013e318181a826




PubMed



        
     
Free Article


 


PubMed ID 18941401
         Pubmed Central ID 6324846 


 



18.
Mozos A, Royo C, Hartmann E, De Jong D, Baró C, Valera A, Fu K, Weisenburger DD, Delabie J, Chuang SS, Jaffe ES, Ruiz-Marcellan C, Dave S, Rimsza L, Braziel R, Gascoyne RD, Solé F, López-Guillermo A, Colomer D, Staudt LM, Rosenwald A, Ott G, Jares P, Campo E (2009). SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype. Haematologica  94, 1555-62.   https://doi.org/10.3324/haematol.2009.010264




PubMed



        
     
Free Article


 


PubMed ID 19880778
         Pubmed Central ID 2770966 


 



19.
Orlov NV, Chen WW, Eckley DM, Macura TJ, Shamir L, Jaffe ES, Goldberg IG (2010). Automatic classification of lymphoma images with transform-based global features. IEEE Trans Inf Technol Biomed  14, 1003-13.   https://doi.org/10.1109/TITB.2010.2050695




PubMed



        
     
Free Article


 


PubMed ID 20659835
         Pubmed Central ID 2911652 


 



20.
Ouansafi I, Bell S, Jaffe ES (2010). Adrenal Hodgkin lymphoma. Br J Haematol  148, 341.   https://doi.org/10.1111/j.1365-2141.2009.07776.x




PubMed


 


PubMed ID 19563514
    
     


 



21.
Piekarz RL, Frye R, Turner M, Wright JJ, Allen SL, Kirschbaum MH, Zain J, Prince HM, Leonard JP, Geskin LJ, Reeder C, Joske D, Figg WD, Gardner ER, Steinberg SM, Jaffe ES, Stetler-Stevenson M, Lade S, Fojo AT, Bates SE (2009). Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma. J Clin Oncol  27, 5410-7.   https://doi.org/10.1200/JCO.2008.21.6150




PubMed



        
     
Free Article


 


PubMed ID 19826128
         Pubmed Central ID 2773225 


 



22.
Rimsza LM, Chan WC, Gascoyne RD, Campo E, Jaffe ES, Staudt LM, Delabie J, Rosenwald A, Murphy SP (2009). CIITA or RFX coding region loss of function mutations occur rarely in diffuse large B-cell lymphoma cases and cell lines with low levels of major histocompatibility complex class II expression. Haematologica  94, 596-8.   https://doi.org/10.3324/haematol.2008.000752




PubMed



        
     
Free Article


 


PubMed ID 19229048
         Pubmed Central ID 2663627 


 



23.
Ritchie D, Piekarz RL, Blombery P, Karai LJ, Pittaluga S, Jaffe ES, Raffeld M, Janik JE, Prince HM, Bates SE (2009). Reactivation of DNA viruses in association with histone deacetylase inhibitor therapy: a case series report. Haematologica  94, 1618-22.   https://doi.org/10.3324/haematol.2009.008607




PubMed



        
     
Free Article


 


PubMed ID 19608677
         Pubmed Central ID 2770976 


 



24.
Shao H, Xi L, Raffeld M, Pittaluga S, Dunleavy K, Wilson WH, Spector N, Milito C, Morais JC, Jaffe ES (2010). Nodal and extranodal plasmacytomas expressing immunoglobulin a: an indolent lymphoproliferative disorder with a low risk of clinical progression. Am J Surg Pathol  34, 1425-35.   https://doi.org/10.1097/PAS.0b013e3181f17d0d




PubMed



               Available in future as a Free Article 


 


PubMed ID 20871216
         Pubmed Central ID 2947321 


 



25.
Valera A, Balagué O, Colomo L, Martínez A, Delabie J, Taddesse-Heath L, Jaffe ES, Campo E (2010). IG/MYC rearrangements are the main cytogenetic alteration in plasmablastic lymphomas. Am J Surg Pathol  34, 1686-94.   https://doi.org/10.1097/PAS.0b013e3181f3e29f




PubMed



               Available in future as a Free Article 


 


PubMed ID 20962620
         Pubmed Central ID 2982261 


 



26.
Vanan I, Redner A, Atlas M, Marin L, Kadkade P, Bandovic J, Jaffe ES (2009). Solitary extramedullary plasmacytoma of the vocal cord in an adolescent. J Clin Oncol  27, e244-7.   https://doi.org/10.1200/JCO.2009.23.7461




PubMed



        
     
Free Article


 


PubMed ID 19858382
         Pubmed Central ID 6340145",https://intramural.nih.gov/search/searchview.taf?ipid=63565
740,SC000892-27,"October 01, 2009 -  September 30, 2010",Molecular Biology of the Metastatic Phenotype,"Patricia  Steeg; PhD



IRP Faculty Profile",NULL,"Developmental Therapeutics Branch, NCI","Joshua Wade Collins



Natascia  Marino



Jean-Claude A Marshall



Devin  Matthews



Joji  Nakayama","Kathy  Miller
(Indiana University)




Maximillian  Murone
(Debio Pharmaceuticals)","Cari E Graff-Cherry (Office Of The Director)



Timothy D Veenstra (Office Of The Director)



Maria  Merino; PhD (Laboratory of Pathology)



Seth M Steinberg; PhD (Office of the Director)



Nealapheur L Khan (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Lee JH, Marshall JC, Steeg PS, Horak CE (2009). Altered gene and protein expression by Nm23-H1 in metastasis suppression. Mol Cell Biochem  329, 141-8.   https://doi.org/10.1007/s11010-009-0124-3




PubMed



        
     
Free Article


 


PubMed ID 19415462
         Pubmed Central ID 3514412 


 



2.
Steeg P, Anderson R, Bar-Eli M, Chambers A, Eccles S, Hunter K, Itoh K, Kang Y, Matrisian L, Sleeman J, Theodorescu D, Thompson E, Welch D (2009) Preclinical drug development must consider the impact on metastasis. Clin Cancer Res 15:4529-30.",https://intramural.nih.gov/search/searchview.taf?ipid=63567
741,SC003657-36,"October 01, 2009 -  September 30, 2010",Immunopathologic Mechanisms Involved in Inflammatory Skin Diseases,"Stephen I Katz; PhD, MD",NULL,"Dermatology Branch, NCI","Jay T Linton



Fumi  Miyagawa



Emily Anne Nelson



Hong G Zhang; PhD",NULL,Howard A Young; PhD (Laboratory of Experimental Immunology),Keiko  Ozato; PhD (NICHD),"Ordered by publication type and then author name.



1.
Gutermuth J, Nograles KE, Miyagawa F, Nelson E, Cho YH, Katz SI (2009). Self-peptides prolong survival in murine autoimmunity via reduced IL-2/IL-7-mediated STAT5 signaling, CD8 coreceptor, and V alpha 2 down-regulation. J Immunol  183, 3130-8.   https://doi.org/10.4049/jimmunol.0900793




PubMed



        
     
Free Article


 


PubMed ID 19675167
         Pubmed Central ID 2730960 


 



2.
Kim BS, Miyagawa F, Cho YH, Bennett CL, Clausen BE, Katz SI (2009). Keratinocytes function as accessory cells for presentation of endogenous antigen expressed in the epidermis. J Invest Dermatol  129, 2805-17.   https://doi.org/10.1038/jid.2009.176




PubMed



        
     
Free Article


 


PubMed ID 19554018
         Pubmed Central ID 2784095 


 



3.
Takeuchi S, Yasukawa F, Furue M, Katz SI (2010). Collared mice: a model to assess the effects of scratching. J Dermatol Sci  57, 44-50.   https://doi.org/10.1016/j.jdermsci.2009.09.008




PubMed



        
     
Free Article


 


PubMed ID 19896338
         Pubmed Central ID 2818307",https://intramural.nih.gov/search/searchview.taf?ipid=63568
742,SC003669-21,"October 01, 2009 -  September 30, 2010",Regulation of Cutaneous Accessory Cell Activity in Health and Disease,Mark  Udey; MD,NULL,"Dermatology Branch, NCI","Stephen I Katz; PhD, MD","Bjorn  Clausen
(University of Amsterdam)




Esther  von Stebut
(Dermatology, University of Mainz)",NULL,NULL,"Ordered by publication type and then author name.



1.
Leitner WW, Baker MC, Berenberg TL, Lu MC, Yannie PJ, Udey MC (2009). Enhancement of DNA tumor vaccine efficacy by gene gun-mediated codelivery of threshold amounts of plasmid-encoded helper antigen. Blood  113, 37-45.   https://doi.org/10.1182/blood-2008-01-136267




PubMed



        
     
Free Article


 


PubMed ID 18832136
         Pubmed Central ID 2614641 


 



2.
Lopez Kostka S, Dinges S, Griewank K, Iwakura Y, Udey MC, von Stebut E (2009). IL-17 promotes progression of cutaneous leishmaniasis in susceptible mice. J Immunol  182, 3039-46.   https://doi.org/10.4049/jimmunol.0713598




PubMed



        
     
Free Article


 


PubMed ID 19234200
         Pubmed Central ID 2658650 


 



3.
Nagao K, Ginhoux F, Leitner WW, Motegi S, Bennett CL, Clausen BE, Merad M, Udey MC (2009). Murine epidermal Langerhans cells and langerin-expressing dermal dendritic cells are unrelated and exhibit distinct functions. Proc Natl Acad Sci U S A  106, 3312-7.   https://doi.org/10.1073/pnas.0807126106




PubMed



        
     
Free Article


 


PubMed ID 19218433
         Pubmed Central ID 2651335",https://intramural.nih.gov/search/searchview.taf?ipid=63569
743,SC003670-18,"October 01, 2009 -  September 30, 2010",Keratinocyte Gene Therapy,Jonathan  Vogel; MD,NULL,"Dermatology Branch, NCI",Carole L Yee,NULL,NULL,Jurgen B Schnermann; MD (NIDDK),"Ordered by publication type and then author name.



1.
Terunuma A, Limgala RP, Park CJ, Choudhary I, Vogel JC (2010). Efficient procurement of epithelial stem cells from human tissue specimens using a Rho-associated protein kinase inhibitor Y-27632. Tissue Eng Part A  16, 1363-8.   https://doi.org/10.1089/ten.TEA.2009.0339




PubMed



        
     
Free Article


 


PubMed ID 19912046
         Pubmed Central ID 2862604 


 



2.
Therrien JP, Kim SM, Terunuma A, Qin Y, Tock CL, Pfützner W, Ohyama M, Schnermann J, Vogel JC (2010). A gene therapy approach for long-term normalization of blood pressure in hypertensive mice by ANP-secreting human skin grafts. Proc Natl Acad Sci U S A  107, 1178-83.   https://doi.org/10.1073/pnas.0908882107




PubMed



        
     
Free Article


 


PubMed ID 20080656
         Pubmed Central ID 2824301",https://intramural.nih.gov/search/searchview.taf?ipid=63570
744,SC004002-41,"October 01, 2009 -  September 30, 2010",IL-2IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design,"Thomas Alexander Waldmann; MD, PhD



IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI","Jing  Chen



Sigrid Priscilla Dubois



Kayhan  Garmestani; PhD



Carolyn  Goldman



John  Janik; MD



Wei  Ju



Show all 15","Richard  Bamford; PhD





Sandor  Damjanovich, M.D.
(Dept of Biophysics and Cell Biology, University of Debrecen)




Bana  Jabri
(University of Chicago)




Nicole  Urquhart
(Dept of, University of the West Indies)","Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)



Stephen I Katz; PhD, MD (Dermatology Branch)



Martin W Brechbiel; PhD (Radiation Oncology Branch)","Bibiana  Bielekova; MD (NINDS) 



Henry F McFarland; MD (NINDS) 



Robert B. Nussenblatt; MD (NEI) 



Steven J Jacobson; PhD (NINDS)","Ordered by publication type and then author name.



1.
Bielekova B, Howard T, Packer AN, Richert N, Blevins G, Ohayon J, Waldmann TA, McFarland HF, Martin R (2009). Effect of anti-CD25 antibody daclizumab in the inhibition of inflammation and stabilization of disease progression in multiple sclerosis. Arch Neurol  66, 483-9.   https://doi.org/10.1001/archneurol.2009.50




PubMed



        
     
Free Article


 


PubMed ID 19364933
         Pubmed Central ID 2742781 


 



2.
Chen J, Zhang M, Ju W, Waldmann TA (2009). Effective treatment of a murine model of adult T-cell leukemia using depsipeptide and its combination with unmodified daclizumab directed toward CD25. Blood  113, 1287-93.   https://doi.org/10.1182/blood-2008-04-149658




PubMed



        
     
Free Article


 


PubMed ID 18948574
         Pubmed Central ID 2637191 


 



3.
Kraynyak KA, Kutzler MA, Cisper NJ, Laddy DJ, Morrow MP, Waldmann TA, Weiner DB (2009). Plasmid-encoded interleukin-15 receptor alpha enhances specific immune responses induced by a DNA vaccine in vivo. Hum Gene Ther  20, 1143-56.   https://doi.org/10.1089/hum.2009.025




PubMed



        
     
Free Article


 


PubMed ID 19530914
         Pubmed Central ID 2829284 


 



4.
Perera PY, Derrick SC, Kolibab K, Momoi F, Yamamoto M, Morris SL, Waldmann TA, Perera LP (2009). A multi-valent vaccinia virus-based tuberculosis vaccine molecularly adjuvanted with interleukin-15 induces robust immune responses in mice. Vaccine  27, 2121-7.   https://doi.org/10.1016/j.vaccine.2009.01.132




PubMed



        
     
Free Article


 


PubMed ID 19356615
         Pubmed Central ID 2667804 


 



5.
Pise-Masison CA, Radonovich M, Dohoney K, Morris JC, O'Mahony D, Lee MJ, Trepel J, Waldmann TA, Janik JE, Brady JN (2009). Gene expression profiling of ATL patients: compilation of disease-related genes and evidence for TCF4 involvement in BIRC5 gene expression and cell viability. Blood  113, 4016-26.   https://doi.org/10.1182/blood-2008-08-175901




PubMed



        
     
Free Article


 


PubMed ID 19131553
         Pubmed Central ID 2673128 


 



6.
Poon LL, Leung YH, Nicholls JM, Perera PY, Lichy JH, Yamamoto M, Waldmann TA, Peiris JS, Perera LP (2009). Vaccinia virus-based multivalent H5N1 avian influenza vaccines adjuvanted with IL-15 confer sterile cross-clade protection in mice. J Immunol  182, 3063-71.   https://doi.org/10.4049/jimmunol.0803467




PubMed



        
     
Free Article


 


PubMed ID 19234203
         Pubmed Central ID 2656349 


 



7.
Yokoyama S, Watanabe N, Sato N, Perera PY, Filkoski L, Tanaka T, Miyasaka M, Waldmann TA, Hiroi T, Perera LP (2009). Antibody-mediated blockade of IL-15 reverses the autoimmune intestinal damage in transgenic mice that overexpress IL-15 in enterocytes. Proc Natl Acad Sci U S A  106, 15849-54.   https://doi.org/10.1073/pnas.0908834106




PubMed



        
     
Free Article


 


PubMed ID 19805228
         Pubmed Central ID 2736142 


 



8.
Zhang M, Yao Z, Dubois S, Ju W, Müller JR, Waldmann TA (2009). Interleukin-15 combined with an anti-CD40 antibody provides enhanced therapeutic efficacy for murine models of colon cancer. Proc Natl Acad Sci U S A  106, 7513-8.   https://doi.org/10.1073/pnas.0902637106




PubMed



        
     
Free Article


 


PubMed ID 19383782
         Pubmed Central ID 2678620 


 



9.
Zhang M, Yao Z, Garmestani K, Yu S, Goldman CK, Paik CH, Brechbiel MW, Carrasquillo JA, Waldmann TA (2009). Preclinical evaluation of an anti-CD25 monoclonal antibody, 7G7/B6, armed with the beta-emitter, yttrium-90, as a radioimmunotherapeutic agent for treating lymphoma. Cancer Biother Radiopharm  24, 303-9.   https://doi.org/10.1089/cbr.2008.0577




PubMed



        
     
Free Article


 


PubMed ID 19538052
         Pubmed Central ID 2925030",https://intramural.nih.gov/search/searchview.taf?ipid=63572
745,SC004020-33,"October 01, 2009 -  September 30, 2010","Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS","Jay Arthur Berzofsky; MD, PhD



IRP Faculty Profile",NULL,"Vaccine Branch, NCI","Alison Elizabeth Hogg



Liat  Izhak



Samir N. Khleif; MD



Karen Muthike Muindi



Charles D Pendleton



Yongjun  Sui



Show all 13","Shizuo  Akira
(Osaka University)




Gurdyal  Besra
(University of Birmingham)




Vincenzo  Bronte





Donald  Burke
(Ctr Immunization Research, Johns Hopkins Sch Publ Health)




David  Carbone
(Vanderbilt University)




Charles  Delisi



Show all 29","Claude  Sportes (Experimental Transplantation and Immunology Branch)



Lalage  Wakefield; PhD (Laboratory of Cancer Biology and Genetics)



Crystal L. Mackall; MD (Pediatric Oncology Branch)



John Charles Morris; MD (Lymphoid Malignancies Branch)



Thomas Alexander Waldmann; MD, PhD (Lymphoid Malignancies Branch)



Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)","Warren J Leonard; MD (NHLBI) 



Gary J Nabel; MD, PhD (NIAID) 



Brian R. Murphy; MD (NIAID) 



Warren  Strober; MD (NIAID) 



David Harvey Margulies; MD, PhD (NIAID) 



Patricia  Earl; PhD (NIAID)","Ordered by publication type and then author name.



1.
Abbadessa G, Accolla R, Aiuti F, Albini A, Aldovini A, Alfano M, Antonelli G, Bartholomew C, Bentwich Z, Bertazzoni U, Berzofsky JA, Biberfeld P, Boeri E, Buonaguro L, Buonaguro FM, Bukrinsky M, Burny A, Caruso A, Cassol S, Chandra P, Ceccherini-Nelli L, Chieco-Bianchi L, Clerici M, Colombini-Hatch S, de Giuli Morghen C, et al. [81 more authors] (2009). Unsung hero Robert C. Gallo. Science  323, 206-7.   https://doi.org/10.1126/science.323.5911.206




PubMed


 


PubMed ID 19131607
    
     


 



2.
Berzofsky JA, Terabe M (2009). The contrasting roles of NKT cells in tumor immunity. Curr Mol Med  9, 667-72.   https://doi.org/10.2174/156652409788970706




PubMed



        
     
Free Article


 


PubMed ID 19689293
         Pubmed Central ID 2729783 


 



3.
Isakov D, Dzutsev A, Belyakov IM, Berzofsky JA (2009). Non-equilibrium and differential function between intraepithelial and lamina propria virus-specific TCRalphabeta(+) CD8alphabeta(+) T cells in the small intestinal mucosa. Mucosal Immunol  2, 450-61.   https://doi.org/10.1038/mi.2009.95




PubMed



        
     
Free Article


 


PubMed ID 19571797
         Pubmed Central ID 3224999 


 



4.
Oakley MS, Majam V, Mahajan B, Gerald N, Anantharaman V, Ward JM, Faucette LJ, McCutchan TF, Zheng H, Terabe M, Berzofsky JA, Aravind L, Kumar S (2009). Pathogenic roles of CD14, galectin-3, and OX40 during experimental cerebral malaria in mice. PLoS One  4, e6793.   https://doi.org/10.1371/journal.pone.0006793




PubMed



        
     
Free Article


 


PubMed ID 19710907
         Pubmed Central ID 2728507 


 



5.
Terabe M, Ambrosino E, Takaku S, O'Konek JJ, Venzon D, Lonning S, McPherson JM, Berzofsky JA (2009). Synergistic enhancement of CD8+ T cell-mediated tumor vaccine efficacy by an anti-transforming growth factor-beta monoclonal antibody. Clin Cancer Res  15, 6560-9.   https://doi.org/10.1158/1078-0432.CCR-09-1066




PubMed



        
     
Free Article


 


PubMed ID 19861451
         Pubmed Central ID 2804258",https://intramural.nih.gov/search/searchview.taf?ipid=63573
746,SC006321-31,"October 01, 2009 -  September 30, 2010",Modulation of Therapeutic Response,"James B Mitchell; PhD



IRP Faculty Profile",NULL,"Radiation Biology Branch, NCI","Rajani  Choudhuri



John Andrew Cook; PhD



William  Degraff



Kristin  Askin



Murali  Krishna; PhD



Janet W Gamson



Show all 8","Dr. Kameron  Maxwell
(Research, Mitos)




Sonya  Zabludoff
(Research, AstraZenca)",Deborah E Citrin (Radiation Oncology Branch),"Carter  Van Waes; MD, PhD (NIDCD) 



Bruce J Baum; DMD, PhD (NIDCR)","Ordered by publication type and then author name.



1.
Brown AP, Chung EJ, Urick ME, Shield WP, Sowers AL, Thetford A, Shankavaram UT, Mitchell JB, Citrin DE (2010). Evaluation of the fullerene compound DF-1 as a radiation protector. Radiat Oncol  5, 34.   https://doi.org/10.1186/1748-717X-5-34




PubMed



        
     
Free Article


 


PubMed ID 20459795
         Pubmed Central ID 2877563 


 



2.
Ishii H, Choudhuri R, Mathias A, Sowers AL, Flanders KC, Cook JA, Mitchell JB (2009). Halofuginone mediated protection against radiation-induced leg contracture. Int J Oncol  35, 315-9.




PubMed



        
     
Free Article


 


PubMed ID 19578745
         Pubmed Central ID 3496156 


 



3.
Kagiya G, Ogawa R, Cook JA, Choudhuri R, Hatashita M, Tanaka Y, DeGraff BG, Mitchell JB (2010). Improvement and induction property of radiation-responsive promoter through DNA shuffling of 5'-flanking regions of the human p21 gene. J Biosci Bioeng  110, 118-23.   https://doi.org/10.1016/j.jbiosc.2009.12.013




PubMed



        
     
Free Article


 


PubMed ID 20541129
         Pubmed Central ID 2886279 


 



4.
Samuni Y, Cook JA, Choudhuri R, Degraff W, Sowers AL, Krishna MC, Mitchell JB (2010). Inhibition of adipogenesis by Tempol in 3T3-L1 cells. Free Radic Biol Med  49, 667-73.   https://doi.org/10.1016/j.freeradbiomed.2010.05.028




PubMed



        
     
Free Article


 


PubMed ID 20561604
         Pubmed Central ID 2904847 


 



5.
Samuni Y, Flores-Santana W, Krishna MC, Mitchell JB, Wink DA (2009). The inhibitors of histone deacetylase suberoylanilide hydroxamate and trichostatin A release nitric oxide upon oxidation. Free Radic Biol Med  47, 419-23.   https://doi.org/10.1016/j.freeradbiomed.2009.05.011




PubMed



        
     
Free Article


 


PubMed ID 19447172
         Pubmed Central ID 2730666 


 



6.
Simone NL, Soule BP, Ly D, Saleh AD, Savage JE, Degraff W, Cook J, Harris CC, Gius D, Mitchell JB (2009). Ionizing radiation-induced oxidative stress alters miRNA expression. PLoS One  4, e6377.   https://doi.org/10.1371/journal.pone.0006377




PubMed



        
     
Free Article


 


PubMed ID 19633716
         Pubmed Central ID 2712071 


 



7.
Soule BP, Simone NL, DeGraff WG, Choudhuri R, Cook JA, Mitchell JB (2010). Loratadine dysregulates cell cycle progression and enhances the effect of radiation in human tumor cell lines. Radiat Oncol  5, 8.   https://doi.org/10.1186/1748-717X-5-8




PubMed



        
     
Free Article


 


PubMed ID 20128919
         Pubmed Central ID 2829588 


 



8.
Zheng C, Cotrim AP, Sunshine AN, Sugito T, Liu L, Sowers A, Mitchell JB, Baum BJ (2009). Prevention of radiation-induced oral mucositis after adenoviral vector-mediated transfer of the keratinocyte growth factor cDNA to mouse submandibular glands. Clin Cancer Res  15, 4641-8.   https://doi.org/10.1158/1078-0432.CCR-09-0819




PubMed



        
     
Free Article


 


PubMed ID 19584147
         Pubmed Central ID 2769927",https://intramural.nih.gov/search/searchview.taf?ipid=63574
747,SC006330-30,"October 01, 2009 -  September 30, 2010",Radiation Field Modeling and Computerized Treatment Planning,Robert W Miller,Kevin A Camphausen; MD,"Radiation Oncology Branch, NCI","Jason Yulin Cheng; PhD



Yeonju Sarah Han-Oh



Frank S Harrington



Holly  Ning



John  Ondos



Hu-Chen  Xie



Show all 7","Wei  Chen
(University of Texas)




Thomas  Fearon
(Radiology, Children's National Medical Center)




Chang-Ming  Ma
(Radiation Oncology Department, Fox Chase Cancer Center)",NULL,NULL,"Ordered by publication type and then author name.



1.
Li G, Arora NC, Xie H, Ning H, Lu W, Low D, Citrin D, Kaushal A, Zach L, Camphausen K, Miller RW (2009). Quantitative prediction of respiratory tidal volume based on the external torso volume change: a potential volumetric surrogate. Phys Med Biol  54, 1963-78.   https://doi.org/10.1088/0031-9155/54/7/007




PubMed


 


PubMed ID 19265201
    
     


 



2.
Li G, Xie H, Ning H, Lu W, Low D, Citrin D, Kaushal A, Zach L, Camphausen K, Miller RW (2009) A novel analytical approach to the prediction of respiratory diaphragm motion based on external torso volume change. Phys Med Biol 54:4113-30.




PubMed


 


PubMed ID 19521009
    
     


 



3.
Zhuge Y, Cao Y, Miller RW (2009). GPU accelerated fuzzy connected image segmentation by using CUDA. Conf Proc IEEE Eng Med Biol Soc  2009, 6341-4.   https://doi.org/10.1109/IEMBS.2009.5333158




PubMed


 


PubMed ID 19964158",https://intramural.nih.gov/search/searchview.taf?ipid=63557
748,SC006353-28,"October 01, 2009 -  September 30, 2010",Metal Chelate Conjugated Monoclonal Antibodies for Tumor Diagnosis and Therapy,"Martin W Brechbiel; PhD



IRP Faculty Profile",NULL,"Radiation Oncology Branch, NCI","Kwamena  Baidoo



Ambika  Bumb



Diane E Milenic



Kevin A Camphausen; MD



Tapankumar Kirankumar Nayak



Deborah E Citrin



Show all 11","Lynn  Francesconi
(Hunter College)




Silvia  Jurisson
(University of Missouri, Columbia)




Ruby  Meredith
(UAB)




Marty  Pomper
(Johns Hopkins)




Tom  Quinn
(U. Missouri, Co.)




Andrew  Scott
(Ludwig Institute for Cancer Research)


Show all 7","Thomas Alexander Waldmann; MD, PhD (Lymphoid Malignancies Branch)



James B Mitchell; PhD (Radiation Biology Branch)",Peter  Herscovitch; MD (CC),"Ordered by publication type and then author name.



1.
Boswell CA, Regino CA, Baidoo KE, Wong KJ, Milenic DE, Kelley JA, Lai CC, Brechbiel MW (2009). A novel side-bridged hybrid phosphonate/acetate pendant cyclam: synthesis, characterization, and 64Cu small animal PET imaging. Bioorg Med Chem  17, 548-52.   https://doi.org/10.1016/j.bmc.2008.11.073




PubMed



        
     
Free Article


 


PubMed ID 19101152
         Pubmed Central ID 2636550 


 



2.
Herbertson RA, Tebbutt NC, Lee FT, MacFarlane DJ, Chappell B, Micallef N, Lee ST, Saunder T, Hopkins W, Smyth FE, Wyld DK, Bellen J, Sonnichsen DS, Brechbiel MW, Murone C, Scott AM (2009). Phase I biodistribution and pharmacokinetic study of Lewis Y-targeting immunoconjugate CMD-193 in patients with advanced epithelial cancers. Clin Cancer Res  15, 6709-15.   https://doi.org/10.1158/1078-0432.CCR-09-0536




PubMed



        
     
Free Article


 


PubMed ID 19825951
         Pubmed Central ID 6944432 


 



3.
Kelly MP, Lee ST, Lee FT, Smyth FE, Davis ID, Brechbiel MW, Scott AM (2009). Therapeutic efficacy of 177Lu-CHX-A''-DTPA-hu3S193 radioimmunotherapy in prostate cancer is enhanced by EGFR inhibition or docetaxel chemotherapy. Prostate  69, 92-104.   https://doi.org/10.1002/pros.20856




PubMed



        
     
Free Article


 


PubMed ID 18942092
         Pubmed Central ID 2597150 


 



4.
Nayak TK, Brechbiel MW (2009). Radioimmunoimaging with longer-lived positron-emitting radionuclides: potentials and challenges. Bioconjug Chem  20, 825-41.   https://doi.org/10.1021/bc800299f




PubMed



        
     
Free Article


 


PubMed ID 19125647
         Pubmed Central ID 3397469 


 



5.
Ray GL, Baidoo KE, Wong KJ, Williams M, Garmestani K, Brechbiel MW, Milenic DE (2009). Preclinical evaluation of a monoclonal antibody targeting the epidermal growth factor receptor as a radioimmunodiagnostic and radioimmunotherapeutic agent. Br J Pharmacol  157, 1541-8.   https://doi.org/10.1111/j.1476-5381.2009.00327.x




PubMed



        
     
Free Article


 


PubMed ID 19681874
         Pubmed Central ID 2765311 


 



6.
Regino CA, Wong KJ, Milenic DE, Holmes EH, Garmestani K, Choyke PL, Brechbiel MW (2009). Preclinical evaluation of a monoclonal antibody (3C6) specific for prostate-specific membrane antigen. Curr Radiopharm  2, 9-17.   https://doi.org/10.2174/1874471010902010009




PubMed



        
     
Free Article


 


PubMed ID 20047017
         Pubmed Central ID 2678849 


 



7.
Wei L, Zhang X, Gallazzi F, Miao Y, Jin X, Brechbiel MW, Xu H, Clifford T, Welch MJ, Lewis JS, Quinn TP (2009). Melanoma imaging using (111)In-, (86)Y- and (68)Ga-labeled CHX-A''-Re(Arg11)CCMSH. Nucl Med Biol  36, 345-54.   https://doi.org/10.1016/j.nucmedbio.2009.01.007




PubMed



        
     
Free Article


 


PubMed ID 19423001
         Pubmed Central ID 2752876 


 



8.
Xu H, Eck PK, Baidoo KE, Choyke PL, Brechbiel MW (2009). Toward preparation of antibody-based imaging probe libraries for dual-modality positron emission tomography and fluorescence imaging. Bioorg Med Chem  17, 5176-81.   https://doi.org/10.1016/j.bmc.2009.05.048




PubMed



        
     
Free Article


 


PubMed ID 19505829
         Pubmed Central ID 2759299 


 



9.
Zhang M, Yao Z, Garmestani K, Yu S, Goldman CK, Paik CH, Brechbiel MW, Carrasquillo JA, Waldmann TA (2009). Preclinical evaluation of an anti-CD25 monoclonal antibody, 7G7/B6, armed with the beta-emitter, yttrium-90, as a radioimmunotherapeutic agent for treating lymphoma. Cancer Biother Radiopharm  24, 303-9.   https://doi.org/10.1089/cbr.2008.0577




PubMed



        
     
Free Article


 


PubMed ID 19538052
         Pubmed Central ID 2925030",https://intramural.nih.gov/search/searchview.taf?ipid=63575
749,SC006387-23,"October 01, 2009 -  September 30, 2010",Nitroxides as Protectors Against Oxidative Stress,"James B Mitchell; PhD



IRP Faculty Profile",NULL,"Radiation Biology Branch, NCI","Rajani  Choudhuri



John Andrew Cook; PhD



William  Degraff



Kristin  Askin



Murali  Krishna; PhD



Janet W Gamson



Show all 8","Dr. Kameron  Maxwell
(Research, Mitos)




Jacquie  Shukaliak-Quandt
(University of British Columbia)","Michael  Potter; MD (Laboratory of Cancer Biology and Genetics)



Frank Jess Gonzalez; PhD (Laboratory of Metabolism)",Tracey Ann Rouault; MD (NICHD),"Ordered by publication type and then author name.



1.
Citrin D, Cotrim AP, Hyodo F, Baum BJ, Krishna MC, Mitchell JB (2010). Radioprotectors and mitigators of radiation-induced normal tissue injury. Oncologist  15, 360-71.   https://doi.org/10.1634/theoncologist.2009-S104




PubMed



        
     
Free Article


 


PubMed ID 20413641
         Pubmed Central ID 3076305",https://intramural.nih.gov/search/searchview.taf?ipid=63577
750,SC006538-17,"October 01, 2009 -  September 30, 2010",Development of Angiogenesis Inhibitors,"William D Figg; PharmD



IRP Faculty Profile",Giuseppe  Giaccone; MD,"Medical Oncology Branch, NCI","Cindy Huong-Bich Chau



Bevin Cathleen English



Christian Tyler Kirkland



Stephen T Pisle



Douglas K Price



Kelie M Reece; PhD



Show all 8","Christopher  Schofield
(University of Oxford)




Neil  Vargesson; PhD
(University of Aberdeen)","William Laurence Dahut; MD (Office of the Director)



James L Gulley; MD, PhD (Laboratory of Tumor Immunology and Biology)



Kevin  Gardner; MD, PhD (Hormone Action and Oncogenesis Section)",NULL,"Ordered by publication type and then author name.



1.
Figg W, Figg W (2010) Pharmacology of Cancer Biotherapeutics: Angiogenesis Agents, in Cancer: Principles and Practices of Oncology, 9th Edition. Lippincott Williams and Wilkins (Philadelphia), in press.




 



2.
Aragon-Ching JB, Jain L, Gulley JL, Arlen PM, Wright JJ, Steinberg SM, Draper D, Venitz J, Jones E, Chen CC, Figg WD, Dahut WL (2009). Final analysis of a phase II trial using sorafenib for metastatic castration-resistant prostate cancer. BJU Int  103, 1636-40.   https://doi.org/10.1111/j.1464-410X.2008.08327.x




PubMed



        
     
Free Article


 


PubMed ID 19154507
         Pubmed Central ID 2818665 


 



3.
Aragon-Ching JB, Ning YM, Chen CC, Latham L, Guadagnini JP, Gulley JL, Arlen PM, Wright JJ, Parnes H, Figg WD, Dahut WL (2009). Higher incidence of Osteonecrosis of the Jaw (ONJ) in patients with metastatic castration resistant prostate cancer treated with anti-angiogenic agents. Cancer Invest  27, 221-6.   https://doi.org/10.1080/07357900802208608




PubMed



        
     
Free Article


 


PubMed ID 19235596
         Pubmed Central ID 2648132 


 



4.
Azad NS, Aragon-Ching JB, Dahut WL, Gutierrez M, Figg WD, Jain L, Steinberg SM, Turner ML, Kohn EC, Kong HH (2009). Hand-foot skin reaction increases with cumulative sorafenib dose and with combination anti-vascular endothelial growth factor therapy. Clin Cancer Res  15, 1411-6.   https://doi.org/10.1158/1078-0432.CCR-08-1141




PubMed



        
     
Free Article


 


PubMed ID 19228742
         Pubmed Central ID 2718558 


 



5.
Cook KM, Hilton ST, Mecinovic J, Motherwell WB, Figg WD, Schofield CJ (2009). Epidithiodiketopiperazines block the interaction between hypoxia-inducible factor-1alpha (HIF-1alpha) and p300 by a zinc ejection mechanism. J Biol Chem  284, 26831-8.   https://doi.org/10.1074/jbc.M109.009498




PubMed



        
     
Free Article


 


PubMed ID 19589782
         Pubmed Central ID 2785371 


 



6.
Dahut WL, Aragon-Ching JB, Woo S, Tohnya TM, Gulley JL, Arlen PM, Wright JJ, Ventiz J, Figg WD (2009). Phase I study of oral lenalidomide in patients with refractory metastatic cancer. J Clin Pharmacol  49, 650-60.   https://doi.org/10.1177/0091270009335001




PubMed



        
     
Free Article


 


PubMed ID 19451403
         Pubmed Central ID 2808857 


 



7.
English BC, Price DK, Figg WD (2009). VEGF inhibition and metastasis: possible implications for antiangiogenic therapy. Cancer Biol Ther  8, 1214-25.   https://doi.org/10.4161/cbt.8.13.8918




PubMed



        
     
Free Article


 


PubMed ID 19483467
         Pubmed Central ID 2802271 


 



8.
Figg WD, Hussain MH, Gulley JL, Arlen PM, Aragon-Ching JB, Petrylak DP, Higano CS, Steinberg SM, Chatta GS, Parnes H, Wright JJ, Sartor O, Dahut WL (2009). A double-blind randomized crossover study of oral thalidomide versus placebo for androgen dependent prostate cancer treated with intermittent androgen ablation. J Urol  181, 1104-13; discussion 1113.   https://doi.org/10.1016/j.juro.2008.11.026




PubMed



        
     
Free Article


 


PubMed ID 19167733
         Pubmed Central ID 2838198 


 



9.
Jain L, Gardner ER, Figg WD, Chernick MS, Kong HH (2010). Lack of association between excretion of sorafenib in sweat and hand-foot skin reaction. Pharmacotherapy  30, 52-6.   https://doi.org/10.1592/phco.30.1.52




PubMed



        
     
Free Article


 


PubMed ID 20030473
         Pubmed Central ID 3542635 


 



10.
Sissung TM, Thordardottir S, Gardner ER, Figg WD (2009). Current status of thalidomide and CC-5013 in the treatment of metastatic prostate cancer. Anticancer Agents Med Chem  9, 1058-69.   https://doi.org/10.2174/187152009789735017




PubMed



        
     
Free Article


 


PubMed ID 19719457
         Pubmed Central ID 6415974 


 



11.
Therapontos C, Erskine L, Gardner ER, Figg WD, Vargesson N (2009). Thalidomide induces limb defects by preventing angiogenic outgrowth during early limb formation. Proc Natl Acad Sci U S A  106, 8573-8.   https://doi.org/10.1073/pnas.0901505106




PubMed



        
     
Free Article


 


PubMed ID 19433787
         Pubmed Central ID 2688998",https://intramural.nih.gov/search/searchview.taf?ipid=63578
751,SC006581-27,"October 01, 2009 -  September 30, 2010",Molecular Pathogenesis of Multiple Myeloma,"Walter M Kuehl; MD, PhD",NULL,"Cancer Genetics Branch, NCI","Leslie Ann Brents



Wei-Dong  Chen



Oleg K Glebov","Bart  Barlogie
(Univ. of Arkansas for Medical Sciences)




P.  Bergsagel
(Divison of Hematology, Mayo Clinic)




Carlo M Croce





Rafael  Fonseca
(Division of Hematology, Mayo Clinic)




John  Shaughnessy
(Universiy of Arkansas for Medical Sciences)




Brendan  Weiss","Ola Anders Landgren (Medical Oncology Branch)



Louis  Staudt; MD (Lymphoid Malignancies Branch)",NULL,"Ordered by publication type and then author name.



1.
Demchenko YN, Glebov OK, Zingone A, Keats JJ, Bergsagel PL, Kuehl WM (2010). Classical and/or alternative NF-kappaB pathway activation in multiple myeloma. Blood  115, 3541-52.   https://doi.org/10.1182/blood-2009-09-243535




PubMed



        
     
Free Article


 


PubMed ID 20053756
         Pubmed Central ID 2867265 


 



2.
Fonseca R, Bergsagel PL, Drach J, Shaughnessy J, Gutierrez N, Stewart AK, Morgan G, Van Ness B, Chesi M, Minvielle S, Neri A, Barlogie B, Kuehl WM, Liebisch P, Davies F, Chen-Kiang S, Durie BG, Carrasco R, Sezer O, Reiman T, Pilarski L, Avet-Loiseau H, International Myeloma Working Group (2009). International Myeloma Working Group molecular classification of multiple myeloma: spotlight review. Leukemia  23, 2210-21.   https://doi.org/10.1038/leu.2009.174




PubMed



        
     
Free Article


 


PubMed ID 19798094
         Pubmed Central ID 2964268 


 



3.
Peterson TR, Laplante M, Thoreen CC, Sancak Y, Kang SA, Kuehl WM, Gray NS, Sabatini DM (2009). DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival. Cell  137, 873-86.   https://doi.org/10.1016/j.cell.2009.03.046




PubMed



        
     
Free Article


 


PubMed ID 19446321
         Pubmed Central ID 2758791 


 



4.
Rasmussen T, Haaber J, Dahl IM, Knudsen LM, Kerndrup G, Lodahl M, Johnsen HE, Kuehl M (2010) Identification of translocation products but not K-RAS mutations in memory B cells from patients with multiple myeloma. Haematologica 95:1730-7




PubMed



        
     
Free Article


 


PubMed ID 20511669
         Pubmed Central ID 2948099 


 



5.
Waxman AJ, Kuehl M, Balakumaran A, Weiss B, Landgren O (2010). Smoldering (asymptomatic) multiple myeloma: revisiting the clinical dilemma and looking into the future. Clin Lymphoma Myeloma Leuk  10, 248-57.   https://doi.org/10.3816/CLML.2010.n.053




PubMed



        
     
Free Article


 


PubMed ID 20709660
         Pubmed Central ID 6849209 


 



6.
Weiss BM, Abadie J, Verma P, Howard RS, Kuehl WM (2009). A monoclonal gammopathy precedes multiple myeloma in most patients. Blood  113, 5418-22.   https://doi.org/10.1182/blood-2008-12-195008




PubMed



        
     
Free Article


 


PubMed ID 19234139
         Pubmed Central ID 2689043 


 



7.
Weiss BM, Kuehl WM (2010). Advances in understanding monoclonal gammopathy of undetermined significance as a precursor of multiple myeloma. Expert Rev Hematol  3, 165-74.   https://doi.org/10.1586/ehm.10.13




PubMed



        
     
Free Article


 


PubMed ID 20473362
         Pubmed Central ID 2869099 


 



8.
Zingone A, Cultraro CM, Shin DM, Bean CM, Morse HC, Janz S, Kuehl WM (2010). Ectopic expression of wild-type FGFR3 cooperates with MYC to accelerate development of B-cell lineage neoplasms. Leukemia  24, 1171-8.   https://doi.org/10.1038/leu.2010.50




PubMed



        
     
Free Article


 


PubMed ID 20393505
         Pubmed Central ID 3118571",https://intramural.nih.gov/search/searchview.taf?ipid=63579
752,SC006663-21,"October 01, 2009 -  September 30, 2010",Molecular Characterization of Breast Duct Epithelium at Risk for Breast Cancer,David  Danforth,NULL,"Surgery Branch, NCI",Marybeth S Hughes,NULL,"Barbara V Vonderhaar; PhD (Mammary Biology and Tumorigenesis Laboratory)



Joanna H Shih (Biometrics Research Branch)



Karl Thomas Ried; MD (Cancer Genetics Branch)



Maria  Merino; PhD (Laboratory of Pathology)



David Erwin Kleiner; MD, PhD (Laboratory of Pathology)



Mark H Greene; MD (Clinical Genetics Branch)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63580
753,SC006732-22,"October 01, 2009 -  September 30, 2010",Multidrug Resistance Mediated by P-glycoprotein,"Antonio  Fojo; MD, PhD",NULL,"Medical Oncology Branch, NCI","Lyn Ann J Mickley



Douglas K Price



Susan  Bates; MD



Edina M Komlodi-pasztor



Wilfred D Stein



Shana Y Trostel



Show all 8",NULL,"William Laurence Dahut; MD (Office of the Director)



James L Gulley; MD, PhD (Laboratory of Tumor Immunology and Biology)



Frank M Balis; MD, PhD (Pediatric Oncology Branch)",Robert  Innis; MD (NIMH),"Ordered by publication type and then author name.



1.
Fojo T, Grady C (2009) How much is life worth: cetuximab, non-small cell lung cancer, and the $440 billion question. J Natl Cancer Inst 101:1044-8.




PubMed



        
     
Free Article


 


PubMed ID 19564563
         Pubmed Central ID 2724853 


 



2.
Komlodi-Pasztor E, Trostel S, Sackett D, Poruchynsky M, Fojo T (2009). Impaired p53 binding to importin: a novel mechanism of cytoplasmic sequestration identified in oxaliplatin-resistant cells. Oncogene  28, 3111-20.   https://doi.org/10.1038/onc.2009.166




PubMed



        
     
Free Article


 


PubMed ID 19581934
         Pubmed Central ID 2867326 


 



3.
Piekarz RL, Frye R, Turner M, Wright JJ, Allen SL, Kirschbaum MH, Zain J, Prince HM, Leonard JP, Geskin LJ, Reeder C, Joske D, Figg WD, Gardner ER, Steinberg SM, Jaffe ES, Stetler-Stevenson M, Lade S, Fojo AT, Bates SE (2009). Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma. J Clin Oncol  27, 5410-7.   https://doi.org/10.1200/JCO.2008.21.6150




PubMed



        
     
Free Article


 


PubMed ID 19826128
         Pubmed Central ID 2773225 


 



4.
Widemann BC, Goodspeed W, Goodwin A, Fojo T, Balis FM, Fox E (2009). Phase I trial and pharmacokinetic study of ixabepilone administered daily for 5 days in children and adolescents with refractory solid tumors. J Clin Oncol  27, 550-6.   https://doi.org/10.1200/JCO.2008.17.6644




PubMed



        
     
Free Article


 


PubMed ID 19075272
         Pubmed Central ID 2645861",https://intramural.nih.gov/search/searchview.taf?ipid=63581
754,SC006737-19,"October 01, 2009 -  September 30, 2010",Development of Novel Therapies for HIV Infection,"Robert  Yarchoan; MD



IRP Faculty Profile",NULL,"HIV and AIDS Malignancy Branch, NCI","Karen O Aleman



David A Davis; MD



Vesselin  Nikolov



Mark Niccolo Polizzotto; MD



Erin Elizabeth Soule



Hiroaki  Mitsuya



Show all 10","Jean  Chmielewski
(Purdue University)




Indira  Hewlett
(Food and Drug  Administration)




Shixing  Tang
(FDA)","Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)



Eric O Freed; PhD (Retroviral Replication Laboratory)



Seth M Steinberg; PhD (Office of the Director)



George N Pavlakis; MD, PhD (Vaccine Branch)



Frank  Maldarelli (Host Virus Interaction Branch)",Paul T Wingfield; PhD (NIAMS),"Ordered by publication type and then author name.



1.
Davis DA, Tebbs IR, Daniels SI, Stahl SJ, Kaufman JD, Wingfield P, Bowman MJ, Chmielewski J, Yarchoan R (2009). Analysis and characterization of dimerization inhibition of a multi-drug-resistant human immunodeficiency virus type 1 protease using a novel size-exclusion chromatographic approach. Biochem J  419, 497-506.   https://doi.org/10.1042/BJ20082068




PubMed



        
     
Free Article


 


PubMed ID 19149765
         Pubmed Central ID 2748811",https://intramural.nih.gov/search/searchview.taf?ipid=63582
755,SC006738-19,"October 01, 2009 -  September 30, 2010",Development of Antiviral Therapy of HIV-1 Infection,Hiroaki  Mitsuya,NULL,"HIV and AIDS Malignancy Branch, NCI","Debananda  Das; PhD



Hirotomo  Nakata



Zachary Haines Smith; BA



Ravikiran S Yedidi



Yasuhiro  Hayashi



Matthew  Trachtenberg","Masayuki  Amano
(Kumamoto University School of Medicine)




Arun  Ghosh





Hiroyuki  Hayakawa
(Yamasa Corporation)




Eiichi  Kodama
(Kyoto University)




Yasuhiro  Koh
(Kumamoto University School of Medicine)




Masao 		  Matsuoka
(Institute for Virus Research, Kyoto University)


Show all 9",NULL,NULL,"Ordered by publication type and then author name.



1.
Mitsuya H, Amano M, Towata T, Danish M, Leshchenko-Yashchuk S, Das D, Nakayama, M, Tojo Y, Ghosh A, Mitsuya H (2010) In vitro selection of highly darunavir-resistant and replication-competent HIV-1 variants using a mixture of clinical HIV-1 isolates resistant to multiple conventional protease inhibitors. J Virol, in press.




 



2.
Mitsuya H, Singh K, Michailidis E, Marchand B, Kodama E, Ashida N, Mitsuya H, Parniak M, Sarafianos S (2010) The sugar ring conformation of 4-ethynyl-2-fluoro-2-deoxyadenosine and its recognition by the polymerase active site of HIV reverse transcriptase. J Biol Chem, in press.




 



3.
Mitsuya H, Xu C, Rao K, Baldridge A, Tie Y, Wang Y, Weber I, Aoki M, Gomez S, Amano M, Mitsuya H (2010) Probing multidrug-resistance and protein-ligand interactions with new oxatricyclic designed ligands in HIV-1 protease inhibitors. Chem Med Chem, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=63558
756,SC006741-18,"October 01, 2009 -  September 30, 2010",Lymphoma Studies,"Wyndham H Wilson; MD, PhD



IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",John  Janik; MD,NULL,"Stefania  Pittaluga (Laboratory of Pathology)



Louis  Staudt; MD (Lymphoid Malignancies Branch)



Elaine S Jaffe; MD (Laboratory of Pathology)



Maryalice  Stetler-Stevenson; MD, PhD (Laboratory of Pathology)



Andrea  Abati; BS, MD (Laboratory of Pathology)","Adrian U Wiestner; MD, PhD (NHLBI)","Ordered by publication type and then author name.



1.
Dunleavy K, Little RF, Pittaluga S, Grant N, Wayne AS, Carrasquillo JA, Steinberg SM, Yarchoan R, Jaffe ES, Wilson WH (2010). The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphoma. Blood  115, 3017-24.   https://doi.org/10.1182/blood-2009-11-253039




PubMed



        
     
Free Article


 


PubMed ID 20130244
         Pubmed Central ID 2858473 


 



2.
Kochenderfer JN, Wilson WH, Janik JE, Dudley ME, Stetler-Stevenson M, Feldman SA, Maric I, Raffeld M, Nathan DA, Lanier BJ, Morgan RA, Rosenberg SA (2010). Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19. Blood  116, 4099-102.   https://doi.org/10.1182/blood-2010-04-281931




PubMed



        
     
Free Article


 


PubMed ID 20668228
         Pubmed Central ID 2993617",https://intramural.nih.gov/search/searchview.taf?ipid=63559
757,SC006891-22,"October 01, 2009 -  September 30, 2010",Solid Tumors,"Lee Jay Helman; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI","Fernanda  Arnaldez



Barbara A Dickens



Patrick  Grohar



Crystal L. Mackall; MD



Su-Young  Kim



Lauren M Long",NULL,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)



Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)



Nealapheur L Khan (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Fox E, Widemann BC, Hawkins DS, Jayaprakash N, Dagher R, Aikin AA, Bernstein D, Long L, Mackall C, Helman L, Steinberg SM, Balis FM (2009). Randomized trial and pharmacokinetic study of pegfilgrastim versus filgrastim after dose-intensive chemotherapy in young adults and children with sarcomas. Clin Cancer Res  15, 7361-7.   https://doi.org/10.1158/1078-0432.CCR-09-0761




PubMed



        
     
Free Article


 


PubMed ID 19920107
         Pubmed Central ID 2787766 


 



2.
Kim SY, Helman LJ (2009). Strategies to explore new approaches in the investigation and treatment of osteosarcoma. Cancer Treat Res  152, 517-28.   https://doi.org/10.1007/978-1-4419-0284-9_31




PubMed


 


PubMed ID 20213413
    
     


 



3.
Kim SY, Toretsky JA, Scher D, Helman LJ (2009). The role of IGF-1R in pediatric malignancies. Oncologist  14, 83-91.   https://doi.org/10.1634/theoncologist.2008-0189




PubMed



        
     
Free Article


 


PubMed ID 19126579
         Pubmed Central ID 2721475 


 



4.
Kummar S, Kinders R, Gutierrez ME, Rubinstein L, Parchment RE, Phillips LR, Ji J, Monks A, Low JA, Chen A, Murgo AJ, Collins J, Steinberg SM, Eliopoulos H, Giranda VL, Gordon G, Helman L, Wiltrout R, Tomaszewski JE, Doroshow JH (2009). Phase 0 clinical trial of the poly (ADP-ribose) polymerase inhibitor ABT-888 in patients with advanced malignancies. J Clin Oncol  27, 2705-11.   https://doi.org/10.1200/JCO.2008.19.7681




PubMed



        
     
Free Article


 


PubMed ID 19364967
         Pubmed Central ID 2739635 


 



5.
Taylor JG, Cheuk AT, Tsang PS, Chung JY, Song YK, Desai K, Yu Y, Chen QR, Shah K, Youngblood V, Fang J, Kim SY, Yeung C, Helman LJ, Mendoza A, Ngo V, Staudt LM, Wei JS, Khanna C, Catchpoole D, Qualman SJ, Hewitt SM, Merlino G, Chanock SJ, Khan J (2009). Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models. J Clin Invest  119, 3395-407.   https://doi.org/10.1172/JCI39703




PubMed



        
     
Free Article


 


PubMed ID 19809159
         Pubmed Central ID 2769177 


 



6.
Wan X, Kim SY, Guenther LM, Mendoza A, Briggs J, Yeung C, Currier D, Zhang H, Mackall C, Li WJ, Tuan RS, Deyrup AT, Khanna C, Helman L (2009). Beta4 integrin promotes osteosarcoma metastasis and interacts with ezrin. Oncogene  28, 3401-11.   https://doi.org/10.1038/onc.2009.206




PubMed



        
     
Free Article


 


PubMed ID 19597468
         Pubmed Central ID 2753583",https://intramural.nih.gov/search/searchview.taf?ipid=63585
758,SC006892-22,"October 01, 2009 -  September 30, 2010",Molecular Biology of Pediatric Tumors,"Lee Jay Helman; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI","Fernanda  Arnaldez



Barbara A Dickens



Patrick  Grohar



Su-Young  Kim



Laura Elizabeth Segars



Xiaolin  Wan



Show all 7",NULL,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)



Glenn  Merlino; PhD (Laboratory of Cancer Biology and Genetics)



Allan M Weissman; MD (Laboratory of Protein Dynamics and Signaling)



Louis  Staudt; MD (Lymphoid Malignancies Branch)



Nealapheur L Khan (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Hong SH, Briggs J, Newman R, Hoffman K, Mendoza A, LeRoith D, Helman L, Yakar S, Khanna C (2009). Murine osteosarcoma primary tumour growth and metastatic progression is maintained after marked suppression of serum insulin-like growth factor I. Int J Cancer  124, 2042-9.   https://doi.org/10.1002/ijc.24169




PubMed



        
     
Free Article


 


PubMed ID 19132750
         Pubmed Central ID 6948843 


 



2.
Kim SY, Toretsky JA, Scher D, Helman LJ (2009). The role of IGF-1R in pediatric malignancies. Oncologist  14, 83-91.   https://doi.org/10.1634/theoncologist.2008-0189




PubMed



        
     
Free Article


 


PubMed ID 19126579
         Pubmed Central ID 2721475 


 



3.
Taylor JG, Cheuk AT, Tsang PS, Chung JY, Song YK, Desai K, Yu Y, Chen QR, Shah K, Youngblood V, Fang J, Kim SY, Yeung C, Helman LJ, Mendoza A, Ngo V, Staudt LM, Wei JS, Khanna C, Catchpoole D, Qualman SJ, Hewitt SM, Merlino G, Chanock SJ, Khan J (2009). Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models. J Clin Invest  119, 3395-407.   https://doi.org/10.1172/JCI39703




PubMed



        
     
Free Article


 


PubMed ID 19809159
         Pubmed Central ID 2769177",https://intramural.nih.gov/search/searchview.taf?ipid=63586
759,SC007256-22,"October 01, 2009 -  September 30, 2010",Mechanisms of Oncogene Action in Tumorigenesis,Frederic  Kaye; MD,NULL,"Cancer Genetics Branch, NCI","Paul S Meltzer; MD, PhD","Yuh Min  Chook
(Pharmacology, University of Texas Southwestern)




Adel  El-Naggar
(MD Anderson Cancer Center)




Isabel  Fonseca
(Pathology, Portugal Cancer Institute)




Levi  Garraway
(Dana-Farber)","Tatiana  Karpova (Laboratory of Receptor Biology and Gene Expression)



Maria  Zajac-Kaye; PhD (Medical Oncology Branch)",NULL,"Ordered by publication type and then author name.



1.
Anzick SL, Chen WD, Park Y, Meltzer P, Bell D, El-Naggar AK, Kaye FJ (2010). Unfavorable prognosis of CRTC1-MAML2 positive mucoepidermoid tumors with CDKN2A deletions. Genes Chromosomes Cancer  49, 59-69.   https://doi.org/10.1002/gcc.20719




PubMed



        
     
Free Article


 


PubMed ID 19827123
         Pubmed Central ID 2783528",https://intramural.nih.gov/search/searchview.taf?ipid=63587
760,SC007263-18,"October 01, 2009 -  September 30, 2010",TRAIL-induced Cell Death in Breast Cancer Cells,"Stanley  Lipkowitz; MD, PhD



IRP Faculty Profile",NULL,"Laboratory of Cellular and Molecular Biology, NCI","Kathryn Jill Chavez



Sireesha  Garimella","Mauricio A Cuello





Sandra M Swain; MD","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)



Jeffrey E Green; MD (Laboratory of Cancer Biology and Genetics)



Natasha  Caplen (Cancer Genetics Branch)",NULL,"Ordered by publication type and then author name.



1.
Rahman M, Pumphrey JG, Lipkowitz S (2009). The TRAIL to targeted therapy of breast cancer. Adv Cancer Res  103, 43-73.   https://doi.org/10.1016/S0065-230X(09)03003-6




PubMed



        
     
Free Article


 


PubMed ID 19854352
         Pubmed Central ID 3538140",https://intramural.nih.gov/search/searchview.taf?ipid=63588
761,SC007281-17,"October 01, 2009 -  September 30, 2010",Nitric Oxide as a Modifier of Oxidative Stress,"David Anderson Wink



IRP Faculty Profile",NULL,"Radiation Biology Branch, NCI","Yuk Sing Robert Cheng



James B Mitchell; PhD



Sharon  Glynn



Lisa Ann Ridnour



Christopher H Switzer","Piero  del Soldato
(Pharma, CTG Pharma)




Micheal  Vitek
(Neurology, Duke Uniuversity Medical School)","Terry  Moody; PhD (Office of the Director)



Curtis  Harris; MD (Laboratory of Human Carcinogenesis)



Stefan  Ambs (Molecular Genetics and Carcinogenesis Section)



Larry K Keefer; PhD (Laboratory of Comparative Carcinogenesis)",NULL,"Ordered by publication type and then author name.



1.
Glynn SA, Boersma BJ, Howe TM, Edvardsen H, Geisler SB, Goodman JE, Ridnour LA, Lønning PE, Børresen-Dale AL, Naume B, Kristensen VN, Chanock SJ, Wink DA, Ambs S (2009). A mitochondrial target sequence polymorphism in manganese superoxide dismutase predicts inferior survival in breast cancer patients treated with cyclophosphamide. Clin Cancer Res  15, 4165-73.   https://doi.org/10.1158/1078-0432.CCR-09-0119




PubMed



        
     
Free Article


 


PubMed ID 19509150
         Pubmed Central ID 2697269",https://intramural.nih.gov/search/searchview.taf?ipid=63589
762,SC009144-26,"October 01, 2009 -  September 30, 2010",Mechanisms of transcription factor integration at the c-myc promoter,"David  Levens; PhD



IRP Faculty Profile",NULL,"Laboratory of Pathology, NCI","Hye-Jung  Chung



Yeung  Ho



Zuqin  Nie; PhD



Na  Salony



Suzanne Laurie Sanford



Matthew  Vogt



Show all 7","Demetrios T Braddock; MD, PhD





John  Cleveland","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)



Gordon Lee Hager; PhD (Laboratory of Receptor Biology and Gene Expression)



Louis  Staudt; MD (Lymphoid Malignancies Branch)



Lino  Tessarollo (Mouse Cancer Genetics Program)","Keji  Zhao; PhD (NHLBI) 



Rafael Cristian Casellas; PhD (NIAMS)","Ordered by publication type and then author name.



1.
Levens D (2010) You Don't Muck with MYC. Genes and Cancer 1:547-554.




 



2.
Rabenhorst U, Beinoraviciute-Kellner R, Brezniceanu ML, Joos S, Devens F, Lichter P, Rieker RJ, Trojan J, Chung HJ, Levens DL, Zörnig M (2009). Overexpression of the far upstream element binding protein 1 in hepatocellular carcinoma is required for tumor growth. Hepatology  50, 1121-9.   https://doi.org/10.1002/hep.23098




PubMed



        
     
Free Article


 


PubMed ID 19637194
         Pubmed Central ID 3474328",https://intramural.nih.gov/search/searchview.taf?ipid=63590
763,SC009163-23,"October 01, 2009 -  September 30, 2010",Signal Transduction Therapy--Basic Science,Elise C Kohn; MD,NULL,"Medical Oncology Branch, NCI","Mathew  Angelos



Giovanna  Casagrande



Christina M Annunziata



Ryan  Henning



Andrea Katherine McCollum



Victoria M Virador","Riccardo  Alessandro
(U-Palermo)




Thomas  Conrads
(University of Pittsburgh Cancer Institute)




Ben  Davidson
(Norwegian Radium Hospital)




Gordon  Mills
(MD Anderson Cancer Center)","David R Gius; MD, PhD (Radiation Oncology Branch)



David Jay Goldstein (Office of the Director)



Brigitte  Widemann; MD (Pediatric Oncology Branch)



Seth M Steinberg; PhD (Office of the Director)



Robert F Murphy (Pediatric Oncology Branch)



Stephen M Hewitt; MD, PhD (Laboratory of Pathology)","Howard A. Nash; MD, PhD (NIMH) 



David John Sandstrom; PhD (NIMH)","Ordered by publication type and then author name.



1.
Devoogdt N, Rasool N, Hoskins E, Simpkins F, Tchabo N, Kohn EC (2009). Overexpression of protease inhibitor-dead secretory leukocyte protease inhibitor causes more aggressive ovarian cancer in vitro and in vivo. Cancer Sci  100, 434-40.   https://doi.org/10.1111/j.1349-7006.2009.01076.x




PubMed



        
     
Free Article


 


PubMed ID 19154415
         Pubmed Central ID 2649994 


 



2.
Elstrand MB, Kleinberg L, Kohn EC, Tropé CG, Davidson B (2009). Expression and clinical role of antiapoptotic proteins of the bag, heat shock, and Bcl-2 families in effusions, primary tumors, and solid metastases in ovarian carcinoma. Int J Gynecol Pathol  28, 211-21.   https://doi.org/10.1097/PGP.0b013e31818b0f5e




PubMed


 


PubMed ID 19620938
    
     


 



3.
Kamrava M, Gius D, Casagrande G, Kohn E (2011). Will targeting insulin growth factor help us or hurt us?: An oncologist's perspective. Ageing Res Rev  10, 62-70.   https://doi.org/10.1016/j.arr.2009.10.007




PubMed



        
     
Free Article


 


PubMed ID 19896561
         Pubmed Central ID 2888889 


 



4.
Virador VM, Davidson B, Czechowicz J, Mai A, Kassis J, Kohn EC (2009). The anti-apoptotic activity of BAG3 is restricted by caspases and the proteasome. PLoS One  4, e5136.   https://doi.org/10.1371/journal.pone.0005136




PubMed



        
     
Free Article


 


PubMed ID 19352495
         Pubmed Central ID 2662420",https://intramural.nih.gov/search/searchview.taf?ipid=63591
764,SC009172-22,"October 01, 2009 -  September 30, 2010",Cellular Interactions with Thrombospondin,"David D Roberts; PhD



IRP Faculty Profile",NULL,"Laboratory of Pathology, NCI","Sukhbir  Kaur



Gema  Martin-Manso



Maria  Tsokos; MD



Thomas W Miller; PhD



Dhammika  Navarathna; PhD



Michael L Pendrak



Show all 9","Willaim  Frazier
(Biochemistry and Molecular Biophysics, Washington University)




Jeff  Isenberg
(University of Pittsburgh)




Deane  Mosher
(University of Wisconsin)",David Anderson Wink (Radiation Biology Branch),Jurgen B Schnermann; MD (NIDDK),"Ordered by publication type and then author name.



1.
Roberts D, Frazier W, Roberts D (2010) Nitric Oxide Signaling in Vascular Cells is Regulated through CD47 by Thrombospondin-1, in Nitric Oxide. Elsevier Inc (Burlington, MA), pp. 415-440.




 



2.
Maxhimer JB, Shih HB, Isenberg JS, Miller TW, Roberts DD (2009). Thrombospondin-1/CD47 blockade following ischemia-reperfusion injury is tissue protective. Plast Reconstr Surg  124, 1880-9.   https://doi.org/10.1097/PRS.0b013e3181bceec3




PubMed



        
     
Free Article


 


PubMed ID 19952644
         Pubmed Central ID 2794041 


 



3.
Maxhimer JB, Soto-Pantoja DR, Ridnour LA, Shih HB, Degraff WG, Tsokos M, Wink DA, Isenberg JS, Roberts DD (2009). Radioprotection in normal tissue and delayed tumor growth by blockade of CD47 signaling. Sci Transl Med  1, 3ra7.   https://doi.org/10.1126/scitranslmed.3000139




PubMed



        
     
Free Article


 


PubMed ID 20161613
         Pubmed Central ID 2811586 


 



4.
Miller TW, Isenberg JS, Roberts DD (2010). Thrombospondin-1 is an inhibitor of pharmacological activation of soluble guanylate cyclase. Br J Pharmacol  159, 1542-7.   https://doi.org/10.1111/j.1476-5381.2009.00631.x




PubMed



        
     
Free Article


 


PubMed ID 20233213
         Pubmed Central ID 2850410 


 



5.
Roberts D, Isenberg J, Kaur S, Roberts D (2010) CD47. Nature Signaling Gateway doi:10.1038/mp.a002870.01.",https://intramural.nih.gov/search/searchview.taf?ipid=63554
765,SC009173-22,"October 01, 2009 -  September 30, 2010",Host Colonization and Vascular Dissemination of Candida albicans,"David D Roberts; PhD



IRP Faculty Profile",NULL,"Laboratory of Pathology, NCI","Gema  Martin-Manso



Dhammika  Navarathna; PhD



Michael L Pendrak



John M Sipes",NULL,NULL,"Jeeva P Munasinghe (NINDS) 



Martin J Lizak; PhD (NINDS)","Ordered by publication type and then author name.



1.
Navarathna DH, Harris SD, Roberts DD, Nickerson KW (2010). Evolutionary aspects of urea utilization by fungi. FEMS Yeast Res  10, 209-13.   https://doi.org/10.1111/j.1567-1364.2010.00602.x




PubMed



        
     
Free Article


 


PubMed ID 20100286
         Pubmed Central ID 2822880",https://intramural.nih.gov/search/searchview.taf?ipid=63555
766,SC009174-22,"October 01, 2009 -  September 30, 2010",Roles of Glycoconjugates and Redox Signaling in Tumor Biology,"David D Roberts; PhD



IRP Faculty Profile",NULL,"Laboratory of Pathology, NCI","Sukhbir  Kaur



Maria  Tsokos; MD



Thomas W Miller; PhD



Michael L Pendrak



Malgorzata  Ptaszynska



John M Sipes","Piero  DelSoldato
(Sulfidris)




Barry  Karger
(Northeastern University)




Anna  Sparatore
(University of Milan)","Terry  Moody; PhD (Office of the Director)



David Anderson Wink (Radiation Biology Branch)



Grace  Yeh; PhD (Laboratory of Metabolism)",NULL,"Ordered by publication type and then author name.



1.
Jia Y, Wu SL, Isenberg JS, Dai S, Sipes JM, Field L, Zeng B, Bandle RW, Ridnour LA, Wink DA, Ramchandran R, Karger BL, Roberts DD (2010). Thiolutin inhibits endothelial cell adhesion by perturbing Hsp27 interactions with components of the actin and intermediate filament cytoskeleton. Cell Stress Chaperones  15, 165-81.   https://doi.org/10.1007/s12192-009-0130-0




PubMed



        
     
Free Article


 


PubMed ID 19579057
         Pubmed Central ID 2866983 


 



2.
Miller TW, Isenberg JS, Roberts DD (2010). Thrombospondin-1 is an inhibitor of pharmacological activation of soluble guanylate cyclase. Br J Pharmacol  159, 1542-7.   https://doi.org/10.1111/j.1476-5381.2009.00631.x




PubMed



        
     
Free Article


 


PubMed ID 20233213
         Pubmed Central ID 2850410 


 



3.
Moody TW, Switzer C, Santana-Flores W, Ridnour LA, Berna M, Thill M, Jensen RT, Sparatore A, Del Soldato P, Yeh GC, Roberts DD, Giaccone G, Wink DA (2010). Dithiolethione modified valproate and diclofenac increase E-cadherin expression and decrease proliferation of non-small cell lung cancer cells. Lung Cancer  68, 154-60.   https://doi.org/10.1016/j.lungcan.2009.06.012




PubMed



        
     
Free Article


 


PubMed ID 19628293
         Pubmed Central ID 3835159 


 



4.
Ptaszynska MM, Pendrak ML, Stracke ML, Roberts DD (2010). Autotaxin signaling via lysophosphatidic acid receptors contributes to vascular endothelial growth factor-induced endothelial cell migration. Mol Cancer Res  8, 309-21.   https://doi.org/10.1158/1541-7786.MCR-09-0288




PubMed



        
     
Free Article


 


PubMed ID 20197381
         Pubmed Central ID 2841699 


 



5.
Shi Q, Nguyen AT, Angell Y, Deng D, Na CR, Burgess K, Roberts DD, Brunicardi FC, Templeton NS (2010). A combinatorial approach for targeted delivery using small molecules and reversible masking to bypass nonspecific uptake in vivo. Gene Ther  17, 1085-97.   https://doi.org/10.1038/gt.2010.55




PubMed



        
     
Free Article


 


PubMed ID 20463761
         Pubmed Central ID 2923228 


 



6.
Switzer CH, Ridnour LA, Cheng RY, Sparatore A, Del Soldato P, Moody TW, Vitek MP, Roberts DD, Wink DA (2009). Dithiolethione compounds inhibit Akt signaling in human breast and lung cancer cells by increasing PP2A activity. Oncogene  28, 3837-46.   https://doi.org/10.1038/onc.2009.244




PubMed



        
     
Free Article


 


PubMed ID 19701246
         Pubmed Central ID 3472634",https://intramural.nih.gov/search/searchview.taf?ipid=63553
767,SC009179-22,"October 01, 2009 -  September 30, 2010",The Role of TIMPs in Cell Growth and Differentiation: Tumor Angiogenesis,"William G Stetler-Stevenson; MD, PhD



IRP Faculty Profile",NULL,"Radiation Oncology Branch, NCI","Dimitra  Bourmpoulia; PhD



Frank  Cuttitta; PhD



Hui  Han



Sandra  Jensen-Taubman



Clifford John Kwityn



Beiyang  Wei","Junseo  Oh
(Korea University Graduate School Of Medicine)




Dong-Wan  Seo
(Laboratory of Molecular Biochemistry, Kangwon National University)","Maryalice  Stetler-Stevenson; MD, PhD (Laboratory of Pathology)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63592
768,SC009374-19,"October 01, 2009 -  September 30, 2010",Signaling Pathways as Molecular Targets in Angiogenesis and Microenvironment,Elise C Kohn; MD,NULL,"Medical Oncology Branch, NCI","Iulia  Giuroiu



Christina M Annunziata



Jasmine  Han; MD



John Lawrence Hays



Geoffrey S Kim; MD



William D Figg; PharmD



Show all 9","Riccardo  Alessandro
(U-Palermo)




Ben  Davidson
(Norwegian Radium Hospital)




Gordon  Mills
(MD Anderson Cancer Center)","Barbara V Vonderhaar; PhD (Mammary Biology and Tumorigenesis Laboratory)



David Jay Goldstein (Office of the Director)



Seth M Steinberg; PhD (Office of the Director)",NULL,"Ordered by publication type and then author name.



1.
Azad N, Perroy A, Gardner E, Imamura CK, Graves C, Sarosy GA, Minasian L, Kotz H, Raggio M, Figg WD, Kohn EC (2009). A phase I study of paclitaxel and continuous daily CAI in patients with refractory solid tumors. Cancer Biol Ther  8, 1800-5.   https://doi.org/10.4161/cbt.8.19.9593




PubMed



        
     
Free Article


 


PubMed ID 19738417
         Pubmed Central ID 3104675 


 



2.
Devoogdt N, Rasool N, Hoskins E, Simpkins F, Tchabo N, Kohn EC (2009). Overexpression of protease inhibitor-dead secretory leukocyte protease inhibitor causes more aggressive ovarian cancer in vitro and in vivo. Cancer Sci  100, 434-40.   https://doi.org/10.1111/j.1349-7006.2009.01076.x




PubMed



        
     
Free Article


 


PubMed ID 19154415
         Pubmed Central ID 2649994 


 



3.
Kamrava M, Gius D, Casagrande G, Kohn E (2011). Will targeting insulin growth factor help us or hurt us?: An oncologist's perspective. Ageing Res Rev  10, 62-70.   https://doi.org/10.1016/j.arr.2009.10.007




PubMed



        
     
Free Article


 


PubMed ID 19896561
         Pubmed Central ID 2888889",https://intramural.nih.gov/search/searchview.taf?ipid=63593
769,SC009375-18,"October 01, 2009 -  September 30, 2010",Signal Transduction Therapy--Clinical,Elise C Kohn; MD,NULL,"Medical Oncology Branch, NCI","Iulia  Giuroiu



Jasmine  Han; MD



Christina M Annunziata



John Lawrence Hays



Geoffrey S Kim; MD



Minshu R Yu



Show all 10","Robert  Bast
(Medicine, MD Anderson Cancer Center)




Andrew  Berchuck
(Gyn Oncology, Duke Univ)




Thomas  Conrads
(University of Pittsburgh Cancer Institute)




Mary B Daly





Ben  Davidson
(Norwegian Radium Hospital)




Michael  Friedlander
(Prince of Wales Hospital)


Show all 10","Peter L Choyke; MD (Molecular Imaging Program)



Yves  Pommier; PhD (Developmental Therapeutics Branch)



Brigitte  Widemann; MD (Pediatric Oncology Branch)



Seth M Steinberg; PhD (Office of the Director)



Bradford J Wood; MD (Office of the Director)



Robert F Murphy (Pediatric Oncology Branch)",NULL,"Ordered by publication type and then author name.



1.
Annunziata CM, Stavnes HT, Kleinberg L, Berner A, Hernandez LF, Birrer MJ, Steinberg SM, Davidson B, Kohn EC (2010). Nuclear factor kappaB transcription factors are coexpressed and convey a poor outcome in ovarian cancer. Cancer  116, 3276-84.   https://doi.org/10.1002/cncr.25190




PubMed



        
     
Free Article


 


PubMed ID 20564628
         Pubmed Central ID 2946598 


 



2.
Azad N, Perroy A, Gardner E, Imamura CK, Graves C, Sarosy GA, Minasian L, Kotz H, Raggio M, Figg WD, Kohn EC (2009). A phase I study of paclitaxel and continuous daily CAI in patients with refractory solid tumors. Cancer Biol Ther  8, 1800-5.   https://doi.org/10.4161/cbt.8.19.9593




PubMed



        
     
Free Article


 


PubMed ID 19738417
         Pubmed Central ID 3104675 


 



3.
Azad NS, Aragon-Ching JB, Dahut WL, Gutierrez M, Figg WD, Jain L, Steinberg SM, Turner ML, Kohn EC, Kong HH (2009). Hand-foot skin reaction increases with cumulative sorafenib dose and with combination anti-vascular endothelial growth factor therapy. Clin Cancer Res  15, 1411-6.   https://doi.org/10.1158/1078-0432.CCR-08-1141




PubMed



        
     
Free Article


 


PubMed ID 19228742
         Pubmed Central ID 2718558 


 



4.
Rasool N, LaRochelle W, Zhong H, Ara G, Cohen J, Kohn EC (2010). Secretory leukocyte protease inhibitor antagonizes paclitaxel in ovarian cancer cells. Clin Cancer Res  16, 600-9.   https://doi.org/10.1158/1078-0432.CCR-09-1979




PubMed



        
     
Free Article


 


PubMed ID 20068074
         Pubmed Central ID 2808000 


 



5.
von Rosenvinge EC, Gopal LD, Heller T, Kohn EC, Yao MD (2009). Rectal fistulae resulting from treatment with sorafenib and bevacizumab. Gastrointest Endosc  70, 1246-7.   https://doi.org/10.1016/j.gie.2009.06.027




PubMed


 


PubMed ID 19683714",https://intramural.nih.gov/search/searchview.taf?ipid=63594
770,SC009389-17,"October 01, 2009 -  September 30, 2010",A Mitogen-induced G Protein-coupled Receptor,"Kathleen  Kelly; PhD



IRP Faculty Profile",NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",NULL,NULL,Sheueyann  Cheng; PhD (Laboratory of Molecular Biology),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63595
771,SC009392-17,"October 01, 2009 -  September 30, 2010",Proteomic Analysis of Renal Tumors,"Maria  Merino; PhD



IRP Faculty Profile",NULL,"Laboratory of Pathology, NCI","Linda S Wrathall



David D Roberts; PhD



Beatriz  Walter-rodriguez; MD",NULL,William Marston Linehan; MD (Urologic Oncology Branch),NULL,"Ordered by publication type and then author name.



1.
Moore LE, Boffetta P, Karami S, Brennan P, Stewart PS, Hung R, Zaridze D, Matveev V, Janout V, Kollarova H, Bencko V, Navratilova M, Szeszenia-Dabrowska N, Mates D, Gromiec J, Holcatova I, Merino M, Chanock S, Chow WH, Rothman N (2010). Occupational trichloroethylene exposure and renal carcinoma risk: evidence of genetic susceptibility by reductive metabolism gene variants. Cancer Res  70, 6527-36.   https://doi.org/10.1158/0008-5472.CAN-09-4167




PubMed



        
     
Free Article


 


PubMed ID 20663906
         Pubmed Central ID 2922418 


 



2.
Xie H, Valera VA, Merino MJ, Amato AM, Signoretti S, Linehan WM, Sukhatme VP, Seth P (2009). LDH-A inhibition, a therapeutic strategy for treatment of hereditary leiomyomatosis and renal cell cancer. Mol Cancer Ther  8, 626-35.   https://doi.org/10.1158/1535-7163.MCT-08-1049




PubMed



        
     
Free Article


 


PubMed ID 19276158
         Pubmed Central ID 2671637",https://intramural.nih.gov/search/searchview.taf?ipid=63596
772,SC010051-15,"October 01, 2009 -  September 30, 2010",Metal Chelate Conjugated Dendrimer Constructs for Diagnosis and Therapy,"Martin W Brechbiel; PhD



IRP Faculty Profile",NULL,"Radiation Oncology Branch, NCI","Kwamena  Baidoo



Ambika  Bumb



Diane E Milenic



Kido  Nwe; PhD



Aaron Joseph Lucero Villaraza



Kwon Joong  Yong","Lynn  Francesconi
(Hunter College)




Marty  Pomper
(Johns Hopkins)




Tom  Quinn
(U. Missouri, Co.)




Roger  Tsien; PhD
(Department of Pharmacology, UC, San Diego)",NULL,"Lacy Henry Bryant (CC) 



Peter  Herscovitch; MD (CC)","Ordered by publication type and then author name.



1.
Nwe K, Brechbiel MW (2009). Growing applications of ""click chemistry"" for bioconjugation in contemporary biomedical research. Cancer Biother Radiopharm  24, 289-302.   https://doi.org/10.1089/cbr.2008.0626




PubMed



        
     
Free Article


 


PubMed ID 19538051
         Pubmed Central ID 2811415 


 



2.
Nwe K, Xu H, Regino CA, Bernardo M, Ileva L, Riffle L, Wong KJ, Brechbiel MW (2009). A new approach in the preparation of dendrimer-based bifunctional diethylenetriaminepentaacetic acid MR contrast agent derivatives. Bioconjug Chem  20, 1412-8.   https://doi.org/10.1021/bc900057z




PubMed



        
     
Free Article


 


PubMed ID 19555072
         Pubmed Central ID 2737254",https://intramural.nih.gov/search/searchview.taf?ipid=63599
773,SC010058-15,"October 01, 2009 -  September 30, 2010",Regulation of Apoptosis in Ewings Sarcoma and Neuroblastoma,Maria  Tsokos; MD,NULL,"Laboratory of Pathology, NCI","Susana Beatriz Galli



Guang  Li



David D Roberts; PhD",NULL,Crystal L. Mackall; MD (Pediatric Oncology Branch),NULL,"Ordered by publication type and then author name.



1.
Maxhimer JB, Soto-Pantoja DR, Ridnour LA, Shih HB, Degraff WG, Tsokos M, Wink DA, Isenberg JS, Roberts DD (2009). Radioprotection in normal tissue and delayed tumor growth by blockade of CD47 signaling. Sci Transl Med  1, 3ra7.   https://doi.org/10.1126/scitranslmed.3000139




PubMed



        
     
Free Article


 


PubMed ID 20161613
         Pubmed Central ID 2811586 


 



2.
Reid GS, Shan X, Coughlin CM, Lassoued W, Pawel BR, Wexler LH, Thiele CJ, Tsokos M, Pinkus JL, Pinkus GS, Grupp SA, Vonderheide RH (2009). Interferon-gamma-dependent infiltration of human T cells into neuroblastoma tumors in vivo. Clin Cancer Res  15, 6602-8.   https://doi.org/10.1158/1078-0432.CCR-09-0829




PubMed



        
     
Free Article


 


PubMed ID 19825945
         Pubmed Central ID 2783677",https://intramural.nih.gov/search/searchview.taf?ipid=63600
774,SC010074-15,"October 01, 2009 -  September 30, 2010",Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction,"Leonard  Neckers; PhD



IRP Faculty Profile",NULL,"Urologic Oncology Branch, NCI","Kristin  Eckfeld



Mehdi  Mollapour



Zachary David Palchick



Thomas L Prince



Bradley T Scroggins



Shinji  Tsutsumi



Show all 10","Brian  Blagg
(Chemistry, University of Kansas)




Robert  Cotter
(Johns Hopkins University)




YunJin  Jung
(Pusan National University)




Larry  Karnitz
(Mayo Clinic)




Neal  Rosen
(Medicine, Memorial Sloan Kettering Cancer Center)




David  Toft
(Cell Biology, Mayo Clinic)


Show all 7","Zhenggang  Liu; PhD (Laboratory Of Genitourinary Cancer Pathogenesis)



James G McNally; PhD (Laboratory of Receptor Biology and Gene Expression)



Jane Beth Trepel (Medical Oncology Branch)",NULL,"Ordered by publication type and then author name.



1.
Ehrlich ES, Wang T, Luo K, Xiao Z, Niewiadomska AM, Martinez T, Xu W, Neckers L, Yu XF (2009). Regulation of Hsp90 client proteins by a Cullin5-RING E3 ubiquitin ligase. Proc Natl Acad Sci U S A  106, 20330-5.   https://doi.org/10.1073/pnas.0810571106




PubMed



        
     
Free Article


 


PubMed ID 19933325
         Pubmed Central ID 2787120 


 



2.
Mollapour M, Tsutsumi S, Donnelly AC, Beebe K, Tokita MJ, Lee MJ, Lee S, Morra G, Bourboulia D, Scroggins BT, Colombo G, Blagg BS, Panaretou B, Stetler-Stevenson WG, Trepel JB, Piper PW, Prodromou C, Pearl LH, Neckers L (2010). Swe1Wee1-dependent tyrosine phosphorylation of Hsp90 regulates distinct facets of chaperone function. Mol Cell  37, 333-43.   https://doi.org/10.1016/j.molcel.2010.01.005




PubMed



        
     
Free Article


 


PubMed ID 20159553
         Pubmed Central ID 2824606 


 



3.
Neckers L, Tsutsumi S, Mollapour M (2009). Visualizing the twists and turns of a molecular chaperone. Nat Struct Mol Biol  16, 235-6.   https://doi.org/10.1038/nsmb0309-235




PubMed


 


PubMed ID 19259122
    
     


 



4.
Scroggins BT, Neckers L (2009). Just say NO: nitric oxide regulation of Hsp90. EMBO Rep  10, 1093-4.   https://doi.org/10.1038/embor.2009.212




PubMed



        
     
Free Article


 


PubMed ID 19763143
         Pubmed Central ID 2759746 


 



5.
Tsutsumi S, Beebe K, Neckers L (2009). Impact of heat-shock protein 90 on cancer metastasis. Future Oncol  5, 679-88.   https://doi.org/10.2217/fon.09.30




PubMed



        
     
Free Article


 


PubMed ID 19519207
         Pubmed Central ID 2714685",https://intramural.nih.gov/search/searchview.taf?ipid=63601
775,SC010093-14,"October 01, 2009 -  September 30, 2010",Targeting the Epigenome for Lung Cancer Therapy,"David  Schrump; MD



IRP Faculty Profile",NULL,"Surgery Branch, NCI","Ana R Hancox



Julie A Hong



Tricia M Frary



Mary R Zhang



Yuwei  Zhang","Nasser  Altorki
(Thoracic Surgery, Cornell University Medical Center)




Lloyd  Old
(Cancer Immunology, Ludwig Cancer Institute)","William D Figg; PharmD (Medical Oncology Branch)



Jane Beth Trepel (Medical Oncology Branch)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63561
776,SC010098-08,"October 01, 2009 -  September 30, 2010",The Evaluation of Novel Therapeutics for Genitourinary Malignancies,"William Laurence Dahut; MD



IRP Faculty Profile",NULL,"Office of the Director, NCI",NULL,"Anthony  D'Amico
(Radiation Oncology, Harvard Medical School)




Phil  Kantoff
(DFCI)","Philip M Arlen; MD (Medical Oncology Branch)



Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)



Kevin A Camphausen; MD (Radiation Oncology Branch)



William D Figg; PharmD (Medical Oncology Branch)



William Marston Linehan; MD (Urologic Oncology Branch)



Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)",NULL,"Ordered by publication type and then author name.



1.
Aragon-Ching JB, Dahut WL (2009). Anti-angiogenesis approach to genitourinary cancer treatment. Update Cancer Ther  3, 182-188.   https://doi.org/10.1016/j.uct.2009.05.002




PubMed



        
     
Free Article


 


PubMed ID 19774201
         Pubmed Central ID 2747324 


 



2.
Aragon-Ching JB, Dahut WL (2009). VEGF inhibitors and prostate cancer therapy. Curr Mol Pharmacol  2, 161-8.   https://doi.org/10.2174/1874467210902020161




PubMed



        
     
Free Article


 


PubMed ID 19617926
         Pubmed Central ID 2711630 


 



3.
Aragon-Ching JB, Jain L, Gulley JL, Arlen PM, Wright JJ, Steinberg SM, Draper D, Venitz J, Jones E, Chen CC, Figg WD, Dahut WL (2009). Final analysis of a phase II trial using sorafenib for metastatic castration-resistant prostate cancer. BJU Int  103, 1636-40.   https://doi.org/10.1111/j.1464-410X.2008.08327.x




PubMed



        
     
Free Article


 


PubMed ID 19154507
         Pubmed Central ID 2818665 


 



4.
Aragon-Ching JB, Ning YM, Chen CC, Latham L, Guadagnini JP, Gulley JL, Arlen PM, Wright JJ, Parnes H, Figg WD, Dahut WL (2009). Higher incidence of Osteonecrosis of the Jaw (ONJ) in patients with metastatic castration resistant prostate cancer treated with anti-angiogenic agents. Cancer Invest  27, 221-6.   https://doi.org/10.1080/07357900802208608




PubMed



        
     
Free Article


 


PubMed ID 19235596
         Pubmed Central ID 2648132 


 



5.
Azad NS, Aragon-Ching JB, Dahut WL, Gutierrez M, Figg WD, Jain L, Steinberg SM, Turner ML, Kohn EC, Kong HH (2009). Hand-foot skin reaction increases with cumulative sorafenib dose and with combination anti-vascular endothelial growth factor therapy. Clin Cancer Res  15, 1411-6.   https://doi.org/10.1158/1078-0432.CCR-08-1141




PubMed



        
     
Free Article


 


PubMed ID 19228742
         Pubmed Central ID 2718558 


 



6.
Dahut WL, Aragon-Ching JB, Woo S, Tohnya TM, Gulley JL, Arlen PM, Wright JJ, Ventiz J, Figg WD (2009). Phase I study of oral lenalidomide in patients with refractory metastatic cancer. J Clin Pharmacol  49, 650-60.   https://doi.org/10.1177/0091270009335001




PubMed



        
     
Free Article


 


PubMed ID 19451403
         Pubmed Central ID 2808857 


 



7.
Figg WD, Hussain MH, Gulley JL, Arlen PM, Aragon-Ching JB, Petrylak DP, Higano CS, Steinberg SM, Chatta GS, Parnes H, Wright JJ, Sartor O, Dahut WL (2009). A double-blind randomized crossover study of oral thalidomide versus placebo for androgen dependent prostate cancer treated with intermittent androgen ablation. J Urol  181, 1104-13; discussion 1113.   https://doi.org/10.1016/j.juro.2008.11.026




PubMed



        
     
Free Article


 


PubMed ID 19167733
         Pubmed Central ID 2838198 


 



8.
Ning YM, Figg WD, Dahut WL (2009). Reversal of docetaxel resistance with bevacizumab and thalidomide. Clin Genitourin Cancer  7, E37-8.   https://doi.org/10.3816/CGC.2009.n.020




PubMed



        
     
Free Article


 


PubMed ID 19692321
         Pubmed Central ID 3438454 


 



9.
Zhu W, Zhu DS, Madan RA, Gulley JL, Figg WD, Dahut WL (2010). Treatment of castration-resistant prostate cancer: updates on therapeutics targeting the androgen receptor signaling pathway. Am J Ther  17, 176-81.   https://doi.org/10.1097/MJT.0b013e3181c6c0b2




PubMed



        
     
Free Article


 


PubMed ID 20019584
         Pubmed Central ID 6357221",https://intramural.nih.gov/search/searchview.taf?ipid=63628
777,SC010100-11,"October 01, 2009 -  September 30, 2010",The Glioma Molecular Diagnostic Initiative: Characterizing Brain Tumor Data,"Howard A Fine; MD, PhD",NULL,"Neuro-Oncology Branch, NCI","Galina Ivanovna Belova



Serdar  Bozdag



Gregory P Riddick



Natalia N Ogurtsova



Jennifer  Walling",NULL,Kenneth  Buetow; PhD (Laboratory of Population Genetics),"Russell R Lonser; MD (NINDS) 



John Keenam Park (NINDS)","Ordered by publication type and then author name.



1.
Fine HA (2009). Glioma stem cells: not all created equal. Cancer Cell  15, 247-9.   https://doi.org/10.1016/j.ccr.2009.03.010




PubMed



        
     
Free Article


 


PubMed ID 19345322
         Pubmed Central ID 6852885 


 



2.
Madhavan S, Zenklusen JC, Kotliarov Y, Sahni H, Fine HA, Buetow K (2009). Rembrandt: helping personalized medicine become a reality through integrative translational research. Mol Cancer Res  7, 157-67.   https://doi.org/10.1158/1541-7786.MCR-08-0435




PubMed



        
     
Free Article


 


PubMed ID 19208739
         Pubmed Central ID 2645472",https://intramural.nih.gov/search/searchview.taf?ipid=63603
778,SC010282-13,"October 01, 2009 -  September 30, 2010",Cytogenetic Studies of B-cell Chronic Lymphocytic Leukemia (B-CLL),Diane Carol Arthur; MD,John Carl Oberholtzer,"Laboratory of Pathology, NCI","Shannon I Skarshaug



Maryalice  Stetler-Stevenson; MD, PhD",NULL,"Daniel H Fowler (Experimental Transplantation and Immunology Branch)



Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)



Steven  Pavletic; MD, MS (Experimental Transplantation and Immunology Branch)



Louis  Staudt; MD (Lymphoid Malignancies Branch)



Neil Edward Caporaso; MS, MD (Genetic Epidemiology Branch)



Michael R Bishop; MD (Experimental Transplantation and Immunology Branch)","Adrian U Wiestner; MD, PhD (NHLBI) 



Gerald Ernest Marti (OD)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63605
779,SC010288-13,"October 01, 2009 -  September 30, 2010",Th1Th2 and Tc1Tc2 T Cell Subsets in Transplantation Therapy,Daniel H Fowler,NULL,"Experimental Transplantation and Immunology Branch, NCI","David Charles Halverson; MD



Steven  Pavletic; MD, MS



Ronald E Gress; MD



Frances  Hakim; PhD



Michael R Bishop; MD","Carl  June
(University of Penn)




Robert  Korngold
(Cancer Center, Hackensack University)




Bruce  Levine
(Abramson Family Cancer Research Center, University of Pennsylvania)","Antonio  Fojo; MD, PhD (Medical Oncology Branch)","David F Stroncek; MD (CC) 



Susan  Leitman; MD (CC) 



Hanh M Khuu; MD (CC)","Ordered by publication type and then author name.



1.
Pollack SM, Steinberg SM, Odom J, Dean RM, Fowler DH, Bishop MR (2009). Assessment of the hematopoietic cell transplantation comorbidity index in non-Hodgkin lymphoma patients receiving reduced-intensity allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant  15, 223-30.   https://doi.org/10.1016/j.bbmt.2008.11.023




PubMed



        
     
Free Article


 


PubMed ID 19167682
         Pubmed Central ID 2842937 


 



2.
Sportès C, Steinberg SM, Liewehr DJ, Gea-Banacloche J, Danforth DN, Avila DN, Bryant KE, Krumlauf MC, Fowler DH, Pavletic S, Hardy NM, Bishop MR, Gress RE (2009). Strategies to improve long-term outcome in stage IIIB inflammatory breast cancer: multimodality treatment including dose-intensive induction and high-dose chemotherapy. Biol Blood Marrow Transplant  15, 963-70.   https://doi.org/10.1016/j.bbmt.2009.04.018




PubMed



        
     
Free Article


 


PubMed ID 19589486
         Pubmed Central ID 2709825",https://intramural.nih.gov/search/searchview.taf?ipid=63606
780,SC010292-12,"October 01, 2009 -  September 30, 2010",Signal Transduction Pathways that Promote Survival of Lung Cancer Cells,"Phillip A Dennis; MD, PhD",NULL,"Medical Oncology Branch, NCI","Yoon Soo Chang; MD



Giuseppe  Giaccone; MD



Chun-Te  Chiang



Matthew C Dallos



Irem  Dogan



Joell J Gills



Show all 17","Vali  Egilsson
(Pathology, University of Iceland)




Pasi  Janne
(Oncology, Dana-Farber Cancer Center)




William  Pao
(Memorial Sloan Kettering Cancer Center)




William  Travis
(Memorial Sloan Kettering Cancer Center)","Jin  Jen (Molecular Genetics and Carcinogenesis Section)



Daniel H Fowler (Experimental Transplantation and Immunology Branch)



Joanna H Shih (Biometrics Research Branch)



Ilona  Linnoila; MD (Laboratory Of Genitourinary Cancer Pathogenesis)



Frederic  Kaye; MD (Cancer Genetics Branch)



Curtis  Harris; MD (Laboratory of Human Carcinogenesis)","J Silvio  Gutkind; PhD (NIDCR) 



Carter  Van Waes; MD, PhD (NIDCD)","Ordered by publication type and then author name.



1.
Dennis PA (2009). Rapamycin for chemoprevention of upper aerodigestive tract cancers. Cancer Prev Res (Phila)  2, 7-9.   https://doi.org/10.1158/1940-6207.CAPR-08-0215




PubMed


 


PubMed ID 19139011
    
     


 



2.
Granville CA, Memmott RM, Balogh A, Mariotti J, Kawabata S, Han W, Lopiccolo J, Foley J, Liewehr DJ, Steinberg SM, Fowler DH, Hollander MC, Dennis PA (2009). A central role for Foxp3+ regulatory T cells in K-Ras-driven lung tumorigenesis. PLoS One  4, e5061.   https://doi.org/10.1371/journal.pone.0005061




PubMed



        
     
Free Article


 


PubMed ID 19330036
         Pubmed Central ID 2659439 


 



3.
Memmott RM, Dennis PA (2009). Akt-dependent and -independent mechanisms of mTOR regulation in cancer. Cell Signal  21, 656-64.   https://doi.org/10.1016/j.cellsig.2009.01.004




PubMed



        
     
Free Article


 


PubMed ID 19166931
         Pubmed Central ID 2650010 


 



4.
Memmott RM, Dennis PA (2009). LKB1 and mammalian target of rapamycin as predictive factors for the anticancer efficacy of metformin. J Clin Oncol  27, e226; author reply e227.   https://doi.org/10.1200/JCO.2009.25.3963




PubMed


 


PubMed ID 19858366
    
     


 



5.
Memmott RM, Dennis PA (2010). The role of the Akt/mTOR pathway in tobacco carcinogen-induced lung tumorigenesis. Clin Cancer Res  16, 4-10.   https://doi.org/10.1158/1078-0432.CCR-09-0234




PubMed



        
     
Free Article


 


PubMed ID 20028747
         Pubmed Central ID 2805044",https://intramural.nih.gov/search/searchview.taf?ipid=63607
781,SC010354-11,"October 01, 2009 -  September 30, 2010",Clinical Development of Novel Drugs for Children with Refractory Cancers,"Brigitte  Widemann; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI","Meredith  Chuk



Diane  Cole



Eva  Dombi



Nalini M Jayaprakash



Aerang  Kim



Leigh  Marcus



Show all 12","Peter Charles Adamson; MD





Larry  Baker
(SARC)




Susan  Blaney
(Texas Children's Cancer Center)




Karen  Cichowski
(Brigham and Women's Hospital)




John  Perentesis
(Pediatric Oncology, Cincinnati Children's Hospital)




Gregory  Reaman
(Children's National Medical Center)


Show all 7","Antonio  Fojo; MD, PhD (Medical Oncology Branch)","Jeffrey M Solomon; BS, MS, PhD (CC)","Ordered by publication type and then author name.



1.
Balis FM, Fox E, Widemann BC, Adamson PC (2009). Clinical drug development for childhood cancers. Clin Pharmacol Ther  85, 127-9.   https://doi.org/10.1038/clpt.2008.237




PubMed



        
     
Free Article


 


PubMed ID 19151636
         Pubmed Central ID 6675566 


 



2.
Fox E, Widemann BC, Hawkins DS, Jayaprakash N, Dagher R, Aikin AA, Bernstein D, Long L, Mackall C, Helman L, Steinberg SM, Balis FM (2009). Randomized trial and pharmacokinetic study of pegfilgrastim versus filgrastim after dose-intensive chemotherapy in young adults and children with sarcomas. Clin Cancer Res  15, 7361-7.   https://doi.org/10.1158/1078-0432.CCR-09-0761




PubMed



        
     
Free Article


 


PubMed ID 19920107
         Pubmed Central ID 2787766 


 



3.
Kim A, Balis FM, Widemann BC (2009). Sorafenib and sunitinib. Oncologist  14, 800-5.   https://doi.org/10.1634/theoncologist.2009-0088




PubMed



        
     
Free Article


 


PubMed ID 19648603
         Pubmed Central ID 6626665 


 



4.
Widemann BC, Goodspeed W, Goodwin A, Fojo T, Balis FM, Fox E (2009). Phase I trial and pharmacokinetic study of ixabepilone administered daily for 5 days in children and adolescents with refractory solid tumors. J Clin Oncol  27, 550-6.   https://doi.org/10.1200/JCO.2008.17.6644




PubMed



        
     
Free Article


 


PubMed ID 19075272
         Pubmed Central ID 2645861",https://intramural.nih.gov/search/searchview.taf?ipid=63609
782,SC010355-11,"October 01, 2009 -  September 30, 2010",Angiogenesis and Tumor Growth,"Giovanna  Tosato; PhD



IRP Faculty Profile",NULL,"Laboratory of Cellular Oncology, NCI","Inn-Inn  Chen



Paola  Gasperini



Peter J Mccormick



Shuhei  Sakakibara; PhD



Ombretta  Salvucci



Marta  Segarra Blasco



Show all 7","Amparo  Acher-Palmer
(University of Frankfurt)




Maria  Cid
(Univ. of Barcelona Medical School)




Catherine  Porcher
(Oxford Univ)","Peter L Choyke; MD (Molecular Imaging Program)



Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)



David A Davis; MD (HIV and AIDS Malignancy Branch)



Stefania  Pittaluga (Laboratory of Pathology)



Elaine S Jaffe; MD (Laboratory of Pathology)","Xuri  Li (NEI) 



Dragan  Maric; PhD (NINDS)","Ordered by publication type and then author name.



1.
Sakakibara S, Pise-Masison CA, Brady JN, Tosato G (2009). Gene regulation and functional alterations induced by Kaposi's sarcoma-associated herpesvirus-encoded ORFK13/vFLIP in endothelial cells. J Virol  83, 2140-53.   https://doi.org/10.1128/JVI.01871-08




PubMed



        
     
Free Article


 


PubMed ID 19091861
         Pubmed Central ID 2643737 


 



2.
Salvucci O, Maric D, Economopoulou M, Sakakibara S, Merlin S, Follenzi A, Tosato G (2009). EphrinB reverse signaling contributes to endothelial and mural cell assembly into vascular structures. Blood  114, 1707-16.   https://doi.org/10.1182/blood-2008-12-192294




PubMed



        
     
Free Article


 


PubMed ID 19411631
         Pubmed Central ID 2731645",https://intramural.nih.gov/search/searchview.taf?ipid=63610
783,SC010356-11,"October 01, 2009 -  September 30, 2010",A Role for KSHV in the Pathogenesis of Malignancies,"Giovanna  Tosato; PhD



IRP Faculty Profile",NULL,"Laboratory of Cellular Oncology, NCI","Paola  Gasperini



Peter J Mccormick



Shuhei  Sakakibara; PhD



Maria de la Luz  Sierra",NULL,"Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)



Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)



Richard  Little; MD, PhD (Clinical Investigations Branch)



David A Davis; MD (HIV and AIDS Malignancy Branch)



Seth M Steinberg; PhD (Office of the Director)



Stefania  Pittaluga (Laboratory of Pathology)","Dragan  Maric; PhD (NINDS) 



Joshua  Farber; MD (NIAID)","Ordered by publication type and then author name.



1.
Gasperini P, Tosato G (2009). Targeting the mammalian target of Rapamycin to inhibit VEGF and cytokines for the treatment of primary effusion lymphoma. Leukemia  23, 1867-74.   https://doi.org/10.1038/leu.2009.117




PubMed



        
     
Free Article


 


PubMed ID 19554030
         Pubmed Central ID 2940422 


 



2.
Sakakibara S, Pise-Masison CA, Brady JN, Tosato G (2009). Gene regulation and functional alterations induced by Kaposi's sarcoma-associated herpesvirus-encoded ORFK13/vFLIP in endothelial cells. J Virol  83, 2140-53.   https://doi.org/10.1128/JVI.01871-08




PubMed



        
     
Free Article


 


PubMed ID 19091861
         Pubmed Central ID 2643737",https://intramural.nih.gov/search/searchview.taf?ipid=63611
784,SC010357-11,"October 01, 2009 -  September 30, 2010",Gene Expression and Post-Transcriptional Regulation of DNA Tumor Viruses,"Zhi Ming  Zheng; MD, PhD



IRP Faculty Profile",NULL,"HIV and AIDS Malignancy Branch, NCI","Masahiko  Ajiro; PhD



Rong  Jia



Jeong Gu  Kang



Robert  Yarchoan; MD



Vladimir  Majerciak



Maria Julia Massimelli



Show all 7","Louise T Chow





Craig  Meyers
(Microbiology and Immunology, Penn State University College of Medicine)","Barbara K Felber (Vaccine Branch)



Michael John Kruhlak; PhD (Experimental Immunology Branch)",John Philip McCoy (NHLBI),"Ordered by publication type and then author name.



1.
Bodaghi S, Jia R, Zheng ZM (2009). Human papillomavirus type 16 E2 and E6 are RNA-binding proteins and inhibit in vitro splicing of pre-mRNAs with suboptimal splice sites. Virology  386, 32-43.   https://doi.org/10.1016/j.virol.2008.12.037




PubMed



        
     
Free Article


 


PubMed ID 19187948
         Pubmed Central ID 2683163 


 



2.
Jia R, Liu X, Tao M, Kruhlak M, Guo M, Meyers C, Baker CC, Zheng ZM (2009). Control of the papillomavirus early-to-late switch by differentially expressed SRp20. J Virol  83, 167-80.   https://doi.org/10.1128/JVI.01719-08




PubMed



        
     
Free Article


 


PubMed ID 18945760
         Pubmed Central ID 2612334 


 



3.
Majerciak V, Zheng ZM (2009). Kaposi's sarcoma-associated herpesvirus ORF57 in viral RNA processing. Front Biosci (Landmark Ed)  14, 1516-28.   https://doi.org/10.2741/3322




PubMed



        
     
Free Article


 


PubMed ID 19273144
         Pubmed Central ID 2654597 


 



4.
Wang X, Wang HK, McCoy JP, Banerjee NS, Rader JS, Broker TR, Meyers C, Chow LT, Zheng ZM (2009). Oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6. RNA  15, 637-47.   https://doi.org/10.1261/rna.1442309




PubMed



        
     
Free Article


 


PubMed ID 19258450
         Pubmed Central ID 2661824",https://intramural.nih.gov/search/searchview.taf?ipid=63612
785,SC010365-11,"October 01, 2009 -  September 30, 2010",Optimizing the Graft-Versus-Tumor Effect in Allogeneic HSCT,Michael R Bishop; MD,NULL,"Experimental Transplantation and Immunology Branch, NCI","Sivasubramanian  Baskar



Daniel H Fowler



Ronald E Gress; MD



Frances  Hakim; PhD



Christoph  Rader; PhD



Nancy M Hardy","Sergio  Giralt
(M.D. ANDERSON CANCER CENTER)




Carl  June
(University of Pennsylvania)




Larry  Kwak
(NCI)




Sattva  Neelapu
(M.D. ANDERSON CANCER CENTER)","Terry J Fry (Pediatric Oncology Branch)



Crystal L. Mackall; MD (Pediatric Oncology Branch)



Stefania  Pittaluga (Laboratory of Pathology)



Alan S Wayne; MD (Pediatric Oncology Branch)



Steven Aaron Rosenberg; MD, PhD (Surgery Branch)",NULL,"Ordered by publication type and then author name.



1.
van den Brink MR, Porter DL, Giralt S, Lu SX, Jenq RR, Hanash A, Bishop MR (2010). Relapse after allogeneic hematopoietic cell therapy. Biol Blood Marrow Transplant  16, S138-45.   https://doi.org/10.1016/j.bbmt.2009.10.023




PubMed



        
     
Free Article


 


PubMed ID 19857588
         Pubmed Central ID 3637945",https://intramural.nih.gov/search/searchview.taf?ipid=63613
786,SC010366-10,"October 01, 2009 -  September 30, 2010",Identification of Genes for Predicting Prognosis in Pediatric Cancers,"Javed  Khan; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI","James  Badgett



Qingrong  Chen



Carol J Thiele



Tai Chi  Cheuk



Jianbin Na He



Peter  Johansson



Show all 10","Peter  Ambros
(Children’s Cancer Research Institute)




Daniel  Catchpoole,
(The Children's Hospital at Westmead)




John  Maris
(Pharmacology, Children's Hospital of Philadelphia)




Andrew  Pearson
(Paediatric Section, Institute of Cancer Research)




Manfred  Schwab
(German Cancer Research Center)




Robert  Seeger
(Division of Pediatric Hematology-Oncology, Children's Hospital of Los Angeles)","Timothy D Veenstra (Office Of The Director)



Stephen M Hewitt; MD, PhD (Laboratory of Pathology)",NULL,"Ordered by publication type and then author name.



1.
Chen QR, Song YK, Yu LR, Wei JS, Chung JY, Hewitt SM, Veenstra TD, Khan J (2010). Global genomic and proteomic analysis identifies biological pathways related to high-risk neuroblastoma. J Proteome Res  9, 373-82.   https://doi.org/10.1021/pr900701v




PubMed



        
     
Free Article


 


PubMed ID 19921788
         Pubmed Central ID 2801773 


 



2.
Taylor JG, Cheuk AT, Tsang PS, Chung JY, Song YK, Desai K, Yu Y, Chen QR, Shah K, Youngblood V, Fang J, Kim SY, Yeung C, Helman LJ, Mendoza A, Ngo V, Staudt LM, Wei JS, Khanna C, Catchpoole D, Qualman SJ, Hewitt SM, Merlino G, Chanock SJ, Khan J (2009). Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models. J Clin Invest  119, 3395-407.   https://doi.org/10.1172/JCI39703




PubMed



        
     
Free Article


 


PubMed ID 19809159
         Pubmed Central ID 2769177 


 



3.
Vasudevan SA, Shang X, Shang X, Chang S, Ge N, Diaz-Miron JL, Russell HV, Hicks MJ, Ludwig AD, Wesson CL, Burlingame SM, Kim ES, Khan J, Yang J, Nuchtern JG (2009). Neuroblastoma-derived secretory protein is a novel secreted factor overexpressed in neuroblastoma. Mol Cancer Ther  8, 2478-89.   https://doi.org/10.1158/1535-7163.MCT-08-1132




PubMed



        
     
Free Article


 


PubMed ID 19671756
         Pubmed Central ID 3618953 


 



4.
Wei JS, Johansson P, Chen QR, Song YK, Durinck S, Wen X, Cheuk AT, Smith MA, Houghton P, Morton C, Khan J (2009). microRNA profiling identifies cancer-specific and prognostic signatures in pediatric malignancies. Clin Cancer Res  15, 5560-8.   https://doi.org/10.1158/1078-0432.CCR-08-3287




PubMed



        
     
Free Article


 


PubMed ID 19706822
         Pubmed Central ID 2737097",https://intramural.nih.gov/search/searchview.taf?ipid=63614
787,SC010370-10,"October 01, 2009 -  September 30, 2010",Comparative Genomics of Genes Located on Chromosomes X and Y,Stephen J O'Brien; PhD,NULL,"Laboratory of Genomic Diversity, NCI","Nicole J Crumpler



Carlos Antonio Driscoll; PhD



Warren  Johnson



Bailey D Kessing



Carrie  Mccracken



Jill  Slattery



Show all 9","Julie  Horvath
(Duke University)




JoGayle  Howard
(Smithsonian National Zoological Park)




Budhan  Pukazhenthi
(Smithsonian National Zoological Park)",Robert  Stephens (Office Of The Director),NULL,"Ordered by publication type and then author name.



1.
Driscoll CA, Clutton-Brock J, Kitchener AC, O'Brien SJ (2009). The Taming of the cat. Genetic and archaeological findings hint that wildcats became housecats earlier--and in a different place--than previously thought. Sci Am  300, 68-75.




PubMed



        
     
Free Article


 


PubMed ID 19485091
         Pubmed Central ID 5790555",https://intramural.nih.gov/search/searchview.taf?ipid=63615
788,SC010372-10,"October 01, 2009 -  September 30, 2010",Molecular Profiling of Patients Undergoing Radiotherapy,"Kevin A Camphausen; MD



IRP Faculty Profile",NULL,"Radiation Oncology Branch, NCI","Ira  Gordon



Christian Alexander Graves



Aditya Narayan Halthore



Tamalee  Scott



Cynthia  Peng



Alisa Jennifer Prager



Show all 9",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Avondoglio D, Scott T, Kil WJ, Sproull M, Tofilon PJ, Camphausen K (2009). High throughput evaluation of gamma-H2AX. Radiat Oncol  4, 31.   https://doi.org/10.1186/1748-717X-4-31




PubMed



        
     
Free Article


 


PubMed ID 19703306
         Pubmed Central ID 2740844 


 



2.
Camphausen K (2009). Seminars in Radiation Oncology. Introduction. Semin Radiat Oncol  19, 141.   https://doi.org/10.1016/j.semradonc.2009.02.008




PubMed


 


PubMed ID 19464627
    
     


 



3.
Kurshan N, Citrin DE, Camphausen KA (2009). Research highlights. Biomark Med  3, 17-9.   https://doi.org/10.2217/17520363.3.1.17




PubMed


 


PubMed ID 20477491",https://intramural.nih.gov/search/searchview.taf?ipid=63616
789,SC010373-10,"October 01, 2009 -  September 30, 2010",The Synergy Between Radiotherapy and Molecularly Targeted Agents,"Kevin A Camphausen; MD



IRP Faculty Profile",NULL,"Radiation Oncology Branch, NCI","Christian Alexander Graves



Aditya Narayan Halthore



Mary T Sproull



Anita T Tandle



Zion  Zibly",NULL,"Howard A Fine; MD, PhD (Neuro-Oncology Branch)



Patricia  Steeg; PhD (Developmental Therapeutics Branch)",NULL,"Ordered by publication type and then author name.



1.
Avondoglio D, Scott T, Kil WJ, Sproull M, Tofilon PJ, Camphausen K (2009). High throughput evaluation of gamma-H2AX. Radiat Oncol  4, 31.   https://doi.org/10.1186/1748-717X-4-31




PubMed



        
     
Free Article


 


PubMed ID 19703306
         Pubmed Central ID 2740844 


 



2.
Baschnagel A, Russo A, Burgan WE, Carter D, Beam K, Palmieri D, Steeg PS, Tofilon P, Camphausen K (2009). Vorinostat enhances the radiosensitivity of a breast cancer brain metastatic cell line grown in vitro and as intracranial xenografts. Mol Cancer Ther  8, 1589-95.   https://doi.org/10.1158/1535-7163.MCT-09-0038




PubMed



        
     
Free Article


 


PubMed ID 19509253
         Pubmed Central ID 3393105 


 



3.
Camphausen K (2009). Seminars in Radiation Oncology. Introduction. Semin Radiat Oncol  19, 141.   https://doi.org/10.1016/j.semradonc.2009.02.008




PubMed


 


PubMed ID 19464627
    
     


 



4.
Chung EJ, Brown AP, Asano H, Mandler M, Burgan WE, Carter D, Camphausen K, Citrin D (2009). In vitro and in vivo radiosensitization with AZD6244 (ARRY-142886), an inhibitor of mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 kinase. Clin Cancer Res  15, 3050-7.   https://doi.org/10.1158/1078-0432.CCR-08-2954




PubMed



        
     
Free Article


 


PubMed ID 19366835
         Pubmed Central ID 2798161 


 



5.
Kamrava M, Bernstein MB, Camphausen K, Hodge JW (2009). Combining radiation, immunotherapy, and antiangiogenesis agents in the management of cancer: the Three Musketeers or just another quixotic combination? Mol Biosyst  5, 1262-70.   https://doi.org/10.1039/b911313b




PubMed



        
     
Free Article


 


PubMed ID 19823740
         Pubmed Central ID 6309404 


 



6.
Kurshan N, Citrin DE, Camphausen KA (2009). Research highlights. Biomark Med  3, 17-9.   https://doi.org/10.2217/17520363.3.1.17




PubMed


 


PubMed ID 20477491
    
     


 



7.
McCord AM, Jamal M, Shankavaram UT, Shankavarum UT, Lang FF, Camphausen K, Tofilon PJ (2009). Physiologic oxygen concentration enhances the stem-like properties of CD133+ human glioblastoma cells in vitro. Mol Cancer Res  7, 489-97.   https://doi.org/10.1158/1541-7786.MCR-08-0360




PubMed



        
     
Free Article


 


PubMed ID 19372578
         Pubmed Central ID 6290460 


 



8.
McCord AM, Jamal M, Williams ES, Camphausen K, Tofilon PJ (2009). CD133+ glioblastoma stem-like cells are radiosensitive with a defective DNA damage response compared with established cell lines. Clin Cancer Res  15, 5145-53.   https://doi.org/10.1158/1078-0432.CCR-09-0263




PubMed



        
     
Free Article


 


PubMed ID 19671863
         Pubmed Central ID 6290462 


 



9.
Russo AL, Kwon HC, Burgan WE, Carter D, Beam K, Weizheng X, Zhang J, Slusher BS, Chakravarti A, Tofilon PJ, Camphausen K (2009). In vitro and in vivo radiosensitization of glioblastoma cells by the poly (ADP-ribose) polymerase inhibitor E7016. Clin Cancer Res  15, 607-12.   https://doi.org/10.1158/1078-0432.CCR-08-2079




PubMed



        
     
Free Article


 


PubMed ID 19147766
         Pubmed Central ID 6322204 


 



10.
Shabason JE, Camphausen K (2010). Cancer stem cells as a prognostic indicator for glioblastoma multiforme. Biomark Med  4, 127-8.   https://doi.org/10.2217/bmm.09.90




PubMed



        
     
Free Article


 


PubMed ID 20387308
         Pubmed Central ID 6334655 


 



11.
Tofilon PJ, Camphausen K (2009). Molecular targets for tumor radiosensitization. Chem Rev  109, 2974-88.   https://doi.org/10.1021/cr800504x




PubMed



        
     
Free Article


 


PubMed ID 19338375
         Pubmed Central ID 3407885",https://intramural.nih.gov/search/searchview.taf?ipid=63617
790,SC010375-10,"October 01, 2009 -  September 30, 2010",TAF7: A Check-point Regulator in Transcription Initiation,"Dinah  Singer; PhD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI","Devaiah Nanjappa Ballachanda



Anne G M Gegonne Bosselut



Jie  Mu



Susan  Sharrow



Katherine Chelsea Soe



Jocelyn D Weissman","Zeynep  Sercan
(Dokuz Eylul Universites)




Hongen  Zhang","Maxwell P Lee; PhD (Laboratory of Population Genetics)



Kent W Hunter; PhD (Laboratory of Cancer Biology and Genetics)



Robert  Clifford (Laboratory of Population Genetics)



Susan  Mackem; MD (Cancer and Developmental Biology Laboratory)



Kenneth  Buetow; PhD (Laboratory of Population Genetics)",Keiko  Ozato; PhD (NICHD),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63618
791,SC010376-10,"October 01, 2009 -  September 30, 2010",Molecular Mechanism of TNF Signaling and Apoptosis,"Zhenggang  Liu; PhD



IRP Faculty Profile",NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI","Cao  Xiumei



Swati Suresh Choksi



Michael J Morgan



Elena  Pobezinskaya



Yan  Zhang



Jie  Zhao",NULL,NULL,"J Silvio  Gutkind; PhD (NIDCR) 



Chuxia  Deng; PhD (NIDDK)","Ordered by publication type and then author name.



1.
Morgan MJ, Kim YS, Liu ZG (2009). Membrane-bound Fas ligand requires RIP1 for efficient activation of caspase-8 within the death-inducing signaling complex. J Immunol  183, 3278-84.   https://doi.org/10.4049/jimmunol.0803428




PubMed



        
     
Free Article


 


PubMed ID 19641134
         Pubmed Central ID 2730434",https://intramural.nih.gov/search/searchview.taf?ipid=63619
792,SC010378-10,"October 01, 2009 -  September 30, 2010",Activation of Proto-Oncogenes by Chromosomal Translocation,"Peter D Aplan; MD



IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","Sarah H Beachy; PhD



Sheryl Maxine Gough



Masahiro  Onozawa



Yang-Jo  Chung



Zhenhua  Zhang","Adolfo  Ferrando
(Genetics, Columbia U.)




Trang  Hoang
(U. Montreal)




Christoph  Plass
(Genetics, Ohio State Univ.)","Linda  Wolff; PhD (Laboratory of Cellular Oncology)



Lino  Tessarollo (Mouse Cancer Genetics Program)","Paul P. Liu; MD, PhD (NHGRI)","Ordered by publication type and then author name.



1.
Beachy SH, Aplan PD (2010). Mouse models of myelodysplastic syndromes. Hematol Oncol Clin North Am  24, 361-75.   https://doi.org/10.1016/j.hoc.2010.02.002




PubMed



        
     
Free Article


 


PubMed ID 20359631
         Pubmed Central ID 2848962 


 



2.
Caudell D, Harper DP, Novak RL, Pierce RM, Slape C, Wolff L, Aplan PD (2010). Retroviral insertional mutagenesis identifies Zeb2 activation as a novel leukemogenic collaborating event in CALM-AF10 transgenic mice. Blood  115, 1194-203.   https://doi.org/10.1182/blood-2009-04-216184




PubMed



        
     
Free Article


 


PubMed ID 20007546
         Pubmed Central ID 2826231 


 



3.
Choi CW, Chung YJ, Slape C, Aplan PD (2009). A NUP98-HOXD13 fusion gene impairs differentiation of B and T lymphocytes and leads to expansion of thymocytes with partial TCRB gene rearrangement. J Immunol  183, 6227-35.   https://doi.org/10.4049/jimmunol.0901121




PubMed



        
     
Free Article


 


PubMed ID 19841179
         Pubmed Central ID 3422874 


 



4.
Mrózek K, Harper DP, Aplan PD (2009). Cytogenetics and molecular genetics of acute lymphoblastic leukemia. Hematol Oncol Clin North Am  23, 991-1010, v.   https://doi.org/10.1016/j.hoc.2009.07.001




PubMed



        
     
Free Article


 


PubMed ID 19825449
         Pubmed Central ID 3607311 


 



5.
Stumpo DJ, Broxmeyer HE, Ward T, Cooper S, Hangoc G, Chung YJ, Shelley WC, Richfield EK, Ray MK, Yoder MC, Aplan PD, Blackshear PJ (2009). Targeted disruption of Zfp36l2, encoding a CCCH tandem zinc finger RNA-binding protein, results in defective hematopoiesis. Blood  114, 2401-10.   https://doi.org/10.1182/blood-2009-04-214619




PubMed



        
     
Free Article


 


PubMed ID 19633199
         Pubmed Central ID 2746470",https://intramural.nih.gov/search/searchview.taf?ipid=63620
793,SC010379-10,"October 01, 2009 -  September 30, 2010",Mechanisms of Chromosomal Translocation,"Peter D Aplan; MD



IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","Masahiro  Onozawa



Zhijun  Qiu; PhD



Zhenhua  Zhang",NULL,Andre A Nussenzweig; PhD (Experimental Immunology Branch),NULL,"Ordered by publication type and then author name.



1.
Beachy SH, Aplan PD (2010). Mouse models of myelodysplastic syndromes. Hematol Oncol Clin North Am  24, 361-75.   https://doi.org/10.1016/j.hoc.2010.02.002




PubMed



        
     
Free Article


 


PubMed ID 20359631
         Pubmed Central ID 2848962 


 



2.
Mrózek K, Harper DP, Aplan PD (2009). Cytogenetics and molecular genetics of acute lymphoblastic leukemia. Hematol Oncol Clin North Am  23, 991-1010, v.   https://doi.org/10.1016/j.hoc.2009.07.001




PubMed



        
     
Free Article


 


PubMed ID 19825449
         Pubmed Central ID 3607311",https://intramural.nih.gov/search/searchview.taf?ipid=63621
794,SC010384-10,"October 01, 2009 -  September 30, 2010",Hematopoietic Stem Cell Gene Therapy for Leukocyte Adhesion Deficiency,"Dennis D Hickstein



IRP Faculty Profile",NULL,"Experimental Transplantation and Immunology Branch, NCI","Thomas R Bauer



Michael J Hunter; PhD



Laura M Tuschong","Alan W Flake; MD
(Department of Surgery, Children's Hospital of Philadelphia)




David  Russell
(University of Washington)",NULL,"Harry Lewis Malech; MD (NIAID) 



Cynthia E Dunbar; MD (NHLBI)","Ordered by publication type and then author name.



1.
Bauer TR, Adler RL, Hickstein DD (2009). Potential large animal models for gene therapy of human genetic diseases of immune and blood cell systems. ILAR J  50, 168-86.   https://doi.org/10.1093/ilar.50.2.168




PubMed



        
     
Free Article


 


PubMed ID 19293460
         Pubmed Central ID 2806185 


 



2.
Peranteau WH, Heaton TE, Gu YC, Volk SW, Bauer TR, Alcorn K, Tuschong LM, Johnson MP, Hickstein DD, Flake AW (2009). Haploidentical in utero hematopoietic cell transplantation improves phenotype and can induce tolerance for postnatal same-donor transplants in the canine leukocyte adhesion deficiency model. Biol Blood Marrow Transplant  15, 293-305.   https://doi.org/10.1016/j.bbmt.2008.11.034




PubMed



        
     
Free Article


 


PubMed ID 19203720
         Pubmed Central ID 2796507",https://intramural.nih.gov/search/searchview.taf?ipid=63622
795,SC010437-10,"October 01, 2009 -  September 30, 2010",Molecular Pathology of Cancer,"Michael R Emmert-Buck; MD, PhD",NULL,"Laboratory of Pathology, NCI","Maria  Merino; PhD



Wusheng  Yan



Liang  Zhu; PhD",NULL,"Philip  Taylor; MD, ScD (Genetic Epidemiology Branch)



William Marston Linehan; MD (Urologic Oncology Branch)",NULL,"Ordered by publication type and then author name.



1.
Arnott D, Emmert-Buck MR (2010). Proteomic profiling of cancer--opportunities, challenges, and context. J Pathol  222, 16-20.   https://doi.org/10.1002/path.2750




PubMed


 


PubMed ID 20623483
    
     


 



2.
Erickson HS, Albert PS, Gillespie JW, Rodriguez-Canales J, Marston Linehan W, Pinto PA, Chuaqui RF, Emmert-Buck MR (2009). Quantitative RT-PCR gene expression analysis of laser microdissected tissue samples. Nat Protoc  4, 902-22.   https://doi.org/10.1038/nprot.2009.61




PubMed



        
     
Free Article


 


PubMed ID 19478806
         Pubmed Central ID 2760821 


 



3.
Erickson HS, Josephson JW, Vira M, Albert PS, Gillespie JW, Rodriguez-Canales J, Pinto PA, Chuaqui RF, Emmert-Buck MR, Coleman JA (2010). Influence of hypoxia induced by minimally invasive prostatectomy on gene expression: implications for biomarker analysis. Am J Transl Res  2, 210-22.




PubMed



        
     
Free Article


 


PubMed ID 20589162
         Pubmed Central ID 2892411 


 



4.
Mukherjee S, Richardson AM, Rodriguez-Canales J, Ylaya K, Erickson HS, Player A, Kawasaki ES, Pinto PA, Choyke PL, Merino MJ, Albert PS, Chuaqui RF, Emmert-Buck MR (2009). Identification of EpCAM as a molecular target of prostate cancer stroma. Am J Pathol  175, 2277-87.   https://doi.org/10.2353/ajpath.2009.090013




PubMed



        
     
Free Article


 


PubMed ID 19850885
         Pubmed Central ID 2789605 


 



5.
Zoon CK, Starker EQ, Wilson AM, Emmert-Buck MR, Libutti SK, Tangrea MA (2009). Current molecular diagnostics of breast cancer and the potential incorporation of microRNA. Expert Rev Mol Diagn  9, 455-67.   https://doi.org/10.1586/erm.09.25




PubMed



        
     
Free Article


 


PubMed ID 19580430
         Pubmed Central ID 2758104",https://intramural.nih.gov/search/searchview.taf?ipid=63624
796,BC010906-03,"October 01, 2009 -  September 30, 2010",Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy,"Thomas Alexander Waldmann; MD, PhD



IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI","Bonita R Bryant



Jing  Chen



Carolyn  Goldman



John  Janik; MD



John Charles Morris; MD



Liyanage P Perera; PhD



Show all 9",NULL,"Steven Aaron Rosenberg; MD, PhD (Surgery Branch)



Jason L Yovandich (Biological Resources Branch)



Stephen  Creekmore; PhD (Biological Resources Branch)",Mario  Roederer; PhD (NIAID),"Ordered by publication type and then author name.



1.
Soman G, Yang X, Jiang H, Giardina S, Vyas V, Mitra G, Yovandich J, Creekmore SP, Waldmann TA, Quiñones O, Alvord WG (2009). MTS dye based colorimetric CTLL-2 cell proliferation assay for product release and stability monitoring of interleukin-15: assay qualification, standardization and statistical analysis. J Immunol Methods  348, 83-94.   https://doi.org/10.1016/j.jim.2009.07.010




PubMed



        
     
Free Article


 


PubMed ID 19646987
         Pubmed Central ID 2786060 


 



2.
Zhang M, Yao Z, Dubois S, Ju W, Müller JR, Waldmann TA (2009). Interleukin-15 combined with an anti-CD40 antibody provides enhanced therapeutic efficacy for murine models of colon cancer. Proc Natl Acad Sci U S A  106, 7513-8.   https://doi.org/10.1073/pnas.0902637106




PubMed



        
     
Free Article


 


PubMed ID 19383782
         Pubmed Central ID 2678620",https://intramural.nih.gov/search/searchview.taf?ipid=63298
797,BC009255-36,"October 01, 2009 -  September 30, 2010",Application of Flow Cytometry to Cell Biology,Susan  Sharrow,Alfred  Singer; MD,"Experimental Immunology Branch, NCI","Anthony J Adams



Lawrence G Granger



Donald G Plugge",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Belkina NV, Liu Y, Hao JJ, Karasuyama H, Shaw S (2009) LOK is a major ERM kinase in resting lymphocytes and regulates cytoskeletal rearrangement through ERM phosphorylation. Proc Natl Acad Sci U S A 106:4707-12.




PubMed



        
     
Free Article


 


PubMed ID 19255442
         Pubmed Central ID 2660762 


 



2.
Bhatia S, Sun K, Almo SC, Nathenson SG, Hodes RJ (2010). Dynamic equilibrium of B7-1 dimers and monomers differentially affects immunological synapse formation and T cell activation in response to TCR/CD28 stimulation. J Immunol  184, 1821-8.   https://doi.org/10.4049/jimmunol.0902869




PubMed



        
     
Free Article


 


PubMed ID 20065109
         Pubmed Central ID 4088257 


 



3.
Bunting SF, Callén E, Wong N, Chen HT, Polato F, Gunn A, Bothmer A, Feldhahn N, Fernandez-Capetillo O, Cao L, Xu X, Deng CX, Finkel T, Nussenzweig M, Stark JM, Nussenzweig A (2010). 53BP1 inhibits homologous recombination in Brca1-deficient cells by blocking resection of DNA breaks. Cell  141, 243-54.   https://doi.org/10.1016/j.cell.2010.03.012




PubMed



        
     
Free Article


 


PubMed ID 20362325
         Pubmed Central ID 2857570 


 



4.
Callén E, Jankovic M, Wong N, Zha S, Chen HT, Difilippantonio S, Di Virgilio M, Heidkamp G, Alt FW, Nussenzweig A, Nussenzweig M (2009). Essential role for DNA-PKcs in DNA double-strand break repair and apoptosis in ATM-deficient lymphocytes. Mol Cell  34, 285-97.   https://doi.org/10.1016/j.molcel.2009.04.025




PubMed



        
     
Free Article


 


PubMed ID 19450527
         Pubmed Central ID 2709792 


 



5.
Chiang YJ, Jordan MS, Horai R, Schwartzberg PL, Koretzky GA, Hodes RJ (2009). Cbl enforces an SLP76-dependent signaling pathway for T cell differentiation. J Biol Chem  284, 4429-38.   https://doi.org/10.1074/jbc.M808679200




PubMed



        
     
Free Article


 


PubMed ID 19074136
         Pubmed Central ID 2640981 


 



6.
Cohen H, Parekh P, Sercan Z, Kotekar A, Weissman JD, Singer DS (2009) In vivo expression of MHC class I genes depends on the presence of a downstream barrier element. PLoS One 4:e6748.




PubMed



        
     
Free Article


 


PubMed ID 19707598
         Pubmed Central ID 2727697 


 



7.
Daniel JA, Santos MA, Wang Z, Zang C, Schwab KR, Jankovic M, Filsuf D, Chen HT, Gazumyan A, Yamane A, Cho YW, Sun HW, Ge K, Peng W, Nussenzweig MC, Casellas R, Dressler GR, Zhao K, Nussenzweig A (2010). PTIP promotes chromatin changes critical for immunoglobulin class switch recombination. Science  329, 917-23.   https://doi.org/10.1126/science.1187942




PubMed



        
     
Free Article


 


PubMed ID 20671152
         Pubmed Central ID 3008398 


 



8.
Murga M, Bunting S, Montaña MF, Soria R, Mulero F, Cañamero M, Lee Y, McKinnon PJ, Nussenzweig A, Fernandez-Capetillo O (2009). A mouse model of ATR-Seckel shows embryonic replicative stress and accelerated aging. Nat Genet  41, 891-8.   https://doi.org/10.1038/ng.420




PubMed



        
     
Free Article


 


PubMed ID 19620979
         Pubmed Central ID 2902278 


 



9.
Park JH, Adoro S, Guinter T, Erman B, Alag AS, Catalfamo M, Kimura MY, Cui Y, Lucas PJ, Gress RE, Kubo M, Hennighausen L, Feigenbaum L, Singer A (2010). Signaling by intrathymic cytokines, not T cell antigen receptors, specifies CD8 lineage choice and promotes the differentiation of cytotoxic-lineage T cells. Nat Immunol  11, 257-64.   https://doi.org/10.1038/ni.1840




PubMed



        
     
Free Article


 


PubMed ID 20118929
         Pubmed Central ID 3555225 


 



10.
Santos MA, Huen MS, Jankovic M, Chen HT, López-Contreras AJ, Klein IA, Wong N, Barbancho JL, Fernandez-Capetillo O, Nussenzweig MC, Chen J, Nussenzweig A (2010). Class switching and meiotic defects in mice lacking the E3 ubiquitin ligase RNF8. J Exp Med  207, 973-81.   https://doi.org/10.1084/jem.20092308




PubMed



        
     
Free Article


 


PubMed ID 20385748
         Pubmed Central ID 2867275 


 



11.
Sarafova SD, Van Laethem F, Adoro S, Guinter T, Sharrow SO, Feigenbaum L, Singer A (2009). Upregulation of CD4 expression during MHC class II-specific positive selection is essential for error-free lineage choice. Immunity  31, 480-90.   https://doi.org/10.1016/j.immuni.2009.07.006




PubMed



        
     
Free Article


 


PubMed ID 19747858
         Pubmed Central ID 2758695",https://intramural.nih.gov/search/searchview.taf?ipid=62765
798,BC010469-08,"October 01, 2009 -  September 30, 2010",Molecular Targets Development Program,James  McMahon; PhD,NULL,"Molecular Targets Laboratory, NCI","Alun  Bermingham



John A Beutler



Heidi  Bokesch



Laura  Cartner



Krishna Prasad Devkota; PhD



Thushara Kelum Kaviraj  Diyabalanage



Show all 30","Edward  Arnold
(Rutgers University)




John W Blunt; PhD
(Chemistry Department, Natural products group)




Anders  Bolmstedt
(Glycovirology, Univ. of Goteborg)




Ihsan  Calis
(Natural product diversity librarires, Hacteppe University)




David  Craik
(Institute for Molecular Bioscience, Univ. of Queensland)




Patrick  Cummings
(Masters Program development, Johns Hopkins University)


Show all 30","Giuseppe  Giaccone; MD (Medical Oncology Branch)



Nancy H Colburn; PhD (Laboratory of Cancer Prevention)



Thomas Joseph Sayers; PhD (Laboratory of Experimental Immunology)



Lalage  Wakefield; PhD (Laboratory of Cancer Biology and Genetics)



Gordon Lee Hager; PhD (Laboratory of Receptor Biology and Gene Expression)



Allan M Weissman; MD (Laboratory of Protein Dynamics and Signaling)",Michael P Bray (NIAID),"Ordered by publication type and then author name.



1.
Beutler JA, Kang MI, Robert F, Clement JA, Pelletier J, Colburn NH, McKee TC, Goncharova E, McMahon JB, Henrich CJ (2009). Quassinoid inhibition of AP-1 function does not correlate with cytotoxicity or protein synthesis inhibition. J Nat Prod  72, 503-6.   https://doi.org/10.1021/np800732n




PubMed



        
     
Free Article


 


PubMed ID 19199792
         Pubmed Central ID 2837105 


 



2.
Dong S, Hamel E, Bai R, Covell DG, Beutler JA, Porco JA (2009) Enantioselective synthesis of (+)-chamaecypanone C: a novel microtubule inhibitor. Angew Chem Int Ed Engl 48:1494-7.




PubMed



        
     
Free Article


 


PubMed ID 19140149
         Pubmed Central ID 2747729 


 



3.
Kang MI, Henrich CJ, Bokesch HR, Gustafson KR, McMahon JB, Baker AR, Young MR, Colburn NH (2009). A selective small-molecule nuclear factor-kappaB inhibitor from a high-throughput cell-based assay for ""activator protein-1 hits"". Mol Cancer Ther  8, 571-81.   https://doi.org/10.1158/1535-7163.MCT-08-0811




PubMed



        
     
Free Article


 


PubMed ID 19258426
         Pubmed Central ID 2813146 


 



4.
Liu Y, Carroll JR, Holt LA, McMahon J, Giomarelli B, Ghirlanda G (2009). Multivalent interactions with gp120 are required for the anti-HIV activity of Cyanovirin. Biopolymers  92, 194-200.   https://doi.org/10.1002/bip.21173




PubMed



               Available in future as a Free Article 


 


PubMed ID 19235857
         Pubmed Central ID 6961781 


 



5.
O'Keefe BR, Vojdani F, Buffa V, Shattock RJ, Montefiori DC, Bakke J, Mirsalis J, d'Andrea AL, Hume SD, Bratcher B, Saucedo CJ, McMahon JB, Pogue GP, Palmer KE (2009). Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide component. Proc Natl Acad Sci U S A  106, 6099-104.   https://doi.org/10.1073/pnas.0901506106




PubMed



        
     
Free Article


 


PubMed ID 19332801
         Pubmed Central ID 2662964 


 



6.
Ratnayake R, Covell D, Ransom TT, Gustafson KR, Beutler JA (2009). Englerin A, a selective inhibitor of renal cancer cell growth, from Phyllanthus engleri. Org Lett  11, 57-60.   https://doi.org/10.1021/ol802339w




PubMed



        
     
Free Article


 


PubMed ID 19061394
         Pubmed Central ID 2651161 


 



7.
Wrona IE, Lowe JT, Turbyville TJ, Johnson TR, Beignet J, Beutler JA, Panek JS (2009) Synthesis of a 35-member stereoisomer library of bistramide A: evaluation of effects on actin state, cell cycle and tumor cell growth. J Org Chem 74:1897-916




PubMed



        
     
Free Article


 


PubMed ID 19191575
         Pubmed Central ID 3480235",https://intramural.nih.gov/search/searchview.taf?ipid=62963
799,BC010517-08,"October 01, 2009 -  September 30, 2010",Large Databases of Small Molecules - Drug Development Tool and Public Resource,"Marc C Nicklaus



IRP Faculty Profile",NULL,"Chemical Biology Laboratory, NCI","Igor V Filippov



Markus  Sitzmann","Stephen  Boyer





Lawrence  Callahan
(FDA)




Eugene  Demchuk
(CDC)




Huixiao  Hong
(NCI)




Wolf-Dietrich  Ihlenfeldt
(Xemistry GmbH)




Ann  Richard
(EPA)


Show all 8",NULL,"Christopher P Austin; AB, MD (NHGRI)","Ordered by publication type and then author name.



1.
Filippov IV, Nicklaus MC (2009). Optical structure recognition software to recover chemical information: OSRA, an open source solution. J Chem Inf Model  49, 740-3.   https://doi.org/10.1021/ci800067r




PubMed



        
     
Free Article


 


PubMed ID 19434905
         Pubmed Central ID 2889020",https://intramural.nih.gov/search/searchview.taf?ipid=62966
800,BC010548-08,"October 01, 2009 -  September 30, 2010",Pharmacokinetic and Pharmacodynamic Modeling of Anticancer Agents,"William D Figg; PharmD



IRP Faculty Profile",Giuseppe  Giaccone; MD,"Medical Oncology Branch, NCI","Cindy Huong-Bich Chau



Kathryn  Compton



Cody John Peer","Edward  Sausville
(University of Maryland)




Alex  Sparreboom",William Laurence Dahut; MD (Office of the Director),NULL,"Ordered by publication type and then author name.



1.
Dahut WL, Aragon-Ching JB, Woo S, Tohnya TM, Gulley JL, Arlen PM, Wright JJ, Ventiz J, Figg WD (2009). Phase I study of oral lenalidomide in patients with refractory metastatic cancer. J Clin Pharmacol  49, 650-60.   https://doi.org/10.1177/0091270009335001




PubMed



        
     
Free Article


 


PubMed ID 19451403
         Pubmed Central ID 2808857 


 



2.
Woo S, Gardner ER, Chen X, Ockers SB, Baum CE, Sissung TM, Price DK, Frye R, Piekarz RL, Bates SE, Figg WD (2009). Population pharmacokinetics of romidepsin in patients with cutaneous T-cell lymphoma and relapsed peripheral T-cell lymphoma. Clin Cancer Res  15, 1496-503.   https://doi.org/10.1158/1078-0432.CCR-08-1215




PubMed



        
     
Free Article


 


PubMed ID 19228751
         Pubmed Central ID 2707030",https://intramural.nih.gov/search/searchview.taf?ipid=63142
801,BC010571-07,"October 01, 2009 -  September 30, 2010",Fluorescence Imaging Facility,James G McNally; PhD,Gordon Lee Hager; PhD,"Laboratory of Receptor Biology and Gene Expression, NCI",Tatiana  Karpova,NULL,"John Edward Niederhuber (Laboratory Of Genitourinary Cancer Pathogenesis)



Michael  Bustin; PhD (Protein Section)



Charles  Vinson; PhD (Nucleic Acids Section)",Keiko  Ozato; PhD (NICHD),"Ordered by publication type and then author name.



1.
Rochman M, Postnikov Y, Correll S, Malicet C, Wincovitch S, Karpova TS, McNally JG, Wu X, Bubunenko NA, Grigoryev S, Bustin M (2009). The interaction of NSBP1/HMGN5 with nucleosomes in euchromatin counteracts linker histone-mediated chromatin compaction and modulates transcription. Mol Cell  35, 642-56.   https://doi.org/10.1016/j.molcel.2009.07.002




PubMed



        
     
Free Article


 


PubMed ID 19748358
         Pubmed Central ID 2757144",https://intramural.nih.gov/search/searchview.taf?ipid=62998
802,BC010596-07,"October 01, 2009 -  September 30, 2010",Pediatric Graft-vs-Host Disease,Alan S Wayne; MD,Crystal L. Mackall; MD,"Pediatric Oncology Branch, NCI","Terry J Fry



Cynthia P Love",NULL,"Daniel H Fowler (Experimental Transplantation and Immunology Branch)



Steven  Pavletic; MD, MS (Experimental Transplantation and Immunology Branch)



Ronald E Gress; MD (Experimental Transplantation and Immunology Branch)



Frances  Hakim; PhD (Experimental Transplantation and Immunology Branch)



Michael R Bishop; MD (Experimental Transplantation and Immunology Branch)","Susan  Leitman; MD (CC) 



Austin John Barrett; MD (NHLBI) 



Charles  Bolan; BS, MS, MD (NHLBI)","Ordered by publication type and then author name.



1.
Baird K, Wayne AS (2009). Extracorporeal photo-apheresis for the treatment of steroid-resistant graft versus host disease. Transfus Apher Sci  41, 209-16.   https://doi.org/10.1016/j.transci.2009.09.007




PubMed



        
     
Free Article


 


PubMed ID 19819186
         Pubmed Central ID 2787192 


 



2.
Bishop MR, Alyea EP, Cairo MS, Falkenburg JH, June CH, Kröger N, Little RF, Miller JS, Pavletic SZ, Porter D, Riddell SR, van Besien K, Wayne AS, Weisdorf DJ, Wu R, Giralt S (2010). Introduction to the reports from the National Cancer Institute First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant  16, 563-4.   https://doi.org/10.1016/j.bbmt.2010.02.025




PubMed



        
     
Free Article


 


PubMed ID 20202482
         Pubmed Central ID 2996879 


 



3.
Capitini CM, Mackall CL, Wayne AS (2010). Immune-based therapeutics for pediatric cancer. Expert Opin Biol Ther  10, 163-78.   https://doi.org/10.1517/14712590903431022




PubMed



        
     
Free Article


 


PubMed ID 19947897
         Pubmed Central ID 2809805 


 



4.
Kröger N, Bacher U, Bader P, Böttcher S, Borowitz MJ, Dreger P, Khouri I, Macapinlac HA, Macapintac H, Olavarria E, Radich J, Stock W, Vose JM, Weisdorf D, Willasch A, Giralt S, Bishop MR, Wayne AS (2010). NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse following Allogeneic Stem Cell Transplantation. Part I: Methods, acute leukemias, and myelodysplastic syndromes. Biol Blood Marrow Transplant  16, 1187-211.   https://doi.org/10.1016/j.bbmt.2010.06.008




PubMed


 


PubMed ID 20558311
    
     


 



5.
Kröger N, Bacher U, Bader P, Böttcher S, Borowitz MJ, Dreger P, Khouri I, Olavarria E, Radich J, Stock W, Vose JM, Weisdorf D, Willasch A, Giralt S, Bishop MR, Wayne AS (2010). NCI first international workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on disease-specific methods and strategies for monitoring relapse following allogeneic stem cell transplantation. part II: chronic leukemias, myeloproliferative neoplasms, and lymphoid malignancies. Biol Blood Marrow Transplant  16, 1325-46.   https://doi.org/10.1016/j.bbmt.2010.07.001




PubMed


 


PubMed ID 20637879
    
     


 



6.
Porter DL, Alyea EP, Antin JH, DeLima M, Estey E, Falkenburg JH, Hardy N, Kroeger N, Leis J, Levine J, Maloney DG, Peggs K, Rowe JM, Wayne AS, Giralt S, Bishop MR, van Besien K (2010). NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant  16, 1467-503.   https://doi.org/10.1016/j.bbmt.2010.08.001




PubMed



        
     
Free Article


 


PubMed ID 20699125
         Pubmed Central ID 2955517 


 



7.
Wayne AS, Baird K, Egeler RM (2010). Hematopoietic stem cell transplantation for leukemia. Pediatr Clin North Am  57, 1-25.   https://doi.org/10.1016/j.pcl.2009.11.005




PubMed



        
     
Free Article


 


PubMed ID 20307709
         Pubmed Central ID 2913522 


 



8.
Wayne AS, Capitini CM, Mackall CL (2010). Immunotherapy of childhood cancer: from biologic understanding to clinical application. Curr Opin Pediatr  22, 2-11.   https://doi.org/10.1097/MOP.0b013e3283350d3e




PubMed



        
     
Free Article


 


PubMed ID 19952749
         Pubmed Central ID 2845444",https://intramural.nih.gov/search/searchview.taf?ipid=62977
803,BC010630-07,"October 01, 2009 -  September 30, 2010",Cancer Vaccines and Modulation of Checkpoint Controls in Immunization,John  Janik; MD,"Thomas Alexander Waldmann; MD, PhD","Lymphoid Malignancies Branch, NCI","Nancy A Harold



Arlethia J Spencer",NULL,"Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=62988
804,BC010639-07,"October 01, 2009 -  September 30, 2010",In Silico Screening for Cancer Targets,"Marc C Nicklaus



IRP Faculty Profile",NULL,"Chemical Biology Laboratory, NCI","Igor V Filippov



Chenzhong  Liao



Megan L Peach



Iwona Elzbieta Weidlich



Terrence R Burke; PhD",NULL,"Barbara  Mroczkowski (Office of the Director)



Stuart F J Le Grice; PhD (Retroviral Replication Laboratory)



Yves  Pommier; PhD (Developmental Therapeutics Branch)



Robert  Shoemaker (Screening Technologies Branch)



Peter  Blumberg; PhD (Laboratory of Cancer Biology and Genetics)



Phillip A Dennis; MD, PhD (Medical Oncology Branch)","Paul P. Liu; MD, PhD (NHGRI)","Ordered by publication type and then author name.



1.
Boyer PL, Vu BC, Ambrose Z, Julias JG, Warnecke S, Liao C, Meier C, Marquez VE, Hughes SH (2009). The nucleoside analogue D-carba T blocks HIV-1 reverse transcription. J Med Chem  52, 5356-64.   https://doi.org/10.1021/jm801176e




PubMed



        
     
Free Article


 


PubMed ID 19678643
         Pubmed Central ID 2756836 


 



2.
Choi WJ, Kim SE, Stephen AG, Weidlich I, Giubellino A, Liu F, Worthy KM, Bindu L, Fivash MJ, Nicklaus MC, Bottaro DP, Fisher RJ, Burke TR (2009). Identification of Shc Src homology 2 domain-binding peptoid-peptide hybrids. J Med Chem  52, 1612-8.   https://doi.org/10.1021/jm800789h




PubMed



        
     
Free Article


 


PubMed ID 19226165
         Pubmed Central ID 2669314 


 



3.
Dexheimer TS, Gediya LK, Stephen AG, Weidlich I, Antony S, Marchand C, Interthal H, Nicklaus M, Fisher RJ, Njar VC, Pommier Y (2009). 4-Pregnen-21-ol-3,20-dione-21-(4-bromobenzenesulfonate) (NSC 88915) and related novel steroid derivatives as tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors. J Med Chem  52, 7122-31.   https://doi.org/10.1021/jm901061s




PubMed



        
     
Free Article


 


PubMed ID 19883083
         Pubmed Central ID 2784989 


 



4.
Ludek OR, Schroeder GK, Liao C, Russ PL, Wolfenden R, Marquez VE (2009). Synthesis and conformational analysis of locked carbocyclic analogues of 1,3-diazepinone riboside, a high-affinity cytidine deaminase inhibitor. J Org Chem  74, 6212-23.   https://doi.org/10.1021/jo901127a




PubMed



        
     
Free Article


 


PubMed ID 19618900
         Pubmed Central ID 2727169 


 



5.
Peach ML, Nicklaus MC (2009). Combining docking with pharmacophore filtering for improved virtual screening. J Cheminform  1, 6.   https://doi.org/10.1186/1758-2946-1-6




PubMed



        
     
Free Article


 


PubMed ID 20298524
         Pubmed Central ID 3152774 


 



6.
Peach ML, Tan N, Choyke SJ, Giubellino A, Athauda G, Burke TR, Nicklaus MC, Bottaro DP (2009). Directed discovery of agents targeting the Met tyrosine kinase domain by virtual screening. J Med Chem  52, 943-51.   https://doi.org/10.1021/jm800791f




PubMed



        
     
Free Article


 


PubMed ID 19199650
         Pubmed Central ID 2698034 


 



7.
Yun SM, Moulaei T, Lim D, Bang JK, Park JE, Shenoy SR, Liu F, Kang YH, Liao C, Soung NK, Lee S, Yoon DY, Lim Y, Lee DH, Otaka A, Appella E, McMahon JB, Nicklaus MC, Burke TR, Yaffe MB, Wlodawer A, Lee KS (2009). Structural and functional analyses of minimal phosphopeptides targeting the polo-box domain of polo-like kinase 1. Nat Struct Mol Biol  16, 876-82.   https://doi.org/10.1038/nsmb.1628




PubMed



        
     
Free Article


 


PubMed ID 19597481
         Pubmed Central ID 2721907",https://intramural.nih.gov/search/searchview.taf?ipid=63001
805,BC010685-06,"October 01, 2009 -  September 30, 2010",Postmortem Pathology,"David Erwin Kleiner; MD, PhD",John Carl Oberholtzer,"Laboratory of Pathology, NCI","Jeannette Marie McNulty



Willie J Young",NULL,NULL,"Kenneth  Olivier; MD, MPH (NIAID) 



Steven M Holland; MD (NIAID) 



Theo  Heller; MD (NIDDK)","Ordered by publication type and then author name.



1.
Koh C, Kleiner DE, Heller T (2009). Don't forget to polarize your lenses! Talc in the liver. Gastroenterology  137, e3-4.   https://doi.org/10.1053/j.gastro.2009.02.053




PubMed



        
     
Free Article


 


PubMed ID 19866528
         Pubmed Central ID 3498506 


 



2.
Vinh DC, Shea YR, Sugui JA, Parrilla-Castellar ER, Freeman AF, Campbell JW, Pittaluga S, Jones PA, Zelazny A, Kleiner D, Kwon-Chung KJ, Holland SM (2009). Invasive aspergillosis due to Neosartorya udagawae. Clin Infect Dis  49, 102-11.   https://doi.org/10.1086/599345




PubMed



        
     
Free Article


 


PubMed ID 19489714
         Pubmed Central ID 4100555",https://intramural.nih.gov/search/searchview.taf?ipid=63026
806,BC010687-06,"October 01, 2009 -  September 30, 2010",Histology Core Laboratory,"David Erwin Kleiner; MD, PhD",John Carl Oberholtzer,"Laboratory of Pathology, NCI","Judith C Horn



Helen G Lynch



Jeannette Marie McNulty



Catherine R Neely



Martha A Pruden



Claire D Roque



Show all 7","Steven  Belle
(University of Pittsburgh)




Elizabeth  Brunt
(Pathology, St. Louis University)




Hari  Conjeevaram
(Gastroenterology, The University of Michigan)




Robert  Fontana
(Gastroenterology, The University of Michigan)




Allan  Kirk
(Emory University)




Joel  Lavine
(Pediatrics, University of California San Diego Medical Center)


Show all 10","Steven  Pavletic; MD, MS (Experimental Transplantation and Immunology Branch)","Yaron  Rotman (NIDDK) 



Marc Gregory Ghany; MD (NIDDK) 



Kenneth  Olivier; MD, MPH (NIAID) 



Caryn G Morse; MD (NIAID) 



Michael  Polis; MD (NIAID) 



Leonard  Seeff (NIDDK)","Ordered by publication type and then author name.



1.
Allison RD, Katsounas A, Koziol DE, Kleiner DE, Alter HJ, Lempicki RA, Wood B, Yang J, Fullmer B, Cortez KJ, Polis MA, Kottilil S (2009). Association of interleukin-15-induced peripheral immune activation with hepatic stellate cell activation in persons coinfected with hepatitis C virus and HIV. J Infect Dis  200, 619-23.   https://doi.org/10.1086/600107




PubMed



        
     
Free Article


 


PubMed ID 19594300
         Pubmed Central ID 2806092 


 



2.
Calado RT, Regal JA, Kleiner DE, Schrump DS, Peterson NR, Pons V, Chanock SJ, Lansdorp PM, Young NS (2009). A spectrum of severe familial liver disorders associate with telomerase mutations. PLoS One  4, e7926.   https://doi.org/10.1371/journal.pone.0007926




PubMed



        
     
Free Article


 


PubMed ID 19936245
         Pubmed Central ID 2775683 


 



3.
Gunay-Aygun M, Parisi MA, Doherty D, Tuchman M, Tsilou E, Kleiner DE, Huizing M, Turkbey B, Choyke P, Guay-Woodford L, Heller T, Szymanska K, Johnson CA, Glass I, Gahl WA (2009). MKS3-related ciliopathy with features of autosomal recessive polycystic kidney disease, nephronophthisis, and Joubert Syndrome. J Pediatr  155, 386-92.e1.   https://doi.org/10.1016/j.jpeds.2009.03.045




PubMed



        
     
Free Article


 


PubMed ID 19540516
         Pubmed Central ID 2925444 


 



4.
Hon YY, Chamberlain CE, Kleiner DE, Ring MS, Hale DA, Kirk AD, Mannon RB (2010). Evaluation of tacrolimus abbreviated area-under-the-curve monitoring in renal transplant patients who are potentially at risk for adverse events. Clin Transplant  24, 557-63.   https://doi.org/10.1111/j.1399-0012.2009.01143.x




PubMed



        
     
Free Article


 


PubMed ID 19925470
         Pubmed Central ID 2889034 


 



5.
Koh C, Hipp JD, Kleiner DE, Heller T (2010). Acute right upper quadrant pain: a lesson in odds. Dig Liver Dis  42, 72-3.   https://doi.org/10.1016/j.dld.2009.05.004




PubMed



        
     
Free Article


 


PubMed ID 19515620
         Pubmed Central ID 3472508 


 



6.
Koh C, Kleiner DE, Heller T (2009). Don't forget to polarize your lenses! Talc in the liver. Gastroenterology  137, e3-4.   https://doi.org/10.1053/j.gastro.2009.02.053




PubMed



        
     
Free Article


 


PubMed ID 19866528
         Pubmed Central ID 3498506 


 



7.
Koh C, Kleiner DE, Sherry RM, Fowler DH, Heller T (2009). When the left got left behind. Am J Gastroenterol  104, 2644-5.   https://doi.org/10.1038/ajg.2009.376




PubMed



        
     
Free Article


 


PubMed ID 19806108
         Pubmed Central ID 3498507 


 



8.
Osinusi A, Kleiner D, Wood B, Polis M, Masur H, Kottilil S (2009). Rapid development of advanced liver fibrosis after acquisition of hepatitis C infection during primary HIV infection. AIDS Patient Care STDS  23, 403-6.   https://doi.org/10.1089/apc.2008.0238




PubMed



        
     
Free Article


 


PubMed ID 19519227
         Pubmed Central ID 2879494 


 



9.
Palmore TN, Shah NL, Loomba R, Borg BB, Lopatin U, Feld JJ, Khokhar F, Lutchman G, Kleiner DE, Young NS, Childs R, Barrett AJ, Liang TJ, Hoofnagle JH, Heller T (2009). Reactivation of hepatitis B with reappearance of hepatitis B surface antigen after chemotherapy and immunosuppression. Clin Gastroenterol Hepatol  7, 1130-7.   https://doi.org/10.1016/j.cgh.2009.06.027




PubMed



        
     
Free Article


 


PubMed ID 19577007
         Pubmed Central ID 2779698 


 



10.
Rotman Y, Koh C, Zmuda JM, Kleiner DE, Liang TJ, NASH CRN (2010). The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease. Hepatology  52, 894-903.   https://doi.org/10.1002/hep.23759




PubMed



        
     
Free Article


 


PubMed ID 20684021
         Pubmed Central ID 2932770 


 



11.
Vinh DC, Shea YR, Sugui JA, Parrilla-Castellar ER, Freeman AF, Campbell JW, Pittaluga S, Jones PA, Zelazny A, Kleiner D, Kwon-Chung KJ, Holland SM (2009). Invasive aspergillosis due to Neosartorya udagawae. Clin Infect Dis  49, 102-11.   https://doi.org/10.1086/599345




PubMed



        
     
Free Article


 


PubMed ID 19489714
         Pubmed Central ID 4100555",https://intramural.nih.gov/search/searchview.taf?ipid=63028
807,BC010858-04,"October 01, 2009 -  September 30, 2010",CCR Confocal Microscopy Core,Susan H Garfield,"Snorri S. Thorgeirsson; MD, PhD","Laboratory of Experimental Carcinogenesis, NCI","Langston  Lim



Poonam  Mannan",NULL,"Benu Brata  Das (Developmental Therapeutics Branch)



Peter  Blumberg; PhD (Laboratory of Cancer Biology and Genetics)



Chand  Khanna; MD (Pediatric Oncology Branch)



Itzhak  Avital (Surgery Branch)



Sukhbir  Kaur (Laboratory of Pathology)



Srinivasa M Srinivasula (Laboratory of Immune Cell Biology)","Chava  Kimchi-Sarfaty (OD) 



Kevin G Chen; MD (NINDS)","Ordered by publication type and then author name.



1.
Das BB, Antony S, Gupta S, Dexheimer TS, Redon CE, Garfield S, Shiloh Y, Pommier Y (2009). Optimal function of the DNA repair enzyme TDP1 requires its phosphorylation by ATM and/or DNA-PK. EMBO J  28, 3667-80.   https://doi.org/10.1038/emboj.2009.302




PubMed



        
     
Free Article


 


PubMed ID 19851285
         Pubmed Central ID 2790489 


 



2.
Geetha S, Allen CE, Hunt RC, Plum E, Garfield S, Friedman SL, Soejima K, Sauna ZE, Kimchi-Sarfaty C (2009). Detection of intracellular ADAMTS13, a secreted zinc-metalloprotease, via flow cytometry. Cytometry A  75, 675-81.   https://doi.org/10.1002/cyto.a.20748




PubMed



        
     
Free Article


 


PubMed ID 19526483
         Pubmed Central ID 2778596 


 



3.
Li L, Shukla S, Lee A, Garfield SH, Maloney DJ, Ambudkar SV, Yuspa SH (2010). The skin cancer chemotherapeutic agent ingenol-3-angelate (PEP005) is a substrate for the epidermal multidrug transporter (ABCB1) and targets tumor vasculature. Cancer Res  70, 4509-19.   https://doi.org/10.1158/0008-5472.CAN-09-4303




PubMed



        
     
Free Article


 


PubMed ID 20460505
         Pubmed Central ID 2880198 


 



4.
Mendoza A, Hong SH, Osborne T, Khan MA, Campbell K, Briggs J, Eleswarapu A, Buquo L, Ren L, Hewitt SM, Dakir el H, Dakir el-H, Garfield S, Walker R, Merlino G, Green JE, Hunter KW, Wakefield LM, Khanna C (2010). Modeling metastasis biology and therapy in real time in the mouse lung. J Clin Invest  120, 2979-88.   https://doi.org/10.1172/JCI40252




PubMed



        
     
Free Article


 


PubMed ID 20644255
         Pubmed Central ID 2912183 


 



5.
Pu Y, Garfield SH, Kedei N, Blumberg PM (2009). Characterization of the differential roles of the twin C1a and C1b domains of protein kinase C-delta. J Biol Chem  284, 1302-12.   https://doi.org/10.1074/jbc.M804796200




PubMed



        
     
Free Article


 


PubMed ID 19001377
         Pubmed Central ID 2613622",https://intramural.nih.gov/search/searchview.taf?ipid=63150
808,BC010859-04,"October 01, 2009 -  September 30, 2010",DNA Sequencing and Digital Gene Expression Core,Kathleen D Hartman,"Snorri S. Thorgeirsson; MD, PhD","Laboratory of Experimental Carcinogenesis, NCI",Steven W Shema,NULL,NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=63153
809,BC010903-03,"October 01, 2009 -  September 30, 2010",Transgenic Core Facility,Deborah A Swing,Terry Anne Van Dyke,"Mouse Cancer Genetics Program, NCI","Robert H Koogle



Holly Marie Morris",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Bauer GL, Praetorius C, Bergsteinsdóttir K, Hallsson JH, Gísladóttir BK, Schepsky A, Swing DA, O'Sullivan TN, Arnheiter H, Bismuth K, Debbache J, Fletcher C, Warming S, Copeland NG, Jenkins NA, Steingrímsson E (2009). The role of MITF phosphorylation sites during coat color and eye development in mice analyzed by bacterial artificial chromosome transgene rescue. Genetics  183, 581-94.   https://doi.org/10.1534/genetics.109.103945




PubMed



        
     
Free Article


 


PubMed ID 19635938
         Pubmed Central ID 2766318",https://intramural.nih.gov/search/searchview.taf?ipid=63285
810,BC010905-03,"October 01, 2009 -  September 30, 2010",Cell Prep Core,John R Wunderlich,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI","Michelle  Pelletier



Azam V Nahvi



Linda L Parker



Thomas E Shelton",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Ahmadzadeh M, Johnson LA, Heemskerk B, Wunderlich JR, Dudley ME, White DE, Rosenberg SA (2009). Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired. Blood  114, 1537-44.   https://doi.org/10.1182/blood-2008-12-195792




PubMed



        
     
Free Article


 


PubMed ID 19423728
         Pubmed Central ID 2927090 


 



2.
Cronin JC, Wunderlich J, Loftus SK, Prickett TD, Wei X, Ridd K, Vemula S, Burrell AS, Agrawal NS, Lin JC, Banister CE, Buckhaults P, Rosenberg SA, Bastian BC, Pavan WJ, Samuels Y (2009). Frequent mutations in the MITF pathway in melanoma. Pigment Cell Melanoma Res  22, 435-44.   https://doi.org/10.1111/j.1755-148X.2009.00578.x




PubMed



        
     
Free Article


 


PubMed ID 19422606
         Pubmed Central ID 2728363 


 



3.
Johnson LA, Morgan RA, Dudley ME, Cassard L, Yang JC, Hughes MS, Kammula US, Royal RE, Sherry RM, Wunderlich JR, Lee CC, Restifo NP, Schwarz SL, Cogdill AP, Bishop RJ, Kim H, Brewer CC, Rudy SF, VanWaes C, Davis JL, Mathur A, Ripley RT, Nathan DA, Laurencot CM, Rosenberg SA (2009). Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen. Blood  114, 535-46.   https://doi.org/10.1182/blood-2009-03-211714




PubMed



        
     
Free Article


 


PubMed ID 19451549
         Pubmed Central ID 2929689 


 



4.
Klapper JA, Thomasian AA, Smith DM, Gorgas GC, Wunderlich JR, Smith FO, Hampson BS, Rosenberg SA, Dudley ME (2009). Single-pass, closed-system rapid expansion of lymphocyte cultures for adoptive cell therapy. J Immunol Methods  345, 90-9.   https://doi.org/10.1016/j.jim.2009.04.009




PubMed



        
     
Free Article


 


PubMed ID 19389403
         Pubmed Central ID 2700005 


 



5.
Palavalli LH, Prickett TD, Wunderlich JR, Wei X, Burrell AS, Porter-Gill P, Davis S, Wang C, Cronin JC, Agrawal NS, Lin JC, Westbroek W, Hoogstraten-Miller S, Molinolo AA, Fetsch P, Filie AC, O'Connell MP, Banister CE, Howard JD, Buckhaults P, Weeraratna AT, Brody LC, Rosenberg SA, Samuels Y (2009). Analysis of the matrix metalloproteinase family reveals that MMP8 is often mutated in melanoma. Nat Genet  41, 518-20.   https://doi.org/10.1038/ng.340




PubMed



        
     
Free Article


 


PubMed ID 19330028
         Pubmed Central ID 2748394 


 



6.
Prickett TD, Agrawal NS, Wei X, Yates KE, Lin JC, Wunderlich JR, Cronin JC, Cruz P, Rosenberg SA, Samuels Y (2009). Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4. Nat Genet  41, 1127-32.   https://doi.org/10.1038/ng.438




PubMed



        
     
Free Article


 


PubMed ID 19718025
         Pubmed Central ID 2897709 


 



7.
Smith FO, Klapper JA, Wunderlich JR, Rosenberg SA, Dudley ME (2009). Impact of a recombinant fowlpox vaccine on the efficacy of adoptive cell therapy with tumor infiltrating lymphocytes in a patient with metastatic melanoma. J Immunother  32, 870-4.   https://doi.org/10.1097/CJI.0b013e3181b36b69




PubMed



        
     
Free Article


 


PubMed ID 19752747
         Pubmed Central ID 6290459",https://intramural.nih.gov/search/searchview.taf?ipid=63314
811,BC010915-03,"October 01, 2009 -  September 30, 2010",EIB Microscopy Core Facility,Michael John Kruhlak; PhD,Alfred  Singer; MD,"Experimental Immunology Branch, NCI","Andre A Nussenzweig; PhD



James Stephen Shaw; PhD



Paul A Roche; PhD",NULL,"Thomas J. Walsh; MD (Pediatric Oncology Branch)



Zhi Ming  Zheng; MD, PhD (HIV and AIDS Malignancy Branch)



David M Segal; PhD (Immune Targeting Section)","Elissa P Lei; BS, PhD (NIDDK) 



Rafael Cristian Casellas; PhD (NIAMS) 



Richard D Leapman; PhD (NIBIB)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63340
812,BC010923-03,"October 01, 2009 -  September 30, 2010",Tissue Array Research Program,"Stephen M Hewitt; MD, PhD",John Carl Oberholtzer,"Laboratory of Pathology, NCI","Reginald L Williams



Ran  Xie



Kristofferson R Ylaya",NULL,"Philip  Taylor; MD, ScD (Genetic Epidemiology Branch)



Lee Elizabeth Moore; PhD, MD (Occupational and Environmental Epidemiology Branch)



Nealapheur L Khan (National Cancer Institute)","Yoke Peng  Loh; PhD (NICHD) 



Ashani T Weeraratna; PhD (NIA) 



Alfredo A Molinolo; MD, PhD (NIDCR)","Ordered by publication type and then author name.



1.
Almanzar G, Olkhanud PB, Bodogai M, Dell'agnola C, Baatar D, Hewitt SM, Ghimenton C, Tummala MK, Weeraratna AT, Hoek KS, Kouprina N, Larionov V, Biragyn A (2009). Sperm-derived SPANX-B is a clinically relevant tumor antigen that is expressed in human tumors and readily recognized by human CD4+ and CD8+ T cells. Clin Cancer Res  15, 1954-63.   https://doi.org/10.1158/1078-0432.CCR-08-1290




PubMed



        
     
Free Article


 


PubMed ID 19276289
         Pubmed Central ID 2667247 


 



2.
Ashktorab H, Belgrave K, Hosseinkhah F, Brim H, Nouraie M, Takkikto M, Hewitt S, Lee EL, Dashwood RH, Smoot D (2009). Global histone H4 acetylation and HDAC2 expression in colon adenoma and carcinoma. Dig Dis Sci  54, 2109-17.   https://doi.org/10.1007/s10620-008-0601-7




PubMed



        
     
Free Article


 


PubMed ID 19057998
         Pubmed Central ID 2737733 


 



3.
Buac K, Xu M, Cronin J, Weeraratna AT, Hewitt SM, Pavan WJ (2009). NRG1 / ERBB3 signaling in melanocyte development and melanoma: inhibition of differentiation and promotion of proliferation. Pigment Cell Melanoma Res  22, 773-84.   https://doi.org/10.1111/j.1755-148X.2009.00616.x




PubMed



        
     
Free Article


 


PubMed ID 19659570
         Pubmed Central ID 3023175 


 



4.
Chung JY, Hewitt SM (2009). Transfer and multiplex immunoblotting of a paraffin embedded tissue. Methods Mol Biol  536, 139-48.   https://doi.org/10.1007/978-1-59745-542-8_16




PubMed


 


PubMed ID 19378053
    
     


 



5.
Darash-Yahana M, Gillespie JW, Hewitt SM, Chen YY, Maeda S, Stein I, Singh SP, Bedolla RB, Peled A, Troyer DA, Pikarsky E, Karin M, Farber JM (2009). The chemokine CXCL16 and its receptor, CXCR6, as markers and promoters of inflammation-associated cancers. PLoS One  4, e6695.   https://doi.org/10.1371/journal.pone.0006695




PubMed



        
     
Free Article


 


PubMed ID 19690611
         Pubmed Central ID 2723911 


 



6.
Lott ST, Chen N, Chandler DS, Yang Q, Wang L, Rodriguez M, Xie H, Balasenthil S, Buchholz TA, Sahin AA, Chaung K, Zhang B, Olufemi SE, Chen J, Adams H, Band V, El-Naggar AK, Frazier ML, Keyomarsi K, Hunt KK, Sen S, Haffty B, Hewitt SM, Krahe R, Killary AM (2009). DEAR1 is a dominant regulator of acinar morphogenesis and an independent predictor of local recurrence-free survival in early-onset breast cancer. PLoS Med  6, e1000068.   https://doi.org/10.1371/journal.pmed.1000068




PubMed



        
     
Free Article


 


PubMed ID 19536326
         Pubmed Central ID 2673042 


 



7.
Singh A, Kapur S, Chattopadhyay I, Purkayastha J, Sharma J, Mishra A, Hewitt SM, Saxena S (2009). Cytokeratin immunoexpression in esophageal squamous cell carcinoma of high-risk population in Northeast India. Appl Immunohistochem Mol Morphol  17, 419-24.   https://doi.org/10.1097/PAI.0b013e31819d3753




PubMed



        
     
Free Article


 


PubMed ID 19417629
         Pubmed Central ID 2836392 


 



8.
Takikita M, Altekruse S, Lynch CF, Goodman MT, Hernandez BY, Green M, Cozen W, Cockburn M, Sibug Saber M, Topor M, Zeruto C, Abedi-Ardekani B, Reichman ME, Hewitt SM (2009). Associations between selected biomarkers and prognosis in a population-based pancreatic cancer tissue microarray. Cancer Res  69, 2950-5.   https://doi.org/10.1158/0008-5472.CAN-08-3879




PubMed



        
     
Free Article


 


PubMed ID 19276352
         Pubmed Central ID 2711977 


 



9.
Takikita M, Hu N, Shou JZ, Wang QH, Giffen C, Taylor PR, Hewitt SM (2009). Biomarkers of apoptosis and survival in esophageal squamous cell carcinoma. BMC Cancer  9, 310.   https://doi.org/10.1186/1471-2407-9-310




PubMed



        
     
Free Article


 


PubMed ID 19728877
         Pubmed Central ID 2745431 


 



10.
Taylor JG, Cheuk AT, Tsang PS, Chung JY, Song YK, Desai K, Yu Y, Chen QR, Shah K, Youngblood V, Fang J, Kim SY, Yeung C, Helman LJ, Mendoza A, Ngo V, Staudt LM, Wei JS, Khanna C, Catchpoole D, Qualman SJ, Hewitt SM, Merlino G, Chanock SJ, Khan J (2009). Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models. J Clin Invest  119, 3395-407.   https://doi.org/10.1172/JCI39703




PubMed



        
     
Free Article


 


PubMed ID 19809159
         Pubmed Central ID 2769177",https://intramural.nih.gov/search/searchview.taf?ipid=63236
813,BC010930-03,"October 01, 2009 -  September 30, 2010",Molecular Cytogenetics Core,Anna V Roschke,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI","Gina Young Kim



Walter M Kuehl; MD, PhD



Kenneth E Nakahara



Oleg K Glebov



Frederic  Kaye; MD



Peter D Aplan; MD



Show all 7","Geula  Klorin
(Rambam: Human Health Care Campus)




Alexei  Protopopov
(Dana-Farber Cancer Institute)",Ola Anders Landgren (Medical Oncology Branch),NULL,"Ordered by publication type and then author name.



1.
Roschke AV, Kirsch IR (2010). Targeting karyotypic complexity and chromosomal instability of cancer cells. Curr Drug Targets  11, 1341-50.   https://doi.org/10.2174/1389450111007011341




PubMed



        
     
Free Article


 


PubMed ID 20840077
         Pubmed Central ID 3309604",https://intramural.nih.gov/search/searchview.taf?ipid=63246
814,BC010934-03,"October 01, 2009 -  September 30, 2010",Immune reconstitution following autologous and allogeneic stem cell transplant,Frances  Hakim; PhD,Ronald E Gress; MD,"Experimental Transplantation and Immunology Branch, NCI","Vicki  Fellowes



Claude  Sportes



Hana Hashim Khidir



Daniel H Fowler



Jeremy J Rose



Liana Angela Senaldi



Show all 12",NULL,"Terry J Fry (Pediatric Oncology Branch)



Crystal L. Mackall; MD (Pediatric Oncology Branch)



Alan S Wayne; MD (Pediatric Oncology Branch)",NULL,"Ordered by publication type and then author name.



1.
Hakim F (2009) Thymic involution and renewal, in Handbook of Immunosenescence. Springer (New York) Volume I, pp. 865-891.




 



2.
Hakim F, Hakim F (2009) Aging, immunity and cancer, in Handbook of Immunosenescence. Springer (New York) Volume 2, pp. 1119-1138.




 



3.
Imanguli MM, Swaim WD, League SC, Gress RE, Pavletic SZ, Hakim FT (2009). Increased T-bet+ cytotoxic effectors and type I interferon-mediated processes in chronic graft-versus-host disease of the oral mucosa. Blood  113, 3620-30.   https://doi.org/10.1182/blood-2008-07-168351




PubMed



        
     
Free Article


 


PubMed ID 19168793
         Pubmed Central ID 2668847 


 



4.
Kapoor V, Hakim FT, Rehman N, Gress RE, Telford WG (2009). Quantum dots thermal stability improves simultaneous phenotype-specific telomere length measurement by FISH-flow cytometry. J Immunol Methods  344, 6-14.   https://doi.org/10.1016/j.jim.2009.02.004




PubMed



        
     
Free Article


 


PubMed ID 19268672
         Pubmed Central ID 2752384",https://intramural.nih.gov/search/searchview.taf?ipid=63230
815,BC010936-03,"October 01, 2009 -  September 30, 2010",CCR VB FACS CORE,Katherine M McKinnon,"Jay Arthur Berzofsky; MD, PhD","Vaccine Branch, NCI","Genoveffa  Franchini; MD



Lois Jean Patterson



Marjorie  Robert-Guroff; PhD",NULL,"Gordon Lee Hager; PhD (Laboratory of Receptor Biology and Gene Expression)



Thomas A Misteli; PhD (Laboratory of Receptor Biology and Gene Expression)



Kevin  Gardner; MD, PhD (Hormone Action and Oncogenesis Section)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63366
816,BC010937-03,"October 01, 2009 -  September 30, 2010",Novel Targets for Vaccine Therapy,Claudia Mercedes Palena,Jeffrey  Schlom; PhD,"Laboratory of Tumor Immunology and Biology, NCI","Marjorie P Duberstein



Kwong Yok Tsang



Romaine Ingrid Fernando



James L Gulley; MD, PhD



Duane Howard Hamilton



Bruce K Huang



Show all 8","Andrei  Kozlov
(biology, The Biomedical Center/St. Petersburg University)




Dmitri  Polev
(St. Petersburg University)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63382
817,BC010941-03,"October 01, 2009 -  September 30, 2010",CCR FACS Core Laboratory,Barbara J Taylor,Stuart H Yuspa; MD,"Laboratory of Cancer Biology and Genetics, NCI",Subhadra  Banerjee,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Borojerdi JP, Ming J, Cooch C, Ward Y, Semino-Mora C, Yu M, Braun HM, Taylor BJ, Poirier MC, Olivero OA (2009). Centrosomal amplification and aneuploidy induced by the antiretroviral drug AZT in hamster and human cells. Mutat Res  665, 67-74.   https://doi.org/10.1016/j.mrfmmm.2009.03.004




PubMed



        
     
Free Article


 


PubMed ID 19427513
         Pubmed Central ID 2680773",https://intramural.nih.gov/search/searchview.taf?ipid=63287
818,BC010947-03,"October 01, 2009 -  September 30, 2010",Cell and Cancer Biology Branch Confocal Microscopy Core,Yvona  Ward; PhD,Kathleen  Kelly; PhD,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI","Ross G Lake



Philip L Martin



Orla Majella Casey



John Edward Niederhuber



Olga  Aprelikova; PhD



Zhenggang  Liu; PhD



Show all 8",NULL,"John R Cornelison (Cancer Genetics Branch)



Paul S Meltzer; MD, PhD (Cancer Genetics Branch)



Paul  Goldsmith; PhD (Basic Research Laboratory)



Susan  Bates; MD (Medical Oncology Branch)



Ofelia  Olivero; PhD (Laboratory of Cancer Biology and Genetics)



Sheueyann  Cheng; PhD (Laboratory of Molecular Biology)",NULL,"Ordered by publication type and then author name.



1.
Aprelikova O, Pandolfi S, Tackett S, Ferreira M, Salnikow K, Ward Y, Risinger JI, Barrett JC, Niederhuber J (2009). Melanoma antigen-11 inhibits the hypoxia-inducible factor prolyl hydroxylase 2 and activates hypoxic response. Cancer Res  69, 616-24.   https://doi.org/10.1158/0008-5472.CAN-08-0811




PubMed



        
     
Free Article


 


PubMed ID 19147576
         Pubmed Central ID 2629394 


 



2.
Borojerdi JP, Ming J, Cooch C, Ward Y, Semino-Mora C, Yu M, Braun HM, Taylor BJ, Poirier MC, Olivero OA (2009). Centrosomal amplification and aneuploidy induced by the antiretroviral drug AZT in hamster and human cells. Mutat Res  665, 67-74.   https://doi.org/10.1016/j.mrfmmm.2009.03.004




PubMed



        
     
Free Article


 


PubMed ID 19427513
         Pubmed Central ID 2680773 


 



3.
Polgar O, Ediriwickrema LS, Robey RW, Sharma A, Hegde RS, Li Y, Xia D, Ward Y, Dean M, Ozvegy-Laczka C, Sarkadi B, Bates SE (2009). Arginine 383 is a crucial residue in ABCG2 biogenesis. Biochim Biophys Acta  1788, 1434-43.   https://doi.org/10.1016/j.bbamem.2009.04.016




PubMed



        
     
Free Article


 


PubMed ID 19406100
         Pubmed Central ID 4163909 


 



4.
Yu M, Ward Y, Poirier MC, Olivero OA (2009). Centrosome amplification induced by the antiretroviral nucleoside reverse transcriptase inhibitors lamivudine, stavudine, and didanosine. Environ Mol Mutagen  50, 718-24.   https://doi.org/10.1002/em.20509




PubMed



        
     
Free Article


 


PubMed ID 19562754
         Pubmed Central ID 2760687",https://intramural.nih.gov/search/searchview.taf?ipid=63301
819,BC010948-03,"October 01, 2009 -  September 30, 2010",DNA Sequencing and FACS Core Facilities,Paul  Robbins,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI","Mona E El gamil



Yili  Li



Yong-Chen  Lu; PhD



Xin  Yao



Shigui  Zhu



Shahram S Farid



Show all 8",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Goff SL, Robbins PF, El-Gamil M, Rosenberg SA (2009). No correlation between clinical response to CTLA-4 blockade and presence of NY-ESO-1 antibody in patients with metastatic melanoma. J Immunother  32, 884-5.   https://doi.org/10.1097/CJI.0b013e3181affbf0




PubMed



        
     
Free Article


 


PubMed ID 19752745
         Pubmed Central ID 6327840 


 



2.
Parkhurst MR, Joo J, Riley JP, Yu Z, Li Y, Robbins PF, Rosenberg SA (2009). Characterization of genetically modified T-cell receptors that recognize the CEA:691-699 peptide in the context of HLA-A2.1 on human colorectal cancer cells. Clin Cancer Res  15, 169-80.   https://doi.org/10.1158/1078-0432.CCR-08-1638




PubMed



        
     
Free Article


 


PubMed ID 19118044
         Pubmed Central ID 3474199",https://intramural.nih.gov/search/searchview.taf?ipid=63240
820,BC010953-03,"October 01, 2009 -  September 30, 2010",Molecular Pathology Research for Cancer Diagnostics and Biomarkers,"Robert Mark Simpson; DVM, PhD",Stuart H Yuspa; MD,"Laboratory of Cancer Biology and Genetics, NCI","Jennifer B Dwyer



John  Hickerson



Lalage  Wakefield; PhD



Shelley B Hoover



Kent W Hunter; PhD



Joshua David Webster; DVM, PhD



Show all 9","Lance  Liotta
(George Mason University)




Emanuel  Petricoin, III
(Food and Drug Administration)","John Edward Niederhuber (Laboratory Of Genitourinary Cancer Pathogenesis)



Charles  Vinson; PhD (Nucleic Acids Section)



Mark  Udey; MD (Dermatology Branch)



Stephen I Katz; PhD, MD (Dermatology Branch)



Howard A Fine; MD, PhD (Neuro-Oncology Branch)",NULL,"Ordered by publication type and then author name.



1.
Miyaji M, Kortum RL, Surana R, Li W, Woolard KD, Simpson RM, Samelson LE, Sommers CL (2009). Genetic evidence for the role of Erk activation in a lymphoproliferative disease of mice. Proc Natl Acad Sci U S A  106, 14502-7.   https://doi.org/10.1073/pnas.0903894106




PubMed



        
     
Free Article


 


PubMed ID 19667175
         Pubmed Central ID 2732887 


 



2.
Wei BR, Hoover SB, Ross MM, Zhou W, Meani F, Edwards JB, Spehalski EI, Risinger JI, Alvord WG, Quiñones OA, Belluco C, Martella L, Campagnutta E, Ravaggi A, Dai RM, Goldsmith PK, Woolard KD, Pecorelli S, Liotta LA, Petricoin EF, Simpson RM (2009). Serum S100A6 concentration predicts peritoneal tumor burden in mice with epithelial ovarian cancer and is associated with advanced stage in patients. PLoS One  4, e7670.   https://doi.org/10.1371/journal.pone.0007670




PubMed



        
     
Free Article


 


PubMed ID 19888321
         Pubmed Central ID 2765613",https://intramural.nih.gov/search/searchview.taf?ipid=63263
821,BC010964-03,"October 01, 2009 -  September 30, 2010",Trans-NIH Angiogenesis Core Facility,Frank  Cuttitta; PhD,Kevin A Camphausen; MD,"Radiation Oncology Branch, NCI","Marta  Aparicio Miguel



Ingalill R Avis



Changge  Fang; PhD



William G Stetler-Stevenson; MD, PhD



Enrique  Zudaire Ubani; PhD","Betty  Eipper
(University of Connecticut Health Center)




Norma  Javitt
(Dept Pediatric Medicine, New York University Medical Center)




Charles  Keese
(Electric Cell Impedance System, Applied Biophysics)




Oliver  Rixe
(University of Cincinnati College of Medicine)




Mary  Sunday
(Dept Pathology, Duke University)




Stefanie  Vogel
(University of Maryland)","David  Salomon; PhD (Mammary Biology and Tumorigenesis Laboratory)



Bradley D St Croix (Mouse Cancer Genetics Program)



William D Figg; PharmD (Medical Oncology Branch)



Howard A Young; PhD (Laboratory of Experimental Immunology)



Stephen M Hewitt; MD, PhD (Laboratory of Pathology)



Javed  Khan; MD (Pediatric Oncology Branch)",NULL,"Ordered by publication type and then author name.



1.
El-Chemaly S, Malide D, Zudaire E, Ikeda Y, Weinberg BA, Pacheco-Rodriguez G, Rosas IO, Aparicio M, Ren P, MacDonald SD, Wu HP, Nathan SD, Cuttitta F, McCoy JP, Gochuico BR, Moss J (2009). Abnormal lymphangiogenesis in idiopathic pulmonary fibrosis with insights into cellular and molecular mechanisms. Proc Natl Acad Sci U S A  106, 3958-63.   https://doi.org/10.1073/pnas.0813368106




PubMed



        
     
Free Article


 


PubMed ID 19237567
         Pubmed Central ID 2646625 


 



2.
Fang C, Miguel MA, Avis I, Martinez A, Zudaire E, Cuttitta F (2009). Non-peptide small molecule regulators of lymphangiogenesis. Lymphat Res Biol  7, 189-96.   https://doi.org/10.1089/lrb.2009.0033




PubMed



        
     
Free Article


 


PubMed ID 20143917
         Pubmed Central ID 2843547",https://intramural.nih.gov/search/searchview.taf?ipid=63195
822,BC010965-03,"October 01, 2009 -  September 30, 2010",CCR Biophysics Resource Core,Sergey G Tarasov,Robert Andrew Byrd,"Structural Biophysics Laboratory, NCI",NULL,"Jose  Casas-Finet





Wuyuan  Lu
(Institute of Virology, University of Maryland)




Marzena E Pazgier","Anil K Patri (Office Of The Director)



Anu  Puri; PhD (Membrane Structure and Function Section)



Dimiter Stanchev Dimitrov; PhD (Membrane Structure and Function Section)



Stuart F J Le Grice; PhD (Retroviral Replication Laboratory)



Pradman  Qasba; PhD (Structural Glycobiology Section)



Marc C Nicklaus (Chemical Biology Laboratory)",NULL,"Ordered by publication type and then author name.



1.
Acchione M, Lipschultz CA, DeSantis ME, Shanmuganathan A, Li M, Wlodawer A, Tarasov S, Smith-Gill SJ (2009). Light chain somatic mutations change thermodynamics of binding and water coordination in the HyHEL-10 family of antibodies. Mol Immunol  47, 457-64.   https://doi.org/10.1016/j.molimm.2009.08.018




PubMed



        
     
Free Article


 


PubMed ID 19781789
         Pubmed Central ID 6291001 


 



2.
Das R, Mariano J, Tsai YC, Kalathur RC, Kostova Z, Li J, Tarasov SG, McFeeters RL, Altieri AS, Ji X, Byrd RA, Weissman AM (2009). Allosteric activation of E2-RING finger-mediated ubiquitylation by a structurally defined specific E2-binding region of gp78. Mol Cell  34, 674-85.   https://doi.org/10.1016/j.molcel.2009.05.010




PubMed



        
     
Free Article


 


PubMed ID 19560420
         Pubmed Central ID 3050579 


 



3.
Gong R, Vu BK, Feng Y, Prieto DA, Dyba MA, Walsh JD, Prabakaran P, Veenstra TD, Tarasov SG, Ishima R, Dimitrov DS (2009). Engineered human antibody constant domains with increased stability. J Biol Chem  284, 14203-10.   https://doi.org/10.1074/jbc.M900769200




PubMed



        
     
Free Article


 


PubMed ID 19307178
         Pubmed Central ID 2682868 


 



4.
Pazgier M, Liu M, Zou G, Yuan W, Li C, Li C, Li J, Monbo J, Zella D, Tarasov SG, Lu W (2009) Structural basis for high-affinity peptide inhibition of p53 interactions with MDM2 and MDMX. Proc Natl Acad Sci U S A 106:4665-70.




PubMed



        
     
Free Article


 


PubMed ID 19255450
         Pubmed Central ID 2660734 


 



5.
Yavlovich A, Singh A, Tarasov S, Capala J, Blumenthal R, Puri A (2009). DESIGN OF LIPOSOMES CONTAINING PHOTOPOLYMERIZABLE PHOSPHOLIPIDS FOR TRIGGERED RELEASE OF CONTENTS. J Therm Anal Calorim  98, 97-104.   https://doi.org/10.1007/s10973-009-0228-8




PubMed



        
     
Free Article


 


PubMed ID 20160877
         Pubmed Central ID 2772073",https://intramural.nih.gov/search/searchview.taf?ipid=63286
823,BC010978-03,"October 01, 2009 -  September 30, 2010",Confocal Core for the Laboratory of Cellular and Molecular Biology,Valarie  Barr; PhD,Lawrence Elliot Samelson; MD,"Laboratory of Cellular and Molecular Biology, NCI","Itoro O Akpan



Carol  Clayberger



Stanley  Lipkowitz; MD, PhD



Paul A Randazzo; MD, PhD



Ying  Zhang



Carole A Parent; PhD","Stephen  Bunnell
(Tufts University School of Medicine)




Janis  Burkhardt
(Children's Hospital of Philadelphia and University of Pennsylvania)




Wolfgang  Losert; PhD
(University of Maryland)",NULL,"Paul E Love; MD, PhD (NICHD)","Ordered by publication type and then author name.



1.
Balagopalan L, Barr VA, Samelson LE (2009). Endocytic events in TCR signaling: focus on adapters in microclusters. Immunol Rev  232, 84-98.   https://doi.org/10.1111/j.1600-065X.2009.00840.x




PubMed



        
     
Free Article


 


PubMed ID 19909358
         Pubmed Central ID 3138075 


 



2.
Barr VA, Bernot KM, Shaffer MH, Burkhardt JK, Samelson LE (2009). Formation of STIM and Orai complexes: puncta and distal caps. Immunol Rev  231, 148-59.   https://doi.org/10.1111/j.1600-065X.2009.00812.x




PubMed



        
     
Free Article


 


PubMed ID 19754895
         Pubmed Central ID 3110759 


 



3.
Barr VA, Bunnell SC (2009). Interference reflection microscopy. Curr Protoc Cell Biol  Chapter 4, Unit 4.23.   https://doi.org/10.1002/0471143030.cb0423s45




PubMed



        
     
Free Article


 


PubMed ID 20013754
         Pubmed Central ID 2824538",https://intramural.nih.gov/search/searchview.taf?ipid=63176
824,BC010981-03,"October 01, 2009 -  September 30, 2010","Design, Develop, Validate, and Implement Biomarkers for Clinical Investigations",Liang  Cao,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI","Zhigang  Kang



Yunkai  Yu",NULL,"Giuseppe  Giaccone; MD (Medical Oncology Branch)



Giovanni  Melillo (Screening Technologies Branch)



Lee Jay Helman; MD (Pediatric Oncology Branch)



William Laurence Dahut; MD (Office of the Director)



William D Figg; PharmD (Medical Oncology Branch)



Chand  Khanna; MD (Pediatric Oncology Branch)",NULL,"Ordered by publication type and then author name.



1.
Cao L, Puppo M, Rapisarda A, Uranchimeg B, Cao L, Burger A, Ziche M, Melillo G (2010) Aminoflavone, a ligand of the Aryl Hydrocarbon Receptor (AhR), inhibits HIF-1alpha expression in an AhR-independent fashion,. Cancer Res, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=63191
825,BC010989-03,"October 01, 2009 -  September 30, 2010",Clinical production of viral vectors for cancer gene therapy,Steven A Feldman,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI","Mary Alexandra Black



Dhana  Chinnasamy; PhD



Nachimuthu  Chinnasamy



Jinyong  Kim



Hui  Xu



Shicheng  Yang



Show all 12",NULL,James N Kochenderfer (Experimental Transplantation and Immunology Branch),NULL,"Ordered by publication type and then author name.



1.
Kochenderfer JN, Feldman SA, Zhao Y, Xu H, Black MA, Morgan RA, Wilson WH, Rosenberg SA (2009). Construction and preclinical evaluation of an anti-CD19 chimeric antigen receptor. J Immunother  32, 689-702.   https://doi.org/10.1097/CJI.0b013e3181ac6138




PubMed



        
     
Free Article


 


PubMed ID 19561539
         Pubmed Central ID 2747302",https://intramural.nih.gov/search/searchview.taf?ipid=63207
826,BC010991-03,"October 01, 2009 -  September 30, 2010",Radiation Oncology Branch - Microarray Facility,"Kevin A Camphausen; MD



IRP Faculty Profile",NULL,"Radiation Oncology Branch, NCI","Biju  Issac



Seth  Johnson



Uma  Shankavaram; PhD



Shuping  Zhao",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63189
827,BC011016-03,"October 01, 2009 -  September 30, 2010",Protein Production,Joseph Edward Tropea,Alexander  Wlodawer; PhD,"Macromolecular Crystallography Laboratory, NCI","Scott R Cherry; BS



Jacek Tadeusz Lubkowski","TOZSER  JOZSEF
(University of Debrecen)




Robert  Ulrich
(Molecular Immunology, USAMRIID)","Yves  Pommier; PhD (Developmental Therapeutics Branch)



Robert  Shoemaker (Screening Technologies Branch)



Terrence R Burke; PhD (Chemical Biology Laboratory)



David S Waugh; PhD (Protein Engineering Section)



Ettore  Appella; MD (Chemical Immunology Section)



Donald L Court; PhD (Molecular Control and Genetics Section)",NULL,"Ordered by publication type and then author name.



1.
Feng H, Jenkins LM, Durell SR, Hayashi R, Mazur SJ, Cherry S, Tropea JE, Miller M, Wlodawer A, Appella E, Bai Y (2009). Structural basis for p300 Taz2-p53 TAD1 binding and modulation by phosphorylation. Structure  17, 202-10.   https://doi.org/10.1016/j.str.2008.12.009




PubMed



        
     
Free Article


 


PubMed ID 19217391
         Pubmed Central ID 2705179 


 



2.
Jenkins LM, Yamaguchi H, Hayashi R, Cherry S, Tropea JE, Miller M, Wlodawer A, Appella E, Mazur SJ (2009). Two distinct motifs within the p53 transactivation domain bind to the Taz2 domain of p300 and are differentially affected by phosphorylation. Biochemistry  48, 1244-55.   https://doi.org/10.1021/bi801716h




PubMed



        
     
Free Article


 


PubMed ID 19166313
         Pubmed Central ID 2848171 


 



3.
Jobson AG, Lountos GT, Lorenzi PL, Llamas J, Connelly J, Cerna D, Tropea JE, Onda A, Zoppoli G, Kondapaka S, Zhang G, Caplen NJ, Cardellina JH, Yoo SS, Monks A, Self C, Waugh DS, Shoemaker RH, Pommier Y (2009). Cellular inhibition of checkpoint kinase 2 (Chk2) and potentiation of camptothecins and radiation by the novel Chk2 inhibitor PV1019 [7-nitro-1H-indole-2-carboxylic acid {4-[1-(guanidinohydrazone)-ethyl]-phenyl}-amide]. J Pharmacol Exp Ther  331, 816-26.   https://doi.org/10.1124/jpet.109.154997




PubMed



        
     
Free Article


 


PubMed ID 19741151
         Pubmed Central ID 2784710 


 



4.
Lountos GT, Tropea JE, Cherry S, Waugh DS (2009). Overproduction, purification and structure determination of human dual-specificity phosphatase 14. Acta Crystallogr D Biol Crystallogr  65, 1013-20.   https://doi.org/10.1107/S0907444909023762




PubMed



        
     
Free Article


 


PubMed ID 19770498
         Pubmed Central ID 2748964 


 



5.
Lountos GT, Tropea JE, Zhang D, Jobson AG, Pommier Y, Shoemaker RH, Waugh DS (2009). Crystal structure of checkpoint kinase 2 in complex with NSC 109555, a potent and selective inhibitor. Protein Sci  18, 92-100.   https://doi.org/10.1002/pro.16




PubMed



        
     
Free Article


 


PubMed ID 19177354
         Pubmed Central ID 2708046 


 



6.
Miller M, Dauter Z, Cherry S, Tropea JE, Wlodawer A (2009). Structure of the Taz2 domain of p300: insights into ligand binding. Acta Crystallogr D Biol Crystallogr  65, 1301-8.   https://doi.org/10.1107/S0907444909040153




PubMed



        
     
Free Article


 


PubMed ID 19966416
         Pubmed Central ID 2789004 


 



7.
Tropea JE, Cherry S, Waugh DS (2009). Expression and purification of soluble His(6)-tagged TEV protease. Methods Mol Biol  498, 297-307.   https://doi.org/10.1007/978-1-59745-196-3_19




PubMed


 


PubMed ID 18988033
    
     


 



8.
Tu C, Tropea JE, Austin BP, Court DL, Waugh DS, Ji X (2009). Structural basis for binding of RNA and cofactor by a KsgA methyltransferase. Structure  17, 374-85.   https://doi.org/10.1016/j.str.2009.01.010




PubMed



        
     
Free Article


 


PubMed ID 19278652
         Pubmed Central ID 2672589 


 



9.
Tu C, Zhou X, Tropea JE, Austin BP, Waugh DS, Court DL, Ji X (2009). Structure of ERA in complex with the 3' end of 16S rRNA: implications for ribosome biogenesis. Proc Natl Acad Sci U S A  106, 14843-8.   https://doi.org/10.1073/pnas.0904032106




PubMed



        
     
Free Article


 


PubMed ID 19706445
         Pubmed Central ID 2736428",https://intramural.nih.gov/search/searchview.taf?ipid=63289
828,BC011020-03,"October 01, 2009 -  September 30, 2010",Cell Production Facility Core,Mark E Dudley,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI","Laura  Devillier



Katherine  Hogan



Michelle  Pelletier



Azam V Nahvi



Linda L Parker



Thomas E Shelton",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Ahmadzadeh M, Johnson LA, Heemskerk B, Wunderlich JR, Dudley ME, White DE, Rosenberg SA (2009). Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired. Blood  114, 1537-44.   https://doi.org/10.1182/blood-2008-12-195792




PubMed



        
     
Free Article


 


PubMed ID 19423728
         Pubmed Central ID 2927090 


 



2.
Johnson LA, Morgan RA, Dudley ME, Cassard L, Yang JC, Hughes MS, Kammula US, Royal RE, Sherry RM, Wunderlich JR, Lee CC, Restifo NP, Schwarz SL, Cogdill AP, Bishop RJ, Kim H, Brewer CC, Rudy SF, VanWaes C, Davis JL, Mathur A, Ripley RT, Nathan DA, Laurencot CM, Rosenberg SA (2009). Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen. Blood  114, 535-46.   https://doi.org/10.1182/blood-2009-03-211714




PubMed



        
     
Free Article


 


PubMed ID 19451549
         Pubmed Central ID 2929689 


 



3.
Klapper JA, Thomasian AA, Smith DM, Gorgas GC, Wunderlich JR, Smith FO, Hampson BS, Rosenberg SA, Dudley ME (2009). Single-pass, closed-system rapid expansion of lymphocyte cultures for adoptive cell therapy. J Immunol Methods  345, 90-9.   https://doi.org/10.1016/j.jim.2009.04.009




PubMed



        
     
Free Article


 


PubMed ID 19389403
         Pubmed Central ID 2700005 


 



4.
Rosenberg SA, Dudley ME (2009). Adoptive cell therapy for the treatment of patients with metastatic melanoma. Curr Opin Immunol  21, 233-40.   https://doi.org/10.1016/j.coi.2009.03.002




PubMed



        
     
Free Article


 


PubMed ID 19304471
         Pubmed Central ID 3459355 


 



5.
Smith FO, Klapper JA, Wunderlich JR, Rosenberg SA, Dudley ME (2009). Impact of a recombinant fowlpox vaccine on the efficacy of adoptive cell therapy with tumor infiltrating lymphocytes in a patient with metastatic melanoma. J Immunother  32, 870-4.   https://doi.org/10.1097/CJI.0b013e3181b36b69




PubMed



        
     
Free Article


 


PubMed ID 19752747
         Pubmed Central ID 6290459 


 



6.
Yeh S, Karne NK, Kerkar SP, Heller CK, Palmer DC, Johnson LA, Li Z, Bishop RJ, Wong WT, Sherry RM, Yang JC, Dudley ME, Restifo NP, Rosenberg SA, Nussenblatt RB (2009). Ocular and systemic autoimmunity after successful tumor-infiltrating lymphocyte immunotherapy for recurrent, metastatic melanoma. Ophthalmology  116, 981-989.e1.   https://doi.org/10.1016/j.ophtha.2008.12.004




PubMed



        
     
Free Article


 


PubMed ID 19410956
         Pubmed Central ID 2715843",https://intramural.nih.gov/search/searchview.taf?ipid=63200
829,BC011021-02,"October 01, 2009 -  September 30, 2010",Basic Research Support for the CCR,Robert  Wiltrout; PhD,NULL,"Laboratory of Experimental Immunology, NCI",NULL,NULL,NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=62747
830,BC011029-03,"October 01, 2009 -  September 30, 2010",Tumor-Infiltrating Donor Derived Lymphocyte Therapy After Allogeneic Transplant,Frances  Hakim; PhD,Ronald E Gress; MD,"Experimental Transplantation and Immunology Branch, NCI","Vicki  Fellowes



Daniel H Fowler



Michael R Bishop; MD



Hana Hashim Khidir



Nancy M Hardy



Jeremy J Rose



Show all 7",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63231
831,BC011030-03,"October 01, 2009 -  September 30, 2010",Peptide Synthesis Core Faciity and Peptide Epitope Identification,Maria  Parkhurst,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI","Steven A Feldman



Nicholas Phillip Restifo; MD



Richard A Morgan; PhD



Paul  Robbins",NULL,NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=63383
832,BC011040-03,"October 01, 2009 -  September 30, 2010",Molecular Profiling of Clinical Specimens,Daniel C Edelman,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI","Lisa  Adams; MSc



Sven  Bilke



Laura Elizabeth Jones



Jonathan Keith Killian



David  Petersen



Marbin A Pineda



Show all 12",NULL,"Laufey Thora Amundadottir (Laboratory Translational Genomics)



Samuel A Wells (Medical Oncology Branch)



Giuseppe  Giaccone; MD (Medical Oncology Branch)



Xiaohong Rose Yang; PhD (Genetic Epidemiology Branch)



Ola Anders Landgren (Medical Oncology Branch)



Ramaprasad  Srinivasan; MD, PhD (Urologic Oncology Branch)",NULL,"Ordered by publication type and then author name.



1.
Cao L, Yu Y, Bilke S, Walker RL, Mayeenuddin LH, Azorsa DO, Yang F, Pineda M, Helman LJ, Meltzer PS (2010). Genome-wide identification of PAX3-FKHR binding sites in rhabdomyosarcoma reveals candidate target genes important for development and cancer. Cancer Res  70, 6497-508.   https://doi.org/10.1158/0008-5472.CAN-10-0582




PubMed



        
     
Free Article


 


PubMed ID 20663909
         Pubmed Central ID 2922412 


 



2.
Eberle FC, Hanson JC, Killian JK, Wei L, Ylaya K, Hewitt SM, Jaffe ES, Emmert-Buck MR, Rodriguez-Canales J (2010). Immunoguided laser assisted microdissection techniques for DNA methylation analysis of archival tissue specimens. J Mol Diagn  12, 394-401.   https://doi.org/10.2353/jmoldx.2010.090200




PubMed



        
     
Free Article


 


PubMed ID 20413681
         Pubmed Central ID 2893622 


 



3.
Liu F, Killian JK, Yang M, Walker RL, Hong JA, Zhang M, Davis S, Zhang Y, Hussain M, Xi S, Rao M, Meltzer PA, Schrump DS (2010). Epigenomic alterations and gene expression profiles in respiratory epithelia exposed to cigarette smoke condensate. Oncogene  29, 3650-64.   https://doi.org/10.1038/onc.2010.129




PubMed



        
     
Free Article


 


PubMed ID 20440268
         Pubmed Central ID 6329296 


 



4.
Voortman J, Lee JH, Killian JK, Suuriniemi M, Wang Y, Lucchi M, Smith WI, Meltzer P, Wang Y, Giaccone G (2010). Array comparative genomic hybridization-based characterization of genetic alterations in pulmonary neuroendocrine tumors. Proc Natl Acad Sci U S A  107, 13040-5.   https://doi.org/10.1073/pnas.1008132107




PubMed



        
     
Free Article


 


PubMed ID 20615970
         Pubmed Central ID 2919980",https://intramural.nih.gov/search/searchview.taf?ipid=63204
833,BC011041-03,"October 01, 2009 -  September 30, 2010",Technical Development of Molecular Profiling Technologies,Daniel C Edelman,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI","Sven  Bilke



Jonathan Keith Killian



Jason  Kralj



David  Petersen



Marbin A Pineda



Holly S Stevenson



Show all 10","Immaculatta  DeVivo
(Harvard University)




Laurie  Locascio; PhD
(National Institute of Standards and Technology)","Su-Young  Kim (Pediatric Oncology Branch)



Stephen M Hewitt; MD, PhD (Laboratory of Pathology)



Frank  Cuttitta; PhD (Radiation Oncology Branch)",NULL,"Ordered by publication type and then author name.



1.
Byun JS, Wong MM, Cui W, Idelman G, Li Q, De Siervi A, Bilke S, Haggerty CM, Player A, Wang YH, Thirman MJ, Kaberlein JJ, Petrovas C, Koup RA, Longo D, Ozato K, Gardner K (2009). Dynamic bookmarking of primary response genes by p300 and RNA polymerase II complexes. Proc Natl Acad Sci U S A  106, 19286-91.   https://doi.org/10.1073/pnas.0905469106




PubMed



        
     
Free Article


 


PubMed ID 19880750
         Pubmed Central ID 2780808 


 



2.
Eberle FC, Hanson JC, Killian JK, Wei L, Ylaya K, Hewitt SM, Jaffe ES, Emmert-Buck MR, Rodriguez-Canales J (2010). Immunoguided laser assisted microdissection techniques for DNA methylation analysis of archival tissue specimens. J Mol Diagn  12, 394-401.   https://doi.org/10.2353/jmoldx.2010.090200




PubMed



        
     
Free Article


 


PubMed ID 20413681
         Pubmed Central ID 2893622 


 



3.
Kino T, Manoli I, Kelkar S, Wang Y, Su YA, Chrousos GP (2009). Glucocorticoid receptor (GR) beta has intrinsic, GRalpha-independent transcriptional activity. Biochem Biophys Res Commun  381, 671-5.   https://doi.org/10.1016/j.bbrc.2009.02.110




PubMed



        
     
Free Article


 


PubMed ID 19248771
         Pubmed Central ID 2796800 


 



4.
Kino T, Takatori H, Manoli I, Wang Y, Tiulpakov A, Blackman MR, Su YA, Chrousos GP, DeCherney AH, Segars JH (2009). Brx mediates the response of lymphocytes to osmotic stress through the activation of NFAT5. Sci Signal  2, ra5.   https://doi.org/10.1126/scisignal.2000081




PubMed



        
     
Free Article


 


PubMed ID 19211510
         Pubmed Central ID 2856329 


 



5.
Nader N, Ng SS, Lambrou GI, Pervanidou P, Wang Y, Chrousos GP, Kino T (2010). AMPK regulates metabolic actions of glucocorticoids by phosphorylating the glucocorticoid receptor through p38 MAPK. Mol Endocrinol  24, 1748-64.   https://doi.org/10.1210/me.2010-0192




PubMed



        
     
Free Article


 


PubMed ID 20660302
         Pubmed Central ID 2940476",https://intramural.nih.gov/search/searchview.taf?ipid=63205
834,BC011042-03,"October 01, 2009 -  September 30, 2010",Global changes in specific histone modifications in cancer,"David  Levens; PhD



IRP Faculty Profile",NULL,"Laboratory of Pathology, NCI","Russell William Bandle



Hye-Jung  Chung



Nancy L Goodman



Elaine S Jaffe; MD",NULL,"Gordon Lee Hager; PhD (Laboratory of Receptor Biology and Gene Expression)



Louis  Staudt; MD (Lymphoid Malignancies Branch)","Katherine Rainsford Calvo (CC) 



Keji  Zhao; PhD (NHLBI)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63346
835,BC011044-03,"October 01, 2009 -  September 30, 2010",Tissue ProcessingSequencing Core,Cathy  Vocke; PhD,William Marston Linehan; MD,"Urologic Oncology Branch, NCI",Robert A Worrell,"William  Kaelin
(Dana-Farber Cancer Institute)




Catherine  Stolle
(Childrenâ€™s Hospital of Philadelphia)","Xiaolin  Wu; PhD (Office Of The Director)



Paul S Meltzer; MD, PhD (Cancer Genetics Branch)



Peter L Choyke; MD (Molecular Imaging Program)



Jonathan  Vogel; MD (Dermatology Branch)



Karl Thomas Ried; MD (Cancer Genetics Branch)



Alan  Rein; PhD (Retroviral Replication Laboratory)","Karel  Pacak; MD, PhD (NICHD)","Ordered by publication type and then author name.



1.
Beroukhim R, Brunet JP, Di Napoli A, Mertz KD, Seeley A, Pires MM, Linhart D, Worrell RA, Moch H, Rubin MA, Sellers WR, Meyerson M, Linehan WM, Kaelin WG, Signoretti S (2009). Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney. Cancer Res  69, 4674-81.   https://doi.org/10.1158/0008-5472.CAN-09-0146




PubMed



        
     
Free Article


 


PubMed ID 19470766
         Pubmed Central ID 2745239 


 



2.
Linehan WM (2009). Genetic basis of bilateral renal cancer: implications for evaluation and management. J Clin Oncol  27, 3731-3.   https://doi.org/10.1200/JCO.2009.23.0045




PubMed



        
     
Free Article


 


PubMed ID 19597019
         Pubmed Central ID 5036849 


 



3.
Linehan WM, Pinto PA, Bratslavsky G, Pfaffenroth E, Merino M, Vocke CD, Toro JR, Bottaro D, Neckers L, Schmidt LS, Srinivasan R (2009). Hereditary kidney cancer: unique opportunity for disease-based therapy. Cancer  115, 2252-61.   https://doi.org/10.1002/cncr.24230




PubMed



        
     
Free Article


 


PubMed ID 19402075
         Pubmed Central ID 2720093 


 



4.
Sudarshan S, Sourbier C, Kong HS, Block K, Valera Romero VA, Yang Y, Galindo C, Mollapour M, Scroggins B, Goode N, Lee MJ, Gourlay CW, Trepel J, Linehan WM, Neckers L (2009). Fumarate hydratase deficiency in renal cancer induces glycolytic addiction and hypoxia-inducible transcription factor 1alpha stabilization by glucose-dependent generation of reactive oxygen species. Mol Cell Biol  29, 4080-90.   https://doi.org/10.1128/MCB.00483-09




PubMed



               Available in future as a Free Article 


 


PubMed ID 19470762
         Pubmed Central ID 2715796",https://intramural.nih.gov/search/searchview.taf?ipid=63296
836,BC011047-03,"October 01, 2009 -  September 30, 2010",Animal Model and Genotyping Core Support Facility,Wendy Dianne Du Bois De Vroylande,Glenn  Merlino; PhD,"Laboratory of Cancer Biology and Genetics, NCI","Mario A Anzano



Valery  Bliskovsky; PhD



Lalage  Wakefield; PhD



Marta  Custer



Hao The Du



Maudeline  Etienne



Show all 14",NULL,"James B Mitchell; PhD (Radiation Biology Branch)



Konrad  Huppi; MD, PhD (Cancer Genetics Branch)



David  Levens; PhD (Laboratory of Pathology)","Rafael Cristian Casellas; PhD (NIAMS) 



Pamela Lee Schwartzberg; MD, PhD (NHGRI) 



Herbert Carpenter Morse; MD (NIAID) 



Alasdair M Gilfillan; PhD (NIAID)","Ordered by publication type and then author name.



1.
Zhang K, Kagan D, DuBois W, Robinson R, Bliskovsky V, Vass WC, Zhang S, Mock BA (2009). Mndal, a new interferon-inducible family member, is highly polymorphic, suppresses cell growth, and may modify plasmacytoma susceptibility. Blood  114, 2952-60.   https://doi.org/10.1182/blood-2009-01-198812




PubMed



        
     
Free Article


 


PubMed ID 19654412
         Pubmed Central ID 2756205",https://intramural.nih.gov/search/searchview.taf?ipid=63199
837,BC011048-03,"October 01, 2009 -  September 30, 2010",Predictive Biomarkers and Mechanism of Action for Anti-IGF1R Agents for Cancer,Liang  Cao,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI","Zhigang  Kang



Yunkai  Yu",NULL,Lee Jay Helman; MD (Pediatric Oncology Branch),NULL,"Ordered by publication type and then author name.



1.
Cao L, Yu Y, Kang Z, Helman L, Cao L (2010) Insulin-like Growth Factor 1 Receptor Antibody Induces Rhabdomyosarcoma Cell Death via a Process Involving AKT and Bcl-xL. Oncogene, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=63192
838,BC011052-03,"October 01, 2009 -  September 30, 2010",Cytopathology Core,Armando  Filie,John Carl Oberholtzer,"Laboratory of Pathology, NCI","Keith R Brosky



Tangi Y Howard



Dana K Erickson



Patricia A Fetsch



May Ester Owens",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Courcoutsakis N, Patronas N, Filie AC, Carney JA, Moraitis A, Stratakis CA (2009). Ectopic thymus presenting as a thyroid nodule in a patient with the Carney complex. Thyroid  19, 293-6.   https://doi.org/10.1089/thy.2008.0404




PubMed



        
     
Free Article


 


PubMed ID 19265501
         Pubmed Central ID 2962859 


 



2.
Loud JT, Thiébaut AC, Abati AD, Filie AC, Nichols K, Danforth D, Giusti R, Prindiville SA, Greene MH (2009). Ductal lavage in women from BRCA1/2 families: is there a future for ductal lavage in women at increased genetic risk of breast cancer? Cancer Epidemiol Biomarkers Prev  18, 1243-51.   https://doi.org/10.1158/1055-9965.EPI-08-0795




PubMed



        
     
Free Article


 


PubMed ID 19336560
         Pubmed Central ID 2729059 


 



3.
Palavalli LH, Prickett TD, Wunderlich JR, Wei X, Burrell AS, Porter-Gill P, Davis S, Wang C, Cronin JC, Agrawal NS, Lin JC, Westbroek W, Hoogstraten-Miller S, Molinolo AA, Fetsch P, Filie AC, O'Connell MP, Banister CE, Howard JD, Buckhaults P, Weeraratna AT, Brody LC, Rosenberg SA, Samuels Y (2009). Analysis of the matrix metalloproteinase family reveals that MMP8 is often mutated in melanoma. Nat Genet  41, 518-20.   https://doi.org/10.1038/ng.340




PubMed



        
     
Free Article


 


PubMed ID 19330028
         Pubmed Central ID 2748394",https://intramural.nih.gov/search/searchview.taf?ipid=63208
839,BC011068-03,"October 01, 2009 -  September 30, 2010",Laser Capture Microdissection Core Laboratory,"Michael R Emmert-Buck; MD, PhD",NULL,"Laboratory of Pathology, NCI","Jeffrey C Hanson



Jaime Andres Rodriguez Canales",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Armani M, Rodriguez-Canales J, Gillespie J, Tangrea M, Erickson H, Emmert-Buck MR, Shapiro B, Smela E (2009). 2D-PCR: a method of mapping DNA in tissue sections. Lab Chip  9, 3526-34.   https://doi.org/10.1039/b910807f




PubMed



        
     
Free Article


 


PubMed ID 20024032
         Pubmed Central ID 2910845 


 



2.
Eberle FC, Hanson JC, Killian JK, Wei L, Ylaya K, Hewitt SM, Jaffe ES, Emmert-Buck MR, Rodriguez-Canales J (2010). Immunoguided laser assisted microdissection techniques for DNA methylation analysis of archival tissue specimens. J Mol Diagn  12, 394-401.   https://doi.org/10.2353/jmoldx.2010.090200




PubMed



        
     
Free Article


 


PubMed ID 20413681
         Pubmed Central ID 2893622 


 



3.
Erickson HS, Albert PS, Gillespie JW, Rodriguez-Canales J, Marston Linehan W, Pinto PA, Chuaqui RF, Emmert-Buck MR (2009). Quantitative RT-PCR gene expression analysis of laser microdissected tissue samples. Nat Protoc  4, 902-22.   https://doi.org/10.1038/nprot.2009.61




PubMed



        
     
Free Article


 


PubMed ID 19478806
         Pubmed Central ID 2760821",https://intramural.nih.gov/search/searchview.taf?ipid=63206
840,BC011071-03,"October 01, 2009 -  September 30, 2010",Molecular Modeling of Ion Channel and Other Membrane Proteins,Stewart  Durell,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",Homer Robert Guy; PhD,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Arispe N, Diaz J, Durell SR, Shafrir Y, Guy HR (2010). Polyhistidine peptide inhibitor of the Abeta calcium channel potently blocks the Abeta-induced calcium response in cells. Theoretical modeling suggests a cooperative binding process. Biochemistry  49, 7847-53.   https://doi.org/10.1021/bi1006833




PubMed


 


PubMed ID 20690616
    
     


 



2.
Durell S, Durell S, Anishkin A, Guy H (2010) Beta-barrel models of soluble amyloid beta oligomers and annular protofibrils. Proteins: Structure, Function and Bioinformatics, in press.




 



3.
Durell S, Durell S, Arispe N, Guy H (2010) Models of Membrane-bound Alzheimer's Abeta Peptide Assemblies. Proteins: Structure, Function and Bioinformatics, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=63201
841,BC011075-03,"October 01, 2009 -  September 30, 2010",Molecular Modeling of the Human P-glycoprotein Transporter Protein,Stewart  Durell,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",Homer Robert Guy; PhD,NULL,Suresh V Ambudkar; PhD (Transport Biochemistry Section),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63202
842,BC011077-03,"October 01, 2009 -  September 30, 2010",Modeling Molecular of Interactions Regulating the Activity of the p53 Protein,Stewart  Durell,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",NULL,NULL,Ettore  Appella; MD (Chemical Immunology Section),Daniel  Appella; PhD (NIDDK),"Ordered by publication type and then author name.



1.
Feng H, Jenkins LM, Durell SR, Hayashi R, Mazur SJ, Cherry S, Tropea JE, Miller M, Wlodawer A, Appella E, Bai Y (2009). Structural basis for p300 Taz2-p53 TAD1 binding and modulation by phosphorylation. Structure  17, 202-10.   https://doi.org/10.1016/j.str.2008.12.009




PubMed



        
     
Free Article


 


PubMed ID 19217391
         Pubmed Central ID 2705179 


 



2.
Hayashi R, Wang D, Hara T, Iera JA, Durell SR, Appella DH (2009). N-acylpolyamine inhibitors of HDM2 and HDMX binding to p53. Bioorg Med Chem  17, 7884-93.   https://doi.org/10.1016/j.bmc.2009.10.032




PubMed



        
     
Free Article


 


PubMed ID 19880322
         Pubmed Central ID 2784108",https://intramural.nih.gov/search/searchview.taf?ipid=63203
843,BC011079-03,"October 01, 2009 -  September 30, 2010",Molecular Diagnostics Core Laboratory,Mark  Raffeld; MD,John Carl Oberholtzer,"Laboratory of Pathology, NCI","Trinh  Pham



Thu A Pham



Liqiang  Xi; MD



Elaine S Jaffe; MD",NULL,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)



Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)



Susan  Bates; MD (Medical Oncology Branch)



James N Kochenderfer (Experimental Transplantation and Immunology Branch)



John  Janik; MD (Lymphoid Malignancies Branch)","Amy D Klion; MD (NIAID) 



Steven M Holland; MD (NIAID)","Ordered by publication type and then author name.



1.
Morovic A, Jaffe ES, Raffeld M, Schrager JA (2009). Metachronous EBV-associated B-cell and T-cell posttransplant lymphoproliferative disorders in a heart transplant recipient. Am J Surg Pathol  33, 149-54.   https://doi.org/10.1097/PAS.0b013e318181a826




PubMed



        
     
Free Article


 


PubMed ID 18941401
         Pubmed Central ID 6324846 


 



2.
Ritchie D, Piekarz RL, Blombery P, Karai LJ, Pittaluga S, Jaffe ES, Raffeld M, Janik JE, Prince HM, Bates SE (2009). Reactivation of DNA viruses in association with histone deacetylase inhibitor therapy: a case series report. Haematologica  94, 1618-22.   https://doi.org/10.3324/haematol.2009.008607




PubMed



        
     
Free Article


 


PubMed ID 19608677
         Pubmed Central ID 2770976",https://intramural.nih.gov/search/searchview.taf?ipid=63390
844,BC011083-02,"October 01, 2009 -  September 30, 2010",Protein Chemistry Core,"Deborah K Morrison



IRP Faculty Profile",NULL,"Laboratory of Cell and Developmental Signaling, NCI",Suzanne I Specht,"David  Allis
(The Rockefeller University)




Michael  Cole; MD





Rueben  Shaw
(Salk Institute)",NULL,NULL,"Ordered by publication type and then author name.



1.
Dougherty MK, Ritt DA, Zhou M, Specht SI, Monson DM, Veenstra TD, Morrison DK (2009). KSR2 is a calcineurin substrate that promotes ERK cascade activation in response to calcium signals. Mol Cell  34, 652-62.   https://doi.org/10.1016/j.molcel.2009.06.001




PubMed



        
     
Free Article


 


PubMed ID 19560418
         Pubmed Central ID 2737517",https://intramural.nih.gov/search/searchview.taf?ipid=62749
845,BC011086-03,"October 01, 2009 -  September 30, 2010",Brain Tumor Animal Therapeutics Core,"Howard A Fine; MD, PhD",NULL,"Neuro-Oncology Branch, NCI","Rolanda  Bailey



Dionne  Davis



Lincoln A Edwards



Hua  Song



Lin  Tang",NULL,"Steven Aaron Rosenberg; MD, PhD (Surgery Branch)","John Keenam Park (NINDS) 



Robert  Innis; MD (NIMH) 



Joseph A Frank; MD, MS (CC)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63212
846,BC011087-03,"October 01, 2009 -  September 30, 2010",Immunohistochemistry Core Laboratory,Mark  Raffeld; MD,John Carl Oberholtzer,"Laboratory of Pathology, NCI","Cynthia A Harris



Hong  Jin



Stefania  Pittaluga



Charisma D Roque



Elaine S Jaffe; MD",NULL,"Giovanni  Melillo (Screening Technologies Branch)



David  Vistica; PhD (Screening Technologies Branch)



Steven Aaron Rosenberg; MD, PhD (Surgery Branch)



James N Kochenderfer (Experimental Transplantation and Immunology Branch)



John  Janik; MD (Lymphoid Malignancies Branch)",NULL,"Ordered by publication type and then author name.



1.
Alper O, Stetler-Stevenson WG, Harris LN, Leitner WW, Ozdemirli M, Hartmann D, Raffeld M, Abu-Asab M, Byers S, Zhuang Z, Oldfield EH, Tong Y, Bergmann-Leitner E, Criss WE, Nagasaki K, Mok SC, Cramer DW, Karaveli FS, Goldbach-Mansky R, Leo P, Stromberg K, Weil RJ (2009). Novel anti-filamin-A antibody detects a secreted variant of filamin-A in plasma from patients with breast carcinoma and high-grade astrocytoma. Cancer Sci  100, 1748-56.   https://doi.org/10.1111/j.1349-7006.2009.01244.x




PubMed



        
     
Free Article


 


PubMed ID 19594548
         Pubmed Central ID 2788299 


 



2.
Morovic A, Jaffe ES, Raffeld M, Schrager JA (2009). Metachronous EBV-associated B-cell and T-cell posttransplant lymphoproliferative disorders in a heart transplant recipient. Am J Surg Pathol  33, 149-54.   https://doi.org/10.1097/PAS.0b013e318181a826




PubMed



        
     
Free Article


 


PubMed ID 18941401
         Pubmed Central ID 6324846 


 



3.
Rapisarda A, Hollingshead M, Uranchimeg B, Bonomi CA, Borgel SD, Carter JP, Gehrs B, Raffeld M, Kinders RJ, Parchment R, Anver MR, Shoemaker RH, Melillo G (2009). Increased antitumor activity of bevacizumab in combination with hypoxia inducible factor-1 inhibition. Mol Cancer Ther  8, 1867-77.   https://doi.org/10.1158/1535-7163.MCT-09-0274




PubMed



        
     
Free Article


 


PubMed ID 19584228
         Pubmed Central ID 2745101 


 



4.
Stockwin LH, Vistica DT, Kenney S, Schrump DS, Butcher DO, Raffeld M, Shoemaker RH (2009). Gene expression profiling of alveolar soft-part sarcoma (ASPS). BMC Cancer  9, 22.   https://doi.org/10.1186/1471-2407-9-22




PubMed



        
     
Free Article


 


PubMed ID 19146682
         Pubmed Central ID 2635365 


 



5.
Vistica DT, Hollingshead M, Borgel SD, Kenney S, Stockwin LH, Raffeld M, Schrump DS, Burkett S, Stone G, Butcher DO, Shoemaker RH (2009). Therapeutic vulnerability of an in vivo model of alveolar soft part sarcoma (ASPS) to antiangiogenic therapy. J Pediatr Hematol Oncol  31, 561-70.   https://doi.org/10.1097/MPH.0b013e3181a6e043




PubMed



        
     
Free Article


 


PubMed ID 19636271
         Pubmed Central ID 2784654 


 



6.
Wang Y, Digiovanna JJ, Stern JB, Hornyak TJ, Raffeld M, Khan SG, Oh KS, Hollander MC, Dennis PA, Kraemer KH (2009). Evidence of ultraviolet type mutations in xeroderma pigmentosum melanomas. Proc Natl Acad Sci U S A  106, 6279-84.   https://doi.org/10.1073/pnas.0812401106




PubMed



        
     
Free Article


 


PubMed ID 19329485
         Pubmed Central ID 2669353",https://intramural.nih.gov/search/searchview.taf?ipid=63386
847,BC011093-03,"October 01, 2009 -  September 30, 2010",FLow Cytometric Detection of Malignant Cells in Body Fluids,"Maryalice  Stetler-Stevenson; MD, PhD",John Carl Oberholtzer,"Laboratory of Pathology, NCI","Gregory A Jasper



Catharine S Mccoy



Linda Shonk Weaver



Christine Gayle Aguhar



Prashant Ramesh  Tembhare",NULL,"Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)



Richard  Little; MD, PhD (Clinical Investigations Branch)",NULL,"Ordered by publication type and then author name.



1.
Jiang L, Abati AD, Wilson W, Stetler-Stevenson M, Yuan C (2009). Persistent non-neoplastic gammadelta-T cells in cerebrospinal fluid of a patient with hepatosplenic (gammadelta) T cell lymphoma: a case report with 6 years of flow cytometry follow-up. Int J Clin Exp Pathol  3, 110-6.




PubMed



        
     
Free Article


 


PubMed ID 19918335
         Pubmed Central ID 2776263 


 



2.
Yeh S, Weichel ED, Faia LJ, Albini TA, Wroblewski KK, Stetler-Stevenson M, Ruiz P, Sen HN, Chan CC, Nussenblatt RB (2010). 25-Gauge transconjunctival sutureless vitrectomy for the diagnosis of intraocular lymphoma. Br J Ophthalmol  94, 633-8.   https://doi.org/10.1136/bjo.2009.167940




PubMed



        
     
Free Article


 


PubMed ID 20447965
         Pubmed Central ID 2928256",https://intramural.nih.gov/search/searchview.taf?ipid=63282
848,BC011104-03,"October 01, 2009 -  September 30, 2010",Flow Cytometric Evaluation of Biomarkers,"Maryalice  Stetler-Stevenson; MD, PhD",John Carl Oberholtzer,"Laboratory of Pathology, NCI","Gregory A Jasper



Catharine S Mccoy



Linda Shonk Weaver



Christine Gayle Aguhar



Prashant Ramesh  Tembhare",NULL,"Ola Anders Landgren (Medical Oncology Branch)



John Charles Morris; MD (Lymphoid Malignancies Branch)



Thomas Alexander Waldmann; MD, PhD (Lymphoid Malignancies Branch)



Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)



Alan S Wayne; MD (Pediatric Oncology Branch)



Ira H Pastan; MD (Molecular Biology Section)","Adrian U Wiestner; MD, PhD (NHLBI)","Ordered by publication type and then author name.



1.
Arons E, Suntum T, Stetler-Stevenson M, Kreitman RJ (2009). VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy. Blood  114, 4687-95.   https://doi.org/10.1182/blood-2009-01-201731




PubMed



        
     
Free Article


 


PubMed ID 19745070
         Pubmed Central ID 2780305 


 



2.
Jiang L, Yuan CM, Hubacheck J, Janik JE, Wilson W, Morris JC, Jasper GA, Stetler-Stevenson M (2009). Variable CD52 expression in mature T cell and NK cell malignancies: implications for alemtuzumab therapy. Br J Haematol  145, 173-9.   https://doi.org/10.1111/j.1365-2141.2009.07606.x




PubMed



        
     
Free Article


 


PubMed ID 19236377
         Pubmed Central ID 3487105",https://intramural.nih.gov/search/searchview.taf?ipid=63281
849,BC011137-02,"October 01, 2009 -  September 30, 2010",Center for Applied Preclinical Research (CAPR),Terry Anne Van Dyke,NULL,"Office of the Director, NCI","N Keith Collins



Simone  Difilippantonio



Serguei V Kozlov



Zoe W Ohler",NULL,"Glenn  Merlino; PhD (Laboratory of Cancer Biology and Genetics)



Howard A Fine; MD, PhD (Neuro-Oncology Branch)



Karlyne M Reilly; BS, PhD (Mouse Cancer Genetics Program)","Christopher P Austin; AB, MD (NHGRI)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=62751
850,BC011138-03,"October 01, 2009 -  September 30, 2010",FACS Core Facility,William G Telford,Ronald E Gress; MD,"Experimental Transplantation and Immunology Branch, NCI","Veena N Kapoor



Nga  Voong",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63388
851,BC011139-03,"October 01, 2009 -  September 30, 2010",Application of novel laser technology for flow cytometric analysis.,William G Telford,Ronald E Gress; MD,"Experimental Transplantation and Immunology Branch, NCI",NULL,"Awtar  Krishan
(University of Miami School of Medicine)




Vladislav  Verkhusha; PhD
(Albert Einstein College of Medicine, Jack and Pearl Resnick Campus)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63389
852,BC011236-02,"October 01, 2009 -  September 30, 2010",CCR-Frederick Flow Cytometry Core,Kathleen  Noer,Giorgio  Trinchieri,"Laboratory of Experimental Immunology, NCI","Roberta M Matthai



Guity  Mohammadi",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63445
853,BC011237-02,"October 01, 2009 -  September 30, 2010",CIP Genomics Core,Colm  Ohuigin,Giorgio  Trinchieri,"Cancer Inflammation Program, NCI","Sara Elizabeth Bass



Hong  Lou



Ying  Qi",NULL,"Mary  Carrington; MS, PhD (Laboratory of Experimental Immunology)



Daniel  McVicar; PhD (Laboratory of Experimental Immunology)



Michael  Dean; PhD (Laboratory of Experimental Immunology)",NULL,"Ordered by publication type and then author name.



1.
Gao X, O'Brien TR, Welzel TM, Marti D, Qi Y, Goedert JJ, Phair J, Pfeiffer R, Carrington M (2010). HLA-B alleles associate consistently with HIV heterosexual transmission, viral load, and progression to AIDS, but not susceptibility to infection. AIDS  24, 1835-40.   https://doi.org/10.1097/QAD.0b013e32833c3219




PubMed



        
     
Free Article


 


PubMed ID 20588164
         Pubmed Central ID 2902625 


 



2.
Julg B, Williams KL, Reddy S, Bishop K, Qi Y, Carrington M, Goulder PJ, Ndung'u T, Walker BD (2010). Enhanced anti-HIV functional activity associated with Gag-specific CD8 T-cell responses. J Virol  84, 5540-9.   https://doi.org/10.1128/JVI.02031-09




PubMed



        
     
Free Article


 


PubMed ID 20335261
         Pubmed Central ID 2876607 


 



3.
Kosmrlj A, Read EL, Qi Y, Allen TM, Altfeld M, Deeks SG, Pereyra F, Carrington M, Walker BD, Chakraborty AK (2010). Effects of thymic selection of the T-cell repertoire on HLA class I-associated control of HIV infection. Nature  465, 350-4.   https://doi.org/10.1038/nature08997




PubMed



        
     
Free Article


 


PubMed ID 20445539
         Pubmed Central ID 3098720 


 



4.
Li Q, Sadowski S, Frank M, Chai C, Váradi A, Ho SY, Lou H, Dean M, Thisse C, Thisse B, Uitto J (2010). The abcc6a gene expression is required for normal zebrafish development. J Invest Dermatol  130, 2561-8.   https://doi.org/10.1038/jid.2010.174




PubMed



        
     
Free Article


 


PubMed ID 20596085
         Pubmed Central ID 3357064 


 



5.
Lou H, Yeager M, Li H, Bosquet JG, Hayes RB, Orr N, Yu K, Hutchinson A, Jacobs KB, Kraft P, Wacholder S, Chatterjee N, Feigelson HS, Thun MJ, Diver WR, Albanes D, Virtamo J, Weinstein S, Ma J, Gaziano JM, Stampfer M, Schumacher FR, Giovannucci E, Cancel-Tassin G, Cussenot O, et al. [11 more authors] (2009). Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibility. Proc Natl Acad Sci U S A  106, 7933-8.   https://doi.org/10.1073/pnas.0902104106




PubMed



        
     
Free Article


 


PubMed ID 19383797
         Pubmed Central ID 2671324 


 



6.
Streeck H, Jolin JS, Qi Y, Yassine-Diab B, Johnson RC, Kwon DS, Addo MM, Brumme C, Routy JP, Little S, Jessen HK, Kelleher AD, Hecht FM, Sekaly RP, Rosenberg ES, Walker BD, Carrington M, Altfeld M (2009). Human immunodeficiency virus type 1-specific CD8+ T-cell responses during primary infection are major determinants of the viral set point and loss of CD4+ T cells. J Virol  83, 7641-8.   https://doi.org/10.1128/JVI.00182-09




PubMed



        
     
Free Article


 


PubMed ID 19458000
         Pubmed Central ID 2708622 


 



7.
Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, O'Huigin C, Kidd J, Kidd K, Khakoo SI, Alexander G, Goedert JJ, Kirk GD, Donfield SM, Rosen HR, Tobler LH, Busch MP, McHutchison JG, Goldstein DB, Carrington M (2009). Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature  461, 798-801.   https://doi.org/10.1038/nature08463




PubMed



        
     
Free Article


 


PubMed ID 19759533
         Pubmed Central ID 3172006 


 



8.
Thomas R, Apps R, Qi Y, Gao X, Male V, O'hUigin C, O'Connor G, Ge D, Fellay J, Martin JN, Margolick J, Goedert JJ, Buchbinder S, Kirk GD, Martin MP, Telenti A, Deeks SG, Walker BD, Goldstein D, McVicar DW, Moffett A, Carrington M (2009). HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C. Nat Genet  41, 1290-4.   https://doi.org/10.1038/ng.486




PubMed



        
     
Free Article


 


PubMed ID 19935663
         Pubmed Central ID 2887091 


 



9.
Yindom LM, Leligdowicz A, Martin MP, Gao X, Qi Y, Zaman SM, van der Loeff MS, van Tienen C, Jaye A, Aveika A, Worwui A, Diatta M, Vincent T, Whittle HC, Rowland-Jones SL, Walton R, Carrington M (2010). Influence of HLA class I and HLA-KIR compound genotypes on HIV-2 infection and markers of disease progression in a Manjako community in West Africa. J Virol  84, 8202-8.   https://doi.org/10.1128/JVI.00116-10




PubMed



        
     
Free Article


 


PubMed ID 20519398
         Pubmed Central ID 2916551",https://intramural.nih.gov/search/searchview.taf?ipid=63446
854,BC011257-01,"October 01, 2009 -  September 30, 2010",Applied Molecular Pathology Laboratory,"Stephen M Hewitt; MD, PhD",John Carl Oberholtzer,"Laboratory of Pathology, NCI","Joon Yong Chung



Jennifer  Martinez",NULL,"Mark E Sherman; MD (Hormonal and Reproductive Epidemiology Branch)



Jonine Danya Figueroa (Hormonal and Reproductive Epidemiology Branch)



Montserrat  Garcia-Closas; MD, PhD (Hormonal and Reproductive Epidemiology Branch)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=67575
855,BC011265-01,"October 01, 2009 -  September 30, 2010",Gene Targeting Facility,"Lino  Tessarollo



IRP Faculty Profile",NULL,"Mouse Cancer Genetics Program, NCI","Jodi L Becker



Mary Ellen  Palko



Susan W Reid



Bradley D St Croix",NULL,"Dolph Lee Hatfield; PhD (Laboratory of Cancer Prevention)



Ola Mae Zack Howard (Laboratory of Molecular Immunoregulation)



Mark  Udey; MD (Dermatology Branch)



Jairaj K Acharya; MBBS, PhD (Laboratory of Cell and Developmental Signaling)



Beverly  Mock; PhD (Laboratory of Cancer Biology and Genetics)



Howard A Young; PhD (Laboratory of Experimental Immunology)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=67591
856,BC011288-01,"October 01, 2009 -  September 30, 2010",Behavioral Science Core,Alan S Wayne; MD,Crystal L. Mackall; MD,"Pediatric Oncology Branch, NCI","Terry J Fry



Lori  Wiener; PhD, LCSW-C



Katherine Elizabeth Warren; MD



Pamela  Wolters



Nia Malika Billings



Katherine Mcintyre Burns



Show all 10",NULL,"Lauren V Wood; MD (Vaccine Branch)



Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)



Kevin A Camphausen; MD (Radiation Oncology Branch)



Ronald E Gress; MD (Experimental Transplantation and Immunology Branch)



Dennis D Hickstein (Experimental Transplantation and Immunology Branch)","David S Wendler; PhD (CC) 



Rohan  Hazra (NICHD) 



Maryland  Pao; MD (NIMH) 



Christine  Grady; PhD, RN (CC) 



Steven M Holland; MD (NIAID) 



John F Tisdale; MD (NHLBI)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=67633
857,BC011309-01,"October 01, 2009 -  September 30, 2010",DNA Extraction Service,Jeffrey A Hammer; MS,Alfred  Singer; MD,"Molecular Regulation Section, NCI",NULL,NULL,"Jung-Hyun  Park (Experimental Immunology Branch)



Andre A Nussenzweig; PhD (Experimental Immunology Branch)



Richard J Hodes; MD (Experimental Immunology Branch)



Dinah  Singer; PhD (Experimental Immunology Branch)



James Stephen Shaw; PhD (Experimental Immunology Branch)



David M Segal; PhD (Immune Targeting Section)",NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=67667
858,BC011310-01,"October 01, 2009 -  September 30, 2010",Hollow Fiber Production of Monoclonal Antibodies,Jeffrey A Hammer; MS,Alfred  Singer; MD,"Molecular Regulation Section, NCI",NULL,NULL,"Jung-Hyun  Park (Experimental Immunology Branch)



Dinah  Singer; PhD (Experimental Immunology Branch)



James Stephen Shaw; PhD (Experimental Immunology Branch)",NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=67669
859,BC011331-01,"October 01, 2009 -  September 30, 2010",CCR Sequencing Facility,"Paul S Meltzer; MD, PhD



IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI",NULL,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=67709
860,CO020007-02,"October 01, 2009 -  September 30, 2010",NCI-Frederick Support and Technical Services,"Douglas  Lowy; MD



IRP Faculty Profile",NULL,"National Cancer Institute, NCI",Craig W Reynolds,NULL,NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=63483
861,CP010178-09,"October 01, 2009 -  September 30, 2010",Core Genotyping Facility,"Stephen J Chanock; MD, PhD



IRP Faculty Profile",NULL,"Laboratory Translational Genomics, NCI",Gilles F Thomas,NULL,Kedest  Teshome (Human Genetics Section),"Jun  Lu (NIEHS) 



Shaila  Sharmeen (NIDDK)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63523
862,CP010203-02,"October 01, 2009 -  September 30, 2010",Applied Molecular Pathology Laboratory,"Margaret Anne Tucker



IRP Faculty Profile",NULL,"Human Genetics Program, NCI",NULL,NULL,"Stephen M Hewitt; MD, PhD (Laboratory of Pathology)



Mark E Sherman; MD (Hormonal and Reproductive Epidemiology Branch)



Karen E Berliner (Office of the Director)",NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=63549
863,SC006536-17,"October 01, 2009 -  September 30, 2010",Sample Processing and Analytical Methods Development for New Anticancer Agents,"Giuseppe  Giaccone; MD

 


 

William D Figg; PharmD



IRP Faculty Profile",NULL,"Medical Oncology Branch, NCI","David E Adelberg; MD



Susan  Bates; MD



Xiaohong  Chen



Kathryn  Compton



Shivaani  Kummar; PhD



Erin  Lepper



Show all 11","Michael  Pacanowski
(FDA)




Jurgen  Venitz
(School of Pharmacy, Virginia Commonwealth University)","Heidi H Kong (Dermatology Branch)



William Laurence Dahut; MD (Office of the Director)",NULL,"Ordered by publication type and then author name.



1.
Aragon-Ching JB, Jain L, Gulley JL, Arlen PM, Wright JJ, Steinberg SM, Draper D, Venitz J, Jones E, Chen CC, Figg WD, Dahut WL (2009). Final analysis of a phase II trial using sorafenib for metastatic castration-resistant prostate cancer. BJU Int  103, 1636-40.   https://doi.org/10.1111/j.1464-410X.2008.08327.x




PubMed



        
     
Free Article


 


PubMed ID 19154507
         Pubmed Central ID 2818665 


 



2.
Dahut WL, Aragon-Ching JB, Woo S, Tohnya TM, Gulley JL, Arlen PM, Wright JJ, Ventiz J, Figg WD (2009). Phase I study of oral lenalidomide in patients with refractory metastatic cancer. J Clin Pharmacol  49, 650-60.   https://doi.org/10.1177/0091270009335001




PubMed



        
     
Free Article


 


PubMed ID 19451403
         Pubmed Central ID 2808857 


 



3.
Danish M, Gardner ER, Chen X, Figg WD (2009). Determination of a benzamide histone deacetylase inhibitor, MS-275, in human plasma by liquid chromatography with mass-spectrometric detection. J Chromatogr B Analyt Technol Biomed Life Sci  877, 355-9.   https://doi.org/10.1016/j.jchromb.2008.12.018




PubMed



        
     
Free Article


 


PubMed ID 19117815
         Pubmed Central ID 2661872 


 



4.
Piekarz RL, Frye R, Turner M, Wright JJ, Allen SL, Kirschbaum MH, Zain J, Prince HM, Leonard JP, Geskin LJ, Reeder C, Joske D, Figg WD, Gardner ER, Steinberg SM, Jaffe ES, Stetler-Stevenson M, Lade S, Fojo AT, Bates SE (2009). Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma. J Clin Oncol  27, 5410-7.   https://doi.org/10.1200/JCO.2008.21.6150




PubMed



        
     
Free Article


 


PubMed ID 19826128
         Pubmed Central ID 2773225",https://intramural.nih.gov/search/searchview.taf?ipid=63626
864,SC006537-17,"October 01, 2009 -  September 30, 2010",Using Clinical Pharmacology Principles to Develop New Anticancer Therapies,"William D Figg; PharmD



IRP Faculty Profile",Giuseppe  Giaccone; MD,"Medical Oncology Branch, NCI","David E Adelberg; MD



Susan  Bates; MD



Xiaohong  Chen



Phillip A Dennis; MD, PhD



Kathryn  Compton



Paul Gustav Kluetz



Show all 11","Alex  Sparreboom





Jurgen  Venitz
(School of Pharmacy, Virginia Commonwealth University)","John J Wright (Investigational Drug Branch)



Seth M Steinberg; PhD (Office of the Director)



William Laurence Dahut; MD (Office of the Director)



Howard A Fine; MD, PhD (Neuro-Oncology Branch)



Patricia  Steeg; PhD (Developmental Therapeutics Branch)",NULL,"Ordered by publication type and then author name.



1.
Chau C, Figg W (2010) Pharmacology of Cancer Biotherapeutics: Angiogenesis Agents, in Cancer: Principles and Practices of Oncology, 9th Edition., pp. 527-36.




 



2.
Aragon-Ching JB, Jain L, Gulley JL, Arlen PM, Wright JJ, Steinberg SM, Draper D, Venitz J, Jones E, Chen CC, Figg WD, Dahut WL (2009). Final analysis of a phase II trial using sorafenib for metastatic castration-resistant prostate cancer. BJU Int  103, 1636-40.   https://doi.org/10.1111/j.1464-410X.2008.08327.x




PubMed



        
     
Free Article


 


PubMed ID 19154507
         Pubmed Central ID 2818665 


 



3.
Azad N, Perroy A, Gardner E, Imamura CK, Graves C, Sarosy GA, Minasian L, Kotz H, Raggio M, Figg WD, Kohn EC (2009). A phase I study of paclitaxel and continuous daily CAI in patients with refractory solid tumors. Cancer Biol Ther  8, 1800-5.   https://doi.org/10.4161/cbt.8.19.9593




PubMed



        
     
Free Article


 


PubMed ID 19738417
         Pubmed Central ID 3104675 


 



4.
Bates SE, Zhan Z, Steadman K, Obrzut T, Luchenko V, Frye R, Robey RW, Turner M, Gardner ER, Figg WD, Steinberg SM, Ling A, Fojo T, To KW, Piekarz RL (2010). Laboratory correlates for a phase II trial of romidepsin in cutaneous and peripheral T-cell lymphoma. Br J Haematol  148, 256-67.   https://doi.org/10.1111/j.1365-2141.2009.07954.x




PubMed



        
     
Free Article


 


PubMed ID 19874311
         Pubmed Central ID 2838427 


 



5.
Dahut WL, Aragon-Ching JB, Woo S, Tohnya TM, Gulley JL, Arlen PM, Wright JJ, Ventiz J, Figg WD (2009). Phase I study of oral lenalidomide in patients with refractory metastatic cancer. J Clin Pharmacol  49, 650-60.   https://doi.org/10.1177/0091270009335001




PubMed



        
     
Free Article


 


PubMed ID 19451403
         Pubmed Central ID 2808857 


 



6.
Figg WD, Hussain MH, Gulley JL, Arlen PM, Aragon-Ching JB, Petrylak DP, Higano CS, Steinberg SM, Chatta GS, Parnes H, Wright JJ, Sartor O, Dahut WL (2009). A double-blind randomized crossover study of oral thalidomide versus placebo for androgen dependent prostate cancer treated with intermittent androgen ablation. J Urol  181, 1104-13; discussion 1113.   https://doi.org/10.1016/j.juro.2008.11.026




PubMed



        
     
Free Article


 


PubMed ID 19167733
         Pubmed Central ID 2838198 


 



7.
Figg WD, Woo S, Zhu W, Chen X, Ajiboye AS, Steinberg SM, Price DK, Wright JJ, Parnes HL, Arlen PM, Gulley JL, Dahut WL (2010). A phase I clinical study of high dose ketoconazole plus weekly docetaxel for metastatic castration resistant prostate cancer. J Urol  183, 2219-26.   https://doi.org/10.1016/j.juro.2010.02.020




PubMed



        
     
Free Article


 


PubMed ID 20399458
         Pubmed Central ID 3474294 


 



8.
Gardner ER, Kelly M, Springman E, Lee KJ, Li H, Moore W, Figg WD (2012). Antiangiogenic and antitumor activity of LP-261, a novel oral tubulin binding agent, alone and in combination with bevacizumab. Invest New Drugs  30, 90-7.   https://doi.org/10.1007/s10637-010-9520-5




PubMed



        
     
Free Article


 


PubMed ID 20820910
         Pubmed Central ID 6446042 


 



9.
Gardner ER, Smith NF, Figg WD, Sparreboom A (2009). Influence of the dual ABCB1 and ABCG2 inhibitor tariquidar on the disposition of oral imatinib in mice. J Exp Clin Cancer Res  28, 99.   https://doi.org/10.1186/1756-9966-28-99




PubMed



        
     
Free Article


 


PubMed ID 19591692
         Pubmed Central ID 2717937 


 



10.
Grant C, Rahman F, Piekarz R, Peer C, Frye R, Robey RW, Gardner ER, Figg WD, Bates SE (2010). Romidepsin: a new therapy for cutaneous T-cell lymphoma and a potential therapy for solid tumors. Expert Rev Anticancer Ther  10, 997-1008.   https://doi.org/10.1586/era.10.88




PubMed



        
     
Free Article


 


PubMed ID 20645688
         Pubmed Central ID 6361116 


 



11.
Kummar S, Gutierrez ME, Gardner ER, Chen X, Figg WD, Zajac-Kaye M, Chen M, Steinberg SM, Muir CA, Yancey MA, Horneffer YR, Juwara L, Melillo G, Ivy SP, Merino M, Neckers L, Steeg PS, Conley BA, Giaccone G, Doroshow JH, Murgo AJ (2010). Phase I trial of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG), a heat shock protein inhibitor, administered twice weekly in patients with advanced malignancies. Eur J Cancer  46, 340-7.   https://doi.org/10.1016/j.ejca.2009.10.026




PubMed



        
     
Free Article


 


PubMed ID 19945858
         Pubmed Central ID 2818572 


 



12.
Kummar S, Gutierrez ME, Gardner ER, Figg WD, Melillo G, Dancey J, Sausville EA, Conley BA, Murgo AJ, Doroshow JH (2010). A phase I trial of UCN-01 and prednisone in patients with refractory solid tumors and lymphomas. Cancer Chemother Pharmacol  65, 383-9.   https://doi.org/10.1007/s00280-009-1154-y




PubMed



        
     
Free Article


 


PubMed ID 19894051
         Pubmed Central ID 2854012 


 



13.
Ning YM, Gulley JL, Arlen PM, Woo S, Steinberg SM, Wright JJ, Parnes HL, Trepel JB, Lee MJ, Kim YS, Sun H, Madan RA, Latham L, Jones E, Chen CC, Figg WD, Dahut WL (2010). Phase II trial of bevacizumab, thalidomide, docetaxel, and prednisone in patients with metastatic castration-resistant prostate cancer. J Clin Oncol  28, 2070-6.   https://doi.org/10.1200/JCO.2009.25.4524




PubMed



        
     
Free Article


 


PubMed ID 20308663
         Pubmed Central ID 2860408 


 



14.
Piekarz RL, Frye R, Turner M, Wright JJ, Allen SL, Kirschbaum MH, Zain J, Prince HM, Leonard JP, Geskin LJ, Reeder C, Joske D, Figg WD, Gardner ER, Steinberg SM, Jaffe ES, Stetler-Stevenson M, Lade S, Fojo AT, Bates SE (2009). Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma. J Clin Oncol  27, 5410-7.   https://doi.org/10.1200/JCO.2008.21.6150




PubMed



        
     
Free Article


 


PubMed ID 19826128
         Pubmed Central ID 2773225",https://intramural.nih.gov/search/searchview.taf?ipid=63627
865,SC006743-17,"October 01, 2009 -  September 30, 2010",Signal Transduction Events and the Regulation of Cell Growth,Jane Beth Trepel,Giuseppe  Giaccone; MD,"Medical Oncology Branch, NCI","Sylvia Vania  Alarcon Velasco



Yeong Sang  Kim



Min Jung Lee



Sunmin T Lee","Jay  Bradner
(Chemical Biology Program, Broad Institute)




Judith  Karp
(Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins)","Daniel H Fowler (Experimental Transplantation and Immunology Branch)



John Charles Morris; MD (Lymphoid Malignancies Branch)



Jeffrey S Rubin; MD, PhD (Laboratory of Cellular and Molecular Biology)



William Marston Linehan; MD (Urologic Oncology Branch)



Donald P Bottaro; PhD (Urologic Oncology Branch)



Thomas J Hornyak (Dermatology Branch)",NULL,"Ordered by publication type and then author name.



1.
Mushinski JF, Nguyen P, Stevens LM, Khanna C, Lee S, Chung EJ, Lee MJ, Kim YS, Linehan WM, Horisberger MA, Trepel JB (2009). Inhibition of tumor cell motility by the interferon-inducible GTPase MxA. J Biol Chem  284, 15206-14.   https://doi.org/10.1074/jbc.M806324200




PubMed



        
     
Free Article


 


PubMed ID 19297326
         Pubmed Central ID 2685701 


 



2.
Pise-Masison CA, Radonovich M, Dohoney K, Morris JC, O'Mahony D, Lee MJ, Trepel J, Waldmann TA, Janik JE, Brady JN (2009). Gene expression profiling of ATL patients: compilation of disease-related genes and evidence for TCF4 involvement in BIRC5 gene expression and cell viability. Blood  113, 4016-26.   https://doi.org/10.1182/blood-2008-08-175901




PubMed



        
     
Free Article


 


PubMed ID 19131553
         Pubmed Central ID 2673128 


 



3.
Sudarshan S, Sourbier C, Kong HS, Block K, Valera Romero VA, Yang Y, Galindo C, Mollapour M, Scroggins B, Goode N, Lee MJ, Gourlay CW, Trepel J, Linehan WM, Neckers L (2009). Fumarate hydratase deficiency in renal cancer induces glycolytic addiction and hypoxia-inducible transcription factor 1alpha stabilization by glucose-dependent generation of reactive oxygen species. Mol Cell Biol  29, 4080-90.   https://doi.org/10.1128/MCB.00483-09




PubMed



               Available in future as a Free Article 


 


PubMed ID 19470762
         Pubmed Central ID 2715796",https://intramural.nih.gov/search/searchview.taf?ipid=63625
866,SC009372-19,"October 01, 2009 -  September 30, 2010",Flow Cytometric Analysis of Benign and Malignant Tumors,"Maryalice  Stetler-Stevenson; MD, PhD",John Carl Oberholtzer,"Laboratory of Pathology, NCI","Gregory A Jasper



Catharine S Mccoy



Linda Shonk Weaver



Christine Gayle Aguhar



Prashant Ramesh  Tembhare",NULL,"Sam  Hwang; MD, PhD (Dermatology Branch)



Claude  Sportes (Experimental Transplantation and Immunology Branch)



Ola Anders Landgren (Medical Oncology Branch)



Daniel H Fowler (Experimental Transplantation and Immunology Branch)



Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)



John Charles Morris; MD (Lymphoid Malignancies Branch)","Adrian U Wiestner; MD, PhD (NHLBI) 



Steven M Holland; MD (NIAID)","Ordered by publication type and then author name.



1.
Arons E, Suntum T, Stetler-Stevenson M, Kreitman RJ (2009). VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy. Blood  114, 4687-95.   https://doi.org/10.1182/blood-2009-01-201731




PubMed



        
     
Free Article


 


PubMed ID 19745070
         Pubmed Central ID 2780305 


 



2.
Arun I, Wulu JA, Janik JE, Jasper GA, Yuan CM, Venzon D, Stetler-Stevenson M (2010). Visual inspection versus quantitative flow cytometry to detect aberrant CD2 expression in malignant T cells. Cytometry B Clin Cytom  78, 169-75.   https://doi.org/10.1002/cyto.b.20507




PubMed



        
     
Free Article


 


PubMed ID 20020522
         Pubmed Central ID 2916169 


 



3.
Jiang L, Abati AD, Wilson W, Stetler-Stevenson M, Yuan C (2009). Persistent non-neoplastic gammadelta-T cells in cerebrospinal fluid of a patient with hepatosplenic (gammadelta) T cell lymphoma: a case report with 6 years of flow cytometry follow-up. Int J Clin Exp Pathol  3, 110-6.




PubMed



        
     
Free Article


 


PubMed ID 19918335
         Pubmed Central ID 2776263 


 



4.
Kreitman RJ, Stetler-Stevenson M, Margulies I, Noel P, Fitzgerald DJ, Wilson WH, Pastan I (2009). Phase II trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with hairy cell leukemia. J Clin Oncol  27, 2983-90.   https://doi.org/10.1200/JCO.2008.20.2630




PubMed



        
     
Free Article


 


PubMed ID 19414673
         Pubmed Central ID 2702232 


 



5.
Piekarz RL, Frye R, Turner M, Wright JJ, Allen SL, Kirschbaum MH, Zain J, Prince HM, Leonard JP, Geskin LJ, Reeder C, Joske D, Figg WD, Gardner ER, Steinberg SM, Jaffe ES, Stetler-Stevenson M, Lade S, Fojo AT, Bates SE (2009). Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma. J Clin Oncol  27, 5410-7.   https://doi.org/10.1200/JCO.2008.21.6150




PubMed



        
     
Free Article


 


PubMed ID 19826128
         Pubmed Central ID 2773225 


 



6.
Stetler-Stevenson M (2009). Flow cytometric immunophenotyping: emerging as an important diagnostic tool in the evaluation of cytopenic patients. Leuk Res  33, 1020-1.   https://doi.org/10.1016/j.leukres.2009.02.029




PubMed



        
     
Free Article


 


PubMed ID 19327830
         Pubmed Central ID 2683904 


 



7.
Stetler-Stevenson M, Yuan CM (2009). Myelodysplastic syndromes: the role of flow cytometry in diagnosis and prognosis. Int J Lab Hematol  31, 479-83.   https://doi.org/10.1111/j.1751-553X.2009.01176.x




PubMed


 


PubMed ID 19555363",https://intramural.nih.gov/search/searchview.taf?ipid=63560
867,SC009431-16,"October 01, 2009 -  September 30, 2010",Histologic and Molecular Characterization of Solid Pediatric Tumors,Maria  Tsokos; MD,NULL,"Laboratory of Pathology, NCI","Susana Beatriz Galli



Chunyan  Liu; PhD



Sarwat Waqar Siddiqui; MD",NULL,"Crystal L. Mackall; MD (Pediatric Oncology Branch)



Brigitte  Widemann; MD (Pediatric Oncology Branch)",NULL,"Ordered by publication type and then author name.



1.
Fitzhugh CD, Wise B, Baird K, Tsokos M, Helman L, Mackall C, Savage SA, Warren KE (2009). Secondary supratentorial primitive neuroectodermal tumor following treatment of childhood osteosarcoma. Pediatr Blood Cancer  53, 496-8.   https://doi.org/10.1002/pbc.22074




PubMed



        
     
Free Article


 


PubMed ID 19434734
         Pubmed Central ID 2760453 


 



2.
Maxhimer JB, Soto-Pantoja DR, Ridnour LA, Shih HB, Degraff WG, Tsokos M, Wink DA, Isenberg JS, Roberts DD (2009). Radioprotection in normal tissue and delayed tumor growth by blockade of CD47 signaling. Sci Transl Med  1, 3ra7.   https://doi.org/10.1126/scitranslmed.3000139




PubMed



        
     
Free Article


 


PubMed ID 20161613
         Pubmed Central ID 2811586",https://intramural.nih.gov/search/searchview.taf?ipid=63598
868,SC010353-11,"October 01, 2009 -  September 30, 2010",Experimental Therapeutics of Pediatric Hematopoietic Malignancies,"Crystal L. Mackall; MD

 




Alan S Wayne; MD",NULL,"Pediatric Oncology Branch, NCI","Hema  Dave



Terry J Fry



Cynthia P Love



Kelly D Richards



Vicki  Richmond



Nirali Niranjan Shah



Show all 8","Deepa  Bhowjani
(St Jude Children's Research Hospital)




Dario  Campana
(St Jude Children's Research Hospital)




Civin  Curt
(Pediatric Oncology, Johns Hopkins University)




Sima  Jeha
(Pediatric Oncology, St Jude Children's Cancer Research Hospital)




Glen  Lew
(Pediatric Hematology-Oncology, Emory University/AFLAC Cancer Center)




David  Loeb
(Pediatric Hematology-Oncology, Johns Hopkins University)


Show all 8","Sivasubramanian  Baskar (Experimental Transplantation and Immunology Branch)



Paul S Meltzer; MD, PhD (Cancer Genetics Branch)



Daniel H Fowler (Experimental Transplantation and Immunology Branch)



Michael Marc Gottesman; MD (Chemical Immunology Section)



Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)



Thomas Alexander Waldmann; MD, PhD (Lymphoid Malignancies Branch)","David F Stroncek; MD (CC) 



Susan  Leitman; MD (CC) 



Austin John Barrett; MD (NHLBI) 



Roger  Kurlander; MD (CC) 



Hanh M Khuu; MD (CC)","Ordered by publication type and then author name.



1.
Guimond M, Freud AG, Mao HC, Yu J, Blaser BW, Leong JW, Vandeusen JB, Dorrance A, Zhang J, Mackall CL, Caligiuri MA (2010). In vivo role of Flt3 ligand and dendritic cells in NK cell homeostasis. J Immunol  184, 2769-75.   https://doi.org/10.4049/jimmunol.0900685




PubMed



        
     
Free Article


 


PubMed ID 20142363
         Pubmed Central ID 2924750",https://intramural.nih.gov/search/searchview.taf?ipid=63608
869,BC010686-06,"October 01, 2009 -  September 30, 2010",Clinical Operations for Laboratory of Pathology,"David Erwin Kleiner; MD, PhD",John Carl Oberholtzer,"Laboratory of Pathology, NCI","Earle J Barnes



Joseph  Chinquee



Kathleen Renee Gittens; RN



Mary E Grissette



Jeannette Marie McNulty



Silke  Williams",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=63027
870,BC010694-06,"October 01, 2009 -  September 30, 2010",Clinical Cancer Cytogenetics,Diane Carol Arthur; MD,John Carl Oberholtzer,"Laboratory of Pathology, NCI","Veronica  Krevinko



Shannon I Skarshaug



Valerie M Zgonc



Stefania  Pittaluga



Elaine S Jaffe; MD



Maryalice  Stetler-Stevenson; MD, PhD",NULL,"Sharon Ann Savage (Clinical Genetics Branch)



Daniel H Fowler (Experimental Transplantation and Immunology Branch)



Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)



Neelam K Giri; MD (Clinical Genetics Branch)



Steven  Pavletic; MD, MS (Experimental Transplantation and Immunology Branch)



Blanche P Alter (Clinical Genetics Branch)","Katherine Rainsford Calvo (CC) 



Adrian U Wiestner; MD, PhD (NHLBI) 



Gerald Ernest Marti (OD) 



Irina  Maric; MD (CC)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=63009
871,BC010882-03,"October 01, 2009 -  September 30, 2010",Clinical Trials Support,"Caryn  Steakley; BA, BSN, MSW",William Laurence Dahut; MD,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=63278
872,BC010950-03,"October 01, 2009 -  September 30, 2010",Research Nursing,Giuseppe  Giaccone; MD,NULL,"Medical Oncology Branch, NCI","Deborah E Allen



Arlene Wendy Berman



Guinevere Joy Ng Chun



Sonja Kashell Crandon; RN



Megan  Disinski



Maureen E Edgerly



Show all 23","M  Gallegos-Ruiz
(Afdeling Geneeskundige Oncologie, VU Medisch Centrum)




Martin  Gutierrez
(Micheal and Dianne Bienes Cancer Center)




Paulo  Zucali
(IRCCS)","William Laurence Dahut; MD (Office of the Director)



James Halpern Doroshow (Developmental Therapeutics Branch)



James L Gulley; MD, PhD (Laboratory of Tumor Immunology and Biology)



Leonard  Neckers; PhD (Urologic Oncology Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=63220
873,BC010951-03,"October 01, 2009 -  September 30, 2010",Medical Directors Office,Giuseppe  Giaccone; MD,NULL,"Medical Oncology Branch, NCI","Janelle D Bingham



Elise C Kohn; MD



Anna C Couvillon; NP



Antonio  Fojo; MD, PhD



Cynthia B Helsabeck



Barry William Miller; CRNP



Show all 16","M  Gallegos-Ruiz
(Afdeling Geneeskundige Oncologie, VU Medisch Centrum)




Yong  Kim
(Seoul National University College of Medicine)




Paulo  Zucali
(IRCCS)",William Laurence Dahut; MD (Office of the Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=63218
874,BC010963-03,"October 01, 2009 -  September 30, 2010",Branch Clinical Research Core,"Ronald E Gress; MD



IRP Faculty Profile",NULL,"Experimental Transplantation and Immunology Branch, NCI","Daniele N Avila



Judy Liliana Baruffaldi



Bazetta A Blacklock-Schuver



Kelly E Snow



Ashley Elizabeth Carpenter



Juan Carlos Gea-Banacloche; MD



Show all 13","Robert  Korngold
(Cancer Center, Hackensack University)




Andrew  Pecora
(Cancer Center, Hackensack University)","Crystal L. Mackall; MD (Pediatric Oncology Branch)



Steven Aaron Rosenberg; MD, PhD (Surgery Branch)



Shivaani  Kummar; PhD (Medical Oncology Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=63225
875,BC010987-03,"October 01, 2009 -  September 30, 2010",Center for Cancer Research Patient Travel,"Caryn  Steakley; BA, BSN, MSW",William Laurence Dahut; MD,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=63279
876,BC010988-03,"October 01, 2009 -  September 30, 2010",Center for Cancer Research Clinical Trials Data Management Service,"Caryn  Steakley; BA, BSN, MSW",William Laurence Dahut; MD,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=63280
877,BC010990-03,"October 01, 2009 -  September 30, 2010",Radiation Oncology Branch - Radiation Clinic,"Kevin A Camphausen; MD



IRP Faculty Profile",NULL,"Radiation Oncology Branch, NCI","Deborah S Mcnally



Sharon L Smith



Leor  Zach",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=63190
878,BC011022-02,"October 01, 2009 -  September 30, 2010",Clinical Research Support for the CCR,Robert  Wiltrout; PhD,NULL,"Laboratory of Experimental Immunology, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=62748
879,BC011089-03,"October 01, 2009 -  September 30, 2010",Clinical Nursing and Data Management Core,"William Marston Linehan; MD



IRP Faculty Profile",NULL,"Urologic Oncology Branch, NCI","Celene  Chua



Donna  Drake



Sarah M Fowler; RN



Rabindra  Gautam



Geri L Hawks



Cristiane  Leite



Show all 15",NULL,"Maria L Turner; MD (Dermatology Branch)



Peter L Choyke; MD (Molecular Imaging Program)



Maria  Merino; PhD (Laboratory of Pathology)



Bradford J Wood; MD (Office of the Director)



William Laurence Dahut; MD (Office of the Director)



Steven  Libutti; MD (Surgery Branch)","Richard  Childs; MD (NHLBI) 



Russell R Lonser; MD (NINDS) 



Karel  Pacak; MD, PhD (NICHD) 



Emily Y Chew; MD (NEI)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=63349
880,BC011092-03,"October 01, 2009 -  September 30, 2010",Consult Core,"William Marston Linehan; MD



IRP Faculty Profile",NULL,"Urologic Oncology Branch, NCI","Kevin Patrick Asher; MD



Gennady  Bratslavsky



Gopal N Gupta



Eric Curtis Kauffman



Peter A Pinto; MD



Ardeshir Rustom Rastinehad



Show all 9",NULL,"Maria L Turner; MD (Dermatology Branch)



Maria  Merino; PhD (Laboratory of Pathology)



William Laurence Dahut; MD (Office of the Director)



Steven  Libutti; MD (Surgery Branch)","Russell R Lonser; MD (NINDS) 



Pamela  Stratton; MD (NICHD) 



Karel  Pacak; MD, PhD (NICHD)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=63350
881,BC011098-03,"October 01, 2009 -  September 30, 2010",Brain Tumor Clinical and Clinical Research Program,"Howard A Fine; MD, PhD",NULL,"Neuro-Oncology Branch, NCI","Sandra  Bresnick



Mabel  Cruz



Sheila J Jean



Jacquelene  Robinson



Laurie  Rosenblatt



Tetiana  Wiggington



Show all 28",NULL,Kevin A Camphausen; MD (Radiation Oncology Branch),"John Anthony Butman; MD, PhD (CC) 



John Keenam Park (NINDS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=63213
882,BC011242-02,"October 01, 2009 -  September 30, 2010",Center for Interventional Oncology,"Bradford J Wood; MD



IRP Faculty Profile",NULL,"Office of the Director, NCI",NULL,"Emad  Boctor
(Johns Hopkins University)




Kevin  Cleary
(Georgetown University)




Thierry  de BaÃ¨re
(Institut de CancÃ©rologie Gustave Roussy)




Mark  Dewhirst
(Duke)




Umar  Mahmood
(Harvard / Massachusetts General Hospital)




Luigi  Solbiati
(Busto Arsizio)


Show all 7","Marybeth S Hughes (Surgery Branch)



Elise C Kohn; MD (Medical Oncology Branch)



Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)



Peter A Pinto; MD (Urologic Oncology Branch)



Crystal L. Mackall; MD (Pediatric Oncology Branch)



Peter L Choyke; MD (Molecular Imaging Program)","Ankur  Kapoor (CC) 



Karun  Sharma (CC) 



Matthew R Dreher; BS, MS, PhD (CC) 



Aradhana M Venkatesan (CC) 



Elliot Brian Levy (CC) 



Nadine  Abi Jaoudeh (CC)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=63476
883,BC011270-01,"October 01, 2009 -  September 30, 2010",Breast Care Research,Giuseppe  Giaccone; MD,NULL,"Medical Oncology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=67601
884,BC011291-01,"October 01, 2009 -  September 30, 2010",Genreal Surgical Pathology,John Carl Oberholtzer,NULL,"Laboratory of Pathology, NCI","Kathleen C Benard



Nancy Ellen Diener



Chyi-Chia Richard Lee



Martha Maria Nicacio Quezado; MD",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=67635
885,BC011317-01,"October 01, 2009 -  September 30, 2010",Dermatology Consultation Service,Edward W Cowen,Mark  Udey; MD,"Dermatology Branch, NCI",Susan L Booher,NULL,"Kristin  Baird (Pediatric Oncology Branch)



Steven  Pavletic; MD, MS (Experimental Transplantation and Immunology Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=67683
886,BC011349-01,"October 01, 2009 -  September 30, 2010",Development of FISH Molecular  Diagnostics to support Clinical Trials at NCI,Svetlana Dmitriyevna Pack; PhD,John Carl Oberholtzer,"Laboratory of Pathology, NCI","Ziedulla  Abdullaev



Maria  Merino; PhD



Maria  Tsokos; MD



Stefania  Pittaluga



Elaine S Jaffe; MD",NULL,"Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=67745
887,SC003800-40,"October 01, 2009 -  September 30, 2010",Surgical Consultants  and  Collaborative Research Involving Surgical Services at,"Steven Aaron Rosenberg; MD, PhD



IRP Faculty Profile",NULL,"Surgery Branch, NCI","Itzhak  Avital



David  Danforth



Marybeth S Hughes



Udai S Kammula



Electron  Kebebew; MD



King F Kwong



Show all 11",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=63571
888,SC006329-30,"October 01, 2009 -  September 30, 2010",Clinical Radiation Physics Service,Robert W Miller,Kevin A Camphausen; MD,"Radiation Oncology Branch, NCI","Barbara Chin Arora



Aradhana  Kaushal



Jason Yulin Cheng; PhD



Karl Erick Haglund



Yeonju Sarah Han-Oh



Frank S Harrington



Show all 13",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=63556
889,SC007202-27,"October 01, 2009 -  September 30, 2010",Biostatistics and Data Management Section,"Seth M Steinberg; PhD



IRP Faculty Profile",William Laurence Dahut; MD,"Office of the Director, NCI","David J Liewehr



David J Venzon; PhD



Wanda  Salzer",NULL,"Giuseppe  Giaccone; MD (Medical Oncology Branch)



Austin Gerard Duffy (Medical Oncology Branch)



Ola Anders Landgren (Medical Oncology Branch)



Heidi H Kong (Dermatology Branch)



Elise C Kohn; MD (Medical Oncology Branch)



Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)",Zenaide Maria Quezado; MD (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=63552
890,SC009394-17,"October 01, 2009 -  September 30, 2010",Diagnostic Electron Microscopy  (EM),Maria  Tsokos; MD,NULL,"Laboratory of Pathology, NCI","Mones S Abu Asab



Sarwat Waqar Siddiqui; MD",NULL,"Phillip A Dennis; MD, PhD (Medical Oncology Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=63597
891,BC010684-06,"October 01, 2009 -  September 30, 2010",Anatomic Pathology Residency Program,"Elaine S Jaffe; MD



IRP Faculty Profile",NULL,"Laboratory of Pathology, NCI","Meghna  Alimchandani; MD



Fatima Zahra Aly; MD, PhD



Constance M Yuan



Michael Andrew Arnold; MD, PhD



John Carl Oberholtzer



Phyu Phyu Aung; MD, PhD



Show all 21",NULL,Magaret G Stetler-Stevenson (Radiation Oncology Branch),NULL,"Ordered by publication type and then author name.



1.
Eberle FC, Mani H, Jaffe ES (2009). Histopathology of Hodgkin's lymphoma. Cancer J  15, 129-37.   https://doi.org/10.1097/PPO.0b013e31819e31cf




PubMed


 


PubMed ID 19390308
    
     


 



2.
Mani H, Climent F, Colomo L, Pittaluga S, Raffeld M, Jaffe ES (2010). Gall bladder and extrahepatic bile duct lymphomas: clinicopathological observations and biological implications. Am J Surg Pathol  34, 1277-86.   https://doi.org/10.1097/PAS.0b013e3181e9bb8b




PubMed



        
     
Free Article


 


PubMed ID 20679881
         Pubmed Central ID 2929270 


 



3.
Mani H, Jaffe ES (2009). Hodgkin lymphoma: an update on its biology with new insights into classification. Clin Lymphoma Myeloma  9, 206-16.   https://doi.org/10.3816/CLM.2009.n.042




PubMed



        
     
Free Article


 


PubMed ID 19525189
         Pubmed Central ID 2806063 


 



4.
Rizzo KA, Streubel B, Pittaluga S, Chott A, Xi L, Raffeld M, Jaffe ES (2010). Marginal zone lymphomas in children and the young adult population; characterization of genetic aberrations by FISH and RT-PCR. Mod Pathol  23, 866-73.   https://doi.org/10.1038/modpathol.2010.63




PubMed



        
     
Free Article


 


PubMed ID 20305621
         Pubmed Central ID 6329460",https://intramural.nih.gov/search/searchview.taf?ipid=63024
892,BC010764-05,"October 01, 2009 -  September 30, 2010",Pediatric Oncology Branch Clinical Care and Education,Alan S Wayne; MD,Crystal L. Mackall; MD,"Pediatric Oncology Branch, NCI","Colleen Elizabeth Annesley



Hema  Dave



Sherri L Depollar



Joanne A Derdak



Calvin Ka Yin Lee; MD



Ashley Taylor-King Munchel; MD



Show all 21","James F Casella; MD
(The Johns Hopkins University School of Medicine)




Kenneth  Cohen
(Pediatric Oncology, Johns Hopkins University)




Ido  Paz-Priel",NULL,NULL,"Ordered by publication type and then author name.



1.
Baird K, Wayne AS (2009). Extracorporeal photo-apheresis for the treatment of steroid-resistant graft versus host disease. Transfus Apher Sci  41, 209-16.   https://doi.org/10.1016/j.transci.2009.09.007




PubMed



        
     
Free Article


 


PubMed ID 19819186
         Pubmed Central ID 2787192 


 



2.
Bishop MR, Alyea EP, Cairo MS, Falkenburg JH, June CH, Kröger N, Little RF, Miller JS, Pavletic SZ, Porter D, Riddell SR, van Besien K, Wayne AS, Weisdorf DJ, Wu R, Giralt S (2010). Introduction to the reports from the National Cancer Institute First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant  16, 563-4.   https://doi.org/10.1016/j.bbmt.2010.02.025




PubMed



        
     
Free Article


 


PubMed ID 20202482
         Pubmed Central ID 2996879 


 



3.
Capitini CM, Mackall CL, Wayne AS (2010). Immune-based therapeutics for pediatric cancer. Expert Opin Biol Ther  10, 163-78.   https://doi.org/10.1517/14712590903431022




PubMed



        
     
Free Article


 


PubMed ID 19947897
         Pubmed Central ID 2809805 


 



4.
Dunleavy K, Little RF, Pittaluga S, Grant N, Wayne AS, Carrasquillo JA, Steinberg SM, Yarchoan R, Jaffe ES, Wilson WH (2010). The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphoma. Blood  115, 3017-24.   https://doi.org/10.1182/blood-2009-11-253039




PubMed



        
     
Free Article


 


PubMed ID 20130244
         Pubmed Central ID 2858473 


 



5.
El-Mallawany NK, Geller L, Bollard CM, Wistinghausen B, Mussai F, Wayne AS, Alobeid B, Cairo MS (2011). Long-term remission in a child with refractory EBV(+) hydroa vacciniforme-like T-cell lymphoma through sequential matched EBV(+)-related allogeneic hematopoietic SCT followed by donor-derived EBV-specific cytotoxic T-lymphocyte immunotherapy. Bone Marrow Transplant  46, 759-61.   https://doi.org/10.1038/bmt.2010.176




PubMed



        
     
Free Article


 


PubMed ID 20661233
         Pubmed Central ID 3175617 


 



6.
Jegalian AG, Buxbaum NP, Facchetti F, Raffeld M, Pittaluga S, Wayne AS, Jaffe ES (2010). Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications. Haematologica  95, 1873-9.   https://doi.org/10.3324/haematol.2010.026179




PubMed



        
     
Free Article


 


PubMed ID 20663945
         Pubmed Central ID 2966909 


 



7.
Kröger N, Bacher U, Bader P, Böttcher S, Borowitz MJ, Dreger P, Khouri I, Macapinlac HA, Macapintac H, Olavarria E, Radich J, Stock W, Vose JM, Weisdorf D, Willasch A, Giralt S, Bishop MR, Wayne AS (2010). NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse following Allogeneic Stem Cell Transplantation. Part I: Methods, acute leukemias, and myelodysplastic syndromes. Biol Blood Marrow Transplant  16, 1187-211.   https://doi.org/10.1016/j.bbmt.2010.06.008




PubMed


 


PubMed ID 20558311
    
     


 



8.
Kröger N, Bacher U, Bader P, Böttcher S, Borowitz MJ, Dreger P, Khouri I, Olavarria E, Radich J, Stock W, Vose JM, Weisdorf D, Willasch A, Giralt S, Bishop MR, Wayne AS (2010). NCI first international workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on disease-specific methods and strategies for monitoring relapse following allogeneic stem cell transplantation. part II: chronic leukemias, myeloproliferative neoplasms, and lymphoid malignancies. Biol Blood Marrow Transplant  16, 1325-46.   https://doi.org/10.1016/j.bbmt.2010.07.001




PubMed


 


PubMed ID 20637879
    
     


 



9.
Porter DL, Alyea EP, Antin JH, DeLima M, Estey E, Falkenburg JH, Hardy N, Kroeger N, Leis J, Levine J, Maloney DG, Peggs K, Rowe JM, Wayne AS, Giralt S, Bishop MR, van Besien K (2010). NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant  16, 1467-503.   https://doi.org/10.1016/j.bbmt.2010.08.001




PubMed



        
     
Free Article


 


PubMed ID 20699125
         Pubmed Central ID 2955517 


 



10.
Raygada M, Arthur DC, Wayne AS, Rennert OM, Toretsky JA, Stratakis CA (2010). Juvenile xanthogranuloma in a child with previously unsuspected neurofibromatosis type 1 and juvenile myelomonocytic leukemia. Pediatr Blood Cancer  54, 173-5.   https://doi.org/10.1002/pbc.22297




PubMed



        
     
Free Article


 


PubMed ID 19785027
         Pubmed Central ID 2783853 


 



11.
Wayne AS, Baird K, Egeler RM (2010). Hematopoietic stem cell transplantation for leukemia. Pediatr Clin North Am  57, 1-25.   https://doi.org/10.1016/j.pcl.2009.11.005




PubMed



        
     
Free Article


 


PubMed ID 20307709
         Pubmed Central ID 2913522 


 



12.
Wayne AS, Capitini CM, Mackall CL (2010). Immunotherapy of childhood cancer: from biologic understanding to clinical application. Curr Opin Pediatr  22, 2-11.   https://doi.org/10.1097/MOP.0b013e3283350d3e




PubMed



        
     
Free Article


 


PubMed ID 19952749
         Pubmed Central ID 2845444 


 



13.
Wayne AS, Kreitman RJ, Findley HW, Lew G, Delbrook C, Steinberg SM, Stetler-Stevenson M, Fitzgerald DJ, Pastan I (2010). Anti-CD22 immunotoxin RFB4(dsFv)-PE38 (BL22) for CD22-positive hematologic malignancies of childhood: preclinical studies and phase I clinical trial. Clin Cancer Res  16, 1894-903.   https://doi.org/10.1158/1078-0432.CCR-09-2980




PubMed



        
     
Free Article


 


PubMed ID 20215554
         Pubmed Central ID 2840067",https://intramural.nih.gov/search/searchview.taf?ipid=63056
893,BC010843-04,"October 01, 2009 -  September 30, 2010",Medical Oncology Fellowship Program,"Antonio  Fojo; MD, PhD",NULL,"Medical Oncology Branch, NCI",Janet A Edds,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63095
894,BC011023-03,"October 01, 2009 -  September 30, 2010",Clinical Fellowship Training Program,Peter A Pinto; MD,William Marston Linehan; MD,"Urologic Oncology Branch, NCI","Compton  Benjamin; MD, PhD



Gopal N Gupta



Kevin Patrick Asher; MD



Eric Curtis Kauffman



Ardeshir Rustom Rastinehad



Brian M Shuch



Show all 10",NULL,"Peter L Choyke; MD (Molecular Imaging Program)



Maria  Merino; PhD (Laboratory of Pathology)



Bradford J Wood; MD (Office of the Director)",NULL,"Ordered by publication type and then author name.



1.
Benhammou JN, Boris RS, Pacak K, Pinto PA, Linehan WM, Bratslavsky G (2010). Functional and oncologic outcomes of partial adrenalectomy for pheochromocytoma in patients with von Hippel-Lindau syndrome after at least 5 years of followup. J Urol  184, 1855-9.   https://doi.org/10.1016/j.juro.2010.06.102




PubMed



               Available in future as a Free Article 


 


PubMed ID 20846682
         Pubmed Central ID 3164541 


 



2.
Singer EA, Bratslavsky G, Linehan WM, Srinivasan R (2010). Targeted therapies for non-clear renal cell carcinoma. Target Oncol  5, 119-29.   https://doi.org/10.1007/s11523-010-0148-3




PubMed



        
     
Free Article


 


PubMed ID 20680492
         Pubmed Central ID 3003336",https://intramural.nih.gov/search/searchview.taf?ipid=63384
895,BC011136-02,"October 01, 2009 -  September 30, 2010",The CCRWalter Reed Army Medical Center (WRAMC) Gynecologic Cancer Program Resear,Elise C Kohn; MD,NULL,"Medical Oncology Branch, NCI","Jasmine  Han; MD



Christina M Annunziata



John H Farley



Tracy J Litzi



Larry  Maxwell



Yovanni  Casablanca; MD","Robert  Bast
(Medicine, MD Anderson Cancer Center)




Andrew  Berchuck
(Gyn Oncology, Duke Univ)




Thomas  Conrads
(University of Pittsburgh Cancer Institute)




Kathleen  Darcy
(Gynecologic Oncology Group)




Anna  Lockshin
(University of Pittsburgh Cancer Institute)




Carl  Morrison
(Roswell Park Cancer Institute)


Show all 8",Barbara V Vonderhaar; PhD (Mammary Biology and Tumorigenesis Laboratory),NULL,"Ordered by publication type and then author name.



1.
Farley JH, Tian C, Rose GS, Brown CL, Birrer M, Maxwell GL (2009) Race does not impact outcome for advanced ovarian cancer patients treated with cisplatin/paclitaxel: an analysis of Gynecologic Oncology Group trials. Cancer 115:4210-7.




PubMed



        
     
Free Article


 


PubMed ID 19536873
         Pubmed Central ID 4459778 


 



2.
Farley JH, Tian C, Rose GS, Brown CL, Birrer M, Risinger JI, Thigpen JT, Fleming GF, Gallion HH, Maxwell GL (2010) Chemotherapy intensity and toxicity among black and white women with advanced and recurrent endometrial cancer: a Gynecologic Oncology Group Study. Cancer 116:355-61.




PubMed



        
     
Free Article


 


PubMed ID 19924790
         Pubmed Central ID 2811766 


 



3.
Krivak TC, Tian C, Rose GS, Armstrong DK, Maxwell GL (2009) A Gynecologic Oncology Group Study of serum CA-125 levels in patients with stage III optimally debulked ovarian cancer treated with intraperitoneal compared to intravenous chemotherapy: an analysis of patients enrolled in GOG 172. Gynecol Oncol 115:81-5.




PubMed



        
     
Free Article


 


PubMed ID 19596139
         Pubmed Central ID 4380179 


 



4.
Levina VV, Nolen B, Su Y, Godwin AK, Fishman D, Liu J, Mor G, Maxwell LG, Herberman RB, Szczepanski MJ, Szajnik ME, Gorelik E, Lokshin AE (2009) Biological significance of prolactin in gynecologic cancers. Cancer Res 69:5226-33.




PubMed



        
     
Free Article


 


PubMed ID 19491263
         Pubmed Central ID 2918393 


 



5.
Zhu K, Devesa SS, Wu H, Zahm SH, Jatoi I, Anderson WF, Peoples GE, Maxwell LG, Granger E, Potter JF, McGlynn KA (2009). Cancer incidence in the U.S. military population: comparison with rates from the SEER program. Cancer Epidemiol Biomarkers Prev  18, 1740-5.   https://doi.org/10.1158/1055-9965.EPI-09-0041




PubMed



        
     
Free Article


 


PubMed ID 19505907
         Pubmed Central ID 2780333",https://intramural.nih.gov/search/searchview.taf?ipid=62750
896,BC011241-02,"October 01, 2009 -  September 30, 2010",Hematopathology Fellowship,"Elaine S Jaffe; MD



IRP Faculty Profile",NULL,"Laboratory of Pathology, NCI","Theresa M Davies Hill



Qingyan  Liu



Constance M Yuan



Stefania  Pittaluga



Mark  Raffeld; MD



Haipeng  Shao; MD



Show all 9","Emily  Howard
(Children's National Medical Center)




Donald  Karcher
(George Washington University Medical Center)",Magaret G Stetler-Stevenson (Radiation Oncology Branch),"Katherine Rainsford Calvo (CC) 



Pierre  Noel (CC) 



Thomas Arthur Fleisher; MD (CC) 



Irina  Maric; MD (CC)","Ordered by publication type and then author name.



1.
Dojcinov SD, Venkataraman G, Raffeld M, Pittaluga S, Jaffe ES (2010). EBV positive mucocutaneous ulcer--a study of 26 cases associated with various sources of immunosuppression. Am J Surg Pathol  34, 405-17.   https://doi.org/10.1097/PAS.0b013e3181cf8622




PubMed



        
     
Free Article


 


PubMed ID 20154586
         Pubmed Central ID 6437677 


 



2.
Eberle FC, Mani H, Jaffe ES (2009). Histopathology of Hodgkin's lymphoma. Cancer J  15, 129-37.   https://doi.org/10.1097/PPO.0b013e31819e31cf




PubMed


 


PubMed ID 19390308
    
     


 



3.
Jegalian AG, Buxbaum NP, Facchetti F, Raffeld M, Pittaluga S, Wayne AS, Jaffe ES (2010). Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications. Haematologica  95, 1873-9.   https://doi.org/10.3324/haematol.2010.026179




PubMed



        
     
Free Article


 


PubMed ID 20663945
         Pubmed Central ID 2966909 


 



4.
Jegalian AG, Facchetti F, Jaffe ES (2009). Plasmacytoid dendritic cells: physiologic roles and pathologic states. Adv Anat Pathol  16, 392-404.   https://doi.org/10.1097/PAP.0b013e3181bb6bc2




PubMed



        
     
Free Article


 


PubMed ID 19851130
         Pubmed Central ID 6329307 


 



5.
Mani H, Climent F, Colomo L, Pittaluga S, Raffeld M, Jaffe ES (2010). Gall bladder and extrahepatic bile duct lymphomas: clinicopathological observations and biological implications. Am J Surg Pathol  34, 1277-86.   https://doi.org/10.1097/PAS.0b013e3181e9bb8b




PubMed



        
     
Free Article


 


PubMed ID 20679881
         Pubmed Central ID 2929270 


 



6.
Mani H, Jaffe ES (2009). Hodgkin lymphoma: an update on its biology with new insights into classification. Clin Lymphoma Myeloma  9, 206-16.   https://doi.org/10.3816/CLM.2009.n.042




PubMed



        
     
Free Article


 


PubMed ID 19525189
         Pubmed Central ID 2806063 


 



7.
Morovic A, Jaffe ES, Raffeld M, Schrager JA (2009). Metachronous EBV-associated B-cell and T-cell posttransplant lymphoproliferative disorders in a heart transplant recipient. Am J Surg Pathol  33, 149-54.   https://doi.org/10.1097/PAS.0b013e318181a826




PubMed



        
     
Free Article


 


PubMed ID 18941401
         Pubmed Central ID 6324846 


 



8.
Ouansafi I, Bell S, Jaffe ES (2010). Adrenal Hodgkin lymphoma. Br J Haematol  148, 341.   https://doi.org/10.1111/j.1365-2141.2009.07776.x




PubMed


 


PubMed ID 19563514
    
     


 



9.
Rizzo KA, Streubel B, Pittaluga S, Chott A, Xi L, Raffeld M, Jaffe ES (2010). Marginal zone lymphomas in children and the young adult population; characterization of genetic aberrations by FISH and RT-PCR. Mod Pathol  23, 866-73.   https://doi.org/10.1038/modpathol.2010.63




PubMed



        
     
Free Article


 


PubMed ID 20305621
         Pubmed Central ID 6329460 


 



10.
Taddesse-Heath L, Meloni-Ehrig A, Scheerle J, Kelly JC, Jaffe ES (2010). Plasmablastic lymphoma with MYC translocation: evidence for a common pathway in the generation of plasmablastic features. Mod Pathol  23, 991-9.   https://doi.org/10.1038/modpathol.2010.72




PubMed



        
     
Free Article


 


PubMed ID 20348882
         Pubmed Central ID 6344124 


 



11.
Vanan I, Redner A, Atlas M, Marin L, Kadkade P, Bandovic J, Jaffe ES (2009). Solitary extramedullary plasmacytoma of the vocal cord in an adolescent. J Clin Oncol  27, e244-7.   https://doi.org/10.1200/JCO.2009.23.7461




PubMed



        
     
Free Article


 


PubMed ID 19858382
         Pubmed Central ID 6340145 


 



12.
Venkataraman G, McClain KL, Pittaluga S, Rao VK, Jaffe ES (2010). Development of disseminated histiocytic sarcoma in a patient with autoimmune lymphoproliferative syndrome and associated Rosai-Dorfman disease. Am J Surg Pathol  34, 589-94.   https://doi.org/10.1097/PAS.0b013e3181d5ddf8




PubMed



        
     
Free Article


 


PubMed ID 20216376
         Pubmed Central ID 2861546",https://intramural.nih.gov/search/searchview.taf?ipid=63426
897,BC011271-01,"October 01, 2009 -  September 30, 2010",Developmental Therapeutics Clinic,Giuseppe  Giaccone; MD,NULL,"Medical Oncology Branch, NCI","Yvonne R Horneffer



Shivaani  Kummar; PhD



Agnes T Strassberger



Lamin  Juwara",NULL,James Halpern Doroshow (Developmental Therapeutics Branch),NULL,"Ordered by publication type and then author name.



1.
Kummar S, Doroshow JH, Tomaszewski JE, Calvert AH, Lobbezoo M, Giaccone G, Task Force on Methodology for the Development of Innovative Cancer Therapies (MDICT) (2009). Phase 0 clinical trials: recommendations from the Task Force on Methodology for the Development of Innovative Cancer Therapies. Eur J Cancer  45, 741-6.   https://doi.org/10.1016/j.ejca.2008.10.024




PubMed



        
     
Free Article


 


PubMed ID 19091546
         Pubmed Central ID 2902269",https://intramural.nih.gov/search/searchview.taf?ipid=67603
898,SC000853-57,"October 01, 2009 -  September 30, 2010",Translational Surgical Pathology,"Maria  Merino; PhD



IRP Faculty Profile",NULL,"Laboratory of Pathology, NCI",Christine Margaret Reaver,NULL,"Peter L Choyke; MD (Molecular Imaging Program)



William Marston Linehan; MD (Urologic Oncology Branch)



Antonio  Fojo; MD, PhD (Medical Oncology Branch)","Karel  Pacak; MD, PhD (NICHD)","Ordered by publication type and then author name.



1.
Linehan WM, Pinto PA, Bratslavsky G, Pfaffenroth E, Merino M, Vocke CD, Toro JR, Bottaro D, Neckers L, Schmidt LS, Srinivasan R (2009). Hereditary kidney cancer: unique opportunity for disease-based therapy. Cancer  115, 2252-61.   https://doi.org/10.1002/cncr.24230




PubMed



        
     
Free Article


 


PubMed ID 19402075
         Pubmed Central ID 2720093 


 



2.
Shah V, Pohida T, Turkbey B, Mani H, Merino M, Pinto PA, Choyke P, Bernardo M (2009). A method for correlating in vivo prostate magnetic resonance imaging and histopathology using individualized magnetic resonance-based molds. Rev Sci Instrum  80, 104301.   https://doi.org/10.1063/1.3242697




PubMed



        
     
Free Article


 


PubMed ID 19895076
         Pubmed Central ID 2774342 


 



3.
Stratton P, Levens ED, Hartog B, Piquion J, Wei Q, Merino M, Nieman LK (2010). Endometrial effects of a single early luteal dose of the selective progesterone receptor modulator CDB-2914. Fertil Steril  93, 2035-41.   https://doi.org/10.1016/j.fertnstert.2008.12.057




PubMed



        
     
Free Article


 


PubMed ID 19200989
         Pubmed Central ID 2911236 


 



4.
Turkbey B, Xu S, Kruecker J, Locklin J, Pang Y, Bernardo M, Merino MJ, Wood BJ, Choyke PL, Pinto PA (2011). Documenting the location of prostate biopsies with image fusion. BJU Int  107, 53-7.   https://doi.org/10.1111/j.1464-410X.2010.09483.x




PubMed



        
     
Free Article


 


PubMed ID 20590543
         Pubmed Central ID 3272674 


 



5.
Wagner M, Browne HN, Marston Linehan W, Merino M, Babar N, Stratton P (2010). Lipid cell tumors in two women with von Hippel-Lindau syndrome. Obstet Gynecol  116 Suppl 2, 535-9.   https://doi.org/10.1097/AOG.0b013e3181e25458




PubMed



        
     
Free Article


 


PubMed ID 20664446
         Pubmed Central ID 2940121",https://intramural.nih.gov/search/searchview.taf?ipid=63566
899,BC010569-07,"October 01, 2009 -  September 30, 2010",Comparative Oncology Program,Chand  Khanna; MD,Crystal L. Mackall; MD,"Pediatric Oncology Branch, NCI","Christina  Mazcko



Melissa C Paoloni



Anita C Epps



Lee Jay Helman; MD","Laurence  Baker
(SARC)




Lisa  Barber
(Veterinary Medicine, Tufts University)




Philip  Bergman
(Veterinary Medicine, The Animal Medical Center)




Matthew  Breen; PhD
(Veterinary Medicine, North Carolina State University)




Jeff  Bryan
(Washington State University)




Timothy  Fan
(Veterinary Clinical Medicine, University of Illinois)


Show all 34","Timothy D Veenstra (Office Of The Director)



Paul S Meltzer; MD, PhD (Cancer Genetics Branch)



Caryn  Steakley; BA, BSN, MSW (Office of the Director)



Stephen M Hewitt; MD, PhD (Laboratory of Pathology)



Joseph E Tomaszewski (Office of the Director)",Elaine A Ostrander; PhD (NHGRI),"Ordered by publication type and then author name.



1.
Gordon I, Paoloni M, Mazcko C, Khanna C (2009). The Comparative Oncology Trials Consortium: using spontaneously occurring cancers in dogs to inform the cancer drug development pathway. PLoS Med  6, e1000161.   https://doi.org/10.1371/journal.pmed.1000161




PubMed



        
     
Free Article


 


PubMed ID 19823573
         Pubmed Central ID 2753665 


 



2.
Khanna C, Gordon I (2009). Catching cancer by the tail: new perspectives on the use of kinase inhibitors. Clin Cancer Res  15, 3645-7.   https://doi.org/10.1158/1078-0432.CCR-09-0132




PubMed


 


PubMed ID 19470723
    
     


 



3.
Khanna C, London C, Vail D, Mazcko C, Hirschfeld S (2009). Guiding the optimal translation of new cancer treatments from canine to human cancer patients. Clin Cancer Res  15, 5671-7.   https://doi.org/10.1158/1078-0432.CCR-09-0719




PubMed



        
     
Free Article


 


PubMed ID 19737961
         Pubmed Central ID 2748812 


 



4.
Paoloni M, Davis S, Lana S, Withrow S, Sangiorgi L, Picci P, Hewitt S, Triche T, Meltzer P, Khanna C (2009). Canine tumor cross-species genomics uncovers targets linked to osteosarcoma progression. BMC Genomics  10, 625.   https://doi.org/10.1186/1471-2164-10-625




PubMed



        
     
Free Article


 


PubMed ID 20028558
         Pubmed Central ID 2803201 


 



5.
Paoloni MC, Tandle A, Mazcko C, Hanna E, Kachala S, Leblanc A, Newman S, Vail D, Henry C, Thamm D, Sorenmo K, Hajitou A, Pasqualini R, Arap W, Khanna C, Libutti SK (2009). Launching a novel preclinical infrastructure: comparative oncology trials consortium directed therapeutic targeting of TNFalpha to cancer vasculature. PLoS One  4, e4972.   https://doi.org/10.1371/journal.pone.0004972




PubMed



        
     
Free Article


 


PubMed ID 19330034
         Pubmed Central ID 2659423 


 



6.
Phillips B, Powers BE, Dernell WS, Straw RC, Khanna C, Hogge GS, Vail DM (2009). Use of single-agent carboplatin as adjuvant or neoadjuvant therapy in conjunction with amputation for appendicular osteosarcoma in dogs. J Am Anim Hosp Assoc  45, 33-8.   https://doi.org/10.5326/0450033




PubMed


 


PubMed ID 19122062",https://intramural.nih.gov/search/searchview.taf?ipid=62996
900,BC010856-04,"October 01, 2009 -  September 30, 2010",Basic and Preclinical Animal Models in support of Cancer and HIVAIDS Research,Mary C Custer,Robert  Wiltrout; PhD,"Office of the Director, NCI",NULL,NULL,NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=63149
901,BC010931-03,"October 01, 2009 -  September 30, 2010",Comparative Biomedical Scientist Training Program,"Robert Mark Simpson; DVM, PhD",Stuart H Yuspa; MD,"Laboratory of Cancer Biology and Genetics, NCI","Laura Jean Baseler



Kara Nichole Corps



Jennifer B Dwyer



Joy Michelle Gary



John  Hickerson



Shelley B Hoover



Show all 13","John M Cullen; VMD, PhD





Margaret  Miller
(Purdue)




Siba  Samal; PhD
(Virginia-Maryland Regional College of Vet Med, University of Maryland)","Kathleen  Kelly; PhD (Laboratory Of Genitourinary Cancer Pathogenesis)



Peter L Choyke; MD (Molecular Imaging Program)



Mark  Raffeld; MD (Laboratory of Pathology)



Giorgio  Trinchieri (Cancer Inflammation Program)



Dennis D Hickstein (Experimental Transplantation and Immunology Branch)



Howard A Fine; MD, PhD (Neuro-Oncology Branch)","Kanta  Subbarao; MD, MPH (NIAID) 



Elisabetta  Mueller (NIDDK) 



Jeffery K Taubenberger; BS, MD, PhD (NIAID)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63262
902,BC010470-08,"October 01, 2009 -  September 30, 2010",Bioinformatic Tools in Cancer Research,Kenneth  Buetow; PhD,NULL,"Laboratory of Population Genetics, NCI","Michael N Edmonson



Richard Phillip Finney



Sharon I Greenblum



Sol  Efroni



Ying  Hu; PhD","TARGET Consortia  NA
(NA)




TCGA Consortia  NA
(NA)




David  Parkinson
(Nodality)","Carl F Schaefer (Cancer Informatics Branch)



Dinah  Singer; PhD (Experimental Immunology Branch)



James Halpern Doroshow (Developmental Therapeutics Branch)",NULL,"Ordered by publication type and then author name.



1.
Braun R, Rowe W, Schaefer C, Zhang J, Buetow K (2009). Needles in the haystack: identifying individuals present in pooled genomic data. PLoS Genet  5, e1000668.   https://doi.org/10.1371/journal.pgen.1000668




PubMed



        
     
Free Article


 


PubMed ID 19798441
         Pubmed Central ID 2747273 


 



2.
Buetow KH, Niederhuber J (2009). Infrastructure for a learning health care system: CaBIG. Health Aff (Millwood)  28, 923-4; author reply 924-5.   https://doi.org/10.1377/hlthaff.28.3.923-a




PubMed


 


PubMed ID 19414908
    
     


 



3.
Madhavan S, Zenklusen JC, Kotliarov Y, Sahni H, Fine HA, Buetow K (2009). Rembrandt: helping personalized medicine become a reality through integrative translational research. Mol Cancer Res  7, 157-67.   https://doi.org/10.1158/1541-7786.MCR-08-0435




PubMed



        
     
Free Article


 


PubMed ID 19208739
         Pubmed Central ID 2645472 


 



4.
MGC Project Team, Temple G, Gerhard DS, Rasooly R, Feingold EA, Good PJ, Robinson C, Mandich A, Derge JG, Lewis J, Shoaf D, Collins FS, Jang W, Wagner L, Shenmen CM, Misquitta L, Schaefer CF, Buetow KH, Bonner TI, Yankie L, Ward M, Phan L, Astashyn A, Brown G, Farrell C, Hart J, et al. [102 more authors] (2009). The completion of the Mammalian Gene Collection (MGC). Genome Res  19, 2324-33.   https://doi.org/10.1101/gr.095976.109




PubMed



        
     
Free Article


 


PubMed ID 19767417
         Pubmed Central ID 2792178 


 



5.
Mullighan CG, Su X, Zhang J, Radtke I, Phillips LA, Miller CB, Ma J, Liu W, Cheng C, Schulman BA, Harvey RC, Chen IM, Clifford RJ, Carroll WL, Reaman G, Bowman WP, Devidas M, Gerhard DS, Yang W, Relling MV, Shurtleff SA, Campana D, Borowitz MJ, Pui CH, Smith M, et al. [4 more authors] (2009) Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med 360:470-80.




PubMed



        
     
Free Article


 


PubMed ID 19129520
         Pubmed Central ID 2674612 


 



6.
Mullighan CG, Zhang J, Harvey RC, Collins-Underwood JR, Schulman BA, Phillips LA, Tasian SK, Loh ML, Su X, Liu W, Devidas M, Atlas SR, Chen IM, Clifford RJ, Gerhard DS, Carroll WL, Reaman GH, Smith M, Downing JR, Hunger SP, Willman CL (2009) JAK mutations in high-risk childhood acute lymphoblastic leukemia. Proc Natl Acad Sci U S A 106:9414-8.




PubMed



        
     
Free Article


 


PubMed ID 19470474
         Pubmed Central ID 2695045 


 



7.
Radtke I, Mullighan CG, Ishii M, Su X, Cheng J, Ma J, Ganti R, Cai Z, Goorha S, Pounds SB, Cao X, Obert C, Armstrong J, Zhang J, Song G, Ribeiro RC, Rubnitz JE, Raimondi SC, Shurtleff SA, Downing JR (2009) Genomic analysis reveals few genetic alterations in pediatric acute myeloid leukemia. Proc Natl Acad Sci U S A 106:12944-9.




PubMed



        
     
Free Article


 


PubMed ID 19651601
         Pubmed Central ID 2716382 


 



8.
Schaefer CF, Anthony K, Krupa S, Buchoff J, Day M, Hannay T, Buetow KH (2009). PID: the Pathway Interaction Database. Nucleic Acids Res  37, D674-9.   https://doi.org/10.1093/nar/gkn653




PubMed



        
     
Free Article


 


PubMed ID 18832364
         Pubmed Central ID 2686461",https://intramural.nih.gov/search/searchview.taf?ipid=62934
903,BC011161-02,"October 01, 2009 -  September 30, 2010",The automated measurement of foci in fluorecence microscopy,"Stuart J Austin



IRP Faculty Profile",NULL,"Cell Cycle Regulation Section, NCI","Therese G Brendler; BS, PhD



Sujatha B Gowda



Manjistha  Sengupta



Brenda L Youngren",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Dabrazhynetskaya A, Brendler T, Ji X, Austin S (2009). Switching protein-DNA recognition specificity by single-amino-acid substitutions in the P1 par family of plasmid partition elements. J Bacteriol  191, 1126-31.   https://doi.org/10.1128/JB.01358-08




PubMed



        
     
Free Article


 


PubMed ID 19028896
         Pubmed Central ID 2632008 


 



2.
Sengupta M, Nielsen HJ, Youngren B, Austin S (2010). P1 plasmid segregation: accurate redistribution by dynamic plasmid pairing and separation. J Bacteriol  192, 1175-83.   https://doi.org/10.1128/JB.01245-09




PubMed



        
     
Free Article


 


PubMed ID 19897644
         Pubmed Central ID 2820840",https://intramural.nih.gov/search/searchview.taf?ipid=63393
904,BC011235-02,"October 01, 2009 -  September 30, 2010",Support of NCI CCR Clinical Research and Bioinformatics,Jeffrey D Shilling,Robert  Wiltrout; PhD,"Office of the Director, NCI","Ave M Cline



Maurice B Edmonds



Susan M Fox



Christopher William Lemieux



Jason Edward Levine



Rohit  Paul



Show all 7",NULL,NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=63455
905,CO020005-02,"October 01, 2009 -  September 30, 2010",caBIG Enterprise,Kenneth  Buetow; PhD,NULL,"Office Of The Director, NCI",NULL,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=63481
906,CP010205-02,"October 01, 2009 -  September 30, 2010",Scientific Computing,"Shelia K Zahm; ScM, ScD",NULL,"Office of the Director, NCI",Karen E Berliner,NULL,"Marianne  Henderson (Office of Division Operations and Analysis)



Sandhya  Xirasagar; PhD (Office of Division Operations and Analysis)



Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)



Margaret Anne Tucker (Human Genetics Program)



Louise  Brinton; PhD (Hormonal and Reproductive Epidemiology Branch)



Stephen J Chanock; MD, PhD (Laboratory Translational Genomics)",NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=63551
907,BC011234-02,"October 01, 2009 -  September 30, 2010",CCR New Space Activation,Darren W Henderson,Robert  Wiltrout; PhD,"Office of the Director, NCI","Darrell  Bell



M Beth Cassell



Gregar D Odegaarden",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=63419
908,CO020002-02,"October 01, 2009 -  September 30, 2010",Space and Facilities Management,"Douglas  Lowy; MD



IRP Faculty Profile",NULL,"National Cancer Institute, NCI",NULL,NULL,NULL,Daryl E Paunil (OD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=63478
909,BC011133-02,"October 01, 2009 -  September 30, 2010",CCR Office of Training and Education,Jonathan S Wiest; PhD,NULL,"Laboratory of Cancer Biology and Genetics, NCI","Viola D Black



Robert Mark Simpson; DVM, PhD



Terry  Moody; PhD",NULL,"Remy J Bosselut; MD, PhD (Laboratory of Immune Cell Biology)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=62752
910,BC011285-01,"October 01, 2009 -  September 30, 2010",CCR Education and Outreach,Kimberly R Martin,Robert  Wiltrout; PhD,"Office of the Director, NCI","Natalie Ann Giannosa; MPH



Donna J Kerrigan",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=67627
911,CP010204-02,"October 01, 2009 -  September 30, 2010","Communications, Education and Outreach","Shelia K Zahm; ScM, ScD",NULL,"Office of the Director, NCI","Catherine B McClave



Jennifer K Loukissas



Alyssa Marie Voss



Wendy  Schneider-Levinson



Saloni  Nayar



May Li-Chi Yu



Show all 7",NULL,"Jackie Ann Lavigne (Office of Education)



Tess  Lee (Epidemiology and Biostatistics Program)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=63550
912,CP010208-01,"October 01, 2009 -  September 30, 2010",Special Studies Institutional Review Board Support,"Shelia K Zahm; ScM, ScD",NULL,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=67763
913,BC010857-04,"October 01, 2009 -  September 30, 2010",Science and Technology Partnerships,David Jay Goldstein,Robert  Wiltrout; PhD,"Office of the Director, NCI","Davida Michelle Bilgrad



Shoshana  Segal",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=63152
914,BC011193-02,"October 01, 2009 -  September 30, 2010",Office of Policy and Intellectual Property,Eric A Hale,Robert  Wiltrout; PhD,"Office of the Director, NCI","Li  Guo



Grace  Yeh; PhD",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=63417
915,CO020001-02,"October 01, 2009 -  September 30, 2010",Technology Transfer Center,"Douglas  Lowy; MD



IRP Faculty Profile",NULL,"National Cancer Institute, NCI",NULL,NULL,Karen M Maurey  (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=63477
